Citrus Sinensis ID: 001238
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1117 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.948 | 0.971 | 0.527 | 0.0 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.888 | 0.870 | 0.491 | 0.0 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.923 | 0.908 | 0.470 | 0.0 | |
| C0LGF5 | 1072 | Probable LRR receptor-lik | no | no | 0.929 | 0.968 | 0.460 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.924 | 0.937 | 0.384 | 0.0 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.920 | 0.914 | 0.381 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.912 | 0.925 | 0.381 | 0.0 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.846 | 0.942 | 0.372 | 1e-170 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.922 | 0.928 | 0.357 | 1e-170 | |
| O65440 | 992 | Leucine-rich repeat recep | no | no | 0.840 | 0.946 | 0.362 | 1e-168 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1076 bits (2782), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 574/1089 (52%), Positives = 766/1089 (70%), Gaps = 29/1089 (2%)
Query: 29 YAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLG 88
+++++QG+ALLSWK S D S+W +D +PC W GV CN +V + L+ +DL G
Sbjct: 23 FSLDQQGQALLSWKSQLNISGDAFSSWHVADTSPCNWVGVKCNRRGEVSEIQLKGMDLQG 82
Query: 89 HVP-TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLR 147
+P T+ SL SL L LS NLTG IPKEI +L LDLS+NSL+G+IP E+ L +
Sbjct: 83 SLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIFRLKK 142
Query: 148 LEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNL 207
L+ L LN+N LEG IP++IGNLS L +L L+DN+L+ IP +IG+LKNL+ +RAGGNKNL
Sbjct: 143 LKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGGNKNL 202
Query: 208 GGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCT 267
G LP EIGNC NLVM+GLAETS+SG LP ++G LKR+QTIAIYT+LLSG IP E+G CT
Sbjct: 203 RGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYCT 262
Query: 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327
ELQ +YLY+N+++GSIP+ +G LK L +L LWQNNLVG IP ELGNC +L +ID S N L
Sbjct: 263 ELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENLL 322
Query: 328 TGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLS 387
TG+IP++ G L +LQELQLSVNQISG IP ++ NC +L +E+DNN ITG IPS NL
Sbjct: 323 TGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNLR 382
Query: 388 NLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNL 447
+LT+ F W N+L G IP S+S C+ L+A+DLS N L+G IP+ IF L+ L KLLLLSN+L
Sbjct: 383 SLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSNDL 442
Query: 448 SGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCR 507
SG IPP++GNC++L R R N N+L G IP EIGNLKNLNF+D+ NRL GSIP I+GC
Sbjct: 443 SGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISGCE 502
Query: 508 NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRF 567
+L FLD+H+NS++G+L G L+F D SDN++ L P +G L+ LTKL L KNR
Sbjct: 503 SLEFLDLHTNSLSGSL-LGTTLPKSLKFIDFSDNALSSTLPPGIGLLTELTKLNLAKNRL 561
Query: 568 AGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGL 627
+G IP ++ +C LQLL+L N SG IP LG+IP+LAI+LNLS N+ GE+P+ + L
Sbjct: 562 SGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRFVGEIPSRFSDL 621
Query: 628 NKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSL 687
LG+LD+SHN+L+G+L+ L +LQNLV LN+S+N+FSG +P+TPFF +LPLS L+ N L
Sbjct: 622 KNLGVLDVSHNQLTGNLNVLTDLQNLVSLNISYNDFSGDLPNTPFFRRLPLSDLASNRGL 681
Query: 688 CFSGNQCADSTYKKDGASRHAGAARVAMVVLLSAACALLLAALYIILGPRIRG--LSGSH 745
S A ST + D +R++ R+ +++L+ L+L A+Y ++ R G L G
Sbjct: 682 YISN---AIST-RPDPTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRARAAGKQLLG-- 735
Query: 746 HNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAV 805
E+++ WE+TLY KLD SI D ++LT+ N+IG G SG+VY++T+PSG ++AV
Sbjct: 736 -----EEID---SWEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRITIPSGESLAV 787
Query: 806 KRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD 865
K+ + ++ +GAF+SEI TL IRHRNIVRLLGW +NR KLLFYDY+PNG+L LH
Sbjct: 788 KKMWSKEE--SGAFNSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHG 845
Query: 866 GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925
G ++W+ R+ + LGVA L+YLHHDC+P I+H DVK+ N+LLG +E LADFGLA
Sbjct: 846 AGKGGCVDWEARYDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLA 905
Query: 926 RLVED--DSGGSFSA---NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKK 980
R + ++G + P AGSYGY+APE+A+M +I+EKSDVYSYGVVLLE++TGK
Sbjct: 906 RTISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVLTGKH 965
Query: 981 PVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRA 1040
P+D P G H+++WVRDHL KKDP +LDP+L G D+ + EMLQ L ++ LC SN+A
Sbjct: 966 PLDPDLPGGAHLVKWVRDHLAEKKDPSRLLDPRLDGRTDSIMHEMLQTLAVAFLCVSNKA 1025
Query: 1041 EDRPTMKDVAALLREIRQEPASGSEAHKPTAAKSTDTASYSSSSVTSAQLLLLQGQGSSH 1100
+RP MKDV A+L EIR SE K K+ S S + ++ GSS+
Sbjct: 1026 NERPLMKDVVAMLTEIRHIDVGRSETEK---IKAGGCGSKEPQQFMSNE-KIINSHGSSN 1081
Query: 1101 CSLAYSSSS 1109
CS A+S S
Sbjct: 1082 CSFAFSDDS 1090
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 969 bits (2504), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/1023 (49%), Positives = 681/1023 (66%), Gaps = 30/1023 (2%)
Query: 54 NWSPSDETPCK-WFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTG 112
NW+ D TPC W ++C+ + +D+ V L +P N + SL +L +SG NLTG
Sbjct: 60 NWNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTG 119
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSL 172
++P+ + L LDLS N L G+IP L L LE L LNSNQL G IP I S L
Sbjct: 120 TLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKL 179
Query: 173 TQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSIS 232
L L+DN LT +IP +GKL LE IR GGNK + G +P EIG+C+NL ++GLAETS+S
Sbjct: 180 KSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVS 239
Query: 233 GFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKN 292
G LP +LG LK+L+T++IYT ++SG+IP +LG+C+EL ++LYEN+L+GSIP ++G L
Sbjct: 240 GNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTK 299
Query: 293 LVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQIS 352
L LFLWQN+LVG IP E+GNCS L +ID+S+N L+GSIP ++G L+ L+E +S N+ S
Sbjct: 300 LEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFS 359
Query: 353 GEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQN 412
G IP I NC L Q++LD NQI+G IPSE G L+ LTL F W N+LEG IPP +++C +
Sbjct: 360 GSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTD 419
Query: 413 LEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT 472
L+A+DLS+N LTG IP G+F L+ L KLLL+SN+LSG IP E+GNCSSL+R R N++T
Sbjct: 420 LQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRIT 479
Query: 473 GFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVR 532
G IP IG+LK +NFLD SNRL G +PDEI C L +D+ +NS+ G+LP + L
Sbjct: 480 GEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSG 539
Query: 533 LQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS 592
LQ D+S N G + LG L SL KL+L+KN F+GSIP+ LG C LQLLDL SN+LS
Sbjct: 540 LQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELS 599
Query: 593 GNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQN 652
G IP+ LG I L IALNLS N++ G++P+++ LNKL ILDLSHN L GDL LA ++N
Sbjct: 600 GEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIEN 659
Query: 653 LVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFSGNQCADSTYKK------DG-AS 705
LV LN+S+N+FSG +PD F +L L GN LC S TY+K DG AS
Sbjct: 660 LVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDAS 719
Query: 706 RHAGAARVAMVVLLSAACALLLAALYIILGPRIRGLSGSHHNEGDEDVEMGPPWELTLYN 765
R +++ ++L A+ +I R + NE D ++ W+ T +
Sbjct: 720 RTRKLRLTLALLITLTVVLMILGAVAVIRARR------NIDNERDSELGETYKWQFTPFQ 773
Query: 766 KLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRF---------RASDKIST 816
KL+ S+ R L N+IG+G SG+VY+ + +G +AVK+ K
Sbjct: 774 KLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVR 833
Query: 817 GAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDT 876
+FS+E+ TL IRH+NIVR LG NR T+LL YDYMPNG+LG LLH+ + L+WD
Sbjct: 834 DSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSS-LDWDL 892
Query: 877 RFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936
R++I LG A+GL+YLHHDC+P I+HRD+K++NIL+G +E +ADFGLA+LV++ G
Sbjct: 893 RYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRC 952
Query: 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWV 996
S AGSYGYIAPEY KI+EKSDVYSYGVV+LE++TGK+P+D + P+G H++ WV
Sbjct: 953 SNT--VAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWV 1010
Query: 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
R + + +EVLD L+ + + EM+Q LG +LLC ++ ++RPTMKDVAA+L+EI
Sbjct: 1011 RQN----RGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEI 1066
Query: 1057 RQE 1059
+QE
Sbjct: 1067 KQE 1069
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 950 bits (2455), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/1071 (47%), Positives = 699/1071 (65%), Gaps = 40/1071 (3%)
Query: 10 YSLILSFVVVIIILFPHTPYAVNRQGEALLSWKRNWKGSDDGL-SNWSPSDETPCKWFGV 68
+S+ LS + F + A + AL+SW + + S W+PSD PC+W +
Sbjct: 18 FSITLSLFLA---FFISSTSASTNEVSALISWLHSSNSPPPSVFSGWNPSDSDPCQWPYI 74
Query: 69 SCNL--NNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNY 126
+C+ N V +++ V L P N +S SL +LV+S TNLTG+I EI ++L
Sbjct: 75 TCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIV 134
Query: 127 LDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAI 186
+DLS NSL GEIP L L L++L LNSN L G IP ++G+ SL L ++DN L++ +
Sbjct: 135 IDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENL 194
Query: 187 PATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQ 246
P +GK+ LE+IRAGGN L G +P EIGNC NL ++GLA T ISG LP +LG L +LQ
Sbjct: 195 PLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQ 254
Query: 247 TIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGI 306
++++Y+ +LSG+IP ELG+C+EL ++LY+N L+G++P +LG L+NL + LWQNNL G
Sbjct: 255 SLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGP 314
Query: 307 IPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLA 366
IP E+G L+ ID+SMN +G+IP++ GNL++LQEL LS N I+G IP+ + NC +L
Sbjct: 315 IPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLV 374
Query: 367 QIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP 426
Q ++D NQI+G IP E G L L + W N+LEG IP ++ CQNL+A+DLSQN LTG
Sbjct: 375 QFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGS 434
Query: 427 IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLN 486
+P G+FQL+ L KLLL+SN +SGVIP E+GNC+SL+R R +N++TG IP IG L+NL+
Sbjct: 435 LPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLS 494
Query: 487 FLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGM 546
FLDL N L+G +P EI+ CR L L++ +N++ G LP L L +LQ D+S N + G
Sbjct: 495 FLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGK 554
Query: 547 LSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALA 606
+ LG L SL +L+L+KN F G IPS LG C LQLLDLSSN +SG IP L I L
Sbjct: 555 IPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLD 614
Query: 607 IALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGR 666
IALNLSWN + G +P ++ LN+L +LD+SHN LSGDL L+ L+NLV LN+SHN FSG
Sbjct: 615 IALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGY 674
Query: 667 VPDTPFFAKLPLSVLSGNPSLCFSG-NQCADSTYKKDGASR--HAGAARVAMVVLLSAAC 723
+PD+ F +L + + GN LC G C S + R H+ R+A+ +L+S
Sbjct: 675 LPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTA 734
Query: 724 AL-LLAALYIILGPRIRGLSGSHHNEGDEDVEMGP---PWELTLYNKLDLSIGDATRSLT 779
L +L L +I ++ D D E G W+ T + KL+ ++ + L
Sbjct: 735 VLAVLGVLAVIRAKQMI--------RDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLV 786
Query: 780 AGNIIGQGRSGIVYKVTLPSGLTVAVKRF----------RASDKISTGAFSSEIATLSRI 829
GN+IG+G SGIVYK +P+ +AVK+ + +FS+E+ TL I
Sbjct: 787 EGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSI 846
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLS 889
RH+NIVR LG N+ T+LL YDYM NG+LG LLH+ L W+ R+KI LG A+GL+
Sbjct: 847 RHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLA 906
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFS-ANPQFAGSYGY 948
YLHHDCVP I+HRD+K++NIL+G +E + DFGLA+LV+D G F+ ++ AGSYGY
Sbjct: 907 YLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDD---GDFARSSNTIAGSYGY 963
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008
IAPEY KI+EKSDVYSYGVV+LE++TGK+P+D + PDG H++ WV+ K ++
Sbjct: 964 IAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVK-----KIRDIQ 1018
Query: 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
V+D LQ P+++++EM+Q LG++LLC + EDRPTMKDVAA+L EI QE
Sbjct: 1019 VIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEICQE 1069
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 819 bits (2115), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/1054 (46%), Positives = 662/1054 (62%), Gaps = 16/1054 (1%)
Query: 30 AVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGH 89
+++ G+ALLS KR S S+W P D+TPC W+G++C+ +N+V+ + + L
Sbjct: 26 SLSSDGQALLSLKR---PSPSLFSSWDPQDQTPCSWYGITCSADNRVISVSIPDTFLNLS 82
Query: 90 VPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLE 149
+ +SL SL L LS TNL+G IP L L LDLS NSL+G IP EL L L+
Sbjct: 83 SIPDLSSLSSLQFLNLSSTNLSGPIPPSFGKLTHLRLLDLSSNSLSGPIPSELGRLSTLQ 142
Query: 150 QLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGG 209
L LN+N+L G+IP QI NL +L L L DN L +IP++ G L +L+ R GGN NLGG
Sbjct: 143 FLILNANKLSGSIPSQISNLFALQVLCLQDNLLNGSIPSSFGSLVSLQQFRLGGNTNLGG 202
Query: 210 SLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTEL 269
+P ++G NL +G A + +SG +P T G L LQT+A+Y +SG IPP+LG C+EL
Sbjct: 203 PIPAQLGFLKNLTTLGFAASGLSGSIPSTFGNLVNLQTLALYDTEISGTIPPQLGLCSEL 262
Query: 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTG 329
+ +YL+ N LTGSIP +LG L+ + +L LW N+L G+IPPE+ NCS L + D+S N LTG
Sbjct: 263 RNLYLHMNKLTGSIPKELGKLQKITSLLLWGNSLSGVIPPEISNCSSLVVFDVSANDLTG 322
Query: 330 SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNL 389
IP LG L L++LQLS N +G+IP ++ NC L ++LD N+++G+IPS+ GNL +L
Sbjct: 323 DIPGDLGKLVWLEQLQLSDNMFTGQIPWELSNCSSLIALQLDKNKLSGSIPSQIGNLKSL 382
Query: 390 TLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSG 449
F+W N + G IP S NC +L A+DLS+N LTG IP +F LK+L+KLLLL N+LSG
Sbjct: 383 QSFFLWENSISGTIPSSFGNCTDLVALDLSRNKLTGRIPEELFSLKRLSKLLLLGNSLSG 442
Query: 450 VIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNL 509
+P + C SL+R R N+L+G IP EIG L+NL FLDL N +G +P EI+ L
Sbjct: 443 GLPKSVAKCQSLVRLRVGENQLSGQIPKEIGELQNLVFLDLYMNHFSGGLPYEISNITVL 502
Query: 510 TFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAG 569
LDVH+N I G++PA L LV L+ DLS NS G + G+LS L KL+LN N G
Sbjct: 503 ELLDVHNNYITGDIPAQLGNLVNLEQLDLSRNSFTGNIPLSFGNLSYLNKLILNNNLLTG 562
Query: 570 SIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNK 629
IP + + KL LLDLS N LSG IP LG++ +L I L+LS+N G +P + L +
Sbjct: 563 QIPKSIKNLQKLTLLDLSYNSLSGEIPQELGQVTSLTINLDLSYNTFTGNIPETFSDLTQ 622
Query: 630 LGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCF 689
L LDLS N L GD+ L L +L LN+S NNFSG +P TPFF + + N +LC
Sbjct: 623 LQSLDLSSNSLHGDIKVLGSLTSLASLNISCNNFSGPIPSTPFFKTISTTSYLQNTNLCH 682
Query: 690 S--GNQCADSTYKKDGASRHAGAARVAMVVLLSAACALLLAALYIILGPRIRGLSGSHHN 747
S G C+ T + +G A A V+L S A+L A L I+ + S + +
Sbjct: 683 SLDGITCSSHTGQNNGVKSPKIVALTA-VILASITIAILAAWLLILRNNHLYKTSQNSSS 741
Query: 748 EGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKR 807
+ PW + KL +++ + SLT N+IG+G SGIVYK +P+G VAVK+
Sbjct: 742 SPSTAEDFSYPWTFIPFQKLGITVNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKK 801
Query: 808 -FRASDKISTG-----AFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGM 861
++ D G +F++EI L IRHRNIV+LLG+ +N+ KLL Y+Y PNG L
Sbjct: 802 LWKTKDNNEEGESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQ 861
Query: 862 LLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921
LL L+W+TR+KIA+G A+GL+YLHHDCVPAILHRDVK +NILL +YE+ LAD
Sbjct: 862 LLQGNRN---LDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILAD 918
Query: 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
FGLA+L+ +S +A + AGSYGYIAPEY I+EKSDVYSYGVVLLEI++G+
Sbjct: 919 FGLAKLMM-NSPNYHNAMSRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSA 977
Query: 982 VDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAE 1041
V+ DG H+++WV+ + + + + VLD KLQG PD +QEMLQ LGI++ C +
Sbjct: 978 VEPQIGDGLHIVEWVKKKMGTFEPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPV 1037
Query: 1042 DRPTMKDVAALLREIRQEPASGSEAHKPTAAKST 1075
+RPTMK+V LL E++ P + +P S+
Sbjct: 1038 ERPTMKEVVTLLMEVKCSPEEWGKTSQPLIKPSS 1071
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 682 bits (1761), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/1092 (38%), Positives = 625/1092 (57%), Gaps = 59/1092 (5%)
Query: 30 AVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCN---LNNQVVGLDLRYVDL 86
+N +G+ LL K + + L NW+ +D PC W GV C+ + +V+ L+L + L
Sbjct: 26 GLNLEGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVL 85
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL 146
G + + L+ L +L LS L+G IPKEI + + L L L+ N GEIP E+ L+
Sbjct: 86 SGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLV 145
Query: 147 RLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKN 206
LE L + +N++ G++P++IGNL SL+QL Y N ++ +P +IG LK L + RAG N
Sbjct: 146 SLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNM- 204
Query: 207 LGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDC 266
+ GSLP EIG C +LVM+GLA+ +SG LP +G+LK+L + ++ SG IP E+ +C
Sbjct: 205 ISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNC 264
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
T L+ + LY+N L G IP +LG+L++L L+L++N L G IP E+GN S ID S N+
Sbjct: 265 TSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENA 324
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNL 386
LTG IP LGN+ L+ L L NQ++G IP ++ + L++++L N +TG IP F L
Sbjct: 325 LTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYL 384
Query: 387 SNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNN 446
L +L ++ N L G IPP + +L +D+S N L+G IP + + L L +NN
Sbjct: 385 RGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNN 444
Query: 447 LSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506
LSG IP + C +L++ R N L G P + N+ ++LG NR GSIP E+ C
Sbjct: 445 LSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNC 504
Query: 507 RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNR 566
L L + N G LP + L +L ++S N + G + ++ + L +L + N
Sbjct: 505 SALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNN 564
Query: 567 FAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGK-----------------IP------ 603
F+G++PS++GS +L+LL LS+N LSG IP +LG IP
Sbjct: 565 FSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSL 624
Query: 604 -ALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDL-HFLAELQNLVVLNVSHN 661
L IALNLS+N++ GE+P EL+ L L L L++N LSG++ A L +L+ N S+N
Sbjct: 625 TGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYN 684
Query: 662 NFSGRVPDTPFFAKLPLSVLSGNPSLCFSG-NQCADST-YKKDGASRHAGAARVAMVVLL 719
+ +G + P + +S GN LC NQC + + ++ G R + ++ +
Sbjct: 685 SLTGPI---PLLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAI 741
Query: 720 SAA----CALLLAALYIILGPR-IRGLSGSHHNEGDEDVEMG---PPWELTLYNKLDLSI 771
+AA +L+L AL + L R +R ++ S + ++ + PP E + L
Sbjct: 742 TAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLV--- 798
Query: 772 GDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIST-----GAFSSEIATL 826
AT + ++G+G G VYK LP+G T+AVK+ ++ + +F +EI TL
Sbjct: 799 -AATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTL 857
Query: 827 SRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE 886
IRHRNIV+L G+ ++ + LL Y+YMP G+LG +LHD C L+W RFKIALG A+
Sbjct: 858 GNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCN--LDWSKRFKIALGAAQ 915
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
GL+YLHHDC P I HRD+KS+NILL +++E+ + DFGLA++++ S SA AGSY
Sbjct: 916 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSA---IAGSY 972
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006
GYIAPEYA K++EKSD+YSYGVVLLE++TGK PV G V+ WVR +++
Sbjct: 973 GYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP-IDQGGDVVNWVRSYIRRDALS 1031
Query: 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEA 1066
VLD +L + + ML L I+LLCTS RP+M+ V +L I E + G +
Sbjct: 1032 SGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML--IESERSEGEQE 1089
Query: 1067 HKPTAAKSTDTA 1078
H T + T
Sbjct: 1090 HLDTEELTQTTT 1101
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 677 bits (1747), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/1094 (38%), Positives = 616/1094 (56%), Gaps = 66/1094 (6%)
Query: 17 VVVIIILFPHTPYAVNRQGEALLSWK-RNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQ 75
V+ ++ L T ++N G+ LL K R ++ S + L NW+ DETPC W GV+C+
Sbjct: 19 VLFLLTLLVWTSESLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGS 78
Query: 76 --------VVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYL 127
V LDL ++L G V + L++L L L+ LTG IP+EI + ++L +
Sbjct: 79 SSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVM 138
Query: 128 DLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIP 187
L+ N G IP E+ L +L + +N+L G +P +IG+L +L +L Y N LT +P
Sbjct: 139 FLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLP 198
Query: 188 ATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQT 247
++G L L RAG N + G++P EIG C NL ++GLA+ ISG LP +G+L +LQ
Sbjct: 199 RSLGNLNKLTTFRAGQN-DFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQE 257
Query: 248 IAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGII 307
+ ++ SG IP ++G+ T L+ + LY N+L G IPS++GN+K+L L+L+QN L G I
Sbjct: 258 VILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTI 317
Query: 308 PPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQ 367
P ELG S++ ID S N L+G IP L ++ L+ L L N+++G IP ++ + LA+
Sbjct: 318 PKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAK 377
Query: 368 IELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPI 427
++L N +TG IP F NL+++ L ++HN L G IP + L VD S+N L+G I
Sbjct: 378 LDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKI 437
Query: 428 PRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNF 487
P I Q L L L SN + G IPP + C SL++ R N+LTG P E+ L NL+
Sbjct: 438 PPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSA 497
Query: 488 LDLGSNRLTGSIPDEITGCR------------------------NLTFLDVHSNSIAGNL 523
++L NR +G +P EI C+ NL +V SNS+ G +
Sbjct: 498 IELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPI 557
Query: 524 PAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQL 583
P+ + LQ DLS NS G L P+LGSL L L L++NRF+G+IP +G+ L
Sbjct: 558 PSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTE 617
Query: 584 LDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGD 643
L + N SG+IP LG + +L IA+NLS+N GE+P E+ L+ L L L++N LSG+
Sbjct: 618 LQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGE 677
Query: 644 LHFLAE-LQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFSGNQCADSTYK-- 700
+ E L +L+ N S+NN +G++P T F + L+ GN LC + D ++
Sbjct: 678 IPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSW 737
Query: 701 ------KDGASRHAGAARVAMVVLLSAACALLLAALYIILGPRIRGLSGSHHNE---GDE 751
K G++R + V+ + L+ ++ + P H E +
Sbjct: 738 PHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQES 797
Query: 752 DVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFR-- 809
D+ P T+ + L +AT+ I+G+G G VYK +PSG T+AVK+
Sbjct: 798 DIYFVPKERFTVKDIL-----EATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESN 852
Query: 810 -----ASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKLLFYDYMPNGTLGML 862
+ + +F +EI TL +IRHRNIVRL + ++ + LL Y+YM G+LG L
Sbjct: 853 REGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGEL 912
Query: 863 LHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADF 922
LH G+ ++W TRF IALG AEGL+YLHHDC P I+HRD+KS+NIL+ E +E+ + DF
Sbjct: 913 LHGGKSHS-MDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDF 971
Query: 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPV 982
GLA++++ S SA AGSYGYIAPEYA K++EK D+YS+GVVLLE++TGK PV
Sbjct: 972 GLAKVIDMPLSKSVSA---VAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPV 1028
Query: 983 DASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL-QGHPDTQIQEMLQALGISLLCTSNRAE 1041
G + W R+H++ E+LDP L + D + M+ I++LCT +
Sbjct: 1029 QP-LEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPS 1087
Query: 1042 DRPTMKDVAALLRE 1055
DRPTM++V +L E
Sbjct: 1088 DRPTMREVVLMLIE 1101
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 677 bits (1746), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/1063 (38%), Positives = 585/1063 (55%), Gaps = 44/1063 (4%)
Query: 30 AVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGH 89
++N +G LL +K S+ L++W+ D PC W G++C V +DL ++L G
Sbjct: 23 SLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHLRTVTSVDLNGMNLSGT 82
Query: 90 VPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLE 149
+ L L +L +S ++G IP++++ L LDL N G IP +L ++ L+
Sbjct: 83 LSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLK 142
Query: 150 QLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGG 209
+L L N L G+IP QIGNLSSL +L +Y N LT IP ++ KL+ L IRAG N G
Sbjct: 143 KLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRN-GFSG 201
Query: 210 SLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTEL 269
+P EI C +L ++GLAE + G LP L L+ L + ++ LSG+IPP +G+ + L
Sbjct: 202 VIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRL 261
Query: 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTG 329
+ + L+EN TGSIP ++G L + L+L+ N L G IP E+GN + ID S N LTG
Sbjct: 262 EVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTG 321
Query: 330 SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNL 389
IP+ G++ +L+ L L N + G IP ++G L +++L N++ G IP E L L
Sbjct: 322 FIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYL 381
Query: 390 TLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSG 449
L ++ N+LEG+IPP I N +D+S N L+GPIP + + L L L SN LSG
Sbjct: 382 VDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSG 441
Query: 450 VIPPEMGNCSSLIRFRANSNKLTGFIPPEI------------------------GNLKNL 485
IP ++ C SL + N+LTG +P E+ G LKNL
Sbjct: 442 NIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNL 501
Query: 486 NFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGG 545
L L +N TG IP EI + ++ SN + G++P L V +Q DLS N G
Sbjct: 502 ERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSG 561
Query: 546 MLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPAL 605
++ +LG L L L L+ NR G IP G +L L L N LS NIP LGK+ +L
Sbjct: 562 YIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSL 621
Query: 606 AIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDL-HFLAELQNLVVLNVSHNNFS 664
I+LN+S N + G +P L L L IL L+ N+LSG++ + L +L++ N+S+NN
Sbjct: 622 QISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLV 681
Query: 665 GRVPDTPFFAKLPLSVLSGNPSLCFSG-NQCADSTYKKDG-------ASRHAGAARVAMV 716
G VPDT F ++ S +GN LC S + C D S+ + +
Sbjct: 682 GTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCI 741
Query: 717 VLLSAACALLLAALYIILGPRIRGLSGSHHNEGDEDVEMGPPWELTLYNKLDLSIGDATR 776
V+ S L + I ++ + D P + Y L DATR
Sbjct: 742 VIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLV----DATR 797
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRF--RASDKISTGAFSSEIATLSRIRHRNI 834
+ + ++G+G G VYK + G +AVK+ R S +F +EI+TL +IRHRNI
Sbjct: 798 NFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNI 857
Query: 835 VRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
V+L G+ ++ + LL Y+YM G+LG L GE LL+W+ R++IALG AEGL YLHHD
Sbjct: 858 VKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHD 917
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
C P I+HRD+KS+NILL ER+++ + DFGLA+L++ S SA AGSYGYIAPEYA
Sbjct: 918 CRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSA---VAGSYGYIAPEYA 974
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
K++EK D+YS+GVVLLE+ITGK PV G ++ WVR +++ +E+ D +L
Sbjct: 975 YTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRSIRNMIPTIEMFDARL 1033
Query: 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057
+ + EM L I+L CTSN RPTM++V A++ E R
Sbjct: 1034 DTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 600 bits (1547), Expect = e-170, Method: Compositional matrix adjust.
Identities = 393/1054 (37%), Positives = 566/1054 (53%), Gaps = 109/1054 (10%)
Query: 36 EALLSWKRNWKGSDDG----LSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVP 91
ALLS K + G+ D LS+W S C W GV+C+++ + HV
Sbjct: 27 RALLSLKTSLTGAGDDKNSPLSSWKVSTSF-CTWIGVTCDVSRR-------------HVT 72
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
+ L LSG NL+G++ +++ L L L L+EN ++
Sbjct: 73 S----------LDLSGLNLSGTLSPDVSHLRLLQNLSLAENLIS---------------- 106
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSL 211
G IP +I +LS L L L +N GS
Sbjct: 107 --------GPIPPEISSLSGLRHLNLSNNVFN-------------------------GSF 133
Query: 212 PHEIGN-CTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQ 270
P EI + NL ++ + +++G LP ++ L +L+ + + +G+IPP G ++
Sbjct: 134 PDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIE 193
Query: 271 YIYLYENALTGSIPSKLGNLKNLVNLFL-WQNNLVGIIPPELGNCSQLSIIDISMNSLTG 329
Y+ + N L G IP ++GNL L L++ + N +PPE+GN S+L D + LTG
Sbjct: 194 YLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTG 253
Query: 330 SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNL 389
IP +G L L L L VN SG + ++G L ++L NN TG IP+ F L NL
Sbjct: 254 EIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNL 313
Query: 390 TLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSG 449
TLL ++ N+L GEIP I + LE + L +N TG IP+ + + KLN + L SN L+G
Sbjct: 314 TLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTG 373
Query: 450 VIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNL 509
+PP M + + L N L G IP +G ++L + +G N L GSIP + G L
Sbjct: 374 TLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKL 433
Query: 510 TFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAG 569
T +++ N ++G LP V L LS+N + G L P +G+ + + KL+L+ N+F G
Sbjct: 434 TQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQG 493
Query: 570 SIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNK 629
IPS++G +L +D S N SG I + + L ++LS N++ GE+P E+T +
Sbjct: 494 PIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTF-VDLSRNELSGEIPNEITAMKI 552
Query: 630 LGILDLSHNELSGDL-HFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLC 688
L L+LS N L G + ++ +Q+L L+ S+NN SG VP T F+ + GNP LC
Sbjct: 553 LNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLC 612
Query: 689 --FSGNQCADSTYKKDGASRHAGAARVAM---VVLLSAACALLLAALYIILGPRIRGLSG 743
+ G C D K S G +M +VL C++ A + II ++ S
Sbjct: 613 GPYLG-PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASE 671
Query: 744 SHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTV 803
S W LT + +LD + D SL NIIG+G +GIVYK +P+G V
Sbjct: 672 SR------------AWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLV 719
Query: 804 AVKRFRASDKISTG--AFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGM 861
AVKR A + S+ F++EI TL RIRHR+IVRLLG+ +N +T LL Y+YMPNG+LG
Sbjct: 720 AVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGE 779
Query: 862 LLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921
+LH G+ G L WDTR+KIAL A+GL YLHHDC P I+HRDVKS+NILL +E+ +AD
Sbjct: 780 VLH-GKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVAD 838
Query: 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
FGLA+ ++D G+ AGSYGYIAPEYA K+ EKSDVYS+GVVLLE++TG+KP
Sbjct: 839 FGLAKFLQDS--GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKP 896
Query: 982 VDASFPDGQHVIQWVRDHLKSKKDPV-EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRA 1040
V F DG ++QWVR S KD V +VLDP+L P I E+ +++LC +A
Sbjct: 897 V-GEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIP---IHEVTHVFYVAMLCVEEQA 952
Query: 1041 EDRPTMKDVAALLREIRQEPASGSEAHKPTAAKS 1074
+RPTM++V +L EI + P S + +A +S
Sbjct: 953 VERPTMREVVQILTEIPKLPPSKDQPMTESAPES 986
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 598 bits (1543), Expect = e-170, Method: Compositional matrix adjust.
Identities = 394/1102 (35%), Positives = 574/1102 (52%), Gaps = 72/1102 (6%)
Query: 26 HTPYAVNRQGEALLSWKRNWKG-SDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYV 84
+ +A+N G ALLS R+W D +W+ SD TPC W GV C+ V L+L
Sbjct: 19 YAAFALNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCSWLGVECDRRQFVDTLNLSSY 78
Query: 85 DLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIP----- 139
+ G + L L ++VLSG GSIP ++ + + L ++DLS NS TG IP
Sbjct: 79 GISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGA 138
Query: 140 -------------------RELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDN 180
L S+ LE + N L G+IP IGN+S LT L+L DN
Sbjct: 139 LQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDN 198
Query: 181 QLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLG 240
Q + +P+++G + L+ + N NL G+LP + N NLV + + S+ G +P
Sbjct: 199 QFSGPVPSSLGNITTLQELYLNDN-NLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFV 257
Query: 241 LLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQ 300
K++ TI++ +G +PP LG+CT L+ + AL+G IPS G L L L+L
Sbjct: 258 SCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAG 317
Query: 301 NNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIG 360
N+ G IPPELG C + + + N L G IP LG L+ LQ L L N +SGE+P I
Sbjct: 318 NHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIW 377
Query: 361 NCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQ 420
Q L ++L N ++G +P + L L L ++ N G IP + +LE +DL++
Sbjct: 378 KIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTR 437
Query: 421 NGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIG 480
N TG IP + KKL +LLL N L G +P ++G CS+L R N L G +P +
Sbjct: 438 NMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLPDFVE 497
Query: 481 NLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSD 540
+NL F DL N TG IP + +N+T + + SN ++G++P L LV+L+ +LS
Sbjct: 498 K-QNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSH 556
Query: 541 NSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASL- 599
N + G+L +L + L++L + N GSIPS LGS +L L L N SG IP SL
Sbjct: 557 NILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLF 616
Query: 600 ----------------GKIPALAI-----ALNLSWNQICGELPAELTGLNKLGILDLSHN 638
G IP + +LNLS N++ G+LP +L L L LD+SHN
Sbjct: 617 QSNKLLNLQLGGNLLAGDIPPVGALQALRSLNLSSNKLNGQLPIDLGKLKMLEELDVSHN 676
Query: 639 ELSGDLHFLAELQNLVVLNVSHNNFSGRVPD--TPFFAKLPLSVLSGNPSLCFS----GN 692
LSG L L+ +Q+L +N+SHN FSG VP T F P S SGN LC + G
Sbjct: 677 NLSGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTS-FSGNSDLCINCPADGL 735
Query: 693 QCADSTY-KKDGASRHAGAARVAMVVLLSAACALLLAALYIILGPRIRGLSGSHHNEGDE 751
C +S+ + + G ++ L A +L A L+II H + +
Sbjct: 736 ACPESSILRPCNMQSNTGKGGLST---LGIAMIVLGALLFIICLFLFSAFLFLHCKKSVQ 792
Query: 752 DVEM-GPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRA 810
++ + + +L NK + +AT +L +IG+G G +YK TL AVK+
Sbjct: 793 EIAISAQEGDGSLLNK----VLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVF 848
Query: 811 SDKISTGAFS--SEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGEC 868
+ I G+ S EI T+ ++RHRN+++L + ++ L+ Y YM NG+L +LH+
Sbjct: 849 TG-IKNGSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNP 907
Query: 869 AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928
L+W TR IA+G A GL+YLH DC PAI+HRD+K NILL E ++DFG+A+L+
Sbjct: 908 PKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLL 967
Query: 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD 988
D S S +N G+ GY+APE A T S +SDVYSYGVVLLE+IT KK +D SF
Sbjct: 968 -DQSATSIPSN-TVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNG 1025
Query: 989 GQHVIQWVRDHLKSKKDPVEVLDPKLQGH--PDTQIQEMLQALGISLLCTSNRAEDRPTM 1046
++ WVR + +++DP L + ++++ +AL ++L C + RPTM
Sbjct: 1026 ETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAEKEVDKRPTM 1085
Query: 1047 KDVAALLREIRQEPASGSEAHK 1068
+DV L S S +K
Sbjct: 1086 RDVVKQLTRWSIRSYSSSVRNK 1107
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 594 bits (1531), Expect = e-168, Method: Compositional matrix adjust.
Identities = 378/1043 (36%), Positives = 555/1043 (53%), Gaps = 104/1043 (9%)
Query: 33 RQGEALLSWKRNWKGSDDGLSNWS-PSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVP 91
RQ L+S K+++ D L +W+ P+ + C W GVSC+ NQ
Sbjct: 33 RQANVLISLKQSFDSYDPSLDSWNIPNFNSLCSWTGVSCDNLNQ---------------- 76
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLN-QLNYLDLSENSLTGEIPRELCSLLRLEQ 150
S+ RL LS N++G+I EI+ L+ L +LD+S NS +GE+P+E+ L LE
Sbjct: 77 -------SITRLDLSNLNISGTISPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEV 129
Query: 151 LRLNSNQLEGAIPIQ-IGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGG 209
L ++SN EG + + ++ L L YDN ++P ++ L LE + GGN G
Sbjct: 130 LNISSNVFEGELETRGFSQMTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNY-FDG 188
Query: 210 SLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTEL 269
+P G+ +L + L+ L G+IP EL + T L
Sbjct: 189 EIPRSYGSFLSLKFLSLSGND------------------------LRGRIPNELANITTL 224
Query: 270 QYIYL-YENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLT 328
+YL Y N G IP+ G L NLV+L L +L G IP ELGN L ++ + N LT
Sbjct: 225 VQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELGNLKNLEVLFLQTNELT 284
Query: 329 GSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSN 388
GS+P+ LGN+TSL+ L LS N + GEIP ++ Q+L L N++ G IP L +
Sbjct: 285 GSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNRLHGEIPEFVSELPD 344
Query: 389 LTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLS 448
L +L +WHN G+IP + + NL +DLS N LTG IP + ++L L+L +N L
Sbjct: 345 LQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCFGRRLKILILFNNFLF 404
Query: 449 GVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITG--- 505
G +P ++G C L RFR N LT +P + L NL+ L+L +N LTG IP+E G
Sbjct: 405 GPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNFLTGEIPEEEAGNAQ 464
Query: 506 CRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKN 565
+LT +++ +N ++G +P + L LQ L N + G + ++GSL SL K+ +++N
Sbjct: 465 FSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEIGSLKSLLKIDMSRN 524
Query: 566 RFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELT 625
F+G P + G C+ L LDLS NQ+SG IP + +I L LN+SWN LP EL
Sbjct: 525 NFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNY-LNVSWNSFNQSLPNEL- 582
Query: 626 GLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNP 685
+++L + SHNNFSG VP + F+ + GNP
Sbjct: 583 ----------------------GYMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNP 620
Query: 686 SLC-FSGNQCADSTYKKDGA------SRHAGAARVAMVVLLSAACALLLAALYIILGPRI 738
LC FS N C S + +R G + ++ +
Sbjct: 621 FLCGFSSNPCNGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKN 680
Query: 739 RGLSGSHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLP 798
R + ++ N W+L + KL + ++IG+G GIVYK +P
Sbjct: 681 RRMRKNNPN----------LWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMP 730
Query: 799 SGLTVAVKRFRASDKIST--GAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856
+G VAVK+ K S+ ++EI TL RIRHRNIVRLL + +N+ LL Y+YMPN
Sbjct: 731 NGEEVAVKKLLTITKGSSHDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPN 790
Query: 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE 916
G+LG +LH G+ L+W+TR +IAL A+GL YLHHDC P I+HRDVKS+NILLG +E
Sbjct: 791 GSLGEVLH-GKAGVFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFE 849
Query: 917 SCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEII 976
+ +ADFGLA+ + D+G S AGSYGYIAPEYA +I EKSDVYS+GVVLLE+I
Sbjct: 850 AHVADFGLAKFMMQDNGAS-ECMSSIAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELI 908
Query: 977 TGKKPVDASFPDGQHVIQWVRDHLK-SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLC 1035
TG+KPVD +G ++QW + +++ V+++D +L P + E ++ +++LC
Sbjct: 909 TGRKPVDNFGEEGIDIVQWSKIQTNCNRQGVVKIIDQRLSNIP---LAEAMELFFVAMLC 965
Query: 1036 TSNRAEDRPTMKDVAALLREIRQ 1058
+ +RPTM++V ++ + +Q
Sbjct: 966 VQEHSVERPTMREVVQMISQAKQ 988
|
Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1117 | ||||||
| 255540579 | 1116 | receptor protein kinase, putative [Ricin | 0.971 | 0.972 | 0.756 | 0.0 | |
| 224135873 | 1113 | predicted protein [Populus trichocarpa] | 0.977 | 0.981 | 0.743 | 0.0 | |
| 224119474 | 1047 | predicted protein [Populus trichocarpa] | 0.935 | 0.998 | 0.771 | 0.0 | |
| 359491309 | 1112 | PREDICTED: probable LRR receptor-like se | 0.949 | 0.954 | 0.746 | 0.0 | |
| 147782461 | 1113 | hypothetical protein VITISV_038730 [Viti | 0.947 | 0.950 | 0.740 | 0.0 | |
| 356562708 | 1122 | PREDICTED: probable LRR receptor-like se | 0.957 | 0.953 | 0.704 | 0.0 | |
| 449526471 | 1131 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.993 | 0.981 | 0.677 | 0.0 | |
| 449441001 | 1132 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.979 | 0.680 | 0.0 | |
| 351723713 | 1117 | receptor-like protein kinase [Glycine ma | 0.904 | 0.904 | 0.726 | 0.0 | |
| 449469562 | 1080 | PREDICTED: probable LRR receptor-like se | 0.933 | 0.965 | 0.628 | 0.0 |
| >gi|255540579|ref|XP_002511354.1| receptor protein kinase, putative [Ricinus communis] gi|223550469|gb|EEF51956.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1597 bits (4136), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 835/1104 (75%), Positives = 943/1104 (85%), Gaps = 19/1104 (1%)
Query: 24 FPHTPYAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRY 83
FP T AVN+QGEALLSWK + G LSNW SDETPC+WFG++CN NN+VV LDLRY
Sbjct: 22 FPFTSLAVNQQGEALLSWKTSLNGMPQVLSNWESSDETPCRWFGITCNYNNEVVSLDLRY 81
Query: 84 VDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIAS-LNQLNYLDLSENSLTGEIPREL 142
VDL G VPTNFTSL +LN+L LSGTNLTGSIPKEIA+ L QL YLDLS+N+LTGE+P EL
Sbjct: 82 VDLFGTVPTNFTSLYTLNKLTLSGTNLTGSIPKEIAAALPQLTYLDLSDNALTGEVPSEL 141
Query: 143 CSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAG 202
C+L +L++L LNSNQL G IP +IGNL+SL + LYDNQL+ +IP TIGKLKNLE IRAG
Sbjct: 142 CNLSKLQELYLNSNQLTGTIPTEIGNLTSLKWMVLYDNQLSGSIPYTIGKLKNLEVIRAG 201
Query: 203 GNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE 262
GNKNL G LP EIGNC+NLV++GLAETSISGFLP TLGLLK+LQTIAIYT+LLSGQIPPE
Sbjct: 202 GNKNLEGPLPQEIGNCSNLVLLGLAETSISGFLPRTLGLLKKLQTIAIYTSLLSGQIPPE 261
Query: 263 LGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDI 322
LGDCTEL+ IYLYEN+LTGSIP LGNL NL NL LWQNNLVG+IPPELGNC+Q+ +ID+
Sbjct: 262 LGDCTELEDIYLYENSLTGSIPKTLGNLGNLKNLLLWQNNLVGVIPPELGNCNQMLVIDV 321
Query: 323 SMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE 382
SMNSLTG+IPQ+ GNLT LQELQLSVNQISGEIP ++GNC++L IELDNNQI+GAIPSE
Sbjct: 322 SMNSLTGNIPQSFGNLTELQELQLSVNQISGEIPTRLGNCRKLTHIELDNNQISGAIPSE 381
Query: 383 FGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLL 442
GNLSNLTLLF+W N++EG+IP SISNC LEA+DLSQN L GPIP GIF+LK LNKLLL
Sbjct: 382 LGNLSNLTLLFLWQNKIEGKIPASISNCHILEAIDLSQNSLMGPIPGGIFELKLLNKLLL 441
Query: 443 LSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDE 502
LSNNLSG IPP++GNC SL+RFRAN+NKL G IP +IGNL+NLNFLDLGSNRLTG IP+E
Sbjct: 442 LSNNLSGEIPPQIGNCKSLVRFRANNNKLAGSIPSQIGNLRNLNFLDLGSNRLTGVIPEE 501
Query: 503 ITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVL 562
I+GC+NLTFLD+HSNSI+GNLP L+QLV LQ D SDN + G L +GSL+SLTKL+L
Sbjct: 502 ISGCQNLTFLDLHSNSISGNLPQSLNQLVSLQLLDFSDNLIQGTLCSSIGSLTSLTKLIL 561
Query: 563 NKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPA 622
+KNR +G IP QLGSC KLQLLDLSSNQ SG IP+SLGKIP+L IALNLS NQ+ E+P+
Sbjct: 562 SKNRLSGQIPVQLGSCSKLQLLDLSSNQFSGIIPSSLGKIPSLEIALNLSCNQLTNEIPS 621
Query: 623 ELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLS 682
E L KLG+LDLSHN+L+GDL +LA LQNLV+LN+SHNNFSGRVP+TPFF+KLPLSVL+
Sbjct: 622 EFAALEKLGMLDLSHNQLTGDLTYLANLQNLVLLNISHNNFSGRVPETPFFSKLPLSVLA 681
Query: 683 GNPSLCFSGNQCADSTYKKDGASRHAGAARVAMVVLLSAACALLLAALYIILGPRIRGLS 742
GNP LCFSGNQCA + R AAR+AMVVLL AC LLLAALYI++G R R
Sbjct: 682 GNPDLCFSGNQCAGGGSSSN--DRRMTAARIAMVVLLCTACVLLLAALYIVIGSRKR--- 736
Query: 743 GSHHNE------GDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVT 796
H E GD DVEMGPPWE+TLY KLDLSI D RSLTA N+IG+GRSG+VY+VT
Sbjct: 737 -HRHAECDIDGRGDTDVEMGPPWEVTLYQKLDLSIADVARSLTANNVIGRGRSGVVYRVT 795
Query: 797 LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856
LPSGLTVAVKRF+ +K S AFSSEIATL+RIRHRNIVRLLGWGANRKTKLLFYDYM N
Sbjct: 796 LPSGLTVAVKRFKTGEKFSAAAFSSEIATLARIRHRNIVRLLGWGANRKTKLLFYDYMSN 855
Query: 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE 916
GTLG LLHDG AGL+EW+TRFKIALGVAEGL+YLHHDCVPAILHRDVK+HNILL +RYE
Sbjct: 856 GTLGGLLHDGN-AGLVEWETRFKIALGVAEGLAYLHHDCVPAILHRDVKAHNILLDDRYE 914
Query: 917 SCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEII 976
+CLADFGLARLVED++ GSFSANPQFAGSYGYIAPEYA M KI+EKSDVYSYGVVLLEII
Sbjct: 915 ACLADFGLARLVEDEN-GSFSANPQFAGSYGYIAPEYACMLKITEKSDVYSYGVVLLEII 973
Query: 977 TGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCT 1036
TGK+PVD SF DGQHVIQWVR+ LKS KDPVE+LDPKLQGHPDTQIQEMLQALGISLLCT
Sbjct: 974 TGKQPVDPSFADGQHVIQWVREQLKSNKDPVEILDPKLQGHPDTQIQEMLQALGISLLCT 1033
Query: 1037 SNRAEDRPTMKDVAALLREIRQEPASGSEAH---KPTAAKSTDTASYSSSSVTSAQLLLL 1093
SNRAEDRPTMKDVAALLREIR EPA+GSEA + + ASYSSSSVT AQLL+L
Sbjct: 1034 SNRAEDRPTMKDVAALLREIRHEPATGSEAQKPTTKSTKTTETPASYSSSSVTPAQLLML 1093
Query: 1094 QGQGSSHCSLAYSSSSGSYISRNQ 1117
QG GSSHCSLAYSSSSGSY+S+NQ
Sbjct: 1094 QG-GSSHCSLAYSSSSGSYVSKNQ 1116
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135873|ref|XP_002322182.1| predicted protein [Populus trichocarpa] gi|222869178|gb|EEF06309.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1565 bits (4053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 822/1105 (74%), Positives = 940/1105 (85%), Gaps = 13/1105 (1%)
Query: 1 MPVYYPWTLYSLILSFVVVIIILFPHTPYAVNRQGEALLSWKRNWKGSDDGLSNWSPSDE 60
MPV PWT +S + ++ LFP T A+N+QGE LLSWKR+ GS +GL NW S+E
Sbjct: 1 MPVN-PWTFFSFLF-LSSTLVSLFPFTASALNQQGETLLSWKRSLNGSPEGLDNWDSSNE 58
Query: 61 TPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIAS 120
TPC WFG++CNLNN+VV L+ RYVDL G +P+NFTSL SLN+L+LSGTNLTGSIPKEI +
Sbjct: 59 TPCGWFGITCNLNNEVVSLEFRYVDLFGKLPSNFTSLFSLNKLILSGTNLTGSIPKEIGT 118
Query: 121 -LNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYD 179
L +L +LDLS+N+LTGEIP ELC L+ LE+L LNSNQLEG+IPI+IGNL+SL +L LYD
Sbjct: 119 ALPRLTHLDLSDNALTGEIPSELCVLITLEELLLNSNQLEGSIPIEIGNLTSLKRLILYD 178
Query: 180 NQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTL 239
NQL+ ++P TIGKL+ LE IRAGGNKNL GSLP EIGNC+NL+++GLAETSISGFLPP+L
Sbjct: 179 NQLSGSMPNTIGKLRYLEVIRAGGNKNLEGSLPQEIGNCSNLLILGLAETSISGFLPPSL 238
Query: 240 GLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLW 299
GLLK+LQTIAIYT+LLSGQIPPELGDCTELQ IYLYEN+LTGSIP LG L+NL NL LW
Sbjct: 239 GLLKKLQTIAIYTSLLSGQIPPELGDCTELQDIYLYENSLTGSIPKTLGQLQNLKNLLLW 298
Query: 300 QNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI 359
QNNLVG+IPPELGNC+Q+ +IDISMNSLTGSIPQ+ GNLT LQE QLS+NQISG IPAQ+
Sbjct: 299 QNNLVGVIPPELGNCNQMLVIDISMNSLTGSIPQSFGNLTELQEFQLSLNQISGVIPAQL 358
Query: 360 GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLS 419
GNC++L IELDNNQI+G+IP E GNLSNLTL ++W NRLEG IPPSISNCQNLEA+DLS
Sbjct: 359 GNCRKLTHIELDNNQISGSIPPEIGNLSNLTLFYLWQNRLEGNIPPSISNCQNLEAIDLS 418
Query: 420 QNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI 479
QNGL GPIP+G+FQLKKLNKLLLLSNNLSG IPPE+GNCSSLIRFRAN+NK+ G IPP+I
Sbjct: 419 QNGLVGPIPKGVFQLKKLNKLLLLSNNLSGEIPPEIGNCSSLIRFRANNNKVAGTIPPQI 478
Query: 480 GNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLS 539
GNLKNLNFLDLGSNR+ G IP+EI+GC+NLTFLD+HSN+I+GNLP ++L LQF D S
Sbjct: 479 GNLKNLNFLDLGSNRIAGDIPEEISGCQNLTFLDLHSNAISGNLPQSFNKLFSLQFVDFS 538
Query: 540 DNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASL 599
+N + G LS LGSLSSLTKL+L KN+ +GSIP+QLGSC KLQLLDLS NQLSGNIP+S+
Sbjct: 539 NNLIEGTLSASLGSLSSLTKLILAKNKLSGSIPNQLGSCSKLQLLDLSGNQLSGNIPSSV 598
Query: 600 GKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVS 659
GKIP+L IALNLS NQ+ GE+P+E TGL KL ILD S+N LSGDL LA L NLVVLNVS
Sbjct: 599 GKIPSLEIALNLSLNQLNGEIPSEFTGLTKLAILDFSYNHLSGDLQHLAALPNLVVLNVS 658
Query: 660 HNNFSGRVPDTPFFAKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAGAARVAMVVLL 719
HNNFSG VPDTPFF+KLPLSVL+GNP+LCFS +QC D + AARVAMVVLL
Sbjct: 659 HNNFSGHVPDTPFFSKLPLSVLTGNPALCFSDSQCDGD----DKRVKRGTAARVAMVVLL 714
Query: 720 SAACALLLAALYIILGPRIRGLSGSHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLT 779
ACALLLAALY IL + G G+ + D+D+EM PPWE+TLY KLDLSI D RSLT
Sbjct: 715 CTACALLLAALYNILRSKKHG-RGAQECDRDDDLEMRPPWEVTLYQKLDLSIADVARSLT 773
Query: 780 AGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
AGN+IG+GRSG+VYKV +PSGL VAVKRF++++KIS +FSSEIATL+ IRHRNIVRLLG
Sbjct: 774 AGNVIGRGRSGVVYKVAIPSGLMVAVKRFKSAEKISAASFSSEIATLAIIRHRNIVRLLG 833
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
WGAN+KTKLLFYDYM NGTLG LLH+ GL+EW+ R KIALGVAEGL+YLHHDCVP I
Sbjct: 834 WGANQKTKLLFYDYMANGTLGTLLHEANDVGLVEWEMRIKIALGVAEGLAYLHHDCVPPI 893
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
LHRDVKSHNILLG+RYE+CLADFGLAR VED+ GSFSA+PQFAGSYGYIAPEYA M KI
Sbjct: 894 LHRDVKSHNILLGDRYEACLADFGLAREVEDEH-GSFSASPQFAGSYGYIAPEYACMLKI 952
Query: 960 SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019
+EKSDVYSYGVVLLEIITGKKPVD SFPDGQHV+QWVRDHLK KKDPVE+LDPKLQGHPD
Sbjct: 953 TEKSDVYSYGVVLLEIITGKKPVDPSFPDGQHVVQWVRDHLKCKKDPVEILDPKLQGHPD 1012
Query: 1020 TQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEAHKPTAAKST---D 1076
TQIQEMLQALGISLLCTSNRAEDRPTMKDVA LLREIRQEP GS+AHKPT S
Sbjct: 1013 TQIQEMLQALGISLLCTSNRAEDRPTMKDVAVLLREIRQEPTVGSDAHKPTNKSSKMMGT 1072
Query: 1077 TASYSSSSVTSAQLLLLQGQGSSHC 1101
SYSSSSVT AQLL+LQ QGSS C
Sbjct: 1073 NPSYSSSSVTPAQLLMLQ-QGSSRC 1096
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119474|ref|XP_002318081.1| predicted protein [Populus trichocarpa] gi|222858754|gb|EEE96301.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1550 bits (4013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 812/1052 (77%), Positives = 924/1052 (87%), Gaps = 7/1052 (0%)
Query: 20 IIILFPHTPYAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGL 79
+++LFP T +AVN+QGE LLSWKR+ GS +GL+NW S+ETPC WFG++CN NN+VV L
Sbjct: 1 LVLLFPFTAFAVNQQGETLLSWKRSLNGSPEGLNNWDSSNETPCGWFGITCNFNNEVVAL 60
Query: 80 DLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIAS-LNQLNYLDLSENSLTGEI 138
LRYV+L G +P+NFT L SLN+LVLSGTNLTG+IPKEI + L QL +LDLSEN+LTGEI
Sbjct: 61 GLRYVNLFGTLPSNFTFLSSLNKLVLSGTNLTGTIPKEIGTALPQLTHLDLSENALTGEI 120
Query: 139 PRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEA 198
P ELC+ +LEQL LNSNQLEG+IPI+IGNL+SL L LYDNQL+ +IP T+GKLK LE
Sbjct: 121 PSELCNFPKLEQLLLNSNQLEGSIPIEIGNLTSLKWLILYDNQLSGSIPNTVGKLKYLEV 180
Query: 199 IRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQ 258
IRAGGNKNL GSLP EIGNC+NL+M+GLAETSISGFLPP+LGLLK+LQT+AIYT LLSGQ
Sbjct: 181 IRAGGNKNLEGSLPKEIGNCSNLLMLGLAETSISGFLPPSLGLLKKLQTVAIYTTLLSGQ 240
Query: 259 IPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLS 318
IPPELGDCTELQ IYLYEN+LTGSIP LG L+NL NL LWQNNLVGIIPPELGNC+Q+
Sbjct: 241 IPPELGDCTELQDIYLYENSLTGSIPKTLGKLRNLRNLLLWQNNLVGIIPPELGNCNQML 300
Query: 319 IIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGA 378
+IDISMNSLTGSIPQ+ GNLT LQELQLS+NQISGEIPAQ+GNCQ++ IELDNNQITG+
Sbjct: 301 VIDISMNSLTGSIPQSFGNLTELQELQLSLNQISGEIPAQLGNCQKIIHIELDNNQITGS 360
Query: 379 IPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLN 438
IP E GNL NLTL ++W N+LEG IPPSISNCQNLEA+DLSQNGL GPIP+G+FQLKKLN
Sbjct: 361 IPPEIGNLFNLTLFYLWQNKLEGNIPPSISNCQNLEAIDLSQNGLVGPIPKGVFQLKKLN 420
Query: 439 KLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGS 498
KLLLLSNNLSG IPPE+GNCSSLIRFRAN+NK++G IP IGNLKNLNFLDLGSNR+TG
Sbjct: 421 KLLLLSNNLSGEIPPEIGNCSSLIRFRANNNKVSGTIPAHIGNLKNLNFLDLGSNRITGV 480
Query: 499 IPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLT 558
IP+EI+GC+NLTFLD+HSN+I+GNLP +L+ LQF D S+N + G LSP LGSLSSLT
Sbjct: 481 IPEEISGCQNLTFLDLHSNAISGNLPQSFDKLISLQFIDFSNNLIEGTLSPSLGSLSSLT 540
Query: 559 KLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICG 618
KL L KNR +GSIPSQLGSC KLQLLDLS NQLSGNIP+S+GKIP+L IALNLS NQ+ G
Sbjct: 541 KLTLAKNRLSGSIPSQLGSCSKLQLLDLSGNQLSGNIPSSVGKIPSLEIALNLSLNQLNG 600
Query: 619 ELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPL 678
E+P+E TGLNKLGILD+S+N L+GDL LA LQNLVVLNVSHNNFSG VPDTPFF+KLPL
Sbjct: 601 EIPSEFTGLNKLGILDISYNHLTGDLQHLAALQNLVVLNVSHNNFSGHVPDTPFFSKLPL 660
Query: 679 SVLSGNPSLCFSGNQCADSTYKKDGASRHAGAARVAMVVLLSAACALLLAALYIILGPRI 738
SVL+GNP+LCFSGNQC D + AARVAM+VLL AACALLLAALYIIL +
Sbjct: 661 SVLAGNPALCFSGNQCDSG----DKHVQRGTAARVAMIVLLCAACALLLAALYIILASKK 716
Query: 739 RGLSGSHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLP 798
RG SG+ EG++DVEM PPWE+TLY KLDLSI D TRSLTAGN++G+GRSG+VYKVT+P
Sbjct: 717 RG-SGAQECEGEDDVEMSPPWEVTLYQKLDLSIADVTRSLTAGNVVGRGRSGVVYKVTIP 775
Query: 799 SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGT 858
SGL VAVKRF++++KIS AFSSEIATL+RIRHRNIVRLLGWGANRKTKLLFYDYM NGT
Sbjct: 776 SGLMVAVKRFKSAEKISAAAFSSEIATLARIRHRNIVRLLGWGANRKTKLLFYDYMANGT 835
Query: 859 LGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESC 918
LG LLH+G GL+EW+TRFKIALGVAEGL+YLHHDCVP ILHRDVK+HNILLG+R+E+
Sbjct: 836 LGTLLHEGNNFGLVEWETRFKIALGVAEGLAYLHHDCVPPILHRDVKAHNILLGDRFEAY 895
Query: 919 LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITG 978
LADFGLARLVED+ GSFSANPQFAGSYGYIAPEYA M KI+EKSDVYSYGVVLLE ITG
Sbjct: 896 LADFGLARLVEDEH-GSFSANPQFAGSYGYIAPEYACMLKITEKSDVYSYGVVLLETITG 954
Query: 979 KKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSN 1038
KKPVD SFPDGQHV+QWVR+HL+SKKDPVE+LDPKLQGHPDTQIQEMLQALGISLLCTSN
Sbjct: 955 KKPVDPSFPDGQHVVQWVRNHLRSKKDPVEILDPKLQGHPDTQIQEMLQALGISLLCTSN 1014
Query: 1039 RAEDRPTMKDVAALLREIRQEPASGSEAHKPT 1070
RAEDRPTMKDVA LL+EIRQE +G EA KPT
Sbjct: 1015 RAEDRPTMKDVAVLLKEIRQELITGGEAQKPT 1046
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491309|ref|XP_003634262.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1507 bits (3902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 804/1077 (74%), Positives = 921/1077 (85%), Gaps = 16/1077 (1%)
Query: 25 PHTPYAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYV 84
P A+N+QG+ALL WK + K + + LSNW S+ETPC WFG+SCN +N VV L+LRYV
Sbjct: 23 PLMASAINQQGQALLWWKGSLKEAPEALSNWDQSNETPCGWFGISCNSDNLVVELNLRYV 82
Query: 85 DLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCS 144
DL G +P+NF+SL SLN+LVL+GTNLTGSIPKEI L LNYLDLS+N+LTGEIP E+CS
Sbjct: 83 DLFGPLPSNFSSLTSLNKLVLTGTNLTGSIPKEIGVLQDLNYLDLSDNALTGEIPSEVCS 142
Query: 145 LLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGN 204
LL+LEQL LNSN LEG+IP+Q+GNL+SLT L LYDNQL+ AIP++IG LK LE IRAGGN
Sbjct: 143 LLKLEQLYLNSNWLEGSIPVQLGNLTSLTWLILYDNQLSGAIPSSIGNLKKLEVIRAGGN 202
Query: 205 KNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELG 264
KNL G LP EIGNCTNL MIGLAETS+SGFLPP+LG LK+LQT+AIYTALLSG IPPELG
Sbjct: 203 KNLEGPLPQEIGNCTNLAMIGLAETSMSGFLPPSLGRLKKLQTLAIYTALLSGPIPPELG 262
Query: 265 DCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISM 324
DCTELQ IYLYENALTGSIP++LG+L+NL NL LWQNNLVG IPPELGNC QL +IDISM
Sbjct: 263 DCTELQNIYLYENALTGSIPARLGSLRNLQNLLLWQNNLVGTIPPELGNCKQLVVIDISM 322
Query: 325 NSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG 384
NS++G +PQT GNL+ LQELQLSVNQISG+IPAQIGNC L IELDNN+ITG IPS G
Sbjct: 323 NSISGRVPQTFGNLSFLQELQLSVNQISGQIPAQIGNCLGLTHIELDNNKITGTIPSSIG 382
Query: 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS 444
L NLTLL++W N LEG IP SISNC++LEAVD S+N LTGPIP+GIFQLKKLNKLLLLS
Sbjct: 383 GLVNLTLLYLWQNMLEGNIPESISNCRSLEAVDFSENSLTGPIPKGIFQLKKLNKLLLLS 442
Query: 445 NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEIT 504
NNL+G IPPE+G CSSLIR RA+ NKL G IPP+IGNLKNLNFLDL NRLTG IP EI+
Sbjct: 443 NNLAGEIPPEIGECSSLIRLRASDNKLAGSIPPQIGNLKNLNFLDLALNRLTGVIPQEIS 502
Query: 505 GCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNK 564
GC+NLTFLD+HSNSIAGNLP L+QLV LQF D+SDN + G LSP LGSLSSLTKL+L K
Sbjct: 503 GCQNLTFLDLHSNSIAGNLPENLNQLVSLQFVDVSDNLIEGTLSPSLGSLSSLTKLILRK 562
Query: 565 NRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAEL 624
NR +G IPS+L SC KL LLDLSSN L+G IP+S+G+IPAL IALNLSWN++ G++P+E
Sbjct: 563 NRLSGLIPSELNSCAKLVLLDLSSNDLTGKIPSSVGEIPALEIALNLSWNKLSGKIPSEF 622
Query: 625 TGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGN 684
T L+KLGILDLSHN+LSGDL L +LQNLVVLN+S+NNFSGRVPDTPFF+KLPLSVL+GN
Sbjct: 623 TDLDKLGILDLSHNQLSGDLQPLFDLQNLVVLNISYNNFSGRVPDTPFFSKLPLSVLAGN 682
Query: 685 PSLCFSGNQCADSTYKKDGASRHAGAARVAMVVLLSAACALLLAALYIILGPRI--RGLS 742
P+LC SG+QCA K+ GA+RHA AARVAMVVLL AACALLLAALYIILG ++ RG
Sbjct: 683 PALCLSGDQCAAD--KRGGAARHAAAARVAMVVLLCAACALLLAALYIILGNKMNPRGPG 740
Query: 743 GSHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLT 802
G H +GD DVEM PPWELTLY KLDLSI D R LT N++G+GRSG+VY+ PSGLT
Sbjct: 741 GPHQCDGDSDVEMAPPWELTLYQKLDLSIADVVRCLTVANVVGRGRSGVVYRANTPSGLT 800
Query: 803 VAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGML 862
+AVKRFR+S+K S AFSSEIATL+RIRHRNIVRLLGW ANRKTKLLFYDY+P+GTLG L
Sbjct: 801 IAVKRFRSSEKFSAAAFSSEIATLARIRHRNIVRLLGWAANRKTKLLFYDYLPSGTLGTL 860
Query: 863 LHDGEC-AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921
LH EC + ++EW++RF IALGVAEGL+YLHHDCVP I+HRDVK+HNILLG+RYE+CLAD
Sbjct: 861 LH--ECNSAIVEWESRFNIALGVAEGLAYLHHDCVPPIIHRDVKAHNILLGDRYEACLAD 918
Query: 922 FGLARLVEDDSG-GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKK 980
FGLARLVEDD G GSFSANPQFAGSYGYIAPEYA M KI+EKSDVYS+GVVLLEIITGKK
Sbjct: 919 FGLARLVEDDDGNGSFSANPQFAGSYGYIAPEYACMLKITEKSDVYSFGVVLLEIITGKK 978
Query: 981 PVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRA 1040
PVD SFPDGQHVIQWVR+ LKSK+DPV++LDPKLQGHPDTQIQEMLQALGISLLCTSNRA
Sbjct: 979 PVDPSFPDGQHVIQWVREQLKSKRDPVQILDPKLQGHPDTQIQEMLQALGISLLCTSNRA 1038
Query: 1041 EDRPTMKDVAALLREIRQEPASGSEAHKPTA--AKSTDTASYSSSSVTSAQLLLLQG 1095
EDRPTMKDVA LLREIR EP++G+E HKP + +K + +YSS QLLLLQG
Sbjct: 1039 EDRPTMKDVAVLLREIRHEPSTGTEPHKPNSNGSKKPEAPAYSS------QLLLLQG 1089
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147782461|emb|CAN61920.1| hypothetical protein VITISV_038730 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1486 bits (3847), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 801/1081 (74%), Positives = 913/1081 (84%), Gaps = 23/1081 (2%)
Query: 25 PHTPYAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYV 84
P A+N+QG+ALL WK + K + + LSNW S+ETPC WFG+SCN +N VV L+LRYV
Sbjct: 23 PLMASAINQQGQALLWWKGSLKEAPEALSNWDQSNETPCGWFGISCNSDNLVVELNLRYV 82
Query: 85 DLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCS 144
DL G +P+NF+SL SLN+LVL+GTNLTGSIPKEI L LNYLDLS+N+LTGEIP E+CS
Sbjct: 83 DLFGPLPSNFSSLTSLNKLVLTGTNLTGSIPKEIGVLQDLNYLDLSDNALTGEIPSEVCS 142
Query: 145 LLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGN 204
LL+LEQL LNSN LEG+IP+Q+GNL+SLT L LYDNQL+ AIP++IG LK LE IRAGGN
Sbjct: 143 LLKLEQLYLNSNWLEGSIPVQLGNLTSLTWLILYDNQLSGAIPSSIGNLKKLEVIRAGGN 202
Query: 205 KNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELG 264
KNL G LP EIGNCTNL MIGLAETS+SGFLPP+LG LK+LQT+AIYTALLSG IPPELG
Sbjct: 203 KNLEGPLPQEIGNCTNLAMIGLAETSMSGFLPPSLGRLKKLQTLAIYTALLSGPIPPELG 262
Query: 265 DCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISM 324
DCTELQ IYLYENALTGSIP++LG+L+NL NL LWQNNLVG IPPELGNC QL +IDISM
Sbjct: 263 DCTELQNIYLYENALTGSIPARLGSLRNLQNLLLWQNNLVGTIPPELGNCKQLVVIDISM 322
Query: 325 NSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG 384
NS++G +PQT GNL+ LQELQLSVNQISG+IPAQIGNC L IELDNN+ITG IPS G
Sbjct: 323 NSISGRVPQTFGNLSFLQELQLSVNQISGQIPAQIGNCLGLTHIELDNNKITGTIPSSIG 382
Query: 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS 444
L NLTLL++W N LEG IP SISNC++LEAVD S+N LTGPIP+GIFQLKKLNKLLLLS
Sbjct: 383 GLVNLTLLYLWQNMLEGNIPESISNCRSLEAVDFSENSLTGPIPKGIFQLKKLNKLLLLS 442
Query: 445 NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEIT 504
NNL+G IPPE+G CSSLIR RA+ NKL G IPP+IGNLKNLNFLDL NRLTG IP EI+
Sbjct: 443 NNLAGEIPPEIGECSSLIRLRASDNKLAGSIPPQIGNLKNLNFLDLALNRLTGVIPQEIS 502
Query: 505 GCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNK 564
GC+NLTFLD+HSNSIAGNLP L+QLV LQF D+SDN + G LSP LGSLSSLTKL+L K
Sbjct: 503 GCQNLTFLDLHSNSIAGNLPENLNQLVSLQFVDVSDNLIEGTLSPSLGSLSSLTKLILRK 562
Query: 565 NRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAEL 624
NR +G IPS+L SC KL LLDLSSN L+G IP+S+G IPAL IALNLSW PA+
Sbjct: 563 NRLSGLIPSELNSCAKLVLLDLSSNDLTGKIPSSVGXIPALEIALNLSW---ATNFPAKF 619
Query: 625 ----TGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSV 680
T L+KLGILDLSHN+LSGDL L +LQNLVVLN+S+NNFSGRVPDTPFF+KLPLSV
Sbjct: 620 RRSSTDLDKLGILDLSHNQLSGDLQPLFDLQNLVVLNISYNNFSGRVPDTPFFSKLPLSV 679
Query: 681 LSGNPSLCFSGNQCADSTYKKDGASRHAGAARVAMVVLLSAACALLLAALYIILGPRI-- 738
L+GNP+LC SG+QCA K+ GA+RHA AARVAMVVLL AACALLLAALYIILG ++
Sbjct: 680 LAGNPALCLSGDQCAAD--KRGGAARHAAAARVAMVVLLCAACALLLAALYIILGNKMNP 737
Query: 739 RGLSGSHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLP 798
RG G H +GD DVEM PPWELTLY KLDLSI D R LT N++G+GRSG+VY+ P
Sbjct: 738 RGPGGPHQCDGDSDVEMAPPWELTLYQKLDLSIADVVRCLTVANVVGRGRSGVVYRANTP 797
Query: 799 SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGT 858
SGLT+AVKRFR+S+K S AFSSEIATL+RIRHRNIVRLLGW ANRKTKLLFYDY+P+GT
Sbjct: 798 SGLTIAVKRFRSSEKFSAAAFSSEIATLARIRHRNIVRLLGWAANRKTKLLFYDYLPSGT 857
Query: 859 LGMLLHDGEC-AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917
LG LLH EC + ++EW++RF IALGVAEGL+YLHHDCVP I+HRDVK+HNILLG+RYE+
Sbjct: 858 LGTLLH--ECNSAIVEWESRFNIALGVAEGLAYLHHDCVPPIIHRDVKAHNILLGDRYEA 915
Query: 918 CLADFGLARLVEDDSG-GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEII 976
CLADFGLARLVEDD G GSFSANPQFAGSYGYIAPEYA M KI+EKSDVYS+GVVLLEII
Sbjct: 916 CLADFGLARLVEDDDGNGSFSANPQFAGSYGYIAPEYACMLKITEKSDVYSFGVVLLEII 975
Query: 977 TGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCT 1036
TGKKPVD SFPDGQHVIQWVR+ LKSK+DPV++LDPKLQGHPDTQIQEMLQALGISLLCT
Sbjct: 976 TGKKPVDPSFPDGQHVIQWVREQLKSKRDPVQILDPKLQGHPDTQIQEMLQALGISLLCT 1035
Query: 1037 SNRAEDRPTMKDVAALLREIRQEPASGSEAHKPTA--AKSTDTASYSSSSVTSAQLLLLQ 1094
SNRA DRPTMKDVA LLREIR EP++G+E HKP + +K + +YSS QLLLLQ
Sbjct: 1036 SNRAADRPTMKDVAVLLREIRHEPSTGTEPHKPNSNGSKKPEAPAYSS------QLLLLQ 1089
Query: 1095 G 1095
G
Sbjct: 1090 G 1090
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356562708|ref|XP_003549611.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1456 bits (3768), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 767/1088 (70%), Positives = 894/1088 (82%), Gaps = 18/1088 (1%)
Query: 1 MPVYYPWTLYSLILSFVVVIIILFPHTPY---AVNRQGEALLSWKRNWKGSDDGLSNWSP 57
MPV PWTL+ F+ + ++L P + AVN+QGE LLSWKR GS + LSNW P
Sbjct: 1 MPVN-PWTLF-----FLCISLLLLPFHSFIAAAVNQQGEGLLSWKRTLNGSLEVLSNWDP 54
Query: 58 SDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKE 117
+TPC W+GVSCN +VV LDLRYVDLLG +PTNFTSLLSL L+L+GTNLTGSIPKE
Sbjct: 55 VQDTPCSWYGVSCNFKKEVVQLDLRYVDLLGRLPTNFTSLLSLTSLILTGTNLTGSIPKE 114
Query: 118 IASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFL 177
I L +L+YLDLS+N+L+GEIP ELC L +LE+L LNSN L G+IP+ IGNL L +L L
Sbjct: 115 IGELVELSYLDLSDNALSGEIPSELCYLPKLEELHLNSNDLVGSIPVAIGNLMKLQKLIL 174
Query: 178 YDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPP 237
YDNQL +P T+G LK+L+ +RAGGNKNL G LP EIGNC++LVM+GLAETS+SG LPP
Sbjct: 175 YDNQLGGEVPGTVGNLKSLQVLRAGGNKNLEGPLPQEIGNCSSLVMLGLAETSLSGSLPP 234
Query: 238 TLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLF 297
+LG LK L+TIAIYT+LLSG+IPPELGDCTELQ IYLYEN+LTGSIPSKLGNLK L NL
Sbjct: 235 SLGFLKNLETIAIYTSLLSGEIPPELGDCTELQNIYLYENSLTGSIPSKLGNLKKLENLL 294
Query: 298 LWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPA 357
LWQNNLVG IPPE+GNC LS+ID+SMNSLTGSIP+T GNLTSLQELQLSVNQISGEIP
Sbjct: 295 LWQNNLVGTIPPEIGNCDMLSVIDVSMNSLTGSIPKTFGNLTSLQELQLSVNQISGEIPG 354
Query: 358 QIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVD 417
++G CQ+L +ELDNN ITG IPSE GNL+NLTLLF+WHN+L+G IP S+ NCQNLEA+D
Sbjct: 355 ELGKCQQLTHVELDNNLITGTIPSELGNLANLTLLFLWHNKLQGNIPSSLPNCQNLEAID 414
Query: 418 LSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPP 477
LSQNGLTGPIP+GIFQLK LNKLLLLSNNLSG IP E+GNCSSLIRFRAN N +TG IP
Sbjct: 415 LSQNGLTGPIPKGIFQLKNLNKLLLLSNNLSGKIPSEIGNCSSLIRFRANDNNITGNIPS 474
Query: 478 EIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFAD 537
+IGNL NLNFLDLG+NR++G +P+EI+GCRNL FLDVHSN IAGNLP L +L LQF D
Sbjct: 475 QIGNLNNLNFLDLGNNRISGVLPEEISGCRNLAFLDVHSNFIAGNLPESLSRLNSLQFLD 534
Query: 538 LSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPA 597
+SDN + G L+P LG L++L+KLVL KNR +GSIPSQLGSC KLQLLDLSSN +SG IP
Sbjct: 535 VSDNMIEGTLNPTLGELAALSKLVLAKNRISGSIPSQLGSCSKLQLLDLSSNNISGEIPG 594
Query: 598 SLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLN 657
S+G IPAL IALNLS NQ+ E+P E +GL KLGILD+SHN L G+L +L LQNLVVLN
Sbjct: 595 SIGNIPALEIALNLSLNQLSSEIPQEFSGLTKLGILDISHNVLRGNLQYLVGLQNLVVLN 654
Query: 658 VSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAGAARVAMVV 717
+S+N FSGRVPDTPFFAKLPLSVL+GNP+LCFSGN+C+ + R A ARVAMVV
Sbjct: 655 ISYNKFSGRVPDTPFFAKLPLSVLAGNPALCFSGNECSGDGGGGGRSGRRARVARVAMVV 714
Query: 718 LLSAACALLLAALYIILGPRIRGLSGSH---HNEGDEDVEMGPPWELTLYNKLDLSIGDA 774
LL AC LL+AALY+++ + RG S + D DV+M PPW++TLY KLDLSI D
Sbjct: 715 LLCTACVLLMAALYVVVAAKRRGDRESDVEVVDGKDSDVDMAPPWQVTLYQKLDLSISDV 774
Query: 775 TRSLTAGNIIGQGRSGIVYKVTLP--SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHR 832
+ L+AGN+IG GRSG+VY+V LP +GL +AVK+FR S+K S AFSSEIATL+RIRHR
Sbjct: 775 AKCLSAGNVIGHGRSGVVYRVDLPAATGLAIAVKKFRLSEKFSAAAFSSEIATLARIRHR 834
Query: 833 NIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
NIVRLLGWGANR+TKLLFYDY+ NG L LLH+G C GL++W+TR +IALGVAEG++YLH
Sbjct: 835 NIVRLLGWGANRRTKLLFYDYLQNGNLDTLLHEG-CTGLIDWETRLRIALGVAEGVAYLH 893
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
HDCVPAILHRDVK+ NILLG+RYE CLADFG AR V++D SFS NPQFAGSYGYIAPE
Sbjct: 894 HDCVPAILHRDVKAQNILLGDRYEPCLADFGFARFVQEDH-ASFSVNPQFAGSYGYIAPE 952
Query: 953 YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG-QHVIQWVRDHLKSKKDPVEVLD 1011
YA M KI+EKSDVYS+GVVLLEIITGK+PVD SFPDG QHVIQWVR+HLKSKKDP+EVLD
Sbjct: 953 YACMLKITEKSDVYSFGVVLLEIITGKRPVDPSFPDGQQHVIQWVREHLKSKKDPIEVLD 1012
Query: 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE-PASGSEAHKPT 1070
KLQGHPDTQIQEMLQALGI+LLCTSNRAEDRPTMKDVAALLREIR + P G++ HKP
Sbjct: 1013 SKLQGHPDTQIQEMLQALGIALLCTSNRAEDRPTMKDVAALLREIRHDPPPPGADPHKPK 1072
Query: 1071 AAKSTDTA 1078
+T A
Sbjct: 1073 PKSNTTEA 1080
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449526471|ref|XP_004170237.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1440 bits (3727), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 768/1133 (67%), Positives = 912/1133 (80%), Gaps = 23/1133 (2%)
Query: 1 MPVYYPWTLYSLILSFVVVIIILFPHTPYAVNRQGEALLSWKRNWKGSDDGLSNWSPSDE 60
MPV WTL S IL V+ + FP A+N QG+ALL+WK ++ GS++ L NW+P++E
Sbjct: 3 MPVN-SWTLPSSILILCSVLYLFFPFGVSAINEQGQALLNWKLSFNGSNEALYNWNPNNE 61
Query: 61 TPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIAS 120
PC WFG+SCN N +VV + LRYV+L G +P NF+ L SLNRLVLSG NLTGSIPKEI++
Sbjct: 62 NPCGWFGISCNRNREVVEVVLRYVNLPGKLPLNFSPLSSLNRLVLSGVNLTGSIPKEISA 121
Query: 121 LNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDN 180
L QL L+LS+N LTGEIP E+C+L+ LEQL LNSN LEG+IP IGNL++L +L LYDN
Sbjct: 122 LTQLRTLELSDNGLTGEIPSEICNLVDLEQLYLNSNLLEGSIPAGIGNLTNLKELILYDN 181
Query: 181 QLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLG 240
QL+ IP +IG LK LE IRAGGNKNL GS+P EIGNC++LV++GLAETSISGFLP +LG
Sbjct: 182 QLSGEIPISIGNLKQLEVIRAGGNKNLHGSVPEEIGNCSSLVILGLAETSISGFLPSSLG 241
Query: 241 LLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQ 300
LK+LQT+AIYTALLSGQIP ELGDCTELQ IYLYEN+L+GSIPS LG L+NL ++ +WQ
Sbjct: 242 RLKKLQTLAIYTALLSGQIPQELGDCTELQNIYLYENSLSGSIPSTLGRLQNLQSVLIWQ 301
Query: 301 NNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIG 360
N+LVG+IPPELG C QL +IDIS+NSLTGSIP T GNLT LQELQLS NQ+SGEIP +IG
Sbjct: 302 NSLVGVIPPELGRCDQLFVIDISINSLTGSIPSTFGNLTLLQELQLSTNQLSGEIPKEIG 361
Query: 361 NCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQ 420
NC R+ IELDNNQ+TG IPSE GNL+NLTLLF+W N+LEG IPP+ISNC+NLEA+DLS
Sbjct: 362 NCPRITHIELDNNQLTGTIPSELGNLTNLTLLFLWQNKLEGSIPPTISNCRNLEALDLSL 421
Query: 421 NGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIG 480
N LTG IP GIFQLK L+KLLLLSNNLSGVIPP +GNCS+L RFRAN+NKL+G IPPEIG
Sbjct: 422 NALTGSIPTGIFQLKXLSKLLLLSNNLSGVIPPAIGNCSALFRFRANNNKLSGEIPPEIG 481
Query: 481 NLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSD 540
NLK+L FLDLG+N LTG++P EI+GCRNLTFLD+HSNSI LP +QL LQ+ DLS+
Sbjct: 482 NLKSLIFLDLGNNHLTGALPPEISGCRNLTFLDMHSNSIKF-LPQEFNQLSSLQYVDLSN 540
Query: 541 NSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLG 600
N + G +P GS +SLTKLVL+ NRF+G IP+++G+C+KLQLLDLS NQLSGNIP SLG
Sbjct: 541 NLIEGSPNPSFGSFNSLTKLVLSNNRFSGPIPTEIGTCLKLQLLDLSCNQLSGNIPPSLG 600
Query: 601 KIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSH 660
KIP+L I+LNLS NQ+ GE+P+EL L+KLG LDLS+N+LSGDLH LA++QNLVVLNVSH
Sbjct: 601 KIPSLEISLNLSLNQLTGEIPSELANLDKLGSLDLSYNQLSGDLHILADMQNLVVLNVSH 660
Query: 661 NNFSGRVPDTPFFAKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAGAARVAMVVLLS 720
NNFSGRVP+TPFF +LPLSVLSGNP LCF+G +C + G H AARVAMVVLL
Sbjct: 661 NNFSGRVPETPFFTQLPLSVLSGNPDLCFAGEKCYSDNHS--GGGHHTLAARVAMVVLLC 718
Query: 721 AACALLLAALYIILGPR---IRGLSGSHHNEG----DEDVEMGPPWELTLYNKLDLSIGD 773
ACALLLAA+YIIL R R ++GS + D D+E+G WE+TLY KLDLSI D
Sbjct: 719 TACALLLAAVYIILKDRHSCRRCINGSRGEDPDTAFDSDLELGSGWEVTLYQKLDLSISD 778
Query: 774 ATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRN 833
+ LT N+IG+G++G+VY+ + SGL +AVKRFR+SDK S AFSSEIATL+RIRHRN
Sbjct: 779 VIKCLTPANVIGRGKTGVVYRACISSGLIIAVKRFRSSDKFSAAAFSSEIATLARIRHRN 838
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
IVRLLGWG NR+TKLLFYDY+PNG LG LLH+G L+W++RFKIALGVAEGL+YLHH
Sbjct: 839 IVRLLGWGXNRRTKLLFYDYLPNGNLGALLHEGNGRVGLDWESRFKIALGVAEGLAYLHH 898
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
DCVPAILHRDVK+HNILLG+RYE+CLADFGLARLVED GS SANPQFAGSYGY APEY
Sbjct: 899 DCVPAILHRDVKAHNILLGDRYEACLADFGLARLVEDGPSGSSSANPQFAGSYGYFAPEY 958
Query: 954 ANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013
M +I+EKSDVYSYGVVLLEIITGKKP D+SF +GQHVIQWVRDHLK KKDPV +LDPK
Sbjct: 959 GCMLRITEKSDVYSYGVVLLEIITGKKPADSSFAEGQHVIQWVRDHLKKKKDPVLILDPK 1018
Query: 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEAH---KPT 1070
LQG PD+QIQE+LQ LGISLLCTS+R+EDRPTMKDVAALLREI+Q+ G+EA KP
Sbjct: 1019 LQGQPDSQIQEILQVLGISLLCTSDRSEDRPTMKDVAALLREIQQD-QMGTEAETADKPP 1077
Query: 1071 AAKSTDTASYSSS--------SVTSAQLLLLQGQGSSHCSLAYSSSSGSYISR 1115
S T+ +++ + S L L Q SS CS A SSSG+YI R
Sbjct: 1078 RKNSNATSFDTTTSFSSSSSMAPASHLLFTLPLQESSRCSYASLSSSGAYIPR 1130
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441001|ref|XP_004138272.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1438 bits (3722), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 772/1135 (68%), Positives = 916/1135 (80%), Gaps = 26/1135 (2%)
Query: 1 MPVYYPWTLYS--LILSFVVVIIILFPHTPYAVNRQGEALLSWKRNWKGSDDGLSNWSPS 58
MPV WTL S LIL F V + + FP A+N QG+ALL+WK ++ GS++ L NW+P+
Sbjct: 3 MPVN-SWTLPSSILILCFSV-LYLFFPFGVSAINEQGQALLNWKLSFNGSNEALYNWNPN 60
Query: 59 DETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEI 118
+E PC WFG+SCN N +VV + LRYV+L G +P NF+ L SLNRLVLSG NLTGSIPKEI
Sbjct: 61 NENPCGWFGISCNRNREVVEVVLRYVNLPGKLPLNFSPLSSLNRLVLSGVNLTGSIPKEI 120
Query: 119 ASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLY 178
++L QL L+LS+N LTGEIP E+C+L+ LEQL LNSN LEG+IP IGNL++L +L LY
Sbjct: 121 SALTQLRTLELSDNGLTGEIPSEICNLVDLEQLYLNSNLLEGSIPAGIGNLTNLKELILY 180
Query: 179 DNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPT 238
DNQL+ IP +IG LK LE IRAGGNKNL GS+P EIGNC++LV++GLAETSISGFLP +
Sbjct: 181 DNQLSGEIPISIGNLKQLEVIRAGGNKNLHGSVPEEIGNCSSLVILGLAETSISGFLPSS 240
Query: 239 LGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFL 298
LG LK+LQT+AIYTALLSGQIP ELGDCTELQ IYLYEN+L+GSIPS LG L+NL ++ +
Sbjct: 241 LGRLKKLQTLAIYTALLSGQIPQELGDCTELQNIYLYENSLSGSIPSTLGRLQNLQSVLI 300
Query: 299 WQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQ 358
WQN+LVG+IPPELG C QL +IDIS+NSLTGSIP T GNLT LQELQLS NQ+SGEIP +
Sbjct: 301 WQNSLVGVIPPELGRCDQLFVIDISINSLTGSIPSTFGNLTLLQELQLSTNQLSGEIPKE 360
Query: 359 IGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDL 418
IGNC R+ IELDNNQ+TG IPSE GNL+NLTLLF+W N+LEG IPP+ISNC+NLEA+DL
Sbjct: 361 IGNCPRITHIELDNNQLTGTIPSELGNLTNLTLLFLWQNKLEGSIPPTISNCRNLEALDL 420
Query: 419 SQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPE 478
S N LTG IP GIFQLKKL+KLLLLSNNLSGVIPP +GNCS+L RFRAN+NKL+G IPPE
Sbjct: 421 SLNALTGSIPTGIFQLKKLSKLLLLSNNLSGVIPPAIGNCSALFRFRANNNKLSGEIPPE 480
Query: 479 IGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADL 538
IGNLK+L FLDLG+N LTG++P EI+GCRNLTFLD+HSNSI LP +QL LQ+ DL
Sbjct: 481 IGNLKSLIFLDLGNNHLTGALPPEISGCRNLTFLDMHSNSIKF-LPQEFNQLSSLQYVDL 539
Query: 539 SDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPAS 598
S+N + G +P GS +SLTKLVL+ NRF+G IP+++G+C+KLQLLDLS NQLSGNIP S
Sbjct: 540 SNNLIEGSPNPSFGSFNSLTKLVLSNNRFSGPIPTEIGTCLKLQLLDLSCNQLSGNIPPS 599
Query: 599 LGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNV 658
LGKIP+L I+LNLS NQ+ GE+P+EL L+KLG LDLS+N+LSGDLH LA++QNLVVLNV
Sbjct: 600 LGKIPSLEISLNLSLNQLTGEIPSELANLDKLGSLDLSYNQLSGDLHILADMQNLVVLNV 659
Query: 659 SHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAGAARVAMVVL 718
SHNNFSGRVP+TPFF +LPLSVLSGNP LCF+G +C + G H AARVAMVVL
Sbjct: 660 SHNNFSGRVPETPFFTQLPLSVLSGNPDLCFAGEKCYSDNHS--GGGHHTLAARVAMVVL 717
Query: 719 LSAACALLLAALYIILGPR---IRGLSGSHHNEG----DEDVEMGPPWELTLYNKLDLSI 771
L ACALLLAA+YIIL R R ++GS + D D+E+G WE+TLY KLDLSI
Sbjct: 718 LCTACALLLAAVYIILKDRHSCRRCINGSRGEDPDTAFDSDLELGSGWEVTLYQKLDLSI 777
Query: 772 GDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH 831
D + LT N+IG+G++G+VY+ + SGL +AVKRFR+SDK S AFSSEIATL+RIRH
Sbjct: 778 SDVIKCLTPANVIGRGKTGVVYRACISSGLIIAVKRFRSSDKFSAAAFSSEIATLARIRH 837
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
RNIVRLLGWGANR+TKLLFYDY+PNG LG LLH+G L+W++RFKIALGVAEGL+YL
Sbjct: 838 RNIVRLLGWGANRRTKLLFYDYLPNGNLGALLHEGNGRVGLDWESRFKIALGVAEGLAYL 897
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
HHDCVPAILHRDVK+HNILLG+RYE+CLADFGLARLVED GS SANPQFAGSYGY AP
Sbjct: 898 HHDCVPAILHRDVKAHNILLGDRYEACLADFGLARLVEDGPSGSSSANPQFAGSYGYFAP 957
Query: 952 EYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011
EY M +I+EKSDVYSYGVVLLEIITGKKP D+SF +GQHVIQWVRDHLK KKDPV +LD
Sbjct: 958 EYGCMLRITEKSDVYSYGVVLLEIITGKKPADSSFAEGQHVIQWVRDHLKKKKDPVLILD 1017
Query: 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEAH---K 1068
PKLQG PD+QIQE+LQ LGISLLCTS+R+EDRPTMKDVAALLREI+Q+ G+EA K
Sbjct: 1018 PKLQGQPDSQIQEILQVLGISLLCTSDRSEDRPTMKDVAALLREIQQD-QMGTEAETADK 1076
Query: 1069 PTAAKSTDTASYSSS--------SVTSAQLLLLQGQGSSHCSLAYSSSSGSYISR 1115
P S T+ +++ + S L L Q SS CS A SSSG+YI R
Sbjct: 1077 PPRKNSNATSFDTTTSFSSSSSMAPASHLLFTLPLQESSRCSYASLSSSGAYIPR 1131
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351723713|ref|NP_001235497.1| receptor-like protein kinase [Glycine max] gi|223452516|gb|ACM89585.1| receptor-like protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1426 bits (3692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 741/1020 (72%), Positives = 853/1020 (83%), Gaps = 10/1020 (0%)
Query: 52 LSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLT 111
LSNW P +TPC W+GVSCN N+VV LDLRYVDLLG +PTNFTSLLSL L+ +GTNLT
Sbjct: 48 LSNWDPVQDTPCSWYGVSCNFKNEVVQLDLRYVDLLGRLPTNFTSLLSLTSLIFTGTNLT 107
Query: 112 GSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSS 171
GSIPKEI L +L YLDLS+N+L+GEIP ELC L +LE+L LNSN L G+IP+ IGNL+
Sbjct: 108 GSIPKEIGELVELGYLDLSDNALSGEIPSELCYLPKLEELHLNSNDLVGSIPVAIGNLTK 167
Query: 172 LTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSI 231
L +L LYDNQL IP TIG LK+L+ IRAGGNKNL G LP EIGNC++LVM+GLAETS+
Sbjct: 168 LQKLILYDNQLGGKIPGTIGNLKSLQVIRAGGNKNLEGLLPQEIGNCSSLVMLGLAETSL 227
Query: 232 SGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLK 291
SG LPPTLGLLK L+TIAIYT+LLSG+IPPELG CT LQ IYLYEN+LTGSIPSKLGNLK
Sbjct: 228 SGSLPPTLGLLKNLETIAIYTSLLSGEIPPELGYCTGLQNIYLYENSLTGSIPSKLGNLK 287
Query: 292 NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQI 351
NL NL LWQNNLVG IPPE+GNC LS+ID+SMNSLTGSIP+T GNLTSLQELQLSVNQI
Sbjct: 288 NLENLLLWQNNLVGTIPPEIGNCEMLSVIDVSMNSLTGSIPKTFGNLTSLQELQLSVNQI 347
Query: 352 SGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQ 411
SGEIP ++G CQ+L +ELDNN ITG IPSE GNL+NLTLLF+WHN+L+G IP S+SNCQ
Sbjct: 348 SGEIPGELGKCQQLTHVELDNNLITGTIPSELGNLANLTLLFLWHNKLQGSIPSSLSNCQ 407
Query: 412 NLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKL 471
NLEA+DLSQNGL GPIP+GIFQLK LNKLLLLSNNLSG IP E+GNCSSLIRFRAN N +
Sbjct: 408 NLEAIDLSQNGLMGPIPKGIFQLKNLNKLLLLSNNLSGKIPSEIGNCSSLIRFRANDNNI 467
Query: 472 TGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLV 531
TG IP +IGNL NLNFLDLG+NR++G IP EI+GCRNL FLDVHSN +AGNLP L +L
Sbjct: 468 TGSIPSQIGNLNNLNFLDLGNNRISGVIPVEISGCRNLAFLDVHSNFLAGNLPESLSRLN 527
Query: 532 RLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQL 591
LQF D SDN + G L+P LG L++L+KLVL KNR +GSIPSQLGSC KLQLLDLSSN +
Sbjct: 528 SLQFLDASDNMIEGTLNPTLGELAALSKLVLAKNRISGSIPSQLGSCSKLQLLDLSSNNI 587
Query: 592 SGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQ 651
SG IP+S+G IPAL IALNLS NQ+ E+P E +GL KLGILD+SHN L G+L +L LQ
Sbjct: 588 SGEIPSSIGNIPALEIALNLSLNQLSSEIPQEFSGLTKLGILDISHNVLRGNLQYLVGLQ 647
Query: 652 NLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAGAA 711
NLVVLN+S+N F+GR+PDTPFFAKLPLSVL+GNP LCFSGN+C + + R A A
Sbjct: 648 NLVVLNISYNKFTGRIPDTPFFAKLPLSVLAGNPELCFSGNECGG----RGKSGRRARMA 703
Query: 712 RVAMVVLLSAACALLLAALYIILGPRIRG--LSGSHHNEGDEDVEMGPPWELTLYNKLDL 769
VAMVVLL A LL+AALY+++ + RG S + D + +M PPWE+TLY KLDL
Sbjct: 704 HVAMVVLLCTAFVLLMAALYVVVAAKRRGDRESDVEVDGKDSNADMAPPWEVTLYQKLDL 763
Query: 770 SIGDATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSR 828
SI D + L+AGN+IG GRSG+VY+V LP +GL +AVK+FR S+K S AFSSEIATL+R
Sbjct: 764 SISDVAKCLSAGNVIGHGRSGVVYRVDLPATGLAIAVKKFRLSEKFSAAAFSSEIATLAR 823
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
IRHRNIVRLLGWGANR+TKLLFYDY+PNG L LLH+G C GL++W+TR +IALGVAEG+
Sbjct: 824 IRHRNIVRLLGWGANRRTKLLFYDYLPNGNLDTLLHEG-CTGLIDWETRLRIALGVAEGV 882
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
+YLHHDCVPAILHRDVK+ NILLG+RYE CLADFG AR VE+D SFS NPQFAGSYGY
Sbjct: 883 AYLHHDCVPAILHRDVKAQNILLGDRYEPCLADFGFARFVEEDH-ASFSVNPQFAGSYGY 941
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG-QHVIQWVRDHLKSKKDPV 1007
IAPEYA M KI+EKSDVYS+GVVLLEIITGK+PVD SFPDG QHVIQWVR+HLKSKKDPV
Sbjct: 942 IAPEYACMLKITEKSDVYSFGVVLLEIITGKRPVDPSFPDGQQHVIQWVREHLKSKKDPV 1001
Query: 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEAH 1067
EVLD KLQGHPDTQIQEMLQALGI+LLCTSNRAEDRPTMKDVAALLREIR +P + +E H
Sbjct: 1002 EVLDSKLQGHPDTQIQEMLQALGIALLCTSNRAEDRPTMKDVAALLREIRHDPPTSAEPH 1061
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469562|ref|XP_004152488.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g26540-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1318 bits (3410), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 662/1053 (62%), Positives = 818/1053 (77%), Gaps = 10/1053 (0%)
Query: 14 LSFVVVIIILFPHTPYAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLN 73
L F++V++ F AVN QG+ALLSWK++ S L+NW +DETPC+WFG+ CN
Sbjct: 8 LFFIIVLLFSFSVFVSAVNHQGKALLSWKQSLNFSAQELNNWDSNDETPCEWFGIICNFK 67
Query: 74 NQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENS 133
+VV ++ RYV L G++PTNF+SL++L +L+ GTN+TG+IPKEI L +LN LDLS+N
Sbjct: 68 QEVVEIEFRYVKLWGNIPTNFSSLVTLKKLIFVGTNITGTIPKEIGDLRELNTLDLSDNG 127
Query: 134 LTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKL 193
LTGEIP E+C LL+LE + L+SN+L G IP IGNL+ L +L L+DNQLT IP +IG L
Sbjct: 128 LTGEIPIEICGLLKLENVDLSSNRLVGLIPAGIGNLTILKELGLHDNQLTGQIPRSIGNL 187
Query: 194 KNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTA 253
K L+ IRAGGNKN+ G++P EIGNCTNLV G AET ISG LPP+LGLLK+L+T+A+YT
Sbjct: 188 KQLKNIRAGGNKNIEGNIPPEIGNCTNLVYAGFAETRISGSLPPSLGLLKKLETLALYTT 247
Query: 254 LLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGN 313
LSGQIPPE+G+C+ LQY+YLYE LTGSIP+ GNL+NL+NLFL++N L G +P ELGN
Sbjct: 248 FLSGQIPPEIGNCSGLQYMYLYETLLTGSIPTSFGNLQNLLNLFLYRNRLTGTLPKELGN 307
Query: 314 CSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNN 373
C QL IDISMNSLTG+IP T NLT LQEL L +N ISG+IPA+I N + L + LDNN
Sbjct: 308 CYQLFDIDISMNSLTGNIPTTFSNLTLLQELNLGMNNISGQIPAEIQNWRELTHLMLDNN 367
Query: 374 QITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ 433
QITG IPSE G L NL +LF+WHN+LEG IP SISNC+ LE +DLS NGLTG IP IF
Sbjct: 368 QITGLIPSELGTLKNLRMLFLWHNKLEGNIPSSISNCEMLEEMDLSINGLTGHIPGQIFH 427
Query: 434 LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493
LKKLN L+LLSNNLSGVIP E+GNC SL RFR + N L G +PP+ GNLKNL+FLDLG N
Sbjct: 428 LKKLNSLMLLSNNLSGVIPTEIGNCLSLNRFRVSKNLLFGALPPQFGNLKNLSFLDLGDN 487
Query: 494 RLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGS 553
+ +G IPDEI+GCRNLTF+D+HSN+I+G LP+GLHQL+ LQ D S+N + G + P LG
Sbjct: 488 QFSGVIPDEISGCRNLTFIDIHSNTISGALPSGLHQLISLQIIDFSNNVIEGNIDPGLGL 547
Query: 554 LSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSW 613
LSSLTKL+L NRF+G IPS+LG+C++LQLLDLS NQLSG +PA LG+IPAL IALNLSW
Sbjct: 548 LSSLTKLILFNNRFSGPIPSELGACLRLQLLDLSVNQLSGYLPAKLGEIPALEIALNLSW 607
Query: 614 NQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFF 673
NQ+ GE+P E L++LGILDLSHN LSGDL +A +QNLVVLN+S NNFSGRVP TPFF
Sbjct: 608 NQLNGEIPKEFAYLDRLGILDLSHNHLSGDLQTIAVMQNLVVLNISDNNFSGRVPVTPFF 667
Query: 674 AKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAGAARVAMVVLLSAACALLLAALYII 733
KLP SVLSGNP L F G QC D ++ A H A+RVA+V+LL A LL+AALY+
Sbjct: 668 EKLPPSVLSGNPDLWF-GTQCTDEKGSRNSA--HESASRVAVVLLLCIAWTLLMAALYVT 724
Query: 734 LG-PRI--RGLSGSHHNEG-DEDVEMGP--PWELTLYNKLDLSIGDATRSLTAGNIIGQG 787
G RI R G H +G D D+E+G WE+TLY KLDLSI D + LTA NI+G+G
Sbjct: 725 FGSKRIARRRYYGGHDGDGVDSDMEIGNELEWEMTLYQKLDLSISDVAKKLTACNILGRG 784
Query: 788 RSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847
RSG+VY+V + GLT+AVKRF+ S+K + AFSSEI+TL+ IRHRNI+RLLGW NRKTK
Sbjct: 785 RSGVVYQVNIAPGLTIAVKRFKTSEKFAAAAFSSEISTLASIRHRNIIRLLGWAVNRKTK 844
Query: 848 LLFYDYMPNGTLGMLLHDGECAG-LLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKS 906
LLFYDY P G LG LLH+ G ++ W+ RFKIA+G+A+GL+YLHHDCVPAI HRDVK
Sbjct: 845 LLFYDYWPQGNLGGLLHECSTGGYVIGWNARFKIAMGLADGLAYLHHDCVPAISHRDVKV 904
Query: 907 HNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVY 966
NILL + Y++CL DFG AR ED+ SANP F GSYGYIAPEY +M K++EKSDVY
Sbjct: 905 QNILLSDEYDACLTDFGFARFTEDNLNEPSSANPLFVGSYGYIAPEYGHMLKVTEKSDVY 964
Query: 967 SYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEML 1026
SYG+VLLE+ITGKKP D SFP+GQH+IQWV+ HL+S+ +P+E+LDPKL+ HP+ +I EML
Sbjct: 965 SYGIVLLEMITGKKPADPSFPEGQHIIQWVQHHLRSQNNPIELLDPKLKIHPNAEIHEML 1024
Query: 1027 QALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
L I+L+CT++RA+DRP MKDVAALLR+I+ E
Sbjct: 1025 HVLEIALICTNHRADDRPMMKDVAALLRKIQTE 1057
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1117 | ||||||
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.910 | 0.933 | 0.515 | 1.4e-284 | |
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.915 | 0.937 | 0.508 | 2.5e-280 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.913 | 0.893 | 0.456 | 1.1e-245 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.908 | 0.894 | 0.450 | 2.3e-238 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.570 | 0.578 | 0.351 | 1.1e-168 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.867 | 0.862 | 0.361 | 9.9e-158 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.590 | 0.528 | 0.354 | 1.6e-156 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.870 | 0.882 | 0.356 | 2.8e-153 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.558 | 0.498 | 0.357 | 3.9e-153 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.791 | 0.881 | 0.376 | 6.7e-152 |
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2734 (967.5 bits), Expect = 1.4e-284, P = 1.4e-284
Identities = 539/1046 (51%), Positives = 708/1046 (67%)
Query: 29 YAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLG 88
++++ QG ALLSWK S D LS+W S+ PC+W G+ CN QV + L+ +D G
Sbjct: 26 FSIDEQGLALLSWKSQLNISGDALSSWKASESNPCQWVGIKCNERGQVSEIQLQVMDFQG 85
Query: 89 HVP-TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCXXXX 147
+P TN + SL L L+ NLTGSIPKE+ L++L LDL++NSL+GEIP ++
Sbjct: 86 PLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLDLADNSLSGEIPVDIFKLKK 145
Query: 148 XXXXXXXXXXXXGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNL 207
G IP ++GNL +L +L L+DN+L IP TIG+LKNLE RAGGNKNL
Sbjct: 146 LKILSLNTNNLEGVIPSELGNLVNLIELTLFDNKLAGEIPRTIGELKNLEIFRAGGNKNL 205
Query: 208 GGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCT 267
G LP EIGNC +LV +GLAETS+SG LP ++G LK++QTIA+YT+LLSG IP E+G+CT
Sbjct: 206 RGELPWEIGNCESLVTLGLAETSLSGRLPASIGNLKKVQTIALYTSLLSGPIPDEIGNCT 265
Query: 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327
ELQ +YLY+N+++GSIP +G LK L +L LWQNNLVG IP ELG C +L ++D+S N L
Sbjct: 266 ELQNLYLYQNSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTELGTCPELFLVDLSENLL 325
Query: 328 TGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLS 387
TG+IP++ GNL +LQELQLSVNQ+SG IP ++ NC +L +E+DNNQI+G IP G L+
Sbjct: 326 TGNIPRSFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEIDNNQISGEIPPLIGKLT 385
Query: 388 NLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQXXXXXXXXXXXXXX 447
+LT+ F W N+L G IP S+S CQ L+A+DLS N L+G IP GIF+
Sbjct: 386 SLTMFFAWQNQLTGIIPESLSQCQELQAIDLSYNNLSGSIPNGIFEIRNLTKLLLLSNYL 445
Query: 448 XGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCR 507
G IPP++GNC++L R R N N+L G IP EIGNLKNLNF+D+ NRL G+IP EI+GC
Sbjct: 446 SGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDISENRLIGNIPPEISGCT 505
Query: 508 NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRF 567
+L F+D+HSN + G LP L + LQF DLSDNS+ G L +GSL+ LTKL L KNRF
Sbjct: 506 SLEFVDLHSNGLTGGLPGTLPK--SLQFIDLSDNSLTGSLPTGIGSLTELTKLNLAKNRF 563
Query: 568 AGSIPSQLGSCVKXXXXXXXXXXXXGNIPASLGKIPALAIALNLSWNQICGELPAELTGL 627
+G IP ++ SC G IP LG+IP+LAI+LNLS N GE+P+ + L
Sbjct: 564 SGEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISLNLSCNHFTGEIPSRFSSL 623
Query: 628 NKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSL 687
LG LD+SHN+L+G+L+ LA+LQNLV LN+S N FSG +P+T FF KLPLSVL N L
Sbjct: 624 TNLGTLDVSHNKLAGNLNVLADLQNLVSLNISFNEFSGELPNTLFFRKLPLSVLESNKGL 683
Query: 688 CFSGNQCADSTYKKDGA-SRHAGAARXXXXXXXXXXXXXXXXXXYIILGPRIRGLSGSHH 746
S T ++G +RH A + Y ++ + + ++G
Sbjct: 684 FIS-------TRPENGIQTRHRSAVKVTMSILVAASVVLVLMAVYTLV--KAQRITGKQ- 733
Query: 747 NEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVK 806
E+++ WE+TLY KLD SI D ++LT+ N+IG G SG+VY+VT+PSG T+AVK
Sbjct: 734 ----EELDS---WEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRVTIPSGETLAVK 786
Query: 807 RFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD- 865
+ + ++ AF+SEI TL IRHRNI+RLLGW +NR KLLFYDY+PNG+L LLH
Sbjct: 787 KMWSKEE--NRAFNSEINTLGSIRHRNIIRLLGWCSNRNLKLLFYDYLPNGSLSSLLHGA 844
Query: 866 GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925
G+ +G +W+ R+ + LGVA L+YLHHDC+P ILH DVK+ N+LLG R+ES LADFGLA
Sbjct: 845 GKGSGGADWEARYDVVLGVAHALAYLHHDCLPPILHGDVKAMNVLLGSRFESYLADFGLA 904
Query: 926 RLVE-----DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKK 980
++V D S P AGSYGY+APE+A+M I+EKSDVYSYGVVLLE++TGK
Sbjct: 905 KIVSGEGVTDGDSSKLSNRPPLAGSYGYMAPEHASMQHITEKSDVYSYGVVLLEVLTGKH 964
Query: 981 PVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRA 1040
P+D P G H++QWVRDHL KKDP E+LDP+L+G D + EMLQ L +S LC SN+A
Sbjct: 965 PLDPDLPGGAHLVQWVRDHLAGKKDPREILDPRLRGRADPIMHEMLQTLAVSFLCVSNKA 1024
Query: 1041 EDRPTMKDVAALLREIRQEPASGSEA 1066
DRP MKD+ A+L+EIRQ SE+
Sbjct: 1025 SDRPMMKDIVAMLKEIRQFDMDRSES 1050
|
|
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2694 (953.4 bits), Expect = 2.5e-280, P = 2.5e-280
Identities = 533/1048 (50%), Positives = 706/1048 (67%)
Query: 29 YAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLG 88
+++++QG+ALLSWK S D S+W +D +PC W GV CN +V + L+ +DL G
Sbjct: 23 FSLDQQGQALLSWKSQLNISGDAFSSWHVADTSPCNWVGVKCNRRGEVSEIQLKGMDLQG 82
Query: 89 HVP-TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCXXXX 147
+P T+ SL SL L LS NLTG IPKEI +L LDLS+NSL+G+IP E+
Sbjct: 83 SLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIFRLKK 142
Query: 148 XXXXXXXXXXXXGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNL 207
G IP++IGNLS L +L L+DN+L+ IP +IG+LKNL+ +RAGGNKNL
Sbjct: 143 LKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGGNKNL 202
Query: 208 GGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCT 267
G LP EIGNC NLVM+GLAETS+SG LP ++G LKR+QTIAIYT+LLSG IP E+G CT
Sbjct: 203 RGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYCT 262
Query: 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327
ELQ +YLY+N+++GSIP+ +G LK L +L LWQNNLVG IP ELGNC +L +ID S N L
Sbjct: 263 ELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENLL 322
Query: 328 TGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLS 387
TG+IP++ G L +LQELQLSVNQISG IP ++ NC +L +E+DNN ITG IPS NL
Sbjct: 323 TGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNLR 382
Query: 388 NLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQXXXXXXXXXXXXXX 447
+LT+ F W N+L G IP S+S C+ L+A+DLS N L+G IP+ IF
Sbjct: 383 SLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSNDL 442
Query: 448 XGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCR 507
G IPP++GNC++L R R N N+L G IP EIGNLKNLNF+D+ NRL GSIP I+GC
Sbjct: 443 SGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISGCE 502
Query: 508 NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRF 567
+L FLD+H+NS++G+L G L+F D SDN++ L P +G L+ LTKL L KNR
Sbjct: 503 SLEFLDLHTNSLSGSL-LGTTLPKSLKFIDFSDNALSSTLPPGIGLLTELTKLNLAKNRL 561
Query: 568 AGSIPSQLGSCVKXXXXXXXXXXXXGNIPASLGKIPALAIALNLSWNQICGELPAELTGL 627
+G IP ++ +C G IP LG+IP+LAI+LNLS N+ GE+P+ + L
Sbjct: 562 SGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRFVGEIPSRFSDL 621
Query: 628 NKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSL 687
LG+LD+SHN+L+G+L+ L +LQNLV LN+S+N+FSG +P+TPFF +LPLS L+ N L
Sbjct: 622 KNLGVLDVSHNQLTGNLNVLTDLQNLVSLNISYNDFSGDLPNTPFFRRLPLSDLASNRGL 681
Query: 688 CFSGNQCADSTYKKDGASRHAGAARXXXXXXXXXXXXXXXXXXYIILGPRIRG--LSGSH 745
S A ST + D +R++ R Y ++ R G L G
Sbjct: 682 YISN---AIST-RPDPTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRARAAGKQLLG-- 735
Query: 746 HNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAV 805
E+++ WE+TLY KLD SI D ++LT+ N+IG G SG+VY++T+PSG ++AV
Sbjct: 736 -----EEIDS---WEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRITIPSGESLAV 787
Query: 806 KRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD 865
K+ + ++ +GAF+SEI TL IRHRNIVRLLGW +NR KLLFYDY+PNG+L LH
Sbjct: 788 KKMWSKEE--SGAFNSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHG 845
Query: 866 GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925
G ++W+ R+ + LGVA L+YLHHDC+P I+H DVK+ N+LLG +E LADFGLA
Sbjct: 846 AGKGGCVDWEARYDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLA 905
Query: 926 RLVED--DSGGSFSA---NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKK 980
R + ++G + P AGSYGY+APE+A+M +I+EKSDVYSYGVVLLE++TGK
Sbjct: 906 RTISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVLTGKH 965
Query: 981 PVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRA 1040
P+D P G H+++WVRDHL KKDP +LDP+L G D+ + EMLQ L ++ LC SN+A
Sbjct: 966 PLDPDLPGGAHLVKWVRDHLAEKKDPSRLLDPRLDGRTDSIMHEMLQTLAVAFLCVSNKA 1025
Query: 1041 EDRPTMKDVAALLREIRQEPASGSEAHK 1068
+RP MKDV A+L EIR SE K
Sbjct: 1026 NERPLMKDVVAMLTEIRHIDVGRSETEK 1053
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2367 (838.3 bits), Expect = 1.1e-245, P = 1.1e-245
Identities = 476/1042 (45%), Positives = 651/1042 (62%)
Query: 32 NRQGEALLSWKRNWKGSDDGLS--NWSPSDETPCK-WFGVSCNLNNQVVGLDLRYVDLLG 88
N + L SW + + LS NW+ D TPC W ++C+ + +D+ V L
Sbjct: 36 NPEASILYSWLHSSSPTPSSLSLFNWNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQL 95
Query: 89 HVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCXXXXX 148
+P N + SL +L +SG NLTG++P+ + L LDLS N L G+IP L
Sbjct: 96 SLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNL 155
Query: 149 XXXXXXXXXXXGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLG 208
G IP I S L L L+DN LT +IP +GKL LE IR GGNK +
Sbjct: 156 ETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEIS 215
Query: 209 GSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTE 268
G +P EIG+C+NL ++GLAETS+SG LP +LG LK+L+T++IYT ++SG+IP +LG+C+E
Sbjct: 216 GQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSE 275
Query: 269 LQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLT 328
L ++LYEN+L+GSIP ++G L L LFLWQN+LVG IP E+GNCS L +ID+S+N L+
Sbjct: 276 LVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLS 335
Query: 329 GSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSN 388
GSIP ++G L+ L+E +S N+ SG IP I NC L Q++LD NQI+G IPSE G L+
Sbjct: 336 GSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTK 395
Query: 389 LTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQXXXXXXXXXXXXXXX 448
LTL F W N+LEG IPP +++C +L+A+DLS+N LTG IP G+F
Sbjct: 396 LTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLS 455
Query: 449 GVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRN 508
G IP E+GNCSSL+R R N++TG IP IG+LK +NFLD SNRL G +PDEI C
Sbjct: 456 GFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSE 515
Query: 509 LTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFA 568
L +D+ +NS+ G+LP + L LQ D+S N G + LG L SL KL+L+KN F+
Sbjct: 516 LQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFS 575
Query: 569 GSIPSQLGSCVKXXXXXXXXXXXXGNIPASLGKIPALAIALNLSWNQICGELPAELTGLN 628
GSIP+ LG C G IP+ LG I L IALNLS N++ G++P+++ LN
Sbjct: 576 GSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLN 635
Query: 629 KLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLC 688
KL ILDLSHN L GDL LA ++NLV LN+S+N+FSG +PD F +L L GN LC
Sbjct: 636 KLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLC 695
Query: 689 FSGNQCADSTYKKDGASRHAGAARXXXXXXXXXXXXXXXXXXYIILGPRIRGLSGSHHNE 748
S TY+K G A +ILG + + + +
Sbjct: 696 SSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGA-VAVIRARRNID 754
Query: 749 GDEDVEMGPP--WELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVK 806
+ D E+G W+ T + KL+ S+ R L N+IG+G SG+VY+ + +G +AVK
Sbjct: 755 NERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVK 814
Query: 807 RFRAS-------DKIST--GAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNG 857
+ + +K +FS+E+ TL IRH+NIVR LG NR T+LL YDYMPNG
Sbjct: 815 KLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNG 874
Query: 858 TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917
+LG LLH+ + L +WD R++I LG A+GL+YLHHDC+P I+HRD+K++NIL+G +E
Sbjct: 875 SLGSLLHERRGSSL-DWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEP 933
Query: 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
+ADFGLA+LV++ G S AGSYGYIAPEY KI+EKSDVYSYGVV+LE++T
Sbjct: 934 YIADFGLAKLVDEGDIGRCSNT--VAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLT 991
Query: 978 GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTS 1037
GK+P+D + P+G H++ WVR + S +EVLD L+ + + EM+Q LG +LLC +
Sbjct: 992 GKQPIDPTVPEGIHLVDWVRQNRGS----LEVLDSTLRSRTEAEADEMMQVLGTALLCVN 1047
Query: 1038 NRAEDRPTMKDVAALLREIRQE 1059
+ ++RPTMKDVAA+L+EI+QE
Sbjct: 1048 SSPDERPTMKDVAAMLKEIKQE 1069
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2298 (814.0 bits), Expect = 2.3e-238, P = 2.3e-238
Identities = 473/1050 (45%), Positives = 655/1050 (62%)
Query: 30 AVNRQGEALLSWKRNWKGSDDGL-SNWSPSDETPCKWFGVSCNL--NNQVVGLDLRYVDL 86
A + AL+SW + + S W+PSD PC+W ++C+ N V +++ V L
Sbjct: 35 ASTNEVSALISWLHSSNSPPPSVFSGWNPSDSDPCQWPYITCSSSDNKLVTEINVVSVQL 94
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCXXX 146
P N +S SL +LV+S TNLTG+I EI ++L +DLS NSL GEIP L
Sbjct: 95 ALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLK 154
Query: 147 XXXXXXXXXXXXXGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKN 206
G IP ++G+ SL L ++DN L++ +P +GK+ LE+IRAGGN
Sbjct: 155 NLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSE 214
Query: 207 LGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDC 266
L G +P EIGNC NL ++GLA T ISG LP +LG L +LQ++++Y+ +LSG+IP ELG+C
Sbjct: 215 LSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNC 274
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
+EL ++LY+N L+G++P +LG L+NL + LWQNNL G IP E+G L+ ID+SMN
Sbjct: 275 SELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNY 334
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNL 386
+G+IP++ GNL++LQEL LS N I+G IP+ + NC +L Q ++D NQI+G IP E G L
Sbjct: 335 FSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLL 394
Query: 387 SNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQXXXXXXXXXXXXX 446
L + W N+LEG IP ++ CQNL+A+DLSQN LTG +P G+FQ
Sbjct: 395 KELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNA 454
Query: 447 XXGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506
GVIP E+GNC+SL+R R +N++TG IP IG L+NL+FLDL N L+G +P EI+ C
Sbjct: 455 ISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNC 514
Query: 507 RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNR 566
R L L++ +N++ G LP L L +LQ D+S N + G + LG L SL +L+L+KN
Sbjct: 515 RQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNS 574
Query: 567 FAGSIPSQLGSCVKXXXXXXXXXXXXGNIPASLGKIPALAIALNLSWNQICGELPAELTG 626
F G IPS LG C G IP L I L IALNLSWN + G +P ++
Sbjct: 575 FNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISA 634
Query: 627 LNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPS 686
LN+L +LD+SHN LSGDL L+ L+NLV LN+SHN FSG +PD+ F +L + + GN
Sbjct: 635 LNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNG 694
Query: 687 LCFSG-NQCADSTYKKDGASRHAGAARXXXXXXXXXXXXXXXXXXYIILGPRIRGLSGSH 745
LC G C S + R + R +LG + +
Sbjct: 695 LCSKGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLA----VLGV-LAVIRAKQ 749
Query: 746 HNEGDEDVEMGP---PWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLT 802
D D E G W+ T + KL+ ++ + L GN+IG+G SGIVYK +P+
Sbjct: 750 MIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREV 809
Query: 803 VAVKRF------RASDKI-STG---AFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852
+AVK+ ++K S+G +FS+E+ TL IRH+NIVR LG N+ T+LL YD
Sbjct: 810 IAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYD 869
Query: 853 YMPNGTLGMLLHD--GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNIL 910
YM NG+LG LLH+ G C+ L W+ R+KI LG A+GL+YLHHDCVP I+HRD+K++NIL
Sbjct: 870 YMSNGSLGSLLHERSGVCS--LGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNIL 927
Query: 911 LGERYESCLADFGLARLVEDDSGGSFSANPQ-FAGSYGYIAPEYANMTKISEKSDVYSYG 969
+G +E + DFGLA+LV+D G F+ + AGSYGYIAPEY KI+EKSDVYSYG
Sbjct: 928 IGPDFEPYIGDFGLAKLVDD---GDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYG 984
Query: 970 VVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQAL 1029
VV+LE++TGK+P+D + PDG H++ WV K +D ++V+D LQ P+++++EM+Q L
Sbjct: 985 VVVLEVLTGKQPIDPTIPDGLHIVDWV----KKIRD-IQVIDQGLQARPESEVEEMMQTL 1039
Query: 1030 GISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
G++LLC + EDRPTMKDVAA+L EI QE
Sbjct: 1040 GVALLCINPIPEDRPTMKDVAAMLSEICQE 1069
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 990 (353.6 bits), Expect = 1.1e-168, Sum P(2) = 1.1e-168
Identities = 225/641 (35%), Positives = 341/641 (53%)
Query: 30 AVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGH 89
++N +G LL +K S+ L++W+ D PC W G++C V +DL ++L G
Sbjct: 23 SLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHLRTVTSVDLNGMNLSGT 82
Query: 90 VPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCXXXXXX 149
+ L L +L +S ++G IP++++ L LDL N G IP +L
Sbjct: 83 LSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLK 142
Query: 150 XXXXXXXXXXGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGG 209
G+IP QIGNLSSL +L +Y N LT IP ++ KL+ L IRAG N G
Sbjct: 143 KLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRN-GFSG 201
Query: 210 SLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTEL 269
+P EI C +L ++GLAE + G LP L L+ L + ++ LSG+IPP +G+ + L
Sbjct: 202 VIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRL 261
Query: 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTG 329
+ + L+EN TGSIP ++G L + L+L+ N L G IP E+GN + ID S N LTG
Sbjct: 262 EVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTG 321
Query: 330 SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNL 389
IP+ G++ +L+ L L N + G IP ++G L +++L N++ G IP E L L
Sbjct: 322 FIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYL 381
Query: 390 TLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQXXXXXXXXXXXXXXXG 449
L ++ N+LEG+IPP I N +D+S N L+GPIP + G
Sbjct: 382 VDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSG 441
Query: 450 VIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNL 509
IP ++ C SL + N+LTG +P E+ NL+NL L+L N L+G+I ++ +NL
Sbjct: 442 NIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNL 501
Query: 510 TFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAG 569
L + +N+ G +P + L ++ ++S N + G + +LGS ++ +L L+ N+F+G
Sbjct: 502 ERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSG 561
Query: 570 SIPSQLGSCVKXXXXXXXXXXXXGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNK 629
I +LG V G IP S G + L + L L N + +P EL L
Sbjct: 562 YIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRL-MELQLGGNLLSENIPVELGKLTS 620
Query: 630 LGI-LDLSHNELSGDL-HFLAELQNLVVLNVSHNNFSGRVP 668
L I L++SHN LSG + L LQ L +L ++ N SG +P
Sbjct: 621 LQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIP 661
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1537 (546.1 bits), Expect = 9.9e-158, P = 9.9e-158
Identities = 362/1002 (36%), Positives = 534/1002 (53%)
Query: 76 VVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLT 135
+V L+L Y L G +P + L + L+ GSIP EI L+QL ++ N L+
Sbjct: 111 LVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLS 170
Query: 136 GEIPRELCXXXXXXXXXXXXXXXXGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKN 195
G +P E+ G +P +GNL+ LT N + IP IGK N
Sbjct: 171 GPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLN 230
Query: 196 LEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALL 255
L+ + N + G LP EIG L + L + SGF+P +G L L+T+A+Y L
Sbjct: 231 LKLLGLAQNF-ISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSL 289
Query: 256 SGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCS 315
G IP E+G+ L+ +YLY+N L G+IP +LG L ++ + +N L G IP EL S
Sbjct: 290 VGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKIS 349
Query: 316 QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQI 375
+L ++ + N LTG IP L L +L +L LS+N ++G IP N + Q++L +N +
Sbjct: 350 ELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSL 409
Query: 376 TGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQXX 435
+G IP G S L ++ N+L G+IPP I NL ++L N + G IP G+ +
Sbjct: 410 SGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCK 469
Query: 436 XXXXXXXXXXXXXGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRL 495
G P E+ +L + N+ +G +PPEIG + L L L +N+
Sbjct: 470 SLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQF 529
Query: 496 TGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLS 555
+ ++P+EI+ NL +V SNS+ G +P+ + LQ DLS NS G L P+LGSL
Sbjct: 530 SSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLH 589
Query: 556 SLTKLVLNKNRFAGSIPSQLGSCVKXXXXXXXXXXXXGNIPASLGKIPALAIALNLSWNQ 615
L L L++NRF+G+IP +G+ G+IP LG + +L IA+NLS+N
Sbjct: 590 QLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYND 649
Query: 616 ICGELPAELTGLNKLGILDLSHNELSGDLHFLAE-LQNLVVLNVSHNNFSGRVPDTPFFA 674
GE+P E+ L+ L L L++N LSG++ E L +L+ N S+NN +G++P T F
Sbjct: 650 FSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQ 709
Query: 675 KLPLSVLSGNPSLCFSGNQCADSTYKK--DGASRHAGAARXXXXXXXXXXXXXXXXXXYI 732
+ L+ GN LC + D ++ +S AG+AR I
Sbjct: 710 NMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLI 769
Query: 733 IL------GPRIRGLSGSHHNEG---DEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNI 783
+ P H E + D+ P T+ + L+ AT+ I
Sbjct: 770 AIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILE-----ATKGFHDSYI 824
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRAS------DKIST-GAFSSEIATLSRIRHRNIVR 836
+G+G G VYK +PSG T+AVK+ ++ + +T +F +EI TL +IRHRNIVR
Sbjct: 825 VGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVR 884
Query: 837 LLGWGANR--KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
L + ++ + LL Y+YM G+LG LLH G+ + +W TRF IALG AEGL+YLHHD
Sbjct: 885 LYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSM-DWPTRFAIALGAAEGLAYLHHD 943
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
C P I+HRD+KS+NIL+ E +E+ + DFGLA++++ S SA AGSYGYIAPEYA
Sbjct: 944 CKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSA---VAGSYGYIAPEYA 1000
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
K++EK D+YS+GVVLLE++TGK PV G + W R+H++ E+LDP L
Sbjct: 1001 YTMKVTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGDLATWTRNHIRDHSLTSEILDPYL 1059
Query: 1015 -QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
+ D + M+ I++LCT + DRPTM++V +L E
Sbjct: 1060 TKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIE 1101
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 947 (338.4 bits), Expect = 1.6e-156, Sum P(2) = 1.6e-156
Identities = 240/677 (35%), Positives = 351/677 (51%)
Query: 28 PYAVNRQGEALLSWKRNWKGS---DDGLSNWSPSDETPCKWFGVSCNLNN--QVVGLDLR 82
P +N + LL K++ + DD L W+ + C W GV+C+ +V+ L+L
Sbjct: 20 PGIINNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLFRVIALNLT 79
Query: 83 YVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPREL 142
+ L G + F +L L LS NL G IP +++L L L L N LTGEIP +L
Sbjct: 80 GLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQL 139
Query: 143 CXXXXXXXXXXXXXXXXGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAG 202
G IP +GNL +L L L +LT IP+ +G+L ++++
Sbjct: 140 GSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQ 199
Query: 203 GNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE 262
N L G +P E+GNC++L + AE ++G +P LG L+ L+ + + L+G+IP +
Sbjct: 200 DNY-LEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQ 258
Query: 263 LGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDI 322
LG+ ++LQY+ L N L G IP L +L NL L L NNL G IP E N SQL + +
Sbjct: 259 LGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVL 318
Query: 323 SMNSLTGSIPQTL-GNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPS 381
+ N L+GS+P+++ N T+L++L LS Q+SGEIP ++ CQ L Q++L NN + G+IP
Sbjct: 319 ANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPE 378
Query: 382 EFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQXXXXXXXX 441
L LT L++ +N LEG + PSISN NL+ + L N L G +P+ I
Sbjct: 379 ALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLF 438
Query: 442 XXXXXXXGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPD 501
G IP E+GNC+SL N G IPP IG LK LN L L N L G +P
Sbjct: 439 LYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPA 498
Query: 502 EITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLV 561
+ C L LD+ N ++G++P+ L L+ L +NS+ G L L SL +LT++
Sbjct: 499 SLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRIN 558
Query: 562 LNKNRFAGSIPSQLGSCVKXXXXXXXXXXXXGNIPASLGKIPALAIALNLSWNQICGELP 621
L+ NR G+I GS IP LG L L L NQ+ G++P
Sbjct: 559 LSHNRLNGTIHPLCGSS-SYLSFDVTNNGFEDEIPLELGNSQNLD-RLRLGKNQLTGKIP 616
Query: 622 AELTGLNKLGILDLSHNELSGDLHF-LAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSV 680
L + +L +LD+S N L+G + L + L +++++N SG +P P+ KL S
Sbjct: 617 WTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIP--PWLGKL--SQ 672
Query: 681 LSGNPSLCFSGNQCADS 697
L L S NQ +S
Sbjct: 673 LG---ELKLSSNQFVES 686
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1495 (531.3 bits), Expect = 2.8e-153, P = 2.8e-153
Identities = 359/1006 (35%), Positives = 520/1006 (51%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEI 138
LDL Y L G +P + SL L L+ G IP EI L L L + N ++G +
Sbjct: 102 LDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSL 161
Query: 139 PRELCXXXXXXXXXXXXXXXXGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEA 198
P E+ G +P IGNL LT N ++ ++P+ IG ++L
Sbjct: 162 PVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVM 221
Query: 199 IRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQ 258
+ N+ L G LP EIG L + L E SGF+P + L+T+A+Y L G
Sbjct: 222 LGLAQNQ-LSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGP 280
Query: 259 IPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLS 318
IP ELGD L+++YLY N L G+IP ++GNL + + +N L G IP ELGN L
Sbjct: 281 IPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLE 340
Query: 319 IIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGA 378
++ + N LTG+IP L L +L +L LS+N ++G IP + L ++L N ++G
Sbjct: 341 LLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGT 400
Query: 379 IPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQXXXXX 438
IP + G S+L +L + N L G IP + N+ ++L N L+G IP GI
Sbjct: 401 IPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLV 460
Query: 439 XXXXXXXXXXGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGS 498
G P + ++ N+ G IP E+GN L L L N TG
Sbjct: 461 QLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGE 520
Query: 499 IPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLT 558
+P EI L L++ SN + G +P+ + LQ D+ N+ G L ++GSL L
Sbjct: 521 LPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLE 580
Query: 559 KLVLNKNRFAGSIPSQLGSCVKXXXXXXXXXXXXGNIPASLGKIPALAIALNLSWNQICG 618
L L+ N +G+IP LG+ + G+IP LG + L IALNLS+N++ G
Sbjct: 581 LLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTG 640
Query: 619 ELPAELTGLNKLGILDLSHNELSGDL-HFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP 677
E+P EL+ L L L L++N LSG++ A L +L+ N S+N+ +G +P +
Sbjct: 641 EIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNIS 697
Query: 678 LSVLSGNPSLCFSG-NQCADS-------TYKKDGASRHAGAARXXXXXXXXXXXXXXXXX 729
+S GN LC NQC + + K G R +
Sbjct: 698 MSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALI 757
Query: 730 XYIILGPRIRGLSGSHHNEGDEDVEMG---PPWELTLYNKLDLSIGDATRSLTAGNIIGQ 786
Y++ P +R ++ S + ++ + PP E + DL AT + ++G+
Sbjct: 758 VYLMRRP-VRTVASSAQDGQPSEMSLDIYFPPKEGFTFQ--DLVA--ATDNFDESFVVGR 812
Query: 787 GRSGIVYKVTLPSGLTVAVKRFRASDKISTG-----AFSSEIATLSRIRHRNIVRLLGWG 841
G G VYK LP+G T+AVK+ ++ + +F +EI TL IRHRNIV+L G+
Sbjct: 813 GACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFC 872
Query: 842 ANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILH 901
++ + LL Y+YMP G+LG +LHD C L+W RFKIALG A+GL+YLHHDC P I H
Sbjct: 873 NHQGSNLLLYEYMPKGSLGEILHDPSCN--LDWSKRFKIALGAAQGLAYLHHDCKPRIFH 930
Query: 902 RDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISE 961
RD+KS+NILL +++E+ + DFGLA++++ S SA AGSYGYIAPEYA K++E
Sbjct: 931 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSA---IAGSYGYIAPEYAYTMKVTE 987
Query: 962 KSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQ 1021
KSD+YSYGVVLLE++TGK PV G V+ WVR +++ VLD +L +
Sbjct: 988 KSDIYSYGVVLLELLTGKAPVQP-IDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERI 1046
Query: 1022 IQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEAH 1067
+ ML L I+LLCTS RP+M+ V +L I E + G + H
Sbjct: 1047 VSHMLTVLKIALLCTSVSPVARPSMRQVVLML--IESERSEGEQEH 1090
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 939 (335.6 bits), Expect = 3.9e-153, Sum P(2) = 3.9e-153
Identities = 226/633 (35%), Positives = 331/633 (52%)
Query: 49 DDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGT 108
+D L +W+ + C W GV+C +++GL+L + L G + + +L + LS
Sbjct: 47 EDVLRDWNSGSPSYCNWTGVTCG-GREIIGLNLSGLGLTGSISPSIGRFNNLIHIDLSSN 105
Query: 109 NLTGSIPKEIASLNQ-LNYLDLSENSLTGEIPRELCXXXXXXXXXXXXXXXXGAIPIQIG 167
L G IP +++L+ L L L N L+G+IP +L G IP G
Sbjct: 106 RLVGPIPTTLSNLSSSLESLHLFSNLLSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFG 165
Query: 168 NLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLA 227
NL +L L L +LT IP+ G+L L+ + N+ L G +P EIGNCT+L + A
Sbjct: 166 NLVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNE-LEGPIPAEIGNCTSLALFAAA 224
Query: 228 ETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKL 287
++G LP L LK LQT+ + SG+IP +LGD +QY+ L N L G IP +L
Sbjct: 225 FNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRL 284
Query: 288 GNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTL-GNLTSLQELQL 346
L NL L L NNL G+I E +QL + ++ N L+GS+P+T+ N TSL++L L
Sbjct: 285 TELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFL 344
Query: 347 SVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPS 406
S Q+SGEIPA+I NCQ L ++L NN +TG IP L LT L++ +N LEG + S
Sbjct: 345 SETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSS 404
Query: 407 ISNCQNLEAVDLSQNGLTGPIPRGIFQXXXXXXXXXXXXXXXGVIPPEMGNCSSLIRFRA 466
ISN NL+ L N L G +P+ I G +P E+GNC+ L
Sbjct: 405 ISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDW 464
Query: 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG 526
N+L+G IP IG LK+L L L N L G+IP + C +T +D+ N ++G++P+
Sbjct: 465 YGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSS 524
Query: 527 LHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKXXXXXX 586
L L+ + +NS+ G L L +L +LT++ + N+F GSI GS
Sbjct: 525 FGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSS-SYLSFDV 583
Query: 587 XXXXXXGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF 646
G+IP LGK L L L NQ G +P +++L +LD+S N LSG +
Sbjct: 584 TENGFEGDIPLELGKSTNLD-RLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPV 642
Query: 647 -LAELQNLVVLNVSHNNFSGRVPDTPFFAKLPL 678
L + L +++++N SG +P + KLPL
Sbjct: 643 ELGLCKKLTHIDLNNNYLSGVIPT--WLGKLPL 673
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1482 (526.7 bits), Expect = 6.7e-152, P = 6.7e-152
Identities = 343/911 (37%), Positives = 494/911 (54%)
Query: 160 GAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGN-C 218
G + + +L L L L +N ++ IP I L L + N GS P EI +
Sbjct: 83 GTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNV-FNGSFPDEISSGL 141
Query: 219 TNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENA 278
NL ++ + +++G LP ++ L +L+ + + +G+IPP G ++Y+ + N
Sbjct: 142 VNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNE 201
Query: 279 LTGSIPSKLGNLKNLVNLFL-WQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGN 337
L G IP ++GNL L L++ + N +PPE+GN S+L D + LTG IP +G
Sbjct: 202 LVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGK 261
Query: 338 LTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHN 397
L L L L VN SG + ++G L ++L NN TG IP+ F L NLTLL ++ N
Sbjct: 262 LQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRN 321
Query: 398 RLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQXXXXXXXXXXXXXXXGVIPPEMGN 457
+L GEIP I + LE + L +N TG IP+ + + G +PP M +
Sbjct: 322 KLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCS 381
Query: 458 CSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSN 517
+ L N L G IP +G ++L + +G N L GSIP + G LT +++ N
Sbjct: 382 GNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDN 441
Query: 518 SIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGS 577
++G LP V L LS+N + G L P +G+ + + KL+L+ N+F G IPS++G
Sbjct: 442 YLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGK 501
Query: 578 CVKXXXXXXXXXXXXGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSH 637
+ G I + + L ++LS N++ GE+P E+T + L L+LS
Sbjct: 502 LQQLSKIDFSHNLFSGRIAPEISRCKLLTF-VDLSRNELSGEIPNEITAMKILNYLNLSR 560
Query: 638 NELSGDLH-FLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLC--FSGNQC 694
N L G + ++ +Q+L L+ S+NN SG VP T F+ + GNP LC + G C
Sbjct: 561 NHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLG-PC 619
Query: 695 ADSTYKKDGASRHAGAARXXXXXXXXXXXXXXXXXXYIILGPRIRGLSGSHHNEGDEDVE 754
D K S G ++ + R L + +
Sbjct: 620 KDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRA----- 674
Query: 755 MGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI 814
W LT + +LD + D SL NIIG+G +GIVYK +P+G VAVKR A +
Sbjct: 675 ----WRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRG 730
Query: 815 STG--AFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLL 872
S+ F++EI TL RIRHR+IVRLLG+ +N +T LL Y+YMPNG+LG +LH G+ G L
Sbjct: 731 SSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLH-GKKGGHL 789
Query: 873 EWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932
WDTR+KIAL A+GL YLHHDC P I+HRDVKS+NILL +E+ +ADFGLA+ ++D
Sbjct: 790 HWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDS- 848
Query: 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHV 992
G+ AGSYGYIAPEYA K+ EKSDVYS+GVVLLE++TG+KPV F DG +
Sbjct: 849 -GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPV-GEFGDGVDI 906
Query: 993 IQWVRDHLKSKKDPV-EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051
+QWVR S KD V +VLDP+L P I E+ +++LC +A +RPTM++V
Sbjct: 907 VQWVRKMTDSNKDSVLKVLDPRLSSIP---IHEVTHVFYVAMLCVEEQAVERPTMREVVQ 963
Query: 1052 LLREIRQEPAS 1062
+L EI + P S
Sbjct: 964 ILTEIPKLPPS 974
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XII.732.1 | hypothetical protein (1047 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1117 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-154 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-04 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 4e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 8e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 485 bits (1250), Expect = e-154
Identities = 339/1037 (32%), Positives = 496/1037 (47%), Gaps = 121/1037 (11%)
Query: 36 EALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFT 95
E LLS+K + LSNW+ S C W G++CN +++VV +DL ++ G + +
Sbjct: 32 ELLLSFKSSINDPLKYLSNWNSSA-DVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIF 90
Query: 96 SLLSLNRLVLSGTNLTGSIPKEIASL-NQLNYLDLSENSLTGEIPRELCSLLRLEQLRLN 154
L + + LS L+G IP +I + + L YL+LS N+ TG IPR S+ LE L L+
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG--SIPNLETLDLS 148
Query: 155 SNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHE 214
+N L G IP IG+ SSL L L N L IP ++ L +LE + N+
Sbjct: 149 NNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ--------- 199
Query: 215 IGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYL 274
L GQIP ELG L++IYL
Sbjct: 200 ----------------------------------------LVGQIPRELGQMKSLKWIYL 219
Query: 275 YENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQT 334
N L+G IP ++G L +L +L L NNL G IP LGN L + + N L+G IP +
Sbjct: 220 GYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279
Query: 335 LGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFV 394
+ +L L L LS N +SGEIP + Q L + L +N TG IP +L L +L +
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339
Query: 395 WHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPE 454
W N+ GEIP ++ NL +DLS N LTG IP G+ L KL+L SN+L G IP
Sbjct: 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399
Query: 455 MGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDV 514
+G C SL R R N +G +P E L + FLD+ +N L G I +L L +
Sbjct: 400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459
Query: 515 HSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ 574
N G LP RL+ DLS N G + LGSLS L +L L++N+ +G IP +
Sbjct: 460 ARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE 518
Query: 575 LGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILD 634
L SC KL LDLS NQLSG IPAS ++P L LD
Sbjct: 519 LSSCKKLVSLDLSHNQLSGQIPASFSEMPV-------------------------LSQLD 553
Query: 635 LSHNELSGDL-HFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLC----F 689
LS N+LSG++ L +++LV +N+SHN+ G +P T F + S ++GN LC
Sbjct: 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTT 613
Query: 690 SGNQCADSTYKKDGASRHAGAARVAMVVLLSAACALLLAALYIILGPRIRGLSGSHHNEG 749
SG K + A +VL A + I G L + +G
Sbjct: 614 SGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVF-----IRGRNNLELKRVENEDG 668
Query: 750 DEDVEMGPPWELTLYNK---LDLSIGDATRSLTAGNIIGQGRSGIVYK-VTLPSGLTVAV 805
WEL ++ ++I D SL N+I +G+ G YK ++ +G+ V
Sbjct: 669 --------TWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVV 720
Query: 806 KRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD 865
K + I SSEIA + +++H NIV+L+G + K L ++Y+ L +L +
Sbjct: 721 KEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776
Query: 866 GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925
L W+ R KIA+G+A+ L +LH C PA++ ++ I++ + E L L
Sbjct: 777 ------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829
Query: 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
L+ D+ S+ Y+APE I+EKSD+Y +G++L+E++TGK P DA
Sbjct: 830 GLLCTDTKCFISS--------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881
Query: 986 FPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT 1045
F +++W R + S +DP ++G E+++ + ++L CT+ RP
Sbjct: 882 FGVHGSIVEWAR-YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC 940
Query: 1046 MKDVAALLREIRQEPAS 1062
DV L + +S
Sbjct: 941 ANDVLKTLESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 8e-43
Identities = 87/274 (31%), Positives = 117/274 (42%), Gaps = 32/274 (11%)
Query: 783 IIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKIST--GAFSSEIATLSRIRHRNIVRLLG 839
+G G G VYK G VAVK + + S EI L R+ H NIVRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
++ L +Y G L L G G L D KIAL + GL YLH + I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN---GI 119
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TK 958
+HRD+K NILL E +ADFGLA+ + S S + F G+ Y+APE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTT---FVGTPWYMAPEVLLGGNG 175
Query: 959 ISEKSDVYSYGVVLLEIITGKKPV-DASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017
K DV+S GV+L E++TGK P + D +I +L P L+
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI-------------RRILGPPLEFD 222
Query: 1018 PDT--QIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
E + L L RPT +++
Sbjct: 223 EPKWSSGSEEAKDLIKKCLNK--DPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 70/197 (35%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKIST-GAFSSEIATLSRIRHRNIVRLLGWG 841
+G+G G VY +G VA+K + D S EI L ++ H NIV+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 842 ANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAIL 900
+ L +Y G+L LL E G L D +I L + EGL YLH + I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSNG----II 114
Query: 901 HRDVKSHNILLGERYESC-LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANMTK 958
HRD+K NILL LADFGL++L+ D + G+ Y+APE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT----IVGTPAYMAPEVLLGKGY 170
Query: 959 ISEKSDVYSYGVVLLEI 975
SEKSD++S GV+L E+
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 68/216 (31%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKIST-GAFSSEIATLSRIRHRNIVRLL 838
+G+G G VY +G VA+K + EI L +++H NIVRL
Sbjct: 4 LEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ L +Y G L LL + L E + RF + L YLH
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARF-YLRQILSALEYLHSKG--- 117
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
I+HRD+K NILL E LADFGLAR ++ F G+ Y+APE
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGE----KLTT-FVGTPEYMAPEVLLGKG 172
Query: 959 ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQ 994
+ D++S GV+L E++TGK P FP +++
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP----FPGDDQLLE 204
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 86/293 (29%), Positives = 135/293 (46%), Gaps = 52/293 (17%)
Query: 778 LTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRA-SDKISTGAFSSEIATLSRIRH 831
L G +G+G G VYK TL + VAVK + + + F E + + ++ H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
NIVRLLG + + +YMP G L L L ++AL +A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYL 118
Query: 892 H-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS-----GGSFSANPQFAGS 945
+ V HRD+ + N L+ E ++DFGL+R + +D GG P
Sbjct: 119 ESKNFV----HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL--PIK--- 169
Query: 946 YGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--HL 1000
++APE K + KSDV+S+GV+L EI T G++P +P + V++ + D L
Sbjct: 170 --WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP----YPGMSNEEVLELLEDGYRL 223
Query: 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
P+ + PD ++ E++ L C + EDRPT ++ L
Sbjct: 224 -----------PRPENCPD-ELYELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 80/292 (27%), Positives = 119/292 (40%), Gaps = 49/292 (16%)
Query: 782 NIIGQGRSGIVYKVTL----PSGLTVAVKRFRASDKISTG-AFSSEIATLSRIRHRNIVR 836
+G+G G VYK L VAVK + F E + ++ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 837 LLGWGANRKTKLLFYDYMPNGTL-GML-----LHDGECAGLLEWDTRFKIALGVAEGLSY 890
LLG + L +YM G L L + L A+ +A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI- 949
L +HRD+ + N L+GE ++DFGL+R V DD + I
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL-----PIR 172
Query: 950 --APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--DGQHVIQWVRD--HLKS 1002
APE + KSDV+S+GV+L EI T G P +P + V++++R L
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPGLSNEEVLEYLRKGYRL-- 226
Query: 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054
PK + PD ++ E++ C EDRPT ++ L
Sbjct: 227 ---------PKPEYCPD-ELYELML------SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 6e-36
Identities = 88/289 (30%), Positives = 128/289 (44%), Gaps = 44/289 (15%)
Query: 778 LTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRH 831
LT G +G+G G VYK TL + VAVK + + F E + ++ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
NIV+LLG + ++ +YMP G L L L AL +A G+ YL
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEYL 119
Query: 892 H-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGS 945
+ + HRD+ + N L+GE ++DFGL+R + DD GG P
Sbjct: 120 ESKNFI----HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL---P----- 167
Query: 946 YGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKK 1004
++APE K + KSDV+S+GV+L EI T G++P G + V ++LK
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAE-VLEYLKKGY 221
Query: 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
PK P + MLQ C + EDRPT ++ +L
Sbjct: 222 -----RLPKPPNCPPELYKLMLQ-------CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 84/289 (29%), Positives = 126/289 (43%), Gaps = 45/289 (15%)
Query: 778 LTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRA-SDKISTGAFSSEIATLSRIRH 831
LT G +G+G G VYK L + VAVK + + + F E + ++ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
N+V+LLG + + +YM G L L L AL +A G+ YL
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYL 118
Query: 892 H-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGS 945
+ + HRD+ + N L+GE ++DFGL+R + DD GG P
Sbjct: 119 ESKNFI----HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL---P----- 166
Query: 946 YGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKK 1004
++APE K + KSDV+S+GV+L EI T G++P G + V ++LK+
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEE-VLEYLKNGY 220
Query: 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
P+ P MLQ C + EDRPT ++ +L
Sbjct: 221 RL-----PQPPNCPPELYDLMLQ-------CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-35
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 781 GNIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTG--AFSSEIATLSRIRHRNIVRL 837
G ++G+G G VY + +G +AVK S A EI LS ++H NIVR
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 838 LG--WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HD 894
G + T +F +Y+ G+L LL L E R K + EGL+YLH +
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIR-KYTRQILEGLAYLHSNG 121
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
I+HRD+K NIL+ LADFG A+ + D G G+ ++APE
Sbjct: 122 ----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG--TGSVRGTPYWMAPEVI 175
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKP 981
+ +D++S G ++E+ TGK P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 86/284 (30%), Positives = 125/284 (44%), Gaps = 53/284 (18%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
SL +G G+ G V+ T VAVK + +S AF E + ++RH +V
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLV 64
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
+L + + + +YM G+L L GE L +A +AEG++YL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL-PQLVDMAAQIAEGMAYLESRN 123
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGSYGYIA 950
+HRD+ + NIL+GE +ADFGLARL+EDD G F + A
Sbjct: 124 Y---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK--------WTA 172
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009
PE AN + + KSDV+S+G++L EI+T G+ P +P G EV
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVP----YP-GMT--------------NREV 213
Query: 1010 LD--------PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT 1045
L+ P+ P+ MLQ C E+RPT
Sbjct: 214 LEQVERGYRMPRPPNCPEELYDLMLQ-------CWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 43/215 (20%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG--- 839
IG+G G VYK +G VA+K + K +EI L + +H NIV+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 840 -----WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFK------IALGVAEGL 888
W + ++ G+L LL + + + +GL
Sbjct: 68 KKDELW--------IVMEFCSGGSLKDLLK--------STNQTLTESQIAYVCKELLKGL 111
Query: 889 SYLH--HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
YLH I+HRD+K+ NILL E L DFGL+ + D+ + G+
Sbjct: 112 EYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNT----MVGTP 161
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
++APE N K+D++S G+ +E+ GK P
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 70/227 (30%), Positives = 110/227 (48%), Gaps = 28/227 (12%)
Query: 757 PPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIST 816
P E TL KL G G G V++ + + VA+K ++ D +
Sbjct: 4 PREEFTLERKL-----------------GSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQ 46
Query: 817 GAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDT 876
F E+ L R+RH++++ L + + + + M G+L L E +L +
Sbjct: 47 QDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE-GQVLPVAS 105
Query: 877 RFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936
+A VAEG++YL +HRD+ + NIL+GE +ADFGLARL+++D S
Sbjct: 106 LIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162
Query: 937 SAN-PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
P Y + APE A+ S KSDV+S+G++L E+ T G+ P
Sbjct: 163 DKKIP-----YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 781 GNIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVR 836
G++IG+G G+VYK + L +G VA+K+ KI A S EI L ++H NIV+
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHD-GECAGLLEWDTRFKIALGVA---EGLSYLH 892
+G + + +Y NG+L ++ G L +A+ V +GL+YLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAYLH 116
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
++HRD+K+ NIL + LADFG+A + D S S G+ ++APE
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS----VVGTPYWMAPE 169
Query: 953 YANMTKISEKSDVYSYGVVLLEIITGKKP 981
M+ S SD++S G ++E++TG P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 85/273 (31%), Positives = 123/273 (45%), Gaps = 31/273 (11%)
Query: 781 GNIIGQGRSGIVYK-VTLPSGLTVAVK--RFRASDKISTGAFSSEIATLSRIRHRNIVRL 837
GN IG G G VY V L +G +AVK R + +D + + E+ L ++H N+V+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
G +R+ +F +Y GTL LL G L E R L + EGL+YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRI--LDEHVIR-VYTLQLLEGLAYLHSH--- 118
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
I+HRD+K NI L L DFG A +++++ AG+ Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 958 KISEK---SDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
K +D++S G V+LE+ TGK+P S D + I + H+ + P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP--WSELDNEFQIMF---HVGAGHKPP------- 226
Query: 1015 QGHPDTQIQEMLQALGISLL--CTSNRAEDRPT 1045
PD L G L C + + RPT
Sbjct: 227 --IPD---SLQLSPEGKDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 82/296 (27%), Positives = 132/296 (44%), Gaps = 50/296 (16%)
Query: 773 DATRSLTAGNIIGQGRSGIVYK--VTLPSG--LTVAVKRFRA--SDKISTGAFSSEIATL 826
D + +T +IG G G V + + LP + VA+K +A SDK F +E + +
Sbjct: 2 DPS-YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIM 59
Query: 827 SRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLL--HDGECAGLLEWDTRFKIALGV 884
+ H NI+RL G + ++ +YM NG+L L +DG+ + G+
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGI 115
Query: 885 AEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAG 944
A G+ YL +HRD+ + NIL+ ++DFGL+R +ED + +
Sbjct: 116 ASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLED-------SEATYTT 165
Query: 945 SYGYI-----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPV-DASFPDGQHVIQWVR 997
G I APE K + SDV+S+G+V+ E+++ G++P D S Q VI+ V
Sbjct: 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAVE 222
Query: 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
D + P++ P Q ML C +RPT + + L
Sbjct: 223 DGYRLPP-PMDC--------PSALYQLMLD-------CWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 9e-25
Identities = 81/338 (23%), Positives = 125/338 (36%), Gaps = 27/338 (7%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGA---FSSEIATLSRIRH-R 832
S +G+G G VY VA+K + + F EI L+ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 833 NIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
NIV+L + + + L +Y+ G+L LL G L I + L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 893 HDCVPAILHRDVKSHNILLGE-RYESCLADFGLARLVEDDSGGSFSANPQ--FAGSYGYI 949
I+HRD+K NILL L DFGLA+L+ D S G+ GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 950 APEYA---NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006
APE ++ S SD++S G+ L E++TG P + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE--GEKNSSATSQTLKIILELP-- 231
Query: 1007 VEVLDPKLQGHPDTQIQEMLQALGISLL--CTSNRAEDRPTMKDV--AALLREIRQEPAS 1062
P L E++ LL + ++R + LL ++ + +
Sbjct: 232 ----TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESD 287
Query: 1063 GSEAHKPTAAKSTDTASYSSSSVTSAQLLLLQGQGSSH 1100
S+ KP + + S + L L GS
Sbjct: 288 LSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDL 325
|
Length = 384 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 57/287 (19%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN 843
IG G+ G+V+ VA+K R +S F E + ++ H +V+L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
R L +++M +G L L G +T + L V EG++YL V +HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSNV---IHRD 125
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG------YIAPEYANMT 957
+ + N L+GE ++DFG+ R V DD Q+ S G + +PE + +
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDD---------QYTSSTGTKFPVKWSSPEVFSFS 176
Query: 958 KISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD----- 1011
K S KSDV+S+GV++ E+ + GK P + +S + VE ++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYEN----------------RSNSEVVETINAGFRL 220
Query: 1012 --PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
P+L + E++Q C R EDRP+ + LL ++
Sbjct: 221 YKPRL---ASQSVYELMQH------CWKERPEDRPSF---SLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 784 IGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTG-AFSSEIATLSRIRHRNIVRLLGWG 841
+GQG SG+VYKV P+G A+K+ E+ TL +V+ +G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC--YG 66
Query: 842 ANRKTKLLFYD---------YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
A FY YM G+L LL + + E + IA + +GL YLH
Sbjct: 67 A-------FYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAY-IARQILKGLDYLH 116
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
I+HRD+K N+L+ + E +ADFG+++++E+ + F G+ Y++PE
Sbjct: 117 TK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT----FVGTVTYMSPE 170
Query: 953 YANMTKISEKSDVYSYGVVLLEIITGKKP 981
S +D++S G+ LLE GK P
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRA-SDKISTGAFSSEIATLSRIRHRNIVRLLGWG 841
+G G SG+V KV P+G +AVK R ++ E+ L + IV G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 842 ANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILH 901
N + +YM G+L +L E G + KIA+ V +GL+YLH I+H
Sbjct: 69 YNNGDISICMEYMDGGSLDKILK--EVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIH 124
Query: 902 RDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISE 961
RDVK NIL+ R + L DFG++ + + +F G+ Y+APE S
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF------VGTSSYMAPERIQGNDYSV 178
Query: 962 KSDVYSYGVVLLEIITGKKPVD 983
KSD++S G+ L+E+ TG+ P
Sbjct: 179 KSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 85/299 (28%), Positives = 132/299 (44%), Gaps = 56/299 (18%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRH 831
+T +IG G G V++ L + VA+K + + F SE + + + H
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLL--HDGE-----CAGLLEWDTRFKIALGV 884
NI+RL G K ++ +YM NG L L HDGE G+L G+
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---------GI 116
Query: 885 AEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAG 944
A G+ YL +HRD+ + NIL+ E ++DFGL+R++EDD G+++
Sbjct: 117 AAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT------ 167
Query: 945 SYGYI-----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPV-DASFPDGQHVIQWVR 997
S G I APE K + SDV+S+G+V+ E+++ G++P D S V++ +
Sbjct: 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS---NHEVMKAIN 224
Query: 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
D + P P Q MLQ C RP D+ LL ++
Sbjct: 225 DGFRL---------PAPMDCPSAVYQLMLQ-------CWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 77/276 (27%), Positives = 122/276 (44%), Gaps = 32/276 (11%)
Query: 778 LTAGNIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR 836
+T + +G G+ G VY+ V LTVAVK + D + F E A + I+H N+V+
Sbjct: 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
LLG + ++M G L L + + +A ++ + YL
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK-- 123
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
+HRD+ + N L+GE + +ADFGL+RL+ D +++A+ + APE
Sbjct: 124 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAY 179
Query: 957 TKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--DGQHVIQWVRDHLKSKKDPVEVLDPK 1013
K S KSDV+++GV+L EI T G P +P D V L K +E +
Sbjct: 180 NKFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVY-----ELLEKGYRME----R 226
Query: 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
+G P + M C DRP+ ++
Sbjct: 227 PEGCPPKVYELMRA-------CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 79/290 (27%), Positives = 126/290 (43%), Gaps = 49/290 (16%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR 836
LT +G G+ G+V+ + VA+K R +S F E + ++ H N+V+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQ 63
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L G ++ + +YM NG L L + + G L + + V E + YL +
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG------YIA 950
+HRD+ + N L+GE ++DFGLAR V DD Q+ S G +
Sbjct: 122 ---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDD---------QYTSSQGTKFPVKWAP 169
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ---HVIQWVRDHLKSKKDP 1006
PE + ++ S KSDV+S+GV++ E+ + GK P + F + + V R + + K P
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSEVVESVSAGYRLY-RPKLAP 227
Query: 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
EV I C + EDRP K LL ++
Sbjct: 228 TEVYT-------------------IMYSCWHEKPEDRPAFK---KLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 4e-23
Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 22/220 (10%)
Query: 781 GNIIGQGRSGIVY-KVTLPSGLTVAVKRFRASDKISTG---------AFSSEIATLSRIR 830
G +IG G G VY + SG +AVK+ ++ A + EIA L ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
H NIV+ LG + +F +Y+P G++ LL++ G E + +GL+Y
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNY 121
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD--SGGSFSANPQFAGSYGY 948
LH+ I+HRD+K NIL+ + ++DFG+++ +E + S + A P GS +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD 988
+APE T + K+D++S G +++E++TGK P FPD
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP----FPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 3e-22
Identities = 65/208 (31%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAF---SSEIATLSRIRHRNIVRLLG 839
+G+G G V V +G A+K + I +E LSRI H IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 840 WGANRKTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVP 897
+ + KL +Y P G L L E RF A + L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAA-EIVLALEYLHSLG--- 113
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
I++RD+K NILL L DFGLA+ + + N F G+ Y+APE
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSE---GSRTN-TFCGTPEYLAPEVLLGK 168
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDAS 985
+ D +S GV+L E++TGK P A
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLP-----SGLTVAVKRFRAS--DKISTGAFSSEIATLSR 828
R L +G+G G V +G VAVK S ++ + F EI L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRT 62
Query: 829 IRHRNIVRLLGW--GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE 886
+ H NIV+ G ++ L +Y+P+G+L L + + + +
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ--RHRDQINLKRLLLFSSQICK 120
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
G+ YL +HRD+ + NIL+ ++DFGLA+++ +D + P + +
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
Y APE +K S SDV+S+GV L E+ T
Sbjct: 178 WY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+ L G IG+G G V G VAVK + + AF +E + ++ +RH N+V
Sbjct: 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLV 63
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
+LLG + +YM G+L L A ++ + AL V EG+ YL
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEK- 121
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-SGGSFSANPQFAGSYGYIAPEYA 954
+HRD+ + N+L+ E + ++DFGLA+ G + APE
Sbjct: 122 --NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEAL 171
Query: 955 NMTKISEKSDVYSYGVVLLEIIT-GKKP 981
K S KSDV+S+G++L EI + G+ P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 779 TAGNIIGQGRSGIVYKVT-LPSGLTVAVK-----RFRASDKIST-GAFSSEIATLSRIRH 831
G +G G Y+ + +G +AVK R +S++ A EI ++R+ H
Sbjct: 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
+I+R+LG LF ++M G++ LL G + + GLSYL
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYL 119
Query: 892 HHDCVPAILHRDVKSHNILL---GERYESCLADFGLA-RLVEDDSG-GSFSANPQFAGSY 946
H + I+HRDVK N+L+ G+R +ADFG A RL +G G F Q G+
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQG--QLLGTI 172
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984
++APE + DV+S G V++E+ T K P +A
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 6e-21
Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN 843
+G G+ G V+ + VAVK + +S AF E + ++H +VRL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+ + +YM G+L L E G + + +AEG++Y+ +HRD
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRD 128
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKS 963
+++ N+L+ E +ADFGLAR++ED+ ++A + APE N + KS
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 964 DVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD-----PKLQGH 1017
DV+S+G++L EI+T GK P +P S D + L P+++
Sbjct: 186 DVWSFGILLYEIVTYGKIP----YPG------------MSNSDVMSALQRGYRMPRMENC 229
Query: 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
PD M C +AE+RPT + ++L
Sbjct: 230 PDELYDIMKT-------CWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 73/267 (27%), Positives = 118/267 (44%), Gaps = 35/267 (13%)
Query: 784 IGQGRSGIVYK----VTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G G+ G V++ T P VAVK + + F +E + ++RH +++L
Sbjct: 14 LGAGQFGEVWEGLWNNTTP----VAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+ + + M G+L L G L+ +A VA G++YL
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NY 124
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
+HRD+ + N+L+GE +ADFGLAR++++D + A + APE A +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDI---YEAREGAKFPIKWTAPEAALYNRF 181
Query: 960 SEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018
S KSDV+S+G++L EI+T G+ P + + V+Q V + P G P
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPY-PGMTNAE-VLQQVDQGYRM---------PCPPGCP 230
Query: 1019 DTQIQEMLQALGISLLCTSNRAEDRPT 1045
ML C +DRPT
Sbjct: 231 KELYDIMLD-------CWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-21
Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 32/275 (11%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN 843
+G G+ G V+ T VAVK + +S +F E + ++RH +V+L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAV-VS 71
Query: 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+ + +YM G+L L DGE L+ +A VA G++Y+ +HRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKS 963
++S NIL+G+ +ADFGLARL+ED+ ++A + APE A + + KS
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 964 DVYSYGVVLLEIIT-GKKPVDASFP--DGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDT 1020
DV+S+G++L E++T G+ P +P + + V++ V + P Q P +
Sbjct: 185 DVWSFGILLTELVTKGRVP----YPGMNNREVLEQVERGYRM---------PCPQDCPIS 231
Query: 1021 QIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
+ MLQ C E+RPT + + + L +
Sbjct: 232 LHELMLQ-------CWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 29/242 (11%)
Query: 782 NIIGQGRSGIVYK-VTLPSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLG 839
+IG G + +VY + LP+ VA+KR + S E+ +S+ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
L Y+ G+L ++ G L+ + V +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQ 123
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
+HRD+K+ NILLGE +ADFG++ + D + F G+ ++APE M ++
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV--MEQV 181
Query: 960 ---SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016
K+D++S+G+ +E+ TG P SK P++VL LQ
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPY-------------------SKYPPMKVLMLTLQN 222
Query: 1017 HP 1018
P
Sbjct: 223 DP 224
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 30/221 (13%)
Query: 784 IGQGRSGIVYK--VTLPSGL----TVAVKRFRASDKIST-GAFSSEIATLSRIRHRNIVR 836
+G+G G VYK +T P+ +VA+K + + + F E +S ++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 837 LLGWGANRKTKLLFYDYMPNGTL-------------GMLLHDGECAGLLEWDTRFKIALG 883
LLG + + ++Y+ +G L G D L+ IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 884 VAEGLSYL--HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQ 941
+A G+ YL HH +HRD+ + N L+GE ++DFGL+R + S + +
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY--SADYYRVQSK 185
Query: 942 FAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
++ PE K + +SD++S+GVVL EI + G +P
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFS--------SEIATLSRIRHR 832
IG+G G V KV G + K +I G + SE+ L ++H
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWK------EIDYGNMTEKEKQQLVSEVNILRELKHP 59
Query: 833 NIVRLLGWGANRKTKLLF--YDYMPNGTLGMLL-HDGECAGLLEWDTRFKIALGVAEGLS 889
NIVR +R + L+ +Y G L L+ + +E + ++I + L
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 890 YLHHDCVP--AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY- 946
H+ P +LHRD+K NI L L DFGLA+++ DS FA +Y
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS--------SFAKTYV 171
Query: 947 G---YIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
G Y++PE N EKSD++S G ++ E+ P A
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 781 GNIIGQGRSGIVY-KVTLPSGLTVAVKRF--------RASDKIST--GAFSSEIATLSRI 829
G +IG+G G VY + + +G +AVK+ R + A SEI TL +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLS 889
H NIV+ LG+ + +F +Y+P G++G L G E V EGL+
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLA 122
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
YLH ILHRD+K+ N+L+ ++DFG+++ +D + + Q GS ++
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVFWM 177
Query: 950 APEYANMTK--ISEKSDVYSYGVVLLEIITGKKP 981
APE + S K D++S G V+LE+ G++P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFR----ASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG+G G VYK L VAVK R K F E L + H NIV+L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK---FLQEAEILKQYDHPNIVKLIG 59
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
++ + + +P G+L L + L +++L A G+ YL
Sbjct: 60 VCVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG-------YIAPE 952
+HRD+ + N L+GE ++DFG++R E++ G + S G + APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--EEEGG-------IYTVSDGLKQIPIKWTAPE 165
Query: 953 YANMTKISEKSDVYSYGVVLLEIITG 978
N + + +SDV+SYG++L E +
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 77/278 (27%), Positives = 136/278 (48%), Gaps = 38/278 (13%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN 843
+G G+ G V+ VA+K + +S AF +E + +++H +VRL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAV-VT 71
Query: 844 RKTKLLFYDYMPNGTLGMLLHDGECAGL-LEWDTRFKIALGVAEGLSYLHHDCVPAILHR 902
++ + +YM NG+L L E G+ L + +A +AEG++++ +HR
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126
Query: 903 DVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEK 962
D+++ NIL+ E +ADFGLARL+ED+ ++A + APE N + K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 963 SDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH---- 1017
SDV+S+G++L EI+T G+ P +P +P EV+ +G+
Sbjct: 184 SDVWSFGILLTEIVTYGRIP----YP--------------GMTNP-EVIQNLERGYRMPR 224
Query: 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
PD +E+ + + LC + E+RPT + + ++L +
Sbjct: 225 PDNCPEELYE---LMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 71/206 (34%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 778 LTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRL 837
LT G IIG+G G V + +G VAVK + ++ AF E A ++++ H+N+VRL
Sbjct: 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRL 64
Query: 838 LGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
LG + ++ + M G L L G + +F +L VAEG+ YL
Sbjct: 65 LGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQF--SLDVAEGMEYLESK-- 119
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
++HRD+ + NIL+ E + ++DFGLAR+ G S P + APE
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP-----VKWTAPEALKH 171
Query: 957 TKISEKSDVYSYGVVLLEIIT-GKKP 981
K S KSDV+SYGV+L E+ + G+ P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 3e-19
Identities = 64/217 (29%), Positives = 94/217 (43%), Gaps = 41/217 (18%)
Query: 782 NIIGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLL 838
IG+G G VYK +G VA+K+ R ++ ++ EI L ++RH NIVRL
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 839 GWGANRKTKLLF--YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALG--------VAEGL 888
++ ++ ++YM HD GLL+ K + EGL
Sbjct: 65 EIVTSKGKGSIYMVFEYMD--------HD--LTGLLD-SPEVKFTESQIKCYMKQLLEGL 113
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG- 947
YLH + ILHRD+K NIL+ LADFGLAR + + +
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY--------TNRV 162
Query: 948 ----YIAPE-YANMTKISEKSDVYSYGVVLLEIITGK 979
Y PE T+ + D++S G +L E+ GK
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 30/274 (10%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN 843
+GQG G V+ T VA+K + +S AF E + ++RH +V+L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAV-VS 71
Query: 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+ + +YM G+L L GE L +A +A G++Y+ +HRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKS 963
+++ NIL+GE +ADFGLARL+ED+ ++A + APE A + + KS
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 964 DVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQI 1022
DV+S+G++L E+ T G+ P +P + EVLD +G+
Sbjct: 185 DVWSFGILLTELTTKGRVP----YPGMVN---------------REVLDQVERGYRMPCP 225
Query: 1023 QEMLQAL-GISLLCTSNRAEDRPTMKDVAALLRE 1055
E ++L + C E+RPT + + A L +
Sbjct: 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 3e-19
Identities = 70/278 (25%), Positives = 115/278 (41%), Gaps = 45/278 (16%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKR---FRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG+G G VY V G +K S+K A + E+ L ++ H NI++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYYE 66
Query: 840 WGANRKTKLLF-YDYMPNGTLGMLLHDGECAG--LLE---WDTRFKIALGVAEGLSYLH- 892
K KL +Y G L + + G E D ++ L L YLH
Sbjct: 67 -SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA----LKYLHS 121
Query: 893 -HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
ILHRD+K NI L L DFG+++++ G+ Y++P
Sbjct: 122 RK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV----DLAKTVVGTPYYLSP 172
Query: 952 EYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011
E + KSD++S G VL E+ T K P F +G+++++ LK + P+
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP----F-EGENLLELALKILKGQYPPIPS-- 225
Query: 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
++++ ++ SLL E+RP++ +
Sbjct: 226 -----QYSSELRNLVS----SLL--QKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 63/231 (27%), Positives = 93/231 (40%), Gaps = 37/231 (16%)
Query: 781 GNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI------STGAFSSEIATLSRI-RHR 832
G IIG+G V + A+K DK E L+R+ H
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKIL---DKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 833 NIVRLLGWGANRKTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
I++L + + L F +Y PNG L + L E TRF A + L YL
Sbjct: 63 GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAE-ILLALEYL 118
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQ---------- 941
H I+HRD+K NILL + + DFG A+ V D + S
Sbjct: 119 HSK---GIIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGDATNIDSQIEK 174
Query: 942 -------FAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
F G+ Y++PE N + SD+++ G ++ +++TGK P S
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 68/225 (30%), Positives = 112/225 (49%), Gaps = 33/225 (14%)
Query: 773 DATRSLTAGNIIGQGRSGIVY--KVTLPSG--LTVAVKRFRA--SDKISTGAFSSEIATL 826
DA+ + +IG G G V ++ LP + VA+K +A ++K F SE + +
Sbjct: 2 DASC-IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-QRRDFLSEASIM 59
Query: 827 SRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLL--HDG-----ECAGLLEWDTRFK 879
+ H NI+ L G K ++ +YM NG+L L HDG + G+L
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR------ 113
Query: 880 IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939
G+A G+ YL +HRD+ + NIL+ ++DFGL+R++EDD +++
Sbjct: 114 ---GIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
Query: 940 PQFAGSYG--YIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
G + APE K + SDV+SYG+V+ E+++ G++P
Sbjct: 168 ---GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 76/280 (27%), Positives = 118/280 (42%), Gaps = 40/280 (14%)
Query: 782 NIIGQGRSGIVYKVTLPS-GLTVAVKR--FRASDKISTGAFSSEIATLSRIRHRNIVRLL 838
N IG+G G+V+KV + A+K+ ++ E L+++ I+R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
++ + +Y NG L LL L E D ++ + + GL++LH
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE-DQVWRFFIQILLGLAHLHSK---K 121
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA----GSYGYIAPEYA 954
ILHRD+KS N+ L + D G+A+L+ S N FA G+ Y++PE
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--------SDNTNFANTIVGTPYYLSPELC 173
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
+EKSDV++ GVVL E TGK P DA + Q + + ++ PV
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGAL--ILKIIRGVFPPV------- 221
Query: 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054
+Q Q + C + RP D LLR
Sbjct: 222 -SQMYSQ-----QLAQLIDQCLTKDYRQRP---DTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 73/275 (26%), Positives = 135/275 (49%), Gaps = 32/275 (11%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN 843
+GQG G V+ T VA+K + + AF E + ++RH +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAV-VS 71
Query: 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+ + ++M G+L L +G+ L+ +A +A+G++Y+ +HRD
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKS 963
+++ NIL+G+ +ADFGLARL+ED+ ++A + APE A + + KS
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 964 DVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDT 1020
DV+S+G++L E++T G+ P +P + V++ V + P QG P++
Sbjct: 185 DVWSFGILLTELVTKGRVP----YPGMVNREVLEQVERGYRM---------PCPQGCPES 231
Query: 1021 QIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
+ E+++ LC ++RPT + + + L +
Sbjct: 232 -LHELMK------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 69/306 (22%)
Query: 778 LTAGNIIGQGRSGIVYK--VTLPSG--LTVAVKRFRASDKIS-TGAFSSEIATLSRIRHR 832
+T G IG+G+ G VY+ P + VAVK + S F E + + H
Sbjct: 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHP 67
Query: 833 NIVRLLG-------WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVA 885
+IV+L+G W + + P G L L + + L+ + + ++
Sbjct: 68 HIVKLIGVITENPVW--------IVMELAPLGELRSYLQVNKYS--LDLASLILYSYQLS 117
Query: 886 EGLSYLHH-DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAG 944
L+YL V HRD+ + N+L+ L DFGL+R +ED+S +
Sbjct: 118 TALAYLESKRFV----HRDIAARNVLVSSPDCVKLGDFGLSRYLEDES--------YYKA 165
Query: 945 SYG-----YIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998
S G ++APE N + + SDV+ +GV + EI+ G KP Q V++
Sbjct: 166 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP-----------FQGVKN 214
Query: 999 HLKSKKDPVEVLD-----PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
D + ++ P P T M + C + RP ++ A L
Sbjct: 215 -----NDVIGRIENGERLPMPPNCPPTLYSLMTK-------CWAYDPSKRPRFTELKAQL 262
Query: 1054 REIRQE 1059
+I QE
Sbjct: 263 SDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 76/275 (27%), Positives = 117/275 (42%), Gaps = 49/275 (17%)
Query: 803 VAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGM 861
VAVK R + F E+ LSR+ NI RLLG + +YM NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 862 LL--HDGECAGL------LEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLG 912
L H E +GL L + T +A +A G+ YL + V HRD+ + N L+G
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV----HRDLATRNCLVG 164
Query: 913 ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI-----------APEYANMTKISE 961
+ Y +ADFG++R + ++ Y + A E + K +
Sbjct: 165 KNYTIKIADFGMSRNL-------------YSSDYYRVQGRAPLPIRWMAWESVLLGKFTT 211
Query: 962 KSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDT 1020
KSDV+++GV L EI+T ++ D Q VI+ + D ++ P+ P
Sbjct: 212 KSDVWAFGVTLWEILTLCREQPYEHLTD-QQVIE--NAGHFFRDDGRQIYLPRPPNCPKD 268
Query: 1021 QIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
+ ML+ C EDRPT +++ L+
Sbjct: 269 IYELMLE-------CWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 74/280 (26%), Positives = 120/280 (42%), Gaps = 43/280 (15%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN 843
+G G+ G+V+ + + VA+K +S F E + ++ H +V+L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+K + ++M NG L L + G L D + V EG+ YL + + +HRD
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRD 125
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG------YIAPEYANMT 957
+ + N L+ ++DFG+ R V DD ++ S G + PE N +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDD---------EYTSSSGAKFPVKWSPPEVFNFS 176
Query: 958 KISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016
K S KSDV+S+GV++ E+ T GK P + + V R + PKL
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRGF--------RLYRPKLAS 227
Query: 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
+ E++ C + E RPT + LLR I
Sbjct: 228 M---TVYEVM------YSCWHEKPEGRPTFAE---LLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 72/280 (25%), Positives = 131/280 (46%), Gaps = 28/280 (10%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR 836
SL +G G+ G V+ T VAVK + +S AF +E + ++H +V+
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVK 65
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L ++ + ++M G+L L E + +AEG++++
Sbjct: 66 LHAV-VTKEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR-- 121
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
+HRD+++ NIL+ +ADFGLAR++ED+ ++A + APE N
Sbjct: 122 -NYIHRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINF 177
Query: 957 TKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
+ KSDV+S+G++L+EI+T G+ P +P G + +R + + P
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP----YP-GMSNPEVIRALERGYRMP--------- 223
Query: 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
P+ +E+ + + C NR E+RPT + + ++L +
Sbjct: 224 -RPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 779 TAGNIIGQGRSGIVYKVTLPSGLTVAVKR--FRASDKIST----GAFSSEIATLSRIRHR 832
T G ++G+G G VY G +AVK+ S+ ++ E+ L ++H
Sbjct: 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 833 NIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
NIV+ LG + T +F +++P G++ +L+ G L K + +G++YLH
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLH 119
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN--PQFAGSYGYIA 950
++CV +HRD+K +N++L L DFG AR + +N G+ ++A
Sbjct: 120 NNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
PE N + KSD++S G + E+ TGK P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 781 GNIIGQGRSGIVYK-VTLPSGLTVAVKRFR-----ASDKISTGAFSSEIATLSRIRHRNI 834
G ++GQG G VY + +G +AVK+ K A EI L ++H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 835 VRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
V+ G + +T +F +YMP G++ L L E TR K + EG+ YLH +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTR-KYTRQILEGVEYLHSN 123
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLA-RLVEDDSGGSFSANPQFAGSYGYIAPEY 953
I+HRD+K NIL L DFG + RL S G+ + G+ +++PE
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWMSPEV 178
Query: 954 ANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ K+DV+S G ++E++T K P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 71/210 (33%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 781 GNIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS-----EIATLSRIRHRNI 834
G ++G G G VY+ + L G AVK +D TG + EIA LS+++H NI
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 835 VRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGEC--AGLLEWDTRFKIALGVAEGLSYLH 892
V+ LG +F + +P G+L LL ++ TR +I L GL YLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILL----GLEYLH 119
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
+HRD+K NIL+ LADFG+A+ V FS F GS ++APE
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-----EFSFAKSFKGSPYWMAPE 171
Query: 953 YANMT-KISEKSDVYSYGVVLLEIITGKKP 981
+D++S G +LE+ TGK P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 38/219 (17%)
Query: 783 IIGQGRSGIVYKVTL-PSG---LTVAVKRFRA--SDKISTGAFSSEIATLSRIRHRNIVR 836
+IG G G V + L G + VA+K ++ ++K F SE + + + H NI+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNIIH 69
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLL--HDG-----ECAGLLEWDTRFKIALGVAEGLS 889
L G + ++ ++M NG L L +DG + G+L G+A G+
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---------GIAAGMK 120
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG-- 947
YL +HRD+ + NIL+ ++DFGL+R +EDD +++P + S G
Sbjct: 121 YLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD-----TSDPTYTSSLGGK 172
Query: 948 ----YIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
+ APE K + SDV+SYG+V+ E+++ G++P
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 14/205 (6%)
Query: 784 IGQGRSGIVYKVTL--PSG--LTVAVKRFRASDKISTGA--FSSEIATLSRIRHRNIVRL 837
+G G G+V + G + VAVK + SDK+S F E A + + H N++RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLK-SDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
G ++ + P G+L L + G T A+ +A G+ YL
Sbjct: 62 YGVVLTHPLMMVT-ELAPLGSLLDRLRK-DALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
+HRD+ + NILL + + DFGL R + + + + + APE
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRAL-PQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 958 KISEKSDVYSYGVVLLEIIT-GKKP 981
S SDV+ +GV L E+ T G++P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 73/305 (23%), Positives = 121/305 (39%), Gaps = 54/305 (17%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLT------VAVKRFR-ASDKISTGAFSSEIATLSR 828
++ +G+G G V+ VAVK + + + F E L+
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLL--HDGECAGLLEWDTR--------- 877
+H NIV+ G ++ ++YM +G L L H + A L D+
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 878 FKIALGVAEGLSYL--HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS--- 932
+IA+ +A G+ YL H +HRD+ + N L+G + DFG++R V
Sbjct: 125 LQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 933 -GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ 990
GG + P ++ PE K + +SDV+S+GVVL EI T GK+P
Sbjct: 180 VGGH-TMLP-----IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW------YG 227
Query: 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVA 1050
+ V + + + +L + P ML C + R +KD+
Sbjct: 228 LSNEEVIECITQGR----LLQRP-RTCPSEVYDIMLG-------CWKRDPQQRINIKDIH 275
Query: 1051 ALLRE 1055
L++
Sbjct: 276 ERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 66/228 (28%), Positives = 101/228 (44%), Gaps = 45/228 (19%)
Query: 778 LTAGNIIGQGRSGIVYK-VTLPSG----LTVAVKRFR-ASDKISTGAFSSEIATLSRIRH 831
L ++G G G VYK V +P G + VA+K R + + E ++ + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLL-----HDGECAG--LLEWDTRFKIALGV 884
++VRLLG + L MP LG LL H LL W + +
Sbjct: 69 PHVVRLLGICLS-SQVQLITQLMP---LGCLLDYVRNHKDNIGSQYLLNW------CVQI 118
Query: 885 AEGLSYL--HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD------SGGSF 936
A+G+SYL ++HRD+ + N+L+ + DFGLA+L++ D GG
Sbjct: 119 AKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173
Query: 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVD 983
++A E + KSDV+SYGV + E++T G KP +
Sbjct: 174 PIK--------WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 62/230 (26%), Positives = 95/230 (41%), Gaps = 43/230 (18%)
Query: 769 LSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLS 827
+S GD IG+G SG VYK T +G VA+K+ R + + EI +
Sbjct: 12 VSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMK 70
Query: 828 RIRHRNIVRLLGWGANRKTKLLFYD-YMPNGTLGML--LHDGEC-AGLLEW-DTRFK--- 879
+H NIV +YD Y+ L ++ DG ++ R
Sbjct: 71 DCKHPNIVD-------------YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ 117
Query: 880 ---IALGVAEGLSYLH--HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934
+ V +GL YLH + ++HRD+KS NILL + LADFG A +
Sbjct: 118 IAYVCREVLQGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFAAQLT----- 167
Query: 935 SFSANPQFAGSYG---YIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ G ++APE K D++S G++ +E+ G+ P
Sbjct: 168 --KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (205), Expect = 5e-17
Identities = 69/208 (33%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRLL 838
+G+G G+VYK +G VA+K+ R D G S+ EI+ L ++H NIV+LL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 839 G-WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
RK L+F +Y L L G L + I + GL+Y H
Sbjct: 65 DVIHTERKLYLVF-EYCDM-DLKKYLDK--RPGPLSPNLIKSIMYQLLRGLAYCHSHR-- 118
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG-----YIAPE 952
ILHRD+K NIL+ LADFGLAR +F P ++ Y APE
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLAR--------AFG-IPLRTYTHEVVTLWYRAPE 168
Query: 953 -YANMTKISEKSDVYSYGVVLLEIITGK 979
S D++S G + E+ITGK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 27/208 (12%)
Query: 784 IGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVRLLG 839
+G G G V V + T A+K + + TG SE L H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLL-EWDTRFKIALGVAEGLSYLHHDCVPA 898
++K + +Y G L +L D GL E+ RF IA V YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIA-CVVLAFEYLHNR---G 113
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
I++RD+K N+LL L DFG A+ + S F G+ Y+APE
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL-----KSGQKTWTFCGTPEYVAPEI----- 163
Query: 959 ISEK-----SDVYSYGVVLLEIITGKKP 981
I K D +S G++L E++TG+ P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 87/299 (29%), Positives = 126/299 (42%), Gaps = 52/299 (17%)
Query: 784 IGQGRSGIVYKVTLPSGLT------VAVKRFR--ASDKISTGAFSSEIATLSRIRHRNIV 835
IGQG G V++ P L VAVK + AS + F E A ++ H NIV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDHPNIV 71
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLL------------HDGECAGL-------LEWDT 876
+LLG A K L ++YM G L L H A L
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 877 RFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936
+ IA VA G++YL +HRD+ + N L+GE +ADFGL+R + S +
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY--SADYY 186
Query: 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQW 995
A+ A ++ PE + + +SDV++YGVVL EI + G +P + VI +
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM--AHEEVIYY 244
Query: 996 VRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054
VRD + PD E+ + LC S DRP+ + +L+
Sbjct: 245 VRDG-------------NVLSCPDNCPLELYNLM---RLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+ L IG+G G V + G VAVK + + + AF +E + ++++RH N+V
Sbjct: 6 KELKLLQTIGKGEFGDVM-LGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 62
Query: 836 RLLGWGANRKTKL-LFYDYMPNGTL-------GMLLHDGECAGLLEWDTRFKIALGVAEG 887
+LLG K L + +YM G+L G + G+C K +L V E
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--------LKFSLDVCEA 114
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
+ YL + +HRD+ + N+L+ E + ++DFGL + E S P
Sbjct: 115 MEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP-----VK 164
Query: 948 YIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
+ APE K S KSDV+S+G++L EI + G+ P
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-16
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 805 VKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF--YDYMPNGTLGML 862
RFR E A +R+ H NIV LL G LLF ++Y+P TL +
Sbjct: 22 RARFRR-----------ETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREV 69
Query: 863 LHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL---GERYESCL 919
L G L ++ L V + L+ H+ I+HRD+K NI++ G R + +
Sbjct: 70 L---AADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKV 123
Query: 920 ADFGLARL---VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEII 976
DFG+ L V D + + + G+ Y APE ++ SD+Y++G++ LE +
Sbjct: 124 LDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECL 183
Query: 977 TGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV-LDPKLQGHP 1018
TG++ V G V + + L PV+V L P + GHP
Sbjct: 184 TGQRVV-----QGASVAEILYQQLS----PVDVSLPPWIAGHP 217
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 79/299 (26%), Positives = 124/299 (41%), Gaps = 47/299 (15%)
Query: 778 LTAGNIIGQGRSGIVYKVTL----PSGLTVAVKRFRASDKISTG--AFSSEIATLSRIRH 831
L G I+G+G G V + L S L VAVK + + F SE A + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 832 RNIVRLLGWGANRKTK------LLFYDYMPNGTLGMLLHDGECAGL---LEWDTRFKIAL 882
N+++L+G + ++ +M +G L L GL L T K +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS---GGSFSAN 939
+A G+ YL + +HRD+ + N +L E C+ADFGL++ + G +
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998
P +IA E + KSDV+++GV + EI T G+ P +P V +
Sbjct: 178 P-----VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP----YPG-------VEN 221
Query: 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQAL-GISLLCTSNRAEDRPTMKDVAALLREI 1056
H E+ D G+ Q ++ L L + C +DRPT + +L I
Sbjct: 222 H--------EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS-------EIATLSRIRHRNIV 835
+G G G V KV +P+G +A K + GA SS E+ + R IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKK------VVHIGAKSSVRKQILRELQIMHECRSPYIV 66
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
G N + ++M G+L + G G + + KIA+ V EGL+YL++
Sbjct: 67 SFYGAFLNENNICMCMEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYN-- 121
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLA-RLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
V I+HRD+K NIL+ R + L DFG++ L+ S F G+ Y++PE
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-------SIADTFVGTSTYMSPERI 174
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
K + KSDV+S G+ ++E+ GK P S
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGKFPFAFS 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 76/274 (27%), Positives = 117/274 (42%), Gaps = 36/274 (13%)
Query: 799 SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG--WGANRKTKLLFYDYMPN 856
+G VAVK+ + S F EI L ++H NIV+ G + A R+ L +Y+P
Sbjct: 32 TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY 91
Query: 857 GTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHRDVKSHNILLGER 914
G+L L E L+ A + +G+ YL V HRD+ + NIL+
Sbjct: 92 GSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSKRYV----HRDLATRNILVESE 144
Query: 915 YESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLE 974
+ DFGL +++ D P + + Y APE +K S SDV+S+GVVL E
Sbjct: 145 NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYE 203
Query: 975 IIT----GKKPVDASF-------PDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQ 1023
+ T P A F GQ ++ + + LK+ P G P +I
Sbjct: 204 LFTYSDKSCSP-PAEFMRMMGNDKQGQMIVYHLIELLKNNGRL-----PAPPGCPA-EIY 256
Query: 1024 EMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057
++ C +N RP+ ++A + IR
Sbjct: 257 AIM------KECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 73/264 (27%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 801 LTVAVKRFRA-SDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859
+ VAVK R ++K + F EI +SR++ NI+RLL + +YM NG L
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 860 GMLL--HDGECAGLLE------WDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL 911
L H+ + A + T +A +A G+ YL +HRD+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV 163
Query: 912 GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVV 971
G+ Y +ADFG++R + SG + + +++ E + K + SDV+++GV
Sbjct: 164 GKNYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 972 LLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGI 1031
L EI+T K S + VI+ + + + V + P L PD+ + ML
Sbjct: 222 LWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALC--PDSLYKLMLS---- 275
Query: 1032 SLLCTSNRAEDRPTMKDVAALLRE 1055
C A++RP+ +++ A L E
Sbjct: 276 ---CWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 25/240 (10%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+ LT +G G+ G+V VA+K + +S F E + ++ H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLV 62
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDG----ECAGLLEWDTRFKIALGVAEGLSYL 891
+L G ++ + +YM NG L L + + + LLE + V EG++YL
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE------MCKDVCEGMAYL 116
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
+HRD+ + N L+ ++ ++DFGL+R V DD S S +F + P
Sbjct: 117 ESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWS--PP 170
Query: 952 EYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ---HVIQ---WVRDHLKSKK 1004
E +K S KSDV+++GV++ E+ + GK P + F + + V Q R HL S+K
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE-RFNNSETVEKVSQGLRLYRPHLASEK 229
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-16
Identities = 98/368 (26%), Positives = 149/368 (40%), Gaps = 59/368 (16%)
Query: 306 IIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRL 365
++P L L ++ S S + + L NL L L L++N++ I + L
Sbjct: 61 LLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNL 118
Query: 366 AQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTG 425
++LDNN IT P SNL L + N++E +P + N NL+ +DLS N L+
Sbjct: 119 TSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD 177
Query: 426 PIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNL 485
+P+ + L LN L L N +S +PPE+ S+L ++N + + + NLKNL
Sbjct: 178 -LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNL 234
Query: 486 NFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGG 545
+ L+L +N+L +P+ I NL LD+ +N I
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI-------------------------- 267
Query: 546 MLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP--ASLGKIP 603
S S LGS L+ LDLS N LS +P A L +
Sbjct: 268 ------------------------SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL 303
Query: 604 ALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNF 663
L + L L+ + +L + L N L + S E L L L L N
Sbjct: 304 ELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLN 363
Query: 664 SGRVPDTP 671
V +
Sbjct: 364 RYIVKNPN 371
|
Length = 394 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 783 IIGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWG 841
++G+G GIVY L + + +A+K D EIA S ++HRNIV+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 842 ANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILH 901
+ +F + +P G+L LL T + EGL YLH + I+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 902 RDVKSHNILLGERYESC-LADFG----LARLVEDDSGGSFSANP---QFAGSYGYIAPEY 953
RD+K N+L+ ++DFG LA + NP F G+ Y+APE
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGI-----------NPCTETFTGTLQYMAPEV 180
Query: 954 AN--MTKISEKSDVYSYGVVLLEIITGKKP 981
+ +D++S G ++E+ TGK P
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRF---RASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG+G GIV+K +G TVA+K+ R I A EI L +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+ +L +YMP L +L D E L E + + +G++Y+H + I
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEE-RPLPEAQVK-SYMRMLLKGVAYMHAN---GI 120
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE--YANMT 957
+HRD+K N+L+ +ADFGLARL ++ +S Q A + Y APE Y
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS--HQVA-TRWYRAPELLYGA-R 176
Query: 958 KISEKSDVYSYGVVLLEIITG 978
K D+++ G + E++ G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 37/82 (45%), Positives = 57/82 (69%)
Query: 279 LTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNL 338
L G IP+ + L++L ++ L N++ G IPP LG+ + L ++D+S NS GSIP++LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 339 TSLQELQLSVNQISGEIPAQIG 360
TSL+ L L+ N +SG +PA +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 782 NIIGQGRSGIVYKVTL-PSGLTV--AVKRFRA-SDKISTGAFSSEIATLSRI-RHRNIVR 836
++IG+G G V K + GL + A+KR + + K F+ E+ L ++ H NI+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIA--------------- 881
LLG +R L +Y P+G L L +LE D F IA
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSR---VLETDPAFAIANSTASTLSSQQLLHF 129
Query: 882 -LGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP 940
VA G+ YL +HRD+ + NIL+GE Y + +ADFGL+R E + P
Sbjct: 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186
Query: 941 QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
++A E N + + SDV+SYGV+L EI++
Sbjct: 187 -----VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 62/225 (27%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 784 IGQGRSGIVY---KVTLPSGLTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVRL 837
I +G G VY K + +G A+K + SD I+ + +E A + V
Sbjct: 4 ISKGAFGSVYLAKKRS--TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 838 LGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L + K L L +Y+ G L+ + G L D + V G+ LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLGVEDLHQR-- 116
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
I+HRD+K N+L+ + L DFGL+R N +F G+ Y+APE
Sbjct: 117 -GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL--------ENKKFVGTPDYLAPETILG 167
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFPDG------QHVIQW 995
+ SD +S G V+ E + G P A PD I W
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 66/200 (33%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 783 IIGQGRSGIVYKVTLPSGLTVAVKRFR----ASDKISTGAFSSEIATLSRIRHRNIVRLL 838
++G+G G V+K TL VAVK + KI F SE L + H NIV+L+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK---FLSEARILKQYDHPNIVKLI 58
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVP 897
G R+ + + +P G L + L+ K AL A G++YL +C+
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCI- 115
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
HRD+ + N L+GE ++DFG++R EDD S S Q + APE N
Sbjct: 116 ---HRDLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQI--PIKWTAPEALNYG 169
Query: 958 KISEKSDVYSYGVVLLEIIT 977
+ S +SDV+SYG++L E +
Sbjct: 170 RYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 782 NIIGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLL 838
N IG+G GIVY+ SG VA+K+ R ++ SS EI L +RH NIV L
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTR-FK------IALGVAEGLSYL 891
+ +F L M + + A LL+ F + L + GL YL
Sbjct: 73 EVVVGKHLDSIF--------LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
H + I+HRD+K N+LL ++ +ADFGLAR + P+ + Y AP
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTPKVV-TLWYRAP 177
Query: 952 EYA-NMTKISEKSDVYSYGVVLLEIITGK 979
E T + D+++ G +L E++ K
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 783 IIGQGRSGIVYK-VTLPSGLTVAVKRFR---ASDKISTGAFSSEIATLSRIRH---RNIV 835
+IG+G G VY+ +P+G VA+K D +S E+A LS++R NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD--IQREVALLSQLRQSQPPNIT 65
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE---GLSYLH 892
+ G + +Y G++ L+ G A I++ + E L Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY-------ISVIIREVLVALKYIH 118
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
++HRD+K+ NIL+ L DFG+A L+ +S S F G+ ++APE
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS----SKRSTFVGTPYWMAPE 171
Query: 953 YANMTKISE-KSDVYSYGVVLLEIITGKKP 981
K + K+D++S G+ + E+ TG P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 783 IIGQGRSG--IVYKVTLPSGLTV--AVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLL 838
++G+G G +Y+ T L V V R S+K A + EI LS ++H NI+
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPNIIAYY 65
Query: 839 GWGANRKTKLLFYDYMPNGTLG-MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+ T L+ +Y GTL ++ + L E + + +SY+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAVSYIHKA--- 120
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
ILHRD+K+ NI L + L DFG+++++ + + + G+ Y++PE
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV----VGTPYYMSPELCQGV 176
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFP 987
K + KSD+++ G VL E++T K+ DA+ P
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 24/263 (9%)
Query: 803 VAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGM 861
VAVK RA K + F EI +SR+++ NI+RLLG + + +YM NG L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 862 LLHDGECAGLL---------EWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912
L E +A+ +A G+ YL +HRD+ + N L+G
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 913 ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVL 972
Y +ADFG++R + SG + + ++A E + K + SDV+++GV L
Sbjct: 164 NHYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 973 LEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGIS 1032
E+ T K S + VI+ + +++ + + L P + M++
Sbjct: 222 WEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLC--PSPVFKLMMR----- 274
Query: 1033 LLCTSNRAEDRPTMKDVAALLRE 1055
C S +DRPT + LRE
Sbjct: 275 --CWSRDIKDRPTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 63/254 (24%), Positives = 100/254 (39%), Gaps = 32/254 (12%)
Query: 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRL 837
+IG+G G V V + A+K + G+ + E L + H +V L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 838 LGWGA--NRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
W + + + L D + G L H + E +F I + L YLH
Sbjct: 66 --WYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWIC-EIVLALEYLHSK- 119
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
I+HRD+K NILL E+ + DF +A V D+ + +G+ GY+APE
Sbjct: 120 --GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-----STSGTPGYMAPEVLC 172
Query: 956 MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
S D +S GV E + GK+P + + +R + D +
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGH---SRTIRDQIR-AKQETADVL-------- 220
Query: 1016 GHPDTQIQEMLQAL 1029
+P T E + A+
Sbjct: 221 -YPATWSTEAIDAI 233
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-15
Identities = 42/108 (38%), Positives = 63/108 (58%), Gaps = 1/108 (0%)
Query: 512 LDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSI 571
L + + + G +P + +L LQ +LS NS+ G + P LGS++SL L L+ N F GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 572 PSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQ-ICG 618
P LG L++L+L+ N LSG +PA+LG + N + N +CG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530
|
Length = 623 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-15
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 769 LSIGDATRSLTAGNIIGQGRSGIVY-KVTLPSGLTVAVKRFRASDKISTGAFSSEIATLS 827
+S+GD + T IGQG SG VY + + +G VA+K+ + +EI +
Sbjct: 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 828 RIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLG-----MLLHDGECAGLLEWDTRFKIAL 882
+H NIV L + +Y+ G+L + +G+ A +
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCR 122
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL-ARLVEDDSGGSFSANPQ 941
+ L +LH + V +HRD+KS NILLG L DFG A++ + S S
Sbjct: 123 ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-----T 174
Query: 942 FAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ ++APE K D++S G++ +E++ G+ P
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA 842
IG G G VYK + +G VA+K + EI+ L RH NIV G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG-SY 69
Query: 843 NRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE---GLSYLHHDCVPA 898
R+ KL + +Y G+L + G L +IA E GL+YLH
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSEL---QIAYVCRETLKGLAYLHETGK-- 122
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
+HRD+K NILL E + LADFG++ + + + F G+ ++APE A + +
Sbjct: 123 -IHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 959 IS---EKSDVYSYGVVLLEIITGKKP 981
K D+++ G+ +E+ + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 78/293 (26%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 778 LTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDKIS-TGAFSSEIATLSRI- 829
L+ G +G G G V + T + + VAVK + + S A SE+ +S +
Sbjct: 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLS 889
H NIV LLG L+ +Y G L L + L D + VA+G++
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMA 155
Query: 890 YL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
+L +C+ HRD+ + N+LL + DFGLAR + +DS N + +
Sbjct: 156 FLASKNCI----HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKW 209
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP-----VDASFPDGQHVIQWVRDHLKS 1002
+APE + +SDV+SYG++L EI + G P VD+ F K
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF-------------YKL 256
Query: 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
K+ + P+ H +I ++++ C RPT K + L+ +
Sbjct: 257 IKEGYRMAQPE---HAPAEIYDIMKT------CWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 82/294 (27%), Positives = 123/294 (41%), Gaps = 62/294 (21%)
Query: 784 IGQGRSGIVYK--VTLPSG--LTVAVKRFRASDKIS-TGAFSSEIATLSRIRHRNIVRLL 838
+G G G V K + SG + VAVK + + F E + ++++ H IVRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 839 G------WGANRKTKLLFYDYMPNGTL-GMLLHDGEC--AGLLEWDTRFKIALGVAEGLS 889
G +L + P G L L E + L E A VA G++
Sbjct: 63 GVCKGEPL-------MLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMA 109
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY--G 947
YL +HRD+ + N+LL R+++ ++DFG++R + GS AG +
Sbjct: 110 YLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL---GAGSDYYRATTAGRWPLK 163
Query: 948 YIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006
+ APE N K S KSDV+SYGV L E + G KP +
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE----------------MKGAEV 207
Query: 1007 VEVLDPKLQGH----PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
+ +L+ G P+ QE+ I L C R EDRPT ++ + R
Sbjct: 208 IAMLE---SGERLPRPEECPQEIYS---IMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRF---RASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG+G G VYK + + VA+K A D+I EI LS+ R I + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED--IQQEIQFLSQCRSPYITKYYG 66
Query: 840 WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+KL + +Y G+ LL + L E F I V GL YLH +
Sbjct: 67 SFLKG-SKLWIIMEYCGGGSCLDLL---KPGKLDETYIAF-ILREVLLGLEYLHEEGK-- 119
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
+HRD+K+ NILL E + LADFG++ + + S F G+ ++APE +
Sbjct: 120 -IHRDIKAANILLSEEGDVKLADFGVSGQLTS----TMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 959 ISEKSDVYSYGVVLLEIITGKKP 981
EK+D++S G+ +E+ G+ P
Sbjct: 175 YDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 38/213 (17%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWG 841
+G+G G VYK +G VA+K + + EI+ L + IV+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ--EIIKEISILKQCDSPYIVKYYG-- 65
Query: 842 ANRKTKLLFYDYMPNGTLGMLLHDGECAG-------------LLEWDTRFKIALGVAEGL 888
Y N L +++ C L E + I +GL
Sbjct: 66 ----------SYFKNTDLWIVME--YCGAGSVSDIMKITNKTLTEEEIAA-ILYQTLKGL 112
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
YLH + +HRD+K+ NILL E ++ LADFG++ + D N G+ +
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRN-TVIGTPFW 165
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
+APE + K+D++S G+ +E+ GK P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 75/233 (32%), Positives = 112/233 (48%), Gaps = 24/233 (10%)
Query: 776 RSLTAGNIIGQGRSGIVYK--VTLPSG--LTVAVKRFRA--SDKISTGAFSSEIATLSRI 829
+S+ I+G GR G + + + LPS L VA+ RA SDK G F +E TL +
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQF 63
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLS 889
H NIVRL G T ++ +YM NG L L E G L + G+A G+
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMK 121
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG-- 947
YL +H+ + +H +L+ ++ F RL ED S ++ +G
Sbjct: 122 YLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTT---MSGKSPVL 173
Query: 948 YIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPV-DASFPDGQHVIQWVRD 998
+ APE S SDV+S+G+V+ E+++ G++P D S GQ VI+ V D
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS---GQDVIKAVED 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 8e-15
Identities = 75/272 (27%), Positives = 119/272 (43%), Gaps = 31/272 (11%)
Query: 801 LTVAVKRFRA-SDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859
L VAVK R ++K + F E+ LSR++ NI+RLLG + + +YM NG L
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 860 GMLLH-----DGE-----------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
L D E C + + + +AL +A G+ YL +HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKS 963
+ + N L+GE +ADFG++R + +G + + ++A E M K + S
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLY--AGDYYRIQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 964 DVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQ 1023
DV+++GV L EI+ K + VI+ + + + V + P P +
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPC--PQGLYE 279
Query: 1024 EMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
MLQ C S +RP+ D+ A L E
Sbjct: 280 LMLQ-------CWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKIST-GAFSSEIATLSRIRHRNIVRLLGWG 841
+G G G+V+KV+ PSGL +A K K + E+ L IV G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 842 ANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILH 901
+ + ++M G+L +L AG + K+++ V +GL+YL I+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK--HKIMH 127
Query: 902 RDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISE 961
RDVK NIL+ R E L DFG++ + D S F G+ Y++PE T S
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRSYMSPERLQGTHYSV 181
Query: 962 KSDVYSYGVVLLEIITGKKPVDASFPDGQHV 992
+SD++S G+ L+E+ G+ P+ PD + +
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPP--PDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASD------KISTGAFSSEIATLSRIRHRNIVR 836
IG+G G+V+K +G VA+K+F S+ KI+ EI L +++H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPNLVN 64
Query: 837 LLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HD 894
L+ RK KL L ++Y + L L + G+ E + KI + +++ H H+
Sbjct: 65 LIEV-FRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCHKHN 120
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY- 953
C+ HRDVK NIL+ ++ + L DFG AR++ +G A + Y APE
Sbjct: 121 CI----HRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRW-YRAPELL 172
Query: 954 ANMTKISEKSDVYSYGVVLLEIITG 978
T+ DV++ G V E++TG
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 781 GNIIGQGRSGIVYKV-TLPSGLTVAVKRFR-------ASDKISTGAFSSEIATLSRIRHR 832
G ++GQG G VY + +G +A K+ + S ++S A EI L ++H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVS--ALECEIQLLKNLQHE 64
Query: 833 NIVRLLGWGANR--KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
IV+ G +R KT +F +YMP G++ L + G L K + EG+SY
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSY 121
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED--DSGGSFSANPQFAGSYGY 948
LH + I+HRD+K NIL L DFG ++ ++ SG + G+ +
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS---VTGTPYW 175
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
++PE + K+DV+S G ++E++T K P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-14
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKIST-GAFSSEIATLSRIRHRNIVRLLGWG 841
+G G G+V KV PSGL +A K K + E+ L IV G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 842 ANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILH 901
+ + ++M G+L +L + A + + K+++ V GL+YL I+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREK--HQIMH 127
Query: 902 RDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISE 961
RDVK NIL+ R E L DFG++ + D SF G+ Y++PE T S
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------VGTRSYMSPERLQGTHYSV 181
Query: 962 KSDVYSYGVVLLEIITGKKPVDASFPDGQHV 992
+SD++S G+ L+E+ G+ P+ PD + +
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPP--PDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 53/295 (17%)
Query: 783 IIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGA-----FSSEIATLSRIRHRNIVR 836
++G G G VYK + +P G TV + +TG F E ++ + H ++VR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGE----CAGLLEWDTRFKIALGVAEGLSYLH 892
LLG + +L+ MP+G L +H+ + LL W + +A+G+ YL
Sbjct: 74 LLGVCLSPTIQLV-TQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS------GGSFSANPQFAGSY 946
++HRD+ + N+L+ + DFGLARL+E D GG
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------- 176
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKD 1005
++A E + K + +SDV+SYGV + E++T G KP D P + + + + +
Sbjct: 177 -WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG-IPT-REIPDLLEKGERLPQP 233
Query: 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060
P+ +D + + + C A+ RP K++AA + ++P
Sbjct: 234 PICTIDVYM----------------VMVKCWMIDADSRPKFKELAAEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-14
Identities = 54/179 (30%), Positives = 86/179 (48%), Gaps = 33/179 (18%)
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL----VEDDSGGSFSANPQFAGSY 946
+HH ++HRD+KS NILL L DFG +++ V DD G +F P
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY----- 210
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006
Y+APE S+K+D++S GV+L E++T K+P DG+++ + + L + DP
Sbjct: 211 -YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-----DGENMEEVMHKTLAGRYDP 264
Query: 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLC-------TSNRAEDRPTMKDVAALLREIRQ 1058
+ P + EM Q + +LL +S++ + P K + L EI Q
Sbjct: 265 L----------PPSISPEM-QEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQ 312
|
Length = 496 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 71/310 (22%), Positives = 126/310 (40%), Gaps = 54/310 (17%)
Query: 777 SLTAGNIIGQGRSGIVYKVT------LPSGLTVAVKRFR-ASDKISTGAFSSEIATLSRI 829
+L G +G+G G V K T TVAVK + + SE L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDG---ECAGLLEWDTR--------- 877
H ++++L G + LL +Y G+L L + + L R
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 878 ---------FKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928
A ++ G+ YL ++HRD+ + N+L+ E + ++DFGL+R V
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 929 -EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASF 986
E+D S+ + ++A E + +SDV+S+GV+L EI+T G P
Sbjct: 178 YEED---SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234
Query: 987 PDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046
P + + ++ + ++ P+ +EM + L C + RPT
Sbjct: 235 P--ERLFNLLKTGYRMER-------------PENCSEEMYN---LMLTCWKQEPDKRPTF 276
Query: 1047 KDVAALLREI 1056
D++ L ++
Sbjct: 277 ADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 80/282 (28%), Positives = 121/282 (42%), Gaps = 37/282 (13%)
Query: 773 DATRSLTAGNIIGQGRSGIVYK-VTLPSGLTVAVKRF---RASDKISTGAFSSEIATLSR 828
D T IG+G G VYK + + VA+K A D+I EI LS+
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED--IQQEITVLSQ 58
Query: 829 IRHRNIVRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEG 887
I R G + TKL + +Y+ G+ LL G LE I + +G
Sbjct: 59 CDSPYITRYYG-SYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKG 113
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
L YLH + +HRD+K+ N+LL E+ + LADFG+A + D F G+
Sbjct: 114 LDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ----IKRNTFVGTPF 166
Query: 948 YIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007
++APE + K+D++S G+ +E+ G+ P P V+ L K P
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP--MRVL-----FLIPKNSP- 218
Query: 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
P L+G +E ++A C + RPT K++
Sbjct: 219 ----PTLEGQYSKPFKEFVEA------CLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 81/296 (27%), Positives = 121/296 (40%), Gaps = 57/296 (19%)
Query: 782 NIIGQGRSGIVYKVTL----PSGLTVAVKRF-RASDKISTGAFSSEIATLSRIRHRNIVR 836
+IG+G G VY TL + AVK R +D F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 837 LLGWG-ANRKTKLLFYDYMPNGTLGMLL----HDGECAGLLEWDTRFKIALGVAEGLSYL 891
LLG + + L+ YM +G L + H+ L+ + L VA+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGF------GLQVAKGMEYL 114
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
+HRD+ + N +L E + +ADFGLAR + D S + ++A
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 952 EYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010
E K + KSDV+S+GV+L E++T G P +PD D ++
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP----YPD---------------VDSFDIT 212
Query: 1011 DPKLQGH--------PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058
LQG PD + ML C + E RPT + L+ I Q
Sbjct: 213 VYLLQGRRLLQPEYCPDPLYEVMLS-------CWHPKPEMRPTFSE---LVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGW 840
+G+G G+V K +G VA+K+F+ S D+ E+ L ++RH NIV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE- 67
Query: 841 GANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPA 898
RK +L L ++Y+ L +L + GL R + + ++Y H H+ +
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELL--EASPGGLPPDAVR-SYIWQLLQAIAYCHSHNII-- 122
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANMT 957
HRD+K NIL+ E L DFG AR + S + + Y APE T
Sbjct: 123 --HRDIKPENILVSESGVLKLCDFGFARAL---RARPASPLTDYVATRWYRAPELLVGDT 177
Query: 958 KISEKSDVYSYGVVLLEIITG 978
+ DV++ G ++ E++ G
Sbjct: 178 NYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 67/235 (28%), Positives = 108/235 (45%), Gaps = 28/235 (11%)
Query: 784 IGQGRSGIVYK--VTLPS---GLTVAVKRFR-ASDKISTGAFSSEIATLSRIRHRNIVRL 837
+G+ G +YK + LP VA+K + ++ G F E + ++ + H NIV L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLL--------------HDGECAGLLEWDTRFKIALG 883
LG + + ++Y+ G L L DG L+ IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
+A G+ YL +H+D+ + NIL+GE+ ++D GL+R E S + P+
Sbjct: 133 IAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSR--EIYSADYYRVQPKSL 187
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVR 997
++ PE K S SD++S+GVVL EI + G +P F + Q VI+ VR
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY-YGFSN-QEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 22/217 (10%)
Query: 784 IGQGRSGIVY----KVTLPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVR 836
I +G G V+ K T G A+K + +D I E LS+ + +V+
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDC 895
L +K L +Y+P G L LL + L E R IA + L YLH +
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGS--LDEDVARIYIA-EIVLALEYLHSNGI 114
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARL----VEDDSGGSFSANPQFAGSYGYIAP 951
+ HRD+K NIL+ L DFGL+++ + + + + G+ YIAP
Sbjct: 115 I----HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 952 EYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD 988
E S+ D +S G +L E + G P P+
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 71/258 (27%), Positives = 112/258 (43%), Gaps = 38/258 (14%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHR-NIVRLLG-W 840
+G G G+V KV PSGL +A K K A ++I ++ H N ++G +
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIK---PAIRNQIIRELKVLHECNSPYIVGFY 65
Query: 841 GANRKTKLLFYD---------YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
GA FY +M G+L +L AG + + KI++ V GL+YL
Sbjct: 66 GA-------FYSDGEISICMEHMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYL 115
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
I+HRDVK NIL+ R E L DFG++ + D S F G+ Y++P
Sbjct: 116 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRSYMSP 167
Query: 952 EYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011
E T + +SD++S G+ L+E+ G+ P+ PD + + + +
Sbjct: 168 ERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP--PDAKELEAMFGRPVSEGEAKESHRP 225
Query: 1012 PKLQGHPDTQ---IQEML 1026
+ I E+L
Sbjct: 226 VSGHPPDSPRPMAIFELL 243
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 24/209 (11%)
Query: 783 IIGQGRSGIVY---KVTLP-SGLTVAVKRFRAS-----DKISTGAFSSEIATLSRIRHRN 833
++GQG G V+ K+T P +G A+K + + D++ T E L+ + H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT---KMERDILAEVNHPF 59
Query: 834 IVRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
IV+L + + KL L D++ G L L + E D +F +A +A L +LH
Sbjct: 60 IVKL-HYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLH 115
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
I++RD+K NILL E L DFGL++ D ++S F G+ Y+APE
Sbjct: 116 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS----FCGTVEYMAPE 168
Query: 953 YANMTKISEKSDVYSYGVVLLEIITGKKP 981
N ++ +D +S+GV++ E++TG P
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 782 NIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLL 838
IG+G G VYK +G VA+K+ R ++ ++ EI L ++ HRNIV L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 839 GWGAN-------RKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIAL--GVAE 886
+ +K K FY +YM + +G+L +GL+ + + + E
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE-----SGLVHFSEDHIKSFMKQLLE 127
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
GL+Y H LHRD+K NILL + + LADFGLARL + ++ +
Sbjct: 128 GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK---VITL 181
Query: 947 GYIAPE-YANMTKISEKSDVYSYGVVLLEIITGKKPV 982
Y PE + DV+S G +L E+ T KKP+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 63/211 (29%), Positives = 88/211 (41%), Gaps = 33/211 (15%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVRLLG 839
IG G G VY + + VA+K+ S K S + E+ L ++RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 840 WGANRKTKLLFYDYMPNGTLGML------LHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
T L +Y +L L + E A I G +GL+YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA---------ICHGALQGLAYLHS 133
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
+HRD+K+ NILL E LADFG A LV SF P + +APE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLV--SPANSFVGTPYW------MAPEV 182
Query: 954 ---ANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ + K DV+S G+ +E+ K P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 51/228 (22%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRF---RASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G+G G VYK + +G VA+K+ D A EI L +++H N+V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74
Query: 840 W-----GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFK--------IALGVAE 886
+++ + Y P + HD +GLLE + K L + E
Sbjct: 75 MAVERPDKSKRKRGSVYMVTP-----YMDHD--LSGLLE-NPSVKLTESQIKCYMLQLLE 126
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
G++YLH + ILHRD+K+ NIL+ + +ADFGLAR + P G
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPP-------PNPKGGG 176
Query: 947 GYIAPEYANM--TK--------ISEKS-----DVYSYGVVLLEIITGK 979
G +Y N+ T+ + E+ D++ G V E+ T +
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 41/209 (19%)
Query: 879 KIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA-RLVEDDSGGSFS 937
KIA+ + + L YLH +++HRDVK N+L+ + L DFG++ LV+
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS------V 158
Query: 938 ANPQFAGSYGYIAPEY----ANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVI 993
A AG Y+APE N KSDV+S G+ ++E+ TG+ P D
Sbjct: 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD---------- 208
Query: 994 QWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
W + + K VE P+L P + Q ++ N E RP
Sbjct: 209 SW-KTPFQQLKQVVEEPSPQL---PAEKFSPEFQDF-VNKCLKKNYKE-RPN-------Y 255
Query: 1054 REIRQEPASGSEAHKPTAAKSTDTASYSS 1082
E+ Q P + +K+TD AS+ S
Sbjct: 256 PELLQHPFF-----ELHLSKNTDVASFVS 279
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 3e-13
Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 12/214 (5%)
Query: 769 LSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLS 827
+SIGD + T IGQG SG V+ + +G VA+K+ + +EI +
Sbjct: 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71
Query: 828 RIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEG 887
+++ NIV L + +Y+ G+L ++ + C + + L +
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECL---QA 127
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
L +LH + ++HRD+KS N+LLG L DFG + + S G+
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ----SKRSTMVGTPY 180
Query: 948 YIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
++APE K D++S G++ +E++ G+ P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 29/200 (14%)
Query: 801 LTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL- 859
+ VAVK + + F E L+ ++H +IV+ G + ++ ++YM +G L
Sbjct: 36 MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 860 ---------GMLLHDGE---CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSH 907
M+L DG+ G L IA +A G+ YL +HRD+ +
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATR 152
Query: 908 NILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG-----YIAPEYANMTKISEK 962
N L+G + DFG++R V +S + G + ++ PE K + +
Sbjct: 153 NCLVGANLLVKIGDFGMSRDV-------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 205
Query: 963 SDVYSYGVVLLEIIT-GKKP 981
SDV+S+GV+L EI T GK+P
Sbjct: 206 SDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 784 IGQGRSGIVYKVT----LPSG--LTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRL 837
+G+G G V+ LP + VAVK + + + + F E L+ ++H++IVR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLH------------DGECAGLLEWDTRFKIALGVA 885
G + L+ ++YM +G L L + G L IA +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 886 EGLSY---LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
G+ Y LH +HRD+ + N L+G+ + DFG++R + S + +
Sbjct: 133 SGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 184
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
++ PE K + +SD++S+GVVL EI T GK+P
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 70/288 (24%), Positives = 111/288 (38%), Gaps = 53/288 (18%)
Query: 782 NIIGQGRSGIVYKVTLPSGLTVAVKRF---RASDKISTGAFSSEIATLSRIRHRNIVRLL 838
+ +G+G G V K L + + + + + E+ + IV+
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKYY 65
Query: 839 GWGANRKTKLLF--YDYMPNGTLGMLLHDGECAGLLEWDTRF------KIALGVAEGLSY 890
G + + + +Y G+L + + + R KIA V +GLSY
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKK-----VKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
LH I+HRD+K NILL + + L DFG V + S + F G+ Y+A
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAGT--FTGTSFYMA 171
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010
PE S SDV+S G+ LLE+ + P P+G+ + P+E+L
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG-----------PIELL 217
Query: 1011 D-------PKLQGHPDTQI---QEMLQALGISLLCTSNRAEDRPTMKD 1048
P+L+ P I +E + C RPT D
Sbjct: 218 SYIVNMPNPELKDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-13
Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 17/289 (5%)
Query: 282 SIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTS- 340
L NL L +L L N L I L + L+ +D+ N++T IP +G L S
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNIT-DIPPLIGLLKSN 141
Query: 341 LQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLE 400
L+EL LS N+I +P+ + N L ++L N ++ +P NLSNL L + N++
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 401 GEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSS 460
++PP I LE +DLS N + + + LK L+ L L +N L + GN S+
Sbjct: 200 -DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESI-GNLSN 256
Query: 461 LIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITG---CRNLTFLDVHSN 517
L ++N+++ +G+L NL LDL N L+ ++P L L +
Sbjct: 257 LETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLK 314
Query: 518 SIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNR 566
++ L + L L + S L SL++L L +
Sbjct: 315 ALELKLNSILLNNNILSNGETSS----PEALSILESLNNLWTLDNALDE 359
|
Length = 394 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 778 LTAGNIIGQGRSGIVYKVTLPSG---LTVAVKRFR--ASDKISTGAFSSEIATLSRI-RH 831
+ ++IG+G G V + + + A+K + AS+ F+ E+ L ++ H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN-DHRDFAGELEVLCKLGHH 62
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRF------------- 878
NI+ LLG NR + +Y P G L L +LE D F
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSR---VLETDPAFAKEHGTASTLTSQ 119
Query: 879 ---KIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935
+ A VA G+ YL +HRD+ + N+L+GE S +ADFGL+R E +
Sbjct: 120 QLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKT 176
Query: 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
P ++A E N + + KSDV+S+GV+L EI++
Sbjct: 177 MGRLP-----VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 778 LTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR--ASDKISTGAFSSEIATLSRI 829
LT G +G+G G V K TVAVK + A++K SE+ + I
Sbjct: 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMI 72
Query: 830 -RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDG-----ECAGLLEWDTRFKI--- 880
+H+NI+ LLG + +Y +G L L + +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 881 -----ALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935
A VA G+ +L +HRD+ + N+L+ E + +ADFGLAR +
Sbjct: 133 DLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189
Query: 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
+ N + ++APE + +SDV+S+GV+L EI T
Sbjct: 190 KTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 23/238 (9%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRA---SDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG+G G+VYK +G VA+K+ + S+ I A EI L + H NI++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65
Query: 840 -WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ L+F ++M + L L+ GL E + + +GL++ H
Sbjct: 66 VFRHKGDLYLVF-EFM-DTDLYKLI-KDRQRGLPESLIKS-YLYQLLQGLAFCHSH---G 118
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANMT 957
ILHRD+K N+L+ LADFGLAR G + + Y APE
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF----GSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
S D++S G + E+++ + FP + Q + ++ P + PK
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR----PLFPGKSEIDQLFKIF-RTLGTPDPEVWPKFT 227
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 70/235 (29%), Positives = 102/235 (43%), Gaps = 27/235 (11%)
Query: 782 NIIGQGRSGIVYKVTLPSGLT-------VAVKRFRASDKISTGA-FSSEIATLSRIRHRN 833
N +G G G VY+ T L VAVK R F E +S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAG----LLEWDTRFKIALGVAEGLS 889
IV+LLG + + + + M G L L D LL I L VA+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESC-----LADFGLAR-LVEDDSGGSFSANPQFA 943
YL +HRD+ + N L+ E+ + DFGLAR + + D + +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY---YRKEGEGL 174
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVR 997
++APE K + +SDV+S+GV++ EI+T G++P A + Q V+Q V
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--NNQEVLQHVT 227
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA 842
+G G G VYK +GL A K + + F EI LS +H NIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE-AY 71
Query: 843 NRKTKLLFY-DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILH 901
+ KL ++ G L ++ + E GL E R+ + + E L++LH ++H
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126
Query: 902 RDVKSHNILLGERYESCLADFGL-ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKIS 960
RD+K+ NILL + LADFG+ A+ F G+ ++APE
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD-----TFIGTPYWMAPEVVACETFK 181
Query: 961 E-----KSDVYSYGVVLLEIITGKKP 981
+ K+D++S G+ L+E+ + P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-13
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 769 LSIGDATRSLTAGNIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSSEIATLS 827
+S+GD + T IGQG SG VY + + +G VA+++ + +EI +
Sbjct: 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 828 RIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLG-----MLLHDGECAGLLEWDTRFKIAL 882
++ NIV L + +Y+ G+L + +G+ A +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCR 123
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
+ L +LH + ++HRD+KS NILLG L DFG + + S
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTM 176
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ ++APE K D++S G++ +E+I G+ P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 10/169 (5%)
Query: 818 AFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTR 877
A +E L + H NI+ K ++ +Y P GTL + C LL+ DT
Sbjct: 45 AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT- 102
Query: 878 FKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESC-LADFGLARLVEDDSGGSF 936
I + L LHH ILHRD+K+ NILL + + DFG+++++ S
Sbjct: 103 --ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-----SSK 155
Query: 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
S G+ YI+PE ++KSD+++ G VL E+ + K+ +A+
Sbjct: 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 17/182 (9%)
Query: 784 IGQGRSGIVYKV---TLPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRL 837
IG+G G VYK G A+K+F+ + TG S EIA L ++H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 838 LGWGANRKTKLLF--YDYMPNGTLGMLLHDGECAGLLEWDTRFKIAL-GVAEGLSYLHHD 894
+ K ++ +DY + ++ + + + K L + G+ YLH +
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127
Query: 895 CVPAILHRDVKSHNILL-GERYESC---LADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
+LHRD+K NIL+ GE E + D GLARL +P + Y A
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV-TIWYRA 183
Query: 951 PE 952
PE
Sbjct: 184 PE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 778 LTAGNIIGQGRSGIVYKVTL---PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHR 832
L G +G+G G V + L S L VAVK + + + F SE + H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 833 NIVRLLG---WGANRK---TKLLFYDYMPNGTL-GMLLHD--GECAGLLEWDTRFKIALG 883
N++RL+G + + ++ +M +G L LL+ G+C L K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS---GGSFSANP 940
+A G+ YL + +HRD+ + N +L E C+ADFGL++ + + G + P
Sbjct: 121 IASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 941 QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
+IA E + KSDV+S+GV + EI T G+ P
Sbjct: 178 -----VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 75/271 (27%), Positives = 121/271 (44%), Gaps = 37/271 (13%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRF---RASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG+G G V+K + + VA+K A D+I EI LS+ + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED--IQQEITVLSQCDSPYVTKYYG 69
Query: 840 WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ TKL + +Y+ G+ LL G L+ I + +GL YLH +
Sbjct: 70 -SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---K 121
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
+HRD+K+ N+LL E E LADFG+A + D F G+ ++APE +
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----IKRNTFVGTPFWMAPEVIKQSA 177
Query: 959 ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018
K+D++S G+ +E+ G+ P P V+ L K +P P L+G+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHP--MKVL-----FLIPKNNP-----PTLEGNY 225
Query: 1019 DTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
++E ++A C + RPT K++
Sbjct: 226 SKPLKEFVEA------CLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 769 LSIGDATRSLTAGNIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSSEIATLS 827
+S+GD + T IGQG SG VY + + +G VA+K+ + +EI +
Sbjct: 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 828 RIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLG-----MLLHDGECAGLLEWDTRFKIAL 882
++ NIV L + +Y+ G+L + +G+ A +
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCR 122
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
+ L +LH + ++HRD+KS NILLG L DFG + + S
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTM 175
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ ++APE K D++S G++ +E++ G+ P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-12
Identities = 41/116 (35%), Positives = 55/116 (47%), Gaps = 10/116 (8%)
Query: 62 PC-----KWFGVSCNLNNQ-----VVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLT 111
PC W G C ++ + GL L L G +P + + L L + LSG ++
Sbjct: 396 PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIR 455
Query: 112 GSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIG 167
G+IP + S+ L LDLS NS G IP L L L L LN N L G +P +G
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 778 LTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASDKISTG--AFSSEIATLSRIRH 831
T G ++G+G G V + L S VAVK +A S+ F E A + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 832 RNIVRLLGWGANRKTK------LLFYDYMPNGTLGMLL---HDGECAGLLEWDTRFKIAL 882
N+++L+G + K ++ +M +G L L GE L T + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
+A G+ YL +HRD+ + N +L E C+ADFGL++ + SG +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIY--SGDYYRQGCAS 175
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
++A E + SDV+++GV + EI+T G+ P
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFS--------SEIATLSRIRHRNIV 835
+G+G G VYKV ++ +F A ++ G+ S +EI L+ + H NI+
Sbjct: 8 LGKGSYGSVYKVK-----RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII 62
Query: 836 R-----LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAG-LLEWDTRFKIALGVAEGLS 889
L G N+ ++ +Y P G L + + L+ ++I + + GL
Sbjct: 63 SYKEAFLDG---NKLCIVM--EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
LH ILHRD+KS NILL + D G++++++ A Q G+ Y+
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK-----KNMAKTQI-GTPHYM 168
Query: 950 APEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984
APE S KSD++S G +L E+ T P +A
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 26/197 (13%)
Query: 801 LTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL- 859
+ VAVK + + + F E L+ ++H +IV+ G ++ ++YM +G L
Sbjct: 36 ILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95
Query: 860 ---------GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNIL 910
+L+ +G L IA +A G+ YL +HRD+ + N L
Sbjct: 96 KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCL 152
Query: 911 LGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG-----YIAPEYANMTKISEKSDV 965
+GE + DFG++R V +S + G + ++ PE K + +SDV
Sbjct: 153 VGENLLVKIGDFGMSRDV-------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 205
Query: 966 YSYGVVLLEIIT-GKKP 981
+S GVVL EI T GK+P
Sbjct: 206 WSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 69/241 (28%), Positives = 105/241 (43%), Gaps = 20/241 (8%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRLLG 839
IG+G G+VYK +G VA+K+ R D + G S+ EI+ L + H NIV+LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
L ++++ + L + D + + +GL++ H V
Sbjct: 67 VIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV--- 121
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
LHRD+K N+L+ LADFGLAR G + Y APE K
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 960 -SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018
S D++S G + E++T + A FP + Q R ++ P EV+ P + P
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRI-FRTLGTPDEVVWPGVTSLP 232
Query: 1019 D 1019
D
Sbjct: 233 D 233
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 782 NIIGQGRSGIVYKVTLPSG---LTVAVKRFRA-SDKISTGAFSSEIATLSRI-RHRNIVR 836
++IG+G G V K + + A+KR + + K F+ E+ L ++ H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRF----------------KI 880
LLG +R L +Y P+G L L +LE D F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSR---VLETDPAFAIANSTASTLSSQQLLHF 117
Query: 881 ALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP 940
A VA G+ YL +HRD+ + NIL+GE Y + +ADFGL+R E + P
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 941 QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
++A E N + + SDV+SYGV+L EI++
Sbjct: 175 -----VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-12
Identities = 36/91 (39%), Positives = 53/91 (58%), Gaps = 1/91 (1%)
Query: 537 DLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP 596
L + + G + D+ L L + L+ N G+IP LGS L++LDLS N +G+IP
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 597 ASLGKIPALAIALNLSWNQICGELPAELTGL 627
SLG++ +L I LNL+ N + G +PA L G
Sbjct: 484 ESLGQLTSLRI-LNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLG 839
++G+G G+V K +G VA+K+F S DK+ EI L ++RH N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+K L ++++ + L L GL E R K + G+ + H I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEK--YPNGLDESRVR-KYLFQILRGIEFCHSH---NI 121
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY-ANMTK 958
+HRD+K NIL+ + L DFG AR + + + Y APE TK
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTL----AAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 959 ISEKSDVYSYGVVLLEIITG 978
D+++ G ++ E++TG
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 78/293 (26%), Positives = 111/293 (37%), Gaps = 69/293 (23%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRFRA-SDKISTGAFSSEIATLSRIRH-RNIVRLLGW 840
IG+G G V K + PSG +AVKR R+ D+ ++ + R IV+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK---- 67
Query: 841 GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLE-WDTRF--------------------- 878
FY G L +G+C +E D
Sbjct: 68 ---------FY--------GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG 110
Query: 879 KIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSA 938
KIA+ + L+YL + I+HRDVK NILL L DFG++ + D S A
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SI-A 163
Query: 939 NPQFAGSYGYIAPEYANMTKISE---KSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995
+ AG Y+APE + + +SDV+S G+ L E+ TGK P + Q
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV 223
Query: 996 VRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKD 1048
V K DP P L + + + LC RP K+
Sbjct: 224 V------KGDP-----PIL--SNSEEREFSPSFVNFINLCLIKDESKRPKYKE 263
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 781 GNIIGQGRSGIVYKV-TLPSGLTVAVKRFR-------ASDKISTGAFSSEIATLSRIRHR 832
G ++GQG G VY +G +AVK+ + S +++ A EI L + H
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVN--ALECEIQLLKNLLHE 64
Query: 833 NIVRLLGW--GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
IV+ G +T +F ++MP G++ L + G L + K + EG+SY
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSY 121
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD--SGGSFSANPQFAGSYGY 948
LH + I+HRD+K NIL L DFG ++ ++ SG + G+ +
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS---VTGTPYW 175
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
++PE + K+D++S G ++E++T K P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 775 TRSLTAGNIIGQGRSGIVYK-VTLPSG----LTVAVKRFR-ASDKISTGAFSSEIATLSR 828
L ++G G G V+K + +P G + VA+K + S + + + + +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
+ H IVRLLG +L+ P G+L L H + L+ + +A+G+
Sbjct: 66 LDHAYIVRLLGICPGASLQLV-TQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGM 122
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
YL ++HR++ + NILL +ADFG+A L+ D F + + +
Sbjct: 123 YYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS--EHKTPIKW 177
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
+A E + + +SDV+SYGV + E+++ G +P
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 82/292 (28%), Positives = 121/292 (41%), Gaps = 46/292 (15%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDKISTGA-FSSEIATLSRI 829
S+T +G G G VY+ L VAVK S + F E +S+
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDG----ECAGLLEWDTRFKIALGVA 885
H+NIVRL+G R + + + M G L L + E L A VA
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 886 EGLSYLHHDCVPAILHRDVKSHNILL---GERYESCLADFGLARLVEDDSGGS-FSANPQ 941
+G YL + +HRD+ + N LL G + +ADFG+AR D S + +
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR---DIYRASYYRKGGR 180
Query: 942 FAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVR 997
++ PE A + I + K+DV+S+GV+L EI + G P +P Q V+++V
Sbjct: 181 AMLPIKWMPPE-AFLDGIFTSKTDVWSFGVLLWEIFSLGYMP----YPGRTNQEVMEFVT 235
Query: 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
+ DP PK G P + M C + EDRP +
Sbjct: 236 --GGGRLDP-----PK--GCPGPVYRIMTD-------CWQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-12
Identities = 34/87 (39%), Positives = 49/87 (56%)
Query: 370 LDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPR 429
LDN + G IP++ L +L + + N + G IPPS+ + +LE +DLS N G IP
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 430 GIFQLKKLNKLLLLSNNLSGVIPPEMG 456
+ QL L L L N+LSG +P +G
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 784 IGQGRSGIVYK------VTLPSGLTVAVKRFRASDKISTG-AFSSEIATLSRIRHRNIVR 836
+GQG G+VY+ V VA+K + + F +E + + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLH----DGECAGLLEWDTRFKI---ALGVAEGLS 889
LLG + + L+ + M G L L + E L T K A +A+G++
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV-EDD--SGGSFSANPQFAGSY 946
YL +HRD+ + N ++ E + DFG+ R + E D G P
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP-----V 185
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
++APE + KSDV+S+GVVL E+ T
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 75/274 (27%), Positives = 119/274 (43%), Gaps = 43/274 (15%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRF---RASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG+G G V+K + + VA+K A D+I EI LS+ + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED--IQQEITVLSQCDSPYVTKYYG 69
Query: 840 WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE---GLSYLHHDC 895
+ TKL + +Y+ G+ LL G +D F+IA + E GL YLH +
Sbjct: 70 -SYLKGTKLWIIMEYLGGGSALDLLRAGP------FD-EFQIATMLKEILKGLDYLHSE- 120
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
+HRD+K+ N+LL E+ + LADFG+A + D F G+ ++APE
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ----IKRNTFVGTPFWMAPEVIQ 174
Query: 956 MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
+ K+D++S G+ +E+ G+ P P +R K+ P L
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHP--------MRVLFLIPKNNP----PTLT 222
Query: 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
G +E + A C + RPT K++
Sbjct: 223 GEFSKPFKEFIDA------CLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-12
Identities = 95/389 (24%), Positives = 166/389 (42%), Gaps = 60/389 (15%)
Query: 89 HVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTG--EIPRELCSLL 146
+ P + +++NRL L+ ++ T + +SL++L LDL S + L +LL
Sbjct: 36 NFPDSNLESVAVNRLALNLSSNTLLL--LPSSLSRLLSLDLLSPSGISSLDGSENLLNLL 93
Query: 147 RLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLK-NLEAIRAGGNK 205
L L LN N+L I + L++LT L L +N +TD IP IG LK NL+ + NK
Sbjct: 94 PLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNK 151
Query: 206 NLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGD 265
SLP + N NL + L+ +S +P L +
Sbjct: 152 IE--SLPSPLRNLPNLKNLDLSFNDLS-------------------------DLPKLLSN 184
Query: 266 CTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325
+ L + L +P ++ L L L L N+++ + L N LS +++S N
Sbjct: 185 LSNLNNLDL-SGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242
Query: 326 SLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPS---- 381
L +P+++GNL++L+ L LS NQIS I + +G+ L +++L N ++ A+P
Sbjct: 243 KLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIALL 299
Query: 382 ----------------EFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTG 425
L+++ L + E P ++S ++L + N
Sbjct: 300 LLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDN-ALD 358
Query: 426 PIPRGIFQLKKLNKLLLLSNNLSGVIPPE 454
+ +K N + L + + +
Sbjct: 359 ESNLNRYIVKNPNAIGSLLDLVKKHVNQL 387
|
Length = 394 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 781 GNIIGQGRSGIVYKV-TLPSGLTVAVKRF-------RASDKISTGAFSSEIATLSRIRHR 832
G ++G+G G VY +G +AVK+ S +++ A EI L +RH
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVN--ALECEIQLLKNLRHD 64
Query: 833 NIVRLLGWGANRKTKLL--FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
IV+ G + + K L F +YMP G++ L + G L + + + +G+SY
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSY 121
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED--DSGGSFSANPQFAGSYGY 948
LH + I+HRD+K NIL L DFG ++ ++ SG + G+ +
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS---VTGTPYW 175
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
++PE + K+DV+S ++E++T K P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-11
Identities = 37/89 (41%), Positives = 50/89 (56%)
Query: 103 LVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAI 162
L L L G IP +I+ L L ++LS NS+ G IP L S+ LE L L+ N G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 163 PIQIGNLSSLTQLFLYDNQLTDAIPATIG 191
P +G L+SL L L N L+ +PA +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 60/245 (24%), Positives = 107/245 (43%), Gaps = 30/245 (12%)
Query: 784 IGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA 842
IG+G +GIV T+ SG VAVK+ + +E+ + +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM----- 82
Query: 843 NRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFK--------IALGVAEGLSYLHHD 894
+ Y+ L +++ E L + T + + L V + LS LH
Sbjct: 83 -------YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
++HRD+KS +ILL L+DFG V + G+ ++APE
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPELI 188
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
+ + D++S G++++E++ G+ P P ++ +RD+L K + + P L
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLKNLHKVSPSL 246
Query: 1015 QGHPD 1019
+G D
Sbjct: 247 KGFLD 251
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 65/238 (27%), Positives = 96/238 (40%), Gaps = 32/238 (13%)
Query: 784 IGQGRSGIVYKV----TLPSGLTVAVKRFRASDKISTG---AFSSEIATLSRIRHRNIVR 836
+G+ R G VYK T P T AV DK F E SR++H NIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLL-------------HDGECAGLLEWDTRFKIALG 883
LLG + + + Y + L L D LE I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 884 VAEGLSYL--HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQ 941
+A G+ +L HH H+D+ + N+L+ ++ ++D GL R V N
Sbjct: 133 IAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 942 FAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998
+++PE K S SD++SYGVVL E+ + G +P Q VI+ +R+
Sbjct: 188 LP--IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVIEMIRN 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 32/93 (34%), Positives = 50/93 (53%)
Query: 413 LEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT 472
++ + L GL G IP I +L+ L + L N++ G IPP +G+ +SL + N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 473 GFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITG 505
G IP +G L +L L+L N L+G +P + G
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 46/225 (20%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTL--------PSGLTVAVKRFRASD-KISTGAFSSEIATL 826
R L ++G+G G KV+L +G VAVK + + +T + EI L
Sbjct: 4 RYLKKIRVLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINIL 60
Query: 827 SRIRHRNIVRLLGWGANR--KTKLLFYDYMPNGTLGMLL--HDGECAGLLEWDTRFKIAL 882
+ H NIV+ G + + K L +Y+P G+L L H A LL + A
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF------AQ 114
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA----------RLVEDDS 932
+ EG++YLH +HRD+ + N+LL + DFGLA R+ ED
Sbjct: 115 QICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
+P F + A E K S SDV+S+GV L E++T
Sbjct: 172 ------SPVF-----WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVRLLG 839
IG G G VY + + VA+K+ S K S + E+ L RI+H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 840 WGANRKTKLLFYDYMPNGTLGML------LHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
T L +Y +L L + E A I G +GL+YLH
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------ITHGALQGLAYLHS 143
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
++HRD+K+ NILL E + LADFG A + S F G+ ++APE
Sbjct: 144 H---NMIHRDIKAGNILLTEPGQVKLADFGSASIA--------SPANSFVGTPYWMAPEV 192
Query: 954 ---ANMTKISEKSDVYSYGVVLLEIITGKKPV 982
+ + K DV+S G+ +E+ K P+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 784 IGQGRSGIVYKVTLPSGLT-VAVKRFRASDKISTGA-FSSEIATLSRIRHRNIVRLLGWG 841
IG+G G V+ L + T VAVK R + A F E L + H NIVRL+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 842 ANRKTKLLFYDYMPNGT-LGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAIL 900
++ + + + G L L +G L+ ++ A G+ YL +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKELIQMVENAAAGMEYLESKHC---I 116
Query: 901 HRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKIS 960
HRD+ + N L+ E+ ++DFG++R ED S Q + APE N + S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP--VKWTAPEALNYGRYS 174
Query: 961 EKSDVYSYGVVLLE 974
+SDV+S+G++L E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 49/158 (31%), Positives = 70/158 (44%), Gaps = 24/158 (15%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS-----------EIATLSR 828
G +G+G +VYK +G VA+K KI G EI L
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIK------KIKLGERKEAKDGINFTALREIKLLQE 58
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
++H NI+ LL ++ L +++M L ++ D L D + L GL
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV-LTPADIK-SYMLMTLRGL 115
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926
YLH + ILHRD+K +N+L+ LADFGLAR
Sbjct: 116 EYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKR---FRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG+G+ +VYK L G VA+K+ F D + EI L ++ H N+++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 840 WGANRKTKLLFYDYMPNGTLG-MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ + G L M+ H + L+ T +K + + L ++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---R 126
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
I+HRD+K N+ + L D GL R + + S G+ Y++PE +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPERIHENG 182
Query: 959 ISEKSDVYSYGVVLLEIITGKKP 981
+ KSD++S G +L E+ + P
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 48/147 (32%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRLLG 839
IG+G G V+K + VA+KR R D G SS EI L ++H+NIVRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+ K L ++Y C G ++ + + +GL++ H +
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 900 LHRDVKSHNILLGERYESCLADFGLAR 926
LHRD+K N+L+ + E LADFGLAR
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 33/212 (15%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVRLLG 839
IG G G VY T + VAVK+ S K + + E+ L +++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 840 WGANRKTKLLFYDYMPNGTLGML------LHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
T L +Y +L L + E A I G +GL+YLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------ITHGALQGLAYLHS 139
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
++HRD+K+ NILL E + LADFG A S F G+ ++APE
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKS--------SPANSFVGTPYWMAPEV 188
Query: 954 ---ANMTKISEKSDVYSYGVVLLEIITGKKPV 982
+ + K DV+S G+ +E+ K P+
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 22/166 (13%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--RFRASDK---ISTGAFSSEIATLSRIR---H 831
IG+G G VYK L +G VA+K R S++ +ST EIA L ++ H
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFEH 60
Query: 832 RNIVRLL----GWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE 886
NIVRLL G +R+ KL L ++++ + L L GL + + +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKD-LMRQLLR 118
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932
G+ +LH I+HRD+K NIL+ + +ADFGLAR+ +
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 782 NIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKIS-TGAFSSEIATLSRIRHRNIVRLLG 839
I+G G G VYK L + +AVK + SE+ L + I+ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 840 --WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+ NR + + ++M G+L + + +IA+ V +GL+YL
Sbjct: 67 AFFVENRIS--ICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 898 AILHRDVKSHNILLGERYESCLADFGLAR-LVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
ILHRDVK N+L+ R + L DFG++ LV S + G+ Y+APE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-------SIAKTYVGTNAYMAPERISG 167
Query: 957 TKISEKSDVYSYGVVLLEIITGKKP 981
+ SDV+S G+ +E+ G+ P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 31/82 (37%), Positives = 49/82 (59%)
Query: 303 LVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNC 362
L G IP ++ L I++S NS+ G+IP +LG++TSL+ L LS N +G IP +G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 363 QRLAQIELDNNQITGAIPSEFG 384
L + L+ N ++G +P+ G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 70/243 (28%), Positives = 105/243 (43%), Gaps = 29/243 (11%)
Query: 757 PPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFR--ASDKI 814
P WEL+ + L++G G ++ GI K +TVAVK + A+DK
Sbjct: 5 PKWELS---RTRLTLGKPLGEGCFGQVVMAEAIGI-DKDKPNKPVTVAVKMLKDDATDK- 59
Query: 815 STGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGL-- 871
SE+ + I +H+NI+ LLG + +Y G L L G+
Sbjct: 60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119
Query: 872 -----------LEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCL 919
L + A VA G+ YL C+ HRD+ + N+L+ E +
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKI 175
Query: 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-G 978
ADFGLAR V + + N + ++APE + +SDV+S+GV+L EI T G
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 233
Query: 979 KKP 981
P
Sbjct: 234 GSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 38/110 (34%), Positives = 57/110 (51%), Gaps = 17/110 (15%)
Query: 879 KIALGVAEGLSYL--HHDCVPAILHRDVKSHNILLGERYESCLADFGLA-RLVEDDSGGS 935
K+ + + + L YL H ++HRDVK NILL L DFG++ RLV+
Sbjct: 118 KMTVAIVKALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS----- 168
Query: 936 FSANPQFAGSYGYIAPEYANMTKISEK----SDVYSYGVVLLEIITGKKP 981
A + AG Y+APE + + K +DV+S G+ L+E+ TG+ P
Sbjct: 169 -KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 39/220 (17%)
Query: 778 LTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIV 835
L N IG G G VYKV P+G A+K + + EI L + H N+V
Sbjct: 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVV 135
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLH--DGECAGLLE----WDTRF--KIALGVAEG 887
+ +D+ NG + +LL DG G LE D +F +A + G
Sbjct: 136 KCHD----------MFDH--NGEIQVLLEFMDG---GSLEGTHIADEQFLADVARQILSG 180
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
++YLH I+HRD+K N+L+ +ADFG++R++ S+ G+
Sbjct: 181 IAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----VGTIA 233
Query: 948 YIAPEYANMTKISE------KSDVYSYGVVLLEIITGKKP 981
Y++PE N T ++ D++S GV +LE G+ P
Sbjct: 234 YMSPERIN-TDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA 842
+G G G VYK L +G AVK + EI + +H NIV G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 843 NRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE---GLSYLHHDCVPAI 899
+R+ + +Y G+L + H G L + +IA E GL+YLH
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH---VTGPL---SELQIAYVCRETLQGLAYLHSK---GK 127
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK- 958
+HRD+K NILL + + LADFG+A + + + F G+ ++APE A + K
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKIT----ATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 959 --ISEKSDVYSYGVVLLEIITGKKPV 982
++ D+++ G+ +E+ + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 782 NIIGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFS----SEIATLSRIRHRNIVR 836
IGQG G V+K + VA+K+ ++ F EI L ++H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVN 75
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVA--------EGL 888
L+ + T + Y + L + + AGLL + K L GL
Sbjct: 76 LIEICRTKATP--YNRYKGSFYLVFEFCEHDLAGLLS-NKNVKFTLSEIKKVMKMLLNGL 132
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926
Y+H + ILHRD+K+ NIL+ + LADFGLAR
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 30/263 (11%)
Query: 766 KLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIA 824
+L +S GD L + IG+G +GIV T +G VAVK+ + +E+
Sbjct: 12 QLVVSPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV 71
Query: 825 TLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFK----- 879
+ H N+V + + Y+ L +++ E L + T +
Sbjct: 72 IMRDYHHENVVDM------------YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ 119
Query: 880 ---IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936
+ L V LSYLH+ ++HRD+KS +ILL L+DFG V +
Sbjct: 120 IATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----V 172
Query: 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWV 996
G+ ++APE + + D++S G++++E+I G+ P P ++ +
Sbjct: 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRI 230
Query: 997 RDHLKSKKDPVEVLDPKLQGHPD 1019
RD+L + + L+G D
Sbjct: 231 RDNLPPRVKDSHKVSSVLRGFLD 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 799 SGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD-YMP 855
+GL VAVK+ + I E+ L ++H N++ LL ++ F D Y+
Sbjct: 41 TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 856 NGTLGMLLHD-GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER 914
+G L++ +C L + +F I + GL Y+H I+HRD+K N+ + E
Sbjct: 101 THLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNED 156
Query: 915 YESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA-NMTKISEKSDVYSYGVVLL 973
E + DFGLAR +D+ G + + Y APE N ++ D++S G ++
Sbjct: 157 CELKILDFGLARHTDDEMTG-------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209
Query: 974 EIITGKKPVDASFPDGQHVIQ 994
E++TG+ FP H+ Q
Sbjct: 210 ELLTGR----TLFPGTDHIDQ 226
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 1/90 (1%)
Query: 127 LDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAI 186
L L L G IP ++ L L+ + L+ N + G IP +G+++SL L L N +I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 187 PATIGKLKNLEAIRAGGNKNLGGSLPHEIG 216
P ++G+L +L + GN L G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNS-LSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 62/218 (28%), Positives = 92/218 (42%), Gaps = 26/218 (11%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS----EIATLSRIRHRNIVRLL 838
+G G G+V +G VA+K+ ST + E+ L +RH NI+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKI--MKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ + Y LG LH + LE + GL Y+H
Sbjct: 76 DIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS---AG 128
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA-NMT 957
++HRD+K NIL+ E + + DFGLAR+ + G S Y Y APE
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR------Y-YRAPEIMLTWQ 181
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995
K + D++S G + E++ G KP+ FP HV Q+
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEG-KPL---FPGKDHVNQF 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 14/108 (12%)
Query: 872 LEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931
L D I + EGL YLH I+HRDVK+ NI + + + C+ D G A+
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP--- 207
Query: 932 SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEII 976
P F G G + APE K + K+D++S G+VL E++
Sbjct: 208 -----VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 52/291 (17%)
Query: 784 IGQGRSGIVYKV--TLPSGLTVAVKR-------FRASDKISTGAFSSEIATLSRI----R 830
+G G G VYKV +A+K F + + ++ ++ I R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 831 HRNIVRLLGWGANRKTKL------LFYDYMPNGTLGMLLHD-GECAGLLEWDTRFKIALG 883
H NIVR KT L + D + LG + E + + I +
Sbjct: 68 HPNIVRY------YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
+ L YLH + I+HRD+ +NI+LGE + + DFGLA+ + +S +
Sbjct: 122 MVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLT-----SVV 174
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003
G+ Y PE EK+DV+++G +L ++ T + P ++ + L
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST------------NMLSLA 222
Query: 1004 KDPVE-VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
VE V +P +G + +++ + C + AE RP + V+A++
Sbjct: 223 TKIVEAVYEPLPEGMYSEDVTDVITS------CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWG 841
+G+G G VYKV P+G+T+A+K R D+ E+ L + IV +G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF--YG 66
Query: 842 ANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
A ++ +YM G+L L G + D +I V +GL +L + I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNI 124
Query: 900 LHRDVKSHNILLGERYESCLADFGLA-RLVEDDSGGSFSANPQFAGSYGYIAPEY---AN 955
+HRDVK N+L+ + L DFG++ LV S G Y+APE
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-------SLAKTNIGCQSYMAPERIKSGG 177
Query: 956 MTKI---SEKSDVYSYGVVLLEIITGKKP 981
+ + +SDV+S G+ +LE+ G+ P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 784 IGQGRSGIVY-KVTLPSGLTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVRLLG 839
IG G G VY + + VA+K+ S K S + E+ L ++RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 840 WGANRKTKLLFYDYMPNGTLGML------LHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
T L +Y +L L + E A + G +GL+YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------VTHGALQGLAYLHS 133
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
++HRDVK+ NILL E L DFG A ++ + F G+ ++APE
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--------APANXFVGTPYWMAPEV 182
Query: 954 ---ANMTKISEKSDVYSYGVVLLEIITGKKPV 982
+ + K DV+S G+ +E+ K P+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 45/274 (16%)
Query: 765 NKLDLSIGDATRSLTAGNIIGQGRSGIV-YKVTLPSGLTVAVKRFR---ASDKISTGAFS 820
NK + D R L +G G G V + +G VA+K+ S+ + A+
Sbjct: 7 NKTIWEVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 821 SEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY---MP-NGT-LGMLLHDGECAGLLEWD 875
E+ L ++H N++ LL + F+D+ MP GT LG L+ + L E
Sbjct: 64 -ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDR 119
Query: 876 TRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935
+F + + +GL Y+H I+HRD+K N+ + E E + DFGLAR + + G
Sbjct: 120 IQF-LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTG- 174
Query: 936 FSANPQFAGSYGYIAPEYA-NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQ 994
+ + Y APE N ++ D++S G ++ E++TGK
Sbjct: 175 ------YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH--------- 219
Query: 995 WVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQA 1028
DHL E++ K+ G P + + LQ+
Sbjct: 220 ---DHLDQLM---EIM--KVTGTPSKEFVQKLQS 245
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 784 IGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSS--EIATLSRIR---HRNIVRL 837
IG G G VYK P SG VA+K R S+ E+A L R+ H NIVRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 838 LGWGA----NRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
+ A +R+TK+ L ++++ + L L GL +T + GL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGL-PAETIKDLMRQFLRGLDFLH 125
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
+C I+HRD+K NIL+ + LADFGLAR+ + P + Y APE
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS----CQMALTPVVVTLW-YRAPE 177
Query: 953 YANMTKISEKSDVYSYGVVLLEIITGKKPV 982
+ + D++S G + E+ +KP+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 11/183 (6%)
Query: 799 SGLTVAVKRFRASDKISTGA-FSSEIATLSRIRHRNIVRLLGW---GANRKTKLLFYDYM 854
+G VAVK + + A EI L + H NIV+ G KL+ +++
Sbjct: 32 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM-EFL 90
Query: 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER 914
P+G+L L + + + K A+ + +G+ YL +HRD+ + N+L+
Sbjct: 91 PSGSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE 145
Query: 915 YESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLE 974
++ + DFGL + +E D ++ + APE +K SDV+S+GV L E
Sbjct: 146 HQVKIGDFGLTKAIETDK-EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
Query: 975 IIT 977
++T
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 784 IGQGRSGIVY----KVTLPSGLTVAVKRFRAS-----DKISTGAFSSEIATLSRIRHRNI 834
+GQG G V+ K T G VA+KR + S +++ +E L+ + +
Sbjct: 9 VGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVR--HVLTERDILTTTKSEWL 63
Query: 835 VRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWD-TRFKIALGVAEGLSYLHH 893
V+LL + + L +Y+P G LL++ G+L D RF +A E + LH
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMF-EAVDALHE 119
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
+HRD+K N L+ L DFGL+ G AN GS Y+APE
Sbjct: 120 ---LGYIHRDLKPENFLIDASGHIKLTDFGLS------KGIVTYAN-SVVGSPDYMAPEV 169
Query: 954 ANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD 988
D +S G +L E + G P S P+
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN 204
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 784 IGQGRSGIVYK----VTLPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVR 836
IG+G G+VYK VT T+A+K+ R ++ G S+ EI+ L ++H NIVR
Sbjct: 10 IGEGTYGVVYKARDRVT---NETIALKKIRL-EQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIAL-GVAEGLSYLHHDC 895
L + K L ++Y+ L + H + K L + G++Y H
Sbjct: 66 LQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 896 VPAILHRDVKSHNILLGERYESC-LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
+LHRD+K N+L+ R + LADFGLAR G + Y APE
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAF----GIPVRTFTHEVVTLWYRAPEIL 175
Query: 955 NMTK-ISEKSDVYSYGVVLLEIITGKKPVDASFP 987
++ S D++S G + E++ +KP+ FP
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN-QKPL---FP 205
|
Length = 294 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 9/169 (5%)
Query: 818 AFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTR 877
A E+ L++++H NIV + +Y G L M + + L D
Sbjct: 45 ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQI 103
Query: 878 FKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGLARLVEDDSGGSF 936
+ ++ GL ++H ILHRD+KS NI L + + L DFG+AR + D ++
Sbjct: 104 LSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160
Query: 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
+ G+ Y++PE + K+D++S G VL E+ T K P + +
Sbjct: 161 TC----VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-10
Identities = 73/276 (26%), Positives = 110/276 (39%), Gaps = 46/276 (16%)
Query: 784 IGQGRSGIV---YKVTLPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLL 838
IG G GIV + L G+ VAVK+ + T A + E+ L + H+NI+ LL
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWD---TRFKIAL-GVAEGLSYLHHD 894
+K+ F D L M L D ++ + R L + G+ +LH
Sbjct: 87 NVFTPQKSLEEFQDVY----LVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS- 141
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
I+HRD+K NI++ + DFGLAR + +F P Y Y APE
Sbjct: 142 --AGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TACTNFMMTPYVVTRY-YRAPEVI 194
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
E D++S G ++ E++ G F H+ QW + +E L
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKGS----VIFQGTDHIDQWNK--------VIEQL---- 238
Query: 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVA 1050
G P + LQ N E+RP ++
Sbjct: 239 -GTPSAEFMNRLQP------TVRNYVENRPQYPGIS 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 783 IIGQGRSGIVYK-VTLPSG----LTVAVKRFRA-SDKISTGAFSSEIATLSRIRHRNIVR 836
++G G G VYK + +P G + VA+K R + + E ++ + + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
LLG +L+ MP G L L + E + + +A+G+SYL
Sbjct: 74 LLGICLTSTVQLV-TQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDS------GGSFSANPQFAGSYGYIA 950
++HRD+ + N+L+ + DFGLARL++ D GG ++A
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK--------WMA 179
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP 987
E + + +SDV+SYGV + E++T G KP D P
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIP 216
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-10
Identities = 29/81 (35%), Positives = 43/81 (53%)
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNL 386
L G IP + L LQ + LS N I G IP +G+ L ++L N G+IP G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 387 SNLTLLFVWHNRLEGEIPPSI 407
++L +L + N L G +P ++
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 73/286 (25%), Positives = 113/286 (39%), Gaps = 37/286 (12%)
Query: 784 IGQGRSGIVYKVTLPSGLTVA---VKRFRASDKISTG-AFSSEIATLSRIRHRNIVRLLG 839
IG G G V G++ A VK RAS F E+ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHD--GECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
LL ++ P G L L G A + + D ++A VA GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 898 AILHRDVKSHNILLGERYESCLADFGLA--RLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
+H D+ N L + D+GLA + ED + A ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED----YYITKDCHAVPLRWLAPELVE 175
Query: 956 M-------TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH-LKSKKDPV 1007
+ ++KS+++S GV + E+ T D Q + Q VR+ +K K
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK--- 232
Query: 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
P+L + E++Q + E RPT ++V LL
Sbjct: 233 ----PQLDLKYSDRWYEVMQFCWLD-------PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 37/258 (14%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA 842
+G G G VYK +G A K + + EI L+ H IV+LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 843 NRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHR 902
+ ++ P G + ++ + + GL E + I + E L YLH I+HR
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQV-ICRQMLEALQYLHSM---KIIHR 134
Query: 903 DVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISE- 961
D+K+ N+LL + LADFG V + + F G+ ++APE + +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFG----VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 962 ----KSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK-SKKDPVEVLDPK--- 1013
K+D++S G+ L+E+ + P H + +R LK +K +P + P
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPP--------HHELNPMRVLLKIAKSEPPTLSQPSKWS 242
Query: 1014 ----------LQGHPDTQ 1021
L HP+T+
Sbjct: 243 MEFRDFLKTALDKHPETR 260
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 35/89 (39%), Positives = 49/89 (55%)
Query: 224 IGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSI 283
+GL + GF+P + L+ LQ+I + + G IPP LG T L+ + L N+ GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 284 PSKLGNLKNLVNLFLWQNNLVGIIPPELG 312
P LG L +L L L N+L G +P LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 34/86 (39%), Positives = 51/86 (59%), Gaps = 2/86 (2%)
Query: 584 LDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGD 643
L L + L G IP + K+ L ++NLS N I G +P L + L +LDLS+N +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 644 L-HFLAELQNLVVLNVSHNNFSGRVP 668
+ L +L +L +LN++ N+ SGRVP
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-09
Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 36/188 (19%)
Query: 878 FKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFS 937
++I L + E +H ++HRD+KS NI L L DFG ++ D S
Sbjct: 176 YQIVLALDE----VHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV--SLD 226
Query: 938 ANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997
F G+ Y+APE + S+K+D++S GV+L E++T +P P + ++Q V
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG--PSQREIMQQV- 283
Query: 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT---------MKD 1048
L K DP + ++AL LL S RPT +K
Sbjct: 284 --LYGKYDPFPC-----------PVSSGMKALLDPLL--SKNPALRPTTQQLLHTEFLKY 328
Query: 1049 VAALLREI 1056
VA L ++I
Sbjct: 329 VANLFQDI 336
|
Length = 478 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 1/81 (1%)
Query: 349 NQ-ISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI 407
NQ + G IP I + L I L N I G IP G++++L +L + +N G IP S+
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 408 SNCQNLEAVDLSQNGLTGPIP 428
+L ++L+ N L+G +P
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 2e-09
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 37/217 (17%)
Query: 782 NIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRL- 837
N I +G G+VY+ +G VA+K+ + + +S EI L +++H NIV +
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 838 -LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE---------- 886
+ G+N + +Y+ HD L+E K +E
Sbjct: 71 EVVVGSNLDKIYMVMEYVE--------HD--LKSLME---TMKQPFLQSEVKCLMLQLLS 117
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
G+++LH + ILHRD+K+ N+LL R + DFGLAR G Q +
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY----GSPLKPYTQLVVTL 170
Query: 947 GYIAPE-YANMTKISEKSDVYSYGVVLLEIITGKKPV 982
Y APE + S D++S G + E++T KKP+
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 769 LSIGDATRSLTA--GNI--IGQGRSGIV---YKVTLPSGLTVAVKRFRASDKISTGAFSS 821
+ IGD+T ++ N+ IG G GIV Y L VA+K+ + T A +
Sbjct: 13 VEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRA 70
Query: 822 --EIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRF- 878
E+ + + H+NI+ LL +K+ F D + M L D +++ +
Sbjct: 71 YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY----IVMELMDANLCQVIQMELDHE 126
Query: 879 KIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSA 938
+++ + + L + H I+HRD+K NI++ + DFGLAR +G SF
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMM 182
Query: 939 NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995
P Y Y APE E D++S G ++ E+I G FP H+ QW
Sbjct: 183 TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 49/173 (28%), Positives = 70/173 (40%), Gaps = 33/173 (19%)
Query: 821 SEIATLSRIRHRNIVRLL---GWG-----ANRKTKLLFYDYMPNGTLGMLLHDGECAGLL 872
EI L I HR I+ L+ W K K + Y+ + +G L
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV------------DRSGPL 182
Query: 873 EWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA-RLVEDD 931
+ I + E L+YLH I+HRDVK+ NI L E + L DFG A +L
Sbjct: 183 PLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239
Query: 932 SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
PQ G G + +PE + K+D++S G+VL E+
Sbjct: 240 D------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 67/226 (29%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 784 IGQGRSGIV---YKVTLPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLL 838
IG G GIV Y G VA+K+ + T A + E+ + + H+NI+ LL
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 839 GWGANRKTKLLFYD-YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL------ 891
+K+ F D Y L M L D +++ D E +SYL
Sbjct: 82 NVFTPQKSLEEFQDVY-----LVMELMDANLCQVIQMDLDH-------ERMSYLLYQMLC 129
Query: 892 --HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
H I+HRD+K NI++ + DFGLAR +G SF P Y Y
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRY-YR 184
Query: 950 APEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995
APE E D++S G ++ E+I G FP H+ QW
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT----VLFPGTDHIDQW 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 18/145 (12%)
Query: 881 ALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR--LVEDDSGGSFSA 938
A +A GL +LH I++RD+K N++L +ADFG+ + + + +F
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 939 NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998
P YIAPE + D +++GV+L E++ G+ P D D + Q + +
Sbjct: 164 TPD------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQSIME 215
Query: 999 HLKS-----KKDPVEVLDPKLQGHP 1018
H S K+ V + L HP
Sbjct: 216 HNVSYPKSLSKEAVSICKGLLTKHP 240
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 47/157 (29%), Positives = 68/157 (43%), Gaps = 11/157 (7%)
Query: 826 LSRIRHRNIVRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGV 884
L ++ R IV L + K L L M G L +++ G E F A +
Sbjct: 47 LEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QI 104
Query: 885 AEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAG 944
GL +LH I++RD+K N+LL + ++D GLA VE G AG
Sbjct: 105 ICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGG---KKIKGRAG 156
Query: 945 SYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ GY+APE D ++ G L E+I G+ P
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR-LVEDDSGGSFSANPQF 942
V+ G+ YL +HRD+ + N+LL ++ + ++DFGL++ L DDS + A
Sbjct: 104 VSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS--YYKARSAG 158
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
+ APE N K S +SDV+SYG+ + E + G+KP
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 40/122 (32%), Positives = 66/122 (54%), Gaps = 13/122 (10%)
Query: 872 LEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930
L+ D + + VA+G+ +L +C+ HRDV + N+LL + + + DFGLAR + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP-----VDA 984
DS N + ++APE + +SDV+SYG++L EI + GK P V++
Sbjct: 265 DSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322
Query: 985 SF 986
F
Sbjct: 323 KF 324
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 33/217 (15%)
Query: 783 IIGQGRSGIVYK-VTLPSG----LTVAVKRFR-ASDKISTGAFSSEIATLSRIRHRNIVR 836
++G G G VYK + +P G + VA+K R A+ + E ++ + + ++ R
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGE----CAGLLEWDTRFKIALGVAEGLSYLH 892
LLG +L+ MP G L + + + LL W + +A+G++YL
Sbjct: 74 LLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 126
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
++HRD+ + N+L+ + DFGLA+L+ D ++ G + +
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE-------KEYHAEGGKVPIK 176
Query: 953 YANMTKI-----SEKSDVYSYGVVLLEIIT-GKKPVD 983
+ + I + +SDV+SYGV + E++T G KP D
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 32/82 (39%), Positives = 48/82 (58%)
Query: 255 LSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNC 314
L G IP ++ LQ I L N++ G+IP LG++ +L L L N+ G IP LG
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 315 SQLSIIDISMNSLTGSIPQTLG 336
+ L I++++ NSL+G +P LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 33/230 (14%)
Query: 778 LTAGNIIGQGRSGIVY--------KVTLPSGLTVAVKRFR--ASDKISTGAFSSEIATLS 827
LT G +G+G G V K +TVAVK + A++K SE+ +
Sbjct: 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMK 75
Query: 828 RI-RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGL-------------LE 873
I +H+NI+ LLG + +Y G L L G+ +
Sbjct: 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 874 WDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932
+ VA G+ YL C+ HRD+ + N+L+ E +ADFGLAR V +
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
+ N + ++APE + +SDV+S+GV++ EI T G P
Sbjct: 192 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 14/203 (6%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA 842
IG G G VYK + +G A+K + EI + +H NIV G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 843 NRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHR 902
R + ++ G+L + H G L ++ +GL YLH +HR
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHR 130
Query: 903 DVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK---I 959
D+K NILL + LADFG++ + + + F G+ ++APE A + +
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQIT----ATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 960 SEKSDVYSYGVVLLEIITGKKPV 982
++ D+++ G+ +E+ + P+
Sbjct: 187 NQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 59/198 (29%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 802 TVAVKRFR--ASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPNGT 858
TVAVK + A+DK SE+ + I +H+NI+ LLG + +Y G
Sbjct: 46 TVAVKMLKDNATDK-DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGN 104
Query: 859 LGMLLH-----------DGE--CAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHRDV 904
L L D L + A VA G+ YL C+ HRD+
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI----HRDL 160
Query: 905 KSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSD 964
+ N+L+ E +ADFGLAR V D ++N + ++APE + +SD
Sbjct: 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSD 218
Query: 965 VYSYGVVLLEIIT-GKKP 981
V+S+G+++ EI T G P
Sbjct: 219 VWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 3e-09
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS---------EIATLSRIR-HR 832
+G+G GIV+K + + VA+K KI AF + EI L + H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK------KI-FDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 833 NIVRLLGW--GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
NIV+LL N K L ++YM LH A +LE + I + + L Y
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETD-----LHAVIRANILEDVHKRYIMYQLLKALKY 122
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV-EDDSGGSFSANPQFAGSYGYI 949
+H ++HRD+K NILL LADFGLAR + E + + + Y
Sbjct: 123 IHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 950 APE--YANMTKISEKSDVYSYGVVLLEIITGK 979
APE + T+ ++ D++S G +L E++ GK
Sbjct: 180 APEILLGS-TRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 16/137 (11%)
Query: 849 LFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKS 906
LF+ +Y+ G L + H E RF A + GL +LH I++RD+K
Sbjct: 71 LFFVMEYLNGGDL--MFHIQSSGRFDEARARF-YAAEIICGLQFLHKK---GIIYRDLKL 124
Query: 907 HNILLGERYESCLADFGLAR--LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSD 964
N+LL + +ADFG+ + + + +F P YIAPE K +E D
Sbjct: 125 DNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD------YIAPEILKGQKYNESVD 178
Query: 965 VYSYGVVLLEIITGKKP 981
+S+GV+L E++ G+ P
Sbjct: 179 WWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 784 IGQGRSGIV-YKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA 842
IG+G +GIV SG VAVK + +E+ + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 843 NRKTKLLFYDYMPNGTLGML-----LHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+ + +++ G L + L++ + A + E V + L YLH
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCE---------SVLQALCYLHSQ--- 136
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
++HRD+KS +ILL L+DFG + D G+ ++APE + T
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----VPKRKSLVGTPYWMAPEVISRT 192
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFP 987
+ D++S G++++E++ G+ P + P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFS-SEIATLSRIRHRNIVRLLGWG 841
+G+G VYK +G VA+K + T + + EI+ + ++H NIVRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66
Query: 842 ANRKTKL-LFYDYMPNGTLG-MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+ + KL L ++YM M H A L+ +T + +G+++ H + +
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTHGVRGA--LDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
LHRD+K N+L+ +R E LADFGLAR G + + Y AP+ ++
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAF----GIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 960 SEKS-DVYSYGVVLLEIITGK 979
S D++S G ++ E+ITG+
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 13/115 (11%)
Query: 871 LLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930
+L+W ++ LGV ++H V LHRD+KS NI L + + L DFG ARL+
Sbjct: 102 ILQWFV--QMCLGV----QHIHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLT- 151
Query: 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
S G+++ + G+ Y+ PE + KSD++S G +L E+ T K P A+
Sbjct: 152 -SPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 784 IGQGRSGIV---YKVTLPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLL 838
IG G GIV Y L VA+K+ + T A + E+ + + H+NI+ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRF-KIALGVAEGLSYLHHDCVP 897
+K+ F D L M L D +++ + +++ + + L + H
Sbjct: 83 NVFTPQKSLEEFQDVY----LVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
I+HRD+K NI++ + DFGLAR +G SF P Y Y APE
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRY-YRAPEVILGM 193
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995
E D++S G ++ E++ K FP ++ QW
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 26/155 (16%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRLLG 839
IG+G G+VYK +G VA+K+ R + G S+ EI+ L + H NIVRLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 840 WGANRKTKLLFYDYMPNGTLGMLL--------HDGECAGLLEWDTRFKIALGVAEGLSYL 891
+ L +++ L + L G L++ + +G++Y
Sbjct: 66 VVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIK-----SYLYQLLQGIAYC 115
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926
H +LHRD+K N+L+ LADFGLAR
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 44/233 (18%)
Query: 766 KLDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIA 824
+L + GD L IG+G +GIV T +G VAVK+ + +E+
Sbjct: 9 QLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV 68
Query: 825 TLSRIRHRNIVRLLG--------WGANRKTKLLFYDYMPNGTL-----GMLLHDGECAGL 871
+ +H NIV + W + +++ G L +++ + A
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGDELW--------VVMEFLEGGALTDIVTHTRMNEEQIA-- 118
Query: 872 LEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931
+ L V + LS+LH ++HRD+KS +ILL L+DFG V +
Sbjct: 119 -------TVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168
Query: 932 SGGSFSANPQ---FAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
P+ G+ ++APE + + D++S G++++E++ G+ P
Sbjct: 169 V-------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 881 ALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939
+ VA G+ +L C+ HRD+ + NILL E + DFGLAR + D +
Sbjct: 179 SFQVARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998
+ ++APE + +SDV+S+GV+L EI + G P +P +Q +
Sbjct: 235 ARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP----YPG----VQIDEE 284
Query: 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058
+ K+ + P+ E+ + L C N EDRPT ++ +L ++ Q
Sbjct: 285 FCRRLKEGTRM------RAPEYATPEIYSIM---LDCWHNNPEDRPTFSELVEILGDLLQ 335
Query: 1059 E 1059
E
Sbjct: 336 E 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 26/172 (15%)
Query: 822 EIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL--------GMLLHDGECAGLLE 873
E+A LS ++H NIV+ + DY G L G+L + + +L+
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ---ILD 105
Query: 874 WDTRFKIALGVAEGLSYLH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932
W + +AL H HD ILHRD+KS NI L + L DFG+AR++
Sbjct: 106 WFVQICLALK--------HVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-- 153
Query: 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984
+ G+ Y++PE + KSD+++ G VL E+ T K +A
Sbjct: 154 --TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-08
Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 32/144 (22%)
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV--EDDSGGSFSANP- 940
+ + Y+H +LHRD+K NILLG E + D+G A E++ +
Sbjct: 122 ICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 941 -----------QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFP-- 987
+ G+ Y+APE SE +D+Y+ GV+L +++T SFP
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT------LSFPYR 232
Query: 988 --DGQHVIQWVRDHLKSKKDPVEV 1009
G+ + RD + S P+EV
Sbjct: 233 RKKGRKIS--YRDVILS---PIEV 251
|
Length = 932 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 784 IGQGRSGIVYKVTLP-SGLTVAVKRFR---ASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G G G V +G VA+K+ S + + E+ L + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 840 WGANRKTKLLFYD-YMPNGTLGMLLHD-GECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+ F D Y+ +G L++ +C L + +F + + GL Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIHS---A 137
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA-NM 956
I+HRD+K NI + E E + DFGLAR +D+ G + + Y APE N
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG-------YVATRWYRAPEIMLNW 190
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQ 994
++ D++S G ++ E++TGK FP H+ Q
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGK----TLFPGSDHIDQ 224
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 29/175 (16%)
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
V+ G+ YL +HRD+ + N+LL ++ + ++DFGL++ + D + A
Sbjct: 104 VSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN-YYKAKTHGK 159
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVR--DHL 1000
+ APE N K S KSDV+S+GV++ E + G+KP G V Q + + +
Sbjct: 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--KGNEVTQMIESGERM 217
Query: 1001 KSKKD-PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054
+ + P E+ D + LC + ++RP V LR
Sbjct: 218 ECPQRCPPEMYD-------------------LMKLCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 49/159 (30%), Positives = 70/159 (44%), Gaps = 16/159 (10%)
Query: 826 LSRIRHRNIVRLLGWGANRKTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGV 884
L ++H +V L + KL F DY+ G L L C LE RF A V
Sbjct: 50 LKNLKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARF-YAAEV 105
Query: 885 AEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR--LVEDDSGGSFSANPQF 942
A + YLH I++RD+K NILL + L DFGL + + +++ +F P+
Sbjct: 106 ASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPE- 161
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
Y+APE D + G VL E++ G P
Sbjct: 162 -----YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-08
Identities = 17/41 (41%), Positives = 25/41 (60%), Gaps = 1/41 (2%)
Query: 32 NRQGEALLSWKRNWKG-SDDGLSNWSPSDETPCKWFGVSCN 71
N +ALL++K + G LS+W+PS PC W GV+C+
Sbjct: 2 NDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-08
Identities = 56/224 (25%), Positives = 84/224 (37%), Gaps = 45/224 (20%)
Query: 784 IGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVRLLG 839
+G G G V V SG A+K + + +E L IRH +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHD---GECAGLLEWDTRFKI------ALGVAEGLSY 890
F D + L +++ GE L RF A V L Y
Sbjct: 69 ---------SFQD---DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
LH I++RD+K N+LL + DFG A+ V+ + + P+ Y+A
Sbjct: 117 LHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-YTLCGTPE------YLA 166
Query: 951 PEYANMTKISEK-----SDVYSYGVVLLEIITGKKPVDASFPDG 989
PE I K D ++ G+++ E++ G P P
Sbjct: 167 PE-----IILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVK--RFRASDKISTGAFSSEIATLSRIRHRNIVRLLGW 840
+G+G VYK ++ +G VA+K + + + A E + L ++H NIV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 841 GANRKTKLLFYDYMPNGTLG-MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
++T ++YM M+ H G GL ++ R + GL+Y+H I
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPG---GLHPYNVRL-FMFQLLRGLAYIHGQ---HI 124
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANMTK 958
LHRD+K N+L+ E LADFGLAR + ++S+ + Y P+ T
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSE---VVTLWYRPPDVLLGATD 180
Query: 959 ISEKSDVYSYGVVLLEIITGK 979
S D++ G + +E++ G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 16/140 (11%)
Query: 849 LFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKS 906
LF+ +Y+ G L + H E RF A + GL +LH I++RD+K
Sbjct: 71 LFFVMEYVNGGDL--MFHIQRSGRFDEPRARF-YAAEIVLGLQFLHER---GIIYRDLKL 124
Query: 907 HNILLGERYESCLADFGLAR--LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSD 964
N+LL +ADFG+ + ++ + +F P YIAPE + D
Sbjct: 125 DNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD------YIAPEILSYQPYGPAVD 178
Query: 965 VYSYGVVLLEIITGKKPVDA 984
++ GV+L E++ G+ P +
Sbjct: 179 WWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 25/238 (10%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKIS---TGAFSSEIATLSRIRHRNIVRLLG 839
+G G G V+ V S A+K + I +E L + H I+RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 840 WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
W + + L + +Y+P G L L + +G T A + L YLH
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSK---E 121
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
I++RD+K NILL + L DFG A+ + D + G+ Y+APE
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW-------TLCGTPEYLAPEVIQSKG 174
Query: 959 ISEKSDVYSYGVVLLEIITGKKPVDASFPDG------QHVIQWVRDHLKSKKDPVEVL 1010
++ D ++ G+++ E++ G P P G +++ R KD ++ L
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKL 232
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 784 IGQGRSGIVYKVTLPSGLT---VAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G+G V+K S LT VA+K R ++ + E++ L ++H NIV L
Sbjct: 13 LGEGTYATVFKGR--SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+ L ++Y+ + L + C L+ + GLSY H I
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANMTK 958
LHRD+K N+L+ E+ E LADFGLAR + ++S + Y P+ T+
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNE---VVTLWYRPPDVLLGSTE 180
Query: 959 ISEKSDVYSYGVVLLEIITGK 979
S D++ G +L E+ TG+
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 784 IGQGRSGIVYKVTLPSGLT---VAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRL 837
+G+G VYK S LT VA+K R + GA + E++ L ++H NIV L
Sbjct: 14 LGEGTYATVYKGR--SKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTL 69
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
K+ L ++Y+ + L L D C + + GL+Y H
Sbjct: 70 HDIIHTEKSLTLVFEYL-DKDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRR--- 123
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANM 956
+LHRD+K N+L+ ER E LADFGLAR + ++S + Y P+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNE---VVTLWYRPPDILLGS 179
Query: 957 TKISEKSDVYSYGVVLLEIITGK 979
T S + D++ G + E+ TG+
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 23/239 (9%)
Query: 783 IIGQGRSGIVYK-VTLPSGLTVAVKRF-RASDKISTGAFS-SEIATLSRIRHRNIVRLLG 839
IG G G+V + SG VA+K+ A D + + E+ L +H NI+ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 840 W----GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
GA+ K + D M + L ++H + L E R+ + GL Y+H
Sbjct: 72 ILRPPGADFKDVYVVMDLMES-DLHHIIHSDQ--PLTEEHIRY-FLYQLLRGLKYIHSAN 127
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA- 954
V +HRD+K N+L+ E E + DFG+AR + ++ + Y APE
Sbjct: 128 V---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDASFP--DGQHVIQWVRDHLKSKKDPVEVLD 1011
++ + + D++S G + E++ G++ + FP + H ++ + L S EVL+
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEML-GRRQL---FPGKNYVHQLKLILSVLGSP--SEEVLN 237
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 18/149 (12%)
Query: 881 ALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR--LVEDDSGGSFSA 938
A ++ GL +LH I++RD+K N++L +ADFG+ + +V+ + +F
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCG 163
Query: 939 NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998
P YIAPE + D ++YGV+L E++ G+ P D D + Q + +
Sbjct: 164 TPD------YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE--DEDELFQSIME 215
Query: 999 HLKS-----KKDPVEVLDPKLQGHPDTQI 1022
H S K+ V + + HP ++
Sbjct: 216 HNVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 64/233 (27%), Positives = 91/233 (39%), Gaps = 45/233 (19%)
Query: 783 IIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLL 838
+IG+G G V+ V +G A+K R SD I +E L+ IV+L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 839 GWGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIA---LGVAEGLSYLHH 893
+ + + L+ +YMP G L LL + E RF IA L + + L
Sbjct: 68 Y--SFQDEEHLYLVMEYMPGGDLMNLLIRKDV--FPEETARFYIAELVLALDS-VHKLGF 122
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLA------------------RLVEDDSGGS 935
+HRD+K NIL+ LADFGL L D+
Sbjct: 123 ------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 936 FSANPQF-------AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ Q G+ YIAPE T + D +S GV+L E++ G P
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 27/241 (11%)
Query: 751 EDVEMGPPWELTLYNKL---DLSIGDATRSLTAGNIIGQGRSG-IVYKVTLP--SGLTVA 804
ED M ++ +++ D S DA+ +L A G ++G + + P G A
Sbjct: 55 EDKHM----DIDIFDIFADEDESDADASLALCAEARAGIEKAGFSILETFTPGAEGFAFA 110
Query: 805 VKRFRASDKI-----STGAFSSEIATLSRIRHRNIVRLLG-WGANRKTKLLFYDYMPNGT 858
+ + + G ++E L I H +I++L G + N+ T L+ Y +
Sbjct: 111 CIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD-- 168
Query: 859 LGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESC 918
L L + + I V + YLH + I+HRD+K+ NI + + C
Sbjct: 169 LYCYLAAKRNIAICDI---LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVC 222
Query: 919 LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITG 978
L DFG A D + + +AG+ APE D++S G+VL E+ T
Sbjct: 223 LGDFGAACFPVDINANKYYG---WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
Query: 979 K 979
Sbjct: 280 H 280
|
Length = 391 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-08
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 399 LEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNC 458
L G IP IS ++L++++LS N + G IP + + L L L N+ +G IP +G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 459 SSLIRFRANSNKLTGFIPPEIGNL----KNLNFLD 489
+SL N N L+G +P +G + NF D
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524
|
Length = 623 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 18/179 (10%)
Query: 822 EIATLSRIRHRNIVRLLGWGANRKTKLLFYD-YMPNGTLGMLLHD-GECAGLLEWDTRFK 879
E+ L ++H N++ LL + F + Y+ +G L++ +C L + +F
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 880 IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939
I + GL Y+H I+HRD+K N+ + E E + DFGLAR +D+ G
Sbjct: 124 I-YQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTG----- 174
Query: 940 PQFAGSYGYIAPEYA-NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997
+ + Y APE N ++ D++S G ++ E++ GK A FP ++ Q R
Sbjct: 175 --YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK----ALFPGNDYIDQLKR 227
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 34/154 (22%)
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR--LVEDDSGGSFSANPQFAG 944
GL +LH I++RD+K N++L +ADFG+ + + D+ +F P
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPD--- 161
Query: 945 SYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPV-----DASFP----DGQHVIQW 995
YIAPE K + D +S+GV+L E++ G+ P D F D H +W
Sbjct: 162 ---YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRW 218
Query: 996 VRDHLKSKKDPVEVL---DP--------KLQGHP 1018
+ K KD +E L DP ++GHP
Sbjct: 219 I---TKESKDILEKLFERDPTRRLGVVGNIRGHP 249
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 58/243 (23%), Positives = 100/243 (41%), Gaps = 47/243 (19%)
Query: 818 AFSSEIATLSRIRHRNIVRLL-GWGANRKTKLLFYDYMPNGTL--------GMLLHDGEC 868
A E LS+++H NIV W + + G L G LL + +
Sbjct: 45 AAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQ- 103
Query: 869 AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928
++EW + +A L YLH ILHRD+K+ N+ L + D G+AR++
Sbjct: 104 --VVEWFVQ------IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
Query: 929 ED--DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASF 986
E+ D + P Y++PE + + KSDV++ G + E+ T K +A
Sbjct: 153 ENQCDMASTLIGTPY------YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK- 205
Query: 987 PDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046
D ++ + +E P + ++ E++ + S R E RP++
Sbjct: 206 -DMNSLVYRI----------IEGKLPPMPKDYSPELGELIATM------LSKRPEKRPSV 248
Query: 1047 KDV 1049
K +
Sbjct: 249 KSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-08
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 56/219 (25%)
Query: 806 KRFRASDKISTGAFSSEIATLSRIRHRNIVRL---LGWGAN-----RKTKLLFYDYMPNG 857
KR +A + + +EI L R+ H NI+++ L AN +K Y +M +
Sbjct: 198 KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE 256
Query: 858 TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917
D + LL TR I + + Y+H ++HRD+K NI L +
Sbjct: 257 AF-----DWKDRPLL-KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKI 306
Query: 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYI------APEYANMTKISEKSDVYSYGVV 971
L DFG A E + A YG++ +PE E +D++S G++
Sbjct: 307 VLGDFGTAMPFE---------KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLI 357
Query: 972 LLEIIT---------GKKP-------------VDASFPD 988
LL++++ G KP D FPD
Sbjct: 358 LLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD 396
|
Length = 501 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 29/223 (13%)
Query: 774 ATRSLTAGNIIGQGRSGIVYK------VTLPSGLTVAVKRFRASDKISTG-AFSSEIATL 826
A +T +GQG G+VY+ V VA+K + + F +E + +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 827 SRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLL-------HDGECAGLLEWDTRFK 879
++VRLLG + + L+ + M G L L + +
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 880 IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939
+A +A+G++YL+ + +HRD+ + N ++ E + + DFG+ R + + +
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-------YETD 173
Query: 940 PQFAGSYG-----YIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
G G +++PE + SDV+S+GVVL EI T
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 59/286 (20%), Positives = 112/286 (39%), Gaps = 35/286 (12%)
Query: 783 IIGQGRSGIVYKVTLPSGLT------VAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIV 835
+G+G G V+ V VK + + D+ F E+ ++ H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLL------HDGECAGLLEWDTRFKIALGVAEGLS 889
RLLG + + +Y G L L + L + + +A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
+L + +HRD+ + N L+ + E L L +D + ++
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185
Query: 950 APEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009
APE S KSDV+S+GV++ E+ T + D + + + L++ K + V
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----LQAGKLELPV 240
Query: 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
+ G P + +++ C + +DRP+ ++ + L E
Sbjct: 241 PE----GCPSR-LYKLMTR------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 25/178 (14%)
Query: 884 VAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
VA G+ +L C+ HRD+ + NILL E + DFGLAR + D + +
Sbjct: 183 VARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLK 1001
++APE + +SDV+S+GV+L EI + G P +P +Q + +
Sbjct: 239 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP----YPG----VQINEEFCQ 288
Query: 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
KD + P+ + I L C ++RPT + +L ++ QE
Sbjct: 289 RLKDGTRMRAPENATP---------EIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 53/149 (35%), Positives = 74/149 (49%), Gaps = 16/149 (10%)
Query: 784 IGQGRSGIVYKVTLPSGLT---VAVKRFRASDKISTGA-FSS--EIATLSRIRHRNIVRL 837
+G+G VYK S LT VA+K R + GA F++ E + L ++H NIV L
Sbjct: 13 LGEGSYATVYKGR--SKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTL 68
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+KT L ++Y+ + L + D C G L + GL+Y H
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQR--- 122
Query: 898 AILHRDVKSHNILLGERYESCLADFGLAR 926
+LHRD+K N+L+ ER E LADFGLAR
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-08
Identities = 30/85 (35%), Positives = 49/85 (57%)
Query: 204 NKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPEL 263
N+ L G +P++I +L I L+ SI G +PP+LG + L+ + + +G IP L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 264 GDCTELQYIYLYENALTGSIPSKLG 288
G T L+ + L N+L+G +P+ LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVRLLG 839
IG+G+ VY+ T L G+ VA+K+ + D + A + EI L ++ H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 840 WGANRKTKLLFYDYMPNGTLG-MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ + G L M+ H + L+ T +K + + L ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---R 126
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
++HRD+K N+ + L D GL R + + S G+ Y++PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPERIHENG 182
Query: 959 ISEKSDVYSYGVVLLEIITGKKP 981
+ KSD++S G +L E+ + P
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 48/204 (23%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKR---FRASDKISTGAFSSEIATLSRIRHRNIVRLL- 838
IG+G+ VY+ T L VA+K+ F D + EI L ++ H N+++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 839 GWGANRKTKLLFYDYMPNGTLG-MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+ + + ++ + G L M+ + + L+ T +K + + + ++H
Sbjct: 70 SFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR--- 125
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
++HRD+K N+ + L D GL R + + S G+ Y++PE +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPERIHEN 181
Query: 958 KISEKSDVYSYGVVLLEIITGKKP 981
+ KSD++S G +L E+ + P
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-08
Identities = 38/110 (34%), Positives = 59/110 (53%), Gaps = 13/110 (11%)
Query: 884 VAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
VA+G+S+L +C+ HRD+ + NILL + + DFGLAR + +DS N +
Sbjct: 223 VAKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT------GKKPVDASF 986
++APE + +SDV+SYG++L EI + PVD+ F
Sbjct: 279 --PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 63/230 (27%), Positives = 93/230 (40%), Gaps = 36/230 (15%)
Query: 773 DATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-R 830
D T +IG+G G VYK +G VA+K + E L +
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSN 61
Query: 831 HRNIVRLLGWGANRKTKL--------LFYDYMPNGTLGMLLHDGECAGLLEWDTRFK--- 879
H NI +GA K L + G++ L+ GL + R K
Sbjct: 62 HPNIATF--YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVK-----GLRKKGKRLKEEW 114
Query: 880 ---IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936
I GL+YLH + V +HRD+K NILL + E L DFG++ ++ G
Sbjct: 115 IAYILRETLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 937 SANPQFAGSYGYIAPE-----YANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ F G+ ++APE +SDV+S G+ +E+ GK P
Sbjct: 172 T----FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 26/237 (10%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA 842
+G G G VYK +G+ A K + + EI L+ H NIV+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 843 NRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHR 902
+ ++ G + ++ + E L E R + E L+YLH + I+HR
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRV-VCKQTLEALNYLHEN---KIIHR 127
Query: 903 DVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISE- 961
D+K+ NIL + LADFG V + + F G+ ++APE M + S+
Sbjct: 128 DLKAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDSFIGTPYWMAPEVV-MCETSKD 182
Query: 962 -----KSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK-SKKDPVEVLDP 1012
K+DV+S G+ L+E+ + P H + +R LK +K +P + P
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPP--------HHELNPMRVLLKIAKSEPPTLAQP 231
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 8e-08
Identities = 43/160 (26%), Positives = 67/160 (41%), Gaps = 30/160 (18%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS--------EIATLSRI-RHRN 833
+G G G VY +G VA+K+ + F S E+ +L ++ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKK-------FYSWEECMNLREVKSLRKLNEHPN 59
Query: 834 IVRLLGWGANRKTKLLF--YDYMPNGTLG--MLLHDGECAGLLEWDTRFKIALGVAEGLS 889
IV+L R+ L+ ++YM G L M G I + +GL+
Sbjct: 60 IVKLKE--VFRENDELYFVFEYM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLA 113
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929
++H HRD+K N+L+ +ADFGLAR +
Sbjct: 114 HIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 52/211 (24%), Positives = 77/211 (36%), Gaps = 18/211 (8%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRF--RASDKISTGAFSSEIATLSRIRHRNIVRLL 838
G + K P+ VAVK+ + K EI T +++H NI+ +
Sbjct: 7 GKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVP 897
+ M G+ LL GL E F I V L Y+H +
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHSKGFI- 123
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG-----YIAPE 952
HR VK+ +ILL + L+ GL V G +++PE
Sbjct: 124 ---HRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 953 --YANMTKISEKSDVYSYGVVLLEIITGKKP 981
N+ +EKSD+YS G+ E+ G P
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 61/214 (28%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 783 IIGQGRSGIVYKVTLPSG--------LTVAVKRFRASDKISTGAFSSEIATLSRIRHRNI 834
++G G G V+ V SG + V K +T +E L IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 835 VRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFK---IALGVAEGLSY 890
+ L + TKL L DY+ NG GE L RFK + + E +
Sbjct: 67 LVTLHYAFQTDTKLHLILDYI-NG--------GELFTHLSQRERFKEQEVQIYSGEIVLA 117
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR-LVEDDSGGSFSANPQFAGSYGYI 949
L H I++RD+K NILL L DFGL++ ED+ ++S F G+ Y+
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS----FCGTIEYM 173
Query: 950 APEY--ANMTKISEKSDVYSYGVVLLEIITGKKP 981
AP+ + D +S GV++ E++TG P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 14/143 (9%)
Query: 881 ALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP 940
A +A GL +LH I++RD+K N++L +ADFG+ + E+ G +
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKT- 160
Query: 941 QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000
F G+ YIAPE + D +++GV+L E++ G+ P + D + Q + +H
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEHN 217
Query: 1001 KS-----KKDPVEVLDPKLQGHP 1018
+ K+ V + + HP
Sbjct: 218 VAYPKSMSKEAVAICKGLMTKHP 240
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLL 838
+ IG+G G+V T P+G+ VA+K+ + T + EI L R +H NI+ +L
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGIL 69
Query: 839 -----GWGANRKTKLLFYDYMPNGTLGML----LHDGECAGLLEWDTRFKIALGVAEGLS 889
+ + + M ++ L + L R GL
Sbjct: 70 DIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR---------GLK 120
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY--- 946
Y+H V LHRD+K N+LL + + DFGLAR+ + + + F Y
Sbjct: 121 YIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD-----HTGFLTEYVAT 172
Query: 947 -GYIAPEYANMTKISEKS-DVYSYGVVLLEIITGKKPVDASFPDGQH 991
Y APE +K K+ D++S G +L E+++ +P+ FP G+
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL---FP-GKD 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 16/149 (10%)
Query: 784 IGQGRSGIVYKVTLPSGLT---VAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRL 837
+G+G V+K S LT VA+K R + GA + E++ L ++H NIV L
Sbjct: 14 LGEGTYATVFKGR--SKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTL 69
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
K+ L ++Y+ + L + D C ++ + GL+Y H
Sbjct: 70 HDIVHTDKSLTLVFEYL-DKDLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRR--- 123
Query: 898 AILHRDVKSHNILLGERYESCLADFGLAR 926
+LHRD+K N+L+ ER E LADFGLAR
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 798 PSGLT-VAVKRFR--ASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDY 853
P+ +T VAVK + A++K SE+ + I +H+NI+ LLG + +Y
Sbjct: 47 PNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 105
Query: 854 MPNGTLGMLLHDGECAGL-------------LEWDTRFKIALGVAEGLSYL-HHDCVPAI 899
G L L G+ L + A VA G+ YL C+
Sbjct: 106 ASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI--- 162
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
HRD+ + N+L+ E +ADFGLAR + + N + ++APE
Sbjct: 163 -HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPEALFDRIY 219
Query: 960 SEKSDVYSYGVVLLEIIT-GKKP 981
+ +SDV+S+GV+L EI T G P
Sbjct: 220 THQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 784 IGQGRSGIVYKVTLPSGLTV-AVKRFRASDKISTGAFSSEIA---TLSRIRHRNIVRLLG 839
IG+G G V +V + A+K R + +S + +A L+++ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLL-EWDTRFKIA-LGVAEGLSYLHHDCVP 897
+ KL NG G L H + G RF A L A L LH V
Sbjct: 60 FSFQSPEKLYLVLAFING--GELFHHLQREGRFDLSRARFYTAELLCA--LENLHKFNV- 114
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARL--VEDDSGGSFSANPQFAGSYGYIAPEYAN 955
++RD+K NILL + L DFGL +L +DD +F P+ Y+APE
Sbjct: 115 --IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE------YLAPELLL 166
Query: 956 MTKISEKSDVYSYGVVLLEIITGKKP 981
++ D ++ GV+L E++TG P
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 784 IGQGRSGIVYKVT--LPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIR---HRNIVR 836
IG+G G V+K G VA+KR R S+ E+A L + H N+VR
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 837 LLG----WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
L +R+TKL + L L G+ +T + + GL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT-ETIKDMMFQLLRGLDFLH 127
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF-SANPQFAGSYGYIAP 951
++HRD+K NIL+ + LADFGLAR+ SF A + Y AP
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY------SFQMALTSVVVTLWYRAP 178
Query: 952 EYANMTKISEKSDVYSYGVVLLEIITGKKPV 982
E + + D++S G + E+ +KP+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 9/111 (8%)
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
GL +LH I++RD+K NILL +ADFG+ + E+ G + + F G+
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCT--FCGTP 160
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997
YIAPE K + D +S+GV+L E++ G+ P D + + Q +R
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH--DEEELFQSIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 24/216 (11%)
Query: 821 SEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGM-LLHDGECAGLLEWDTRFK 879
+E L ++ R +V L + L M G L + H GE AG E F
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVF- 106
Query: 880 IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939
A + GL LH + I++RD+K NILL + ++D GLA V G +
Sbjct: 107 YAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR 161
Query: 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH 999
G+ GY+APE + + D ++ G +L E+I G+ P +
Sbjct: 162 ---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ-------------QRK 205
Query: 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLC 1035
K K++ VE L ++Q + ++L LLC
Sbjct: 206 KKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 50/157 (31%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 826 LSRIRHRNIVRLLGWGANRKTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGV 884
L ++H +V L + KL F DY+ G L L C LE RF A +
Sbjct: 50 LKNVKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARF-YAAEI 105
Query: 885 AEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAG 944
A L YLH I++RD+K NILL + L DFGL + + +G + + F G
Sbjct: 106 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST----FCG 158
Query: 945 SYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ Y+APE + D + G VL E++ G P
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRL---LG 839
+G G +G+V+ V VAVK+ +D S EI + R+ H NIV++ LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 840 WGANRKTKLLFYDYMPNGT-LGMLLHDGECAGLLEWDTRFK-----IALGVAEGLSYLHH 893
+ T+ + N + + + A +LE + + GL Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132
Query: 894 DCVPAILHRDVKSHNILLG-ERYESCLADFGLARLVEDD--SGGSFSANPQFAGSYGYIA 950
V LHRD+K N+ + E + DFGLAR+V+ G S + Y +
Sbjct: 133 ANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG---LVTKWYRS 186
Query: 951 PEY----ANMTKISEKSDVYSYGVVLLEIITGK 979
P N TK D+++ G + E++TGK
Sbjct: 187 PRLLLSPNNYTK---AIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 4e-07
Identities = 38/113 (33%), Positives = 55/113 (48%), Gaps = 20/113 (17%)
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
GL Y+H +LHRD+K N+LL + + DFGLAR + S F Y
Sbjct: 120 GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTEY 168
Query: 947 ----GYIAPE-YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQ 994
Y APE N ++ + DV+S G + E++ G+KP+ FP +V Q
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL---FPGKDYVHQ 217
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 66/297 (22%), Positives = 126/297 (42%), Gaps = 58/297 (19%)
Query: 784 IGQGRSGIVYK------VTLPSGLTVAVKRFRASDKISTG-AFSSEIATLSRIRHRNIVR 836
+GQG G+VY+ + + VAVK S + F +E + + ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHD---------GECAGLLEWDTRFKIALGVAEG 887
LLG + + L+ + M +G L L G L+ ++A +A+G
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 131
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
++YL+ +HRD+ + N ++ + + DFG+ R + + + G G
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-------YETDYYRKGGKG 181
Query: 948 -----YIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLK 1001
++APE + SD++S+GVVL EI + ++P + V+++V D
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--SNEQVLKFVMDG-- 237
Query: 1002 SKKDPVEVLDPKLQGHPDT---QIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
LD PD ++ ++++ +C + RPT ++ LL++
Sbjct: 238 ------GYLD-----QPDNCPERVTDLMR------MCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLLGW 840
+G+G VYK + +G VA+K R ++ T F++ E + L ++H NIV L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 841 GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAIL 900
++T L ++Y+ + D GL + + + + GLSY+H IL
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFL-FQLLRGLSYIHQR---YIL 125
Query: 901 HRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANMTKI 959
HRD+K N+L+ + E LADFGLAR S S + + + + Y P+ T+
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARA---KSVPSHTYSNEVVTLW-YRPPDVLLGSTEY 181
Query: 960 SEKSDVYSYGVVLLEIITGKKPVDASFP 987
S D++ G + +E+I G A+FP
Sbjct: 182 STCLDMWGVGCIFVEMIQGV----AAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 5e-07
Identities = 38/114 (33%), Positives = 57/114 (50%), Gaps = 20/114 (17%)
Query: 887 GLSYLHHDCVPA-ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945
GL YLH A ++HRD+K NIL+ + + DFGLAR V+ D F
Sbjct: 115 GLKYLHS----ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD-----EDEKGFLTE 165
Query: 946 Y----GYIAPE-YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQ 994
Y Y APE + ++ ++ D++S G + E++T KP+ FP G+ I
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL---FP-GRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 783 IIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGW 840
++G G G VYK + +G A+K ++ EI L + HRNI G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 841 ------GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
+ L ++ G++ L+ + + L E D I + GL++LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWIAYICREILRGLAHLH-- 138
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
++HRD+K N+LL E E L DFG++ ++ G F G+ ++APE
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVI 193
Query: 955 NMTKISE-----KSDVYSYGVVLLEIITGKKPV 982
+ + +SD++S G+ +E+ G P+
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 821 SEIATLSRIRHRNIVRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFK 879
+E L +R + L + TKL L DY+ G L L+ E E + R
Sbjct: 53 TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVY 110
Query: 880 IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR-LVEDDSGGSFSA 938
IA V L +LH I++RD+K NILL L DFGL++ + ++ ++S
Sbjct: 111 IAEIVL-ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS- 165
Query: 939 NPQFAGSYGYIAPEYANMTKISEKS--DVYSYGVVLLEIITGKKP 981
F G+ Y+APE D +S GV+ E++TG P
Sbjct: 166 ---FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 821 SEIATLSRIRHRNIVRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFK 879
+E L ++ R +V L + K L L M G L +++ G E F
Sbjct: 49 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF- 106
Query: 880 IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939
A + GL LH + I++RD+K NILL + ++D GLA VE G +
Sbjct: 107 YAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGR 161
Query: 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ GY+APE + + D + G ++ E+I GK P
Sbjct: 162 ---VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 75/246 (30%), Positives = 100/246 (40%), Gaps = 51/246 (20%)
Query: 770 SIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSR 828
S+GD T + IG+G G VYKVT G AVK D IS EI
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISD--VDEEIEAEYN 70
Query: 829 I-----RHRNIVRLLGWGANRKTKLLFY--DYMPNGTLGMLL---HDGECA----GLLEW 874
I H N+V+ G +FY D + G L ++L + G GLL
Sbjct: 71 ILQSLPNHPNVVKFYG---------MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121
Query: 875 DTRFK------IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL---- 924
R I G GL +LH++ I+HRDVK +NILL L DFG+
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178
Query: 925 --ARLVEDDSGGS-FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
RL + S G+ F P+ IA E + DV+S G+ +E+ G P
Sbjct: 179 TSTRLRRNTSVGTPFWMAPEV------IACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
Query: 982 VDASFP 987
+ P
Sbjct: 233 LFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 783 IIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGW 840
++G G G VYK + +G A+K + EI L + HRNI G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 841 GANRKTK------LLFYDYMPNGTLGMLLHDGECAGLLE-WDTRFKIALGVAEGLSYLHH 893
+ L ++ G++ L+ + + L E W I + GLS+LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ 129
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
++HRD+K N+LL E E L DFG++ ++ G F G+ ++APE
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEV 182
Query: 954 ANMTKISE-----KSDVYSYGVVLLEIITGKKPV 982
+ + KSD++S G+ +E+ G P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 42/142 (29%), Positives = 63/142 (44%), Gaps = 9/142 (6%)
Query: 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKS 906
+L F NG ++ H + E RF A + L +LH I++RD+K
Sbjct: 70 RLFFVMEFVNGG-DLMFHIQKSRRFDEARARF-YAAEITSALMFLHDK---GIIYRDLKL 124
Query: 907 HNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVY 966
N+LL LADFG+ + E G ++ F G+ YIAPE D +
Sbjct: 125 DNVLLDHEGHCKLADFGMCK--EGIFNGKTTST--FCGTPDYIAPEILQEMLYGPSVDWW 180
Query: 967 SYGVVLLEIITGKKPVDASFPD 988
+ GV+L E++ G P +A D
Sbjct: 181 AMGVLLYEMLCGHAPFEAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRLLG 839
IG+G G+VYK +G VA+K+ R + G S+ EI+ L ++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
L ++++ + L L ++ + + +G+ + H +
Sbjct: 67 VLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANMTK 958
LHRD+K N+L+ + LADFGLAR G + Y APE +
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAF----GIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 959 ISEKSDVYSYGVVLLEIITGKKPV 982
S D++S G + E+ T KKP+
Sbjct: 179 YSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 38/226 (16%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR------- 836
IG+G G VY+V +R A +S ++ I RNI+
Sbjct: 1 IGKGTFGQVYQVRKKD-----TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 837 --LLGWGANRKTKLLFY---DYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
++G + +T Y DYM G L L +G E +F IA V L +
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVL-ALEH 111
Query: 891 LH-HDCVPAILHRDVKSHNILLGERYESCLADFGLAR--LVEDDSGGSFSANPQFAGSYG 947
LH +D I++RD+K NILL L DFGL++ L ++ + + F G+
Sbjct: 112 LHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT------FCGTTE 161
Query: 948 YIAPEYANMTK-ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHV 992
Y+APE K ++ D +S GV++ E+ G P A D Q +
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA--EDTQQM 205
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-07
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 34/218 (15%)
Query: 783 IIGQGRSGIVYKVTLPSG--------LTVAVKRFRASDKISTGAFSSEIATLSRIRHRNI 834
++G+G G V++V +G + V K ++ T +E L ++H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 835 VRLLGWGANRKTKL-LFYDYMPNGTL-------GMLLHDGECAGLLEWDTRFKIALGVAE 886
V L+ + KL L +Y+ G L G+ + D C L E ++
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE----------ISL 111
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
L +LH I++RD+K NILL + L DFGL + E G+ + F G+
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHT--FCGTI 164
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984
Y+APE + + D +S G ++ +++TG P A
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 50/159 (31%), Positives = 74/159 (46%), Gaps = 12/159 (7%)
Query: 826 LSRIRHRNIVRLLGWGANRKTKL-LFYDYMPNGTLGMLLH--DGECAGLLEWDTRFKIAL 882
L+++ R IV L + KT L L M G L ++ D E G E F A
Sbjct: 47 LAKVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA- 104
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
+ GL +LH I++RD+K N+LL ++D GLA VE G S + +
Sbjct: 105 QIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKG--Y 157
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
AG+ G++APE + D ++ GV L E+I + P
Sbjct: 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-07
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 40/213 (18%)
Query: 784 IGQGRSGIV-YKVTLPSGLTVAVKRFR---ASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G G G V + +G VA+K+ S+ + A+ E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 840 WGANRKTKLLFYDY---MP------NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+ + F D+ MP +G L + + L+ + GL Y
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV---------YQMLCGLKY 132
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAG---SYG 947
+H I+HRD+K N+ + E E + DFGLAR A+ + G +
Sbjct: 133 IHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR----------HADAEMTGYVVTRW 179
Query: 948 YIAPEYA-NMTKISEKSDVYSYGVVLLEIITGK 979
Y APE N ++ D++S G ++ E++TGK
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 9e-07
Identities = 48/164 (29%), Positives = 71/164 (43%), Gaps = 17/164 (10%)
Query: 825 TLSRIRHRNIVRLLGWGANRKTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALG 883
T + RH +V L + + F +Y G L M +H E F A
Sbjct: 55 TANSERHPFLVNLFAC-FQTEDHVCFVMEYAAGGDLMMHIHTDV---FSEPRAVFYAAC- 109
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
V GL YLH + I++RD+K N+LL +ADFGL + E G F
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EG--MGFGDRTSTFC 162
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFP 987
G+ ++APE T + D + GV++ E++ G+ P FP
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 53/232 (22%), Positives = 85/232 (36%), Gaps = 47/232 (20%)
Query: 781 GNIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS---------------EIA 824
G +G+G G V K +G VA+K+ + +IS E+
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 825 TLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFK----- 879
++ I+H NI+ L+ L D M + +++ R
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVDRKIRLTESQVK 122
Query: 880 -IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR-LVEDDSGGSFS 937
I L + GL+ LH +HRD+ NI + + +ADFGLAR + S
Sbjct: 123 CILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 938 ANPQFAG---------SYGYIAPE-YANMTKISEKSDVYSYGVVLLEIITGK 979
+ + Y APE K D++S G + E++TGK
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 36/113 (31%), Positives = 55/113 (48%), Gaps = 8/113 (7%)
Query: 876 TRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935
+RF A V L +LH +++RD+K NILL LADFG+ + E G
Sbjct: 98 SRF-YAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGV 151
Query: 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD 988
+ F G+ YIAPE + D ++ GV++ E++ G+ P +A D
Sbjct: 152 TTTT--FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 67/229 (29%), Positives = 96/229 (41%), Gaps = 57/229 (24%)
Query: 784 IGQGRSGIVYKVTLPS---GLTVAVKRFRASDKISTGAFSSEIATLSRIR---------- 830
+GQG GIV TVA+K KI T FS +I +R
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIK------KI-TNVFSKKILAKRALRELKLLRHFRG 60
Query: 831 HRNIVRLLG----WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIAL-GVA 885
H+NI L + N L+ + M L ++ G+ D F+ + +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLT----DAHFQSFIYQIL 115
Query: 886 EGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP----- 940
GL Y+H V LHRD+K N+L+ E + DFGLAR FS NP
Sbjct: 116 CGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLAR--------GFSENPGENAG 164
Query: 941 ---QFAGSYGYIAPE----YANMTKISEKSDVYSYGVVLLEIITGKKPV 982
++ + Y APE + + TK DV+S G +L E++ G+KPV
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTK---AIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 44/138 (31%), Positives = 58/138 (42%), Gaps = 11/138 (7%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
KL F DY+ G L L E RF A +A L YLH I++RD
Sbjct: 68 ADKLYFVLDYVNGGELFFHLQRERS--FPEPRARF-YAAEIASALGYLHS---LNIIYRD 121
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKS 963
+K NILL + L DFGL + E ++ F G+ Y+APE
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTST--FCGTPEYLAPEVLRKQPYDRTV 177
Query: 964 DVYSYGVVLLEIITGKKP 981
D + G VL E++ G P
Sbjct: 178 DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 821 SEIATLSRIRHRNIVRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFK 879
+E L +R + L + + KL L DY+ G M H + E + RF
Sbjct: 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGE--MFTHLYQRDNFSEDEVRFY 110
Query: 880 IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR-LVEDDSGGSFSA 938
+ L +LH I++RD+K NILL L DFGL++ + ++ ++S
Sbjct: 111 SG-EIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS- 165
Query: 939 NPQFAGSYGYIAPEYANMTKISEKS-DVYSYGVVLLEIITGKKP 981
F G+ Y+APE K+ D +S G+++ E++TG P
Sbjct: 166 ---FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
+ G+ +LH I++RD+K N+LL ++ L+D GLA VE G + + Q A
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTIT---QRA 155
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ GY+APE S D ++ G + E++ G+ P
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 62/250 (24%), Positives = 100/250 (40%), Gaps = 43/250 (17%)
Query: 783 IIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLL 838
+IG+G G V V +G A+K R +D K G +E L +V++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
++ L +++P G + LL + L E +T+F IA V + +H
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVL-AIDSIHQ---LG 121
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN------------------- 939
+HRD+K N+LL + L+DFGL ++ F N
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 940 --------PQFA----GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFP 987
Q A G+ YIAPE T ++ D +S GV++ E++ G P + P
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 988 DGQH--VIQW 995
+ V+ W
Sbjct: 242 QETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAF--------SSEIATLSRIRHRNIV 835
+G+G G VY V VA +R + +I G + E LS++ H IV
Sbjct: 8 LGKGSFGTVYLVK--DKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAG-------LLEWDTRFKIALGVAEGL 888
+ R + +Y L L + + G + EW ++ LGV
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW--FIQLLLGV---- 119
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
Y+H ILHRD+K+ NI L + DFG++RL+ GS F G+ Y
Sbjct: 120 HYMH---QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLM----GSCDLATTFTGTPYY 171
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEI 975
++PE KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 15/142 (10%)
Query: 845 KTKLLFY-DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+++L F +Y+ G L + H L E RF A ++ L+YLH I++RD
Sbjct: 68 ESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHER---GIIYRD 121
Query: 904 VKSHNILLGERYESCLADFGLAR--LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISE 961
+K N+LL L D+G+ + L D+ +F P YIAPE
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN------YIAPEILRGEDYGF 175
Query: 962 KSDVYSYGVVLLEIITGKKPVD 983
D ++ GV++ E++ G+ P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 64/231 (27%), Positives = 90/231 (38%), Gaps = 41/231 (17%)
Query: 784 IGQGRSGIVYKVTLP-SGLTVAVK-----RFRASDKISTGAFSSEIATLSRIRHRNIVRL 837
+G+G G V+ V L +G A+K +K+ EI L+ + H + L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPTL 66
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLL--HDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
L DY P G L LL G+C L E RF A + L YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKC--LSEEVARFYAAEVLL-ALEYLH--- 120
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLA-------RLVEDDSGGS------------- 935
+ I++RD+K NILL E L+DF L+ V
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 936 FSANP-----QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
FS P F G+ YIAPE + D ++ G++L E++ G P
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 46/143 (32%), Positives = 66/143 (46%), Gaps = 14/143 (9%)
Query: 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNI 909
Y + + LL D GL D VA G+ +L +CV HRD+ + N+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL-LSFTYQVARGMEFLASKNCV----HRDLAARNV 268
Query: 910 LLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYG 969
LL + + DFGLAR + DS S F ++APE + SDV+SYG
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDS-NYVSKGSTFL-PVKWMAPESIFDNLYTTLSDVWSYG 326
Query: 970 VVLLEIIT-GKKP-----VDASF 986
++L EI + G P VD++F
Sbjct: 327 ILLWEIFSLGGTPYPGMIVDSTF 349
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLT---VAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRL 837
G +G+G G VYK G A+K+ + IS A EIA L ++H N++ L
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSA-CREIALLRELKHPNVISL 63
Query: 838 ---LGWGANRKTKLLFYDYMPNGTLGML-LHDGECA---------GLLEWDTRFKIALGV 884
A+RK LLF DY + ++ H A G+++ + +
Sbjct: 64 QKVFLSHADRKVWLLF-DYAEHDLWHIIKFHRASKANKKPVQLPRGMVK-----SLLYQI 117
Query: 885 AEGLSYLHHDCVPAILHRDVKSHNILL----GERYESCLADFGLARLVEDDSGGSFSANP 940
+G+ YLH + V LHRD+K NIL+ ER +AD G ARL +P
Sbjct: 118 LDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 941 QFAGSYGYIAPEYANMTKISEKS-DVYSYGVVLLEIITGK 979
++ Y APE + K+ D+++ G + E++T +
Sbjct: 175 VVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
GL L + I++RD+K NILL +R ++D GLA V+ G + G+
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGR---VGTV 165
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
GY+APE N K + D + G ++ E+I G+ P
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
L Y+H V HRD+K NIL + + DFGLAR+ +D+ + A +
Sbjct: 115 ALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 947 GYIAPEYAN--MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVI 993
Y APE +K + D++S G + E++TG KP+ FP G++V+
Sbjct: 172 -YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL---FP-GKNVV 214
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 60/253 (23%), Positives = 113/253 (44%), Gaps = 28/253 (11%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLLG 839
++G+G G+V K + VA+K+F+ S++ ++ E+ L ++ NIV L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
R L ++Y+ L +L + G+ R I + + + + H + I
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELL--EEMPNGVPPEKVRSYI-YQLIKAIHWCHKN---DI 121
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
+HRD+K N+L+ L DFG AR + + S +++ ++ + Y +PE
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT---EYVATRWYRSPELLLGAPY 178
Query: 960 SEKSDVYSYGVVLLEIITGKKPVDASFP-----DGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
+ D++S G +L E+ G +P+ FP D IQ V L +++ + +P+
Sbjct: 179 GKAVDMWSVGCILGELSDG-QPL---FPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234
Query: 1015 QG-------HPDT 1020
G HP +
Sbjct: 235 HGLRFPAVNHPQS 247
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 35/107 (32%), Positives = 50/107 (46%), Gaps = 12/107 (11%)
Query: 877 RFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR--LVEDDSGG 934
RF A +A L YLH I++RD+K NILL + L DFGL + + + D+
Sbjct: 99 RFYAA-EIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154
Query: 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
+F P+ Y+APE D + G VL E++ G P
Sbjct: 155 TFCGTPE------YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 43/250 (17%)
Query: 783 IIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLL 838
+IG+G G V V +G A+K R +D K +E L +V++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+++ L +++P G + LL + L E T+F IA V + +H
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVL-AIDAIHQ---LG 121
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF----SANP-------------- 940
+HRD+K N+LL + L+DFGL ++ F + NP
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 941 ---------QFA----GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFP 987
Q A G+ YIAPE T ++ D +S GV++ E++ G P + P
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 988 DGQH--VIQW 995
+ V+ W
Sbjct: 242 QETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-06
Identities = 38/136 (27%), Positives = 61/136 (44%), Gaps = 10/136 (7%)
Query: 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSH 907
L +Y+ G L + H L E RF A + L++LH I++RD+K
Sbjct: 72 FLVIEYVNGGDL--MFHMQRQRKLPEEHARF-YAAEICIALNFLHER---GIIYRDLKLD 125
Query: 908 NILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYS 967
N+LL L D+G+ + + G F G+ YIAPE + D ++
Sbjct: 126 NVLLDADGHIKLTDYGMCK----EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181
Query: 968 YGVVLLEIITGKKPVD 983
GV++ E++ G+ P D
Sbjct: 182 LGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-06
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 25/177 (14%)
Query: 884 VAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
VA+G+ +L C+ HRD+ + NILL E + DFGLAR + D + +
Sbjct: 188 VAKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLK 1001
++APE + +SDV+S+GV+L EI + G P +P G + + LK
Sbjct: 244 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YP-GVKIDEEFCRRLK 296
Query: 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058
+++ PD EM Q + L C RPT ++ L + Q
Sbjct: 297 EGT--------RMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
GL LH + ++RD+K NILL + ++D GLA V+ G S G+
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR---VGTV 165
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984
GY+APE N + + D + G ++ E+I G+ P
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 8e-06
Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 7/108 (6%)
Query: 871 LLEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929
L + + VA G+ +L +CV HRD+ + N+L+ E + DFGLAR +
Sbjct: 235 ALSYMDLVGFSYQVANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
DS S F ++APE + SDV+S+G++L EI T
Sbjct: 291 RDS-NYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 62/238 (26%), Positives = 92/238 (38%), Gaps = 54/238 (22%)
Query: 804 AVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF-YDYMPNGTL 859
A+K R +D + +E L+ + +V+L + K L F DY+P G +
Sbjct: 30 AMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDM 88
Query: 860 GMLLHDGECAGLLEWD-TRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESC 918
LL G+ E D RF IA + + +H +HRD+K NIL+
Sbjct: 89 MSLLIR---LGIFEEDLARFYIA-ELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIK 141
Query: 919 LADFGLA---RLVED----DSGG-----SFSANPQFA----------------------- 943
L DFGL R D G S + +++
Sbjct: 142 LTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLA 201
Query: 944 ----GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG-QH-VIQW 995
G+ YIAPE T ++ D +S GV+L E++ G+ P A P Q VI W
Sbjct: 202 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 58/228 (25%), Positives = 88/228 (38%), Gaps = 43/228 (18%)
Query: 784 IGQGRSGIVYKVTLP-SGLTVAVKR----FRASDKISTGAFSSEIATLSRIRHRNIVRLL 838
IG G G+V+ VT P G VA+K+ F+ + +S E+ L +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ--NLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALG--------------- 883
D + + L++ D KI +
Sbjct: 66 -------------DILQPPHIDPFEEIYVVTELMQSDLH-KIIVSPQPLSSDHVKVFLYQ 111
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
+ GL YLH ILHRD+K N+L+ + DFGLAR+ E D S +
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVV 166
Query: 944 GSYGYIAPE-YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ 990
Y Y APE + D++S G + E++ + A P Q
Sbjct: 167 TQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 781 GNIIGQGRSGIVYKVTLPSGL---TVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV-- 835
G +G+G G VYK G A+K+ + IS A EIA L ++H N++
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSA-CREIALLRELKHPNVIAL 63
Query: 836 -RLLGWGANRKTKLLFYDYMPNGTLGML-LHDGECAG----LLEWDTRFKIALGVAEGLS 889
++ ++RK LLF DY + ++ H A L + + +G+
Sbjct: 64 QKVFLSHSDRKVWLLF-DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 890 YLHHDCVPAILHRDVKSHNILL----GERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945
YLH + V LHRD+K NIL+ ER +AD G ARL +P +
Sbjct: 123 YLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-T 178
Query: 946 YGYIAPEYANMTKISEKS-DVYSYGVVLLEIITGK 979
+ Y APE + K+ D+++ G + E++T +
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 44/139 (31%), Positives = 64/139 (46%), Gaps = 18/139 (12%)
Query: 847 KLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVK 905
KL F D M G L H + E + RF A + GL ++H+ V ++RD+K
Sbjct: 71 KLCFILDLMNGGDLHY--HLSQHGVFSEKEMRF-YATEIILGLEHMHNRFV---VYRDLK 124
Query: 906 SHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA--GSYGYIAPEYANM-TKISEK 962
NILL E ++D GLA FS A G++GY+APE T
Sbjct: 125 PANILLDEHGHVRISDLGLA--------CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS 176
Query: 963 SDVYSYGVVLLEIITGKKP 981
+D +S G +L +++ G P
Sbjct: 177 ADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-05
Identities = 21/60 (35%), Positives = 29/60 (48%)
Query: 292 NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQI 351
NL +L L N L I L ++D+S N+LT P+ L SL+ L LS N +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 61/246 (24%), Positives = 103/246 (41%), Gaps = 30/246 (12%)
Query: 744 SHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYK-VTLPSGLT 802
SH+N ED + E + N ++ S +S GNIIG G G+VY+ + + +
Sbjct: 41 SHNNNAGEDEDE----EKMIDNDINRS---PNKSYKLGNIIGNGSFGVVYEAICIDTSEK 93
Query: 803 VAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGW------GANRKTKLL--FYDYM 854
VA+K+ + + E+ + + H NI+ L + N K L +++
Sbjct: 94 VAIKKVLQDPQYK----NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI 149
Query: 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER 914
P + H L + + L+Y+H I HRD+K N+L+
Sbjct: 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPN 206
Query: 915 YESC-LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA-NMTKISEKSDVYSYGVVL 972
+ L DFG A+ + G S + + S Y APE T + D++S G ++
Sbjct: 207 THTLKLCDFGSAK---NLLAGQRSVS--YICSRFYRAPELMLGATNYTTHIDLWSLGCII 261
Query: 973 LEIITG 978
E+I G
Sbjct: 262 AEMILG 267
|
Length = 440 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 24/187 (12%)
Query: 806 KRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL----LFYDYMPNGTLGM 861
K+F K+ +EI L RI NI+++ G+ + L L +Y G L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 862 LLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHRDVKSHNILLGERYESCLA 920
+L + L + T+ +A+ +GL L+ + P ++++ S + L+ E Y+ +
Sbjct: 112 VLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKII 165
Query: 921 DFGLARLVEDDSGGSFSANPQF--AGSYGYIAPEYAN--MTKISEKSDVYSYGVVLLEII 976
GL +++ ++P F Y + + N ++ + K D+YS GVVL EI
Sbjct: 166 CHGLEKIL---------SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
Query: 977 TGKKPVD 983
TGK P +
Sbjct: 217 TGKIPFE 223
|
Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 25/160 (15%)
Query: 873 EWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932
E + RF A + GL ++H+ V ++RD+K NILL E ++D GLA
Sbjct: 96 EAEMRF-YAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA------- 144
Query: 933 GGSFSANPQFA--GSYGYIAPE-YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG 989
FS A G++GY+APE +D +S G +L +++ G P
Sbjct: 145 -CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
Query: 990 QHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQAL 1029
+H I + +L +++ +L+ L
Sbjct: 204 KHEI----------DRMTLTMAVELPDSFSPELRSLLEGL 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 783 IIGQGRSGIVYKVTLPSGLTV-AVKRFRASDKI--STGAFSSEIATLSRIRHRN---IVR 836
+IG+G G V V S V A+K + I S AF E + + H N IV+
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWIVQ 107
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L + K + +YMP G L L+ + + +W RF A V L +H
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KW-ARFYTA-EVVLALDAIHS--- 160
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLA-RLVEDDSGGSFSANPQFAGSYGYIAPEY-- 953
+HRDVK N+LL + LADFG ++ + +A G+ YI+PE
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA----VGTPDYISPEVLK 216
Query: 954 --ANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ D +S GV L E++ G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 29/164 (17%)
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+ N ++L K +L DY+ +G L LL L E + + KI + E L+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVK-KIIRQLVEALND 124
Query: 891 LH-HDCVPAILHRDVKSHNILLGERYES--CLADFGLARLVEDDSGGSFSANPQFAGSYG 947
LH H I+H D+K N+L +R + L D+GL +++ G+ S + G+
Sbjct: 125 LHKH----NIIHNDIKLENVLY-DRAKDRIYLCDYGLCKII-----GTPSC---YDGTLD 171
Query: 948 YIAPEYANMTKISEKS-----DVYSYGVVLLEIITGKKPVDASF 986
Y +PE KI + D ++ GV+ E++TGK P
Sbjct: 172 YFSPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-05
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 59 DETPCKWFGVSCNLNNQ---------------VVGLDLRYVDLLGHVPTNFTSLLSLNRL 103
D T KWF L+NQ + ++L + G++P + S+ SL L
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471
Query: 104 VLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL 146
LS + GSIP+ + L L L+L+ NSL+G +P L L
Sbjct: 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 22/212 (10%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRL 837
+++G+G G V V +G A+K + S + + F E LS I +L
Sbjct: 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWD-TRFKIALGVAEGLSYLHHDCV 896
++ L +Y P G L LL+ E + D +F +A + + +H
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLA-ELVLAIHSVHQ--- 120
Query: 897 PAILHRDVKSHNILLGERYESCLADFG-LARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
+HRD+K N+L+ LADFG ARL + S P G+ YIAPE
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN--KMVNSKLP--VGTPDYIAPEVLT 176
Query: 956 MTKISEKS------DVYSYGVVLLEIITGKKP 981
K D +S GV+ E+I G+ P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 34/121 (28%), Positives = 53/121 (43%), Gaps = 8/121 (6%)
Query: 861 MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLA 920
+ H E RF A + L YLH +++RD+K N++L + +
Sbjct: 82 LFFHLSRERVFSEDRARFYGA-EIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKIT 137
Query: 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKK 980
DFGL + E S G+ F G+ Y+APE D + GVV+ E++ G+
Sbjct: 138 DFGLCK--EGISDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193
Query: 981 P 981
P
Sbjct: 194 P 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 783 IIGQGRSGIVYKV-TLPSGLTVAVKRFR-----ASDKISTGAFSSEIATLSRIRHRNIVR 836
++G+G G V V SG A+K + A D+++ S + L RH +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRV--LKNTRHPFLTS 59
Query: 837 LLGWGANRKTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
L + K +L F +Y+ G L H E TRF A + L YLH
Sbjct: 60 L-KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA-EIVSALDYLHSG- 114
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
I++RD+K N++L + + DFGL + D+ + F G+ Y+APE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----ATMKTFCGTPEYLAPEVLE 168
Query: 956 MTKISEKSDVYSYGVVLLEIITGKKP 981
D + GVV+ E++ G+ P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-05
Identities = 72/334 (21%), Positives = 120/334 (35%), Gaps = 68/334 (20%)
Query: 290 LKNLVNLFLWQNNLVGI----IPPELGNCSQLSIIDISMNSL------TGSIPQTLGNLT 339
L L L L N L + L L + +S+N S+ Q L
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 340 SLQELQLSVNQISGEIPAQIGNCQR---LAQIELDNNQITGAIPSEFG-----NLSNLTL 391
LQEL LS N + + + + R L +++L+NN + L
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 392 LFVWHNRLEGEIPPSISN----CQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNN 446
L + NRLEG +++ ++L+ ++L+ NG+ R + + LK L +L N
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201
Query: 447 LSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506
+G+ + + +LK+L L+LG N LT
Sbjct: 202 NNGLTDEGASALAETLA-----------------SLKSLEVLNLGDNNLT---------- 234
Query: 507 RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG----GMLSPDLGSLSSLTKLVL 562
D + ++A L + L+ L LS N + L+ L SL +L L
Sbjct: 235 ------DAGAAALASALLSPNISLLTL---SLSCNDITDDGAKDLAEVLAEKESLLELDL 285
Query: 563 NKNRFAG-----SIPSQLGSCVKLQLLDLSSNQL 591
N+F S L +L+ L + +
Sbjct: 286 RGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-05
Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 12/137 (8%)
Query: 849 LFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKS 906
LF+ +++ G L + H L E RF A ++ L++LH I++RD+K
Sbjct: 71 LFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNFLHER---GIIYRDLKL 124
Query: 907 HNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVY 966
N+LL L D+G+ + E G ++ F G+ YIAPE D +
Sbjct: 125 DNVLLDAEGHIKLTDYGMCK--EGIRPGDTTST--FCGTPNYIAPEILRGEDYGFSVDWW 180
Query: 967 SYGVVLLEIITGKKPVD 983
+ GV++ E++ G+ P D
Sbjct: 181 ALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 18/171 (10%)
Query: 821 SEIATLSRIRHRNIVRLLGWGANRKTK-LLFYDYMPNGTLGMLLHD---GECAGLLEWDT 876
E L + H+NI+ +L + Y YM G L + L GE T
Sbjct: 57 QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116
Query: 877 R--FKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR-LVEDD-- 931
+ +A+ +A G+SYLH ++H+D+ + N ++ E + + D L+R L D
Sbjct: 117 QQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173
Query: 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
G P ++A E + S SDV+S+GV+L E++T G+ P
Sbjct: 174 CLGDNENRP-----VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 58/216 (26%), Positives = 88/216 (40%), Gaps = 35/216 (16%)
Query: 783 IIGQGRSGIVYKV-TLPSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRN-IVRL 837
IG+G G VYK +G VA+K+ R + I A EI+ L + IVRL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRL 66
Query: 838 LGW----GANRKTKL-LFYDYMPNGTLG-MLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
L N K L L ++Y+ + M + L T + +G+++
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 892 HHDCVPAILHRDVKSHNILLGERYESC-LADFGLARLVEDDSGGSFSANPQFAGSYG--- 947
H ++HRD+K N+L+ ++ +AD GL R +FS P SY
Sbjct: 127 HKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR--------AFSI-P--VKSYTHEI 172
Query: 948 ----YIAPE-YANMTKISEKSDVYSYGVVLLEIITG 978
Y APE T S D++S G + E+
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-04
Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 25/155 (16%)
Query: 74 NQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENS 133
N++ LD+ + L +PT +L SL RL LSG + S P +I++ +++LDL E +
Sbjct: 681 NKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFP-DIST--NISWLDLDETA 736
Query: 134 LTGEIPRELC--SLLRLEQLRLNSNQLEGAI----PIQIGNLSSLTQLFLYDNQLTDAIP 187
+ E P L +L L + S +L + P+ SLT+LFL D +P
Sbjct: 737 IE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELP 795
Query: 188 ATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLV 222
++I L LE + EI NC NL
Sbjct: 796 SSIQNLHKLEHL--------------EIENCINLE 816
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-04
Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 64/247 (25%)
Query: 783 IIGQGRSG---IVYKVTLPSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVR 836
+IG+G G +V K +G A+K+ R S+ K +E L+ + +V+
Sbjct: 8 VIGRGAFGEVRLVQKKD--TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L + L +Y+P G + LL + E +TRF IA + +
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIA------------ETI 111
Query: 897 PAI--------LHRDVKSHNILLGERYESCLADFGL------------ARLVEDDSGGSF 936
AI +HRD+K N+LL + L+DFGL R++ +F
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 937 SANPQ----------------------FAGSYGYIAPEYANMTKISEKSDVYSYGVVLLE 974
G+ YIAPE T +++ D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 975 IITGKKP 981
++ G P
Sbjct: 232 MLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 11/90 (12%)
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
+ Y+H + I+HRD+K+ N+L+ + CL DFG A GS+S P G G
Sbjct: 273 IDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR----GSWST-PFHYGIAG 324
Query: 948 YI---APEYANMTKISEKSDVYSYGVVLLE 974
+ APE + D++S G+V+ E
Sbjct: 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 36/218 (16%)
Query: 784 IGQGRSGIVYKVTLPSG--LTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVRLL 838
+G G G V T + VA+KRF S I SE L+ I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALG---------VAEGLS 889
G + L +++ +G GE L + RF +G + E L
Sbjct: 98 GSFKDESYLYLVLEFV----IG-----GEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
L+ I++RD+K N+LL + + DFG A++V+ + G+ YI
Sbjct: 149 SLN------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-------TRTYTLCGTPEYI 195
Query: 950 APEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFP 987
APE + +D ++ G+ + EI+ G P A+ P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 11/102 (10%)
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
L LH + I+ RD+ +NILL +R L F VED G A
Sbjct: 98 LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE-------AVENM 147
Query: 948 YIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG 989
Y APE +++ +E D +S G +L E++TGK V+ P G
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 63/235 (26%), Positives = 98/235 (41%), Gaps = 20/235 (8%)
Query: 783 IIGQGRSGIVYKVTLPSGLTV-AVK---RFRASDKISTGAFSSEIATLSRIRHRNIVRLL 838
+IG+G G V V S V A+K +F + + F E ++ +V+L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ K + +YMP G L L+ + + +W +F A V L +H
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KW-AKFYTA-EVVLALDAIHS---MG 162
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
++HRDVK N+LL + LADFG ++ D G + G+ YI+PE
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTA-VGTPDYISPEVLKSQG 219
Query: 959 ----ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009
+ D +S GV L E++ G P A G + + DH S P +V
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY--SKIMDHKNSLNFPEDV 272
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-04
Identities = 61/214 (28%), Positives = 89/214 (41%), Gaps = 23/214 (10%)
Query: 783 IIGQGRSGIVYKVTLPSGLTV----AVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLL 838
+IG+G G V V L + V + ++ + T F E L ++ I L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVA--EGLSYLHHDCV 896
+ L DY G L LL E L E RF +A V + + LH+
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 897 PAILHRDVKSHNILLGERYESCLADFG-LARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
+HRD+K NIL+ LADFG +L+ED + S A G+ YI+PE
Sbjct: 124 ---VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA----VGTPDYISPEILQ 176
Query: 956 MT-----KISEKSDVYSYGVVLLEIITGKKPVDA 984
K + D +S GV + E++ G+ P A
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-04
Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 72/281 (25%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
TEL+ L + IP ++ L L N L + GN L + N
Sbjct: 181 TELRLKILGLTTIPACIPEQI------TTLILDNNELKSLPENLQGNIKTLY---ANSNQ 231
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNL 386
LT SIP TL + ++QE++LS+N+I+ E+P + +PS
Sbjct: 232 LT-SIPATLPD--TIQEMELSINRIT-ELPER--------------------LPSA---- 263
Query: 387 SNLTLLFVWHNRLEGEIPPSISN-CQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSN 445
L L ++HN++ +P ++ + L D S L +P GI L + L
Sbjct: 264 --LQSLDLFHNKISC-LPENLPEELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLTA-- 318
Query: 446 NLSGVIPPEMGNCSSLIRFRANSNKLTGF---IPPEIGNLKNLNFLDLGSNRLTGSIPDE 502
L +PP L A N LT +PPE+ LD+ N++T +P+
Sbjct: 319 -LPETLPP------GLKTLEAGENALTSLPASLPPELQV------LDVSKNQIT-VLPET 364
Query: 503 ITGCRNLTFLDVHSNSIAG---NLPAGL-------HQLVRL 533
+ +T LDV N++ NLPA L + LVRL
Sbjct: 365 LP--PTITTLDVSRNALTNLPENLPAALQIMQASRNNLVRL 403
|
Length = 754 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 73/277 (26%), Positives = 109/277 (39%), Gaps = 33/277 (11%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWG 841
IG+G G V+KV +G AVK I +E L + H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYGMY 84
Query: 842 ANRKTK-----LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFK---IALGVAEGLSYLHH 893
+ K L + G++ L+ G L+ R + IA + E L L H
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVK-----GFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGL-ARLVEDDSGGSFSANPQFAGSYGYIAPE 952
V +HRDVK +NILL L DFG+ A+L + S F + IA E
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 953 YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012
+ + DV+S G+ +E+ G P+ P +R K ++P P
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--------MRALFKIPRNP----PP 247
Query: 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
L P+ E + C + E RPT+ D+
Sbjct: 248 TLH-QPELWSNEFNDFIR---KCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 6/98 (6%)
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
+ L YLH + +++RD+K N++L + + DFGL + D G + F
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKT---FC 157
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ Y+APE D + GVV+ E++ G+ P
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 46/143 (32%), Positives = 60/143 (41%), Gaps = 17/143 (11%)
Query: 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGV--AEGLSYLHHDCVPAILHRDVKS 906
L DY G L LL E L E RF IA V + LH+ +HRD+K
Sbjct: 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHY------VHRDIKP 130
Query: 907 HNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN-----MTKISE 961
N+LL LADFG + D S G+ YI+PE M K
Sbjct: 131 DNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA---VGTPDYISPEILQAMEDGMGKYGP 187
Query: 962 KSDVYSYGVVLLEIITGKKPVDA 984
+ D +S GV + E++ G+ P A
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 6e-04
Identities = 67/266 (25%), Positives = 108/266 (40%), Gaps = 67/266 (25%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKR----FRASDKISTGAFSSEIATLSRIR-HRNIVRL 837
IG+G V K + +G A+K F++ ++++ EI L R+ H NI+RL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL 63
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRF-------KIALGVAEGLSY 890
+ +RKT L L L D L++ R + + L +
Sbjct: 64 IEVLFDRKTGRL--------ALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP--QFAGSYGY 948
+H + I HRD+K NIL+ + LADFG R G +S P ++ + Y
Sbjct: 116 MHRN---GIFHRDIKPENILI-KDDILKLADFGSCR-------GIYSKPPYTEYISTRWY 164
Query: 949 IAPE-------YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK 1001
APE Y K D+++ G V EI++ P+ FP + Q + H
Sbjct: 165 RAPECLLTDGYY------GPKMDIWAVGCVFFEILS-LFPL---FPGTNELDQIAKIH-- 212
Query: 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQ 1027
+VL G PD ++ + +
Sbjct: 213 ------DVL-----GTPDAEVLKKFR 227
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 41/140 (29%), Positives = 60/140 (42%), Gaps = 14/140 (10%)
Query: 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHN 908
+ +YMP G L L+ + + +W RF A V L +H +HRDVK N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE--KW-ARFYTA-EVVLALDAIHS---MGFIHRDVKPDN 172
Query: 909 ILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK----ISEKSD 964
+LL + LADFG + + G + G+ YI+PE + D
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKE--GMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 965 VYSYGVVLLEIITGKKPVDA 984
+S GV L E++ G P A
Sbjct: 230 WWSVGVFLYEMLVGDTPFYA 249
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 7e-04
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 460 SLIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNS 518
+L ++N+LT IP L NL LDL N LT P+ +G +L LD+ N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 519 I 519
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-04
Identities = 97/396 (24%), Positives = 135/396 (34%), Gaps = 120/396 (30%)
Query: 263 LGDCT---ELQYIYLYENALTGSIPSKLGNLKNL---VNL-FLWQNNLVGIIPPELGNCS 315
L DC+ EL Y N L S+ NL+ L +NL L++ NL G CS
Sbjct: 664 LSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSG--------CS 715
Query: 316 QL-SIIDISMNSLTGSIPQT----------LGNLTSLQELQLSVNQISGEI----PAQIG 360
+L S DIS N + +T L NL L ++ ++ + P
Sbjct: 716 RLKSFPDISTNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTM 775
Query: 361 NCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQ 420
L ++ L + +PS NL L L I NC NLE
Sbjct: 776 LSPSLTRLFLSDIPSLVELPSSIQNLHKLEHL-------------EIENCINLET----- 817
Query: 421 NGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKL-------TG 473
+P GI N L S +LSG CS L F S + TG
Sbjct: 818 ------LPTGI------NLESLESLDLSG--------CSRLRTFPDISTNISDLNLSRTG 857
Query: 474 F--IPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLV 531
+P I NL+FLD+ GC NL + ++ + +L
Sbjct: 858 IEEVPWWIEKFSNLSFLDMN-------------GCNNLQRVSLN-----------ISKLK 893
Query: 532 RLQFADLSDNSVGGMLSPDLGSLSSLTKLVLN-KNRFAGSIPSQLGSCVKLQLLDLSSNQ 590
L+ D SD S + GS S + N ++ ++ +C L L Q
Sbjct: 894 HLETVDFSDCGALTEASWN-GSPSEVAMATDNIHSKLPSTVCINFINCFNLDQEALLQQQ 952
Query: 591 -------LSGN----------IPASLGKIPALAIAL 609
LSG ASL IP L I+
Sbjct: 953 SIFKQLILSGEEVPSYFTHRTTGASLTNIPLLHISP 988
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 24/201 (11%)
Query: 791 IVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850
+V KV PS +A+ AF + +S++ H ++ + G ++
Sbjct: 47 VVLKVLDPSHRDIAL------------AFFETASLMSQVSHIHLAFVHGVCVRGSENIMV 94
Query: 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNIL 910
+++ +G L + L + + W + +A +A LSYL ++H +V + NIL
Sbjct: 95 EEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNIL 149
Query: 911 LGERYESCLADFGLARLVEDDSGGSFSA--NPQFAGSYGYIAPE-YANMTKISEKSDVYS 967
L LA+ + D G SF+A + +IAPE +S +D +S
Sbjct: 150 LARL---GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWS 206
Query: 968 YGVVLLEI-ITGKKPVDASFP 987
+G LLEI G+ P+ P
Sbjct: 207 FGTTLLEICFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 9e-04
Identities = 24/61 (39%), Positives = 27/61 (44%), Gaps = 2/61 (3%)
Query: 99 SLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQ 157
+L L LS LT IP L L LDLS N+LT P L L L L+ N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 158 L 158
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 9e-04
Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 10/92 (10%)
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
YLH I++RD+K N+LL + + DFG A+ V D +F+ G+ Y+
Sbjct: 133 YLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---TFT----LCGTPEYL 182
Query: 950 APEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
APE + D ++ GV+L E I G P
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
+ L YLH V ++RD+K N++L + + DFGL + E S G+ F
Sbjct: 104 IVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGA--TMKTFC 156
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ Y+APE D + GVV+ E++ G+ P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 39/135 (28%), Positives = 61/135 (45%), Gaps = 24/135 (17%)
Query: 866 GECAGLLEWDTRFKIALG---VAE---GLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919
G+CA LL+ + + AE L YLH+ I+HRD+K N+L+ L
Sbjct: 86 GDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKL 142
Query: 920 ADFGLARL-------------VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVY 966
DFGL+++ +E D+ F + Q G+ YIAPE + D +
Sbjct: 143 TDFGLSKIGLMSLTTNLYEGHIEKDT-REFL-DKQVCGTPEYIAPEVILRQGYGKPVDWW 200
Query: 967 SYGVVLLEIITGKKP 981
+ G++L E + G P
Sbjct: 201 AMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 16/60 (26%), Positives = 26/60 (43%)
Query: 340 SLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRL 399
+L+ L LS N+++ L ++L N +T P F L +L L + N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 900 LHRDVKSHNILLGERYESCLADFG-LARLVEDDSGGSFSANPQFAGSYGYIAPEY----- 953
+HRD+K N+LL + LADFG RL+ D + S A G+ YI+PE
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA----VGTPDYISPEILQAME 179
Query: 954 ANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ + D +S GV + E++ G+ P
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 25/62 (40%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 388 NLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSN 445
NL L + +NRL IP NL+ +DLS N LT I F L L L L N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGN 58
Query: 446 NL 447
NL
Sbjct: 59 NL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1117 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.05 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.03 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.02 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.97 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.97 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.69 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.62 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.61 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.58 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.41 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.37 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-115 Score=1135.50 Aligned_cols=917 Identities=35% Similarity=0.591 Sum_probs=708.7
Q ss_pred chhHHHHHHHHHhhccCCCCCCCCCCCCCCCCcceeeEEecCCCcEEEEecccccccCcCCccccccccCCeEeccCCCC
Q 001238 31 VNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNL 110 (1117)
Q Consensus 31 ~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~~~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l 110 (1117)
.+.|+.||++||+++.++...+++|... .+||.|.||+|+..++|+.++|.++++.|.+|..|..+++|+.|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 3578999999999998776778999753 579999999998778999999999988888888888899999999999999
Q ss_pred CCCchhhhc-ccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCccc
Q 001238 111 TGSIPKEIA-SLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPAT 189 (1117)
Q Consensus 111 ~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~ 189 (1117)
+|.+|..+. ++++|++|||++|+++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 888887765 888999999999988887775 45778888888888888788888888888888888888877666665
Q ss_pred ccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCC
Q 001238 190 IGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTEL 269 (1117)
Q Consensus 190 ~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L 269 (1117)
++++++|++|++++| .+.+.+|..++.+++|
T Consensus 184 ~~~l~~L~~L~L~~n-------------------------------------------------~l~~~~p~~l~~l~~L 214 (968)
T PLN00113 184 LTNLTSLEFLTLASN-------------------------------------------------QLVGQIPRELGQMKSL 214 (968)
T ss_pred hhhCcCCCeeeccCC-------------------------------------------------CCcCcCChHHcCcCCc
Confidence 555555554444443 3334566667777888
Q ss_pred cEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccc
Q 001238 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVN 349 (1117)
Q Consensus 270 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N 349 (1117)
++|+|++|++++.+|..|+++++|++|++++|++.+.+|..|+++++|+.|+|++|.+++.+|..+.++++|++|+|++|
T Consensus 215 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 294 (968)
T PLN00113 215 KWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294 (968)
T ss_pred cEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCC
Confidence 88889888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcc
Q 001238 350 QISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPR 429 (1117)
Q Consensus 350 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 429 (1117)
.+.+.+|..+.++++|+.|++++|.+++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|+|++|++++.+|.
T Consensus 295 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~ 374 (968)
T PLN00113 295 SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374 (968)
T ss_pred eeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCCh
Confidence 88888888888888888888888888888888888888888888888888777777777777788888888877777777
Q ss_pred cccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCC
Q 001238 430 GIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNL 509 (1117)
Q Consensus 430 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 509 (1117)
.+..+.+|+.|++++|++.+.+|..+..+++|+.|++++|++++.+|..|.++++|+.|++++|++++.+|..+..+++|
T Consensus 375 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 454 (968)
T PLN00113 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL 454 (968)
T ss_pred hHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCC
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777666677777
Q ss_pred ceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecccc
Q 001238 510 TFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSN 589 (1117)
Q Consensus 510 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 589 (1117)
+.|+|++|++.+.+|..+ ...+|+.|++++|++.+..|..|..+++|+.|+|++|
T Consensus 455 ~~L~L~~n~~~~~~p~~~-------------------------~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 509 (968)
T PLN00113 455 QMLSLARNKFFGGLPDSF-------------------------GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509 (968)
T ss_pred cEEECcCceeeeecCccc-------------------------ccccceEEECcCCccCCccChhhhhhhccCEEECcCC
Confidence 777777777766555432 2356777788888887778888888888888888888
Q ss_pred ccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch-hhhcccceEEEeecccccCCCC
Q 001238 590 QLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF-LAELQNLVVLNVSHNNFSGRVP 668 (1117)
Q Consensus 590 ~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~-l~~l~~L~~L~ls~N~l~~~~p 668 (1117)
++++.+|..+..+++| +.|+|++|.+++.+|..|..+++|+.|||++|++++.+|. +..+++|+.|++++|+++|.+|
T Consensus 510 ~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 510 KLSGEIPDELSSCKKL-VSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred cceeeCChHHcCccCC-CEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 8888888888888887 7888888888888999999999999999999999997776 8889999999999999999999
Q ss_pred CCcccccCCcccccCCCCCCcCC-----CCCCCCccccCCCccccchhHHHHHHHHHHHHHHHHHHHHhhheeccccCCC
Q 001238 669 DTPFFAKLPLSVLSGNPSLCFSG-----NQCADSTYKKDGASRHAGAARVAMVVLLSAACALLLAALYIILGPRIRGLSG 743 (1117)
Q Consensus 669 ~~~~~~~~~~~~~~gN~~~c~~~-----~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (1117)
..+++.++...++.|||.+||.. ++|.... . .......+++++++++++++++++ ++++++| ++...
T Consensus 589 ~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~----~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~ 660 (968)
T PLN00113 589 STGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR----K--TPSWWFYITCTLGAFLVLALVAFG-FVFIRGR-NNLEL 660 (968)
T ss_pred CcchhcccChhhhcCCccccCCccccCCCCCcccc----c--cceeeeehhHHHHHHHHHHHHHHH-HHHHHhh-hcccc
Confidence 99999999999999999999863 3453210 1 111111122222222222222222 2222222 21111
Q ss_pred CCCCCCCCccccCCCccchhhc---cchhhHHHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHH
Q 001238 744 SHHNEGDEDVEMGPPWELTLYN---KLDLSIGDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAF 819 (1117)
Q Consensus 744 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~ 819 (1117)
+....++.. ++...+. .......+....|+..+.||+|+||.||+|.. .+|+.||||+++.... ..
T Consensus 661 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~ 730 (968)
T PLN00113 661 KRVENEDGT------WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IP 730 (968)
T ss_pred ccccccccc------ccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----cc
Confidence 111100000 1110000 01123445556788889999999999999985 5789999999864332 22
Q ss_pred HHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCce
Q 001238 820 SSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899 (1117)
Q Consensus 820 ~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 899 (1117)
.+|++.+++++|||||+++++|.+++..++||||+++|+|.++++. ++|.++.+++.|+|+|++|||..+.++|
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~i 804 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAV 804 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 4578999999999999999999999999999999999999999963 7899999999999999999997666699
Q ss_pred eeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCC
Q 001238 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGK 979 (1117)
Q Consensus 900 vHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~ 979 (1117)
+||||||+||+++.++.+++. ||.+..... .....+|++|+|||++.+..++.++|||||||++|||++|+
T Consensus 805 iH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~ 875 (968)
T PLN00113 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875 (968)
T ss_pred ecCCCCHHhEEECCCCceEEE-ecccccccc--------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCC
Confidence 999999999999999888775 665543321 12236889999999999999999999999999999999999
Q ss_pred CCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 980 KPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 980 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.||+..........+|++..... ......+++.+.........++.+..+++..||+.+|++||+|+||++.|+++.+.
T Consensus 876 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 876 SPADAEFGVHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCCCcccCCCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 99976655566677777654332 23344556666554444455666777889999999999999999999999987653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-61 Score=629.03 Aligned_cols=514 Identities=37% Similarity=0.608 Sum_probs=370.6
Q ss_pred ccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhh-hhhhhhhhhccCCCcCCCCchhccCCcCCcEEe
Q 001238 98 LSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELC-SLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLF 176 (1117)
Q Consensus 98 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~ 176 (1117)
.+++.|+|++|+++|.+|..|..+++|++|||++|+++|.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 3678899999999999999999999999999999999888887765 788888888888888877774 5577788888
Q ss_pred ccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeeccccccc
Q 001238 177 LYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLS 256 (1117)
Q Consensus 177 L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~ 256 (1117)
|++|++++.+|..++.+++|++|++++| .+.
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n-------------------------------------------------~l~ 177 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGN-------------------------------------------------VLV 177 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccC-------------------------------------------------ccc
Confidence 8888777655554444443333333332 233
Q ss_pred ccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccC
Q 001238 257 GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLG 336 (1117)
Q Consensus 257 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~ 336 (1117)
+.+|..+.++++|++|+|++|.+++.+|..++++++|++|+|++|++.+.+|..++++++|++|+|++|.+++.+|..++
T Consensus 178 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 257 (968)
T PLN00113 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG 257 (968)
T ss_pred ccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh
Confidence 34555566666677777777777766777777777777777777777766676677777777777777777666666666
Q ss_pred CCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCccccccee
Q 001238 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAV 416 (1117)
Q Consensus 337 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 416 (1117)
++++|++|+|++|.+.+.+|..+.++++|++|++++|.+.+.+|..+.++++|+.|++++|.+++.+|..+..+++|+.|
T Consensus 258 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L 337 (968)
T PLN00113 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVL 337 (968)
T ss_pred CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEE
Confidence 66677777777666666666666666666666666666666555555555555555555555554444444444455555
Q ss_pred ecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCC
Q 001238 417 DLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLT 496 (1117)
Q Consensus 417 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 496 (1117)
+|++ |++.+.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|++.
T Consensus 338 ~L~~------------------------n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~ 393 (968)
T PLN00113 338 QLWS------------------------NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393 (968)
T ss_pred ECcC------------------------CCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEec
Confidence 5544 4444444555555555555555555555555555555556666666666666
Q ss_pred CCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccc
Q 001238 497 GSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLG 576 (1117)
Q Consensus 497 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 576 (1117)
+.+|..+..+++|+.|++++|++++.+|..|..++.|+.|++++|.+.+..+..+..+++|+.|+|++|++.+.+|..+.
T Consensus 394 ~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~ 473 (968)
T PLN00113 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473 (968)
T ss_pred ccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc
Confidence 66666666666666666666666666666666666666666666666666666666777888888888888888887664
Q ss_pred cccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch-hhhcccceE
Q 001238 577 SCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF-LAELQNLVV 655 (1117)
Q Consensus 577 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~-l~~l~~L~~ 655 (1117)
..+|+.||+++|++++.+|..+..++++ +.|+|++|++++.+|..+..+++|++|||++|++++.+|. +..+++|+.
T Consensus 474 -~~~L~~L~ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 551 (968)
T PLN00113 474 -SKRLENLDLSRNQFSGAVPRKLGSLSEL-MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551 (968)
T ss_pred -cccceEEECcCCccCCccChhhhhhhcc-CEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCE
Confidence 5899999999999999999999999998 7999999999999999999999999999999999997765 889999999
Q ss_pred EEeecccccCCCCCC-cccccCCcccccCCCCCC
Q 001238 656 LNVSHNNFSGRVPDT-PFFAKLPLSVLSGNPSLC 688 (1117)
Q Consensus 656 L~ls~N~l~~~~p~~-~~~~~~~~~~~~gN~~~c 688 (1117)
|||++|+++|.+|.. ..+..+....+++|+..+
T Consensus 552 L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred EECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 999999999999974 346677888899998775
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=440.75 Aligned_cols=291 Identities=43% Similarity=0.755 Sum_probs=248.6
Q ss_pred CccchhhccchhhHHHhccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceE
Q 001238 758 PWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRL 837 (1117)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 837 (1117)
+...+.|+ ++..+|++|...++||+|+||.||+|...+|+.||||++.........+|.+|++++.+++|||+|++
T Consensus 61 ~~~~fs~~----el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYD----ELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHH----HHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccE
Confidence 44556666 88999999999999999999999999999999999998876543314569999999999999999999
Q ss_pred EeeeecCC-ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc
Q 001238 838 LGWGANRK-TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE 916 (1117)
Q Consensus 838 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 916 (1117)
+|||.+.+ +.++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.|.||||||||+|||+|++++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 99999999 599999999999999999986543 6899999999999999999999999889999999999999999999
Q ss_pred ceeccccccccccC-CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCC-CChhHHH
Q 001238 917 SCLADFGLARLVED-DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFP-DGQHVIQ 994 (1117)
Q Consensus 917 ~kl~DfGla~~~~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~-~~~~~~~ 994 (1117)
+||+|||+|+.... .. ...+...||.+|+|||++..+..+.|+|||||||++.|+++|+.|.+...+ ....+..
T Consensus 216 aKlsDFGLa~~~~~~~~----~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~ 291 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDT----SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE 291 (361)
T ss_pred EEccCccCcccCCcccc----ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence 99999999976543 11 111111799999999999999999999999999999999999999876442 3445888
Q ss_pred HHHHHHhcCCCCccccCcccC-CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 995 WVRDHLKSKKDPVEVLDPKLQ-GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
|+...+... ...+.+|+.+. +.... ..++.+.+.++..|++.+|.+||+|.+|+++|+.+...
T Consensus 292 w~~~~~~~~-~~~eiiD~~l~~~~~~~-~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 292 WAKPLLEEG-KLREIVDPRLKEGEYPD-EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHCc-chhheeCCCccCCCCCh-HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 887777665 78899999987 44332 26677778899999999999999999999999665543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=399.47 Aligned_cols=259 Identities=33% Similarity=0.526 Sum_probs=211.8
Q ss_pred CCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccc--hHHHHHHHHHHhccCCCCcceEEeeeecCC-ceEEEEEec
Q 001238 778 LTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIS--TGAFSSEIATLSRIRHRNIVRLLGWGANRK-TKLLFYDYM 854 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~ 854 (1117)
+.+.+.+|+|+||+||+|.+.....||||++...+... .++|.+|+.++.+++|||||+++|+|.+.. ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 44456699999999999999554459999998653222 458999999999999999999999999987 799999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc-eeeeccccCeEEEcCCC-cceeccccccccccCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA-ILHRDVKSHNILLGERY-ESCLADFGLARLVEDDS 932 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivHrDlkp~Nill~~~~-~~kl~DfGla~~~~~~~ 932 (1117)
++|+|.++++.. ..+.+++..++++|.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999874 235599999999999999999999999 7 99999999999999997 99999999998765421
Q ss_pred CCccccCCccccccccCChhhhc--cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYAN--MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
...+...||++|||||++. ...|+.|+||||||+++|||+||+.||....+ .+.+........
T Consensus 199 ----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~~~------ 263 (362)
T KOG0192|consen 199 ----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVGGL------ 263 (362)
T ss_pred ----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCC------
Confidence 2333468999999999999 67999999999999999999999999975322 222222222221
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
.|.++...+..+..+++. ||+.||++||++.+++..|+.+.....
T Consensus 264 Rp~~p~~~~~~l~~l~~~------CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMER------CWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCCccCCHHHHHHHHH------hCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 133344355566666655 999999999999999999998876544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=379.78 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=215.2
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCc-eEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT-KLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv~e~ 853 (1117)
+.+..+.||+|..|+||+++++ +++.+|+|++... +....+++.+|++++++.+||+||.+||.|...+. ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3455678999999999999864 6889999999543 44456789999999999999999999999999984 9999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|++|+|++++... +.+++....+++.+|++||.|||+ + +||||||||+|||+...|++||||||.++.+...
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999865 459999999999999999999996 5 9999999999999999999999999999987642
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
...+++||..|||||.+++..|+.++||||||++++|+++|+.||....+......+.+..+....+ |
T Consensus 233 -----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-------P 300 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-------P 300 (364)
T ss_pred -----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-------C
Confidence 4457899999999999999999999999999999999999999997643334456666666655432 3
Q ss_pred ccCCC-CchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1013 KLQGH-PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1013 ~l~~~-~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.++.. ++.+.+.++.. |+++||.+||+++|+++.
T Consensus 301 ~lP~~~fS~ef~~FV~~------CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSC------CLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHH------HhcCCcccCCCHHHHhcC
Confidence 44443 77778888877 999999999999999873
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=376.32 Aligned_cols=199 Identities=33% Similarity=0.468 Sum_probs=179.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
..+|.+.+.||+|+||+||+|+++ ++..||||.+... .+...+.+..|+++++.++|||||++++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 456888889999999999999854 5899999999765 4445667889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC------Ccceecccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER------YESCLADFGLA 925 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~------~~~kl~DfGla 925 (1117)
|||.||+|.++++... .+++++++.++.|+|.||++||++ +||||||||+|||++.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999763 499999999999999999999999 99999999999999864 45799999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
|.+... ....+.+|++-|||||++...+|+.|+|+||+|+++|||++|+.||+.
T Consensus 163 R~L~~~-----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQPG-----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCch-----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 998743 234567999999999999999999999999999999999999999975
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=396.28 Aligned_cols=480 Identities=28% Similarity=0.450 Sum_probs=407.6
Q ss_pred ccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCc
Q 001238 94 FTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLT 173 (1117)
Q Consensus 94 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~ 173 (1117)
...-..++.|++++|.++ .+.+.+.+|..|++|++++|+++ ..|.+++.+..++.|+.++|+++ .+|..++++.+|+
T Consensus 41 wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~ 117 (565)
T KOG0472|consen 41 WWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLV 117 (565)
T ss_pred hhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhh
Confidence 344456778899999998 56667899999999999999998 88999999999999999999998 8999999999999
Q ss_pred EEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccc
Q 001238 174 QLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTA 253 (1117)
Q Consensus 174 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~ 253 (1117)
.|++++|++. ++|++++.+..|+.++..+|+. .++|..++++.+|..+++.+|.+....|..+. |+.|+.|+...|
T Consensus 118 ~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i--~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N 193 (565)
T KOG0472|consen 118 KLDCSSNELK-ELPDSIGRLLDLEDLDATNNQI--SSLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSN 193 (565)
T ss_pred hhhcccccee-ecCchHHHHhhhhhhhcccccc--ccCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchh
Confidence 9999999998 6899999999999999998876 47899999999999999999999876665555 999999999888
Q ss_pred cccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCC-CCCCCCEEEcCCCcCCCCCc
Q 001238 254 LLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELG-NCSQLSIIDISMNSLTGSIP 332 (1117)
Q Consensus 254 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~LdLs~N~l~~~~p 332 (1117)
.+ +.+|++++.+.+|.-|||..|+|. .+| .|..+..|++|+++.|+|. .+|.+.. ++.+|.+|||..|+++ ..|
T Consensus 194 ~L-~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~P 268 (565)
T KOG0472|consen 194 LL-ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVP 268 (565)
T ss_pred hh-hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCc
Confidence 66 578999999999999999999999 677 7999999999999999998 6666654 8999999999999999 789
Q ss_pred cccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccc--cchHHHHh--ccccccc-------
Q 001238 333 QTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNL--SNLTLLFV--WHNRLEG------- 401 (1117)
Q Consensus 333 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L--~~N~l~~------- 401 (1117)
+.++-+++|++||+|+|.|+ ..|..++++ .|+.|.+.+|.+..+-.+.+..- .-|++|.= ..-.++.
T Consensus 269 de~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~ 346 (565)
T KOG0472|consen 269 DEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTET 346 (565)
T ss_pred hHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccc
Confidence 99999999999999999999 677889999 99999999999873222222111 12444432 1111110
Q ss_pred --c-CCC---CCCcccccceeecccccccCCCcccccCCCC---CCeeeccCccCCCCCCCCcccccccceeccCCCccc
Q 001238 402 --E-IPP---SISNCQNLEAVDLSQNGLTGPIPRGIFQLKK---LNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT 472 (1117)
Q Consensus 402 --~-~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 472 (1117)
. .+. ....+.+.+.|+++.-+++ .+|...+.-.+ ....+++.|++. .+|..+..++.+.+.-..+|+..
T Consensus 347 ~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 347 AMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred cCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc
Confidence 0 111 2234567889999999999 69998887665 889999999998 67888888887776555555555
Q ss_pred ccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcC
Q 001238 473 GFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLG 552 (1117)
Q Consensus 473 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~ 552 (1117)
+.+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|.|++. .+|.....+..|+.+-.++|+|+.+++..+.
T Consensus 425 sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~ 502 (565)
T KOG0472|consen 425 SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLK 502 (565)
T ss_pred ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhh
Confidence 599999999999999999999998 78999999999999999999999 7899999999999999999999999999999
Q ss_pred CCccccEEeccccccCCCCCcccccccceeEEeccccccc
Q 001238 553 SLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS 592 (1117)
Q Consensus 553 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 592 (1117)
++.+|..|+|.+|.|. .+|..+++|++|++|++++|.|.
T Consensus 503 nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 503 NMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 9999999999999998 68888999999999999999998
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=403.83 Aligned_cols=528 Identities=29% Similarity=0.422 Sum_probs=341.2
Q ss_pred eEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCC
Q 001238 102 RLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQ 181 (1117)
Q Consensus 102 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~ 181 (1117)
.|+++++.+. ..|.++.++. ..+|+ -+.+..-..|+.|++++|.++ .+-..+.+|..|.+|++++|+
T Consensus 13 ~lnlsnr~l~-~vp~~vyq~~----------~t~~e-~e~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~ 79 (565)
T KOG0472|consen 13 SLNLSNRSLK-DVPTEVYQIN----------LTTGE-GENWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNK 79 (565)
T ss_pred ccccccchhh-hccHHHHHHH----------hhccc-hhhhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccch
Confidence 4566666665 6777777654 11222 234555667899999999998 666778899999999999999
Q ss_pred CCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCc
Q 001238 182 LTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPP 261 (1117)
Q Consensus 182 l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~ 261 (1117)
++ ..|++++.+.+++.|+.++|+. ..+|.+++++.+|+.+++++|.+.. +|+.++
T Consensus 80 l~-~lp~aig~l~~l~~l~vs~n~l--s~lp~~i~s~~~l~~l~~s~n~~~e-l~~~i~--------------------- 134 (565)
T KOG0472|consen 80 LS-QLPAAIGELEALKSLNVSHNKL--SELPEQIGSLISLVKLDCSSNELKE-LPDSIG--------------------- 134 (565)
T ss_pred hh-hCCHHHHHHHHHHHhhcccchH--hhccHHHhhhhhhhhhhccccceee-cCchHH---------------------
Confidence 98 6888999999999999999875 4678888888888888888777763 344444
Q ss_pred CCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCc
Q 001238 262 ELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSL 341 (1117)
Q Consensus 262 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L 341 (1117)
.+..|..|+..+|+++ ..|..++++.+|..|++.+|+++.. |+..-+++.|++||...|.++ .+|..++.+.+|
T Consensus 135 ---~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L 208 (565)
T KOG0472|consen 135 ---RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE-TLPPELGGLESL 208 (565)
T ss_pred ---HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh-cCChhhcchhhh
Confidence 4444444444444444 3444444444455555555554422 222222445555555555444 344445555555
Q ss_pred ceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccc-cccchHHHHhccccccccCCCCCCcccccceeeccc
Q 001238 342 QELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG-NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQ 420 (1117)
Q Consensus 342 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 420 (1117)
+-|+|.+|+|. ..| .|.+++.|++|+++.|+|. .+|.+.+ +++++..|||.+|++. +.|+.++.+++|+.||+|+
T Consensus 209 ~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSN 284 (565)
T KOG0472|consen 209 ELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSN 284 (565)
T ss_pred HHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccC
Confidence 55555555554 333 4444555555555555554 3333332 4445555555555554 4444455555555555555
Q ss_pred ccccCCCcccccCCCCCCeeeccCccCCCCCCCCccc--ccccceecc-------CCC---c-----ccccCCCCcCCCC
Q 001238 421 NGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGN--CSSLIRFRA-------NSN---K-----LTGFIPPEIGNLK 483 (1117)
Q Consensus 421 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~l-------~~N---~-----l~~~~~~~~~~l~ 483 (1117)
|.|+ ..|..++++ .|+.|-+.+|.+..+--+.+.. -.-|++|+= +.- + ...........+.
T Consensus 285 N~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i 362 (565)
T KOG0472|consen 285 NDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAII 362 (565)
T ss_pred Cccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhh
Confidence 5554 244444444 4555555555444221111110 001222211 000 0 0001111233456
Q ss_pred CCCEEEccCCcCCCCCCcccccCC---CCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEE
Q 001238 484 NLNFLDLGSNRLTGSIPDEITGCR---NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKL 560 (1117)
Q Consensus 484 ~L~~L~Ls~N~l~~~~p~~~~~l~---~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 560 (1117)
+.+.|+++.-+++ .+|+...... -.+..+++.|++. .+|..+..+..+...-+..|++.++.+..++.+++|+.|
T Consensus 363 ~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L 440 (565)
T KOG0472|consen 363 TTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFL 440 (565)
T ss_pred hhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceee
Confidence 7899999999999 5666654433 3889999999999 688889988888776555555566778889999999999
Q ss_pred eccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccc
Q 001238 561 VLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNEL 640 (1117)
Q Consensus 561 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l 640 (1117)
+|++|.+. .+|..++.+..|+.||+|.|+|. .+|..+..+..+ +.+-.+.|++....|..+.+|.+|.+|||.+|.+
T Consensus 441 ~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~l-Etllas~nqi~~vd~~~l~nm~nL~tLDL~nNdl 517 (565)
T KOG0472|consen 441 DLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTL-ETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDL 517 (565)
T ss_pred ecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHH-HHHHhccccccccChHHhhhhhhcceeccCCCch
Confidence 99999987 68888999999999999999998 899888777666 6677778999988888899999999999999999
Q ss_pred cCCcchhhhcccceEEEeecccccCCCCCCcc-cccCCcccccCCC
Q 001238 641 SGDLHFLAELQNLVVLNVSHNNFSGRVPDTPF-FAKLPLSVLSGNP 685 (1117)
Q Consensus 641 ~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~~~-~~~~~~~~~~gN~ 685 (1117)
...+|.++++++|++|++++|+|+ .+|.... ..+....+|.+++
T Consensus 518 q~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrdr 562 (565)
T KOG0472|consen 518 QQIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILSYLRDR 562 (565)
T ss_pred hhCChhhccccceeEEEecCCccC-CCHHHHhccChHHHHHHhccc
Confidence 999999999999999999999999 3333222 2344444455544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=372.81 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=199.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCC-------ccchHHHHHHHHHHhccCCCCcceEEeeeecCCc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASD-------KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 846 (1117)
.+.|.+.+.||+|+||.|-+|. .++|+.||||++.+.. ......+++|+++|++++|||||++++++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3467889999999999999986 5679999999997532 1122346799999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC---Ccceecccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER---YESCLADFG 923 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfG 923 (1117)
.|+||||++||+|.+.+-.+. .+.++....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999987764 377888899999999999999999 99999999999999765 788999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCC---CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHH
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI---SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
+|+..... .-..+++||+.|.|||++..+.+ ..++|+||+||++|-+++|.+||.+...+ ..+.+.+.
T Consensus 325 lAK~~g~~-----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-~sl~eQI~--- 395 (475)
T KOG0615|consen 325 LAKVSGEG-----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-PSLKEQIL--- 395 (475)
T ss_pred hhhccccc-----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-ccHHHHHh---
Confidence 99987632 34567899999999999976543 34889999999999999999999764333 22222222
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+...... |......++... .++.+++..||++||++.|+++
T Consensus 396 ~G~y~f~----p~~w~~Iseea~------dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAFG----PLQWDRISEEAL------DLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCccccc----ChhhhhhhHHHH------HHHHHhhEeCcccCcCHHHHhc
Confidence 2221111 111222222333 3445588899999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=385.58 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=211.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.+|..++.||+|||+.||+++. .+|+.||+|++.+. .....+.+.+||++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999986 78999999999763 3445677899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|+|+.++|..++++. +.+++.+++.+++||+.||.|||++ +|+|||||..|++++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999854 4599999999999999999999999 9999999999999999999999999999988754
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. ....+.+|||.|.|||++....++..+||||+|||+|.|+.|++||+. ..+.+...++.....
T Consensus 172 ~----Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-----k~vkety~~Ik~~~Y------- 235 (592)
T KOG0575|consen 172 G----ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-----KTVKETYNKIKLNEY------- 235 (592)
T ss_pred c----cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-----chHHHHHHHHHhcCc-------
Confidence 3 244578999999999999999999999999999999999999999964 234444444333322
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++.......+++++. .++.+|.+||++++|+.
T Consensus 236 -~~P~~ls~~A~dLI~~------lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 -SMPSHLSAEAKDLIRK------LLRPNPSERPSLDEVLD 268 (592)
T ss_pred -ccccccCHHHHHHHHH------HhcCCcccCCCHHHHhc
Confidence 1223444455666665 88999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=379.20 Aligned_cols=257 Identities=32% Similarity=0.546 Sum_probs=210.4
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
.++.++.||+|-||+||.|.+.....||+|.++.. ....++|.+|+++|++++|++||+++++|..++..|||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 35566889999999999999977779999999865 34567899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.++++... .+.+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+||...++ .+
T Consensus 286 GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~---~Y 358 (468)
T KOG0197|consen 286 GSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD---EY 358 (468)
T ss_pred CcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC---ce
Confidence 99999999733 34588999999999999999999999 9999999999999999999999999999955433 23
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......-...|.|||.+....++.|||||||||++|||+| |+.||... ...++.+.+. +.... |.-.
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--sn~ev~~~le---~GyRl------p~P~ 427 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--SNEEVLELLE---RGYRL------PRPE 427 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--CHHHHHHHHh---ccCcC------CCCC
Confidence 33344445678999999999999999999999999999999 99998653 2223333333 22211 1212
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.++ ..+-+++.. ||+.+|++|||++.+...++++...
T Consensus 428 ~CP-~~vY~lM~~------CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 428 GCP-DEVYELMKS------CWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCC-HHHHHHHHH------HhhCCcccCCCHHHHHHHHHHhhhc
Confidence 333 344444444 9999999999999999999887643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=354.97 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=204.2
Q ss_pred CCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEe-eeecCCc-eEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLG-WGANRKT-KLLFY 851 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lv~ 851 (1117)
.|.+.++||+|.||+||++. ..+|..||.|.+.-. +....+....|+.++++++|||||++++ -+.++.+ .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 57888999999999999986 678999999988733 3344566888999999999999999998 3444444 78999
Q ss_pred EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eeeeccccCeEEEcCCCcceeccccccccc
Q 001238 852 DYMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA--ILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
|||.+|+|...++.- .....+++.++++++.|+++||..+|.+ .|+ |+||||||.||+++.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999988763 2334699999999999999999999994 235 999999999999999999999999999998
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
... .......+|||.||+||.+.+..|+.|+||||+||++|||+.-+.||.+ ....+..+++.+.+.
T Consensus 179 ~s~----~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-----~n~~~L~~KI~qgd~---- 245 (375)
T KOG0591|consen 179 SSK----TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-----DNLLSLCKKIEQGDY---- 245 (375)
T ss_pred cch----hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-----ccHHHHHHHHHcCCC----
Confidence 643 2344578999999999999999999999999999999999999999975 244444444433321
Q ss_pred ccCcccC-CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1009 VLDPKLQ-GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1009 ~~~~~l~-~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
|.++ ..++..+.+++.. |+..||+.||+...+++.+
T Consensus 246 ---~~~p~~~YS~~l~~li~~------ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 ---PPLPDEHYSTDLRELINM------CIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ---CCCcHHHhhhHHHHHHHH------HccCCcccCCCcchHHHHH
Confidence 1222 3344555655555 9999999999854444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=361.27 Aligned_cols=248 Identities=28% Similarity=0.388 Sum_probs=207.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.++||+|+||+||.++.+ +++.+|+|++++.. ..+.+...+|..++.+++||.||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357899999999999999999754 58899999997653 23456688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
+||+.||.|...+++. +.++++.+.-++.+|+.||.|||++ +|||||+||+|||+|++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999875 4489999999999999999999999 999999999999999999999999999996544
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.+ ....+++||+.|||||++....|+.++|.||+|+++|||++|.+||.+ ....++.....+.+.
T Consensus 178 ~~----~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-----~~~~~~~~~I~~~k~------ 242 (357)
T KOG0598|consen 178 DG----DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-----EDVKKMYDKILKGKL------ 242 (357)
T ss_pred CC----CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-----ccHHHHHHHHhcCcC------
Confidence 32 244568999999999999999999999999999999999999999964 345566666655541
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC----CHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP----TMKDVA 1050 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP----s~~~v~ 1050 (1117)
+..+...+...+.+++. .+..+|++|- ++.+|.
T Consensus 243 -~~~p~~ls~~ardll~~------LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 243 -PLPPGYLSEEARDLLKK------LLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred -CCCCccCCHHHHHHHHH------HhccCHHHhcCCCCChHHhh
Confidence 12233344455566555 6778999995 455543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=364.80 Aligned_cols=270 Identities=22% Similarity=0.358 Sum_probs=218.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecC---CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRAS---DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|..++.||+|+|++||+|+ ..+++.||||++.+. .+...+-+.+|-.+|.+| .||.|++++-.|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4578999999999999999997 456899999998653 223345577899999999 89999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
|+||+++|+|.++++.. |.+++..++.++.+|+.||+|||++ |||||||||+|||+|++++++|+|||-|+.+.
T Consensus 152 vLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999875 5599999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCC---------ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHH
Q 001238 930 DDSGG---------SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 930 ~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
+.... .......++||..|.+||++.....++.+|+||||||+|+|+.|++||.+. .....+++++
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-----NeyliFqkI~ 300 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-----NEYLIFQKIQ 300 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-----cHHHHHHHHH
Confidence 54332 111125699999999999999999999999999999999999999999752 2333444444
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH-------HHhhhcCCCCCCCCCCC
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL-------LREIRQEPASGSEAHKP 1069 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~-------L~~~~~~~~~~~~~~~~ 1069 (1117)
.... .++..++..+.++++. .+..||.+|++..+|.+. ++.+.+..++.-.+..+
T Consensus 301 ~l~y--------~fp~~fp~~a~dLv~K------LLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p 362 (604)
T KOG0592|consen 301 ALDY--------EFPEGFPEDARDLIKK------LLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKP 362 (604)
T ss_pred Hhcc--------cCCCCCCHHHHHHHHH------HHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCC
Confidence 4332 3344455566666666 667799999999988773 34455544444444333
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=382.25 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=214.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
.+....+.||+|+||+||+|+. ++...||||.++..... ..++|++|++++..++|||||+++|.|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 4566678899999999999874 24568999999876555 6788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcc
Q 001238 849 LFYDYMPNGTLGMLLHDGEC-----------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 917 (1117)
+|+|||..|+|.++|....+ .++++..+.+.||.|||.|++||-++ .+|||||..+|+||+++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 99999999999999975321 23478899999999999999999999 99999999999999999999
Q ss_pred eeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHH
Q 001238 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 918 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~ 996 (1117)
||+|||++|.+...+ .++....-.-.++|||||.+..++++++|||||||||+||+++ |+.||.+. ..+++.+.+
T Consensus 643 KIsDfGLsRdiYssD--YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl--Sn~EVIe~i 718 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSD--YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL--SNQEVIECI 718 (774)
T ss_pred Eecccccchhhhhhh--hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc--chHHHHHHH
Confidence 999999999876533 2333334455789999999999999999999999999999999 99999753 334455544
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
++ +.- .+. +...+..+.+++. .||+..|.+||+++||...|+...+...
T Consensus 719 ~~----g~l-----L~~-Pe~CP~~vY~LM~------~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 719 RA----GQL-----LSC-PENCPTEVYSLML------ECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred Hc----CCc-----ccC-CCCCCHHHHHHHH------HHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 43 211 112 2233334444443 4999999999999999999998765433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=349.79 Aligned_cols=261 Identities=26% Similarity=0.363 Sum_probs=211.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.+.|++.+.||.|..++||+|+ .+.++.||||++.-++.. ..+.+++|+..|+.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4578889999999999999997 567899999999765433 35789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
||.+|++.++++.....| +++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+.+.+
T Consensus 105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999998876555 89999999999999999999999 99999999999999999999999999987776644
Q ss_pred CCccccC-CccccccccCChhhhc--cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc-
Q 001238 933 GGSFSAN-PQFAGSYGYIAPEYAN--MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE- 1008 (1117)
Q Consensus 933 ~~~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1008 (1117)
.+.... ..++||+.|||||++. ...|+.|+||||||++..||++|..||....+ .+.+...++..+....
T Consensus 181 -~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-----mkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 181 -DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-----MKVLLLTLQNDPPTLLT 254 (516)
T ss_pred -ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-----HHHHHHHhcCCCCCccc
Confidence 332333 7789999999999854 35799999999999999999999999975432 2333333333321111
Q ss_pred -ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 -VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 -~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+.+-...++...++|+.. |++.||++|||+++++.
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~------CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIAL------CLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHH------HhhcCcccCCCHHHHhc
Confidence 11112122233345555554 99999999999999865
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=355.04 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=208.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCC--ceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRK--TKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e 852 (1117)
.+|..++.||+|+||+||++... +|+..|||.+...+....+.+.+|++++++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35777899999999999999854 48999999987654333667899999999999999999999755554 5889999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-CCcceeccccccccccCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-RYESCLADFGLARLVEDD 931 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~~~ 931 (1117)
|+++|+|.+++.+... .+++..++++++||++||+|||++ |||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~- 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES- 170 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc-
Confidence 9999999999987642 599999999999999999999999 9999999999999999 79999999999987653
Q ss_pred CCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
..........+.||+.|||||++..+ ...+++||||+||++.||+||++||... .....++-...... .
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~------~ 240 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGRED------S 240 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccC------C
Confidence 11122334467899999999999854 3446999999999999999999999642 11222222222222 1
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
.|.++...+...++++.. |+..+|++||||.++++..-...
T Consensus 241 ~P~ip~~ls~~a~~Fl~~------C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRK------CFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCCCCcccCHHHHHHHHH------HhhcCcccCcCHHHHhhChhhhc
Confidence 235555666677888877 99999999999999988654433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=335.07 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=198.9
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.|+...++|+|+||+||+++.+ +|+.||||++.... +.-.+-..+|++++++++|+|+|.++.+|......++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 5677788999999999999865 59999999997543 22334567999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
|+..-|.++ .+.. .| ++...+.++++|++.|+.|+|++ ++|||||||+|||++.+|.+||||||+|+.+...+
T Consensus 83 ~dhTvL~eL-e~~p-~G-~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 83 CDHTVLHEL-ERYP-NG-VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred cchHHHHHH-Hhcc-CC-CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 987655554 3332 23 78899999999999999999999 99999999999999999999999999999887422
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHH----------HHHhc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR----------DHLKS 1002 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~----------~~~~~ 1002 (1117)
...+..+.|.+|.|||.+-+ ..|+..+||||+||++.||++|.+-|.+....+ .+..+.+ ..+..
T Consensus 156 ---d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-QLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 156 ---DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-QLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred ---chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-HHHHHHHHHcccCHHHHHHhcc
Confidence 24556789999999998765 899999999999999999999999987643322 2222111 11111
Q ss_pred CCCCccccCcccCCCCchhHHHH----HHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1003 KKDPVEVLDPKLQGHPDTQIQEM----LQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1003 ~~~~~~~~~~~l~~~~~~~~~~~----l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+.+..+.-|.... +....+.+ --.+.++..|++.||++|++.++++.
T Consensus 232 N~~F~Gv~lP~~~~-~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEH-PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCceeeeecCCCCC-ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111121111 11111111 12345667799999999999998864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=346.08 Aligned_cols=268 Identities=29% Similarity=0.413 Sum_probs=199.2
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhc--cCCCCcceEEeeeecCC----ceEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSR--IRHRNIVRLLGWGANRK----TKLLF 850 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lv 850 (1117)
.....+.||+|+||.||||.. +++.||||++.... .+.|++|-++++. ++|+||++++++-.... ++++|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 456678899999999999998 55899999997543 4567777776554 58999999999866554 78999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC------CCceeeeccccCeEEEcCCCcceeccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC------VPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
+||.+.|+|.++++.+. ++|....+|+..+++||+|||+.. +|+|+|||||++||||..|+++.|+|||+
T Consensus 287 t~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999864 899999999999999999999863 57999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCC------CCcCCCeeehhhhHHHHHhCCCCCC------------CCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK------ISEKSDVYSYGVVLLEIITGKKPVD------------ASF 986 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlG~vl~ell~g~~P~~------------~~~ 986 (1117)
|..+...... ......+||.+|||||++.+.- .-.+.||||+|.|+|||+++..-++ ...
T Consensus 363 Al~~~p~~~~--~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 363 ALRLEPGKPQ--GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred eEEecCCCCC--cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9988754332 2333479999999999987532 2247999999999999999754332 111
Q ss_pred CCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 987 PDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
.....+.+...-.++++.++ ...+.-........+.+ ....||+.||+.|-|+.-|.+.+.++.....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP-~~p~~W~~h~~~~~l~e------t~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRP-KIPDAWRKHAGMAVLCE------TIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cCCCCHHHHHHHHHhhccCC-CChhhhhcCccHHHHHH------HHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 11222333322223332221 11111111222223333 4445999999999999999998887765443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.82 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=216.7
Q ss_pred CCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
..++.++||.|.||+||+|+++ ....||||.++.... ....+|..|+.+|.++.||||+++.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567889999999999999864 245799999987643 34557999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|||++|+|+.+|+.++ +.+++.+...+.++||.|+.||-+. ++|||||.++||||+.+..+|++|||++|.+.++
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999999876 5599999999999999999999999 9999999999999999999999999999988776
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
....+..... .-..+|.|||.+..++++.++||||||+|+||.++ |.+||-+. ..+++...+.+.++..
T Consensus 785 ~~~~ytt~GG-KIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--SNQdVIkaIe~gyRLP------- 854 (996)
T KOG0196|consen 785 PEAAYTTLGG-KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVIKAIEQGYRLP------- 854 (996)
T ss_pred CCccccccCC-ccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--chHHHHHHHHhccCCC-------
Confidence 5332222211 12468999999999999999999999999999888 99999643 3444555444433221
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCCCC
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEA 1066 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~ 1066 (1117)
.-.+++.... ++++.||++|-.+||.+.+|+..|+++...+.+-...
T Consensus 855 --pPmDCP~aL~-------qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~ 901 (996)
T KOG0196|consen 855 --PPMDCPAALY-------QLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTI 901 (996)
T ss_pred --CCCCCcHHHH-------HHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhccc
Confidence 1122333222 3455699999999999999999999998887765433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=354.57 Aligned_cols=264 Identities=21% Similarity=0.280 Sum_probs=204.9
Q ss_pred HhccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHH-HHHHHHHHhccC-CCCcceEEeeeecCC-ceE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA-FSSEIATLSRIR-HRNIVRLLGWGANRK-TKL 848 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~ 848 (1117)
...++|++.++||.|.||.||+|+ ..+|..||||+++..-....+. -.||+..++++. |||||++.+.+.+.+ ..|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 345689999999999999999997 4568999999998764433332 358999999998 999999999998888 999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+|||||+ .+|..+++++ ...+++.+++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.+
T Consensus 87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999994 6899999886 45699999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCCCCccccCCccccccccCChhhh-ccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYA-NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
... .+.+..+.|.+|+|||++ +.+.|+.+.||||+|||++|+.+-++-|.+... .+.+.++...-+.+.
T Consensus 161 ~Sk-----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-----~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 161 RSK-----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-----IDQIYKICEVLGTPD 230 (538)
T ss_pred ccC-----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-----HHHHHHHHHHhCCCc
Confidence 653 356678899999999976 568899999999999999999999998865321 111222221111121
Q ss_pred cccCc-----------ccCCCCchhHHHH-----HHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1008 EVLDP-----------KLQGHPDTQIQEM-----LQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1008 ~~~~~-----------~l~~~~~~~~~~~-----l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
+..++ .++......+..+ .+.+.++..|+++||++|||+++.++.
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111 1111111112211 133445556999999999999999884
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=359.83 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=213.5
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++....|+..++||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...++.|+|
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 4455678888999999999999986 457889999999877666667788999999999999999999999888999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
||||+||+|.+++.... +++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999998754 89999999999999999999999 999999999999999999999999999988865
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. ..+.+.+|||.|||||+.....|++|+||||||+|++||+.|++||-.. ...+.+......+ .+ +.
T Consensus 422 ~~----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE-----~PlrAlyLIa~ng-~P-~l- 489 (550)
T KOG0578|consen 422 EQ----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-----NPLRALYLIATNG-TP-KL- 489 (550)
T ss_pred cc----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-----ChHHHHHHHhhcC-CC-Cc-
Confidence 43 3566789999999999999999999999999999999999999999531 1122222222222 11 11
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+++++.. |+..|+++||++.|+++
T Consensus 490 --k~~~klS~~~kdFL~~------cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 --KNPEKLSPELKDFLDR------CLVVDVEQRASAKELLE 522 (550)
T ss_pred --CCccccCHHHHHHHHH------HhhcchhcCCCHHHHhc
Confidence 1123445677888887 99999999999999987
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.51 Aligned_cols=271 Identities=27% Similarity=0.387 Sum_probs=213.3
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhc--cCCCCcceEEeeeecCC----c
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSR--IRHRNIVRLLGWGANRK----T 846 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~ 846 (1117)
...++.++.+.||+|.||+||+|+| .|+.||||++...++ +.+.+|.++++. ++|+||..+++.-..+. +
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3456788999999999999999999 688999999987654 345667777665 59999999998754433 5
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcc-----CCCceeeeccccCeEEEcCCCcceecc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD-----CVPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
+++|.+|.+.|||.|+|.+.. ++.+..++++..+|+||++||.. +.|+|+|||||+.||||..++.+.|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 799999999999999998853 88999999999999999999965 579999999999999999999999999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhccCC------CCcCCCeeehhhhHHHHHhC----------CCCCCCC
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK------ISEKSDVYSYGVVLLEIITG----------KKPVDAS 985 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlG~vl~ell~g----------~~P~~~~ 985 (1117)
+|+|.......+.-.......+||.+|||||++...- .-..+||||||.|+||++.+ +.||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999887765555556667889999999999986532 23479999999999999874 5788766
Q ss_pred CCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 986 FPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
-+.++...++.+-... +.+.|.++..+. ....+....+++..||..+|.-|-|+-.+.+.+.++.+
T Consensus 440 Vp~DPs~eeMrkVVCv------~~~RP~ipnrW~-s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCV------QKLRPNIPNRWK-SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCHHHHhcceee------cccCCCCCcccc-cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 5555555444332221 123344444432 12334444567888999999999999999988888764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=349.25 Aligned_cols=262 Identities=27% Similarity=0.333 Sum_probs=209.3
Q ss_pred cCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecC--CceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 850 (1117)
..|+.+++||+|.||.||+|+ ..+|+.||+|+++... .....-..+||.+|+++.||||+++.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 356667889999999999997 5679999999997653 44455678999999999999999999988776 688999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
+|||++ +|.-++.... -.+++.++..++.|+++||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 197 FeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999975 7777776542 2389999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... ...+..+.|.+|.|||.+.+ ..|+.++|+||.|||+.||++|++.|++ ...++.+..+++.-+.+.+.
T Consensus 271 ~~~---~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G-----~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 271 SGS---APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG-----RTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred CCC---cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC-----ccHHHHHHHHHHHhCCCChh
Confidence 432 34677889999999997765 6899999999999999999999999964 34455666666665556555
Q ss_pred cCc--ccCC--------CCchhHHHHH-----HHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDP--KLQG--------HPDTQIQEML-----QALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~--~l~~--------~~~~~~~~~l-----~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++ .++. .+...+++.. ..+.+.-..+..||++|.|+.++++
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 555 2221 1122233332 2344555678889999999998876
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=366.83 Aligned_cols=318 Identities=21% Similarity=0.244 Sum_probs=234.2
Q ss_pred cEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccc
Q 001238 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVN 349 (1117)
Q Consensus 270 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N 349 (1117)
+.|+|.+|.|+..-.+.+..++.|+.|||+.|.|+.+.-..|..-.++++|+|++|+|+..-...|.++.+|..|.|++|
T Consensus 128 ~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrN 207 (873)
T KOG4194|consen 128 EKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRN 207 (873)
T ss_pred eEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccC
Confidence 33344444443333333444444444444444444333334444455666666666666555555666666666666666
Q ss_pred cccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcc
Q 001238 350 QISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPR 429 (1117)
Q Consensus 350 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 429 (1117)
+|+...+..|.++++|+.|+|..|+|.-..--.|.+|++|+.|.|..|+++..-...|..|.++++|+|+.|+++..-..
T Consensus 208 rittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g 287 (873)
T KOG4194|consen 208 RITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEG 287 (873)
T ss_pred cccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcc
Confidence 66655555666666666666666666633345677788888888888888777777788888888888888888876677
Q ss_pred cccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCC
Q 001238 430 GIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNL 509 (1117)
Q Consensus 430 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 509 (1117)
+++++..|+.|+|++|.|..+-++.+..+++|++|+|++|+|+...+..|..|..|++|+|++|++..+-..+|.++++|
T Consensus 288 ~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL 367 (873)
T KOG4194|consen 288 WLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSL 367 (873)
T ss_pred cccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhh
Confidence 88888888888888888888888888888899999999999988888888889999999999999987777888899999
Q ss_pred ceEEccCCccccccch---hhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEec
Q 001238 510 TFLDVHSNSIAGNLPA---GLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDL 586 (1117)
Q Consensus 510 ~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 586 (1117)
++|||++|.|+..+.+ .|..+++|+.|+|.+|+|+.|...+|.++.+|++|+|.+|.|..+.|++|..+ .|+.|.+
T Consensus 368 ~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 368 HKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred hhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence 9999999988876544 47788888888888888888888888888999999999998888888888888 7887776
Q ss_pred cc
Q 001238 587 SS 588 (1117)
Q Consensus 587 s~ 588 (1117)
..
T Consensus 447 nS 448 (873)
T KOG4194|consen 447 NS 448 (873)
T ss_pred cc
Confidence 44
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=358.96 Aligned_cols=259 Identities=31% Similarity=0.454 Sum_probs=201.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+.+.+.+.||+|.||+||+|+|.. .||||++.... ....++|+.|+.++++-+|.||+-+.|||..+.. .+|..+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 346778899999999999999843 79999998653 3345789999999999999999999999999887 899999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
|+|.+|..+++..+ ..++..+.+.||+|||+|+.|||.+ +|||||+|..||++.+++.|||+|||++..-..-.+
T Consensus 469 CeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred ccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999999765 3488999999999999999999999 999999999999999999999999999965433211
Q ss_pred CccccCCccccccccCChhhhcc---CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM---TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
........|...|||||+++. .+|++.+||||||+|+|||++|..||... ..++ +.-++. + +.-..+..
T Consensus 544 --~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dq-IifmVG---r-G~l~pd~s 615 (678)
T KOG0193|consen 544 --EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQ-IIFMVG---R-GYLMPDLS 615 (678)
T ss_pred --ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhh-eEEEec---c-cccCccch
Confidence 123334568889999999864 57899999999999999999999999732 1111 111110 1 10000100
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.........+.+++ ..||..++++||.+.+|+..|+.+..
T Consensus 616 --~~~s~~pk~mk~Ll------~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 616 --KIRSNCPKAMKRLL------SDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred --hhhccCHHHHHHHH------HHHHhcCcccCccHHHHHHHHHHhhh
Confidence 01112223344444 45999999999999999998888765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=350.33 Aligned_cols=246 Identities=29% Similarity=0.393 Sum_probs=206.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+..+ .+.+.+.+|++++++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46888899999999999999854 588999999876533 335568999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+.| +|..++... +.++++.+..++.++++||.|||+. +|+|||+||+|||+++.+.+|+||||+|+....
T Consensus 82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 9977 999999875 3499999999999999999999999 999999999999999999999999999997654
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.....+...|||-|||||...++.|+..+|+||+||++||+++|++||-. ..+.+.++.+.+....+.
T Consensus 153 --~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d~v~~p----- 220 (808)
T KOG0597|consen 153 --NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKDPVKPP----- 220 (808)
T ss_pred --CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcCCCCCc-----
Confidence 23455677899999999999999999999999999999999999999953 345555655554432221
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.........+++- -+..||.+|-+..+++.
T Consensus 221 ---~~~S~~f~nfl~g------LL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 221 ---STASSSFVNFLQG------LLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---ccccHHHHHHHHH------HhhcChhhcccHHHHhc
Confidence 1223344444444 56779999999988866
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.69 Aligned_cols=373 Identities=25% Similarity=0.240 Sum_probs=238.2
Q ss_pred cEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccc
Q 001238 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVN 349 (1117)
Q Consensus 270 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N 349 (1117)
+.|++++|++....+..|.++++|+++++..|.++ .+|.......+|+.|+|.+|.|+..-.+.+..++.|+.||||.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 44666666666555555666666666666666665 44544444445666666666666555555666666666666666
Q ss_pred cccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcc
Q 001238 350 QISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPR 429 (1117)
Q Consensus 350 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 429 (1117)
.|+.+.-..|..-.++++|+|++|.|+....+.|..+.+|..|.|+.|+++...+..|.+++.|+.|+|..|+|.-.---
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l 239 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL 239 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence 66644444455555566666666666655555666666666666666666655555566666666666666666521133
Q ss_pred cccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCC
Q 001238 430 GIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNL 509 (1117)
Q Consensus 430 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 509 (1117)
.|.++++|+.|.|..|+|+......|..+.++++|+|..|+++..-..++.+|+.|+.|+||+|.|..+-++...-.++|
T Consensus 240 tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL 319 (873)
T KOG4194|consen 240 TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL 319 (873)
T ss_pred hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc
Confidence 45556666666666666666666666666666666666666666666666667777777777777766666666666677
Q ss_pred ceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCC---CcccccccceeEEec
Q 001238 510 TFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSI---PSQLGSCVKLQLLDL 586 (1117)
Q Consensus 510 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L 586 (1117)
++|+|++|+|+...+..|..+..|+.|+|++|+|+.+...+|..+.+|++|+|++|.|...+ ...|..+++|+.|+|
T Consensus 320 ~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l 399 (873)
T KOG4194|consen 320 KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRL 399 (873)
T ss_pred eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheee
Confidence 77777777777666666777777777777777777776677777777777777777666433 234666777777777
Q ss_pred cccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcc
Q 001238 587 SSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLH 645 (1117)
Q Consensus 587 s~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~ 645 (1117)
.+|+|....-..|..+++| +.|||.+|.|..+-|.+|..| +|+.|-++.-.+-|++.
T Consensus 400 ~gNqlk~I~krAfsgl~~L-E~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 400 TGNQLKSIPKRAFSGLEAL-EHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQ 456 (873)
T ss_pred cCceeeecchhhhccCccc-ceecCCCCcceeecccccccc-hhhhhhhcccceEEecc
Confidence 7777764334556666666 677777777777777788887 78888777766766654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=353.78 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=207.9
Q ss_pred hccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecC----Cc-cchHHHHHHHHHHhccC-CCCcceEEeeeecCCc
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRAS----DK-ISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKT 846 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 846 (1117)
..+.|.+++.||+|+||+|+.|. ..+|+.||+|++... .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 35689999999999999999996 456899999977653 11 23456778999999998 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-Ccceecccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGLA 925 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla 925 (1117)
.|+||||+.||+|.+++... +++.+.++.++++|+++|++|+|++ +|+||||||+||+++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999873 4588999999999999999999999 99999999999999999 99999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCC-CC-cCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK-IS-EKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
..... ......+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+. .......+...+..
T Consensus 169 ~~~~~----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 169 AISPG----EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNVPNLYRKIRKGE 239 (370)
T ss_pred cccCC----CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccHHHHHHHHhcCC
Confidence 87631 113456789999999999999877 86 899999999999999999999975 23333333333332
Q ss_pred CCCccccCcccCCCC-chhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1004 KDPVEVLDPKLQGHP-DTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~-~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
... +... +.....+++. |+..+|.+|+++.+|. .-.-++
T Consensus 240 ~~~--------p~~~~S~~~~~Li~~------mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 240 FKI--------PSYLLSPEARSLIEK------MLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred ccC--------CCCcCCHHHHHHHHH------HcCCCcccCCCHHHHh-hChhhc
Confidence 222 2222 4456666665 9999999999999998 333333
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=315.80 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=207.1
Q ss_pred cCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCcc--chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKI--STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.+|...+++|+|.||.||+|+ .++|+.||||+++..... -.....+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 367778999999999999997 567999999999865322 12346789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
||+ .+|..++++.. -.+...++..++.++++|++|+|++ .|+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 58999998764 4589999999999999999999999 99999999999999999999999999999987543
Q ss_pred CCccccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
...+..+.|.+|.|||.+. .+.|+..+||||.|||+.||+.|.+-|.+. ...+.+...++.-+.+.+..+
T Consensus 156 ----~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-----sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 156 ----RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-----SDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred ----cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-----chHHHHHHHHHHcCCCCcccC
Confidence 2333448899999999765 578999999999999999999998877542 233344444444445554445
Q ss_pred cccCCCCchhH-H-------------HHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1012 PKLQGHPDTQI-Q-------------EMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1012 ~~l~~~~~~~~-~-------------~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
|++..-++... + .--..+++...++..+|.+|.+++|.+++
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 54433322110 0 00123445556899999999999998774
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=321.65 Aligned_cols=227 Identities=24% Similarity=0.323 Sum_probs=191.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccch---HHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKIST---GAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|...+.||.|+||.|..++.+ +|..+|+|++.+.+.... +...+|-.+++.+.||.++++++.+.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888899999999999999854 588999999987644333 34567999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||++||.|..++++. +++++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||.|+.+..
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999999875 3499999999999999999999999 999999999999999999999999999998753
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
..-+.+|||.|+|||+++.+.|..++|.|||||++|||+.|.+||.+.. ......+++..+-..
T Consensus 197 ------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~-----~~~iY~KI~~~~v~f----- 260 (355)
T KOG0616|consen 197 ------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN-----PIQIYEKILEGKVKF----- 260 (355)
T ss_pred ------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC-----hHHHHHHHHhCcccC-----
Confidence 2446799999999999999999999999999999999999999996532 245555555554333
Q ss_pred cccCCCCchhHHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQA 1028 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~ 1028 (1117)
+..++...+.+++.
T Consensus 261 ---P~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 261 ---PSYFSSDAKDLLKK 274 (355)
T ss_pred ---CcccCHHHHHHHHH
Confidence 33344445555544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=343.29 Aligned_cols=265 Identities=26% Similarity=0.414 Sum_probs=214.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccc-hHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIS-TGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.....++++||+|-||.|..+....+..||||+++...... ..+|.+|+++|.+++|||||+++|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 35677889999999999999998778999999998765433 47899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
|++|+|..++..+.... .......+|+.|||+|++||.+. ++||||+.++|+|+|+++++||+|||++|-+..+
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg-- 690 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG-- 690 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC--
Confidence 99999999999875433 45566788999999999999998 9999999999999999999999999999976543
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh--CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT--GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
..+......+-..+|||||.+.-+++++++|||+||+++||+++ .+.||... .++.+++-.......... .++.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l--t~e~vven~~~~~~~~~~--~~~l 766 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL--TDEQVVENAGEFFRDQGR--QVVL 766 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh--hHHHHHHhhhhhcCCCCc--ceec
Confidence 23344555677889999999999999999999999999999776 88999653 334455544444443322 2222
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
+.-+.++....+ +++.||..+.++||+++++...|.+.
T Consensus 767 ~~P~~cp~~lye-------lml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYE-------LMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHH-------HHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 232333333332 33449999999999999999988764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.98 Aligned_cols=241 Identities=27% Similarity=0.449 Sum_probs=199.1
Q ss_pred CCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCC
Q 001238 779 TAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGT 858 (1117)
Q Consensus 779 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 858 (1117)
...+.||.|+.|.||+|+. .++.||||+++.- -+.+|+.|++|+||||+.|.|+|.....+|+|||||+.|-
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3467899999999999998 5689999987632 2468999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcccc
Q 001238 859 LGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSA 938 (1117)
Q Consensus 859 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 938 (1117)
|..+++... .+.......+..+||.|+.|||.+ .|||||||.-||||..+..+||+|||.++...+. ..
T Consensus 199 L~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-----ST 267 (904)
T KOG4721|consen 199 LYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-----ST 267 (904)
T ss_pred HHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-----hh
Confidence 999998764 378888899999999999999999 9999999999999999999999999999987643 34
Q ss_pred CCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCC
Q 001238 939 NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018 (1117)
Q Consensus 939 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1018 (1117)
...++||..|||||+++..+.+.|+||||||||+|||+||..||.... .. .++.. .+. ..+.-.++...
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd---ss--AIIwG---VGs---NsL~LpvPstc 336 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD---SS--AIIWG---VGS---NSLHLPVPSTC 336 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc---hh--eeEEe---ccC---CcccccCcccC
Confidence 567899999999999999999999999999999999999999996421 11 01110 011 11111223334
Q ss_pred chhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1019 DTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1019 ~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
+.-+.-+++. ||+..|..||++++++..|+-
T Consensus 337 P~GfklL~Kq------cw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 337 PDGFKLLLKQ------CWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chHHHHHHHH------HHhcCCCCCccHHHHHHHHhh
Confidence 4455556665 999999999999999988763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=357.47 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=202.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCCc-cchHHHHHHHHHHhcc-CCCCcceEEeeeecCC-
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDK-ISTGAFSSEIATLSRI-RHRNIVRLLGWGANRK- 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~- 845 (1117)
.++|++.++||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45789999999999999999963 2357899999875432 2345688999999999 8999999999887644
Q ss_pred ceEEEEEecCCCChhhhhcCCCC---------------------------------------------------------
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGEC--------------------------------------------------------- 868 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 868 (1117)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999998865321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCcccccc
Q 001238 869 --AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946 (1117)
Q Consensus 869 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~ 946 (1117)
...+++.++.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....... ........+++
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~~ 240 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGSARLPL 240 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc--hhcccCCCCCc
Confidence 12377889999999999999999999 999999999999999999999999999986543211 11222345678
Q ss_pred ccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHH
Q 001238 947 GYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEM 1025 (1117)
Q Consensus 947 ~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 1025 (1117)
.|+|||++....++.++|||||||++|||++ |+.||...... .. +......... ...+...+..+.++
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~----~~~~~~~~~~------~~~~~~~~~~l~~l 309 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EE----FCQRLKDGTR------MRAPENATPEIYRI 309 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HH----HHHHHhcCCC------CCCCCCCCHHHHHH
Confidence 8999999998899999999999999999997 99999653221 11 1122222111 11122233344444
Q ss_pred HHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1026 LQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1026 l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
+ ..||+.||++||++.++++.|+++.++
T Consensus 310 i------~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 310 M------LACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred H------HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 4 459999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=348.91 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=210.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.-|+.++.||+|+.|.|..|++ .+|+.+|||++.+.. ......+++|+-+|+-+.||||+++|+++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4588899999999999999975 579999999997652 222456899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|.|.+++... |.+++.++.+++.||+.|+.|+|+. +|+|||+||+|+|+|.++.+||+|||+|.....+
T Consensus 92 Eyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999765 4589999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccCCccccccccCChhhhccCCCC-cCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKIS-EKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
....+-||++.|.|||++.+.+|+ .++||||+|||+|.|++|+.||++ +.+...+.+..++..
T Consensus 166 -----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV~~G~f------ 229 (786)
T KOG0588|consen 166 -----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKVQRGVF------ 229 (786)
T ss_pred -----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHHHcCcc------
Confidence 344567999999999999999986 899999999999999999999973 344444444444432
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.++...+...+.++.. ++..||++|-|++||.+.
T Consensus 230 --~MPs~Is~eaQdLLr~------ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 --EMPSNISSEAQDLLRR------MLDVDPSTRITTEEILKH 263 (786)
T ss_pred --cCCCcCCHHHHHHHHH------HhccCccccccHHHHhhC
Confidence 2344555677888777 788899999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=350.69 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=207.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC--C---cEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS--G---LTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
.+..+.++||+|+||.||+|+.+. + ..||||..+.. ......+|.+|+++|++++|||||++||++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 345566899999999999997532 2 23899998853 244567799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++|||+|+||+|.++++.... .++..++.+++.++|+||+|||++ +++||||.++|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999998643 489999999999999999999999 999999999999999999999999999886
Q ss_pred ccCCCCCccccCC-ccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 928 VEDDSGGSFSANP-QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 928 ~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
... +.... ...-..+|+|||.+....|++++|||||||++||+++ |..||.+. ...+....+......
T Consensus 312 ~~~-----~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~-----~~~~v~~kI~~~~~r 381 (474)
T KOG0194|consen 312 GSQ-----YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM-----KNYEVKAKIVKNGYR 381 (474)
T ss_pred Ccc-----eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC-----CHHHHHHHHHhcCcc
Confidence 531 11111 2235679999999999999999999999999999999 89999653 222222222122211
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~~ 1062 (1117)
...+...+..++.+... ||..+|++||+|.++.+.++.+......
T Consensus 382 ------~~~~~~~p~~~~~~~~~------c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 382 ------MPIPSKTPKELAKVMKQ------CWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ------CCCCCCCHHHHHHHHHH------hccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11122334455555544 9999999999999999999998766553
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.26 Aligned_cols=249 Identities=28% Similarity=0.403 Sum_probs=211.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
...|+..+.||+|.||.||+|. ...++.||+|++.-. .+.+.+.+++|+.++..++++||.++|+.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3457777999999999999996 456899999999754 34456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
||.||++.+.++... .+++.....+++++..|+.|+|++ +.+|||||+.||++..+|.+|++|||.+.......
T Consensus 92 y~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999997653 347888888999999999999999 99999999999999999999999999998876432
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
..+.+++||+.|||||++....|+.|+||||+|++.+||++|.+|+....+.. .+ .-......|
T Consensus 166 ----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------vl---flIpk~~PP 229 (467)
T KOG0201|consen 166 ----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------VL---FLIPKSAPP 229 (467)
T ss_pred ----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------EE---EeccCCCCC
Confidence 33478899999999999999999999999999999999999999997644310 00 001122335
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+.+.+...++++++. |++.+|+.||++.++++
T Consensus 230 ~L~~~~S~~~kEFV~~------CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEA------CLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccccCHHHHHHHHH------HhhcCcccCcCHHHHhh
Confidence 6667777788888887 99999999999998865
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=383.25 Aligned_cols=496 Identities=28% Similarity=0.328 Sum_probs=275.2
Q ss_pred cCCccccccccCCeEeccCCCCCCCch-hhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhcc
Q 001238 89 HVPTNFTSLLSLNRLVLSGTNLTGSIP-KEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIG 167 (1117)
Q Consensus 89 ~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 167 (1117)
.||..+-.-..++.|+++.|-+- ..| +.+.+.-+|+.||+|+|.+. ..|..+..+.+|+.|+++.|.+. ..|.+.+
T Consensus 12 ~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~ 88 (1081)
T KOG0618|consen 12 LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCS 88 (1081)
T ss_pred ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhh
Confidence 46666666666888888888776 333 22344555888888888886 78888888888888888888887 7788888
Q ss_pred CCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccce
Q 001238 168 NLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQT 247 (1117)
Q Consensus 168 ~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~ 247 (1117)
++.+|++|.|.+|++. .+|.++..+++|++|+++.|+. +.+|.-+..++.+..+..++|...
T Consensus 89 ~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f--~~~Pl~i~~lt~~~~~~~s~N~~~--------------- 150 (1081)
T KOG0618|consen 89 NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHF--GPIPLVIEVLTAEEELAASNNEKI--------------- 150 (1081)
T ss_pred hhhcchhheeccchhh-cCchhHHhhhcccccccchhcc--CCCchhHHhhhHHHHHhhhcchhh---------------
Confidence 8888888888888886 5788888888888888877764 345555555555555544444110
Q ss_pred eecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcC
Q 001238 248 IAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327 (1117)
Q Consensus 248 L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l 327 (1117)
..++.. ..+.+++..|.+.+.++..+..+++ .|+|++|.+. . -.+.++.+|+.|..+.|++
T Consensus 151 -------------~~lg~~-~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~l 211 (1081)
T KOG0618|consen 151 -------------QRLGQT-SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQL 211 (1081)
T ss_pred -------------hhhccc-cchhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhccc
Confidence 001111 1556666666666666666665555 5666666665 1 2445556666666666666
Q ss_pred CCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCC
Q 001238 328 TGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI 407 (1117)
Q Consensus 328 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 407 (1117)
.... + ..++|+.|+.++|.++...+. ..-.+|+++++++|+++ .+|++++.+.+|+.+...+|+++ .+|..+
T Consensus 212 s~l~---~-~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri 283 (1081)
T KOG0618|consen 212 SELE---I-SGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRI 283 (1081)
T ss_pred ceEE---e-cCcchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHH
Confidence 5221 1 125566666666666522111 11234555666666655 33455555555555555555554 445555
Q ss_pred CcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccc-cceeccCCCcccccCCCCcCCCCCCC
Q 001238 408 SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSS-LIRFRANSNKLTGFIPPEIGNLKNLN 486 (1117)
Q Consensus 408 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~ 486 (1117)
...++|+.|++.+|.+. -+|....+++.|+.|+|..|+|....+..|.-... |..|+.+.|++.......=..++.|+
T Consensus 284 ~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq 362 (1081)
T KOG0618|consen 284 SRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQ 362 (1081)
T ss_pred hhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHH
Confidence 55555555555555555 34554555555555555555555332222222222 44444444544422211111233445
Q ss_pred EEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccc
Q 001238 487 FLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNR 566 (1117)
Q Consensus 487 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~ 566 (1117)
.|++.+|.+++..-..+.++.+|+.|+|++|+|.......+.++..|+.|+||+|+++.+
T Consensus 363 ~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~L-------------------- 422 (1081)
T KOG0618|consen 363 ELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTL-------------------- 422 (1081)
T ss_pred HHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhh--------------------
Confidence 555555555444444444445555555555554433333444444444444444444444
Q ss_pred cCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCcccc-CCcc
Q 001238 567 FAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELS-GDLH 645 (1117)
Q Consensus 567 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~-~~~~ 645 (1117)
|.....+..|++|...+|+|. ..| .+..++.+ +.+|+|.|+|+...-......++|++|||++|... -+-.
T Consensus 423 -----p~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL-~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~ 494 (1081)
T KOG0618|consen 423 -----PDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQL-KVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHK 494 (1081)
T ss_pred -----hHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcc-eEEecccchhhhhhhhhhCCCcccceeeccCCcccccchh
Confidence 344444444444444444444 333 34444444 34444444443322222222378888888888742 2344
Q ss_pred hhhhcccceEEEeecc
Q 001238 646 FLAELQNLVVLNVSHN 661 (1117)
Q Consensus 646 ~l~~l~~L~~L~ls~N 661 (1117)
.+..+.++...+++-|
T Consensus 495 ~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 495 TLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhHHhhhhhheecccC
Confidence 4666666777776666
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.15 Aligned_cols=264 Identities=28% Similarity=0.447 Sum_probs=201.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-----------------CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-----------------SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRL 837 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 837 (1117)
++|++.++||+|+||.||+|.+. ++..||+|++.... .....+|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46888999999999999999743 23479999987643 2234578999999999999999999
Q ss_pred EeeeecCCceEEEEEecCCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceee
Q 001238 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGE----------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILH 901 (1117)
Q Consensus 838 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 901 (1117)
++++.+.+..++||||+++|+|.+++.... ....+++.++.+++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999886431 112367889999999999999999999 9999
Q ss_pred eccccCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh--CC
Q 001238 902 RDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT--GK 979 (1117)
Q Consensus 902 rDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~--g~ 979 (1117)
|||||+||++++++.+||+|||+++...... .........++..|+|||++....++.++||||||+++|||++ +.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD--YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCc--eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999998664322 1122234456789999999988899999999999999999987 56
Q ss_pred CCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 980 KPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 980 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
.||... ........+............ ...+...+..+.+++ ..||+.+|++||++.+|.+.|++
T Consensus 240 ~p~~~~--~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li------~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGEL--TDEQVIENAGEFFRDQGRQVY---LFRPPPCPQGLYELM------LQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcC--CHHHHHHHHHHHhhhcccccc---ccCCCCCCHHHHHHH------HHHccCCchhCcCHHHHHHHHhC
Confidence 677542 222333333332222111111 111122233444444 45999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.74 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=198.0
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCccc---hHHHHHHHHHHhccCCCCcceEEeeeec----CCceEEEEEec
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIS---TGAFSSEIATLSRIRHRNIVRLLGWGAN----RKTKLLFYDYM 854 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~ 854 (1117)
..||+|++|.||+|.. +|+.||||+++...... .+.|.+|++++++++|||||++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 78999999997653333 4668899999999999999999999876 34678999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++.... .+++..+.+++.|++.|++|||+.. +++||||||+||++++++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 9999999997643 4889999999999999999999732 7889999999999999999999999999865432
Q ss_pred ccccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 935 SFSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+........... +
T Consensus 177 ----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~------~ 241 (283)
T PHA02988 177 ----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-----TKEIYDLIINKNNS------L 241 (283)
T ss_pred ----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcCCC------C
Confidence 123468899999999876 689999999999999999999999997431 12222222222211 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
.++...+..+.+++.. ||+.||++||+++++++.|+.+.
T Consensus 242 ~~~~~~~~~l~~li~~------cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 KLPLDCPLEIKCIVEA------CTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCcCcHHHHHHHHH------HhcCCcccCcCHHHHHHHHHHHH
Confidence 1222234455665555 99999999999999999998765
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=356.73 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=206.2
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcCCC-cEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEee-eec------C
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLPSG-LTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGW-GAN------R 844 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~------~ 844 (1117)
...++++.+.|.+|||+.||.|....+ ..||+|++...++.....+.+||++|++|+ |+|||.++|. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345788899999999999999986555 999999998888888888999999999996 9999999993 221 1
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
.++++.||||+||.|-+++..+...+ +++.++++|+.|+++|+++||.. .|+|||||||-+||||+.++..||||||-
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 35678999999999999998765444 99999999999999999999996 67899999999999999999999999999
Q ss_pred cccccCCCCCc-----cccCCccccccccCChhhh---ccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHH
Q 001238 925 ARLVEDDSGGS-----FSANPQFAGSYGYIAPEYA---NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 925 a~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~ 996 (1117)
|.......... ....-....|+.|+|||++ .+..+++|+||||+||+||-|+....||+..-.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence 87543322110 0111234689999999977 467899999999999999999999999975211
Q ss_pred HHHHhcCCCCccccCccc--C--CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 997 RDHLKSKKDPVEVLDPKL--Q--GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l--~--~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
...++..+ + ..+...+..+++ .|++.+|++||++-+|...+-+++..+.
T Consensus 264 ----------laIlng~Y~~P~~p~ys~~l~~LI~------~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 264 ----------LAILNGNYSFPPFPNYSDRLKDLIR------TMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ----------eeEEeccccCCCCccHHHHHHHHHH------HHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 11111111 1 122233444444 4999999999999999999988876544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=334.76 Aligned_cols=206 Identities=23% Similarity=0.319 Sum_probs=178.2
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
..++|.+.+.||+|+||.||.|+. .+|..+|+|++++.. ....+.+..|-.+|....+|.||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 346899999999999999999974 469999999998763 3344567889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||++||++..+|... +.+++..++.++.+++.|++.+|+. |+|||||||+|+|||..|++||+|||++.-+.
T Consensus 219 iMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999875 4599999999999999999999999 99999999999999999999999999985432
Q ss_pred CCC-------------------CCccc-----c-------------------CCccccccccCChhhhccCCCCcCCCee
Q 001238 930 DDS-------------------GGSFS-----A-------------------NPQFAGSYGYIAPEYANMTKISEKSDVY 966 (1117)
Q Consensus 930 ~~~-------------------~~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 966 (1117)
... ..... . ....+|||-|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 100 00000 0 0124799999999999999999999999
Q ss_pred ehhhhHHHHHhCCCCCCCC
Q 001238 967 SYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 967 SlG~vl~ell~g~~P~~~~ 985 (1117)
|+|||+|||+.|-+||.+.
T Consensus 373 SLG~ImyEmLvGyPPF~s~ 391 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSE 391 (550)
T ss_pred HHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.34 Aligned_cols=262 Identities=24% Similarity=0.288 Sum_probs=206.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccc--hHHHHHHHHHHhccCCCCcceEEeeee--cCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKIS--TGAFSSEIATLSRIRHRNIVRLLGWGA--NRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~l 849 (1117)
.+.|...++|++|.||.||+|+. ++++.||+|+++...... .-.-.+||.++.+.+|||||.+..+.. +-+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 35688889999999999999985 468899999998653211 123478999999999999999988654 3467899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
|||||+. +|..++.... .++...++..++.|+++|++|||+. .|+|||+|++|+|+...|.+||+|||+||.++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999965 8998888765 3488899999999999999999999 99999999999999999999999999999986
Q ss_pred CCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.. ....+..+.|.+|.|||.+.+ ..|+++.|+||+|||+.||+++++-|.+. .....+..+++.-+.+.+
T Consensus 229 sp----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~-----sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 229 SP----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK-----SEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred CC----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC-----chHHHHHHHHHHhCCCcc
Confidence 53 356778899999999997765 67999999999999999999999988653 334445555555566666
Q ss_pred ccCcccCCCCc-----------hhHHHH-------HHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPD-----------TQIQEM-------LQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~-----------~~~~~~-------l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++|.+...+. ..++.- -....+....+..||.+|-|+.+.++
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 66665443221 011100 01223444577889999999999876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=310.00 Aligned_cols=267 Identities=22% Similarity=0.355 Sum_probs=208.1
Q ss_pred hccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecC-----Cce
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANR-----KTK 847 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 847 (1117)
..++|++.+.+|+|||+.||.++ ..+++.||+|++......+.+...+|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45689999999999999999997 557889999999887777788899999999999999999999986543 348
Q ss_pred EEEEEecCCCChhhhhcCCCCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAG-LLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
|++++|...|+|.+.+......+ .+++.+.++|+.++++||++||+. .|+++||||||.||++.+.+.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999998765444 799999999999999999999997 3469999999999999999999999999987
Q ss_pred cccCCCCCc-----cccCCccccccccCChhhhcc---CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHH
Q 001238 927 LVEDDSGGS-----FSANPQFAGSYGYIAPEYANM---TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 927 ~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
...-.-.+. .........|..|.|||.+.. ...++++|||||||++|+|+.|.-||+.....+..+.-.+..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n 257 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN 257 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence 543221111 111223457899999998864 456889999999999999999999997543333322221111
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
. ....|+ ...+++...+ ++.+|++.||.+||++.+++..++.+
T Consensus 258 ~--------q~s~P~-~~~yse~l~~------lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 258 A--------QISIPN-SSRYSEALHQ------LIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred c--------ccccCC-CCCccHHHHH------HHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0 011111 1123333344 44459999999999999999988765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=363.61 Aligned_cols=264 Identities=29% Similarity=0.465 Sum_probs=208.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC--CCc----EEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP--SGL----TVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
....+..+.||+|+||.||+|... .|. .||||.++.. +.++..+|.+|+.+|+++.|||||+++|++-+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345667789999999999999743 243 4999998764 455677899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGEC----AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
++++|||++|+|..++++.+. ...+...+.+.++.|||+|+.||+++ ++|||||.++|+|+++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987632 23488899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
+|+.+.+.+. +.......-..+|||||.+.++.++.|+|||||||++||+++ |..||... ...++.. .....
T Consensus 848 lArDiy~~~y--yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~--~n~~v~~---~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDY--YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR--SNFEVLL---DVLEG 920 (1025)
T ss_pred hhHhhhhchh--eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc--chHHHHH---HHHhC
Confidence 9996654322 222222234578999999999999999999999999999999 99999642 2222222 12222
Q ss_pred CCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1003 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
. . ++ ....+++ .+.+++.. ||+.+|++||+++.+++.++.+.....
T Consensus 921 g-R----L~-~P~~CP~-~ly~lM~~------CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 921 G-R----LD-PPSYCPE-KLYQLMLQ------CWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred C-c----cC-CCCCCCh-HHHHHHHH------HccCChhhCccHHHHHhhhhhhhhhhc
Confidence 2 1 11 1122333 33344443 999999999999999998888765443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=344.04 Aligned_cols=242 Identities=21% Similarity=0.324 Sum_probs=198.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|.+.++||+|.||+|+++..+ +++.+|||++++.. ..+.+....|.+++... +||.++.++.+|+..++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 357899999999999999999854 58899999998764 33455677888887777 59999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+.||++..+.+. +.+++..+.-+|..|+.||+|||++ +|||||||.+|||+|.+|++||+|||+++..-
T Consensus 447 vmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999995444443 3499999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
-. .....+++|||.|||||++.+..|+.++|.|||||++|||+.|+.||.+. +++ +....++..
T Consensus 520 ~~----g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEe---e~FdsI~~d------- 583 (694)
T KOG0694|consen 520 GQ----GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEE---EVFDSIVND------- 583 (694)
T ss_pred CC----CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHH---HHHHHHhcC-------
Confidence 21 13556899999999999999999999999999999999999999999752 222 223333222
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~ 1046 (1117)
++.++...+.+...+++. .+..+|++|--+
T Consensus 584 -~~~yP~~ls~ea~~il~~------ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EVRYPRFLSKEAIAIMRR------LLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCCcccHHHHHHHHH------HhccCcccccCC
Confidence 244555555555555554 788899999744
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.34 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=204.4
Q ss_pred cCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCcc---chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.+|++.+.||+|.||.|-+|. +..|+.||||.+++.... +.-.+++|+++|..++||||+.++.+|...+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 467888999999999999986 578999999999865433 3335789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||..+|.|.+|+.+. +.+++.+++.+++||.+|+.|+|.+ ++||||+|.+|||+|.++++||+|||++-.+.+.
T Consensus 133 EYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999875 3499999999999999999999999 9999999999999999999999999999887643
Q ss_pred CCCccccCCccccccccCChhhhccCCCC-cCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKIS-EKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.-.++++|++-|.+||++.+.+|. +.+|.||+||++|.++.|..||++ .+....++++-.... .
T Consensus 207 -----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-----~Dhk~lvrQIs~GaY-----r 271 (668)
T KOG0611|consen 207 -----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-----RDHKRLVRQISRGAY-----R 271 (668)
T ss_pred -----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-----chHHHHHHHhhcccc-----c
Confidence 234578999999999999999985 899999999999999999999975 223333333322221 1
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
.|.-+......++ |++..+|++|.|..+|...+.
T Consensus 272 EP~~PSdA~gLIR----------wmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 272 EPETPSDASGLIR----------WMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred CCCCCchHHHHHH----------HHHhcCcccchhHHHHhhhhe
Confidence 1222222222333 355569999999999988664
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=343.07 Aligned_cols=244 Identities=22% Similarity=0.321 Sum_probs=198.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.+|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999864 68999999987532 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999998764 3478899999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.........
T Consensus 172 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i~~~~-------- 231 (329)
T PTZ00263 172 -------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD-----TPFRIYEKILAGR-------- 231 (329)
T ss_pred -------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCC--------
Confidence 12357999999999999999999999999999999999999999642 1222222222221
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
..++...+....++++. |++.||.+||+ +++++.
T Consensus 232 ~~~p~~~~~~~~~li~~------~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 232 LKFPNWFDGRARDLVKG------LLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred cCCCCCCCHHHHHHHHH------HhhcCHHHcCCCCCCCHHHHhc
Confidence 11223334455555555 99999999996 566654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=304.26 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=206.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
-++|.+++.||+|.||.||.|+. +++..||+|++.+. ......++.+|+++-..++||||.++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35789999999999999999984 56788999998654 233456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
+||.++|++...++.... ..+++.....++.|+|.|+.|+|.+ +++||||||+|+|++.++..|++|||-+.....
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999986543 3488899999999999999999999 999999999999999999999999999875432
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
..+.+.+||.-|.+||...+..++..+|+|++|+..||++.|.+||.... .......++ +.+.
T Consensus 177 ------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~---k~~~------ 239 (281)
T KOG0580|consen 177 ------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIR---KVDL------ 239 (281)
T ss_pred ------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHH---Hccc------
Confidence 35567899999999999999999999999999999999999999997643 222222222 2211
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
.++...+...++++.. |+..+|.+|.+..|+++.-
T Consensus 240 --~~p~~is~~a~dlI~~------ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 240 --KFPSTISGGAADLISR------LLVKNPIERLALTEVMDHP 274 (281)
T ss_pred --cCCcccChhHHHHHHH------HhccCccccccHHHHhhhH
Confidence 1122333445555554 9999999999999998753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=335.27 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=198.3
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.|+..+.||+|+||+||+|.. .+|+.||+|++.... ......+.+|++++++++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999975 578999999987532 2223457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999888765332 2488999999999999999999999 99999999999999999999999999998754321
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .....+....... . .
T Consensus 157 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~---~----~ 222 (285)
T cd05631 157 -----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--VKREEVDRRVKED---Q----E 222 (285)
T ss_pred -----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--hhHHHHHHHhhcc---c----c
Confidence 123457899999999999999999999999999999999999999753221 1111122111111 0 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
.+....+..+..+++. |++.||++||+ ++++++
T Consensus 223 ~~~~~~s~~~~~li~~------~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRM------LLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHH------HhhcCHHHhcCCCCCCHHHHhc
Confidence 1223344455555555 99999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.65 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=195.5
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--------------ccchHHHHHHHHHHhccCCCCcceEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--------------KISTGAFSSEIATLSRIRHRNIVRLL 838 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~l~ 838 (1117)
.-++|++.+.||+|.||.|-+|+. .+++.||||++.+.. ....+..++||.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 357899999999999999999974 468999999986431 11234788999999999999999999
Q ss_pred eeeecC--CceEEEEEecCCCChhhhhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC
Q 001238 839 GWGANR--KTKLLFYDYMPNGTLGMLLHDGECAGL-LEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY 915 (1117)
Q Consensus 839 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 915 (1117)
.+..+. +..|+|+|||..|.+...=. .++ +.+.++++++++++.||+|||.+ +||||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 988765 57899999999888754322 233 89999999999999999999999 999999999999999999
Q ss_pred cceeccccccccccCCCCC-ccccCCccccccccCChhhhccCC----CCcCCCeeehhhhHHHHHhCCCCCCCCCCCCh
Q 001238 916 ESCLADFGLARLVEDDSGG-SFSANPQFAGSYGYIAPEYANMTK----ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ 990 (1117)
Q Consensus 916 ~~kl~DfGla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~ 990 (1117)
++||+|||.+......... ........+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||-+ +
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-----~ 322 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-----D 322 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-----c
Confidence 9999999999866433211 112223468999999999887632 35789999999999999999999964 2
Q ss_pred hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
...+...++....-.. |..+ ...+..+.+++ .++.+||++|.+..+|.....
T Consensus 323 ~~~~l~~KIvn~pL~f-----P~~p-e~~e~~kDli~------~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 323 FELELFDKIVNDPLEF-----PENP-EINEDLKDLIK------RLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred hHHHHHHHHhcCcccC-----CCcc-cccHHHHHHHH------HHhhcChhheeehhhheecce
Confidence 3334344433222111 1111 11223344443 488889999999998876543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=339.03 Aligned_cols=243 Identities=24% Similarity=0.327 Sum_probs=199.1
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6888999999999999999864 68999999987532 1234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 82 YVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 99999999998764 3488999999999999999999999 9999999999999999999999999999866431
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||... ..............
T Consensus 155 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~~-------- 215 (291)
T cd05612 155 ------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD-----NPFGIYEKILAGKL-------- 215 (291)
T ss_pred ------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCc--------
Confidence 12356899999999999889999999999999999999999999642 12222233222221
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
.++...+..+.++++. |++.||.+||+ +.++++
T Consensus 216 ~~~~~~~~~~~~li~~------~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 EFPRHLDLYAKDLIKK------LLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCCccCCHHHHHHHHH------HcCCCHHHccCCccCCHHHHhc
Confidence 1223334456666665 99999999995 777665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=341.33 Aligned_cols=241 Identities=21% Similarity=0.278 Sum_probs=194.9
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNG 857 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 857 (1117)
+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 468999999997532 223456778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccc
Q 001238 858 TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFS 937 (1117)
Q Consensus 858 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 937 (1117)
+|.+++... +.+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----~ 150 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----A 150 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----C
Confidence 999988754 3489999999999999999999999 99999999999999999999999999997543211 1
Q ss_pred cCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCC
Q 001238 938 ANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017 (1117)
Q Consensus 938 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1017 (1117)
......||+.|+|||++.+..++.++||||+||++|||++|+.||... ............. ..++..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~~~~~~~~~--------~~~p~~ 217 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILMEE--------IRFPRT 217 (323)
T ss_pred cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-----CHHHHHHHHHcCC--------CCCCCC
Confidence 223467999999999999999999999999999999999999999642 1112222222211 122333
Q ss_pred CchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1018 PDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1018 ~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
.+..+.++++. |++.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~------~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAG------LLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHH------HccCCHHHcCCCCCCCHHHHHc
Confidence 44556666655 9999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=348.30 Aligned_cols=261 Identities=28% Similarity=0.423 Sum_probs=202.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 846 (1117)
.++|++.+.||+|+||.||+|.+ .++..||||+++... ......+.+|+++++.+ +|||||++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34788999999999999999863 234589999997543 22345688999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCC-----------------------------------------------------------
Q 001238 847 KLLFYDYMPNGTLGMLLHDGE----------------------------------------------------------- 867 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 867 (1117)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885421
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccC
Q 001238 868 --------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939 (1117)
Q Consensus 868 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 939 (1117)
....+++.++++++.||++||+|||++ +|+||||||+||++++++.+||+|||+++....... ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--~~~~ 271 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--YVVK 271 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc--eeec
Confidence 012478889999999999999999999 999999999999999999999999999986643211 1122
Q ss_pred CccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCC
Q 001238 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018 (1117)
Q Consensus 940 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1018 (1117)
....++..|+|||++....++.++|||||||++|||++ |+.||...... ..... ....... +..+...
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~----~~~~~~~------~~~~~~~ 340 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYK----MVKRGYQ------MSRPDFA 340 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHH----HHHcccC------ccCCCCC
Confidence 23345678999999988899999999999999999997 99999653221 11111 1111111 1112222
Q ss_pred chhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1019 DTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1019 ~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
+..+.+++.. ||+.||++||++.+|+++|+++.
T Consensus 341 ~~~l~~li~~------cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 PPEIYSIMKM------CWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHh
Confidence 3345555544 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=348.94 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=202.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 846 (1117)
.++|++.+.||+|+||.||+|.+ .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45789999999999999999863 246689999987543 23345788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC----------------------------------------------------------
Q 001238 847 KLLFYDYMPNGTLGMLLHDGEC---------------------------------------------------------- 868 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 868 (1117)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998864320
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 869 --------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 869 --------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
...+++..+.+++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN- 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence 12478889999999999999999999 999999999999999999999999999987643221
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
........++..|+|||++.+..++.++|||||||++|||++ |..||..... .......+. .... +.
T Consensus 270 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-~~~~~~~~~----~~~~------~~ 337 (375)
T cd05104 270 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-DSKFYKMIK----EGYR------ML 337 (375)
T ss_pred -ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-hHHHHHHHH----hCcc------CC
Confidence 112223345678999999999999999999999999999998 8999865322 122222222 1111 01
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
.+...+..+.+++. .|++.||++||++.+|++.|++.
T Consensus 338 ~~~~~~~~l~~li~------~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 SPECAPSEMYDIMK------SCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCHHHHHHHH------HHccCChhHCcCHHHHHHHHHhh
Confidence 11222334444444 49999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=341.72 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=199.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 58999999997542 223456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999754 3488999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....... ......+
T Consensus 154 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~-~~~~~~~ 224 (333)
T cd05600 154 ------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--NETWENLKYWKETL-QRPVYDD 224 (333)
T ss_pred ------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--HHHHHHHHhccccc-cCCCCCc
Confidence 22345799999999999989999999999999999999999999965311 11111111110000 0000001
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
+. ...+..+.+++.. |+..+|++||++.++++.
T Consensus 225 ~~--~~~s~~~~~li~~------~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PR--FNLSDEAWDLITK------LINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cc--cccCHHHHHHHHH------HhhChhhhcCCHHHHHhC
Confidence 10 1123344444444 999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=365.03 Aligned_cols=463 Identities=28% Similarity=0.357 Sum_probs=373.6
Q ss_pred EEEEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccC
Q 001238 76 VVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNS 155 (1117)
Q Consensus 76 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 155 (1117)
++.++++.+-+....-+.+.+-.+|+.|+|++|++. .+|..+..+.+|+.|+++.|.++ .+|.+.+.+.+|++|.|..
T Consensus 23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~ 100 (1081)
T KOG0618|consen 23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKN 100 (1081)
T ss_pred HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheecc
Confidence 667777776654432234555666999999999997 89999999999999999999998 8999999999999999999
Q ss_pred CCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccC
Q 001238 156 NQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFL 235 (1117)
Q Consensus 156 N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~l 235 (1117)
|++. .+|.++..+.+|+.|+++.|++. .+|..+..++.++.+..++|.. ...++ ...
T Consensus 101 n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~-~~~lg----~~~---------------- 157 (1081)
T KOG0618|consen 101 NRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEK-IQRLG----QTS---------------- 157 (1081)
T ss_pred chhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchh-hhhhc----ccc----------------
Confidence 9999 99999999999999999999997 7999999999999999999931 11111 111
Q ss_pred CcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCC
Q 001238 236 PPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCS 315 (1117)
Q Consensus 236 p~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 315 (1117)
.+.+++..+.+.+.++.++..++. .|+|.+|.+. -..+.++.+|+.|....|+++... -.-+
T Consensus 158 ---------ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~ 219 (1081)
T KOG0618|consen 158 ---------IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGP 219 (1081)
T ss_pred ---------chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCc
Confidence 344555666666677777777776 6889888887 234667788889999999887431 2347
Q ss_pred CCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhc
Q 001238 316 QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVW 395 (1117)
Q Consensus 316 ~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 395 (1117)
+|+.|+.++|.++...+. ..-.+|+++++++|+++ .+|.+++.+.+|+.++..+|+++ .+|..+....+|+.|.+.
T Consensus 220 ~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 220 SLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA 295 (1081)
T ss_pred chheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence 889999999999843332 22358999999999999 56699999999999999999997 788888889999999999
Q ss_pred cccccccCCCCCCcccccceeecccccccCCCcccccC-CC-CCCeeeccCccCCCCCCCCcccccccceeccCCCcccc
Q 001238 396 HNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ-LK-KLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTG 473 (1117)
Q Consensus 396 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 473 (1117)
+|.++ .+|.....++.|++|+|..|+|. ..|..+.. +. .|..|+.+.|++.....-.=..++.|+.|++.+|.+++
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 99999 77888888999999999999998 56665543 33 47889999999985542233346789999999999999
Q ss_pred cCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCC
Q 001238 474 FIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGS 553 (1117)
Q Consensus 474 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 553 (1117)
...+.+.+.+.|+.|+|++|+|.......+.++..|+.|+||+|+++ .+|.....+..|++|...+|+|..++ .+..
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP--e~~~ 450 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP--ELAQ 450 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech--hhhh
Confidence 88889999999999999999998555556789999999999999999 67899999999999999999988665 6777
Q ss_pred CccccEEeccccccCCCCCcccccccceeEEeccccc
Q 001238 554 LSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQ 590 (1117)
Q Consensus 554 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 590 (1117)
+++|+.+|++.|+|+...-..-..-++|++|||++|.
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 7888888888888774332222222677777777776
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=336.96 Aligned_cols=237 Identities=24% Similarity=0.300 Sum_probs=191.5
Q ss_pred eeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 784 IGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 784 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
||+|+||.||+|... +++.||+|+++.. .......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999854 5889999998753 223345678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccC
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 939 (1117)
.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~ 150 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD----DKT 150 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC----Ccc
Confidence 9998764 3489999999999999999999999 99999999999999999999999999998643221 122
Q ss_pred CccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCc
Q 001238 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019 (1117)
Q Consensus 940 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1019 (1117)
....||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+......... ..++...+
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~~~--------~~~~~~~~ 217 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQEP--------LRFPDGFD 217 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcCC--------CCCCCcCC
Confidence 3457999999999999999999999999999999999999999642 2233333333222 12223344
Q ss_pred hhHHHHHHHHhHhhhccCCCCCCCCCHHHH
Q 001238 1020 TQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049 (1117)
Q Consensus 1020 ~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v 1049 (1117)
..+.+++.. |++.||++||++..+
T Consensus 218 ~~~~~li~~------~L~~dp~~R~~~~~~ 241 (312)
T cd05585 218 RDAKDLLIG------LLSRDPTRRLGYNGA 241 (312)
T ss_pred HHHHHHHHH------HcCCCHHHcCCCCCH
Confidence 455666555 999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.68 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=210.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCc-eEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT-KLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv~ 851 (1117)
++|..++++|+|+||.++.++++ ++..||+|++.-... ........|+.++++++|||||.+++.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46888899999999999998754 578999999875432 233457889999999999999999999999888 89999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
+|++||++.+.+.+.+ ...++++++.+++.|++.|+.|||++ +|+|||||+.||+++.++.+||+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998865 35589999999999999999999988 9999999999999999999999999999988754
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. ....+.+||+.||.||.+.+.+|..|+||||+||++|||++-+++|.+. +....+.+..+...
T Consensus 160 ~----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~~~~~------- 223 (426)
T KOG0589|consen 160 D----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKINRGLY------- 223 (426)
T ss_pred h----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHhhccC-------
Confidence 3 2344678999999999999999999999999999999999999999753 33344444443331
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
..++..+....+.+++- |++.+|+.||++.+++..
T Consensus 224 ~Plp~~ys~el~~lv~~------~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKS------MLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHH------HhhcCCccCCCHHHHhhC
Confidence 22344555566666655 999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.20 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|++.+.||+|+||.||+|.++ .+..||+|+++.... .....|.+|++++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888999999999999999642 467899999876532 2345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|+|.+++.... +.+++.+++.++.|++.||+|||++ +++||||||+||+++.++.++++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999987642 3489999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.. ........++..|+|||.+....++.++|||||||++||+++ |+.||.... .. ..+... ......
T Consensus 160 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--~~---~~~~~~-~~~~~~--- 227 (266)
T cd05064 160 EA---IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--GQ---DVIKAV-EDGFRL--- 227 (266)
T ss_pred cc---hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--HH---HHHHHH-HCCCCC---
Confidence 11 111112345678999999999999999999999999999775 999996431 11 222221 111111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
..+...+..+.+++. .||+.+|++||++.++.+.|+++
T Consensus 228 ---~~~~~~~~~~~~li~------~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ---PAPRNCPNLLHQLML------DCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHH------HHcCCCchhCCCHHHHHHHHHhh
Confidence 112233344444444 49999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=307.33 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=198.9
Q ss_pred ccCCCCCCeeeecCCeEEEEE-EcCCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKV-TLPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++.|.+.+.||+|.|+.||+. ..++|+.+|+|++... .....+.+.+|+++.+.++|||||++.+.+.+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456888899999999999996 4568999999987533 2335678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceeccccccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLADFGLARLV 928 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGla~~~ 928 (1117)
|+|.|++|..-+-.+ ..+++..+-.+++||++||.|+|.+ +|||||+||+|+++-. ...+|++|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999996544432 2378889999999999999999999 9999999999999953 346899999999988
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.++ .....++|||+|||||+....+|+..+|||+.||++|-++.|.+||.+. +-....+++.+...+...
T Consensus 164 ~~g-----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-----~~~rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 164 NDG-----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYEQIKAGAYDYPS 233 (355)
T ss_pred CCc-----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-----cHHHHHHHHhccccCCCC
Confidence 732 2345678999999999999999999999999999999999999999642 222333333333333322
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..++ ...+..+.+++. ++..||.+|.|+.|.+.
T Consensus 234 ~~w~----~is~~Ak~Lvrr------ML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PEWD----TVTPEAKSLIRR------MLTVNPKKRITADEALK 266 (355)
T ss_pred cccC----cCCHHHHHHHHH------HhccChhhhccHHHHhC
Confidence 2222 223344454444 77779999999887643
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=335.20 Aligned_cols=241 Identities=21% Similarity=0.281 Sum_probs=193.9
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNG 857 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 857 (1117)
+.||+|+||.||++.. .+|+.||+|+++.. .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999975 46899999999753 2223456778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccc
Q 001238 858 TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFS 937 (1117)
Q Consensus 858 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 937 (1117)
+|..++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----~ 150 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----A 150 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC----C
Confidence 999888754 2488999999999999999999999 99999999999999999999999999987543211 1
Q ss_pred cCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCC
Q 001238 938 ANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017 (1117)
Q Consensus 938 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1017 (1117)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ ..++..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~~~~~~~~~~--------~~~p~~ 217 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFELILMEE--------IRFPRT 217 (323)
T ss_pred ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCC--------CCCCCC
Confidence 2234579999999999998999999999999999999999999996421 112222222211 112233
Q ss_pred CchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1018 PDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1018 ~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
.+..++++++. |++.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~------~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSPEAKSLLAG------LLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHHHH------HccCCHHHhCCCCCCCHHHHHc
Confidence 44556666665 9999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=339.67 Aligned_cols=244 Identities=23% Similarity=0.277 Sum_probs=197.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC--CcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS--GLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999997433 368999998643 222345688899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999997643 488999999999999999999999 999999999999999999999999999986532
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 184 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~i~~~~~------ 245 (340)
T PTZ00426 184 R-------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----PLLIYQKILEGII------ 245 (340)
T ss_pred C-------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----HHHHHHHHhcCCC------
Confidence 1 224579999999999998889999999999999999999999996421 1122222222111
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
.++...+....++++. |++.+|++|+ +++++.+
T Consensus 246 --~~p~~~~~~~~~li~~------~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 --YFPKFLDNNCKHLMKK------LLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred --CCCCCCCHHHHHHHHH------HcccCHHHcCCCCCCCHHHHHc
Confidence 1223334455555555 9999999995 7877765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=335.92 Aligned_cols=242 Identities=22% Similarity=0.284 Sum_probs=194.8
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNG 857 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 857 (1117)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 468999999997542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccc
Q 001238 858 TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFS 937 (1117)
Q Consensus 858 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 937 (1117)
+|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----~ 150 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----A 150 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----c
Confidence 999888654 3488999999999999999999999 99999999999999999999999999987543211 1
Q ss_pred cCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCC
Q 001238 938 ANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017 (1117)
Q Consensus 938 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1017 (1117)
......||+.|+|||++.+..++.++|||||||++|||++|+.||... ............. ..++..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-----~~~~~~~~~~~~~--------~~~p~~ 217 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILMED--------IKFPRT 217 (328)
T ss_pred ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC-----CHHHHHHHhccCC--------ccCCCC
Confidence 223457999999999999889999999999999999999999999642 1122222222111 122333
Q ss_pred CchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHHH
Q 001238 1018 PDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAAL 1052 (1117)
Q Consensus 1018 ~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~~ 1052 (1117)
.+....++++. |++.||++|| ++.++++.
T Consensus 218 ~~~~~~~li~~------~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSG------LLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHH------HcCCCHHHcCCCCCCCHHHHhcC
Confidence 44455555555 9999999997 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.75 Aligned_cols=263 Identities=23% Similarity=0.274 Sum_probs=203.2
Q ss_pred CCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCC-cceEEeeeecCC------c
Q 001238 777 SLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRN-IVRLLGWGANRK------T 846 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------~ 846 (1117)
.|...++||+|+||+||+|+ ..+|+.||+|+++-..+ .......+|+.++++++|+| ||++++++.... .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45566789999999999997 45789999999986533 23345689999999999999 999999998877 7
Q ss_pred eEEEEEecCCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECA-GLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
.++|+||+ .-+|..++...... ..++...+..+++|+++||+|||++ +|+||||||+||+++++|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 88999999 46899998875432 2367789999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
+...-. ....+..++|.+|.|||++.+. .|++..||||+||+++||+++++-|.+.. ..+....+.+.-+
T Consensus 168 ra~~ip----~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s-----e~~ql~~If~~lG 238 (323)
T KOG0594|consen 168 RAFSIP----MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS-----EIDQLFRIFRLLG 238 (323)
T ss_pred HHhcCC----cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc-----HHHHHHHHHHHcC
Confidence 976532 2345667899999999988764 79999999999999999999998886532 2444444444444
Q ss_pred CCccccCcccCCCC-----------chhHHHH-----HHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1005 DPVEVLDPKLQGHP-----------DTQIQEM-----LQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~-----------~~~~~~~-----l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.+.+..+|.....+ ...+..+ -...++..+|++.+|.+|.+++.++++
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 44443333322111 0111111 133455666999999999999988774
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=340.69 Aligned_cols=203 Identities=24% Similarity=0.332 Sum_probs=174.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|.. .+++.||||+++... ......+.+|++++++++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688899999999999999975 468999999997532 223356788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998764 3489999999999999999999999 9999999999999999999999999999765321
Q ss_pred CCCc-------------------------------cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCC
Q 001238 932 SGGS-------------------------------FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKK 980 (1117)
Q Consensus 932 ~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~ 980 (1117)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 001124579999999999999999999999999999999999999
Q ss_pred CCCC
Q 001238 981 PVDA 984 (1117)
Q Consensus 981 P~~~ 984 (1117)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=323.10 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=200.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
.+|++.+.||+|+||.||+|.++++..||+|.+... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357788999999999999999888889999988643 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|.++++... +.+++..+..++.|++.||+|||++ +|+||||||+||++++++.+|++|||.++......
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~--- 154 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--- 154 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc---
Confidence 999999987543 3488999999999999999999999 99999999999999999999999999998654321
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
........++..|+|||++....++.++||||||+++|||++ |+.||... . ..+.+......... ..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~--~---~~~~~~~i~~~~~~----~~--- 222 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--S---NYEVVEMISRGFRL----YR--- 222 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC--C---HHHHHHHHHCCCCC----CC---
Confidence 111223345678999999988889999999999999999999 89998642 1 12222222221110 01
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
+...+..+. .++..||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~------~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKLASMTVY------EVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCHHHH------HHHHHHccCCcccCcCHHHHHHhh
Confidence 111222333 345559999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=343.59 Aligned_cols=257 Identities=21% Similarity=0.270 Sum_probs=195.2
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.|++++.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 477889999999999999974 568899999997542 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987643 488899999999999999999999 99999999999999999999999999986432110
Q ss_pred CCc-------------------------------------------cccCCccccccccCChhhhccCCCCcCCCeeehh
Q 001238 933 GGS-------------------------------------------FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYG 969 (1117)
Q Consensus 933 ~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG 969 (1117)
... .......+||+.|+|||++....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 000 0011235799999999999988999999999999
Q ss_pred hhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHH
Q 001238 970 VVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049 (1117)
Q Consensus 970 ~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v 1049 (1117)
|++|||++|+.||..... .............. . .+. ....+....+++.. +.|...+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~-~--~~~-~~~~s~~~~dli~~----ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP-----TETQLKVINWENTL-H--IPP-QVKLSPEAVDLITK----LCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCH-----HHHHHHHHcccccc-C--CCC-CCCCCHHHHHHHHH----HccCcccccCCCCHHHH
Confidence 999999999999965321 11111111111000 0 011 01122334444433 23677778889999999
Q ss_pred HHH
Q 001238 1050 AAL 1052 (1117)
Q Consensus 1050 ~~~ 1052 (1117)
++.
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 773
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=329.61 Aligned_cols=199 Identities=27% Similarity=0.367 Sum_probs=170.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|.+.++||+|+||+||+|.. .+++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688899999999999999975 468899999987542 22345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 975 8888876542 3478899999999999999999999 99999999999999999999999999997653221
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 158 ---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred ---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12234568999999998865 5689999999999999999999999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=313.35 Aligned_cols=202 Identities=27% Similarity=0.405 Sum_probs=174.9
Q ss_pred hccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeec--CCccchHHHHHHHHHHhccCCCCcceEEeeeec-----CC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRA--SDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN-----RK 845 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~ 845 (1117)
....|...+.||+|+||.|+.+. ..+|+.||||++.. ......++..+|+++++.++|+||+.+++.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 44566668999999999999986 45789999999873 345556788899999999999999999998765 34
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..|+|+|+| +.+|...++.+. .++.+.+..+++|+++||.|+|+. +|+|||+||+|++++.+...||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 679999999 679999998753 389999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhh-ccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYA-NMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
|..... ......+..+.|.+|.|||.+ ...+|+.+.||||.|||+.||++|++-|.+
T Consensus 173 R~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 173 RYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred eecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 987643 222345678899999999976 457899999999999999999999999865
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=333.81 Aligned_cols=241 Identities=25% Similarity=0.371 Sum_probs=193.3
Q ss_pred CeeeecCCeEEEEEEc----CCCcEEEEEEeecCC----ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 782 NIIGQGRSGIVYKVTL----PSGLTVAVKRFRASD----KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+.||+|+||.||+++. .+++.||+|+++... ......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999874 357899999987531 22334578899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.+++... +.+.+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 9999999998754 3478889999999999999999999 99999999999999999999999999997543221
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.......||+.|+|||++....++.++|||||||++|||++|+.||... .....+........ .
T Consensus 155 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~-----~~~~~~~~~~~~~~--------~ 218 (323)
T cd05584 155 ---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE-----NRKKTIDKILKGKL--------N 218 (323)
T ss_pred ---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCC--------C
Confidence 1223457999999999999888999999999999999999999999642 12222333322221 1
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
++...+..+.++++. |++.+|++|| ++.++.+
T Consensus 219 ~~~~~~~~~~~li~~------~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 LPPYLTPEARDLLKK------LLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCHHHHHHHHH------HcccCHhHcCCCCCCCHHHHhc
Confidence 222334455555555 9999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=322.97 Aligned_cols=255 Identities=27% Similarity=0.476 Sum_probs=203.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4688899999999999999998788899999987543 245688999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.++++... ...+++.+++.++.|+++||+|||+. +++||||||+||++++++.++|+|||+++......
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--- 157 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE--- 157 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc---
Confidence 999999987643 23488899999999999999999998 99999999999999999999999999998764321
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
........++..|+|||++....++.++|||||||++|||++ |+.||.... .......+ ...... +.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~----~~~~~~-----~~- 225 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSAL----QRGYRM-----PR- 225 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHH----HcCCCC-----CC-
Confidence 112223346778999999988889999999999999999998 999996421 11222221 111111 11
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
....+..+.+++ ..|++.+|++||+++++.++|+++
T Consensus 226 ~~~~~~~~~~li------~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 MENCPDELYDIM------KTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCHHHHHHH------HHHccCCcccCcCHHHHHHHHhcC
Confidence 112233444444 459999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=335.49 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=197.1
Q ss_pred CCCCCCeeeecCCeEEEEEEc----CCCcEEEEEEeecC----CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCce
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL----PSGLTVAVKRFRAS----DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 847 (1117)
+|++.+.||+|+||+||+++. .+++.||+|++... .....+.+.+|+++++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999874 35889999998743 222345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999988754 2388999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 155 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~---- 226 (332)
T cd05614 155 FLSEEK---ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-NTQSEVSRRILKC---- 226 (332)
T ss_pred ccccCC---CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-CCHHHHHHHHhcC----
Confidence 543221 122345799999999998764 4789999999999999999999999643221 1112222222221
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
++.++...+..+.++++. |++.||++|| +++++++
T Consensus 227 ----~~~~~~~~~~~~~~li~~------~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 ----DPPFPSFIGPEAQDLLHK------LLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CCCCCCCCCHHHHHHHHH------HcCCCHHHcCCCCCCCHHHHHc
Confidence 122333444556666665 9999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=335.31 Aligned_cols=198 Identities=29% Similarity=0.425 Sum_probs=174.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||+|+||.||++... +|..||+|++.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57889999999999999999754 68899999987542 22345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.+++.... .+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 85 MDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999997643 3889999999999999999999852 6999999999999999999999999999866432
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12345789999999999988999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=340.50 Aligned_cols=263 Identities=26% Similarity=0.392 Sum_probs=203.2
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCc-cchHHHHHHHHHHhccC-CCCcceEEeeeecCC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIR-HRNIVRLLGWGANRK 845 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 845 (1117)
..++|.++++||+|+||.||+|... .+..||||+++.... ...+.+.+|+++++++. |||||++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568999999999999999998742 234799999975432 23457899999999996 999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCC---------------------------------------------------------
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGEC--------------------------------------------------------- 868 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 868 (1117)
..|+||||+++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999988764210
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc
Q 001238 869 ------------------------------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 869 ------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 912 (1117)
...+++.++.+++.|+++||+|||+. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 12377888899999999999999999 999999999999999
Q ss_pred CCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChh
Q 001238 913 ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQH 991 (1117)
Q Consensus 913 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~ 991 (1117)
+++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....+ ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-~~ 348 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSN--YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-ST 348 (400)
T ss_pred CCCEEEEEeCCcceecccccc--ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-HH
Confidence 999999999999987643221 122233457788999999988899999999999999999997 99998643211 11
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.. ........ +..+...+..+.+++ ..||+.+|++||++.+|.++|+++.+
T Consensus 349 ~~----~~~~~~~~------~~~~~~~~~~l~~li------~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FY----NKIKSGYR------MAKPDHATQEVYDIM------VKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HH----HHHhcCCC------CCCCccCCHHHHHHH------HHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11 11121111 111222233444444 45999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=337.65 Aligned_cols=203 Identities=23% Similarity=0.279 Sum_probs=172.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||++.. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999874 578999999986532 223456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998754 3488999999999999999999999 9999999999999999999999999999643221
Q ss_pred CCCc----------c---------------------------------ccCCccccccccCChhhhccCCCCcCCCeeeh
Q 001238 932 SGGS----------F---------------------------------SANPQFAGSYGYIAPEYANMTKISEKSDVYSY 968 (1117)
Q Consensus 932 ~~~~----------~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~Sl 968 (1117)
.... . ......+||+.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0000 0 00012469999999999998999999999999
Q ss_pred hhhHHHHHhCCCCCCC
Q 001238 969 GVVLLEIITGKKPVDA 984 (1117)
Q Consensus 969 G~vl~ell~g~~P~~~ 984 (1117)
||++|||++|+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (377)
T cd05629 235 GAIMFECLIGWPPFCS 250 (377)
T ss_pred chhhhhhhcCCCCCCC
Confidence 9999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=333.10 Aligned_cols=244 Identities=22% Similarity=0.325 Sum_probs=192.1
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHH---hccCCCCcceEEeeeecCCceEEE
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATL---SRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
|++.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++ ++++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999975 468999999997532 22345566776655 566899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|+|..+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999888653 389999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||... ...+..........
T Consensus 154 ~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~-----~~~~~~~~i~~~~~------ 218 (324)
T cd05589 154 FG----DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD-----DEEEVFDSIVNDEV------ 218 (324)
T ss_pred CC----CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCC------
Confidence 11 1223567999999999999999999999999999999999999999642 11222222222221
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
..+...+..+.++++. |++.||++||+ +.++++
T Consensus 219 --~~p~~~~~~~~~li~~------~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 --RYPRFLSREAISIMRR------LLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCCHHHHHHHHH------HhhcCHhHcCCCCCCCHHHHhh
Confidence 1222334445555554 99999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=330.04 Aligned_cols=200 Identities=23% Similarity=0.353 Sum_probs=172.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|++.+.||+|+||+||+|+.+ +++.||+|+++... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999864 58899999987542 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|++++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99998777654432 3488999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 155 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 155 N---ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred c---ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 1 122345789999999999988899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=329.42 Aligned_cols=201 Identities=28% Similarity=0.351 Sum_probs=170.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||+||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 457999999999999999999864 688999999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|++ +++.+++.... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 57777766432 3488899999999999999999999 99999999999999999999999999997543221
Q ss_pred CCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
.......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 158 ----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred ----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12234568999999998864 56889999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=330.59 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=201.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCc----EEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGL----TVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.+|++.+.||+|+||+||+|.+. +++ .||+|+++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999753 333 48999987542 23456788999999999999999999988764 5789
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
|+||+++|+|.+++.... ..+++..+++++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999998653 3488999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
..... .......++..|+|||++....++.++|||||||++|||++ |+.||.+.. ..+. ...........
T Consensus 161 ~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----~~~~-~~~~~~~~~~~- 231 (316)
T cd05108 161 ADEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEI-SSILEKGERLP- 231 (316)
T ss_pred CCCcc--eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHH-HHHHhCCCCCC-
Confidence 43211 11122334678999999999999999999999999999998 999986421 1111 12222111110
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
.+...+..+.. ++..||+.+|++||++.++++.+.++.+.+.
T Consensus 232 -----~~~~~~~~~~~------li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 232 -----QPPICTIDVYM------IMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred -----CCCCCCHHHHH------HHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 01122223333 4455999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=338.35 Aligned_cols=255 Identities=24% Similarity=0.287 Sum_probs=201.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999864 68999999997532 233457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++++|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999765 3489999999999999999999998 9999999999999999999999999999876543
Q ss_pred CC-------------------------CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCC
Q 001238 932 SG-------------------------GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASF 986 (1117)
Q Consensus 932 ~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~ 986 (1117)
.. ..........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 20 00112234579999999999999999999999999999999999999996532
Q ss_pred CCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-HHHHHHH
Q 001238 987 PDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-MKDVAAL 1052 (1117)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-~~~v~~~ 1052 (1117)
................ .+.. ...+..+.+++.. |+. +|.+||+ +.++++.
T Consensus 235 -----~~~~~~~i~~~~~~~~---~p~~-~~~~~~~~~li~~------ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 -----LQETYNKIINWKESLR---FPPD-PPVSPEAIDLICR------LLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----HHHHHHHHhccCCccc---CCCC-CCCCHHHHHHHHH------Hcc-ChhhcCCCHHHHhcC
Confidence 1222222222111100 0111 1124455555554 887 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=333.70 Aligned_cols=241 Identities=21% Similarity=0.274 Sum_probs=193.4
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNG 857 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 857 (1117)
+.||+|+||.||++.. .+|+.||+|+++... ......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999974 568999999997532 223456778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 858 TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 858 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
+|.+++... +.+++.++..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---- 150 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---- 150 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----
Confidence 999888654 248999999999999999999997 6 99999999999999999999999999987543221
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ ..++.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~~~~~~i~~~~--------~~~p~ 217 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILMEE--------IRFPR 217 (325)
T ss_pred cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----HHHHHHHHhcCC--------CCCCC
Confidence 12234579999999999998999999999999999999999999996421 112222221111 11223
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
..+..+.++++. |++.||++|+ ++.++++
T Consensus 218 ~~~~~~~~li~~------~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 218 TLSPEAKSLLSG------LLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCHHHHHHHHH------HhhcCHHHhCCCCCCCHHHHhc
Confidence 344455666655 9999999996 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=339.34 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=196.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999854 68999999997532 223456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++.....
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998764 3489999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCCcc----------------------------------ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh
Q 001238 932 SGGSF----------------------------------SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977 (1117)
Q Consensus 932 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~ 977 (1117)
..... ......+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 11000 00112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC---HHHHHH
Q 001238 978 GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT---MKDVAA 1051 (1117)
Q Consensus 978 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs---~~~v~~ 1051 (1117)
|+.||.... ..+............. . +. ....+....++++. |+. +|.+|++ +.++++
T Consensus 235 G~~Pf~~~~-----~~~~~~~i~~~~~~~~--~-~~-~~~~s~~~~~li~~------ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDN-----PQETYRKIINWKETLQ--F-PD-EVPLSPEAKDLIKR------LCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCC-----HHHHHHHHHcCCCccC--C-CC-CCCCCHHHHHHHHH------Hcc-CHhhcCCCCCHHHHhc
Confidence 999996421 1222222222111110 0 11 01223345555554 665 8999997 888866
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=325.62 Aligned_cols=261 Identities=24% Similarity=0.384 Sum_probs=206.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|.+.+.||+|+||.||++.. .++..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4688899999999999999873 2356799999876555556679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCccee
Q 001238 850 FYDYMPNGTLGMLLHDGE----------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 123489999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHH
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
+|||+++....... ........++..|+|||++....++.++|||||||++|||++ |+.||..... ......
T Consensus 162 ~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-----~~~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----NEVIEC 234 (288)
T ss_pred ccCCccccccCCce--eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH
Confidence 99999986543211 112223446788999999998899999999999999999998 9999864321 112222
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
..... . +......+..+.++ +..|++.+|.+||++.++.+.|+.+.+.
T Consensus 235 i~~~~-~------~~~~~~~~~~l~~l------i~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGR-V------LQRPRTCPKEVYDL------MLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCC-c------CCCCCCCCHHHHHH------HHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22111 1 01112233344444 4459999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=325.47 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=203.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC------CcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS------GLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
++|++.+.||+|+||.||+|.... ...||+|.++.... ...++|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 368889999999999999997532 25799999875432 23456899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC
Q 001238 849 LFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY 915 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 915 (1117)
++|||+++|+|.+++..... ...+++.++..++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999875321 13478899999999999999999999 999999999999999999
Q ss_pred cceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHH
Q 001238 916 ESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQ 994 (1117)
Q Consensus 916 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~ 994 (1117)
.++|+|||+++....... ........+++.|+|||.+....++.++|||||||++|||++ |..||.+... .....
T Consensus 162 ~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEVIE 237 (283)
T ss_pred cEEECCCcceeecccccc--ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence 999999999986543211 112234456889999999988899999999999999999998 9999965321 22222
Q ss_pred HHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 995 WVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
.+ ..... +..+...+..+.+++.. ||+.+|++||++++|.+.|+.
T Consensus 238 ~i----~~~~~------~~~~~~~~~~~~~l~~~------c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MI----RSRQL------LPCPEDCPARVYALMIE------CWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH----HcCCc------CCCcccCCHHHHHHHHH------HccCChhhCcCHHHHHHHHhc
Confidence 21 11111 11223334455555554 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=333.63 Aligned_cols=238 Identities=26% Similarity=0.320 Sum_probs=191.7
Q ss_pred CeeeecCCeEEEEEEc----CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 782 NIIGQGRSGIVYKVTL----PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
+.||+|+||.||+++. .+|+.||+|+++... ......+..|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 368899999997532 1233457789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--- 152 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--- 152 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC---
Confidence 99999988654 3489999999999999999999999 99999999999999999999999999998654321
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......||+.|+|||++....++.++|||||||++|||++|+.||... .............. .++
T Consensus 153 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-----~~~~~~~~i~~~~~--------~~p 218 (318)
T cd05582 153 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-----DRKETMTMILKAKL--------GMP 218 (318)
T ss_pred -CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC-----CHHHHHHHHHcCCC--------CCC
Confidence 1223457899999999999888999999999999999999999999642 11222222222211 122
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHH
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKD 1048 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~ 1048 (1117)
...+..+..+++. |++.||++||++.+
T Consensus 219 ~~~~~~~~~li~~------~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRA------LFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHH------HhhcCHhHcCCCCC
Confidence 3334455666655 99999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=349.99 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=201.3
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-C-CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-S-GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.|.+.+.||+|+||.||+|... + ++.||+|.+...+......+.+|+++++.++|||||++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4788899999999999999643 3 6789999876555544556888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 855 PNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 855 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
++|+|.++++.. .....+++.++..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887643 2234588999999999999999999999 999999999999999999999999999987653211
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.......+||++|+|||++....++.++|||||||++|||++|+.||... ...+.+......... .
T Consensus 225 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-----~~~~~~~~~~~~~~~-------~ 290 (478)
T PTZ00267 225 --LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP-----SQREIMQQVLYGKYD-------P 290 (478)
T ss_pred --cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCC-------C
Confidence 12234567999999999999999999999999999999999999999642 122233333222211 1
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+...+..+.+++.. |++.+|++||++.+++.
T Consensus 291 ~~~~~s~~~~~li~~------~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 FPCPVSSGMKALLDP------LLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCccCCHHHHHHHHH------HhccChhhCcCHHHHHh
Confidence 122233345555554 99999999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.16 Aligned_cols=199 Identities=27% Similarity=0.342 Sum_probs=166.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-C-CCcEEEEEEeecCC--ccchHHHHHHHHHHhcc---CCCCcceEEeeee-----c
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-P-SGLTVAVKRFRASD--KISTGAFSSEIATLSRI---RHRNIVRLLGWGA-----N 843 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~ 843 (1117)
++|++.+.||+|+||+||+|+. . +++.||+|+++... ......+.+|+++++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999975 2 46889999987542 22234566788877766 6999999999875 2
Q ss_pred CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 844 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
....++||||++ ++|.+++..... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456799999996 688888875432 3388999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+++..... .......||+.|+|||++....++.++|||||||++|||++|++||.+
T Consensus 156 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 156 LARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred ceEeccCC-----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 99865432 123345789999999999888999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=325.47 Aligned_cols=261 Identities=24% Similarity=0.410 Sum_probs=206.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|.+.+.||+|+||.||+|+. .++..||+|.++.......+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3577889999999999999864 2356799999876655555679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc
Q 001238 850 FYDYMPNGTLGMLLHDGE-------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE 916 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 916 (1117)
||||+++++|.+++.... ..+.+++..+++++.|++.|++|||++ +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999986532 123488999999999999999999999 9999999999999999999
Q ss_pred ceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHH
Q 001238 917 SCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQW 995 (1117)
Q Consensus 917 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~ 995 (1117)
++|+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....+
T Consensus 162 ~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--TEVIE- 236 (291)
T ss_pred EEECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH-
Confidence 99999999976543211 112233456789999999998999999999999999999999 9999864211 11221
Q ss_pred HHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 996 VRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.. .... .. ......+..+.+++. .|++.+|++||++.+|+++|+++.+.
T Consensus 237 --~~-~~~~-~~-----~~~~~~~~~~~~li~------~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 --CI-TQGR-VL-----ERPRVCPKEVYDIML------GCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred --HH-hCCC-CC-----CCCccCCHHHHHHHH------HHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11 1111 10 111222334444444 49999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=321.82 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=207.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
..+|++.++||+|+||.||+|...+++.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34688899999999999999998789999999998766555678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++.... ...+++.++.+++.|++.|++|||+. +|+||||||+||++++++.+||+|||.+.......
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 9999999998753 23489999999999999999999999 99999999999999999999999999998764321
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.......++..|+|||.+....++.++||||||+++|+|++ |+.||.... ...... ...... . +.
T Consensus 159 --~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~---~~~~~~-~------~~ 224 (261)
T cd05148 159 --YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYD---QITAGY-R------MP 224 (261)
T ss_pred --ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHH---HHHhCC-c------CC
Confidence 11123346778999999988899999999999999999998 899996421 112222 221111 1 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
.+...+..+.++ +..|++.+|++||+++++++.|+.+
T Consensus 225 ~~~~~~~~~~~~------i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 CPAKCPQEIYKI------MLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCHHHHHH------HHHHcCCCchhCcCHHHHHHHHhcC
Confidence 122223344444 4459999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=323.30 Aligned_cols=250 Identities=31% Similarity=0.513 Sum_probs=192.7
Q ss_pred CCCeeeecCCeEEEEEEcC-----CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 780 AGNIIGQGRSGIVYKVTLP-----SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 780 ~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+.+.||.|.||.||+|.+. .+..|+||+++.... ...+.|.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999865 357899999965432 2367899999999999999999999999988889999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.+++.... ...+++.++.+|+.|+++||+|||++ +|+||||+++||++++++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~-- 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK-- 156 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS--
T ss_pred cccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence 99999999998862 23489999999999999999999999 9999999999999999999999999999876321
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
..............|+|||.+....++.++||||||+++|||++ |+.||... ...+..... ..... .
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~-~~~~~------~ 224 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKL-KQGQR------L 224 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHH-HTTEE------T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccc-ccccc------c
Confidence 11123334457789999999999899999999999999999999 78998542 222222222 21111 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
..+...+..+.+++.. ||+.+|++||+++++++.|
T Consensus 225 ~~~~~~~~~~~~li~~------C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQ------CWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHH------HT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHH------HcCCChhhCcCHHHHHhcC
Confidence 1223344556666665 9999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.94 Aligned_cols=244 Identities=27% Similarity=0.439 Sum_probs=197.0
Q ss_pred eeeecCCeEEEEEEcCC-CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCChhh
Q 001238 783 IIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGM 861 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 861 (1117)
+||+|.||+||.|+..+ ...+|||.+...+....+-+..|+..-+.++|.|||+++|.+.+.++.-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999998654 56799999987666666778999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc-CCCcceeccccccccccCCCCCcccc
Q 001238 862 LLHDGECAGLL--EWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG-ERYESCLADFGLARLVEDDSGGSFSA 938 (1117)
Q Consensus 862 ~l~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~ 938 (1117)
+++..- |++ .+.+.-.+..||++||.|||++ .|||||||-+|||+. -.|.+||+|||.++.+..- ...
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi----nP~ 732 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI----NPC 732 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC----Ccc
Confidence 998753 335 6778888999999999999999 999999999999996 4689999999999987532 234
Q ss_pred CCccccccccCChhhhccC--CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 939 NPQFAGSYGYIAPEYANMT--KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 939 ~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
..++.||..|||||++..+ .|+.++|||||||++.||.||++||-..-.. . ..+++- ..-...|.++.
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--q-AAMFkV-------GmyKvHP~iPe 802 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--Q-AAMFKV-------GMYKVHPPIPE 802 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--h-Hhhhhh-------cceecCCCCcH
Confidence 5678999999999999764 5889999999999999999999999643111 1 111111 11122344444
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......+. +++.|..+||.+||+++++++
T Consensus 803 elsaeak~------FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKN------FILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHH------HHHHHcCCCcccCccHHHhcc
Confidence 43333333 555699999999999999987
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.81 Aligned_cols=242 Identities=20% Similarity=0.305 Sum_probs=189.7
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||+||+|.. .+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 46889999999754 222345577899888777 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|..++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---- 150 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---- 150 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----
Confidence 9999888654 3489999999999999999999999 99999999999999999999999999997543211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCC---ChhHHHHHHHHHhcCCCCccccCcc
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD---GQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......++........ ..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------~~ 223 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IR 223 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-------CC
Confidence 1223467999999999999999999999999999999999999999632111 1122222322222211 12
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~ 1046 (1117)
++...+.....+++. |++.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~------~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKS------FLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHH------HhcCCHHHcCCC
Confidence 233334445555554 999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=324.46 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=202.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
++|.+.+.||+|+||.||+|... +++.||||+++..... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 46888899999999999999753 3478999998765433 3568999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcc
Q 001238 849 LFYDYMPNGTLGMLLHDGE-----------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 917 (1117)
+||||+++++|.+++.... ....+++.++..++.|++.|++|||++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999987532 123478899999999999999999999 99999999999999999999
Q ss_pred eeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHH
Q 001238 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 918 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~ 996 (1117)
+|+|||+++....... ........+++.|+|||++....++.++|||||||++|||++ |+.||.... ......
T Consensus 162 kl~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~--~~~~~~-- 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS--NEEVIE-- 235 (280)
T ss_pred EECCcccceecccCcc--eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHH--
Confidence 9999999976533211 112223356789999999999999999999999999999998 999986421 122222
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
...... . +......+..+.++++. ||+.+|++||++.||++.|+
T Consensus 236 -~~~~~~--~-----~~~~~~~~~~~~~li~~------~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 -CITQGR--L-----LQRPRTCPSEVYDIMLG------CWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHcCC--c-----CCCCCCCCHHHHHHHHH------HcCCCcccCCCHHHHHHHhh
Confidence 211111 1 11112333455555555 99999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=326.78 Aligned_cols=256 Identities=28% Similarity=0.457 Sum_probs=207.9
Q ss_pred CCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
+++..++||-|-||.||.|.|+. .-.||||.++. +....++|..|+.+|+.++|||+|+++|+|..+..+|+|.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 35567899999999999999865 56899999874 55678899999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
.|+|.+|+++.... .++.-..+.+|.||++|++||..+ .+||||+.++|+||+++..+|++|||+++....+ .
T Consensus 347 yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD---T 419 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD---T 419 (1157)
T ss_pred CccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC---c
Confidence 99999999986543 367778889999999999999999 9999999999999999999999999999987643 2
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
+.+.....-.+.|.|||-+....++.|+|||+|||++||+.| |..||.+. +-..++..+.+.++-+ .-
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--dlSqVY~LLEkgyRM~---------~P 488 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYGLLEKGYRMD---------GP 488 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--cHHHHHHHHhcccccc---------CC
Confidence 233333334578999999999999999999999999999999 99998642 1112233332222111 11
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.+++ ..+.++++. ||+..|.+||+++|+.+.++.+..
T Consensus 489 eGCP-pkVYeLMra------CW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 489 EGCP-PKVYELMRA------CWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCC-HHHHHHHHH------HhcCCcccCccHHHHHHHHHHHhc
Confidence 3344 345555554 999999999999999999987653
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=328.82 Aligned_cols=240 Identities=22% Similarity=0.344 Sum_probs=189.3
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||+||+|+. .+++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 458899999997532 22334556677777654 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|..++... +.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---- 150 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---- 150 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----
Confidence 9999988754 3488999999999999999999999 99999999999999999999999999998653221
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... +.++.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~~~--------~~~~~ 217 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----EDELFDSILNDR--------PHFPR 217 (316)
T ss_pred CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCC--------CCCCC
Confidence 22334579999999999998899999999999999999999999996421 122222222111 22233
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHH-HHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMK-DVA 1050 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~-~v~ 1050 (1117)
..+....++++. |++.+|++||++. ++.
T Consensus 218 ~~~~~~~~ll~~------~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 218 WISKEAKDCLSK------LFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCHHHHHHHHH------HccCCHHHcCCChHHHH
Confidence 344455555555 9999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=330.14 Aligned_cols=241 Identities=20% Similarity=0.289 Sum_probs=191.4
Q ss_pred CeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||.||+|+.. +++.||+|+++.. .....+.+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999754 5789999998753 222344577888988866 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|..++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 150 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---- 150 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC----
Confidence 9999888654 2488999999999999999999999 99999999999999999999999999997643221
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++....++.++||||+||++|||++|+.||.... ............. ..+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~~~~~~~i~~~~~--------~~p~ 217 (321)
T cd05591 151 VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----EDDLFESILHDDV--------LYPV 217 (321)
T ss_pred ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCCC--------CCCC
Confidence 12334579999999999998999999999999999999999999996421 1222222222221 1122
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCC-------CHHHHHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRP-------TMKDVAA 1051 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RP-------s~~~v~~ 1051 (1117)
..+....++++. |++.||++|| ++.++.+
T Consensus 218 ~~~~~~~~ll~~------~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 218 WLSKEAVSILKA------FMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCHHHHHHHHH------HhccCHHHcCCCCCCCCCHHHHhc
Confidence 233445555554 9999999999 6677654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.72 Aligned_cols=247 Identities=19% Similarity=0.295 Sum_probs=193.4
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|..+++++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999975 468899999997542 22345678899999998 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---- 150 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---- 150 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC----
Confidence 9999888654 3489999999999999999999999 99999999999999999999999999987532211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCC---ChhHHHHHHHHHhcCCCCccccCcc
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD---GQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ......+..+...... ..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~~ 223 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-------IR 223 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-------CC
Confidence 1223457999999999999999999999999999999999999999642111 1112223333222221 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCC------HHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPT------MKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs------~~~v~~ 1051 (1117)
++...+.....+++. |++.||.+||+ +.++++
T Consensus 224 ~p~~~~~~~~~li~~------~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKG------FLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHH------HhccCHHHcCCCCCCCCHHHHhc
Confidence 233334445555555 99999999997 556643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.92 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=202.5
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
+|.+.+.||+|+||.||+|... .++.||+|++... ....+++.+|++++++++||||+++++++...+..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4777889999999999998754 5889999998754 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 86 ~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~--- 158 (263)
T cd05052 86 YGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--- 158 (263)
T ss_pred CCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce---
Confidence 9999999876432 3489999999999999999999999 99999999999999999999999999998764321
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
........++..|+|||.+.+..++.++|||||||++|||++ |..||... ...+...... ... .+..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~~~-~~~------~~~~ 226 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELLE-KGY------RMER 226 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHH-CCC------CCCC
Confidence 111122334678999999998999999999999999999998 99998642 1122222211 110 1112
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
+...+..+.+++.. |++.+|++||++.+++++|+.+
T Consensus 227 ~~~~~~~~~~li~~------cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRA------CWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHH------HccCCcccCCCHHHHHHHHHhh
Confidence 22333455555554 9999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=333.90 Aligned_cols=261 Identities=29% Similarity=0.418 Sum_probs=200.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecC-Cc
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANR-KT 846 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 846 (1117)
++|++.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4689999999999999999853 235789999987542 22235677899999999 899999999987654 56
Q ss_pred eEEEEEecCCCChhhhhcCCCC----------------------------------------------------------
Q 001238 847 KLLFYDYMPNGTLGMLLHDGEC---------------------------------------------------------- 868 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 868 (1117)
.+++|||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999998864221
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCcccccccc
Q 001238 869 AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948 (1117)
Q Consensus 869 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y 948 (1117)
...+++..+.+++.||++||+|||+. +|+||||||+||++++++.++|+|||+++.+..... ........++..|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--~~~~~~~~~~~~y 241 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPLKW 241 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcc--hhhccCCCCCccc
Confidence 12478999999999999999999999 999999999999999999999999999987643211 1122334567789
Q ss_pred CChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHH
Q 001238 949 IAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQ 1027 (1117)
Q Consensus 949 ~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 1027 (1117)
+|||++.+..++.++|||||||++|||++ |+.||...... +.... ....... +..+......+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~----~~~~~~~------~~~~~~~~~~~~---- 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCR----RLKEGTR------MRAPEYATPEIY---- 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHH----HHhccCC------CCCCccCCHHHH----
Confidence 99999999999999999999999999998 99999653221 11111 1111111 011111222233
Q ss_pred HHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1028 ALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1028 ~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.++..|++.+|++||++.++++.|+++.+
T Consensus 307 --~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 --SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred --HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 35556999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.33 Aligned_cols=237 Identities=24% Similarity=0.315 Sum_probs=187.1
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHH-HHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIA-TLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||+||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999985 468999999987532 222334445544 56789999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++... +.+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---- 150 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----
Confidence 9999988764 3488999999999999999999999 99999999999999999999999999987543211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.......... .+..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~--------~~~~ 217 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTAEMYDNILNKPL--------RLKP 217 (323)
T ss_pred CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----CHHHHHHHHHcCCC--------CCCC
Confidence 1233457999999999999999999999999999999999999999642 22233333322211 1122
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMK 1047 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~ 1047 (1117)
..+....++++. |++.||.+||++.
T Consensus 218 ~~~~~~~~li~~------~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEG------LLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHH------HhhcCHHhCCCCC
Confidence 234455555555 9999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=331.80 Aligned_cols=198 Identities=29% Similarity=0.444 Sum_probs=173.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.++||+|+||.||++.+. ++..||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57999999999999999999864 68899999887542 22345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.+++... +.+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 85 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999998764 34788999999999999999999742 7999999999999999999999999999765432
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12334689999999999988999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=330.04 Aligned_cols=237 Identities=22% Similarity=0.299 Sum_probs=189.5
Q ss_pred CeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||+||+|+.+ +++.||||+++.. .....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999854 5889999998753 223345677888888876 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---- 150 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---- 150 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----
Confidence 99999887542 488999999999999999999999 99999999999999999999999999987543211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... .............. ..+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-----~~~~~~~~i~~~~~--------~~~~ 217 (320)
T cd05590 151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE-----NEDDLFEAILNDEV--------VYPT 217 (320)
T ss_pred CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC-----CHHHHHHHHhcCCC--------CCCC
Confidence 1233457999999999999899999999999999999999999999642 12222333222211 1222
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMK 1047 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~ 1047 (1117)
..+....++++. |++.||++||++.
T Consensus 218 ~~~~~~~~li~~------~L~~dP~~R~~~~ 242 (320)
T cd05590 218 WLSQDAVDILKA------FMTKNPTMRLGSL 242 (320)
T ss_pred CCCHHHHHHHHH------HcccCHHHCCCCC
Confidence 334455555555 9999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.44 Aligned_cols=252 Identities=24% Similarity=0.408 Sum_probs=200.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.+.||+|+||+||+|++.++..||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3578889999999999999988777789999987543 345679999999999999999999999999899999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|.+++.... ..+++.++++++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++......
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--- 154 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--- 154 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc---
Confidence 999999987643 2489999999999999999999999 99999999999999999999999999998664321
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
........++..|+|||......++.++||||||+++|||++ |+.||.... .... .......... ..
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~---~~~~~~~~~~-------~~ 222 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--NSET---VEKVSQGLRL-------YR 222 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHH---HHHHhcCCCC-------CC
Confidence 111222345678999999988889999999999999999998 999986421 1111 1222111111 11
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
+...+..+.+++. .||+.+|++||++.++++.++
T Consensus 223 ~~~~~~~~~~li~------~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMY------SCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHH------HHcCCCcccCCCHHHHHHhhC
Confidence 1122334444444 499999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=331.88 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=198.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|.+.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688899999999999999975 468999999997532 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++.... +.+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999997652 3489999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCccccCCccccccccCChhhhc------cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYAN------MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||.... .............
T Consensus 156 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~~~- 226 (330)
T cd05601 156 KM---VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-----SAKTYNNIMNFQR- 226 (330)
T ss_pred Cc---eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-----HHHHHHHHHcCCC-
Confidence 21 1223347899999999986 4567899999999999999999999996421 1222222222211
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.... +. ....+..+.++++. |++ +|++||++.++++
T Consensus 227 ~~~~--~~-~~~~~~~~~~li~~------ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKF--PE-DPKVSSDFLDLIQS------LLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCC--CC-CCCCCHHHHHHHHH------Hcc-ChhhCCCHHHHhC
Confidence 1100 11 11223345555554 887 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.62 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=202.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.++|++.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688899999999999999987778899999987543 34567899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 9999999997653 23489999999999999999999999 999999999999999999999999999987653211
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
........+..|+|||+.....++.++||||||+++|||++ |+.||.+.. ..... . ........ .
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~---~-~~~~~~~~------~ 224 (261)
T cd05068 159 --EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVL---Q-QVDQGYRM------P 224 (261)
T ss_pred --cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHH---H-HHHcCCCC------C
Confidence 11112233468999999988899999999999999999999 999996421 11111 1 11111111 0
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
.....+..+.+ ++..|++.+|++||++.++.+.|++
T Consensus 225 ~~~~~~~~~~~------li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCPKELYD------IMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCCHHHHH------HHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11122233444 4445999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.98 Aligned_cols=260 Identities=20% Similarity=0.344 Sum_probs=205.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688999999999999999985 468999999876432 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 852 DYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
||+++|+|.+++.... ....+++..+..++.|+++||+|||++ +++||||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886422 123478899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... .....+... +.....+
T Consensus 159 ~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~-~~~~~~~---- 226 (267)
T cd08228 159 KT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLFSLCQK-IEQCDYP---- 226 (267)
T ss_pred hh----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc---ccHHHHHHH-HhcCCCC----
Confidence 21 11223468889999999988889999999999999999999999985422 122222222 1111111
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
+......+..+.+++.. ||+.+|++||++.+|++.+++++
T Consensus 227 -~~~~~~~~~~~~~li~~------cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 -PLPTEHYSEKLRELVSM------CIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCChhhcCHHHHHHHHH------HCCCCcccCcCHHHHHHHHHHhc
Confidence 11112233445555554 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.63 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=198.1
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+|++.++||+|+||+||++.. .+++.||+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999975 468999999987532 1223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886542 23489999999999999999999999 99999999999999999999999999998654321
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
......|++.|+|||++....++.++||||+||++|||++|+.||.... .....+.+...+.... .
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~-------~ 222 (285)
T cd05605 157 -----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK--EKVKREEVERRVKEDQ-------E 222 (285)
T ss_pred -----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc--hhhHHHHHHHHhhhcc-------c
Confidence 1223478999999999998899999999999999999999999997532 1111122222222111 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
.++...+..+.+++.. |++.||++|| ++.++.+
T Consensus 223 ~~~~~~~~~~~~li~~------~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 EYSEKFSEAARSICRQ------LLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCcccCHHHHHHHHH------HccCCHHHhcCCCCCCHHHHhc
Confidence 1222334455555555 9999999999 7778755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=328.25 Aligned_cols=237 Identities=25% Similarity=0.305 Sum_probs=184.8
Q ss_pred CeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHH-HHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIA-TLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
++||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68899999987532 122334555554 57889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|...+... ..+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---- 150 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----
Confidence 9998888653 3378889999999999999999999 99999999999999999999999999987542211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++....++.++|||||||++|||++|+.||... ............. ..++.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~--------~~~~~ 217 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DVSQMYDNILHKP--------LQLPG 217 (321)
T ss_pred CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----CHHHHHHHHhcCC--------CCCCC
Confidence 1233457899999999999889999999999999999999999999642 2222222222211 11222
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMK 1047 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~ 1047 (1117)
.....+.+++. .|++.+|.+||++.
T Consensus 218 ~~~~~~~~li~------~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLV------GLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHH------HHccCCHhhcCCCC
Confidence 23334444444 49999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=334.88 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=191.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.+|+..++||+|+||+||+|.. .+|+.||||++..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3567778999999999999975 4689999999865432 2345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.... ...+..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986532 256778889999999999999999 99999999999999999999999999998764321
Q ss_pred CccccCCccccccccCChhhhcc-----CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||..... ..............
T Consensus 223 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~----- 292 (353)
T PLN00034 223 ---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICMSQ----- 292 (353)
T ss_pred ---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhccC-----
Confidence 12234579999999998743 2345689999999999999999999973211 11112122111111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.+......+..+.++++. ||+.||++||++.|+++.
T Consensus 293 --~~~~~~~~~~~l~~li~~------~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 --PPEAPATASREFRHFISC------CLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCCCCccCHHHHHHHHH------HccCChhhCcCHHHHhcC
Confidence 011222334455555554 999999999999999873
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.18 Aligned_cols=270 Identities=25% Similarity=0.346 Sum_probs=193.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCC-----ceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRK-----TKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l 849 (1117)
-.|...+++|.|+||.||+|.. .+++.||||+.-...+. =.+|+++|+++.|||||++.-+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3567789999999999999984 45789999998755432 246999999999999999998875432 2358
Q ss_pred EEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-Ccceecccccccc
Q 001238 850 FYDYMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGLARL 927 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla~~ 927 (1117)
||||||. +|.++++.. .....++...+.-+++|+.+||+|||+. +|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999975 788777742 1122377778888999999999999998 99999999999999976 8999999999998
Q ss_pred ccCCCCCccccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHH------
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL------ 1000 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~------ 1000 (1117)
+..+. +......|..|+|||.+. ...|+.+.||||.|||+.||+-|++-|.+... .+.++++++-.-
T Consensus 176 L~~~e-----pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 176 LVKGE-----PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTRED 249 (364)
T ss_pred eccCC-----CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 87643 334567899999999775 47899999999999999999999999976322 223333332110
Q ss_pred -hc-CCCCccccCcccCCCCchh-H--HHHHHHHhHhhhccCCCCCCCCCHHHHHH--HHHhhhcC
Q 001238 1001 -KS-KKDPVEVLDPKLQGHPDTQ-I--QEMLQALGISLLCTSNRAEDRPTMKDVAA--LLREIRQE 1059 (1117)
Q Consensus 1001 -~~-~~~~~~~~~~~l~~~~~~~-~--~~~l~~~~i~~~C~~~~p~~RPs~~~v~~--~L~~~~~~ 1059 (1117)
.. .....+...|.+...+-.. . ..-.+.+++...++..+|.+|.++.|+++ .+++++..
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 00 0000111112222221000 0 00012334455599999999999999876 45555543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.56 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=200.0
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCc
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 846 (1117)
.+++|++.+.||+|+||.||+|... .++.||+|++.... .....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999998642 35679999986432 2234568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCccee
Q 001238 847 KLLFYDYMPNGTLGMLLHDGEC-------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
.++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 12367889999999999999999998 9999999999999999999999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHH
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
+|||+++....... ........+++.|+|||++....++.++|||||||++|||++ |..||.... .......
T Consensus 161 ~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQVLRF 233 (277)
T ss_pred CCCCCccccCCcce--eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Confidence 99999986543211 111222345788999999998899999999999999999999 788986421 1122222
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
...... +..+...+..+.+++. .|++.+|++||++.++++.+++
T Consensus 234 ~~~~~~-------~~~~~~~~~~~~~li~------~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGL-------LDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCc-------CCCCCCCCHHHHHHHH------HHcCCChhhCcCHHHHHHHhhC
Confidence 111111 1112222334444444 4999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=340.07 Aligned_cols=367 Identities=29% Similarity=0.443 Sum_probs=319.7
Q ss_pred EEEEeccccccc-CcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhcc
Q 001238 76 VVGLDLRYVDLL-GHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLN 154 (1117)
Q Consensus 76 v~~l~l~~~~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 154 (1117)
|.++|++++++. +.+|.+...++.++.|.|...++. .+|.+++.|.+|++|.+++|++. .+..++..|+.|+.+++.
T Consensus 9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R 86 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR 86 (1255)
T ss_pred eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence 678999999999 579999999999999999999998 89999999999999999999998 788899999999999999
Q ss_pred CCCcC-CCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCcc-cccccccccccccccccc
Q 001238 155 SNQLE-GAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHE-IGNCTNLVMIGLAETSIS 232 (1117)
Q Consensus 155 ~N~l~-~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~-l~~l~~L~~L~l~~~~~~ 232 (1117)
.|++. .-||..|..|..|++||||+|+++ +.|..+..-+++-+|+|++|++ .++|.. +-+++.|-+|+|++|.+.
T Consensus 87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~I--etIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNI--ETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcc--ccCCchHHHhhHhHhhhccccchhh
Confidence 99996 358999999999999999999998 6999999999999999999975 578876 468999999999999986
Q ss_pred ccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccC-CcCCccCCCCCCCcEEEccCCcCcccCCcCC
Q 001238 233 GFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALT-GSIPSKLGNLKNLVNLFLWQNNLVGIIPPEL 311 (1117)
Q Consensus 233 ~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~ 311 (1117)
.+|+.+..|..|++|.+++|.+.-.--..+-.+++|+.|.+++.+=+ ..+|.++..|.+|..++|+.|++. ..|+.+
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl 241 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECL 241 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence 67888999999999999999765433334556788888888886432 368888889999999999999998 788889
Q ss_pred CCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCcccc-CCCCcccccccchH
Q 001238 312 GNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT-GAIPSEFGNLSNLT 390 (1117)
Q Consensus 312 ~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~ 390 (1117)
.++++|+.|+||+|+|+ .+.-..+...+|++|+||.|+++ .+|..++++++|+.|.+.+|+++ .-+|+.++.+.+|+
T Consensus 242 y~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Le 319 (1255)
T KOG0444|consen 242 YKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLE 319 (1255)
T ss_pred hhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhH
Confidence 99999999999999998 55556677788999999999998 88889999999999999999876 45788889999999
Q ss_pred HHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCC
Q 001238 391 LLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPP 453 (1117)
Q Consensus 391 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 453 (1117)
.+..++|++. .+|+.++.|..|+.|.|+.|++. .+|+++--++.|+.||+..|.=--.+|.
T Consensus 320 vf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 320 VFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred HHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 9999999988 88899999999999999999987 5888888888999999988865434444
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=347.41 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=202.5
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCC----
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK---- 845 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 845 (1117)
...++|++.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+..+..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999974 578999999987542 233456888999999999999999988765432
Q ss_pred ----ceEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceec
Q 001238 846 ----TKLLFYDYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLA 920 (1117)
Q Consensus 846 ----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 920 (1117)
..++||||+++|+|.++++... ....+++..+..++.|++.||+|+|++ +|+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 3579999999999999887532 234589999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHH
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
|||+++........ .......||+.|+|||++....++.++|||||||++|||++|+.||... .....+....
T Consensus 186 DFGls~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~~~~~~~ 258 (496)
T PTZ00283 186 DFGFSKMYAATVSD--DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEEVMHKTL 258 (496)
T ss_pred ecccCeeccccccc--cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHh
Confidence 99999876432111 1223467999999999999999999999999999999999999999642 2233333333
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
..... .++...+..+.+++.. |++.+|++||++.++++.
T Consensus 259 ~~~~~-------~~~~~~~~~l~~li~~------~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYD-------PLPPSISPEMQEIVTA------LLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCC-------CCCCCCCHHHHHHHHH------HcccChhhCcCHHHHHhC
Confidence 22211 1223334455555555 999999999999998763
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=333.23 Aligned_cols=201 Identities=25% Similarity=0.309 Sum_probs=173.5
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
..++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999864 5889999998642 22234457889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999998754 278899999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccCCccccccccCChhhhccC----CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMT----KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
... ........||+.|+|||++... .++.++||||+||++|||++|+.||..
T Consensus 194 ~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 194 ETG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred cCC---ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 321 1122356799999999998754 378899999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=317.61 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=202.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|++.+.||+|+||+||+|.++ +...||||+++... ......|.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46889999999999999999864 24579999987543 23345788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++.... +.+++.++.+++.|++.|++|||+. +|+||||||+||++++++.++++|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999997643 3589999999999999999999998 999999999999999999999999999987752
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.... .......++..|+|||.+....++.++||||||+++|||++ |..||... ..... ..........+
T Consensus 159 ~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~--~~~~~---~~~~~~~~~~~--- 228 (266)
T cd05033 159 SEAT--YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM--SNQDV---IKAVEDGYRLP--- 228 (266)
T ss_pred cccc--eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC--CHHHH---HHHHHcCCCCC---
Confidence 2111 11112345678999999998899999999999999999998 99998542 11122 22211111111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
.+...+..+.+++. .|++.+|++||++.++++.|+++
T Consensus 229 ----~~~~~~~~l~~li~------~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ----PPMDCPSALYQLML------DCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCHHHHHHHH------HHcCCCcccCcCHHHHHHHHHhh
Confidence 11222334444444 49999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=333.80 Aligned_cols=200 Identities=25% Similarity=0.377 Sum_probs=167.6
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecC-----CceE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR-----KTKL 848 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~ 848 (1117)
+|++.++||+|+||.||+|.. .+|+.||||++... ......++.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999975 46899999998743 222345688999999999999999999987543 2479
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||++ ++|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 6888888654 2489999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCccccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
....... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 154 FNDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ccccCcc-ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 4322111 12234579999999999865 6789999999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=334.44 Aligned_cols=253 Identities=23% Similarity=0.277 Sum_probs=197.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 357889999999999999999754 6889999998643 222334578899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999998754 278888999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCccccCCccccccccCChhhhccC----CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMT----KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
.. ........||+.|+|||++... .++.++|||||||++|||++|+.||... ................
T Consensus 195 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~~~~~ 266 (370)
T cd05596 195 NG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGTYSKIMDHKNSL 266 (370)
T ss_pred CC---cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcCCCcC
Confidence 21 1122345799999999988643 4789999999999999999999999642 1222233332221111
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCC--CCCHHHHHHH
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAED--RPTMKDVAAL 1052 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~--RPs~~~v~~~ 1052 (1117)
. .+. ....+....++++. |+..+|++ ||++.++++.
T Consensus 267 -~--~~~-~~~~s~~~~~li~~------~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 -T--FPD-DIEISKQAKDLICA------FLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -C--CCC-cCCCCHHHHHHHHH------HccChhhccCCCCHHHHhcC
Confidence 0 011 01123445555554 88888987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=339.30 Aligned_cols=365 Identities=29% Similarity=0.450 Sum_probs=218.8
Q ss_pred cccCCeEeccCCCCC-CCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEE
Q 001238 97 LLSLNRLVLSGTNLT-GSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQL 175 (1117)
Q Consensus 97 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L 175 (1117)
|+.++-.|+++|.++ +.+|..+..++++++|-|...++. .+|++++.|.+|++|.+++|++. .+-..+..|+.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 345566788888888 458888888888888888888886 78888888888888888888887 555667777777777
Q ss_pred eccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccc
Q 001238 176 FLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALL 255 (1117)
Q Consensus 176 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l 255 (1117)
++..|++.. .-
T Consensus 84 ~~R~N~LKn------------------------sG--------------------------------------------- 94 (1255)
T KOG0444|consen 84 IVRDNNLKN------------------------SG--------------------------------------------- 94 (1255)
T ss_pred hhhcccccc------------------------CC---------------------------------------------
Confidence 777777652 11
Q ss_pred cccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCcccc
Q 001238 256 SGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTL 335 (1117)
Q Consensus 256 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l 335 (1117)
+|+.+..+..|+.|||++|+++ +.|..+..-+++-.|+|++|+|..+..+.|.+++.|-.||||+|++. .+|.-+
T Consensus 95 ---iP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~ 169 (1255)
T KOG0444|consen 95 ---IPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQI 169 (1255)
T ss_pred ---CCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHH
Confidence 3334444444555555555555 45555555555555555555555333333445555555555555555 333345
Q ss_pred CCCCCcceEecccccccCcccccccCCCCCcEEEecCcccc-CCCCcccccccchHHHHhccccccccCCCCCCcccccc
Q 001238 336 GNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT-GAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLE 414 (1117)
Q Consensus 336 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 414 (1117)
..|..|++|+|++|.+.-..-..+-.+++|+.|.+++.+-+ ..+|.++..+.+|..+|+++|.+. .+|+.+-++.+|+
T Consensus 170 RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~Lr 248 (1255)
T KOG0444|consen 170 RRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLR 248 (1255)
T ss_pred HHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhh
Confidence 55555555555555554333333344455555555554422 345555555556666666666655 5555555556666
Q ss_pred eeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCccc-ccCCCCcCCCCCCCEEEccCC
Q 001238 415 AVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT-GFIPPEIGNLKNLNFLDLGSN 493 (1117)
Q Consensus 415 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N 493 (1117)
.|+||+|+|+ .+........+|++|+|+.|+++ ..|.+++.++.|+.|.+.+|+++ .-+|..++.+.+|+++..++|
T Consensus 249 rLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN 326 (1255)
T KOG0444|consen 249 RLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANN 326 (1255)
T ss_pred eeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcc
Confidence 6666666655 34444444555566666666665 45556666666666666666554 234555666666666666666
Q ss_pred cCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCc
Q 001238 494 RLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNS 542 (1117)
Q Consensus 494 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 542 (1117)
++. ..|..++.+..|+.|.|+.|++- .+|+++.-++.|+.||+..|.
T Consensus 327 ~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 327 KLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred ccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 665 55666666666666666666655 456666666666666666654
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=327.27 Aligned_cols=240 Identities=21% Similarity=0.317 Sum_probs=190.4
Q ss_pred CeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||.||+|+.+ +|+.||+|+++... ......+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999864 68899999997532 22344567788887754 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---- 150 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----
Confidence 9999888754 3488999999999999999999999 99999999999999999999999999987532211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... . ..+......... +.++.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~--~---~~~~~~~~~~~~--------~~~~~ 217 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--D---EDELFESIRVDT--------PHYPR 217 (316)
T ss_pred CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--C---HHHHHHHHHhCC--------CCCCC
Confidence 1233467999999999999999999999999999999999999999642 1 112222221111 22233
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHH-HHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMK-DVA 1050 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~-~v~ 1050 (1117)
..+..+.++++. |++.||++||++. ++.
T Consensus 218 ~~~~~~~~li~~------~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEK------LFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHH------HccCCHHHcCCChHHHH
Confidence 344455666655 9999999999974 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.52 Aligned_cols=241 Identities=19% Similarity=0.256 Sum_probs=191.3
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCC-CCcceEEeeeecCCceEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRH-RNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~ 851 (1117)
+|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|++++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999754 5789999999753 22334567889999999976 46888999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999988654 3488999999999999999999999 9999999999999999999999999998753221
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.........
T Consensus 155 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~i~~~~-------- 217 (324)
T cd05587 155 G----KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----EDELFQSIMEHN-------- 217 (324)
T ss_pred C----CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCC--------
Confidence 1 12234579999999999999999999999999999999999999996421 122222222221
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~ 1046 (1117)
..++...+....++++. |++.+|.+|++.
T Consensus 218 ~~~~~~~~~~~~~li~~------~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSYPKSLSKEAVSICKG------LLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCHHHHHHHHH------HhhcCHHHcCCC
Confidence 12223334444555554 999999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=321.53 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=200.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-----CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.+|++.+.||+|+||+||+|.. .+++.||+|.++... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577889999999999999873 356789999987533 2234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC
Q 001238 850 FYDYMPNGTLGMLLHDGEC--------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY 915 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 915 (1117)
||||+++++|.+++..... ...+++.++..++.|++.||+|||++ +|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999998853211 12478899999999999999999999 999999999999999999
Q ss_pred cceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHH
Q 001238 916 ESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQ 994 (1117)
Q Consensus 916 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~ 994 (1117)
.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||.+.. .....+
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADY--YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQEVIE 237 (283)
T ss_pred cEEeccccccccccCCcc--eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHH
Confidence 999999999987643221 112233456778999999988889999999999999999998 999986421 112222
Q ss_pred HHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 995 WVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
.+ ...... ..+...+..+.+++. .|++.+|++||++.+|.+.++.
T Consensus 238 ~~----~~~~~~------~~~~~~~~~~~~li~------~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MV----RKRQLL------PCSEDCPPRMYSLMT------ECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH----HcCCcC------CCCCCCCHHHHHHHH------HHcccCcccCcCHHHHHHHhhc
Confidence 22 111111 112223334444444 4999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=338.18 Aligned_cols=202 Identities=25% Similarity=0.316 Sum_probs=172.1
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.|++.++||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999975 468899999987532 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++|+|.+++.+. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998764 3478899999999999999999999 99999999999999999999999999985432100
Q ss_pred CC-------------------------------------------ccccCCccccccccCChhhhccCCCCcCCCeeehh
Q 001238 933 GG-------------------------------------------SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYG 969 (1117)
Q Consensus 933 ~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG 969 (1117)
.. ........+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00 00011235799999999999999999999999999
Q ss_pred hhHHHHHhCCCCCCC
Q 001238 970 VVLLEIITGKKPVDA 984 (1117)
Q Consensus 970 ~vl~ell~g~~P~~~ 984 (1117)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=315.17 Aligned_cols=253 Identities=29% Similarity=0.447 Sum_probs=200.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.++||+|+||.||+|..+++..||+|.++.... ..+.+.+|++++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46888999999999999999988888999999876433 4567999999999999999999999875 456899999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.++++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05070 84 KGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc--
Confidence 9999999876432 3489999999999999999999999 999999999999999999999999999986643211
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......++..|+|||+.....++.++||||||+++|||++ |+.||.... ..+......... . +..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~~~~~~~-~------~~~ 224 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----NREVLEQVERGY-R------MPC 224 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCC-C------CCC
Confidence 11122345678999999988889999999999999999999 899986421 112222221111 1 111
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
+...+..+.+++. .|+..+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~li~------~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELML------QCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHH------HHcccCcccCcCHHHHHHHHhc
Confidence 2223334555554 4999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=338.17 Aligned_cols=202 Identities=26% Similarity=0.332 Sum_probs=172.4
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 588999999999999999975 468999999986432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++|+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999998764 3478899999999999999999999 99999999999999999999999999985331100
Q ss_pred CC---------------------------------------ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHH
Q 001238 933 GG---------------------------------------SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLL 973 (1117)
Q Consensus 933 ~~---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ 973 (1117)
.. .........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00 000112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCC
Q 001238 974 EIITGKKPVDA 984 (1117)
Q Consensus 974 ell~g~~P~~~ 984 (1117)
||++|+.||..
T Consensus 236 ell~G~~Pf~~ 246 (376)
T cd05598 236 EMLVGQPPFLA 246 (376)
T ss_pred ehhhCCCCCCC
Confidence 99999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=328.80 Aligned_cols=240 Identities=24% Similarity=0.285 Sum_probs=186.9
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHH-HHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIA-TLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||+||+|+. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999975 468999999987531 222344555555 46778999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|..++... +.+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---- 150 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---- 150 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----
Confidence 9999888654 3488999999999999999999999 99999999999999999999999999987543211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.......... .+..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-----~~~~~~~~~~~~~~--------~~~~ 217 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR-----DVAEMYDNILHKPL--------VLRP 217 (325)
T ss_pred CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC-----CHHHHHHHHHcCCc--------cCCC
Confidence 1233557999999999999999999999999999999999999999642 12222333222211 1111
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVA 1050 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~ 1050 (1117)
..+....++++. |++.+|.+||++++.+
T Consensus 218 ~~~~~~~~ll~~------ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 GASLTAWSILEE------LLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCHHHHHHHHH------HhccCHHhcCCCCCCH
Confidence 223344444444 9999999999876433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=322.38 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=203.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC---CC--cEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP---SG--LTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~---~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
.+..+..+.||+|-||.||+|... .| -.||||.-+.. .....+.|..|+.+|++++|||||+++|+|.+ ...+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 345667789999999999999632 33 35899988764 34456789999999999999999999999876 5689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+|||.++-|.|..+++.++ ..++..+...++.|++.||+|||++ .+|||||..+|||+....-+|++|||++|.+
T Consensus 467 ivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999999865 3488999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
.++.. +.+. ...-.+.|||||-+..+.++.++|||.|||.+||++. |..||.+....+ +.- ++..+..
T Consensus 542 ed~~y--YkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--VI~----~iEnGeR-- 610 (974)
T KOG4257|consen 542 EDDAY--YKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--VIG----HIENGER-- 610 (974)
T ss_pred cccch--hhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--eEE----EecCCCC--
Confidence 76532 2222 3345678999999999999999999999999999988 999997642221 111 1111111
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
...+..++..+..++.. ||+.+|.+||.+.++.+.|.++.+
T Consensus 611 ----lP~P~nCPp~LYslmsk------cWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 ----LPCPPNCPPALYSLMSK------CWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----CCCCCCCChHHHHHHHH------HhccCcccCCcHHHHHHHHHHHHH
Confidence 11222233334444444 999999999999999998877654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.04 Aligned_cols=266 Identities=25% Similarity=0.364 Sum_probs=198.0
Q ss_pred CCCCCCeeeecCCeEEEEEE-----cCCCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecC--CceE
Q 001238 777 SLTAGNIIGQGRSGIVYKVT-----LPSGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKL 848 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 848 (1117)
.|++.+.||+|+||+||++. ..+++.||+|.++.... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 34888999999999998754 24678999999875432 2356788999999999999999999987654 3578
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+++++|.+++... .+++.++..++.|++.|++|||++ +|+||||||+||++++++.++|+|||+++..
T Consensus 85 lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999998754 289999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
...... ........++..|+|||.+....++.++||||||+++|||++|+.||......-........... ......+
T Consensus 158 ~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 235 (283)
T cd05080 158 PEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM-TVVRLIE 235 (283)
T ss_pred CCcchh-hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc-chhhhhh
Confidence 532211 11122234567799999998889999999999999999999999998643211000000000000 0000000
Q ss_pred c----cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1009 V----LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1009 ~----~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
. .....+...+..+.+++. .||+.+|++||+++++++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~------~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMK------NCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHH------HHhccChhhCCCHHHHHHHHHHhh
Confidence 0 001112233344555444 499999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=351.73 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=201.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.++||+|+||.||+|... +|+.||+|+++... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999754 58999999987532 223457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 852 DYMPNGTLGMLLHDGE--------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
||++||+|.+++.... .....++..+++++.||++||+|||++ +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 112356778899999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC--------------ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCC
Q 001238 924 LARLVEDDSGG--------------SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG 989 (1117)
Q Consensus 924 la~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~ 989 (1117)
+++........ ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 99876221110 01112235799999999999999999999999999999999999999965211
Q ss_pred hhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-CHHHHHHHHHhhhcC
Q 001238 990 QHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-TMKDVAALLREIRQE 1059 (1117)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-s~~~v~~~L~~~~~~ 1059 (1117)
.... ..... ..+... .+ ....+..+.+ ++..|++.||++|| +++++.+.|+...+.
T Consensus 237 ~ki~--~~~~i---~~P~~~-~p--~~~iP~~L~~------LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 237 RKIS--YRDVI---LSPIEV-AP--YREIPPFLSQ------IAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhh--hhhhc---cChhhc-cc--cccCCHHHHH------HHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1110 01100 011110 00 0112233344 44459999999996 677788888776543
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=321.04 Aligned_cols=246 Identities=22% Similarity=0.258 Sum_probs=191.3
Q ss_pred eeecCCeEEEEEEc-CCCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 784 IGQGRSGIVYKVTL-PSGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 784 lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
||+|+||+||++.. .+|+.||+|++..... ...+.+..|++++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999875 4689999999875422 1234577899999999999999999999999999999999999999
Q ss_pred hhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcccc
Q 001238 860 GMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSA 938 (1117)
Q Consensus 860 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 938 (1117)
.+++... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~----~~ 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ----SK 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC----cc
Confidence 8877542 2234589999999999999999999999 99999999999999999999999999998664322 12
Q ss_pred CCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCC
Q 001238 939 NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018 (1117)
Q Consensus 939 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1018 (1117)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............. . ..++...
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~---~-----~~~~~~~ 224 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILND---S-----VTYPDKF 224 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc-hhHHHHHHhhccc---C-----CCCcccC
Confidence 23457899999999999999999999999999999999999999642211 1111111111111 0 1122233
Q ss_pred chhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1019 DTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1019 ~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
+..+.+++.. |++.||++|| +++++++
T Consensus 225 ~~~~~~li~~------~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 225 SPASKSFCEA------LLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CHHHHHHHHH------HhcCCHHHhcCCCCCCHHHHhc
Confidence 4455555555 9999999999 5666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=325.73 Aligned_cols=241 Identities=22% Similarity=0.310 Sum_probs=189.5
Q ss_pred CeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||+||+|... +++.||||+++... ......+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999854 57899999997542 22344566788888764 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---- 150 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----
Confidence 9999998754 2388999999999999999999999 99999999999999999999999999987543211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+......... +.++.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~i~~~~--------~~~~~ 217 (316)
T cd05619 151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEELFQSIRMDN--------PCYPR 217 (316)
T ss_pred CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC--------CCCCc
Confidence 12234578999999999998899999999999999999999999996421 112222211111 11222
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHH-HHHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMK-DVAA 1051 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~-~v~~ 1051 (1117)
..+..+.+++.. |++.+|++||++. ++.+
T Consensus 218 ~~~~~~~~li~~------~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVK------LFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHH------HhccCHhhcCCChHHHHc
Confidence 334445555554 9999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=327.05 Aligned_cols=241 Identities=19% Similarity=0.256 Sum_probs=190.7
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
+|.+.+.||+|+||+||+|... +++.||||+++... ......+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999754 57899999987542 22234566788888777 5899999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888654 3488999999999999999999999 9999999999999999999999999999754321
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. .......||+.|+|||++....++.++|||||||++|||++|+.||.... ............
T Consensus 155 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----~~~~~~~i~~~~-------- 217 (323)
T cd05616 155 G----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDELFQSIMEHN-------- 217 (323)
T ss_pred C----CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCC--------
Confidence 1 12234579999999999999999999999999999999999999996421 122222222221
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~ 1046 (1117)
..++...+....+++.. |++.+|++|++.
T Consensus 218 ~~~p~~~s~~~~~li~~------~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKG------LMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHH------HcccCHHhcCCC
Confidence 11222333444555544 999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=326.62 Aligned_cols=241 Identities=21% Similarity=0.334 Sum_probs=192.6
Q ss_pred CeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999754 5789999999753 223345677899998888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 150 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---- 150 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----
Confidence 9999888764 2489999999999999999999999 99999999999999999999999999987532211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ ..++.
T Consensus 151 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~i~~~~--------~~~~~ 217 (318)
T cd05570 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQSILEDE--------VRYPR 217 (318)
T ss_pred CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHcCC--------CCCCC
Confidence 12234578999999999999999999999999999999999999996421 122222222211 11222
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCH-----HHHHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTM-----KDVAA 1051 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~-----~~v~~ 1051 (1117)
..+..+.++++. |++.||++||++ .++++
T Consensus 218 ~~~~~~~~li~~------~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLSKEAKSILKS------FLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCHHHHHHHHH------HccCCHHHcCCCCCCCHHHHhc
Confidence 334455555555 999999999998 77755
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=319.42 Aligned_cols=263 Identities=27% Similarity=0.393 Sum_probs=199.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-----CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeec--CCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN--RKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 848 (1117)
++|++.+.||+|+||+||++.. .+++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788899999999999999863 3578999999886655556789999999999999999999997654 34678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+++|+|.+++.... +.+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999987542 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCC----------ChhHHHHHHH
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD----------GQHVIQWVRD 998 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~----------~~~~~~~~~~ 998 (1117)
...... ........++..|+|||+..+..++.++||||||+++|||++|..|+...... .......+..
T Consensus 159 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 159 PQDKEY-YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred cCCCcc-eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 543211 11111223445699999999889999999999999999999988776432110 0000011111
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
....... .......+..+.+++ ..||+.+|++|||+.+|++.|+.+
T Consensus 238 ~~~~~~~------~~~~~~~~~~~~~li------~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGR------LPAPPGCPAEIYAIM------KECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCc------CCCCCCCCHHHHHHH------HHHccCChhhCCCHHHHHHHHHhc
Confidence 1111100 011122233444444 459999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=317.58 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=198.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCc----EEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGL----TVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|++.+.||+|+||+||+|.+. +++ .||+|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999853 344 47778775332 2233567888889999999999999998754 55788
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
++||+++|+|.+++.... +.+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999997643 3489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... ........++..|+|||++....++.++||||||+++||+++ |+.||.+..+ ....+ .+.......
T Consensus 161 ~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~~- 231 (279)
T cd05111 161 PDDK--KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPD----LLEKGERLA- 231 (279)
T ss_pred CCCc--ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH----HHHCCCcCC-
Confidence 3221 112234557789999999988899999999999999999998 9999965311 11222 222221111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
.+ ...+..... ++..||+.+|++||++.++.+.+..+.+.+
T Consensus 232 --~~---~~~~~~~~~------li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 232 --QP---QICTIDVYM------VMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred --CC---CCCCHHHHH------HHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 11 112222333 444599999999999999999999877644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=335.81 Aligned_cols=194 Identities=24% Similarity=0.323 Sum_probs=168.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
..+|++.+.||+|+||.||++.. .+++.||+|+.. .+.+.+|++++++++|||||++++++......++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46799999999999999999974 568999999753 23578899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+. ++|..++... ..+++.+++.++.|+++||+|||++ +||||||||+||+++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 6888777654 2388999999999999999999999 999999999999999999999999999975432211
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......||+.|+|||++....++.++||||+||++|||++|+.||..
T Consensus 238 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 238 ---NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ---cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 122345799999999999988999999999999999999999988743
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=314.21 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=198.8
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+|++.+.||+|+||.||+|.++++..+|+|++.... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 478889999999999999988777889999986433 2345788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
++|.+++.... +.+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--- 155 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--- 155 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc---
Confidence 99999987643 2489999999999999999999999 999999999999999999999999999986643211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......++..|+|||.+....++.++||||||+++|||++ |+.||..... ... ... ...... ...+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~---~~~-~~~~~~------~~~~ 223 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEV---VES-VSAGYR------LYRP 223 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHH---HHH-HHcCCc------CCCC
Confidence 11112234568999999998999999999999999999999 8999864211 111 111 111111 1112
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
...+..+.+++. .|++.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~li~------~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMY------SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHH------HHhcCChhhCcCHHHHHHHh
Confidence 223444555444 49999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=320.09 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=201.3
Q ss_pred CCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
+|++.+.||+|+||.||+|... ....||+|.+..... ...+++.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999998742 235789998875432 234578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCe
Q 001238 850 FYDYMPNGTLGMLLHDGE---------------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHN 908 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 908 (1117)
||||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999876421 113478999999999999999999998 99999999999
Q ss_pred EEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCC
Q 001238 909 ILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP 987 (1117)
Q Consensus 909 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~ 987 (1117)
|++++++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |+.||.+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDS--YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccc--hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-
Confidence 9999999999999999986543221 112223345778999999988889999999999999999998 999996421
Q ss_pred CChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 988 DGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
...+.+. ...... ...+...+..+.++ +..|++.+|++||+++++++.|+++..
T Consensus 235 -~~~~~~~----~~~~~~------~~~~~~~~~~~~~~------i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 -PERLFNL----LKTGYR------MERPENCSEEMYNL------MLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHHHHH----HhCCCC------CCCCCCCCHHHHHH------HHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1122222 211111 11122233344444 445999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=317.40 Aligned_cols=260 Identities=20% Similarity=0.347 Sum_probs=205.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||+|.. .+++.||||.+...+ ....+++.+|+++++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3678889999999999999984 578999999886532 223457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 852 DYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
||+++++|.+++.... ....+++.++++++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 234589999999999999999999999 999999999999999999999999999886643
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .......++..|+|||++.+..++.++||||||+++|||++|..||..... ..............
T Consensus 159 ~~----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~------ 225 (267)
T cd08229 159 KT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEQCDY------ 225 (267)
T ss_pred CC----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---hHHHHhhhhhcCCC------
Confidence 21 112234688999999999988899999999999999999999999964221 12222222111110
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
.+......+..+..++.. |++.+|++|||+.+|.++++++.
T Consensus 226 ~~~~~~~~~~~~~~li~~------~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPLPSDHYSEELRQLVNM------CINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCcccccHHHHHHHHH------hcCCCcccCCCHHHHHHHHhhhc
Confidence 011112233455555554 99999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=318.76 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=201.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|...++||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4677889999999999999863 2466899999876655556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcc
Q 001238 850 FYDYMPNGTLGMLLHDGEC------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 917 (1117)
||||+++++|.+++..... ...+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999876431 12478999999999999999999999 99999999999999999999
Q ss_pred eeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHH
Q 001238 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 918 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~ 996 (1117)
||+|||+++...... .........+++.|+|||.+....++.++|||||||++|||++ |++||..... . ..+
T Consensus 162 kL~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~---~~~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTD--YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--T---EAI 234 (280)
T ss_pred EECCCCceeEcCCCc--eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--H---HHH
Confidence 999999997654321 1111223345788999999998999999999999999999998 9999854211 1 112
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
........ . ..+...+..+.+++.. ||+.||++||++.+|.+.|+
T Consensus 235 ~~~~~~~~-~------~~~~~~~~~~~~li~~------cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGRE-L------ERPRTCPPEVYAIMQG------CWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCcc-C------CCCCCCCHHHHHHHHH------HccCChhhCCCHHHHHHHHh
Confidence 22211111 0 1112233445555555 99999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=321.10 Aligned_cols=256 Identities=24% Similarity=0.325 Sum_probs=199.5
Q ss_pred CCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
+|.+.+.||+|+||.||+|... .++.||+|+++..... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667788999999999999753 3578999999754322 23568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc
Q 001238 850 FYDYMPNGTLGMLLHDGE-------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE 916 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 916 (1117)
++||+++++|.+++.... ....+++..+.+++.|++.||+|+|++ +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999885321 123478889999999999999999999 9999999999999999999
Q ss_pred ceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHH
Q 001238 917 SCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQW 995 (1117)
Q Consensus 917 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~ 995 (1117)
+||+|||+++....... ........+++.|+|||++....++.++||||||+++|||++ |..||.+. ...++
T Consensus 163 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-----~~~~~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-----SNQDV 235 (283)
T ss_pred eEecccccccccccchh--eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----CHHHH
Confidence 99999999986643211 112233456789999999988889999999999999999998 88888642 11222
Q ss_pred HHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 996 VRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
.......... ..+...+..+..++. .|++.+|++||++++|++.|+.
T Consensus 236 ~~~i~~~~~~-------~~~~~~~~~~~~li~------~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQVL-------PCPDDCPAWVYTLML------ECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCcC-------CCCCCCCHHHHHHHH------HHhCCCcccCCCHHHHHHHhhC
Confidence 3222222111 112333444555444 4999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=326.46 Aligned_cols=240 Identities=24% Similarity=0.293 Sum_probs=186.6
Q ss_pred CeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHH-HHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEI-ATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||+||+|... +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999754 57889999987532 11223344444 456788999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++... +.+.+..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---- 150 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---- 150 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----
Confidence 9999988764 2377888899999999999999999 99999999999999999999999999997543221
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+.......... .+..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~~--------~~~~ 217 (325)
T cd05602 151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----NTAEMYDNILNKPL--------QLKP 217 (325)
T ss_pred CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC-----CHHHHHHHHHhCCc--------CCCC
Confidence 1233457999999999999999999999999999999999999999642 11222222222211 1122
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVA 1050 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~ 1050 (1117)
..+....++++. |++.+|.+||++.+.+
T Consensus 218 ~~~~~~~~li~~------~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 NITNSARHLLEG------LLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCHHHHHHHHH------HcccCHHHCCCCCCCH
Confidence 233455565555 9999999999876443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=313.22 Aligned_cols=253 Identities=28% Similarity=0.468 Sum_probs=202.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.++||+|+||.||+|..++++.||+|.+.... ...+++.+|++++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4688899999999999999998889999999987543 34568999999999999999999999864 467899999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 156 (260)
T cd05067 84 NGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE--- 156 (260)
T ss_pred CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC---
Confidence 999999887643 23489999999999999999999998 99999999999999999999999999997765321
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
........++..|+|||++....++.++||||||+++||+++ |+.||.... .......+ ...... ..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~----~~~~~~------~~ 224 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNL----ERGYRM------PR 224 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHH----HcCCCC------CC
Confidence 112223345778999999998899999999999999999999 999996431 12222221 111111 11
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
+...+..+.+++.. |++.+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~li~~------~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRL------CWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHH------HccCChhhCCCHHHHHHHhhc
Confidence 22233345555554 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=321.75 Aligned_cols=263 Identities=26% Similarity=0.417 Sum_probs=198.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC---------------CcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS---------------GLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLG 839 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~ 839 (1117)
++|++.+.||+|+||.||++.... ...||+|+++... ....+.|.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999986532 2358999987542 223456899999999999999999999
Q ss_pred eeecCCceEEEEEecCCCChhhhhcCCCC---------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEE
Q 001238 840 WGANRKTKLLFYDYMPNGTLGMLLHDGEC---------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNIL 910 (1117)
Q Consensus 840 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 910 (1117)
++...+..++||||+++++|.+++..... ...+++..+++++.|+++|++|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999999865321 12368899999999999999999999 9999999999999
Q ss_pred EcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh--CCCCCCCCCCC
Q 001238 911 LGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT--GKKPVDASFPD 988 (1117)
Q Consensus 911 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~--g~~P~~~~~~~ 988 (1117)
+++++.+||+|||+++...... .........++..|+|||+...+.++.++|||||||++|||++ |..||... .
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~--~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD--YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL--S 237 (295)
T ss_pred EcCCCcEEecccccccccccCc--ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc--C
Confidence 9999999999999998654321 1112223345778999999988899999999999999999998 66677542 1
Q ss_pred ChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 989 GQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
.................... .......+..+.+ ++..|++.+|++||++.+|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~------li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIY---LSQTPLCPSPVFK------LMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHHHHHHHHHhhhhcccccc---CCCCCCCCHHHHH------HHHHHcCCCchhCcCHHHHHHHHh
Confidence 12222222222211111000 0111112233444 444599999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=320.59 Aligned_cols=264 Identities=27% Similarity=0.422 Sum_probs=198.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-----------------CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-----------------SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRL 837 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 837 (1117)
++|++.++||+|+||.||++... ++..||+|+++... ....+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999998532 24469999987543 2334678999999999999999999
Q ss_pred EeeeecCCceEEEEEecCCCChhhhhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeE
Q 001238 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGEC--------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNI 909 (1117)
Q Consensus 838 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Ni 909 (1117)
++++...+..++||||+++|+|.+++..... ...+++.++.+++.|++.|++|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999876321 12377889999999999999999999 999999999999
Q ss_pred EEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh--CCCCCCCCCC
Q 001238 910 LLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT--GKKPVDASFP 987 (1117)
Q Consensus 910 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~--g~~P~~~~~~ 987 (1117)
+++.++.++|+|||+++....... ........++..|+|||......++.++|||||||++|||++ |..||....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~- 238 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS- 238 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc--eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC-
Confidence 999999999999999986543211 111223345678999999888889999999999999999998 778885421
Q ss_pred CChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 988 DGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
.................. ...+. +...+..+.+ ++..||+.+|++||++.+|.+.|++
T Consensus 239 -~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~------li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 -DEQVIENTGEFFRDQGRQ--VYLPK-PALCPDSLYK------LMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -hHHHHHHHHHHHhhcccc--ccCCC-CCCCCHHHHH------HHHHHcCCCcccCCCHHHHHHHHhC
Confidence 112222121111111000 01111 1122234444 4445999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=332.86 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=203.3
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCc-cchHHHHHHHHHHhccC-CCCcceEEeeeecCC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIR-HRNIVRLLGWGANRK 845 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 845 (1117)
..++|.+.++||+|+||.||+|.+. .++.||+|+++.... ...+.+.+|++++.++. |||||++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888999999999999999743 346899999975432 22346889999999997 999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCC---------------------------------------------------------
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGEC--------------------------------------------------------- 868 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 868 (1117)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999865321
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEE
Q 001238 869 --------------------------------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNIL 910 (1117)
Q Consensus 869 --------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nil 910 (1117)
...+++..+.+++.|++.||+|||+. +|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 12367788899999999999999998 9999999999999
Q ss_pred EcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCC
Q 001238 911 LGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDG 989 (1117)
Q Consensus 911 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~ 989 (1117)
+++++.+|++|||+++....... ........+++.|+|||.+....++.++|||||||++|||++ |+.||.....
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-- 347 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSN--YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-- 347 (401)
T ss_pred EeCCCEEEEEecCcceecccccc--cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--
Confidence 99999999999999986543211 112223457889999999988889999999999999999998 8999864311
Q ss_pred hhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 990 QHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
.+.....+..... +..+...+..+.+++.. ||..+|++||++++|++.|+++.
T Consensus 348 ---~~~~~~~~~~~~~------~~~p~~~~~~l~~li~~------cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 ---NEQFYNAIKRGYR------MAKPAHASDEIYEIMQK------CWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---hHHHHHHHHcCCC------CCCCCCCCHHHHHHHHH------HcCCChhHCcCHHHHHHHHHHHh
Confidence 1111122222111 11122233455555555 99999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=314.18 Aligned_cols=260 Identities=22% Similarity=0.357 Sum_probs=206.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||+|... +|+.||+|.++.. +....+++.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999865 7899999988643 2233567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 852 DYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
||+++|+|.+++.... ....+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++++|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 234488999999999999999999999 999999999999999999999999999886543
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.... .............. .
T Consensus 159 ~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~--~---- 225 (267)
T cd08224 159 KT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCD--Y---- 225 (267)
T ss_pred CC----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCC--C----
Confidence 21 11233468889999999988889999999999999999999999985422 22222222211111 0
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
.+......+..+.+++.. |+..+|++||++.+|+++++++.
T Consensus 226 ~~~~~~~~~~~~~~~i~~------cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 PPLPADHYSEELRDLVSR------CINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCChhhcCHHHHHHHHH------HcCCCcccCCCHHHHHHHHHHhc
Confidence 011111233345555544 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=314.40 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=199.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.++||+|+||.||+|.+.++..||+|+++... ...+++.+|++++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4689999999999999999987777789999987533 24567899999999999999999999874 456799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|.+++.... ...+++..+..++.|+++||+|+|+. +|+||||||+||++++++.++|+|||.++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-- 157 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 157 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc--
Confidence 999999997643 23478999999999999999999999 999999999999999999999999999986643221
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......++..|+|||+.....++.++||||||+++|||++ |+.||..... . +......... .. ..
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--~---~~~~~~~~~~-~~------~~ 224 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--R---EVLDQVERGY-RM------PC 224 (262)
T ss_pred -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--H---HHHHHHhcCC-CC------CC
Confidence 11223346778999999988899999999999999999999 8888864311 1 1112111111 00 11
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
....+..+.+ ++..|++.+|++||++.++.+.|+..
T Consensus 225 ~~~~~~~l~~------li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 PPECPESLHD------LMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccccCHHHHH------HHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1222333444 44559999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=319.60 Aligned_cols=261 Identities=26% Similarity=0.353 Sum_probs=201.9
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRK 845 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 845 (1117)
..++|++.+.||+|+||.||++... ....||+|++.... .....++.+|+++++++ +||||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3457888999999999999999753 23689999987542 22345688999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDG-------------ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 912 (1117)
..+++|||+++|+|..+++.. ...+.+++..+++++.|++.||+|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999998643 1234588999999999999999999998 999999999999999
Q ss_pred CCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChh
Q 001238 913 ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQH 991 (1117)
Q Consensus 913 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~ 991 (1117)
+++.+||+|||+++....... ........++..|+|||+.....++.++|||||||++|||++ |..||....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----- 239 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDY--YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----- 239 (293)
T ss_pred CCCeEEeCccccccccccccc--eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-----
Confidence 999999999999987653211 111222335678999999988899999999999999999998 999986421
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
..+.. ......... ..+...+..+.+ ++..|++.+|++||++.++++.|+++.
T Consensus 240 ~~~~~-~~~~~~~~~------~~~~~~~~~~~~------li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 VEELF-KLLKEGYRM------EKPQNCTQELYH------LMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHH-HHHHcCCcC------CCCCCCCHHHHH------HHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111 111111111 111222233444 444599999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=320.01 Aligned_cols=264 Identities=28% Similarity=0.439 Sum_probs=201.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCC-----------------CcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPS-----------------GLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVR 836 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 836 (1117)
..+|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999987432 3468999987543 234567889999999999999999
Q ss_pred EEeeeecCCceEEEEEecCCCChhhhhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCe
Q 001238 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGEC--------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHN 908 (1117)
Q Consensus 837 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 908 (1117)
+++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999876431 12489999999999999999999999 99999999999
Q ss_pred EEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh--CCCCCCCCC
Q 001238 909 ILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT--GKKPVDASF 986 (1117)
Q Consensus 909 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~--g~~P~~~~~ 986 (1117)
|+++.++.++++|||+++...... .........+++.|+|||++....++.++|||||||++|||++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~- 237 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD--YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL- 237 (296)
T ss_pred eeecCCCceEEccccceeecccCc--ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc-
Confidence 999999999999999998654321 1122234456789999999988889999999999999999998 67787542
Q ss_pred CCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 987 PDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
........+....+........ + .+...+..+.+ ++..|++.+|++||++.+|++.|+
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~l~~------li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 -TDQQVIENAGHFFRDDGRQIYL--P-RPPNCPKDIYE------LMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -ChHHHHHHHHhccccccccccC--C-CccCCCHHHHH------HHHHHhccChhcCCCHHHHHHHhc
Confidence 1222222222221111111110 1 11122233344 455599999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=314.78 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=197.0
Q ss_pred CCCCCeeeecCCeEEEEEEcCC----CcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCc-----
Q 001238 778 LTAGNIIGQGRSGIVYKVTLPS----GLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT----- 846 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 846 (1117)
|++.+.||+|+||.||+|.... +..||+|+++... ....+.+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999997532 4689999987542 2234578999999999999999999998766554
Q ss_pred -eEEEEEecCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccc
Q 001238 847 -KLLFYDYMPNGTLGMLLHDGE---CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADF 922 (1117)
Q Consensus 847 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 922 (1117)
.++||||+++|+|..++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999998885432 123589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHh
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLK 1001 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~ 1001 (1117)
|+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||.... .. +.......
T Consensus 158 g~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~---~~~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NH---EIYDYLRH 230 (273)
T ss_pred cceeeccccccc--cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HH---HHHHHHHc
Confidence 999876533211 11222345678999999988889999999999999999999 899986421 11 22222111
Q ss_pred cCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1002 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
.. . +..+...+..+.+++ ..|++.||++||++.++++.|+++
T Consensus 231 ~~-~------~~~~~~~~~~~~~li------~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN-R------LKQPEDCLDELYDLM------YSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC-C------CCCCcCCCHHHHHHH------HHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1 111222333444444 449999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=324.35 Aligned_cols=254 Identities=26% Similarity=0.440 Sum_probs=204.1
Q ss_pred CCCCCCeeeecCCeEEEEEEcC--CCc--EEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP--SGL--TVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
..+..++||+|.||+|++|.|. +|+ .||||.++..... ..+.|.+|+.+|.+|+|||++++||...+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 4556688999999999999874 344 6899999876544 56789999999999999999999998877 6778999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|.++.|+|.+.++. ...+.+-......++.|||.|+.||.++ ++||||+..+|+++-....+||+|||+.|.+...
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999998 3445688889999999999999999999 9999999999999999999999999999988765
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.+. +...........|+|||.++...++.++|||+|||++|||++ |+.||.+- .-.++++.. +.+...
T Consensus 266 ed~-Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-----~g~qIL~~i-D~~erL---- 334 (1039)
T KOG0199|consen 266 EDM-YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-----RGIQILKNI-DAGERL---- 334 (1039)
T ss_pred Ccc-eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-----CHHHHHHhc-cccccC----
Confidence 433 333344456778999999999999999999999999999999 89999652 222222222 111111
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
++ +..+++.+..+++. ||..+|++||++..|.+.+-
T Consensus 335 -pR-Pk~csedIY~imk~------cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 335 -PR-PKYCSEDIYQIMKN------CWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -CC-CCCChHHHHHHHHH------hccCCccccccHHHHHHhHH
Confidence 11 22334455555554 99999999999999986543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=330.20 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=195.3
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
..++|++.+.||+|+||.||+++.+ +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 4578999999999999999999864 5889999998642 22233457889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999999998754 278889999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccCCccccccccCChhhhccC----CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMT----KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
... ........||+.|+|||++... .++.++|||||||++|||++|+.||... ...............
T Consensus 194 ~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~~~ 265 (371)
T cd05622 194 KEG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGTYSKIMNHKNS 265 (371)
T ss_pred cCC---cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCc
Confidence 321 1122356799999999998653 3789999999999999999999999642 222223333222111
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCC--CCCHHHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAED--RPTMKDVAAL 1052 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~--RPs~~~v~~~ 1052 (1117)
... +. ....+.....++.. |+..++.+ ||++.++.+.
T Consensus 266 -~~~--~~-~~~~s~~~~~li~~------~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 -LTF--PD-DNDISKEAKNLICA------FLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -ccC--CC-cCCCCHHHHHHHHH------HcCChhhhcCCCCHHHHhcC
Confidence 111 11 11233344554444 77643333 6788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.61 Aligned_cols=255 Identities=22% Similarity=0.277 Sum_probs=199.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|.-|+||+++..+ +..+|+|++.+.. .....+.+.|-+||+.+.||.++.+|+.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457788899999999999998654 5899999997642 333456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|||+||+|..+.+++. .+.+++..++-++.+|+-||+|||.. |||+|||||+||||.++|++-|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999988865 45599999999999999999999999 9999999999999999999999999987543210
Q ss_pred C-------------------------------CCc---------------------cccCCccccccccCChhhhccCCC
Q 001238 932 S-------------------------------GGS---------------------FSANPQFAGSYGYIAPEYANMTKI 959 (1117)
Q Consensus 932 ~-------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 959 (1117)
. ... ......++||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 000 011235789999999999999999
Q ss_pred CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCC
Q 001238 960 SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNR 1039 (1117)
Q Consensus 960 ~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~ 1039 (1117)
+.++|.|+|||++|||+.|+.||.+... . +.+..++.+....++. + ......+++++. -+.+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~-~----~Tl~NIv~~~l~Fp~~--~----~vs~~akDLIr~------LLvKd 375 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNN-K----ETLRNIVGQPLKFPEE--P----EVSSAAKDLIRK------LLVKD 375 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCc-h----hhHHHHhcCCCcCCCC--C----cchhHHHHHHHH------HhccC
Confidence 9999999999999999999999976322 2 2233333333222111 1 112334454444 67789
Q ss_pred CCCCCC----HHHHHH
Q 001238 1040 AEDRPT----MKDVAA 1051 (1117)
Q Consensus 1040 p~~RPs----~~~v~~ 1051 (1117)
|.+|-. +.||-+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999987 666644
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=323.06 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=206.4
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCCcc---chHHHHHHHHHHhccC-CCCcceEEeeeecCCceE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKI---STGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 848 (1117)
....|.+.+.||+|.||.||++..+. |+.+|+|++.+.... ....+.+|+++|+++. |||||.+++++.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45678899999999999999998654 999999999765432 3458899999999998 999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC----Ccceeccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER----YESCLADFGL 924 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~----~~~kl~DfGl 924 (1117)
+|||++.||.|.+.+... . +++..+..++.|++.|+.|||+. ||+|||+||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998776 2 89999999999999999999998 99999999999999643 4799999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
+...... ......+||+.|+|||++....|+..+||||+||++|.|++|..||.+.... ...........
T Consensus 186 a~~~~~~-----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-----~~~~~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKPG-----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-----EIFLAILRGDF 255 (382)
T ss_pred ceEccCC-----ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-----HHHHHHHcCCC
Confidence 9987651 2445679999999999999999999999999999999999999999753222 11223333332
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.... ...........+++. ++..||.+|+++.++++
T Consensus 256 ~f~~~----~w~~is~~akd~i~~------ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 DFTSE----PWDDISESAKDFIRK------LLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCC----CccccCHHHHHHHHH------hcccCcccCCCHHHHhc
Confidence 22222 222223445555554 88999999999999988
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=324.22 Aligned_cols=243 Identities=19% Similarity=0.284 Sum_probs=190.5
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||+||+|+. .+++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999975 467899999997542 22345678899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|..++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 150 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---- 150 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----
Confidence 9999888654 2489999999999999999999999 99999999999999999999999999997532211
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCC-ChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD-GQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......++........ ..++
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~p 223 (327)
T cd05617 151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-------IRIP 223 (327)
T ss_pred CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-------CCCC
Confidence 1223457999999999999999999999999999999999999999643221 1112222222222211 1122
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHH
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMK 1047 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~ 1047 (1117)
...+....++++. |++.||++|+++.
T Consensus 224 ~~~~~~~~~li~~------~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKG------FLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHH------HhccCHHHcCCCC
Confidence 2333445555554 9999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=319.92 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=200.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC-C--cEEEEEEeecC-CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS-G--LTVAVKRFRAS-DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|++.+.||+|+||.||+|..++ + ..+|+|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999997543 3 35788888743 223345788999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcc
Q 001238 851 YDYMPNGTLGMLLHDGE-------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 917 (1117)
|||+++++|.+++.... ..+.+++..+++++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999986532 113488999999999999999999998 99999999999999999999
Q ss_pred eeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHH
Q 001238 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 918 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~ 996 (1117)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |+.||.... .....
T Consensus 159 kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-----~~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY-----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-----CAELY 228 (297)
T ss_pred EECCcCCCccccce-----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHH
Confidence 99999998643211 11111223567999999988889999999999999999997 999996431 11222
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
....... .+..+...+..+.+++.. |++.+|.+||+++++++.|+.+....
T Consensus 229 ~~~~~~~-------~~~~~~~~~~~~~~li~~------~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 EKLPQGY-------RMEKPRNCDDEVYELMRQ------CWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHhcCC-------CCCCCCCCCHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 2221111 111122233445555554 99999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=320.74 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=203.9
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
.+++...+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++......+
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 3455667899999999999999999974 568999999998765555678899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 94 lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred EeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 999999999999998653 378899999999999999999999 9999999999999999999999999998865
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... .......+++.|+|||.+....++.++|||||||++|||++|+.||....+. ..............
T Consensus 167 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~- 236 (296)
T cd06654 167 TPEQ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGTPEL- 236 (296)
T ss_pred cccc----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-----HhHHHHhcCCCCCC-
Confidence 4321 1123446889999999998888999999999999999999999999643211 11111111111100
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+.+++ ..|+..+|++||++.++++
T Consensus 237 ----~~~~~~~~~l~~li------~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 ----QNPEKLSAIFRDFL------NRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ----CCccccCHHHHHHH------HHHCcCCcccCcCHHHHhh
Confidence 01112223344444 4499999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=323.82 Aligned_cols=262 Identities=26% Similarity=0.355 Sum_probs=202.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC--------CCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP--------SGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRK 845 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 845 (1117)
.+|++.+.||+|+||.||+|... .+..||+|.++... ....+++.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 36889999999999999998632 12468999887532 22346789999999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGE-------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 912 (1117)
..+++|||+++|+|.+++.... ....+++.++.+++.|+++||+|||++ +|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999987532 123478899999999999999999999 999999999999999
Q ss_pred CCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChh
Q 001238 913 ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQH 991 (1117)
Q Consensus 913 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~ 991 (1117)
+++.+||+|||+++....... ........++..|+|||++....++.++||||||+++|||++ |..||... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~ 241 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-----P 241 (334)
T ss_pred CCCcEEECCcccceecccccc--cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-----C
Confidence 999999999999986643211 111222334568999999998999999999999999999998 88998642 1
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
..+......... . +..+......+..++ ..|++.+|++||++.++++.|+++....
T Consensus 242 ~~~~~~~~~~~~-~------~~~~~~~~~~l~~li------~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 242 VEELFKLLKEGH-R------MDKPANCTHELYMIM------RECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHHHcCC-C------CCCCCCCCHHHHHHH------HHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 222222221111 1 011122233344444 4499999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=317.60 Aligned_cols=245 Identities=22% Similarity=0.279 Sum_probs=190.9
Q ss_pred eeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 784 IGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 784 lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
||+|+||+||+++. .+|+.||+|++.... ......+..|++++++++||||+++++++....+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999975 468999999986432 11233456799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccC
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 939 (1117)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~ 151 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-----TI 151 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----ee
Confidence 988865432 2388999999999999999999999 99999999999999999999999999998664321 12
Q ss_pred CccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCc
Q 001238 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019 (1117)
Q Consensus 940 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1019 (1117)
....|+..|+|||++....++.++||||+||++|||++|+.||..... ................ . ......+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~------~-~~~~~~~ 223 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE-KVAKEELKRRTLEDEV------K-FEHQNFT 223 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc-hhhHHHHHHHhhcccc------c-cccccCC
Confidence 234689999999999988899999999999999999999999964221 1112222222221110 0 0011234
Q ss_pred hhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1020 TQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1020 ~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
....+++.. |++.||++||+++|+++
T Consensus 224 ~~~~~li~~------~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 224 EESKDICRL------FLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHH------HhccCHhhCCCCccchh
Confidence 455555555 99999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=320.15 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=202.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 847 (1117)
++|.+.+.||+|+||.||++.. ..+..||+|+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688999999999999999863 235589999987543 22345789999999999 799999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++|+|.++++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.++++|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999976432 3389999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
...... ........++..|+|||.+....++.++||||+||++|||++ |..||..... ...... .......
T Consensus 191 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-~~~~~~----~~~~~~~- 262 (302)
T cd05055 191 IMNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKFYK----LIKEGYR- 262 (302)
T ss_pred ccCCCc--eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-hHHHHH----HHHcCCc-
Confidence 643221 112223456788999999998899999999999999999998 9999865321 111111 1111111
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
+..+...+..+.++++ .|++.+|++||++.++++.|+++
T Consensus 263 -----~~~~~~~~~~~~~li~------~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 -----MAQPEHAPAEIYDIMK------TCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----CCCCCCCCHHHHHHHH------HHcCCCchhCcCHHHHHHHHHhh
Confidence 0111222334445444 49999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=321.11 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=195.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+++. .+++.||+|++... .....+.+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3688899999999999999985 46899999998742 2223456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999997532 3488999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccCCccccccccCChhhhcc-----CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
.. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||... ...+............
T Consensus 156 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-----~~~~~~~~i~~~~~~~ 227 (331)
T cd05597 156 GT---VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKEHF 227 (331)
T ss_pred CC---ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-----CHHHHHHHHHcCCCcc
Confidence 21 12223469999999999863 45788999999999999999999999642 2222222222211110
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
. +.+. ....+...+.+++. +.|...++..||++.++++.
T Consensus 228 -~-~~~~-~~~~~~~~~~li~~----ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 -Q-FPPD-VTDVSEEAKDLIRR----LICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -c-CCCc-cCCCCHHHHHHHHH----HccCcccccCCCCHHHHhcC
Confidence 0 1111 11233445555543 12555555568899888774
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=305.31 Aligned_cols=247 Identities=22% Similarity=0.357 Sum_probs=202.1
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
-|.+.++||+|+||.||++.+ .+|..||||++... .+.+++..|+.+|++++.|++|++||.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 356678999999999999864 57999999998654 346789999999999999999999999888899999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
.|+..++++.+. .++.+.++..+.+..++||+|||.. .-+|||||+.|||+..+|.+|++|||.|..+.+.
T Consensus 112 AGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT---- 182 (502)
T KOG0574|consen 112 AGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT---- 182 (502)
T ss_pred CCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh----
Confidence 999999998654 4599999999999999999999998 8899999999999999999999999999887653
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC-CCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK-DPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 1014 (1117)
...+.+..||+-|||||++..-.|..++||||+|++..||..|++||.+..+. +..+.... .++....
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--------RAIFMIPT~PPPTF~K--- 251 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--------RAIFMIPTKPPPTFKK--- 251 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--------ceeEeccCCCCCCCCC---
Confidence 34566789999999999999999999999999999999999999999754331 11111111 1111111
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+..++....++++. |+-..|++|-|+-++.+
T Consensus 252 PE~WS~~F~DFi~~------CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRS------CLIKKPEERKTALRLCE 282 (502)
T ss_pred hHhhhhHHHHHHHH------HhcCCHHHHHHHHHHhh
Confidence 12233344455554 99999999998877754
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=312.18 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=193.0
Q ss_pred CeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 782 NIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999754 68999999876432 23345789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccC
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 939 (1117)
.+++.... ..+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+|++|||+++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~ 153 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--ASTG 153 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccc--cccC
Confidence 99987542 3488999999999999999999999 999999999999999999999999999976532110 0111
Q ss_pred CccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCC
Q 001238 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018 (1117)
Q Consensus 940 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1018 (1117)
.....+..|+|||.+....++.++||||||+++|||++ |..||..... .. .......... ...+...
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~----~~~~~~~~~~------~~~~~~~ 221 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQ----TREAIEQGVR------LPCPELC 221 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HH----HHHHHHcCCC------CCCcccC
Confidence 11223567999999998899999999999999999998 8888864211 11 1111111111 1112222
Q ss_pred chhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1019 DTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1019 ~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
+..+.++++ .|++.+|++||++.++.++|+
T Consensus 222 ~~~~~~li~------~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLME------RCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHH------HHcCCChhhCcCHHHHHHHHh
Confidence 334444544 499999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=314.53 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=194.3
Q ss_pred CCCCCeeeecCCeEEEEEEcCC-Cc--EEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecC------Cc
Q 001238 778 LTAGNIIGQGRSGIVYKVTLPS-GL--TVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR------KT 846 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 846 (1117)
|.++++||+|+||.||+|...+ +. .||+|.++.. .....+.+.+|++++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999998644 32 6999988654 233356788999999999999999999976432 24
Q ss_pred eEEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDG---ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
.++||||+++|+|.+++... .....+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887432 1223488999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
+++....... ........+++.|+|||+.....++.++||||||+++|||++ |+.||... ... +... ....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~---~~~~-~~~~ 229 (272)
T cd05075 158 LSKKIYNGDY--YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--ENS---EIYD-YLRQ 229 (272)
T ss_pred cccccCcccc--eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CHH---HHHH-HHHc
Confidence 9987643221 111223346778999999998999999999999999999999 88998642 111 1112 1222
Q ss_pred CCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1003 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
.... .........+.+++. .||+.+|++||++.++++.|+++
T Consensus 230 ~~~~------~~~~~~~~~~~~li~------~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRL------KQPPDCLDGLYSLMS------SCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC------CCCCCCCHHHHHHHH------HHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 111223334444444 49999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=316.08 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=197.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4789999999999999999985 568899999997655445567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.++++.. +.+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||+++......
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 999999988754 3488999999999999999999999 99999999999999999999999999998664321
Q ss_pred ccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 935 SFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+... ..........+...
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~-- 231 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----LFLMSKSNFQPPKL-- 231 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-----heeeecCCCCCCCC--
Confidence 1223456889999999874 34578899999999999999999999854221100 00000000000000
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
......+..+.++++ .|++.+|++||+++++++.
T Consensus 232 -~~~~~~~~~~~~li~------~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 -KDKTKWSSTFHNFVK------ISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -ccccccCHHHHHHHH------HHhhCChhhCcCHHHHhcC
Confidence 001122334445444 4999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=311.87 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=193.5
Q ss_pred eeeecCCeEEEEEEc---CCCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCC
Q 001238 783 IIGQGRSGIVYKVTL---PSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNG 857 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 857 (1117)
.||+|+||.||+|.+ +++..||+|+++.... ...+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999864 3578999999875432 23457889999999999999999999875 45678999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccc
Q 001238 858 TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFS 937 (1117)
Q Consensus 858 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 937 (1117)
+|.+++... +.+++..+.+++.|++.|++|+|++ +|+||||||+||++++++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~-~~ 153 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY-YK 153 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe-ee
Confidence 999998754 2488999999999999999999999 9999999999999999999999999999876543211 11
Q ss_pred cCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 938 ANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 938 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
......++..|+|||.+....++.++||||||+++|||++ |+.||.... .......+ ..... +..+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~i----~~~~~------~~~~~ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--GNEVTQMI----ESGER------MECPQ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HCCCC------CCCCC
Confidence 1222344678999999988889999999999999999998 999996421 12222222 11111 11223
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
..+..+.++++. ||+.+|++||++++|++.|+.
T Consensus 222 ~~~~~l~~li~~------~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 RCPPEMYDLMKL------CWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCHHHHHHHHH------HhccCchhCcCHHHHHHHHhc
Confidence 334455555555 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=320.71 Aligned_cols=262 Identities=26% Similarity=0.365 Sum_probs=204.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc--------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecC
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL--------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANR 844 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 844 (1117)
..+|++.+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 34688899999999999999863 134579999987532 23346789999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL 911 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 911 (1117)
+..++||||+++|+|.+++..... ...+++.++..++.|+++||+|||++ +|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999876421 12478889999999999999999999 99999999999999
Q ss_pred cCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCCh
Q 001238 912 GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ 990 (1117)
Q Consensus 912 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~ 990 (1117)
++++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----- 243 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----- 243 (304)
T ss_pred cCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----
Confidence 99999999999999876432211 11223346678999999988889999999999999999998 78888542
Q ss_pred hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
...+.... ....... ..+...+..+..++.. ||+.+|++||++.++++.|+++...
T Consensus 244 ~~~~~~~~-~~~~~~~------~~~~~~~~~~~~li~~------cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 244 PVEELFKL-LKEGHRM------DKPANCTNELYMMMRD------CWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CHHHHHHH-HHcCCcC------CCCCCCCHHHHHHHHH------HcccChhhCCCHHHHHHHHHHHHHh
Confidence 12222222 2221111 1112233445555554 9999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.69 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=197.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeee-cCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA-NRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~ 854 (1117)
++|++.+.||+|+||.||++.. .|..||+|.++... ..+.+.+|++++++++|+|++++++++. ..+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4688889999999999999976 47889999986432 3567899999999999999999999754 456789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.++++.... ..+++..+.+++.|++.||+|||++ +|+||||||+||++++++.+|++|||+++......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999876432 3488999999999999999999999 99999999999999999999999999988654321
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
....++..|+|||++....++.++||||||+++|||++ |+.||... ...+......... . +.
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~~-~------~~ 219 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKGY-K------MD 219 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCC-C------CC
Confidence 12244678999999998899999999999999999998 99998642 1222222211111 1 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
.....+..+.+++.. |++.+|++||++.++++.|+++
T Consensus 220 ~~~~~~~~~~~li~~------~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 APDGCPPVVYDVMKQ------CWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCHHHHHHHHH------HhcCChhhCcCHHHHHHHHhcC
Confidence 222333445555544 9999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=338.49 Aligned_cols=197 Identities=24% Similarity=0.340 Sum_probs=161.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecC--------C
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANR--------K 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~ 845 (1117)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 46799999999999999999975 468899999886432 2346799999999999999999876432 2
Q ss_pred ceEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC-cceecccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-ESCLADFG 923 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfG 923 (1117)
..++||||+++ ++.+++... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999975 666655431 2234589999999999999999999999 999999999999999665 79999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+
T Consensus 217 la~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 217 SAKNLLAGQ-----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred cchhccCCC-----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 998764321 2234578999999998865 4689999999999999999999999965
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=316.85 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=203.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCC-----CcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeec-CCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPS-----GLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGAN-RKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 847 (1117)
.++|++.+.||+|+||.||+|.+.+ +..||+|+++... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578889999999999999998655 6889999887542 2334568899999999999999999998766 4678
Q ss_pred EEEEEecCCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECA-----GLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADF 922 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 922 (1117)
++++||+++|+|.+++...... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+|++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998764322 3589999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHh
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLK 1001 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~ 1001 (1117)
|+++.+...... .......++..|+|||++....++.++||||||+++||+++ |+.||.... ..++.. ...
T Consensus 162 g~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~-~~~ 233 (280)
T cd05043 162 ALSRDLFPMDYH--CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----PFEMAA-YLK 233 (280)
T ss_pred CCcccccCCceE--EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-----HHHHHH-HHH
Confidence 999866432211 11123346778999999988889999999999999999999 999996421 112221 122
Q ss_pred cCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1002 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
...... .....+..+.+++. .||+.+|++||++.++++.|+.+.+
T Consensus 234 ~~~~~~------~~~~~~~~~~~li~------~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYRLA------QPINCPDELFAVMA------CCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCCCC------CCCcCCHHHHHHHH------HHcCCChhhCCCHHHHHHHHHHHHh
Confidence 211111 11122334444444 4999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=329.86 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=202.1
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCC----cEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSG----LTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.+..++||+|+||+||+|.| +.| -+||||++... .....+++.+|+.+|.+++|||++|++++|.... ..+|.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 45568899999999999864 344 46899988654 3445678999999999999999999999998766 78999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
+||+.|+|.++++.++ +.+-....+.|..|||+||.|||++ ++|||||..+||||..-..+|+.|||+++....+
T Consensus 777 q~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999999864 4478889999999999999999999 9999999999999999999999999999988765
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.... ........+.|||-|.+....|+.++|||||||++||++| |..||++.. .+.+.+.++....
T Consensus 852 ~~ey--~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~------~~eI~dlle~geR----- 918 (1177)
T KOG1025|consen 852 EKEY--SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP------AEEIPDLLEKGER----- 918 (1177)
T ss_pred cccc--cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC------HHHhhHHHhcccc-----
Confidence 4322 1122234578999999999999999999999999999999 999997632 2223333333321
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
++..+.-. +.+..++.+||..|++.||+++++.+.+.++.+.
T Consensus 919 ---LsqPpiCt----iDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 919 ---LSQPPICT----IDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ---CCCCCCcc----HHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 11111111 1122244559999999999999999998877554
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=322.92 Aligned_cols=241 Identities=19% Similarity=0.255 Sum_probs=190.1
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 851 (1117)
+|...+.||+|+||+||+|.. .+|+.||+|+++... ....+.+..|.++++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 366778999999999999975 468999999987532 223456778899988885 578889999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999988754 3489999999999999999999999 9999999999999999999999999999754322
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .............
T Consensus 155 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~i~~~~~------- 218 (323)
T cd05615 155 G----VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-----EDELFQSIMEHNV------- 218 (323)
T ss_pred C----ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhCCC-------
Confidence 1 12234569999999999998999999999999999999999999996531 1222222222211
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~ 1046 (1117)
.++...+....+++. .|++.+|.+|++.
T Consensus 219 -~~p~~~~~~~~~li~------~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSKEAVSICK------GLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCHHHHHHHH------HHcccCHhhCCCC
Confidence 112223334444444 4999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.89 Aligned_cols=253 Identities=27% Similarity=0.468 Sum_probs=199.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|.+.+.||+|+||.||+|....+..||+|++.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3578889999999999999988777789999886543 33567899999999999999999999875 456899999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|.++++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc--
Confidence 999999997643 23478999999999999999999998 999999999999999999999999999987643211
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......++..|+|||......++.++||||||+++|||++ |+.||.... ......++ ...... ..
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~----~~~~~~------~~ 224 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQV----ERGYRM------PC 224 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCCCC------CC
Confidence 12223346778999999988899999999999999999999 999986421 11111211 111111 11
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
+...+..+.++++. |++.+|++||++++|.+.|++
T Consensus 225 ~~~~~~~~~~li~~------~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKL------CWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHH------HccCCcccCcCHHHHHHHHhc
Confidence 12233345555544 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=345.87 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=194.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeec--CCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN--RKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l 849 (1117)
.++|++.+.||+|+||+||+|... ++..||+|++... .......|..|+.++++++|||||++++++.+ ....|+
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 457999999999999999999754 5778999998753 22334678899999999999999999998754 356899
Q ss_pred EEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCC----CceeeeccccCeEEEcC-----------
Q 001238 850 FYDYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCV----PAILHRDVKSHNILLGE----------- 913 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivHrDlkp~Nill~~----------- 913 (1117)
||||+++|+|.+++.... ..+.+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 999999999999987532 22458999999999999999999998521 25999999999999964
Q ss_pred ------CCcceeccccccccccCCCCCccccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 914 ------RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 914 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
.+.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999998664321 2234579999999998854 45889999999999999999999999642
Q ss_pred CCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 986 FPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......+.. +...... .. ...+..+..++.. ||+.+|++||++.++++
T Consensus 247 ----~~~~qli~~-lk~~p~l------pi-~~~S~eL~dLI~~------~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 ----NNFSQLISE-LKRGPDL------PI-KGKSKELNILIKN------LLNLSAKERPSALQCLG 294 (1021)
T ss_pred ----CcHHHHHHH-HhcCCCC------Cc-CCCCHHHHHHHHH------HhcCChhHCcCHHHHhc
Confidence 122222222 2222111 01 1123345555554 99999999999999985
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.60 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=200.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
.++|++.++||+|+||.||+|..+ .+..||+|.+..... ....++.+|+.++++++||||+++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 457899999999999999998643 245899998864432 2234678899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceec
Q 001238 848 LLFYDYMPNGTLGMLLHDGEC-------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLA 920 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 920 (1117)
++||||+++|+|.+++..... ....++..+.+++.|++.||+|||++ +|+||||||+||++++++.++++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999975321 12356788899999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHH
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
|||+++....... ........++..|+|||.+....++.++|||||||++|||++ |+.||.... ..+.....
T Consensus 162 Dfg~~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----~~~~~~~~ 234 (288)
T cd05061 162 DFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----NEQVLKFV 234 (288)
T ss_pred cCCcccccccccc--ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH
Confidence 9999986543211 112223345678999999998899999999999999999999 788986421 11222222
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
..... +..+...+..+.+++. .|++.+|++||++.++++.+++..
T Consensus 235 ~~~~~-------~~~~~~~~~~~~~li~------~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGGY-------LDQPDNCPERVTDLMR------MCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCC-------CCCCCCCCHHHHHHHH------HHcCCChhHCcCHHHHHHHHHhhc
Confidence 21111 1111222334555554 499999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.06 Aligned_cols=243 Identities=27% Similarity=0.372 Sum_probs=194.6
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc---chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.|.-.+.||.|+||.||-|+. .+.+.||||++.-..++ .+..+..|++.+++++|||+|.+.|+|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 455567799999999999974 46789999999755433 35578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|| -|+-.|++.-.+ .++.+.++..|..+.+.||+|||++ +.||||||+.|||+++.|.||++|||.|....
T Consensus 107 YC-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred HH-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 99 467777765443 3488899999999999999999999 99999999999999999999999999997654
Q ss_pred CCccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
+...++|||.|||||++. .+.|+-|+||||+|++..|+...++|+-.. ..+ ..+-.+.+...
T Consensus 178 -----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM----NAM-SALYHIAQNes----- 242 (948)
T KOG0577|consen 178 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAM-SALYHIAQNES----- 242 (948)
T ss_pred -----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc----hHH-HHHHHHHhcCC-----
Confidence 344689999999999874 578999999999999999999999997432 111 11111112221
Q ss_pred cCccc-CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKL-QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l-~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
|.+ .+.++..+..++.. |++.-|.+|||..+++.
T Consensus 243 --PtLqs~eWS~~F~~Fvd~------CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 --PTLQSNEWSDYFRNFVDS------CLQKIPQERPTSEELLK 277 (948)
T ss_pred --CCCCCchhHHHHHHHHHH------HHhhCcccCCcHHHHhh
Confidence 112 34555566666665 99999999999887644
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=321.03 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=201.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC--------CCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP--------SGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRK 845 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 845 (1117)
++|.+.+.||+|+||.||+|... ++..||+|.++... .....++.+|+++++++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46899999999999999998642 23579999987542 22345688899999999 7999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 912 (1117)
..++||||+++|+|.+++..... ...+++.++++++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999976421 12488999999999999999999998 999999999999999
Q ss_pred CCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChh
Q 001238 913 ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQH 991 (1117)
Q Consensus 913 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~ 991 (1117)
+++.+||+|||.++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-----~ 247 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----P 247 (307)
T ss_pred CCCcEEECCCcccccccccch--hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-----C
Confidence 999999999999976543211 111112234578999999988889999999999999999998 88888542 1
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
..+... ....... ...+...+..+..++. .|++.+|++||++.+|++.|+++...
T Consensus 248 ~~~~~~-~~~~~~~------~~~~~~~~~~~~~li~------~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 VEELFK-LLKEGHR------MDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHH-HHHcCCC------CCCCCcCCHHHHHHHH------HHcccChhhCcCHHHHHHHHHHHHHH
Confidence 112221 1221111 1112222334444444 49999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.31 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=192.2
Q ss_pred eeeecCCeEEEEEEcC---CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCC
Q 001238 783 IIGQGRSGIVYKVTLP---SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGT 858 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 858 (1117)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|++++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999998653 356799999875432 23456899999999999999999999875 457899999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcccc
Q 001238 859 LGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSA 938 (1117)
Q Consensus 859 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 938 (1117)
|.+++.... ..+++.++.+++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++........ ...
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 154 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKA 154 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccc-eec
Confidence 999987542 3489999999999999999999999 9999999999999999999999999999865433211 111
Q ss_pred CCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCC
Q 001238 939 NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017 (1117)
Q Consensus 939 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1017 (1117)
.....++..|+|||++....++.++||||||+++||+++ |+.||.... .. ...... ..... +..+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~---~~~~~~-~~~~~------~~~~~~ 222 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--GP---EVMSFI-EQGKR------LDCPAE 222 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--HH---HHHHHH-HCCCC------CCCCCC
Confidence 222234678999999988889999999999999999996 999996431 11 222221 11111 111222
Q ss_pred CchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1018 ~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
.+..+.+++.. ||..+|++||++.+|.+.|+.+
T Consensus 223 ~~~~l~~li~~------c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKD------CWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHH------HcCCChhhCcCHHHHHHHHhhh
Confidence 23344554444 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.38 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=200.7
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||+|... +++.||+|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3677889999999999999754 6899999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++.... ...+++..+++++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence 99999999997642 23588999999999999999999998 99999999999999999999999999998765422
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.......|++.|+|||+.....++.++||||||+++|||++|+.||.... ............. +.
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-------~~ 220 (256)
T cd08529 156 ---NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----QGALILKIIRGVF-------PP 220 (256)
T ss_pred ---chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCCC-------CC
Confidence 12233468899999999998899999999999999999999999996431 1122222222111 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+....+..+.++++. |++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~------~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQ------CLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHH------HccCCcccCcCHHHHhh
Confidence 222333445555554 99999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=314.14 Aligned_cols=263 Identities=23% Similarity=0.379 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-----CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecC--Cce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 847 (1117)
+.|++.+.||+|+||.||.++. .+++.||+|.++... ....+++.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999863 357899999987543 33346789999999999999999999988775 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999986542 2489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCC---------CChhHHHHHHH
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFP---------DGQHVIQWVRD 998 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~---------~~~~~~~~~~~ 998 (1117)
....... ........++..|+|||++.+..++.++||||||+++|||++++.|+..... .+.........
T Consensus 159 ~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 159 IETDKEY-YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cccCccc-eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 6543211 1122345577789999999888899999999999999999998876532110 01111111111
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
....... .......+..+.+++. .|++.+|++||++.++++.++++
T Consensus 238 ~~~~~~~------~~~~~~~~~~~~~li~------~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKR------LPRPPNCPEEVYQLMR------KCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCcc------CCCCCCCCHHHHHHHH------HHccCCcccCcCHHHHHHHHHhh
Confidence 1111111 0111223334455444 49999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=314.70 Aligned_cols=250 Identities=20% Similarity=0.270 Sum_probs=194.8
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
|+..+.||+|+||+||+|.. .+++.||+|++.... ......+.+|++++++++|++|+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66678899999999999875 468999999986542 12234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988865432 3489999999999999999999999 99999999999999999999999999997653221
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||..... ......+........ ..
T Consensus 157 ----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~--~~~~~~~~~~~~~~~-------~~ 223 (285)
T cd05632 157 ----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE--KVKREEVDRRVLETE-------EV 223 (285)
T ss_pred ----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhhhccc-------cc
Confidence 12244789999999999888999999999999999999999999964211 111111211111110 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
+....+..+.+++. .|++.+|++||+ +.++++
T Consensus 224 ~~~~~~~~~~~li~------~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKFSEEAKSICK------MLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccCCHHHHHHHH------HHccCCHhHcCCCcccChHHHHc
Confidence 22223334444444 499999999999 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=315.23 Aligned_cols=257 Identities=26% Similarity=0.374 Sum_probs=198.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
+++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 457889999999999999999764 35689999886443 22345688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC---cceec
Q 001238 848 LLFYDYMPNGTLGMLLHDGEC----AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY---ESCLA 920 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~ 920 (1117)
++||||+++++|.+++..... ...+++..+.+++.||+.|++|||++ +++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999876431 12489999999999999999999999 999999999999998754 58999
Q ss_pred cccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHH
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
|||+++....... .........+..|+|||++.+..++.++|||||||++|||++ |+.||..... ... +..
T Consensus 162 dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~~~---~~~- 233 (277)
T cd05036 162 DFGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEV---MEF- 233 (277)
T ss_pred cCccccccCCccc--eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHH---HHH-
Confidence 9999987632211 111122234568999999998899999999999999999997 9999964211 122 211
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
....... ..+...+..+.+++. .|++.+|++||++.+|++.|+
T Consensus 234 ~~~~~~~------~~~~~~~~~~~~~i~------~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGRL------DPPKGCPGPVYRIMT------DCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCcC------CCCCCCCHHHHHHHH------HHcCCCcccCcCHHHHHHHhh
Confidence 1111111 112223334444444 499999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.06 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=188.5
Q ss_pred eeeecCCeEEEEEEcCC---CcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCC
Q 001238 783 IIGQGRSGIVYKVTLPS---GLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGT 858 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 858 (1117)
.||+|+||+||+|...+ ...||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996433 3578888776432 2234568889999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 859 LGMLLHDGEC--AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 859 L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|.+++..... ....++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~ 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED--YY 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccch--he
Confidence 9999876432 22356788899999999999999999 99999999999999999999999999987543321 11
Q ss_pred ccCCccccccccCChhhhcc-------CCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 937 SANPQFAGSYGYIAPEYANM-------TKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.......++..|+|||+... ..++.++|||||||++|||++ |..||..... .+......... ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~~--~~~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-----EQVLKQVVREQ--DIK 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHhhcc--Ccc
Confidence 12233456778999998753 356789999999999999999 7888864211 11122222211 112
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
...+.+....+..+.+++.. || .||++||++++|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~------~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 230 LPKPQLDLKYSDRWYEVMQF------CW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCcccccCCHHHHHHHHH------Hh-cCcccccCHHHHHHHh
Confidence 22233333444445555544 88 4999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=314.91 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=201.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+++++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 46888999999999999998753 24689999986543 223456889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecc
Q 001238 849 LFYDYMPNGTLGMLLHDGEC-------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
+||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 99999999999999865321 23478899999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHH
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
||+++....... ........++..|+|||.+....++.++|||||||++||+++ |+.||... ........+
T Consensus 163 fg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~~---- 234 (277)
T cd05032 163 FGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--SNEEVLKFV---- 234 (277)
T ss_pred cccchhhccCcc--cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC--CHHHHHHHH----
Confidence 999986643221 112233456789999999988889999999999999999998 99998642 112222222
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
..... +..+...+..+.+++.. |++.+|++||++.++++.|+
T Consensus 235 ~~~~~------~~~~~~~~~~~~~li~~------~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGH------LDLPENCPDKLLELMRM------CWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCC------CCCCCCCCHHHHHHHHH------HcCCChhhCCCHHHHHHHhc
Confidence 11111 11222334445555544 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.66 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=190.3
Q ss_pred CeeeecCCeEEEEEEcCC---CcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCC
Q 001238 782 NIIGQGRSGIVYKVTLPS---GLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNG 857 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 857 (1117)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999997543 46799998875432 23357888999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 858 TLGMLLHDGEC--AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 858 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|.+++..... ....++..+..++.|+++|++|||+. +++||||||+||+++.++.+|++|||+++...... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~--~ 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED--Y 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcc--e
Confidence 99999875321 22367788889999999999999999 99999999999999999999999999997543221 1
Q ss_pred cccCCccccccccCChhhhccC-------CCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 936 FSANPQFAGSYGYIAPEYANMT-------KISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
........++..|+|||++... .++.++||||||+++|||++ |+.||..... ...... .... ...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~~~---~~~~--~~~ 228 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTY---TVRE--QQL 228 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--HHHHHH---Hhhc--ccC
Confidence 1222344678899999988642 35789999999999999996 9999964321 111111 1111 111
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
....+.+.......+..+++. || .+|++||++++|++.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~~------c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLPLSDRWYEVMQF------CW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCCCChHHHHHHHH------Hh-cCcccCCCHHHHHHHhc
Confidence 122233333333444555554 88 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.98 Aligned_cols=259 Identities=29% Similarity=0.441 Sum_probs=198.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCc--EEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGL--TVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|++.+.||+|+||.||+|.+. ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888899999999999999854 454 46777766432 23345788999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcc
Q 001238 851 YDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 917 (1117)
|||+++|+|.++++.... ...+++.+++.++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999875321 23478999999999999999999999 99999999999999999999
Q ss_pred eeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHH
Q 001238 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 918 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~ 996 (1117)
||+|||+++..... .......++..|+|||++....++.++|||||||++|||++ |..||..... .+..
T Consensus 164 kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELY 233 (303)
T ss_pred EeCccccCcccchh-----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----HHHH
Confidence 99999998643211 11112234678999999988889999999999999999998 9999964211 1111
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
.. ...... ...+...+..+.++ +..|++.+|++||++.++++.++++....
T Consensus 234 ~~-~~~~~~------~~~~~~~~~~~~~l------i~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 234 EK-LPQGYR------LEKPLNCDDEVYDL------MRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HH-HhcCCc------CCCCCCCCHHHHHH------HHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 111100 11111222334444 44599999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.14 Aligned_cols=255 Identities=30% Similarity=0.492 Sum_probs=203.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.++|++.++||+|+||.||+|..++++.||||.+.... ...+++.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 35788999999999999999988788899999987543 34578999999999999999999999999889999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++.... ...+++.++..++.|++.|++|||++ +++||||||+||++++++.++++|||.++......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-- 157 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh--
Confidence 9999999997653 23489999999999999999999999 99999999999999999999999999998764311
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
........++..|+|||.+.+..++.++||||+|+++||+++ |+.||.+.. .. ............ .
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~---~~~~~~~~~~~~-------~ 224 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NR---EVLEQVERGYRM-------P 224 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HH---HHHHHHHcCCCC-------C
Confidence 111222335678999999998899999999999999999998 999996421 11 222222211110 0
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
.+...+..+.+++. .|++.+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~------~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLML------QCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHH------HHcccCcccCCCHHHHHHHHhc
Confidence 11112334444444 4999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.16 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=199.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CC---cEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SG---LTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|+..+.||+|+||.||+|..+ ++ ..||+|+++... ....+.+..|++++++++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999864 23 379999987542 33356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++.... +.+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999987643 4489999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
..... ........+..|+|||++....++.++|||||||++|||++ |+.||.... .. ............
T Consensus 160 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--~~---~~~~~i~~~~~~---- 229 (268)
T cd05063 160 DPEGT-YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--NH---EVMKAINDGFRL---- 229 (268)
T ss_pred ccccc-eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--HH---HHHHHHhcCCCC----
Confidence 22111 11112233567999999998899999999999999999998 999996421 11 222222111111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
+. ....+..+.+ ++..|++.+|++||++.+|++.|+++
T Consensus 230 --~~-~~~~~~~~~~------li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 --PA-PMDCPSAVYQ------LMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CC-CCCCCHHHHH------HHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 1112223333 44559999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=313.88 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCc----EEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGL----TVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|++.++||+|+||+||+|.+ .+|+ .||+|+++... ......+.+|+.+++.+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4688889999999999999974 3444 58999987543 2334578899999999999999999998875 45789
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
+|||+++|+|.+++.... +.+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999987643 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
..... .......+++.|+|||......++.++|||||||++|||++ |..||+... ......++. ......
T Consensus 161 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~----~~~~~~- 231 (279)
T cd05109 161 IDETE--YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLE----KGERLP- 231 (279)
T ss_pred cccce--eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHH----CCCcCC-
Confidence 32211 11122345678999999988899999999999999999998 999986421 112222222 211110
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
.+...+..+.+ ++..||+.||++||++.++++.++++...+
T Consensus 232 -----~~~~~~~~~~~------li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 -----QPPICTIDVYM------IMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -----CCccCCHHHHH------HHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 11122233444 444599999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=311.61 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.+|++.+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999753 23479999886542 22345789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++.... +.+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999997643 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
..... .......++..|+|||++....++.++||||||+++||+++ |+.||..... ......+ . .....
T Consensus 159 ~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~---~-~~~~~--- 228 (267)
T cd05066 159 DPEAA-YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAI---E-EGYRL--- 228 (267)
T ss_pred cccee-eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHH---h-CCCcC---
Confidence 32111 11122234568999999998899999999999999999887 9999964211 1122211 1 11111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
......+..+.+++. .|++.+|++||++.++++.|+++
T Consensus 229 ---~~~~~~~~~~~~li~------~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ---PAPMDCPAALHQLML------DCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CCCCCCCHHHHHHHH------HHcccCchhCCCHHHHHHHHHhh
Confidence 111222334444444 49999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.90 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=197.2
Q ss_pred CeeeecCCeEEEEEEcCC--C--cEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLPS--G--LTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||.||+|.+.+ + ..||||.+..... ...+++.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997543 3 3699999986654 456689999999999999999999999888 888999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~ 154 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH-Y 154 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc-e
Confidence 999999977542 4589999999999999999999999 9999999999999999999999999999877543221 1
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......++..|+|||++....++.++||||||+++|||++ |+.||... ...+............ ..+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~~~~~~~~~~~~~------~~~ 223 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-----SGSQILKKIDKEGERL------ERP 223 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhcCCcC------CCC
Confidence 12223457889999999998999999999999999999998 99999642 1112222222111100 111
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
...+..+.+++. .|++.+|++||++.++++.|.
T Consensus 224 ~~~~~~~~~li~------~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVML------QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHH------HHCCCCcccCCCHHHHHHHhc
Confidence 222334455444 499999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=290.20 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=199.2
Q ss_pred hccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCc----cc----hHHHHHHHHHHhcc-CCCCcceEEeeeec
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDK----IS----TGAFSSEIATLSRI-RHRNIVRLLGWGAN 843 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 843 (1117)
..+.|...+.+|.|..++|.+.. .++|..+|+|++..... .. .++-.+|+.+++++ .||+|+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34567888999999999998864 55788999999864311 11 13346799999998 79999999999999
Q ss_pred CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 844 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
+...++|+|.|+.|.|.|++.... .+++...++|++|+.+|++|||.. .|||||+||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999998753 389999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhcc------CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHH
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANM------TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~ 997 (1117)
.|+.+..+. .....+|||+|+|||.+.. ..|+..+|+||+||++|.++.|.+||-- ..-.-+++
T Consensus 169 Fa~~l~~Ge-----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-----RkQmlMLR 238 (411)
T KOG0599|consen 169 FACQLEPGE-----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-----RKQMLMLR 238 (411)
T ss_pred eeeccCCch-----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-----HHHHHHHH
Confidence 999887542 3346799999999998754 4688899999999999999999999942 11112223
Q ss_pred HHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 998 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++.++..... |. ....+.....++.. |++.||.+|-|++|.++
T Consensus 239 ~ImeGkyqF~s---pe-Wadis~~~KdLIsr------lLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKYQFRS---PE-WADISATVKDLISR------LLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhcccccCC---cc-hhhccccHHHHHHH------HHeeCchhcccHHHHhc
Confidence 33333322211 11 11223344555554 99999999999999987
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=324.99 Aligned_cols=261 Identities=26% Similarity=0.380 Sum_probs=198.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCCc-cchHHHHHHHHHHhcc-CCCCcceEEeeeecC-Cc
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDK-ISTGAFSSEIATLSRI-RHRNIVRLLGWGANR-KT 846 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 846 (1117)
++|++.+.||+|+||+||+|.+ .+++.||||+++.... .....+.+|++++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4799999999999999999863 3578999999975432 2345688899999999 689999999987654 45
Q ss_pred eEEEEEecCCCChhhhhcCCCC----------------------------------------------------------
Q 001238 847 KLLFYDYMPNGTLGMLLHDGEC---------------------------------------------------------- 868 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 868 (1117)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999998864210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCcc
Q 001238 869 ------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942 (1117)
Q Consensus 869 ------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 942 (1117)
...+++.++.+++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++....... .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~ 241 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDA 241 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcc--hhhcCCC
Confidence 12367888999999999999999999 999999999999999999999999999987543211 1112233
Q ss_pred ccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchh
Q 001238 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQ 1021 (1117)
Q Consensus 943 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 1021 (1117)
.++..|+|||.+....++.++||||||+++|||++ |..||...... .. ........... ..+...+..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~----~~~~~~~~~~~------~~~~~~~~~ 310 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EE----FCRRLKEGTRM------RAPDYTTPE 310 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HH----HHHHHhccCCC------CCCCCCCHH
Confidence 45678999999988899999999999999999997 99998643211 11 11112111110 111112222
Q ss_pred HHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1022 IQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1022 ~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
+. .++..||+.+|++||++.+|++.|+.+.+
T Consensus 311 ~~------~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 311 MY------QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HH------HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22 34556999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=315.09 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=194.4
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+|++.++||+|+||.||+|.. .+++.||+|++.... .....++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577889999999999999974 568899999987542 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 999996542 267888999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChh--HHHHHHHHHhcCCCCccccCc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQH--VIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
......||..|+|||++.+..++.++||||||+++|||++|+.||......... ............ . +
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~-----~ 218 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--P-----P 218 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--C-----C
Confidence 223457899999999999889999999999999999999999999653222111 111111111111 1 1
Q ss_pred cc-CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1013 KL-QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1013 ~l-~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.+ ....+..+.++ +..|++.+|++||+++++++.
T Consensus 219 ~~~~~~~~~~~~~l------i~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLPVGQFSEKFVHF------ITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCcCCHHHHHH------HHHHhhCChhhCCCHHHHhcC
Confidence 11 11122334444 445999999999999999774
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.08 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=199.2
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+|++.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999754 6889999998643 2334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+|+||||+||++++++.++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 9999999886533 23478999999999999999999999 99999999999999999999999999997664321
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......|++.|+|||++....++.++||||||+++|+|++|+.||... ............... .+
T Consensus 155 --~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~-------~~ 220 (255)
T cd08219 155 --AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKVCQGSYK-------PL 220 (255)
T ss_pred --cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHHhcCCCC-------CC
Confidence 1123456889999999999888999999999999999999999999642 112222222111111 11
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
+...+..+.++++ .||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~li~------~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIK------QMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHH------HHHhCCcccCCCHHHHhhc
Confidence 2223334444444 4999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=311.40 Aligned_cols=257 Identities=25% Similarity=0.444 Sum_probs=198.8
Q ss_pred CCCCCCeeeecCCeEEEEEEcCC-C---cEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPS-G---LTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.|++.+.||+|+||.||+|.... + ..||||+++.. .....++|..|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 47788999999999999997542 3 36999998754 2334567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++++|.+++.... +.+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+|++|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999987643 3489999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCCc-cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 932 SGGS-FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 932 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.... .........+..|+|||++....++.++|||||||++|||++ |..||.... ......++. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i~----~~~~~--- 230 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAIE----QDYRL--- 230 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHHH----cCCcC---
Confidence 2111 011111112457999999998999999999999999999886 999996421 122222221 11110
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
..+...+..+.+++. .||+.+|++||++.++++.|+++
T Consensus 231 ---~~~~~~~~~~~~li~------~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 ---PPPMDCPTALHQLML------DCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CCcccCCHHHHHHHH------HHcCCChhhCcCHHHHHHHHHhh
Confidence 011122334444444 49999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=309.17 Aligned_cols=250 Identities=29% Similarity=0.420 Sum_probs=200.1
Q ss_pred CeeeecCCeEEEEEEcCC----CcEEEEEEeecCCccc-hHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLPS----GLTVAVKRFRASDKIS-TGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||.||+|.... +..||+|++....... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998643 7899999997654332 67889999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 857 GTLGMLLHDGEC------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 857 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
++|.+++..... ...+++.++.+++.|+++|++|||++ +|+||||||+||++++++.++|+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 24589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... ........++..|+|||.+....++.++||||+|+++|||++ |+.||... .. .+....... ...
T Consensus 158 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~---~~~~~~~~~-~~~---- 225 (262)
T cd00192 158 DDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SN---EEVLEYLRK-GYR---- 225 (262)
T ss_pred ccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--CH---HHHHHHHHc-CCC----
Confidence 321 122334567889999999988889999999999999999999 69999753 11 122222211 111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
...+...+..+.+++.. |++.+|++||++.++++.|+
T Consensus 226 --~~~~~~~~~~~~~li~~------~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 --LPKPEYCPDELYELMLS------CWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCccCChHHHHHHHH------HccCCcccCcCHHHHHHhhC
Confidence 11122223445555554 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=318.96 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=194.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.++||+|+||+||+++.+ +++.||+|++.+. .......+..|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999854 5788999998642 2223345888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999997632 3488999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||... ...+............
T Consensus 156 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~ 227 (332)
T cd05623 156 GT---VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHKERF 227 (332)
T ss_pred Cc---ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHHHHHHHHhCCCccc
Confidence 11 1223457999999999886 346889999999999999999999999642 2223333332221111
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
. + +......+....++++. +.|...++..|+++.++++.
T Consensus 228 -~-~-p~~~~~~s~~~~~li~~----ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 -Q-F-PAQVTDVSEDAKDLIRR----LICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -c-C-CCccccCCHHHHHHHHH----HccChhhhcCCCCHHHHhCC
Confidence 0 1 11111223445555544 12444455557899888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.80 Aligned_cols=254 Identities=27% Similarity=0.378 Sum_probs=191.1
Q ss_pred CeeeecCCeEEEEEEcC----CCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeee-cCCceEEEEEecC
Q 001238 782 NIIGQGRSGIVYKVTLP----SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGA-NRKTKLLFYDYMP 855 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~~~ 855 (1117)
+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999743 2457999988543 2233567889999999999999999999765 4556789999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|.+++.... ...++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999987643 2367788899999999999999998 99999999999999999999999999998654321111
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhC-CCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITG-KKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
........++..|+|||.+....++.++||||||+++|||++| .+||... .............. + ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~~~~~~~~-~------~~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYLLQGRR-L------LQ 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHhcCCC-C------CC
Confidence 1112233567789999999888999999999999999999995 5566431 12222222222111 1 11
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
+...+..+.+ ++..||+.+|++||++.++++.++++..
T Consensus 224 ~~~~~~~~~~------li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 PEYCPDPLYE------VMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCcCCHHHHH------HHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 1122233444 4445999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=327.37 Aligned_cols=202 Identities=24% Similarity=0.333 Sum_probs=173.7
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+|++.+.||+|+||+||+|.. .+++.||+|+++... ......+.+|++++..++||+|+++++++.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 578889999999999999975 468999999997532 2334568889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 82 FLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999998754 3488999999999999999999999 99999999999999999999999999987553211
Q ss_pred CCc-------------------------------cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCC
Q 001238 933 GGS-------------------------------FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981 (1117)
Q Consensus 933 ~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P 981 (1117)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 000 0011235799999999999999999999999999999999999999
Q ss_pred CCC
Q 001238 982 VDA 984 (1117)
Q Consensus 982 ~~~ 984 (1117)
|..
T Consensus 236 f~~ 238 (360)
T cd05627 236 FCS 238 (360)
T ss_pred CCC
Confidence 964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=315.20 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=199.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
.++|++.+.||+|+||.||+|... ++..||+|++.... ....+++.+|++++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356889999999999999999753 46789999987543 22345788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCe
Q 001238 848 LLFYDYMPNGTLGMLLHDGE-------------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHN 908 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 908 (1117)
++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999986431 112378889999999999999999999 99999999999
Q ss_pred EEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCC
Q 001238 909 ILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP 987 (1117)
Q Consensus 909 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~ 987 (1117)
|++++++.++|+|||+++....... .........+..|+|||.+....++.++|||||||++|||++ |..||.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~-- 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY--YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-- 236 (288)
T ss_pred eEecCCCceEECccccceecccCcc--ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--
Confidence 9999999999999999876543211 111222345678999999988899999999999999999998 88888532
Q ss_pred CChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 988 DGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
...+......... .. ..+...+..+.++ +.+|++.+|++||++.|+++.|++
T Consensus 237 ---~~~~~~~~~~~~~-~~------~~~~~~~~~l~~l------i~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 ---AHEEVIYYVRDGN-VL------SCPDNCPLELYNL------MRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---CHHHHHHHHhcCC-CC------CCCCCCCHHHHHH------HHHHcccCcccCCCHHHHHHHhhC
Confidence 1122222222111 10 1112223344444 445999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=319.03 Aligned_cols=201 Identities=26% Similarity=0.292 Sum_probs=172.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+++.. +++.||+|++... .......+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999854 6889999998642 2223445788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997632 3488999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCCccccCCccccccccCChhhhcc-----CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.. .......||++|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 156 GT---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred Cc---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 21 12233579999999999875 4678999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.84 Aligned_cols=250 Identities=21% Similarity=0.270 Sum_probs=196.6
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc---chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
|+..+.||+|+||+||++.. .+++.||+|.+...... ..+.+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999875 46899999998754221 234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999998865432 2388999999999999999999998 99999999999999999999999999997654221
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
......||..|+|||++.+..++.++||||+|+++|||++|+.||....... ............ ...
T Consensus 157 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~~~~-------~~~ 223 (285)
T cd05630 157 ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEV-------QEE 223 (285)
T ss_pred ----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhhhhh-------hhh
Confidence 1123478999999999998999999999999999999999999997532211 111111111111 011
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
.....+....++++. |++.||++||+ +.++++
T Consensus 224 ~~~~~~~~~~~li~~------~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFSPDARSLCKM------LLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCCHHHHHHHHH------HhhcCHHHccCCCCCchHHHHc
Confidence 222334455555555 99999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=319.70 Aligned_cols=199 Identities=25% Similarity=0.369 Sum_probs=169.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|.+.+.||+|+||+||+|+.+ +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999754 67899999987543 22334678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++ ++.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 975 7877776542 3478899999999999999999999 99999999999999999999999999997653321
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 159 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 159 ---KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred ---cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 12223467899999998764 5688999999999999999999999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=306.03 Aligned_cols=247 Identities=27% Similarity=0.396 Sum_probs=194.3
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCChh
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLG 860 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 860 (1117)
++||+|+||.||+|...+++.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999875432 22346889999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCC
Q 001238 861 MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP 940 (1117)
Q Consensus 861 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 940 (1117)
+++.... ..+++.++..++.|++.||.|+|++ +++||||||+||+++.++.+|++|||+++...... .....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---~~~~~ 152 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---YSSSG 152 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc---cccCC
Confidence 9887543 3478999999999999999999998 99999999999999999999999999997543221 11112
Q ss_pred ccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCc
Q 001238 941 QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019 (1117)
Q Consensus 941 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1019 (1117)
...++..|+|||++....++.++||||||+++||+++ |..||.... ....... ...... ...+...+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-----~~~~~~~-~~~~~~------~~~~~~~~ 220 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-----NQQAREQ-VEKGYR------MSCPQKCP 220 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH-HHcCCC------CCCCCCCC
Confidence 2344678999999998899999999999999999998 999996421 1111111 111111 11112223
Q ss_pred hhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1020 TQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1020 ~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
..+.++ +..|++.+|++||++.++.+.|.
T Consensus 221 ~~~~~l------i~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKV------MQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHH------HHHHcccCcccCCCHHHHHHHhc
Confidence 344444 44599999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=309.10 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc-----cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK-----ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|.+.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999975 4689999999864321 123468889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++++|.+++... +.+++..+.+++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988754 3378899999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.... .........++..|+|||++.+..++.++||||+|+++|||++|+.||.... . ...+........
T Consensus 156 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~-~~~~~~~~~~~~----- 224 (263)
T cd06625 156 TICS-SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE----A-MAAIFKIATQPT----- 224 (263)
T ss_pred cccc-ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc----h-HHHHHHHhccCC-----
Confidence 3211 1111134567889999999998889999999999999999999999996421 1 111111111111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.+.++...+..+.++++. |+..+|++||++.++++.
T Consensus 225 -~~~~~~~~~~~~~~li~~------~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -NPQLPSHVSPDARNFLRR------TFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCccCCHHHHHHHHH------HhhcCcccCCCHHHHhhC
Confidence 122333344456666555 999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=307.91 Aligned_cols=249 Identities=28% Similarity=0.424 Sum_probs=201.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.+.||+|+||.||+|.. .|+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4688899999999999999987 478999999976543 46789999999999999999999999998899999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.++......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999876532 2489999999999999999999999 99999999999999999999999999998763221
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.....+..|+|||++....++.++||||||+++|||++ |+.||.... ... +......... +..
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~----~~~~~~~~~~------~~~ 220 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKD----VVPHVEKGYR------MEA 220 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--HHH----HHHHHhcCCC------CCC
Confidence 12234668999999988889999999999999999997 999986421 111 2222222111 111
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
+...+..+.+++. .|+..+|++||++.+++++|+.
T Consensus 221 ~~~~~~~~~~li~------~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMK------DCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHH------HHhccChhhCcCHHHHHHHHhc
Confidence 1222334444444 4999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=325.53 Aligned_cols=197 Identities=25% Similarity=0.348 Sum_probs=167.2
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCC-----
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRK----- 845 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 845 (1117)
..++|++.+.||+|+||.||++.. .+|+.||+|++... ......++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 456899999999999999999975 46899999998653 2233456789999999999999999999886543
Q ss_pred -ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 846 -TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 846 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
..|+||||+++ ++...+.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999975 55555543 278889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 170 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 170 ARTACTN-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred ccccccC-----ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 9765322 122345789999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=306.58 Aligned_cols=253 Identities=27% Similarity=0.453 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.+.||+|+||.||+|...++..||+|.++... ...+.+.+|++++++++|+||+++++++.+ ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 5788999999999999999987778889999887542 345678999999999999999999998877 77899999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 157 (260)
T cd05073 84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-- 157 (260)
T ss_pred CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc--
Confidence 999999997643 23478899999999999999999998 999999999999999999999999999986643211
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......++..|+|||++....++.++|||||||++|++++ |+.||... ........+ ...... ..
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~----~~~~~~------~~ 224 (260)
T cd05073 158 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRAL----ERGYRM------PR 224 (260)
T ss_pred -ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC--CHHHHHHHH----hCCCCC------CC
Confidence 12223345678999999998889999999999999999999 99999642 111222221 111110 01
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
....+..+.++ +..|++.+|++||++.++.++|+.
T Consensus 225 ~~~~~~~~~~~------i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNI------MMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHH------HHHHcccCcccCcCHHHHHHHHhc
Confidence 12222334444 445999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.23 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=207.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+.|.++..||.|+||.||+|..++ +...|-|++........+.|.-|++++..+.||+||++++.|..++.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 356677789999999999997654 5566788888777777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
.||-.+.++-.-. ..+.+.++..+++|++.||.|||++ .|||||+|+.|||++-+|.++|+|||.+.....
T Consensus 112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~---- 182 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS---- 182 (1187)
T ss_pred CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh----
Confidence 9999998877653 3499999999999999999999999 999999999999999999999999999865432
Q ss_pred ccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.......+.|||.|||||+.. +.+|+.++||||||+++.||..+.+|... ......+.++.+.. ++..
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-----lnpMRVllKiaKSe--PPTL 255 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-----LNPMRVLLKIAKSE--PPTL 255 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-----cchHHHHHHHhhcC--CCcc
Confidence 223456789999999999764 57899999999999999999999999753 23444455554443 3333
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+- +..+...+.++++. |+..+|+.||+++++++
T Consensus 256 lq---PS~Ws~~F~DfLk~------cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 LQ---PSHWSRSFSDFLKR------CLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cC---cchhhhHHHHHHHH------HHhcCCccCCCHHHHhh
Confidence 32 33455567777776 99999999999998865
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=307.75 Aligned_cols=251 Identities=29% Similarity=0.475 Sum_probs=199.8
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccc---------hHHHHHHHHHHhccCCCCcceEEeeeecCCc
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKIS---------TGAFSSEIATLSRIRHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 846 (1117)
+|.+.+.||+|+||.||+|.. .+++.||+|.+....... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999975 458899999886543221 2468889999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.++||||+++++|.+++... +.+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999764 3478899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCC--ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 927 LVEDDSGG--SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 927 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
........ .........|+..|+|||.+....++.++||||+|+++|||++|+.||.... . ...+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~-~~~~~~~~~--- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT----Q-LQAIFKIGE--- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc----H-HHHHHHHhc---
Confidence 76532111 1112223568899999999998889999999999999999999999996421 1 111111111
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
...+.++...+..+..+++. |++.+|++||++.++++
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~------~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ----NASPEIPSNISSEAIDFLEK------TFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----cCCCcCCcccCHHHHHHHHH------HccCCchhCcCHHHHhh
Confidence 11122333444556666665 99999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=317.35 Aligned_cols=197 Identities=30% Similarity=0.436 Sum_probs=172.1
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+|++.+.||+|+||.||++... ++..||+|.+..... ....++.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 6888999999999999999754 688899998875422 23456889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.++++.. +.+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 82 DGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 999999999764 34889999999999999999999732 8999999999999999999999999998765332
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 12345789999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.60 Aligned_cols=239 Identities=22% Similarity=0.357 Sum_probs=185.1
Q ss_pred CeeeecCCeEEEEEEcCC-------------CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 782 NIIGQGRSGIVYKVTLPS-------------GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
+.||+|+||.||+|.+.. ...||+|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997432 2358999887655545567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc-------ceecc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE-------SCLAD 921 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~-------~kl~D 921 (1117)
+||||+++|+|..++.... +.+++..+.+++.||++|++|||++ +|+||||||+||+++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998887542 3489999999999999999999999 9999999999999987654 89999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHH-hCCCCCCCCCCCChhHHHHHHHH
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEII-TGKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell-~g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
||++..... .....++..|+|||++. ...++.++|||||||++|||+ .|+.||..... .+ ....
T Consensus 156 ~g~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~-~~~~ 221 (262)
T cd05077 156 PGIPITVLS--------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-----AE-KERF 221 (262)
T ss_pred CCCCccccC--------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-----hH-HHHH
Confidence 999875532 12345788999999886 567899999999999999998 58888754211 11 1111
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
..... . ........+.. ++..||+.||++||++.++++.+
T Consensus 222 ~~~~~---~-----~~~~~~~~~~~------li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 YEGQC---M-----LVTPSCKELAD------LMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HhcCc---c-----CCCCChHHHHH------HHHHHcCCChhhCcCHHHHHHhc
Confidence 11110 0 01111223344 44459999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=315.97 Aligned_cols=261 Identities=25% Similarity=0.363 Sum_probs=200.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC--------CCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP--------SGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRK 845 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 845 (1117)
.+|.+.++||+|+||.||+|... .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46888999999999999998631 24579999987542 22345688999999999 6999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 912 (1117)
..++||||+++|+|.+++..... ...+++.++.+++.|++.||+|||++ +|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 99999999999999999865321 23488999999999999999999998 999999999999999
Q ss_pred CCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChh
Q 001238 913 ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQH 991 (1117)
Q Consensus 913 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~ 991 (1117)
+++.+||+|||+++........ .......++..|+|||++....++.++||||||+++|||++ |..||.... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--~~~ 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYY--KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--VEE 244 (314)
T ss_pred CCCcEEEccccccccccccccc--cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC--HHH
Confidence 9999999999999866432111 11112234567999999988899999999999999999999 899986421 111
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
....+ ..... ...+...+..+.+++ ..|++.+|++||++.++++.|+++...
T Consensus 245 ~~~~~----~~~~~------~~~~~~~~~~l~~li------~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 245 LFKLL----REGHR------MDKPSNCTHELYMLM------RECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHH----HcCCC------CCCCCCCCHHHHHHH------HHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 22211 11111 011222223344444 459999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=308.59 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=200.5
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.+..-|.+.+.||+|.|++|-.|++- +|+.||||++.+. +......+.+|++.|+.++|||||++|.+.......|+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 34456888899999999999998743 7999999999765 34445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc-CCCcceeccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG-ERYESCLADFGLARLV 928 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfGla~~~ 928 (1117)
|.|.-++|+|.+|+..++. .+.++.+.+++.||+.|+.|+|.. .+||||+||+||.+- +-|-+|+.|||++-.+
T Consensus 95 iLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999999987653 289999999999999999999999 899999999999875 4589999999999877
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCC-cCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKIS-EKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
.++ ...++.+|+..|-|||++.+..|+ +++||||+|||+|-+++|++||+..... +-..++.+ =+..
T Consensus 170 ~PG-----~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--ETLTmImD---CKYt-- 237 (864)
T KOG4717|consen 170 QPG-----KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--ETLTMIMD---CKYT-- 237 (864)
T ss_pred CCc-----chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--hhhhhhhc---cccc--
Confidence 653 245677999999999999999887 7899999999999999999999764221 11222211 1111
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
++.....+.+.++.. |+..||.+|.+.++|+.
T Consensus 238 ------vPshvS~eCrdLI~s------MLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 ------VPSHVSKECRDLIQS------MLVRDPKKRASLEEIVS 269 (864)
T ss_pred ------CchhhhHHHHHHHHH------HHhcCchhhccHHHHhc
Confidence 122222333443333 66679999999888754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.12 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=197.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
++|++.+.||+|+||.||+|.. .+++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4678888999999999999975 468899999998665445567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++... +.+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 999999988654 3489999999999999999999999 99999999999999999999999999987654321
Q ss_pred ccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 935 SFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.......|+..|+|||++. ...++.++||||+||++|||++|+.||....+. ..+.........+... .
T Consensus 161 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~-~ 232 (267)
T cd06645 161 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----RALFLMTKSNFQPPKL-K 232 (267)
T ss_pred --cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-----hhHHhhhccCCCCCcc-c
Confidence 2233457899999999874 456889999999999999999999998542211 1111111111111110 0
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. ....+..+.+++. .|++.+|++||+++++++
T Consensus 233 -~-~~~~~~~~~~li~------~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 -D-KMKWSNSFHHFVK------MALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -c-cCCCCHHHHHHHH------HHccCCchhCcCHHHHhc
Confidence 0 0112233444444 499999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=325.91 Aligned_cols=199 Identities=26% Similarity=0.352 Sum_probs=168.3
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCC-----ceE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRK-----TKL 848 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 848 (1117)
+|++.+.||+|+||+||+|.. .+|+.||||++... .....+++.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999985 47899999998643 2233457889999999999999999999988776 789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 5777777543 3489999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
..... .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 154 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 154 EPDES---KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred ccCcc---ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 43211 12234468899999999876 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=315.21 Aligned_cols=253 Identities=22% Similarity=0.385 Sum_probs=202.8
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++...+|++.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 33445789999999999999999874 57899999999766555567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|..++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 95 MEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999988653 389999999999999999999999 999999999999999999999999999886543
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
... ......++..|+|||.+....++.++|||||||++|+|++|+.||....+ ...............
T Consensus 168 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-----~~~~~~~~~~~~~~~--- 235 (296)
T cd06655 168 EQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGTPEL--- 235 (296)
T ss_pred ccc----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcCCccc---
Confidence 221 12334688999999999888899999999999999999999999965321 111111111111110
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+.++++. ||..+|++||++.++++
T Consensus 236 --~~~~~~~~~~~~li~~------~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 --QNPEKLSPIFRDFLNR------CLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --CCcccCCHHHHHHHHH------HhhcChhhCCCHHHHhh
Confidence 0112223344555444 99999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=311.08 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=196.0
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEee--cCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFR--ASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 850 (1117)
..+.|++.++||+||.+.||++...+.+.||+|++. ..+....+-|..|+..|.++ .|.+||++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 456799999999999999999998888889988764 34556677899999999999 599999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||- ..+|..+++..... ...| .++.+..||+.|+.++|.+ ||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9985 56899999876432 1334 7788999999999999999 9999999999999864 7999999999998865
Q ss_pred CCCCccccCCccccccccCChhhhccCC-----------CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHH
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTK-----------ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
+.. .......+||+.||+||.+.... +++++||||+|||+|+|+.|+.||.. ....+.+.
T Consensus 512 DTT--sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-------~~n~~aKl 582 (677)
T KOG0596|consen 512 DTT--SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-------IINQIAKL 582 (677)
T ss_pred ccc--ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-------HHHHHHHH
Confidence 432 23445679999999999886432 56899999999999999999999953 12111111
Q ss_pred HhcCCCC-ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1000 LKSKKDP-VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1000 ~~~~~~~-~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. ...++ .+.--|.++... .+.++++. |++.||.+||+..++++
T Consensus 583 ~-aI~~P~~~Iefp~~~~~~--~li~~mK~------CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 583 H-AITDPNHEIEFPDIPEND--ELIDVMKC------CLARDPKKRWSIPELLQ 626 (677)
T ss_pred H-hhcCCCccccccCCCCch--HHHHHHHH------HHhcCcccCCCcHHHhc
Confidence 1 11112 111112222222 24444444 99999999999999977
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=309.15 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=196.6
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+++.+.....||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 345555667899999999999974 4678899999876655556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-CCcceeccccccccccCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-RYESCLADFGLARLVEDD 931 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~~~ 931 (1117)
|+++++|.+++.........++..+..++.|+++|++|||++ +|+||||||+||+++. ++.++|+|||.+......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 999999999987642211127888899999999999999999 9999999999999986 679999999999765432
Q ss_pred CCCccccCCccccccccCChhhhccC--CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMT--KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
. .......+++.|+|||++... .++.++||||||+++|||++|+.||..... .....+......
T Consensus 163 ~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~--~~~~~~~~~~~~-------- 228 (268)
T cd06624 163 N----PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE--PQAAMFKVGMFK-------- 228 (268)
T ss_pred C----CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC--hhhhHhhhhhhc--------
Confidence 1 122234588999999998654 378899999999999999999999964211 111111111001
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+.++...+..+..+++ .|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~li~------~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 IHPEIPESLSAEAKNFIL------RCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCCCCCcccCHHHHHHHH------HHcCCCchhCCCHHHHHh
Confidence 112223333444555554 499999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=311.92 Aligned_cols=198 Identities=30% Similarity=0.360 Sum_probs=165.1
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhcc---CCCCcceEEeeeec-----CC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRI---RHRNIVRLLGWGAN-----RK 845 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~ 845 (1117)
+|++.+.||+|+||+||+|... +++.||+|.++.... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999754 689999999875322 2233566788877766 69999999998764 24
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..++||||+++ +|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999974 88888876432 3389999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+...... ......||..|+|||++.+..++.++||||+||++|||++|++||..
T Consensus 156 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 156 RIYSCQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred ccccCcc-----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 8764321 22345689999999999888999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=308.79 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=200.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC----CcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS----GLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|++.+.||+|+||.||+|...+ ...||||...... ....+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 458888999999999999997533 3479999887554 3345678999999999999999999998875 567899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999997643 2489999999999999999999998 999999999999999999999999999986643
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.. ........++..|+|||.+....++.++||||||+++||+++ |..||..... ......+ ......
T Consensus 160 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~----~~~~~~--- 227 (270)
T cd05056 160 ES---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVIGRI----ENGERL--- 227 (270)
T ss_pred cc---ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHH----HcCCcC---
Confidence 21 111122334568999999988889999999999999999996 9999965321 1111111 111111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
..+...+..+.+++. .|+..+|++||++.++++.|+++..+
T Consensus 228 ---~~~~~~~~~~~~li~------~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 ---PMPPNCPPTLYSLMT------KCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---CCCCCCCHHHHHHHH------HHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 112233345555554 49999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=324.23 Aligned_cols=197 Identities=23% Similarity=0.293 Sum_probs=167.3
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecC------
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANR------ 844 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 844 (1117)
..++|++.+.||+|+||.||++.. ..++.||||++.... .....++.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999975 468899999987532 22345678899999999999999999987643
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
...++||||+++ ++...+.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 346999999975 56665543 278899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 166 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 166 ARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred cccCCCc-----cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9865432 122345789999999999988999999999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.04 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=195.8
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecC------
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANR------ 844 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------ 844 (1117)
+++..|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+++++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3566788889999999999999975 468899999987543 3456788999999998 699999999988653
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
...++||||+++++|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 45789999999999999987643 23488999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHH
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
++...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||..... ..... ..
T Consensus 158 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~~-~~ 228 (272)
T cd06637 158 SAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALF-LI 228 (272)
T ss_pred ceeccccc----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHHH-HH
Confidence 98654321 1234467899999999885 34688899999999999999999999964211 11111 11
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
... ..... .....+..+.+++. .|+..+|.+||++.++++
T Consensus 229 -~~~-~~~~~----~~~~~~~~~~~li~------~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 -PRN-PAPRL----KSKKWSKKFQSFIE------SCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -hcC-CCCCC----CCCCcCHHHHHHHH------HHcCCChhhCCCHHHHhh
Confidence 111 01111 11122334455444 499999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=311.30 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=196.3
Q ss_pred CCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 778 LTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999854 5788999998765555566788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
++|..++.... +.+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||++.......
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99998876532 3489999999999999999999999 99999999999999999999999999997654321
Q ss_pred ccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 937 SANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.......++..|+|||++. ...++.++|||||||++|||++|++||.... ..+.+......... ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~~~~--~~~- 229 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSEPP--TLA- 229 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-----HHHHHHHHhhcCCC--CCC-
Confidence 1223456899999999873 4557889999999999999999999986421 11222222211111 111
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+...+..+.++++. ||+.+|++||++.++++
T Consensus 230 --~~~~~~~~~~~li~~------~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 --QPSRWSSEFKDFLKK------CLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CccccCHHHHHHHHH------HccCChhhCcCHHHHhc
Confidence 112233455555554 99999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=316.17 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=202.8
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++...+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 45567899999999999999999974 57899999999866555567788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999999998653 378899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .......+++.|+|||...+..++.++|||||||++|+|++|+.||....+.. ......... .+ .
T Consensus 168 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-----~~~~~~~~~-~~-~-- 234 (297)
T cd06656 168 EQ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATNG-TP-E-- 234 (297)
T ss_pred Cc----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-----heeeeccCC-CC-C--
Confidence 21 11234468899999999998889999999999999999999999996432211 000001111 00 0
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
...+...+..+.+++. .|++.+|++||++.++++
T Consensus 235 -~~~~~~~~~~~~~li~------~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 -LQNPERLSAVFRDFLN------RCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -CCCccccCHHHHHHHH------HHccCChhhCcCHHHHhc
Confidence 0011222334444444 499999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=324.51 Aligned_cols=197 Identities=23% Similarity=0.307 Sum_probs=167.4
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecC------
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR------ 844 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 844 (1117)
..++|++.+.||+|+||.||++.. ..++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 356899999999999999999975 46889999998753 223345678899999999999999999987543
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
...|+||||+++ ++.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 356999999965 66666643 278899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 173 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 173 ARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred ccccCCC-----CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 9865432 122345789999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=308.68 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=189.4
Q ss_pred eeeecCCeEEEEEEcCCC---cEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCC
Q 001238 783 IIGQGRSGIVYKVTLPSG---LTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGT 858 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 858 (1117)
.||+|+||+||+|...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999875433 346677665432 2345678999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccc
Q 001238 859 LGMLLHDGEC-AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFS 937 (1117)
Q Consensus 859 L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 937 (1117)
|.++++.... ....++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~--~~~ 156 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED--YIE 156 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcch--hhh
Confidence 9999876422 23366778889999999999999998 99999999999999999999999999986432211 111
Q ss_pred cCCccccccccCChhhhcc-------CCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 938 ANPQFAGSYGYIAPEYANM-------TKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 938 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
......++..|+|||++.. ..++.++||||||+++|||++ |..||... ...+.+....... ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-----~~~~~~~~~~~~~--~~~~ 229 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-----SDREVLNHVIKDQ--QVKL 229 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhhc--cccc
Confidence 2234568899999998743 345789999999999999997 57787532 1122222222222 2223
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
.++.+....+..+.++++. || .+|++||++++|++.|
T Consensus 230 ~~~~~~~~~~~~~~~l~~~------c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 230 FKPQLELPYSERWYEVLQF------CW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCCccCCCCcHHHHHHHHH------Hh-hCcccCCCHHHHHHHh
Confidence 3455554455555565555 88 5799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=307.93 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=199.6
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCc------cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDK------ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
+|++.+.||+|+||+||+|...+++.||+|.++.... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999887899999998864321 1234688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++.+. +.+++..+..++.|++.|++|||+. +|+|+||||+||++++++.++|+|||+++....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999764 2378999999999999999999999 999999999999999999999999999986532
Q ss_pred CCCC--ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 931 DSGG--SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 931 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... .........|+..|+|||++.+..++.++||||||+++|||++|+.||.... ..... ....... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~-~~~~~~~-~--- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD----RLAAM-FYIGAHR-G--- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC----hHHHH-HHhhhcc-C---
Confidence 1111 1112234568999999999998889999999999999999999999996421 11111 1111110 0
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+.++...+..+..+++. |++.+|++||++.++++
T Consensus 226 -~~~~~~~~~~~~~~~~i~~------~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -LMPRLPDSFSAAAIDFVTS------CLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCCCCCCHHHHHHHHH------HhcCCcccCCCHHHHhc
Confidence 1122333344455555555 99999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=327.93 Aligned_cols=197 Identities=25% Similarity=0.330 Sum_probs=169.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC---CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP---SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
..+|.+.+.||+|+||.||++... .++.||+|.+... ..+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999998642 4678999987643 24568999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+. ++|.+++... +.+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++.....
T Consensus 166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 6788877432 3489999999999999999999999 9999999999999999999999999999866542
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
.. ........||+.|+|||++....++.++|||||||++|||++|+.||.+.
T Consensus 239 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 239 PD--TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cc--cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 21 11223467999999999999999999999999999999999999999653
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=311.96 Aligned_cols=200 Identities=26% Similarity=0.336 Sum_probs=170.4
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999854 68999999986532 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
++ ++|.+++........+++..+..++.|+++||+|||++ +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68888887644445689999999999999999999999 99999999999999999999999999997654321
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......+++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred ---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12223457889999998765 4578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=307.45 Aligned_cols=250 Identities=29% Similarity=0.461 Sum_probs=191.7
Q ss_pred CeeeecCCeEEEEEEcCC-Cc--EEEEEEeecC-CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLPS-GL--TVAVKRFRAS-DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||.||+|..++ +. .+|+|.++.. .....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998643 43 5788888743 233445788999999999 799999999999999999999999999
Q ss_pred CChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 857 GTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 857 gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
|+|.+++..... ...+++.++.+++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999875321 12478999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
+++..... ........+..|+|||++....++.++||||||+++|||++ |+.||.... ....... ...
T Consensus 158 l~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~~-~~~ 226 (270)
T cd05047 158 LSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEK-LPQ 226 (270)
T ss_pred Cccccchh-----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHHHHHH-HhC
Confidence 98633211 11112234567999999988899999999999999999997 999996421 1111111 111
Q ss_pred CCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1003 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
... ...+...+..+.+++ ..|++.+|.+||++.++++.|+++.
T Consensus 227 ~~~------~~~~~~~~~~~~~li------~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYR------LEKPLNCDDEVYDLM------RQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC------CCCCCcCCHHHHHHH------HHHcccChhhCCCHHHHHHHHHHhh
Confidence 100 111122233444444 4599999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=304.77 Aligned_cols=250 Identities=30% Similarity=0.434 Sum_probs=194.2
Q ss_pred CeeeecCCeEEEEEEcC--C--CcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLP--S--GLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
++||+|+||.||+|... + +..||+|.+..... ...+++.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999998642 2 36899999875533 24567889999999999999999999876 4567999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~-~ 152 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-Y 152 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc-c
Confidence 99999997653 488999999999999999999999 9999999999999999999999999999876543211 1
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......++..|+|||......++.++||||||+++|||++ |+.||... .......++. ..... ..+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~--~~~~~~~~~~----~~~~~------~~~ 220 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--KGAEVIAMLE----SGERL------PRP 220 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHH----cCCcC------CCC
Confidence 11222234568999999998899999999999999999998 99999643 2222323222 11110 111
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
...+..+.+ ++..|+..+|++||++.++.+.|+++.
T Consensus 221 ~~~~~~l~~------li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYS------IMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHH------HHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 222334444 444599999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=317.38 Aligned_cols=197 Identities=25% Similarity=0.370 Sum_probs=160.6
Q ss_pred CCeeeecCCeEEEEEEcC---CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeec--CCceEEEEEecC
Q 001238 781 GNIIGQGRSGIVYKVTLP---SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN--RKTKLLFYDYMP 855 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 855 (1117)
+++||+|+||+||+|+.. +++.||+|++.... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999987543 23457889999999999999999998754 456789999985
Q ss_pred CCChhhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE----cCCCcceecccccc
Q 001238 856 NGTLGMLLHDGE------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL----GERYESCLADFGLA 925 (1117)
Q Consensus 856 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfGla 925 (1117)
++|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57777765321 122488999999999999999999999 99999999999999 45678999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+....... .........||+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 160 ~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCc-cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87643221 1122345678999999998876 4689999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=305.48 Aligned_cols=250 Identities=28% Similarity=0.473 Sum_probs=198.6
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+|++.+.||+|+||.||+|.+.+++.+|+|+++... ...++|.+|++++++++|||++++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 577789999999999999988778899999887543 3456799999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
++|.+++.... +.++++.+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++...... .
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---~ 155 (256)
T cd05112 84 GCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---Y 155 (256)
T ss_pred CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc---c
Confidence 99999987643 3478999999999999999999999 99999999999999999999999999998654321 1
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......++.+|+|||...+..++.++||||||+++|||++ |+.||.... ............ ....+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~~----~~~~~--- 223 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEVVETINAGF----RLYKP--- 223 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHHhCCC----CCCCC---
Confidence 11222345678999999998899999999999999999998 999986421 112222211111 00111
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
...+..+.+ ++.+|++.+|++||++.++++.+
T Consensus 224 ~~~~~~~~~------l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYE------LMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHH------HHHHHcccChhhCCCHHHHHHhh
Confidence 112233334 45559999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=292.67 Aligned_cols=248 Identities=21% Similarity=0.287 Sum_probs=200.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccch---HHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKIST---GAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|...++||+|.||.|-.++. .+|+.||+|++++...... ..-..|-++++..+||.+..+.-.|+..+..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788999999999999999874 4699999999987643333 3345699999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+.||.|.-++.+.+ .++++.++.+-..|+.||.|||++ +||+||+|.+|.++|.+|++||+|||+++.-..
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999998887753 388888889999999999999999 999999999999999999999999999986543
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. ....+++|||.|+|||++....|+.++|.|.+|||+|||++|+.||... +...+.+.+.. .+
T Consensus 321 ~g----~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~--dh~kLFeLIl~---ed------- 384 (516)
T KOG0690|consen 321 YG----DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK--DHEKLFELILM---ED------- 384 (516)
T ss_pred cc----ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc--chhHHHHHHHh---hh-------
Confidence 22 3456789999999999999999999999999999999999999999642 22333333221 11
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
-.++.........++.- .+..||.+|- ++.||.+
T Consensus 385 -~kFPr~ls~eAktLLsG------LL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 385 -LKFPRTLSPEAKTLLSG------LLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred -ccCCccCCHHHHHHHHH------HhhcChHhhcCCCchhHHHHHh
Confidence 12233334445555544 5677999994 5666654
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=312.44 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=198.3
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+|++.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788899999999999999864 6899999988754 2233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|..++........+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 99999998876433345899999999999999999999632 8999999999999999999999999999765322
Q ss_pred ccccCCccccccccCChhhhccC------CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMT------KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.... .......+....... +
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~--~-- 227 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--YANIFAQLSAIVDGD--P-- 227 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc--hhhHHHHHHHHhhcC--C--
Confidence 12234678899999988544 35889999999999999999999996421 112222222222111 1
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.++...+..+.+++.. |++.+|++||++.++++
T Consensus 228 ---~~~~~~~~~~~~~li~~------~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ---PTLPSGYSDDAQDFVAK------CLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ---CCCCcccCHHHHHHHHH------HcccCcccCCCHHHHhc
Confidence 12222344455555554 99999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=312.34 Aligned_cols=252 Identities=30% Similarity=0.466 Sum_probs=196.4
Q ss_pred CCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchH--HHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 778 LTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTG--AFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
|++++.||+|+||+||+++.. +++.||+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999865 4678999999876543332 2345999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++... +.+++.++..++.|+++||+|||+. +|+||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---- 150 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---- 150 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS----
T ss_pred cccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc----
Confidence 999999999822 3489999999999999999999999 999999999999999999999999999976421
Q ss_pred ccccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.........++..|+|||++. ...++.++||||+|+++|+|++|..||... ........+.......... . ..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~-~---~~ 224 (260)
T PF00069_consen 151 NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKILKRPLPS-S---SQ 224 (260)
T ss_dssp TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHHTHHHH-H---TT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhcccccccc-c---cc
Confidence 112344567899999999998 888999999999999999999999999753 1122222222222111000 0 00
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
........+.++++ .|++.||++||++.++++
T Consensus 225 ~~~~~~~~l~~li~------~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIK------KMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHH------HHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHH------HHccCChhHCcCHHHHhc
Confidence 00011134444444 499999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=328.18 Aligned_cols=193 Identities=22% Similarity=0.290 Sum_probs=166.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.+|.+.+.||+|+||.||++.+. .++.||||... ...+.+|++++++++|||||++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46999999999999999999864 57899999643 234678999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
. ++|.+++.... ..+++.+++.++.|+++||+|||++ +||||||||+|||++.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~- 315 (461)
T PHA03211 243 R-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS- 315 (461)
T ss_pred C-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc-
Confidence 5 68888776532 3489999999999999999999999 999999999999999999999999999987643211
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCC
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPV 982 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~ 982 (1117)
........||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 316 -~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 -TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred -cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 11223457999999999999999999999999999999999988765
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=306.41 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=203.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||.|+||+||+|... ++..||+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36889999999999999999854 67899999986532 22456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++......+.+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997654334589999999999999999999999 999999999999999999999999999987765432
Q ss_pred CccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
..........|+..|+|||++... .++.++|||||||++|||++|+.||...... ....+....... ....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~---~~~~ 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-----KVLMLTLQNDPP---SLET 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-----hhHHHHhcCCCC---CcCC
Confidence 221223445789999999998776 7899999999999999999999999653221 112222222111 1111
Q ss_pred cc-CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KL-QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l-~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.. ....+..+.+++. .|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~li~------~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GADYKKYSKSFRKMIS------LCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccccHHHHHHHH------HHcCCChhhCcCHHHHhh
Confidence 10 1122334445544 499999999999999876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=310.44 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=202.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-----CCcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeec--CCce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-----SGLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGAN--RKTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 847 (1117)
+.|++.+.||+|+||.||+|.+. +++.||||+++..... ..+.|.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999743 4689999999765442 45679999999999999999999999877 5578
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999997653 2489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCCh---------hHHHHHHH
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ---------HVIQWVRD 998 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~---------~~~~~~~~ 998 (1117)
....... ........++..|+|||......++.++||||||+++|||++|+.|+........ .....+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDY-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred cccCCcc-eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 6532211 1112223456679999999888999999999999999999999999864322110 01111112
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
........ ..+...+..+. .++..|++.+|++||++.+|+++|+.+
T Consensus 238 ~~~~~~~~------~~~~~~~~~~~------~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERL------PRPPSCPDEVY------DLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcC------CCCccCCHHHH------HHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22211110 00111222333 345569999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=312.15 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=200.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
++|++.+.||+|+||.||+|.. .++..||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 4688889999999999999986 468899999998765555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++.... ..+++..+.+++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (280)
T cd06611 85 DGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-- 157 (280)
T ss_pred CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence 9999999987643 3489999999999999999999999 99999999999999999999999999987654321
Q ss_pred ccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.......+++.|+|||.+. ...++.++||||||+++|||++|+.||.... ....+........ + ..
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-~-~~ 228 (280)
T cd06611 158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-----PMRVLLKILKSEP-P-TL 228 (280)
T ss_pred --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-----HHHHHHHHhcCCC-C-Cc
Confidence 1223456899999999874 3456789999999999999999999996421 1122222221111 0 00
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+.+++.. |++.+|++||++.++++
T Consensus 229 ---~~~~~~~~~~~~li~~------~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 229 ---DQPSKWSSSFNDFLKS------CLVKDPDDRPTAAELLK 261 (280)
T ss_pred ---CCcccCCHHHHHHHHH------HhccChhhCcCHHHHhc
Confidence 0112233455555554 99999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=313.51 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=200.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788899999999999999754 68899999887543 23356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++... +.+++..+..++.+++.|+.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 9999999988764 34899999999999999999999732 8999999999999999999999999998754321
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCC------hhHHHHHHHHHhcCCCCc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG------QHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~------~~~~~~~~~~~~~~~~~~ 1007 (1117)
......|+..|+|||++....++.++|||||||++|||++|+.||......+ ......+........
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--- 230 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC---
Confidence 1224578999999999988899999999999999999999999997543211 112223333222111
Q ss_pred cccCcccCC-CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1008 EVLDPKLQG-HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1008 ~~~~~~l~~-~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
+.+.. ..+..+.+++. .|++.||++||++.|++++..
T Consensus 231 ----~~~~~~~~~~~~~~li~------~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 231 ----PRLPSSDFPEDLRDFVD------ACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred ----CCCCchhcCHHHHHHHH------HHhcCCcccCcCHHHHhcCcc
Confidence 11111 12233444444 499999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=319.73 Aligned_cols=240 Identities=25% Similarity=0.272 Sum_probs=183.6
Q ss_pred eeecCCeEEEEEEcC-CCcEEEEEEeecCCc---cchHHHHHHHHHHhcc---CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 784 IGQGRSGIVYKVTLP-SGLTVAVKRFRASDK---ISTGAFSSEIATLSRI---RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 784 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
||+|+||+||+|+.. +++.||||++..... .....+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999754 689999999864321 1223345566666655 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++... +.+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---- 150 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---- 150 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----
Confidence 9999888754 3489999999999999999999999 99999999999999999999999999997643221
Q ss_pred ccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 937 SANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||... ...+............. .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~~~~-------~ 218 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-----DTQQMYRNIAFGKVRFP-------K 218 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-----CHHHHHHHHHcCCCCCC-------C
Confidence 123346799999999988654 5899999999999999999999999642 12222222222211110 1
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCC----HHHHHH
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPT----MKDVAA 1051 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs----~~~v~~ 1051 (1117)
...+....++++. |++.+|.+||+ +.++++
T Consensus 219 ~~~~~~~~~li~~------~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKG------LLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHH------HcCCCHHHCCCCCCCHHHHhc
Confidence 1223445555555 99999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=308.13 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=199.5
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc------cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK------ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
+|+..+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999974 5789999999874321 124568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC-cceeccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-ESCLADFGLARLV 928 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~~ 928 (1117)
||||+++++|.+++... +.+++..+..++.|++.||+|||++ +++||||||+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998754 3488999999999999999999999 999999999999998776 5899999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
...............++..|+|||.+....++.++||||+|+++|+|++|+.||...... .....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~----- 227 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASAT----- 227 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhccC-----
Confidence 543221112223456889999999998888999999999999999999999999643211 1112221111111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+..+...+..+.+++.. |+..+|++||++.+++.
T Consensus 228 -~~~~~~~~~~~~~~~~i~~------~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 -TAPSIPEHLSPGLRDVTLR------CLELQPEDRPPSRELLK 263 (268)
T ss_pred -CCCCCchhhCHHHHHHHHH------HcCCCcccCcCHHHHhc
Confidence 1122233333445555544 99999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=311.46 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=197.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999864 58899999998766555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|..++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999988876533 3489999999999999999999999 99999999999999999999999999987543221
Q ss_pred ccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.......+++.|+|||++. ...++.++|||||||++|||++|+.||.... ....+....... .+ ..
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~-~~-~~ 235 (292)
T cd06644 165 --QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSE-PP-TL 235 (292)
T ss_pred --cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-----HHHHHHHHhcCC-Cc-cC
Confidence 1223456888999999874 3457889999999999999999999986421 112222222111 11 10
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+.++++ .|++.+|++||++.++++
T Consensus 236 ---~~~~~~~~~~~~li~------~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 ---SQPSKWSMEFRDFLK------TALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CCCcccCHHHHHHHH------HHhcCCcccCcCHHHHhc
Confidence 011122233444444 499999999999999876
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=307.69 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=200.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCc----EEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGL----TVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.+|++.+.||+|+||+||+|..+ +|+ .||+|....... ....++.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999753 233 689998875432 234578899999999999999999999887 78899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++.... +.+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999987643 3489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
..... .......++..|+|||.+....++.++||||||+++||+++ |+.||.... ..+.... +......
T Consensus 161 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~-~~~~~~~-- 230 (279)
T cd05057 161 VDEKE--YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-----AVEIPDL-LEKGERL-- 230 (279)
T ss_pred Ccccc--eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH-HhCCCCC--
Confidence 32211 11112234678999999988899999999999999999998 999996531 1122222 1111110
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
..+...+..+..++ ..||..+|.+||++.++++.++++.+.+
T Consensus 231 ----~~~~~~~~~~~~~~------~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 231 ----PQPPICTIDVYMVL------VKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ----CCCCCCCHHHHHHH------HHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 11111222344444 4499999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=320.98 Aligned_cols=198 Identities=24% Similarity=0.342 Sum_probs=168.4
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecC----
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANR---- 844 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---- 844 (1117)
....++|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34567899999999999999999974 568899999987532 22345677899999999999999999987543
Q ss_pred --CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccc
Q 001238 845 --KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADF 922 (1117)
Q Consensus 845 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 922 (1117)
...|++||++ +++|.+++... .+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 78998887643 389999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 163 g~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 163 GLARQADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred ccceecCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999865431 234578999999999876 5789999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=303.35 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|+..+.||+|+||.||.++. .+++.||+|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999874 468899999886542 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++.... ...+++.++..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997653 23489999999999999999999998 999999999999999999999999999987643221
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
......+++.|+|||...+..++.++||||||+++|||++|+.||... ...+.+.........+
T Consensus 157 ----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~~~~------- 220 (256)
T cd08221 157 ----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----NPLNLVVKIVQGNYTP------- 220 (256)
T ss_pred ----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcCCCCC-------
Confidence 223456899999999998888899999999999999999999999642 2223333322221111
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.....+..+.+++. .|++.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~------~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVH------SLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHH------HHcccCcccCCCHHHHhhC
Confidence 11222334444444 4999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=310.35 Aligned_cols=238 Identities=23% Similarity=0.350 Sum_probs=183.2
Q ss_pred eeeecCCeEEEEEEcC-------------------------CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceE
Q 001238 783 IIGQGRSGIVYKVTLP-------------------------SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRL 837 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 837 (1117)
.||+|+||.||+|.+. ....||+|++.........+|.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999998631 123589998875544344578889999999999999999
Q ss_pred EeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC--
Q 001238 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-- 915 (1117)
Q Consensus 838 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-- 915 (1117)
++++.+....++||||+++|+|..++.... +.+++..+.+++.|+++||+|||++ +|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999886532 3488999999999999999999999 999999999999998643
Q ss_pred -----cceeccccccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHH-hCCCCCCCCCCC
Q 001238 916 -----ESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEII-TGKKPVDASFPD 988 (1117)
Q Consensus 916 -----~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell-~g~~P~~~~~~~ 988 (1117)
.+|++|||.+...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.||....+
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~- 227 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP- 227 (274)
T ss_pred cCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-
Confidence 3799999998654321 12357788999998865 56899999999999999995 69999865322
Q ss_pred ChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 989 GQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
...... ...... .+......+.+ ++..||+.+|++||++.+|++.|
T Consensus 228 -~~~~~~----~~~~~~--------~~~~~~~~~~~------li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 -SEKERF----YEKKHR--------LPEPSCKELAT------LISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHHHHH----HHhccC--------CCCCCChHHHH------HHHHHcccChhhCcCHHHHHHhh
Confidence 111111 111111 11111123333 44459999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=317.86 Aligned_cols=245 Identities=24% Similarity=0.402 Sum_probs=197.4
Q ss_pred CCCCeeeecCCeEEEEEEc-CCCcEEEEEEeec----CCccchHHHHHHHHHHhccCCCCcceEEeeeecCCc--eEEEE
Q 001238 779 TAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRA----SDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT--KLLFY 851 (1117)
Q Consensus 779 ~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lv~ 851 (1117)
+..++||+|+|-+||+|.+ .+|..||--.++. ......++|..|+.+|+.|+|||||++|+++.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 5567899999999999964 4577887433321 133345789999999999999999999999988766 56889
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-CCcceeccccccccccC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-RYESCLADFGLARLVED 930 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~~ 930 (1117)
|.+..|+|..|+++.+ .........|++||++||.|||++ .|+|+|||||.+||+|++ .|.+||+|.|+|.....
T Consensus 123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999998764 378889999999999999999997 679999999999999986 58999999999987754
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
. ......|||.|||||... ..|...+||||||+.++||+|+.+||.. =....++.++...+.+ |.
T Consensus 199 s------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~AQIYKKV~SGiK-P~--- 263 (632)
T KOG0584|consen 199 S------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPAQIYKKVTSGIK-PA--- 263 (632)
T ss_pred c------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHHHHHHHHHcCCC-HH---
Confidence 2 223478999999999887 8999999999999999999999999964 2334555555544432 21
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+..-.+..+++++.. |+.. .++||++.|++.
T Consensus 264 --sl~kV~dPevr~fIek------Cl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 --ALSKVKDPEVREFIEK------CLAT-KSERLSAKELLK 295 (632)
T ss_pred --HhhccCCHHHHHHHHH------HhcC-chhccCHHHHhh
Confidence 1222334567777766 9998 999999999987
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=307.46 Aligned_cols=256 Identities=21% Similarity=0.362 Sum_probs=200.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
.+|++.+.||+|+||+||+|+.+ +.+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999853 3467999988654332 3467999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECA------GLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADF 922 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 922 (1117)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998765421 1489999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHh
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLK 1001 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~ 1001 (1117)
|+++...... ........++..|+|||.+....++.++||||||+++|||++ |..||.... .... +... .
T Consensus 162 ~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--~~~~---~~~~-~ 232 (275)
T cd05046 162 SLSKDVYNSE---YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--DEEV---LNRL-Q 232 (275)
T ss_pred ccccccCccc---ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--hHHH---HHHH-H
Confidence 9987543221 122334466788999999988889999999999999999999 888985421 1111 1111 1
Q ss_pred cCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1002 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
..... .......+..+.+++.. |++.+|++||++.++++.|.
T Consensus 233 ~~~~~-----~~~~~~~~~~l~~~i~~------~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLE-----LPVPEGCPSRLYKLMTR------CWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcC-----CCCCCCCCHHHHHHHHH------HcCCCcccCCCHHHHHHHhc
Confidence 11100 01122333455555554 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=348.45 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=207.4
Q ss_pred chhhHHHhccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeec
Q 001238 767 LDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGAN 843 (1117)
Q Consensus 767 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 843 (1117)
+...+...+-+|..+..||.|.||.||.|. ..+|+-.|+|-++..+ ....+...+|..++..+.|||+|+++|+-.+
T Consensus 1226 la~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1226 LASSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred HHHHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec
Confidence 333455567788889999999999999986 5579999999876542 3334567899999999999999999999999
Q ss_pred CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 844 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
++..++.||||++|+|.+.+...+ ..++.....+..|++.|++|||++ |||||||||+||+++.+|.+|++|||
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccc
Confidence 999999999999999999998753 366777788999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccC---CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHH
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT---KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
.|..+...............||+.|||||++.+. ....++||||+|||+.||+||++||.....+ ...+-...
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----~aIMy~V~ 1455 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----WAIMYHVA 1455 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch----hHHHhHHh
Confidence 9998865432223344567899999999999754 3567999999999999999999999643221 11111111
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
... .|.++......-..+++. |+..||+.|.++.|+++
T Consensus 1456 ~gh-------~Pq~P~~ls~~g~dFle~------Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1456 AGH-------KPQIPERLSSEGRDFLEH------CLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ccC-------CCCCchhhhHhHHHHHHH------HHhcCchhhhHHHHHHH
Confidence 111 133444445555666666 99999999988876655
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=313.82 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=197.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+.|.....||+|+||.||++.. .++..||||++........+.+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 3445557799999999999975 468899999987655445667889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++... .+++.++..++.|++.|++|||++ +|+||||||+||++++++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 102 EGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 999999988643 378999999999999999999999 99999999999999999999999999987654321
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......|+..|+|||......++.++||||||+++|||++|+.||..... ...+........ .... .
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~~--~~~~---~ 240 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----LQAMRRIRDNLP--PRVK---D 240 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcCC--Cccc---c
Confidence 122345689999999999888999999999999999999999999964211 111111111110 0000 0
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
....+..+..++.. |+..+|.+||++.++++.
T Consensus 241 ~~~~~~~~~~li~~------~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDL------MLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHH------HccCChhHCcCHHHHhhC
Confidence 11223345555555 999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=311.64 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=198.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCc----EEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGL----TVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.+|+..+.||+|+||.||+|.+. +|+ .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46788899999999999999753 343 578898865432 2234688999999999999999999988754 4679
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999987643 3478999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
..... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ...... .........
T Consensus 161 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~----~~~~~~~~~- 231 (303)
T cd05110 161 GDEKE--YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPD----LLEKGERLP- 231 (303)
T ss_pred Ccccc--cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHH----HHHCCCCCC-
Confidence 32211 11223345778999999998899999999999999999997 999986421 112222 222221111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
.+...+..+.+ ++..||..+|++||+++++++.++++...+
T Consensus 232 -----~~~~~~~~~~~------li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 232 -----QPPICTIDVYM------VMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -----CCCCCCHHHHH------HHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 11112223333 444599999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=305.32 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=199.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
++|++.+.||+|+||.||+|...+ ++.||+|.+..... .+++.+|++++++++||||+++++++.+....+++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999998654 78999999875433 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++.... ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-- 153 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-- 153 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence 9999999986533 3489999999999999999999999 99999999999999999999999999998765422
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......++..|+|||++.+..++.++||||||+++|||++|+.||....+. .......... . ... ..
T Consensus 154 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~--~-~~~--~~ 221 (256)
T cd06612 154 --AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-----RAIFMIPNKP--P-PTL--SD 221 (256)
T ss_pred --cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-----hhhhhhccCC--C-CCC--Cc
Confidence 1223445788999999999889999999999999999999999999643221 1111100000 0 000 01
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
....+..+.+++. .|++.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~i~------~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVK------KCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHH------HHHhcChhhCcCHHHHhc
Confidence 1122234444444 499999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=303.11 Aligned_cols=247 Identities=29% Similarity=0.446 Sum_probs=195.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.+.||+|+||.||++.. +++.||+|+++... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3588899999999999999875 67889999986542 346789999999999999999999988654 5799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999876432 3478999999999999999999998 9999999999999999999999999999764321
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
......+..|+|||.+....++.++||||||+++|||++ |+.||.... ..+.... ...... . ..
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~-~~~~~~-~-----~~ 218 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKEC-VEKGYR-M-----EP 218 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHH-HhCCCC-C-----CC
Confidence 112234568999999988899999999999999999998 999986421 1122221 111111 0 11
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
....+..+.+++. .|++.+|++||+++++++.+++
T Consensus 219 ~~~~~~~~~~li~------~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMT------SCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHH------HHcCCChhhCcCHHHHHHHHcc
Confidence 1222334444444 4999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.33 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=194.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc-----cchHHHHHHHHHHhccCCCCcceEEeeeecC--Cce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK-----ISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 847 (1117)
.+|+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999975 4588999998864321 1234688899999999999999999987653 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999987542 378899999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
....... ........++..|+|||++....++.++||||+||++|||++|+.||.... ....+.......
T Consensus 156 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-----~~~~~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMS-GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-----AMAAIFKIATQP---- 225 (266)
T ss_pred ccccccc-CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc-----hHHHHHHHhcCC----
Confidence 5321111 111223468899999999998889999999999999999999999996421 112222111111
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+.++...+..++.++ .||..+|++||++++|++
T Consensus 226 --~~~~~~~~~~~~~~~li-------~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 --TNPQLPSHISEHARDFL-------GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCCchhcCHHHHHHH-------HHhcCChhhCcCHHHHhc
Confidence 12333333334444444 388899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=307.01 Aligned_cols=246 Identities=28% Similarity=0.426 Sum_probs=200.1
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+|++.+.||.|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5788899999999999999754 68899999987543 334467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++... .+++..+..++.|++.|++|||++ +++||||+|+||++++++.++++|||+++......
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 999999998764 489999999999999999999999 99999999999999999999999999998775432
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......+++.|+|||++.+..++.++||||||+++|||++|+.||....+ ........... . +.+
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~--~-----~~~ 218 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----MRVLFLIPKNN--P-----PSL 218 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----HHHHHHhhhcC--C-----CCC
Confidence 123345688899999999988899999999999999999999999964321 11111111111 1 111
Q ss_pred CCC-CchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1015 QGH-PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1015 ~~~-~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
... .+..+.+++.. |+..+|++||+++++++
T Consensus 219 ~~~~~~~~~~~~l~~------~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 219 EGNKFSKPFKDFVSL------CLNKDPKERPSAKELLK 250 (274)
T ss_pred cccccCHHHHHHHHH------HhhCChhhCcCHHHHhh
Confidence 111 33445555554 99999999999999977
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=311.43 Aligned_cols=247 Identities=28% Similarity=0.394 Sum_probs=196.9
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 355667899999999999975 457899999987442 333457899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++... .+++..+..++.|+++|++|||++ +++|+||+|+||++++++.++++|||+++......
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 999999988643 388999999999999999999998 99999999999999999999999999998664321
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......++..|+|||++.+..++.++||||||+++|||++|+.||....+. ..... .... ..+.+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~-~~~~------~~~~~ 221 (277)
T cd06642 156 --IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVLFL-IPKN------SPPTL 221 (277)
T ss_pred --hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHHhh-hhcC------CCCCC
Confidence 1222346888999999999889999999999999999999999998643221 11111 1111 11222
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
....+..+.+++. .|++.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~------~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVE------ACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHH------HHccCCcccCcCHHHHHHh
Confidence 2333334455544 4999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=311.40 Aligned_cols=199 Identities=27% Similarity=0.366 Sum_probs=169.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999754 68899999987543 22344678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
++ ++|..++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||+++......
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 97 58888876542 3478999999999999999999999 99999999999999999999999999997653321
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......+++.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 159 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 159 ---KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred ---CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11223457899999998765 4578899999999999999999999965
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.83 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=197.5
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecC-CceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANR-KTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e 852 (1117)
+|++.+.||+|+||.||++..+ +++.||+|++.... ....+.+.+|++++++++|||++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999754 57899999986532 23345688999999999999999999887644 45789999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999987643 23489999999999999999999999 99999999999999999999999999998764321
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.......+++.|+|||+.....++.++||||+|+++|||++|+.||... .............. +
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~~~~~~~-------~ 220 (257)
T cd08223 157 ----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYRIIEGKL-------P 220 (257)
T ss_pred ----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcCC-------C
Confidence 1223456889999999999999999999999999999999999998642 11222222222111 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+.+++.. |++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~li~~------~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PMPKDYSPELGELIAT------MLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCccccCHHHHHHHHH------HhccCcccCCCHHHHhc
Confidence 1222334455555554 99999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.69 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=200.0
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||++.. .+|+.||+|++... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999874 46899999998743 223345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++..... ..+++.++.+++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999998875432 2378999999999999999999998 99999999999999999999999999998664321
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.......|++.|+|||+..+..++.++|||||||++|+|++|+.||... .....+........ +.
T Consensus 156 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~~-------~~ 220 (256)
T cd08218 156 ---ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIRGSY-------PP 220 (256)
T ss_pred ---hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhcCCC-------CC
Confidence 1122346888999999999888999999999999999999999998632 22233333322221 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+...+..+..+++. |++.+|++||++.+|++
T Consensus 221 ~~~~~~~~~~~li~~------~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQ------LFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHH------HhhCChhhCcCHHHHhh
Confidence 222333445555554 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=307.28 Aligned_cols=251 Identities=29% Similarity=0.437 Sum_probs=202.8
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+|+..+.||+|+||.||++..+ +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999865 68999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
++++|.+++.... ..+++..+.+++.|+++|++|+|+ . +++||||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 9999999997653 348899999999999999999999 7 99999999999999999999999999987654321
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.....++..|+|||...+..++.++||||||+++|+|++|+.||...........+.+........ +.
T Consensus 156 -----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~ 223 (265)
T cd06605 156 -----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------PR 223 (265)
T ss_pred -----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-------CC
Confidence 112578899999999998899999999999999999999999996543222334444443332221 11
Q ss_pred cCCC-CchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1014 LQGH-PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1014 l~~~-~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
++.. .+..+.+++.. |+..+|++||++.+++.
T Consensus 224 ~~~~~~~~~~~~li~~------~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSGKFSPDFQDFVNL------CLIKDPRERPSYKELLE 256 (265)
T ss_pred CChhhcCHHHHHHHHH------HcCCCchhCcCHHHHhh
Confidence 1111 33445555554 99999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=322.78 Aligned_cols=192 Identities=26% Similarity=0.352 Sum_probs=164.2
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999864 5788999975432 34569999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+. ++|.+++.... ..+++..+.+++.||+.||+|||++ +||||||||+||+++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 995 57877776532 3489999999999999999999999 9999999999999999999999999999754321
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPV 982 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~ 982 (1117)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223457899999999999899999999999999999999865554
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=305.29 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=199.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
++|++.+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56888899999999999999754 57899999998765556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++.... ..+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||.+.......
T Consensus 83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 9999999887642 3488999999999999999999999 99999999999999999999999999997654321
Q ss_pred ccccCCccccccccCChhhhccC---CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 935 SFSANPQFAGSYGYIAPEYANMT---KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.......++..|+|||.+... .++.++||||||+++|||++|+.||....+ .................
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~-- 226 (262)
T cd06613 156 --AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-----MRALFLISKSNFPPPKL-- 226 (262)
T ss_pred --hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhccCCCccc--
Confidence 122345688899999998776 889999999999999999999999964321 11111111111011000
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......+..+.+ ++.+|+..+|.+||++.+|+.
T Consensus 227 -~~~~~~~~~~~~------li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHD------FIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHH------HHHHHcCCChhhCCCHHHHhc
Confidence 001111223334 445599999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=316.99 Aligned_cols=201 Identities=21% Similarity=0.238 Sum_probs=165.7
Q ss_pred CCCeeeec--CCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 780 AGNIIGQG--RSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 780 ~~~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+.++||+| +|++||++.. .+|+.||+|++.... ....+.+++|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999874 578999999987542 223356788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++..... ..+++..+.+++.|++.||+|||++ +|+||||||+||+++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999875432 2388999999999999999999999 9999999999999999999999999876543321110
Q ss_pred c---cccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 935 S---FSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 935 ~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
. ........++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 001122356788999999875 4689999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=319.04 Aligned_cols=200 Identities=30% Similarity=0.441 Sum_probs=174.4
Q ss_pred CCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecC------CceE
Q 001238 777 SLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR------KTKL 848 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~ 848 (1117)
.|...+.||+||||.||+|+ ..+|+.||||.++.. .....++..+|++++++++|||||++++.-.+. +...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35566889999999999998 567999999999764 233456788999999999999999999975543 3568
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc--CCC--cceeccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG--ERY--ESCLADFGL 924 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~--~~~--~~kl~DfGl 924 (1117)
+|||||.+|+|..++.+.+....+++.+.+.+..+++.||.|||++ +||||||||.||++- ++| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999999876666699999999999999999999998 999999999999983 333 468999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
|+.+.++. ....++||..|.+||... .+.|+..+|.|||||++||.+||..||..
T Consensus 171 Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99987643 566789999999999988 58899999999999999999999999964
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=314.53 Aligned_cols=195 Identities=27% Similarity=0.351 Sum_probs=170.9
Q ss_pred CCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CC-----CcceEEeeeecCCceEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HR-----NIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~~l 849 (1117)
+|.+.+.||+|+||.|-++. .++++.||||+++.... -..+-..|+.+|..++ |. |+|+++++|...++.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78899999999999999985 56799999999986533 3445667999999996 43 89999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC--Ccceecccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER--YESCLADFGLARL 927 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl~DfGla~~ 927 (1117)
|+|.+ .-+|.++++.+.-.+ ++...++.++.||+.||.+||+. +|||+||||+|||+.+- ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999 569999999876555 99999999999999999999999 99999999999999753 4789999999998
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.... .. +.+-+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.+
T Consensus 341 ~~q~------vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQR------VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCc------ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 7542 11 45667889999999999999999999999999999999887765
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=308.15 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=197.2
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeee-----
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGA----- 842 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~----- 842 (1117)
++.++.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...++.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 4556788999999999999999999975 4588999998865322 245688999999999 6999999999874
Q ss_pred cCCceEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecc
Q 001238 843 NRKTKLLFYDYMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 843 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
..+..++||||+++++|.+++... .....+++..+..++.|+++|+.|||+. +|+||||||+||++++++.++++|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEcc
Confidence 345689999999999999887642 2234588999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhcc-----CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHH
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~ 996 (1117)
||+++...... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||..... ...+
T Consensus 168 fg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-----~~~~ 238 (286)
T cd06638 168 FGVSAQLTSTR----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-----MRAL 238 (286)
T ss_pred CCceeecccCC----CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-----hHHH
Confidence 99998764321 12233468999999998753 4578899999999999999999999864211 1111
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
...... ......+ +...+..+..++. .|++.+|++||++.++++.
T Consensus 239 ~~~~~~--~~~~~~~---~~~~~~~~~~li~------~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 FKIPRN--PPPTLHQ---PELWSNEFNDFIR------KCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hhcccc--CCCcccC---CCCcCHHHHHHHH------HHccCCcccCCCHHHHhhc
Confidence 111111 1111111 1112233444444 4999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.26 Aligned_cols=199 Identities=26% Similarity=0.394 Sum_probs=171.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999865 58999999986542 2233567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|++++++..+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999988877543 2389999999999999999999998 99999999999999999999999999998765422
Q ss_pred CCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+
T Consensus 155 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 155 D----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred c----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 1 1223457889999998865 5578999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.13 Aligned_cols=246 Identities=21% Similarity=0.267 Sum_probs=197.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.+.|+.-++||+||||.||-+. ..+|+.||.|++.+. .+........|-+++.++..+.||.+--+|...+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 3567778899999999999976 457999999988543 222333456799999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
+..|.||+|.-++......+ +++..++-+|.+|+.||++||.. +||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~~g-F~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPG-FDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCCCC-CchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999998876544 99999999999999999999999 999999999999999999999999999998865
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .....+||.+|||||++....|+...|.||+||++|||+.|+.||... .... -.+.+.+.....
T Consensus 340 g~-----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~-KeKv-k~eEvdrr~~~~------- 405 (591)
T KOG0986|consen 340 GK-----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR-KEKV-KREEVDRRTLED------- 405 (591)
T ss_pred CC-----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh-hhhh-hHHHHHHHHhcc-------
Confidence 43 233458999999999999999999999999999999999999999642 1111 111222222211
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP 1044 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP 1044 (1117)
...++..+++..+.+.+. -++.||++|-
T Consensus 406 ~~ey~~kFS~eakslc~~------LL~Kdp~~RL 433 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEG------LLTKDPEKRL 433 (591)
T ss_pred hhhcccccCHHHHHHHHH------HHccCHHHhc
Confidence 123445556666666665 6677888885
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=299.58 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=194.7
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCChh
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLG 860 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 860 (1117)
++||+|+||.||++...+++.||+|+++..... ..+.+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998766999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCC
Q 001238 861 MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP 940 (1117)
Q Consensus 861 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 940 (1117)
+++.... ..+++..+..++.+++.|++|||++ +++||||||+||+++.++.++|+|||+++....... .....
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~ 153 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--TVSDG 153 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcc--eeccc
Confidence 9986542 2478999999999999999999999 999999999999999999999999999986542111 11111
Q ss_pred ccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCc
Q 001238 941 QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019 (1117)
Q Consensus 941 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1019 (1117)
...++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...... ....... ..+...+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~----~~~~~~~------~~~~~~~ 221 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRER----IESGYRM------PAPQLCP 221 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHH----HhcCCCC------CCCccCC
Confidence 2234677999999988899999999999999999999 8888864211 111111 1111100 1112223
Q ss_pred hhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1020 TQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1020 ~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
..+.+++. .|+..+|++||++.++++.|+
T Consensus 222 ~~~~~li~------~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLML------QCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHH------HHhccChhhCcCHHHHHHHhh
Confidence 34444444 499999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=300.78 Aligned_cols=247 Identities=30% Similarity=0.422 Sum_probs=198.2
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-----ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-----KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
+|+..+.||+|+||+||+|... +++.||+|.+.... +...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999865 78999999986543 22345788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++... +.+++..+..++.|+++|++|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998764 2378999999999999999999999 999999999999999999999999999887543
Q ss_pred CCCCccccCCccccccccCChhhhccCC-CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTK-ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.... ............ ..
T Consensus 155 ~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~-~~--- 220 (258)
T cd06632 155 FS-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----GVAAVFKIGRSK-EL--- 220 (258)
T ss_pred cc-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----HHHHHHHHHhcc-cC---
Confidence 22 223456889999999987766 8999999999999999999999996432 111111111101 11
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.++...+..+.++++. |++.+|++||++.+++.
T Consensus 221 --~~~~~~~~~~~~~li~~------~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 --PPIPDHLSDEAKDFILK------CLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CCcCCCcCHHHHHHHHH------HhhcCcccCcCHHHHhc
Confidence 12223334455555554 99999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=312.94 Aligned_cols=197 Identities=25% Similarity=0.374 Sum_probs=159.9
Q ss_pred CCeeeecCCeEEEEEEcC---CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeec--CCceEEEEEecC
Q 001238 781 GNIIGQGRSGIVYKVTLP---SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN--RKTKLLFYDYMP 855 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~ 855 (1117)
+.+||+|+||+||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 467999999999999854 45789999987543 23467899999999999999999998753 456789999986
Q ss_pred CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE----cCCCcceecccccc
Q 001238 856 NGTLGMLLHDG------ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL----GERYESCLADFGLA 925 (1117)
Q Consensus 856 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfGla 925 (1117)
+ +|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 676665421 1123488999999999999999999999 99999999999999 46679999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+....... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 160 ~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcc-cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 87654321 1122345678999999998876 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=303.25 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=195.9
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc----------chHHHHHHHHHHhccCCCCcceEEeeeecCC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI----------STGAFSSEIATLSRIRHRNIVRLLGWGANRK 845 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 845 (1117)
+|.+.+.||+|+||.||+|.. .+|+.||+|.++..... ..+.+.+|++++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999974 46899999988642110 1235788999999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..++||||+++++|.+++... +.+++..+..++.|++.|+.|||++ +++||||||+||+++.++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998765 3488999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCC--CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK--ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
+....... ........|+..|+|||.+.... ++.++||||||+++||+++|+.||... ... ..........
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~~~-~~~~~~~~~~ 228 (272)
T cd06629 156 KKSDDIYD--NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE----EAI-AAMFKLGNKR 228 (272)
T ss_pred cccccccc--ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc----chH-HHHHHhhccc
Confidence 76543211 11223456889999999987654 789999999999999999999998532 111 1111111111
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
....+.+......+..+.+++.. |++.+|++||++.+|++
T Consensus 229 --~~~~~~~~~~~~~~~~~~~li~~------~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 --SAPPIPPDVSMNLSPVALDFLNA------CFTINPDNRPTARELLQ 268 (272)
T ss_pred --cCCcCCccccccCCHHHHHHHHH------HhcCChhhCCCHHHHhh
Confidence 11111122222233445555554 99999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.79 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=197.2
Q ss_pred CCCCCCeeeecCCeEEEEEEcCC--CcEEEEEEeecCC----------ccchHHHHHHHHHHhc-cCCCCcceEEeeeec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPS--GLTVAVKRFRASD----------KISTGAFSSEIATLSR-IRHRNIVRLLGWGAN 843 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 843 (1117)
+|++.+.||+|+||.||+|.... ++.||+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998654 6889999885321 1223456778888765 799999999999999
Q ss_pred CCceEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccc
Q 001238 844 RKTKLLFYDYMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADF 922 (1117)
Q Consensus 844 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 922 (1117)
.+..++||||+++++|.+++... .....+++..+++++.|++.|+.|||+.. +++||||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887542 12235889999999999999999999631 8999999999999999999999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
|.+....... ......|+..|+|||......++.++||||||+++|||++|+.||... ............
T Consensus 159 g~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~ 228 (269)
T cd08528 159 GLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NMLSLATKIVEA 228 (269)
T ss_pred cceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHHHHHHHHhhc
Confidence 9998754321 223456889999999999888999999999999999999999998642 122222222221
Q ss_pred CCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1003 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
... +......+..+.++++ +|++.+|++||++.|+.++++
T Consensus 229 ~~~------~~~~~~~~~~l~~li~------~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE------PLPEGMYSEDVTDVIT------SCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC------cCCcccCCHHHHHHHH------HHCCCCCccCCCHHHHHHHhc
Confidence 111 1111122334555554 499999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=299.84 Aligned_cols=251 Identities=30% Similarity=0.453 Sum_probs=197.7
Q ss_pred CCCCCeeeecCCeEEEEEEcCC-----CcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 778 LTAGNIIGQGRSGIVYKVTLPS-----GLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
+++.+.||+|+||.||++...+ +..||+|+++..... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998643 488999999755432 4668999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++++|.+++....... +++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhcc-CCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999997653221 89999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
... ......+++.|+|||.+....++.++||||+|+++|||++ |+.||... . ............ ..
T Consensus 157 ~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~---~~~~~~~~~~~~-~~---- 223 (258)
T smart00219 157 DYY---KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--S---NEEVLEYLKKGY-RL---- 223 (258)
T ss_pred ccc---ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--C---HHHHHHHHhcCC-CC----
Confidence 211 1112237789999999988889999999999999999998 88888641 1 122222222111 11
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
..+...+..+.+++. .|+..+|++||++.++++.|
T Consensus 224 --~~~~~~~~~~~~~i~------~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 --PKPENCPPEIYKLML------QCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCcCCHHHHHHHH------HHCcCChhhCcCHHHHHhhC
Confidence 111223334444444 49999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=306.81 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=197.6
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5677789999999999999754 58899999987543 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++... .+++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 85 GGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 999999988653 378899999999999999999999 99999999999999999999999999997664321
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......++..|+|||++.+..++.++|||||||++|||++|+.||....+. ...... ... . .+.+
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~-~~~-~-----~~~~ 221 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLFLI-PKN-N-----PPTL 221 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhhhh-hcC-C-----CCCC
Confidence 1223346788999999998888999999999999999999999999643211 111111 111 0 1122
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
....+..+.+++ ..|++.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li------~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFI------DACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHH------HHHcccCcccCcCHHHHHhC
Confidence 222333444444 45999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=301.92 Aligned_cols=252 Identities=29% Similarity=0.462 Sum_probs=198.7
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc--chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI--STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||+|.. .+++.||+|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478889999999999999975 46899999998765442 456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++... +.+++..+..++.|+++|++|||+. +|+||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998764 2378899999999999999999999 999999999999999999999999999987654322
Q ss_pred CccccCCccccccccCChhhhccCC---CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTK---ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
..........+++.|+|||++.... ++.++||||||+++||+++|+.||..... ....... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----~~~~~~~-~~~~~------ 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIMFH-VGAGH------ 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----hHHHHHH-HhcCC------
Confidence 1111122356789999999988766 88999999999999999999999964321 1111111 11111
Q ss_pred CcccCCCC--chhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHP--DTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~--~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+.++... +..+.++++ .|++.+|++||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~------~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDSLQLSPEGKDFLD------RCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcccccCHHHHHHHH------HHccCCcccCCCHHHHhc
Confidence 11112211 334445444 499999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=301.94 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=192.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc-----cchHHHHHHHHHHhccCCCCcceEEeeeecC--Cce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK-----ISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 847 (1117)
.+|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999975 4589999998864321 1234688899999999999999999988764 457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++++|.+++... +.+++..+.+++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998754 2378889999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
...... .........++..|+|||++....++.++||||||+++|||++|+.||... .....+.......
T Consensus 156 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~---- 225 (265)
T cd06652 156 LQTICL-SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-----EAMAAIFKIATQP---- 225 (265)
T ss_pred cccccc-cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc-----chHHHHHHHhcCC----
Confidence 532111 111223456889999999998888999999999999999999999999642 1111122211111
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+..+...+..+..++.. |+. +|++||+++++++
T Consensus 226 --~~~~~~~~~~~~~~~~i~~------~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 --TNPVLPPHVSDHCRDFLKR------IFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCCCchhhCHHHHHHHHH------Hhc-ChhhCCCHHHHhc
Confidence 0122222233344444444 664 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=310.89 Aligned_cols=255 Identities=24% Similarity=0.303 Sum_probs=198.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc---chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|... +++.||+|.+...... ..+.+..|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999764 5899999999765322 3456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987543 24589999999999999999999999 9999999999999999999999999998765332
Q ss_pred CCCc-------------------------cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCC
Q 001238 932 SGGS-------------------------FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASF 986 (1117)
Q Consensus 932 ~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~ 986 (1117)
.... ........||..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 001123468999999999998889999999999999999999999996432
Q ss_pred CCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC----HHHHHH
Q 001238 987 PDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT----MKDVAA 1051 (1117)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs----~~~v~~ 1051 (1117)
. .............. +. ....+..+.++++. |++.+|++||+ +.++++
T Consensus 237 ~-----~~~~~~~~~~~~~~-----~~-~~~~~~~~~~li~~------~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 R-----DETFSNILKKEVTF-----PG-SPPVSSSARDLIRK------LLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred h-----HHHHHHHhcCCccC-----CC-ccccCHHHHHHHHH------HccCCHhHCCCchhhHHHHHc
Confidence 1 11112222111110 00 01133455565555 99999999999 555544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=282.41 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=198.1
Q ss_pred CCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC-CccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEEec
Q 001238 778 LTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.+....||.|..|.||+++.+ +|...|||.+.+. .+.+.+++...+.++.+-. .|+||+.+|||......++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 445567999999999999754 5889999998765 4555677888888877664 899999999999999999999998
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
. .-.+.++++.. +++++..+-++...+.+||.||-+++ +|+|||+||+|||+|+.|.+|+||||++..+.+.
T Consensus 174 s-~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--- 245 (391)
T KOG0983|consen 174 S-TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--- 245 (391)
T ss_pred H-HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc---
Confidence 4 34566666543 34888888999999999999999875 9999999999999999999999999999877653
Q ss_pred ccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 935 SFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.+.+..+|-+.|||||.+. ...|+-++||||||++++|++||+.||..- ....+.+...+...+ ..++
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c----~tdFe~ltkvln~eP---P~L~ 316 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC----KTDFEVLTKVLNEEP---PLLP 316 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC----CccHHHHHHHHhcCC---CCCC
Confidence 3445668999999999885 457899999999999999999999999652 223344444444332 2222
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+... ++...+++++. |+..|+.+||.+.++++
T Consensus 317 ~~~g--FSp~F~~fv~~------CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHMG--FSPDFQSFVKD------CLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cccC--cCHHHHHHHHH------HhhcCcccCcchHHHhc
Confidence 2222 55567777766 99999999999999876
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=330.82 Aligned_cols=197 Identities=20% Similarity=0.236 Sum_probs=163.5
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCC------CCcceEEeeeecC-
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH------RNIVRLLGWGANR- 844 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~~~- 844 (1117)
..+++|++.++||+|+||+||+|.. ..++.||||+++.... ....+..|+++++.++| .+++++++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 4467899999999999999999975 4588999999975322 23456678888877755 4588899988764
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEcCCC--------
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLGERY-------- 915 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~-------- 915 (1117)
.+.|+|||++ +++|.+++... +.+++..+..++.||+.||+|||+ . +||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccc
Confidence 5688999988 77888877654 348999999999999999999997 5 899999999999998765
Q ss_pred --------cceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 916 --------ESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 916 --------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 489999998864321 23356899999999999999999999999999999999999999975
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=309.06 Aligned_cols=248 Identities=22% Similarity=0.361 Sum_probs=197.0
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
|.....||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33445799999999999975 46899999998765555566788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
++|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 103 ~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~---- 171 (297)
T cd06659 103 GALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---- 171 (297)
T ss_pred CCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc----
Confidence 9999887653 388999999999999999999999 99999999999999999999999999987654321
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||.... . ...+... ....... .....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~---~~~~~~~-~~~~~~~----~~~~~ 241 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--P---VQAMKRL-RDSPPPK----LKNAH 241 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--H---HHHHHHH-hccCCCC----ccccC
Confidence 12234578999999999998899999999999999999999999996421 1 1111111 1111110 01111
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
..+..+.++++. |++.+|++||++.++++.
T Consensus 242 ~~~~~l~~~i~~------~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLER------MLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHH------HhcCCcccCcCHHHHhhC
Confidence 223345555554 999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.76 Aligned_cols=250 Identities=29% Similarity=0.447 Sum_probs=192.8
Q ss_pred CeeeecCCeEEEEEEcCC-------CcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 782 NIIGQGRSGIVYKVTLPS-------GLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+.||+|+||.||+|+..+ ++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997542 2579999886542 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC-----cceeccccc
Q 001238 854 MPNGTLGMLLHDGE----CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-----ESCLADFGL 924 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-----~~kl~DfGl 924 (1117)
+++++|.+++.... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999987532 123478899999999999999999998 999999999999999877 899999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
++....... ........++..|+|||++....++.++||||||+++|||++ |+.||... ........ ....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~--~~~~~~~~----~~~~ 229 (269)
T cd05044 158 ARDIYKSDY--YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--NNQEVLQH----VTAG 229 (269)
T ss_pred ccccccccc--cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc--CHHHHHHH----HhcC
Confidence 986543211 112223345788999999999999999999999999999998 99998642 11111111 1111
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
... ......+..+.+++. .|+..+|++||+++++.+.|+
T Consensus 230 ~~~------~~~~~~~~~~~~li~------~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRL------QKPENCPDKIYQLMT------NCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred Ccc------CCcccchHHHHHHHH------HHcCCCcccCCCHHHHHHHHh
Confidence 100 111222334444444 599999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=306.79 Aligned_cols=239 Identities=21% Similarity=0.338 Sum_probs=185.8
Q ss_pred CeeeecCCeEEEEEEcCC--------CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 782 NIIGQGRSGIVYKVTLPS--------GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+.||+|+||.||+|.... ...||+|.+........+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 235888888655444556788999999999999999999999998999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc--------ceecccccc
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE--------SCLADFGLA 925 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~--------~kl~DfGla 925 (1117)
+++|+|.++++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999997653 2488999999999999999999999 9999999999999988765 589999988
Q ss_pred ccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCC-CCCCCCCCCChhHHHHHHHHHhcC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGK-KPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~-~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .||.... . ..... .....
T Consensus 156 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---~--~~~~~-~~~~~ 221 (258)
T cd05078 156 ITVLP--------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---S--QKKLQ-FYEDR 221 (258)
T ss_pred cccCC--------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc---H--HHHHH-HHHcc
Confidence 65432 223467889999999876 45789999999999999999985 5554311 1 11111 11111
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
..++......+.+++. .|++.+|++||+++++++.|
T Consensus 222 --------~~~~~~~~~~~~~li~------~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 --------HQLPAPKWTELANLIN------QCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --------ccCCCCCcHHHHHHHH------HHhccChhhCCCHHHHHHhc
Confidence 1112222234444444 49999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=302.03 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=193.8
Q ss_pred CCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCC------
Q 001238 778 LTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK------ 845 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 845 (1117)
|++.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999743 46899999987542 233557889999999999999999999876532
Q ss_pred ceEEEEEecCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGE---CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADF 922 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 922 (1117)
..++++||+++|+|.+++.... ....+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999988775321 112478899999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHh
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLK 1001 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~ 1001 (1117)
|.++....... ........+++.|++||......++.++||||||+++|||++ |+.||.... ......++ .
T Consensus 158 g~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--~~~~~~~~---~- 229 (273)
T cd05074 158 GLSKKIYSGDY--YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--NSEIYNYL---I- 229 (273)
T ss_pred cccccccCCcc--eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--HHHHHHHH---H-
Confidence 99986643211 112223345678999999998889999999999999999999 889986421 11121111 1
Q ss_pred cCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1002 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
..... .........+.+ ++..|++.+|++||++.++++.|+++
T Consensus 230 ~~~~~------~~~~~~~~~~~~------l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRL------KQPPDCLEDVYE------LMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcC------CCCCCCCHHHHH------HHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 011112223333 44559999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=305.91 Aligned_cols=244 Identities=24% Similarity=0.304 Sum_probs=198.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999754 68999999987532 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++++|.+++... +.+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998764 3488999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.....+++.|+|||.+.....+.++||||||+++|+|++|+.||.... ............
T Consensus 155 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~-------- 214 (290)
T cd05580 155 -------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKILEGK-------- 214 (290)
T ss_pred -------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCC--------
Confidence 234468999999999988888999999999999999999999996422 111122222111
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
..++...+..+.++++. |+..+|.+|| +++++.+
T Consensus 215 ~~~~~~~~~~l~~li~~------~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 VRFPSFFSPDAKDLIRN------LLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCccCCHHHHHHHHH------HccCCHHHccCcccCCHHHHHc
Confidence 12223334566666665 9999999999 5666643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.38 Aligned_cols=237 Identities=22% Similarity=0.343 Sum_probs=185.1
Q ss_pred CeeeecCCeEEEEEEcCCC-----------cEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 782 NIIGQGRSGIVYKVTLPSG-----------LTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~-----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
+.||+|+||.||+|...+. ..||+|++...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4699999999999986542 25788887654433 6788999999999999999999999888 778999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC-------cceecccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-------ESCLADFG 923 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-------~~kl~DfG 923 (1117)
|||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+|++|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999976432 488999999999999999999998 999999999999999887 79999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccC--CCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHH
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT--KISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
+++.... .....++..|+|||++... .++.++||||||+++|||++ |..||..... . .+.....
T Consensus 154 ~a~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~---~~~~~~~ 220 (259)
T cd05037 154 IPITVLS--------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--S---EKERFYQ 220 (259)
T ss_pred ccccccc--------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--h---hHHHHHh
Confidence 9986543 1223567789999998876 78999999999999999999 5777754321 1 1111111
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
... . .+......+.+ ++..|+..+|++||++.++++.|
T Consensus 221 ~~~--~-------~~~~~~~~~~~------li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 DQH--R-------LPMPDCAELAN------LINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred cCC--C-------CCCCCchHHHH------HHHHHhccChhhCCCHHHHHHhc
Confidence 110 0 01111123333 44459999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=306.54 Aligned_cols=199 Identities=29% Similarity=0.388 Sum_probs=168.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||+|+||.||+|..+ +++.||||.+...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999864 6899999998754322 234567899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++ +|.+++.... +.+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 157 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS- 157 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence 975 8988887543 3488999999999999999999999 99999999999999999999999999987543211
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......++..|+|||++.+ ..++.++||||+|+++|||++|+.||..
T Consensus 158 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 158 ---KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred ---ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11122346889999998865 5588999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=308.19 Aligned_cols=257 Identities=19% Similarity=0.247 Sum_probs=198.9
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6888899999999999999754 57899999987543 2234567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++... +.+++..+..++.|+++|++|||+. +++||||||+||+++.++.++++|||+++......
T Consensus 82 ~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 82 YVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 99999999999764 3488999999999999999999999 99999999999999999999999999987421110
Q ss_pred CC-----------ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHh
Q 001238 933 GG-----------SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK 1001 (1117)
Q Consensus 933 ~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 1001 (1117)
.. .........++..|+|||.+....++.++||||||+++|||++|+.||.+. ...+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-----~~~~~~~~~~~ 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-----TPEELFGQVIS 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHh
Confidence 00 001112346788999999998888999999999999999999999999642 11222222222
Q ss_pred cCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1002 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
.... .+......+..+.++++. |++.+|++||++.++.+.++.
T Consensus 231 ~~~~-----~~~~~~~~~~~~~~li~~------~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDIE-----WPEGDEALPADAQDLISR------LLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccC-----CCCccccCCHHHHHHHHH------HhccChhhccCccCHHHHHhC
Confidence 1111 111112233445555555 999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=298.38 Aligned_cols=248 Identities=23% Similarity=0.365 Sum_probs=197.5
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|+..+.||+|+||.||++.. .+++.||+|++.... ......+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999875 468899999987542 23356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-CcceeccccccccccCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGLARLVEDDS 932 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla~~~~~~~ 932 (1117)
+++++|.+++.... ...+++..+.+++.|+++|++|||++ +|+||||||+||+++++ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 23488999999999999999999999 99999999999999865 457999999998765321
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
......++..|+|||.+....++.++||||||+++|+|++|+.||.... ....+........ .
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~~~~~~~~~~~~~-------~ 219 (256)
T cd08220 157 -----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----LPALVLKIMSGTF-------A 219 (256)
T ss_pred -----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-----hHHHHHHHHhcCC-------C
Confidence 1223468899999999998889999999999999999999999996421 1122222222111 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++...+..+.+++.. ||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~l~~li~~------~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 PISDRYSPDLRQLILS------MLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCcCHHHHHHHHH------HccCChhhCCCHHHHhh
Confidence 1122233445555554 99999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=298.64 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=204.0
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+|.+.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++.+++++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5788899999999999999865 589999999876543 34567999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 999999999764 348999999999999999999999 8 999999999999999999999999999987643221
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
......++..|+|||.+....++.++||||||+++|||++|+.||..... ....+......... .+.
T Consensus 156 ----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~-------~~~ 222 (264)
T cd06623 156 ----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGP-------PPS 222 (264)
T ss_pred ----cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCC-------CCC
Confidence 12245688999999999988999999999999999999999999965322 12222222222111 111
Q ss_pred cCCC-CchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1014 LQGH-PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1014 l~~~-~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.... .+..+.++++. |++.+|++||++.++++.
T Consensus 223 ~~~~~~~~~l~~li~~------~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISA------CLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHH------HccCChhhCCCHHHHHhC
Confidence 2222 34456666665 999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.03 Aligned_cols=197 Identities=27% Similarity=0.370 Sum_probs=166.2
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999854 68999999987532 22235678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
++ ++|.+++.... +.+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 97 57777765432 3489999999999999999999999 99999999999999999999999999998654321
Q ss_pred CccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVD 983 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~ 983 (1117)
.......++..|+|||++.+. .++.++|||||||++|||++|+.|+.
T Consensus 154 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 154 ---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred ---CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 112234678899999988664 47899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=303.97 Aligned_cols=259 Identities=25% Similarity=0.318 Sum_probs=196.3
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecC--CceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 852 (1117)
+|...+.||.|++|.||+|.. .+++.||+|.+..... ....++.+|++++++++||||+++++++.+. +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 577788999999999999986 4588999999875432 3456789999999999999999999988654 46799999
Q ss_pred ecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 853 YMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999998875421 234478899999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. .....++..|+|||.+....++.++||||+|+++|||++|+.||...........+......... .+....+
T Consensus 159 ~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (287)
T cd06621 159 L------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-NPELKDE 231 (287)
T ss_pred c------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-chhhccC
Confidence 1 12345788999999999899999999999999999999999999754221112222222211111 1100000
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+......+..+.+ ++..|++.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~------li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PGNGIKWSEEFKD------FIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCchHHHHHH------HHHHHcCCCcccCCCHHHHHh
Confidence 1101112233344 445599999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=305.26 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=195.7
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeec------
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGAN------ 843 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------ 843 (1117)
......|++.+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 34557889999999999999999975 468899999986543 2345788899999998 69999999998853
Q ss_pred CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 844 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
.+..+++|||+++|+|.+++..... ..+++..+..++.|+++|++|||+. +|+||||||+||++++++.++|+|||
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCc
Confidence 4567999999999999999876432 3478888999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHH
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
++....... .......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+. ..+..
T Consensus 167 ~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-----~~~~~ 237 (282)
T cd06636 167 VSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-----RALFL 237 (282)
T ss_pred chhhhhccc----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-----hhhhh
Confidence 987653221 1223456899999999875 356888999999999999999999999642211 11111
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.... ..... .....+..+.++++. ||+.+|++||++.++++
T Consensus 238 ~~~~--~~~~~----~~~~~~~~~~~li~~------cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IPRN--PPPKL----KSKKWSKKFIDFIEG------CLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhhC--CCCCC----cccccCHHHHHHHHH------HhCCChhhCcCHHHHhc
Confidence 1111 11110 112233445555554 99999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=305.10 Aligned_cols=202 Identities=27% Similarity=0.317 Sum_probs=168.6
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++.+|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+++++.++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 456899999999999999999974 4688999999875432 22346788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+. +++.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 66766655432 3377888999999999999999999 9999999999999999999999999999764332
Q ss_pred CCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
.. ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||+..
T Consensus 157 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 157 SQ----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CC----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 11 1223457899999998865 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=306.59 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=201.3
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++..++|.+.+.||+|+||.||++.. .++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 34456899999999999999999974 46889999998765555566789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
+||+++++|.+++... .+++..+..++.|++.|+.|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999998753 278899999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
... ......+++.|+|||.+....++.++||||||+++||+++|+.||...... ..+....... .+. .
T Consensus 168 ~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~-----~~~~~~~~~~-~~~--~ 235 (293)
T cd06647 168 EQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYLIATNG-TPE--L 235 (293)
T ss_pred ccc----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-----hheeehhcCC-CCC--C
Confidence 221 223346889999999998888999999999999999999999999653211 1111111111 000 0
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
......+..+.++++ .||+.+|++||++.+++..
T Consensus 236 --~~~~~~~~~l~~li~------~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 --QNPEKLSAIFRDFLN------RCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCccccCHHHHHHHH------HHccCChhhCcCHHHHhcC
Confidence 001112233444444 4999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=303.73 Aligned_cols=258 Identities=26% Similarity=0.355 Sum_probs=196.7
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecC---
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANR--- 844 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--- 844 (1117)
++++++++|.+.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.+++++ +|||++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 4556788999999999999999999975 4688999999865422 345788899999999 899999999988653
Q ss_pred --CceEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecc
Q 001238 845 --KTKLLFYDYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 845 --~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
+..++||||+++++|.++++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEee
Confidence 35799999999999999886421 223589999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhccC-----CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHH
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-----KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~ 996 (1117)
||+++....... ......|+..|+|||.+... .++.++|||||||++|||++|+.||..... ...+
T Consensus 172 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-----~~~~ 242 (291)
T cd06639 172 FGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-----VKTL 242 (291)
T ss_pred cccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----HHHH
Confidence 999986543211 12234688999999987543 368899999999999999999999964211 1111
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
....+.. .....+ +......+.+ ++..|++.+|++||++.++++
T Consensus 243 ~~~~~~~--~~~~~~---~~~~~~~l~~------li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 FKIPRNP--PPTLLH---PEKWCRSFNH------FISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHhcCC--CCCCCc---ccccCHHHHH------HHHHHhhcChhhCcCHHHHhc
Confidence 1111111 111111 1112223333 445599999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=304.04 Aligned_cols=199 Identities=27% Similarity=0.369 Sum_probs=171.8
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999985 468999999987653 23346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+ +++|.+++.... ..+++.+++.++.|+++||+|||+. +++|+||||+||+++.++.++++|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987543 3489999999999999999999999 999999999999999999999999999987654321
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......++..|+|||++.. ..++.++||||+|+++|||++|++||..
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 155 ---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred ---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 12234568999999998764 4468999999999999999999888854
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=299.86 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=198.1
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
-|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 467788999999999999974 468899999886432 233457889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||++.......
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 999999998653 388999999999999999999998 99999999999999999999999999987664321
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......++..|+|||.+....++.++|||||||++|+|++|..||.... ............ .+.+
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~-------~~~~ 221 (277)
T cd06641 156 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-----PMKVLFLIPKNN-------PPTL 221 (277)
T ss_pred --hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc-----hHHHHHHHhcCC-------CCCC
Confidence 12233468889999999988888999999999999999999999996421 111111111111 1122
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
....+..+.+++.. |++.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~------~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEA------CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHH------HccCChhhCcCHHHHHhC
Confidence 33334445555544 999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=306.97 Aligned_cols=199 Identities=26% Similarity=0.416 Sum_probs=170.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|++.+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999865 589999998865322 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|++++++..+.... ..+++.++..++.|+++|++|||+. +|+||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998876543 2389999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......++..|+|||+..+ ..++.++||||||+++|||++|++||..
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 155 ----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred ----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 12233567899999998865 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=304.15 Aligned_cols=260 Identities=17% Similarity=0.255 Sum_probs=182.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCC----CcEEEEEEeecCCccch-H----------HHHHHHHHHhccCCCCcceEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPS----GLTVAVKRFRASDKIST-G----------AFSSEIATLSRIRHRNIVRLLG 839 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~-~----------~~~~E~~~l~~l~H~niv~l~~ 839 (1117)
.++|.+.++||+|+||+||+|.+.+ +..+|+|+......... + ....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999998644 45667775433221111 0 1122334456678999999999
Q ss_pred eeecCC----ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC
Q 001238 840 WGANRK----TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY 915 (1117)
Q Consensus 840 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 915 (1117)
++.... ..++++|++. .++.+.+.... ..++..+..++.|+++||+|||++ +|+||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 765543 3467788764 35666655432 256788899999999999999999 999999999999999999
Q ss_pred cceeccccccccccCCCCCc---cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhH
Q 001238 916 ESCLADFGLARLVEDDSGGS---FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHV 992 (1117)
Q Consensus 916 ~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~ 992 (1117)
.++|+|||+|+......... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-NL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-HH
Confidence 99999999998764322111 112233579999999999999999999999999999999999999997642222 21
Q ss_pred HHHHH-HHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 993 IQWVR-DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 993 ~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
..... +........ .. ..+ ..+..+.++++. |+..+|++||++.++.+.+
T Consensus 243 ~~~~~~~~~~~~~~~-~~---~~~-~~~~~~~~~~~~------~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEG-KI---KIK-NANKFIYDFIEC------VTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhh-hh---ccC-CCCHHHHHHHHH------HHhCCCCCCCCHHHHHHhh
Confidence 11111 111111000 00 111 123455566665 9999999999999999876
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=304.27 Aligned_cols=199 Identities=26% Similarity=0.375 Sum_probs=168.4
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999754 68999999886542 22335788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+. ++|..++..... ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.+|++|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 688888865432 3489999999999999999999999 99999999999999999999999999987654321
Q ss_pred CccccCCccccccccCChhhhccCC-CCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTK-ISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......++..|+|||+..+.. ++.++||||||+++|||++|+.||..
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 155 ---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred ---cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1122335688999999876544 68899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=300.21 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=197.6
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
.|...+.||+|++|.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344557899999999999975 4688999999876554455678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.+++... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.++++|||.+.......
T Consensus 100 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--- 169 (285)
T cd06648 100 GGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--- 169 (285)
T ss_pred CCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC---
Confidence 99999998762 388999999999999999999999 99999999999999999999999999987654321
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......|++.|+|||...+..++.++||||||+++|||++|+.||... ............. ..... ..
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-----~~~~~~~~~~~~~--~~~~~---~~ 238 (285)
T cd06648 170 -PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-----PPLQAMKRIRDNL--PPKLK---NL 238 (285)
T ss_pred -cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-----CHHHHHHHHHhcC--CCCCc---cc
Confidence 1222356899999999998888999999999999999999999998642 1122222222111 11100 01
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
...+..+.++++. |++.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~------~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDR------MLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHH------HcccChhhCcCHHHHcc
Confidence 1123345555555 99999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=303.98 Aligned_cols=198 Identities=27% Similarity=0.362 Sum_probs=169.3
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc-----chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI-----STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
+|++.+.||+|+||.||+|.. .+|+.||||+++..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999999999985 46899999999765322 234567899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+ +|+|.+++.... ..+++..+.+++.|+++||+|||++ +|+||||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999997653 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
... ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||..
T Consensus 155 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 155 PNR----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CCc----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 221 1223356788999998854 4678999999999999999999888764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=300.92 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=197.0
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCC-----
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRK----- 845 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~----- 845 (1117)
..+++|++.+.||+|+||.||+|..+ +++.||+|++..... ..+++.+|+++++++ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 34678999999999999999999864 578999999876543 456799999999999 6999999999986644
Q ss_pred -ceEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 846 -TKLLFYDYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 846 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999886532 234589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhcc-----CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHH
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
.+....... .......|+..|+|||++.. ..++.++||||||+++|||++|+.||..... ......
T Consensus 159 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~ 229 (275)
T cd06608 159 VSAQLDSTL----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-----MRALFK 229 (275)
T ss_pred cceecccch----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-----HHHHHH
Confidence 997654321 12234568999999998753 3567899999999999999999999964211 111111
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..... ...... .......+.++++ +|+..||++||++.++++
T Consensus 230 ~~~~~--~~~~~~---~~~~~~~~~~li~------~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNP--PPTLKS---PENWSKKFNDFIS------ECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccC--CCCCCc---hhhcCHHHHHHHH------HHhhcChhhCcCHHHHhc
Confidence 11111 111110 1112334445444 499999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=300.36 Aligned_cols=246 Identities=25% Similarity=0.407 Sum_probs=195.9
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC-CccchHHHHHHHHHHhccC---CCCcceEEeeeecCCceEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS-DKISTGAFSSEIATLSRIR---HRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.|++.+.||+|+||.||+|.+ .+++.||+|.++.. .....+++.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999985 57899999998754 3334567889999999996 999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++++|.+++... .+++..+..++.|+++|+.|||+. +|+||||+|+||++++++.++++|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998653 488999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
. .......|+..|+|||.+.. ..++.++||||||+++|+|++|+.||.... ........ ... .
T Consensus 155 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-----~~~~~~~~-~~~-~----- 218 (277)
T cd06917 155 S----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-----AFRAMMLI-PKS-K----- 218 (277)
T ss_pred c----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-----hhhhhhcc-ccC-C-----
Confidence 2 12234468899999998865 456899999999999999999999996421 11111111 111 0
Q ss_pred CcccCCC-CchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGH-PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~-~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+.+... .+..+.+++. .|++.+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~i~------~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDNGYSKLLREFVA------ACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcccCCHHHHHHHH------HHcCCCcccCcCHHHHhh
Confidence 1112221 3334455444 499999999999999977
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.27 Aligned_cols=200 Identities=27% Similarity=0.378 Sum_probs=177.8
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
....|.+...||+|.|++|..|++ .++..||||.+.+.. ......+.+|+++|+.+.|||||+++.+.......|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345788899999999999999974 469999999997653 33334588999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+.+|.+.+++.... ...+..+..++.|+.+|++|+|++ .|||||||++||+++.+..+||+|||++.++..
T Consensus 134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999998763 366688899999999999999999 999999999999999999999999999998864
Q ss_pred CCCCccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
. ....+++|++.|.|||++.+.+| ++.+|+||+|+++|.|+.|..||++
T Consensus 208 ~-----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 208 G-----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred c-----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 3 24457799999999999998777 4899999999999999999999975
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=302.06 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=190.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHH-HhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIAT-LSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|++.+.||+|+||.||+|... +|+.||+|+++... .....++..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999754 69999999987542 2223455566665 566789999999999999999999999
Q ss_pred ecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 853 YMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|++ |+|.+++... .....+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6787777542 22345899999999999999999999853 7999999999999999999999999999865432
Q ss_pred CCCccccCCccccccccCChhhhcc----CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANM----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..... ..+.+....... .
T Consensus 158 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~--~- 225 (283)
T cd06617 158 V-----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----PFQQLKQVVEEP--S- 225 (283)
T ss_pred c-----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----CHHHHHHHHhcC--C-
Confidence 1 2233468899999998754 4568899999999999999999999963211 112222222111 1
Q ss_pred cccCcccC-CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 EVLDPKLQ-GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~-~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.++ ...+..+.+++.. |+..+|++||++.++++
T Consensus 226 ----~~~~~~~~~~~l~~li~~------~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 ----PQLPAEKFSPEFQDFVNK------CLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----CCCCccccCHHHHHHHHH------HccCChhhCcCHHHHhc
Confidence 1111 1223345555554 99999999999999977
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=298.66 Aligned_cols=247 Identities=23% Similarity=0.269 Sum_probs=198.0
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999865 589999999975432 335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998764 3488999999999999999999999 99999999999999999999999999998764321
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
......|+..|+|||.+....++.++|+||+|+++|+|++|+.||...... ....+....... . +
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~---~----~ 219 (258)
T cd05578 155 -----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQETA---D----V 219 (258)
T ss_pred -----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhccc---c----c
Confidence 223456888999999998888999999999999999999999999753221 122222222211 1 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH--HHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM--KDVA 1050 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~--~~v~ 1050 (1117)
..+...+....+++.. |++.+|++||++ +|+.
T Consensus 220 ~~~~~~~~~~~~~i~~------~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINK------LLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHH------HccCChhHcCCccHHHHh
Confidence 1122233445555554 999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=297.65 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=197.4
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeec--CCceEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGAN--RKTKLLFY 851 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~ 851 (1117)
+|++.+.||.|+||.||+|.. .+++.||+|++.... ....+++..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999974 468899999987542 2334568889999999999999999997754 34578999
Q ss_pred EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHh-----ccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 852 DYMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLH-----HDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
||+++++|.+++... .....+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+|++|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998653 22345899999999999999999999 66 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
........ ......+++.|+|||.+....++.++||||||+++|+|++|+.||.... . ...... .....
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~---~~~~~~-~~~~~- 226 (265)
T cd08217 158 KILGHDSS----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--Q---LQLASK-IKEGK- 226 (265)
T ss_pred ccccCCcc----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--H---HHHHHH-HhcCC-
Confidence 87654321 1223468999999999998889999999999999999999999997531 1 122221 11111
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.+.++...+..+..++.. |++.+|++||++.+|++.
T Consensus 227 -----~~~~~~~~~~~~~~l~~~------~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 -----FRRIPYRYSSELNEVIKS------MLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCCccccCHHHHHHHHH------HccCCcccCCCHHHHhhC
Confidence 112233334455555554 999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=300.70 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=203.2
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.+.++.|+..+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++|+||+++++++...+..++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345677888899999999999999865 688999999986544 456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999998753 2489999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+ ........... .....
T Consensus 169 ~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-----~~~~~~~~~~~--~~~~~ 237 (286)
T cd06614 169 EKS----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-----LRALFLITTKG--IPPLK 237 (286)
T ss_pred chh----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcC--CCCCc
Confidence 211 22234578899999999888899999999999999999999999864211 11111111111 11100
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. ....+..+.++++. |++.+|.+||++.++++
T Consensus 238 ~---~~~~~~~l~~li~~------~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 N---PEKWSPEFKDFLNK------CLVKDPEKRPSAEELLQ 269 (286)
T ss_pred c---hhhCCHHHHHHHHH------HhccChhhCcCHHHHhh
Confidence 0 11123345555554 99999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=306.12 Aligned_cols=204 Identities=25% Similarity=0.345 Sum_probs=168.9
Q ss_pred CCCCCCeeeecCCeEEEEEEcC---CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecC--CceE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP---SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKL 848 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 848 (1117)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999864 47899999998632 33345678899999999999999999999888 7899
Q ss_pred EEEEecCCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC----CCcceeccc
Q 001238 849 LFYDYMPNGTLGMLLHDGE--CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE----RYESCLADF 922 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~----~~~~kl~Df 922 (1117)
+||||+++ ++.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5666554322 123588999999999999999999999 9999999999999999 999999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
|+++........ ........++..|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus 157 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 999876443211 122334578899999998765 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=296.27 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=198.0
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999754 58899999986542 23445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc-ceeccccccccccCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE-SCLADFGLARLVEDDS 932 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~-~kl~DfGla~~~~~~~ 932 (1117)
+++++|.+++..... ..+++..+..++.|+++|++|||+. +++|+||||+||++++++. +|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999876432 2478999999999999999999999 9999999999999998864 6999999998764322
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
. ......|++.|+|||+.....++.++||||||+++|||++|+.||... ...+++........ +
T Consensus 157 ~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~-------~ 220 (257)
T cd08225 157 E----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQGYF-------A 220 (257)
T ss_pred c----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcccC-------C
Confidence 1 112346889999999998888999999999999999999999998642 22233333222111 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......+..+.+++.. |+..+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~i~~------~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 PISPNFSRDLRSLISQ------LFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCHHHHHHHHH------HhccChhhCcCHHHHhh
Confidence 1122233345555554 99999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=301.02 Aligned_cols=201 Identities=27% Similarity=0.398 Sum_probs=170.9
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+|++.+.||+|++|.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999864 688999999876532 23456788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++ +|.+++........+++..+.+++.|+++||+|||+. +++||||||+||++++++.++++|||+++......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 85 8888876654334589999999999999999999999 99999999999999999999999999997654321
Q ss_pred ccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 935 SFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
.......++..|++||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 155 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 155 --NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred --cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12223457889999998765 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=302.97 Aligned_cols=199 Identities=27% Similarity=0.411 Sum_probs=172.1
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||+|..+ +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6888899999999999999865 5889999998753 233356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
++++.+..+.... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9987777665443 2388999999999999999999999 999999999999999999999999999987654321
Q ss_pred CccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......++..|+|||++... .++.++||||||+++|||++|+.||..
T Consensus 156 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 156 ---SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred ---ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 122345678999999999877 889999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=308.15 Aligned_cols=202 Identities=23% Similarity=0.321 Sum_probs=169.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeec----CCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGAN----RKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~ 848 (1117)
++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6789999999999999999975 468999999987542 2334567889999999999999999987753 34679
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+. |+|.+++... +.+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 6888888654 3389999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
...............++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 5432222122234578999999998765 5688999999999999999999999965
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=297.36 Aligned_cols=242 Identities=23% Similarity=0.271 Sum_probs=184.8
Q ss_pred eeeecCCeEEEEEEc-CCCcEEEEEEeecCCc---cchHHHHHHHHHHhc---cCCCCcceEEeeeecCCceEEEEEecC
Q 001238 783 IIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK---ISTGAFSSEIATLSR---IRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
.||+|+||.||++.. .+++.||+|.+..... .....+.+|..+++. .+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999975 4689999998865421 112234455444433 479999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---- 150 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence 99999988754 3489999999999999999999999 9999999999999999999999999999765322
Q ss_pred cccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
......||..|+|||.+. +..++.++||||+||++|||++|+.||......... .+...... ....+
T Consensus 151 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~-------~~~~~ 218 (279)
T cd05633 151 --KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLT-------VNVEL 218 (279)
T ss_pred --CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhhc-------CCcCC
Confidence 112346899999999886 456889999999999999999999999753222211 11111110 11223
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAAL 1052 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~~ 1052 (1117)
+...+..+..+++. |++.+|++|| +++++++.
T Consensus 219 ~~~~~~~~~~li~~------~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEG------LLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHH------HhcCCHHHhcCCCCCCHHHHHhC
Confidence 33344455565555 9999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=308.80 Aligned_cols=201 Identities=25% Similarity=0.397 Sum_probs=167.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecC-----Cce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANR-----KTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 847 (1117)
+++|++.++||+|+||.||+|.. .+|+.||+|++.... .....++.+|++++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999974 568999999986432 22345678899999999999999999876544 357
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||++ +++.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999996 4777777543 389999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
...... .........||..|+|||.+.. ..++.++||||+||++|||++|+.||.+
T Consensus 156 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 156 ADPEHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred cccccc-ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 643221 1112234578999999998654 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=301.81 Aligned_cols=209 Identities=25% Similarity=0.297 Sum_probs=169.9
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCc
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 846 (1117)
.+....++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...+.
T Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred cccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 34455567999999999999999999754 689999999865422 223356789999999999999999998866543
Q ss_pred --------eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcce
Q 001238 847 --------KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESC 918 (1117)
Q Consensus 847 --------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~k 918 (1117)
.++||||+. +++.+.+.... ..+++.++..++.|+++||+|||++ +++||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k 159 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILK 159 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEE
Confidence 499999996 47777776532 3489999999999999999999999 999999999999999999999
Q ss_pred eccccccccccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 919 LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 919 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
|+|||++..................++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999987654322211222345678899999987654 478899999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=290.17 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
.|+..+.||+|++|.||++... +++.||+|++........+.+.+|++++++++||+++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677899999999999999864 688999999986654456789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.+++.... +.+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999987653 3489999999999999999999998 999999999999999999999999999987654321
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.....++..|+|||.+....++.++||||||+++|+|++|+.||.... ........... ....... .
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~--~~~~~~~---~ 220 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-----PMKALFKIATN--GPPGLRN---P 220 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-----hHHHHHHHHhc--CCCCcCc---c
Confidence 334578899999999988889999999999999999999999996421 11111111111 1111111 1
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
...+..+.+++.. |++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~i~~------~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKK------CLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHH------HccCChhhCCCHHHHhc
Confidence 1113345555554 99999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=299.94 Aligned_cols=199 Identities=26% Similarity=0.325 Sum_probs=168.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc--chHHHHHHHHHHhccCCCCcceEEeeeecC--CceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI--STGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv 850 (1117)
++|++.+.||+|+||.||+|... +++.||+|.++..... ....+.+|++++++++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999865 5889999999754322 233567899999999999999999998877 889999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||++ ++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 48988887643 2489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.. .......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||..
T Consensus 159 ~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 159 PL----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred Cc----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 31 122334578899999988654 468999999999999999999999965
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=300.76 Aligned_cols=254 Identities=27% Similarity=0.380 Sum_probs=190.5
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|...+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455667899999999999875 468999999987543 234557889999999996 99999999999999999999999
Q ss_pred cCCCChhhhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 854 MPNGTLGMLL---HDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 854 ~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
++. ++.++. ... ....+++..+.+++.|++.||+|||+.. +|+||||||+||+++.++.++|+|||+++....
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 554433 221 1244899999999999999999999742 899999999999999999999999999976543
Q ss_pred CCCCccccCCccccccccCChhhhccC---CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMT---KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||.... ...+.+........ +
T Consensus 161 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~-~- 229 (288)
T cd06616 161 SI-----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDP-P- 229 (288)
T ss_pred CC-----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCC-C-
Confidence 21 12234688999999998765 68999999999999999999999996421 22222222222111 1
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.+.+......+..+.++++ .|++.+|++||++.+|++.
T Consensus 230 -~~~~~~~~~~~~~l~~li~------~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 -ILSNSEEREFSPSFVNFIN------LCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -cCCCcCCCccCHHHHHHHH------HHccCChhhCcCHHHHhcC
Confidence 1111111223334445444 4999999999999999773
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-33 Score=327.91 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=189.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeec---------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN--------- 843 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------- 843 (1117)
..+|+..+.||+||||.||+++.+ ||+.||||++... .......+.+|+..+++++|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 346778899999999999999854 8999999999754 33344568899999999999999999832100
Q ss_pred ----------------------------------------------C---------------------------------
Q 001238 844 ----------------------------------------------R--------------------------------- 844 (1117)
Q Consensus 844 ----------------------------------------------~--------------------------------- 844 (1117)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 001238 845 -------------------------------KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893 (1117)
Q Consensus 845 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~ 893 (1117)
...|+-||||+..++.++++++.... .....++++++|++||+|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 11367799999999999988764321 467889999999999999999
Q ss_pred cCCCceeeeccccCeEEEcCCCcceecccccccccc--------------CCCCCccccCCccccccccCChhhhccC--
Q 001238 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVE--------------DDSGGSFSANPQFAGSYGYIAPEYANMT-- 957 (1117)
Q Consensus 894 ~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~--------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 957 (1117)
+ |||||||||.||++|++..+||+|||+|.... ...+......+..+||.-|+|||++.+.
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998722 0111222345678999999999998765
Q ss_pred -CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhcc
Q 001238 958 -KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCT 1036 (1117)
Q Consensus 958 -~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~ 1036 (1117)
.|+.|+|+||+|||++||+. ||.. ..+....+.. ++... ++...+-...++....+++.+++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~T----sMERa~iL~~-LR~g~---------iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGT----SMERASILTN-LRKGS---------IPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCc----hHHHHHHHHh-cccCC---------CCCCcccccccchHHHHHHHHHh
Confidence 49999999999999999986 4642 1122222222 22211 11111111223334445666799
Q ss_pred CCCCCCCCCHHHHHH
Q 001238 1037 SNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1037 ~~~p~~RPs~~~v~~ 1051 (1117)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999865
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=299.31 Aligned_cols=244 Identities=22% Similarity=0.365 Sum_probs=194.0
Q ss_pred CCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 781 GNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
..+||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36799999999999975 47899999998655444556789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccC
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 939 (1117)
.+++... .+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++....... ...
T Consensus 105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----~~~ 173 (292)
T cd06657 105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----PRR 173 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc----ccc
Confidence 9987643 378999999999999999999999 99999999999999999999999999987654321 122
Q ss_pred CccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCc
Q 001238 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019 (1117)
Q Consensus 940 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1019 (1117)
....|++.|+|||.+....++.++||||+|+++|||++|+.||... ........+... ..... +.. ...+
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~--~~~~~~~~~~~~---~~~~~----~~~-~~~~ 243 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDN---LPPKL----KNL-HKVS 243 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhh---CCccc----CCc-ccCC
Confidence 3356889999999998888999999999999999999999998642 111122222111 11000 011 1123
Q ss_pred hhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1020 TQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1020 ~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+..++.. |++.+|.+||++.++++
T Consensus 244 ~~l~~li~~------~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDR------LLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHH------HHhCCcccCcCHHHHhc
Confidence 345555554 99999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=300.64 Aligned_cols=248 Identities=26% Similarity=0.350 Sum_probs=192.0
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc---chHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
..+.|...+.||+|+||+||+|... +++.||+|++...... ..+++.+|+++++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 4456888999999999999999754 6899999998644322 23468899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||++ |++.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 56666665432 3489999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
.. ....+++.|+|||++. ...++.++||||||+++|||++|+.||.... ............ .
T Consensus 167 ~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----~~~~~~~~~~~~--~ 231 (307)
T cd06607 167 PA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQND--S 231 (307)
T ss_pred CC--------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----HHHHHHHHhcCC--C
Confidence 21 2346788999999874 4568899999999999999999999986421 111111111111 1
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
... . ...++..+..+++ .||+.+|++||++.+++..
T Consensus 232 ~~~-~---~~~~~~~~~~li~------~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL-S---SNDWSDYFRNFVD------SCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC-C---chhhCHHHHHHHH------HHhcCChhhCcCHHHHhcC
Confidence 110 0 1112333444444 5999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=291.80 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=195.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC-----CccchHHHHHHHHHHhccCCCCcceEEeeeecC--Cce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS-----DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 847 (1117)
.+|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3688899999999999999975 46899999987532 122345788999999999999999999988664 457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++++|.+++... +.+++..+.+++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998754 2378899999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
........ .......++..|+|||++.+..++.++|||||||++|||++|+.||... .....+.+.....
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~---- 225 (264)
T cd06653 156 IQTICMSG-TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY-----EAMAAIFKIATQP---- 225 (264)
T ss_pred cccccccC-ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc-----CHHHHHHHHHcCC----
Confidence 54211111 1123456899999999998888999999999999999999999999642 1112222222111
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+.++......++++++. |+. +|..||++.+++.
T Consensus 226 --~~~~~p~~~~~~~~~~i~~------~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --TKPMLPDGVSDACRDFLKQ------IFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCCCcccCHHHHHHHHH------Hhc-CcccCccHHHHhc
Confidence 1123344444556666665 888 5799999997764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=298.42 Aligned_cols=201 Identities=24% Similarity=0.286 Sum_probs=166.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc--cchHHHHHHHHHHhccC-CCCcceEEeeeecCCc-----
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKT----- 846 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----- 846 (1117)
++|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|++++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688889999999999999985 4689999998865422 22356888999999995 6999999998877665
Q ss_pred eEEEEEecCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-CCcceecccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGEC--AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-RYESCLADFG 923 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG 923 (1117)
.|+||||+++ ++.+++..... ...+++..++.++.||++||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78887764321 23589999999999999999999999 9999999999999998 8899999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+++...... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||..
T Consensus 157 ~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 157 LGRAFSIPV----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cceecCCCc----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 998654321 11223356889999998754 5678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=278.64 Aligned_cols=273 Identities=22% Similarity=0.273 Sum_probs=206.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC---C--CcEEEEEEeecCCccc--hHHHHHHHHHHhccCCCCcceEEeeeec-CCc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP---S--GLTVAVKRFRASDKIS--TGAFSSEIATLSRIRHRNIVRLLGWGAN-RKT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 846 (1117)
...|+....||+|.||.||+|..+ + ...+|||+++...+.+ .....+|+..++.++||||+.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346888899999999999999532 2 2379999998653321 2356789999999999999999998877 778
Q ss_pred eEEEEEecCCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC----Ccceec
Q 001238 847 KLLFYDYMPNGTLGMLLHDGE--CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER----YESCLA 920 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~----~~~kl~ 920 (1117)
.++++||.+. +|..+++.++ ....++...+..|+.||+.|+.|||++ =|+|||+||.||||..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999975 7777775432 234688999999999999999999999 79999999999999877 899999
Q ss_pred cccccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCC----ChhHHHH
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPD----GQHVIQW 995 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~----~~~~~~~ 995 (1117)
|||++|.+...- .........+.|.+|.|||.+.+ ..|+++.||||.|||+.||++-++-|.+.... ...-...
T Consensus 179 DlGlaR~~~~pl-kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 179 DLGLARLFNNPL-KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred cccHHHHhhccc-cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999886532 22334556789999999997765 67999999999999999999999988653221 1233445
Q ss_pred HHHHHhcCCCCccccCcccCCCCch--hHHHHH---------------------HHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 996 VRDHLKSKKDPVEVLDPKLQGHPDT--QIQEML---------------------QALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~l~~~~~~--~~~~~l---------------------~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
+.+++..-+.+.+..+|.+..-++. .+..+. ..+.+...++..||.+|-|+.+.++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 5555555555555555555443321 111111 13345556889999999999988764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=300.31 Aligned_cols=200 Identities=30% Similarity=0.373 Sum_probs=167.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc--chHHHHHHHHHHhccCCCCcceEEeeeecC--CceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI--STGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 849 (1117)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++..... ....+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45789999999999999999985 46899999998754321 223467899999999999999999988655 46799
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||++ ++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 47888776542 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
... .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..
T Consensus 160 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 160 LPA----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred Ccc----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 322 11223346788999998865 5678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=292.72 Aligned_cols=247 Identities=20% Similarity=0.282 Sum_probs=189.8
Q ss_pred HHHhccCCCCCCee--eecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCc
Q 001238 771 IGDATRSLTAGNII--GQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 771 ~~~~~~~~~~~~~l--g~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 846 (1117)
.....+.|++.+.+ |+|+||.||++.. .+++.+|+|++....... .|+.....+ +||||+++++++...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34445677777776 9999999999874 468899999987542211 122222222 69999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC-cceecccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-ESCLADFGLA 925 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla 925 (1117)
.++||||+++++|.+++.... .+++.++..++.|+++|++|||+. +++||||||+||+++.++ .++++|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 999999999999999997653 489999999999999999999999 999999999999999998 9999999998
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
+..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||............+.... ...
T Consensus 158 ~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-- 226 (267)
T PHA03390 158 KIIGTP--------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK-- 226 (267)
T ss_pred eecCCC--------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc--
Confidence 765422 123588999999999988999999999999999999999999975433222222222211 111
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-HHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-MKDVAA 1051 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-~~~v~~ 1051 (1117)
.......+....+++.. |++.+|.+||+ ++++++
T Consensus 227 ------~~~~~~~~~~~~~li~~------~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 ------LPFIKNVSKNANDFVQS------MLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------CCcccccCHHHHHHHHH------HhccChhhCCchHHHHhc
Confidence 01112344455666655 99999999995 588764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-33 Score=281.85 Aligned_cols=252 Identities=27% Similarity=0.319 Sum_probs=194.1
Q ss_pred CCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCc-cchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCC
Q 001238 780 AGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDK-ISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 780 ~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
-...||.|+||+|+|.. .+.|+..|||+++.... .+++++..|.++..+- ..||||+++|++..++..|+.||.|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 34569999999999975 56799999999987643 5667888899875554 78999999999999999999999994
Q ss_pred CChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 857 GTLGMLLHDG--ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 857 gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
.+++.+-+.- .....+++.-.-.|....+.||+||-+.. .|||||+||+|||++..|.+||||||++..+.+.
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--- 221 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--- 221 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH---
Confidence 5666544321 11234888888889999999999998775 8999999999999999999999999999877542
Q ss_pred ccccCCccccccccCChhhhc--cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 935 SFSANPQFAGSYGYIAPEYAN--MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.+.+.-+|-..|||||.+. +..|+-++||||+|+++||++||+.||+. ...+.+.+.....+.+ +....+
T Consensus 222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~----w~svfeql~~Vv~gdp--p~l~~~ 293 (361)
T KOG1006|consen 222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK----WDSVFEQLCQVVIGDP--PILLFD 293 (361)
T ss_pred --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch----HHHHHHHHHHHHcCCC--CeecCc
Confidence 3445557889999999885 34589999999999999999999999964 4556777777665542 211111
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.-.-.+...... .+..|+-.|-.+||.+.++.+
T Consensus 294 ~~~~~~s~~~~~------fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 KECVHYSFSMVR------FINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccccCHHHHH------HHHHHhhcccccCcchhhhhc
Confidence 111122222333 344599999999999999866
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=297.84 Aligned_cols=198 Identities=26% Similarity=0.357 Sum_probs=167.8
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
|++.+.||+|++|.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999975 479999999987543 222356888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
+ ++|.+++..... ..+++..+..++.|+++||+|||++ +++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-- 153 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-- 153 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--
Confidence 5 689988876432 3489999999999999999999998 99999999999999999999999999997654221
Q ss_pred ccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 935 SFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 154 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 154 --RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred --cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 112233568899999987654 578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=306.42 Aligned_cols=197 Identities=24% Similarity=0.332 Sum_probs=167.9
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecC------
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR------ 844 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 844 (1117)
..++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+++.+|++++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 456899999999999999999975 47899999998643 223345677899999999999999999987643
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
...|+||||++ ++|.+.+... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35699999996 5787777542 78889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 165 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 165 ARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred ceeCCCCC-----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 98754321 12334688999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=289.20 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=200.1
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999754 678999999976543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++... +.+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998764 3489999999999999999999999 999999999999999999999999999987754322
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
......++..|+|||......++.++||||+|+++|+|++|+.||.... .. .......... .+.
T Consensus 155 ----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~-~~~~~~~~~~-------~~~ 218 (254)
T cd06627 155 ----DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PM-AALFRIVQDD-------HPP 218 (254)
T ss_pred ----cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HH-HHHHHHhccC-------CCC
Confidence 1234568899999999988888999999999999999999999986421 11 1111111111 112
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
++...+..+.+++.. |+..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~------~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQ------CFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHH------HHhCChhhCcCHHHHhc
Confidence 223334455555554 99999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=289.41 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=201.9
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecC--CceEEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKLLFY 851 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 851 (1117)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999865 689999999876542 3456789999999999999999999999888 8899999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++++|.+++.... .+++.++..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987653 489999999999999999999998 9999999999999999999999999999877543
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
... .......++..|+|||......++.++||||||+++|+|++|+.||.... .....+....... . .
T Consensus 155 ~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~-~-----~ 222 (260)
T cd06606 155 ETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGSSG-E-----P 222 (260)
T ss_pred ccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhccccC-C-----C
Confidence 211 11234568899999999988889999999999999999999999997532 1111111111100 1 1
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.++...+..+.+++.. |++.+|++||++.++++
T Consensus 223 ~~~~~~~~~~l~~~i~~------~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRK------CLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHH------hCcCChhhCCCHHHHhh
Confidence 22233334455555554 99999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=292.03 Aligned_cols=242 Identities=25% Similarity=0.336 Sum_probs=193.0
Q ss_pred eeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 784 IGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 784 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999864 48899999987542 22346789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccC
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 939 (1117)
.+++.... .+++..+..++.|++.||+|+|+. +++|+||||+||+++.++.++|+|||+++...... ..
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----~~ 149 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KT 149 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----cc
Confidence 99997642 388999999999999999999998 99999999999999999999999999998765421 12
Q ss_pred CccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCc
Q 001238 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019 (1117)
Q Consensus 940 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1019 (1117)
....++..|+|||.+....++.++|+||+|+++|||++|+.||..... ............... ...+...+
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~ 220 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---DPMEIYNDILKGNGK------LEFPNYID 220 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---CHHHHHHHHhccCCC------CCCCcccC
Confidence 234688999999999888899999999999999999999999965322 122333332221111 11222223
Q ss_pred hhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1020 TQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1020 ~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
..+.+++.. |++.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~------~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQ------LLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHH------HccCChhhCcCCcccCHHHHhc
Confidence 455555555 99999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=294.27 Aligned_cols=244 Identities=21% Similarity=0.258 Sum_probs=190.6
Q ss_pred eeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 784 IGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 784 lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
||+|+||+||++.. .+|+.||+|++.... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999874 468999999986532 22234567899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccC
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 939 (1117)
.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.++..... ...
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-----~~~ 151 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-----KKI 151 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-----Ccc
Confidence 999876542 3489999999999999999999999 9999999999999999999999999998765431 112
Q ss_pred CccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCc
Q 001238 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019 (1117)
Q Consensus 940 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1019 (1117)
....++..|+|||++.+..++.++||||+|+++|+|++|+.||...... .. ...+...... .....+...+
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~-~~~~~~~~~~-------~~~~~~~~~~ 222 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VE-KEELKRRTLE-------MAVEYPDKFS 222 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-cc-HHHHHhcccc-------ccccCCccCC
Confidence 2346788999999998888999999999999999999999999653221 11 1111111111 0112233344
Q ss_pred hhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1020 TQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1020 ~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
..+.++++. |++.+|++|| ++.++++
T Consensus 223 ~~~~~li~~------~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 PEAKDLCEA------LLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHH------HccCChhHccCCCcccHHHHHh
Confidence 566666665 9999999999 5665654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=296.16 Aligned_cols=200 Identities=26% Similarity=0.326 Sum_probs=166.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|++.+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999864 688999999865322 233568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-CCcceeccccccccccCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-RYESCLADFGLARLVEDD 931 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~~~ 931 (1117)
|++ +++.+++..... ...++..+..++.||+.||+|||++ +++||||||+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 577777654332 2367888899999999999999999 9999999999999985 557899999999765432
Q ss_pred CCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
. .......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||..
T Consensus 157 ~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 157 V----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred c----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 11223467889999998865 4578999999999999999999999964
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=296.01 Aligned_cols=251 Identities=23% Similarity=0.294 Sum_probs=194.6
Q ss_pred CCCCCCeeeecCCeEEEEEEc----CCCcEEEEEEeecCC----ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCce
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL----PSGLTVAVKRFRASD----KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 847 (1117)
+|++.+.||+|+||.||+|+. .+|+.||+|+++... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 377889999999999999875 368999999987532 22345688899999999 599999999999998999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998764 2378899999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCCccccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
...... .......|+..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ...............
T Consensus 155 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~-- 228 (290)
T cd05613 155 FHEDEV---ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE-- 228 (290)
T ss_pred cccccc---cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC--
Confidence 543211 12224568899999998865 3467899999999999999999999964211 122223222222221
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
+..+...+..+.++++. |++.+|++|| ++.++..
T Consensus 229 ------~~~~~~~~~~~~~ll~~------~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ------PPYPQEMSALAKDIIQR------LLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------CCCCccCCHHHHHHHHH------HhcCCHHHhcCCCCCCHHHHHc
Confidence 11222334455666655 9999999997 5566544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=278.87 Aligned_cols=198 Identities=24% Similarity=0.366 Sum_probs=170.2
Q ss_pred CeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
+.||+|+||.|--+. ..+|.+||||++.+.......++-+|++++... .|+||+++++||+++...|+|||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999998864 678999999999888777788899999999999 599999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC---cceeccccccccccCCCC---
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY---ESCLADFGLARLVEDDSG--- 933 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfGla~~~~~~~~--- 933 (1117)
...++.+.. +.+.++.++.++|+.||+|||.+ ||.|||+||+|||-.+.. .+|||||.++.-......
T Consensus 164 LshI~~~~~---F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRKH---FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999987643 89999999999999999999999 999999999999986543 579999988754432211
Q ss_pred CccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
.......+.+|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||.+.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 1222334678999999999763 356899999999999999999999999763
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=293.65 Aligned_cols=248 Identities=24% Similarity=0.310 Sum_probs=193.8
Q ss_pred eeecCCeEEEEEEcC-CCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 784 IGQGRSGIVYKVTLP-SGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 784 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
||+|+||.||++... +|+.||+|++..... ...+.+.+|++++++++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999865 489999999875433 3445788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc----
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS---- 935 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~---- 935 (1117)
.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997643 489999999999999999999999 99999999999999999999999999987654321100
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
........++..|+|||......++.++||||||+++||+++|+.||.... ................. .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~-----~- 223 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PEEIFQNILNGKIEWPE-----D- 223 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCCcCCCc-----c-
Confidence 112234567889999999988889999999999999999999999996432 12222222221111110 0
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
...+..+..+++. |++.+|++||++.++.+.++
T Consensus 224 ~~~~~~~~~~i~~------~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 224 VEVSDEAIDLISK------LLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ccCCHHHHHHHHH------HhcCCHhhcCCCccHHHHhc
Confidence 0123345555554 99999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=301.16 Aligned_cols=201 Identities=21% Similarity=0.210 Sum_probs=165.0
Q ss_pred CCCCeeeecCCeEEEEEEcCCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 779 TAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 779 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
.+++.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445556666666666555 7899999998754 333456799999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC--
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG-- 934 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-- 934 (1117)
|++.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+|++|||.+.........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999999986532 2388999999999999999999999 9999999999999999999999999998765432111
Q ss_pred -ccccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 935 -SFSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 935 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.........++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 0111233457889999999865 4588999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=297.85 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=193.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
+.|...+.||+|+||.||+|+. .++..||+|++..... .....+.+|++++++++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477788999999999999985 4688999999875422 22346888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++ ++.+.+.... ..+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 99975 7777665432 3489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.....+++.|+|||++. .+.++.++|||||||++|||++|+.||... ................
T Consensus 178 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-----~~~~~~~~~~~~~~~~-- 243 (317)
T cd06635 178 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNESPT-- 243 (317)
T ss_pred -------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHhccCCC--
Confidence 12346888999999873 456889999999999999999999998642 1111111222111110
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
......+..+.+++. .|++.+|.+||++.++++......
T Consensus 244 ----~~~~~~~~~l~~li~------~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 ----LQSNEWSDYFRNFVD------SCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ----CCCccccHHHHHHHH------HHccCCcccCcCHHHHHhChhhhc
Confidence 011122334444444 599999999999999998655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=296.08 Aligned_cols=202 Identities=32% Similarity=0.400 Sum_probs=168.0
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCC-----
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK----- 845 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 845 (1117)
..++|++.+.||+|+||.||+|..+ +|+.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567999999999999999999864 58899999987543 223356788999999999999999999887654
Q ss_pred -----ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceec
Q 001238 846 -----TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLA 920 (1117)
Q Consensus 846 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 920 (1117)
..++||||+++ ++...+.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 6666665432 3489999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
|||++........ .......++..|+|||.+.. ..++.++|||||||++|||++|++||..
T Consensus 159 dfg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 159 DFGLARLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred cccccccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999987654321 11223356788999998764 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=321.01 Aligned_cols=218 Identities=25% Similarity=0.295 Sum_probs=187.6
Q ss_pred HHHhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeec---CCccchHHHHHHHHHHhccCCCCcceEEeeeecCCc
Q 001238 771 IGDATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRA---SDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 771 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 846 (1117)
+.....+|.+.++||+|+||.|..++++ +++.||+|++.+ -...+...|..|-.+|..-..+=||+++-.|.++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3344578999999999999999999864 588999999876 234456679999999999889999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
+|+|||||+||+|-.++.... .++++.++.++..|+-||+-+|+. |+|||||||+|||+|..|++||+|||.+-
T Consensus 150 LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999998764 489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhcc-----CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHh
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK 1001 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 1001 (1117)
....++ .......+|||-|.+||+++. +.|++.+|.||+||++|||+.|..||.. +.+++...+++.
T Consensus 224 km~~dG---~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-----dslveTY~KIm~ 295 (1317)
T KOG0612|consen 224 KMDADG---TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-----DSLVETYGKIMN 295 (1317)
T ss_pred hcCCCC---cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-----HHHHHHHHHHhc
Confidence 776432 234556799999999998853 6789999999999999999999999964 355555555554
Q ss_pred c
Q 001238 1002 S 1002 (1117)
Q Consensus 1002 ~ 1002 (1117)
.
T Consensus 296 h 296 (1317)
T KOG0612|consen 296 H 296 (1317)
T ss_pred h
Confidence 3
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=291.53 Aligned_cols=241 Identities=22% Similarity=0.269 Sum_probs=184.5
Q ss_pred eeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc---chHHHHHHHHH---HhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 783 IIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI---STGAFSSEIAT---LSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
.||+|+||.||+|.. .+++.||+|.+...... ....+..|..+ ++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999975 45889999998754211 11223444443 444579999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|.+++... +.+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||+++.....
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---- 150 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---- 150 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence 99999988653 3489999999999999999999998 9999999999999999999999999999765322
Q ss_pred cccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
......|+..|+|||.+..+ .++.++||||+|+++|||++|+.||......... ..... ... ..+.+
T Consensus 151 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~-~~~-------~~~~~ 218 (278)
T cd05606 151 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRM-TLT-------MAVEL 218 (278)
T ss_pred --CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHH-hhc-------cCCCC
Confidence 12234689999999998744 6899999999999999999999999753222111 11111 111 11222
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
+...+..+.++++. |+..+|++|| ++.++++
T Consensus 219 ~~~~s~~~~~li~~------~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEG------LLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHH------HhhcCHHhccCCCCCCHHHHHh
Confidence 33334455666655 9999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=251.65 Aligned_cols=223 Identities=26% Similarity=0.337 Sum_probs=180.2
Q ss_pred CCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.|...++||+|.||+||+|+ +.+++.||+|+++-.+ +.......+|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556789999999999998 4568899999987543 33345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
|. .+|..+.... .+.++.+.+..++.|+++|+.|+|++ .+.|||+||+|.++..+|+.|++|||+++.++-.
T Consensus 83 cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-- 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-- 154 (292)
T ss_pred hh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence 94 5788877654 35589999999999999999999999 9999999999999999999999999999987542
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.......+.|.+|.+|+++.+ +-|++..|+||.||++.|+.. |++-|.+ .++....+++.+.-..+.+.-+
T Consensus 155 --vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg-----~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-----NDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred --eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC-----CcHHHHHHHHHHHhCCCccccC
Confidence 233445578999999998765 558899999999999999998 5555543 3445555555554444544444
Q ss_pred ccc
Q 001238 1012 PKL 1014 (1117)
Q Consensus 1012 ~~l 1014 (1117)
|.+
T Consensus 228 ps~ 230 (292)
T KOG0662|consen 228 PSM 230 (292)
T ss_pred Ccc
Confidence 443
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=287.45 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=202.4
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||++... +++.||+|++..... ...+.+.+|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999854 688999999976533 4556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 854 MPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
+++++|.+++.... ....+++.++..++.+++.|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 124589999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.......|++.|+|||......++.++||||+|+++|+|++|+.||.... ............. +
T Consensus 158 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-------~ 221 (258)
T cd08215 158 ----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQY-------P 221 (258)
T ss_pred ----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCCC-------C
Confidence 12234568899999999988889999999999999999999999996421 2222222222211 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++...+..+.++++. |+..+|++||++.++++
T Consensus 222 ~~~~~~~~~~~~~i~~------~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIPSQYSSELRNLVSS------LLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCHHHHHHHHH------HcCCChhhCcCHHHHhc
Confidence 2222334455555554 99999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=295.67 Aligned_cols=255 Identities=22% Similarity=0.276 Sum_probs=197.5
Q ss_pred CCCCCCeeeecCCeEEEEEEc----CCCcEEEEEEeecCC----ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCce
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL----PSGLTVAVKRFRASD----KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 847 (1117)
+|++.+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999863 357889999987432 22345688899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999988653 2478899999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCC--CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTK--ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
...... .......|+..|+|||...+.. .+.++||||||+++|||++|+.||..... ........+......
T Consensus 155 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-- 228 (288)
T cd05583 155 FLAEEE---ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSK-- 228 (288)
T ss_pred cccccc---cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHccC--
Confidence 543221 1122346889999999987654 78899999999999999999999953211 111222222222221
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
+..+...+..+.+++.. |++.+|++||++.++.+.++.
T Consensus 229 ------~~~~~~~~~~l~~li~~------~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 ------PPFPKTMSAEARDFIQK------LLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------CCCCcccCHHHHHHHHH------HhcCCHhhccCcchHHHHhcC
Confidence 11222233445555554 999999999999988877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=285.57 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=193.7
Q ss_pred cCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCc--c-----chHHHHHHHHHHhccCCCCcceEEeeeec-CCc
Q 001238 776 RSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDK--I-----STGAFSSEIATLSRIRHRNIVRLLGWGAN-RKT 846 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~--~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 846 (1117)
++|-..+.||+|||+.||+|. ....+.||||+-..... . -.+...+|.++-+.+.||.||++|+|+.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 567788899999999999986 55678999998653311 1 11235689999999999999999999864 567
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceecccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLADFG 923 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfG 923 (1117)
+|-|.|||+|.+|+-+++.++ .+++.+++.|+.||+.||.||.+. .|+|||-|+||.|||+-. -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 889999999999999998764 489999999999999999999986 569999999999999953 4789999999
Q ss_pred ccccccCCCCC---ccccCCccccccccCChhhhccC----CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHH
Q 001238 924 LARLVEDDSGG---SFSANPQFAGSYGYIAPEYANMT----KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 924 la~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~ 996 (1117)
+++...++... ........+||.+|++||++--+ +.+.|+||||.|||+|+.+.|+.||... ..-..++
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn----qsQQdIL 694 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN----QSQQDIL 694 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc----hhHHHHH
Confidence 99988765443 22344578999999999977543 5688999999999999999999999632 1111111
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHH
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVA 1050 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~ 1050 (1117)
....-.. ..++--|. ........+.+++. |+++.-++|.+..++.
T Consensus 695 qeNTIlk--AtEVqFP~-KPvVsseAkaFIRR------CLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 QENTILK--ATEVQFPP-KPVVSSEAKAFIRR------CLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhhchhc--ceeccCCC-CCccCHHHHHHHHH------HHHhhhhhhhhHHHHc
Confidence 1110000 01111011 11223345555555 9999999998776664
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=294.37 Aligned_cols=198 Identities=31% Similarity=0.396 Sum_probs=168.6
Q ss_pred CCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecC--CceEEEEE
Q 001238 778 LTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKLLFYD 852 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e 852 (1117)
|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999865 58899999998653 33345688999999999999999999999888 78999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++ +|.+++.... ..+++..++.++.|+++|++|||+. +++|+||||+||++++++.++++|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888876542 3489999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 155 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 155 S---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred c---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 12233457889999997654 4578999999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=289.73 Aligned_cols=243 Identities=23% Similarity=0.284 Sum_probs=186.1
Q ss_pred CeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc---chHHHHHHHHHH-hccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI---STGAFSSEIATL-SRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||.||+|.. .+|+.||+|+++..... ....+..|..++ ...+|||++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999975 46899999998754321 122344555544 445899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
++|.+++... +.+++..+.+++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999999764 2488999999999999999999999 999999999999999999999999999876432
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.....++..|+|||...+..++.++||||+|+++|||++|..||.... ................ +....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~----~~~~~ 218 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-----PDAVFDNILSRRINWP----EEVKE 218 (260)
T ss_pred --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcccCCC----Ccccc
Confidence 223468889999999988888999999999999999999999996421 1122222221111111 11122
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
..+..+.++++. |++.+|++||++.++.+.+
T Consensus 219 ~~~~~~~~~i~~------~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 219 FCSPEAVDLINR------LLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCCHHHHHHHHH------HccCCHHHccCCCcHHHHH
Confidence 233455555554 9999999999876665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=301.51 Aligned_cols=203 Identities=29% Similarity=0.395 Sum_probs=168.2
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC--CccchHHHHHHHHHHhcc-CCCCcceEEeeeecC--Cce
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS--DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANR--KTK 847 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 847 (1117)
..++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+++++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467889999999999999999854 6889999988542 222345677899999999 999999999987654 357
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||++ ++|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5898888653 378999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCC-ccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 928 VEDDSGG-SFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 928 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
....... .........||..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 6543211 0112234568999999997754 5678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=319.13 Aligned_cols=201 Identities=19% Similarity=0.259 Sum_probs=158.8
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC--CCcEEEEE------------------EeecCCccchHHHHHHHHHHhccCCCC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP--SGLTVAVK------------------RFRASDKISTGAFSSEIATLSRIRHRN 833 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n 833 (1117)
...+|++.+.||+|+||+||++..+ .+..+++| .++ ........+.+|++++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 4568999999999999999997642 22222222 111 11122346889999999999999
Q ss_pred cceEEeeeecCCceEEEEEecCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE
Q 001238 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGEC--AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL 911 (1117)
Q Consensus 834 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 911 (1117)
||++++++...+..|+|+|++. +++..++..... .......++..++.|++.||+|||++ +||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 466666543211 12234567788999999999999999 99999999999999
Q ss_pred cCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCC
Q 001238 912 GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPV 982 (1117)
Q Consensus 912 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~ 982 (1117)
+.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999987653211 1223457999999999999999999999999999999999987644
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=293.65 Aligned_cols=197 Identities=27% Similarity=0.371 Sum_probs=169.3
Q ss_pred CCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc--chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 778 LTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI--STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
|++.+.||+|++|.||+|... +++.+|+|++...... ....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864 6889999998754322 3467888999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++ ++.+++.... ..+++.++..++.|+++||+|||+. +|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 8877776542 3489999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 935 SFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......++..|+|||.+... .++.++||||+|+++|+|++|+.||..
T Consensus 153 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 153 --RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred --ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 122234678899999988766 789999999999999999999999964
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=291.35 Aligned_cols=195 Identities=26% Similarity=0.300 Sum_probs=162.3
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc-cchHHHHHHHHHHhccC-CCCcceEEeeeecC--CceEEEEE
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK-ISTGAFSSEIATLSRIR-HRNIVRLLGWGANR--KTKLLFYD 852 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e 852 (1117)
|++.+.||+|+||.||+|.. .+++.||+|+++.... .......+|+.+++++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56778999999999999974 4688999999875422 22233457899999885 99999999999887 88999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|++ |++.+.+.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 57777776532 3489999999999999999999999 9999999999999999 999999999998764321
Q ss_pred CCccccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
......++..|+|||+.. ...++.++||||+||++|||++|..||..
T Consensus 154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 154 -----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred -----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 122346789999999764 45678899999999999999999999965
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=319.57 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=202.3
Q ss_pred CCCCCCeeeecCCeEEEEEEcC----C----CcEEEEEEeecC-CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCc
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP----S----GLTVAVKRFRAS-DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 846 (1117)
+..+.+.+|+|.||.||+|... . ...||||.++.. ...+.+.+..|+++|+.+ +||||+.++|+|...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 4466679999999999998631 1 457999998754 334567899999999999 59999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCC------CC-------CCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC
Q 001238 847 KLLFYDYMPNGTLGMLLHDGE------CA-------GLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE 913 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~------~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~ 913 (1117)
.++|+||++.|+|.++++..+ .. ..+...+...++.|||.|++||++. ++||||+.++|||+++
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecC
Confidence 999999999999999998765 00 1378889999999999999999999 9999999999999999
Q ss_pred CCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhH
Q 001238 914 RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHV 992 (1117)
Q Consensus 914 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~ 992 (1117)
+..+||+|||+|+................ -...|||||.+....|+.++|||||||++||+++ |..||.+. +....+
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-~~~~~l 531 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-PPTEEL 531 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-CcHHHH
Confidence 99999999999997654332211111111 3456999999999999999999999999999999 99999651 212233
Q ss_pred HHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 993 IQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
.++ ++.+... ..+......+..+++ .||+.+|++||++.++++.++...
T Consensus 532 ~~~----l~~G~r~------~~P~~c~~eiY~iM~------~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 532 LEF----LKEGNRM------EQPEHCSDEIYDLMK------SCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHH----HhcCCCC------CCCCCCCHHHHHHHH------HHhCCCcccCCCHHHHHHHHHHHH
Confidence 333 3332211 112222334444444 499999999999999999998854
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=293.87 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=191.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCCc-cchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDK-ISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.++|++.+.||+|+||.||+|.+.+ ++.||||+++.... .....+..|++++.+.. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3568889999999999999998754 89999999975432 23445667887777764 999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||++ +++.++..... +.+++..+.+++.|+++|++|||+.. +|+||||+|+||++++++.+||+|||++......
T Consensus 94 e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 46777665532 35899999999999999999999731 8999999999999999999999999999765432
Q ss_pred CCCccccCCccccccccCChhhhccCC----CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTK----ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
. ......++..|+|||.+.... ++.++||||||+++|||++|+.||.... ...+.............
T Consensus 169 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 169 K-----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK----TEFEVLTKILQEEPPSL 239 (296)
T ss_pred C-----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch----hHHHHHHHHhcCCCCCC
Confidence 1 112335788999999987543 7899999999999999999999996421 11222222222221110
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
. .....+..+.+++. .|++.+|++||++.++++.
T Consensus 240 ~-----~~~~~~~~l~~li~------~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 P-----PNEGFSPDFCSFVD------LCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-----CCCCCCHHHHHHHH------HHccCChhhCCCHHHHhcC
Confidence 0 01122334444444 4999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=288.51 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=197.5
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+|++.+.||+|+||.||++.. .+++.+|+|++.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999864 468899999987542 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 854 MPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
+++++|.+++.+.. ....+++..++.++.|+++||+|||+. +++||||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999886632 123488999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
......+++.|+|||...+..++.++|+||+|+++|||++|+.||.... ..+......... . +
T Consensus 157 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~--~-----~ 219 (256)
T cd08530 157 -----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLRYKVQRGK--Y-----P 219 (256)
T ss_pred -----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCC--C-----C
Confidence 1122457889999999998899999999999999999999999996421 111111111111 1 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+....+..+..++. .|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~li~------~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIR------SMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHH------HHcCCCcccCCCHHHHhc
Confidence 112223334444444 499999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=301.08 Aligned_cols=199 Identities=24% Similarity=0.373 Sum_probs=167.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecC-----Cc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR-----KT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 846 (1117)
.++|.+.+.||+|+||+||+|.. .+++.||||+++.. ......++.+|+++++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45789999999999999999974 46899999998753 223345677899999999999999999987644 34
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.++||||+. ++|.+++... +.+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 6888888654 3489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..
T Consensus 157 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 157 TTSEKG----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred ccCCCc----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 764321 11233467889999998764 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=298.49 Aligned_cols=199 Identities=22% Similarity=0.286 Sum_probs=162.2
Q ss_pred Ceeeec--CCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQG--RSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+| +||+||++.+ .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999985 479999999987542 22346788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc-
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS- 935 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~- 935 (1117)
+++.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999998765332 388999999999999999999998 99999999999999999999999998654332211110
Q ss_pred --cccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 936 --FSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 936 --~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
........++..|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 001111235667999999876 3478999999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=290.28 Aligned_cols=197 Identities=28% Similarity=0.348 Sum_probs=165.7
Q ss_pred CCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc--chHHHHHHHHHHhcc---CCCCcceEEeeeecCCc-----
Q 001238 778 LTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI--STGAFSSEIATLSRI---RHRNIVRLLGWGANRKT----- 846 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 846 (1117)
|++.+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|+++++++ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999875 4899999999754221 234566788877666 59999999999988776
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.+++|||+++ +|.+++..... ..+++..++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 78888866432 2489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
...... ......++..|+|||++.+..++.++||||||+++|||++|++||..
T Consensus 156 ~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 156 IYSFEM-----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred eccCCc-----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 764321 11233578899999999988999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=301.92 Aligned_cols=201 Identities=24% Similarity=0.353 Sum_probs=165.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecC---------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANR--------- 844 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------- 844 (1117)
..+|++.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36789999999999999999975 46899999999776655567788999999999999999999866543
Q ss_pred -----CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-CCcce
Q 001238 845 -----KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-RYESC 918 (1117)
Q Consensus 845 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~k 918 (1117)
...++||||++ ++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 5888877543 388999999999999999999999 9999999999999984 55789
Q ss_pred eccccccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 919 LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 919 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++|||+++......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 156 l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 156 IGDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred ECCcccceecCCccccc-cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999997654321111 11123357889999997654 5678899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=300.14 Aligned_cols=200 Identities=26% Similarity=0.373 Sum_probs=169.0
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecC--
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANR-- 844 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-- 844 (1117)
++...+++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 4566788999999999999999999974 578999999987532 22345678899999999999999999987543
Q ss_pred ----CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceec
Q 001238 845 ----KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLA 920 (1117)
Q Consensus 845 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 920 (1117)
...+++++++ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence 3467888876 78998887653 388999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
|||+++.... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 163 dfg~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 163 DFGLARHTDD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cccccccccc-------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999976432 1233467899999998765 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=298.54 Aligned_cols=200 Identities=26% Similarity=0.382 Sum_probs=168.8
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCC-
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK- 845 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~- 845 (1117)
.+....++|++.+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 344456789999999999999999997 4578999999986432 222356789999999999999999999887553
Q ss_pred -----ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceec
Q 001238 846 -----TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLA 920 (1117)
Q Consensus 846 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 920 (1117)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 358999998 77998887643 389999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
|||++...... .....+++.|+|||.+.. ..++.++||||+|+++|++++|+.||..
T Consensus 161 dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 161 DFGLARQTDSE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred ecccccccccC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999865421 123467889999998865 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=299.41 Aligned_cols=200 Identities=27% Similarity=0.365 Sum_probs=171.5
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCC-----ceE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK-----TKL 848 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 848 (1117)
+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999864 48999999987643 334567899999999999999999999987775 789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||++ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 57888887543 589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
...... ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||..
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~ 209 (330)
T cd07834 154 DPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209 (330)
T ss_pred cccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence 543211 1122345678999999999877 789999999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=291.58 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=199.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 850 (1117)
++|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999754 68999999986532 223456888999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997642 489999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCC----------------ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHH
Q 001238 931 DSGG----------------SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQ 994 (1117)
Q Consensus 931 ~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~ 994 (1117)
.... .........++..|+|||......++.++||||+|+++|++++|+.||.... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~ 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-----EYL 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----HHH
Confidence 3211 0122334567899999999988889999999999999999999999997431 111
Q ss_pred HHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH----HHHHH
Q 001238 995 WVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM----KDVAA 1051 (1117)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~----~~v~~ 1051 (1117)
......... ..++...+..+.++++. |++.+|++||++ .++++
T Consensus 230 ~~~~~~~~~--------~~~~~~~~~~~~~li~~------~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQKILKLE--------YSFPPNFPPDAKDLIEK------LLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHhcC--------CCCCCccCHHHHHHHHH------HhcCCHhhCCCcccCHHHHhc
Confidence 122222111 11222233445555554 999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=292.24 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=190.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
+.|+..+.||+|+||.||+|... +++.||+|.+.... .....++.+|+++++.++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777788999999999999854 57899999986432 223346788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+. |++.+.+.... ..+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++++|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 9996 57777665432 3478999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.....+++.|+|||.+. ...++.++|||||||++|||++|+.||.... ............. ..
T Consensus 168 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~--~~ 233 (308)
T cd06634 168 -------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNES--PA 233 (308)
T ss_pred -------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-----HHHHHHHHhhcCC--CC
Confidence 12346888999999874 3567889999999999999999999985421 1111111111111 00
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
......+..+.++++. ||+.+|++||++.+++..-
T Consensus 234 ----~~~~~~~~~~~~li~~------cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 234 ----LQSGHWSEYFRNFVDS------CLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ----cCcccccHHHHHHHHH------HhhCCcccCCCHHHHhhCc
Confidence 0112233345555554 9999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=287.62 Aligned_cols=194 Identities=26% Similarity=0.413 Sum_probs=171.2
Q ss_pred CCeeeecCCeEEEEEE-cCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCC
Q 001238 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNG 857 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g 857 (1117)
.++||.|-||+||-|+ .++|+.||||++.+.. .....++++|++++++++||.||.+-..|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 5789999999999997 4679999999997642 233467999999999999999999999999999999999999777
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC---CcceeccccccccccCCCCC
Q 001238 858 TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER---YESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 858 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfGla~~~~~~~~~ 934 (1117)
-|..++.... +++++.....++.||+.||.|||.+ +|||+|+||+|||+... ..+||||||.||.+....
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 7777776543 5699999999999999999999999 99999999999999643 578999999999987532
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
-+...+||+.|+|||+++.+.|...-|+||.||++|--++|..||..
T Consensus 722 ---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 722 ---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred ---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 23467899999999999999999999999999999999999999964
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=296.27 Aligned_cols=201 Identities=26% Similarity=0.362 Sum_probs=164.2
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-C--CcEEEEEEeecC--CccchHHHHHHHHHHhcc-CCCCcceEEeeeec----CCc
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-S--GLTVAVKRFRAS--DKISTGAFSSEIATLSRI-RHRNIVRLLGWGAN----RKT 846 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~ 846 (1117)
+|++.+.||+|+||.||++... + +..||+|++... .....+.+.+|+++++++ .||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999854 3 778999998643 222345678899999999 59999999986533 245
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.++++||+. ++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688899985 6888888653 3489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.................||..|+|||+..+ ..++.++||||+||++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 765432221122234578999999998765 5689999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=299.04 Aligned_cols=194 Identities=26% Similarity=0.373 Sum_probs=163.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCC------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK------ 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 845 (1117)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999985 468999999987532 222346789999999999999999999876543
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..++|+||+. .++..+... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4589999996 467665432 388999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+
T Consensus 165 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 165 RHADA-------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred cCCCC-------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 76432 1223467889999998865 4688999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=273.09 Aligned_cols=254 Identities=21% Similarity=0.275 Sum_probs=191.4
Q ss_pred hccCCCC-CCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeec----CCc
Q 001238 774 ATRSLTA-GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGAN----RKT 846 (1117)
Q Consensus 774 ~~~~~~~-~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~ 846 (1117)
.+++|++ -++||-|-.|.|-.+. ..+|+.+|+|++... ...++|++.--.. .|||||.++++|.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 3455655 3679999999999875 457899999998643 3457888874444 79999999998765 345
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceecccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLADFG 923 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfG 923 (1117)
+.+|||.|+||.|...++++.. ..+++.++..|+.||+.|+.|||+. .|+||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 6789999999999999988654 4599999999999999999999999 9999999999999974 4578999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
+|+.-... ....+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||.... +..+..-++..++..
T Consensus 210 FAK~t~~~-----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h--g~aispgMk~rI~~g 282 (400)
T KOG0604|consen 210 FAKETQEP-----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH--GLAISPGMKRRIRTG 282 (400)
T ss_pred cccccCCC-----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC--CccCChhHHhHhhcc
Confidence 99875432 23445678999999999999999999999999999999999999997542 233333344333322
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
. .+.-+++. .+.++..++ ++...+..+|.+|-|+.++++.
T Consensus 283 q--y~FP~pEW-s~VSe~aKd------lIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 283 Q--YEFPEPEW-SCVSEAAKD------LIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred C--ccCCChhH-hHHHHHHHH------HHHHHhcCCchhheeHHHhhcC
Confidence 1 11111111 111122222 3333678899999999998763
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=286.35 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=191.6
Q ss_pred CCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecC-----CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRAS-----DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
+|.+.+.||+|+||.||++.... +..+++|+.+.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999997543 455666665432 122334577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 851 YDYMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
|||+++++|.+++... .....+++.+++.++.|+++|++|||+. +++|+||||+||+++. +.++++|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888642 1234589999999999999999999999 9999999999999975 569999999997764
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... .......|++.|+|||......++.++||||||+++|+|++|+.||... .............
T Consensus 157 ~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~------ 221 (260)
T cd08222 157 GSC----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRIVEGP------ 221 (260)
T ss_pred CCc----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcCC------
Confidence 322 1222346788999999998888899999999999999999999998531 2222222222211
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+..+...+..+.++++ .|++.+|++||++.++++
T Consensus 222 -~~~~~~~~~~~~~~li~------~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 -TPSLPETYSRQLNSIMQ------SMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCcchhcHHHHHHHH------HHhcCChhhCcCHHHHhh
Confidence 11222233334444444 499999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=293.75 Aligned_cols=204 Identities=27% Similarity=0.372 Sum_probs=165.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc--chHHHHHHHHHHhccCCCCcceEEeeeecCC------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI--STGAFSSEIATLSRIRHRNIVRLLGWGANRK------ 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 845 (1117)
.++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999854 6899999998654221 2345788999999999999999999765433
Q ss_pred --ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 846 --TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 846 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
..++||||+.+ ++...+.... ..+++.++..++.|+++||+|||++ +|+||||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 46899999965 6666665432 3489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCc-------cccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 924 LARLVEDDSGGS-------FSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 924 la~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+++......... ....+...+++.|+|||.+.+ ..++.++||||||+++|||++|++||.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 998654322111 112234467889999998764 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=296.77 Aligned_cols=197 Identities=25% Similarity=0.375 Sum_probs=167.3
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeec-CCceE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN-RKTKL 848 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~ 848 (1117)
.++++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4677899999999999999999974 47899999988643 22234568889999999999999999998865 55788
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+ +++|.++++.. .+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||.++..
T Consensus 87 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 56888887643 378888889999999999999999 9999999999999999999999999999754
Q ss_pred cCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 159 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 159 DP-------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred CC-------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 32 1123467889999998765 5689999999999999999999999965
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=288.72 Aligned_cols=197 Identities=25% Similarity=0.370 Sum_probs=167.2
Q ss_pred CCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc-cchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEEec
Q 001238 778 LTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
|++.+.||+|+||+||+|... +++.||||++..... .......+|+..+++++ ||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999865 578999999865422 22334567999999998 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
+|++.+++.... ...+++..+..++.|+++||+|||++ +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 889988887653 23489999999999999999999999 99999999999999999999999999998664321
Q ss_pred ccccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 935 SFSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
......++..|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 154 ---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred ---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 123346788999999874 45678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=295.63 Aligned_cols=202 Identities=25% Similarity=0.274 Sum_probs=165.9
Q ss_pred cCCC-CCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccc--------------hHHHHHHHHHHhccCCCCcceEEe
Q 001238 776 RSLT-AGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKIS--------------TGAFSSEIATLSRIRHRNIVRLLG 839 (1117)
Q Consensus 776 ~~~~-~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~ 839 (1117)
++|. +.+.||+|+||+||+|.. .+++.||||+++...... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 457899999999999975 468999999986542211 124678999999999999999999
Q ss_pred eeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCccee
Q 001238 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 840 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
++...+..++||||++ |+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999996 6888888653 3388999999999999999999998 9999999999999999999999
Q ss_pred ccccccccccCCCCC----------ccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 920 ADFGLARLVEDDSGG----------SFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+|||+++........ .........++..|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999866421100 01112234568899999988654 468999999999999999999999965
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=318.46 Aligned_cols=145 Identities=28% Similarity=0.341 Sum_probs=130.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.++||+|+||+||+|... +++.||||+++.... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999864 689999999975432 22356889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
||+++++|.+++... +.+++..+++++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998754 3478899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=288.65 Aligned_cols=197 Identities=31% Similarity=0.401 Sum_probs=169.3
Q ss_pred CCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 778 LTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
|+..+.||+|+||.||+|... +++.||+|++.... ....+.+..|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999865 58999999997653 333457788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
+ ++|.+++.... ..+++..+.+++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 58999987652 3489999999999999999999999 999999999999999999999999999987643221
Q ss_pred ccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 935 SFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
......++..|+|||.+... .++.++||||||+++|||++|+.||..
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 154 ---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred ---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 22233567889999988766 789999999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=289.54 Aligned_cols=243 Identities=26% Similarity=0.349 Sum_probs=189.0
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
|...+.||+|+||+||+|+. .+|+.||+|++..... ...+.+.+|++++++++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999975 4688999999875432 2234678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+. |++.+++.... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 56777665432 3489999999999999999999999 99999999999999999999999999986432
Q ss_pred CccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 934 GSFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
......|+..|+|||++. ...++.++|||||||++|||++|+.||.... ....+....... .....
T Consensus 173 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~~--~~~~~ 241 (313)
T cd06633 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQND--SPTLQ 241 (313)
T ss_pred ----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcC--CCCCC
Confidence 122456889999999874 4568889999999999999999999986421 111122211111 11111
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
...++..+++++.. |++.+|.+||++.+++.
T Consensus 242 ----~~~~~~~l~~li~~------~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 ----SNEWTDSFRGFVDY------CLQKIPQERPASAELLR 272 (313)
T ss_pred ----ccccCHHHHHHHHH------HccCChhhCcCHHHHhc
Confidence 11223345555554 99999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=297.81 Aligned_cols=197 Identities=26% Similarity=0.384 Sum_probs=167.6
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCc---
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT--- 846 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--- 846 (1117)
...++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34568999999999999999999864 5889999998653 22234567789999999999999999998766554
Q ss_pred ---eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 847 ---KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 847 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
.++|+||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 67999888753 389999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++...... .....++..|+|||.+.. ..++.++||||+|+++|||++|+.||..
T Consensus 164 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 164 LARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred cccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99865432 223467889999998765 4678999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=272.52 Aligned_cols=265 Identities=21% Similarity=0.310 Sum_probs=203.0
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEcCC------CcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeee
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTLPS------GLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGA 842 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 842 (1117)
++.....+++....+-+|.||.||+|.|.+ .+.|-+|.++.. .+.....+..|.-.+....|||+..+.+.+.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 344455678888899999999999996543 345677776643 2333456788999999999999999999876
Q ss_pred cC-CceEEEEEecCCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc
Q 001238 843 NR-KTKLLFYDYMPNGTLGMLLH-----DGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE 916 (1117)
Q Consensus 843 ~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 916 (1117)
++ +..+++|.++.-|+|..++. +......++..+...++.|++.|++|||++ +|||.||..+|.++|+.-+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhee
Confidence 54 56788899999999999998 333344577778889999999999999999 9999999999999999999
Q ss_pred ceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHH
Q 001238 917 SCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQW 995 (1117)
Q Consensus 917 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~ 995 (1117)
+||+|-.++|.+.+.+.... .........||+||.+....|+.++|||||||++|||+| |+.||.+. +..++..+
T Consensus 435 VkltDsaLSRDLFP~DYhcL--GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI--DPfEm~~y 510 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCL--GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI--DPFEMEHY 510 (563)
T ss_pred EEeccchhccccCccccccc--CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc--CHHHHHHH
Confidence 99999999998876543322 222335678999999999999999999999999999999 99999642 11223333
Q ss_pred HHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 996 VRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
+ +++...... -.+++ ++-.++.. ||+..|++||++++++.-|.++-
T Consensus 511 l----kdGyRlaQP-----~NCPD-eLf~vMac------CWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 511 L----KDGYRLAQP-----FNCPD-ELFTVMAC------CWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred H----hccceecCC-----CCCcH-HHHHHHHH------HHhcCcccCCCHHHHHHHHHHHH
Confidence 3 333222211 12333 33333333 99999999999999999988763
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=266.98 Aligned_cols=203 Identities=27% Similarity=0.340 Sum_probs=168.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeec--CCccchHHHHHHHHHHhccCCCCcceEEeeeec--------C
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRA--SDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN--------R 844 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~ 844 (1117)
..|....+||+|.||+||+|+.+ +|+.||+|++-- ..........+|++++..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34566678999999999999854 578899987643 222233456789999999999999999887743 2
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
...|+||++|+. +|.-++.... ..++..++.+++.++..||.|+|+. .|+|||+||+|+|++.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999965 7777777653 2388999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++.+...........+..+.|.+|.+||.+. .+.|+++.|||+.|||+.||.+|.+-+++
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 9877655444444567788899999999765 57899999999999999999999998875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=296.08 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=202.0
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeec-----C
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGAN-----R 844 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----~ 844 (1117)
.+.+..|.+.+.||+|.+|.||+++ .++|+.+|+|+...... ..++++.|..+++.. .|||++.++|+|.. +
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3556778999999999999999997 45688999998875433 456788899999888 69999999998753 5
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
+++|+|||||.+|+.-|+++... ...+.|+....|++.++.|+.+||.. .++|||||-.|||++.++.+|++|||.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeee
Confidence 78899999999999999998866 55699999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhcc-----CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHH
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
+..+... ...+.+..||+.|||||++.. ..|+.++|+||+|++..||.-|.+|+-+..+. +..
T Consensus 170 SaQldsT----~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raL 237 (953)
T KOG0587|consen 170 SAQLDST----VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RAL 237 (953)
T ss_pred eeeeecc----cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhh
Confidence 9887543 245567899999999998864 45788999999999999999999998654331 222
Q ss_pred HhcCCCCccccCcccC--CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1000 LKSKKDPVEVLDPKLQ--GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.....+. |.+. ..+...+.+ .+..|+..|.++||++.++++
T Consensus 238 F~IpRNPP----PkLkrp~kWs~~Fnd------FIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 FLIPRNPP----PKLKRPKKWSKKFND------FISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccCCCCCC----ccccchhhHHHHHHH------HHHHHHhhccccCcchhhhcc
Confidence 22222221 1111 112223333 444599999999999888754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=275.95 Aligned_cols=199 Identities=24% Similarity=0.328 Sum_probs=171.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc---chHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI---STGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 850 (1117)
.+|....+||+|+||.|..+..+ +.+.+|||++++.... +.+.-..|-+++... +-|.+++++.+++.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 36888899999999999999754 4678999999865222 222334566676666 568999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+.||+|-..+++- +.+.+..+.-+|.+||-||-+||++ ||++||+|.+||++|.+|++||+|||+++.-.-
T Consensus 429 MEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999998888764 4488889999999999999999999 999999999999999999999999999985432
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+ .....+++|||-|+|||++..++|+..+|.|||||++|||+.|++||++
T Consensus 503 ~----~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 503 D----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred C----CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 2 1345578999999999999999999999999999999999999999986
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=277.56 Aligned_cols=236 Identities=27% Similarity=0.321 Sum_probs=190.0
Q ss_pred eeecCCeEEEEEEcC-CCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 784 IGQGRSGIVYKVTLP-SGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 784 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
||+|+||.||++... +++.||+|++..... ...+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999864 589999999876432 2345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccC
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 939 (1117)
.+++.... .+++..+..++.|+++|+.|+|+. +++|+||||+||+++.++.++++|||.+....... ...
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~ 150 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----SRT 150 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC----Ccc
Confidence 99997653 389999999999999999999998 99999999999999999999999999998764321 122
Q ss_pred CccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCc
Q 001238 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019 (1117)
Q Consensus 940 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1019 (1117)
....++..|+|||...+...+.++|+||||+++||+++|+.||.... . ........... ..++...+
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--~---~~~~~~~~~~~--------~~~~~~~~ 217 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED--R---KEIYEKILKDP--------LRFPEFLS 217 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--H---HHHHHHHhcCC--------CCCCCCCC
Confidence 34568889999999988888999999999999999999999996421 1 22222222211 11222223
Q ss_pred hhHHHHHHHHhHhhhccCCCCCCCCCHHH
Q 001238 1020 TQIQEMLQALGISLLCTSNRAEDRPTMKD 1048 (1117)
Q Consensus 1020 ~~~~~~l~~~~i~~~C~~~~p~~RPs~~~ 1048 (1117)
..+.++++. |+..||++||++.+
T Consensus 218 ~~l~~~i~~------~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISG------LLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHH------HhcCCHhhCCCccc
Confidence 445555554 99999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=290.10 Aligned_cols=239 Identities=24% Similarity=0.287 Sum_probs=192.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++.|.+...+|.|+|+.|-.+. ..+++..|+|++.... ....+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5567788889999999998875 5578899999997652 2345678776666 69999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE-cCCCcceeccccccccccCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL-GERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill-~~~~~~kl~DfGla~~~~~~ 931 (1117)
++.|+-+.+.+...+ .....+..|+.+|+.|+.|||++ |+||||+||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999998887776543 22267778999999999999999 99999999999999 68899999999999987643
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
....+-|..|.|||+.....|++++|+||+|+++|+|++|+.||..... + ..+...+...
T Consensus 470 -------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-~----~ei~~~i~~~-------- 529 (612)
T KOG0603|consen 470 -------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-G----IEIHTRIQMP-------- 529 (612)
T ss_pred -------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc-h----HHHHHhhcCC--------
Confidence 2334678899999999999999999999999999999999999976322 2 1122222211
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......+...+++++. |++.||.+||+|.++..
T Consensus 530 -~~s~~vS~~AKdLl~~------LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 530 -KFSECVSDEAKDLLQQ------LLQVDPALRLGADEIGA 562 (612)
T ss_pred -ccccccCHHHHHHHHH------hccCChhhCcChhhhcc
Confidence 1123444566666666 99999999999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=249.43 Aligned_cols=214 Identities=27% Similarity=0.372 Sum_probs=172.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC-CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS-DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+....+..||+|++|.|-+.++ .+|+..|+|+++.. ..+..++..+|+.+..+. .+|.+|.++|.....+..++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3445567899999999988764 57999999999764 334456777888876554 79999999999999999999999
Q ss_pred ecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 853 YMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
.|+ .+|+.+-++- ...+.+++...-+||..|.+||.|||++. .++|||+||+|||++.+|++|+||||++..+.+.
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 994 5777655432 23456899999999999999999999986 8999999999999999999999999999887653
Q ss_pred CCCccccCCccccccccCChhhhc----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHh
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYAN----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK 1001 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 1001 (1117)
.+.+...|...|||||.+. ...|+-|+||||+|+++.||++++.||+. .....+.+++.+.
T Consensus 203 -----iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~----w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 203 -----IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES----WGTPFQQLKQVVE 267 (282)
T ss_pred -----hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc----cCCHHHHHHHHhc
Confidence 2333356888999999875 34789999999999999999999999974 3334455555443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=274.64 Aligned_cols=221 Identities=23% Similarity=0.230 Sum_probs=175.0
Q ss_pred cCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCChhhhhcC
Q 001238 787 GRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD 865 (1117)
Q Consensus 787 G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 865 (1117)
|.||.||++.. .+++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999975 468999999987543 234556666666899999999999999999999999999999998875
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCccccc
Q 001238 866 GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945 (1117)
Q Consensus 866 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt 945 (1117)
.. .+++..+..++.|+++||+|+|+. +|+||||||+||+++.++.++++|||.+...... .....++
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-------~~~~~~~ 145 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-------CDGEAVE 145 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-------cccCCcC
Confidence 42 389999999999999999999998 9999999999999999999999999988765432 1123457
Q ss_pred cccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHH
Q 001238 946 YGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEM 1025 (1117)
Q Consensus 946 ~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 1025 (1117)
..|+|||......++.++||||+|+++|||++|+.|+...... ... .....++...+..+.++
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~~~------~~~~~~~~~~~~~~~~l 208 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------INT------HTTLNIPEWVSEEARSL 208 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------ccc------ccccCCcccCCHHHHHH
Confidence 7899999998888999999999999999999999887532110 000 00011223334455555
Q ss_pred HHHHhHhhhccCCCCCCCCCHHH
Q 001238 1026 LQALGISLLCTSNRAEDRPTMKD 1048 (1117)
Q Consensus 1026 l~~~~i~~~C~~~~p~~RPs~~~ 1048 (1117)
++. |++.||++||++.+
T Consensus 209 i~~------~l~~dp~~R~~~~~ 225 (237)
T cd05576 209 LQQ------LLQFNPTERLGAGV 225 (237)
T ss_pred HHH------HccCCHHHhcCCCc
Confidence 555 99999999998643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-31 Score=284.17 Aligned_cols=199 Identities=28% Similarity=0.348 Sum_probs=176.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCC-cEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSG-LTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.++..+..||-||||.|-.++.... ..+|+|++++. +....+.+..|-.+|...+.|.||++|..|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 3566677899999999999876443 34899988764 3333455778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|-|-||.+...++++ +.++..++..++..+.+|++|||++ +||+||+||+|.++|.+|-+||.|||.|+.+..+
T Consensus 500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999875 4589999999999999999999999 9999999999999999999999999999998754
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
. ...+++|||.|.|||++..+..+.++|.||+|+++||+++|.+||.+.
T Consensus 574 ~-----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 574 R-----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred C-----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 2 456789999999999999999999999999999999999999999764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=279.58 Aligned_cols=208 Identities=26% Similarity=0.337 Sum_probs=174.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.-|..++.||-|+||+|.+++. .+...||+|.+++.+. .....++.|-.||..-..+=||++|-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4577788999999999999864 3466799999876543 23345788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc---
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV--- 928 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~--- 928 (1117)
||++||++-.+|-+. +.++++.++.++.++.+|+++.|.. |+|||||||+|||||.+|++||+|||++.-+
T Consensus 709 dYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999988765 4588999999999999999999999 9999999999999999999999999997532
Q ss_pred ------cCCCCCc-----------------------------cccCCccccccccCChhhhccCCCCcCCCeeehhhhHH
Q 001238 929 ------EDDSGGS-----------------------------FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLL 973 (1117)
Q Consensus 929 ------~~~~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ 973 (1117)
..++... .......+||+.|+|||++....|+..+|.||.|||+|
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1110000 00011347999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCC
Q 001238 974 EIITGKKPVDASFPDG 989 (1117)
Q Consensus 974 ell~g~~P~~~~~~~~ 989 (1117)
||+.|+.||-...+.+
T Consensus 863 em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHhhCCCCccCCCCCc
Confidence 9999999997765544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=259.59 Aligned_cols=200 Identities=22% Similarity=0.329 Sum_probs=176.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 849 (1117)
-++|...++||+|+|++|..++++ +.+.||+|++++. +....+.++.|-.+..+- +||.+|.+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999854 5788999999864 444566678888877666 79999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
|.||++||+|--.+++++ .++++.++.+..+|.-||.|||+. ||++||+|.+|||+|.+|++|++|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999977776653 499999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
... ....+++|||.|.|||++++.+|...+|.|++||+++||+.|+.||+.
T Consensus 403 ~~g----d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 403 GPG----DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCC----cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 322 345678999999999999999999999999999999999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=296.79 Aligned_cols=200 Identities=23% Similarity=0.288 Sum_probs=142.7
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-C----CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEee------ee
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-S----GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGW------GA 842 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~ 842 (1117)
..++|.+.++||+|+||.||+|.+. + +..||+|++..... .+....| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999864 4 68999998764321 1111111 1122222223222221 24
Q ss_pred cCCceEEEEEecCCCChhhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccc
Q 001238 843 NRKTKLLFYDYMPNGTLGMLLHDGECA-----------------GLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVK 905 (1117)
Q Consensus 843 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 905 (1117)
.....++||||+++++|.+++...... .......+..++.|+++||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 566789999999999999988754210 0112344568999999999999999 99999999
Q ss_pred cCeEEEcC-CCcceeccccccccccCCCCCccccCCccccccccCChhhhccC----------------------CCCcC
Q 001238 906 SHNILLGE-RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT----------------------KISEK 962 (1117)
Q Consensus 906 p~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 962 (1117)
|+|||+++ ++.+||+|||+|+....... .......+|++|+|||.+... .++.+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999986 57999999999986543211 223456789999999965322 23456
Q ss_pred CCeeehhhhHHHHHhCCCCCC
Q 001238 963 SDVYSYGVVLLEIITGKKPVD 983 (1117)
Q Consensus 963 ~Dv~SlG~vl~ell~g~~P~~ 983 (1117)
+||||+||++|||+++..|++
T Consensus 360 ~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCc
Confidence 799999999999999877654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=285.64 Aligned_cols=203 Identities=22% Similarity=0.261 Sum_probs=153.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-----------------CCCcEEEEEEeecCCccchHH--------------HHHHH
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-----------------PSGLTVAVKRFRASDKISTGA--------------FSSEI 823 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~ 823 (1117)
.++|.+.++||+|+||+||+|.. ..++.||||++........++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999853 245789999987543222222 33477
Q ss_pred HHHhccCCCCc-----ceEEeeeec--------CCceEEEEEecCCCChhhhhcCCCC---------------------C
Q 001238 824 ATLSRIRHRNI-----VRLLGWGAN--------RKTKLLFYDYMPNGTLGMLLHDGEC---------------------A 869 (1117)
Q Consensus 824 ~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~ 869 (1117)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 677777653 3567999999999999999874210 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccC
Q 001238 870 GLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949 (1117)
Q Consensus 870 ~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~ 949 (1117)
..+++..+..++.|+++||+|+|+. +|+||||||+||+++.++.+||+|||+++....... .......+|+.|+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---~~~~~g~~tp~Y~ 377 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---FNPLYGMLDPRYS 377 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc---cCccccCCCccee
Confidence 1246788899999999999999999 999999999999999999999999999976543211 1111234578999
Q ss_pred ChhhhccCC--------------------C--CcCCCeeehhhhHHHHHhCCC-CCC
Q 001238 950 APEYANMTK--------------------I--SEKSDVYSYGVVLLEIITGKK-PVD 983 (1117)
Q Consensus 950 aPE~~~~~~--------------------~--~~~~Dv~SlG~vl~ell~g~~-P~~ 983 (1117)
|||.+.... | ..+.||||+||++|||++|.. ||.
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 999875322 1 235799999999999999885 664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=263.93 Aligned_cols=197 Identities=23% Similarity=0.311 Sum_probs=168.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhccC-C-C----CcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-H-R----NIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~~~~~~~~~~ 847 (1117)
+++|.+...+|+|.||.|-++. ...+..||||+++...+ -.++..-|+++++++. + | -+|.+.+||...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 7899999999999999999974 44588999999986543 2345667999999993 3 3 378888999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC--------------
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-------------- 913 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-------------- 913 (1117)
|+|+|.+ |-|+.+++..+.. .+++.++++.|++|++++++|||+. +++|-|+||+||++.+
T Consensus 167 Civfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 6699999988654 3489999999999999999999999 9999999999999832
Q ss_pred ------CCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 914 ------RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 914 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
...+|++|||-|+..... ....+.|..|.|||++.+-.++.++||||+|||++|+.+|..-|+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 235789999999876532 2456889999999999999999999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=260.34 Aligned_cols=238 Identities=29% Similarity=0.396 Sum_probs=189.5
Q ss_pred CCeEEEEEEcC-CCcEEEEEEeecCCccc-hHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCChhhhhcC
Q 001238 788 RSGIVYKVTLP-SGLTVAVKRFRASDKIS-TGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD 865 (1117)
Q Consensus 788 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 865 (1117)
+||.||+|... +|+.||+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999875 48999999998665444 67899999999999999999999999998999999999999999999876
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCccccc
Q 001238 866 GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945 (1117)
Q Consensus 866 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt 945 (1117)
... +++..+..++.+++++++|||+. +++|+||+|+||++++++.++++|||.+....... ......++
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~ 149 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFVGT 149 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----ccccccCC
Confidence 432 78999999999999999999999 99999999999999999999999999998765431 23345688
Q ss_pred cccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHH
Q 001238 946 YGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEM 1025 (1117)
Q Consensus 946 ~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 1025 (1117)
..|++||......++.++||||+|+++|++++|..||... .. ....... ........... ....+..+.++
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-~~---~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~ 220 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-DQ---LLELFKK-IGKPKPPFPPP----EWKISPEAKDL 220 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-Cc---HHHHHHH-HhccCCCCccc----cccCCHHHHHH
Confidence 8999999998888999999999999999999999999642 11 1122221 11111110000 00022334444
Q ss_pred HHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1026 LQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1026 l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.+|+..+|++||++.++++
T Consensus 221 ------i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 ------IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ------HHHHccCCchhccCHHHHhh
Confidence 44599999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=286.26 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=187.0
Q ss_pred CCCCCeeeecCCeE-EEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecC
Q 001238 778 LTAGNIIGQGRSGI-VYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
|.-.+++|.|+-|+ ||+|.. +|+.||||++-.. ..+..++|++.++.- +|||||++++.-.++...|++.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 34456789999985 699988 6889999998643 234678999999998 6999999999999999999999999
Q ss_pred CCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---C--Ccceecccccccccc
Q 001238 856 NGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---R--YESCLADFGLARLVE 929 (1117)
Q Consensus 856 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~--~~~kl~DfGla~~~~ 929 (1117)
..+|.+++... ...........+.+..|+++||++||+- +|||||+||+||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999874 1111111134567889999999999998 9999999999999975 3 578999999999987
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.+. ..........||-+|+|||++....-+.++||||+|||+|+.++ |..||...... -..++........
T Consensus 663 ~~~-sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-------~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGK-SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-------QANILTGNYTLVH 734 (903)
T ss_pred CCc-chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-------hhhhhcCccceee
Confidence 653 33344667889999999999998888889999999999999999 59999642111 1122222222211
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+....+....+ ++-.+++++|..||++.+|+.
T Consensus 735 -----L~~~~d~eA~d------LI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 -----LEPLPDCEAKD------LISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----eccCchHHHHH------HHHHhcCCCcccCCCHHHHhC
Confidence 11122113333 444499999999999999964
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=240.07 Aligned_cols=253 Identities=19% Similarity=0.304 Sum_probs=190.1
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEe-eeecCCceEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLG-WGANRKTKLLF 850 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~-~~~~~~~~~lv 850 (1117)
-.+.|++.+.+|+|.||.+-.++++ +.+.+|+|-+.+. ....++|.+|.----.+ .|.||+.-|+ .|+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3457899999999999999999864 5778999988654 33567899998765555 5899998887 46777888899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc--CCCcceeccccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG--ERYESCLADFGLARLV 928 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~--~~~~~kl~DfGla~~~ 928 (1117)
|||+|.|+|..-+... | +-+....+++.|+++|++|+|++ .+||||||.+||||- +..++|+||||+.+..
T Consensus 101 qE~aP~gdL~snv~~~---G-igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA---G-IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCcc---c-ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999888663 2 77888899999999999999999 999999999999994 3458999999999865
Q ss_pred cCCCCCccccCCccccccccCChhhhccC-----CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMT-----KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
+.. ....--+..|.+||..... ...+.+|||.||+++|.+++|++||+...-.+....+|..-..+..
T Consensus 174 g~t-------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 174 GTT-------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred Cce-------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 421 1122345679999976532 3567899999999999999999999876666666666655433322
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.. -|+.-..+.+...++.+. -+.++|++|--..++..+
T Consensus 247 ~~-----~P~~F~~fs~~a~r~Fkk------~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 PA-----LPKKFNPFSEKALRLFKK------SLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cc-----CchhhcccCHHHHHHHHH------hcCCcccccchhHHHHHH
Confidence 21 122223334445555555 778899999544444443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=238.77 Aligned_cols=203 Identities=22% Similarity=0.313 Sum_probs=168.3
Q ss_pred hccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeecCC--ceEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRK--TKLL 849 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~l 849 (1117)
..++|++.+++|+|.|++||.|. ..+.+.++||+++... .+.+.+|+.+++.++ ||||+++++...++. ...+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45689999999999999999997 4578899999998643 467899999999996 999999999987764 4579
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-Ccceeccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGLARLV 928 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla~~~ 928 (1117)
|+||+.+.+...+... ++...++.++.+++.||+|+|++ ||.|||+||.||++|.. ...+++|+|+|.++
T Consensus 113 iFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999999887765532 67778889999999999999999 99999999999999965 57899999999988
Q ss_pred cCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHH
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVI 993 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~ 993 (1117)
.... ...-.+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||-......+.++
T Consensus 184 Hp~~-----eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV 244 (338)
T KOG0668|consen 184 HPGK-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 244 (338)
T ss_pred CCCc-----eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence 7643 2333456778899997754 6788999999999999999999999954333333333
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-28 Score=246.53 Aligned_cols=198 Identities=28% Similarity=0.364 Sum_probs=164.5
Q ss_pred CCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCC-----ceEEEE
Q 001238 780 AGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRK-----TKLLFY 851 (1117)
Q Consensus 780 ~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~ 851 (1117)
..+.||-|+||.||.+.+ ++|+.||+|++... .-...+++-+|++++..++|.|+...+++..-.. +.|++.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 346799999999999875 47999999988642 2334567889999999999999998888755432 457888
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|.| ..+|..++.... .++.+.+.-+.+||++||.|||+. +|.||||||.|.|++.+-..||||||+++....+
T Consensus 137 ELm-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELM-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 888 457877776543 388889999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFP 987 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~ 987 (1117)
. ....+..+.|..|.|||.+.+ +.|+.+.||||.||++.|++.++.-|+...+
T Consensus 210 ~---~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 210 D---RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred h---hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 2 234456678999999998765 6799999999999999999999998876443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=255.38 Aligned_cols=150 Identities=25% Similarity=0.376 Sum_probs=122.8
Q ss_pred CCCccchhhccchhhHHHh--ccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhccC--
Q 001238 756 GPPWELTLYNKLDLSIGDA--TRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-- 830 (1117)
Q Consensus 756 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-- 830 (1117)
...+....|+.+ .+++. ..+|.+.++||.|.|++||++. ..+.+.||+|+.+.... -.+....||+++++++
T Consensus 58 ~~dY~kGGYHpV--~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 58 PEDYRKGGYHPV--RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREG 134 (590)
T ss_pred hhhhhcCCCcee--eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhc
Confidence 334566667654 34443 3689999999999999999986 45678999999986533 3456678999999984
Q ss_pred ---C---CCcceEEeeeec----CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCcee
Q 001238 831 ---H---RNIVRLLGWGAN----RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAIL 900 (1117)
Q Consensus 831 ---H---~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 900 (1117)
| .+||+++++|.. +.+.|+|+|++ |.+|..++......| ++...+.+|++||+.||+|||++| +||
T Consensus 135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gII 210 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GII 210 (590)
T ss_pred CCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--Ccc
Confidence 3 379999998865 45789999999 778888888776666 899999999999999999999998 999
Q ss_pred eeccccCeEEEc
Q 001238 901 HRDVKSHNILLG 912 (1117)
Q Consensus 901 HrDlkp~Nill~ 912 (1117)
|.||||+|||+.
T Consensus 211 HTDlKPENvLl~ 222 (590)
T KOG1290|consen 211 HTDLKPENVLLC 222 (590)
T ss_pred ccCCCcceeeee
Confidence 999999999993
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=263.68 Aligned_cols=196 Identities=24% Similarity=0.312 Sum_probs=169.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCCc--------cchHHHHHHHHHHhccC---CCCcceEEeeeec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDK--------ISTGAFSSEIATLSRIR---HRNIVRLLGWGAN 843 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 843 (1117)
..|+..+.+|+|+||.|+.+.++. ...|+||.+.+... .....+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 368899999999999999997654 56799998876421 11233567999999997 9999999999999
Q ss_pred CCceEEEEEec-CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccc
Q 001238 844 RKTKLLFYDYM-PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADF 922 (1117)
Q Consensus 844 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 922 (1117)
.+.+|++||-. ++-+|.+++..+. .+++.++.-|++||+-|+++||++ +|||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 99999999986 4568899987753 389999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCC
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVD 983 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~ 983 (1117)
|-|.....+ +...++||..|.|||++.+.+| +..-||||+|+++|.++....||.
T Consensus 715 gsaa~~ksg------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876542 4556899999999999998887 467899999999999999998884
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-28 Score=267.77 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=205.8
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
...+|...+++|.|.||.|||++. .+++.+|+|+++-......+-+++|+-+++..+|||||.+++.+-..+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 345788999999999999999985 4689999999987766667788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
||.+|+|.+.-+-. +++++.+...+.+...+|++|||++ +-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 93 ycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred ecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh--
Confidence 99999999987653 5699999999999999999999999 889999999999999999999999999987653
Q ss_pred CCccccCCccccccccCChhhh---ccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYA---NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
....+..+.||+.|||||+. +.+.|..++|||+.|+...|+..-++|.... +..+...-.-+....+...
T Consensus 165 --ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-----hpmr~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 165 --TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-----HPMRALFLMTKSGFQPPTL 237 (829)
T ss_pred --hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-----chHHHHHHhhccCCCCCcc
Confidence 23455678999999999965 4577899999999999999999988885322 2222222222334444443
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVA 1050 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~ 1050 (1117)
-|+. .+...+-++.+. |+..+|.+||++..++
T Consensus 238 kDk~---kws~~fh~fvK~------altknpKkRptaeklL 269 (829)
T KOG0576|consen 238 KDKT---KWSEFFHNFVKG------ALTKNPKKRPTAEKLL 269 (829)
T ss_pred cCCc---cchHHHHHHHHH------HhcCCCccCCChhhhe
Confidence 3332 333445555555 9999999999987764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=235.33 Aligned_cols=210 Identities=35% Similarity=0.561 Sum_probs=179.1
Q ss_pred eeecCCeEEEEEEcCC-CcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCChhh
Q 001238 784 IGQGRSGIVYKVTLPS-GLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGM 861 (1117)
Q Consensus 784 lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 861 (1117)
||+|++|.||++.... ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998654 899999999865432 34679999999999999999999999999899999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-CCcceeccccccccccCCCCCccccCC
Q 001238 862 LLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-RYESCLADFGLARLVEDDSGGSFSANP 940 (1117)
Q Consensus 862 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~ 940 (1117)
++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++++|||.+........ ...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~~~ 151 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----LLK 151 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----hhh
Confidence 987642 2388999999999999999999999 9999999999999999 89999999999987654321 123
Q ss_pred ccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCc
Q 001238 941 QFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019 (1117)
Q Consensus 941 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1019 (1117)
...+...|++||..... .++.++|+|++|++++++
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 34578899999998877 888999999999999999
Q ss_pred hhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1020 TQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1020 ~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
..+.+++.. |++.+|++||++.++++.
T Consensus 188 ~~~~~~l~~------~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRK------MLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHH------HhhCCcccCcCHHHHhhC
Confidence 133444444 999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=238.43 Aligned_cols=199 Identities=33% Similarity=0.447 Sum_probs=173.0
Q ss_pred CCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 778 LTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999998654 889999999865444 56788999999999999999999999999899999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.+++..... .+++..+..++.+++.++.|||+. +++|+|++|.||+++.++.++++|||.+........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-- 153 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-- 153 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--
Confidence 9999999876532 178899999999999999999999 999999999999999999999999999987754320
Q ss_pred cccCCccccccccCChhhh-ccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 936 FSANPQFAGSYGYIAPEYA-NMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122345678899999998 667788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=227.81 Aligned_cols=264 Identities=19% Similarity=0.282 Sum_probs=206.0
Q ss_pred cCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
-+|+++++||+|.||+.+.|+ .-+++.||||.-.... ..-++..|.+..+.|. .++|..++-|+.++.+-.+|||.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 379999999999999999997 5579999999865433 3457889999999995 69999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-----Ccceeccccccccc
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-----YESCLADFGLARLV 928 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-----~~~kl~DfGla~~~ 928 (1117)
+ |.+|.|++.-.. +.++..++..+|.|++.-++|+|++ .+|+|||||+|+||+.. ..+.++|||+|+.+
T Consensus 106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 889999887543 4599999999999999999999999 99999999999999743 35679999999988
Q ss_pred cCCCCC---ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 929 EDDSGG---SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 929 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
.+.... .+.......||.+||+-..+.+++.+.+.|+-|+|-|+++.+-|..||++.-.+ ..-..+-+-..+++..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-TNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-chHHHHHHhccccccC
Confidence 765432 345556778999999999999999999999999999999999999999875332 1112222222233334
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
+.+.+...++ .+...-++. .-..+-++-|+++.+...+..+..
T Consensus 259 ~i~~Lc~g~P----~efa~Yl~y------vR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 259 PIEVLCEGFP----EEFATYLRY------VRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred CHHHHHhcCH----HHHHHHHHH------HHhcCcccCCCHHHHHHHHHHHHH
Confidence 4444443332 222222322 234578889999998888876654
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-27 Score=250.58 Aligned_cols=386 Identities=23% Similarity=0.256 Sum_probs=240.8
Q ss_pred CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCC-CcCCCCCccccCCCCCcceEec
Q 001238 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISM-NSLTGSIPQTLGNLTSLQELQL 346 (1117)
Q Consensus 268 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~-N~l~~~~p~~l~~l~~L~~L~L 346 (1117)
.-.+++|..|+|+...|..|+.+++|+.|+|++|+|+.+-|.+|.++.+|..|-+-+ |+|+......|++|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 446788888888866667788888888888888888888888888888876665544 8888655567888888888888
Q ss_pred ccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcccccc------------ccCCCCCCcccccc
Q 001238 347 SVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLE------------GEIPPSISNCQNLE 414 (1117)
Q Consensus 347 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------~~~~~~~~~l~~L~ 414 (1117)
.-|++.-.....|..+++|..|.+..|.+..+--..|..+..++.+.+..|.+- ...|..++......
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 888888777788888888888888888888444447888888888888888732 22233344444444
Q ss_pred eeecccccccCCCcccccC-CCCCCe-eeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccC
Q 001238 415 AVDLSQNGLTGPIPRGIFQ-LKKLNK-LLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGS 492 (1117)
Q Consensus 415 ~L~Ls~N~l~~~~p~~~~~-l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 492 (1117)
-..+.++++..+.+.-|.. +..+.. +....+...-.....|..+++|+.|+|++|+|+++.+.+|.++..+++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 4445555554332322221 111111 11112222212223466666666666666666666666666666666666666
Q ss_pred CcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCC----------------CCCCCcCCCcc
Q 001238 493 NRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGG----------------MLSPDLGSLSS 556 (1117)
Q Consensus 493 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~----------------~~~~~~~~l~~ 556 (1117)
|+|..+....|.++.+|+.|+|.+|+|+...|.+|..+.+|..|+|-.|.+.- +...--.+-..
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~ 387 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGF 387 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCch
Confidence 66665555566666666666666666666666666666666666666554420 00001111123
Q ss_pred ccEEeccccccCCC---CCccc---------ccccceeEE-eccccccccccccccCCchhHHHhhcCCCCcccCCcccc
Q 001238 557 LTKLVLNKNRFAGS---IPSQL---------GSCVKLQLL-DLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAE 623 (1117)
Q Consensus 557 L~~L~L~~N~l~~~---~~~~~---------~~l~~L~~L-~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~ 623 (1117)
++.+.++++.+... .|+.. ..++-+.+. .-|++.++ .+|..+ |.=..+|.|.+|+++ .+|.+
T Consensus 388 ~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~i---P~d~telyl~gn~~~-~vp~~ 462 (498)
T KOG4237|consen 388 VRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGI---PVDVTELYLDGNAIT-SVPDE 462 (498)
T ss_pred hccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCC---CchhHHHhcccchhc-ccCHH
Confidence 44555555544311 11111 122333333 23444443 555543 333368999999998 66766
Q ss_pred ccCCCCccEEeccCccccCCcch-hhhcccceEEEeecc
Q 001238 624 LTGLNKLGILDLSHNELSGDLHF-LAELQNLVVLNVSHN 661 (1117)
Q Consensus 624 l~~l~~L~~LdLs~N~l~~~~~~-l~~l~~L~~L~ls~N 661 (1117)
.+.+| .+|||+|+|+..-.. |.+++.|.+|-||+|
T Consensus 463 --~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 463 --LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred --HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 67778 899999999875544 888999999999987
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=236.62 Aligned_cols=208 Identities=27% Similarity=0.353 Sum_probs=171.6
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecC
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANR 844 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 844 (1117)
.+....+.|..+++||+|.|++||++... .++.||+|.+.... ...++.+|++++..+ .+.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34556678999999999999999998632 46789999987654 356799999999999 599999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-CCcceecccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-RYESCLADFG 923 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfG 923 (1117)
+...+|+||+++....++... ++...+..+++.+..||+++|.+ |||||||||+|++.+. .++-.|.|||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred CeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 999999999999998888765 66788999999999999999999 9999999999999985 4677899999
Q ss_pred ccccccCCC-----------------CC-----------------------ccccCCccccccccCChhhhc-cCCCCcC
Q 001238 924 LARLVEDDS-----------------GG-----------------------SFSANPQFAGSYGYIAPEYAN-MTKISEK 962 (1117)
Q Consensus 924 la~~~~~~~-----------------~~-----------------------~~~~~~~~~gt~~y~aPE~~~-~~~~~~~ 962 (1117)
+|....... +. ........+||+||.|||++. ....+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997221100 00 000112357999999999875 4677899
Q ss_pred CCeeehhhhHHHHHhCCCCCCCCCCC
Q 001238 963 SDVYSYGVVLLEIITGKKPVDASFPD 988 (1117)
Q Consensus 963 ~Dv~SlG~vl~ell~g~~P~~~~~~~ 988 (1117)
+||||.||++.-+++++.||-....+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd 284 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDD 284 (418)
T ss_pred cceeeccceeehhhccccccccCccc
Confidence 99999999999999999999654444
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=229.96 Aligned_cols=195 Identities=26% Similarity=0.348 Sum_probs=164.6
Q ss_pred ccCCCCCCeeeecCCeEEEEE-EcCCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCC------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKV-TLPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRK------ 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 845 (1117)
..+|.-.+.+|.|.- .|..+ +.-.++.||+|+.... .....++..+|...+..+.|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777788899988 55544 3446899999987543 3445677889999999999999999999886543
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..|+||||| ..+|...+... ++-++...+..|++.|+.|+|+. +|+|||+||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILME-----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 469999999 56888887732 77889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+..... -..+..+.|..|.|||++-+..|.+.+||||.||++.||++|+.-|.+
T Consensus 166 r~e~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 166 RTEDTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred cccCcc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 865432 245677899999999999888899999999999999999999988864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=218.53 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=207.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhccCC-CCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH-RNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e 852 (1117)
...|.++++||.|+||.+|.|. ..+|+.||||+-+.... ..++..|.++...++| ..|+.+..|+.+.+...+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4578999999999999999996 56899999999876543 3467889999999976 788888999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC---Ccceecccccccccc
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER---YESCLADFGLARLVE 929 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfGla~~~~ 929 (1117)
.+ |.+|.+++.-.. ..++..+++-+|-|++.-++|+|.+ ++|||||||+|+|.+-+ ..+.++|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 889999887543 3488999999999999999999999 99999999999999754 456799999999876
Q ss_pred CCCCC---ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHH-HhcCCC
Q 001238 930 DDSGG---SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH-LKSKKD 1005 (1117)
Q Consensus 930 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~~~~ 1005 (1117)
+.... .+.......||.+|.+-...-+.+.+.+.|+-|+|.++.+...|..||++..+. .-.+..+++ .++...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~--tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA--TKKQKYEKISEKKMST 243 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh--hHHHHHHHHHHhhcCC
Confidence 54332 344556778999999999888888999999999999999999999999875332 111122222 223334
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
+.+++.+.++. +..-.+.. |-...-++-|++..+.+.++-+..
T Consensus 244 ~ie~LC~G~P~----EF~myl~Y------~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 244 PIEVLCKGFPA----EFAMYLNY------CRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred CHHHHhCCCcH----HHHHHHHH------HhhcCCCCCCcHHHHHHHHHHHHh
Confidence 55555444433 33333444 888889999999999888776644
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-26 Score=242.40 Aligned_cols=421 Identities=22% Similarity=0.222 Sum_probs=192.2
Q ss_pred EEEEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccC-CCcCCCCchhhhhhhhhhhhhcc
Q 001238 76 VVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSE-NSLTGEIPRELCSLLRLEQLRLN 154 (1117)
Q Consensus 76 v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~ 154 (1117)
.|.++|..+.+...-|..|+.+..|++||||+|+|+..-|++|..|..|..|-+-+ |+|+...-+.|+.|..|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 34555555555443334455555555555555555555555555555554444433 55552222345555555555555
Q ss_pred CCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCcccccccccccccccccccccc
Q 001238 155 SNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGF 234 (1117)
Q Consensus 155 ~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~ 234 (1117)
-|++.......|..|++|..|.+++|.+...--.+|..+..++.+++..|... ..++++.+... ...
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i------cdCnL~wla~~-------~a~ 215 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI------CDCNLPWLADD-------LAM 215 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc------cccccchhhhH-------Hhh
Confidence 55555555555555555555555555555322225555555555555555421 12222222211 111
Q ss_pred CCcccccccccceeecccccccccCCcCCCCC-CCCcEEecCCCccCCcCC-ccCCCCCCCcEEEccCCcCcccCCcCCC
Q 001238 235 LPPTLGLLKRLQTIAIYTALLSGQIPPELGDC-TELQYIYLYENALTGSIP-SKLGNLKNLVNLFLWQNNLVGIIPPELG 312 (1117)
Q Consensus 235 lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~~~~ 312 (1117)
.|..++..+-..-..++..++...-+..|... .++..=..+.+...+.-| ..|..|++|++|+|++|+|+++-+.+|.
T Consensus 216 ~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe 295 (498)
T KOG4237|consen 216 NPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFE 295 (498)
T ss_pred chhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhc
Confidence 23333333333333444433332222222111 112111222222222333 2355555555555555555555555555
Q ss_pred CCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHH
Q 001238 313 NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLL 392 (1117)
Q Consensus 313 ~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 392 (1117)
.+..++.|.|..|+|...-...|.++..|+.|+|.+|+|+...|..|..+.+|.+|+|-.|.+.-. ..|..|
T Consensus 296 ~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn--------C~l~wl 367 (498)
T KOG4237|consen 296 GAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN--------CRLAWL 367 (498)
T ss_pred chhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc--------cchHHH
Confidence 555555555555555544444455555555555555555555555555555555555544443200 011111
Q ss_pred --HhccccccccCCCCCCcccccceeecccccccCC---CcccccCCCCCCeeeccCccCCCCCCCCccccccccee-cc
Q 001238 393 --FVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP---IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF-RA 466 (1117)
Q Consensus 393 --~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~l 466 (1117)
.|..+.-.|..| -..-..++.++++.+.+... .|+... +.-++. .-..++-+.+. ..
T Consensus 368 ~~Wlr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~------------~~~s~~---cP~~c~c~~tVvRc 430 (498)
T KOG4237|consen 368 GEWLRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELG------------CLTSSP---CPPPCTCLDTVVRC 430 (498)
T ss_pred HHHHhhCCCCCCCC--CCCCchhccccchhccccccccCCccccC------------CCCCCC---CCCCcchhhhhHhh
Confidence 122222111111 11122345555555544310 111100 000000 11122333332 23
Q ss_pred CCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCC
Q 001238 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDN 541 (1117)
Q Consensus 467 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 541 (1117)
+++.++ .+|..+- ....+|++.+|.++ .+|.. .+.+| .+|+++|+|...-...|.++.+|.+|-+++|
T Consensus 431 Snk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 431 SNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred cccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 333333 3443322 34566777777777 55555 45566 7777777777655566777777777777665
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=240.32 Aligned_cols=199 Identities=23% Similarity=0.230 Sum_probs=169.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccC------CCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIR------HRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~~~~~ 848 (1117)
.+|.+....|+|-|++|.+|.. ..|..||||+++.... ..+.=..|+++|++|. --|+++++..|....++|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 5788888899999999999974 4588999999986543 2344567999999995 248999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-Ccceecccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGLARL 927 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla~~ 927 (1117)
+|+|-+ .-+|.++++.....-.+....+..+++|+.-||..|-.. +|+|.||||.||||.+. ..+||||||.|..
T Consensus 511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccc
Confidence 999987 568999998754444488899999999999999999987 99999999999999975 4679999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
..... .+....+.-|.|||++.+.+|+...|+||.||++||+.||+.-|.+.
T Consensus 587 ~~ene------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 587 ASENE------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ccccc------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 76532 23445677899999999999999999999999999999999988763
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=278.83 Aligned_cols=337 Identities=20% Similarity=0.230 Sum_probs=198.9
Q ss_pred cccccccCCeEeccCCC------CCCCchhhhcccc-cCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchh
Q 001238 93 NFTSLLSLNRLVLSGTN------LTGSIPKEIASLN-QLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQ 165 (1117)
Q Consensus 93 ~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 165 (1117)
.|.++.+|+.|.+..+. +...+|..+..++ +|++|++.+|.++ .+|..+ ...+|+.|+|++|+++ .+|..
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence 46667777777665442 2334555555553 4677777776665 566655 3566677777777666 56666
Q ss_pred ccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCccccccccc
Q 001238 166 IGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRL 245 (1117)
Q Consensus 166 ~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L 245 (1117)
+..+++|+.|+|++|.....+|. ++.+++|+.|++++|..+ ..+|..++++++|+.|++++|.....+|.
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L-~~lp~si~~L~~L~~L~L~~c~~L~~Lp~-------- 699 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSL-VELPSSIQYLNKLEDLDMSRCENLEILPT-------- 699 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCc-cccchhhhccCCCCEEeCCCCCCcCccCC--------
Confidence 66667777777766554444553 556666666666665433 34555555555555555555443333443
Q ss_pred ceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCC
Q 001238 246 QTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325 (1117)
Q Consensus 246 ~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N 325 (1117)
.+ ++++|++|+|++|...+.+|.. ..+|++|+|++|.+. .+|..+ .+++|+.|++.++
T Consensus 700 ----------------~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~ 757 (1153)
T PLN03210 700 ----------------GI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEM 757 (1153)
T ss_pred ----------------cC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-ccccccccccccc
Confidence 33 3445555555544333333321 234455555555544 233332 3445555555442
Q ss_pred cC-------CCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcccc
Q 001238 326 SL-------TGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNR 398 (1117)
Q Consensus 326 ~l-------~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 398 (1117)
.. ....+..+...++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ ++++|+.|++++|.
T Consensus 758 ~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~ 836 (1153)
T PLN03210 758 KSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCS 836 (1153)
T ss_pred chhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCC
Confidence 21 11111122233567777777776666667777777777777777665444556544 56777777777765
Q ss_pred ccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCc-cCCCCCCCCcccccccceeccCCCc
Q 001238 399 LEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSN-NLSGVIPPEMGNCSSLIRFRANSNK 470 (1117)
Q Consensus 399 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~ 470 (1117)
....+|.. .++|+.|+|++|.++ .+|.++..+++|+.|+|++| ++. .+|..+..++.|+.+++++|.
T Consensus 837 ~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 837 RLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 44344432 357888889999888 58888888899999999884 455 467777888888888887763
|
syringae 6; Provisional |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-23 Score=233.91 Aligned_cols=265 Identities=24% Similarity=0.326 Sum_probs=200.3
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCC--cEEEEEEeecCCccchHHHHHHHHHHhccCC----CCcceEEeee-ecCCceEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSG--LTVAVKRFRASDKISTGAFSSEIATLSRIRH----RNIVRLLGWG-ANRKTKLL 849 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l 849 (1117)
+|++.+.||+|+||.||.|..... ..+|+|............+..|+.++..+.+ +++.++++.+ ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986543 5899998876533333378889999999873 6999999999 57788899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-----Ccceeccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-----YESCLADFGL 924 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-----~~~kl~DfGl 924 (1117)
||+.+ |.+|.++..... .+.++..++.+++.|++.+|+++|+. |++||||||+|+.++.. ..+.+.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999886654 45699999999999999999999999 99999999999999865 3588999999
Q ss_pred cc--cccCCCCCc---ccc-CCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHH
Q 001238 925 AR--LVEDDSGGS---FSA-NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 925 a~--~~~~~~~~~---~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
++ .+....+.. ... ...+.||.+|++++++.+.+.+++.|+||++.++.|+..|..||....... . ...+..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~-~-~~~~~~ 251 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD-L-KSKFEK 251 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc-h-HHHHHH
Confidence 98 433332221 111 234669999999999999999999999999999999999999996532211 1 111111
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
....... .. .....+.....+... +-..+..++|.+..+...++......
T Consensus 252 ~~~~~~~-----~~-~~~~~~~~~~~~~~~------~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 252 DPRKLLT-----DR-FGDLKPEEFAKILEY------IDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred Hhhhhcc-----cc-ccCCChHHHHHHHHH------hhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111100 00 222333344444444 45578999999999999988776554
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=273.62 Aligned_cols=316 Identities=22% Similarity=0.258 Sum_probs=236.2
Q ss_pred CchhccCCc-CCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccc
Q 001238 162 IPIQIGNLS-SLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLG 240 (1117)
Q Consensus 162 ~p~~~~~L~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~ 240 (1117)
+|..|..++ +|+.|++.+|.+. .+|..| ...+|+.|++.+|+. ..+|..+..+++|+.|+++++.....+| .+.
T Consensus 580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l--~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls 654 (1153)
T PLN03210 580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKL--EKLWDGVHSLTGLRNIDLRGSKNLKEIP-DLS 654 (1153)
T ss_pred cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccc--cccccccccCCCCCEEECCCCCCcCcCC-ccc
Confidence 444444432 3555555555554 344444 345555555555542 2355555566666666666655444455 367
Q ss_pred cccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEE
Q 001238 241 LLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSII 320 (1117)
Q Consensus 241 ~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 320 (1117)
.+++|++|++.+|.....+|..+.++++|++|++++|...+.+|..+ ++++|+.|++++|...+.+|.. ..+|+.|
T Consensus 655 ~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L 730 (1153)
T PLN03210 655 MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWL 730 (1153)
T ss_pred cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCee
Confidence 78888888888888778889999999999999999976555788766 7999999999999776666643 4689999
Q ss_pred EcCCCcCCCCCccccCCCCCcceEeccccccc-------CcccccccCCCCCcEEEecCccccCCCCcccccccchHHHH
Q 001238 321 DISMNSLTGSIPQTLGNLTSLQELQLSVNQIS-------GEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLF 393 (1117)
Q Consensus 321 dLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 393 (1117)
+|++|.+. .+|..+ .+++|++|++.++... ...+..+...++|+.|++++|...+.+|..++++++|+.|+
T Consensus 731 ~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~ 808 (1153)
T PLN03210 731 DLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLE 808 (1153)
T ss_pred ecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEE
Confidence 99999998 577655 5789999999875432 12222334457899999999988888999999999999999
Q ss_pred hccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCC-Cccc
Q 001238 394 VWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANS-NKLT 472 (1117)
Q Consensus 394 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~ 472 (1117)
+++|...+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.|+ .+|..+..+++|+.|++++ |+++
T Consensus 809 Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~ 883 (1153)
T PLN03210 809 IENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ 883 (1153)
T ss_pred CCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC
Confidence 99986555777766 7899999999998755455543 368999999999998 5788999999999999998 4555
Q ss_pred ccCCCCcCCCCCCCEEEccCCc
Q 001238 473 GFIPPEIGNLKNLNFLDLGSNR 494 (1117)
Q Consensus 473 ~~~~~~~~~l~~L~~L~Ls~N~ 494 (1117)
.+|..+..+++|+.|++++|.
T Consensus 884 -~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 884 -RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred -ccCcccccccCCCeeecCCCc
Confidence 577788999999999999874
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-24 Score=268.14 Aligned_cols=198 Identities=17% Similarity=0.174 Sum_probs=137.6
Q ss_pred ccCC-CCcceEEeee-------ecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCce
Q 001238 828 RIRH-RNIVRLLGWG-------ANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899 (1117)
Q Consensus 828 ~l~H-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 899 (1117)
.++| +||+++++++ ...+..+.+|||+ +++|.+++.... ..+++.+++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4456 6888888876 2334567788987 669999997542 3489999999999999999999999 99
Q ss_pred eeeccccCeEEEcC-------------------CCcceeccccccccccCCCCCc------------cccCCcccccccc
Q 001238 900 LHRDVKSHNILLGE-------------------RYESCLADFGLARLVEDDSGGS------------FSANPQFAGSYGY 948 (1117)
Q Consensus 900 vHrDlkp~Nill~~-------------------~~~~kl~DfGla~~~~~~~~~~------------~~~~~~~~gt~~y 948 (1117)
|||||||+|||++. ++.+|++|||+++......... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4556677777776432110000 0011124689999
Q ss_pred CChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHH
Q 001238 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQA 1028 (1117)
Q Consensus 949 ~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 1028 (1117)
||||++.+..|+.++|||||||++|||++|..|+... .. .+....... ..+..... ..+.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~----~~---~~~~~~~~~------~~~~~~~~-------~~~~ 241 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK----SR---TMSSLRHRV------LPPQILLN-------WPKE 241 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH----HH---HHHHHHHhh------cChhhhhc-------CHHH
Confidence 9999999999999999999999999999998886421 11 111111100 01111111 1112
Q ss_pred HhHhhhccCCCCCCCCCHHHHHH
Q 001238 1029 LGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1029 ~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..++..|++.+|.+||++.|+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 24455699999999999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-23 Score=229.02 Aligned_cols=177 Identities=19% Similarity=0.180 Sum_probs=135.0
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC--CCcEEEEEEeecC-----CccchHHHHHHHHHHhccCCCCcce-EEeeeecC
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP--SGLTVAVKRFRAS-----DKISTGAFSSEIATLSRIRHRNIVR-LLGWGANR 844 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~ 844 (1117)
....+|.+.+.||+|+||+||+|.+. +++.||||++... .....+.|.+|++++++++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34567999999999999999999754 5778899987532 1222456899999999999999985 5442
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeecc-ccCeEEEcCCCcceecccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDV-KSHNILLGERYESCLADFG 923 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~Nill~~~~~~kl~DfG 923 (1117)
+..|+||||++|++|... .. .. ...++.|+++||+|||++ +|+|||| ||+||+++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999632 11 11 146788999999999999 9999999 9999999999999999999
Q ss_pred ccccccCCCCCcc----ccCCccccccccCChhhhccCC------CCcCCCee
Q 001238 924 LARLVEDDSGGSF----SANPQFAGSYGYIAPEYANMTK------ISEKSDVY 966 (1117)
Q Consensus 924 la~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~ 966 (1117)
+|+.+........ ..-....+++.|+|||.+...+ .+..+|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9997765432111 1124667889999999886432 23446666
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=206.01 Aligned_cols=171 Identities=21% Similarity=0.194 Sum_probs=124.5
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.++++... ..+++.+++.++.|+++||+|||++ + ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc-----
Confidence 68889887542 3489999999999999999999998 5 999999999999999 9999876432
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
...||+.|||||++.+..++.++|||||||++|||++|+.||............... ..... ++.-.
T Consensus 63 ----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----~~~~~----~~~~~- 129 (176)
T smart00750 63 ----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN----GMPAD----DPRDR- 129 (176)
T ss_pred ----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH----HhccC----Ccccc-
Confidence 125889999999999999999999999999999999999999653222222222211 11100 00000
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.....+.......+++..|++.+|++||++.++++.+.....
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 001111111123445666999999999999999998876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=241.79 Aligned_cols=261 Identities=28% Similarity=0.360 Sum_probs=143.4
Q ss_pred CcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecC
Q 001238 293 LVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDN 372 (1117)
Q Consensus 293 L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 372 (1117)
-..|+|++|+++ .+|+.+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p---------- 261 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---P---------- 261 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---c----------
Confidence 445556666555 3444443 24555555555555 23321 244555555555554 22321 1
Q ss_pred ccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCC
Q 001238 373 NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIP 452 (1117)
Q Consensus 373 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 452 (1117)
++|+.|++++|.++ .+|.. .++|+.|+|++|+++ .+|.. +++|+.|+|++|+|+++ |
T Consensus 262 --------------~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~L-p 318 (788)
T PRK15387 262 --------------PGLLELSIFSNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASL-P 318 (788)
T ss_pred --------------cccceeeccCCchh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCccccC-C
Confidence 23444444444444 22221 134555666666665 24432 24566666666666542 2
Q ss_pred CCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccc
Q 001238 453 PEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVR 532 (1117)
Q Consensus 453 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 532 (1117)
.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+. +|..
T Consensus 319 ~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l------ 380 (788)
T PRK15387 319 AL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL------ 380 (788)
T ss_pred CC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc------
Confidence 21 1235555566666553 2321 1356666666666663 3332 2345555555555553 2211
Q ss_pred cccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCC
Q 001238 533 LQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLS 612 (1117)
Q Consensus 533 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls 612 (1117)
..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|... ..+ ..|+|+
T Consensus 381 ---------------------~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L-~~L~Ls 430 (788)
T PRK15387 381 ---------------------PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGL-LSLSVY 430 (788)
T ss_pred ---------------------ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhh-hhhhhc
Confidence 1345666666666663 3332 246788888888887 466543 233 678899
Q ss_pred CCcccCCccccccCCCCccEEeccCccccCCcch
Q 001238 613 WNQICGELPAELTGLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 613 ~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
+|+|+ .+|..+.++++|+.|||++|+|++..+.
T Consensus 431 ~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 431 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 99998 6888899999999999999999986554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-23 Score=205.54 Aligned_cols=251 Identities=19% Similarity=0.327 Sum_probs=190.0
Q ss_pred CCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 778 LTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
.....+|.+...|+.|+|+| .|..+++|++...+. .....|..|.-.++.+.||||..+++.|..+.+..++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 34456788999999999999 456677787754322 223468999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
.|+|..++++... -..+..++.+++.+||+|++|||+. .|-|.---+.+..|++|++.+++|. .+-+++....
T Consensus 271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfqe---- 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE---- 343 (448)
T ss_pred chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeeec----
Confidence 9999999998643 3377889999999999999999997 3344455789999999999988864 2222222111
Q ss_pred cccCCccccccccCChhhhccCCCC---cCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKIS---EKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
....-.|.||+||.++.++.+ .++|+|||++++||+.|+..||.+..+.+-. .+-..+-+..
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-----------mkialeglrv 408 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-----------MKIALEGLRV 408 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-----------hhhhhccccc
Confidence 112346789999999876554 5799999999999999999999764332111 1112233445
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
.++.........++.. |+..||.+||.++.|+-.||+++
T Consensus 409 ~ippgis~hm~klm~i------cmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNI------CMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHH------HhcCCCCcCCCcceehhhHHHhc
Confidence 5555555555555555 99999999999999999998764
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=236.87 Aligned_cols=264 Identities=28% Similarity=0.341 Sum_probs=157.5
Q ss_pred CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecc
Q 001238 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347 (1117)
Q Consensus 268 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls 347 (1117)
.-..|+|++|.++ .+|..+. ++|+.|++.+|+++. +|.. .++|++|+|++|+|+ .+|.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 3556788888777 5776665 367888888888773 4532 467888888888888 44542 3577888888
Q ss_pred cccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCC
Q 001238 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPI 427 (1117)
Q Consensus 348 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 427 (1117)
+|.++ .+|..+ .+|+.|++++|+++ .+|.. +++|+.|++++|++++ +|.. ..+|+.|++++|+|++ +
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-L 337 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-c
Confidence 88877 444432 45777778888777 34432 3556777777777664 3332 1345666677777663 4
Q ss_pred cccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCC
Q 001238 428 PRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCR 507 (1117)
Q Consensus 428 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 507 (1117)
|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.. .+
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s 402 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PS 402 (788)
T ss_pred ccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---cc
Confidence 431 1356666666666664 2322 1345555555565553 3322 2345555555555552 3322 13
Q ss_pred CCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecc
Q 001238 508 NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLS 587 (1117)
Q Consensus 508 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 587 (1117)
+|+.|++++|+|+ +++.. ..+|+.|++++|+|+ .+|..+..+..|+.|+|+
T Consensus 403 ~L~~LdLS~N~Ls------------------------sIP~l----~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 403 ELKELMVSGNRLT------------------------SLPML----PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred CCCEEEccCCcCC------------------------CCCcc----hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 4455555555544 33211 124556666777766 466677777788888888
Q ss_pred cccccccccccc
Q 001238 588 SNQLSGNIPASL 599 (1117)
Q Consensus 588 ~N~l~~~~p~~l 599 (1117)
+|+|++.+|..+
T Consensus 454 ~N~Ls~~~~~~L 465 (788)
T PRK15387 454 GNPLSERTLQAL 465 (788)
T ss_pred CCCCCchHHHHH
Confidence 888887766655
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=234.45 Aligned_cols=247 Identities=26% Similarity=0.471 Sum_probs=147.9
Q ss_pred ccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhc
Q 001238 122 NQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRA 201 (1117)
Q Consensus 122 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 201 (1117)
.+.+.|++++++++ .+|..+. .+|+.|+|++|.++ .+|..+. ++|++|++++|+|+ .+|..+. .+|+.|++
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 45677888888887 5776554 46788888888888 5666554 47888888888887 4565443 24555555
Q ss_pred cCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCC
Q 001238 202 GGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTG 281 (1117)
Q Consensus 202 ~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 281 (1117)
++|+.. .+|..+. ++|+.|++++|.+. .+|+.+. ++|++|+|++|+++
T Consensus 249 s~N~L~--~LP~~l~--------------------------s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt- 296 (754)
T PRK15370 249 SINRIT--ELPERLP--------------------------SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR- 296 (754)
T ss_pred cCCccC--cCChhHh--------------------------CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-
Confidence 555421 2332221 23444444444444 2444432 36777777777777
Q ss_pred cCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccC
Q 001238 282 SIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGN 361 (1117)
Q Consensus 282 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 361 (1117)
.+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+.
T Consensus 297 ~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp- 366 (754)
T PRK15370 297 TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP- 366 (754)
T ss_pred cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc-
Confidence 3554433 367777777777773 444332 567777777777774 555543 57777777777776 4555442
Q ss_pred CCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCC----cccccceeeccccccc
Q 001238 362 CQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSIS----NCQNLEAVDLSQNGLT 424 (1117)
Q Consensus 362 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~Ls~N~l~ 424 (1117)
++|+.|++++|+|+ .+|..+. ..|+.|++++|+++ .+|..+. .++.+..|++.+|.++
T Consensus 367 -~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 -PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred -CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 56777777777777 3454443 35777777777766 3343322 2244445555555544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-21 Score=232.00 Aligned_cols=159 Identities=28% Similarity=0.463 Sum_probs=76.0
Q ss_pred cceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCC
Q 001238 245 LQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISM 324 (1117)
Q Consensus 245 L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~ 324 (1117)
...|+++++.+.. +|..+. ++|+.|+|++|+|+ .+|..+. ++|++|++++|+++ .+|..+. ++|+.|+|++
T Consensus 180 ~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 3445555555442 343332 34556666666665 3444333 35566666666555 3343332 3455566666
Q ss_pred CcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCC
Q 001238 325 NSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIP 404 (1117)
Q Consensus 325 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 404 (1117)
|++. .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|++++|++++ +|..+. ++|+.|++++|+++. +|
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP 320 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LP 320 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CC
Confidence 6555 3444432 35555555555555 3444332 345555555555552 333221 245555555555542 23
Q ss_pred CCCCcccccceeeccccccc
Q 001238 405 PSISNCQNLEAVDLSQNGLT 424 (1117)
Q Consensus 405 ~~~~~l~~L~~L~Ls~N~l~ 424 (1117)
..+. ++|+.|++++|.++
T Consensus 321 ~~l~--~sL~~L~Ls~N~Lt 338 (754)
T PRK15370 321 ETLP--PGLKTLEAGENALT 338 (754)
T ss_pred cccc--ccceeccccCCccc
Confidence 2221 34444444444444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-19 Score=205.58 Aligned_cols=202 Identities=32% Similarity=0.441 Sum_probs=170.2
Q ss_pred CCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCcc---chHHHHHHHHHHhccCCC-CcceEEeeeecCCceEEEEEe
Q 001238 778 LTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHR-NIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~ 853 (1117)
|.+.+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788999999999999875 78999998765332 356799999999999988 799999999777778999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC-cceeccccccccccCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-ESCLADFGLARLVEDDS 932 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~~~~~~ 932 (1117)
+.++++.+++........+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776542112488899999999999999999999 999999999999999988 79999999998654432
Q ss_pred CCcc--ccCCccccccccCChhhhcc---CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 933 GGSF--SANPQFAGSYGYIAPEYANM---TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 933 ~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.... .......||..|+|||.... ..+....|+||+|++++++++|..||..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2111 13456789999999999987 5788999999999999999999999764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=196.46 Aligned_cols=171 Identities=12% Similarity=0.138 Sum_probs=135.1
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHH---------HHHHHHHHhccCCCCcceEEeeeecC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGA---------FSSEIATLSRIRHRNIVRLLGWGANR 844 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~~~~~~~ 844 (1117)
..++|+..+++|.|+||.||.+.. ++..+|||+++......... +++|++.+.++.||+|+.+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999766 57789999997653333322 68999999999999999999886543
Q ss_pred --------CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc
Q 001238 845 --------KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE 916 (1117)
Q Consensus 845 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 916 (1117)
+..++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 35789999999999987732 232 2456999999999999 999999999999999988
Q ss_pred ceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHH
Q 001238 917 SCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEII 976 (1117)
Q Consensus 917 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell 976 (1117)
++++|||..+....... ...+.....|..++|+|+||+++....
T Consensus 173 i~liDfg~~~~~~e~~a----------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA----------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh----------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998875532110 011444566778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=191.41 Aligned_cols=140 Identities=17% Similarity=0.176 Sum_probs=109.1
Q ss_pred CCeeeecCCeEEEEEEcCCCcEEEEEEeecCCcc--c-------hHH-----------------HHHHHHHHhccCCCCc
Q 001238 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI--S-------TGA-----------------FSSEIATLSRIRHRNI 834 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 834 (1117)
...||+|+||.||+|..++|+.||||+++..... . ..+ ...|++.++++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999754211 1 112 2349999999988877
Q ss_pred ceEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCceeeeccccCeEEEcC
Q 001238 835 VRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGE 913 (1117)
Q Consensus 835 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHrDlkp~Nill~~ 913 (1117)
.....+.. ...++||||++++++....... +.+++.++.+++.|++.+|+|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 44333222 2238999999988775543221 3488999999999999999999 688 999999999999998
Q ss_pred CCcceecccccccccc
Q 001238 914 RYESCLADFGLARLVE 929 (1117)
Q Consensus 914 ~~~~kl~DfGla~~~~ 929 (1117)
++.++++|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-21 Score=232.13 Aligned_cols=255 Identities=21% Similarity=0.243 Sum_probs=185.4
Q ss_pred CCCCeeeecCCeEEEEEEc-CCCcEEEEEEeec---CCccc---hHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 779 TAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRA---SDKIS---TGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 779 ~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
...+++|.|++|.|+.+.. ......+.|.++. ..... ...+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998887653 2344445554431 11111 112556888888899999998888777776666669
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|||++ +|...+... +.+...++..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+....-+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999988775 3478888999999999999999999 9999999999999999999999999999877654
Q ss_pred CCCccccCCccccccccCChhhhccCCCCc-CCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISE-KSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
...........+|+..|+|||.+...+|++ ..||||.|++++.|.+|+.||......++..........
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~---------- 543 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ---------- 543 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccc----------
Confidence 444345666789999999999999999985 689999999999999999999765444332211000000
Q ss_pred CcccCCCCchhHHHHHHH-HhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQA-LGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~-~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......+......+... -.++-.+++.+|.+|-++.+|++
T Consensus 544 -~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 -RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 01111111111111111 13444588999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=184.86 Aligned_cols=140 Identities=19% Similarity=0.198 Sum_probs=111.6
Q ss_pred CCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccc--------------------------hHHHHHHHHHHhccCCCCc
Q 001238 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIS--------------------------TGAFSSEIATLSRIRHRNI 834 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~ni 834 (1117)
...||+|+||.||+|...+|+.||||+++...... ...++.|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999997789999999987642110 1124678999999999987
Q ss_pred ceEEeeeecCCceEEEEEecCCCChhhh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEc
Q 001238 835 VRLLGWGANRKTKLLFYDYMPNGTLGML-LHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 835 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~ 912 (1117)
.....+... ..++||||++++++... +.. ..++..++.+++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 544443332 24899999998865433 332 237788899999999999999999 8 999999999999999
Q ss_pred CCCcceeccccccccccC
Q 001238 913 ERYESCLADFGLARLVED 930 (1117)
Q Consensus 913 ~~~~~kl~DfGla~~~~~ 930 (1117)
++.++|+|||+++....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.2e-19 Score=180.85 Aligned_cols=188 Identities=15% Similarity=0.091 Sum_probs=141.4
Q ss_pred CCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccc----hHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEEe
Q 001238 779 TAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIS----TGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 779 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.+...|++|+||+||.+.. .+++++.+.+....... ...+.+|+++++++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998776 67888888776543211 125889999999995 5889999986 346999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeecc-ccCeEEEcCCCcceeccccccccccCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDV-KSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
++|.+|...... . ...++.|++++++++|++ ||+|||| ||+||+++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998654321 1 134778999999999999 9999999 7999999999999999999998654322
Q ss_pred CC----ccc-----cCCccccccccCChhhhccC-CCC-cCCCeeehhhhHHHHHhCCCCCCC
Q 001238 933 GG----SFS-----ANPQFAGSYGYIAPEYANMT-KIS-EKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 933 ~~----~~~-----~~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.. ... .......++.|++|+...-- ..+ .+.+.++-|..+|.++|++.|+-+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 000 00112367889999855422 233 567888999999999999988743
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-20 Score=176.15 Aligned_cols=164 Identities=33% Similarity=0.524 Sum_probs=106.1
Q ss_pred hcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccch
Q 001238 118 IASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLE 197 (1117)
Q Consensus 118 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 197 (1117)
+..+.+.+.|-||+|+++ .+|..+..|.+|+.|++++|+++ .+|.+++.|++|++|++.-|++. .+|..||.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445667777788888887 67777888888888888888888 78888888888888888888886 6788888888888
Q ss_pred hhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCC
Q 001238 198 AIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYEN 277 (1117)
Q Consensus 198 ~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n 277 (1117)
+|+|..|+.-...+|..|..++.|+-|++++|.+. .+|++++.+++|+.|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-------------------------~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-------------------------ILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-------------------------cCChhhhhhcceeEEeeccC
Confidence 88888776555556655555555555555555443 23334444444444444444
Q ss_pred ccCCcCCccCCCCCCCcEEEccCCcCcccCCcCC
Q 001238 278 ALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPEL 311 (1117)
Q Consensus 278 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~ 311 (1117)
.+- .+|..++.++.|++|++.+|+++ .+|+++
T Consensus 161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel 192 (264)
T KOG0617|consen 161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPEL 192 (264)
T ss_pred chh-hCcHHHHHHHHHHHHhcccceee-ecChhh
Confidence 444 34444444444444444444444 334333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-19 Score=212.91 Aligned_cols=249 Identities=22% Similarity=0.223 Sum_probs=178.3
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC-ccchHHHHHHHHH--HhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD-KISTGAFSSEIAT--LSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.|...+.+|.+.|=+|.+|+++.|. |+||++.+.+ ....+.|.++++- ...++|||.+++.-+-......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677789999999999999998887 9999987654 4455566655544 3445899999998887777788899999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+. .+|.|.+..+ +.+...+.+.|+.|++.|+..+|.. ||+|||||.+|||++.=.-+.|+||.--+...-..
T Consensus 103 vk-hnLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe- 174 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE- 174 (1431)
T ss_pred Hh-hhhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC-
Confidence 84 4788888754 4578888899999999999999999 99999999999999998888999997655332111
Q ss_pred CccccCCcccc----ccccCChhhhccC----------C-CCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHH
Q 001238 934 GSFSANPQFAG----SYGYIAPEYANMT----------K-ISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVR 997 (1117)
Q Consensus 934 ~~~~~~~~~~g----t~~y~aPE~~~~~----------~-~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~ 997 (1117)
+.....+-+.. -..|.|||.+... . .+++.||||+|||+.|+++ |++||.- .+...
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------SQL~a 246 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------SQLLA 246 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------HHHHh
Confidence 11111122222 2369999976431 1 5788999999999999999 8999852 11111
Q ss_pred HHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 998 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
+-.......+.+ +..-.+..++.|+.. |++.||++|-++++.++.
T Consensus 247 -Yr~~~~~~~e~~---Le~Ied~~~Rnlil~------Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 -YRSGNADDPEQL---LEKIEDVSLRNLILS------MIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -HhccCccCHHHH---HHhCcCccHHHHHHH------HHccCchhccCHHHHHHh
Confidence 111111111111 111122345555554 888999999999999886
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-19 Score=202.37 Aligned_cols=185 Identities=26% Similarity=0.305 Sum_probs=156.7
Q ss_pred eeecCCeEEEEEE----cCCCcEEEEEEeecCCccc--hHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEEecCC
Q 001238 784 IGQGRSGIVYKVT----LPSGLTVAVKRFRASDKIS--TGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 784 lg~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+|+|.||.|+.++ ...|..+|+|+.++..... ......|..++...+ ||.+|++.-.+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999864 3347789999886542111 114556888888886 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|.+...+.... .+++.....+...++-|++++|+. +|+|||+|++||+++.+|++++.|||+++..-+..
T Consensus 82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99988887653 367777888889999999999999 99999999999999999999999999998765422
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
..+||..|||||++. ....++|.||||++++||++|..||..
T Consensus 152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 128999999999998 678899999999999999999999964
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-20 Score=174.82 Aligned_cols=166 Identities=33% Similarity=0.557 Sum_probs=141.2
Q ss_pred ccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCc
Q 001238 94 FTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLT 173 (1117)
Q Consensus 94 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~ 173 (1117)
+..+.+.++|.||+|+++ .+|+.|+.|.+|+.|++++|++. ++|.++..+++|+.|+++-|++. .+|..||.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 456788899999999999 88889999999999999999998 89999999999999999999998 9999999999999
Q ss_pred EEeccCCCCCC-CCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeeccc
Q 001238 174 QLFLYDNQLTD-AIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYT 252 (1117)
Q Consensus 174 ~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~ 252 (1117)
.|||.+|++.. .+|..|..+..|+.|+|++|.. ..+|.+++++++|+.|.+.+|.+..
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndf--e~lp~dvg~lt~lqil~lrdndll~------------------- 164 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDF--EILPPDVGKLTNLQILSLRDNDLLS------------------- 164 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCc--ccCChhhhhhcceeEEeeccCchhh-------------------
Confidence 99999999874 6899999999999999999975 5799999999999999999988752
Q ss_pred ccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCC
Q 001238 253 ALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNL 290 (1117)
Q Consensus 253 ~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 290 (1117)
+|.+++.+++|++|.+.+|+++ .+|..++++
T Consensus 165 ------lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 165 ------LPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred ------CcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 3445555555555566666665 555555443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.6e-18 Score=174.52 Aligned_cols=137 Identities=18% Similarity=0.174 Sum_probs=107.1
Q ss_pred CCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhcc-----CCCCcceEEeeeecCC---ceE-E
Q 001238 779 TAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-----RHRNIVRLLGWGANRK---TKL-L 849 (1117)
Q Consensus 779 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~~~-l 849 (1117)
.-.+.||+|+||.||. .-.++.. +||++........+.+.+|+++++.+ .||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 3233444 79988765444567899999999999 5799999999998763 333 7
Q ss_pred EEEe--cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHhccCCCceeeeccccCeEEEcC----CCcceeccc
Q 001238 850 FYDY--MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL-SYLHHDCVPAILHRDVKSHNILLGE----RYESCLADF 922 (1117)
Q Consensus 850 v~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivHrDlkp~Nill~~----~~~~kl~Df 922 (1117)
|||| +++|+|.+++.+.. +++. ..++.+++.++ +|||++ +||||||||+||+++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 66899999997632 5555 35677888777 999999 9999999999999974 347999995
Q ss_pred cccc
Q 001238 923 GLAR 926 (1117)
Q Consensus 923 Gla~ 926 (1117)
+.++
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 5443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-18 Score=186.17 Aligned_cols=201 Identities=21% Similarity=0.313 Sum_probs=131.4
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc---cchHHHHHHHHHHhccCC----------CCcceEEe
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRH----------RNIVRLLG 839 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H----------~niv~l~~ 839 (1117)
..+.+..++.||.|+|+.||.+.+. +|+++|+|++..... ...+++++|.-....+.+ -.++-.++
T Consensus 10 ~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 10 RPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp -EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred CceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 3445566789999999999999854 589999999865432 234567777655555322 12222222
Q ss_pred eee---------cC---C-----ceEEEEEecCCCChhhhhcC---CC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCc
Q 001238 840 WGA---------NR---K-----TKLLFYDYMPNGTLGMLLHD---GE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898 (1117)
Q Consensus 840 ~~~---------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 898 (1117)
... .. . ..+++|+-+ .++|.+++.. .. ....+....+..+..|+++.+++||+. |
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---G 165 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---G 165 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---c
Confidence 211 11 1 235677777 5688777542 11 111244556677889999999999999 9
Q ss_pred eeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhcc--------CCCCcCCCeeehhh
Q 001238 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM--------TKISEKSDVYSYGV 970 (1117)
Q Consensus 899 ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~ 970 (1117)
+||+||||+|++++.+|.++|+||+.....+.. ... ...+..|.+||.... ..++.+.|.|++|+
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCce----eec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999999887765421 111 234578999997644 25788999999999
Q ss_pred hHHHHHhCCCCCCCC
Q 001238 971 VLLEIITGKKPVDAS 985 (1117)
Q Consensus 971 vl~ell~g~~P~~~~ 985 (1117)
++|.|.+|+.||+..
T Consensus 239 ~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLS 253 (288)
T ss_dssp HHHHHHHSS-STCCC
T ss_pred HHHHHHHccCCCCCC
Confidence 999999999999753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=185.76 Aligned_cols=219 Identities=23% Similarity=0.400 Sum_probs=161.1
Q ss_pred HhccCCCCcceEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCce-eeecc
Q 001238 826 LSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI-LHRDV 904 (1117)
Q Consensus 826 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vHrDl 904 (1117)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... -.+++.-...++++++.||+|+|.- +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 457899999999999999999999999999999999998743 2388889999999999999999987 44 99999
Q ss_pred ccCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCC-------CCcCCCeeehhhhHHHHHh
Q 001238 905 KSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK-------ISEKSDVYSYGVVLLEIIT 977 (1117)
Q Consensus 905 kp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~SlG~vl~ell~ 977 (1117)
++.|.++|....+|++|||+....... ..........-..-|.|||.+.... .+.++||||||++++|+++
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~--~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEET--AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccc--ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 999999999999999999998776431 1111222233456799999887631 4678999999999999999
Q ss_pred CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 978 GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 978 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
.+.||+........ .+.+....+ .......|.+.... .... ..+.++..||..+|++||++++|...++.+.
T Consensus 154 r~~~~~~~~~~~~~-~eii~~~~~---~~~~~~rP~i~~~~--e~~~--~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDP-DEIILRVKK---GGSNPFRPSIELLN--ELPP--ELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccCccccccccCCh-HHHHHHHHh---cCCCCcCcchhhhh--hcch--HHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99999764333222 222222222 11122223332111 0111 2334556699999999999999998887765
Q ss_pred cC
Q 001238 1058 QE 1059 (1117)
Q Consensus 1058 ~~ 1059 (1117)
..
T Consensus 226 ~~ 227 (484)
T KOG1023|consen 226 KG 227 (484)
T ss_pred cc
Confidence 54
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-19 Score=206.13 Aligned_cols=88 Identities=26% Similarity=0.303 Sum_probs=38.6
Q ss_pred cCCCCCCCEEEccCCcCCCCCCcccc-----cCCCCceEEccCCcccc----ccchhhhcccccccccccCCcCCCCCC-
Q 001238 479 IGNLKNLNFLDLGSNRLTGSIPDEIT-----GCRNLTFLDVHSNSIAG----NLPAGLHQLVRLQFADLSDNSVGGMLS- 548 (1117)
Q Consensus 479 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~i~~~~~- 548 (1117)
+..+++|++|++++|++++.....+. ..+.|++|++++|.++. .+...+..+++|+++++++|.++....
T Consensus 217 ~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~ 296 (319)
T cd00116 217 LASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQ 296 (319)
T ss_pred hcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHH
Confidence 33445555555555555432222221 12455555555555541 122333444555555555555553321
Q ss_pred ---CCcCCC-ccccEEeccccc
Q 001238 549 ---PDLGSL-SSLTKLVLNKNR 566 (1117)
Q Consensus 549 ---~~~~~l-~~L~~L~L~~N~ 566 (1117)
..+... +.|+.|++.+|.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 297 LLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred HHHHHHhhcCCchhhcccCCCC
Confidence 112222 355555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-17 Score=173.72 Aligned_cols=143 Identities=19% Similarity=0.248 Sum_probs=113.0
Q ss_pred cCCCCCCeeeecCCeEEEEEE--cCCCcEEEEEEeecCCcc------------------------chHHHHHHHHHHhcc
Q 001238 776 RSLTAGNIIGQGRSGIVYKVT--LPSGLTVAVKRFRASDKI------------------------STGAFSSEIATLSRI 829 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 829 (1117)
..|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+.+|++.++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358889999999999999997 568999999998754210 012356899999999
Q ss_pred CCC--CcceEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc-eeeecccc
Q 001238 830 RHR--NIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA-ILHRDVKS 906 (1117)
Q Consensus 830 ~H~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivHrDlkp 906 (1117)
.+. .+++++++ ...++||||++++++....... ...+..++..++.|++.+++|||++ + |+||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 763 34555543 2358999999998887654322 2255667789999999999999999 8 99999999
Q ss_pred CeEEEcCCCcceecccccccccc
Q 001238 907 HNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 907 ~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
+||+++ ++.++++|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999988654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-17 Score=174.77 Aligned_cols=199 Identities=25% Similarity=0.287 Sum_probs=134.8
Q ss_pred CCCCcceEEeeeec---------------------------CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 001238 830 RHRNIVRLLGWGAN---------------------------RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIAL 882 (1117)
Q Consensus 830 ~H~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 882 (1117)
+|||||++.++|.+ ....|+||...+ .+|..++..+. .+...+.-+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 59999999887643 224588997764 58888887653 55677788999
Q ss_pred HHHHHHHHHhccCCCceeeeccccCeEEE--cCCC--cceeccccccccccCCCC--CccccCCccccccccCChhhhcc
Q 001238 883 GVAEGLSYLHHDCVPAILHRDVKSHNILL--GERY--ESCLADFGLARLVEDDSG--GSFSANPQFAGSYGYIAPEYANM 956 (1117)
Q Consensus 883 ~i~~~L~~LH~~~~~~ivHrDlkp~Nill--~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~ 956 (1117)
|+++|+.|||.+ ||.|||+|++|||+ |+|+ ...++|||.+-.-....- ..........|...-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999998 4443 457999998743221000 00111223457778999998865
Q ss_pred CC------CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHh
Q 001238 957 TK------ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALG 1030 (1117)
Q Consensus 957 ~~------~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~ 1030 (1117)
.+ --.|+|.|+.|.+.||++...-||.. .+....+. +. ..+.--|.++...+...+++...
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~---rGem~L~~-r~-------Yqe~qLPalp~~vpp~~rqlV~~-- 492 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK---RGEMLLDT-RT-------YQESQLPALPSRVPPVARQLVFD-- 492 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc---cchheech-hh-------hhhhhCCCCcccCChHHHHHHHH--
Confidence 32 13589999999999999999999964 12111111 11 11111244455555556665554
Q ss_pred HhhhccCCCCCCCCCHHHHHHHH
Q 001238 1031 ISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1031 i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
.++.||.+|++..-....+
T Consensus 493 ----lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 ----LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred ----HhcCCccccCCccHHHhHH
Confidence 7889999999865554444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.6e-17 Score=199.78 Aligned_cols=196 Identities=20% Similarity=0.233 Sum_probs=160.0
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccC---CCCcceEEeeeecCCceEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR---HRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv 850 (1117)
....|.|.+.||+|+||+||+|...+|+.||+|+-+..... +|.--.+++.+|+ -+.|..+..++...+.-++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 34578888999999999999999888999999998766542 2333345555555 34556666666777888999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-------CCcceecccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-------RYESCLADFG 923 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-------~~~~kl~DfG 923 (1117)
+||.+.|+|.+++... +.++|.-++.++.|+++.++.||.. +|||+||||+|++|.. ...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999844 4489999999999999999999999 9999999999999952 3467999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKK 980 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~ 980 (1117)
-+.....-..+ ......++|-.+--+|...++.++..+|.|.++.+++-|+.|++
T Consensus 847 ~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 98655432222 23345678889999999999999999999999999999999985
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=3e-19 Score=203.05 Aligned_cols=139 Identities=22% Similarity=0.289 Sum_probs=87.8
Q ss_pred cCCCCCCCCcEEecCCCccCCc----CCccCCCCCCCcEEEccCCcCccc----CCcCCCCCCCCCEEEcCCCcCCCCCc
Q 001238 261 PELGDCTELQYIYLYENALTGS----IPSKLGNLKNLVNLFLWQNNLVGI----IPPELGNCSQLSIIDISMNSLTGSIP 332 (1117)
Q Consensus 261 ~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~LdLs~N~l~~~~p 332 (1117)
..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+.+. ++..+..+++|++|++++|.+++...
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~ 238 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHH
Confidence 3455566677777777777632 233344556777777777777633 23345667788888888888775322
Q ss_pred cccC-----CCCCcceEecccccccC----cccccccCCCCCcEEEecCccccCC----CCcccccc-cchHHHHhcccc
Q 001238 333 QTLG-----NLTSLQELQLSVNQISG----EIPAQIGNCQRLAQIELDNNQITGA----IPSEFGNL-SNLTLLFVWHNR 398 (1117)
Q Consensus 333 ~~l~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~L~~N~ 398 (1117)
..+. ..+.|++|++++|.++. .+...+..+++|+++++++|.++.. ....+... +.|++|++.+|.
T Consensus 239 ~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 239 AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred HHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 2222 23678888888888762 2334555667888888888888744 23333334 577888877765
Q ss_pred c
Q 001238 399 L 399 (1117)
Q Consensus 399 l 399 (1117)
+
T Consensus 319 ~ 319 (319)
T cd00116 319 F 319 (319)
T ss_pred C
Confidence 3
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=165.57 Aligned_cols=141 Identities=21% Similarity=0.257 Sum_probs=112.2
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCcc----------------------chHHHHHHHHHHhccCC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI----------------------STGAFSSEIATLSRIRH 831 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H 831 (1117)
....|.+.+.||+|+||.||++..++|+.||||++...... ....+..|+.++.++.|
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 33458888999999999999999888999999987643210 01235678999999988
Q ss_pred C--CcceEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeE
Q 001238 832 R--NIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNI 909 (1117)
Q Consensus 832 ~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Ni 909 (1117)
+ .+++.++. ...++||||+++++|...... .....++.++++++.++|+. +|+||||||+||
T Consensus 93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Ni 156 (198)
T cd05144 93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNI 156 (198)
T ss_pred cCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccE
Confidence 7 45555543 345899999999998765431 23457889999999999998 999999999999
Q ss_pred EEcCCCcceeccccccccccC
Q 001238 910 LLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 910 ll~~~~~~kl~DfGla~~~~~ 930 (1117)
++++++.++|+|||.+.....
T Consensus 157 ll~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcCCCcEEEEECCccccCCC
Confidence 999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=167.58 Aligned_cols=134 Identities=19% Similarity=0.300 Sum_probs=113.8
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCcc--------chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI--------STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+.||+|++|.||+|.+ .|..|++|+....... ...++.+|++++..++|++++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6788999986543211 123577899999999999988777777777888999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++|++|.+++.... + ++..++.+++.+++++|+. +++|||++|+||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886531 2 7889999999999999999 999999999999999 78899999999874
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.6e-16 Score=186.16 Aligned_cols=137 Identities=20% Similarity=0.302 Sum_probs=111.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecC--C------ccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRAS--D------KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
..|...+.||+|+||+||+|.+... .+++|+.... . ....+++.+|++++++++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4456789999999999999987443 4444443211 1 11234688999999999999999888877777788
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++++|.+++. ....++.+++++++|||+. +|+|||+||+||++ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988775 3467899999999999999 99999999999999 678999999999975
Q ss_pred c
Q 001238 928 V 928 (1117)
Q Consensus 928 ~ 928 (1117)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-16 Score=192.73 Aligned_cols=152 Identities=30% Similarity=0.461 Sum_probs=94.4
Q ss_pred ccchhHHHHHHHHHhhccCCCCCCCCCCCCCCC--CcceeeEEecCC-----CcEEEEecccccccCcCCccccccccCC
Q 001238 29 YAVNRQGEALLSWKRNWKGSDDGLSNWSPSDET--PCKWFGVSCNLN-----NQVVGLDLRYVDLLGHVPTNFTSLLSLN 101 (1117)
Q Consensus 29 ~~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~~--~C~W~gv~C~~~-----~~v~~l~l~~~~l~~~~~~~~~~l~~L~ 101 (1117)
.+...|..||+++|+++.++. ..+|..+.+. .|.|.||.|+.. .+|..|+|+++++.|.+|..|..+++|+
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~--~~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~ 445 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPL--RFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445 (623)
T ss_pred ccCchHHHHHHHHHHhcCCcc--cCCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence 345678999999999996543 2589742111 127999999532 1366666666666666666666666666
Q ss_pred eEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCC-cCCcEEeccCC
Q 001238 102 RLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNL-SSLTQLFLYDN 180 (1117)
Q Consensus 102 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L-~~L~~L~L~~N 180 (1117)
.|+|++|+++|.+|..++.+++|++|||++|+++|.+|+.+++|++|++|+|++|+++|.+|..++.+ .++..+++.+|
T Consensus 446 ~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N 525 (623)
T PLN03150 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525 (623)
T ss_pred EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCC
Confidence 66666666666666666666666666666666666666666666666666666666666666555542 34455555555
Q ss_pred CC
Q 001238 181 QL 182 (1117)
Q Consensus 181 ~l 182 (1117)
..
T Consensus 526 ~~ 527 (623)
T PLN03150 526 AG 527 (623)
T ss_pred cc
Confidence 43
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.1e-16 Score=163.21 Aligned_cols=130 Identities=22% Similarity=0.382 Sum_probs=106.8
Q ss_pred eeeecCCeEEEEEEcCCCcEEEEEEeecCCc--------cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 783 IIGQGRSGIVYKVTLPSGLTVAVKRFRASDK--------ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.||+|+||.||+|.+ +|..|++|+...... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 678899998654321 11245778999999999887665555555667779999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
+|++|.+++.... . .++.+++.+|+++|+. +++|||++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875431 1 7899999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.1e-17 Score=179.37 Aligned_cols=126 Identities=24% Similarity=0.384 Sum_probs=111.1
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..|+.|++|...+|.+++.+.+.....++.....++.|++.|++| + +.+|||+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999877766678899999999999999999 6 8999999999999999999999999998
Q ss_pred ccccCCCC--CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh
Q 001238 926 RLVEDDSG--GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977 (1117)
Q Consensus 926 ~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~ 977 (1117)
........ ......+...||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 76654331 12334567789999999999999999999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.4e-16 Score=184.46 Aligned_cols=167 Identities=26% Similarity=0.342 Sum_probs=122.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.+|..++.|..|+||.||.++++. .+.+|+|+-+... -.++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCccee-------------------
Confidence 568888999999999999998764 6678885433221 0111 22222333333
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
|+=.+.++.. +.++.+. +.+++|+|+. +|+|||+||+|.+|+.-|++|+.|||+++........
T Consensus 136 --gDc~tllk~~---g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKNI---GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcccC---CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 3434444432 2344332 7899999999 9999999999999999999999999998754321111
Q ss_pred -----------ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 935 -----------SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 935 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
..-...+.+||+.|.|||++..+.|+..+|.|++|+++||.+.|+.||.+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 111234568999999999999999999999999999999999999999764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=9e-15 Score=152.06 Aligned_cols=137 Identities=20% Similarity=0.267 Sum_probs=100.5
Q ss_pred CCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccc--hHH----------------------HHHHHHHHhccCCCC--c
Q 001238 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIS--TGA----------------------FSSEIATLSRIRHRN--I 834 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n--i 834 (1117)
.+.||+|+||+||+|...+|+.||||+++...... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999987542211 111 135666666665443 4
Q ss_pred ceEEeeeecCCceEEEEEecCCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEc
Q 001238 835 VRLLGWGANRKTKLLFYDYMPNGTLGM-LLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 835 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~ 912 (1117)
++.+++ ...++||||++++.+.. .+.... .. .++..++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 455543 24589999999965422 121110 11 5678899999999999999 7 999999999999999
Q ss_pred CCCcceeccccccccccC
Q 001238 913 ERYESCLADFGLARLVED 930 (1117)
Q Consensus 913 ~~~~~kl~DfGla~~~~~ 930 (1117)
++.++++|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=144.13 Aligned_cols=136 Identities=20% Similarity=0.218 Sum_probs=115.4
Q ss_pred CCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCC--CCcceEEeeeecCCceEEEEEecCCC
Q 001238 780 AGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH--RNIVRLLGWGANRKTKLLFYDYMPNG 857 (1117)
Q Consensus 780 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g 857 (1117)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+++++.++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999998744 7899999865433 4678999999999976 59999999888888899999999987
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 858 TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 858 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
.+..+ +......++.+++++++++|....++++|||++|+||++++.+.++++|||.++..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 76543 44667788999999999999864457999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-14 Score=153.66 Aligned_cols=136 Identities=19% Similarity=0.311 Sum_probs=106.6
Q ss_pred CCeee-ecCCeEEEEEEcCCCcEEEEEEeecCC-------------ccchHHHHHHHHHHhccCCCCc--ceEEeeeecC
Q 001238 781 GNIIG-QGRSGIVYKVTLPSGLTVAVKRFRASD-------------KISTGAFSSEIATLSRIRHRNI--VRLLGWGANR 844 (1117)
Q Consensus 781 ~~~lg-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 844 (1117)
...|| .||.|+||.++.. +..+|||++.... .....++.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999999874 7789999885421 1223467889999999998875 6777764433
Q ss_pred Cc----eEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCccee
Q 001238 845 KT----KLLFYDYMPN-GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 845 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
.. .++||||++| .+|.+++... .++.. .+.+++.++.+||+. ||+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 6898887653 24443 356899999999999 9999999999999999999999
Q ss_pred ccccccccc
Q 001238 920 ADFGLARLV 928 (1117)
Q Consensus 920 ~DfGla~~~ 928 (1117)
+|||.++..
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.3e-15 Score=179.10 Aligned_cols=257 Identities=22% Similarity=0.279 Sum_probs=186.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC--CCcEEEEEEeecCC--ccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP--SGLTVAVKRFRASD--KISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 850 (1117)
..|.+.+.||+|+|+.|-..... ....+|+|.+.... .........|..+-+.+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45777788999999999887643 34567777665442 223344556888777776 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-ccCCCceeeeccccCeEEEcCCC-cceeccccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHRDVKSHNILLGERY-ESCLADFGLARLV 928 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~~ 928 (1117)
.||..++++.+-+...... ..+...+..++.|+..++.|+| .. +++|||+||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~~~-~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST-GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCCcc-CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998888322211 2556677789999999999999 77 999999999999999999 9999999999887
Q ss_pred cCCCCCccccCCcccc-ccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 929 EDDSGGSFSANPQFAG-SYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
.... +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...........|..... ..
T Consensus 176 ~~~~-g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~----~~ 250 (601)
T KOG0590|consen 176 RNKN-GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG----RF 250 (601)
T ss_pred cccC-CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc----cc
Confidence 6621 22233345567 9999999988774 4568999999999999999999999765444433333333210 00
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.. ............++.. ++..+|+.|.+.+++..
T Consensus 251 ~~----~~~~~~~~~~~~~l~k------~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 TQ----LPWNSISDQAHDLLHK------ILKENPSNRLSIEELKL 285 (601)
T ss_pred cc----CccccCChhhhhcccc------cccCCchhccccccccc
Confidence 01 1111122222333333 66688999998777644
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.7e-15 Score=163.74 Aligned_cols=213 Identities=34% Similarity=0.500 Sum_probs=133.2
Q ss_pred eEeccCCCCCCCchh--hhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccC
Q 001238 102 RLVLSGTNLTGSIPK--EIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYD 179 (1117)
Q Consensus 102 ~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~ 179 (1117)
+|.|++.++. .+|- .=..|.--...||+.|+++ ++|.+++.+..|+.|.|..|.+. .+|..+++|..|++|||+.
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 3555555554 3331 1134555566777777777 77777777777777777777777 7777777777777777777
Q ss_pred CCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccC
Q 001238 180 NQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQI 259 (1117)
Q Consensus 180 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~ 259 (1117)
|+++ .+|..++.|+ |+.|-+++|++ + .+
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNkl-------------------------~-------------------------~l 158 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNKL-------------------------T-------------------------SL 158 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCcc-------------------------c-------------------------cC
Confidence 7776 4565555544 33333333332 1 23
Q ss_pred CcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCC
Q 001238 260 PPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLT 339 (1117)
Q Consensus 260 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~ 339 (1117)
|+.++.+..|..|+.+.|++. .+|+.++.+.+|+.|.++.|++. .+|+++..| .|..||+|.|++. .+|-.|.+|+
T Consensus 159 p~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~ 234 (722)
T KOG0532|consen 159 PEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMR 234 (722)
T ss_pred CcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhh
Confidence 444444455556666666666 56666777777777777777776 456666633 4667777777777 5677777777
Q ss_pred CcceEecccccccCcccccccCCCC---CcEEEecCcc
Q 001238 340 SLQELQLSVNQISGEIPAQIGNCQR---LAQIELDNNQ 374 (1117)
Q Consensus 340 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~ 374 (1117)
.|++|-|.+|.+. ..|..++-..+ .++|+..-++
T Consensus 235 ~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 235 HLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred hheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 7777777777776 55555543322 3455555553
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-14 Score=160.27 Aligned_cols=176 Identities=28% Similarity=0.416 Sum_probs=136.1
Q ss_pred cccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcE
Q 001238 95 TSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQ 174 (1117)
Q Consensus 95 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~ 174 (1117)
-.++.-...+|+.|++. ++|.++..+..|+.|.|.+|.+. .+|..+++|..|++|||+.|+++ .+|..+..|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 46677788999999998 99999999999999999999998 89999999999999999999999 9999999998 999
Q ss_pred EeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeeccccc
Q 001238 175 LFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTAL 254 (1117)
Q Consensus 175 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~ 254 (1117)
|-+++|+++ .+|+.++.+..|..|+.+.|... ++|..++.+++|+.|.+..|.+.
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~--slpsql~~l~slr~l~vrRn~l~---------------------- 202 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ--SLPSQLGYLTSLRDLNVRRNHLE---------------------- 202 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh--hchHHhhhHHHHHHHHHhhhhhh----------------------
Confidence 999999998 69999999999999999988753 45555555555555555544443
Q ss_pred ccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCc
Q 001238 255 LSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLV 304 (1117)
Q Consensus 255 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 304 (1117)
.+|+++.. -.|..||+++|+++ .+|-.|.+|++|++|.|.+|-+.
T Consensus 203 ---~lp~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 203 ---DLPEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred ---hCCHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 23334432 23555666666665 45555555555555555555554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.8e-13 Score=153.42 Aligned_cols=145 Identities=20% Similarity=0.207 Sum_probs=102.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccch---------------------------------------
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIST--------------------------------------- 816 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------- 816 (1117)
..|. .+.||.|++|.||+|+.++|+.||||+.+.......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 368999999999999999999999999865411000
Q ss_pred -HHHHHHHHHHhccC----CCCcceEEee-eecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHH
Q 001238 817 -GAFSSEIATLSRIR----HRNIVRLLGW-GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE-GLS 889 (1117)
Q Consensus 817 -~~~~~E~~~l~~l~----H~niv~l~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~ 889 (1117)
-.|.+|++.+.+++ |.+-+.+-.. .......++||||++|+++.++...... + . .+.+++.+++. .+.
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~-~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-G-L---DRKALAENLARSFLN 271 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-C-C---CHHHHHHHHHHHHHH
Confidence 02455666666652 3222222222 2223457999999999999887653211 1 2 23456666666 478
Q ss_pred HHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 890 ~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
.+|.. |++|+|+||.||+++++++++++|||++..+.
T Consensus 272 ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88988 99999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=9.4e-13 Score=154.09 Aligned_cols=180 Identities=35% Similarity=0.524 Sum_probs=93.1
Q ss_pred CCcceEecccccccCcccccccCCC-CCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceee
Q 001238 339 TSLQELQLSVNQISGEIPAQIGNCQ-RLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVD 417 (1117)
Q Consensus 339 ~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 417 (1117)
+.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+..++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 44444444444444 3333333332 4444444444444 33334444555555555555554 3333333445555555
Q ss_pred cccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCC
Q 001238 418 LSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTG 497 (1117)
Q Consensus 418 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 497 (1117)
+++|+++ .+|........|++|.+++|++. ..+..+.++..+..+.+.+|++.. .+..++++++++.|++++|.++.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~ 269 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISS 269 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceeccccccccc
Confidence 5555555 34444444444555555555432 234455555556666666666552 24556666666666666666663
Q ss_pred CCCcccccCCCCceEEccCCccccccchh
Q 001238 498 SIPDEITGCRNLTFLDVHSNSIAGNLPAG 526 (1117)
Q Consensus 498 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 526 (1117)
..+ +..+.+++.|++++|.+...++..
T Consensus 270 i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 270 ISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred ccc--ccccCccCEEeccCccccccchhh
Confidence 322 666666666666666666554443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=6e-13 Score=162.46 Aligned_cols=115 Identities=33% Similarity=0.512 Sum_probs=84.6
Q ss_pred ceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch-hhhcccceEEEe
Q 001238 580 KLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF-LAELQNLVVLNV 658 (1117)
Q Consensus 580 ~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~-l~~l~~L~~L~l 658 (1117)
.++.|+|++|.++|.+|..++.+++| +.|+|++|+|+|.+|..+..+++|+.|||++|++++.+|. +..+++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L-~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHL-QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCC-CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 36677777777777777777777777 6777777777777777777788888888888888876665 777888888888
Q ss_pred ecccccCCCCCCc--ccccCCcccccCCCCCCcCC--CCCC
Q 001238 659 SHNNFSGRVPDTP--FFAKLPLSVLSGNPSLCFSG--NQCA 695 (1117)
Q Consensus 659 s~N~l~~~~p~~~--~~~~~~~~~~~gN~~~c~~~--~~c~ 695 (1117)
++|+|+|.+|... .+.++....+.+|+++|+.+ ..|.
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 8888888887642 12344566789999999863 4664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.9e-12 Score=151.46 Aligned_cols=148 Identities=36% Similarity=0.496 Sum_probs=79.5
Q ss_pred EEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCC-CCCEEEcCCCcCCCCCccccCCCCCcceEecccc
Q 001238 271 YIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCS-QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVN 349 (1117)
Q Consensus 271 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N 349 (1117)
.+++..|.+.. .+..+..++.++.|++.+|.++ .+++....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 45555555532 2333444556666666666666 4444555553 6666666666666 44445566666666666666
Q ss_pred cccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeeccccccc
Q 001238 350 QISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLT 424 (1117)
Q Consensus 350 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 424 (1117)
+++ .+|...+.++.|+.|++++|++. .+|........|++|.+++|++. ..+..+.+++++..+.+.+|++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~ 245 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE 245 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee
Confidence 665 44444445556666666666665 34443334444555555555433 23344444555555555555544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.2e-12 Score=132.37 Aligned_cols=156 Identities=21% Similarity=0.335 Sum_probs=117.6
Q ss_pred HHHhccCCCCcceEEeeeecCC-----ceEEEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 001238 824 ATLSRIRHRNIVRLLGWGANRK-----TKLLFYDYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897 (1117)
Q Consensus 824 ~~l~~l~H~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 897 (1117)
.-+-++.|-|||+++.|+.+.. ...++.|||..|++..+|++.+ ....+......+++.||..||.|||+ +.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3455567999999999886643 3578899999999999998753 23346777788999999999999999 588
Q ss_pred ceeeeccccCeEEEcCCCcceeccccccccccCC-CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHH
Q 001238 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDD-SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEII 976 (1117)
Q Consensus 898 ~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell 976 (1117)
.|+|+++..+-|++..+|-+|+.- +.-...... ............+-++|.|||.-.....+.++|||+||+...||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999998888742 111111000 001111222335678999999887778889999999999999999
Q ss_pred hCCCC
Q 001238 977 TGKKP 981 (1117)
Q Consensus 977 ~g~~P 981 (1117)
.+..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 98754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.3e-11 Score=124.28 Aligned_cols=130 Identities=18% Similarity=0.145 Sum_probs=97.7
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCc-ceEEeeeecCCceEEEEEecCCCChh
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNI-VRLLGWGANRKTKLLFYDYMPNGTLG 860 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~ 860 (1117)
+.++.|.++.||+++.. ++.|++|+...... ....+.+|+++++.+.+.++ ++++.+.. ...++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 56899999999999874 77899999765432 23357889999999866554 45555433 3458999999998875
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC--CCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 861 MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC--VPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 861 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
.. . . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~--~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE--D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc--c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 43 0 0 11345678999999999983 12369999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.3e-11 Score=143.05 Aligned_cols=147 Identities=15% Similarity=0.099 Sum_probs=96.6
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCCccc----------------------------------h-
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKIS----------------------------------T- 816 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~- 816 (1117)
..-..|+. +.||.|++|.||+|+.++ |+.||||+.++..... .
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34456776 789999999999999877 9999999997541100 0
Q ss_pred -----HHHHHHHHHHhccC----CCCcceEEeeee-cCCceEEEEEecCCCChhhhh--cCCC-CCCCCCHHHHHHHHHH
Q 001238 817 -----GAFSSEIATLSRIR----HRNIVRLLGWGA-NRKTKLLFYDYMPNGTLGMLL--HDGE-CAGLLEWDTRFKIALG 883 (1117)
Q Consensus 817 -----~~~~~E~~~l~~l~----H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~~ 883 (1117)
-.|.+|+..+.+++ +...+.+-..+. .....++||||++|+.+.++- .... ....+....+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 02445665555553 333333333222 245678999999999997742 2211 0001222223333333
Q ss_pred HHHHHHHHhccCCCceeeeccccCeEEEcCCC----cceeccccccccccC
Q 001238 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERY----ESCLADFGLARLVED 930 (1117)
Q Consensus 884 i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~DfGla~~~~~ 930 (1117)
++.. |++|+|+||.||+++.++ +++++|||++..+..
T Consensus 276 -------if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -------VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3456 999999999999999888 999999999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2e-11 Score=139.37 Aligned_cols=201 Identities=25% Similarity=0.270 Sum_probs=158.0
Q ss_pred cCCCCCCeeee--cCCeEEEEEEc---CCCcEEEEEEeecCC--ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCce
Q 001238 776 RSLTAGNIIGQ--GRSGIVYKVTL---PSGLTVAVKRFRASD--KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~--G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 847 (1117)
..|-+.+.+|. |.+|.||.+.. .++..+|+|+-+..- .....+=.+|+...+++ .|++.|+.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666788999 99999999865 468899999854322 22223335677777777 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHhccCCCceeeeccccCeEEEcCC-Ccceeccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE----GLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADF 922 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~Df 922 (1117)
++-.|++. .++..+.+... ..++....+.+..+..+ |+.++|+. .++|-|+||.||+..++ ..++++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 99999984 77777776543 23677778888888888 99999999 99999999999999999 88999999
Q ss_pred cccccccCCCCCc-cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCC
Q 001238 923 GLARLVEDDSGGS-FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVD 983 (1117)
Q Consensus 923 Gla~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~ 983 (1117)
|+...+.+..-.. ........|...|++||..+ .-++.++|+|++|.++.+..++..+..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 9999887654222 22222336778899999876 678899999999999999999877653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.3e-10 Score=115.67 Aligned_cols=136 Identities=17% Similarity=0.204 Sum_probs=100.5
Q ss_pred CeeeecCCeEEEEEEcCC-------CcEEEEEEeecC-------------Cc---------cchHHHH----HHHHHHhc
Q 001238 782 NIIGQGRSGIVYKVTLPS-------GLTVAVKRFRAS-------------DK---------ISTGAFS----SEIATLSR 828 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~-------------~~---------~~~~~~~----~E~~~l~~ 828 (1117)
..||.|.=+.||.|...+ +..+|||+++.. +. ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 579999988532 00 0112233 79999999
Q ss_pred cCC--CCcceEEeeeecCCceEEEEEecCCCChh-hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCceeeecc
Q 001238 829 IRH--RNIVRLLGWGANRKTKLLFYDYMPNGTLG-MLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDV 904 (1117)
Q Consensus 829 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHrDl 904 (1117)
+.. -++++.+++ ...++||||+.++.+. ..+++. .++..+...+..+++.++.++ |.. +|||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 954 567777765 4568999999765442 223221 245556677889999999999 787 9999999
Q ss_pred ccCeEEEcCCCcceecccccccccc
Q 001238 905 KSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 905 kp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
++.||++++ +.++++|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 679999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.3e-10 Score=130.25 Aligned_cols=168 Identities=19% Similarity=0.244 Sum_probs=130.4
Q ss_pred EcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHH
Q 001238 796 TLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWD 875 (1117)
Q Consensus 796 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~ 875 (1117)
+..++.+|.|..++.......+...+-++.++.+|||||+++++.+..++..|+|+|-+. -|..++++. ...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKE 104 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHH
Confidence 345688899998876655445567788899999999999999999999999999999874 466677653 355
Q ss_pred HHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhc
Q 001238 876 TRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955 (1117)
Q Consensus 876 ~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 955 (1117)
.....+.||+.||.|||.+| +++|++|.-.-|+|++.|+.||++|-++........ ......--..|..|+.+.
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccccchhhhcccChhhcC
Confidence 66778899999999999776 899999999999999999999999998875543211 111222334567777554
Q ss_pred cCCCCcCCCeeehhhhHHHHHhCC
Q 001238 956 MTKISEKSDVYSYGVVLLEIITGK 979 (1117)
Q Consensus 956 ~~~~~~~~Dv~SlG~vl~ell~g~ 979 (1117)
... -..|.|-||+++||++.|.
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCcc
Confidence 322 3569999999999999993
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.9e-12 Score=128.30 Aligned_cols=127 Identities=26% Similarity=0.328 Sum_probs=76.4
Q ss_pred CCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEc
Q 001238 435 KKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDV 514 (1117)
Q Consensus 435 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 514 (1117)
+.|+++||++|.|+ .+.++..-.+.++.|+++.|.|... ..+..+++|+.||||+|.++ .+..+-..+.+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 34444444444444 2333444445555555555555522 23666778888888888887 55566677888888888
Q ss_pred cCCccccccchhhhcccccccccccCCcCCCCCC-CCcCCCccccEEecccccc
Q 001238 515 HSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS-PDLGSLSSLTKLVLNKNRF 567 (1117)
Q Consensus 515 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l 567 (1117)
++|.|... .++..+.+|..||+++|+|..++. ..+++++-|+.+.|.+|.|
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 88888742 456777777888888887765532 2333333344444433333
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.6e-11 Score=143.71 Aligned_cols=219 Identities=28% Similarity=0.352 Sum_probs=143.4
Q ss_pred ccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceec
Q 001238 386 LSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFR 465 (1117)
Q Consensus 386 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 465 (1117)
+..++.+++..|.+.. +-..+..+++|+.|++.+|+|.+ +...+..+.+|++|++++|+|+.+ ..+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhhe
Confidence 4445555555555552 22335566667777777777763 333355667777777777777654 3345556678888
Q ss_pred cCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCC-cccccCCCCceEEccCCccccccchhhhcccccccccccCCcCC
Q 001238 466 ANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIP-DEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG 544 (1117)
Q Consensus 466 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 544 (1117)
+.+|.|+.+ ..+..+++|+.+++++|++..+.+ . ...+.+++.+++.+|.+..+ ..+..+..+..+++..|.+.
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce
Confidence 888888744 356668888999999999885444 2 57788889999999988743 44556666777788889888
Q ss_pred CCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCccc
Q 001238 545 GMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQIC 617 (1117)
Q Consensus 545 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~ 617 (1117)
.+.........+|+.+++++|++.. .+..+..+..+..||+++|++...- .+...+.+ ..++++.|.+.
T Consensus 222 ~~~~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~-~~~~~~~~~~~ 290 (414)
T KOG0531|consen 222 KLEGLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLE--GLERLPKL-SELWLNDNKLA 290 (414)
T ss_pred eccCcccchhHHHHHHhcccCcccc-ccccccccccccccchhhccccccc--cccccchH-HHhccCcchhc
Confidence 7654322222248889999998873 3356677888889999998887322 12223333 45666666654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.8e-10 Score=117.98 Aligned_cols=142 Identities=20% Similarity=0.246 Sum_probs=111.8
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCc-cchHHHHHHHHHHhccCC--CCcceEEeeeecCC---ceEEEEEecC
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRH--RNIVRLLGWGANRK---TKLLFYDYMP 855 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lv~e~~~ 855 (1117)
+.|+.|.++.||++...+|+.+++|+...... .....+..|+++++.+++ ..+++++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999876678999999765432 134578999999999976 44677888766543 5689999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC----------------------------------------
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC---------------------------------------- 895 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------- 895 (1117)
|.++.+.+.. +.++..+...++.++++++.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776532 23677788888999999999998531
Q ss_pred -------------CCceeeeccccCeEEEcC--CCcceecccccccc
Q 001238 896 -------------VPAILHRDVKSHNILLGE--RYESCLADFGLARL 927 (1117)
Q Consensus 896 -------------~~~ivHrDlkp~Nill~~--~~~~kl~DfGla~~ 927 (1117)
...++|+|++|.||++++ ++.+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56678999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-10 Score=132.84 Aligned_cols=246 Identities=20% Similarity=0.225 Sum_probs=173.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc--CCCcEEEEEEeecCCccchHHH--HHHHHHHhcc-CCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL--PSGLTVAVKRFRASDKISTGAF--SSEIATLSRI-RHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 849 (1117)
..+|..+..||.|.|+.|++... .++..|++|.....-....++. ..|+.+...+ .|.++++.+..+..-+..|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 45788889999999999999753 4578899998765433222222 3466666666 58999998888888888889
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-Ccceeccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGLARLV 928 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla~~~ 928 (1117)
--||+++++......- ...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..+
T Consensus 344 p~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence 9999999998766522 23478888999999999999999998 99999999999999886 77889999998643
Q ss_pred cCCCCCccccCCccccccccC--ChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 929 EDDSGGSFSANPQFAGSYGYI--APEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
.... .....+-+++ +++......+-.++|+||||..+.|.+++..--.. . .+|... +
T Consensus 418 ~~~~-------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~---~~~~~i--~----- 476 (524)
T KOG0601|consen 418 AFSS-------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----G---VQSLTI--R----- 476 (524)
T ss_pred ceec-------ccccccccccccchhhccccccccccccccccccccccccCcccCcc----c---ccceee--e-----
Confidence 2211 1112233344 55566667788999999999999999998653211 1 111110 0
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
....+..++.. ...+.+.++ ...+++..||.+.++....+.
T Consensus 477 -~~~~p~~~~~~-~~~q~~~kv------~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 477 -SGDTPNLPGLK-LQLQVLLKV------MINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -cccccCCCchH-Hhhhhhhhh------hcCCccccchhhhhhcccchh
Confidence 01112333333 345555555 677899999998887665443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.6e-10 Score=107.88 Aligned_cols=132 Identities=23% Similarity=0.373 Sum_probs=101.9
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCC--------ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--------KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
..+++|+=+.+|.+.+ -|.++++|.-.++. +-...+-.+|++++.+++--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999977 34456677543221 11123467799999999776666555566777888999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
++|..|.+.+... ...++..+-.-+.-||.. +|||+|+.++||++..++ +.++|||++...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888754 245677788888999999 999999999999998875 889999999753
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.1e-11 Score=138.92 Aligned_cols=226 Identities=26% Similarity=0.300 Sum_probs=110.1
Q ss_pred CCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCc
Q 001238 287 LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLA 366 (1117)
Q Consensus 287 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 366 (1117)
+..+++|+.|++.+|+|..+ ...+..+++|++|||++|.|+... .+..++.|+.|++++|.|+. ...+..+..|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISD--ISGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhheeccCcchh--ccCCccchhhh
Confidence 44444444444444444422 111444555555555555555321 23444445555555555542 12233345555
Q ss_pred EEEecCccccCCCC-cccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCC--CCCeeecc
Q 001238 367 QIELDNNQITGAIP-SEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLK--KLNKLLLL 443 (1117)
Q Consensus 367 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~ 443 (1117)
.+++++|++....+ . ...+.+++.+++..|.+... ..+..+..+..+++..|.++..- .+..+. .|+.++++
T Consensus 166 ~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~ 240 (414)
T KOG0531|consen 166 LLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLS 240 (414)
T ss_pred cccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceecc--CcccchhHHHHHHhcc
Confidence 55555555553332 1 34455555555555555421 22333344444455555555211 122222 25566666
Q ss_pred CccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCC---CCcc-cccCCCCceEEccCCcc
Q 001238 444 SNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGS---IPDE-ITGCRNLTFLDVHSNSI 519 (1117)
Q Consensus 444 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L~Ls~N~l 519 (1117)
+|.+... +..+..+..+..|++.+|++... ..+.....+..+.+..|.+... .... ....+.++.+.+..|.+
T Consensus 241 ~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (414)
T KOG0531|consen 241 GNRISRS-PEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPI 317 (414)
T ss_pred cCccccc-cccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcc
Confidence 6665522 24455556666666666666533 2244445566666666665421 1111 34556777777777777
Q ss_pred ccccch
Q 001238 520 AGNLPA 525 (1117)
Q Consensus 520 ~~~~~~ 525 (1117)
....+.
T Consensus 318 ~~~~~~ 323 (414)
T KOG0531|consen 318 RKISSL 323 (414)
T ss_pred cccccc
Confidence 765443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.1e-11 Score=124.01 Aligned_cols=131 Identities=25% Similarity=0.252 Sum_probs=68.7
Q ss_pred ccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEE
Q 001238 410 CQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLD 489 (1117)
Q Consensus 410 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 489 (1117)
++.|++||||+|.|+ .+..+..-+++++.|++++|.|..+ +.+..+++|+.|||++|.++ .+..+-..+-+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 344445555555544 2444444444555555555555432 22445555555555555555 2233444455666666
Q ss_pred ccCCcCCCCCCcccccCCCCceEEccCCcccccc-chhhhcccccccccccCCcCCCC
Q 001238 490 LGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNL-PAGLHQLVRLQFADLSDNSVGGM 546 (1117)
Q Consensus 490 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~i~~~ 546 (1117)
|+.|.|... ..+..+-+|..||+++|+|.... -..++.++-|+.+.|.+|.+..+
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 666666422 33455556666666666665321 12456666666666666666654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=8.8e-11 Score=146.14 Aligned_cols=231 Identities=23% Similarity=0.245 Sum_probs=103.0
Q ss_pred hhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccc
Q 001238 142 LCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNL 221 (1117)
Q Consensus 142 ~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L 221 (1117)
|..++.|++|||++|.=-+.+|.+|++|-+||+|+|++..++ .+|..+++|++|.+|++..+..+. .+|.-+..+++|
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~-~~~~i~~~L~~L 644 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLE-SIPGILLELQSL 644 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccc-cccchhhhcccc
Confidence 333444444444444433344444444444444444444444 344444444444444444443322 113333334444
Q ss_pred ccccccccc--ccccCCcccccccccceeecccccccccCCcCCCCCCCCc----EEecCCCccCCcCCccCCCCCCCcE
Q 001238 222 VMIGLAETS--ISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQ----YIYLYENALTGSIPSKLGNLKNLVN 295 (1117)
Q Consensus 222 ~~L~l~~~~--~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~ 295 (1117)
++|.+.... .....-..+.+|.+|+.+.+..... .+-..+..++.|. .+.+.++... ..+..++.+.+|+.
T Consensus 645 r~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~ 721 (889)
T KOG4658|consen 645 RVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEE 721 (889)
T ss_pred cEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcce
Confidence 444443322 1112223334444444444433222 1112222333332 3333333333 45566777788888
Q ss_pred EEccCCcCcccCCcCCCCC------CCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEE
Q 001238 296 LFLWQNNLVGIIPPELGNC------SQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIE 369 (1117)
Q Consensus 296 L~L~~n~l~~~~p~~~~~l------~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 369 (1117)
|.+.++.+........... +++..+...++... ..+.+.-..++|+.|++..+.....+......+..++.+.
T Consensus 722 L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i 800 (889)
T KOG4658|consen 722 LSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELI 800 (889)
T ss_pred EEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEE
Confidence 8888777764333222111 12222222222211 1222233446777777777766555555555555566555
Q ss_pred ecCccccCC
Q 001238 370 LDNNQITGA 378 (1117)
Q Consensus 370 L~~N~l~~~ 378 (1117)
+..+.+.+.
T Consensus 801 ~~f~~~~~l 809 (889)
T KOG4658|consen 801 LPFNKLEGL 809 (889)
T ss_pred ecccccccc
Confidence 555555544
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.4e-11 Score=147.33 Aligned_cols=280 Identities=20% Similarity=0.212 Sum_probs=180.4
Q ss_pred chhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCC--cCCCCchhccCCcCCcEEeccCCCCCCCCccccc
Q 001238 114 IPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQ--LEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIG 191 (1117)
Q Consensus 114 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~--l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~ 191 (1117)
+|+ ..+....+...+-+|.+. .++.... .++|++|-+..|. +.-..+..|..++.|++|||++|.=-+.+|..++
T Consensus 516 ~~~-~~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~ 592 (889)
T KOG4658|consen 516 IPQ-VKSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG 592 (889)
T ss_pred ccc-ccchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh
Confidence 443 344467788888888775 4544433 3368888888886 5533445578899999999999988889999999
Q ss_pred CcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeeccccc--ccccCCcCCCCCCCC
Q 001238 192 KLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTAL--LSGQIPPELGDCTEL 269 (1117)
Q Consensus 192 ~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~--l~~~~p~~l~~l~~L 269 (1117)
.|-+|++|++++... ..+|..+++++.|.+|++..+.....+|.....|.+|++|.+.... .....-.++..+.+|
T Consensus 593 ~Li~LryL~L~~t~I--~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L 670 (889)
T KOG4658|consen 593 ELVHLRYLDLSDTGI--SHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHL 670 (889)
T ss_pred hhhhhhcccccCCCc--cccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccch
Confidence 999999999999875 4899999999999999999998877778888889999999997654 222334455666667
Q ss_pred cEEecCCCccCCcCCccCCCCCCCc----EEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCC------
Q 001238 270 QYIYLYENALTGSIPSKLGNLKNLV----NLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLT------ 339 (1117)
Q Consensus 270 ~~L~L~~n~l~~~~p~~l~~l~~L~----~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~------ 339 (1117)
+.|....... .+-..+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++.+............
T Consensus 671 ~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~ 747 (889)
T KOG4658|consen 671 ENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFP 747 (889)
T ss_pred hhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHH
Confidence 6666644333 1112233444443 3343333333 4556778889999999999888743332222211
Q ss_pred CcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcccccccc
Q 001238 340 SLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGE 402 (1117)
Q Consensus 340 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 402 (1117)
++..+...++..- ..+.+..-.++|+.|++..+.....+.+....+..+..+.+..+.+.+.
T Consensus 748 ~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 748 NLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred HHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 2222222222111 1122223456777777777765544444444444454444555555443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.7e-10 Score=115.50 Aligned_cols=122 Identities=30% Similarity=0.397 Sum_probs=39.2
Q ss_pred CCceEEccCCccccccchhhh-cccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEec
Q 001238 508 NLTFLDVHSNSIAGNLPAGLH-QLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDL 586 (1117)
Q Consensus 508 ~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 586 (1117)
++++|+|++|.|+.+ +.+. .+.+|+.|||++|.|+.+. .+..++.|++|++++|+|+...+.....+++|+.|+|
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccccchHHhCCcCCEEEC
Confidence 344444444444422 1222 2344444444444444442 2445566666666666666432221234667777777
Q ss_pred cccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch----hhhcccceEEE
Q 001238 587 SSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF----LAELQNLVVLN 657 (1117)
Q Consensus 587 s~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~----l~~l~~L~~L~ 657 (1117)
++|+|.. +..+ ..+..+++|+.|+|.+|+++..... +..+|+|+.||
T Consensus 96 ~~N~I~~-----l~~l-------------------~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 96 SNNKISD-----LNEL-------------------EPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp TTS---S-----CCCC-------------------GGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred cCCcCCC-----hHHh-------------------HHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 7777751 1111 2345678888888888888765432 67788888887
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.1e-11 Score=128.61 Aligned_cols=192 Identities=21% Similarity=0.233 Sum_probs=98.6
Q ss_pred CCCCCCCCEEEcCCCcCCCCC--ccccCCCCCcceEecccccccCccccc-ccCCCCCcEEEecCccccCCC-Ccccccc
Q 001238 311 LGNCSQLSIIDISMNSLTGSI--PQTLGNLTSLQELQLSVNQISGEIPAQ-IGNCQRLAQIELDNNQITGAI-PSEFGNL 386 (1117)
Q Consensus 311 ~~~l~~L~~LdLs~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~-p~~~~~l 386 (1117)
...|++++.||||.|-+..-. -.....|++|+.|+|+.|.+....... -..++.|+.|.|+.|.++... ......+
T Consensus 142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~f 221 (505)
T KOG3207|consen 142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTF 221 (505)
T ss_pred hhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhC
Confidence 344555566666655554221 122344566666666666654222111 124566777777777766221 1123446
Q ss_pred cchHHHHhccccccccCCCCCCcccccceeecccccccCCCc--ccccCCCCCCeeeccCccCCCCCCCCccccccccee
Q 001238 387 SNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIP--RGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464 (1117)
Q Consensus 387 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 464 (1117)
|+|..|+|..|............++.|+.|||++|++-. .+ .....++.|+.|+++.+.+..+--..-.
T Consensus 222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~-------- 292 (505)
T KOG3207|consen 222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVE-------- 292 (505)
T ss_pred CcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhhccccCcchhcCCCcc--------
Confidence 777777777775332333344456677777777777652 33 2344566666666666666543111110
Q ss_pred ccCCCcccccCCCCcCCCCCCCEEEccCCcCCC-CCCcccccCCCCceEEccCCcccc
Q 001238 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTG-SIPDEITGCRNLTFLDVHSNSIAG 521 (1117)
Q Consensus 465 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~ 521 (1117)
.-.-...+++|++|+++.|++.. ..-+.+..+++|+.|....|.+..
T Consensus 293 ----------s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 293 ----------SLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ----------chhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 00011234556666666666632 111234445566666666666653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.5e-10 Score=114.29 Aligned_cols=125 Identities=28% Similarity=0.351 Sum_probs=41.8
Q ss_pred cccccceeccCCCcccccCCCCcC-CCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhh-hcccccc
Q 001238 457 NCSSLIRFRANSNKLTGFIPPEIG-NLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL-HQLVRLQ 534 (1117)
Q Consensus 457 ~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~ 534 (1117)
+...+++|+|.+|+|+.+ +.++ .+.+|+.|+|++|.|+.. ..+..++.|++|++++|+|+... ..+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~-~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSIS-EGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-C-HHHHHH-TT--
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccc-cchHHhCCcCC
Confidence 334455566666665532 2343 356666777777776633 24556667777777777776432 233 3466777
Q ss_pred cccccCCcCCCCCC-CCcCCCccccEEeccccccCCCC---CcccccccceeEEec
Q 001238 535 FADLSDNSVGGMLS-PDLGSLSSLTKLVLNKNRFAGSI---PSQLGSCVKLQLLDL 586 (1117)
Q Consensus 535 ~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L 586 (1117)
.|++++|+|.++.. ..+..+++|+.|+|.+|.++... ...+..+++|+.||-
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 77777777766543 34566777888888888777431 113456777888774
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.1e-09 Score=103.11 Aligned_cols=143 Identities=21% Similarity=0.238 Sum_probs=106.9
Q ss_pred CCCeeeecCCeEEEEEEcCCCcEEEEEEeecC--------CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 780 AGNIIGQGRSGIVYKVTLPSGLTVAVKRFRAS--------DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 780 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
....+-+|+-+.|+++.+ .|+.+.||.-... .+-..++..+|++.+.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457889999999999988 6778777743221 1223456788999999987666654444566667778999
Q ss_pred EecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC---cceecccccccc
Q 001238 852 DYMPN-GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY---ESCLADFGLARL 927 (1117)
Q Consensus 852 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfGla~~ 927 (1117)
||++| .++.+++....... .+......++..|-+.+.-||.. +|+|+|+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 47777776643322 22333367899999999999999 999999999999997654 347999999864
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3e-11 Score=127.73 Aligned_cols=133 Identities=25% Similarity=0.320 Sum_probs=89.8
Q ss_pred cccccccccCCcCCCCCC----CCcCCCccccEEeccccccCCC----CCcccccccceeEEeccccccccc----cccc
Q 001238 531 VRLQFADLSDNSVGGMLS----PDLGSLSSLTKLVLNKNRFAGS----IPSQLGSCVKLQLLDLSSNQLSGN----IPAS 598 (1117)
Q Consensus 531 ~~L~~L~Ls~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 598 (1117)
+.|+++....|++.+-.. ..|...+.|+.+.+..|.|... ...+|..++.|+.|||..|-|+.. +...
T Consensus 157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Laka 236 (382)
T KOG1909|consen 157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKA 236 (382)
T ss_pred cceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHH
Confidence 456666666666654433 2344556677777777766522 234567778888888888877733 3344
Q ss_pred cCCchhHHHhhcCCCCcccCCcccc----c-cCCCCccEEeccCccccCCcc-----hhhhcccceEEEeeccccc
Q 001238 599 LGKIPALAIALNLSWNQICGELPAE----L-TGLNKLGILDLSHNELSGDLH-----FLAELQNLVVLNVSHNNFS 664 (1117)
Q Consensus 599 l~~l~~l~~~L~Ls~N~l~~~~p~~----l-~~l~~L~~LdLs~N~l~~~~~-----~l~~l~~L~~L~ls~N~l~ 664 (1117)
+..++++ ++|++++|.+...-... + ...++|++|+|.+|.++.+-. .....+.|..|+|++|+|.
T Consensus 237 L~s~~~L-~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 237 LSSWPHL-RELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred hcccchh-eeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 5566766 67888888886643333 2 346899999999999986432 2667899999999999994
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.9e-11 Score=127.00 Aligned_cols=214 Identities=21% Similarity=0.179 Sum_probs=117.0
Q ss_pred cccccceeecccccccccCC--cCCCCCCCCcEEecCCCccCCcCC--ccCCCCCCCcEEEccCCcCcccCCcCC-CCCC
Q 001238 241 LLKRLQTIAIYTALLSGQIP--PELGDCTELQYIYLYENALTGSIP--SKLGNLKNLVNLFLWQNNLVGIIPPEL-GNCS 315 (1117)
Q Consensus 241 ~l~~L~~L~l~~~~l~~~~p--~~l~~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~L~~n~l~~~~p~~~-~~l~ 315 (1117)
++.+|+...+.++.... .+ .....|++++.|+|+.|-+....| .-...|++|+.|+|+.|++........ ..++
T Consensus 119 n~kkL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 34444444444443321 11 355677888888888887764322 334567888888888888763332221 2467
Q ss_pred CCCEEEcCCCcCCCCC-ccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCC-cccccccchHHHH
Q 001238 316 QLSIIDISMNSLTGSI-PQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIP-SEFGNLSNLTLLF 393 (1117)
Q Consensus 316 ~L~~LdLs~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ 393 (1117)
+|+.|.|+.|.++..- -..+..+|+|+.|+|..|............+..|++|+|++|++-...- ...+.++.|..|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 7778888887777321 1223456777778887775333334444456667777777777652211 2345666677777
Q ss_pred hccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCC-CCCCcccccccceeccCCCccc
Q 001238 394 VWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGV-IPPEMGNCSSLIRFRANSNKLT 472 (1117)
Q Consensus 394 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~ 472 (1117)
++.|.+...--... ..+ .-...+++|++|++..|+|..- .-..+..+++|+.|....|.++
T Consensus 278 ls~tgi~si~~~d~------~s~------------~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 278 LSSTGIASIAEPDV------ESL------------DKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ccccCcchhcCCCc------cch------------hhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 77766653321111 000 0012244555555555555321 0122334556666666667665
Q ss_pred c
Q 001238 473 G 473 (1117)
Q Consensus 473 ~ 473 (1117)
.
T Consensus 340 ~ 340 (505)
T KOG3207|consen 340 K 340 (505)
T ss_pred c
Confidence 3
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.5e-10 Score=122.61 Aligned_cols=224 Identities=20% Similarity=0.224 Sum_probs=124.2
Q ss_pred cCCCCCCCcEEEccCCcCccc----CCcCCCCCCCCCEEEcCCCcC---CCCCcc-------ccCCCCCcceEecccccc
Q 001238 286 KLGNLKNLVNLFLWQNNLVGI----IPPELGNCSQLSIIDISMNSL---TGSIPQ-------TLGNLTSLQELQLSVNQI 351 (1117)
Q Consensus 286 ~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~LdLs~N~l---~~~~p~-------~l~~l~~L~~L~Ls~N~l 351 (1117)
.+..+..++.++|++|.+... +...+.+.++|+..++|.=.. ...+|. .+-..++|++|+||.|.|
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 345566777888888877532 233455667777777765321 122332 233345677777777766
Q ss_pred cCccccc----ccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCC-
Q 001238 352 SGEIPAQ----IGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP- 426 (1117)
Q Consensus 352 ~~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~- 426 (1117)
.-..+.. +.++..|++|.|.||.+.-.-...++ ..|..|. .|+. ...-+.|+++...+|++...
T Consensus 105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~g 173 (382)
T KOG1909|consen 105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNKK-------AASKPKLRVFICGRNRLENGG 173 (382)
T ss_pred CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHhc-------cCCCcceEEEEeecccccccc
Confidence 5333332 23455666666666655421111111 1234333 2221 23346789999999988642
Q ss_pred ---CcccccCCCCCCeeeccCccCCCCC----CCCcccccccceeccCCCccccc----CCCCcCCCCCCCEEEccCCcC
Q 001238 427 ---IPRGIFQLKKLNKLLLLSNNLSGVI----PPEMGNCSSLIRFRANSNKLTGF----IPPEIGNLKNLNFLDLGSNRL 495 (1117)
Q Consensus 427 ---~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l 495 (1117)
+...|...+.|+.+.++.|.|.... ...|..|++|+.|||..|.++.. +...+..+++|++|++++|.+
T Consensus 174 a~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll 253 (382)
T KOG1909|consen 174 ATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLL 253 (382)
T ss_pred HHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccc
Confidence 2233445678888888888876321 12455667777777777766532 223455556666777777666
Q ss_pred CCCCCcccc-----cCCCCceEEccCCccc
Q 001238 496 TGSIPDEIT-----GCRNLTFLDVHSNSIA 520 (1117)
Q Consensus 496 ~~~~p~~~~-----~l~~L~~L~Ls~N~l~ 520 (1117)
...-..+|. ..++|+.|.|.+|.|+
T Consensus 254 ~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 254 ENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred ccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 543333321 2456666666666665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.2e-08 Score=104.08 Aligned_cols=126 Identities=24% Similarity=0.309 Sum_probs=84.3
Q ss_pred EEEEEEcCCCcEEEEEEeecCC-------------cc--------c-----hHHHHHHHHHHhccCCC--CcceEEeeee
Q 001238 791 IVYKVTLPSGLTVAVKRFRASD-------------KI--------S-----TGAFSSEIATLSRIRHR--NIVRLLGWGA 842 (1117)
Q Consensus 791 ~Vy~~~~~~~~~vavK~~~~~~-------------~~--------~-----~~~~~~E~~~l~~l~H~--niv~l~~~~~ 842 (1117)
.||.|...+|..||||+.+... .. . ....++|++.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999885420 00 0 12357799999999765 567777653
Q ss_pred cCCceEEEEEecC--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HhccCCCceeeeccccCeEEEcCCCccee
Q 001238 843 NRKTKLLFYDYMP--NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY-LHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 843 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
..++||||++ |..+..+.... ++......++.+++..+.. +|.. ||||+|+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 3479999998 65555443322 1123455677788886666 4677 99999999999999988 9999
Q ss_pred cccccccccc
Q 001238 920 ADFGLARLVE 929 (1117)
Q Consensus 920 ~DfGla~~~~ 929 (1117)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.5e-09 Score=129.88 Aligned_cols=205 Identities=23% Similarity=0.244 Sum_probs=147.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.+.+.+.+.+-.|.++.++.++- ..|-..++|+...... ...+...++-.+.-..+||-+++...-+.-....++|
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45677778889999999998753 2343444444332211 1112222232333333456666665555567788999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
++|..++++...++... ..+.+.+......+..+.+|||.. .+.|||++|.|.+...+++.+++|||.......
T Consensus 883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999888753 355666677778889999999998 799999999999999999999999984432221
Q ss_pred CCC---------------------------CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCC
Q 001238 931 DSG---------------------------GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVD 983 (1117)
Q Consensus 931 ~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~ 983 (1117)
... ..........||+.|.+||...+......+|.|+.|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 100 00012334679999999999999999999999999999999999999997
Q ss_pred CC
Q 001238 984 AS 985 (1117)
Q Consensus 984 ~~ 985 (1117)
..
T Consensus 1037 a~ 1038 (1205)
T KOG0606|consen 1037 AE 1038 (1205)
T ss_pred Cc
Confidence 64
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.3e-09 Score=79.75 Aligned_cols=40 Identities=40% Similarity=0.962 Sum_probs=29.8
Q ss_pred hhHHHHHHHHHhhccC-CCCCCCCCCCCC-CCCcceeeEEec
Q 001238 32 NRQGEALLSWKRNWKG-SDDGLSNWSPSD-ETPCKWFGVSCN 71 (1117)
Q Consensus 32 ~~~~~aLl~~k~~~~~-~~~~l~sW~~~~-~~~C~W~gv~C~ 71 (1117)
+.|++||++||+++.+ +...+++|+... .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 5799999999999985 446799999764 789999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.4e-08 Score=105.51 Aligned_cols=141 Identities=15% Similarity=0.157 Sum_probs=100.8
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCcc-----------chHHHHHHHHHHhccCCCCc--ceEEeeeec-----
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI-----------STGAFSSEIATLSRIRHRNI--VRLLGWGAN----- 843 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~----- 843 (1117)
+.+-+.....|+++.. +|+.|.||+....... ....+.+|.+.+.++...+| ++.++++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667766 6788999977543211 11147899999988854443 344555543
Q ss_pred CCceEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-------CC
Q 001238 844 RKTKLLFYDYMPNG-TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-------RY 915 (1117)
Q Consensus 844 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-------~~ 915 (1117)
....++|||++++. +|.+++.... ....+...+..++.+++..+.-||.. ||+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23468999999986 8988875421 12255677788999999999999999 9999999999999985 46
Q ss_pred cceecccccccc
Q 001238 916 ESCLADFGLARL 927 (1117)
Q Consensus 916 ~~kl~DfGla~~ 927 (1117)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 789999998864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.3e-07 Score=99.66 Aligned_cols=195 Identities=16% Similarity=0.271 Sum_probs=129.3
Q ss_pred CCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEe------eeecCCc-eEE
Q 001238 778 LTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLG------WGANRKT-KLL 849 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~------~~~~~~~-~~l 849 (1117)
...++.||+|+-+.+|-... -+..+-|++.........+ -++.|.+. .||-+-.-+. ++.++.. ..+
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34567899999999997432 1234557776543322222 23333343 5664433121 1223333 567
Q ss_pred EEEecCCCC-hhhhhc---CCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 850 FYDYMPNGT-LGMLLH---DGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 850 v~e~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
.|..+++.- ..++.. +........|.-.+++++.+|.+.+.||.. |.+-+|+.++|+|+++++.+.+.|-.--
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 888877642 222221 122223478999999999999999999999 9999999999999999999999874322
Q ss_pred ccccCCCCCccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhC-CCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITG-KKPVDAS 985 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g-~~P~~~~ 985 (1117)
..... + ......+|...|.+||.-. +...+...|-|.+||++++++.| +.||.+.
T Consensus 165 qi~~n---g--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 165 QINAN---G--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeccC---C--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 22111 1 1222347889999999654 34557789999999999999996 9999764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=8.6e-08 Score=99.70 Aligned_cols=136 Identities=24% Similarity=0.309 Sum_probs=97.9
Q ss_pred CCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC----------------------ccchHHHHHHHHHHhccCCC--C
Q 001238 778 LTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD----------------------KISTGAFSSEIATLSRIRHR--N 833 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~H~--n 833 (1117)
..++.+||.|.=+.||.|..++|.++|||.-+... ..+....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678899999999999999999999999543210 01122457899999999654 7
Q ss_pred cceEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC
Q 001238 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE 913 (1117)
Q Consensus 834 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~ 913 (1117)
+++.+++ +...+||||++|-.|...-- +.+..-.++..|++-+..+-.. ||||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 7777765 44579999999866654321 1222233444444444444455 9999999999999999
Q ss_pred CCcceeccccccccc
Q 001238 914 RYESCLADFGLARLV 928 (1117)
Q Consensus 914 ~~~~kl~DfGla~~~ 928 (1117)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.3e-08 Score=82.30 Aligned_cols=58 Identities=40% Similarity=0.568 Sum_probs=24.0
Q ss_pred cceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCc
Q 001238 461 LIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNS 518 (1117)
Q Consensus 461 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 518 (1117)
|++|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3334444444443333344444444444444444443333444444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.4e-08 Score=82.19 Aligned_cols=15 Identities=40% Similarity=0.576 Sum_probs=5.4
Q ss_pred cccccceeEEecccc
Q 001238 575 LGSCVKLQLLDLSSN 589 (1117)
Q Consensus 575 ~~~l~~L~~L~Ls~N 589 (1117)
|..+++|+.|++++|
T Consensus 45 f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 45 FSNLPNLRYLDLSNN 59 (61)
T ss_dssp TTTSTTESEEEETSS
T ss_pred HcCCCCCCEEeCcCC
Confidence 333333333333333
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.4e-09 Score=122.54 Aligned_cols=127 Identities=26% Similarity=0.269 Sum_probs=96.5
Q ss_pred CCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEecc
Q 001238 484 NLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLN 563 (1117)
Q Consensus 484 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~ 563 (1117)
.|...+.++|++. ....++.-++.|+.|||++|+++... .+..++.|++|||++|.+..++.....++. |..|.++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4788899999998 66777888899999999999998653 788999999999999999988776666665 9999999
Q ss_pred ccccCCCCCcccccccceeEEeccccccccccc-cccCCchhHHHhhcCCCCccc
Q 001238 564 KNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP-ASLGKIPALAIALNLSWNQIC 617 (1117)
Q Consensus 564 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~l~~~L~Ls~N~l~ 617 (1117)
||.++.. ..+.++.+|+.||||+|-|.+.-. .-++.+..| +.|+|.||.+.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L-~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSL-IVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHH-HHHhhcCCccc
Confidence 9998742 346788899999999999884321 112223333 45555555554
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.52 E-value=5.2e-07 Score=100.87 Aligned_cols=167 Identities=20% Similarity=0.273 Sum_probs=125.3
Q ss_pred eEEEEEE-cCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeec----CCceEEEEEecCC-CChhhhh
Q 001238 790 GIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN----RKTKLLFYDYMPN-GTLGMLL 863 (1117)
Q Consensus 790 g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~l 863 (1117)
.+.|++. ..||..|++|++..........-..-+++++++.|+|||++.+++.. +...++||+|.|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 4678886 45899999999955443333334456889999999999999998763 3457899999986 5666544
Q ss_pred cCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 864 HDGE------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 864 ~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
.... .....+++..|.++.|+..||.++|+. |+.-+-+.|.+|+++++.+++|+..|+...+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 3221 122367889999999999999999999 9999999999999999999999888887665432
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKK 980 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~ 980 (1117)
... .-|. -.+-|.=.+|.++..|.||..
T Consensus 447 ~~~---------------~le~------~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PTE---------------PLES------QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCc---------------chhH------HhhhhHHHHHHHHHHHhhccc
Confidence 200 0011 135677789999999999954
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=5e-07 Score=105.97 Aligned_cols=141 Identities=21% Similarity=0.256 Sum_probs=94.5
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCccch------------------------------H----------HHHH
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIST------------------------------G----------AFSS 821 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 821 (1117)
+.|+.++-|.||+|++++|+.||||+.++.-.... + .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999998865311000 0 1445
Q ss_pred HHHHHhccC-----CCCcceEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHhccC
Q 001238 822 EIATLSRIR-----HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEG-LSYLHHDC 895 (1117)
Q Consensus 822 E~~~l~~l~-----H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~ 895 (1117)
|+..+.+++ .|.+.-..=|..-.....++|||++|-.+.+...-.. .+ .+... ++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g-~d~k~---ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AG-IDRKE---LAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cC-CCHHH---HHHHHHHHHHHHHHhc-
Confidence 666665552 2333211112333466799999999999888743322 12 44322 33333332 2233334
Q ss_pred CCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 896 ~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|+.|.|..|.||+++.+|++.+.|||+...+.+
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999987754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.9e-06 Score=86.92 Aligned_cols=140 Identities=14% Similarity=0.083 Sum_probs=102.9
Q ss_pred eeecCCeEEEEEEcCCCcEEEEEEeecC-----C-ccchHHHHHHHHHHhccCCC--CcceEEeeeec--C--CceEEEE
Q 001238 784 IGQGRSGIVYKVTLPSGLTVAVKRFRAS-----D-KISTGAFSSEIATLSRIRHR--NIVRLLGWGAN--R--KTKLLFY 851 (1117)
Q Consensus 784 lg~G~fg~Vy~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~--~--~~~~lv~ 851 (1117)
-|+||-+.|++... +|..+-+|+-... . +.....|.+|+..+.++..- .+++...+... + ...++|+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 36689999999876 4447888876421 1 23456799999999999533 34555522222 1 2357999
Q ss_pred EecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc--ceeccccccccc
Q 001238 852 DYMPN-GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE--SCLADFGLARLV 928 (1117)
Q Consensus 852 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~DfGla~~~ 928 (1117)
|-+++ -+|.+++..... ...+...+..+..+++..++-||+. |+.|+|+.+.||+++.++. ++++||--++..
T Consensus 105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 97754 588888865432 2367788889999999999999999 9999999999999986666 899999877643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.2e-06 Score=92.01 Aligned_cols=107 Identities=25% Similarity=0.336 Sum_probs=85.2
Q ss_pred hHHHHHHHHHHhccCCCC--cceEEeeeecCC----ceEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 001238 816 TGAFSSEIATLSRIRHRN--IVRLLGWGANRK----TKLLFYDYMPNG-TLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888 (1117)
Q Consensus 816 ~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L 888 (1117)
..+..+|.+.+.++...+ +++.+++..... ..++|+|++++. +|.+++..... .+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 446788999988885443 456666665432 348999999884 79998876322 45667788999999999
Q ss_pred HHHhccCCCceeeeccccCeEEEcCCC---cceeccccccccc
Q 001238 889 SYLHHDCVPAILHRDVKSHNILLGERY---ESCLADFGLARLV 928 (1117)
Q Consensus 889 ~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfGla~~~ 928 (1117)
+-||+. ||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999887 8899999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=7.1e-09 Score=118.75 Aligned_cols=127 Identities=30% Similarity=0.308 Sum_probs=68.8
Q ss_pred CCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecc
Q 001238 508 NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLS 587 (1117)
Q Consensus 508 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 587 (1117)
.|...+.++|.+. .+-.++.-++.|+.|||++|++.++. .+..++.|++|||+.|+++...--....+. |+.|.++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 3555666666666 34445555666666666666666553 445555555555555555532221222222 5555555
Q ss_pred ccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccC--CcchhhhcccceEEEeecccccC
Q 001238 588 SNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSG--DLHFLAELQNLVVLNVSHNNFSG 665 (1117)
Q Consensus 588 ~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~--~~~~l~~l~~L~~L~ls~N~l~~ 665 (1117)
+|.++ .. ..+.+|++|+-||||+|-|.+ +..+++.|.+|+.|+|.+|.+.+
T Consensus 241 nN~l~-------------------------tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 241 NNALT-------------------------TL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ccHHH-------------------------hh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 55554 21 134455566666666666665 33446666666666666666653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.1e-08 Score=92.15 Aligned_cols=125 Identities=26% Similarity=0.357 Sum_probs=83.9
Q ss_pred EEeccccccCCCCCcc---cccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEec
Q 001238 559 KLVLNKNRFAGSIPSQ---LGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDL 635 (1117)
Q Consensus 559 ~L~L~~N~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdL 635 (1117)
.++|+++.|. .++++ +.....|+..+|++|.+. ..|..|.......+.|||++|.|+ .+|.++..|+.|+.|++
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 3444544443 23332 334456777788888887 666666665544478888888888 67777888888888888
Q ss_pred cCccccCCcchhhhcccceEEEeecccccCCCCCCcccccCCcc-cccCCCCC
Q 001238 636 SHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLS-VLSGNPSL 687 (1117)
Q Consensus 636 s~N~l~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~-~~~gN~~~ 687 (1117)
+.|++.-.+..+..|.+|..||.-+|.+- .||...+..+.+.. .+..+||-
T Consensus 108 ~~N~l~~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~ 159 (177)
T KOG4579|consen 108 RFNPLNAEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLG 159 (177)
T ss_pred ccCccccchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCccc
Confidence 88888887777777888888888888765 45544444444433 35555654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.4e-06 Score=89.75 Aligned_cols=133 Identities=14% Similarity=0.142 Sum_probs=87.3
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCC--cceEEeeeecCCceEEEEEecCCCC-
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRN--IVRLLGWGANRKTKLLFYDYMPNGT- 858 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 858 (1117)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +++.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24567888876532 3456789999999986433 5778888877778889999999863
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHH---------------------------------------HHHhcc-CCCc
Q 001238 859 LGMLLHDGECAGLLEWDTRFKIALGVAEGL---------------------------------------SYLHHD-CVPA 898 (1117)
Q Consensus 859 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L---------------------------------------~~LH~~-~~~~ 898 (1117)
+...+.. +......++.++++.+ ++|... ..+.
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2211110 0011111111122211 122111 1246
Q ss_pred eeeeccccCeEEEcCCCcceecccccccc
Q 001238 899 ILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 899 ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++|+|+.|.||++++++ +.++||+.+..
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 78999999999999888 89999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1117 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-52 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-52 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-31 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-25 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-16 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 8e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-09 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 9e-09 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 8e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-07 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-07 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 6e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-07 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 6e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 6e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-07 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 8e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 5e-06 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 6e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 4e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-04 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 5e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 5e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-04 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 594 bits (1533), Expect = 0.0
Identities = 188/622 (30%), Positives = 291/622 (46%), Gaps = 23/622 (3%)
Query: 79 LDLRYVDLLGHVPT-NFTSLLSLNRLVLSGTNLTGSIPKEIA---SLNQLNYLDLSENSL 134
L++ L L SL L LS +++G+ +L +L +S N +
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190
Query: 135 TGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLK 194
+G++ + + LE L ++SN IP +G+ S+L L + N+L+ I
Sbjct: 191 SGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCT 247
Query: 195 NLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTL-GLLKRLQTIAIYTA 253
L+ + N G +P +L + LAE +G +P L G L + +
Sbjct: 248 ELKLLNISSN-QFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 254 LLSGQIPPELGDCTELQYIYLYENALTGSIP-SKLGNLKNLVNLFLWQNNLVGIIPPELG 312
G +PP G C+ L+ + L N +G +P L ++ L L L N G +P L
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364
Query: 313 NCS-QLSIIDISMNSLTGSIPQTLGN--LTSLQELQLSVNQISGEIPAQIGNCQRLAQIE 369
N S L +D+S N+ +G I L +LQEL L N +G+IP + NC L +
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 370 LDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPR 429
L N ++G IPS G+LS L L +W N LEGEIP + + LE + L N LTG IP
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
Query: 430 GIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLD 489
G+ LN + L +N L+G IP +G +L + ++N +G IP E+G+ ++L +LD
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD 544
Query: 490 LGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSV--GGML 547
L +N G+IP + + +N IAG + + + N + G+
Sbjct: 545 LNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600
Query: 548 SPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAI 607
S L LS+ + + G + + LD+S N LSG IP +G +P L
Sbjct: 601 SEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL-F 659
Query: 608 ALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDL-HFLAELQNLVVLNVSHNNFSGR 666
LNL N I G +P E+ L L ILDLS N+L G + ++ L L +++S+NN SG
Sbjct: 660 ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 719
Query: 667 VPDTPFFAKLPLSVLSGNPSLC 688
+P+ F P + NP LC
Sbjct: 720 IPEMGQFETFPPAKFLNNPGLC 741
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 551 bits (1423), Expect = 0.0
Identities = 181/681 (26%), Positives = 296/681 (43%), Gaps = 64/681 (9%)
Query: 23 LFPHTPYAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLR 82
++ R+ L+S+K + L +WS + + PC + GV+C +++V +DL
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLP-DKNLLPDWSSN-KNPCTFDGVTCR-DDKVTSIDLS 58
Query: 83 YVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPREL 142
L ++ + SL L L LS + + G +
Sbjct: 59 SKPL---------------------NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GF 96
Query: 143 CSLLRLEQLRLNSNQLEGAIP--IQIGNLSSLTQLFLYDNQLTDAIPATIG-KLKNLEAI 199
L L L+ N L G + +G+ S L L + N L + G KL +LE +
Sbjct: 97 KCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156
Query: 200 RAGGNKNLGGSLPHEI---GNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLS 256
N ++ G+ C L + ++ ISG + + L+ + + + S
Sbjct: 157 DLSAN-SISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFS 213
Query: 257 GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ 316
I P LGDC+ LQ++ + N L+G + L L + N VG IPP
Sbjct: 214 TGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKS 270
Query: 317 LSIIDISMNSLTGSIPQTL-GNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQI 375
L + ++ N TG IP L G +L L LS N G +P G+C L + L +N
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330
Query: 376 TGAIPSE-FGNLSNLTLLFVWHNRLEGEIPPSISNC-QNLEAVDLSQNGLTGPIPRGIFQ 433
+G +P + + L +L + N GE+P S++N +L +DLS N +GPI + Q
Sbjct: 331 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 390
Query: 434 --LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLG 491
L +L L +N +G IPP + NCS L+ + N L+G IP +G+L L L L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 492 SNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDL 551
N L G IP E+ + L L + N + G +P+GL L + LS+N + G + +
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
Query: 552 GSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNL 611
G L +L L L+ N F+G+IP++LG C L LDL++N +G IPA++ K A +
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570
Query: 612 S---------------------WNQICGELPAELTGLNKLGILDLSHNELSGDL-HFLAE 649
+ + G +L L+ +++ G
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 650 LQNLVVLNVSHNNFSGRVPDT 670
+++ L++S+N SG +P
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKE 651
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 6e-64
Identities = 92/308 (29%), Positives = 146/308 (47%), Gaps = 17/308 (5%)
Query: 384 GNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLL 443
++++ L N + S+ + LE++ LS + + G + G L L L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 444 SNNLSGVIPP--EMGNCSSLIRFRANSNKLTGFIP-PEIGNLKNLNFLDLGSNRLTGSIP 500
N+LSG + +G+CS L +SN L L +L LDL +N ++G+
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 501 DEIT---GCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSL 557
GC L L + N I+G++ + V L+F D+S N+ + P LG S+L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGI-PFLGDCSAL 225
Query: 558 TKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQIC 617
L ++ N+ +G + +C +L+LL++SSNQ G IP + +L L+L+ N+
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQY-LSLAENKFT 282
Query: 618 GELPAELTG-LNKLGILDLSHNELSGDL-HFLAELQNLVVLNVSHNNFSGRVPDTPFFAK 675
GE+P L+G + L LDLS N G + F L L +S NNFSG +P K
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP-MDTLLK 341
Query: 676 LP-LSVLS 682
+ L VL
Sbjct: 342 MRGLKVLD 349
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-24
Identities = 38/138 (27%), Positives = 60/138 (43%), Gaps = 1/138 (0%)
Query: 75 QVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSL 134
+ ++ G L + N ++ G + + +LD+S N L
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
Query: 135 TGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLK 194
+G IP+E+ S+ L L L N + G+IP ++G+L L L L N+L IP + L
Sbjct: 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 704
Query: 195 NLEAIRAGGNKNLGGSLP 212
L I N NL G +P
Sbjct: 705 MLTEIDLSNN-NLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 7e-18
Identities = 37/107 (34%), Positives = 58/107 (54%), Gaps = 1/107 (0%)
Query: 74 NQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENS 133
++ LD+ Y L G++P S+ L L L +++GSIP E+ L LN LDLS N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691
Query: 134 LTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDN 180
L G IP+ + +L L ++ L++N L G IP ++G + +N
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIP-EMGQFETFPPAKFLNN 737
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 387 bits (995), Expect = e-121
Identities = 110/672 (16%), Positives = 202/672 (30%), Gaps = 121/672 (18%)
Query: 33 RQGEALLSWKR-----NWKGSDDG---LSNWSPSDETPCKW---FGVSCNLNNQVVGLDL 81
+ AL NW G +NW+ + E W GVS N N +V GL L
Sbjct: 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKE-LDMWGAQPGVSLNSNGRVTGLSL 88
Query: 82 RYVDLLGHVPTNFTSLLSLNRLVLSGTNLTG----SIPKEIASLNQLNYLDLSENSLTGE 137
G VP L L L L PK I++
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148
Query: 138 IPREL--CSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKN 195
L + +NS+ + +I TQ+ N +T
Sbjct: 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT------------ 196
Query: 196 LEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALL 255
+ + T L + + + +
Sbjct: 197 --------------FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA-----QQ 237
Query: 256 SGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGI--------I 307
+ + +L + +Y +P+ L L + + + N +
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297
Query: 308 PPELGNCSQLSIIDISMNSLT-GSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLA 366
+ ++ II I N+L + +L + L L+ NQ+ G++PA G+ +LA
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLA 356
Query: 367 QIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPP--SISNCQNLEAVDLSQNGLT 424
+ L NQIT + G + L HN+L+ IP + + A+D S N +
Sbjct: 357 SLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIG 415
Query: 425 GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKN 484
+ + P ++ ++N+++ F
Sbjct: 416 S-----------------VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 485 LNFLDLGSNRLTG-------SIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFAD 537
L+ ++L N LT + LT +D+ N + L
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFR--------- 508
Query: 538 LSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLL------DLSSNQL 591
+L L + L+ N F P+Q + L+ D N+
Sbjct: 509 -------------ATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRT 554
Query: 592 SGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSG-DLHFLAEL 650
P + P+L L + N I ++ ++ + +LD+ N DL ++
Sbjct: 555 LREWPEGITLCPSLTQ-LQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISIDLSYVCPY 610
Query: 651 QNLVVLNVSHNN 662
+ + ++
Sbjct: 611 IEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 310 bits (795), Expect = 6e-93
Identities = 80/472 (16%), Positives = 151/472 (31%), Gaps = 43/472 (9%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEI 138
+ + + L ++ N+T + K + L +L + + E
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 139 PRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEA 198
E E + ++ NL LT + +Y+ +P + L ++
Sbjct: 223 ICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 199 IRAGGNKNLG-------GSLPHEIGNCTNLVMIGLAETSI-SGFLPPTLGLLKRLQTIAI 250
I N+ + + + +I + ++ + + +L +K+L +
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337
Query: 251 YTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPP- 309
L G P G +L + L N +T + G + + NL N L I
Sbjct: 338 LYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIF 396
Query: 310 ELGNCSQLSIIDISMNSLTG-------SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNC 362
+ + S +S ID S N + + T ++ + LS NQIS
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456
Query: 363 QRLAQIELDNNQITG-------AIPSEFGNLSNLTLLFVWHNRLEGEIPPSI--SNCQNL 413
L+ I L N +T F N LT + + N+L + + L
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYL 515
Query: 414 EAVDLSQNGLTGPIPRGIFQLKKL------NKLLLLSNNLSGVIPPEMGNCSSLIRFRAN 467
+DLS N + P L N+ N P + C SL + +
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 468 SNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSI 519
SN + + +I N++ LD+ N + + +
Sbjct: 575 SNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = 1e-92
Identities = 89/600 (14%), Positives = 173/600 (28%), Gaps = 89/600 (14%)
Query: 111 TGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLS 170
I +A + L+ S G + + ++L + Q + + +
Sbjct: 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQ----PGVSLNSNG 81
Query: 171 SLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGG---SLPHEIGNCTNLVMIGLA 227
+T L L + +P IG+L LE + G + P I +
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 228 ETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKL 287
++L + + SI
Sbjct: 142 RMHYQKTFVDYDPRED----------------------FSDLIKDCINSDPQQKSIKKSS 179
Query: 288 GNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347
+ NN+ + + ++L + + + + Q
Sbjct: 180 RITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238
Query: 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRL-------- 399
+ N + L +E+ N +P+ L + L+ V NR
Sbjct: 239 -----KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293
Query: 400 EGEIPPSISNCQNLEAVDLSQNGLT-GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNC 458
+ + + ++ + + N L P+ + ++KKL L L N L G P G+
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSE 352
Query: 459 SSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPD--EITGCRNLTFLDVHS 516
L N++T G + + L N+L IP+ + ++ +D
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY 411
Query: 517 NSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLG 576
N I L P +++ + L+ N+ +
Sbjct: 412 NEIGSVDGKNFDPL-----------------DPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 577 SCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLS 636
+ L ++L N L+ IP + + L +DL
Sbjct: 455 TGSPLSSINLMGNMLTE-IPKN-----------------SLKDENENFKNTYLLTSIDLR 496
Query: 637 HNELSG--DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP-LSVLSGNPSLCFSGNQ 693
N+L+ D L LV +++S+N+FS P P L GN+
Sbjct: 497 FNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL--NSSTLKGFGIRNQRDAQGNR 553
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 3e-71
Identities = 62/415 (14%), Positives = 123/415 (29%), Gaps = 44/415 (10%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLT--- 135
+ Y + +L L + + +P + +L ++ ++++ N
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 136 -----GEIPRELCSLLRLEQLRLNSNQL-EGAIPIQIGNLSSLTQLFLYDNQLTDAIPAT 189
+ + +++ + + N L + + + L L NQL +PA
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA- 348
Query: 190 IGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGL--LKRLQT 247
G L ++ N + + G + + A + +P + +
Sbjct: 349 FGSEIKLASLNLAYN-QITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSA 406
Query: 248 IAIYTALLSG-------QIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQ 300
I + + P + I L N ++ L ++ L
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466
Query: 301 NNLVGI-------IPPELGNCSQLSIIDISMNSLTGSIPQ-TLGNLTSLQELQLSVNQIS 352
N L I N L+ ID+ N LT L L + LS N S
Sbjct: 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS 526
Query: 353 GEIPAQIGNCQRLAQIELDN------NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPS 406
P Q N L + N N+ P +LT L + N + +
Sbjct: 527 K-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEK 584
Query: 407 ISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSL 461
I N+ +D+ N + + +L + ++ C +L
Sbjct: 585 I--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-----DIRGCDAL 632
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-109
Identities = 117/638 (18%), Positives = 205/638 (32%), Gaps = 59/638 (9%)
Query: 71 NLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLS 130
+L + L+L + L NFT L L + ++ P+ L L L+L
Sbjct: 22 DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81
Query: 131 ENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATI 190
N L+ + L +L L SN ++ +L L L N L+ T
Sbjct: 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141
Query: 191 GKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLK--RLQTI 248
+L+NL+ + NK I L + L+ +
Sbjct: 142 VQLENLQELLLSNNK-------------------------IQALKSEELDIFANSSLKKL 176
Query: 249 AIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLG---NLKNLVNLFLWQNNLVG 305
+ + + P L ++L L S+ KL ++ NL L + L
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236
Query: 306 IIPPELGNC--SQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQ 363
+ L+++D+S N+L + L L+ L N I +
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296
Query: 364 RLAQIELDNN---------QITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLE 414
+ + L + + F L L L + N + G + NL+
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356
Query: 415 AVDLSQNGLT-GPIPRGIFQ---LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNK 470
+ LS + + + F L+ L L N +S + L N+
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNE 416
Query: 471 LTGFIPP-EIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG--NLPAGL 527
+ + E L+N+ + L N+ + +L L + ++ + P+
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
Query: 528 HQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNR--------FAGSIPSQLGSCV 579
L L DLS+N++ + L L L L L N G L
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536
Query: 580 KLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNE 639
L +L+L SN + L I ++L N + + L L+L N
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKI-IDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 640 LSG--DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAK 675
++ F +NL L++ N F +F
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 332 bits (854), Expect = e-101
Identities = 126/597 (21%), Positives = 205/597 (34%), Gaps = 42/597 (7%)
Query: 123 QLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQL 182
D S LT ++P +L + L L NQL S LT L + N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 183 TDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLL 242
+ P KL L+ + N L CTNL + L SI
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHN-ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 243 KRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKN--LVNLFLWQ 300
K L T+ + LS LQ + L N + +L N L L L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 301 NNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLG---NLTSLQELQLSVNQISGEIPA 357
N + P +L + ++ L S+ + L TS++ L LS +Q+S
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 358 QIGNCQ--RLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEA 415
+ L ++L N + F L L F+ +N ++ S+ N+
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 416 VDLSQN---------GLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRA 466
++L ++ L LK L L + N++ G+ +L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 467 NSNKLTGFIPPEIG----NLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGN 522
+++ + L+ L+L N+++ D + +L LD+ N I
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 523 LPAG-LHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAG--SIPSQLGSCV 579
L L + LS N + + SL +L+L + S PS
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 580 KLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQI--------CGELPAELTGLNKLG 631
L +LDLS+N ++ L + L I L+L N + G L GL+ L
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEI-LDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 632 ILDLSHNELSG-DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP-LSV--LSGN 684
IL+L N + +L L ++++ NN + F L L N
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV--FNNQVSLKSLNLQKN 594
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 1e-76
Identities = 93/429 (21%), Positives = 163/429 (37%), Gaps = 26/429 (6%)
Query: 266 CT-ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISM 324
CT + LT +P L N+ L L N L + SQL+ +D+
Sbjct: 2 CTVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 325 NSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG 384
N+++ P+ L L+ L L N++S C L ++ L +N I + F
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPR--GIFQLKKLNKLLL 442
NL L + HN L + +NL+ + LS N + IF L KL L
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178
Query: 443 LSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIG---NLKNLNFLDLGSNRLTGSI 499
SN + P L N+ +L + ++ ++ L L +++L+ +
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238
Query: 500 PDEITGCR--NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSL 557
G + NLT LD+ N++ L +L++ L N++ + S L L ++
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298
Query: 558 TKLVLNKNRFAGSI---------PSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIA 608
L L ++ SI L+ L++ N + G + L
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY- 357
Query: 609 LNLSWNQICGELPAELT----GLNKLGILDLSHNELSG-DLHFLAELQNLVVLNVSHNNF 663
L+LS + T + L IL+L+ N++S + + L +L VL++ N
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 664 SGRVPDTPF 672
+ +
Sbjct: 418 GQELTGQEW 426
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-106
Identities = 126/620 (20%), Positives = 198/620 (31%), Gaps = 57/620 (9%)
Query: 69 SCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLD 128
+ N ++ +P N S L LS L S +L LD
Sbjct: 4 VEVVPNITY--QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 129 LSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPA 188
LS + SL L L L N ++ LSSL +L + L
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 189 TIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTI 248
IG LK L+ + N LP N TNL + L+ I L +L ++ +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 249 AIYTALLSGQI---PPELGDCTELQYIYLYENALTGSIP-------SKLGNLKNLVNLFL 298
+ L + P L + L N + ++ + L + ++ F
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 299 WQNNLVGIIPPELGNCSQLSIIDISMNSLTGS---IPQTLGNLTSLQELQLSVNQISGEI 355
+ NL L L+I + + L I LT++ L I
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 356 PAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEA 415
+EL N + + +L LT +G S + +LE
Sbjct: 299 D--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEF 351
Query: 416 VDLSQNGLT--GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTG 473
+DLS+NGL+ G + F L L L N + + L + L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 474 FIPPEI-GNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG-LHQLV 531
+ +L+NL +LD+ + G +L L + NS N +L
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 532 RLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQL 591
L F DLS + + SLSSL L ++ N F LQ+LD S N +
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 592 SGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLH---FLA 648
+ L P + L L+L+ N+ + FL
Sbjct: 531 MTSKKQELQHFP------------------------SSLAFLNLTQNDFACTCEHQSFLQ 566
Query: 649 ELQNLVVLNVSHNNFSGRVP 668
+++ L V P
Sbjct: 567 WIKDQRQLLVEVERMECATP 586
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 329 bits (846), Expect = e-104
Identities = 116/313 (37%), Positives = 176/313 (56%), Gaps = 20/313 (6%)
Query: 748 EGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKR 807
E D +V +G + +L A+ + + NI+G+G G VYK L G VAVKR
Sbjct: 7 EEDPEVHLGQLKRFS-LRELQ----VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR 61
Query: 808 FRASDKISTGA---FSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLH 864
++ + G F +E+ +S HRN++RL G+ +LL Y YM NG++ L
Sbjct: 62 L--KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 119
Query: 865 D-GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923
+ E L+W R +IALG A GL+YLH C P I+HRDVK+ NILL E +E+ + DFG
Sbjct: 120 ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVD 983
LA+L++ +A G+ G+IAPEY + K SEK+DV+ YGV+LLE+ITG++ D
Sbjct: 180 LAKLMDYKDTHVTTA---VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236
Query: 984 ASFPDGQ---HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRA 1040
+ ++ WV+ L +K ++D LQG+ +E+ Q + ++LLCT +
Sbjct: 237 LARLANDDDVMLLDWVK-GLLKEKKLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSP 293
Query: 1041 EDRPTMKDVAALL 1053
+RP M +V +L
Sbjct: 294 MERPKMSEVVRML 306
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 332 bits (852), Expect = 1e-98
Identities = 104/636 (16%), Positives = 195/636 (30%), Gaps = 92/636 (14%)
Query: 40 SWKRNWKGSDDGLSNWSPSDETPCKWF---GVSCNLNNQVVGLDLRYVDLLGHVPTNFTS 96
+ + NW+ + E W GV + N +V GL L
Sbjct: 287 RYYSGTINNTIHSLNWNFNKE-LDMWGDQPGVDLDNNGRVTGLSL--------------- 330
Query: 97 LLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSN 156
+G G +P I L +L L +S T L + +
Sbjct: 331 ---------AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKH 381
Query: 157 QLEGAIP-IQIGNLSSLTQLFLYDNQLT---DAIPATIGKLKNLEAIRAGGNKNLGGSLP 212
++ + + L L + + + P +L+ + G N +
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFIS 441
Query: 213 HEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYI 272
I T L +I A + + + +L +
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYA-----KQYENEELSWSNLKDLTDV 496
Query: 273 YLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGI---------IPPELGNCSQLSIIDIS 323
LY +P L +L L +L + N + + + ++ I +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 324 MNSLTG-SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE 382
N+L +L + L L N++ + A G +L ++LD NQI IP +
Sbjct: 557 YNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEE-IPED 613
Query: 383 -FGNLSNLTLLFVWHNRLEGEIPP--SISNCQNLEAVDLSQNGLTG-----PIPRGIFQL 434
+ L HN+L+ IP + + + +VD S N + ++
Sbjct: 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 435 KKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT-------GFIPPEIGNLKNLNF 487
+ + L N + S + ++N +T N L
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 488 LDLGSNRLTGSIPDEITGCR--NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGG 545
+DL N+LT S+ D+ L+ +DV N + P +L+ +
Sbjct: 733 IDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ---- 786
Query: 546 MLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPAL 605
NR P+ + +C L L + SN + + L P L
Sbjct: 787 --------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQL 829
Query: 606 AIALNLSWNQICGELPAELTGLNKLGILDLSHNELS 641
I L+++ N + + G+ L +++
Sbjct: 830 YI-LDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 318 bits (816), Expect = 1e-93
Identities = 87/593 (14%), Positives = 183/593 (30%), Gaps = 68/593 (11%)
Query: 127 LDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAI 186
+ + + +L + R+ L L +G +P IG L+ L L + T +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 187 PATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSIS-----GFLPPTLGL 241
+ + ++ + L + L + +I+ + +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423
Query: 242 LKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQN 301
+ I T ++ I + T+LQ IY + T + + +
Sbjct: 424 SLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYA 477
Query: 302 NLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISG-------- 353
N L+ +++ +P L +L LQ L ++ N+
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 354 -EIPAQIGNCQRLAQIELDNNQITGAIPSE--FGNLSNLTLLFVWHNRLEGEIPPSISNC 410
+ ++ + N + P+ + L LL HN++ +
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTN 594
Query: 411 QNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPP--EMGNCSSLIRFRAN 467
L + L N + IP ++ L N L IP + + +
Sbjct: 595 VKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFS 652
Query: 468 SNKLTG-----FIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSI--- 519
NK+ + N + + L N + + ++ + + +N +
Sbjct: 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712
Query: 520 ----AGNLPAGLHQLVRLQFADLSDNSVGGMLSPDL--GSLSSLTKLVLNKNRFAGSIPS 573
L DL N + LS D +L L+ + ++ N F+ S P+
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPT 770
Query: 574 QLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGIL 633
Q + +L+ + + N+I + P +T L L
Sbjct: 771 QPLNSSQLKAFGIRHQ-------------------RDAEGNRILRQWPTGITTCPSLIQL 811
Query: 634 DLSHNELSGDLHFLAELQNLVVLNVSHN-NFSGRVPDTPFFAKLPLSVLSGNP 685
+ N++ L L +L+++ N N S V + + + VL +
Sbjct: 812 QIGSNDIRKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-50
Identities = 62/419 (14%), Positives = 133/419 (31%), Gaps = 56/419 (13%)
Query: 318 SIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITG 377
+D + + + ++ + + N R+ + L G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNK-ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 378 AIPSEFGNLSNLTLLFVWHNRLEGEIPP-------------------------SISNCQN 412
+P G L+ L +L + + Q
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
Query: 413 LEAVDLSQNGLT-----GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRAN 467
L DL Q+ + PI + K ++ L+N ++ I + + L
Sbjct: 398 LNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFA 456
Query: 468 SNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL 527
++ T + + + + + ++LT +++++ LP L
Sbjct: 457 NSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511
Query: 528 HQLVRLQFADLSDNSVGGM---------LSPDLGSLSSLTKLVLNKNRFAGSIPSQ-LGS 577
+ L LQ +++ N L+ D + + + N S L
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQK 571
Query: 578 CVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAEL-TGLNKLGILDLS 636
VKL LLD N++ ++ + G L L L +NQI E+P + +++ L S
Sbjct: 572 MVKLGLLDCVHNKVR-HLE-AFGTNVKLTD-LKLDYNQI-EEIPEDFCAFTDQVEGLGFS 627
Query: 637 HNELSG--DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFSGNQ 693
HN+L ++ + + ++ S+N + + ++ S N+
Sbjct: 628 HNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI--SCSMDDYKGINASTVTLSYNE 684
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = 1e-95
Identities = 112/597 (18%), Positives = 197/597 (32%), Gaps = 44/597 (7%)
Query: 56 SPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIP 115
+ S + C N+ + + L +P + S L S L
Sbjct: 1 TTSSDQKC-----IEKEVNKTY--NCENLGL-NEIPGTLPN--STECLEFSFNVLPTIQN 50
Query: 116 KEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQL 175
+ L L +LDL+ + S RL+ L L +N L + +L L
Sbjct: 51 TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHL 110
Query: 176 FLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFL 235
F ++ + K LE++ G N ++ + L ++ +I
Sbjct: 111 FFIQTGISSIDFIPLHNQKTLESLYLGSN-HISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169
Query: 236 PPTLGLLKRLQTIAIYTALLS-GQIPPELGDCTELQYIYLYENALTGSIPSKLGN--LKN 292
+ L++ +++ I P D Q + I L N +++
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229
Query: 293 LVNLFLWQNNLVGIIPPELGNCSQLSI--IDISMNSLTGSIPQTLGNLTSLQELQLSVNQ 350
L + I P ++S+ I++ + T + LQEL L+
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH 289
Query: 351 ISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPP-SISN 409
+S E+P+ + L ++ L N+ N +LT L + N E+ + N
Sbjct: 290 LS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348
Query: 410 CQNLEAVDLSQNGLT--GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRAN 467
+NL +DLS + + + L L L L N + C L
Sbjct: 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408
Query: 468 SNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG 526
+L NL L L+L + L S G L L++ N
Sbjct: 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI-- 466
Query: 527 LHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDL 586
+ L +L L LVL+ + S + +DL
Sbjct: 467 -------------------QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDL 507
Query: 587 SSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGD 643
S N+L+ + +L + + LNL+ N I LP+ L L++ ++L N L
Sbjct: 508 SHNRLTSSSIEALSHLKGI--YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 4e-71
Identities = 94/441 (21%), Positives = 154/441 (34%), Gaps = 21/441 (4%)
Query: 258 QIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQL 317
+IP L + + N L + L NL L L + + I + +L
Sbjct: 26 EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 318 SIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITG 377
+ ++ N L L +L+ L IS + N + L + L +N I+
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 378 AIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAV--DLSQNGLTGPIPRGIFQLK 435
+ L +L +N + +S+ Q + +L+ N + G I G F
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSA 202
Query: 436 KLNKLLLLSNNLSGVIPPEMGNCS--SLIRFRANSNKLTGFIPPEIGNLKNLN--FLDLG 491
L VI + N + SL P L ++ ++L
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 492 SNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDL 551
+ + L LD+ + ++ LP+GL L L+ LS N +
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 552 GSLSSLTKLVLNKNRFAGSIPSQ-LGSCVKLQLLDLSSNQL--SGNIPASLGKIPALAIA 608
+ SLT L + N + + L + L+ LDLS + + S L + L +
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL-QS 380
Query: 609 LNLSWNQICGELPAELTGLNKLGILDLSHNELSG--DLHFLAELQNLVVLNVSHNNFSGR 666
LNLS+N+ +L +LDL+ L L L VLN+SH+
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 667 VPDTPFFAKLP-LSVL--SGN 684
F LP L L GN
Sbjct: 441 SEQL--FDGLPALQHLNLQGN 459
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 4e-69
Identities = 80/445 (17%), Positives = 147/445 (33%), Gaps = 18/445 (4%)
Query: 255 LSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNC 314
L L ++ L + + L L L N L+ + L
Sbjct: 45 LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104
Query: 315 SQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQ 374
L + ++ L N +L+ L L N IS + ++L ++ NN
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 375 ITGAIPSEFGNLSNLTLLFVW--HNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIF 432
I + +L T L + N + I P + ++++ I +G+
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
Query: 433 --QLKKLNKLLLLSNNLSGVIPPEMGNCS--SLIRFRANSNKLTGFIPPEIGNLKNLNFL 488
++ L + + P S+ + L L
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283
Query: 489 DLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS 548
DL + L+ +P + G L L + +N L + N+ L
Sbjct: 284 DLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
Query: 549 PD-LGSLSSLTKLVLNKNR--FAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPAL 605
L +L +L +L L+ + + QL + LQ L+LS N+ + + P L
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402
Query: 606 AIALNLSWNQICG-ELPAELTGLNKLGILDLSHNELSG-DLHFLAELQNLVVLNVSHNNF 663
+ L+L++ ++ + + L+ L +L+LSH+ L L L LN+ N+F
Sbjct: 403 EL-LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461
Query: 664 SGRVPDTP-FFAKLP-LSVL--SGN 684
L L +L S
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFC 486
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 1e-92
Identities = 98/289 (33%), Positives = 149/289 (51%), Gaps = 17/289 (5%)
Query: 773 DATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTG----AFSSEIATLSR 828
D GN +G+G G+VYK + TVAVK+ A I+T F EI +++
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
+H N+V LLG+ ++ L Y YMPNG+L L + L W R KIA G A G+
Sbjct: 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
++LH + +HRD+KS NILL E + + ++DFGLAR E + ++ + G+ Y
Sbjct: 147 NFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS--RIVGTTAY 201
Query: 949 IAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007
+APE + +I+ KSD+YS+GVVLLEIITG VD Q ++ + +K
Sbjct: 202 MAPEA--LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIE 258
Query: 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
+ +D K+ + ++ C + RP +K V LL+E+
Sbjct: 259 DYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 6e-92
Identities = 95/290 (32%), Positives = 143/290 (49%), Gaps = 10/290 (3%)
Query: 771 IGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR 830
+ +AT + +IG G G VYK L G VA+KR F +EI TLS R
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD-GECAGLLEWDTRFKIALGVAEGLS 889
H ++V L+G+ R +L Y YM NG L L+ + W+ R +I +G A GL
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
YLH I+HRDVKS NILL E + + DFG+++ + S G+ GYI
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV--KGTLGYI 208
Query: 950 APEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ-HVIQWVRDHLKSKKDPVE 1008
PEY +++EKSDVYS+GVVL E++ + + S P ++ +W + +
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQ 267
Query: 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058
++DP L + + + ++ C + +EDRP+M DV L +
Sbjct: 268 IVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 5e-84
Identities = 76/299 (25%), Positives = 129/299 (43%), Gaps = 27/299 (9%)
Query: 204 NKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPEL 263
N+ G L + + L+ ++ IP L
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPK----------------------PYPIPSSL 72
Query: 264 GDCTELQYIYLY-ENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDI 322
+ L ++Y+ N L G IP + L L L++ N+ G IP L L +D
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 323 SMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQ-IELDNNQITGAIPS 381
S N+L+G++P ++ +L +L + N+ISG IP G+ +L + + N++TG IP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 382 EFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLL 441
F NL NL + + N LEG+ + +N + + L++N L + + + K LN L
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLD 250
Query: 442 LLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIP 500
L +N + G +P + L + N L G I P+ GNL+ + +N+ P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 6e-84
Identities = 87/308 (28%), Positives = 135/308 (43%), Gaps = 19/308 (6%)
Query: 282 SIPSKLGNLKNLVNLFLW-------QNNLVGIIPPELGNCSQLSIIDISMNSLTGS--IP 332
I LGN L + W +G++ +++ +D+S +L IP
Sbjct: 13 QIKKDLGNPTTLSS---WLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP 69
Query: 333 QTLGNLTSLQELQLS-VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTL 391
+L NL L L + +N + G IP I +L + + + ++GAIP + L
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129
Query: 392 LFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS-NNLSGV 450
L +N L G +PPSIS+ NL + N ++G IP KL + +S N L+G
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 451 IPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLT 510
IPP N +L + N L G G+ KN + L N L + ++ +NL
Sbjct: 190 IPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLN 247
Query: 511 FLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGS 570
LD+ +N I G LP GL QL L ++S N++ G + P G+L N+
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCG 306
Query: 571 IPSQLGSC 578
P L +C
Sbjct: 307 SP--LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-80
Identities = 80/278 (28%), Positives = 126/278 (45%), Gaps = 8/278 (2%)
Query: 156 NQLEGAIPIQIGNLSSLTQLFLYDNQL--TDAIPATIGKLKNLEAIRAGGNKNLGGSLPH 213
G + + L L L IP+++ L L + GG NL G +P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 214 EIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIY 273
I T L + + T++SG +P L +K L T+ LSG +PP + L I
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 274 LYENALTGSIPSKLGNLKNLVN-LFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIP 332
N ++G+IP G+ L + + +N L G IPP N + L+ +D+S N L G
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDAS 214
Query: 333 QTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLL 392
G+ + Q++ L+ N ++ ++ ++G + L ++L NN+I G +P L L L
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 393 FVWHNRLEGEIPPSISNCQNLEAVDLSQN-GLTG-PIP 428
V N L GEI P N Q + + N L G P+P
Sbjct: 274 NVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-80
Identities = 87/367 (23%), Positives = 135/367 (36%), Gaps = 82/367 (22%)
Query: 330 SIPQTLGNLTSLQ----ELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITG--AIPSEF 383
I + LGN T+L G + R+ ++L + IPS
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 384 GNLSNLTLLFVWH-NRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLL 442
NL L L++ N L G IPP+I+ L + ++ ++G IP + Q+K L L
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 443 LSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNL-NFLDLGSNRLTGSIPD 501
N LSG +PP + + +L+ + N+++G IP G+ L + + NRLTG IP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 502 EITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLV 561
NL F+D+ N + G+ GS + K+
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDAS------------------------VLFGSDKNTQKIH 227
Query: 562 LNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELP 621
L KN A + +G L LDL +N++ G +P L +
Sbjct: 228 LAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQ-------------------- 266
Query: 622 AELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVL 681
L+ L LNVS NN G +P + +S
Sbjct: 267 ----------------------------LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 682 SGNPSLC 688
+ N LC
Sbjct: 299 ANNKCLC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 1e-79
Identities = 98/353 (27%), Positives = 155/353 (43%), Gaps = 59/353 (16%)
Query: 35 GEALLSWKRNWKGSDDGLSNWSPS-DETPCKWFGVSCNLNNQ---VVGLDLRYVDLLG-- 88
+ALL K++ G+ LS+W P+ D W GV C+ + Q V LDL ++L
Sbjct: 8 KQALLQIKKDL-GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 89 HVPTNFTSLLSLNRLVLSGTN-LTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLR 147
+P++ +L LN L + G N L G IP IA L QL+YL ++ +++G IP L +
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 148 LEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNL 207
L L + N L G +P I +L +L + N+++
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS------------------------ 162
Query: 208 GGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCT 267
G++P G+ + L ++ I L+G+IPP +
Sbjct: 163 -GAIPDSYGSFSKL-----------------------FTSMTISRNRLTGKIPPTFANLN 198
Query: 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327
L ++ L N L G G+ KN + L +N+L + ++G L+ +D+ N +
Sbjct: 199 -LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRI 256
Query: 328 TGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIP 380
G++PQ L L L L +S N + GEIP Q GN QR NN+ P
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 8e-80
Identities = 104/564 (18%), Positives = 182/564 (32%), Gaps = 30/564 (5%)
Query: 69 SCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLD 128
+ N L VP + S S + LS L ++ ++L +LD
Sbjct: 8 IEVVPNITY--QCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLD 62
Query: 129 LSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPA 188
LS + + L L L L N ++ P L+SL L + +L
Sbjct: 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESF 122
Query: 189 TIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTI 248
IG+L L+ + N LP N TNLV + L+ I L L+ +
Sbjct: 123 PIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV 182
Query: 249 AIYTALLS---GQIPPELGDCTELQYIYLYENALTGSIPSKLGN-------LKNLVNLFL 298
+ + I + +L + L N + +I + ++ F
Sbjct: 183 NLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242
Query: 299 WQNNLVGIIPPELGNCSQLSI--IDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIP 356
+ NL P + ++I ++ + L ++ + L+ I
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--L 300
Query: 357 AQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAV 416
+ + + + Q+ +L L L + N+ I +L +
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYL 355
Query: 417 DLSQNGLTGPIPRGIFQLKKLNKL--LLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGF 474
DLS+N L+ + N L L LS N + ++ L + L
Sbjct: 356 DLSRNALSF-SGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRV 414
Query: 475 IPPE-IGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG-LHQLVR 532
+L+ L +LD+ G +L L + NS N +
Sbjct: 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474
Query: 533 LQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS 592
L F DLS + + +L L L ++ N S L LD S N++
Sbjct: 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534
Query: 593 GNIPASLGKIPALAIALNLSWNQI 616
+ +LA NL+ N +
Sbjct: 535 TSKGILQHFPKSLAF-FNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 5e-72
Identities = 107/605 (17%), Positives = 191/605 (31%), Gaps = 70/605 (11%)
Query: 95 TSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLN 154
++ L+ +P +I + +DLS N L + L+ L L+
Sbjct: 8 IEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLS 64
Query: 155 SNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHE 214
++E L L+ L L N + P + L +LE + A L
Sbjct: 65 RCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET-KLASLESFP 123
Query: 215 IGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYL 274
IG L + +A I ++P + T L ++ L
Sbjct: 124 IGQLITLKKLNVAHNFIHSC-----------------------KLPAYFSNLTNLVHVDL 160
Query: 275 YENALTGSIPSKLGNLKNLVNLFLW---QNNLVGIIPPELGNCSQLSIIDISMNSLTGSI 331
N + + L L+ + L N + I + +L + + N + +I
Sbjct: 161 SYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNI 220
Query: 332 PQT-LGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLT 390
+T L NL L +L + + + PS L ++T
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKD------------------ERNLEIFEPSIMEGLCDVT 262
Query: 391 LLFV--WHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLS 448
+ + + N+ A+ L+ + + K L ++ L
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFK-WQSLSIIRCQLK 320
Query: 449 GVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPD--EITGC 506
+ L NK + I + L +L++LDL N L+ S G
Sbjct: 321 QFPT---LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375
Query: 507 RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPD-LGSLSSLTKLVLNKN 565
+L LD+ N + A L LQ D +++ + SL L L ++
Sbjct: 376 NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 566 RFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPAS-LGKIPALAIALNLSWNQICGELPAEL 624
L L ++ N N ++ L L+LS Q+
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF-LDLSKCQLEQISWGVF 493
Query: 625 TGLNKLGILDLSHNELSG-DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP-LSVL- 681
L++L +L++SHN L D +L +L L+ S N L+
Sbjct: 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET--SKGILQHFPKSLAFFN 551
Query: 682 -SGNP 685
+ N
Sbjct: 552 LTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 4e-67
Identities = 102/540 (18%), Positives = 186/540 (34%), Gaps = 28/540 (5%)
Query: 71 NLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLS 130
++ + +DL + L +F++ L L LS + K L+ L+ L L+
Sbjct: 29 DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88
Query: 131 ENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDA-IPAT 189
N + P L LE L +L IG L +L +L + N + +PA
Sbjct: 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
Query: 190 IGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNL----VMIGLAETSISGFLPPTLGLLKRL 245
L NL + N + +++ + + ++ I F+ +L
Sbjct: 149 FSNLTNLVHVDLSYN-YIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKL 206
Query: 246 QTIAIYTALLSGQIPPE-LGDCTELQYIYLYENALTGSI------PSKLGNLKNLV--NL 296
+ + S I L + L L PS + L ++
Sbjct: 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266
Query: 297 FLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIP 356
L N + + +S + ++ S+ + + Q L + Q+ + P
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFP 323
Query: 357 AQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISN--CQNLE 414
+ L + L N+ + I + L +L+ L + N L S S+ +L
Sbjct: 324 TL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379
Query: 415 AVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEM-GNCSSLIRFRANSNKLTG 473
+DLS NG + L++L L + L V + L+ +
Sbjct: 380 HLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 474 FIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAGLHQLVR 532
L +LN L + N + + NLTFLD+ + L R
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 533 LQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS 592
LQ ++S N++ + S L SL+ L + NR S L +L++N ++
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-60
Identities = 98/602 (16%), Positives = 177/602 (29%), Gaps = 115/602 (19%)
Query: 112 GSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSS 171
GS+ I + + + L+ ++P ++ S + + L+ N L+ N S
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPSST--KNIDLSFNPLKILKSYSFSNFSE 57
Query: 172 LTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSI 231
L L L ++ L +L + GN
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP-------------------------- 91
Query: 232 SGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLK 291
+ P T L+ + E L +G L
Sbjct: 92 -----------------------IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLI 128
Query: 292 NLVNLFLWQNNLVGI-IPPELGNCSQLSIIDISMNSLTGSIPQTLGNLT----SLQELQL 346
L L + N + +P N + L +D+S N + L L L +
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 347 SVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE-FGNLSNLTLLFVWHNRLEGEIPP 405
S+N I I Q +L ++ L N + I NL+ L + + + E
Sbjct: 189 SLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247
Query: 406 SISNCQNLEAV--------DLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGN 457
I +E + L+ L ++ + L ++ + ++
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPK 305
Query: 458 CSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSN 517
+L F +L L L L N+ SI + +L++LD+ N
Sbjct: 306 HFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRN 360
Query: 518 SIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGS 577
++ ++DL +SL L L+ N + +
Sbjct: 361 AL--------SFSGCCSYSDLG--------------TNSLRHLDLSFNGA-IIMSANFMG 397
Query: 578 CVKLQLLDLSSNQLSGNIPAS-LGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLS 636
+LQ LD + L S + L L++S+ + GL L L ++
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLY-LDISYTNTKIDFDGIFLGLTSLNTLKMA 456
Query: 637 HNELSGDL--HFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCF---SG 691
N + + A NL L++S + V L S
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ----------ISWGVFDTLHRLQLLNMSH 506
Query: 692 NQ 693
N
Sbjct: 507 NN 508
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-45
Identities = 64/403 (15%), Positives = 127/403 (31%), Gaps = 29/403 (7%)
Query: 62 PCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKE-IAS 120
+ LD+ + + + L+ L L G + +I K + +
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227
Query: 121 LNQLNYLDLSENSLTGEIPRELCSL--------LRLEQLRLNSNQLEGAIPIQIGNLSSL 172
L L+ L E E+ + +++ RL ++ L+++
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANV 287
Query: 173 TQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSIS 232
+ + L + K +++ + P + L + L S
Sbjct: 288 SAMSLAGVSIKYLEDVP--KHFKWQSLSIIRCQL--KQFPT--LDLPFLKSLTLTMNKGS 341
Query: 233 GFLPPTLGLLKRLQTI-----AIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKL 287
+ L L + A+ SG L+++ L N + +
Sbjct: 342 --ISFKKVALPSLSYLDLSRNALSF---SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANF 395
Query: 288 GNLKNLVNLFLWQNNLVGIIPPE-LGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQL 346
L+ L +L + L + + +L +DIS + LTSL L++
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455
Query: 347 SVNQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPP 405
+ N + + N L ++L Q+ F L L LL + HN L
Sbjct: 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515
Query: 406 SISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLS 448
+ +L +D S N + K L L +N+++
Sbjct: 516 HYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-34
Identities = 60/342 (17%), Positives = 110/342 (32%), Gaps = 18/342 (5%)
Query: 39 LSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLL 98
L R G N + + C++ L Y + F L
Sbjct: 231 LHVHRLILGEFKDERNLEIFEPSI---MEGLCDVTIDE--FRLTYTNDFSDDIVKFHCLA 285
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158
+++ + L+G ++ +++ + L + L + P L L+ L L N+
Sbjct: 286 NVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMNKG 340
Query: 159 EGAIPIQIGNLSSLTQLFLYDNQLTDAIPAT--IGKLKNLEAIRAGGNKNLGGSLPHEIG 216
I + L SL+ L L N L+ + + +L + N + +
Sbjct: 341 S--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI--IMSANFM 396
Query: 217 NCTNLVMIGLAETSISGFLPP-TLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLY 275
L + +++ L++L + I T L + +
Sbjct: 397 GLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMA 456
Query: 276 ENALTGSIPSK-LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQT 334
N+ + S N NL L L + L I +L ++++S N+L
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516
Query: 335 LGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376
L SL L S N+I + LA L NN +
Sbjct: 517 YNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 4e-73
Identities = 85/340 (25%), Positives = 136/340 (40%), Gaps = 47/340 (13%)
Query: 743 GSHHNEGDEDVEMGPP-WELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGL 801
G HH+ V++G + L + +GR G V+K L
Sbjct: 2 GHHHHHHSSGVDLGTENLYF------------QSMPLQLLEVKARGRFGCVWKAQLL-NE 48
Query: 802 TVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG---WGANRKTKL-LFYDYMPNG 857
VAVK F DK S E+ +L ++H NI++ +G G + L L + G
Sbjct: 49 YVAVKIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107
Query: 858 TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV-------PAILHRDVKSHNIL 910
+L L ++ W+ IA +A GL+YLH D PAI HRD+KS N+L
Sbjct: 108 SLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL 163
Query: 911 LGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-----KISEKSDV 965
L +C+ADFGLA E + + Q G+ Y+APE + D+
Sbjct: 164 LKNNLTACIADFGLALKFEAGK-SAGDTHGQ-VGTRRYMAPEVLEGAINFQRDAFLRIDM 221
Query: 966 YSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV-----LDPKLQGH--P 1018
Y+ G+VL E+ + D + + S +D EV P L+ +
Sbjct: 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK 281
Query: 1019 DTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058
+ + + C + AE R + V + ++++
Sbjct: 282 HAGMAMLCE---TIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 4e-69
Identities = 105/516 (20%), Positives = 195/516 (37%), Gaps = 63/516 (12%)
Query: 153 LNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLP 212
+ L+ + L +TD + L + ++A
Sbjct: 9 TQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG---IKSI 61
Query: 213 HEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYI 272
+ NL I + ++ L + T+L I
Sbjct: 62 DGVEYLNNLTQINFSNNQLTDI--------------------------TPLKNLTKLVDI 95
Query: 273 YLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIP 332
+ N + P L NL NL L L+ N + I P L N + L+ +++S N+++
Sbjct: 96 LMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--I 149
Query: 333 QTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLL 392
L LTSLQ+L NQ++ P + N L ++++ +N+++ S L+NL L
Sbjct: 150 SALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 204
Query: 393 FVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIP 452
+N++ P + NL+ + L+ N L + L L L L +N +S + P
Sbjct: 205 IATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP 260
Query: 453 PEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFL 512
+ + L + +N+++ P + L L L+L N+L P I+ +NLT+L
Sbjct: 261 --LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314
Query: 513 DVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIP 572
++ N+I+ P + L +LQ +N V + L +L+++ L N+ + P
Sbjct: 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370
Query: 573 SQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGI 632
L + ++ L L+ + + N++ I PA ++
Sbjct: 371 --LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI---APATISDGGSYTE 425
Query: 633 LDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVP 668
D++ N S V + FSG V
Sbjct: 426 PDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-54
Identities = 94/409 (22%), Positives = 159/409 (38%), Gaps = 31/409 (7%)
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
T +L L ++++ + P +A+L L L L N +T P L +L L +L
Sbjct: 84 TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRL 139
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSL 211
L+SN + + L+SL QL NQ+TD P + L LE + NK S
Sbjct: 140 ELSSNTISDISA--LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKV---SD 191
Query: 212 PHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQY 271
+ TNL + IS P LG+L L +++ L L T L
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 272 IYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSI 331
+ L N ++ P L L L L L N + I P L + L+ ++++ N L
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 303
Query: 332 PQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTL 391
P + NL +L L L N IS P + + +L ++ NN+++ S NL+N+
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINW 357
Query: 392 LFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVI 451
L HN++ P ++N + + L+ T P + + +
Sbjct: 358 LSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL-IA 413
Query: 452 PPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIP 500
P + + S N + + + G+ +G++
Sbjct: 414 PATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-25
Identities = 58/266 (21%), Positives = 93/266 (34%), Gaps = 40/266 (15%)
Query: 91 PTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQ 150
SL +L L L+ ++ P ++ L +L L L N ++ P L L L
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 291
Query: 151 LRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGS 210
L LN NQLE P I NL +LT L LY N ++D P + L L+ + NK S
Sbjct: 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV---S 344
Query: 211 LPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQ 270
+ N TN+ + IS L + T +
Sbjct: 345 DVSSLANLTNINWLSAGHNQISDL--------------------------TPLANLTRIT 378
Query: 271 YIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGS 330
+ L + A T + + N+ N + I P + + + DI+ N +
Sbjct: 379 QLGLNDQAWTNAPVNYKANVSIP-NTVKNVTGAL-IAPATISDGGSYTEPDITWNLPS-Y 435
Query: 331 IPQTLGNLTSLQELQLSVNQISGEIP 356
+ + + SG +
Sbjct: 436 TNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-62
Identities = 115/552 (20%), Positives = 178/552 (32%), Gaps = 35/552 (6%)
Query: 62 PCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASL 121
PC + N ++ +P N S L LS L S
Sbjct: 2 PC-----VEVVPNITY--QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSF 51
Query: 122 NQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQ 181
+L LDLS + SL L L L N ++ LSSL +L +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 182 LTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGL 241
L IG LK L+ + N LP N TNL + L+ I L +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 242 LKRLQTIAIYTALLSGQI---PPELGDCTELQYIYLYENALTGSIP-------SKLGNLK 291
L ++ + + L + P L + L N + ++ + L +
Sbjct: 172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231
Query: 292 NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGS---IPQTLGNLTSLQELQLSV 348
++ F + NL L L+I + + L I LT++ L
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 349 NQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSIS 408
I + N +EL N + + +L LT N+ S
Sbjct: 292 VTIE-RVKDFSYNFG-WQHLELVNCKFGQFPTLKLKSLKRLTFT---SNKGGN--AFSEV 344
Query: 409 NCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKL--LLLSNNLSGVIPPEMGNCSSLIRFRA 466
+ +LE +DLS+NGL+ L L LS N + L
Sbjct: 345 DLPSLEFLDLSRNGLSF-KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDF 403
Query: 467 NSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPA 525
+ L + +L+NL +LD+ + G +L L + NS N
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
Query: 526 G-LHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLL 584
+L L F DLS + + SLSSL L + N+ LQ +
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523
Query: 585 DLSSNQLSGNIP 596
L +N + P
Sbjct: 524 WLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-37
Identities = 66/373 (17%), Positives = 122/373 (32%), Gaps = 28/373 (7%)
Query: 321 DISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIP 380
+ IP L S + L LS N + + L ++L +I
Sbjct: 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 381 SEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKL 440
+ +LS+L+ L + N ++ + S +L+ + + L I LK L +L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 441 LLLSNNLSGV-IPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNF----LDLGSNRL 495
+ N + +P N ++L +SNK+ ++ L + LDL N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 496 TGSIPDEITGCRNLTFLDVHSNSIAGNLPAG-LHQLVRLQFADLSDNSVGG---MLSPDL 551
I L L + +N + N+ + L L+ L + D
Sbjct: 190 N-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 552 GSLSSLTKLVLNKNR------FAGSIPSQLGSCVKLQLLDLSSNQLSGNIPAS-LGKIPA 604
+L L L + + R + I + L S + S
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308
Query: 605 LAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFS 664
L + +N + Q L L L + N+ + +L +L L++S N S
Sbjct: 309 LEL-VNCKFGQFPTL------KLKSLKRLTFTSNKGGNAFSEV-DLPSLEFLDLSRNGLS 360
Query: 665 GRVPDTPFFAKLP 677
+ +
Sbjct: 361 FKGCCSQSDFGTT 373
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-22
Identities = 49/212 (23%), Positives = 80/212 (37%), Gaps = 13/212 (6%)
Query: 477 PEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFA 536
P + + N+ + IPD + + LD+ N + LQ
Sbjct: 2 PCVEVVPNITY-QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 537 DLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP 596
DLS + + SLS L+ L+L N LQ L L+
Sbjct: 58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117
Query: 597 ASLGKIPALAIALNLSWNQI-CGELPAELTGLNKLGILDLSHNELS----GDLHFLAELQ 651
+G + L LN++ N I +LP + L L LDLS N++ DL L ++
Sbjct: 118 FPIGHLKTLKE-LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 652 NLVV-LNVSHNNFSGRVPDTPFFAKLPLSVLS 682
L + L++S N + + F ++ L L+
Sbjct: 177 LLNLSLDLSLNPMN-FIQPGA-FKEIRLHKLT 206
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 3e-62
Identities = 104/555 (18%), Positives = 182/555 (32%), Gaps = 110/555 (19%)
Query: 91 PTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQ 150
P N S L + +NLT +P E ++ + + P +
Sbjct: 5 PRNV-SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 151 LRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGS 210
RL +L L + L+ +P L++L A + N
Sbjct: 63 SRLRDC-----------LDRQAHELELNNLGLSS-LPELPPHLESLVA-----SCNSLTE 105
Query: 211 LPHEIGNCTNLVMIGLAETSISGFLPPTLGLLK----RLQTIAIYTALLSGQIPPELGDC 266
LP + +L++ ++S LPP L L +L+ + PEL +
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSD-LPPLLEYLGVSNNQLEKL------------PELQNS 152
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
+ L+ I + N+L +P +L+ + N L + PEL N L+ I NS
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLEEL--PELQNLPFLTAIYADNNS 206
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNL 386
L +P + L+ + N + ++ N L I DNN + +P +L
Sbjct: 207 LK-KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSL 259
Query: 387 SNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNN 446
L + N L ++P + L D+S+N +G + L LN S+N
Sbjct: 260 EALNVR---DNYLT-DLPELPQSLTFL---DVSENIFSG-LSELPPNLYYLN----ASSN 307
Query: 447 LSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506
+ + L ++NKL +P L+ L N L +P+
Sbjct: 308 EIRSLCDLPPS---LEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQ-- 357
Query: 507 RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNR 566
NL L V N + P S+ L +N +
Sbjct: 358 -NLKQLHVEYNPLR-EFPD---------------------------IPESVEDLRMNSHL 388
Query: 567 FAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTG 626
+P + L+ L + +N L P + L ++ ++
Sbjct: 389 --AEVPELPQN---LKQLHVETNPLR-EFPDIPESVE----DLRMNSERVVDPYEFAHET 438
Query: 627 LNKLGILDLSHNELS 641
+KL H+
Sbjct: 439 TDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-57
Identities = 106/510 (20%), Positives = 187/510 (36%), Gaps = 97/510 (19%)
Query: 162 IPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNL 221
I + + + L + + + LT +P E N +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT--------------------------EMPVEAENVKSK 36
Query: 222 VMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTG 281
A + PP G + + + L + + L L+
Sbjct: 37 TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL-----------DRQAHELELNNLGLS- 84
Query: 282 SIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSL 341
S+P +L++LV N+L +P + L + + ++ +L+ P L
Sbjct: 85 SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LL 133
Query: 342 QELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEG 401
+ L +S NQ+ ++P ++ N L I++DNN + +P +L + +N+LE
Sbjct: 134 EYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAG---NNQLE- 186
Query: 402 EIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSL 461
P + N L A+ N L +P L+ + +N L PE+ N L
Sbjct: 187 -ELPELQNLPFLTAIYADNNSLKK-LPDLPLSLESIV---AGNNILE--ELPELQNLPFL 239
Query: 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG 521
A++N L +P +L+ LN D N LT +P+ +LTFLDV N +
Sbjct: 240 TTIYADNNLLKT-LPDLPPSLEALNVRD---NYLT-DLPELPQ---SLTFLDVSENIFS- 290
Query: 522 NLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKL 581
L L L + S N + SL +L ++ N+ +P+ +L
Sbjct: 291 GLSELPPNLYYL---NASSNE----IRSLCDLPPSLEELNVSNNKLI-ELPALPP---RL 339
Query: 582 QLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELS 641
+ L S N L+ +P + L++ +N + E P + L ++ L+
Sbjct: 340 ERLIASFNHLA-EVPELPQNL----KQLHVEYNPL-REFPDIPESVEDL----RMNSHLA 389
Query: 642 GDLHFLAELQNLVVLNVSHNNFSGRVPDTP 671
QNL L+V N PD P
Sbjct: 390 ---EVPELPQNLKQLHVETNPLR-EFPDIP 415
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 42/200 (21%), Positives = 69/200 (34%), Gaps = 24/200 (12%)
Query: 474 FIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRL 533
FI P + L S+ LT +P E ++ T + N P G + +
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 534 QFADLSDNSVGGMLSPDLG---------SLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLL 584
+ L D +L L LV + N +P S L +
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVD 119
Query: 585 DLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDL 644
+ + LS ++P L L +S NQ+ +LP EL + L I+D+ +N L
Sbjct: 120 NNNLKALS-DLPPLLEY-------LGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK--- 166
Query: 645 HFLAELQNLVVLNVSHNNFS 664
+L + +N
Sbjct: 167 KLPDLPPSLEFIAAGNNQLE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-16
Identities = 47/300 (15%), Positives = 97/300 (32%), Gaps = 89/300 (29%)
Query: 81 LRYVDL----LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTG 136
L + L +P SL +LN + LT +P+ SL L+ + + L+
Sbjct: 239 LTTIYADNNLLKTLPDLPPSLEALN---VRDNYLT-DLPELPQSLTFLDVSENIFSGLSE 294
Query: 137 EIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNL 196
P L L +SN++ ++ SL +L + +N+L + +PA +L+ L
Sbjct: 295 LPP-------NLYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLIE-LPALPPRLERL 342
Query: 197 EAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLS 256
A + N +P N
Sbjct: 343 IA-----SFNHLAEVPELPQN--------------------------------------- 358
Query: 257 GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ 316
L+ +++ N L P ++++L N+ + +P N Q
Sbjct: 359 ------------LKQLHVEYNPLR-EFPDIPESVEDLR-----MNSHLAEVPELPQNLKQ 400
Query: 317 LSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376
L + N L P + +++L+++ ++ +L +++
Sbjct: 401 L---HVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-61
Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 29/289 (10%)
Query: 778 LTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRL 837
+ ++G+G G+V K VA+K+ + + AF E+ LSR+ H NIV+L
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKL 66
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
G A L +Y G+L +LH E L ++G++YLH
Sbjct: 67 YG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 898 AILHRDVKSHNILLGERYESC-LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
A++HRD+K N+LL + DFG A ++ + GS ++APE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-------KGSAAWMAPEVFEG 177
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016
+ SEK DV+S+G++L E+IT +KP D ++ V + + P L
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----------PPLIK 227
Query: 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSE 1065
+ I+ ++ C S RP+M+++ ++ + + E
Sbjct: 228 NLPKPIESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-60
Identities = 80/396 (20%), Positives = 157/396 (39%), Gaps = 51/396 (12%)
Query: 269 LQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLT 328
+ + P +L + L + ++ ++ ++ + ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 329 GSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSN 388
SI + LT+L+ L L+ NQI+ P + N +L + + N+IT S NL+N
Sbjct: 58 -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 389 LTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLS 448
L L++ + + ++N + +++L N + + LN L + + +
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168
Query: 449 GVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRN 508
V P + N + L N N++ P + +L +L++ N++T P +
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 509 LTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFA 568
L L + +N I L +LS LT L + N+
Sbjct: 223 LNSLKIGNNKITD--------------------------LSPLANLSQLTWLEIGTNQI- 255
Query: 569 GSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLN 628
S + + KL++L++ SNQ+S + L + L L L+ NQ+ E + GL
Sbjct: 256 -SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNS-LFLNNNQLGNEDMEVIGGLT 311
Query: 629 KLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFS 664
L L LS N ++ D+ LA L + + ++
Sbjct: 312 NLTTLFLSQNHIT-DIRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 6e-59
Identities = 84/360 (23%), Positives = 157/360 (43%), Gaps = 27/360 (7%)
Query: 257 GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ 316
QI P D E L + ++T + L+++ L + + I + +
Sbjct: 13 NQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI--QGIEYLTN 67
Query: 317 LSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376
L ++++ N +T P L NL L L + N+I+ +I A + N L ++ L+ + I+
Sbjct: 68 LEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISA-LQNLTNLRELYLNEDNIS 123
Query: 377 GAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKK 436
P NL+ + L + N ++ P +SN L + ++++ + P I L
Sbjct: 124 DISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTD 178
Query: 437 LNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLT 496
L L L N + + P + + +SL F A N++T P + N+ LN L +G+N++T
Sbjct: 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234
Query: 497 GSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSS 556
P + LT+L++ +N I+ + L +L+ ++ N + + L +LS
Sbjct: 235 DLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQ 288
Query: 557 LTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQI 616
L L LN N+ +G L L LS N ++ P L + + + + I
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS-ADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 3e-57
Identities = 88/420 (20%), Positives = 151/420 (35%), Gaps = 76/420 (18%)
Query: 100 LNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLE 159
L + P A L + L + S+T + L + +L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 160 GAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCT 219
I L++L L L NQ+TD P + N
Sbjct: 58 SIQG--IEYLTNLEYLNLNGNQITDISP---------------------------LSNLV 88
Query: 220 NLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENAL 279
L + + I+ L + T L+ +YL E+ +
Sbjct: 89 KLTNLYIGTNKIT--------------------------DISALQNLTNLRELYLNEDNI 122
Query: 280 TGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLT 339
+ P L NL + +L L N+ + + P L N + L+ + ++ + + P + NLT
Sbjct: 123 SDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLT 177
Query: 340 SLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRL 399
L L L+ NQI P + + L NQIT P N++ L L + +N++
Sbjct: 178 DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233
Query: 400 EGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCS 459
++N L +++ N ++ + L KL L + SN +S + + N S
Sbjct: 234 TD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLS 287
Query: 460 SLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSI 519
L N+N+L IG L NL L L N +T P + + D + I
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-56
Identities = 87/394 (22%), Positives = 158/394 (40%), Gaps = 52/394 (13%)
Query: 148 LEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNL 207
L + P +L+ + L +TD + +L+++ + G +
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE-KV 56
Query: 208 GGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCT 267
S+ I TNL + L I+ L +
Sbjct: 57 A-SIQ-GIEYLTNLEYLNLNGNQITDI--------------------------SPLSNLV 88
Query: 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327
+L +Y+ N +T S L NL NL L+L ++N+ I P L N +++ +++ N
Sbjct: 89 KLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN 144
Query: 328 TGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLS 387
S L N+T L L ++ +++ P I N L + L+ NQI P +L+
Sbjct: 145 L-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLT 199
Query: 388 NLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNL 447
+L + N++ P ++N L ++ + N +T P + L +L L + +N +
Sbjct: 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255
Query: 448 SGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCR 507
S + + + + L SN+++ + NL LN L L +N+L + I G
Sbjct: 256 SDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311
Query: 508 NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDN 541
NLT L + N I P L L ++ AD ++
Sbjct: 312 NLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-55
Identities = 92/374 (24%), Positives = 164/374 (43%), Gaps = 50/374 (13%)
Query: 75 QVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSL 134
+ + L+ + L S+ +LV++G + SI I L L YL+L+ N +
Sbjct: 23 EGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQI 78
Query: 135 TGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLK 194
T P L +L++L L + +N++ + NL++L +L+L ++ ++D P + L
Sbjct: 79 TDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLT 132
Query: 195 NLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTAL 254
+ ++ G N NL S + N T L + + E+ +
Sbjct: 133 KMYSLNLGANHNL--SDLSPLSNMTGLNYLTVTESKVKDV-------------------- 170
Query: 255 LSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNC 314
+ + T+L + L N + P L +L +L + N + I P + N
Sbjct: 171 ------TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220
Query: 315 SQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQ 374
++L+ + I N +T P L NL+ L L++ NQIS I A + + +L + + +NQ
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-INA-VKDLTKLKMLNVGSNQ 276
Query: 375 ITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQL 434
I+ S NLS L LF+ +N+L E I NL + LSQN +T P + L
Sbjct: 277 ISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASL 332
Query: 435 KKLNKLLLLSNNLS 448
K++ + +
Sbjct: 333 SKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-49
Identities = 74/348 (21%), Positives = 135/348 (38%), Gaps = 30/348 (8%)
Query: 341 LQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLE 400
L I+ P + + L +T + L ++T L V ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 401 GEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSS 460
I NLE ++L+ N +T P + L KL L + +N ++ + N ++
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 461 LIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIA 520
L N + ++ P + NL + L+LG+N S ++ L +L V + +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 521 GNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVK 580
+ L L L+ N + + L SL+SL N+ P + + +
Sbjct: 169 D--VTPIANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 581 LQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNEL 640
L L + +N+++ P L + L L + NQI + L KL +L++ N++
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTW-LEIGTNQI--SDINAVKDLTKLKMLNVGSNQI 277
Query: 641 SGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP-LSVL--SGNP 685
S D+ L L L L +++N + L L+ L S N
Sbjct: 278 S-DISVLNNLSQLNSLFLNNNQLGNEDMEV--IGGLTNLTTLFLSQNH 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-58
Identities = 85/332 (25%), Positives = 143/332 (43%), Gaps = 43/332 (12%)
Query: 736 PRIRGLSGSHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKV 795
P + N + G ++ + L++ IG G G V++
Sbjct: 9 PMSDYDIPTTENLYFQGAMDGDDMDI-PWCDLNI-----------KEKIGAGSFGTVHRA 56
Query: 796 TLPSGLTVAVKRFRASDKISTG--AFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853
G VAVK D + F E+A + R+RH NIV +G + +Y
Sbjct: 57 EW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115
Query: 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE 913
+ G+L LLH L+ R +A VA+G++YLH+ P I+HR++KS N+L+ +
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK 174
Query: 914 RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLL 973
+Y + DFGL+RL S S AG+ ++APE +EKSDVYS+GV+L
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSSKS----AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 974 EIITGKKPVDASFPD---GQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALG 1030
E+ T ++P + + Q V + ++ + + Q+ +++
Sbjct: 231 ELATLQQP----WGNLNPAQVVAAVGFKCKR----------LEIPRNLNPQVAAIIEG-- 274
Query: 1031 ISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
C +N RP+ + LLR + +
Sbjct: 275 ----CWTNEPWKRPSFATIMDLLRPLIKSAVP 302
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-56
Identities = 71/295 (24%), Positives = 127/295 (43%), Gaps = 44/295 (14%)
Query: 778 LTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKISTG-------AFSSEIATLSRI 829
+ IG+G G+V+K L VA+K D F E+ +S +
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLS 889
H NIV+L G + +++P G L L D A ++W + ++ L +A G+
Sbjct: 81 NHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIE 136
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESC-----LADFGLARLVEDDSGGSFSANPQFAG 944
Y+ + P I+HRD++S NI L E+ +ADFGL++ G G
Sbjct: 137 YMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL-------LG 188
Query: 945 SYGYIAPE--YANMTKISEKSDVYSYGVVLLEIITGKKP-VDASFPDGQHVIQWVRDHLK 1001
++ ++APE A +EK+D YS+ ++L I+TG+ P + S+ + + + L+
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
P + +++ +++ C S + RP + L E+
Sbjct: 249 ----------PTIPEDCPPRLRNVIEL------CWSGDPKKRPHFSYIVKELSEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-56
Identities = 77/317 (24%), Positives = 125/317 (39%), Gaps = 39/317 (12%)
Query: 774 ATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSE--IATLSRIRH 831
+L +IG+GR G VYK +L VAVK F +++ + F +E I + + H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEH 66
Query: 832 RNIVRLLG-----WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE 886
NI R + R LL +Y PNG+L L +W + ++A V
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTR 122
Query: 887 GLSYLHHD------CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS----GGSF 936
GL+YLH + PAI HRD+ S N+L+ ++DFGL+ + + G
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 937 SANPQFAGSYGYIAPEYA-------NMTKISEKSDVYSYGVVLLEIITGKKPV--DASFP 987
+A G+ Y+APE + ++ D+Y+ G++ EI + S P
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 988 DGQHVIQWVRDHLKSKKDPVEV-----LDPKLQGHPDTQIQEMLQALGISLLCTSNRAED 1042
+ Q Q + + +D + PK + C AE
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 1043 RPTMKDVAALLREIRQE 1059
R T + + E+
Sbjct: 303 RLTAQXAEERMAELMMI 319
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-55
Identities = 78/301 (25%), Positives = 120/301 (39%), Gaps = 56/301 (18%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGA----FSSEIATLSRIRH 831
LT IIG G G VY+ G VAVK R E + ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
NI+ L G L ++ G L +L + D A+ +A G++YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYL 121
Query: 892 HHDCVPAILHRDVKSHNILLGERYESC--------LADFGLARLVEDDSGGSFSANPQFA 943
H + + I+HRD+KS NIL+ ++ E+ + DFGLAR + S A
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS------AA 175
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003
G+Y ++APE + S+ SDV+SYGV+L E++TG+ P F
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRG--------------- 216
Query: 1004 KDPVEVLDPKLQGH-----PDT---QIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
D + V P T ++++ C + RP+ ++ L
Sbjct: 217 IDGLAVAYGVAMNKLALPIPSTCPEPFAKLMED------CWNPDPHSRPSFTNILDQLTT 270
Query: 1056 I 1056
I
Sbjct: 271 I 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-55
Identities = 76/302 (25%), Positives = 121/302 (40%), Gaps = 36/302 (11%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
L G ++G+G G KVT +G + +K D+ + F E+ + + H N++
Sbjct: 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 836 RLLGWGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
+ +G K K L + +Y+ GTL ++ + W R A +A G++YLH
Sbjct: 71 KFIG--VLYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHS 126
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQ----------FA 943
I+HRD+ SHN L+ E +ADFGLARL+ D+
Sbjct: 127 MN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003
G+ ++APE N EK DV+S+G+VL EII PD +++
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRTMDFGLNVRGF 239
Query: 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASG 1063
D P + ++ C E RP+ + L +R A
Sbjct: 240 LDR-----YCPPNCPPSFFPITVR-------CCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
Query: 1064 SE 1065
Sbjct: 288 LP 289
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-55
Identities = 118/646 (18%), Positives = 213/646 (32%), Gaps = 54/646 (8%)
Query: 69 SCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLD 128
SC+ + ++ R+ +L VP + L LS + L QL L+
Sbjct: 1 SCSFDGRIA--FYRFCNL-TQVPQVLNTTERLL---LSFNYIRTVTASSFPFLEQLQLLE 54
Query: 129 LSENSLTGEIPRELC-SLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAI 186
L I +E +L L L L S+++ + L L +L LY L+DA+
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAV 113
Query: 187 --PATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLL-- 242
LK L + N+ L G +L I + I L L
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
Query: 243 KRLQTIAIYTALLSGQIPPELGDCTE------LQYIYLYEN------------ALTGSIP 284
K L ++ L ++ + G C L+ + + N A++ S
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233
Query: 285 SKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSI--IDISMNSLTGSIPQTLGNLTSLQ 342
L +++ +N+ ++ S+ +D+S + + L L+
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293
Query: 343 ELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGE 402
L L+ N+I+ L + L N + S F L + + + N +
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII 353
Query: 403 IPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLI 462
+ + L+ +DL N LT I + + + L N L + +
Sbjct: 354 QDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPK----INLTAN 404
Query: 463 RFRANSNKLTGF-IPPEIGNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIA 520
+ N+L I + + +L L L NR + D+ + +L L + N +
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 521 GNLPAGLH-----QLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQL 575
L L LQ L+ N + + L++L L LN NR + L
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL 524
Query: 576 GSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDL 635
+ L++LD+S NQL P + L I N IC + + +
Sbjct: 525 PA--NLEILDISRNQLLAPNPDVFVSLSVLDITHN---KFICECELSTFINWLNHTNVTI 579
Query: 636 SHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVL 681
+ + + + ++S L +
Sbjct: 580 AGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCT 625
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-53
Identities = 80/294 (27%), Positives = 124/294 (42%), Gaps = 40/294 (13%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGL---TVAVKRFRAS--DKISTGAFSSEIATLSRIRH 831
+T G IG G G VYK G VAVK + AF +E+ L + RH
Sbjct: 25 QITVGQRIGSGSFGTVYK-----GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 832 RNIVRLLGWGANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
NI+ +G+ T + +L LH E E IA A G+
Sbjct: 80 VNILLFMGY----STAPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGM 133
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
YLH +I+HRD+KS+NI L E + DFGLA SG +GS +
Sbjct: 134 DYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL--SGSILW 188
Query: 949 IAPE---YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005
+APE + S +SDVY++G+VL E++TG+ P Q + R L
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL- 247
Query: 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
K++ + +++ ++ C + ++RP+ + A + E+ +E
Sbjct: 248 ------SKVRSNCPKRMKRLMAE------CLKKKRDERPSFPRILAEIEELARE 289
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-53
Identities = 78/314 (24%), Positives = 131/314 (41%), Gaps = 52/314 (16%)
Query: 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNI 834
R +T +G+GR G V++ + G VAVK F + D+ S +E+ +RH NI
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSW-FRETELYNTVMLRHENI 64
Query: 835 VRLLG---WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+ + + T+L L Y G+L L L+ + +I L +A GL++
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAH 120
Query: 891 LHHDCV-----PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945
LH + PAI HRD+KS NIL+ + + C+AD GLA + + N G+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 946 YGYIAPE------YANMTKISEKSDVYSYGVVLLEIITGKK----------------PVD 983
Y+APE + ++ D++++G+VL E+ P D
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 984 ASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP-DTQIQEMLQALGISLLCTSNRAED 1042
SF D + V+ D + P + + P T + ++++ C
Sbjct: 241 PSFEDMRKVV--CVDQQR----P--NIPNRWFSDPTLTSLAKLMKE------CWYQNPSA 286
Query: 1043 RPTMKDVAALLREI 1056
R T + L +I
Sbjct: 287 RLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 8e-53
Identities = 75/310 (24%), Positives = 117/310 (37%), Gaps = 40/310 (12%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+ + IG+GR G V+ G VAVK F +++ S +EI +RH NI+
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASW-FRETEIYQTVLMRHENIL 94
Query: 836 RLLG---WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
+ G T+L L DY NG+L L L+ + K+A GL +L
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHL 150
Query: 892 H-----HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
H PAI HRD+KS NIL+ + C+AD GLA D+ G+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 947 GYIAPE------YANMTKISEKSDVYSYGVVLLEIITG----------KKPVDASFPDGQ 990
Y+ PE N + +D+YS+G++L E+ + P P
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270
Query: 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHP-DTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
K P + Q+ +++ C ++ R T V
Sbjct: 271 SYEDMREIVCIKKLRPS--FPNRWSSDECLRQMGKLMTE------CWAHNPASRLTALRV 322
Query: 1050 AALLREIRQE 1059
L ++ +
Sbjct: 323 KKTLAKMSES 332
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 8e-53
Identities = 60/337 (17%), Positives = 118/337 (35%), Gaps = 24/337 (7%)
Query: 281 GSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTS 340
GS + NL+ + + L + D + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 341 LQELQLSVNQISGEIPAQIGNCQRLAQIELD--NNQITGAIPSEFGNLSNLTLLFVWHNR 398
Q + + + + + ++ L+ + + P + LS+L + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 399 LEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNC 458
L E+P ++ LE + L++N L +P I L +L +L + + +P + +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 459 S---------SLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNL 509
+L R + +P I NL+NL L + ++ L+ ++ I L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231
Query: 510 TFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAG 569
LD+ + N P L+ L D S L D+ L+ L KL L
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 570 SIPSQLGSCVKLQLLDLSSN---QLSGNIPASLGKIP 603
+PS + ++ + + QL + P + P
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 63/355 (17%), Positives = 113/355 (31%), Gaps = 35/355 (9%)
Query: 209 GSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSG-QIPPELGDCT 267
GS H + + + ++ L +R Y A + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRH-----YNADRNRWHSAWRQANSN 56
Query: 268 ELQYIYLYENALTGSIPSKLGNLK--NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325
Q AL + L + V L L L P + S L + I
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 326 SLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIEL-DNNQITGAIPSEFG 384
L +P T+ L+ L L+ N + +PA I + RL ++ + ++T +P
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT-ELPEPLA 171
Query: 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS 444
+ NL+++ L G+ +P I L+ L L + +
Sbjct: 172 STD---------------ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRN 215
Query: 445 NNLSGVIPPEMGNCSSLIRFR-ANSNKLTGFIPPEIGNLKNLNFLDL-GSNRLTGSIPDE 502
+ LS + P + + L L PP G L L L + L ++P +
Sbjct: 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLL-TLPLD 272
Query: 503 ITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSL 557
I L LD+ LP+ + QL + + + + +
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-48
Identities = 50/329 (15%), Positives = 101/329 (30%), Gaps = 30/329 (9%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158
L G+ ++ + D + + + L
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRAL 68
Query: 159 EGAIPIQIGNLSS--LTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIG 216
+ A + + + L L L P +L +L+ + LP +
Sbjct: 69 K-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL--MELPDTMQ 124
Query: 217 NCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYE 276
L + LA + LP ++ L RL+ ++I ++P L
Sbjct: 125 QFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST---------- 173
Query: 277 NALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLG 336
+ L NL +L L + +P + N L + I + L+ ++ +
Sbjct: 174 -----DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIH 226
Query: 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIEL-DNNQITGAIPSEFGNLSNLTLLFVW 395
+L L+EL L P G L ++ L D + + +P + L+ L L +
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLR 285
Query: 396 HNRLEGEIPPSISNCQNLEAVDLSQNGLT 424
+P I+ + + +
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-46
Identities = 52/387 (13%), Positives = 106/387 (27%), Gaps = 76/387 (19%)
Query: 112 GSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSS 171
GS + L ++ L R N + N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 172 LTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCT--NLVMIGLAET 229
L + + + T V + L
Sbjct: 58 PQIETRTGRALK--------------------------ATADLLEDATQPGRVALELRSV 91
Query: 230 SISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGN 289
+ Q P + + LQ++ + L +P +
Sbjct: 92 PLP-------------------------QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQ 125
Query: 290 LKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVN 349
L L L +N L +P + + ++L + I +P+ L +
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST----------- 173
Query: 350 QISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISN 409
+ + L + L+ I ++P+ NL NL L + ++ L + P+I +
Sbjct: 174 ----DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227
Query: 410 CQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSN 469
LE +DL P L +L+L + +P ++ + L +
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287
Query: 470 KLTGFIPPEIGNLKNLNFLDLGSNRLT 496
+P I L + + +
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-45
Identities = 52/275 (18%), Positives = 102/275 (37%), Gaps = 18/275 (6%)
Query: 89 HVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLN--YLDLSENSLTGEIPRELCSLL 146
H + + +G L + + Q L+L L + P + L
Sbjct: 47 HSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS 104
Query: 147 RLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKN 206
L+ + +++ L +P + + L L L N L A+PA+I L L +
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPE 162
Query: 207 LGGSLPHEIGNC---------TNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSG 257
L LP + + NL + L T I LP ++ L+ L+++ I + LS
Sbjct: 163 LT-ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS- 219
Query: 258 QIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQL 317
+ P + +L+ + L + P G L L L + + +P ++ +QL
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL 279
Query: 318 SIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQIS 352
+D+ +P + L + + + + +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 56/344 (16%), Positives = 97/344 (28%), Gaps = 53/344 (15%)
Query: 329 GSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSN 388
GS + + + L + + QR D N+ N +N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRH--YNADRNRWH--SAWRQANSNN 57
Query: 389 LTLLFVWHNRLEGEIPPSISNCQ--NLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNN 446
+ L+ + + A++L L
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP---------------------- 94
Query: 447 LSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506
P + S L ++ L +P + L L L N L ++P I
Sbjct: 95 ---QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASL 149
Query: 507 RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNR 566
L L + + LP L S + L +L L L
Sbjct: 150 NRLRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTG 194
Query: 567 FAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTG 626
S+P+ + + L+ L + ++ LS + ++ +P L L+L P G
Sbjct: 195 IR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL-EELDLRGCTALRNYPPIFGG 251
Query: 627 LNKLGILDLSHNELSGDL-HFLAELQNLVVLNVSHNNFSGRVPD 669
L L L L + L L L++ R+P
Sbjct: 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 13/67 (19%), Positives = 22/67 (32%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEI 138
L L+ L +P + L L +L L G +P IA L + + +
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317
Query: 139 PRELCSL 145
+
Sbjct: 318 QHRPVAR 324
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-52
Identities = 51/292 (17%), Positives = 114/292 (39%), Gaps = 42/292 (14%)
Query: 778 LTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGA--FSSEIATLSRIRHRNIV 835
L + + SG ++K G + VK + D + + F+ E L H N++
Sbjct: 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 836 RLLGWGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
+LG + +MP G+L +LH+G +++ K AL +A G+++LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHT 129
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
P I + S ++++ E + ++ + + + ++APE
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR---------MYAPAWVAPEA 179
Query: 954 ANM---TKISEKSDVYSYGVVLLEIITGKKPVDASFPD---GQHVIQWVRDHLKSKKDPV 1007
+D++S+ V+L E++T + P F D + ++ + L+
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP----FADLSNMEIGMKVALEGLR------ 229
Query: 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
P + + ++++ C + RP + +L +++ +
Sbjct: 230 ----PTIPPGISPHVSKLMKI------CMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 8e-52
Identities = 79/310 (25%), Positives = 130/310 (41%), Gaps = 40/310 (12%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
R++ IG+GR G V++ G VAVK F + ++ S +EI +RH NI+
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENIL 99
Query: 836 RLLG---WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
+ T+L L DY +G+L L+ + + K+AL A GL++L
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHL 155
Query: 892 HHDCV-----PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
H + V PAI HRD+KS NIL+ + C+AD GLA + + A G+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 947 GYIAPE----YANMTKI--SEKSDVYSYGVVLLEIITG----------KKPVDASFPDGQ 990
Y+APE NM +++D+Y+ G+V EI + P P
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHP-DTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
V + + + K P + + Q + ++++ C R T +
Sbjct: 276 SVEEMRKVVCEQKLRPN--IPNRWQSCEALRVMAKIMRE------CWYANGAARLTALRI 327
Query: 1050 AALLREIRQE 1059
L ++ Q+
Sbjct: 328 KKTLSQLSQQ 337
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-51
Identities = 65/306 (21%), Positives = 114/306 (37%), Gaps = 49/306 (16%)
Query: 778 LTAGNIIGQGRSGIVYKVTLPSGL---TVAVKRFRASD--KISTGAFSSEIATLSRIRHR 832
L G +IG+GR G VY G VA++ + AF E+ + RH
Sbjct: 35 LEIGELIGKGRFGQVYH-----GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 833 NIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
N+V +G + + TL ++ D + L+ + +IA + +G+ YLH
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH 147
Query: 893 HDCVPAILHRDVKSHNILLGERYESC-LADFGLARLVEDDSGGSFSAN-PQFAGSYGYIA 950
ILH+D+KS N+ + DFGL + G G ++A
Sbjct: 148 A---KGILHKDLKSKNVFYDNG--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 951 PEYANMTKI---------SEKSDVYSYGVVLLEIITGKKPVDASFPD--GQHVIQWVRDH 999
PE S+ SDV++ G + E+ + P F + +I +
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKTQPAEAIIWQMGTG 258
Query: 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
+K ++ + I ++L C + E+RPT + +L ++ +
Sbjct: 259 MKP-------NLSQIGMGKE--ISDILLF------CWAFEQEERPTFTKLMDMLEKLPKR 303
Query: 1060 PASGSE 1065
S
Sbjct: 304 NRRLSH 309
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-50
Identities = 91/530 (17%), Positives = 187/530 (35%), Gaps = 62/530 (11%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELC-SL 145
+P+ T+ ++ L LS +T ++ + L L L + + I + SL
Sbjct: 17 FTSIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSL 73
Query: 146 LRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTD-AIPATIGKLKNLEAIRAGGN 204
LE L L+ N L G LSSL L L N + + L NL+ +R G
Sbjct: 74 GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV 133
Query: 205 KNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELG 264
+ + T+L + + S+ + +L ++ + + ++ + + +
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFAD 193
Query: 265 DCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGI----------IPPELGNC 314
+ ++Y+ L + L S L + + + + +
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253
Query: 315 SQLSIIDISMNSLTGSIPQTLG--------NLTSLQELQLSVNQISGEIPAQIGNCQRLA 366
S++ D ++N L P +++ L + + ++ +++
Sbjct: 254 SEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313
Query: 367 QIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPS---ISNCQNLEAVDLSQNGL 423
+I ++N+++ S +L +L L + N + E + +L+ + LSQN L
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
Query: 424 TGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLK 483
+ + L L L L ++S N +P +
Sbjct: 374 RS-MQKTGEILLTLKNLTSL--DISR-------------------NTFH-PMPDSCQWPE 410
Query: 484 NLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSV 543
+ FL+L S + + I + L LDV +N++ + L +L L +S N
Sbjct: 411 KMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-SFSLFLPRLQEL---YISRNK- 462
Query: 544 GGMLS--PDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQL 591
L PD L + +++N+ LQ + L +N
Sbjct: 463 ---LKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-48
Identities = 100/564 (17%), Positives = 186/564 (32%), Gaps = 54/564 (9%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158
+ + T SIP + + LDLS N +T +L + L+ L L S+++
Sbjct: 6 ASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 159 EGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNC 218
+L SL L L DN L+ + G L +L+ + GN + N
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 219 TNLVMIGLAET-SISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYEN 277
TNL + + + S L L + I L L ++ ++ L+ +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 278 ALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGN 337
+ L ++ L L NL L S + + ++
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 338 LTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHN 397
L L L ++++ +C + + ++ + L +
Sbjct: 243 LLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 398 RLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEM- 455
L ++ S + ++ + + + + +P Q LK L L L N +
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 456 --GNCSSLIRFRANSNKLTGFIPPEIG---NLKNLNFLDLGSNRLTGSIPDEITGCRNLT 510
G SL + N L + LKNL LD+ N +PD +
Sbjct: 356 CKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMR 413
Query: 511 FLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGS 570
FL++ S I + + L+ D+S+N+ L L L +L +++N+ +
Sbjct: 414 FLNLSSTGIR-VVKTCI--PQTLEVLDVSNNN----LDSFSLFLPRLQELYISRNKLK-T 465
Query: 571 IPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKL 630
+P L ++ +S NQL ++P + L L
Sbjct: 466 LPD-ASLFPVLLVMKISRNQLK-SVPDGI------------------------FDRLTSL 499
Query: 631 GILDLSHNELSGDLHFLAELQNLV 654
+ L N + L +
Sbjct: 500 QKIWLHTNPWDCSCPRIDYLSRWL 523
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 7e-47
Identities = 89/454 (19%), Positives = 156/454 (34%), Gaps = 37/454 (8%)
Query: 258 QIPPE-LGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ 316
I L C LQ + L + + +L +L +L L N+L + G S
Sbjct: 40 YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99
Query: 317 LSIIDISMNSLTG-SIPQTLGNLTSLQELQLSVNQISGEIPAQ-IGNCQRLAQIELDNNQ 374
L +++ N + NLT+LQ L++ + EI L ++E+
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159
Query: 375 ITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQL 434
+ ++ ++ L + + + ++ ++L L +
Sbjct: 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219
Query: 435 KKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRAN----------SNKLTGFIPPEIGNLKN 484
+ + + L+ S + L+R+ N L F P E +
Sbjct: 220 EVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSE 279
Query: 485 LNF--------LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG-LHQLVRLQF 535
L L + L + + + + V ++ + +P L L+F
Sbjct: 280 LGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV-FLVPCSFSQHLKSLEF 338
Query: 536 ADLSDN---SVGGMLSPDLGSLSSLTKLVLNKNRFA--GSIPSQLGSCVKLQLLDLSSNQ 590
DLS+N S G+ SL LVL++N L + L LD+S N
Sbjct: 339 LDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT 398
Query: 591 LSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAEL 650
+P S + LNLS I + + L +LD+S+N L F L
Sbjct: 399 FH-PMPDSCQWPEKMRF-LNLSSTGI-RVVKTCI--PQTLEVLDVSNNNLD---SFSLFL 450
Query: 651 QNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGN 684
L L +S N +PD F L + +S N
Sbjct: 451 PRLQELYISRNKLK-TLPDASLFPVLLVMKISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-44
Identities = 81/455 (17%), Positives = 149/455 (32%), Gaps = 43/455 (9%)
Query: 266 CTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325
C + T SIPS L + +L L N + I +L C+ L ++ + +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 326 SLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITG-AIPSEFG 384
+ +L SL+ L LS N +S + G L + L N + S F
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
Query: 385 NLSNLTLLFVWHNRLEGEIPP-SISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLL 442
NL+NL L + + EI + +L +++ L + ++ ++ L L
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTL 179
Query: 443 LSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTG----- 497
+ + ++ SS+ L F + + + + + R +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 498 -----SIPDEITGCRNLTFLDVHSNSIAGNLPAGLH--------QLVRLQFADLSDNSVG 544
+ I + F D N + P+ + V ++ + +
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 545 GMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGS-CVKLQLLDLSSNQLSGNI---PASLG 600
LS L + ++ + ++ +P L+ LDLS N + A G
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358
Query: 601 KIPALAIALNLSWNQI--CGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNV 658
P+L L LS N + + L L L LD+S N + + LN+
Sbjct: 359 AWPSLQT-LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNL 417
Query: 659 SHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFSGNQ 693
S + + L S N
Sbjct: 418 SSTGIR----------VVKTCIPQTLEVLDVSNNN 442
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-41
Identities = 58/390 (14%), Positives = 122/390 (31%), Gaps = 30/390 (7%)
Query: 313 NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDN 372
+C + D S T SIP L +++ L LS N+I+ + C L + L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 373 NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIF 432
++I F +L +L L + N L +L+ ++L N +F
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 433 Q-LKKLNKLLLLSNNLSGVIPPEM-GNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDL 490
L L L + + I +SL + L + + ++++++ L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 491 GSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPD 550
+ + ++ +L++ ++A + L +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 551 LGSLSSLTKLV------------------LNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS 592
L L + + N + V ++ L + L
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 593 GNIPASLGKIPALAIALNLSWNQICGELPAE-LTGLNKLGILDLSHNELS----GDLHFL 647
++ + + + + +++ +P L L LDLS N + +
Sbjct: 300 YDLSTVYSLLEKVKR-ITVENSKV-FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 648 AELQNLVVLNVSHNNFSGRVPDTPFFAKLP 677
+L L +S N+ L
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-13
Identities = 40/237 (16%), Positives = 80/237 (33%), Gaps = 26/237 (10%)
Query: 78 GLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTG 136
L + L + T ++ L + R+ + + + +P L L +LDLSEN +
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 137 EIPRE---LCSLLRLEQLRLNSNQLE--GAIPIQIGNLSSLTQLFLYDNQLTDAIPATIG 191
E + + L+ L L+ N L + L +LT L + N +P +
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQ 407
Query: 192 KLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIY 251
+ + + + + I L ++ ++ ++ L L+ L
Sbjct: 408 WPEKMRFLNLSST-GIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQEL------ 456
Query: 252 TALLSG----QIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLV 304
+S +P L + + N L L +L ++L N
Sbjct: 457 --YISRNKLKTLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 1e-48
Identities = 67/486 (13%), Positives = 142/486 (29%), Gaps = 47/486 (9%)
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSL 172
+I + + N+ ++++SL + S +++L L+ N L + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 173 TQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSIS 232
L L N L + + + L L + N E+ ++ + A +IS
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNY------VQELLVGPSIETLHAANNNIS 112
Query: 233 GFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKN 292
++ G + IYL N +T G
Sbjct: 113 -------------------------RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSR 145
Query: 293 LVNLFLWQNNLVGIIPPEL-GNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQI 351
+ L L N + + EL + L +++ N + + + L+ L LS N++
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL 203
Query: 352 SGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQ 411
+ + + + + I L NN++ I NL + N +
Sbjct: 204 A-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSK 260
Query: 412 NLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKL 471
N +++ + + + + + P +L R
Sbjct: 261 NQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSG 320
Query: 472 TG----FIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL 527
G + E N +D + I + L+ ++ + G
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380
Query: 528 HQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFA-GSIPSQLGSCVKLQLLDL 586
L L S L L R+ + Q ++ D+
Sbjct: 381 RAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDM 439
Query: 587 SSNQLS 592
++ +
Sbjct: 440 YQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-44
Identities = 62/459 (13%), Positives = 140/459 (30%), Gaps = 22/459 (4%)
Query: 210 SLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTEL 269
++ N + + ++S+ L ++ + + LS +L T+L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTG 329
+ + L N L ++ L +L L L L N + EL + + + N+++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 330 SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITG-AIPSEFGNLSN 388
+ + + L+ N+I+ G R+ ++L N+I +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 389 LTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLS 448
L L + +N + ++ + L+ +DLS N L + + + L +N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227
Query: 449 GVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRN 508
+I + +L F N KN + + C
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 509 LTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGM----LSPDLGSLSSLTKLVLNK 564
T + +L+ L+ + + S G L + + + ++ K
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 565 NRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPAL-AIALNLSWNQICGELPAE 623
++ I L+ L + L E
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
Query: 624 LTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNN 662
+ L L + + E+ + + + ++ +
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQ-QSVQNNAIRDWDMYQHK 443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-37
Identities = 59/301 (19%), Positives = 108/301 (35%), Gaps = 16/301 (5%)
Query: 378 AIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKL 437
AI N + + V + L+ + + N++ +DLS N L+ + KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 438 NKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTG 497
L L SN L ++ + S+L N+N + E+ ++ L +N ++
Sbjct: 61 ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 498 SIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDL-GSLSS 556
+ + + + +N I R+Q+ DL N + + +L S +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 557 LTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQI 616
L L L N + Q+ KL+ LDLSSN+L+ + + ++L N++
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-ISLRNNKL 226
Query: 617 CGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKL 676
+ L L DL N +N V V+ +
Sbjct: 227 -VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 677 P 677
P
Sbjct: 286 P 286
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-36
Identities = 58/423 (13%), Positives = 122/423 (28%), Gaps = 21/423 (4%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEI 138
LDL L + L L LS L ++ + SL+ L LDL+ N +
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ--- 93
Query: 139 PRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEA 198
EL +E L +N + + ++L +N++T G ++
Sbjct: 94 --ELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 199 IRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQ 258
+ N+ + + L + L I + +L+T+ + + L+
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA-F 205
Query: 259 IPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLS 318
+ PE + +I L N L I L +NL + L N +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQR 263
Query: 319 IIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRL-----AQIELDNN 373
+ ++ ++ Q T L A + +
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323
Query: 374 QITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ 433
+ + E N + + + I Q ++ + L + G
Sbjct: 324 ETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRA 382
Query: 434 LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493
+L+ L + + + ++ + + D+ +
Sbjct: 383 HAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQH 442
Query: 494 RLT 496
+ T
Sbjct: 443 KET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-29
Identities = 67/367 (18%), Positives = 110/367 (29%), Gaps = 18/367 (4%)
Query: 81 LRYVDL----LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTG 136
+ + + V + + L+ +T + +++ YLDL N +
Sbjct: 101 IETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158
Query: 137 -EIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKN 195
S LE L L N + + Q+ + L L L N+L +
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAG 215
Query: 196 LEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSIS-GFLPPTLGLLKRLQTIAI-YTA 253
+ I NK L + + NL L G L +R+QT+A
Sbjct: 216 VTWISLRNNK-L-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
Query: 254 LLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLW-QNNLVGIIPPELG 312
L+GQ E T Y L +L LK + L Q + + E
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 313 NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDN 372
N ++ ID I Q + L+ + ++ L
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 373 NQITGAIPSEFGNLSNLTLLFVWHNRL-EGEIPPSISNCQNLEAVDLSQNGLTGPIPRGI 431
+ S L LL R E + + D+ Q+ T +
Sbjct: 394 VGQI-ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-QLAEEN 451
Query: 432 FQLKKLN 438
+LKKLN
Sbjct: 452 ARLKKLN 458
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 49/208 (23%), Positives = 79/208 (37%), Gaps = 14/208 (6%)
Query: 479 IGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADL 538
N + + L ++ N+ LD+ N ++ A L +L+ +L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 539 SDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPAS 598
S N + DL SLS+L L LN N +L ++ L ++N +S + S
Sbjct: 66 SSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS 117
Query: 599 LGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSG--DLHFLAELQNLVVL 656
G + L+ N+I + +++ LDL NE+ A L L
Sbjct: 118 RG--QGKKN-IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 657 NVSHNNFSGRVPDTPFFAKLPLSVLSGN 684
N+ +N V FAKL LS N
Sbjct: 175 NLQYNFIY-DVKGQVVFAKLKTLDLSSN 201
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 16/149 (10%), Positives = 40/149 (26%), Gaps = 4/149 (2%)
Query: 69 SCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGT-NLTGSIPKEIASLNQLNYL 127
C + DL +L +LSG + T + E + + +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREI 341
Query: 128 DLSENSLTGEIPRELCSLLR-LEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAI 186
D + + ++ + L L+ + + L + +
Sbjct: 342 DALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIE-L 399
Query: 187 PATIGKLKNLEAIRAGGNKNLGGSLPHEI 215
+ L+ +RA + + +
Sbjct: 400 QHATEEQSPLQLLRAIVKRYEEMYVEQQS 428
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 8e-47
Identities = 78/385 (20%), Positives = 148/385 (38%), Gaps = 25/385 (6%)
Query: 307 IPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRL 365
I L + I M + L + + + + + ++PA + + +++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 366 AQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLT 424
+ L++ QI F + L++ N + +PP + N L + L +N L+
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 425 GPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLK 483
+PRGIF KL L + +NNL + +SL + +SN+LT ++ +
Sbjct: 131 S-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIP 186
Query: 484 NLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSV 543
+L ++ N L+ + + LD NSI + + V L L N++
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 238
Query: 544 GGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIP 603
L + L ++ L+ N + +L+ L +S+N+L + IP
Sbjct: 239 TDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 604 ALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNF 663
L + L+LS N + + ++L L L HN + L L L +SHN++
Sbjct: 296 TLKV-LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST-HHTLKNLTLSHNDW 351
Query: 664 SGRVPDTPFFAKLPLSVLSGNPSLC 688
F + + C
Sbjct: 352 DC-NSLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-41
Identities = 68/393 (17%), Positives = 136/393 (34%), Gaps = 31/393 (7%)
Query: 71 NLNNQVVGLDLRYVDLLGHVPTNFT--SLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYL 127
NL V D+ V F +L + + + + +P + S Q+ L
Sbjct: 16 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 74
Query: 128 DLSENSLTGEIPRE-LCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDA 185
+L++ + EI +++L + N + +P + N+ LT L L N L+
Sbjct: 75 NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 186 IPATIGKLKNLEAIRAGGNKNLGGSLPHEI-GNCTNLVMIGLAETSISGFLPPTLGLLKR 244
L + N L + + T+L + L+ ++ L L+
Sbjct: 133 PRGIFHNTPKLTTLSMSNNN-L-ERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPS 187
Query: 245 LQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLV 304
L +S + L ++ + N++ + L L L NNL
Sbjct: 188 LFHA-----NVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT 239
Query: 305 GIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQR 364
L N L +D+S N L + + L+ L +S N++ +
Sbjct: 240 DT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296
Query: 365 LAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLT 424
L ++L +N + + L L++ HN + + S L+ + LS N
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352
Query: 425 GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGN 457
R +F+ + + + + I ++ +
Sbjct: 353 CNSLRALFR--NVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-40
Identities = 74/436 (16%), Positives = 142/436 (32%), Gaps = 80/436 (18%)
Query: 90 VPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRE-LCSLLRL 148
+ +N + + E +LN + +++ ++P L S ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 149 EQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLG 208
E L LN Q+E ++ +L++ N + P + L + N L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND-L- 129
Query: 209 GSLPHEI-GNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE-LGDC 266
SLP I N L + ++ ++ +I +
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLE-------------------------RIEDDTFQAT 164
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
T LQ + L N LT + L + +L + + N L L + +D S NS
Sbjct: 165 TSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNS 216
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNL 386
+ + L L+L N ++ + + N L +++L N++ + F +
Sbjct: 217 IN-VVRG--PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKM 271
Query: 387 SNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNN 446
L L++ +NRL + L+ +DLS N L + R Q +L L L N+
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS 329
Query: 447 LSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506
+ + ++ L L L N +
Sbjct: 330 IVTL---------------------------KLSTHHTLKNLTLSHNDWDCN-------S 355
Query: 507 RNLTFLDVHSNSIAGN 522
F +V ++
Sbjct: 356 LRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 73/459 (15%), Positives = 148/459 (32%), Gaps = 102/459 (22%)
Query: 138 IPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLE 197
I L + ++ + + L++ + ++ + A + + +E
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 198 AIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSG 257
+ L + I
Sbjct: 73 LLN-------------------------LNDLQIE------------------------- 82
Query: 258 QIPPE-LGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ 316
+I +Q +Y+ NA+ P N+ L L L +N+L + N +
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 142
Query: 317 LSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376
L+ + +S N+L T TSLQ LQLS N+++ +
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD-------------------- 181
Query: 377 GAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKK 436
+ +L V +N L +++ +E +D S N + + + +
Sbjct: 182 ------LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPVNV--E 227
Query: 437 LNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRL 495
L L L NNL+ + N L+ + N+L I ++ L L + +NRL
Sbjct: 228 LTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 284
Query: 496 TGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLS 555
++ L LD+ N + ++ Q RL+ L NS+ + L +
Sbjct: 285 V-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---KLSTHH 339
Query: 556 SLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGN 594
+L L L+ N + + ++ +++ +
Sbjct: 340 TLKNLTLSHNDWD-------CNSLRALFRNVARPAVDDA 371
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-43
Identities = 80/406 (19%), Positives = 153/406 (37%), Gaps = 25/406 (6%)
Query: 307 IPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRL 365
I L + I M + L + + + + + ++PA + + +++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 366 AQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLT 424
+ L++ QI F + L++ N + +PP + N L + L +N L+
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136
Query: 425 GPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLK 483
+PRGIF KL L + +NNL + +SL + +SN+LT ++ +
Sbjct: 137 S-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIP 192
Query: 484 NLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSV 543
+L ++ N L+ + + LD NSI + + V L L N++
Sbjct: 193 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 244
Query: 544 GGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIP 603
L + L ++ L+ N + +L+ L +S+N+L + IP
Sbjct: 245 TDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 301
Query: 604 ALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNF 663
L + L+LS N + + ++L L L HN + L + L L +SHN++
Sbjct: 302 TLKV-LDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKNLTLSHNDW 357
Query: 664 SGRVPDTPFFAKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAG 709
F + + C Q K+ +
Sbjct: 358 DC-NSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLD 402
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-38
Identities = 90/550 (16%), Positives = 172/550 (31%), Gaps = 81/550 (14%)
Query: 90 VPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRE-LCSLLRL 148
+ +N + + E +LN + +++ ++P L S ++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 149 EQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLG 208
E L LN Q+E ++ +L++ N + P + L + N
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND--- 134
Query: 209 GSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE-LGDCT 267
+S +L T+++ L +I + T
Sbjct: 135 ----------------------LSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATT 171
Query: 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327
LQ + L N LT + L + +L + + N L L + +D S NS+
Sbjct: 172 SLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSI 223
Query: 328 TGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLS 387
+ L L+L N ++ + + N L +++L N++ + F +
Sbjct: 224 N-VVRG--PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278
Query: 388 NLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNL 447
L L++ +NRL + L+ +DLS N L + R Q +L L L N++
Sbjct: 279 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI 336
Query: 448 SGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCR 507
+ ++ L L L N +
Sbjct: 337 VTL---------------------------KLSTHHTLKNLTLSHNDWDCN-------SL 362
Query: 508 NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRF 567
F +V ++ +L+ S L L + +LT +V R
Sbjct: 363 RALFRNVARPAVDDA-DQHCKIDYQLEHGLCCKESDKPYLDRLLQYI-ALTSVVEKVQRA 420
Query: 568 AGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGL 627
G + + +Q L Q G ++ A L Q+ E + L
Sbjct: 421 QGRCSA-TDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLL 479
Query: 628 NKLGILDLSH 637
L ++
Sbjct: 480 QGLHAEIDTN 489
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-37
Identities = 71/393 (18%), Positives = 138/393 (35%), Gaps = 31/393 (7%)
Query: 71 NLNNQVVGLDLRYVDLLGHVPTNFT--SLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYL 127
NL V D+ V F +L + + + + +P + S Q+ L
Sbjct: 22 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 80
Query: 128 DLSENSLTGEIPRE-LCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDA 185
+L++ + EI +++L + N + +P + N+ LT L L N L+
Sbjct: 81 NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSL 138
Query: 186 IPATIGKLKNLEAIRAGGNKNLGGSLPHEI-GNCTNLVMIGLAETSISGFLPPTLGLLKR 244
L + N NL + + T+L + L+ ++ L L+
Sbjct: 139 PRGIFHNTPKLTTLSMSNN-NL-ERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPS 193
Query: 245 LQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLV 304
L + LLS L ++ + N++ + L L L NNL
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT 245
Query: 305 GIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQR 364
L N L +D+S N L + + L+ L +S N++ +
Sbjct: 246 DT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302
Query: 365 LAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLT 424
L ++L +N + + L L++ HN + + S L+ + LS N
Sbjct: 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 358
Query: 425 GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGN 457
R +F+ + + + + I ++ +
Sbjct: 359 CNSLRALFR--NVARPAVDDADQHCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 70/360 (19%), Positives = 136/360 (37%), Gaps = 41/360 (11%)
Query: 354 EIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQN 412
I + + + +D E L+N ++ ++ + ++P ++ + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 413 LEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEM-GNCSSLIRFRANSNK 470
+E ++L+ + I F + KL + N + +PP + N L N
Sbjct: 77 VELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 471 LTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAGLH 528
L+ +P I N L L + +N L I D+ +L L + SN + ++ L
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL- 190
Query: 529 QLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSS 588
+ L A++S N + L ++ +L + N + V+L +L L
Sbjct: 191 -IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQH 241
Query: 589 NQLSGNIPASLGKIPALAIALNLSWNQICGELPAE-LTGLNKLGILDLSHNELSGDLHFL 647
N L+ + L P L ++LS+N++ ++ + +L L +S+N L +
Sbjct: 242 NNLT-DTAW-LLNYPGLVE-VDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLVALNLYG 297
Query: 648 AELQNLVVLNVSHNNFSGRVPDTPF--------------FAKLPLSVLSGNPSLCFSGNQ 693
+ L VL++SHN+ V L LS +L S N
Sbjct: 298 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHND 356
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 74/448 (16%), Positives = 145/448 (32%), Gaps = 95/448 (21%)
Query: 122 NQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQ 181
Q Y I L + ++ + + L++ + ++
Sbjct: 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 182 LTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEI-GNCTNLVMIGLAETSISGFLPPTLG 240
+ LP + + + ++ L + I
Sbjct: 63 MR--------------------------KLPAALLDSFRQVELLNLNDLQIE-------- 88
Query: 241 LLKRLQTIAIYTALLSGQIPPE-LGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLW 299
+I +Q +Y+ NA+ P N+ L L L
Sbjct: 89 -----------------EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131
Query: 300 QNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI 359
+N+L + N +L+ + +S N+L T TSLQ LQLS N+++ +
Sbjct: 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--- 187
Query: 360 GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLS 419
+ +L V +N L +++ +E +D S
Sbjct: 188 -----------------------LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 219
Query: 420 QNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI 479
N + + + +L L L NNL+ + N L+ + N+L +
Sbjct: 220 HNSINV-VRGPVNV--ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPF 274
Query: 480 GNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLS 539
++ L L + +NRL ++ L LD+ N + ++ Q RL+ L
Sbjct: 275 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 332
Query: 540 DNSVGGMLSPDLGSLSSLTKLVLNKNRF 567
NS +++ L + +L L L+ N +
Sbjct: 333 HNS---IVTLKLSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-15
Identities = 59/376 (15%), Positives = 127/376 (33%), Gaps = 32/376 (8%)
Query: 81 LRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPR 140
L + ++ ++ + +++ L S ++ + + +L L L N+LT +
Sbjct: 194 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA- 248
Query: 141 ELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIR 200
L + L ++ L+ N+LE + + L +L++ +N+L + + L+ +
Sbjct: 249 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 307
Query: 201 AGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQ----------TIAI 250
N L + L + L SI T LK L A+
Sbjct: 308 LSHNHLL--HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRAL 365
Query: 251 YTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPE 310
+ + + C Y E+ L K + + ++ ++V +
Sbjct: 366 FRNVARPAVDDADQHCKID---YQLEHGLCCKESDK--PYLDRLLQYIALTSVVEKVQRA 420
Query: 311 LGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIEL 370
G CS I+ + Q L ++L+ VN++ E+ Q+L ++
Sbjct: 421 QGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV-------QQLTNEQI 473
Query: 371 DNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRG 430
Q+ + +E +NL + + L +L+ + T
Sbjct: 474 QQEQLLQGLHAE--IDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTE 531
Query: 431 IFQLKKLNKLLLLSNN 446
+K + L N
Sbjct: 532 ADAKQKETEDLEQENI 547
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 43/314 (13%), Positives = 93/314 (29%), Gaps = 35/314 (11%)
Query: 81 LRYVDL----LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTG 136
L + + L + + +L L LS +L + + ++L L L NS+
Sbjct: 280 LERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV- 337
Query: 137 EIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNL 196
+ + L+ L L+ N + + ++ + + D I +
Sbjct: 338 TLKLS--THHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCC 393
Query: 197 EAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLS 256
+K L I T++V + T+ ++ L +
Sbjct: 394 ----KESDKPYLDRLLQYI-ALTSVVE-KVQRAQGRCSATDTINSVQSLSHYITQQGGVP 447
Query: 257 GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ 316
Q +L E+ + LT + L+ L +
Sbjct: 448 LQGNEQLE--AEVNELRAEVQQLTNEQIQQEQLLQGL----------------HAEIDTN 489
Query: 317 LSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQR-LAQIELDNNQI 375
L + + L S T L+E Q + + + Q+ +E +N +
Sbjct: 490 LRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIAL 549
Query: 376 TGAIPSEFGNLSNL 389
+ ++ + L
Sbjct: 550 EKQLDNKRAKQAEL 563
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-43
Identities = 88/434 (20%), Positives = 152/434 (35%), Gaps = 60/434 (13%)
Query: 257 GQIPPELGDCTE--LQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNC 314
+ ++ C + + E+ LT ++P L ++ L + NNL +P
Sbjct: 28 AAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPEL 83
Query: 315 SQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQ 374
L ++S N LT S+P L L + + PA +L + NQ
Sbjct: 84 RTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL---WIFGNQ 132
Query: 375 ITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQL 434
+T ++P L L++ N+L +P S L N LT +P L
Sbjct: 133 LT-SLPVLPPGLQELSVS---DNQLA-SLPALPSELCKL---WAYNNQLTS-LPMLPSGL 183
Query: 435 KKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNR 494
++L+ +S+N +P L A +N+LT +P LK L + NR
Sbjct: 184 QELS----VSDNQLASLPTLPSELYKL---WAYNNRLT-SLPALPSGLKEL---IVSGNR 232
Query: 495 LTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSL 554
LT S+P + L L V N + +LP L+ L + N + L L L
Sbjct: 233 LT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHL 283
Query: 555 SSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWN 614
SS T + L N + Q ++ S + + P AL+L+
Sbjct: 284 SSETTVNLEGNPLS-ERTLQA--LREITSAPGYSGPII-RFDMAGASAPRETRALHLAAA 339
Query: 615 QICGELPAELTGLNKLGILDLSHNEL-SGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFF 673
+PA + E + + + + F ++
Sbjct: 340 --DWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSW--- 394
Query: 674 AKLPLSVLSGNPSL 687
L+ L+ + +L
Sbjct: 395 ----LAQLAEDEAL 404
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 9e-40
Identities = 80/402 (19%), Positives = 131/402 (32%), Gaps = 71/402 (17%)
Query: 141 ELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIR 200
C L + + L +P + +T L + DN LT +PA +L+ LE
Sbjct: 35 RACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPALPPELRTLEV-- 88
Query: 201 AGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIP 260
+ N SLP L + T +
Sbjct: 89 ---SGNQLTSLPVLPPGLLELSIFSNPLTHLPALP------------------------- 120
Query: 261 PELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSII 320
+ L ++++ N LT S+P L+ L + N L +P +L
Sbjct: 121 ------SGLCKLWIFGNQLT-SLPVLPPGLQEL---SVSDNQL-ASLPALPSELCKL--- 166
Query: 321 DISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIP 380
N LT S+P L QEL +S NQ++ +P +L NN++T ++P
Sbjct: 167 WAYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLP 217
Query: 381 SEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKL 440
+ S L L V NRL +P S + L +S N LT +P L L+
Sbjct: 218 AL---PSGLKELIVSGNRLT-SLPVLPSELKEL---MVSGNRLTS-LPMLPSGLLSLS-- 267
Query: 441 LLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIP 500
+ N +P + + SS N L+ + + + R +
Sbjct: 268 --VYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325
Query: 501 DEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNS 542
R L ++ + R DN+
Sbjct: 326 SAPRETRALH--LAAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 2e-39
Identities = 83/451 (18%), Positives = 137/451 (30%), Gaps = 123/451 (27%)
Query: 117 EIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLF 176
N L++ E+ LT +P L + + L + N L ++P L +L
Sbjct: 35 RACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE--- 87
Query: 177 LYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLP 236
+ NQLT SLP L + T +
Sbjct: 88 VSGNQLT--------------------------SLPVLPPGLLELSIFSNPLTHLPALP- 120
Query: 237 PTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNL 296
+ L ++++ N LT S+P L+ L
Sbjct: 121 ------------------------------SGLCKLWIFGNQLT-SLPVLPPGLQEL--- 146
Query: 297 FLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIP 356
+S N L S+P L L NQ++ +P
Sbjct: 147 ------------------------SVSDNQLA-SLPALPSELCK---LWAYNNQLT-SLP 177
Query: 357 AQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAV 416
Q L + +NQ+ ++P+ L L +NRL +P S + L
Sbjct: 178 MLPSGLQEL---SVSDNQLA-SLPTLPSELYKLWAY---NNRLT-SLPALPSGLKEL--- 226
Query: 417 DLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIP 476
+S N LT +P +LK+L +S N +P SL N+LT +P
Sbjct: 227 IVSGNRLTS-LPVLPSELKELM----VSGNRLTSLPMLPSGLLSL---SVYRNQLT-RLP 277
Query: 477 PEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSI--AGNLPAGLHQLVRLQ 534
+ +L + ++L N L+ + R +T +S I A + R
Sbjct: 278 ESLIHLSSETTVNLEGNPLS-ERTLQA--LREITSAPGYSGPIIRFDMAGASAPRETRAL 334
Query: 535 FADLSDNSVGGMLSPDLGSLSSLTKLVLNKN 565
+D V + N
Sbjct: 335 HLAAADWLVPAREG-EPAPADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-30
Identities = 76/351 (21%), Positives = 123/351 (35%), Gaps = 53/351 (15%)
Query: 71 NLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLS 130
L + L + +L +P L +L +SG LT S+P L +L+
Sbjct: 58 CLPAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNP 112
Query: 131 ENSLTGEIPRELCSLL--------------RLEQLRLNSNQLEGAIPIQIGNLSSLTQLF 176
L +P LC L L++L ++ NQL ++P L L
Sbjct: 113 LTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPALPSELCKLW--- 167
Query: 177 LYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLP 236
Y+NQLT ++P L+ L + N SLP L TS LP
Sbjct: 168 AYNNQLT-SLPMLPSGLQELSV-----SDNQLASLPTLPSELYKLWAYNNRLTS----LP 217
Query: 237 PTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNL 296
LK L + L+ +P EL+ + + N LT S+P L +L
Sbjct: 218 ALPSGLKELI---VSGNRLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLSL--- 266
Query: 297 FLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIP 356
+++N L + P L + S + +++ N L+ Q L +TS + +
Sbjct: 267 SVYRNQLTRL-PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325
Query: 357 AQIGNCQRLAQIELD-------NNQITGAIPSEFGNLSNLTLLFVWHNRLE 400
+ + L D FG N ++ +RL
Sbjct: 326 SAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 49/356 (13%), Positives = 106/356 (29%), Gaps = 64/356 (17%)
Query: 330 SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNL 389
+I + N + +++ + + + + + + +++L N ++ ++ + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 390 TLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSG 449
LL + N L + + L +DL+ N + + + L +NN+S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS- 112
Query: 450 VIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTG-SIPDEITGCRN 508
+ G +NK+T + G + +LDL N + + +
Sbjct: 113 RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 509 LTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFA 568
L L++ N I ++ + + L L L+ N+ A
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-------------------------VFAKLKTLDLSSNKLA 204
Query: 569 GSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLN 628
+ + S + + L +N+L + L
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV--------------------------LIEKALRFSQ 237
Query: 629 KLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGN 684
L DL N +N V V+ +P G
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 52/335 (15%), Positives = 119/335 (35%), Gaps = 66/335 (19%)
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSL 172
+I + + N+ ++++SL + S +++L L+ N L + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 173 TQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSIS 232
L L N L + + L L + N E+ ++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNY------VQELLVGPSI----------- 101
Query: 233 GFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKN 292
+ ++ N ++ + +
Sbjct: 102 -------------------------------------ETLHAANNNIS-RVSC--SRGQG 121
Query: 293 LVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTG-SIPQTLGNLTSLQELQLSVNQI 351
N++L N + + + G S++ +D+ +N + + + + +L+ L L N I
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 352 SGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQ 411
++ Q+ +L ++L +N++ + EF + + +T + + +N+L I ++ Q
Sbjct: 182 Y-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 412 NLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNN 446
NLE DL NG R F K ++ ++
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFF--SKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 55/364 (15%), Positives = 111/364 (30%), Gaps = 66/364 (18%)
Query: 94 FTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRL 153
+ ++ ++L ++ S + LDLS N L+ +L +LE L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 154 NSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPH 213
+SN L + + +LS+L L L +N + + ++E + A N
Sbjct: 66 SSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANN--------- 109
Query: 214 EIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIY 273
+ + G + IY
Sbjct: 110 ------------------------------NISRV-----------SCSRG--QGKKNIY 126
Query: 274 LYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPEL-GNCSQLSIIDISMNSLTGSIP 332
L N +T G + L L N + + EL + L +++ N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185
Query: 333 QTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLL 392
+ L+ L LS N+++ + + + + I L NN++ I NL
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 393 FVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIP 452
+ N +N +++ + + + + L +P
Sbjct: 243 DLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLP 300
Query: 453 PEMG 456
Sbjct: 301 APFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 58/323 (17%), Positives = 108/323 (33%), Gaps = 40/323 (12%)
Query: 71 NLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLS 130
N N + L + + S ++ L LSG L+ ++A +L L+LS
Sbjct: 8 NGNR-YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 131 ENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATI 190
N L E +L SL L L LN+N ++ ++ S+ L +N ++ + +
Sbjct: 67 SNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSR 118
Query: 191 GKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAI 250
+ + I NK + + G + + + L I L
Sbjct: 119 --GQGKKNIYLANNK-ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL----------- 164
Query: 251 YTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPE 310
L+++ L N + + ++ L L L N L + PE
Sbjct: 165 ------------AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPE 209
Query: 311 LGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQIS-GEIPAQIGNCQRLAQIE 369
+ + ++ I + N L I + L +L+ L N G + QR+ +
Sbjct: 210 FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA 268
Query: 370 LDNNQITGAIPSEFGNLSNLTLL 392
+ E + L
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHY 291
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-41
Identities = 75/420 (17%), Positives = 150/420 (35%), Gaps = 44/420 (10%)
Query: 100 LNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLE 159
V + + + L L LD +S+T ++ + L L +L SN +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 160 GAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCT 219
+ + ++LT L N+LT+ + + L L + NK L +
Sbjct: 78 T---LDLSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKL--TKLD--VSQNP 127
Query: 220 NLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENAL 279
L + A +++ + +L + + ++ T+L + N +
Sbjct: 128 LLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKI 182
Query: 280 TGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLT 339
T + + K L L NN+ + +L QL+ +D S N LT I + LT
Sbjct: 183 T-ELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLT 233
Query: 340 SLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRL 399
L SVN ++ E+ + +L + + + + + L R
Sbjct: 234 QLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRK 287
Query: 400 EGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCS 459
E+ +++ L +D G+T + + Q KL L L + L+ + + +
Sbjct: 288 IKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDV--SHNT 339
Query: 460 SLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSI 519
L + + F +G + LN + ++P E +LT + V + +
Sbjct: 340 KLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLT-IAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-40
Identities = 99/535 (18%), Positives = 182/535 (34%), Gaps = 102/535 (19%)
Query: 148 LEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNK-- 205
+ +++ I L++LT L +++ +TD I KL L + N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNIT 77
Query: 206 NLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGD 265
L ++ TNL + ++ ++
Sbjct: 78 TL------DLSQNTNLTYLACDSNKLTNL---------------------------DVTP 104
Query: 266 CTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325
T+L Y+ N LT + + L L +N L I ++ + +QL+ +D +N
Sbjct: 105 LTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLN 158
Query: 326 SLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGN 385
+ + T L L S N+I+ E+ + + L ++ D N IT +
Sbjct: 159 KKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL---DLNQ 210
Query: 386 LSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSN 445
LT L N+L EI ++ L D S N LT + + L KL L +
Sbjct: 211 NIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQT 264
Query: 446 NLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITG 505
+L + ++ + + LI F+A + + ++ + L LD + +T + ++
Sbjct: 265 DLLEI---DLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQ 316
Query: 506 CRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKN 565
L +L +++ +L L D+ + L L
Sbjct: 317 NPKLVYLYLNNT-----------ELTEL----------------DVSHNTKLKSLSCVNA 349
Query: 566 RFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELT 625
S +G L + Q +P +L IA++ G
Sbjct: 350 HIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEP 406
Query: 626 GLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNN--FSGRVPDTPFFAKLPL 678
G G+ D + N ++ L+ V + N G V TPF A P+
Sbjct: 407 GDG--GVYDQATNTIT--WENLSTDNPAVTYTFTSENGAIVGTVT-TPFEAPQPI 456
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-39
Identities = 78/437 (17%), Positives = 147/437 (33%), Gaps = 44/437 (10%)
Query: 261 PELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSII 320
+ T L + N +T ++ L NL L N L + ++ ++L+ +
Sbjct: 58 TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYL 111
Query: 321 DISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIP 380
+ N LT + + L L + N ++ EI + + +L +++ N+ +
Sbjct: 112 NCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165
Query: 381 SEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKL 440
+ LT L N++ E+ +S + L ++ N +T + + Q +L L
Sbjct: 166 --VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFL 217
Query: 441 LLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIP 500
SN L+ + ++ + L F + N LT ++ L L L L I
Sbjct: 218 DCSSNKLTEI---DVTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-EID 270
Query: 501 DEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKL 560
+T L + L + +L D + DL L L
Sbjct: 271 --LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAG---ITELDLSQNPKLVYL 323
Query: 561 VLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGEL 620
LN + + KL+ L + + + S+GKIPAL + Q
Sbjct: 324 YLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPAL-NNNFEAEGQTITMP 377
Query: 621 PAELTGLNKLGILDLSHNELSGDLHFLAELQNLVV----LNVSHNNFSGRVPDTPFFAKL 676
LT + + + G+ + V ++ N S P +
Sbjct: 378 KETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTS 437
Query: 677 PLSVLSGNPSLCFSGNQ 693
+ G + F Q
Sbjct: 438 ENGAIVGTVTTPFEAPQ 454
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-38
Identities = 70/393 (17%), Positives = 137/393 (34%), Gaps = 55/393 (13%)
Query: 291 KNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQ 350
N + + + L+ +D +S+T + + LT L +L + N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN 75
Query: 351 ISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPS---- 406
I+ + + L + D+N++T + L+ LT L N+L ++ S
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPL 128
Query: 407 ---------------ISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVI 451
+S+ L +D N + + +L L N ++ +
Sbjct: 129 LTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL- 185
Query: 452 PPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTF 511
++ L R ++N +T ++ L FLD SN+LT I +T LT+
Sbjct: 186 --DVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTY 237
Query: 512 LDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSI 571
D N + L + L +L + + DL + L R +
Sbjct: 238 FDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIKEL 291
Query: 572 PSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLG 631
+ +L LLD + ++ + L + P L L L+ ++ EL ++ KL
Sbjct: 292 D--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVY-LYLNNTELT-ELD--VSHNTKLK 342
Query: 632 ILDLSHNELSGDLHFLAELQNLVVLNVSHNNFS 664
L + + D + ++ L +
Sbjct: 343 SLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-37
Identities = 72/405 (17%), Positives = 141/405 (34%), Gaps = 42/405 (10%)
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
T L L +L+ + N+T ++ ++ L YL N LT + + L +L L
Sbjct: 58 TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSL 211
++N+L + + LT L N LT+ + L + NK +
Sbjct: 112 NCDTNKLT---KLDVSQNPLLTYLNCARNTLTE---IDVSHNTQLTELDCHLNKKIT--- 162
Query: 212 PHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQY 271
++ T L + + I+ + K L + T ++ +L +L +
Sbjct: 163 KLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTF 216
Query: 272 IYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSI 331
+ N LT I + L L N L + ++ S+L+ + L I
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-EI 269
Query: 332 PQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTL 391
L + T L Q + E+ + + +L ++ IT + L
Sbjct: 270 D--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVY 322
Query: 392 LFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVI 451
L++ + L E+ +S+ L+++ + + ++ LN +
Sbjct: 323 LYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTI-TM 376
Query: 452 PPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLT 496
P E +SL + + L F P + D +N +T
Sbjct: 377 PKETLTNNSLTIAVSP-DLLDQFGNPMNIEPGDGGVYDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 61/323 (18%), Positives = 126/323 (39%), Gaps = 43/323 (13%)
Query: 371 DNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRG 430
P + N ++ ++ S L ++D + +T + G
Sbjct: 7 QTQSFNDWFPDD--NFASEVAA---AFEMQATDTISEEQLATLTSLDCHNSSITD-MT-G 59
Query: 431 IFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDL 490
I +L L KL+ SNN++ + ++ ++L +SNKLT ++ L L +L+
Sbjct: 60 IEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNC 113
Query: 491 GSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPD 550
+N+LT + ++ LT+L+ N++ + + +L D N + D
Sbjct: 114 DTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLD 165
Query: 551 LGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALN 610
+ + LT L + N+ + + L L+ +N ++ + L + L L+
Sbjct: 166 VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQL-TFLD 218
Query: 611 LSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDT 670
S N++ E+ +T L +L D S N L+ +L + L L L+ +
Sbjct: 219 CSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDV-STLSKLTTLHCIQTDLL------ 267
Query: 671 PFFAKLPLSVLSGNPSLCFSGNQ 693
++ L+ + G +
Sbjct: 268 ----EIDLTHNTQLIYFQAEGCR 286
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-40
Identities = 89/493 (18%), Positives = 175/493 (35%), Gaps = 36/493 (7%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL 146
L HVP + + L +S ++ +I SL++L L +S N +
Sbjct: 12 LIHVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQ 69
Query: 147 RLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTD-AIPATIGKLKNLEAIRAGGNK 205
LE L L+ N+L I +L L L N I G + L+ +
Sbjct: 70 ELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH 126
Query: 206 NLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGD 265
L S I + ++ + + P L+ T +++ + + + D
Sbjct: 127 -LEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILD 183
Query: 266 CTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPE-LGNCSQLSIIDISM 324
+ L +L N+K ++ L + + S L++ +I
Sbjct: 184 VSVKTVANL-----------ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
Query: 325 NSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNC-----QRLAQIELDNNQITGAI 379
+ L T++ +S ++ G++ + + + L+ ++ ++
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 380 PSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIF-QLKKLN 438
+ SN+ + + S +D S N LT L +L
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD-TVFENCGHLTELE 351
Query: 439 KLLLLSNNLSGVIPPEMG---NCSSLIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNR 494
L+L N L + SL + + N ++ K+L L++ SN
Sbjct: 352 TLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410
Query: 495 LTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSL 554
LT +I + + LD+HSN I ++P + +L LQ +++ N + + L
Sbjct: 411 LTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467
Query: 555 SSLTKLVLNKNRF 567
+SL K+ L+ N +
Sbjct: 468 TSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-33
Identities = 63/428 (14%), Positives = 137/428 (32%), Gaps = 28/428 (6%)
Query: 258 QIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQL 317
+P +L + + + +N ++ S + +L L L + N + + +L
Sbjct: 14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 318 SIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQI-SGEIPAQIGNCQRLAQIELDNNQIT 376
+D+S N L I +L+ L LS N + I + GN +L + L +
Sbjct: 72 EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 377 GAIPSEFGNLSNLTLLFVWHNRLEGEIPP-SISNCQNLE-AVDLSQNGLTGPIPRGIFQL 434
+ +L+ +L V + P + + + N I +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 435 KKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT----------GFIPPEIGNLKN 484
+L + L + + ++ + LT ++
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 485 LNFLDLGSNRLTGSIPDEI-----TGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLS 539
+ + + + +L G + T + L+ V S+ + + +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
Query: 540 DNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASL 599
+ + +S L + N ++ G +L+ L L NQL +
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIA 367
Query: 600 GKIPALA--IALNLSWNQICGELPAEL-TGLNKLGILDLSHNELSGDLHFLAELQNLVVL 656
+ L++S N + + + L L++S N L+ D F + VL
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT-DTIFRCLPPRIKVL 426
Query: 657 NVSHNNFS 664
++ N
Sbjct: 427 DLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-32
Identities = 86/568 (15%), Positives = 172/568 (30%), Gaps = 103/568 (18%)
Query: 105 LSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPI 164
S L +PK+++ + L++S+N ++ ++ SL +L L ++ N+++
Sbjct: 7 RSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 165 QIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMI 224
L L L N+L I NL+ + N
Sbjct: 64 VFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNA------------------- 101
Query: 225 GLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIP 284
+ I E G+ ++L+++ L L S
Sbjct: 102 --------------------FDALPI---------CKEFGNMSQLKFLGLSTTHLEKSSV 132
Query: 285 SKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQEL 344
+ +L L + + + + + T + +++
Sbjct: 133 LPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVA 190
Query: 345 QLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIP 404
L ++ I + + +L N LSNLTL +
Sbjct: 191 NLELSNIKCVLEDNKCSYFLSILAKLQTNP----------KLSNLTLNNIETTWNSFIRI 240
Query: 405 PSISNCQNLEAVDLSQNGLTGPIPRGIF-----QLKKLNKLLLLSNNLSGVIPPEMGNCS 459
+ + +S L G + F LK L+ ++S+ S
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300
Query: 460 SLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSI 519
++ + + LD +N LT ++ + L L + N +
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
Query: 520 A--GNLPAGLHQLVRLQFADLSDNSVGGMLSPDL-GSLSSLTKLVLNKNRFAGSIPSQLG 576
+ Q+ LQ D+S NSV SL L ++ N +I L
Sbjct: 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP 420
Query: 577 SCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLS 636
++++LDL SN++ +P ++ L L L+++
Sbjct: 421 P--RIKVLDLHSNKIK--------------------------SIPKQVVKLEALQELNVA 452
Query: 637 HNELSG-DLHFLAELQNLVVLNVSHNNF 663
N+L L +L + + N +
Sbjct: 453 SNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-32
Identities = 90/523 (17%), Positives = 171/523 (32%), Gaps = 56/523 (10%)
Query: 125 NYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTD 184
+D S+N L +P++L + L ++ N + I +LS L L + N++
Sbjct: 3 FLVDRSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 185 AIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKR 244
+ + LE + NK L + NL + L+ + P
Sbjct: 60 LDISVFKFNQELEYLDLSHNK-L-VKIS--CHPTVNLKHLDLSFNAFDAL--PICKEFGN 113
Query: 245 LQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLV 304
+ ++L+++ L L S + +L L +
Sbjct: 114 M---------------------SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY- 151
Query: 305 GIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQR 364
+ + + + T + +++ L ++ I + +
Sbjct: 152 -GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL 210
Query: 365 LAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLT 424
+L N LSNLTL + + + +S L
Sbjct: 211 SILAKLQTNP----------KLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 425 GPIPRGIF-----QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI 479
G + F LK L+ ++S+ S++ +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 480 GNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIA--GNLPAGLHQLVRLQFAD 537
+ LD +N LT ++ + L L + N + + Q+ LQ D
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 538 LSDNSVGGMLSPDL-GSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP 596
+S NSV SL L ++ N +I L ++++LDL SN++ +IP
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIP 437
Query: 597 ASLGKIPALAIALNLSWNQICGELPAE-LTGLNKLGILDLSHN 638
+ K+ AL LN++ NQ+ +P L L + L N
Sbjct: 438 KQVVKLEALQE-LNVASNQL-KSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 8e-18
Identities = 53/297 (17%), Positives = 95/297 (31%), Gaps = 53/297 (17%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEI 138
++ +L V S++ + L G SL L+ + +
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 139 PRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEA 198
+ + + +S L +N LTD + G L LE
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 199 IRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQ 258
+ N+ LK L IA T +
Sbjct: 353 LILQMNQ------------------------------------LKELSKIAEMTTQM--- 373
Query: 259 IPPELGDCTELQYIYLYENALTGSIPSKL-GNLKNLVNLFLWQNNLVGIIPPELGNCSQL 317
LQ + + +N+++ K+L++L + N L I L ++
Sbjct: 374 --------KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRI 423
Query: 318 SIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNN 373
++D+ N + SIP+ + L +LQEL ++ NQ+ +P I L +I L N
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 55/367 (14%), Positives = 104/367 (28%), Gaps = 51/367 (13%)
Query: 355 IPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQN 412
+P + L + N I+ S+ +LS L +L + HNR++ + S+ Q
Sbjct: 15 VPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQE 70
Query: 413 LEAVDLSQNGLTG----------------------PIPRGIFQLKKLNKLLLLSNNLSGV 450
LE +DLS N L PI + + +L L L + +L
Sbjct: 71 LEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS 130
Query: 451 IPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLT 510
+ + + P L++ N L T I T
Sbjct: 131 SVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 511 FLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS--------------PDLGSLSS 556
++ ++I L A L N L+ L ++
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 557 LTKLVLNKNRFAGSIPSQLGSCV-----KLQLLDLSSNQLSGNIPASLGKIPALAIALNL 611
+ ++ + G + + L + + S+ + I N
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI-KNF 307
Query: 612 SWNQICGELPAELTGLNKLGILDLSHNEL-SGDLHFLAELQNLVVLNVSHNNFSGRVPDT 670
+ + + ++ LD S+N L L L L + N
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA 367
Query: 671 PFFAKLP 677
++
Sbjct: 368 EMTTQMK 374
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 41/234 (17%), Positives = 77/234 (32%), Gaps = 13/234 (5%)
Query: 468 SNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG- 526
N L +P ++ + L++ N ++ +I L L + N I L
Sbjct: 9 KNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISV 64
Query: 527 LHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIP--SQLGSCVKLQLL 584
L++ DLS N ++ +L L L+ N F ++P + G+ +L+ L
Sbjct: 65 FKFNQELEYLDLSHNK---LVKISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFL 120
Query: 585 DLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLN--KLGILDLSHNELSG 642
LS+ L + + + + L L E P L N L I+ ++ E
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHF 180
Query: 643 DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFSGNQCAD 696
L + + L+ L +L + +
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-38
Identities = 86/364 (23%), Positives = 145/364 (39%), Gaps = 42/364 (11%)
Query: 309 PELGNCS-QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQ 367
P CS Q + ++P+ + T + L L N+I + + L +
Sbjct: 4 PPRCECSAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEE 60
Query: 368 IELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGP 426
+EL+ N ++ P F NL NL L + NRL+ IP + + NL +D+S+N +
Sbjct: 61 LELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVI- 118
Query: 427 IPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNL 485
+ +FQ L L L + N+L I F L +L
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLV-YISHRA--------FS---------------GLNSL 154
Query: 486 NFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG 544
L L LT SIP E + L L + +I +L RL+ ++S
Sbjct: 155 EQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213
Query: 545 GMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ-LGSCVKLQLLDLSSNQLSGNIPA-SLGKI 602
++P+ +LT L + ++P + V L+ L+LS N +S I L ++
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHEL 271
Query: 603 PALAIALNLSWNQICGELPAE-LTGLNKLGILDLSHNELSG-DLHFLAELQNLVVLNVSH 660
L + L Q+ + GLN L +L++S N+L+ + + NL L +
Sbjct: 272 LRLQ-EIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329
Query: 661 NNFS 664
N +
Sbjct: 330 NPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-37
Identities = 74/362 (20%), Positives = 137/362 (37%), Gaps = 39/362 (10%)
Query: 307 IPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRL 365
+P + ++ ++D+ N + + L+EL+L+ N +S + N L
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNL 82
Query: 366 AQIELDNNQITGAIPSE-FGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGL 423
+ L +N++ IP F LSNLT L + N++ + + + NL+++++ N L
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL 140
Query: 424 TGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNL 482
I F L L +L L NL+ + + + LI R + L
Sbjct: 141 VY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 483 KNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG-LHQLVRLQFADLSDN 541
L L++ ++ NLT L + ++ +P + LV L+F +LS N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYN 258
Query: 542 SVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ-LGSCVKLQLLDLSSNQLSGNIPASLG 600
+ + L L L ++ L + A + L++L++S NQL+ + S+
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESV- 315
Query: 601 KIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSH 660
+ L L L N L+ D L + LN +
Sbjct: 316 -----------------------FHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNR 352
Query: 661 NN 662
Sbjct: 353 QQ 354
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-36
Identities = 77/385 (20%), Positives = 139/385 (36%), Gaps = 64/385 (16%)
Query: 69 SCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLD 128
C+ ++ V + VP + L L + E AS L L+
Sbjct: 8 ECSAQDRAV--LCHRKRFV-AVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELE 62
Query: 129 LSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIP 187
L+EN ++ P +L L L L SN+L+ IP+ + LS+LT+L + +N++ +
Sbjct: 63 LNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLD 121
Query: 188 ATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQT 247
L NL+++ G N + L L+
Sbjct: 122 YMFQDLYNLKSLEVGDND-------------------------LVYISHRAFSGLNSLEQ 156
Query: 248 IAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSK-LGNLKNLVNLFLWQNNLVGI 306
+ L + LT SIP++ L +L L+ L L N+ I
Sbjct: 157 ------------------------LTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAI 191
Query: 307 IPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQ-IGNCQRL 365
+L +++IS ++ +L L ++ ++ +P + + L
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYL 250
Query: 366 AQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLT 424
+ L N I+ S L L + + +L + P L +++S N LT
Sbjct: 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309
Query: 425 GPIPRGIFQ-LKKLNKLLLLSNNLS 448
+ +F + L L+L SN L+
Sbjct: 310 T-LEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-33
Identities = 63/308 (20%), Positives = 118/308 (38%), Gaps = 14/308 (4%)
Query: 219 TNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE-LGDCTELQYIYLYEN 277
T ++ L + I L+ + + ++S + P + L+ + L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90
Query: 278 ALTGSIPSK-LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIP-QTL 335
L IP L NL L + +N +V ++ + L +++ N L I +
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 336 GNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFV 394
L SL++L L ++ IP + + L + L + I F L L +L +
Sbjct: 149 SGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEI 207
Query: 395 WHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPP 453
H + P+ NL ++ ++ LT +P + L L L L N +S +
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPISTIEGS 266
Query: 454 EMGNCSSLIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTF 511
+ L + +L + P L L L++ N+LT ++ + + NL
Sbjct: 267 MLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLET 324
Query: 512 LDVHSNSI 519
L + SN +
Sbjct: 325 LILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-19
Identities = 62/271 (22%), Positives = 89/271 (32%), Gaps = 60/271 (22%)
Query: 416 VDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFI 475
V + +P GI + L L N + + E + L N N ++ +
Sbjct: 16 VLCHRKRFVA-VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AV 71
Query: 476 PPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAGLHQLVRL 533
P NL NL L L SNRL IP + TG NLT LD+ N I L +
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYM------ 123
Query: 534 QFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ-LGSCVKLQLLDLSSNQLS 592
L +L L + N I + L+ L L L+
Sbjct: 124 -----------------FQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT 165
Query: 593 GNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSG-DLHFLAELQ 651
IP A L+ L+ L +L L H ++ + L
Sbjct: 166 --------SIPTEA-----------------LSHLHGLIVLRLRHLNINAIRDYSFKRLY 200
Query: 652 NLVVLNVSHNNFSGRVPDTPFFAKLPLSVLS 682
L VL +SH + + L L+ LS
Sbjct: 201 RLKVLEISHWPYLDTMTPN-CLYGLNLTSLS 230
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-37
Identities = 73/295 (24%), Positives = 113/295 (38%), Gaps = 44/295 (14%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRA-SDKISTGAFSSEIATLSRIRHRNI 834
L G IG+G G V+ L VAVK R F E L + H NI
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 835 VRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-H 893
VRL+G ++ + + + G L L T ++ A G+ YL
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI---A 950
C+ HRD+ + N L+ E+ ++DFG++R D + Q + A
Sbjct: 233 CCI----HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP-----VKWTA 283
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--DGQHVIQWVRD--HLKSKKD 1005
PE N + S +SDV+S+G++L E + G P +P Q ++V L
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASP----YPNLSNQQTREFVEKGGRL----- 334
Query: 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060
P + PD + M Q C + RP+ + L+ IR+
Sbjct: 335 ------PCPELCPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 77/299 (25%), Positives = 123/299 (41%), Gaps = 54/299 (18%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
LT IG G+ G+V+ + VA+K R +S F E + ++ H +V
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHD 894
+L G + L ++M +G L L GL +T + L V EG++YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGSYGYI 949
+ HRD+ + N L+GE ++DFG+ R V DD +G F P +
Sbjct: 125 VI----HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF---P--------V 169
Query: 950 ---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--HLK 1001
+PE + ++ S KSDV+S+GV++ E+ + GK P + + V++ + L
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDISTGFRL- 224
Query: 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060
K + Q M C R EDRP + L EI +
Sbjct: 225 ----------YKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 81/314 (25%), Positives = 129/314 (41%), Gaps = 54/314 (17%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+T + +G G+ G VY+ LTVAVK + D + F E A + I+H N+V
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHD 894
+LLG + ++M G L L + + +A ++ + YL +
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGSYGYI 949
+ HRD+ + N L+GE + +ADFGL+RL+ D +G F P I
Sbjct: 132 FI----HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---P--------I 176
Query: 950 ---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--DGQHVIQWVRD--HLK 1001
APE K S KSDV+++GV+L EI T G P +P D V + + +
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRM- 231
Query: 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061
+ +G P+ + M C DRP+ ++ + QE +
Sbjct: 232 ----------ERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFETMFQESS 274
Query: 1062 SGSEAHKPTAAKST 1075
E K + T
Sbjct: 275 ISDEVEKELGKRGT 288
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-36
Identities = 78/311 (25%), Positives = 128/311 (41%), Gaps = 48/311 (15%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+T + +G G+ G VY+ LTVAVK + D + F E A + I+H N+V
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HD 894
+LLG + ++M G L L + + +A ++ + YL +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGSYGYI 949
+ HR++ + N L+GE + +ADFGL+RL+ D +G F +
Sbjct: 339 FI----HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--------PIKWT 386
Query: 950 APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--DGQHVIQWVRD--HLKSKK 1004
APE K S KSDV+++GV+L EI T G P +P D V + + +
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRM---- 438
Query: 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGS 1064
+ +G P+ + M C DRP+ ++ + QE +
Sbjct: 439 -------ERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFETMFQESSISD 484
Query: 1065 EAHKPTAAKST 1075
E K + T
Sbjct: 485 EVEKELGKRGT 495
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 70/282 (24%), Positives = 113/282 (40%), Gaps = 38/282 (13%)
Query: 781 GNIIGQGRSGIVYK-VTLPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRL 837
IG+G VYK + + + VA + K F E L ++H NIVR
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 838 LG-WGANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
W + K K + M +GTL L +++ + +GL +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH- 146
Query: 894 DCVPAILHRDVKSHNILLGERYESC-LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
P I+HRD+K NI + S + D GLA L + P+F +APE
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF------MAPE 200
Query: 953 YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012
K E DVY++G+ +LE+ T + P + + Q+ Q R + S P
Sbjct: 201 MYE-EKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYR-RVTSGVKP-----A 249
Query: 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054
+++E+++ C ++R ++KD LL
Sbjct: 250 SFDKVAIPEVKEIIE------GCIRQNKDERYSIKD---LLN 282
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 79/303 (26%), Positives = 124/303 (40%), Gaps = 50/303 (16%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSG----LTVAVKRFRA-SDKISTGAFSSEIATLSRIR 830
+ IIG G SG V L + VA+K +A + F SE + + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
H NI+RL G + ++ +YM NG+L L + G + GV G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRY 166
Query: 891 L-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
L V HRD+ + N+L+ ++DFGL+R++EDD + + + G I
Sbjct: 167 LSDLGYV----HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP------DAAYTTTGGKI 216
Query: 950 -----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--H 999
APE S SDV+S+GVV+ E++ G++P + + + VI V +
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP----YWNMTNRDVISSVEEGYR 272
Query: 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
L P G P Q ML C RP + ++L + +
Sbjct: 273 L-----------PAPMGCPHALHQLMLD-------CWHKDRAQRPRFSQIVSVLDALIRS 314
Query: 1060 PAS 1062
P S
Sbjct: 315 PES 317
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 84/341 (24%), Positives = 147/341 (43%), Gaps = 56/341 (16%)
Query: 744 SHHNEGDEDVEMGPPWELTLYNKLDLSIGDATR-----SLTAGNIIGQGRSGIVYK---- 794
HH++ D ++ + + + ++ T +T +IG G G VYK
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLK 66
Query: 795 -VTLPSGLTVAVKRFRA-SDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852
+ + VA+K +A + F E + + H NI+RL G + K ++ +
Sbjct: 67 TSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126
Query: 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILL 911
YM NG L L + + G + G+A G+ YL + + V HRD+ + NIL+
Sbjct: 127 YMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMNYV----HRDLAARNILV 180
Query: 912 GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI-----APEYANMTKISEKSDVY 966
++DFGL+R++EDD +++ S G I APE + K + SDV+
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEATYTT------SGGKIPIRWTAPEAISYRKFTSASDVW 234
Query: 967 SYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQ 1021
S+G+V+ E++T G++P + + V++ + D L P P
Sbjct: 235 SFGIVMWEVMTYGERP----YWELSNHEVMKAINDGFRL-----------PTPMDCPSAI 279
Query: 1022 IQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
Q M+Q C RP D+ ++L ++ + P S
Sbjct: 280 YQLMMQ-------CWQQERARRPKFADIVSILDKLIRAPDS 313
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 70/298 (23%), Positives = 117/298 (39%), Gaps = 54/298 (18%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+T +G G+ G+V VAVK + +S F E T+ ++ H +V
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHD 894
+ G + + +Y+ NG L L LE ++ V EG+++L H
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGSYGYI 949
+ HRD+ + N L+ ++DFG+ R V DD G F P +
Sbjct: 125 FI----HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF---P--------V 169
Query: 950 ---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--HLK 1001
APE + K S KSDV+++G+++ E+ + GK P + V+ V L
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP----YDLYTNSEVVLKVSQGHRL- 224
Query: 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
+ DT Q M C E RPT + + + + +R++
Sbjct: 225 ----------YRPHLASDTIYQIMYS-------CWHELPEKRPTFQQLLSSIEPLREK 265
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 76/306 (24%), Positives = 116/306 (37%), Gaps = 61/306 (19%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSG----LTVAVKRFR--ASDKISTGAFSSEIATLSRIR 830
+ G IG+G+ G V++ S L VA+K + SD F E T+ +
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-VREKFLQEALTMRQFD 74
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
H +IV+L+G + + G L L + L+ + A ++ L+Y
Sbjct: 75 HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 131
Query: 891 L-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAG 944
L V HRD+ + N+L+ L DFGL+R +ED S G P
Sbjct: 132 LESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL---P---- 180
Query: 945 SYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD 998
I APE N + + SDV+ +GV + EI+ G KP F VI + +
Sbjct: 181 ----IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIEN 232
Query: 999 --HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
L P P T M + C + RP ++ A L I
Sbjct: 233 GERL-----------PMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLSTI 274
Query: 1057 RQEPAS 1062
+E +
Sbjct: 275 LEEEKA 280
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 90/366 (24%), Positives = 136/366 (37%), Gaps = 65/366 (17%)
Query: 743 GSHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLP---- 798
G HH+ + P R L + +G+G G V
Sbjct: 2 GHHHHHHAQLYACQDPTIFE------------ERHLKYISQLGKGNFGSVELCRYDPLGD 49
Query: 799 -SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG--WGANRKTKLLFYDYMP 855
+G VAVK+ + S F EI L + IV+ G +G R++ L +Y+P
Sbjct: 50 NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 109
Query: 856 NGTLGMLL--HDGEC--AGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHRDVKSHNIL 910
+G L L H + LL + + + +G+ YL CV HRD+ + NIL
Sbjct: 110 SGCLRDFLQRHRARLDASRLLLY------SSQICKGMEYLGSRRCV----HRDLAARNIL 159
Query: 911 LGERYESCLADFGLARLVEDD-------SGGSFSANPQFAGSYGYIAPEYANMTKISEKS 963
+ +ADFGLA+L+ D G P F + APE + S +S
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---PIF-----WYAPESLSDNIFSRQS 211
Query: 964 DVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD-----PKLQGH 1017
DV+S+GVVL E+ T K S + + + +E+L+ P
Sbjct: 212 DVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPAC 269
Query: 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEAHKPTAAKSTDT 1077
P + M C + +DRP+ + L + G E H TA
Sbjct: 270 PAEVHELMKL-------CWAPSPQDRPSFSALGPQLDMLWSGS-RGCETHAFTAHPEGKH 321
Query: 1078 ASYSSS 1083
S S S
Sbjct: 322 HSLSFS 327
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 65/300 (21%), Positives = 117/300 (39%), Gaps = 54/300 (18%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+ LT +G G+ G+V VA+K + +S F E + + H +V
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHD 894
+L G ++ + +YM NG L L + + ++ V E + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGSYGYI 949
+ HRD+ + N L+ ++ ++DFGL+R V DD G F P +
Sbjct: 141 FL----HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---P--------V 185
Query: 950 ---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--HLK 1001
PE +K S KSD++++GV++ EI + GK P + + + L
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFTNSETAEHIAQGLRL- 240
Query: 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061
+ + M C +A++RPT K + + + ++ E +
Sbjct: 241 ----------YRPHLASEKVYTIMYS-------CWHEKADERPTFKILLSNILDVMDEES 283
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-35
Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 60/303 (19%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR 836
SL +G G+ G V+ T VAVK + +S AF +E + ++H +V+
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 837 LLGWGANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-H 892
L TK Y ++M G+L L E + +AEG++++
Sbjct: 248 LHA----VVTKEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGSYG 947
+ + HRD+++ NIL+ +ADFGLAR++ED+ G F P
Sbjct: 303 RNYI----HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF---P------- 348
Query: 948 YI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--H 999
I APE N + KSDV+S+G++L+EI+T G+ P +P VI+ +
Sbjct: 349 -IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP----YPGMSNPEVIRALERGYR 403
Query: 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
+ P+ + P+ M++ C NR E+RPT + + ++L +
Sbjct: 404 M-----------PRPENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDDFYTA 445
Query: 1060 PAS 1062
S
Sbjct: 446 TES 448
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 75/329 (22%), Positives = 123/329 (37%), Gaps = 71/329 (21%)
Query: 759 WELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSG---LTVAVKRFRA-SDKI 814
L + +L I D +G G G V + + VA+K + ++K
Sbjct: 4 LFL---KRDNLLIADI--------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA 52
Query: 815 STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEW 874
T E + ++ + IVRL+G + +L + G L L +
Sbjct: 53 DTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKR--EEIPV 109
Query: 875 DTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-- 931
++ V+ G+ YL + V HRD+ + N+LL R+ + ++DFGL++ + D
Sbjct: 110 SNVAELLHQVSMGMKYLEEKNFV----HRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
Query: 932 -----SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPV 982
S G + P + APE N K S +SDV+SYGV + E ++ G+KP
Sbjct: 166 YYTARSAGKW---P--------LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP- 213
Query: 983 DASFPD--GQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSN 1038
+ G V+ ++ + P M C
Sbjct: 214 ---YKKMKGPEVMAFIEQGKRM-----------ECPPECPPELYALMSD-------CWIY 252
Query: 1039 RAEDRPTMKDVAALLREIRQEPASGSEAH 1067
+ EDRP V +R AS E H
Sbjct: 253 KWEDRPDFLTVEQRMRACYYSLASKVEGH 281
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-35
Identities = 72/382 (18%), Positives = 128/382 (33%), Gaps = 46/382 (12%)
Query: 91 PTNFTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPRE-LCSLLRL 148
T+F+ L L L + I L+ L L L N ++ L L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANL 105
Query: 149 EQLRLNSNQLEGAIPIQIG---NLSSLTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGN 204
E L L L+GA+ + L+SL L L DN + PA+ ++ + N
Sbjct: 106 EVLTLTQCNLDGAV-LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
Query: 205 KNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELG 264
K + ++ N L L + + L +
Sbjct: 165 K-VKSICEEDLLNFQGKHFTLLR--------------LSSITLQDMNEYWLGWEKCGNPF 209
Query: 265 DCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGN----------- 313
T + + L N S+ + + + + + G+
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 314 ----CSQLSIIDISMNSLTGSIP-QTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQ 367
S + D+S + + ++ + T L++L L+ N+I+ +I L +
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327
Query: 368 IELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGP 426
+ L N + F NL L +L + +N + + NL+ + L N L
Sbjct: 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS- 385
Query: 427 IPRGIFQ-LKKLNKLLLLSNNL 447
+P GIF L L K+ L +N
Sbjct: 386 VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-34
Identities = 83/398 (20%), Positives = 146/398 (36%), Gaps = 42/398 (10%)
Query: 315 SQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIE---LD 371
+ ++ +D+S+NS+ + L LQ L++ I + L+ + LD
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN--NTFRGLSSLIILKLD 87
Query: 372 NNQITGAIPSE-FGNLSNLTLLFVWHNRL-EGEIPPSI-SNCQNLEAVDLSQNGLTGPIP 428
NQ + + F L+NL +L + L + + +LE + L N + P
Sbjct: 88 YNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 429 RGIFQ-LKKLNKLLLLSNNLSGVIPPEM---GNCSSLIRFRANSNKLTGFIPPEIG---- 480
F +++ + L L N + I E R +S L +G
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 481 ----NLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFA 536
++ LDL N S+ T + S + N+ + F
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT---NFK 262
Query: 537 DLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLDLSSNQLSGNI 595
D + + G+ S + L+K++ ++ + L+ L L+ N+++ I
Sbjct: 263 DPDNFTFKGL------EASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KI 314
Query: 596 PA-SLGKIPALAIALNLSWNQICGELPAEL-TGLNKLGILDLSHNELSG-DLHFLAELQN 652
+ + L LNLS N + G + + + L+KL +LDLS+N + L N
Sbjct: 315 DDNAFWGLTHLLK-LNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPN 372
Query: 653 LVVLNVSHNNFSGRVPDTPF--FAKLPLSVLSGNPSLC 688
L L + N VPD F L L NP C
Sbjct: 373 LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 409
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 75/396 (18%), Positives = 133/396 (33%), Gaps = 44/396 (11%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPEL-GNCSQLSIIDISMN 325
+ Y+ L N++ + L++L L + Q +I S L I+ + N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 326 SLTGSIP-QTLGNLTSLQELQLSVNQI-SGEIPAQI-GNCQRLAQIELDNNQITGAIP-S 381
+ L +L+ L L+ + + L + L +N I P S
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 382 EFGNLSNLTLLFVWHNRLEGEIPPSI---SNCQNLEAVDLSQNGLT-------GPIPRGI 431
F N+ +L + N+++ I ++ + LS L G G
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 432 F-QLKKLNKLLLLSNNLSGVIPPEM-----GNCSSLIRFRANSNKLTGFIPPEIGNLKNL 485
+ + L L N + G + + N + F + N
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 486 NFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL-HQLVRLQFADLSDNSVG 544
F L ++ + D+ + I L + L+ L+ N +
Sbjct: 268 TFKGLEAS--------------GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN 312
Query: 545 GMLSPDLGSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLDLSSNQLSGNIPA-SLGKI 602
+ L+ L KL L++N GSI S++ + KL++LDLS N + + S +
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGL 370
Query: 603 PALAIALNLSWNQICGELPAELTGLNKLGILDLSHN 638
P L L L NQ+ L L + L N
Sbjct: 371 PNLKE-LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 82/484 (16%), Positives = 136/484 (28%), Gaps = 116/484 (23%)
Query: 106 SGTNLTG--SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIP 163
L +P + NY+DLS NS+ L L+ L++ I
Sbjct: 18 INRGLHQVPELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71
Query: 164 IQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLV 222
LSSL L L NQ L NLE + G L
Sbjct: 72 NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSG--------- 122
Query: 223 MIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGS 282
K L T L+ + L +N +
Sbjct: 123 -----------------NFFKPL---------------------TSLEMLVLRDNNIKKI 144
Query: 283 IPSKL-GNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSL 341
P+ N++ L L N + + + G L L+S+
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKV---------KSICEEDLL----NFQGKHFTLL-RLSSI 190
Query: 342 QELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEG 401
++ + E + ++L N ++ F + T +
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 402 EIPPSISNCQ---------------NLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSN 445
+ S + ++ DLS++ + + + +F L +L L N
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQN 309
Query: 446 NLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-T 504
++ I F L +L L+L N L SI +
Sbjct: 310 EIN-KIDDNA--------FW---------------GLTHLLKLNLSQNFLG-SIDSRMFE 344
Query: 505 GCRNLTFLDVHSNSIAGNLPAGL-HQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLN 563
L LD+ N I L L L+ L N + + L+SL K+ L+
Sbjct: 345 NLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 403
Query: 564 KNRF 567
N +
Sbjct: 404 TNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-08
Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 11/111 (9%)
Query: 80 DLRYVDL----LGHVPTN-FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENS 133
DL + L + + N F L L +L LS L SI + +L++L LDLS N
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNH 358
Query: 134 LTGEIPRELCS-LLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQL 182
+ + + L L++L L++NQL+ ++P I L+SL +++L+ N
Sbjct: 359 IR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 78/306 (25%), Positives = 127/306 (41%), Gaps = 41/306 (13%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLP-----SGLTVAVKRFRASDKISTGAFSSEIATLSRIR 830
R L +G+G G V +G VAVK+ + S + F EI L ++
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 831 HRNIVRLLG--WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
H NIV+ G + A R+ L +Y+P G+L L + ++ + + +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGM 127
Query: 889 SYLH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-------SGGSFSANP 940
YL + HRD+ + NIL+ + DFGL +++ D G P
Sbjct: 128 EYLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES---P 180
Query: 941 QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000
F + APE +K S SDV+S+GVVL E+ T + + + +I +
Sbjct: 181 IF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235
Query: 1001 KSKKDPVEVLD-----PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
+E+L P+ G PD M + C +N RP+ +D+A + +
Sbjct: 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSFRDLALRVDQ 288
Query: 1056 IRQEPA 1061
IR A
Sbjct: 289 IRDNMA 294
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-34
Identities = 83/496 (16%), Positives = 167/496 (33%), Gaps = 44/496 (8%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELC-SL 145
L HVP + L LS +++ +I+ L++L L LS N + + +
Sbjct: 43 LTHVPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFN 99
Query: 146 LRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTD-AIPATIGKLKNLEAIRAGGN 204
LE L ++ N+L+ I ++SL L L N + G L L +
Sbjct: 100 QDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAA 156
Query: 205 KNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLK--RLQTIAIYTALLSGQIPPE 262
K L + +++ L I G +L + L + +L S Q+
Sbjct: 157 KFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216
Query: 263 LGDCTELQYIYLYENALTGSIPS-------KLGNLKNLVNLFLWQNNLVGIIPPELGNCS 315
+ LQ + N + L N+ + + +
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 316 QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQI 375
+ ++I ++T I + + L + + N
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK-------------------NQVF 317
Query: 376 TGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLK 435
+ + + + + + + + + + ++ +QN T + +G LK
Sbjct: 318 LFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLK 377
Query: 436 KLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNL----KNLNFLDLG 491
+L L+L N L ++ L +++ L+L
Sbjct: 378 RLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436
Query: 492 SNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDL 551
SN LTGS+ + + LD+H+N I ++P + L LQ +++ N + +
Sbjct: 437 SNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVF 493
Query: 552 GSLSSLTKLVLNKNRF 567
L+SL + L+ N +
Sbjct: 494 DRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 87/570 (15%), Positives = 179/570 (31%), Gaps = 109/570 (19%)
Query: 105 LSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPI 164
S NLT +PK++ + L LS+NS++ ++ L L LRL+ N++ ++
Sbjct: 38 YSNRNLT-HVPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93
Query: 165 QI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVM 223
+ L L + N+L I + +L + N
Sbjct: 94 HVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFND------------------ 132
Query: 224 IGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSI 283
+ + E G+ T+L ++ L
Sbjct: 133 ---------------------FDVLPV---------CKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 284 PSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQE 343
+ +L L + + E +++ + + + Q ++ +L
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGH 222
Query: 344 LQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEI 403
LQLS +++ E ++ +T S F W
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR------ 276
Query: 404 PPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKL----NKLLLLSNNLSGVIPPEMGNCS 459
+E +++ +T I R F + + + N + + +
Sbjct: 277 --------PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328
Query: 460 SLIRFRANS-NKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNS 518
+ + + S + + + FL+ N T S+ + + L L + N
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388
Query: 519 IAGNLPAG---LHQLVRLQFADLSDNSVGGMLSPDL-GSLSSLTKLVLNKNRFAGSIPSQ 574
+ N + L+ D+S NS+ S+ L L+ N GS+
Sbjct: 389 LK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447
Query: 575 LGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILD 634
L K+++LDL +N++ +P ++T L L L+
Sbjct: 448 LPP--KVKVLDLHNNRIM--------------------------SIPKDVTHLQALQELN 479
Query: 635 LSHNEL-SGDLHFLAELQNLVVLNVSHNNF 663
++ N+L S L +L + + N +
Sbjct: 480 VASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-27
Identities = 95/499 (19%), Positives = 168/499 (33%), Gaps = 62/499 (12%)
Query: 258 QIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQL 317
+P +L + + L +N+++ + L L L L N + + L
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102
Query: 318 SIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQI-SGEIPAQIGNCQRLAQIELDNNQIT 376
+D+S N L +I + SL+ L LS N + + GN +L + L +
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 377 GAIPSEFGNLSNLTLLFVWHNRLEGEIPP------SISNCQNLEAVDLSQNGLTGPIPRG 430
+ +++L L + + + I I N L V + + +
Sbjct: 160 Q---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216
Query: 431 IFQLKKL----NKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNL---K 483
+ L L KL + E+ +L+ + T ++ +
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 484 NLNFLDLGSNRLTGSIPDEI-----TGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADL 538
+ +L++ + +T I E T ++L V + + A + L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 539 SDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS-----G 593
S + + S SS T L +N F S+ + +LQ L L N L
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVA 396
Query: 594 NIPASLGK---------------------IPALAIALNLSWNQICGELPAELTGLNKLGI 632
+ ++ + LNLS N + G + L K+ +
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKV 454
Query: 633 LDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPF--FAKLPLSVLSGNPSLCFS 690
LDL +N + + LQ L LNV+ N VPD F L L NP C
Sbjct: 455 LDLHNNRIMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDC-- 511
Query: 691 GNQCADSTYKKDGASRHAG 709
C Y + ++H+G
Sbjct: 512 --TCPGIRYLSEWINKHSG 528
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-15
Identities = 48/302 (15%), Positives = 94/302 (31%), Gaps = 53/302 (17%)
Query: 74 NQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENS 133
+ V L L++ L ++ +L L +
Sbjct: 257 QHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQV 316
Query: 134 LTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKL 193
+ L+ + + + SS T L N TD++ L
Sbjct: 317 FLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTL 376
Query: 194 KNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTA 253
K L+ + N LK +A+ T
Sbjct: 377 KRLQTLILQRNG------------------------------------LKNFFKVALMTK 400
Query: 254 LLSGQIPPELGDCTELQYIYLYENALTGSIPSKL-GNLKNLVNLFLWQNNLVGIIPPELG 312
+ + L+ + + N+L + ++++ L L N L G + L
Sbjct: 401 NM-----------SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
Query: 313 NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELD 371
++ ++D+ N + SIP+ + +L +LQEL ++ NQ+ +P + L I L
Sbjct: 450 --PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 372 NN 373
+N
Sbjct: 506 DN 507
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-34
Identities = 79/329 (24%), Positives = 136/329 (41%), Gaps = 50/329 (15%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSG----LTVAVKRFRA-SDKISTGAFSSEIATLSRIRH 831
+++ ++G G G V L ++VA+K + + F E + + + H
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
NI+RL G K ++ +YM NG+L L + + G+A G+ YL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYL 163
Query: 892 -HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI- 949
V HRD+ + NIL+ ++DFGL R++EDD +++ G I
Sbjct: 164 SDMGYV----HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT------RGGKIP 213
Query: 950 ----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--HL 1000
+PE K + SDV+SYG+VL E+++ G++P + + Q VI+ V + L
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQDVIKAVDEGYRL 269
Query: 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060
P P Q ML C +RP + + ++L ++ + P
Sbjct: 270 -----------PPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSILDKLIRNP 311
Query: 1061 ASGSEAHKPTAAKSTDTASYSSSSVTSAQ 1089
S A S S+ +T+ +
Sbjct: 312 GSLKIITSAAARPSNLLLDQSNVDITTFR 340
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 63/307 (20%), Positives = 111/307 (36%), Gaps = 61/307 (19%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSG-----LTVAVKRFRA-SDKISTGAFSSEIATLSRIR 830
++G G G VYK + VA+K R + + E ++ +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+ ++ RLLG T L MP G L + + + + + +A+G++Y
Sbjct: 76 NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNY 132
Query: 891 L-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD------SGGSFSANPQFA 943
L V HRD+ + N+L+ + DFGLA+L+ + GG P
Sbjct: 133 LEDRRLV----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV---P--- 182
Query: 944 GSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVR 997
I A E + +SDV+SYGV + E++T G KP + + +
Sbjct: 183 -----IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILE 233
Query: 998 D--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
L P+ M + C A+ RP +++ +
Sbjct: 234 KGERL-----------PQPPICTIDVYMIMRK-------CWMIDADSRPKFRELIIEFSK 275
Query: 1056 IRQEPAS 1062
+ ++P
Sbjct: 276 MARDPQR 282
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 73/306 (23%), Positives = 120/306 (39%), Gaps = 55/306 (17%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSG----LTVAVKRFRA-SDKISTGAFSSEIATLSRIRH 831
+ I+G+G G VY+ + + VAVK + + F SE + + H
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
+IV+L+G + + + P G LG L + L+ T +L + + ++YL
Sbjct: 73 PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYL 129
Query: 892 -HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGS 945
+CV HRD+ NIL+ L DFGL+R +ED+ S P
Sbjct: 130 ESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL---P----- 177
Query: 946 YGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRDH 999
I +PE N + + SDV+ + V + EI++ GK+P F + VI +
Sbjct: 178 ---IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP----FFWLENKDVIGVLEKG 230
Query: 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
+ L PK P M + C DRP ++ L ++ Q
Sbjct: 231 --------DRL-PKPDLCPPVLYTLMTR-------CWDYDPSDRPRFTELVCSLSDVYQM 274
Query: 1060 PASGSE 1065
+
Sbjct: 275 EKDIAM 280
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 73/333 (21%), Positives = 120/333 (36%), Gaps = 65/333 (19%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRA-SDKISTGAFSSEIATLSRIR 830
L ++G G G V+K + V +K S + S A + + + +
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
H +IVRLLG + L Y+P G+L + G L + +A+G+ Y
Sbjct: 74 HAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYY 130
Query: 891 LH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD------SGGSFSANPQFA 943
L H V HR++ + N+LL + +ADFG+A L+ D S P
Sbjct: 131 LEEHGMV----HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT---P--- 180
Query: 944 GSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVR 997
I A E + K + +SDV+SYGV + E++T G +P + V +
Sbjct: 181 -----IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP----YAGLRLAEVPDLLE 231
Query: 998 D--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
L + Q M++ C RPT K++A
Sbjct: 232 KGERL-----------AQPQICTIDVYMVMVK-------CWMIDENIRPTFKELANEFTR 273
Query: 1056 IRQEPAS----GSEAHKPTAAKSTDTASYSSSS 1084
+ ++P E+ A +
Sbjct: 274 MARDPPRYLVIKRESGPGIAPGPEPHGLTNKKL 306
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 77/304 (25%), Positives = 127/304 (41%), Gaps = 41/304 (13%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLP-----SGLTVAVKRFRASDKISTGAFSSEIATLSRIR 830
R L +G+G G V +G VAVK+ + S + F EI L ++
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 831 HRNIVRLLG--WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
H NIV+ G + A R+ L +Y+P G+L L + ++ + + +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGM 158
Query: 889 SYLH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-------SGGSFSANP 940
YL + HRD+ + NIL+ + DFGL +++ D G P
Sbjct: 159 EYLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES---P 211
Query: 941 QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000
F + APE +K S SDV+S+GVVL E+ T + + + +I +
Sbjct: 212 IF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 266
Query: 1001 KSKKDPVEVLD-----PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
+E+L P+ G PD M + C +N RP+ +D+A + +
Sbjct: 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSFRDLALRVDQ 319
Query: 1056 IRQE 1059
IR +
Sbjct: 320 IRDQ 323
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 69/307 (22%), Positives = 117/307 (38%), Gaps = 62/307 (20%)
Query: 783 IIGQGRSGIVYKVTLPSG---LTVAVKRFR--ASDKISTGAFSSEIATLSRIRHRNIVRL 837
+G G G V K TVAVK + A+D +E + ++ + IVR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHDCV 896
+G ++ +L + G L L ++ ++ V+ G+ YL + V
Sbjct: 84 IGI-CEAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDD-------SGGSFSANPQFAGSYGYI 949
HRD+ + N+LL ++ + ++DFGL++ + D + G + P +
Sbjct: 140 ----HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW---P--------V 184
Query: 950 ---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--HLK 1001
APE N K S KSDV+S+GV++ E + G+KP + G V + +
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP----YRGMKGSEVTAMLEKGERM- 239
Query: 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061
G P M C + E+RP V LR +
Sbjct: 240 ----------GCPAGCPREMYDLMNL-------CWTYDVENRPGFAAVELRLRNYYYDVV 282
Query: 1062 SGSEAHK 1068
+ H
Sbjct: 283 NEGHHHH 289
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 81/303 (26%), Positives = 130/303 (42%), Gaps = 60/303 (19%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR 836
+L +G G+ G V+ VAVK + +S AF +E + +++H+ +VR
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 837 LLGWGANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-H 892
L T+ Y +YM NG+L L L + +A +AEG++++
Sbjct: 73 LYA----VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGSYG 947
+ + HRD+++ NIL+ + +ADFGLARL+ED+ G F P
Sbjct: 128 RNYI----HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF---P------- 173
Query: 948 YI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--H 999
I APE N + KSDV+S+G++L EI+T G+ P +P VIQ +
Sbjct: 174 -IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP----YPGMTNPEVIQNLERGYR 228
Query: 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
+ + P+ Q M C R EDRPT + ++L +
Sbjct: 229 M-----------VRPDNCPEELYQLMRL-------CWKERPEDRPTFDYLRSVLEDFFTA 270
Query: 1060 PAS 1062
Sbjct: 271 TEG 273
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 57/311 (18%), Positives = 116/311 (37%), Gaps = 24/311 (7%)
Query: 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327
L+ + + L +P L + L L N + I + N L + + N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 328 TGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE-FGNL 386
+ P L L+ L LS NQ+ E+P + L ++ + N+IT + F L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 387 SNLTLLFVWHNRL-EGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS 444
+ + ++ + N L I + L + ++ +T IP+G+ L +L L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPP--SLTELHLDG 201
Query: 445 NNLSGVIPPEM-GNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI 503
N ++ + ++L + + N ++ + N +L L L +N+L +P +
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 504 TGCRNLTFLDVHSNSI------AGNLPAGLHQLVRLQFADLSDNSVG-GMLSPDL-GSLS 555
+ + + +H+N+I P + L N V + P +
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
Query: 556 SLTKLVLNKNR 566
+ L +
Sbjct: 320 VRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 25/296 (8%)
Query: 307 IPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRL 365
+P +L +++D+ N +T NL +L L L N+IS +I +L
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKL 102
Query: 366 AQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLT 424
++ L NQ+ +P + L L V N + ++ S+ + + V+L N L
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 425 -GPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI-GN 481
I G FQ +KKL+ + + N++ IP G SL + NK+T +
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKG 214
Query: 482 LKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDN 541
L NL L L N ++ + +L L +++N + +P GL +Q L +N
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 542 -----SVGGMLSPDLGS-LSSLTKLVLNKNRF-AGSIPSQLGSCV-KLQLLDLSSN 589
P + +S + + L N I CV + L +
Sbjct: 274 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 71/333 (21%), Positives = 127/333 (38%), Gaps = 45/333 (13%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158
L + S L +PK++ LDL N +T + +L L L L +N++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 159 EGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNC 218
P L L +L+L NQL +P K L+ +R N+
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENE------------- 132
Query: 219 TNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYT-ALLSGQIPPE-LGDCTELQYIYLYE 276
I+ L ++ + + T L S I +L YI + +
Sbjct: 133 ------------ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180
Query: 277 NALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLG 336
+T +IP L +L L L N + + L + L+ + +S NS++ +L
Sbjct: 181 TNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237
Query: 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITG------AIPSEFGNLSNLT 390
N L+EL L+ N++ ++P + + + + + L NN I+ P ++ +
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 296
Query: 391 LLFVWHNRLE-GEIPPSI-SNCQNLEAVDLSQN 421
+ ++ N ++ EI PS AV L
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 61/289 (21%), Positives = 119/289 (41%), Gaps = 23/289 (7%)
Query: 219 TNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE-LGDCTELQYIYLYEN 277
+ ++ L I+ LK L T+ + +S +I P +L+ +YL +N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKN 110
Query: 278 ALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSI--PQTL 335
L +P K+ K L L + +N + + +Q+ ++++ N L S
Sbjct: 111 QLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 336 GNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE-FGNLSNLTLLFV 394
+ L ++++ I+ IP G L ++ LD N+IT + + L+NL L +
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGL 223
Query: 395 WHNRLEGEIPP-SISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGV--- 450
N + + S++N +L + L+ N L +P G+ K + + L +NN+S +
Sbjct: 224 SFNSIS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSN 281
Query: 451 ---IPPEMGNCSSLIRFRANSNKLTGF-IPPEI-GNLKNLNFLDLGSNR 494
P +S SN + + I P + + LG+ +
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 66/360 (18%), Positives = 129/360 (35%), Gaps = 93/360 (25%)
Query: 313 NCS-QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELD 371
C L ++ S L +P+ L L L N+I+ N + L + L
Sbjct: 28 RCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILI 84
Query: 372 NNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGI 431
NN+I+ P F L L L++ N+L+ E+P + + L+ + + +N +T + + +
Sbjct: 85 NNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITK-VRKSV 140
Query: 432 FQ-LKKLNKLLLLSNNL-SGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLD 489
F L ++ + L +N L S I F+ +K L+++
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGA--------FQ---------------GMKKLSYIR 177
Query: 490 LGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSP 549
+ +T +IP + +LT L + N I + A
Sbjct: 178 IADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAA----------------------- 210
Query: 550 DLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIAL 609
L L++L KL L+ N + L + L+ L L++N+L
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV----------------- 253
Query: 610 NLSWNQICGELPAELTGLNKLGILDLSHNELS-------GDLHFLAELQNLVVLNVSHNN 662
++P L + ++ L +N +S + + + +++ N
Sbjct: 254 ---------KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 304
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 65/338 (19%), Positives = 119/338 (35%), Gaps = 79/338 (23%)
Query: 80 DLRYVDL----LGHVPTN-FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENS 133
D +DL + + F +L +L+ L+L ++ I A L +L L LS+N
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQ 111
Query: 134 LTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAI--PATI 190
L E+P ++ L++LR++ N++ + + L+ + + L N L +
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 191 GKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAI 250
+K L IR I T+I LPP+
Sbjct: 168 QGMKKLSYIRIADTN---------I-------------TTIPQGLPPS------------ 193
Query: 251 YTALLSGQIPPELGDCTELQYIYLYENALTGSIPSK-LGNLKNLVNLFLWQNNLVGIIPP 309
L ++L N +T + + L L NL L L N++ +
Sbjct: 194 ------------------LTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNG 234
Query: 310 ELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQ-------IGNC 362
L N L + ++ N L +P L + +Q + L N IS I +
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKK 292
Query: 363 QRLAQIELDNNQIT-GAIPSE-FGNLSNLTLLFVWHNR 398
+ + L +N + I F + + + + +
Sbjct: 293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 55/247 (22%), Positives = 96/247 (38%), Gaps = 39/247 (15%)
Query: 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSN---SIAGNL 523
+ L +P ++ + LDL +N++T + +NL L + +N I+
Sbjct: 39 SDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95
Query: 524 PAGLHQLVRLQFA------------------DLSDNSVGGMLSPDLGSLSSLTKLVLNKN 565
A L +L RL + + +N + + L+ + + L N
Sbjct: 96 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 155
Query: 566 RF-AGSIPSQ-LGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAE 623
+ I + KL + ++ ++ IP L P L+L N+I ++ A
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKI-TKVDAA 210
Query: 624 -LTGLNKLGILDLSHNELSG-DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP-LSV 680
L GLN L L LS N +S D LA +L L++++N +VP A + V
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG--LADHKYIQV 267
Query: 681 --LSGNP 685
L N
Sbjct: 268 VYLHNNN 274
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 80/299 (26%), Positives = 128/299 (42%), Gaps = 52/299 (17%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR 836
SL +GQG G V+ T VA+K + +S AF E + ++RH +V+
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLL--HDGECAGLLEWDTRFKIALGVAEGLSYLH-H 893
L + + + +YM G+L L G+ L +A +A G++Y+
Sbjct: 244 LYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERM 299
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGSYGY 948
+ V HRD+++ NIL+GE +ADFGLARL+ED+ G F +
Sbjct: 300 NYV----HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--------PIKW 347
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--DGQHVIQWVRD--HLKSK 1003
APE A + + KSDV+S+G++L E+ T G+ P +P + V+ V +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YPGMVNREVLDQVERGYRM--- 400
Query: 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
P P++ M Q C E+RPT + + A L +
Sbjct: 401 --------PCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 77/300 (25%), Positives = 120/300 (40%), Gaps = 56/300 (18%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+ L IG+G G V G VAVK + + AF +E + ++++RH N+V
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLV 77
Query: 836 RLLGWGANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL- 891
+LLG + K Y +YM G+L L +L D K +L V E + YL
Sbjct: 78 QLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV-EDDSGGSFSANPQFAGSYGYI- 949
++ V HRD+ + N+L+ E + ++DFGL + G P +
Sbjct: 135 GNNFV----HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---P--------VK 179
Query: 950 --APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--DGQHVIQWVRD--HLKS 1002
APE K S KSDV+S+G++L EI + G+ P +P + V+ V +
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP----YPRIPLKDVVPRVEKGYKM-- 233
Query: 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
G P + M C A RP+ + L I+
Sbjct: 234 ---------DAPDGCPPAVYEVMKN-------CWHLDAAMRPSFLQLREQLEHIKTHELH 277
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-33
Identities = 79/296 (26%), Positives = 118/296 (39%), Gaps = 50/296 (16%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR 836
L IG+G G V G VAVK + + AF +E + ++++RH N+V+
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQ 250
Query: 837 LLGWGANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-H 892
LLG + K Y +YM G+L L +L D K +L V E + YL
Sbjct: 251 LLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLAR-LVEDDSGGSFSANPQFAGSYGYIAP 951
++ V HRD+ + N+L+ E + ++DFGL + G P + AP
Sbjct: 308 NNFV----HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---P-----VKWTAP 355
Query: 952 EYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--DGQHVIQWVRD--HLKSKKDP 1006
E K S KSDV+S+G++L EI + G+ P +P + V+ V +
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVP----YPRIPLKDVVPRVEKGYKM------ 405
Query: 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
G P M C A RPT + L IR
Sbjct: 406 -----DAPDGCPPAVYDVMKN-------CWHLDAATRPTFLQLREQLEHIRTHELH 449
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 58/217 (26%), Positives = 85/217 (39%), Gaps = 14/217 (6%)
Query: 768 DLSIGDATRSLTAGNIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSSEIATL 826
D + +T +G+G G V++ +G AVK+ R E+
Sbjct: 50 DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVAC 104
Query: 827 SRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE 886
+ + IV L G +F + + G+LG L+ G L D E
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALE 161
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESC-LADFGLA-RLVEDDSGGSFSANPQFAG 944
GL YLH ILH DVK+ N+LL L DFG A L D G S G
Sbjct: 162 GLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 945 SYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ ++APE K D++S ++L ++ G P
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 66/305 (21%), Positives = 111/305 (36%), Gaps = 45/305 (14%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLP-----SGLTVAVKRFRA-SDKISTGAFSSEIATLSRI 829
R L +G+G G V +G VAVK + S EI L +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 830 RHRNIVRLLG--WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEG 887
H NIV+ G L +++P+G+L L + + + K A+ + +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKG 138
Query: 888 LSYLH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-------SGGSFSAN 939
+ YL V HRD+ + N+L+ ++ + DFGL + +E D
Sbjct: 139 MDYLGSRQYV----HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS--- 191
Query: 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998
P F + APE +K SDV+S+GV L E++T + +
Sbjct: 192 PVF-----WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246
Query: 999 HLKSKKDPVEVLD-----PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
+ V L P PD Q M + C + +R + +++
Sbjct: 247 --MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRK-------CWEFQPSNRTSFQNLIEGF 297
Query: 1054 REIRQ 1058
+ +
Sbjct: 298 EALLK 302
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 79/297 (26%), Positives = 126/297 (42%), Gaps = 48/297 (16%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR 836
SL +GQG G V+ T VA+K + +S AF E + ++RH +V+
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDC 895
L + + + +YM G+L L L +A +A G++Y+ +
Sbjct: 327 LYAV-VSEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAGSYGYIA 950
V HRD+++ NIL+GE +ADFGLARL+ED+ G F + A
Sbjct: 385 V----HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--------PIKWTA 432
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--DGQHVIQWVRD--HLKSKKD 1005
PE A + + KSDV+S+G++L E+ T G+ P +P + V+ V +
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP----YPGMVNREVLDQVERGYRM----- 483
Query: 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
P P++ M Q C E+RPT + + A L +
Sbjct: 484 ------PCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 60/303 (19%), Positives = 112/303 (36%), Gaps = 53/303 (17%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSG-----LTVAVKRFRA-SDKISTGAFSSEIATLSRIR 830
++G G G VYK + VA+K R + + E ++ +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+ ++ RLLG T L MP G L + + + + + +A+G++Y
Sbjct: 76 NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNY 132
Query: 891 L-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
L V HRD+ + N+L+ + DFGLA+L+ + ++ G +
Sbjct: 133 LEDRRLV----HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-------EYHAEGGKV 181
Query: 950 -----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--H 999
A E + +SDV+SYGV + E++T G KP + + +
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGER 237
Query: 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
L P+ M++ C A+ RP +++ ++ ++
Sbjct: 238 L-----------PQPPICTIDVYMIMVK-------CWMIDADSRPKFRELIIEFSKMARD 279
Query: 1060 PAS 1062
P
Sbjct: 280 PQR 282
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 781 GNIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
++G+G GIVY L + + +A+K D + EIA ++H+NIV+ LG
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+ +F + +P G+L LL T + EGL YLH + I
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---I 143
Query: 900 LHRDVKSHNILLGERYESC-LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
+HRD+K N+L+ ++DFG ++ + + + + F G+ Y+APE +
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET----FTGTLQYMAPEIIDKGP 199
Query: 959 I--SEKSDVYSYGVVLLEIITGKKP 981
+ +D++S G ++E+ TGK P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 84/343 (24%), Positives = 133/343 (38%), Gaps = 66/343 (19%)
Query: 744 SHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTL-----P 798
HH+ G +V P + T+++K R L +G+G G V
Sbjct: 8 HHHHHGALEVLFQGPGDPTVFHK---------RYLKKIRDLGEGHFGKVSLYCYDPTNDG 58
Query: 799 SGLTVAVKRFRA-SDKISTGAFSSEIATLSRIRHRNIVRLLG--WGANRKTKLLFYDYMP 855
+G VAVK +A + + EI L + H +I++ G A + L +Y+P
Sbjct: 59 TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 856 NGTLGMLL--HDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHRDVKSHNILLG 912
G+L L H A LL + A + EG++YLH + HRD+ + N+LL
Sbjct: 119 LGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYLHAQHYI----HRDLAARNVLLD 168
Query: 913 ERYESCLADFGLARLVEDD-------SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDV 965
+ DFGLA+ V + G P F + APE K SDV
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDS---PVF-----WYAPECLKEYKFYYASDV 220
Query: 966 YSYGVVLLEIIT-GKKPVDASF--------PDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016
+S+GV L E++T GQ + + + L+ E L P+
Sbjct: 221 WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG----ERL-PRPDK 275
Query: 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
P M C A RPT +++ +L+ + ++
Sbjct: 276 CPAEVYHLMKN-------CWETEASFRPTFENLIPILKTVHEK 311
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 52/316 (16%), Positives = 104/316 (32%), Gaps = 63/316 (19%)
Query: 776 RSLTAGNIIGQGRSGIVYK--------VTLPSGLTVAVKRFRASDKISTGAFSSEIATLS 827
L +GQG ++K V +K + + + +F + +S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 828 RIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEG 887
++ H+++V G +L +++ G+L L + + + ++A +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAA 125
Query: 888 LSYL-HHDCVPAILHRDVKSHNILLGERYESC--------LADFGLARLVEDDSGGSFSA 938
+ +L + + H +V + NILL + L+D G++ V
Sbjct: 126 MHFLEENTLI----HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-- 179
Query: 939 NPQFAGSYGYI---APEYANMTKI-SEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQH 991
I PE K + +D +S+G L EI + G KP Q
Sbjct: 180 -R--------IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP----LSALDSQR 226
Query: 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051
+Q+ D L P + + + C + RP+ + +
Sbjct: 227 KLQFYEDR--------HQL-PAPKAAELANL--INN-------CMDYEPDHRPSFRAIIR 268
Query: 1052 LLREIRQEPASGSEAH 1067
L + +H
Sbjct: 269 DLNSLFTPDLVPRGSH 284
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-31
Identities = 69/302 (22%), Positives = 116/302 (38%), Gaps = 60/302 (19%)
Query: 784 IGQGRSGIVYKVTLPSG---LTVAVKRFRA-SDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G G G V + + VA+K + ++K T E + ++ + IVRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHDCVPA 898
+ +L + G L L + ++ V+ G+ YL + V
Sbjct: 404 V-CQAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFV-- 458
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDD-------SGGSFSANPQFAGSYGYI-- 949
HR++ + N+LL R+ + ++DFGL++ + D S G + P +
Sbjct: 459 --HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW---P--------LKW 505
Query: 950 -APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--HLKSK 1003
APE N K S +SDV+SYGV + E ++ G+KP + G V+ ++ +
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQGKRM--- 558
Query: 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASG 1063
P M C + EDRP V +R AS
Sbjct: 559 --------ECPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQRMRACYYSLASK 603
Query: 1064 SE 1065
E
Sbjct: 604 VE 605
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 68/328 (20%), Positives = 115/328 (35%), Gaps = 75/328 (22%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL----PSGLTVAVK--RFRASDKISTGAFSSEIATLSRIR 830
T G ++G+G G V + L S + VAVK + F E A +
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 831 HRNIVRLLG---WGANRKTKLLFY---DYMPNGTLGMLL---HDGECAGLLEWDTRFKIA 881
H ++ +L+G + + +M +G L L GE L T +
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 882 LGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD------SGG 934
+ +A G+ YL + + HRD+ + N +L E C+ADFGL+R +
Sbjct: 144 VDIACGMEYLSSRNFI----HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 935 SFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ 990
P + A E + SDV+++GV + EI+T G+ P +
Sbjct: 200 KL---P--------VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----YAG-- 242
Query: 991 HVIQWVRDHLKSKKDPVEVLDPKLQGH--------PDTQIQEMLQALGISLLCTSNRAED 1042
+ E+ + + G+ + M Q C S +
Sbjct: 243 -------------IENAEIYNYLIGGNRLKQPPECMEEVYDLMYQ-------CWSADPKQ 282
Query: 1043 RPTMKDVAALLREIRQEPASGSEAHKPT 1070
RP+ + L I + S + P
Sbjct: 283 RPSFTCLRMELENILGHLSVLSTSQDPL 310
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-31
Identities = 76/431 (17%), Positives = 137/431 (31%), Gaps = 42/431 (9%)
Query: 210 SLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDC--T 267
S+ I N +L +ISG + + A+ + L +C
Sbjct: 2 SIMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPG-ENRNEAVSLLKECLIN 59
Query: 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327
+ + L L+ S+P L + L + QN L+ +P + L +D N L
Sbjct: 60 QFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNRL 112
Query: 328 TGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLS 387
+ ++P+ +L + L + NQ++ +P + + DNNQ+T +P +
Sbjct: 113 S-TLPELPASL---KHLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPEL---PT 160
Query: 388 NLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLL---LS 444
+L +L V +N+L +P + + L D+S N L +P + + +
Sbjct: 161 SLEVLSVRNNQLT-FLPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETEIFFRCR 215
Query: 445 NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEIT 504
N IP + + N L+ I + + S + T
Sbjct: 216 ENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNT 275
Query: 505 GCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNK 564
R L +++ P V + S L LS
Sbjct: 276 LHRPLA------DAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTS 329
Query: 565 NRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIA----LNLSWNQICGEL 620
F + + L L S ++ + S AL L G
Sbjct: 330 G-FREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLF 388
Query: 621 PAELTGLNKLG 631
+ L LG
Sbjct: 389 DNDTGALLSLG 399
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-30
Identities = 55/315 (17%), Positives = 103/315 (32%), Gaps = 58/315 (18%)
Query: 355 IPAQIGNCQRLAQIELDNN--QITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQN 412
I I N L+Q N S + L N + +
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQ 60
Query: 413 LEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKL 471
+ L++ L+ +P + + L ++ N +P + L A N+L
Sbjct: 61 FSELQLNRLNLSS-LPDNLPPQITVLE----ITQNALISLPELPASLEYLD---ACDNRL 112
Query: 472 TGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLV 531
+ +P +LK+L+ + +N+LT +P+ L +++ +N + LP
Sbjct: 113 S-TLPELPASLKHLD---VDNNQLT-MLPELPA---LLEYINADNNQL-TMLPE------ 157
Query: 532 RLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQL 591
+SL L + N+ +P S L+ LD+S+N L
Sbjct: 158 ---------------------LPTSLEVLSVRNNQL-TFLPELPES---LEALDVSTNLL 192
Query: 592 SGNIPASLGKIPAL---AIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLA 648
++PA + I N+I +P + L+ + L N LS +
Sbjct: 193 E-SLPAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESL 250
Query: 649 ELQNLVVLNVSHNNF 663
Q +
Sbjct: 251 SQQTAQPDYHGPRIY 265
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-29
Identities = 61/437 (13%), Positives = 124/437 (28%), Gaps = 67/437 (15%)
Query: 68 VSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLS-LNRLVLSG---TNLTGSIPKEIASLNQ 123
+ +NN + + + ++ S + L G + + +NQ
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQ 60
Query: 124 LNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLT 183
+ L L+ +L+ +P L ++ L + N L ++P + L L DN+L+
Sbjct: 61 FSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDNRLS 113
Query: 184 DAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLK 243
+P LK+L+ + N LP + ++ LP L+
Sbjct: 114 -TLPELPASLKHLDV-----DNNQLTMLPELPALLEYI---NADNNQLT-MLPELPTSLE 163
Query: 244 RLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNL 303
L + N LT +P +L+ L + N L
Sbjct: 164 VL---------------------------SVRNNQLT-FLPELPESLE---ALDVSTNLL 192
Query: 304 VGIIPPELGNCSQLS----IIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI 359
+P N +T IP+ + +L + L N +S I +
Sbjct: 193 ES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250
Query: 360 GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLS 419
+ +I ++ N + L +S + +
Sbjct: 251 SQQTAQP--DYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEH 308
Query: 420 QNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI 479
N + + ++ + S+ R S +
Sbjct: 309 ANTFSA-FLDRLSDTVSARNTSGFREQVAAWLE----KLSASAELRQQSFAVAADATESC 363
Query: 480 GNLKNLNFLDLGSNRLT 496
+ L + +L L
Sbjct: 364 EDRVALTWNNLRKTLLV 380
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 1e-14
Identities = 39/198 (19%), Positives = 74/198 (37%), Gaps = 30/198 (15%)
Query: 479 IGNLKNLNFLDLGSNRLTGSIPDEITGC----RNLTFLDVHSNSIAGNLPAG-LHQLVRL 533
I N +L+ + N ++ + + N L ++Q L
Sbjct: 7 INNNFSLS-QNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64
Query: 534 QFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSG 593
L+ ++ L +L +T L + +N S+P S L+ LD N+LS
Sbjct: 65 ---QLNRLNLSS-LPDNLPP--QITVLEITQNAL-ISLPELPAS---LEYLDACDNRLS- 113
Query: 594 NIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNL 653
+P + L++ NQ+ LP L + + +N+L+ +L
Sbjct: 114 TLPELPASL----KHLDVDNNQLT-MLPELPALLEYI---NADNNQLT---MLPELPTSL 162
Query: 654 VVLNVSHNNFSGRVPDTP 671
VL+V +N + +P+ P
Sbjct: 163 EVLSVRNNQLT-FLPELP 179
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-31
Identities = 73/301 (24%), Positives = 115/301 (38%), Gaps = 55/301 (18%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSG----LTVAVKRFR--ASDKISTGAFSSEIATLSRIR 830
+ G IG+G+ G V++ S + VA+K + SD F E T+ +
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-VREKFLQEALTMRQFD 449
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
H +IV+L+G + + G L L + L+ + A ++ L+Y
Sbjct: 450 HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAY 506
Query: 891 LH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-----SGGSFSANPQFAG 944
L V HRD+ + N+L+ L DFGL+R +ED S G
Sbjct: 507 LESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----- 557
Query: 945 SYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD--H 999
++APE N + + SDV+ +GV + EI+ G KP F VI + +
Sbjct: 558 ---WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGER 610
Query: 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
L P P T M + C + RP ++ A L I +E
Sbjct: 611 L-----------PMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLSTILEE 652
Query: 1060 P 1060
Sbjct: 653 E 653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 75/304 (24%), Positives = 118/304 (38%), Gaps = 58/304 (19%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL--PSGLT--VAVKRFRA---SDKISTGAFSSEIATLSRI 829
L +G G G+V + PSG T VAVK + S + F E+ + +
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLS 889
HRN++RL G + + P G+L L + G T + A+ VAEG+
Sbjct: 79 DHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMG 135
Query: 890 YL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-------SGGSFSANPQ 941
YL + HRD+ + N+LL R + DFGL R + + P
Sbjct: 136 YLESKRFI----HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---P- 187
Query: 942 FAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPD--GQHVIQWVRD 998
+ + APE S SD + +GV L E+ T G++P + G ++ +
Sbjct: 188 ----FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP----WIGLNGSQILHKIDK 239
Query: 999 H---LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
L P+ + P M+Q C +++ EDRPT + L E
Sbjct: 240 EGERL-----------PRPEDCPQDIYNVMVQ-------CWAHKPEDRPTFVALRDFLLE 281
Query: 1056 IRQE 1059
+
Sbjct: 282 AQPT 285
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 69/306 (22%), Positives = 109/306 (35%), Gaps = 39/306 (12%)
Query: 768 DLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATL 826
+ I + + +G+G V V L G A+KR ++ E
Sbjct: 23 MVIIDN--KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMH 80
Query: 827 SRIRHRNIVRLLGWGANRKTK-----LLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKI 880
H NI+RL+ + + LL + GTL + + L D +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLL-PFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 881 ALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP 940
LG+ GL +H HRD+K NILLG+ + L D G GS A
Sbjct: 140 LLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 941 -----QFAGSYGYIAPE----YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQH 991
+ Y APE ++ I E++DV+S G VL ++ G+ P D F G
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255
Query: 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051
V V++ L + P L + M+ RP + + +
Sbjct: 256 VALAVQNQLSIPQSP--RHSSALWQ----LLNSMMTV----------DPHQRPHIPLLLS 299
Query: 1052 LLREIR 1057
L ++
Sbjct: 300 QLEALQ 305
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 69/306 (22%), Positives = 115/306 (37%), Gaps = 50/306 (16%)
Query: 768 DLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSG----LTVAVKRFRA-SDKISTGAFSSE 822
D+ I + +IG+G G+VY + A+K ++ AF E
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 823 IATLSRIRHRNIVRLLGWGANRK-TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIA 881
+ + H N++ L+G + + YM +G L + +
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFG 130
Query: 882 LGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP 940
L VA G+ YL V HRD+ + N +L E + +ADFGLAR + D
Sbjct: 131 LQVARGMEYLAEQKFV----HRDLAARNCMLDESFTVKVADFGLARDILDR-----EYYS 181
Query: 941 QFAGSYGYI-----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--DGQHV 992
+ + A E + + KSDV+S+GV+L E++T G P + D +
Sbjct: 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP----YRHIDPFDL 237
Query: 993 IQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVA 1050
++ L P+ + PD+ Q M Q C RPT + +
Sbjct: 238 THFLAQGRRL-----------PQPEYCPDSLYQVMQQ-------CWEADPAVRPTFRVLV 279
Query: 1051 ALLREI 1056
+ +I
Sbjct: 280 GEVEQI 285
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-31
Identities = 74/337 (21%), Positives = 126/337 (37%), Gaps = 47/337 (13%)
Query: 313 NCS-QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELD 371
C L ++ S L ++P+ + L L N IS Q L + L
Sbjct: 30 GCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLV 86
Query: 372 NNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGI 431
NN+I+ F L L L++ N L EIPP++ +L + + N + +P+G+
Sbjct: 87 NNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRK-VPKGV 142
Query: 432 FQ-LKKLNKLLLLSNNLSGV-IPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLD 489
F L+ +N + + N L P + L R + KLTG IP + LN L
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPK--DLPETLNELH 199
Query: 490 LGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS 548
L N++ +I E L L + N I + G
Sbjct: 200 LDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGS--------------------- 236
Query: 549 PDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS---GNIPASLGKIPAL 605
L L +L +L L+ N+ + +P+ L LQ++ L +N ++ N +G
Sbjct: 237 --LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKR 293
Query: 606 A--IALNLSWNQI-CGELPAEL-TGLNKLGILDLSHN 638
A ++L N + E+ + + +
Sbjct: 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 69/334 (20%), Positives = 123/334 (36%), Gaps = 48/334 (14%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRE-LCSLLRLEQLRLNSNQ 157
L + S L ++PKEI+ LDL N ++ E+ ++ L L L L +N+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89
Query: 158 LEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGN 217
+ L L +L++ N L + IP +L +R N+
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLVE-IPP--NLPSSLVELRIHDNR------------ 134
Query: 218 CTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYT-ALLSGQIPPELGDCTELQYIYLYE 276
I L+ + I + L + P D +L Y+ + E
Sbjct: 135 -------------IRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181
Query: 277 NALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLG 336
LT IP L + L L L N + I +L S+L + + N + +L
Sbjct: 182 AKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE-------FGNLSNL 389
L +L+EL L N++S +PA + + + L + L N IT + +
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
Query: 390 TLLFVWHNRLE-GEIPPSI-SNCQNLEAVDLSQN 421
+ +++N + E+ P+ + A+
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 77/370 (20%), Positives = 136/370 (36%), Gaps = 63/370 (17%)
Query: 329 GSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQ-RLAQIELDNNQITGAIPSEFGNLS 387
S +T + L L + + + P C L ++ + + A+P E
Sbjct: 4 ASGAETTSGIPDLDSLPPTYSAMC---PF---GCHCHLRVVQCSDLGLK-AVPKEIS--P 54
Query: 388 NLTLLFVWHNRLEGEIPP-SISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSN 445
+ TLL + +N + E+ Q+L A+ L N ++ I F L+KL KL + N
Sbjct: 55 DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKN 112
Query: 446 NLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLT-GSIPDEI 503
+L IPP + SSL+ R + N++ +P + L+N+N +++G N L
Sbjct: 113 HLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 504 TGCRNLTFLDVHSN---SIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKL 560
L +L + I +LP L++L L N + + DL S L +L
Sbjct: 169 FDGLKLNYLRISEAKLTGIPKDLPETLNEL------HLDHNKIQAIELEDLLRYSKLYRL 222
Query: 561 VLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGEL 620
L N+ L L+ L L +N+LS +
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS--------------------------RV 256
Query: 621 PAELTGLNKLGILDLSHNELS-------GDLHFLAELQNLVVLNVSHNNFSGRVPDTPFF 673
PA L L L ++ L N ++ + F + +++ +N F
Sbjct: 257 PAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316
Query: 674 AKLP-LSVLS 682
+ +
Sbjct: 317 RCVTDRLAIQ 326
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 63/299 (21%), Positives = 118/299 (39%), Gaps = 28/299 (9%)
Query: 210 SLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE-LGDCTE 268
++P EI + ++ L IS L+ L + + +S +I + +
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103
Query: 269 LQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLT 328
LQ +Y+ +N L IP L +LV L + N + + ++ I++ N L
Sbjct: 104 LQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 329 GSI--PQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE-FGN 385
S P L L L++S +++ IP + L ++ LD+N+I AI E
Sbjct: 161 NSGFEPGAFDGL-KLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLR 215
Query: 386 LSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS 444
S L L + HN++ I S L + L N L+ +P G+ LK L + L +
Sbjct: 216 YSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHT 273
Query: 445 NNLSGVIPPEM-------GNCSSLIRFRANSNKLTGF-IPPEI-GNLKNLNFLDLGSNR 494
NN++ + + +N + + + P + + + G+ +
Sbjct: 274 NNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 63/335 (18%), Positives = 115/335 (34%), Gaps = 74/335 (22%)
Query: 80 DLRYVDL----LGHVPTN-FTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSL 134
D +DL + + + F L L LVL ++ K + L +L L +S+N L
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 135 TGEIPRELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKL 193
EIP L L +LR++ N++ +P + L ++ + + N L ++
Sbjct: 115 V-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENS-------- 162
Query: 194 KNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTA 253
G L L + ++E ++
Sbjct: 163 ----GFEPGAFDGL------------KLNYLRISEAKLT--------------------- 185
Query: 254 LLSGQIPPELGDCTELQYIYLYENALTGSIPSK-LGNLKNLVNLFLWQNNLVGIIPPELG 312
IP +L L ++L N + +I + L L L L N + I L
Sbjct: 186 ----GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 313 NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-------GNCQRL 365
L + + N L+ +P L +L LQ + L N I+ ++
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
Query: 366 AQIELDNNQITGAI--PSEFGNLSNLTLLFVWHNR 398
I L NN + P+ F +++ + + +
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 1e-30
Identities = 37/329 (11%), Positives = 80/329 (24%), Gaps = 57/329 (17%)
Query: 771 IGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA---FSSEIATL 826
+ R L + G +V+ V + A+K F + S
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116
Query: 827 SRIRHRNIVRLLGW-----------------------GANRKTKLLFYDYMP--NGTLGM 861
+R+ + G + + MP + L +
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176
Query: 862 LLHD----GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917
L G + + + L ++H N+ +
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRL 233
Query: 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY--ANMTKISEKSDVYSYGVVLLEI 975
L D V P + Y E+ A+ + + + G+ + +
Sbjct: 234 MLGDVSALWKVGTRG-------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 976 ITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLC 1035
P P + + + L T + + ++ L I
Sbjct: 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGT--------DSLAFGSCTPLPDFVKTL-IGRFL 337
Query: 1036 TSNRAEDRPTMKDVAA--LLREIRQEPAS 1062
+R R + +++ E +S
Sbjct: 338 NFDR-RRRLLPLEAMETPEFLQLQNEISS 365
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 76/310 (24%), Positives = 118/310 (38%), Gaps = 59/310 (19%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSG----LTVAVKRFRA-SDKISTGAFSSEIATLSRIRH 831
+ +IG+G G VY TL + AVK +D F +E + H
Sbjct: 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 832 RNIVRLLGWGANRKTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
N++ LLG + L YM +G L + + L VA+G+ Y
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKY 143
Query: 891 LH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
L V HRD+ + N +L E++ +ADFGLAR + D + +
Sbjct: 144 LASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDK-----EYYSVHNKTGAKL 194
Query: 950 -----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSK 1003
A E K + KSDV+S+GV+L E++T G P +PD
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP----YPD--------------- 235
Query: 1004 KDPVEVLDPKLQGH--------PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055
+ ++ LQG PD + ML+ C +AE RP+ ++ + +
Sbjct: 236 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISA 288
Query: 1056 IRQEPASGSE 1065
I G
Sbjct: 289 IF-STFIGEH 297
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 71/319 (22%)
Query: 776 RSLTAGNIIGQGRSGIVYK------VTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI 829
R + +G+G G V+ + VAVK + + F E L+ +
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTL-------------GMLLHDGECAGLLEWDT 876
+H +IV+ G + ++ ++YM +G L + + G L
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 877 RFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD---- 931
IA +A G+ YL V HRD+ + N L+G + DFG++R V
Sbjct: 135 MLHIASQIASGMVYLASQHFV----HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190
Query: 932 --SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDAS 985
P I PE K + +SDV+S+GV+L EI T GK+P
Sbjct: 191 VGGHTML---P--------IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---- 235
Query: 986 FP--DGQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAE 1041
+ VI+ + L + + P ML C +
Sbjct: 236 WFQLSNTEVIECITQGRVL-----------ERPRVCPKEVYDVMLG-------CWQREPQ 277
Query: 1042 DRPTMKDVAALLREIRQEP 1060
R +K++ +L + +
Sbjct: 278 QRLNIKEIYKILHALGKAT 296
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 74/317 (23%), Positives = 116/317 (36%), Gaps = 74/317 (23%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR--ASDKISTGAFSSEIATLSR 828
++ +G+ R G VYK L VA+K + A + F E +R
Sbjct: 10 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE-EFRHEAMLRAR 68
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTL-------------GMLLHDGECAGLLEWD 875
++H N+V LLG + + + Y +G L G D LE
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 876 TRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD--- 931
+ +A G+ YL H V H+D+ + N+L+ ++ ++D GL R V
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAADYY 184
Query: 932 ---SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDA 984
P I APE K S SD++SYGVVL E+ + G +P
Sbjct: 185 KLLGNSLL---P--------IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--- 230
Query: 985 SFPD--GQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRA 1040
+ Q V++ +R+ L P P M++ C +
Sbjct: 231 -YCGYSNQDVVEMIRNRQVL-----------PCPDDCPAWVYALMIE-------CWNEFP 271
Query: 1041 EDRPTMKDVAALLREIR 1057
RP KD+ + LR
Sbjct: 272 SRRPRFKDIHSRLRAWG 288
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 74/317 (23%), Positives = 119/317 (37%), Gaps = 70/317 (22%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGL------TVAVKRFRASDKISTGAFSSEIATLSRIR 830
+ +G+G G V+ + L VAVK + + + + F E L+ ++
Sbjct: 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 101
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLL------------HDGECAGLLEWDTRF 878
H++IVR G + L+ ++YM +G L L + G L
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 879 KIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD----SG 933
+A VA G+ YL V HRD+ + N L+G+ + DFG++R + G
Sbjct: 162 AVASQVAAGMVYLAGLHFV----HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 934 GSFSANPQFAGSYGYI-----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP 987
G + PE K + +SDV+S+GVVL EI T GK+P +
Sbjct: 218 GR-----------TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP----WY 262
Query: 988 D--GQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDR 1043
I + L + + P M C + R
Sbjct: 263 QLSNTEAIDCITQGREL-----------ERPRACPPEVYAIMRG-------CWQREPQQR 304
Query: 1044 PTMKDVAALLREIRQEP 1060
++KDV A L+ + Q P
Sbjct: 305 HSIKDVHARLQALAQAP 321
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 73/303 (24%), Positives = 119/303 (39%), Gaps = 62/303 (20%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSG----LTVAVKRFRASDKISTGA-FSSEIATLSRIRH 831
+ +IG+G G VY TL + AVK I + F +E + H
Sbjct: 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 832 RNIVRLLGWGANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
N++ LLG +++ YM +G L + + L VA+G+
Sbjct: 150 PNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGM 205
Query: 889 SYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
+L V HRD+ + N +L E++ +ADFGLAR + D + +
Sbjct: 206 KFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDK-----EFDSVHNKTGA 256
Query: 948 YI-----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLK 1001
+ A E K + KSDV+S+GV+L E++T G P +PD
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP----YPD------------- 299
Query: 1002 SKKDPVEVLDPKLQGH--------PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053
+ ++ LQG PD + ML+ C +AE RP+ ++ + +
Sbjct: 300 --VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRI 350
Query: 1054 REI 1056
I
Sbjct: 351 SAI 353
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 73/315 (23%), Positives = 113/315 (35%), Gaps = 74/315 (23%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL----PSGLTVAVK--RFRASDKISTGAFSSEIATLSRIR 830
L G I+G+G G V + L + L VAVK + S + F SE A +
Sbjct: 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 831 HRNIVRLLG-----WGANRKTKLLFYDYMPNGTLGMLL---HDGECAGLLEWDTRFKIAL 882
H N++RLLG ++ +M G L L + T K +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 883 GVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD------SGGS 935
+A G+ YL + + + HRD+ + N +L + C+ADFGL++ +
Sbjct: 155 DIALGMEYLSNRNFL----HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 936 FSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQH 991
P + A E + KSDV+++GV + EI T G P +P
Sbjct: 211 M---P--------VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP----YPG--- 252
Query: 992 VIQWVRDHLKSKKDPVEVLDPKLQGH--------PDTQIQEMLQALGISLLCTSNRAEDR 1043
E+ D L GH D + M C DR
Sbjct: 253 ------------VQNHEMYDYLLHGHRLKQPEDCLDELYEIMYS-------CWRTDPLDR 293
Query: 1044 PTMKDVAALLREIRQ 1058
PT + L ++ +
Sbjct: 294 PTFSVLRLQLEKLLE 308
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 46/216 (21%), Positives = 84/216 (38%), Gaps = 25/216 (11%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTG-AFSSEIATLSRIRHRNIVRLLG-- 839
+G+G G+V++ A+KR R ++ E+ L+++ H IVR
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 840 -------WGANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLS 889
K+ Y L ++ E I L +AE +
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD--------SGGSFSANPQ 941
+LH ++HRD+K NI + DFGL ++ D +++ +
Sbjct: 133 FLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 942 FAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT 977
G+ Y++PE + S K D++S G++L E++
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 60/287 (20%), Positives = 114/287 (39%), Gaps = 55/287 (19%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFR-ASDKISTGAFSSEIATLSRIRHRNIVRLL 838
+IG G G V+K G T +KR + ++K E+ L+++ H NIV
Sbjct: 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE-----REVKALAKLDHVNIVHYN 70
Query: 839 G--------------WGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIAL 882
G + KTK LF ++ GTL + L + ++
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK-VLALELFE 129
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
+ +G+ Y+H +++RD+K NI L + + + DFGL +++D + +
Sbjct: 130 QITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT-----RS 181
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS 1002
G+ Y++PE + ++ D+Y+ G++L E++ +
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----AFETSKFFT-------- 229
Query: 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
++ D + D + + +LQ LL EDRP ++
Sbjct: 230 -----DLRDGIISDIFDKKEKTLLQ----KLLSKK--PEDRPNTSEI 265
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 71/335 (21%), Positives = 131/335 (39%), Gaps = 50/335 (14%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVKR--FRASDKISTGAFSSEIATLSRIRH--RNIVR 836
IG G S V++V A+K +D + ++ +EIA L++++ I+R
Sbjct: 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDC 895
L + + + + N L L + + W+ + + E + +H H
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKS-YWKNMLEAVHTIHQHG- 128
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE--- 952
I+H D+K N L+ + L DFG+A ++ D+ G+ Y+ PE
Sbjct: 129 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD--SQVGTVNYMPPEAIK 182
Query: 953 --------YANMTKISEKSDVYSYGVVLLEIITGKKP----------------VDASFPD 988
+ +KIS KSDV+S G +L + GK P +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 989 GQHVIQWVRDHLKS--KKDPVEVLD-PKLQGHP--DTQIQEMLQALGISLLCTSNRAEDR 1043
+ ++D LK K+DP + + P+L HP Q + Q +
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQL 302
Query: 1044 PTMKDVAALLREIR--QEPASGSEAHKPTAAKSTD 1076
+ ++L+ + E SG E+H +++K+ +
Sbjct: 303 VGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFE 337
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 31/230 (13%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVKR--FRASDKISTGAFSSEIATLSRIRHRN--IVR 836
IG G S V++V A+K +D + ++ +EIA L++++ + I+R
Sbjct: 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDC 895
L + + + + N L L + + W+ + + E + +H H
Sbjct: 93 LYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKS-YWKNMLEAVHTIHQHG- 147
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE--- 952
I+H D+K N L+ + L DFG+A ++ D+ G+ Y+ PE
Sbjct: 148 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD--SQVGTVNYMPPEAIK 201
Query: 953 --------YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQ 994
+ +KIS KSDV+S G +L + GK P F + I
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQIS 247
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 38/302 (12%)
Query: 784 IGQGRSGIVYK---VTLPSGLTVAVKRFR---ASDKISTGAFSSEIATLSRIRHRNIVRL 837
+G G VY L + VA+K + + F E+ S++ H+NIV +
Sbjct: 19 LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+ L +Y+ TL + G L DT + +G+ + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM--- 130
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
I+HRD+K NIL+ + DFG+A+ + S S + G+ Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDG---QHVIQWVRDHLKSKKDPVEVLDPKL 1014
E +D+YS G+VL E++ G+ P + +H+ +D V P +
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-----------QDSV----PNV 232
Query: 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRP-TMKDVAALLREIRQEPASGSEAHKPTAAK 1073
I + L + L T +R T++++ L + E + + ++ K
Sbjct: 233 TTDVRKDIPQSLSN--VILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMK 290
Query: 1074 ST 1075
+
Sbjct: 291 TI 292
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 80/352 (22%), Positives = 127/352 (36%), Gaps = 87/352 (24%)
Query: 745 HHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTL---PSGL 801
HH+ G + + L + ++IG+G G V K + +
Sbjct: 6 HHHHGKNNPDPTIYPVLDW------------NDIKFQDVIGEGNFGQVLKARIKKDGLRM 53
Query: 802 TVAVKRFR--ASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMPNGT 858
A+KR + AS F+ E+ L ++ H NI+ LLG +R L +Y P+G
Sbjct: 54 DAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112
Query: 859 L-------------GMLLHDGECAGLLEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDV 904
L A L A VA G+ YL + HRD+
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI----HRDL 168
Query: 905 KSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI-----APEYANMTKI 959
+ NIL+GE Y + +ADFGL+R + + G + A E N +
Sbjct: 169 AARNILVGENYVAKIADFGLSR--GQEV--------YVKKTMGRLPVRWMAIESLNYSVY 218
Query: 960 SEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH- 1017
+ SDV+SYGV+L EI++ G P + E+ + QG+
Sbjct: 219 TTNSDVWSYGVLLWEIVSLGGTP----YCG---------------MTCAELYEKLPQGYR 259
Query: 1018 -------PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
D M Q C + +RP+ + L + +E +
Sbjct: 260 LEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-29
Identities = 77/318 (24%), Positives = 125/318 (39%), Gaps = 37/318 (11%)
Query: 781 GNIIGQGRSGIVYK---VTLPSGLTVAVKRFR---ASDKISTGAFSSEIATLSRIRHRNI 834
G I+G G V+ + VAVK R A D F E + + H I
Sbjct: 17 GEILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 835 VRLLGWG-ANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
V + G A L Y +Y+ TL ++H G + ++ + L++
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNF 131
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
H + I+HRDVK NI++ + DFG+AR + DSG S + G+ Y++
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTAQYLS 187
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010
PE A + +SDVYS G VL E++TG+ P F G + H++ P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP----F-TGDSPVSVAYQHVREDPIPPSAR 242
Query: 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEAHKPT 1070
+ L A + L + E+R + A + ++ + +G P
Sbjct: 243 HE--------GLSADLDA--VVLKALAKNPENRY--QTAAEMRADLVR-VHNGEPPEAPK 289
Query: 1071 AAKSTDTASYSSSSVTSA 1088
+ S SS+ +
Sbjct: 290 VLTDAERTSLLSSAAGNL 307
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFS--------SEIATLSRIRHRN 833
IG G G K+ G + K ++ G+ + SE+ L ++H N
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWK------ELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 834 IVRLLGWGANRKTKLLFY--DYMPNGTLGMLL-HDGECAGLLEWDTRFKIALGVAEGLSY 890
IVR +R L+ +Y G L ++ + L+ + ++ + L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 891 LH--HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
H D +LHRD+K N+ L + L DFGLAR++ D+ + + F G+ Y
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT----FVGTPYY 182
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
++PE N +EKSD++S G +L E+ P A
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 68/312 (21%), Positives = 125/312 (40%), Gaps = 64/312 (20%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR--ASDKISTGAFSSEIATLSR 828
+T +GQG G+VY+ VA+K AS + F +E + +
Sbjct: 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKE 84
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLL----HDGECAGLLEWDTR---FKIA 881
++VRLLG + + L+ + M G L L +L + ++A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 882 LGVAEGLSYLH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD----SGGSF 936
+A+G++YL+ + V HRD+ + N ++ E + + DFG+ R + + GG
Sbjct: 145 GEIADGMAYLNANKFV----HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK- 199
Query: 937 SANPQFAGSYGYI-----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--D 988
G + +PE + SDV+S+GVVL EI T ++P +
Sbjct: 200 ----------GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLS 245
Query: 989 GQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKD 1048
+ V+++V + +L K PD + M C + RP+ +
Sbjct: 246 NEQVLRFVME--------GGLL-DKPDNCPDMLFELMRM-------CWQYNPKMRPSFLE 289
Query: 1049 VAALLREIRQEP 1060
+ + ++E +
Sbjct: 290 IISSIKEEMEPG 301
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 64/268 (23%), Positives = 100/268 (37%), Gaps = 16/268 (5%)
Query: 405 PSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464
PS +C E + + GLT +P GI +L L SN L + + L +
Sbjct: 2 PSRCSCSGTE-IRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKL 57
Query: 465 RANSNKLTGFIPPEIG---NLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG 521
+SN L+ F +L +LDL N + ++ G L LD +++
Sbjct: 58 SLSSNGLS-FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 115
Query: 522 NLPAGL-HQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ-LGSCV 579
+ L L + D+S + LSSL L + N F +
Sbjct: 116 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 175
Query: 580 KLQLLDLSSNQLSGNIPA-SLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHN 638
L LDLS QL + + + +L LN+S N LN L +LD S N
Sbjct: 176 NLTFLDLSQCQLE-QLSPTAFNSLSSL-QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 639 ELSG--DLHFLAELQNLVVLNVSHNNFS 664
+ +L LN++ N+F+
Sbjct: 234 HIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 59/264 (22%), Positives = 99/264 (37%), Gaps = 18/264 (6%)
Query: 314 CSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNN 373
CS + I + LT S+P + +S L+L N++ +L ++ L +N
Sbjct: 7 CS-GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62
Query: 374 QIT--GAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGI 431
++ G ++L L + N + + + + LE +D + L +
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 121
Query: 432 FQ-LKKLNKLLLLSNNLSGVIPPEM-GNCSSLIRFRANSNKLTGFIPPEI-GNLKNLNFL 488
F L+ L L + + V + SSL + N P+I L+NL FL
Sbjct: 122 FLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180
Query: 489 DLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAG-LHQLVRLQFADLSDNSVGGM 546
DL +L + +L L++ N+ +L L LQ D S N +
Sbjct: 181 DLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI-MT 237
Query: 547 LSPDL--GSLSSLTKLVLNKNRFA 568
SSL L L +N FA
Sbjct: 238 SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 66/268 (24%), Positives = 101/268 (37%), Gaps = 33/268 (12%)
Query: 354 EIPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLE--GEIPPSISNC 410
+P I + RL EL++N++ F L+ LT L + N L G S
Sbjct: 21 SVPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 411 QNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNK 470
+L+ +DLS NG+ + L++L L +NL + + F
Sbjct: 78 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV--------FL----- 123
Query: 471 LTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAG-LH 528
+L+NL +LD+ + I G +L L + NS N
Sbjct: 124 ----------SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 172
Query: 529 QLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSS 588
+L L F DLS + + SLSSL L ++ N F LQ+LD S
Sbjct: 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232
Query: 589 NQLSGNIPASLGKIPALAIALNLSWNQI 616
N + + L P+ LNL+ N
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 59/284 (20%), Positives = 97/284 (34%), Gaps = 38/284 (13%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158
S + + LT S+P I + L+L N L L +L +L L+SN L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 159 EGAIPIQIG---NLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEI 215
+SL L L N + + + L+ LE + + NL +
Sbjct: 65 S-FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS-NLKQMSEFSV 121
Query: 216 -GNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYL 274
+ NL+ + ++ T G+ L + L+ + +
Sbjct: 122 FLSLRNLIYLDISHTHTR-VAFN--GIFNGL---------------------SSLEVLKM 157
Query: 275 YENALTGSIPSK-LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQ 333
N+ + L+NL L L Q L + P + S L ++++S N+
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 217
Query: 334 TLGNLTSLQELQLSVNQISGEIPAQI--GNCQRLAQIELDNNQI 375
L SLQ L S+N I Q LA + L N
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 53/212 (25%), Positives = 79/212 (37%), Gaps = 13/212 (6%)
Query: 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIA-GNLPA 525
NS LT +P I + L+L SN+L LT L + SN ++ +
Sbjct: 15 NSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 526 G-LHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ--LGSCVKLQ 582
L++ DLS N V +S + L L L + + S L
Sbjct: 72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLI 129
Query: 583 LLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAE-LTGLNKLGILDLSHNELS 641
LD+S + +L + L ++ N + T L L LDLS +L
Sbjct: 130 YLDISHTHTRVAFNGIFNGLSSLEV-LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
Query: 642 G-DLHFLAELQNLVVLNVSHNNFSGRVPDTPF 672
L +L VLN+SHNNF + P+
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPY 219
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 42/143 (29%), Positives = 61/143 (42%), Gaps = 11/143 (7%)
Query: 552 GSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS--GNIPASLGKIPALAIAL 609
G SS T+L L N+ +L L LSSN LS G S +L L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY-L 83
Query: 610 NLSWNQICGELPAELTGLNKLGILDLSHNELS--GDLHFLAELQNLVVLNVSHNNFSGRV 667
+LS+N + + + GL +L LD H+ L + L+NL+ L++SH +
Sbjct: 84 DLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VA 141
Query: 668 PDTPFFAKLP-LSVL--SGNPSL 687
+ F L L VL +GN
Sbjct: 142 FNG-IFNGLSSLEVLKMAGNSFQ 163
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 32/131 (24%), Positives = 50/131 (38%), Gaps = 6/131 (4%)
Query: 79 LDLRYVDLLGHVPTN-FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTG 136
LD ++ +L + F SL +L L +S T+ I L+ L L ++ NS
Sbjct: 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQE 164
Query: 137 EIPRE-LCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLK 194
+ L L L L+ QLE + +LSSL L + N L
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223
Query: 195 NLEAIRAGGNK 205
+L+ + N
Sbjct: 224 SLQVLDYSLNH 234
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 26/85 (30%), Positives = 33/85 (38%), Gaps = 8/85 (9%)
Query: 81 LRYVDL----LGHVPTN-FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSL 134
L ++DL L + F SL SL L +S N S+ LN L LD S N +
Sbjct: 177 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI 235
Query: 135 TGEIPRELCSLLR-LEQLRLNSNQL 158
+EL L L L N
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 11/232 (4%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
T + + L+EN + + +L++L L L +N++ I + L+ +++ N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIEL-DNNQITGAIPSEFG 384
LT L+ L+EL L N I IP+ L +++L + +++ F
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
Query: 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLL 443
LSNL L + L P+++ L+ +DLS N L+ I G FQ L L KL ++
Sbjct: 183 GLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMI 239
Query: 444 SNNLSGVIPPEM-GNCSSLIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSN 493
+ + VI N SL+ N LT +P ++ L +L + L N
Sbjct: 240 QSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-27
Identities = 61/257 (23%), Positives = 100/257 (38%), Gaps = 37/257 (14%)
Query: 315 SQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNN 373
+ ++++ N + + +L L+ LQLS N I I L +EL +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN 122
Query: 374 QITGAIPSE-FGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGI 431
++T IP+ F LS L L++ +N +E IP + +L +DL + I G
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180
Query: 432 FQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDL 490
F+ L L L L NL + P + L L+ LDL
Sbjct: 181 FEGLSNLRYLNLAMCNLREI--------------------------PNLTPLIKLDELDL 214
Query: 491 GSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG-LHQLVRLQFADLSDNSVGGMLSP 549
N L+ P G +L L + + I + L L +L+ N++ +L
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNL-TLLPH 272
Query: 550 D-LGSLSSLTKLVLNKN 565
D L L ++ L+ N
Sbjct: 273 DLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 62/266 (23%), Positives = 110/266 (41%), Gaps = 19/266 (7%)
Query: 380 PSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLN 438
PS + + + L E+P IS N ++L +N + I F+ L+ L
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQI-IKVNSFKHLRHLE 91
Query: 439 KLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTG 497
L L N++ + ++L N+LT IP L L L L +N +
Sbjct: 92 ILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE- 149
Query: 498 SIPDEI-TGCRNLTFLDV-HSNSIAGNLPAG-LHQLVRLQFADLSDNSVGGMLSPDLGSL 554
SIP +L LD+ ++ + G L L++ +L+ ++ + P+L L
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLREI--PNLTPL 206
Query: 555 SSLTKLVLNKNRFAGSIPSQ-LGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSW 613
L +L L+ N + +I + LQ L + +Q+ + + +L +NL+
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE-INLAH 264
Query: 614 NQICGELPAE-LTGLNKLGILDLSHN 638
N + LP + T L+ L + L HN
Sbjct: 265 NNL-TLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 74/293 (25%), Positives = 113/293 (38%), Gaps = 44/293 (15%)
Query: 405 PSISNCQN-LEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIR 463
PS+ +C N V + L +P GI L L N + + + L
Sbjct: 36 PSVCSCSNQFSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEI 92
Query: 464 FRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAG 521
+ + N + I L NLN L+L NRLT +IP+ L L + +N I
Sbjct: 93 LQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE- 149
Query: 522 NLPAGL-HQLVRLQFADLSDNSVGGMLSPD-LGSLSSLTKLVLNKNRFAGSIPSQLGSCV 579
++P+ +++ L+ DL + +S LS+L L L IP+ L +
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLI 207
Query: 580 KLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNE 639
KL LDLS N LS I + GL L L + ++
Sbjct: 208 KLDELDLSGNHLS--------AIRPGS-----------------FQGLMHLQKLWMIQSQ 242
Query: 640 LSG-DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP-LSV--LSGNPSLC 688
+ + + LQ+LV +N++HNN + D F L L L NP C
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLTLLPHDL--FTPLHHLERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 61/289 (21%), Positives = 93/289 (32%), Gaps = 56/289 (19%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL 146
L VP ++ + L L + L L L LS N + L
Sbjct: 55 LREVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLA 112
Query: 147 RLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNK 205
L L L N+L IP LS L +L+L +N + ++ +L +
Sbjct: 113 NLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD----- 166
Query: 206 NLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGD 265
LG LKRL I+
Sbjct: 167 ---------------------------------LGELKRLSYISEGA----------FEG 183
Query: 266 CTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325
+ L+Y+ L L IP+ L L L L L N+L I P L + + +
Sbjct: 184 LSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 326 SLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNN 373
+ NL SL E+ L+ N ++ +P + L +I L +N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 55/240 (22%), Positives = 92/240 (38%), Gaps = 14/240 (5%)
Query: 71 NLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDL 129
++ L+L + +F L L L LS ++ +I L LN L+L
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLEL 119
Query: 130 SENSLTGEIPRE-LCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYD-NQLTDAI 186
+N LT IP L +L++L L +N +E +IP + SL +L L + +L+
Sbjct: 120 FDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYIS 177
Query: 187 PATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQ 246
L NL + +P+ + L + L+ +S P + L LQ
Sbjct: 178 EGAFEGLSNLRYLNLAMCN--LREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ 234
Query: 247 TIAIYTALLSGQIPPE-LGDCTELQYIYLYENALTGSIPSK-LGNLKNLVNLFLWQNNLV 304
+ + + + I + L I L N LT +P L +L + L N
Sbjct: 235 KLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-28
Identities = 73/362 (20%), Positives = 134/362 (37%), Gaps = 59/362 (16%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVKR--FRASDKISTGAFSSEIATLSRIRH--RNIVR 836
IG G S V++V A+K +D + ++ +EIA L++++ I+R
Sbjct: 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDC 895
L + + + + N L L + + W+ + + E + +H H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKS-YWKNMLEAVHTIHQHG- 175
Query: 896 VPAILHRDVKSHNILLGERYESC-LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-- 952
I+H D+K N L+ + L DFG+A ++ D+ G+ Y+ PE
Sbjct: 176 ---IVHSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKD--SQVGAVNYMPPEAI 228
Query: 953 ---------YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003
+ +KIS KSDV+S G +L + GK P F + I + +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKLHAIIDPN 284
Query: 1004 KDPV--EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKD------VAALLRE 1055
+ ++ + LQ D ++ L+ + R ++ + V
Sbjct: 285 HEIEFPDIPEKDLQ---DV-LKCCLKR----------DPKQRISIPELLAHPYVQIQTHP 330
Query: 1056 IRQEPASGSEAHKPTAAKSTDTASYSSSSVTSAQLLLLQGQGSSHCSLAYSSSSGSYISR 1115
+ Q +E K + S +S + L G SH SSSS ++ +
Sbjct: 331 VNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESH----NSSSSKTFEKK 386
Query: 1116 NQ 1117
Sbjct: 387 RG 388
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 67/301 (22%), Positives = 113/301 (37%), Gaps = 60/301 (19%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
++GQG G V K A+K+ R +++ + S E+ L+ + H+ +VR
Sbjct: 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQYVVRYYA 69
Query: 840 ----------WGANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE 886
K K + +Y NGTL L+H + D +++ + E
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILE 127
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQ----- 941
LSY+H I+HRD+K NI + E + DFGLA+ V +
Sbjct: 128 ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 942 -----FAGSYGYIAPE-YANMTKISEKSDVYSYGVVLLE-----------------IITG 978
G+ Y+A E +EK D+YS G++ E + +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSV 244
Query: 979 KKPVDASFPDGQHVIQWVRDHLKS--KKDP------VEVL-DPKLQ-GHPDTQIQEMLQA 1028
F D + ++ + ++ DP +L L H D I+E L++
Sbjct: 245 SIEFPPDFDD--NKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALKS 302
Query: 1029 L 1029
L
Sbjct: 303 L 303
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 61/294 (20%), Positives = 116/294 (39%), Gaps = 27/294 (9%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKR---FRASDKISTGAFSSEIATLSRIRHRNIVR 836
IG+G+ VY+ L G+ VA+K+ F D + EI L ++ H N+++
Sbjct: 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLL-HDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
+ + G L ++ H + L+ T +K + + L ++H
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
++HRD+K N+ + L D GL R + + S G+ Y++PE +
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPERIH 209
Query: 956 MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
+ KSD++S G +L E+ + P + + + + + P+
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---EQCDYPPL-------- 258
Query: 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEAHKP 1069
P E L+ L +++ + E RP + V + + + AS E H
Sbjct: 259 --PSDHYSEELRQL-VNMCINPD-PEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 48/258 (18%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 285 SKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQEL 344
L N + + ++N+ + + ++ + +T +I + L +L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGL 68
Query: 345 QLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIP 404
+L NQI+ ++ + N ++ ++EL N + S L ++ L + ++ ++
Sbjct: 69 ELKDNQIT-DLAP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQIT-DVT 123
Query: 405 PSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464
P ++ NL+ + L N +T I + L L L + + +S + P + N S L
Sbjct: 124 P-LAGLSNLQVLYLDLNQITN-IS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLP 524
+A+ NK++ + +L NL + L +N+++ P + NL + + + +I
Sbjct: 179 KADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234
Query: 525 AGLHQLVRLQFADLSDNS 542
+ LV +
Sbjct: 235 FYNNNLVVPNVVKGPSGA 252
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 66/311 (21%), Positives = 111/311 (35%), Gaps = 49/311 (15%)
Query: 118 IASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFL 177
+L + ++++T + L + L + +Q L++L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLEL 70
Query: 178 YDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPP 237
DNQ+TD P + L + + GN I ++ + L T I+
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPL---KNVSAIAGLQSIKTLDLTSTQITDV--- 122
Query: 238 TLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLF 297
L + LQ +YL N +T +I L L NL L
Sbjct: 123 -----------------------TPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLS 157
Query: 298 LWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPA 357
+ + + P L N S+L+ + N ++ I L +L +L E+ L NQIS P
Sbjct: 158 IGNAQVSDLTP--LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP- 212
Query: 358 QIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEI--PPSISNCQNLEA 415
+ N L + L N IT NL ++ G P +IS+ +
Sbjct: 213 -LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV----KGPSGAPIAPATISDNGTYAS 267
Query: 416 VDLSQNGLTGP 426
+L+ N +
Sbjct: 268 PNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 53/283 (18%), Positives = 109/283 (38%), Gaps = 23/283 (8%)
Query: 335 LGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFV 394
L + ++ + ++ + + + + +T L+NL L +
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 395 WHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPE 454
N++ ++ P + N + ++LS N L I L+ + L L S ++ V P
Sbjct: 71 KDNQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP-- 124
Query: 455 MGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDV 514
+ S+L + N++T P + L NL +L +G+ +++ + + LT L
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKA 180
Query: 515 HSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ 574
N I+ ++ L L L L +N + +SP L + S+L + L
Sbjct: 181 DDNKIS-DIS-PLASLPNLIEVHLKNNQI-SDVSP-LANTSNLFIVTLTNQTITNQPVFY 236
Query: 575 LGSCVKLQLL-DLSSNQLSGNIPASLGKIPALAIALNLSWNQI 616
+ V ++ S ++ + G + NL+WN
Sbjct: 237 NNNLVVPNVVKGPSGAPIAPATISDNGTY----ASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 56/296 (18%), Positives = 102/296 (34%), Gaps = 70/296 (23%)
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
L +L L L +T + + +L ++ L+LS N L + + L ++ L
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTL 112
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSL 211
L S Q+ P+ LS+L L+L NQ+T+ P
Sbjct: 113 DLTSTQITDVTPLA--GLSNLQVLYLDLNQITNISP------------------------ 146
Query: 212 PHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQY 271
+ TNL + + +S L + ++L
Sbjct: 147 ---LAGLTNLQYLSIGNAQVSDL--------------------------TPLANLSKLTT 177
Query: 272 IYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSI 331
+ +N ++ I L +L NL+ + L N + + P L N S L I+ ++ ++T
Sbjct: 178 LKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233
Query: 332 PQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLS 387
NL ++ PA I + + +T + S N+S
Sbjct: 234 VFYNNNLVVPNVVKGPSGAPI--APATISD-----NGTYASPNLTWNLTSFINNVS 282
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 72/314 (22%), Positives = 114/314 (36%), Gaps = 68/314 (21%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR--ASDKISTGAFSSEIATLSR 828
++T +G G G VY+ + PS L VAVK S++ F E +S+
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-DELDFLMEALIISK 89
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLL----HDGECAGLLEWDTRFKIALGV 884
H+NIVR +G + + + M G L L L +A +
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 885 AEGLSYL-HHDCVPAILHRDVKSHNILLGERYES---CLADFGLARLVEDD----SGGSF 936
A G YL + + HRD+ + N LL + DFG+AR + GG
Sbjct: 150 ACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC- 204
Query: 937 SANPQFAGSYGYI-----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--D 988
+ PE + K+D +S+GV+L EI + G P +P
Sbjct: 205 ----------AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP----YPSKS 250
Query: 989 GQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046
Q V+++V + + P + M Q C ++ EDRP
Sbjct: 251 NQEVLEFVTSGGRM-----------DPPKNCPGPVYRIMTQ-------CWQHQPEDRPNF 292
Query: 1047 KDVAALLREIRQEP 1060
+ + Q+P
Sbjct: 293 AIILERIEYCTQDP 306
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 62/282 (21%), Positives = 101/282 (35%), Gaps = 44/282 (15%)
Query: 292 NLVNLFLWQNNLVGI---IPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSV 348
+ + L + IP +++ N++ T +L L+ LQL
Sbjct: 55 QFSKVVCTRRGLSEVPQGIPS------NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGR 108
Query: 349 NQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSE-FGNLSNLTLLFVWHNRLEGEIPPS 406
N I +I L +EL +N +T IPS F LS L L++ +N +E IP
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165
Query: 407 I-SNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464
+ +L +DL + I G F+ L L L L N+ +
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-------------- 211
Query: 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLP 524
P + L L L++ N P G +L L V ++ ++
Sbjct: 212 ------------PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259
Query: 525 AGLHQLVRLQFADLSDNSVGGMLSPD-LGSLSSLTKLVLNKN 565
L L +L+ N++ L D L L +L L+ N
Sbjct: 260 NAFDGLASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 62/259 (23%), Positives = 107/259 (41%), Gaps = 37/259 (14%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
+ +Y+ L EN + +L +L L L +N++ I + L+ +++ N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 327 LTGSIP-QTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIEL-DNNQITGAIPSE- 382
LT IP L+ L+EL L N I IP+ L +++L + ++ I
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGA 191
Query: 383 FGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLL 441
F L NL L + ++ P+++ LE +++S N I G F L L KL
Sbjct: 192 FEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPE-IRPGSFHGLSSLKKLW 248
Query: 442 LLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPD 501
++++ +S +I F L +L L+L N L+ S+P
Sbjct: 249 VMNSQVS-LIERNA--------FD---------------GLASLVELNLAHNNLS-SLPH 283
Query: 502 EI-TGCRNLTFLDVHSNSI 519
++ T R L L +H N
Sbjct: 284 DLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 65/260 (25%), Positives = 105/260 (40%), Gaps = 15/260 (5%)
Query: 410 CQN-LEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANS 468
C N V ++ GL+ +P+GI L L+ NN+ + + L +
Sbjct: 52 CSNQFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGR 108
Query: 469 NKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAG 526
N + I L +LN L+L N LT IP L L + +N I ++P+
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165
Query: 527 -LHQLVRLQFADLSDNSVGGMLSPD-LGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLL 584
+++ L DL + +S L +L L L +P+ L V L+ L
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEEL 223
Query: 585 DLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSG-D 643
++S N P S + +L L + +Q+ GL L L+L+HN LS
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKK-LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLP 282
Query: 644 LHFLAELQNLVVLNVSHNNF 663
L+ LV L++ HN +
Sbjct: 283 HDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 8e-21
Identities = 56/278 (20%), Positives = 96/278 (34%), Gaps = 35/278 (12%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158
+++V + L+ +P+ I + YL+L EN++ L LE L+L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 159 EGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGN 217
I + L+SL L L+DN LT L L + N
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP------------ 158
Query: 218 CTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE-LGDCTELQYIYLYE 276
I + L + + I L+Y+ L
Sbjct: 159 -------------IESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205
Query: 277 NALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLG 336
+ +P+ L L L L + N+ I P S L + + + ++
Sbjct: 206 CNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD 263
Query: 337 NLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNN 373
L SL EL L+ N +S +P + + L ++ L +N
Sbjct: 264 GLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-17
Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 17/195 (8%)
Query: 484 NLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG-LHQLVRLQFADLSDNS 542
+ + L+ +P I N +L++ N+I + A L L+ L NS
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110
Query: 543 VGGMLSPD-LGSLSSLTKLVLNKNRFAGSIPSQ-LGSCVKLQLLDLSSNQLSGNIPA-SL 599
+ + L+SL L L N IPS KL+ L L +N + +IP+ +
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167
Query: 600 GKIPALAIALNLS-WNQICGELPAE-LTGLNKLGILDLSHNELSGDLHFLAELQNLVVLN 657
++P+L + L+L ++ + GL L L+L + D+ L L L L
Sbjct: 168 NRVPSL-MRLDLGELKKL-EYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELE 224
Query: 658 VSHNNFSGRVPDTPF 672
+S N+F + F
Sbjct: 225 MSGNHFP-EIRPGSF 238
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-15
Identities = 54/241 (22%), Positives = 91/241 (37%), Gaps = 16/241 (6%)
Query: 71 NLNNQVVGLDLRYVDLLGHVPTN-FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLD 128
+ + L+L + + + + F L L L L ++ I L LN L+
Sbjct: 72 GIPSNTRYLNLME-NNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLE 129
Query: 129 LSENSLTGEIPRE-LCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYD-NQLTDA 185
L +N LT IP L +L +L L +N +E +IP + SL +L L + +L
Sbjct: 130 LFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYI 187
Query: 186 IPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRL 245
L NL+ + G N+ + L + ++ P + L L
Sbjct: 188 SEGAFEGLFNLKYLNLGMC-NI--KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 246 QTIAIYTALLSGQIPPE-LGDCTELQYIYLYENALTGSIPSK-LGNLKNLVNLFLWQNNL 303
+ + + + +S I L + L N L+ S+P L+ LV L L N
Sbjct: 245 KKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
Query: 304 V 304
Sbjct: 303 N 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 21/109 (19%), Positives = 35/109 (32%), Gaps = 15/109 (13%)
Query: 580 KLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNE 639
+ + + LS +P IP+ LNL N I L+ L +L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQG---IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 640 LSG-DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSL 687
+ ++ L +L L + N + +P L
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT----------VIPSGAFEYLSKL 149
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 74/341 (21%), Positives = 131/341 (38%), Gaps = 48/341 (14%)
Query: 769 LSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLS 827
+ +G+ L ++ +G VY+ + SG A+KR ++++ A E+ +
Sbjct: 23 VELGE--LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 828 RIR-HRNIVRLLGWGANRK-------TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFK 879
++ H NIV+ + K + L + G L L E G L DT K
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 880 IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939
I + ++H P I+HRD+K N+LL + L DFG A + S+SA
Sbjct: 141 IFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 940 PQFA--------GSYGYIAPE----YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFP 987
+ + Y PE Y+N I EK D+++ G +L + + P F
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FE 254
Query: 988 DGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMK 1047
DG + +++ K P + +L ++L + E+R ++
Sbjct: 255 DG---------------AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERLSIA 297
Query: 1048 DVAALLREIRQEPASGSEAHKPTAAKSTDTASYSSSSVTSA 1088
+V L+EI P Y S++++
Sbjct: 298 EVVHQLQEIAAAR--NVNPKSPITELLEQNGGYGSATLSRG 336
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 72/316 (22%), Positives = 114/316 (36%), Gaps = 68/316 (21%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR--ASDKISTGAFSSEIATLSR 828
++T +G G G VY+ + PS L VAVK S++ F E +S+
Sbjct: 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-DELDFLMEALIISK 130
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLL----HDGECAGLLEWDTRFKIALGV 884
H+NIVR +G + + + M G L L L +A +
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 885 AEGLSYL-HHDCVPAILHRDVKSHNILLGERYES---CLADFGLARLVEDD----SGGSF 936
A G YL + + HRD+ + N LL + DFG+AR + GG
Sbjct: 191 ACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC- 245
Query: 937 SANPQFAGSYGYI-----APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFP--D 988
+ PE + K+D +S+GV+L EI + G P +P
Sbjct: 246 ----------AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP----YPSKS 291
Query: 989 GQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046
Q V+++V + + P + M Q C ++ EDRP
Sbjct: 292 NQEVLEFVTSGGRM-----------DPPKNCPGPVYRIMTQ-------CWQHQPEDRPNF 333
Query: 1047 KDVAALLREIRQEPAS 1062
+ + Q+P
Sbjct: 334 AIILERIEYCTQDPDV 349
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 19/210 (9%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLG 839
+++G G G + + VAVKR E+ L H N++R
Sbjct: 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIRYFC 85
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+R+ + + + TL + + A L + + GL++LH I
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVEQKDFA-HLGLEPI-TLLQQTTSGLAHLHSL---NI 139
Query: 900 LHRDVKSHNILLGERYESC-----LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY- 953
+HRD+K HNIL+ ++DFGL + + SFS G+ G+IAPE
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-HSFSRRSGVPGTEGWIAPEML 198
Query: 954 --ANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ D++S G V +I+
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 60/392 (15%), Positives = 119/392 (30%), Gaps = 87/392 (22%)
Query: 751 EDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFR 809
+ + W +++ +G+ R+L G ++GQ + T +G + V
Sbjct: 53 DSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPY 112
Query: 810 ASDKISTGA---FSSEIATLSRIR-------------------------HRNIVRLLGWG 841
+++ + A E+ L +R + ++R+
Sbjct: 113 FTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDE 172
Query: 842 ANRKTKLLFYDYM-PNGTLGM----LLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
+ F+ Y L LL L R ++ L V L+ LHH
Sbjct: 173 RDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDS---GGSFSANPQFAGSYGYIAPEY 953
++H ++ +I+L +R L F + G A P+ A
Sbjct: 232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPE------TTAERM 283
Query: 954 ANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008
T ++ D ++ G+ + I P G +W+ K+ PV
Sbjct: 284 LPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG--GSEWIFRSCKNIPQPVR 341
Query: 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKD-------------VAALLRE 1055
L ++ L+ EDR ++A L
Sbjct: 342 AL-----------LEGFLRY----------PKEDRLLPLQAMETPEYEQLRTELSAALPL 380
Query: 1056 IRQEPASGSEAHKPTAAKSTDTASYSSSSVTS 1087
+ + E P + S + ++ +VT+
Sbjct: 381 YQTDGEPTREGGAPPSGTSQPDEAGAAEAVTA 412
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-27
Identities = 70/319 (21%), Positives = 114/319 (35%), Gaps = 77/319 (24%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL--------PSGLTVAVKRFR--ASDKISTGAFSSEIATL 826
LT G +G+G G V +TVAVK + A++K SE+ +
Sbjct: 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMM 140
Query: 827 SRI-RHRNIVRLLGWGANRKTKLLFYDYMPNGTL-------------GMLLHDGECAGLL 872
I +H+NI+ LLG + +Y G L + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 873 EWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931
+ +A G+ YL C+ HRD+ + N+L+ E +ADFGLAR + +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 932 ------SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
+ G P + APE + +SDV+S+GV++ EI T G P
Sbjct: 257 DYYKKTTNGRL---P--------VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 982 VDASFP--DGQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTS 1037
+P + + + +++ + K + M C
Sbjct: 306 ----YPGIPVEELFKLLKEGHRM-----------DKPANCTNELYMMMRD-------CWH 343
Query: 1038 NRAEDRPTMKDVAALLREI 1056
RPT K + L I
Sbjct: 344 AVPSQRPTFKQLVEDLDRI 362
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 70/325 (21%), Positives = 115/325 (35%), Gaps = 77/325 (23%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLP--------SGLTVAVKRFR--ASDKISTGAFSSEIATL 826
LT G +G+G G V +TVAVK + A++K SE+ +
Sbjct: 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMM 94
Query: 827 SRI-RHRNIVRLLGWGANRKTKLLFYDYMPNGTL-------------GMLLHDGECAGLL 872
I +H+NI+ LLG + +Y G L + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 873 EWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931
+ +A G+ YL C+ HRD+ + N+L+ E +ADFGLAR + +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 932 ------SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
+ G P + APE + +SDV+S+GV++ EI T G P
Sbjct: 211 DYYKKTTNGRL---P--------VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 982 VDASFP--DGQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTS 1037
+P + + + +++ + K + M C
Sbjct: 260 ----YPGIPVEELFKLLKEGHRM-----------DKPANCTNELYMMMRD-------CWH 297
Query: 1038 NRAEDRPTMKDVAALLREIRQEPAS 1062
RPT K + L I +
Sbjct: 298 AVPSQRPTFKQLVEDLDRILTLTTN 322
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 62/306 (20%), Positives = 102/306 (33%), Gaps = 38/306 (12%)
Query: 374 QITGAIPSEF--GNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGI 431
GA E G S LL + I +L+ + + + I G
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 432 FQLKKLNKLL---LLSNNLSGVIPPEMGNCSSL----IRFRANSNKLTGFIPPEIGNL-- 482
++ ++ L L + ++G PP + + + R S E+
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148
Query: 483 KNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNS 542
L L + +++ L+ LD+ N L +
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE------------------LGERG 190
Query: 543 VGGMLSPDLGSLSSLTKLVLNKNRFA---GSIPSQLGSCVKLQLLDLSSNQLSGNIPASL 599
+ L P +L L L G + + V+LQ LDLS N L A
Sbjct: 191 LISALCP--LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 600 GKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVS 659
P+ +LNLS+ + ++P L KL +LDLS+N L EL + L++
Sbjct: 249 CDWPSQLNSLNLSFTGL-KQVPKGL--PAKLSVLDLSYNRLDR-NPSPDELPQVGNLSLK 304
Query: 660 HNNFSG 665
N F
Sbjct: 305 GNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 53/309 (17%), Positives = 87/309 (28%), Gaps = 41/309 (13%)
Query: 277 NALTGSIPSKLGNLKNLVNLFLWQNNLVGIIP-PELGNCSQLSIIDISMNSLTGSIPQT- 334
N L + G ++L L + + ++ L + + + I
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 335 --LGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELD--NNQITG--AIPSEFGNLSN 388
+ ++ LQEL L +++G P + L+ N A +E
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148
Query: 389 LTL--LFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGI----FQLKKLNKLLL 442
L L + + L +DLS N G + L L L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 443 LSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDE 502
+ + +G L LDL N L +
Sbjct: 209 RNAGM---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247
Query: 503 I-TGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLV 561
L L++ + +P GL +L DLS N + P L + L
Sbjct: 248 SCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNLS 302
Query: 562 LNKNRFAGS 570
L N F S
Sbjct: 303 LKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 7e-21
Identities = 46/277 (16%), Positives = 81/277 (29%), Gaps = 20/277 (7%)
Query: 238 TLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPS---KLGNLKNLV 294
G + ++ L+ + + + I ++ + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 295 NLFLWQNNLVGIIPPELGNCS--QLSIIDISMNSLTG--SIPQTLGNL--TSLQELQLSV 348
L L + G PP L + L+I+++ S + L L+ L ++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 349 NQISGEIPAQIGNCQRLAQIELDNNQITGAI-------PSEFGNLSNLTLLFVWHNRLEG 401
Q+ L+ ++L +N G P +F L L L G
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 402 EIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSL 461
+ L+ +DLS N L L LS +P + + L
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKL 276
Query: 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGS 498
+ N+L P L + L L N S
Sbjct: 277 SVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 49/305 (16%), Positives = 91/305 (29%), Gaps = 49/305 (16%)
Query: 103 LVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL---RLEQLRLNSNQLE 159
L T +I L L + + I +L L++L L + ++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 160 GAIPIQIGNL--SSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGN 217
G P + L L L + A + +L+
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK------------------- 148
Query: 218 CTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYEN 277
L ++ +A+ F + + L T+ + G+ C
Sbjct: 149 -PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC----------- 196
Query: 278 ALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIP-QTLG 336
P K L+ L G+ QL +D+S NSL + +
Sbjct: 197 ------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWH 396
+ L L LS + ++P + +L+ ++L N++ PS L + L +
Sbjct: 251 WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKG 305
Query: 397 NRLEG 401
N
Sbjct: 306 NPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 43/216 (19%), Positives = 74/216 (34%), Gaps = 20/216 (9%)
Query: 480 GNLKNLNFLDLGSNRLTGSIPD-EITGCRNLTFLDVHSNSIAGNLPAGLHQLV---RLQF 535
G ++L +L + +I +L L V + I + G +++ LQ
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99
Query: 536 ADLSDNSVGGMLSPDLGSLS--SLTKLVLNKNRFAG--SIPSQLGSCVK--LQLLDLSSN 589
L + V G P L + L L L +A + ++L +K L++L ++
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159
Query: 590 QLSGNIPASLGKIPALAIALNLSWNQICGELPAELT----GLNKLGILDLSHNELS---- 641
+ PAL+ L+LS N GE L +L L + +
Sbjct: 160 HSLNFSCEQVRVFPALST-LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 642 GDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP 677
A L L++SHN+ P
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRD-AAGAPSCDWPS 253
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 30/117 (25%), Positives = 45/117 (38%), Gaps = 6/117 (5%)
Query: 90 VPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL-RL 148
P F +L L +G A+ QL LDLS NSL C +L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 149 EQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNK 205
L L+ L+ +P + + L+ L L N+L P+ +L + + GN
Sbjct: 256 NSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNP 307
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 30/145 (20%), Positives = 45/145 (31%), Gaps = 12/145 (8%)
Query: 73 NNQVVGLDLRYVDLLGHVP----TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLD 128
+ L+LR V L L ++ + +++ L+ LD
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 129 LSENSLTGEIP--RELC--SLLRLEQLRLNSNQLE---GAIPIQIGNLSSLTQLFLYDNQ 181
LS+N GE LC L+ L L + +E G L L L N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 182 LTDAIPATI-GKLKNLEAIRAGGNK 205
L DA A L ++
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTG 264
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 72/325 (22%), Positives = 111/325 (34%), Gaps = 77/325 (23%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLP--------SGLTVAVKRFR--ASDKISTGAFSSEIATL 826
L G +G+G G V VAVK + A++K SE+ +
Sbjct: 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMM 128
Query: 827 SRI-RHRNIVRLLGWGANRKTKLLFYDYMPNGTL-------------GMLLHDGECAGLL 872
I +H+NI+ LLG + +Y G L L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 873 EWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931
A VA G+ YL C+ HRD+ + N+L+ E +ADFGLAR +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 932 ------SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
+ G P + APE + +SDV+S+GV+L EI T G P
Sbjct: 245 DYYKKTTNGRL---P--------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 982 VDASFP--DGQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTS 1037
+P + + + +++ + K + M C
Sbjct: 294 ----YPGVPVEELFKLLKEGHRM-----------DKPSNCTNELYMMMRD-------CWH 331
Query: 1038 NRAEDRPTMKDVAALLREIRQEPAS 1062
RPT K + L I ++
Sbjct: 332 AVPSQRPTFKQLVEDLDRIVALTSN 356
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 81/330 (24%), Positives = 120/330 (36%), Gaps = 82/330 (24%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGL------TVAVKRFR--ASDKISTGAFSSEIATLSR 828
++ IG+G G V++ P L VAVK + AS F E A ++
Sbjct: 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAE 106
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTL---------------------GMLLHDGE 867
+ NIV+LLG A K L ++YM G L
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 868 CAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926
L + IA VA G++YL V HRD+ + N L+GE +ADFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSR 222
Query: 927 LVEDD------SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT 977
+ + P I PE + + +SDV++YGVVL EI +
Sbjct: 223 NIYSADYYKADGNDAI---P--------IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 978 -GKKPVDASFP--DGQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGIS 1032
G +P + + VI +VRD L + P M
Sbjct: 272 YGLQP----YYGMAHEEVIYYVRDGNIL-----------ACPENCPLELYNLMRL----- 311
Query: 1033 LLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
C S DRP+ + +L+ + +
Sbjct: 312 --CWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 68/263 (25%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 784 IGQGRSGIVYKVTL-PSGLTVAVKRFRA-SDKISTGAFSSEIATLSRIRHRNIVRLLGWG 841
+G G G+V+KV+ PSGL +A K E+ L IV G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG-- 98
Query: 842 ANRKTKLLFYD---------YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
FY +M G+L +L G + K+++ V +GL+YL
Sbjct: 99 -------AFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLR 148
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
I+HRDVK NIL+ R E L DFG++ + D S F G+ Y++PE
Sbjct: 149 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVGTRSYMSPE 200
Query: 953 YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012
T S +SD++S G+ L+E+ G+ P+ ++ + + + P P
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 1013 KLQG-------HPDTQIQEMLQA 1028
P I E+L
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDY 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 49/207 (23%), Positives = 79/207 (38%), Gaps = 17/207 (8%)
Query: 784 IGQGRSGIVYK---VTLPSGLTVAVKRFR---ASDKISTGAFSSEIATLSRIRHRNIVRL 837
+G+G G VY+ VA+K +SD + E T R++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+G + + L +L G L I + L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA--- 153
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
HRDVK NIL+ + L DFG+A D + G+ Y+APE + +
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTD---EKLTQLGNTVGTLYYMAPERFSES 210
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDA 984
+ ++D+Y+ VL E +TG P
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQG 237
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 77/331 (23%), Positives = 121/331 (36%), Gaps = 90/331 (27%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR--ASDKISTGAFSSEIATLSR 828
+L G +G+G G V K T TVAVK + AS SE L +
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLSEFNVLKQ 82
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTL---------------------GMLLHDGE 867
+ H ++++L G + LL +Y G+L D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 868 CAGLLEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926
L A +++G+ YL V HRD+ + NIL+ E + ++DFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV----HRDLAARNILVAEGRKMKISDFGLSR 198
Query: 927 LVEDD------SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT 977
V ++ S G P + A E + +SDV+S+GV+L EI+T
Sbjct: 199 DVYEEDSYVKRSQGRI---P--------VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 978 -GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH----PDT---QIQE-MLQA 1028
G P +P P + + GH PD ++ MLQ
Sbjct: 248 LGGNP----YPG---------------IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQ- 287
Query: 1029 LGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
C + RP D++ L ++ +
Sbjct: 288 ------CWKQEPDKRPVFADISKDLEKMMVK 312
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--------RFRASDKISTGAFSSEIATLSRIRH 831
GN++G+G VY+ + +GL VA+K + ++ +E+ +++H
Sbjct: 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ-----NEVKIHCQLKH 70
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
+I+ L + + L + NG + L + E + R + + G+ YL
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMH-QIITGMLYL 128
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
H + LHRD+ N+LL +ADFGLA ++ ++ G+ YI+P
Sbjct: 129 HSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT----LCGTPNYISP 181
Query: 952 EYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
E A + +SDV+S G + ++ G+ P D
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFS--------SEIATLSRIRHRN 833
IG+G G V G +K +I+ S E+A L+ ++H N
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIK------EINISRMSSKEREESRREVAVLANMKHPN 84
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
IV+ + + DY G L ++ + L + D + + L ++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
ILHRD+KS NI L + L DFG+AR++ + + G+ Y++PE
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA----CIGTPYYLSPEI 196
Query: 954 ANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
+ KSD+++ G VL E+ T K +A
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA---FSSEIATLSRIRHRNIVR 836
G +G+G+ G VY S +A+K + G E+ S +RH NI+R
Sbjct: 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L G+ + L +Y P GT+ L + + E T I +A LSY H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITE-LANALSYCHSK-- 128
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
++HRD+K N+LLG E +ADFG + G+ Y+ PE
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD------LCGTLDYLPPEMIEG 181
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDAS 985
EK D++S GV+ E + GK P +A+
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 27/269 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRF-RASDKISTGAFSSEIATLSRIRHRNIVRLL 838
+I+GQG + V++ +G A+K F S E L ++ H+NIV+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 839 G--WGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
+ K+L ++ P G+L +L GL E + + V G+++L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN- 131
Query: 896 VPAILHRDVKSHNILLGERYESC----LADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
I+HR++K NI+ + L DFG AR +EDD G+ Y+ P
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV-----SLYGTEEYLHP 184
Query: 952 E--------YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003
+ + K D++S GV TG P F + + + + K
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP-FEGPRRNKEVMYKIITGK 243
Query: 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGIS 1032
K + P +M + +S
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLS 272
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 77/318 (24%), Positives = 120/318 (37%), Gaps = 72/318 (22%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR--ASDKISTGAFSSEIATLSR 828
+L G +G G G V + T + L VAVK + A A SE+ +S
Sbjct: 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-EKEALMSELKIMSH 105
Query: 829 I-RHRNIVRLLGWGANRKTKLLFYDYMPNGTL-----------GMLLHDGECAGLLEWDT 876
+ +H NIV LLG + L+ +Y G L
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 877 RFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD---- 931
+ VA+G+++L +C+ HRDV + N+LL + + + DFGLAR + +D
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 932 --SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDAS 985
P + APE + +SDV+SYG++L EI + G P
Sbjct: 222 VKGNARL---P--------VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP---- 266
Query: 986 FPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH----PDTQIQEMLQALGISLLCTSNRAE 1041
+P G V +K G+ P + + I C +
Sbjct: 267 YP-GILVNSKFYKLVK-------------DGYQMAQPAFAPKNIYS---IMQACWALEPT 309
Query: 1042 DRPTMKDVAALLREIRQE 1059
RPT + + + L+E QE
Sbjct: 310 HRPTFQQICSFLQEQAQE 327
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 74/323 (22%), Positives = 118/323 (36%), Gaps = 72/323 (22%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR--ASDKISTGAFSSEIATLSR 828
L+ G +G G G V + T + +TVAVK + A A SE+ LS
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-EREALMSELKVLSY 82
Query: 829 I-RHRNIVRLLGWGANRKTKLLFYDYMPNGTL--------GMLLHDGECAGLLEWDTR-- 877
+ H NIV LLG L+ +Y G L + ++E D
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 878 -----FKIALGVAEGLSYLH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931
+ VA+G+++L +C+ HRD+ + NILL + + DFGLAR +++D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 932 ------SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKP 981
P + APE + +SDV+SYG+ L E+ + G P
Sbjct: 199 SNYVVKGNARL---P--------VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 982 VDASFPDGQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNR 1039
P + +++ + + P M C
Sbjct: 248 Y-PGMPVDSKFYKMIKEGFRM-----------LSPEHAPAEMYDIMKT-------CWDAD 288
Query: 1040 AEDRPTMKDVAALLREIRQEPAS 1062
RPT K + L+ + E +
Sbjct: 289 PLKRPTFKQIVQLIEKQISESTN 311
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 52/345 (15%), Positives = 105/345 (30%), Gaps = 83/345 (24%)
Query: 766 KLDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA------ 818
+++ +G+ R+L G ++GQ + T +G + V +++ + A
Sbjct: 63 RVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 122
Query: 819 ----------------------FSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856
F + + + ++R+ + F+ Y
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182
Query: 857 GT-----LGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL 911
+ +LL L R ++ L V L+ LHH ++H ++ +I+L
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVL 239
Query: 912 GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY-----------ANMTKIS 960
+R L F A + S G+ PE T ++
Sbjct: 240 DQRGGVFLTGFEHLV--------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMT 291
Query: 961 EKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD-PVEVLDPKLQGHPD 1019
D ++ G+V+ I P + +S K+ P V L
Sbjct: 292 FSFDAWALGLVIYWIWCADLP----I-TKDAALGGSEWIFRSCKNIPQPVRA--L----- 339
Query: 1020 TQIQEMLQALGISLLCTSNRAEDRPTMKDVAA--LLREIRQEPAS 1062
++ L+ EDR ++R E ++
Sbjct: 340 --LEGFLRY----------PKEDRLLPLQAMETPEYEQLRTELSA 372
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 76/320 (23%), Positives = 114/320 (35%), Gaps = 67/320 (20%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR--ASDKISTGAFSSEIATLSR 828
L G +G+G G V + + TVAVK + A+ A SE+ L
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIH 86
Query: 829 I-RHRNIVRLLGWGANRKTKLLF-YDYMPNGTL-------------GMLLHDGECAGLLE 873
I H N+V LLG L+ ++ G L + + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 874 WDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD- 931
+ + VA+G+ +L C+ HRD+ + NILL E+ + DFGLAR + D
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 932 -----SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT-GKKPV 982
P + APE + +SDV+S+GV+L EI + G P
Sbjct: 203 DYVRKGDARL---P--------LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP- 250
Query: 983 DASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAED 1042
+P G + + LK + Q ML C
Sbjct: 251 ---YP-GVKIDEEFCRRLKEGT----RM-RAPDYTTPEMYQTMLD-------CWHGEPSQ 294
Query: 1043 RPTMKDVAALLREIRQEPAS 1062
RPT ++ L + Q A
Sbjct: 295 RPTFSELVEHLGNLLQANAQ 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 59/301 (19%), Positives = 102/301 (33%), Gaps = 21/301 (6%)
Query: 399 LEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNC 458
E + +C S L IP G+ + + L L +N ++ + ++ C
Sbjct: 19 KEESSNQASLSCDRNGICKGSSGSLNS-IPSGLTE--AVKSLDLSNNRITYISNSDLQRC 75
Query: 459 SSLIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHS 516
+L SN + I + +L +L LDL N L+ ++ +LTFL++
Sbjct: 76 VNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133
Query: 517 NSIAGNLPAGL-HQLVRLQFADLSDNSVGGMLSPD-LGSLSSLTKLVLNKNRFAGSIPSQ 574
N L L +LQ + + + L+ L +L ++ + P
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193
Query: 575 LGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICG----ELPA----ELTG 626
L S + L L Q + + + L L + EL L
Sbjct: 194 LKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 627 LNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPF--FAKLPLSVLSGN 684
+ ++ L + L ++ L+ L S N VPD F L L N
Sbjct: 253 KFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
Query: 685 P 685
P
Sbjct: 312 P 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 58/336 (17%), Positives = 109/336 (32%), Gaps = 56/336 (16%)
Query: 67 GVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNY 126
+SC+ N G L +P+ T ++ L LS +T ++ L
Sbjct: 27 SLSCDRNGICKGSSGS----LNSIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQA 80
Query: 127 LDLSENSLTGEIPREL-CSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTD 184
L L+ N + I + SL LE L L+ N L + LSSLT L L N
Sbjct: 81 LVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKT 138
Query: 185 AIPATI-GKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLK 243
++ L L+ +R G T I L
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTF---------------------TKIQ---RKDFAGLT 174
Query: 244 RLQTIAIYTALLSGQIPPE-LGDCTELQYIYLYENALTGSIPSKL-GNLKNLVNLFLWQN 301
L+ + I + L P+ L + ++ L+ + ++ L L
Sbjct: 175 FLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDT 232
Query: 302 NLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGN 361
+L + L+ +L + + ++++ + ++ +
Sbjct: 233 DLDT----------------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQ 275
Query: 362 CQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHN 397
L ++E NQ+ F L++L +++ N
Sbjct: 276 ISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 61/353 (17%), Positives = 113/353 (32%), Gaps = 75/353 (21%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158
S +L SIP + + LDLS N +T +L + L+ L L SN +
Sbjct: 32 RNGICKGSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88
Query: 159 EGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGN 217
I +L SL L L N L++ + L +L + GN
Sbjct: 89 N-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNP------------ 135
Query: 218 CTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYEN 277
K L ++++ L LQ + +
Sbjct: 136 ------------------------YKTLGETSLFSHLTK------------LQILRVGNM 159
Query: 278 ALTGSIPSK-LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQ-TL 335
I K L L L + ++L P L + +S + + M + + +
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFV 218
Query: 336 GNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVW 395
+S++ L+L + ++++ + + +
Sbjct: 219 DVTSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKIT 262
Query: 396 HNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNNL 447
L ++ ++ L ++ S+N L +P GIF L L K+ L +N
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 47/269 (17%), Positives = 98/269 (36%), Gaps = 25/269 (9%)
Query: 258 QIPPE-LGDCTELQYIYLYENALTGSIPSKL-GNLKNLVNLFLWQNNLVGIIPPELGNCS 315
I L C LQ + L N + +I +L +L +L L N L + S
Sbjct: 66 YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLS 124
Query: 316 QLSIIDISMNSLTGSIPQ--TLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDN 372
L+ +++ N ++ + +LT LQ L++ +I + L ++E+D
Sbjct: 125 SLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 373 NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGP----I 427
+ + P ++ N++ L + + + ++E ++L L +
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242
Query: 428 PRGIFQ-LKKLNKL--LLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI-GNLK 483
G L K + +++ + + S L+ + N+L +P I L
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLT 301
Query: 484 NLNFLDLGSNRLTGSIPDEITGCRNLTFL 512
+L + L +N C + +L
Sbjct: 302 SLQKIWLHTNPWD-------CSCPRIDYL 323
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 45/251 (17%), Positives = 101/251 (40%), Gaps = 18/251 (7%)
Query: 293 LVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQIS 352
+ + I P ++ ++ S+T ++ L S+ ++ + + I
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 353 GEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQN 412
+ I + ++ L+ N++T NL NL LF+ N+++ ++ + + +
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKK 110
Query: 413 LEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT 472
L+++ L NG++ I G+ L +L L L +N ++ + + + L N+++
Sbjct: 111 LKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS 166
Query: 473 GFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVR 532
+ L L L L N ++ + + G +NL L++ S LV
Sbjct: 167 DI--VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 533 LQFADLSDNSV 543
+D S+
Sbjct: 223 PNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 5e-24
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 437 LNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLT 496
+ + + +S + + P + + I+ +T + L +++ + ++ +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 497 GSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSS 556
S+ I N+T L ++ N + ++ L L L + L +N + + L L
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIKDL--SSLKDLKK 110
Query: 557 LTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQI 616
L L L N + I L +L+ L L +N+++ +I L ++ L L+L NQI
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDT-LSLEDNQI 165
Query: 617 CGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFS 664
++ L GL KL L LS N +S DL LA L+NL VL +
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECL 210
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 6e-24
Identities = 66/322 (20%), Positives = 118/322 (36%), Gaps = 69/322 (21%)
Query: 100 LNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLE 159
+ + T + P + + +L + S+T + L ++Q+ N++ ++
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 160 GAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCT 219
IQ L ++T+LFL N+LTD P + LKNL + NK
Sbjct: 57 SVQGIQ--YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI------------- 99
Query: 220 NLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENAL 279
+S L D +L+ + L N +
Sbjct: 100 ---------KDLSS-----------------------------LKDLKKLKSLSLEHNGI 121
Query: 280 TGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLT 339
+ I L +L L +L+L N + I L ++L + + N ++ I L LT
Sbjct: 122 S-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLT 175
Query: 340 SLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRL 399
LQ L LS N IS ++ A + + L +EL + + + NL + L
Sbjct: 176 KLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
Query: 400 EGEIPPSISNCQNLEAVDLSQN 421
P IS+ + E ++ +
Sbjct: 234 --VTPEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-24
Identities = 47/276 (17%), Positives = 98/276 (35%), Gaps = 43/276 (15%)
Query: 172 LTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSI 231
+ + + + + + L + S+
Sbjct: 1 MGETITVSTPIKQ--------IFPDD-------------------AFAETIKDNLKKKSV 33
Query: 232 SGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLK 291
+ T L + I + + + + + ++L N LT I L NLK
Sbjct: 34 TDA--VTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLK 87
Query: 292 NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQI 351
NL LFL +N + + L + +L + + N ++ I L +L L+ L L N+I
Sbjct: 88 NLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKI 143
Query: 352 SGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQ 411
+ +I + +L + L++NQI+ L+ L L++ N + ++ ++ +
Sbjct: 144 T-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLK 197
Query: 412 NLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNL 447
NL+ ++L L N + +L
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-24
Identities = 44/235 (18%), Positives = 95/235 (40%), Gaps = 16/235 (6%)
Query: 285 SKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQEL 344
+ L + ++ + + + I + + + S+ Q + L ++ +L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 70
Query: 345 QLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIP 404
L+ N+++ +I + N + L + LD N+I + S +L L L + HN + +I
Sbjct: 71 FLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DIN 125
Query: 405 PSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464
+ + LE++ L N +T + +L KL+ L L N +S + + + L
Sbjct: 126 G-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNL 180
Query: 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSI 519
+ N ++ + LKNL+ L+L S + + + S+
Sbjct: 181 YLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (259), Expect = 5e-23
Identities = 55/261 (21%), Positives = 108/261 (41%), Gaps = 19/261 (7%)
Query: 402 EIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSL 461
+I P +L + +T + +L +++++ ++++ V + ++
Sbjct: 13 QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNV 67
Query: 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG 521
+ N NKLT P + NLKNL +L L N++ + + + L L + N I+
Sbjct: 68 TKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS- 122
Query: 522 NLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKL 581
++ GL L +L+ L +N + + L L+ L L L N+ + I L KL
Sbjct: 123 DIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKL 177
Query: 582 QLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELS 641
Q L LS N +S ++ A L + L + L L + + + L + + L
Sbjct: 178 QNLYLSKNHIS-DLRA-LAGLKNLDV-LELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
Query: 642 GDLHFLAELQNLVVLNVSHNN 662
+++ + NV +
Sbjct: 235 -TPEIISDDGDYEKPNVKWHL 254
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.3 bits (213), Expect = 2e-17
Identities = 45/232 (19%), Positives = 81/232 (34%), Gaps = 49/232 (21%)
Query: 466 ANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPA 525
S + P +L +T ++ ++ + +++ I ++
Sbjct: 6 TVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ- 59
Query: 526 GLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLD 585
G+ L + L+ N + + L +L +L L L++N+ + S L KL+ L
Sbjct: 60 GIQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLS 115
Query: 586 LSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLH 645
L N +S I L L +L L L +N+++ D+
Sbjct: 116 LEHNGIS--------DINGLV-------------------HLPQLESLYLGNNKIT-DIT 147
Query: 646 FLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP-LSVLSGNPSLCFSGNQCAD 696
L+ L L L++ N S D A L L L S N +D
Sbjct: 148 VLSRLTKLDTLSLEDNQIS----DIVPLAGLTKLQNLY------LSKNHISD 189
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 7e-04
Identities = 13/74 (17%), Positives = 26/74 (35%), Gaps = 2/74 (2%)
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
L L L LS +++ + + +A L L+ L+L + +L+ +
Sbjct: 169 VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
Query: 152 RLNSNQLEGAIPIQ 165
+ L I
Sbjct: 227 KNTDGSLVTPEIIS 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 60/316 (18%), Positives = 109/316 (34%), Gaps = 57/316 (18%)
Query: 784 IGQGRSGIVYK---VTLPSGLTVAVKRFR-ASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
I G G +Y + +G V +K + D + +E L+ + H +IV++
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 840 WG--ANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
+ +R + Y +Y+ +L L L + LSYLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
+++ D+K NI+L E + L D G + G+ G+ APE
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG--------YLYGTPGFQAPEIV 249
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
T + +D+Y+ G L + +G++V D + DP L
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDLPT-----RNGRYV------------DGLPEDDPVL 291
Query: 1015 QGHPDTQIQEMLQALGISLL-CTSNRAEDRP-TMKDVAALLREIRQEPASGSEAHKPTAA 1072
+ + L L R T ++++A L + +E + + P
Sbjct: 292 KTYDS------YGRL---LRRAIDPDPRQRFTTAEEMSAQLTGVLREVVA-QDTGVPRPG 341
Query: 1073 KSTDTASYSSSSVTSA 1088
ST + S+
Sbjct: 342 LSTIFSPSRSTFGVDL 357
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 26/215 (12%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--------RFRASDKISTGAFSSEIATLSRIRH 831
G +G+G ++++ + A K + +K+S EI+ + H
Sbjct: 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-----EISIHRSLAH 100
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+++V G+ + + + +L + L E + R+ + + G Y
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLR-QIVLGCQY 156
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
LH + V +HRD+K N+ L E E + DFGLA VE D G G+ YIA
Sbjct: 157 LHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKV--LCGTPNYIA 209
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
PE + S + DV+S G ++ ++ GK P + S
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 71/329 (21%), Positives = 118/329 (35%), Gaps = 79/329 (24%)
Query: 777 SLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR--ASDKISTGAFSSEIATLSR 828
+L G ++G G G V T + VAVK + A A SE+ +++
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQ 104
Query: 829 I-RHRNIVRLLGWGANRKTKLLFYDYMPNGTL--------------------GMLLHDGE 867
+ H NIV LLG L ++Y G L L + E
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 868 CAGLLEWDTRFKIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926
+L ++ A VA+G+ +L CV HRD+ + N+L+ + DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV----HRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 927 LVEDD------SGGSFSANPQFAGSYGYI---APEYANMTKISEKSDVYSYGVVLLEIIT 977
+ D P + APE + KSDV+SYG++L EI +
Sbjct: 221 DIMSDSNYVVRGNARL---P--------VKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 978 -GKKPVDASFPDGQHVIQWVRD--HLKSKKDPVEVLDPKLQGHPDTQIQE-MLQALGISL 1033
G P P + + +++ + + + +I M
Sbjct: 270 LGVNPY-PGIPVDANFYKLIQNGFKM-----------DQPFYATE-EIYIIMQS------ 310
Query: 1034 LCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
C + + RP+ ++ + L +
Sbjct: 311 -CWAFDSRKRPSFPNLTSFLGCQLADAEE 338
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 26/215 (12%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--------RFRASDKISTGAFSSEIATLSRIRH 831
G +G+G ++++ + A K + +K+S EI+ + H
Sbjct: 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-----EISIHRSLAH 74
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+++V G+ + + + +L + L E + R+ + + G Y
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLR-QIVLGCQY 130
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
LH + V +HRD+K N+ L E E + DFGLA VE D G G+ YIA
Sbjct: 131 LHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKV--LCGTPNYIA 183
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
PE + S + DV+S G ++ ++ GK P + S
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-25
Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 21/216 (9%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFR-ASDKISTGAFSSEIATLSRIRHRNIVRLL 838
+G G G V + +G VA+K+ R + + EI + ++ H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 839 ------GWGANRKTKLLFYDYMPNGTLGMLLHD-GECAGLLEWDTRFKIALGVAEGLSYL 891
A LL +Y G L L+ C GL E R + ++ L YL
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYL 137
Query: 892 HHDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAGSYGY 948
H + I+HRD+K NI+L + + D G A+ ++ G +F G+ Y
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCT--EFVGTLQY 189
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984
+APE K + D +S+G + E ITG +P
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 14/223 (6%)
Query: 325 NSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG 384
L ++P + + Q + L N+IS A C+ L + L +N + + F
Sbjct: 21 QGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 385 NLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLL 442
L+ L L + N + P+ L + L + GL + G+F+ L L L L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYL 136
Query: 443 LSNNLSGVIPPEM-GNCSSLIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIP 500
N L +P + + +L + N+++ +P L +L+ L L NR+ +
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVH 193
Query: 501 DEI-TGCRNLTFLDVHSNSIAGNLPAG-LHQLVRLQFADLSDN 541
L L + +N+++ LP L L LQ+ L+DN
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 61/230 (26%), Positives = 88/230 (38%), Gaps = 17/230 (7%)
Query: 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG 526
L +P I + L NR++ CRNLT L +HSN +A + A
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA 74
Query: 527 -LHQLVRLQFADLSDNSVGGMLSPD-LGSLSSLTKLVLNKNRFAGSIPSQ-LGSCVKLQL 583
L L+ DLSDN+ + P L L L L++ + LQ
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 584 LDLSSNQLSGNIPA-SLGKIPALAIALNLSWNQICGELPAE-LTGLNKLGILDLSHNELS 641
L L N L +P + + L L L N+I +P GL+ L L L N ++
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTH-LFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 642 G-DLHFLAELQNLVVLNVSHNNFSGRVPDTPF--FAKLPLSVLSGNPSLC 688
H +L L+ L + NN S +P L L+ NP +C
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 45/281 (16%), Positives = 82/281 (29%), Gaps = 57/281 (20%)
Query: 120 SLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYD 179
+ L +P + +++ L+ N++ +LT L+L+
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 180 NQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTL 239
N L A L LE + N L + P
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLR-------------------------SVDPAT 100
Query: 240 GLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSK-LGNLKNLVNLFL 298
L ++L L + L L L+L
Sbjct: 101 -----------------------FHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136
Query: 299 WQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQ 358
N L + + L+ + + N ++ + L SL L L N+++ +
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPH 195
Query: 359 I-GNCQRLAQIELDNNQITGAIPSE-FGNLSNLTLLFVWHN 397
+ RL + L N ++ A+P+E L L L + N
Sbjct: 196 AFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 53/266 (19%), Positives = 88/266 (33%), Gaps = 56/266 (21%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL 146
L VP + + R+ L G ++ + L L L N L L
Sbjct: 23 LQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80
Query: 147 RLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNK 205
LEQL L+ N ++ L L L L L + P L L+ + N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 206 NLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGD 265
L+ L D
Sbjct: 141 ------------------------------------LQALPDDT-------------FRD 151
Query: 266 CTELQYIYLYENALTGSIPSK-LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISM 324
L +++L+ N ++ S+P + L +L L L QN + + P + +L + +
Sbjct: 152 LGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 325 NSLTGSIPQ-TLGNLTSLQELQLSVN 349
N+L+ ++P L L +LQ L+L+ N
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 57/272 (20%), Positives = 86/272 (31%), Gaps = 59/272 (21%)
Query: 106 SGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQ 165
L ++P I + L N ++ + L L L+SN L I
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA 74
Query: 166 I-GNLSSLTQLFLYDN-QLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVM 223
L+ L QL L DN QL PAT L L +
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC------------------- 115
Query: 224 IGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSI 283
LQ + LQY+YL +NAL ++
Sbjct: 116 --------------------GLQELGPGL----------FRGLAALQYLYLQDNALQ-AL 144
Query: 284 PSK-LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQ 342
P +L NL +LFL N + + L + + N + P +L L
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 343 ELQLSVNQISGEIPAQI-GNCQRLAQIELDNN 373
L L N +S +P + + L + L++N
Sbjct: 205 TLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 27/269 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRF-RASDKISTGAFSSEIATLSRIRHRNIVRLL 838
+I+GQG + V++ +G A+K F S E L ++ H+NIV+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 839 GW--GANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
+ K+L ++ P G+L +L GL E + + V G+++L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN- 131
Query: 896 VPAILHRDVKSHNILLGERYESC----LADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
I+HR++K NI+ + L DFG AR +EDD G+ Y+ P
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV-----SLYGTEEYLHP 184
Query: 952 E--------YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003
+ + K D++S GV TG P F + + + + K
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP-FEGPRRNKEVMYKIITGK 243
Query: 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGIS 1032
K + P +M + +S
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLS 272
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 781 GNIIGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGA---FSSEIATLSRIRHRNIVR 836
G +G+G+ G VY + +A+K S G EI S +RH NI+R
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 837 LLGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
+ + +RK L ++ P G L L G E + + +A+ L Y H
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEE-LADALHYCHERK 134
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
V +HRD+K N+L+G + E +ADFG + + G+ Y+ PE
Sbjct: 135 V---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT------MCGTLDYLPPEMIE 185
Query: 956 MTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
EK D++ GV+ E + G P D+
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 46/235 (19%), Positives = 80/235 (34%), Gaps = 45/235 (19%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVK--------RFRASDKISTGAFSS---------EI 823
+ QG+ + A+K + R K + S E+
Sbjct: 36 IRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 824 ATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL------GMLLHDGECAGLLEWDTR 877
++ I++ + G N + Y+YM N ++ +L + +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 878 FKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFS 937
I V SY+H++ I HRDVK NIL+ + L+DFG + + D
Sbjct: 155 CIIK-SVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG-- 209
Query: 938 ANPQFAGSYGYIAPE-------YANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
G+Y ++ PE Y K D++S G+ L + P
Sbjct: 210 ----SRGTYEFMPPEFFSNESSYNG-----AKVDIWSLGICLYVMFYNVVPFSLK 255
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 51/268 (19%), Positives = 88/268 (32%), Gaps = 22/268 (8%)
Query: 308 PPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLA 366
+ +CS + +T IP L + EL+ + ++ I L
Sbjct: 3 HHRICHCSNRVF-LCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLE 57
Query: 367 QIELDNNQITGAIPSE-FGNLSNLTLLFVWH-NRLEGEIPPSI-SNCQNLEAVDLSQNGL 423
+IE+ N + I ++ F NL L + + N L I P N NL+ + +S G+
Sbjct: 58 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI 116
Query: 424 TGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEM--GNCSSLIRFRANSNKLTGFIPPEI- 479
+P + L + N I G + N N + I
Sbjct: 117 KH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAF 174
Query: 480 GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADL 538
+ +N L +P+++ G LD+ I GL L +L+
Sbjct: 175 NGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 233
Query: 539 SDNSVGGMLSPDLGSLSSLTKLVLNKNR 566
+ P L L +L + L
Sbjct: 234 YNLKK----LPTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-18
Identities = 53/253 (20%), Positives = 87/253 (34%), Gaps = 16/253 (6%)
Query: 127 LDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAI 186
E+ +T EIP +L +LR +L L ++ + N + + I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 187 PA-TIGKLKNLEAIRAGGNKNLGGSLPHEI-GNCTNLVMIGLAETSISGFLPPTLGLLKR 244
A L L IR NL + E N NL + ++ T I +
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129
Query: 245 LQTIAIYTALLSGQIPPEL--GDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNN 302
+ I + I G E ++L +N + I + N L L L NN
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN 188
Query: 303 LVGIIPPE-LGNCSQLSIIDISMNSLTGSIPQ-TLGNLTSLQELQLSVNQISGEIPAQIG 360
+ +P + S I+DIS + S+P L NL L+ + ++P +
Sbjct: 189 NLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-LE 243
Query: 361 NCQRLAQIELDNN 373
L + L
Sbjct: 244 KLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 7e-18
Identities = 57/313 (18%), Positives = 99/313 (31%), Gaps = 51/313 (16%)
Query: 404 PPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIR 463
I +C N ++ +T IP + + +L + L + L +
Sbjct: 3 HHRICHCSN-RVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 464 FRANSNKLTGFIPPEI-GNLKNLNFLDL-GSNRLTGSIPDEI-TGCRNLTFLDVHSNSIA 520
+ N + I ++ NL L+ + + +N L I E NL +L + + I
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK 117
Query: 521 GNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQL--GSC 578
+LP L + N +I G
Sbjct: 118 -HLPDVHKI-----------------------HSLQKVLLDIQDNINIHTIERNSFVGLS 153
Query: 579 VKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAE-LTGLNKLGILDLSH 637
+ +L L+ N + I S L N + ELP + G + ILD+S
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISR 211
Query: 638 NELSG-DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP-LSVLS-GNPSLCFSGNQC 694
+ + L L+ L + + P KL L S PS C C
Sbjct: 212 TRIHSLPSYGLENLKKLRARSTYNLK------KLPTLEKLVALMEASLTYPSHC-----C 260
Query: 695 ADSTYKKDGASRH 707
A + +++ + H
Sbjct: 261 AFANWRRQISELH 273
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-23
Identities = 31/185 (16%), Positives = 72/185 (38%), Gaps = 10/185 (5%)
Query: 481 NLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSD 540
K LG + ++ +LT++ + + ++ +L G+ ++ +++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMN---SLTYITLANINVT-DLT-GIEYAHNIKDLTINN 75
Query: 541 NSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLG 600
+P + LS+L +L + L L LLD+S + +I +
Sbjct: 76 IHATN-YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 601 KIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSH 660
+P + +++LS+N ++ L L +L L++ + + D + + L L
Sbjct: 134 TLPKV-NSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFS 190
Query: 661 NNFSG 665
G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 36/209 (17%), Positives = 75/209 (35%), Gaps = 34/209 (16%)
Query: 289 NLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSV 348
K +N L Q++ I ++ + + +++ +I++ LTG + ++++L ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 349 NQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSIS 408
+ + LSNL L + + + P++S
Sbjct: 76 IHATN--------------------------YNPISGLSNLERLRIMGKDVTSDKIPNLS 109
Query: 409 NCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANS 468
+L +D+S + I I L K+N + L N I P + L
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQF 168
Query: 469 NKLTGFIPPEIGNLKNLNFLDLGSNRLTG 497
+ + + I + LN L S + G
Sbjct: 169 DGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-21
Identities = 26/163 (15%), Positives = 68/163 (41%), Gaps = 7/163 (4%)
Query: 288 GNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347
+ +L + L N+ + + + + I+ T P + L++L+ L++
Sbjct: 41 AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96
Query: 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI 407
++ + + L +++ ++ +I ++ L + + + +N +I P +
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-L 155
Query: 408 SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGV 450
L+++++ +G+ RGI KLN+L S + G
Sbjct: 156 KTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 33/185 (17%), Positives = 59/185 (31%), Gaps = 10/185 (5%)
Query: 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWH 396
+ L + + AQ+ + L I L N +T + N+ L + +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNS---LTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 397 NRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMG 456
P IS NLE + + +T + L L L + + I ++
Sbjct: 76 IHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 457 NCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHS 516
+ + N I P + L L L++ + + I L L S
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 517 NSIAG 521
+I G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 38/186 (20%), Positives = 71/186 (38%), Gaps = 10/186 (5%)
Query: 408 SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRAN 467
S + L Q+ T I Q+ L + L + N++ + + ++ N
Sbjct: 20 STFKAYLNGLLGQSS-TANITEA--QMNSLTYITLANINVTDLTG--IEYAHNIKDLTIN 74
Query: 468 SNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL 527
+ T + P I L NL L + +T ++G +LT LD+ ++ ++ +
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 528 HQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLS 587
+ L ++ DLS N + P L +L L L + + + KL L
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 588 SNQLSG 593
S + G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 23/140 (16%), Positives = 52/140 (37%), Gaps = 5/140 (3%)
Query: 263 LGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDI 322
+ ++ + + T P + L NL L + ++ P L + L+++DI
Sbjct: 62 IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 323 SMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE 382
S ++ SI + L + + LS N +I + L + + + +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG-- 176
Query: 383 FGNLSNLTLLFVWHNRLEGE 402
+ L L+ + + G+
Sbjct: 177 IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 32/213 (15%), Positives = 61/213 (28%), Gaps = 39/213 (18%)
Query: 144 SLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGG 203
+ L + I ++SLT + L + +TD I N++ +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 204 NK--NLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPP 261
N I +NL + + ++ P L L L + I + I
Sbjct: 76 IHATNYNP-----ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 262 ELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIID 321
++ ++ I L N I L L L +L + + +
Sbjct: 131 KINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG------------- 176
Query: 322 ISMNSLTGSIPQTLGNLTSLQELQLSVNQISGE 354
+ + L +L I G+
Sbjct: 177 -------------IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 26/144 (18%), Positives = 53/144 (36%), Gaps = 10/144 (6%)
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
T ++ L ++ + T P I+ L+ L L + +T + L L L L
Sbjct: 60 TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNK--NLGG 209
++ + + +I +I L + + L N I + L L+++ + + G
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG 176
Query: 210 SLPHEIGNCTNLVMIGLAETSISG 233
I + L + +I G
Sbjct: 177 -----IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 26/106 (24%), Positives = 47/106 (44%), Gaps = 3/106 (2%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEI 138
L + D+ N + L SL L +S + SI +I +L ++N +DLS N +I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 139 PRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTD 184
L +L L+ L + + + I+ + L QL+ + +
Sbjct: 153 M-PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 18/126 (14%), Positives = 51/126 (40%), Gaps = 11/126 (8%)
Query: 553 SLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLS 612
+ + +L ++ A +Q+ L + L++ ++ ++ + + L ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DLTG-IEYAHNI-KDLTIN 74
Query: 613 WNQICGELPAELTGLNKLGILDLSHNELSG-DLHFLAELQNLVVLNVSHNNFSGRVPDTP 671
++GL+ L L + +++ + L+ L +L +L++SH+ +
Sbjct: 75 NIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL--T 130
Query: 672 FFAKLP 677
LP
Sbjct: 131 KINTLP 136
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 36/227 (15%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRA-SDKISTGAFSSEIA-TLSRIRHRNIVRLLGW 840
+G+G G+V K+ +PSG +AVKR RA + ++ ++ + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG- 73
Query: 841 GANRKTKLLFYD---------YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
+ M + + D KIA+ + + L +L
Sbjct: 74 --------ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
H +++HRDVK N+L+ + + DFG++ + D + + AG Y+AP
Sbjct: 126 HSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKD-IDAGCKPYMAP 178
Query: 952 E----YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQ 994
E N S KSD++S G+ ++E+ + P + Q
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP----YDSWGTPFQ 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 49/227 (21%), Positives = 83/227 (36%), Gaps = 34/227 (14%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLG 839
I+G G SG V G VAVKR EI L+ H N++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVIRYYC 76
Query: 840 WGANRKTKLLFYDYMPNGTL-----GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
+ + + N L + D E++ + +A G+++LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSL 134
Query: 895 CVPAILHRDVKSHNILLGERYESC-------------LADFGLARLVEDDSGGSFSANPQ 941
I+HRD+K NIL+ ++DFGL + ++ +
Sbjct: 135 K---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 942 FAGSYGYIAPE-------YANMTKISEKSDVYSYGVVLLEIITGKKP 981
+G+ G+ APE +++ D++S G V I++ K
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 49/207 (23%), Positives = 70/207 (33%), Gaps = 20/207 (9%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFR---ASDKISTGAFSSEIATLSRIRHRNIVR 836
+ +G G G V+KV G AVKR K + + +H VR
Sbjct: 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 837 LLG-WGANRKTKLLFY-DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
L W L + +L L + L++LH
Sbjct: 122 LEQAW--EEGGILYLQTELC-GPSLQQHCE--AWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
++H DVK NI LG R L DFGL + G G Y+APE
Sbjct: 177 ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE-----VQEGDPRYMAPE-L 227
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKP 981
+DV+S G+ +LE+ +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRF---RASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG+G G V+K + + VA+K A D+I EI LS+ + + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED--IQQEITVLSQCDSPYVTKYYG 87
Query: 840 WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ TKL + +Y+ G+ LL G L E I + +GL YLH +
Sbjct: 88 -SYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIAT-ILREILKGLDYLHSE---K 139
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
+HRD+K+ N+LL E E LADFG+A + D + F G+ ++APE +
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 959 ISEKSDVYSYGVVLLEIITGKKP 981
K+D++S G+ +E+ G+ P
Sbjct: 196 YDSKADIWSLGITAIELARGEPP 218
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 45/249 (18%), Positives = 101/249 (40%), Gaps = 18/249 (7%)
Query: 295 NLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGE 354
+ I ++ ++ S+T ++ L S+ ++ + + I
Sbjct: 6 ETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-S 60
Query: 355 IPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLE 414
+ I + ++ L+ N++T NL NL LF+ N+++ ++ + + + L+
Sbjct: 61 VQG-IQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLK 115
Query: 415 AVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGF 474
++ L NG++ I G+ L +L L L +N ++ + + + L N+++
Sbjct: 116 SLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI 171
Query: 475 IPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQ 534
+P + L L L L N ++ + + G +NL L++ S LV
Sbjct: 172 VP--LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 227
Query: 535 FADLSDNSV 543
+D S+
Sbjct: 228 TVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 47/231 (20%), Positives = 93/231 (40%), Gaps = 16/231 (6%)
Query: 217 NCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYE 276
+ L + S++ T L + I + + + + + ++L
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 277 NALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLG 336
N LT I L NLKNL LFL +N + + L + +L + + N ++ I L
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DIN-GLV 131
Query: 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWH 396
+L L+ L L N+I+ +I + +L + L++NQI+ L+ L L++
Sbjct: 132 HLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSK 187
Query: 397 NRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNL 447
N + ++ ++ +NL+ ++L L N + +L
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 46/279 (16%)
Query: 118 IASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFL 177
+ + +L + S+T + L ++Q+ N++ ++ IQ L ++T+LFL
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFL 75
Query: 178 YDNQLTDAIPATIGKLKNLEAIRAGGNK--NLGGSLPHEIGNCTNLVMIGLAETSISGFL 235
N+LTD P + LKNL + NK +L + + L + L IS
Sbjct: 76 NGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS-----LKDLKKLKSLSLEHNGIS--- 125
Query: 236 PPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVN 295
I L +L+ +YL N +T I L L L
Sbjct: 126 ----------------------DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDT 160
Query: 296 LFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEI 355
L L N + I+P L ++L + +S N ++ + + L L +L L+L + +
Sbjct: 161 LSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKP 216
Query: 356 PAQIGNCQRLAQIE-LDNNQITGAIPSEFGNLSNLTLLF 393
N ++ D + +T I S+ G+ + +
Sbjct: 217 INHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKW 255
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 16/231 (6%)
Query: 335 LGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFV 394
+ L ++ + + QI +N+ I L N+T LF+
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 75
Query: 395 WHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPE 454
N+L +I P ++N +NL + L +N + + LKKL L L N +S +
Sbjct: 76 NGNKLT-DIKP-LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGISDING-- 129
Query: 455 MGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDV 514
+ + L +NK+T + L L+ L L N+++ I + G L L +
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 185
Query: 515 HSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKN 565
N I+ +L L L L +L +L +
Sbjct: 186 SKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 43/248 (17%), Positives = 82/248 (33%), Gaps = 59/248 (23%)
Query: 466 ANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPA 525
+ +L +T ++ ++ + +++ I ++
Sbjct: 9 TVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ- 62
Query: 526 GLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLD 585
G+ L + L+ N + + L +L +L L L++N+ + S L KL+ L
Sbjct: 63 GIQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLS 118
Query: 586 LSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLH 645
L N +S I L L +L L L +N+++ D+
Sbjct: 119 LEHNGIS--------DINGLV-------------------HLPQLESLYLGNNKIT-DIT 150
Query: 646 FLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP--------------LSVLSGNPSL---C 688
L+ L L L++ N S D A L L L+G +L
Sbjct: 151 VLSRLTKLDTLSLEDNQIS----DIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLE 206
Query: 689 FSGNQCAD 696
+C +
Sbjct: 207 LFSQECLN 214
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 45/260 (17%), Positives = 91/260 (35%), Gaps = 63/260 (24%)
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
L S+++++ + +++ S+ + I L + L L+ N LT +I L +L L L
Sbjct: 40 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWL 95
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSL 211
L+ N+++ ++ +L L L L N ++D + L
Sbjct: 96 FLDENKVKDLSSLK--DLKKLKSLSLEHNGISD--------INGLV-------------- 131
Query: 212 PHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQY 271
+ L + L I+ I L T+L
Sbjct: 132 -----HLPQLESLYLGNNKIT-------------------------DITV-LSRLTKLDT 160
Query: 272 IYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSI 331
+ L +N ++ I L L L NL+L +N++ + L L ++++
Sbjct: 161 LSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 216
Query: 332 PQTLGNLTSLQELQLSVNQI 351
NL ++ + +
Sbjct: 217 INHQSNLVVPNTVKNTDGSL 236
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 5e-22
Identities = 48/212 (22%), Positives = 74/212 (34%), Gaps = 22/212 (10%)
Query: 784 IGQGRS--GIVYKVT-LPSGLTVAVKRF--RASDKISTGAFSSEIATLSRIRHRNIVRLL 838
IG+G V P+G V V+R A E+ H NIV
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 839 GWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIAL---GVAEGLSYLHHD 894
+L + +M G+ L+ G+ E IA GV + L Y+HH
Sbjct: 93 A-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE----LAIAYILQGVLKALDYIHHM 147
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG---GSFSANPQFAGSYGYIAP 951
+HR VK+ +IL+ + L+ + +++P
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 952 E--YANMTKISEKSDVYSYGVVLLEIITGKKP 981
E N+ KSD+YS G+ E+ G P
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 784 IGQGRSGIVYK-VTLPSGLTVAVKRF---RASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG G + +V P VA+KR + + EI +S+ H NIV
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE--LLKEIQAMSQCHHPNIVSYYT 80
Query: 840 WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWD--TRFKIALGVAE---GLSYLHH 893
K +L L + G++ ++ G + IA + E GL YLH
Sbjct: 81 -SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGL-ARLVEDDSGGSFSANPQFAGSYGYIAPE 952
+ +HRDVK+ NILLGE +ADFG+ A L F G+ ++APE
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 953 YANMTKIS---EKSDVYSYGVVLLEIITGKKP 981
M ++ K+D++S+G+ +E+ TG P
Sbjct: 197 V--MEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 9e-22
Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 61/245 (24%)
Query: 769 LSIGDATRSLTAGNI-----IGQGRSGIVYKVT-LPSGLTVAVKRFRA-SDKISTGAFSS 821
L+IG ++ +G G G V+K+ +G +AVK+ R +K
Sbjct: 13 LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM 72
Query: 822 EIATLSR-IRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGEC--------AGLL 872
++ + + IV+ + G + + +
Sbjct: 73 DLDVVLKSHDCPYIVQ-------------CF--------GTFITNTDVFIAMELMGTCAE 111
Query: 873 EWDTRF----------KIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADF 922
+ R K+ + + + L YL ++HRDVK NILL ER + L DF
Sbjct: 112 KLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDF 169
Query: 923 GL-ARLVEDDSGGSFSANPQFAGSYGYIAPE-----YANMTKISEKSDVYSYGVVLLEII 976
G+ RLV+ + + + AG Y+APE ++DV+S G+ L+E+
Sbjct: 170 GISGRLVD-----DKAKD-RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223
Query: 977 TGKKP 981
TG+ P
Sbjct: 224 TGQFP 228
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 45/257 (17%), Positives = 94/257 (36%), Gaps = 39/257 (15%)
Query: 738 IRGLSGSHHNE------------GDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIG 785
+RG HH+ D D W+ + +++ G +G
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELG 60
Query: 786 QGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANR 844
G G+V++ +G K + +EI+ ++++ H ++ L ++
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 845 KTKLLFYDYMPNGTL-------GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+L +++ G L + + E + + A EGL ++H
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM------RQAC---EGLKHMHEH--- 168
Query: 898 AILHRDVKSHNILLGERYESCL--ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
+I+H D+K NI+ + S + DFGLA + + + APE +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVK---VTTATAEFAAPEIVD 223
Query: 956 MTKISEKSDVYSYGVVL 972
+ +D+++ GV+
Sbjct: 224 REPVGFYTDMWAIGVLG 240
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-21
Identities = 49/248 (19%), Positives = 79/248 (31%), Gaps = 50/248 (20%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK-----RFRASDKISTGAFSSEIATLSRIRHRNI 834
IGQG G+V + A+K + R + +E+ + ++ H NI
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 835 VRLLGWGANRKTKLLFYDYMPNGTL-------------------------------GMLL 863
RL + + L + G L +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 864 HDGECAGLLEWDTRF------KIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917
+ D I + L YLH+ I HRD+K N L
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207
Query: 918 CL--ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE--YANMTKISEKSDVYSYGVVLL 973
+ DFGL++ + G + AG+ ++APE K D +S GV+L
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 974 EIITGKKP 981
++ G P
Sbjct: 268 LLLMGAVP 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 14/218 (6%)
Query: 766 KLDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIA 824
D +G+G G VYK +G VA+K+ + EI+
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE--IIKEIS 76
Query: 825 TLSRIRHRNIVRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALG 883
+ + ++V+ G + T L + +Y G++ ++ L D I
Sbjct: 77 IMQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQS 133
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
+GL YLH +HRD+K+ NILL + LADFG+A + D + +
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD----TMAKRNTVI 186
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ ++APE + +D++S G+ +E+ GK P
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 2e-21
Identities = 30/222 (13%), Positives = 71/222 (31%), Gaps = 28/222 (12%)
Query: 781 GNIIGQGRSGIVYKVT------LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNI 834
+++G+G VY+ T + +K + ++ + + L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 835 VRLLGWGANRKTKLLFYDYMPNGTLGMLL---HDGECAGLLEWDTRFKIALGVAEGLSYL 891
++ + +L + GTL + + + + A+ + + +
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS-FAMRMLYMIEQV 188
Query: 892 HHDCVPAILHRDVKSHNILLGERYES-----------CLADFGLAR-LVEDDSGGSFSAN 939
H I+H D+K N +LG + L D G + + G F+A
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA- 244
Query: 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ G+ E + + + D + + ++ G
Sbjct: 245 --KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 59/228 (25%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRA-SDKISTGAFSSEIATLSR-IRHRNIVRLLGW 840
IG+G G V K+ PSG +AVKR R+ D+ ++ + R IV+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85
Query: 841 GANRKTKLLFYDYMPNGTLGMLLHDGE-------CAGLLEWDTRF--------------- 878
FY G L +G+ + + ++
Sbjct: 86 ---------FY--------GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 879 KIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL-ARLVEDDSGGSFS 937
KI L + L++L + I+HRD+K NILL L DFG+ +LV DS
Sbjct: 129 KITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DS----I 180
Query: 938 ANPQFAGSYGYIAPE----YANMTKISEKSDVYSYGVVLLEIITGKKP 981
A + AG Y+APE A+ +SDV+S G+ L E+ TG+ P
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-21
Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 21/204 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK-----RFRASDKISTGAFSSEIATLSRIRHRNI 834
+IG+G +V + +G AVK +F +S +ST E + ++H +I
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 835 VRLLGWGANRKTKLLFYDYMPNGTL--GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
V LL ++ + +++M L ++ E + E L Y H
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS-HYMRQILEALRYCH 147
Query: 893 -HDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAGSYGY 948
++ I+HRDVK H +LL + S L FG+A + + G G+ +
Sbjct: 148 DNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAG---GRVGTPHF 199
Query: 949 IAPEYANMTKISEKSDVYSYGVVL 972
+APE + DV+ GV+L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 46/213 (21%), Positives = 87/213 (40%), Gaps = 16/213 (7%)
Query: 267 TELQYIYLYENALTGSIPSK-LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325
+ + L N L + S + L L L + + I + S LS + ++ N
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 326 SLTGSIPQ-TLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSE- 382
+ S+ L+SLQ+L ++ + G+ + L ++ + +N I +
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143
Query: 383 -FGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAV----DLSQNGLTGPIPRGIFQLKK 436
F NL+NL L + N+++ I + + + DLS N + I G F+ +
Sbjct: 144 YFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIR 201
Query: 437 LNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSN 469
L +L L +N L V +SL + ++N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 18/222 (8%)
Query: 354 EIPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQ 411
+IP + + + L +L N + F + L +L + ++ I +
Sbjct: 21 KIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 412 NLEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSNNLSGVIPPEM-GNCSSLIRFRANSN 469
+L + L+ N + + G F L L KL+ + NL+ + G+ +L N
Sbjct: 77 HLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHN 134
Query: 470 KLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTF----LDVHSNSIAGNL 523
+ F PE NL NL LDL SN++ SI + LD+ N + +
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 524 PAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKN 565
G + +RL+ L N + + L+SL K+ L+ N
Sbjct: 193 QPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/266 (18%), Positives = 90/266 (33%), Gaps = 42/266 (15%)
Query: 405 PSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464
P + N+ + IP + L L N L + + L
Sbjct: 2 PCVEVVPNIT-YQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 465 RANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGN 522
+ ++ I +L +L+ L L N + S+ +G +L L ++A +
Sbjct: 58 DLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-S 114
Query: 523 LPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ--LGSCVK 580
L +G L +L +L + N S +
Sbjct: 115 LENFP-----------------------IGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTN 150
Query: 581 LQLLDLSSNQLSGNIPA----SLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLS 636
L+ LDLSSN++ +I L ++P L ++L+LS N + + +L L L
Sbjct: 151 LEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALD 208
Query: 637 HNELSGDLH-FLAELQNLVVLNVSHN 661
N+L L +L + + N
Sbjct: 209 TNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 47/207 (22%), Positives = 77/207 (37%), Gaps = 16/207 (7%)
Query: 321 DISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQITGAI 379
D+S N L + + LQ L LS +I I + L+ + L N I ++
Sbjct: 34 DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SL 91
Query: 380 PSE-FGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIF-QLKK 436
F LS+L L L + + + L+ ++++ N + F L
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 437 LNKLLLLSNNLSGVIPPEM-GNCSSLIRFRA----NSNKLTGFIPPEIGNLKNLNFLDLG 491
L L L SN + I + + N + FI P L L L
Sbjct: 151 LEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALD 208
Query: 492 SNRLTGSIPDEI-TGCRNLTFLDVHSN 517
+N+L S+PD I +L + +H+N
Sbjct: 209 TNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 56/253 (22%), Positives = 88/253 (34%), Gaps = 42/253 (16%)
Query: 106 SGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQ 165
N IP + LDLS N L S L+ L L+ +++ I
Sbjct: 15 MELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 166 I-GNLSSLTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGNKNLGGSLPHEI-GNCTNLV 222
+LS L+ L L N + ++ L +L+ + A SL + G+ L
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA--SLENFPIGHLKTLK 127
Query: 223 MIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGS 282
+ +A I F L T L+++ L N + S
Sbjct: 128 ELNVAHNLIQSF--KLPEYFSNL---------------------TNLEHLDLSSNKIQ-S 163
Query: 283 IP----SKLGNLKNL-VNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQ-TLG 336
I L + L ++L L N + I P +L + + N L S+P
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLKELALDTNQLK-SVPDGIFD 221
Query: 337 NLTSLQELQLSVN 349
LTSLQ++ L N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 37/143 (25%), Positives = 54/143 (37%), Gaps = 14/143 (9%)
Query: 555 SSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASL-GKIPALAIALNLSW 613
S L L+ N S +LQ+LDLS ++ I + L+ L L+
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLST-LILTG 85
Query: 614 NQICGELPAEL-TGLNKLGILDLSHNELSGDLHFLAE-LQNLVVLNVSHNNFSGRVPDTP 671
N I L +GL+ L L L+ +F L+ L LNV+HN
Sbjct: 86 NPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143
Query: 672 FFAKLP-LSVLSGNPSLCFSGNQ 693
+F+ L L L S N+
Sbjct: 144 YFSNLTNLEHLD------LSSNK 160
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 25/242 (10%)
Query: 755 MGPPWELTLYNKLDL-SIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFR-AS 811
M +++DL ++ D ++G G G VYK + +G A+K
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 812 DKISTGAFSSEIATLSRI-RHRNIVRLLG-----WGANRKTKL-LFYDYMPNGTLGMLLH 864
D+ EI L + HRNI G +L L ++ G++ L+
Sbjct: 62 DEEEE--IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 865 DGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924
+ + L E + I + GLS+LH V +HRD+K N+LL E E L DFG+
Sbjct: 120 NTKGNTLKEEWIAY-ICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISE-----KSDVYSYGVVLLEIITGK 979
+ ++ G + F G+ ++APE + + KSD++S G+ +E+ G
Sbjct: 176 SAQLDRTVGRRNT----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
Query: 980 KP 981
P
Sbjct: 232 PP 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 43/264 (16%), Positives = 84/264 (31%), Gaps = 37/264 (14%)
Query: 260 PPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSI 319
+C + + + + IPS + + L L + +L I N +S
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISR 59
Query: 320 IDISMNSLTGSIP-QTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQITG 377
I +S++ + + NL+ + +++ + I L + + N +
Sbjct: 60 IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK- 118
Query: 378 AIPSE--FGNLSNLTLLFVWHNRLEGEIPP-SISNCQN-LEAVDLSQNGLTGPIPRGIFQ 433
P + +L + N IP + N + L NG T + F
Sbjct: 119 MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFN 177
Query: 434 LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493
KL+ + L N VI + F G + LD+
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDA--------FG--------------GVYSGPSLLDVSQT 215
Query: 494 RLTGSIPDEITGCRNLTFLDVHSN 517
+T ++P + G +L L +
Sbjct: 216 SVT-ALPSK--GLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 50/315 (15%), Positives = 90/315 (28%), Gaps = 93/315 (29%)
Query: 308 PPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQ 367
C Q ++ + IP S Q L+L + IP
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIP----------- 47
Query: 368 IELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPI 427
F NL N++ + +S + +
Sbjct: 48 ------------SHAFSNLPNISRI------------------------YVSIDVTLQQL 71
Query: 428 PRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLN 486
F L K+ + + + I P+ + L L
Sbjct: 72 ESHSFYNLSKVTHIEIRNTRNLTYIDPDA--------LK---------------ELPLLK 108
Query: 487 FLDLGSNRLTGSIPDE--ITGCRNLTFLDVHSNSIAGNLPAGL-----HQLVRLQFADLS 539
FL + + L PD + L++ N ++P ++ + L L
Sbjct: 109 FLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL---KLY 164
Query: 540 DNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQL--GSCVKLQLLDLSSNQLSGNIPA 597
+N + + + L + LNKN++ I G LLD+S ++ +P+
Sbjct: 165 NNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS 222
Query: 598 -SLGKIPALAIALNL 611
L + L IA N
Sbjct: 223 KGLEHLKEL-IARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 51/308 (16%), Positives = 91/308 (29%), Gaps = 84/308 (27%)
Query: 362 CQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPP-SISNCQNLEAVDLSQ 420
C + + I IPS + L + L IP + SN N+ + +S
Sbjct: 10 CHQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 421 NGLTGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI 479
+ + F L K+ + + + I P+ +
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA--------LK-------------- 102
Query: 480 GNLKNLNFLDLGSNRLTGSIPDE--ITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFAD 537
L L FL + + L PD + L++ N ++P F
Sbjct: 103 -ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA-------FQG 153
Query: 538 LSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPA 597
L + L L N F S+ + KL + L+ N+
Sbjct: 154 LC---------------NETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKY------ 191
Query: 598 SLGKIPALAIALNLSWNQICGELPAELTGL-NKLGILDLSHNELSGDLHFLAELQNLVVL 656
L I A G+ + +LD+S ++ L L++L L
Sbjct: 192 -LTVIDKDA-----------------FGGVYSGPSLLDVSQTSVT-ALPSKG-LEHLKEL 231
Query: 657 NVSHNNFS 664
+ N ++
Sbjct: 232 I-ARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 46/264 (17%), Positives = 85/264 (32%), Gaps = 39/264 (14%)
Query: 141 ELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIR 200
C + E R+ ++ IP S L L + L L N+ I
Sbjct: 6 PPCECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIY 61
Query: 201 AGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIP 260
+ L + + L ++ I I I
Sbjct: 62 VSIDVTL---------------------QQLE---SHSFYNLSKVTHIEIRNTRNLTYID 97
Query: 261 PE-LGDCTELQYIYLYENALTGSIP--SKLGNLKNLVNLFLWQNNLVGIIPPEL--GNCS 315
P+ L + L+++ ++ L P +K+ + L + N + IP G C+
Sbjct: 98 PDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN 156
Query: 316 QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI--GNCQRLAQIELDNN 373
+ + + N T S+ N T L + L+ N+ I G + +++
Sbjct: 157 ETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
Query: 374 QITGAIPSE-FGNLSNLTLLFVWH 396
+T A+PS+ +L L W
Sbjct: 216 SVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 41/252 (16%), Positives = 86/252 (34%), Gaps = 55/252 (21%)
Query: 99 SLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPREL-CSLLRLEQLRLNSN 156
S L L T+L +IP ++L ++ + +S + ++ +L ++ + + +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 157 QLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEI 215
+ I L L L +++ L P +
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTK-----------------------V 126
Query: 216 GNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLY 275
+ ++ + + +P + L C E + LY
Sbjct: 127 YSTDIFFILEITDNPYMTSIPV--NAFQGL--------------------CNETLTLKLY 164
Query: 276 ENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPEL--GNCSQLSIIDISMNSLTGSIP- 332
N T S+ N L ++L +N + +I + G S S++D+S S+T ++P
Sbjct: 165 NNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS 222
Query: 333 QTLGNLTSLQEL 344
+ L +L L
Sbjct: 223 KGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 19/124 (15%), Positives = 43/124 (34%), Gaps = 7/124 (5%)
Query: 554 LSSLTKLVLNKNRFAGSIPSQ-LGSCVKLQLLDLSSNQLSGNIPA-SLGKIPALAIALNL 611
S L L + +IPS + + + +S + + + S + + + +
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH-IEI 87
Query: 612 SWNQICGELPAE-LTGLNKLGILDLSHNELS--GDLHFLAELQNLVVLNVSHNNFSGRVP 668
+ + + L L L L + + L DL + +L ++ N + +P
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 669 DTPF 672
F
Sbjct: 148 VNAF 151
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 766 KLDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIA 824
+ +S+GD + T IGQG SG VY + +G VA+++ + +EI
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 825 TLSRIRHRNIVRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIAL- 882
+ ++ NIV L +L + +Y+ G+L ++ + +IA
Sbjct: 70 VMRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETCM-------DEGQIAAV 121
Query: 883 --GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP 940
+ L +LH + ++HRD+KS NILLG L DFG + + +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--- 175
Query: 941 QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ ++APE K D++S G++ +E+I G+ P
Sbjct: 176 -MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 40/208 (19%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
++G G V+ V +G A+K + S + +EIA L +I+H NIV L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 840 WGANRKTKLLFYDYMPNGTLGM-LLHDGECAGLLEW----------DTRFKIALGVAEGL 888
+ +Y L M L+ GE L + D + V +
Sbjct: 74 IYESTTH---YY-------LVMQLVSGGE---LFDRILERGVYTEKDAS-LVIQQVLSAV 119
Query: 889 SYLH-HDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAG 944
YLH + I+HRD+K N+L E+ + DFGL+++ ++ G S G
Sbjct: 120 KYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMS---TACG 169
Query: 945 SYGYIAPEYANMTKISEKSDVYSYGVVL 972
+ GY+APE S+ D +S GV+
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 14/218 (6%)
Query: 766 KLDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIA 824
++ + GD L + IG+G +GIV SG VAVK + +E+
Sbjct: 35 RMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVV 94
Query: 825 TLSRIRHRNIVRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALG 883
+ +H N+V + +L + +++ G L ++ L E +
Sbjct: 95 IMRDYQHFNVVEMYK-SYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIAT-VCEA 149
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
V + L+YLH ++HRD+KS +ILL L+DFG + D S
Sbjct: 150 VLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS----LV 202
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ ++APE + + + + D++S G++++E++ G+ P
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 4e-20
Identities = 49/242 (20%), Positives = 95/242 (39%), Gaps = 17/242 (7%)
Query: 736 PRIRGLSGSHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKV 795
+ + + G + D + W+ +++ +G G G+V++V
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176
Query: 796 T-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854
T +G A K + EI T+S +RH +V L + ++ Y++M
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 855 PNGTL--GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912
G L + + + E + + V +GL ++H + +H D+K NI+
Sbjct: 237 SGGELFEKVADEHNK---MSEDEAV-EYMRQVCKGLCHMHEN---NYVHLDLKPENIMFT 289
Query: 913 ERYESCL--ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGV 970
+ + L DFGL ++ S G+ + APE A + +D++S GV
Sbjct: 290 TKRSNELKLIDFGLTAHLDP--KQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 971 VL 972
+
Sbjct: 345 LS 346
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-20
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 777 SLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+++ I+G GR G V+K +GL +A K + +EI+ ++++ H N++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 836 RLLGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
+L ++ +L +Y+ G L ++ + L E DT + EG+ ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTI-LFMKQICEGIRHMHQM 206
Query: 895 CVPAILHRDVKSHNILLGERYESCL--ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
ILH D+K NIL R + DFGLAR + N G+ ++APE
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REKLKVN---FGTPEFLAPE 258
Query: 953 YANMTKISEKSDVYSYGVVL 972
N +S +D++S GV+
Sbjct: 259 VVNYDFVSFPTDMWSVGVIA 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 39/226 (17%), Positives = 75/226 (33%), Gaps = 36/226 (15%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS--EIATLSRI-RHRNIVR 836
IG G G V+K G A+KR + S ++ E+ + + +H ++VR
Sbjct: 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 837 LLGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
A L+ +Y G+L + + + + L V GL Y+H
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM- 134
Query: 896 VPAILHRDVKSHNILLGERYESC-------------------LADFGLARLVEDDSGGSF 936
+++H D+K NI + + D G
Sbjct: 135 --SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV--------TRI 184
Query: 937 SANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKP 981
S+ G ++A E K+D+++ + ++ +
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 50/210 (23%), Positives = 79/210 (37%), Gaps = 41/210 (19%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRF--RASDKISTGAFSSEIATLSRIRHRNIVRL 837
+G+G +V + +GL A K + E +++H NIVRL
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAG------------LLEWDTRFKIALGVA 885
L L G E D +
Sbjct: 71 HD----------SIQEESFHYLVFDL----VTGGELFEDIVAREFYSEADAS-HCIQQIL 115
Query: 886 EGLSYLHHDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQF 942
E ++Y H + I+HR++K N+LL + + LADFGLA V D ++ F
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWH---GF 167
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVL 972
AG+ GY++PE S+ D+++ GV+L
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-20
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK---RFRASDKISTGAFSSEIATLSRIRHRNIVR 836
++G+G G V +G AVK + + K + E+ L ++ H NI++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L + ++ L + G L E D +I V G++Y+H +
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAA-RIIRQVLSGITYMHKN-- 145
Query: 897 PAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
I+HRD+K N+LL + + + DFGL+ E G+ YIAPE
Sbjct: 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK-----DKIGTAYYIAPEV 199
Query: 954 ANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ EK DV+S GV+L +++G P
Sbjct: 200 LHG-TYDEKCDVWSTGVILYILLSGCPP 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKR--FRASDKISTGAFSSEIATLSRIRHRNIVRLLGW 840
+G G G VYK +G A K ++ +++ + EI L+ H IV+LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKLLG- 83
Query: 841 GANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
KL + ++ P G + ++ + + GL E + + + E L++LH I
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQV-VCRQMLEALNFLHSK---RI 138
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
+HRD+K+ N+L+ + LADFG++ + F G+ ++APE +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLK----TLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 960 SE-----KSDVYSYGVVLLEIITGKKP 981
+ K+D++S G+ L+E+ + P
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFS------SEIATLSRIRHRN 833
G +G G+ IV K +GL A K + ++ E++ L ++ H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
++ L NR +L + + G L L E L E + + +G++YLH
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEAT-SFIKQILDGVNYLHT 133
Query: 894 DCVPAILHRDVKSHNILLGERYESC----LADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
I H D+K NI+L ++ L DFGLA +ED G F G+ ++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFK---NIFGTPEFV 185
Query: 950 APEYANMTKISEKSDVYSYGVVL 972
APE N + ++D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 53/194 (27%), Positives = 71/194 (36%), Gaps = 14/194 (7%)
Query: 408 SNCQ-NLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRA 466
+ + V+ + LT +P + K L L N L + + L +
Sbjct: 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG 526
+ +LT G L L LDL N+L S+P LT LDV N + +LP G
Sbjct: 63 DRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG 118
Query: 527 L-HQLVRLQFADLSDNSVGGMLSPDL-GSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQL 583
L LQ L N + L P L L KL L N +P+ L L
Sbjct: 119 ALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176
Query: 584 LDLSSNQLSGNIPA 597
L L N L IP
Sbjct: 177 LLLQENSLY-TIPK 189
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 11/205 (5%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
+ + LT ++P L K+ L L +N L L ++L+ +++
Sbjct: 10 ASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNL 386
LT + G L L L LS NQ+ +P L +++ N++T L
Sbjct: 67 LT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 387 SNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLS 444
L L++ N L+ +PP + + LE + L+ N LT +P G+ L+ L+ LLL
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQE 181
Query: 445 NNLSGVIPPEMGNCSSLIRFRANSN 469
N+L IP L + N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 55/198 (27%), Positives = 77/198 (38%), Gaps = 13/198 (6%)
Query: 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG 526
+ LT +PP++ K+ L L N L + LT L++ + L
Sbjct: 18 DKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD 73
Query: 527 LHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLD 585
L L DLS N + L +L +LT L ++ NR S+P +LQ L
Sbjct: 74 GT-LPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELY 130
Query: 586 LSSNQLSGNIPASL-GKIPALAIALNLSWNQICGELPAEL-TGLNKLGILDLSHNELSGD 643
L N+L +P L P L L+L+ N + ELPA L GL L L L N L
Sbjct: 131 LKGNELK-TLPPGLLTPTPKLEK-LSLANNNL-TELPAGLLNGLENLDTLLLQENSLYTI 187
Query: 644 LHFLAELQNLVVLNVSHN 661
L + N
Sbjct: 188 PKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 52/282 (18%), Positives = 84/282 (29%), Gaps = 88/282 (31%)
Query: 168 NLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLA 227
++S ++ LT A+P +
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL------------------------------------- 29
Query: 228 ETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGD-CTELQYIYLYENALTGSIPSK 286
P +L L +YT T L + L LT +
Sbjct: 30 --------PKDTTIL-HLSENLLYT------FSLATLMPYTRLTQLNLDRAELT-KLQV- 72
Query: 287 LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQL 346
G L L L L N L S+P L +L L +
Sbjct: 73 DGTLPVLGTLDLSHNQLQ-------------------------SLPLLGQTLPALTVLDV 107
Query: 347 SVNQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSE-FGNLSNLTLLFVWHNRLEGEIP 404
S N+++ +P L ++ L N++ +P L L + +N L E+P
Sbjct: 108 SFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELP 164
Query: 405 PSI-SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSN 445
+ + +NL+ + L +N L IP+G F L L N
Sbjct: 165 AGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 53/227 (23%), Positives = 81/227 (35%), Gaps = 34/227 (14%)
Query: 124 LNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLT 183
++ + +LT +P +L L L+ N L + + LTQL L +LT
Sbjct: 12 HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 184 DAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLK 243
+ G L L + N+ SLP L ++ ++ ++ LP G L+
Sbjct: 69 -KLQV-DGTLPVLGTLDLSHNQ--LQSLPLLGQTLPALTVLDVSFNRLT-SLPL--GALR 121
Query: 244 RLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKL-GNLKNLVNLFLWQNN 302
L ELQ +YL N L ++P L L L L NN
Sbjct: 122 GL---------------------GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN 159
Query: 303 LVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVN 349
L + L L + + NSL +IP+ L L N
Sbjct: 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 35/217 (16%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL 146
L +P + L LS L + +L L+L LT ++ +L
Sbjct: 22 LTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLP 77
Query: 147 RLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGNK 205
L L L+ NQL+ ++P+ L +LT L + N+LT ++P L L+ + GN+
Sbjct: 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNE 135
Query: 206 NLGGSLPHEI-GNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELG 264
L +LP + L + LA +++ LP GLL L
Sbjct: 136 -L-KTLPPGLLTPTPKLEKLSLANNNLTE-LPA--GLLNGL------------------- 171
Query: 265 DCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQN 301
L + L EN+L +IP L FL N
Sbjct: 172 --ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 24/106 (22%), Positives = 37/106 (34%), Gaps = 10/106 (9%)
Query: 572 PSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLG 631
++ L+ +P +P L+LS N + A L +L
Sbjct: 5 EVS-KVA-SHLEVNCDKRNLT-ALPPD---LPKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 632 ILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP 677
L+L EL+ L L L L++SHN +P LP
Sbjct: 59 QLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLL--GQTLP 100
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-19
Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 33/206 (16%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRF--RASDKISTGAFSSEIATLSRIRHRNIVRL 837
+G+G +V + +GL A K + E +++H NIVRL
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 838 LGWGANRKTKLLFYDYMPNGTL-------GMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
L +D + G L E D + E ++Y
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYS---------EADAS-HCIQQILESIAY 143
Query: 891 LH-HDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAGSY 946
H + I+HR++K N+LL + + LADFGLA V D ++ FAG+
Sbjct: 144 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWH---GFAGTP 194
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVL 972
GY++PE S+ D+++ GV+L
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 46/206 (22%), Positives = 79/206 (38%), Gaps = 32/206 (15%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRF--RASDKISTGAFSSEIATLSRIRHRNIVRL 837
+G+G +V + + +G A + E ++H NIVRL
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 838 LGWGANRKTKLLFYDYMPNGTL-------GMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+ L +D + G L E D + E + +
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYS---------EADAS-HCIQQILEAVLH 125
Query: 891 LH-HDCVPAILHRDVKSHNILLGERYES---CLADFGLARLVEDDSGGSFSANPQFAGSY 946
H ++HR++K N+LL + + LADFGLA VE + ++ FAG+
Sbjct: 126 CHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWF---GFAGTP 177
Query: 947 GYIAPEYANMTKISEKSDVYSYGVVL 972
GY++PE + D+++ GV+L
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 31/137 (22%), Positives = 53/137 (38%), Gaps = 11/137 (8%)
Query: 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912
L ++ E I + +AE + +LH ++HRD+K NI
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFT 198
Query: 913 ERYESCLADFGLARLVEDDSGGSFSANPQFA--------GSYGYIAPEYANMTKISEKSD 964
+ DFGL ++ D P A G+ Y++PE + S K D
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 965 VYSYGVVLLEIITGKKP 981
++S G++L E++
Sbjct: 259 IFSLGLILFELLYSFST 275
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 64/258 (24%), Positives = 100/258 (38%), Gaps = 40/258 (15%)
Query: 744 SHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLT 802
HH+ G E++ + T + G + +G G G V + +
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 803 VAVK--RFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLG 860
A+K R + S E+A L + H NI++L F++ N L
Sbjct: 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD----------FFEDKRNYYLV 114
Query: 861 MLLHDGECAG--LLEW---DTRF------KIALGVAEGLSYLHHDCVPAILHRDVKSHNI 909
M G L + +F I V G++YLH I+HRD+K N+
Sbjct: 115 MEC----YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENL 167
Query: 910 LLGERYESC---LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVY 966
LL + + + DFGL+ + E+ + G+ YIAPE K EK DV+
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFEN--QKKMK---ERLGTAYYIAPEVLRK-KYDEKCDVW 221
Query: 967 SYGVVLLEIITGKKPVDA 984
S GV+L ++ G P
Sbjct: 222 SIGVILFILLAGYPPFGG 239
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFS------SEIATLSRIRHRN 833
G +G G+ IV K +GL A K + ++ E++ L ++ H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
I+ L NR +L + + G L L E L E + + +G++YLH
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEAT-SFIKQILDGVNYLHT 133
Query: 894 DCVPAILHRDVKSHNILLGERYESC----LADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
I H D+K NI+L ++ L DFGLA +ED G F G+ ++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFK---NIFGTPEFV 185
Query: 950 APEYANMTKISEKSDVYSYGVVL 972
APE N + ++D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 44/214 (20%), Positives = 78/214 (36%), Gaps = 41/214 (19%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRF--------RASDKISTGAFSSEIATLSRIRH 831
+G G G V + VA++ A + +EI L ++ H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTL-------GMLLHDGECAGLLEWDTRFKIALGV 884
I+++ + ++ + M G L L E + +
Sbjct: 200 PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK---------RLKEATCK-LYFYQM 248
Query: 885 AEGLSYLHHDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQ 941
+ YLH + I+HRD+K N+LL + E C + DFG ++++ + S
Sbjct: 249 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-----T 300
Query: 942 FAGSYGYIAPE---YANMTKISEKSDVYSYGVVL 972
G+ Y+APE + D +S GV+L
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 32/204 (15%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--RFRASDKISTGAFSSEIATLSRIRHRNIVRL 837
+G+G GIV++ S T K + + +D+ EI+ L+ RHRNI+ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRNILHL 66
Query: 838 LGWGANRKTKLLFYDYMPNGTL-------GMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+ + ++ ++++ + L++ E + V E L +
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH---------QVCEALQF 117
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCL--ADFGLARLVEDDSGGSFSANPQFAGSYGY 948
LH I H D++ NI+ R S + +FG AR ++ G +F + Y
Sbjct: 118 LHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFR---LLFTAPEY 169
Query: 949 IAPEYANMTKISEKSDVYSYGVVL 972
APE +S +D++S G ++
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 44/214 (20%), Positives = 77/214 (35%), Gaps = 41/214 (19%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRF--------RASDKISTGAFSSEIATLSRIRH 831
+G G G V + VA+K A + +EI L ++ H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTL-------GMLLHDGECAGLLEWDTRFKIALGV 884
I+++ + ++ + M G L L E + +
Sbjct: 75 PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLK---------EATCK-LYFYQM 123
Query: 885 AEGLSYLHHDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQ 941
+ YLH + I+HRD+K N+LL + E C + DFG ++++ +
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMR---T 175
Query: 942 FAGSYGYIAPE---YANMTKISEKSDVYSYGVVL 972
G+ Y+APE + D +S GV+L
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 52/215 (24%), Positives = 84/215 (39%), Gaps = 46/215 (21%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS------EIATLSRIRHRN 833
G +G G+ IV K +G A K + S+ S E+ L IRH N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAG------------LLEWDTRFKIA 881
I+ L ++ + L + L +G L E + +
Sbjct: 70 IITLHD----------IFENKTDVVLILEL----VSGGELFDFLAEKESLTEDEAT-QFL 114
Query: 882 LGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESC----LADFGLARLVEDDSGGSFS 937
+ +G+ YLH I H D+K NI+L ++ L DFG+A +E G F
Sbjct: 115 KQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFK 169
Query: 938 ANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVL 972
G+ ++APE N + ++D++S GV+
Sbjct: 170 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 57/209 (27%), Positives = 85/209 (40%), Gaps = 29/209 (13%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKR---FRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG G G VY + + VA+K+ E+ L ++RH N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 840 WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIAL---GVAEGLSYLHHDC 895
R+ L +Y +L + L E +IA G +GL+YLH
Sbjct: 122 -CYLREHTAWLVMEYCLGSASDLLEVHKKP--LQE----VEIAAVTHGALQGLAYLHSH- 173
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
++HRDVK+ NILL E L DFG A + F G+ ++APE
Sbjct: 174 --NMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVIL 223
Query: 956 MTKISE---KSDVYSYGVVLLEIITGKKP 981
+ K DV+S G+ +E+ K P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 46/199 (23%), Positives = 82/199 (41%), Gaps = 16/199 (8%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--RFRASDKISTGAFSSEIATLSRIRHR-NIVR 836
+G+G+ +V + +G A K + R + EIA L + ++
Sbjct: 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L N +L +Y G + L + E D ++ + EG+ YLH +
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI-RLIKQILEGVYYLHQN-- 150
Query: 897 PAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
I+H D+K NILL Y + DFG++R + + G+ Y+APE
Sbjct: 151 -NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELR---EIMGTPEYLAPEI 204
Query: 954 ANMTKISEKSDVYSYGVVL 972
N I+ +D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 41/208 (19%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+ +G+G + IVY+ + A+K + + +EI L R+ H NI++L
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK--IVRTEIGVLLRLSHPNIIKLKE 115
Query: 840 WGANRKTKLLFYDYMPNGTLGM-LLHDGECAGLLEW----------DTRFKIALGVAEGL 888
++ +L + L+ GE L + D + E +
Sbjct: 116 I----------FETPTEISLVLELVTGGE---LFDRIVEKGYYSERDAA-DAVKQILEAV 161
Query: 889 SYLH-HDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAG 944
+YLH + I+HRD+K N+L +ADFGL+++VE G
Sbjct: 162 AYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMK---TVCG 212
Query: 945 SYGYIAPEYANMTKISEKSDVYSYGVVL 972
+ GY APE + D++S G++
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 29/302 (9%), Positives = 66/302 (21%), Gaps = 63/302 (20%)
Query: 784 IGQGRSGIVYK---VTLPSGLTVAVKRFR---ASDKISTGAFSSEIATLSRIRHRNIVRL 837
G ++ L VA+ S LSRI + R+
Sbjct: 39 HGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
L R L+ +++ G+L + + +A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
+ + + + G L +
Sbjct: 149 GVALSIDHPSRVRV--------SIDGDVVL----------------AYPATMPDA----- 179
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017
+ + D+ G L ++ + P+ + + + +D +
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRS--GLAPAERDTAGQPIEPADIDRDIPFQ 235
Query: 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEAHKPTAAKSTDT 1077
++ R + LL ++Q A
Sbjct: 236 ISA----------VAARSVQGDGGIRSA----STLLNLMQQATAVADRTEVLGPIDEAPV 281
Query: 1078 AS 1079
++
Sbjct: 282 SA 283
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 26/217 (11%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS----EIATLSRIRHRNIV 835
G+++G+G G V +V + AVK + + EI L R+RH+N++
Sbjct: 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 836 RLLG-WGANRKTKL-LFYDYMPNGTLGMLLHDGECAG-LLEWDTRFK----IALGVAEGL 888
+L+ K K+ + +Y G ML D I GL
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEML--DSVPEKRFPVCQAHGYFCQLID-----GL 122
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
YLH I+H+D+K N+LL ++ G+A + + Q GS +
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAF 177
Query: 949 IAPEYANMTKISE--KSDVYSYGVVLLEIITGKKPVD 983
PE AN K D++S GV L I TG P +
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 40/218 (18%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRF--RASDKISTGAFSSEIATLSRIRHRNIVRL 837
++G+G G V K + AVK ++ T E+ L ++ H NI++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAG--LLEW---DTRF------KIALGVAE 886
+ + + L G L + RF +I V
Sbjct: 87 FE----------ILEDSSSFYIVGEL----YTGGELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFA 943
G++Y+H I+HRD+K NILL + + C + DFGL+ + ++
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMK---DRI 184
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
G+ YIAPE EK DV+S GV+L +++G P
Sbjct: 185 GTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-18
Identities = 58/254 (22%), Positives = 89/254 (35%), Gaps = 29/254 (11%)
Query: 745 HHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTV 803
HH+ + + + G S +G G G V
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 804 AVK-------------RFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850
A+K + + +EI+ L + H NI++L ++K L
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLV 124
Query: 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNIL 910
++ G L E D I + G+ YLH I+HRD+K NIL
Sbjct: 125 TEFYEGGEL--FEQIINRHKFDECDAA-NIMKQILSGICYLHKH---NIVHRDIKPENIL 178
Query: 911 LGERYESC---LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYS 967
L + + DFGL+ D G+ YIAPE K +EK DV+S
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDY--KLR---DRLGTAYYIAPEVLKK-KYNEKCDVWS 232
Query: 968 YGVVLLEIITGKKP 981
GV++ ++ G P
Sbjct: 233 CGVIMYILLCGYPP 246
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 54/215 (25%), Positives = 82/215 (38%), Gaps = 52/215 (24%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRF--RASDKISTGAFSSEIATLSRIRHRNIVRL 837
++G+G G V K + AVK ++ T E+ L ++ H NI++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAG--LL----------EWDTRFKIALGVA 885
+ + + L G L E D +I V
Sbjct: 87 FE----------ILEDSSSFYIVGEL----YTGGELFDEIIKRKRFSEHDAA-RIIKQVF 131
Query: 886 EGLSYLHHDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQF 942
G++Y+H I+HRD+K NILL + + C + DFGL+ +
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMK---DR 183
Query: 943 AGSYGYIAPE-----YANMTKISEKSDVYSYGVVL 972
G+ YIAPE Y EK DV+S GV+L
Sbjct: 184 IGTAYYIAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 38/217 (17%)
Query: 355 IPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNC-QN 412
IP+ I + ++L +L +N+++ F L+ L LL++ N+L+ +P I +N
Sbjct: 31 IPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 413 LEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKL 471
LE + ++ N L +P G+F QL L +L L + N+L
Sbjct: 87 LETLWVTDNKLQA-LPIGVFDQLVNLAELRL------------------------DRNQL 121
Query: 472 TGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAGL-H 528
+PP + +L L +L LG N L S+P + +L L +++N + +P G
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFD 178
Query: 529 QLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKN 565
+L L+ L +N + + SL L L L +N
Sbjct: 179 KLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 66/244 (27%), Positives = 90/244 (36%), Gaps = 39/244 (15%)
Query: 401 GEIPPSISNC-QNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCS 459
+ + +C N +VD S LT IP I +
Sbjct: 5 CKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIP--------------------------A 37
Query: 460 SLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNS 518
+ SNKL+ L L L L N+L ++P I +NL L V N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 519 IAGNLPAGL-HQLVRLQFADLSDNSVGGMLSPDL-GSLSSLTKLVLNKNRFAGSIPSQL- 575
+ LP G+ QLV L L N + L P + SL+ LT L L N S+P +
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 576 GSCVKLQLLDLSSNQLSGNIPASL-GKIPALAIALNLSWNQICGELPAELTGLNKLGILD 634
L+ L L +NQL +P K+ L L L NQ+ L KL +L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKT-LKLDNNQLKRVPEGAFDSLEKLKMLQ 211
Query: 635 LSHN 638
L N
Sbjct: 212 LQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG 526
+S KLT IP I + LDL SN+L+ L L ++ N + LPAG
Sbjct: 24 SSKKLTA-IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAG 79
Query: 527 L-HQLVRLQFADLSDNSVGGMLSPDL-GSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQL 583
+ +L L+ ++DN + L + L +L +L L++N+ S+P ++ S KL
Sbjct: 80 IFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTY 137
Query: 584 LDLSSNQLSGNIPASL-GKIPALAIALNLSWNQICGELPAEL-TGLNKLGILDLSHNELS 641
L L N+L ++P + K+ +L L L NQ+ +P L +L L L +N+L
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLTSLKE-LRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLK 194
Query: 642 ----GDLHFLAELQNL 653
G L +L+ L
Sbjct: 195 RVPEGAFDSLEKLKML 210
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 68/284 (23%), Positives = 100/284 (35%), Gaps = 92/284 (32%)
Query: 122 NQLNYLDLSENSLT---GEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLY 178
N N +D S LT IP + ++L L SN+L L+ L L+L
Sbjct: 16 NNKNSVDCSSKKLTAIPSNIPADT------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 179 DNQLTDAIPATI-GKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPP 237
DN+L +PA I +LKNLE + N
Sbjct: 70 DNKLQ-TLPAGIFKELKNLETLWVTDN--------------------------------- 95
Query: 238 TLGLLKRLQTIAIYTALLSGQIPPELGDC-TELQYIYLYENALTGSIPSKL-GNLKNLVN 295
+LQ +P + D L + L N L S+P ++ +L L
Sbjct: 96 ------KLQA-----------LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTY 137
Query: 296 LFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTL-GNLTSLQELQLSVNQISGE 354
L L N L S+P+ + LTSL+EL+L NQ+
Sbjct: 138 LSLGYNELQ-------------------------SLPKGVFDKLTSLKELRLYNNQLK-R 171
Query: 355 IPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHN 397
+P L ++LDNNQ+ F +L L +L + N
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 12/161 (7%)
Query: 267 TELQYIYLYENALTGSIPSKL-GNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325
T+L+ +YL +N L ++P+ + LKNL L++ N L + L+ + + N
Sbjct: 61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRN 119
Query: 326 SLTGSIPQTL-GNLTSLQELQLSVNQISGEIPAQIGNCQRLAQ---IELDNNQITGAIPS 381
L S+P + +LT L L L N++ +P G +L + L NNQ+
Sbjct: 120 QLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK--GVFDKLTSLKELRLYNNQLKRVPEG 175
Query: 382 EFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQN 421
F L+ L L + +N+L+ +P + + L+ + L +N
Sbjct: 176 AFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 55/240 (22%), Positives = 88/240 (36%), Gaps = 59/240 (24%)
Query: 90 VPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELC-SLLRL 148
+P+N + +L L L+ K L +L L L++N L +P + L L
Sbjct: 31 IPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 149 EQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGNKN 206
E L + N+L+ A+PI + L +L +L L NQL ++P + L L + G N+
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE- 144
Query: 207 LGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDC 266
L SLP G+ +L
Sbjct: 145 L-QSLPK--------------------------GVFDKL--------------------- 156
Query: 267 TELQYIYLYENALTGSIPSKL-GNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325
T L+ + LY N L +P L L L L N L + + +L ++ + N
Sbjct: 157 TSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 11/132 (8%)
Query: 81 LRYVDL----LGHVPTN-FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSL 134
L + + L +P F L++L L L L S+P + SL +L YL L N L
Sbjct: 87 LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 135 TGEIPRELC-SLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGK 192
+P+ + L L++LRL +NQL+ +P L+ L L L +NQL
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDS 203
Query: 193 LKNLEAIRAGGN 204
L+ L+ ++ N
Sbjct: 204 LEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 81 LRYVDL----LGHVPTN-FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSL 134
LR + L L +P F L +L L ++ L ++P + L L L L N L
Sbjct: 63 LRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL 121
Query: 135 TGEIPRELC-SLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATI-G 191
+P + SL +L L L N+L+ ++P + L+SL +L LY+NQL +P
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFD 178
Query: 192 KLKNLEAIRAGGNKNLGGSLPHEI-GNCTNLVMIGL 226
KL L+ ++ N+ +P + L M+ L
Sbjct: 179 KLTELKTLKLDNNQLK--RVPEGAFDSLEKLKMLQL 212
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 17/199 (8%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRF-RASDKISTGAFSSEIATLSRIRHRNIVRLL 838
+G G G V+ V SGL +K + ++ +EI L + H NI+++
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 839 GWGANRKTKLLFYDYMPNGTL--GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
+ + + G L ++ L E ++ + L+Y H
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFHSQ-- 143
Query: 897 PAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
++H+D+K NIL + + DFGLA L + D + AG+ Y+APE
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HST---NAAGTALYMAPEV 197
Query: 954 ANMTKISEKSDVYSYGVVL 972
++ K D++S GVV+
Sbjct: 198 FK-RDVTFKCDIWSAGVVM 215
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 46/215 (21%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFS------SEIATLSRIRHRN 833
G +G G+ +V K +GL A K + S+ E++ L I+H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAG------------LLEWDTRFKIA 881
++ L Y+ + L + L AG L E + +
Sbjct: 76 VITLHE----------VYENKTDVILILEL----VAGGELFDFLAEKESLTEEEAT-EFL 120
Query: 882 LGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES----CLADFGLARLVEDDSGGSFS 937
+ G+ YLH I H D+K NI+L +R + DFGLA ++ G F
Sbjct: 121 KQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFK 175
Query: 938 ANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVL 972
G+ ++APE N + ++D++S GV+
Sbjct: 176 ---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 56/223 (25%), Positives = 83/223 (37%), Gaps = 40/223 (17%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--------RFRASDKISTGAFSSEIATLSRIRH 831
+ +G G G V+ V VK + G + EIA LSR+ H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD--GECAGLLEWDTRFK---IALGVAE 886
NI+++L N+ F M G+ L L E + + V
Sbjct: 89 ANIIKVLDIFENQGF---FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG- 144
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
YL I+HRD+K NI++ E + L DFG A +E G F F G+
Sbjct: 145 ---YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYT---FCGTI 193
Query: 947 GYIAPE------YANMTKISEKSDVYSYGVVLLEIITGKKPVD 983
Y APE Y + +++S GV L ++ + P
Sbjct: 194 EYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFC 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 30/219 (13%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS-------EIATLSRIR-- 830
G ++G+G G V+ L L VA+K +++ + S E+A L ++
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIK-VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 831 --HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD--GECAGLLEWDTRFKIALGVAE 886
H ++RLL W ++ F + L D E L E +R V
Sbjct: 95 GGHPGVIRLLDWFETQEG---FMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVA 150
Query: 887 GLSYLHHDCVPAILHRDVKSHNILL-GERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945
+ + H V +HRD+K NIL+ R + L DFG L+ D ++ F G+
Sbjct: 151 AIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTD---FDGT 201
Query: 946 YGYIAPEYANMTK-ISEKSDVYSYGVVLLEIITGKKPVD 983
Y PE+ + + + + V+S G++L +++ G P +
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 28/217 (12%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS-------EIATLSRIRHR 832
G ++G G G VY + L VA+K D+IS E+ L ++
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIK-HVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 833 --NIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD--GECAGLLEWDTRFKIALGVAEGL 888
++RLL W + F + L D E L E R V E +
Sbjct: 107 FSGVIRLLDWFERPDS---FVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 162
Query: 889 SYLHHDCVPAILHRDVKSHNILL-GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
+ H+ V LHRD+K NIL+ R E L DFG L++D ++ F G+
Sbjct: 163 RHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTD---FDGTRV 213
Query: 948 YIAPEYANMTK-ISEKSDVYSYGVVLLEIITGKKPVD 983
Y PE+ + + V+S G++L +++ G P +
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 42/234 (17%), Positives = 85/234 (36%), Gaps = 17/234 (7%)
Query: 263 LGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDI 322
L + ++T L + N +N+ + + + L + +
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70
Query: 323 SMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE 382
S N ++ + L +LT L+EL ++ N++ + L+++ LDNN++
Sbjct: 71 SHNQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRD--TDS 123
Query: 383 FGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLL 442
+L NL +L + +N+L+ I + LE +DL N +T G+ +LKK+N + L
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDL 179
Query: 443 LSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLT 496
+ + P I N + +
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 51/276 (18%), Positives = 92/276 (33%), Gaps = 52/276 (18%)
Query: 153 LNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGN--KNLGGS 210
+ P L++ + L +TD + +L ++ + ++L G
Sbjct: 4 QRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG- 58
Query: 211 LPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQ 270
+ TNL + L+ IS + P L D T+L+
Sbjct: 59 ----MQFFTNLKELHLSHNQIS-------------------------DLSP-LKDLTKLE 88
Query: 271 YIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGS 330
+ + N L ++ + + + L LFL N L L + L I+ I N L S
Sbjct: 89 ELSVNRNRLK-NL-NGIPSA-CLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK-S 142
Query: 331 IPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLT 390
I LG L+ L+ L L N+I+ + +++ I+L + L
Sbjct: 143 IVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITN 199
Query: 391 LLFVWHNRLEGEI--PPSISNCQNLEAVDLSQNGLT 424
+ +G P ISN + +
Sbjct: 200 TV----KDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 40/198 (20%), Positives = 81/198 (40%), Gaps = 26/198 (13%)
Query: 503 ITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVL 562
G N ++ S+ +L +Q + ++++ + + ++L +L L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 563 NKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAI-ALNLSWNQICGELP 621
+ N+ S S L KL+ L ++ N+L +L IP+ + L L N++
Sbjct: 71 SHNQI--SDLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNEL--RDT 121
Query: 622 AELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP-LSV 680
L L L IL + +N+L + L L L VL++ N + +T +L ++
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEIT----NTGGLTRLKKVNW 176
Query: 681 LSGNPSLCFSGNQCADST 698
+ +G +C +
Sbjct: 177 ID------LTGQKCVNEP 188
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 39/296 (13%), Positives = 86/296 (29%), Gaps = 71/296 (23%)
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
L + + L ++T + L+ + + +++ + + L++L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKEL 68
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSL 211
L+ NQ+ P++ +L+ L +L + N+L + + + +
Sbjct: 69 HLSHNQISDLSPLK--DLTKLEELSVNRNRLKN-----LNGIPSA--------------- 106
Query: 212 PHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQY 271
L + L + L L+
Sbjct: 107 --------CLSRLFLDNNELRDTDS--------------------------LIHLKNLEI 132
Query: 272 IYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSI 331
+ + N L SI LG L L L L N + L +++ ID++
Sbjct: 133 LSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEP 188
Query: 332 PQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLS 387
+ L ++ + P I N + + +P +S
Sbjct: 189 VKYQPELYITNTVKDPDGRWIS--PYYISNG-----GSYVDGCVLWELPVYTDEVS 237
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 30/210 (14%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTG---------AFSSEIATLSRI- 829
I+G+G S +V + P+ AVK + S A E+ L ++
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGL 888
H NI++L L +D M G L L L E +TR KI + E +
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETR-KIMRALLEVI 137
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
LH I+HRD+K NILL + L DFG + ++ G + G+ Y
Sbjct: 138 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLR---EVCGTPSY 189
Query: 949 IAPE------YANMTKISEKSDVYSYGVVL 972
+APE N ++ D++S GV++
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 41/221 (18%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK------RFRASDKISTGAFSSEIATLSRIRHRN 833
+G+G G V + VAVK + I EI + H N
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-----EICINKMLNHEN 66
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFK----IALGVAEGL 888
+V+ G + LF +Y G L + D G+ E D + +A G+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMA-----GV 118
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
YLH I HRD+K N+LL ER ++DFGLA + ++ G+ Y
Sbjct: 119 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK--MCGTLPY 173
Query: 949 IAPE------YANMTKISEKSDVYSYGVVLLEIITGKKPVD 983
+APE + +E DV+S G+VL ++ G+ P D
Sbjct: 174 VAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 47/214 (21%), Positives = 80/214 (37%), Gaps = 41/214 (19%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGW 840
++G+G V L + AVK E+ L + + HRN++ L+
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE- 78
Query: 841 GANRKTKLLFYDYMPNGTLGM-LLHDGECAGLL----------EWDTRFKIALGVAEGLS 889
F++ L + G +L E + + VA L
Sbjct: 79 ---------FFEEEDRFYLVFEKMRGGS---ILSHIHKRRHFNELEAS-VVVQDVASALD 125
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQF---A 943
+LH+ I HRD+K NIL + + DF L ++ + S + P+
Sbjct: 126 FLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 944 GSYGYIAPE-----YANMTKISEKSDVYSYGVVL 972
GS Y+APE + ++ D++S GV+L
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 50/159 (31%), Positives = 69/159 (43%), Gaps = 19/159 (11%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFR-ASDKISTGAFSS----EIATL---SRIRHR 832
IG G G VYK SG VA+K R + G E+A L H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 833 NIVRLL----GWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEG 887
N+VRL+ +R+ K+ L ++++ L L GL + + G
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLRG 132
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926
L +LH +C I+HRD+K NIL+ LADFGLAR
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 50/165 (30%), Positives = 69/165 (41%), Gaps = 35/165 (21%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRL 837
IGQG G V+K +G VA+K+ + G + EI L ++H N+V L
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 838 LG-----WGANRKTKLLFY---DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVA---- 885
+ + K Y D+ HD AGLL + K L
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCE--------HD--LAGLLS-NVLVKFTLSEIKRVM 130
Query: 886 ----EGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926
GL Y+H + ILHRD+K+ N+L+ LADFGLAR
Sbjct: 131 QMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 49/213 (23%), Positives = 73/213 (34%), Gaps = 50/213 (23%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
N IG+G G V + + A K+ F EI + + H NI+RL
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAG--LL----------EWDTRFKIALGVAEG 887
++ + L M L C G L E D +I V
Sbjct: 74 ----------TFEDNTDIYLVMEL----CTGGELFERVVHKRVFRESDAA-RIMKDVLSA 118
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAG 944
++Y H + HRD+K N L L DFGLA + G G
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMR---TKVG 170
Query: 945 SYGYIAPE-----YANMTKISEKSDVYSYGVVL 972
+ Y++P+ Y + D +S GV++
Sbjct: 171 TPYYVSPQVLEGLY------GPECDEWSAGVMM 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 51/220 (23%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTG--------AFSSEIATLSRIR- 830
++IG+G S +V + +G AVK + + + A E L ++
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAG--LL----------EWDTRF 878
H +I+ L+ Y+ L L L E +TR
Sbjct: 159 HPHIITLID----------SYESSSFMFLVFDL----MRKGELFDYLTEKVALSEKETR- 203
Query: 879 KIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSA 938
I + E +S+LH + I+HRD+K NILL + + L+DFG + +E G
Sbjct: 204 SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLR- 257
Query: 939 NPQFAGSYGYIAPE------YANMTKISEKSDVYSYGVVL 972
+ G+ GY+APE ++ D+++ GV+L
Sbjct: 258 --ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-16
Identities = 77/434 (17%), Positives = 137/434 (31%), Gaps = 85/434 (19%)
Query: 291 KNLVNLFLWQNNL----VGIIPPELGNCSQLSIIDISMNSLT----GSIPQTLGNLTSLQ 342
++ +L + L + P L C + + LT I L +L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVV---RLDDCGLTEARCKDISSALRVNPALA 59
Query: 343 ELQLSVNQISGEIPAQIGNC-----QRLAQIELDNNQIT----GAIPSEFGNLSNLTLLF 393
EL L N++ + ++ ++ L N +T G + S L L L
Sbjct: 60 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 394 VWHNRLEGEIPPSIS-----NCQNLEAVDLSQNGLTGPIPRGIFQL----KKLNKLLLLS 444
+ N L + LE + L L+ + + +L + +
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 445 NNLS--GVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLT----GS 498
N+++ GV C L + L L L S +T
Sbjct: 180 NDINEAGV----RVLCQGLKD-----------------SPCQLEALKLESCGVTSDNCRD 218
Query: 499 IPDEITGCRNLTFLDVHSNSIAGN-----LPAGLHQLVRLQFADLSDNSVG----GMLSP 549
+ + +L L + SN + P LH RL+ + + + G L
Sbjct: 219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278
Query: 550 DLGSLSSLTKLVLNKNRFAGSIPSQLGSCVK-----LQLLDLSSNQLSG----NIPASLG 600
L + SL +L L N L + L+ L + S + + + L
Sbjct: 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLA 338
Query: 601 KIPALAIALNLSWNQICGE----LPAELTGLN-KLGILDLSHNELSGD-LHFLAEL---- 650
+ L L +S N++ L L L +L L+ ++S LA
Sbjct: 339 QNRFLLE-LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397
Query: 651 QNLVVLNVSHNNFS 664
+L L++S+N
Sbjct: 398 HSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-14
Identities = 91/519 (17%), Positives = 163/519 (31%), Gaps = 117/519 (22%)
Query: 98 LSLNRLVLSGTNLTGSIPKEIAS-LNQLNYLDLSENSLTGEIPRELCSLLR----LEQLR 152
L + L + L+ + E+ L Q + L + LT +++ S LR L +L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 153 LNSNQL--EGAIPIQIG---NLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNL 207
L SN+L G + G + +L L + LT A G L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA-----------------GCGVL 105
Query: 208 GGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCT 267
+L L + L++ + GL + LL
Sbjct: 106 SSTL----RTLPTLQELHLSDNLLGDA-----GLQ------LLCEGLLDP--------QC 142
Query: 268 ELQYIYLYENALT----GSIPSKLGNLKNLVNLFLWQNNL----VGIIPPELG-NCSQLS 318
L+ + L +L+ + S L + L + N++ V ++ L + QL
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202
Query: 319 IIDISMNSLT----GSIPQTLGNLTSLQELQLSVNQISGE-----IPAQIGNCQRLAQIE 369
+ + +T + + + SL+EL L N++ P + RL +
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262
Query: 370 LDNNQIT----GAIPSEFGNLSNLTLLFVWHNRLEGEIPPSIS------NCQNLEAVDLS 419
+ IT G + +L L + N L E + CQ LE++ +
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ-LESLWVK 321
Query: 420 QNGLTGPIPRGIFQLKKLNKLLL---LSNNLSGVIPPEMGN--CSSLIRFRANSNKLTGF 474
T + N+ LL +SNN + + L +
Sbjct: 322 SCSFTAACCSHFSSVLAQNRFLLELQISNN-------RLEDAGVRELCQGLGQPG----- 369
Query: 475 IPPEIGNLKNLNFLDLGSNRLT----GSIPDEITGCRNLTFLDVHSNSI----AGNLPAG 526
L L L ++ S+ + +L LD+ +N + L
Sbjct: 370 --------SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 421
Query: 527 L-HQLVRLQFADLSDNSVGGMLSPDLGSL----SSLTKL 560
+ L+ L D + L +L SL +
Sbjct: 422 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 92/453 (20%), Positives = 147/453 (32%), Gaps = 85/453 (18%)
Query: 269 LQYIYLYENALT----GSIPSKLGNLKNLVNLFLWQNNL----VGIIPPELGNCS-QLSI 319
Q + L + LT I S L L L L N L V + L S ++
Sbjct: 30 CQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQK 89
Query: 320 IDISMNSLT----GSIPQTLGNLTSLQELQLSVNQISGE-----IPAQIGNCQRLAQIEL 370
+ + LT G + TL L +LQEL LS N + + RL +++L
Sbjct: 90 LSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQL 149
Query: 371 DNNQIT----GAIPSEFGNLSNLTLLFVWHNRLEGE----IPPSISNCQ-NLEAVDLSQN 421
+ ++ + S + L V +N + + + + LEA+ L
Sbjct: 150 EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESC 209
Query: 422 GLT----GPIPRGIFQLKKLNKLLLLSNNL--SGVIP----PEMGNCSSLIRFRANSNKL 471
G+T + + L +L L SN L G+ + L +
Sbjct: 210 GVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR-LRTLWIWECGI 268
Query: 472 T----GFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-----TGCRNLTFLDVHSNSI--- 519
T G + + ++L L L N L + L L V S S
Sbjct: 269 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA 328
Query: 520 -AGNLPAGLHQLVRLQFADLSDNSVGG----MLSPDLGS-LSSLTKLVLNKNRF----AG 569
+ + L Q L +S+N + L LG S L L L
Sbjct: 329 CCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCS 388
Query: 570 SIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNK 629
S+ + L + L+ LDLS+N LG L + ++
Sbjct: 389 SLAATLLANHSLRELDLSNNC--------LGDAGILQLVESVRQPG------------CL 428
Query: 630 LGILDLSHNELSGD-LHFLAELQ----NLVVLN 657
L L L S + L L+ +L V++
Sbjct: 429 LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-10
Identities = 39/246 (15%), Positives = 78/246 (31%), Gaps = 37/246 (15%)
Query: 483 KNLNFLDLGSNRLT-GSIPDEITGCRNLTFLDVHSNSI----AGNLPAGLHQLVRLQFAD 537
++ LD+ L+ + + + + + + ++ + L L +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 538 LSDNSVGG----MLSPDLGSLS-SLTKLVLNKNRF----AGSIPSQLGSCVKLQLLDLSS 588
L N +G + L + S + KL L G + S L + LQ L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 589 NQLSG---NIPASLGKIPALAI-ALNLSWNQI----CGELPAELTGLNKLGILDLSHNEL 640
N L + P + L L + + C L + L L +S+N++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 641 SGD-LHFLAEL-----QNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPS---LCFSG 691
+ + L + L L + + + +++ S L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSD--NCRDLC----GIVASKASLRELALGS 236
Query: 692 NQCADS 697
N+ D
Sbjct: 237 NKLGDV 242
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 41/221 (18%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK------RFRASDKISTGAFSSEIATLSRIRHRN 833
+G+G G V + VAVK + I EI + H N
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-----EICINKMLNHEN 66
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFK----IALGVAEGL 888
+V+ G + LF +Y G L + D G+ E D + +A G+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMA-----GV 118
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
YLH I HRD+K N+LL ER ++DFGLA + ++ G+ Y
Sbjct: 119 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK--MCGTLPY 173
Query: 949 IAPE------YANMTKISEKSDVYSYGVVLLEIITGKKPVD 983
+APE + +E DV+S G+VL ++ G+ P D
Sbjct: 174 VAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 52/148 (35%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRLL 838
IG+G G+VYK G T A+K+ R +K G S+ EI+ L ++H NIV+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+K +L ++++ L LL C G LE T L + G++Y H
Sbjct: 67 DVIHTKKRLVLVFEHLDQD-LKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 899 ILHRDVKSHNILLGERYESCLADFGLAR 926
+LHRD+K N+L+ E +ADFGLAR
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 43/199 (21%), Positives = 76/199 (38%), Gaps = 24/199 (12%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGW 840
++G G +G V + +G A+K S K E+ + +IV +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILDV 90
Query: 841 ----GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
++ L+ + M G L + + E + +I + + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTAIQFLHSHN- 148
Query: 897 PAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
I HRDVK N+L + + L DFG A+ + + Y+APE
Sbjct: 149 --IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQ---TPCYTPYYVAPEV 200
Query: 954 ANMTKISEKSDVYSYGVVL 972
K + D++S GV++
Sbjct: 201 LGPEKYDKSCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 51/209 (24%), Positives = 77/209 (36%), Gaps = 38/209 (18%)
Query: 779 TAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVR 836
+G+G I K S AVK + +T EI L H NIV+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVK 70
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLL----------EWDTRFKIALGVAE 886
L ++ L + + NG GE L E + I +
Sbjct: 71 LHEVFHDQLHTFLVMELL-NG--------GE---LFERIKKKKHFSETEAS-YIMRKLVS 117
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFA 943
+S++H ++HRD+K N+L + ++ + DFG ARL D
Sbjct: 118 AVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLK---TPC 170
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVL 972
+ Y APE N E D++S GV+L
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 50/231 (21%), Positives = 83/231 (35%), Gaps = 44/231 (19%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS--EIATLSR-IRHRNIVR 836
IG G + + + + AVK I EI L R +H NI+
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLL----------EWDTRFKIALGVAE 886
L + K + + M G E LL E + + + +
Sbjct: 81 LKDVYDDGKYVYVVTELMKGG---------E---LLDKILRQKFFSEREAS-AVLFTITK 127
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGERYESC----LADFGLARLVEDDSGGSFSANPQF 942
+ YLH ++HRD+K NIL + + + DFG A+ + ++G +
Sbjct: 128 TVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP---- 180
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVI 993
+ ++APE D++S GV+L ++TG P D I
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 5e-16
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 24/186 (12%)
Query: 744 SHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTV 803
HH+ + + Y KL +G+G G+VYK G V
Sbjct: 3 HHHHHSSGRENLYFQGLMEKYQKL--------------EKVGEGTYGVVYKAKDSQGRIV 48
Query: 804 AVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLG 860
A+KR R D G S+ EI+ L + H NIV L+ + + L +++M L
Sbjct: 49 ALKRIRL-DAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LK 106
Query: 861 MLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLA 920
+L + + GL + + + G+++ H ILHRD+K N+L+ LA
Sbjct: 107 KVLDENK-TGLQDSQIK-IYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLA 161
Query: 921 DFGLAR 926
DFGLAR
Sbjct: 162 DFGLAR 167
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--RFRASDKISTGAFSSEIATLSRIRHRNIVRL 837
IG+G V + +G VA+K + S E+ + + H NIV+L
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 838 LGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
KT L +Y G + L+ G + E + R + + Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEAR-SKFRQIVSAVQYCHQKR- 134
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YAN 955
I+HRD+K+ N+LL +ADFG + GG A F G+ Y APE +
Sbjct: 135 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDA---FCGAPPYAAPELFQG 187
Query: 956 MTKISEKSDVYSYGVVLLEIITGKKPVDAS 985
+ DV+S GV+L +++G P D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-16
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 12/151 (7%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFR--ASDKISTGAFSS---EIATLSRIRHRNIV 835
+ +G+G+ VYK + VA+K+ + + G + EI L + H NI+
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
LL ++ L +D+M L +++ D + +L L +GL YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMETD-LEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLAR 926
ILHRD+K +N+LL E LADFGLA+
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 10/149 (6%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRL 837
IG+G G+VYK +G VA+K+ R D + G S+ EI+ L + H NIV+L
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
L L ++++ L + G+ + + +GL++ H
Sbjct: 68 LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLLQGLAFCHSHR-- 123
Query: 898 AILHRDVKSHNILLGERYESCLADFGLAR 926
+LHRD+K N+L+ LADFGLAR
Sbjct: 124 -VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 35/154 (22%), Positives = 72/154 (46%), Gaps = 14/154 (9%)
Query: 319 IIDISMNSLTGSIP--QTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQI 375
++D+S N+L+ + T LT+L L LS N ++ I ++ L ++L +N +
Sbjct: 43 LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL 100
Query: 376 TGAIPSE-FGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIFQ 433
+ F +L L +L +++N + + + + L+ + LSQN ++ P + +
Sbjct: 101 H-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIK 157
Query: 434 ----LKKLNKLLLLSNNLSGVIPPEMGNCSSLIR 463
L KL L L SN L + ++ + ++
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 42/186 (22%), Positives = 67/186 (36%), Gaps = 31/186 (16%)
Query: 267 TELQYIYLYENALTGSIPSK--LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISM 324
+ + L N L+ + ++ L NL +L L N+L I L +D+S
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97
Query: 325 NSLTGSIP-QTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSE 382
N L ++ +L +L+ L L N I + + +L ++ L NQI+
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVEL 155
Query: 383 FGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLL 441
+ + L L +DLS N L +P Q L K
Sbjct: 156 IKDGNKLP---------------------KLMLLDLSSNKLKK-LPLTDLQKLPAWVKNG 193
Query: 442 L-LSNN 446
L L NN
Sbjct: 194 LYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 43/195 (22%), Positives = 70/195 (35%), Gaps = 40/195 (20%)
Query: 354 EIPAQI-GNCQRLAQIELDNNQITGAIPSE--FGNLSNLTLLFVWHNRLEGEIPPSI-SN 409
+P + L +L +N ++ + +E L+NL L + HN L I
Sbjct: 32 NVPQSLPSYTALL---DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVP 86
Query: 410 CQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANS 468
NL +DLS N L + +F L+ L LLL +N++ V+ F
Sbjct: 87 VPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNA--------FE--- 133
Query: 469 NKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI----TGCRNLTFLDVHSNSIAGNLP 524
++ L L L N+++ P E+ L LD+ SN +
Sbjct: 134 ------------DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPL 180
Query: 525 AGLHQLVRLQFADLS 539
L +L L
Sbjct: 181 TDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 44/182 (24%), Positives = 72/182 (39%), Gaps = 18/182 (9%)
Query: 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEIT--GCRNLTFLDVHSNSIAGNLP 524
+ +L +P + + LDL N L+ + E T NL L + N + +
Sbjct: 26 SKQQLP-NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FIS 80
Query: 525 AG-LHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPS-QLGSCVKLQ 582
+ + L++ DLS N + + L +L L+L N + +LQ
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQ 139
Query: 583 LLDLSSNQLSGNIPA----SLGKIPALAIALNLSWNQICGELPAELTGLNKLG--ILDLS 636
L LS NQ+S P K+P L + L+LS N++ +L L L L
Sbjct: 140 KLYLSQNQIS-RFPVELIKDGNKLPKLML-LDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
Query: 637 HN 638
+N
Sbjct: 198 NN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 43/218 (19%), Positives = 75/218 (34%), Gaps = 46/218 (21%)
Query: 484 NLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG--LHQLVRLQFADLSDN 541
N L +L ++P + LD+ N+++ L A +L L LS N
Sbjct: 19 ASNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHN 74
Query: 542 SVGGMLSPD-LGSLSSLTKLVLNKNRFAGSIPSQ-LGSCVKLQLLDLSSNQLSGNIPASL 599
+ +S + + +L L L+ N ++ L++L L +N +
Sbjct: 75 HLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV------- 125
Query: 600 GKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELS----GDLHFLAELQNLVV 655
+ A + +L L LS N++S + +L L++
Sbjct: 126 -VVDRNA-----------------FEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML 167
Query: 656 LNVSHNNFSGRVPDTPFFAKLPLSV-----LSGNPSLC 688
L++S N KLP V L NP C
Sbjct: 168 LDLSSNKLKKLPLTD--LQKLPAWVKNGLYLHNNPLEC 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 36/138 (26%), Positives = 55/138 (39%), Gaps = 8/138 (5%)
Query: 94 FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPRE-LCSLLRLEQL 151
T L +L+ L+LS +L I E + L YLDLS N L + L LE L
Sbjct: 60 PTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVL 117
Query: 152 RLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRA-GGNKNLGG 209
L +N + + +++ L +L+L NQ++ I L + + N
Sbjct: 118 LLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 210 SLPHE-IGNCTNLVMIGL 226
LP + V GL
Sbjct: 177 KLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 30/160 (18%), Positives = 60/160 (37%), Gaps = 33/160 (20%)
Query: 242 LKRLQTIAIYTALLSGQIPPE-LGDCTELQYIYLYENALTGSIPSK-LGNLKNLVNLFLW 299
L L ++ + L+ I E L+Y+ L N L ++ +L+ L L L+
Sbjct: 63 LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLY 120
Query: 300 QNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI 359
N++V ++ ++ LQ+L LS NQIS P ++
Sbjct: 121 NNHIV-VVDRN-----------------------AFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 360 ----GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVW 395
+L ++L +N++ ++ L ++
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 31/115 (26%), Positives = 54/115 (46%), Gaps = 14/115 (12%)
Query: 81 LRYVDL----LGHVPTN-FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSL 134
LRY+DL L + F+ L +L L+L ++ + + + QL L LS+N +
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI 148
Query: 135 TGEIPRE----LCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQ--LFLYDNQLT 183
+ P E L +L L L+SN+L+ + L + + L+L++N L
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 23/160 (14%)
Query: 784 IGQGRSGIVYK---VTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG- 839
+G+G G VYK A+K+ + + EIA L ++H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC--REIALLRELKHPNVISLQKV 86
Query: 840 --WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRF------KIALGVAEGLSYL 891
A+RK LLF DY + L ++ + + + + + +G+ YL
Sbjct: 87 FLSHADRKVWLLF-DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 892 HHDCVPAILHRDVKSHNILLGERYESC----LADFGLARL 927
H + +LHRD+K NIL+ +AD G ARL
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 49/158 (31%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 782 NIIGQGRSGIVYKV--TLPSGLTVAVKRFRASDKISTGAFSS---EIATL---SRIRHRN 833
IG+G G V+K G VA+KR R G S E+A L H N
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 834 IVRLL----GWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
+VRL +R+TKL L ++++ L L G+ + + + GL
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQLLRGL 133
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926
+LH ++HRD+K NIL+ + LADFGLAR
Sbjct: 134 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 782 NIIGQGRSGIVYK-VTLPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLL 838
IG+G G+V+K +G VA+K+F S+ + EI L +++H N+V LL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 839 GWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
RK +L L ++Y + T+ L D G+ E + I + +++ H
Sbjct: 69 EV-FRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVK-SITWQTLQAVNFCHKHN-- 122
Query: 898 AILHRDVKSHNILLGERYESCLADFGLAR 926
+HRDVK NIL+ + L DFG AR
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-15
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 11/149 (7%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS--EIATLSRIRHRNIVRLL 838
++G+G G+V K +G VA+K+F SD + EI L ++RH N+V LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 839 GWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+K + L ++++ + T+ L + GL + K + G+ + H
Sbjct: 91 EV-CKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQ-KYLFQIINGIGFCHSHN-- 144
Query: 898 AILHRDVKSHNILLGERYESCLADFGLAR 926
I+HRD+K NIL+ + L DFG AR
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 48/149 (32%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRL 837
IG+G G V+K + VA+KR R D G SS EI L ++H+NIVRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+ K L +++ L C G L+ + + +GL + H
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 898 AILHRDVKSHNILLGERYESCLADFGLAR 926
+LHRD+K N+L+ E LA+FGLAR
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 51/237 (21%), Positives = 92/237 (38%), Gaps = 43/237 (18%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK-----------------RFRASDKISTGAFSS- 821
+ IG+G G+V A+K R + G
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 822 --------EIATLSRIRHRNIVRLLG-WGANRKTKL-LFYDYMPNGTLGMLLHDGECAGL 871
EIA L ++ H N+V+L+ + L + ++ + G + +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----VMEVPTLKP 133
Query: 872 LEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931
L D + +G+ YLH+ I+HRD+K N+L+GE +ADFG++ +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG- 189
Query: 932 SGGSFSANPQFAGSYGYIAPEYANMTKIS---EKSDVYSYGVVLLEIITGKKPVDAS 985
+ +N G+ ++APE + T+ + DV++ GV L + G+ P
Sbjct: 190 -SDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 5e-15
Identities = 48/201 (23%), Positives = 81/201 (40%), Gaps = 23/201 (11%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLL 838
++G G +G V ++ + A+K + K E+ R + +IVR++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIV 121
Query: 839 GW----GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
A RK L+ + + G L + D E + +I + E + YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHSI 180
Query: 895 CVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
I HRDVK N+L + + L DFG A+ S + + Y+AP
Sbjct: 181 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLT---TPCYTPYYVAP 232
Query: 952 EYANMTKISEKSDVYSYGVVL 972
E K + D++S GV++
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 53/228 (23%), Positives = 85/228 (37%), Gaps = 59/228 (25%)
Query: 783 IIGQGRSGIVYKVTL-PSGLTVAVKRFR--ASDKISTGAFSSEIATLSRIRHRNIVRLL- 838
+ GQG G V +G++VA+K+ + + L+ + H NIV+L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIMQDLAVLHHPNIVQLQS 86
Query: 839 -----GWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE------ 886
G R L + +Y+P LH R ++A
Sbjct: 87 YFYTLGERDRRDIYLNVVMEYVP-----DTLHR-----CCRNYYRRQVAPPPILIKVFLF 136
Query: 887 ----GLSYLHHDCVPAILHRDVKSHNILLGERYESC---LADFGLAR-LVEDDSGGSFSA 938
+ LH V + HRD+K HN+L+ E L DFG A+ L + ++
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNE--ADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 939 NPQFAGSYGYIAPE-------YANMTKISEKSDVYSYGVVLLEIITGK 979
S Y APE Y T + D++S G + E++ G+
Sbjct: 194 ------SRYYRAPELIFGNQHYT--TAV----DIWSVGCIFAEMMLGE 229
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-14
Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 782 NIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRL 837
+ +G+G VYK + VA+K R + GA + E++ L ++H NIV L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTL 65
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
K+ L ++Y+ L L D C ++ + GL+Y H
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK-- 120
Query: 898 AILHRDVKSHNILLGERYESCLADFGLAR 926
+LHRD+K N+L+ ER E LADFGLAR
Sbjct: 121 -VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 13/152 (8%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRL 837
+G G VYK +G+ VA+K + + G S+ EI+ + ++H NIVRL
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRL 68
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHD---GECAGLLEWDTRFKIALGVAEGLSYLHHD 894
L +++M N L + G LE + + +GL++ H +
Sbjct: 69 YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLAR 926
ILHRD+K N+L+ +R + L DFGLAR
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-14
Identities = 47/195 (24%), Positives = 78/195 (40%), Gaps = 26/195 (13%)
Query: 744 SHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTA---GNIIGQGRSGIVYKVT-LPS 799
HH+ G + + P + +S + S+ +G+G G VYK +
Sbjct: 5 HHHHMGTLEAQTQGP------GSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVT 58
Query: 800 GLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856
TVA+KR R + G + E++ L ++HRNI+ L + L ++Y N
Sbjct: 59 NETVAIKRIRL-EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE 916
L + + + + G+++ H LHRD+K N+LL
Sbjct: 118 -DLKKYMDK--NPDVSMRVIK-SFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDA 170
Query: 917 SC-----LADFGLAR 926
S + DFGLAR
Sbjct: 171 SETPVLKIGDFGLAR 185
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 77.5 bits (190), Expect = 1e-14
Identities = 44/228 (19%), Positives = 80/228 (35%), Gaps = 13/228 (5%)
Query: 428 PRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNF 487
R ++L LS S V+ E+ +C L + I + L L +
Sbjct: 342 CRDSATDEQL-FRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 488 LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGML 547
+ + R D+ S + + ++ L+ + +
Sbjct: 401 EKETLQYFSTL--KAVDPMRAAYLDDLRSKFL-LENSVLKMEYADVRVLHLAHKDLTVL- 456
Query: 548 SPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAI 607
L L +T L L+ NR ++P L + L++L S N L N+ + +P L
Sbjct: 457 -CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQE 512
Query: 608 ALNLSWNQICGELPA--ELTGLNKLGILDLSHNELSGDLHFLAELQNL 653
L L N++ + A L +L +L+L N L + L +
Sbjct: 513 -LLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 76.3 bits (187), Expect = 2e-14
Identities = 44/254 (17%), Positives = 79/254 (31%), Gaps = 12/254 (4%)
Query: 147 RLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKN 206
L LN + + S + L ++ + L K+
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCELSVEKS 361
Query: 207 LGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDC 266
L E+ +C L + + + L L S + D
Sbjct: 362 T--VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL---KAVDP 416
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
Y+ + ++ L L +L + L ++ +D+S N
Sbjct: 417 MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNR 474
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITG-AIPSEFGN 385
L ++P L L L+ LQ S N + + + N RL ++ L NN++ A +
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 386 LSNLTLLFVWHNRL 399
L LL + N L
Sbjct: 532 CPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.9 bits (178), Expect = 3e-13
Identities = 39/296 (13%), Positives = 81/296 (27%), Gaps = 58/296 (19%)
Query: 244 RLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNL 303
L ++ L + L ++ + L L
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKS 361
Query: 304 VGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISG---------- 353
++ EL +C +L ++ +I + L L + ++ S
Sbjct: 362 T-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420
Query: 354 -----------EIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGE 402
E + + L + +T + L +T L + HNRL
Sbjct: 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-A 477
Query: 403 IPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLI 462
+PP+++ + LE + S N L+ + + N L
Sbjct: 478 LPPALAALRCLEVLQASDN-----------ALENV---------------DGVANLPRLQ 511
Query: 463 RFRANSNKLTGF-IPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCR----NLTFLD 513
+N+L + + L L+L N L +++ +
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.1 bits (163), Expect = 2e-11
Identities = 32/119 (26%), Positives = 50/119 (42%), Gaps = 6/119 (5%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL 146
L + L L+ +LT + + L + +LDLS N L +P L +L
Sbjct: 430 LLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALR 486
Query: 147 RLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTD-AIPATIGKLKNLEAIRAGGN 204
LE L+ + N LE + + NL L +L L +N+L A + L + GN
Sbjct: 487 CLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 3e-09
Identities = 32/187 (17%), Positives = 63/187 (33%), Gaps = 31/187 (16%)
Query: 476 PPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQF 535
+ + L +L + T + E+ C+ L L+ + + + L L +
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 536 ADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNI 595
+ L S+L + + + + S+ + ++ + ++
Sbjct: 401 EKET-----------LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV---- 445
Query: 596 PASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVV 655
L+L+ + + L L + LDLSHN L LA L+ L V
Sbjct: 446 -------------LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEV 490
Query: 656 LNVSHNN 662
L S N
Sbjct: 491 LQASDNA 497
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 1e-08
Identities = 42/270 (15%), Positives = 79/270 (29%), Gaps = 62/270 (22%)
Query: 80 DLRYVDLLGHVPTNFTSLL-SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEI 138
L +L T S L S L + I + L+ L + +L
Sbjct: 350 QLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS 409
Query: 139 PRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEA 198
+ +R L ++ + + + L L LT
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--------------- 454
Query: 199 IRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQ 258
L H + + + L+ +
Sbjct: 455 -----------VLCH-LEQLLLVTHLDLSHNRLR-------------------------A 477
Query: 259 IPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGI-IPPELGNCSQL 317
+PP L L+ + +NAL ++ + NL L L L N L L +C +L
Sbjct: 478 LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535
Query: 318 SIIDISMNSLT------GSIPQTLGNLTSL 341
++++ NSL + + L +++S+
Sbjct: 536 VLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 56/377 (14%), Positives = 109/377 (28%), Gaps = 86/377 (22%)
Query: 98 LSLNRLVLSGTNLTG----SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLR----LE 149
S+ L +T S+ + + + + LS N++ E R L + LE
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 150 QLRLNSNQL--------EGAIPI--QIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAI 199
+ E + + L + L DN +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF------ 117
Query: 200 RAGGNKNLGGSLPHEIGNCTNLVMIGLAETSIS--GFLPPTLGLLKRLQTIAIYTALLSG 257
+ T L + L + I AL
Sbjct: 118 ---------------LSKHTPLEHLYLHNNGLGPQA-------------GAKIARALQEL 149
Query: 258 QIPPELGDCTELQYIYLYENALTG----SIPSKLGNLKNLVNLFLWQNNL-----VGIIP 308
+ + + L+ I N L + + L + + QN + ++
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 309 PELGNCSQLSIIDISMNSLTG----SIPQTLGNLTSLQELQLSVNQIS-------GEIPA 357
L C +L ++D+ N+ T ++ L + +L+EL L+ +S + +
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269
Query: 358 QIGNCQRLAQIELDNNQITGAIPSEFG-----NLSNLTLLFVWHNRL--EGEIPPSI--- 407
++ N L + L N+I + +L L + NR E ++ I
Sbjct: 270 KLENIG-LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 328
Query: 408 -SNCQNLEAVDLSQNGL 423
S E +L
Sbjct: 329 FSTRGRGELDELDDMEE 345
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 52/392 (13%), Positives = 113/392 (28%), Gaps = 79/392 (20%)
Query: 287 LGNLKNLVNLFLWQNNL----VGIIPPELGNCSQLSIIDISMNSLTG----SIPQTLGNL 338
+ ++ L + + + L + I +S N++ + + + +
Sbjct: 1 MARF-SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 339 TSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNR 398
L+ + S + L Q L L + + N
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQ-ALLKCP-------------KLHTVRLSDNA 105
Query: 399 LEGE----IPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPE 454
+ +S LE + L NGL P+ K+ + L +
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAG---AKIARALQELAVNK-----K 154
Query: 455 MGNCSSLIRFRANSNKLTG----FIPPEIGNLKNLNFLDLGSNRLT-----GSIPDEITG 505
N L N+L + + L+ + + N + + + +
Sbjct: 155 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214
Query: 506 CRNLTFLDVHSNSI----AGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLV 561
C+ L LD+ N+ + L L L+ L+D + G+ + +
Sbjct: 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS-----ARGAAAVVDAFS 269
Query: 562 LNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGN----IPASLGKIPALAIALNLSWNQI- 616
+N LQ L L N++ + + + + + L L+ N+
Sbjct: 270 KLENI-------------GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
Query: 617 -----CGELPAELTGLNKLGILDLSHNELSGD 643
E+ + + + +L E D
Sbjct: 317 EEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 40/221 (18%), Positives = 70/221 (31%), Gaps = 44/221 (19%)
Query: 488 LDLGSNRLTG----SIPDEITGCRNLTFLDVHSNSI----AGNLPAGLHQLVRLQFADLS 539
L + +T S+ + ++ + + N+I A L + L+ A+ S
Sbjct: 9 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 68
Query: 540 DNSVGGM----------LSPDLGSLSSLTKLVLNKNRF----AGSIPSQLGSCVKLQLLD 585
D G + L L L + L+ N F + L L+ L
Sbjct: 69 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 128
Query: 586 LSSNQLS----GNIPASLGKIPALAIA--------LNLSWNQICGE----LPAELTGLNK 629
L +N L I +L ++ A + N++
Sbjct: 129 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 188
Query: 630 LGILDLSHNELS--GDLHFLAEL----QNLVVLNVSHNNFS 664
L + + N + G H L E Q L VL++ N F+
Sbjct: 189 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 53/317 (16%), Positives = 95/317 (29%), Gaps = 78/317 (24%)
Query: 96 SLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLR----LEQL 151
S + R+ + + + +L+ + LS+N+ L L LE L
Sbjct: 68 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 127
Query: 152 RLNSNQL--EGAIPI-----------QIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEA 198
L++N L + I + N L + N+L +
Sbjct: 128 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG------------- 174
Query: 199 IRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQ 258
K + + L + + + I I LL G
Sbjct: 175 ----SMKEWAKTF----QSHRLLHTVKMVQNGIR--------------PEGIEHLLLEG- 211
Query: 259 IPPELGDCTELQYIYLYENALTG----SIPSKLGNLKNLVNLFLWQNNL----VGIIPPE 310
L C EL+ + L +N T ++ L + NL L L L +
Sbjct: 212 ----LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267
Query: 311 LGNCS--QLSIIDISMNSLTGSIPQTLG-----NLTSLQELQLSVNQIS--GEIPAQIG- 360
L + + N + +TL + L L+L+ N+ S ++ +I
Sbjct: 268 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIRE 327
Query: 361 ---NCQRLAQIELDNNQ 374
R ELD+ +
Sbjct: 328 VFSTRGRGELDELDDME 344
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 37/234 (15%), Positives = 66/234 (28%), Gaps = 56/234 (23%)
Query: 479 IGNLKNLNFLDLGSNRLTG----SIPDEITGCRNLTFLDVHSNSI----------AGNLP 524
+ ++ + L N + + + I ++L + L
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87
Query: 525 AGLHQLVRLQFADLSDNSVG--GM--LSPDLGSLSSLTKLVLNKNRF------------- 567
L + +L LSDN+ G L L + L L L+ N
Sbjct: 88 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147
Query: 568 AGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIA---------LNLSWNQI-- 616
++ + + L+ + N+L N A + + N I
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRL-ENGSMK-----EWAKTFQSHRLLHTVKMVQNGIRP 201
Query: 617 --CGELPAELTGLNK-LGILDLSHNELSGD-LHFLAE----LQNLVVLNVSHNN 662
L E + L +LDL N + LA NL L ++
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 4e-14
Identities = 44/157 (28%), Positives = 68/157 (43%), Gaps = 11/157 (7%)
Query: 826 LSRIRHRNIVRLLGWGANRKTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGV 884
L ++ R +V L + K L M G L ++ AG E F A +
Sbjct: 238 LEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EI 295
Query: 885 AEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAG 944
GL LH + I++RD+K NILL + ++D GLA V + G
Sbjct: 296 CCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-----GRVG 347
Query: 945 SYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ GY+APE + + D ++ G +L E+I G+ P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 4e-14
Identities = 48/193 (24%), Positives = 74/193 (38%), Gaps = 45/193 (23%)
Query: 879 KIALGVAEGLSYL-HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS----- 932
+ VA+G+ +L C+ HRD+ + NILL E+ + DFGLAR + D
Sbjct: 197 CYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 933 -GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ 990
P ++APE + +SDV+S+GV+L EI + G P +
Sbjct: 253 GDARL---P-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDE 303
Query: 991 HVIQWVRDHLKSKKDPVEVLDPKLQGH----PDTQIQEMLQALGISLLCTSNRAEDRPTM 1046
+ +++ G PD EM Q L C RPT
Sbjct: 304 EFCRRLKE-----------------GTRMRAPDYTTPEMYQ---TMLDCWHGEPSQRPTF 343
Query: 1047 KDVAALLREIRQE 1059
++ L + Q
Sbjct: 344 SELVEHLGNLLQA 356
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-14
Identities = 61/290 (21%), Positives = 104/290 (35%), Gaps = 56/290 (19%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---------EIATLSRIRH 831
IG G GIV VA+K K+S F + E+ + + H
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIK------KLS-RPFQNQTHAKRAYRELVLMKCVNH 120
Query: 832 RNIVRLLGWGANRKTKLLFYD-YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+NI+ LL +KT F D Y+ + L L + + + G+ +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKH 179
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
LH + +HRD+K NI++ + DFGLAR + + Y A
Sbjct: 180 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-----FMMTPYVVTRYYRA 231
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW--------------- 995
PE E D++S G ++ E++ K + FP ++ QW
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRH-KIL---FPGRDYIDQWNKVIEQLGTPCPEFM 287
Query: 996 ------VRDHLKS----KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLC 1035
VR+++++ L P D++ ++ + LL
Sbjct: 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 337
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 8e-14
Identities = 84/513 (16%), Positives = 166/513 (32%), Gaps = 60/513 (11%)
Query: 63 CK-WFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASL 121
C+ WF + + + V + L Y + F +L SL L G + +L
Sbjct: 41 CRRWFKID-SETREHVTMALCYTATPDRLSRRFPNLRSLK--------LKGKPRAAMFNL 91
Query: 122 NQLNYLDLSENSLTGEIPRELCSLLR-LEQLRLNSNQL--EGAIPIQIGNLSSLTQLFLY 178
N+ + E+ + LR L+ + + + L L L
Sbjct: 92 IPENWGGYVTPWV-----TEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD 146
Query: 179 D-NQLTDAIPATIGK-LKNLEAIRAGGNK--NLGGSLPHEIG-NCTNLVMIGLAETSISG 233
+ T +I + ++ + + G HE+ + T+L ++ T +
Sbjct: 147 KCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAK 206
Query: 234 FLPPTLGLL----KRLQTIAI-YTALLSGQ-IPPELGDCTELQYIYLYENALTGSIPSKL 287
P L + + L ++ + +L + E L E+ L
Sbjct: 207 ISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNL 266
Query: 288 GNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL-TGSIPQTLGNLTSLQELQL 346
+ L L L + P +Q+ +D+ L T + +L+ L+
Sbjct: 267 VFPRKLCRLGLSYMGPNEM-PILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLET 325
Query: 347 SVNQISGEIPAQIG-NCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPP 405
N I + C++L ++ ++ + E G +S L+ +
Sbjct: 326 R-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL----------- 373
Query: 406 SISNCQNLEAVDLSQNGLT----GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMG----- 456
CQ LE + + + +T I + L +LL +P + G
Sbjct: 374 -AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLL 432
Query: 457 -NCSSL--IRFRANSNKLTGFIPPEIG-NLKNLNFLDLGSNRLT-GSIPDEITGCRNLTF 511
C L F LT IG N+ ++ LG + + + GC NL
Sbjct: 433 IGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQK 492
Query: 512 LDVHSNSIAGN-LPAGLHQLVRLQFADLSDNSV 543
L++ + + A + +L L++ +
Sbjct: 493 LEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 45/401 (11%), Positives = 113/401 (28%), Gaps = 51/401 (12%)
Query: 311 LGNCSQLSIIDISMNSLTGSIPQTL----GNLTSLQELQLSVNQISGEIPAQI--GNCQR 364
L + ++ ++ + G + + NL L+ + +S ++
Sbjct: 80 LKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADD 139
Query: 365 LAQIELDN-NQITGAIPSEFG-NLSNLTLLFVWHNRLEGEIPPSIS----NCQNLEAVDL 418
L ++LD + T + + L + + + + + +LE ++
Sbjct: 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNF 199
Query: 419 SQNGLTGPIPRGIFQL-KKLNKL--LLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFI 475
P+ + + + L + + + + ++L F S +
Sbjct: 200 YMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGM 259
Query: 476 PPEIGNLKNLNFLDLGSNRLTG--SIPDEITGCRNLTFLDVHSNSIAGN----LPAGLHQ 529
P + NL L G +P + LD+ + L
Sbjct: 260 PEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN 319
Query: 530 LVRLQFAD-LSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLG------------ 576
L L+ + + D + + L +L + + + + G
Sbjct: 320 LEVLETRNVIGDRGLEVLAQ----YCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ 375
Query: 577 SCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQIC---------GELPAELTGL 627
C +L+ + + + ++ S+G L + + L G
Sbjct: 376 GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGC 435
Query: 628 NKLGILDLSHNEL----SGDLHFLAELQNLVVLNVSHNNFS 664
KL + G + N+ + + + S
Sbjct: 436 KKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGES 476
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 781 GNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVR 836
G I+G+G V + A+K I E +SR+ H V+
Sbjct: 35 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 837 LLGWGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-H 893
L + + + L++ Y NG L + E TRF A + L YLH
Sbjct: 95 L--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTA-EIVSALEYLHGK 149
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
I+HRD+K NILL E + DFG A+++ +S + + + F G+ Y++PE
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS--FVGTAQYVSPEL 203
Query: 954 ANMTKISEKSDVYSYGVVLLEIITGKKP 981
+ SD+++ G ++ +++ G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-14
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 826 LSRIRHRNIVRLLGWGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIA-L 882
+ + H +V L W + + + +F D + G L L E + I L
Sbjct: 69 MQGLEHPFLVNL--WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICEL 124
Query: 883 GVAEGLSYLH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQ 941
+A L YL I+HRD+K NILL E + DF +A ++ ++ +
Sbjct: 125 VMA--LDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT-----T 173
Query: 942 FAGSYGYIAPEYANMTKISE--KS-DVYSYGVVLLEIITGKKP 981
AG+ Y+APE + K + + D +S GV E++ G++P
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 60/220 (27%), Positives = 86/220 (39%), Gaps = 49/220 (22%)
Query: 783 IIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLL--- 838
+IG G G+VY+ L SG VA+K+ DK E+ + ++ H NIVRL
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN---RELQIMRKLDHCNIVRLRYFF 116
Query: 839 --GWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIAL-GVAEGLSYLH-H 893
+ L L DY+P T+ + A K+ + + L+Y+H
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 894 DCVPAILHRDVKSHNILLGERYESC-LADFGLARLVEDDSGGSFSANPQFAGSYGYI--- 949
I HRD+K N+LL L DFG A+ YI
Sbjct: 176 G----ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--------QLVRGEPNV---SYICSR 220
Query: 950 ---APE-------YANMTKISEKSDVYSYGVVLLEIITGK 979
APE Y + I DV+S G VL E++ G+
Sbjct: 221 YYRAPELIFGATDYT--SSI----DVWSAGCVLAELLLGQ 254
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 2e-13
Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 17/161 (10%)
Query: 824 ATLSRIRHRNIVRLLGWGANR-KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIA 881
+ +S IV + A KL F D M G L L + E D RF A
Sbjct: 244 SLVSTGDCPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAA 299
Query: 882 LGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQ 941
+ GL ++H+ +++RD+K NILL E ++D GLA + +
Sbjct: 300 -EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHA---- 349
Query: 942 FAGSYGYIAPEYANMTKISEKS-DVYSYGVVLLEIITGKKP 981
G++GY+APE + S D +S G +L +++ G P
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 58/222 (26%), Positives = 86/222 (38%), Gaps = 44/222 (19%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--------RFRASDKISTGAFSSEIATLSRIRH 831
G+ +G G G V +G VAVK KI EI L RH
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-----EIQNLKLFRH 70
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFK---IALGVAEG 887
+I++L + + +Y+ G L + G + E + R I V
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVD-- 125
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
Y H ++HRD+K N+LL + +ADFGL+ ++ D GS
Sbjct: 126 --YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-----TSCGSPN 175
Query: 948 YIAPE------YANMTKISEKSDVYSYGVVLLEIITGKKPVD 983
Y APE YA + D++S GV+L ++ G P D
Sbjct: 176 YAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGTLPFD 212
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 52/228 (22%), Positives = 85/228 (37%), Gaps = 66/228 (28%)
Query: 783 IIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLL---- 838
+IG G G+V++ L VA+K+ DK E+ + ++H N+V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVL-QDKRFKN---RELQIMRIVKHPNVVDLKAFFY 102
Query: 839 -GWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE---------- 886
+ L L +Y+P ++ + K + +
Sbjct: 103 SNGDKKDEVFLNLVLEYVP-----ETVYR-----ASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 887 GLSYLHHDCVPAILHRDVKSHNILL-GERYESCLADFGLAR-LVEDDSGGSFSANPQFAG 944
L+Y+H I HRD+K N+LL L DFG A+ L+ +
Sbjct: 153 SLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP------------ 197
Query: 945 SYGYI------APE-------YANMTKISEKSDVYSYGVVLLEIITGK 979
+ YI APE Y T I D++S G V+ E++ G+
Sbjct: 198 NVSYICSRYYRAPELIFGATNYT--TNI----DIWSTGCVMAELMQGQ 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 56/217 (25%), Positives = 79/217 (36%), Gaps = 36/217 (16%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG G G+ + + VAVK + EI +RH NIVR
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 840 WGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFK---IALGVAEGLSYLHHDC 895
+ +Y G L + + G E + RF + GV SY H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGV----SYCHSMQ 136
Query: 896 VPAILHRDVKSHNILLGERYESCL--ADFGLARLVEDDSGGSFSANPQ-FAGSYGYIAPE 952
+ HRD+K N LL L DFG ++ S P+ G+ YIAPE
Sbjct: 137 I---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------QPKSTVGTPAYIAPE 187
Query: 953 ------YANMTKISEKSDVYSYGVVLLEIITGKKPVD 983
Y + +DV+S GV L ++ G P +
Sbjct: 188 VLLRQEYD-----GKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 31/128 (24%), Positives = 53/128 (41%), Gaps = 4/128 (3%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGE 137
+ L + P F+ L R+ LS ++ + + L LN L L N +T
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 138 IPRELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNL 196
L L+ L LN+N++ + + +L +L L LYDN+L T L+ +
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154
Query: 197 EAIRAGGN 204
+ + N
Sbjct: 155 QTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 37/169 (21%), Positives = 66/169 (39%), Gaps = 36/169 (21%)
Query: 354 EIPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQ 411
EIP + + L+ N I P F L + + +N++ E+ P +
Sbjct: 25 EIPTNLPETITEI---RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 412 NLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNK 470
+L ++ L N +T +P+ +F+ L L LLL N+NK
Sbjct: 81 SLNSLVLYGNKITE-LPKSLFEGLFSLQLLLL------------------------NANK 115
Query: 471 LTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSN 517
+ + + +L NLN L L N+L +I + R + + + N
Sbjct: 116 INC-LRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 31/145 (21%), Positives = 55/145 (37%), Gaps = 9/145 (6%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELC-SL 145
L +PTN ++ + L + P + +L +DLS N ++ E+ + L
Sbjct: 23 LTEIPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGL 79
Query: 146 LRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGN 204
L L L N++ +P + L SL L L N++ L NL + N
Sbjct: 80 RSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN 138
Query: 205 KNLGGSLPHEI-GNCTNLVMIGLAE 228
K ++ + + LA+
Sbjct: 139 KL--QTIAKGTFSPLRAIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 28/134 (20%), Positives = 52/134 (38%), Gaps = 6/134 (4%)
Query: 267 TELQYIYLYENALTGSIPSK-LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325
+ I L +N + IP K L + L N + + P L+ + + N
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90
Query: 326 SLTGSIPQ-TLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSEF 383
+T +P+ L SLQ L L+ N+I+ + + L + L +N++ F
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF 148
Query: 384 GNLSNLTLLFVWHN 397
L + + + N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 35/133 (26%), Positives = 63/133 (47%), Gaps = 6/133 (4%)
Query: 292 NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQ-TLGNLTSLQELQLSVNQ 350
+ + L QN + I P +L ID+S N ++ + L SL L L N+
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 351 ISGEIPAQI-GNCQRLAQIELDNNQITGAIPSE-FGNLSNLTLLFVWHNRLEGEIPPSIS 408
I+ E+P + L + L+ N+I + + F +L NL LL ++ N+L+ + S
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 409 NCQNLEAVDLSQN 421
+ ++ + L+QN
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 25/107 (23%), Positives = 39/107 (36%), Gaps = 4/107 (3%)
Query: 488 LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL-HQLVRLQFADLSDNSVGGM 546
+ L N + P + + L +D+ +N I+ L L L L N + +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 547 LSPDLGSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLDLSSNQLS 592
L SL L+LN N+ + L LL L N+L
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 31/126 (24%), Positives = 50/126 (39%), Gaps = 6/126 (4%)
Query: 467 NSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLP 524
N + IPP K L +DL +N+++ + + G R+L L ++ N I LP
Sbjct: 40 EQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELP 96
Query: 525 AGL-HQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQL 583
L L LQ L+ N + + L +L L L N+ +Q
Sbjct: 97 KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT 156
Query: 584 LDLSSN 589
+ L+ N
Sbjct: 157 MHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 33/150 (22%), Positives = 64/150 (42%), Gaps = 10/150 (6%)
Query: 106 SGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQ 165
G LT IP + + + L +N++ P +L ++ L++NQ+ +
Sbjct: 19 RGKGLT-EIPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74
Query: 166 I-GNLSSLTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGNKNLGGSLPHEI-GNCTNLV 222
L SL L LY N++T +P ++ L +L+ + NK L + + NL
Sbjct: 75 AFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANK--INCLRVDAFQDLHNLN 131
Query: 223 MIGLAETSISGFLPPTLGLLKRLQTIAIYT 252
++ L + + T L+ +QT+ +
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 37/141 (26%), Positives = 62/141 (43%), Gaps = 13/141 (9%)
Query: 555 SSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWN 614
++T++ L +N P KL+ +DLS+NQ+S P + + +L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS-LVLYGN 90
Query: 615 QICGELPAEL-TGLNKLGILDLSHNELS----GDLHFLAELQNLVVLNVSHNNFSGRVPD 669
+I ELP L GL L +L L+ N+++ L L L + ++N +
Sbjct: 91 KI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL----YDNKLQTIAK 145
Query: 670 TPFFAKLPLSV--LSGNPSLC 688
F + L+ NP +C
Sbjct: 146 GTFSPLRAIQTMHLAQNPFIC 166
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 33/228 (14%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---------EIATLSRIRH 831
IG G GIV VA+K K+S F + E+ + + H
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIK------KLS-RPFQNQTHAKRAYRELVLMKCVNH 83
Query: 832 RNIVRLLGWGANRKTKLLFYD-YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+NI+ LL +K+ F D Y+ + L L + + + G+ +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKH 142
Query: 891 LHHDCVPA-ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
LH A I+HRD+K NI++ + DFGLAR + + + Y
Sbjct: 143 LH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT-----PYVVTRYYR 193
Query: 950 APEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997
APE E D++S G ++ E+I G FP H+ QW +
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQWNK 237
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 19/183 (10%)
Query: 414 EAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT 472
E + +S P F + K N L +++ +S+ + AN++ +
Sbjct: 1 ETITVSTPIKQI-FPDDAFAETIKAN---LKKKSVTDA--VTQNELNSIDQIIANNSDIK 54
Query: 473 GFIPPEIGNLKNLNFLDLGSNRLTGSIP--DEITGCRNLTFLDVHSNSIAGNLPAGL-HQ 529
I L N+ +L LG N+L I E+T NLT+L + N + +LP G+ +
Sbjct: 55 SV--QGIQYLPNVRYLALGGNKLH-DISALKELT---NLTYLILTGNQLQ-SLPNGVFDK 107
Query: 530 LVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLDLSS 588
L L+ L +N + + L++LT L L N+ S+P + L LDLS
Sbjct: 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSY 166
Query: 589 NQL 591
NQL
Sbjct: 167 NQL 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 20/193 (10%)
Query: 261 PELGDCTELQYIYLYENALT--GSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLS 318
+ + I + + I L N+ L L N L I L + L+
Sbjct: 35 VTQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLHDI--SALKELTNLT 88
Query: 319 IIDISMNSLTGSIPQTL-GNLTSLQELQLSVNQIS---GEIPAQIGNCQRLAQIELDNNQ 374
+ ++ N L S+P + LT+L+EL L NQ+ + ++ N L L +NQ
Sbjct: 89 YLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL---NLAHNQ 144
Query: 375 ITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIF- 432
+ F L+NLT L + +N+L+ +P + L+ + L QN L +P G+F
Sbjct: 145 LQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFD 202
Query: 433 QLKKLNKLLLLSN 445
+L L + L N
Sbjct: 203 RLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 44/198 (22%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 403 IPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLI 462
P +L + +T +L +++++ ++++ V + ++
Sbjct: 13 FPDDAFA--ETIKANLKKKSVTD-AVTQN-ELNSIDQIIANNSDIKSV--QGIQYLPNVR 66
Query: 463 RFRANSNKLTGFIPPEIG---NLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNS 518
NKL +I L NL +L L N+L S+P+ + NL L + N
Sbjct: 67 YLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ 120
Query: 519 IAGNLPAGL-HQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPS---- 573
+ +LP G+ +L L + +L+ N + + L++LT+L L+ N+ S+P
Sbjct: 121 LQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD 178
Query: 574 QLGSCVKLQLLDLSSNQL 591
+L +L+ L L NQL
Sbjct: 179 KL---TQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 488 LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGML 547
+L +T + ++ + +++ I ++ G+ L +++ L N +
Sbjct: 24 ANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKL---- 75
Query: 548 SPDLG---SLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLDLSSNQLSGNIPASLGKIP 603
D+ L++LT L+L N+ S+P+ + L+ L L NQL ++P +
Sbjct: 76 -HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKL 132
Query: 604 ALAIALNLSWNQICGELPA----ELTGLNKLGILDLSHNEL----SGDLHFLAELQNLVV 655
LNL+ NQ+ LP +LT L LDLS+N+L G L +L++L +
Sbjct: 133 TNLTYLNLAHNQL-QSLPKGVFDKLT---NLTELDLSYNQLQSLPEGVFDKLTQLKDLRL 188
Query: 656 LNVSHNNFSGRVPDTPF--FAKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAG 709
+ N VPD F L L NP C C Y + ++H+G
Sbjct: 189 ----YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----TCPGIRYLSEWINKHSG 236
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 6/107 (5%)
Query: 94 FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLR 152
L +L L+L+G L S+P + L L L L EN L L L L
Sbjct: 81 LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139
Query: 153 LNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATI-GKLKNLE 197
L NQL+ ++P + L++LT+L L NQL ++P + KL L+
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLK 184
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 39/241 (16%)
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSL 172
P + + + +L + S+T + + L ++Q+ N++ ++ IQ L ++
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQY--LPNV 65
Query: 173 TQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNC-TNLVMIGLAETSI 231
L L N+L I A + +L NL + GN+ SLP+ + + TNL + L E +
Sbjct: 66 RYLALGGNKLH-DISA-LKELTNLTYLILTGNQL--QSLPNGVFDKLTNLKELVLVENQL 121
Query: 232 SGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKL-GNL 290
LP G+ +L T L Y+ L N L S+P + L
Sbjct: 122 Q-SLPD--GVFDKL---------------------TNLTYLNLAHNQLQ-SLPKGVFDKL 156
Query: 291 KNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQ-TLGNLTSLQELQLSVN 349
NL L L N L + +QL + + N L S+P LTSLQ + L N
Sbjct: 157 TNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
Query: 350 Q 350
Sbjct: 216 P 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 9/110 (8%)
Query: 80 DLRYVDL----LGHVPTN-FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENS 133
+L Y+ L L +P F L +L LVL L S+P + L L YL+L+ N
Sbjct: 86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQ 144
Query: 134 LTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQL 182
L L L +L L+ NQL+ ++P + L+ L L LY NQL
Sbjct: 145 LQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 33/94 (35%), Positives = 46/94 (48%), Gaps = 12/94 (12%)
Query: 94 FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPRELC-SLLRLEQL 151
F L +L L L+ L S+PK + L L LDLS N L +P + L +L+ L
Sbjct: 129 FDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDL 186
Query: 152 RLNSNQL----EGAIPIQIGNLSSLTQLFLYDNQ 181
RL NQL +G L+SL ++L+DN
Sbjct: 187 RLYQNQLKSVPDGVF----DRLTSLQYIWLHDNP 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 28/211 (13%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLG-- 839
+G+G+ V++ + + V VK + K EI L +R NI+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPNIITLADIV 100
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPA 898
+T L ++++ N L L ++D RF + + + L Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYM-YEILKALDYCHSMG---- 150
Query: 899 ILHRDVKSHNILL-GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANM 956
I+HRDVK HN+++ E + L D+GLA N + A Y + PE +
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRY-FKGPELLVDY 205
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFP 987
D++S G +L +I K+P F
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF---FH 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 70/319 (21%), Positives = 115/319 (36%), Gaps = 103/319 (32%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS----EIATLSRIRHRNIV 835
+G+G G V T + VA+K F + + EI+ L +RH +I+
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALK-FISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 836 RLLGWGANRKTKLLFYDYMPNGT-LGMLLHDGECAG------------LLEWDTRFK--- 879
+L YD + T + M++ E AG + E + R
Sbjct: 73 KL-------------YDVITTPTDIVMVI---EYAGGELFDYIVEKKRMTEDEGRRFFQQ 116
Query: 880 IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSAN 939
I + Y H I+HRD+K N+LL + +ADFGL+ ++ D + S
Sbjct: 117 IICAI----EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-- 167
Query: 940 PQFAGSYGYIAPE------YANMTKISEKSDVYSYGVVLLEIITGKKPVD---------- 983
GS Y APE YA + DV+S G+VL ++ G+ P D
Sbjct: 168 ---CGSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK 219
Query: 984 ---ASF-------PDGQHVIQ--------------------WVRDHLKSKKDPVEVLDPK 1013
+ P Q +I+ W +L P+E + +
Sbjct: 220 VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPME--EVQ 277
Query: 1014 LQGHPDTQIQEMLQALGIS 1032
+ ++ +A+G S
Sbjct: 278 GSYADSRIVSKLGEAMGFS 296
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 2e-12
Identities = 58/212 (27%), Positives = 86/212 (40%), Gaps = 25/212 (11%)
Query: 783 IIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKIS---TGAFSSEIATLSRIRHRNIVRLL 838
+IG+G G V V L + A+K + + T F E L + I L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 839 GWGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDC 895
A + L+ DY G L LL E L E RF +A + + +H
Sbjct: 140 -HYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLA-EMVIAIDSVHQLH- 195
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLA-RLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
+HRD+K NIL+ LADFG +L+ED + S G+ YI+PE
Sbjct: 196 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV----AVGTPDYISPEIL 248
Query: 955 NMTKISEKS-----DVYSYGVVLLEIITGKKP 981
+ + D +S GV + E++ G+ P
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 2e-12
Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 826 LSRIRHRNIVRLLGWGANRKTKLLF-YDYMPNGTLGMLLHDG--ECAGLLEWDTRFKIAL 882
L+++ R IV L + KT L M G + +++ + G E F A
Sbjct: 239 LAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA- 296
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
+ GL +LH I++RD+K N+LL + ++D GLA ++ + +
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG----Y 349
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981
AG+ G++APE + D ++ GV L E+I + P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-12
Identities = 62/222 (27%), Positives = 90/222 (40%), Gaps = 44/222 (19%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--------RFRASDKISTGAFSSEIATLSRIRH 831
G+ +G G G V +G VAVK KI EI L RH
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-----EIQNLKLFRH 75
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTL-GMLLHDGECAGLLEWDTRFK---IALGVAEG 887
+I++L + + +Y+ G L + +G L E ++R I GV
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVD-- 130
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
Y H V +HRD+K N+LL + +ADFGL+ ++ D G GS
Sbjct: 131 --YCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRT---SCGSPN 180
Query: 948 YIAPE------YANMTKISEKSDVYSYGVVLLEIITGKKPVD 983
Y APE YA + D++S GV+L ++ G P D
Sbjct: 181 YAAPEVISGRLYAGP-----EVDIWSSGVILYALLCGTLPFD 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 783 IIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKIS---TGAFSSEIATLSRIRHRNIVRLL 838
+IG+G G V V + A+K + I + F E ++ +V+L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 134
Query: 839 GWGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
+ A + + L+ +YMP G L L+ + + E RF A V L +H
Sbjct: 135 -FYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTA-EVVLALDAIHSM-- 187
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLA-RLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
+HRDVK N+LL + LADFG ++ ++ + G+ YI+PE
Sbjct: 188 -GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT----AVGTPDYISPE--- 239
Query: 956 MTKISEKSDVY-------SYGVVLLEIITGKKP 981
+ K Y S GV L E++ G P
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 52/237 (21%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---------EIATLSRIRH 831
+G G G V SG VA+K K+S F S E+ L ++H
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIK------KLS-RPFQSEIFAKRAYRELLLLKHMQH 82
Query: 832 RNIVRLL------GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVA 885
N++ LL N L +M L ++ E ++ + +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG----LKFSEEKIQY-LVYQML 136
Query: 886 EGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945
+GL Y+H ++HRD+K N+ + E E + DFGLAR + + G
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG----------- 182
Query: 946 YG----YIAPEYA-NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997
Y Y APE + ++ D++S G ++ E++TG K + F ++ Q +
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL---FKGKDYLDQLTQ 235
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 55/248 (22%), Positives = 96/248 (38%), Gaps = 20/248 (8%)
Query: 744 SHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRSLTAGN-----IIGQGRSGIVYKVTL- 797
+ D G P + + ++++S+ +T ++G+G G V V
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 170
Query: 798 PSGLTVAVKRFRASDKISTGAFSS---EIATLSRIRHRNIVRLLGWGANRKTKLLF-YDY 853
+G A+K + ++ + E L RH + L + +L F +Y
Sbjct: 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEY 229
Query: 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE 913
G L L E RF A + L YLH + +++RD+K N++L +
Sbjct: 230 ANGGELFFHLS--RERVFSEDRARFYGA-EIVSALDYLHSEK--NVVYRDLKLENLMLDK 284
Query: 914 RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLL 973
+ DFGL + D + F G+ Y+APE D + GVV+
Sbjct: 285 DGHIKITDFGLCKEGIKDGATMKT----FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340
Query: 974 EIITGKKP 981
E++ G+ P
Sbjct: 341 EMMCGRLP 348
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 52/213 (24%), Positives = 78/213 (36%), Gaps = 25/213 (11%)
Query: 783 IIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKIS---TGAFSSEIATLSRIRHRNIVRLL 838
+IG+G V V + +G A+K D + F E L R I +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL- 126
Query: 839 GWGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
A + L+ +Y G L LL + RF +A + + +H
Sbjct: 127 -HFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLA-EIVMAIDSVHRL-- 181
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLA-RLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
+HRD+K NILL LADFG +L D + S G+ Y++PE
Sbjct: 182 -GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV----AVGTPDYLSPEILQ 236
Query: 956 MTKISEKSDVY-------SYGVVLLEIITGKKP 981
+ Y + GV E+ G+ P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 33/129 (25%), Positives = 51/129 (39%), Gaps = 5/129 (3%)
Query: 79 LDLRYVDLLGHVPT-NFTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTG 136
L L + T F L L ++ S +T I + + +N + L+ N L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN 95
Query: 137 EIPRELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKN 195
+ L L+ L L SN++ + LSS+ L LYDNQ+T P L +
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 196 LEAIRAGGN 204
L + N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 33/141 (23%), Positives = 58/141 (41%), Gaps = 9/141 (6%)
Query: 313 NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISG-EIPAQIGNCQRLAQIELD 371
C + +D S L IP+ + EL+L+ N+ + E +L +I
Sbjct: 10 RCEG-TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFS 65
Query: 372 NNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRG 430
NN+IT F S + + + NRLE + + ++L+ + L N +T +
Sbjct: 66 NNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGND 123
Query: 431 IFQ-LKKLNKLLLLSNNLSGV 450
F L + L L N ++ V
Sbjct: 124 SFIGLSSVRLLSLYDNQITTV 144
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 29/135 (21%), Positives = 51/135 (37%), Gaps = 7/135 (5%)
Query: 267 TELQYIYLYENALTGSIPSK--LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISM 324
+ L N T + + L L + N + I S ++ I ++
Sbjct: 32 QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90
Query: 325 NSLTGSIP-QTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSE 382
N L ++ + L SL+ L L N+I+ + + + L +NQIT P
Sbjct: 91 NRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGA 148
Query: 383 FGNLSNLTLLFVWHN 397
F L +L+ L + N
Sbjct: 149 FDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 33/154 (21%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 489 DLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL-HQLVRLQFADLSDNSVGGML 547
D + +L IP+ I + L +++N G+ +L +L+ + S+N + +
Sbjct: 17 DCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-I 72
Query: 548 SPD-LGSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLDLSSNQLSGNIPA-SLGKIPA 604
S + +++L NR ++ ++ L+ L L SN+++ + S + +
Sbjct: 73 EEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSS 130
Query: 605 LAIALNLSWNQICGELPAELTGLNKLGILDLSHN 638
+ + L+L NQI P L+ L L+L N
Sbjct: 131 VRL-LSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 6/92 (6%)
Query: 94 FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPREL-CSLLRLEQL 151
F +N ++L+ L ++ ++ L L L L N +T + + L + L
Sbjct: 77 FEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLL 134
Query: 152 RLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQL 182
L NQ+ + L SL+ L L N
Sbjct: 135 SLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 33/168 (19%)
Query: 402 EIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLLSNNLSGVIPPEMGNCSS 460
+IP I Q + L+ N T GIF+ L +L K+ +N ++
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD----------- 71
Query: 461 LIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNS 518
I +N + L SNRL ++ ++ G +L L + SN
Sbjct: 72 --------------IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNR 116
Query: 519 IAGNLPAGL-HQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKN 565
I + L ++ L DN + + +L SL+ L L N
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 28/156 (17%), Positives = 55/156 (35%), Gaps = 30/156 (19%)
Query: 149 EQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNL 207
+LRLN+N+ I L L ++ +N++TD + I N+ L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR-L 93
Query: 208 GGSLPHEI-GNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDC 266
++ H++ +L + L I+ + L
Sbjct: 94 -ENVQHKMFKGLESLKTLMLRSNRIT-CVGN--DSFIGL--------------------- 128
Query: 267 TELQYIYLYENALTGSIP-SKLGNLKNLVNLFLWQN 301
+ ++ + LY+N +T ++ L +L L L N
Sbjct: 129 SSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 48/244 (19%), Positives = 88/244 (36%), Gaps = 54/244 (22%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---------EIATLSRIRHR 832
+G G +G+V+ VA+K KI + EI + R+ H
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIK------KI---VLTDPQSVKHALREIKIIRRLDHD 68
Query: 833 NIVRLL--------GWGANRKTKLLFYD-YMPNGTLGMLLHDGECAGLLEWDTRFK-IAL 882
NIV++ + + Y+ + L + G L + +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL-EEHARLFMY 127
Query: 883 GVAEGLSYLHHDCVPA-ILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSA 938
+ GL Y+H A +LHRD+K N+ + E + DFGLAR+++
Sbjct: 128 QLLRGLKYIH----SANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPHYS----- 176
Query: 939 NPQFAGSY----GYIAPE-YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVI 993
+ Y +P + ++ D+++ G + E++TG K + F +
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL---FAGAHELE 232
Query: 994 QWVR 997
Q
Sbjct: 233 QMQL 236
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 33/224 (14%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---------EIATLSRIRHRN 833
+G G G V +G VA+K K+ F S E+ L +RH N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIK------KLY-RPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 834 IVRLLGWGANRKTKLLFYD-YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
++ LL +T F D Y+ +G L L D + + +GL Y+H
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
I+HRD+K N+ + E E + DFGLAR + + + + Y APE
Sbjct: 146 A---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-------TGYVVTRWYRAPE 195
Query: 953 YA-NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995
N + ++ D++S G ++ E+ITG K + F H+ Q
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITG-KTL---FKGSDHLDQL 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 55/235 (23%), Positives = 80/235 (34%), Gaps = 42/235 (17%)
Query: 783 IIGQGRSGIVYKVTLPSGLTVAVKR--FRASDKISTGAFSS---------EIATLSRIRH 831
I G G V G+ VA+KR SD + S EI L+ H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 832 RNIVRLL-----GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAE 886
NI+ L L + M L ++HD + ++ +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIV-ISPQHIQY-FMYHILL 145
Query: 887 GLSYLHHDCVPA-ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945
GL LH A ++HRD+ NILL + + + DF LAR D
Sbjct: 146 GLHVLH----EAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD---------ANKTH 192
Query: 946 YG----YIAPEY-ANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995
Y Y APE ++ D++S G V+ E+ K + F Q
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL---FRGSTFYNQL 243
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 60/232 (25%), Positives = 94/232 (40%), Gaps = 41/232 (17%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---------EIATLSRIRH 831
+ IG+G G+V + + VA+K KIS F EI L R RH
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIK------KIS--PFEHQTYCQRTLREIKILLRFRH 84
Query: 832 RNIVRLL-----GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFK-IALGVA 885
NI+ + K + D M L+ L + +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS-NDHICYFLYQIL 138
Query: 886 EGLSYLHHDCVPA-ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAG 944
GL Y+H A +LHRD+K N+LL + + DFGLAR+ + D + A
Sbjct: 139 RGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 945 SYGYIAPEYA-NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995
+ Y APE N ++ D++S G +L E+++ +P+ FP ++ Q
Sbjct: 195 RW-YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI---FPGKHYLDQL 241
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-11
Identities = 29/114 (25%), Positives = 52/114 (45%), Gaps = 10/114 (8%)
Query: 553 SLSSLTKLVLNKNRF-AGSIPSQLGSCVKLQLLDLSSNQLS--GNIPASLGKIPALAIAL 609
+ S + +LVL+ +R G + +L+ L + L+ N+P K+ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKK-L 69
Query: 610 NLSWNQICGELPAELTGLNKLGILDLSHNELS--GDLHFLAELQNLVVLNVSHN 661
LS N++ G L L L+LS N++ + L +L+NL L++ +
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 26/111 (23%), Positives = 49/111 (44%), Gaps = 4/111 (3%)
Query: 96 SLLSLNRLVLSGTNLT-GSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLN 154
+ + LVL + G + +L +L LT I L L +L++L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 155 SNQLEGAIPIQIGNLSSLTQLFLYDNQLTD-AIPATIGKLKNLEAIRAGGN 204
N++ G + + +LT L L N++ D + + KL+NL+++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 26/111 (23%), Positives = 43/111 (38%), Gaps = 4/111 (3%)
Query: 289 NLKNLVNLFLWQNNLVGIIPPELG-NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347
++ L L + L +L + LT SI L L L++L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 348 VNQISGEIPAQIGNCQRLAQIELDNNQITG-AIPSEFGNLSNLTLLFVWHN 397
N++SG + C L + L N+I + L NL L +++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 32/149 (21%), Positives = 52/149 (34%), Gaps = 31/149 (20%)
Query: 512 LDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSI 571
LD ++ G L + L+F + + + +L L+ L KL L+ NR +G +
Sbjct: 24 LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGL 80
Query: 572 PSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLG 631
C L L+LS N++ + I L L L
Sbjct: 81 EVLAEKCPNLTHLNLSGNKIK-------------------DLSTI-----EPLKKLENLK 116
Query: 632 ILDLSHNELSGDLHF----LAELQNLVVL 656
LDL + E++ + L L L
Sbjct: 117 SLDLFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 3/97 (3%)
Query: 257 GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ 316
G++ + EL+++ LT SI + L L L L L N + G + C
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 317 LSIIDISMNSLTG-SIPQTLGNLTSLQELQLSVNQIS 352
L+ +++S N + S + L L +L+ L L +++
Sbjct: 90 LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 30/115 (26%), Positives = 45/115 (39%), Gaps = 11/115 (9%)
Query: 433 QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNL---KNLNFLD 489
+K+L L S + G + L + LT I NL L L+
Sbjct: 18 DVKELV--LDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLE 70
Query: 490 LGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG-NLPAGLHQLVRLQFADLSDNSV 543
L NR++G + C NLT L++ N I + L +L L+ DL + V
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 21/90 (23%), Positives = 34/90 (37%), Gaps = 9/90 (10%)
Query: 120 SLNQLNYLDLSENSLT-GEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSS---LTQL 175
+ + + L L + G++ LE L + L I NL L +L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69
Query: 176 FLYDNQLTDAIPATIGKLKNLEAIRAGGNK 205
L DN+++ + K NL + GNK
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNK 99
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 33/109 (30%), Positives = 55/109 (50%), Gaps = 5/109 (4%)
Query: 339 TSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNR 398
+ EL L NQ + +P ++ N + L I+L NN+I+ F N++ L L + +NR
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 399 LEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSN 445
L IPP ++L + L N ++ +P G F L L+ L + +N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 5/105 (4%)
Query: 102 RLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGA 161
L L G T +PKE+++ L +DLS N ++ + ++ +L L L+ N+L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 162 IPIQI-GNLSSLTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGN 204
IP + L SL L L+ N ++ +P L L + G N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 30/110 (27%), Positives = 48/110 (43%), Gaps = 13/110 (11%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGE 137
L L + VP ++ L + LS ++ ++ + +++ QL L LS N L
Sbjct: 36 LYLDG-NQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 138 IPRELC-SLLRLEQLRLNSNQL----EGAIPIQIGNLSSLTQLFLYDNQL 182
IP L L L L+ N + EGA +LS+L+ L + N L
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISVVPEGAF----NDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 5/109 (4%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
++ +YL N T +P +L N K+L + L N + + N +QL + +S N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 327 LTGSIPQ-TLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNN 373
L IP T L SL+ L L N IS +P + L+ + + N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 29/103 (28%), Positives = 45/103 (43%), Gaps = 8/103 (7%)
Query: 492 SNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDL 551
+ L +P I R++T L + N +P L L DLS+N + LS
Sbjct: 19 NKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQS 73
Query: 552 -GSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLDLSSNQLS 592
+++ L L+L+ NR IP + L+LL L N +S
Sbjct: 74 FSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 4/85 (4%)
Query: 558 TKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQIC 617
T+L L+ N+F +P +L + L L+DLS+N++S S + L L LS+N++
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLT-LILSYNRL- 90
Query: 618 GELPAELT-GLNKLGILDLSHNELS 641
+P GL L +L L N++S
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 27/109 (24%), Positives = 47/109 (43%), Gaps = 21/109 (19%)
Query: 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIP----DEITGCRNLTFLDVHSNSIAGN 522
+ N+ T +P E+ N K+L +DL +NR++ ++ +T L L + N +
Sbjct: 39 DGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMT---QLLTLILSYNRLR-C 92
Query: 523 LPAGL-HQLVRLQFADLSDN---SVGGMLSPD--LGSLSSLTKLVLNKN 565
+P L L+ L N V P+ LS+L+ L + N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISVV-----PEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 37/167 (22%), Positives = 57/167 (34%), Gaps = 57/167 (34%)
Query: 354 EIPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQN 412
+P I + L LD NQ T +P E N +LTL+
Sbjct: 24 VLPKGIPRDVTEL---YLDGNQFT-LVPKELSNYKHLTLI-------------------- 59
Query: 413 LEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKL 471
DLS N ++ + F + +L L+L N L IPP F + L
Sbjct: 60 ----DLSNNRIST-LSNQSFSNMTQLLTLILSYNRLR-CIPPRT--------F----DGL 101
Query: 472 TGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSN 517
+L L L N ++ +P+ L+ L + +N
Sbjct: 102 K-----------SLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 43/231 (18%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---------EIATLSRIRHRN 833
+G G G V +GL VAVK K+S F S E+ L ++H N
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVK------KLS-RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 834 IVRLL------GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEG 887
++ LL L M L ++ C L + +F + + G
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK---CQKLTDDHVQF-LIYQILRG 144
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
L Y+H I+HRD+K N+ + E E + DFGLAR D+ + +
Sbjct: 145 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-------TGYVATRW 194
Query: 948 YIAPEYA-NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997
Y APE N ++ D++S G ++ E++TG+ FP H+ Q
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTDHIDQLKL 241
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 3e-10
Identities = 16/112 (14%), Positives = 36/112 (32%), Gaps = 5/112 (4%)
Query: 410 CQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEM-GNCSSLIRFRANS 468
+ +++G + + L +L + + + L
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 469 NKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSI 519
+ L F+ P+ L+ L+L N L S+ + +L L + N +
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 20/136 (14%), Positives = 39/136 (28%), Gaps = 29/136 (21%)
Query: 314 CSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQ-IGNCQRLAQIELDN 372
S + + + L +L EL + Q + + + L + +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 373 NQITGAIPSE-FGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGI 431
+ + + + F L+ L +LS N L +
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRL------------------------NLSFNALES-LSWKT 99
Query: 432 FQLKKLNKLLLLSNNL 447
Q L +L+L N L
Sbjct: 100 VQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 20/117 (17%), Positives = 41/117 (35%), Gaps = 8/117 (6%)
Query: 69 SCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKE-IASLNQLNYL 127
+ ++ + D + +L L + + + L +L L
Sbjct: 6 CPHGSSGLRCTR----DGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 128 DLSENSLTGEIPRE-LCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLT 183
+ ++ L + + RL +L L+ N LE ++ + SL +L L N L
Sbjct: 62 TIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 4/94 (4%)
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRE-LCSLLRLEQLRLNSNQLEGAIPIQI-GNLS 170
+ L L + + L L L L + + L +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 171 SLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGN 204
L++L L N L ++ + +L+ + GN
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 21/112 (18%), Positives = 38/112 (33%), Gaps = 5/112 (4%)
Query: 458 CSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDE-ITGCRNLTFLDVHS 516
R + + +NL L + + + + + G L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 517 NSIAGNLPAG-LHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRF 567
+ + + H RL +LS N++ LS SL +LVL+ N
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 17/96 (17%), Positives = 31/96 (32%), Gaps = 2/96 (2%)
Query: 282 SIPSKLGNLKNLVNLFLWQNNLVGIIPPE-LGNCSQLSIIDISMNSLTGSIPQTLGNLTS 340
L +NL L++ + + L +L + I + L P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 341 LQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376
L L LS N + + + L ++ L N +
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 25/134 (18%), Positives = 36/134 (26%), Gaps = 29/134 (21%)
Query: 558 TKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQIC 617
+ + A L L L + + Q ++
Sbjct: 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLE--------------------- 48
Query: 618 GELPAELTGLNKLGILDLSHNELSG-DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKL 676
+L GL +L L + + L L LN+S N T L
Sbjct: 49 ---LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKT--VQGL 103
Query: 677 PLSV--LSGNPSLC 688
L LSGNP C
Sbjct: 104 SLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 12/85 (14%), Positives = 27/85 (31%), Gaps = 2/85 (2%)
Query: 122 NQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQ-IGNLSSLTQLFLYDN 180
+ + L + + + L L +L + + Q + ++ + L L L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 181 QLTDAIPATIGKLKNLEAIRAGGNK 205
L P L + N
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNA 91
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 46/209 (22%), Positives = 79/209 (37%), Gaps = 31/209 (14%)
Query: 784 IGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFS---SEIATLSRIRHRNIVRLLG 839
+G G G V V SG A+K + +E L + +V+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL-- 106
Query: 840 WGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
+ + L+ +Y+ G + L E RF A + YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAA-QIVLTFEYLHSL--- 160
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
+++RD+K N+L+ ++ + DFG A+ V+ + G+ +APE
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------TLCGTPEALAPEI---- 209
Query: 958 KISEKS-----DVYSYGVVLLEIITGKKP 981
I K D ++ GV++ E+ G P
Sbjct: 210 -ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 6e-10
Identities = 45/139 (32%), Positives = 70/139 (50%), Gaps = 13/139 (9%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHR 902
+ KL D++ G L L E D +F +A +A L +LH I++R
Sbjct: 98 EGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLA-ELALALDHLHSLG----IIYR 150
Query: 903 DVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEK 962
D+K NILL E L DFGL++ D ++S F G+ Y+APE N ++
Sbjct: 151 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS----FCGTVEYMAPEVVNRRGHTQS 206
Query: 963 SDVYSYGVVLLEIITGKKP 981
+D +S+GV++ E++TG P
Sbjct: 207 ADWWSFGVLMFEMLTGTLP 225
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 6e-10
Identities = 37/138 (26%), Positives = 62/138 (44%), Gaps = 11/138 (7%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+L F +Y+ G L + E F A +A GL +L I++RD
Sbjct: 414 MDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAA-EIAIGLFFLQSK---GIIYRD 467
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKS 963
+K N++L +ADFG+ + D + + F G+ YIAPE +
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT----FCGTPDYIAPEIIAYQPYGKSV 523
Query: 964 DVYSYGVVLLEIITGKKP 981
D +++GV+L E++ G+ P
Sbjct: 524 DWWAFGVLLYEMLAGQAP 541
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 42/213 (19%), Positives = 72/213 (33%), Gaps = 68/213 (31%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLL 838
++G G +G V ++ + A+K + K E+ R + +IVR++
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIV 77
Query: 839 GWGANRKTKLLFYDYMPNGT---LGM-LLHDGECAGLLE-----WDTRF------KIALG 883
++ + + M L GE L D F +I
Sbjct: 78 D---------VYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKS 125
Query: 884 VAEGLSYLH-HDCVPAILHRDVKSHNILLGERYESC---LADFGLARLVEDDSGGSFSAN 939
+ E + YLH + I HRDVK N+L + + L DFG A+
Sbjct: 126 IGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------- 171
Query: 940 PQFAGSYGYIAPEYANMTKISEKSDVYSYGVVL 972
Y + D++S GV++
Sbjct: 172 ---GEKYD-------------KSCDMWSLGVIM 188
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 41/154 (26%), Positives = 60/154 (38%), Gaps = 10/154 (6%)
Query: 321 DISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIE---LDNNQITG 377
D+ L T LT L L L NQ+ + A G L ++ L NNQ+
Sbjct: 41 DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSA--GVFDDLTELGTLGLANNQLAS 97
Query: 378 AIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIF-QLK 435
F +L+ L L++ N+L+ +P + L+ + L+ N L IP G F +L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLT 155
Query: 436 KLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSN 469
L L L +N L V L N
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 48/158 (30%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 488 LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL-HQLVRLQFADLSDNSVGGM 546
LDL S L G LT+L++ N + L AG+ L L L++N +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL-AS 97
Query: 547 LSPDL-GSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLDLSSNQLSGNIPA----SLG 600
L + L+ L KL L N+ S+PS + KL+ L L++NQL +IPA L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 601 KIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHN 638
+ L+LS NQ+ L KL + L N
Sbjct: 156 NLQ----TLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 43/183 (23%), Positives = 71/183 (38%), Gaps = 32/183 (17%)
Query: 339 TSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNR 398
++L L ++ A +L + LD NQ+ F +L+ L L + +N+
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 399 LEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSNNLSGVIPPEMG 456
L +P + + L+ + L N L +P G+F +L KL +L L
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRL-------------- 138
Query: 457 NCSSLIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDV 514
N+N+L IP L NL L L +N+L S+P L + +
Sbjct: 139 ----------NTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITL 186
Query: 515 HSN 517
N
Sbjct: 187 FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 30/182 (16%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
+ + + L L + L L L L N L +
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ---------------------T 73
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSEFGN 385
L+ + +LT L L L+ NQ++ +P + + +L ++ L NQ+ F
Sbjct: 74 LSAGVFD---DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDR 129
Query: 386 LSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLL 443
L+ L L + N+L+ IP NL+ + LS N L +P G F +L KL + L
Sbjct: 130 LTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLF 187
Query: 444 SN 445
N
Sbjct: 188 GN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 7/154 (4%)
Query: 102 RLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGA 161
+L L T L L +L +L+L N L L L L L +NQL +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 162 IPIQI-GNLSSLTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGNKNLGGSLPHEI-GNC 218
+P+ + +L+ L +L+L NQL ++P+ + +L L+ +R N+ L S+P
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ-L-QSIPAGAFDKL 154
Query: 219 TNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYT 252
TNL + L+ + L +LQTI ++
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 50/205 (24%), Positives = 66/205 (32%), Gaps = 55/205 (26%)
Query: 149 EQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGNKNL 207
E+L L S L L+ LT L L NQL + A + L L + N+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQ-- 94
Query: 208 GGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCT 267
S LP G+ L T
Sbjct: 95 --------------------LAS----LPL--GVFDHL---------------------T 107
Query: 268 ELQYIYLYENALTGSIPSKL-GNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
+L +YL N L S+PS + L L L L N L I + L + +S N
Sbjct: 108 QLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ 166
Query: 327 LTGSIPQ-TLGNLTSLQELQLSVNQ 350
L S+P L LQ + L NQ
Sbjct: 167 LQ-SVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 29/90 (32%), Positives = 41/90 (45%), Gaps = 4/90 (4%)
Query: 94 FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPRELC-SLLRLEQL 151
F L L++L L G L S+P + L +L L L+ N L IP L L+ L
Sbjct: 103 FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTL 160
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQ 181
L++NQL+ L L + L+ NQ
Sbjct: 161 SLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 40/179 (22%), Positives = 55/179 (30%), Gaps = 33/179 (18%)
Query: 558 TKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQIC 617
KL L A + KL L+L NQL + A + L L+ NQ+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL- 95
Query: 618 GELPAEL-TGLNKLGILDLSHNEL----SGDLHFLAELQNLVVLN--------------- 657
LP + L +L L L N+L SG L +L+ L +
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155
Query: 658 -----VSHNNFSGRVPDTPF--FAKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAG 709
N VP F KL L GN C + Y ++
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC----SRCEILYLSQWIRENSN 210
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 10/118 (8%)
Query: 548 SPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALA- 606
+ + +L L + I + + + +D S N++ L P L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRR 65
Query: 607 -IALNLSWNQICGELPAELTGLNKLGILDLSHNELS--GDLHFLAELQNLVVLNVSHN 661
L ++ N+IC L L L L++N L GDL LA L++L L + N
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 33/176 (18%), Positives = 57/176 (32%), Gaps = 37/176 (21%)
Query: 488 LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIA--GNLPAGLHQLVRLQFADLSDNSVGG 545
+ L + + + + T LD+ I NL A L Q + D SDN +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAI---DFSDNEIRK 56
Query: 546 MLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPAL 605
+ L L L++N NR + L L L++N L
Sbjct: 57 L--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV------------- 101
Query: 606 AIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF----LAELQNLVVLN 657
+ L L L L + N ++ H+ + ++ + VL+
Sbjct: 102 ------ELGDLD-----PLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 27/141 (19%), Positives = 48/141 (34%), Gaps = 28/141 (19%)
Query: 285 SKLGNLKNLVNLFLWQNNLVGIIPPELG-NCSQLSIIDISMNSLTGSIPQTLGNLTSLQE 343
++ N L L + I LG Q ID S N + + L L+
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68
Query: 344 LQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEI 403
L ++ N+I L ++ L NN + E G+L L
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPL-------------- 109
Query: 404 PPSISNCQNLEAVDLSQNGLT 424
++ ++L + + +N +T
Sbjct: 110 ----ASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 26/109 (23%), Positives = 51/109 (46%), Gaps = 5/109 (4%)
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
+T+ + L L G + I A+L+Q + +D S+N + ++ L RL+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIR 200
+N+N++ L LT+L L +N L + + L +L+++
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLT 116
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 28/119 (23%), Positives = 53/119 (44%), Gaps = 13/119 (10%)
Query: 573 SQLGSCVKLQLLDLSSNQLS--GNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKL 630
+Q + V+ + LDL ++ N+ A+L + A++ S N+I +L L +L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATLDQF----DAIDFSDNEIR-KL-DGFPLLRRL 66
Query: 631 GILDLSHNELSG-DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP-LSVLS--GNP 685
L +++N + L +L L +++N+ + D A L L+ L NP
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNP 124
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 31/177 (17%), Positives = 53/177 (29%), Gaps = 56/177 (31%)
Query: 369 ELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIP 428
+L I A +++ N L + ++ I + +A+D S N +
Sbjct: 3 KLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---- 55
Query: 429 RGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFL 488
KL GF L+ L L
Sbjct: 56 -----------------------------------------KLDGF-----PLLRRLKTL 69
Query: 489 DLGSNRLTGSIPDEITGCRNLTFLDVHSNSIA--GNLPAGLHQLVRLQFADLSDNSV 543
+ +NR+ +LT L + +NS+ G+L L L L + + N V
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPV 125
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 9e-10
Identities = 78/531 (14%), Positives = 162/531 (30%), Gaps = 84/531 (15%)
Query: 96 SLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNS 155
+ R + N P + + + L G+ +L+
Sbjct: 39 EIERWCRRKVFIGNCYAVSPATVIR----RFPKVRSVELKGKPHFADFNLVPDGWGGYVY 94
Query: 156 NQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGK-LKNLEAIRAGGNKNLGGSLPHE 214
+E + + L ++ L +TD I K KN + + +
Sbjct: 95 PWIEAMSS----SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA 150
Query: 215 IG-NCTNLVMIGLAETSISGF-------LPPTLGLLKRLQTIAIYTALLSGQIPPELGD- 265
I C NL + L E+ + P T L L I+ + +S L
Sbjct: 151 IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL-NISCLASEVSFSALERLVTR 209
Query: 266 CTELQYIYLYENALTGSIPSKLGNLKNLVNLFLW------QNNLVGIIPPELGNCSQLSI 319
C L+ + L + + L L L + ++ + L C +L
Sbjct: 210 CPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRC 269
Query: 320 IDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGE-IPAQIGNCQRLAQIELDNNQIT-- 376
+ +++ +P + L L LS + + + C +L ++ + + I
Sbjct: 270 LSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV-LDYIEDA 328
Query: 377 --GAIPSEFGNLSNLTLLFVWHNRLEGEIPPS-------ISNCQNLEAVDLSQNGLTGPI 427
+ S +L L + +E + + C LE+V +T
Sbjct: 329 GLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTN-- 386
Query: 428 PRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNF 487
+ + + N ++ RFR + ++
Sbjct: 387 -AALITIAR--------------------NRPNMTRFR-------------LCIIEPKAP 412
Query: 488 LDLGSNRLTGSIPDEITGCRNLTFLDV---HSNSIAGNLPAGLHQL--VRLQFADLSDNS 542
L L + C++L L + ++ + + ++ + + FA SD
Sbjct: 413 DYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472
Query: 543 VGGMLSPDLGSLSSLTKLVLNKNRFAG-SIPSQLGSCVKLQLLDLSSNQLS 592
+ +LS SL KL + F ++ + ++ L +SS +S
Sbjct: 473 MHHVLS----GCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 5/110 (4%)
Query: 339 TSLQELQLSVNQISG-EIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHN 397
EL L+ N++ G L ++EL NQ+TG P+ F S++ L + N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 398 RLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSN 445
+++ EI + L+ ++L N ++ + G F L L L L SN
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 28/93 (30%), Positives = 40/93 (43%), Gaps = 12/93 (12%)
Query: 94 FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPRELC-SLLRLEQL 151
F L L +L L LT I + + L L EN + EI ++ L +L+ L
Sbjct: 50 FGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTL 107
Query: 152 RLNSNQL----EGAIPIQIGNLSSLTQLFLYDN 180
L NQ+ G+ +L+SLT L L N
Sbjct: 108 NLYDNQISCVMPGSF----EHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 25/103 (24%), Positives = 45/103 (43%), Gaps = 6/103 (5%)
Query: 492 SNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL-HQLVRLQFADLSDNSVGGMLSPD 550
L IP +I + T L ++ N + GL +L L +L N + G+
Sbjct: 17 GRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73
Query: 551 LGSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLDLSSNQLS 592
S + +L L +N+ I +++ +L+ L+L NQ+S
Sbjct: 74 FEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 29/111 (26%), Positives = 45/111 (40%), Gaps = 23/111 (20%)
Query: 467 NSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIP----DEITGCRNLTFLDVHSNSIAG 521
N N+L + G L +L L+L N+LT I + + ++ L + N I
Sbjct: 37 NDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS---HIQELQLGENKIK- 91
Query: 522 NLPAGL-HQLVRLQFADLSDN---SVGGMLSPDLG---SLSSLTKLVLNKN 565
+ + L +L+ +L DN V G L+SLT L L N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISCV-----MP-GSFEHLNSLTSLNLASN 136
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 57/251 (22%), Positives = 95/251 (37%), Gaps = 57/251 (22%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR----------- 830
+G G V+ + + VA+K R DK+ T A EI L R+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGT--------LGM----LLHDGECAGLLEWDTRF 878
+I++LL F PNG LG L+ E G+ +
Sbjct: 85 ANHILKLLDH---------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK- 134
Query: 879 KIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESC------LADFGLARLVEDDS 932
+I+ + GL Y+H C I+H D+K N+L+ +AD G A ++
Sbjct: 135 QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH- 191
Query: 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHV 992
++ + Q + Y +PE +D++S ++ E+ITG D F
Sbjct: 192 ---YTNSIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFE-PDEG 240
Query: 993 IQWVR--DHLK 1001
+ + DH+
Sbjct: 241 HSYTKDDDHIA 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 66/248 (26%), Positives = 101/248 (40%), Gaps = 56/248 (22%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---------EIATLSRIR- 830
+G+G GIV+K +G VAVK KI AF + EI L+ +
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVK------KI-FDAFQNSTDAQRTFREIMILTELSG 67
Query: 831 HRNIVRLLG--WGANRKTKLLFYDYMPNGT-LGMLLHDGECAGLLEWDTRFK-IALGVAE 886
H NIV LL N + L +DYM T L ++ A +LE + + + +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIR----ANILE-PVHKQYVVYQLIK 120
Query: 887 GLSYLHHDCVPA-ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945
+ YLH +LHRD+K NILL +ADFGL+R + + + +
Sbjct: 121 VIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 946 YGYIAPEYANMT------------------KISEKSDVYSYGVVLLEIITGKKPVDASFP 987
+ +T K ++ D++S G +L EI+ G KP+ FP
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI---FP 232
Query: 988 DGQHVIQW 995
+ Q
Sbjct: 233 GSSTMNQL 240
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 45/139 (32%), Positives = 63/139 (45%), Gaps = 13/139 (9%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHR 902
KL F DY+ G L L C LE RF A +A L YLH + I++R
Sbjct: 111 ADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAA-EIASALGYLHSLN----IVYR 163
Query: 903 DVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEK 962
D+K NILL + L DFGL + + + + + F G+ Y+APE +
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST----FCGTPEYLAPEVLHKQPYDRT 219
Query: 963 SDVYSYGVVLLEIITGKKP 981
D + G VL E++ G P
Sbjct: 220 VDWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 42/141 (29%), Positives = 64/141 (45%), Gaps = 17/141 (12%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHR 902
K L F +Y+ G L + C F A + GL +LH I++R
Sbjct: 90 KENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAA-EIILGLQFLHSKG----IVYR 142
Query: 903 DVKSHNILLGERYESCLADFGLAR--LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKIS 960
D+K NILL + +ADFG+ + ++ D +F P YIAPE K +
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD------YIAPEILLGQKYN 196
Query: 961 EKSDVYSYGVVLLEIITGKKP 981
D +S+GV+L E++ G+ P
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSP 217
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 2e-09
Identities = 100/585 (17%), Positives = 175/585 (29%), Gaps = 159/585 (27%)
Query: 5 YPWTLYSLI-----------LSFVVVIIILF----PHTPYAVNRQG------EALLSWKR 43
Y + L S I ++ L+ Y V+R +ALL +
Sbjct: 91 YKF-LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP 149
Query: 44 NW-------KGSDDG---LSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTN 93
GS G ++ + C + V C ++ ++ L+L+ + V
Sbjct: 150 AKNVLIDGVLGS--GKTWVAL-----DV-CLSYKVQCKMDFKIFWLNLKNCNSPETVLEM 201
Query: 94 FTSLLS-LNRLVLSGTNLTGSIPKEIASL-NQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
LL ++ S ++ + +I I S+ +L L L LL L +
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPY----EN---CLLVLLNV 253
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGN------- 204
+ N+ A NLS L Q+TD + A +L+
Sbjct: 254 Q-NAKAWN-AF-----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306
Query: 205 --KNLG---GSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTAL---LS 256
K L LP E+ + +AE SI T K + + T + L+
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIAE-SIRDG-LATWDNWKHVNCDKLTTIIESSLN 364
Query: 257 GQIPPELGDCTELQYIYLY---ENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGN 313
P E + L +A IP+ L L +W + + + +
Sbjct: 365 VLEPAEYRKM----FDRLSVFPPSAH---IPTIL-----LS--LIWFDVIKSDVMVVVNK 410
Query: 314 CSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNN 373
+ S+++ T SIP + L E+ ++ N L + +D+
Sbjct: 411 LHKYSLVEKQPKESTISIPS----------IYL-------ELKVKLENEYALHRSIVDHY 453
Query: 374 QITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ 433
I S+ L F H I + N ++ E + L
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSH------IGHHLKNIEHPERMTL--------------- 492
Query: 434 LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493
+ L + RF + G++ N L
Sbjct: 493 ---FRMVFL---DF---------------RFLEQKIRHDSTAWNASGSILNT-LQQLKFY 530
Query: 494 RLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADL 538
+ I C N + N+I LP L+ ++ DL
Sbjct: 531 K------PYI--CDNDPKYERLVNAILDFLPKIEENLICSKYTDL 567
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 3e-08
Identities = 94/715 (13%), Positives = 202/715 (28%), Gaps = 239/715 (33%)
Query: 409 NCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF---- 464
+C++++ D+ P+ I ++++ +++ + +SG L F
Sbjct: 34 DCKDVQ--DM---------PKSILSKEEIDHIIMSKDAVSGT----------LRLFWTLL 72
Query: 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEIT----GCRNLTFLDVHSNSIA 520
+ F+ E N FL + + P +T R+ + D +
Sbjct: 73 SKQEEMVQKFV--EEVLRINYKFL-MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA-K 128
Query: 521 GNLPAGLHQLVRLQFA--DLSDNS---VGGMLSPDLGS-LSSLTKLVLNKNRFAGSIPSQ 574
N+ L ++L+ A +L + G+L GS + + V + + +
Sbjct: 129 YNVSR-LQPYLKLRQALLELRPAKNVLIDGVL----GSGKTWVALDVCLSYKVQCKMDFK 183
Query: 575 -----LGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGL-- 627
L +C + + +L I + + + L + + AEL L
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH----SIQAELRRLLK 239
Query: 628 -----NKLGILD-LSHNEL-------------SGDLHFLAELQNLVVLNVSHNNFS-GRV 667
N L +L + + + + L ++S ++ S
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 668 PD--TPFFAK--------LPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAGAARVAMVV 717
PD K LP VL+ NP
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNP-------------------------------- 327
Query: 718 LLSAACALLLAALYIILGPRIRGLSGSHHNEGDEDVEMGPPWELTLYNKLDLSIGDATRS 777
L+ I+ IR + + W+ +KL I +
Sbjct: 328 -------RRLS----IIAESIR-----------DGLATWDNWKHVNCDKLTTIIESSLNV 365
Query: 778 LTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRL 837
L R ++ L+V F S I T LS I
Sbjct: 366 LEPAEY----RK--MFD-----RLSV----FPPSAHIPT-------ILLSLI-------- 395
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
W ++ D M ++++ L+E + E +
Sbjct: 396 --WF-----DVIKSDVM------VVVNKLHKYSLVEKQPK--------ESTISIPS---- 430
Query: 898 AILHRDVKS--------HNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
++ ++K H ++ + Y + + Y +I
Sbjct: 431 --IYLELKVKLENEYALHRSIV-DHY----------NIPKTFDSDDLIPPYLDQYFYSHI 477
Query: 950 APEY----ANMT-KISEKSDVY-SYGVVLLEIITGKKPVDA--SFPDGQHVIQWVRDHLK 1001
+ +++ V+ + + +I +A S + +++ + ++
Sbjct: 478 G--HHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYI- 534
Query: 1002 SKKDPV------EVLD------PKLQGHPDTQI-QEMLQALGISLLCTSNRAEDR 1043
DP +LD L T + + L A ++ +++ R
Sbjct: 535 CDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-04
Identities = 31/170 (18%), Positives = 58/170 (34%), Gaps = 25/170 (14%)
Query: 68 VSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQL-NY 126
V + + Y++L + + +L+R ++ N+ + + L Y
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLE----NEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
Query: 127 --------LDLSENSLTGEIPRELCSLLR-LEQ-LRLNSNQLEGAIPIQIGNLSSLTQLF 176
L E+ + R + R LEQ +R +S + I L++L QL
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI----LNTLQQLK 528
Query: 177 LYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGL 226
Y + D P + + +NL T+L+ I L
Sbjct: 529 FYKPYICDNDPKYERLVNAILDFLPKIEENL------ICSKYTDLLRIAL 572
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 34/120 (28%), Positives = 49/120 (40%), Gaps = 5/120 (4%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL 146
VP + + L L +T P SL L L L N L SL
Sbjct: 31 HASVPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLT 88
Query: 147 RLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNK 205
+L L L +NQL +P + L L +LF+ N+LT +P I +L +L + N+
Sbjct: 89 QLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 32/89 (35%), Positives = 41/89 (46%), Gaps = 3/89 (3%)
Query: 94 FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLR 152
F SL L L L LT +P + L L L + N LT E+PR + L L L
Sbjct: 84 FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141
Query: 153 LNSNQLEGAIPIQIGNLSSLTQLFLYDNQ 181
L+ NQL+ LSSLT +L+ N
Sbjct: 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 40/138 (28%), Positives = 65/138 (47%), Gaps = 7/138 (5%)
Query: 314 CSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNN 373
CS ++ D S+P G T+ Q L L NQI+ P + L ++ L +N
Sbjct: 19 CSGTTV-DCRSKRHA-SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN 74
Query: 374 QITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIF 432
Q+ F +L+ LT+L + N+L +P ++ +L+ + + N LT +PRGI
Sbjct: 75 QLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIE 132
Query: 433 QLKKLNKLLLLSNNLSGV 450
+L L L L N L +
Sbjct: 133 RLTHLTHLALDQNQLKSI 150
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 9/142 (6%)
Query: 355 IPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQN 412
+PA I N Q L L +NQIT P F +L NL L++ N+L +P + +
Sbjct: 34 VPAGIPTNAQIL---YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 413 LEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKL 471
L +DL N LT +P +F +L L +L + N L+ +P + + L + N+L
Sbjct: 90 LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
Query: 472 TGFIPPEIGNLKNLNFLDLGSN 493
L +L L N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 40/135 (29%), Positives = 66/135 (48%), Gaps = 9/135 (6%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGI---IPPELGNCSQLSIIDIS 323
T Q +YL++N +T P +L NL L+L N L + + L L+++D+
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ---LTVLDLG 96
Query: 324 MNSLTGSIPQTL-GNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE 382
N LT +P + L L+EL + N+++ E+P I L + LD NQ+
Sbjct: 97 TNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA 154
Query: 383 FGNLSNLTLLFVWHN 397
F LS+LT +++ N
Sbjct: 155 FDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 30/105 (28%), Positives = 43/105 (40%), Gaps = 3/105 (2%)
Query: 488 LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL-HQLVRLQFADLSDNSVGGM 546
L L N++T P NL L + SN + LP G+ L +L DL N + +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 547 LSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQL 591
S L L +L + N+ +P + L L L NQL
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 43/142 (30%), Positives = 68/142 (47%), Gaps = 8/142 (5%)
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSS 171
S+P I + Q L L +N +T P SL+ L++L L SNQL A+P+ + +L+
Sbjct: 33 SVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 172 LTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETS 230
LT L L NQLT +P+ + +L +L+ + NK L LP I T+L + L +
Sbjct: 90 LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNK-L-TELPRGIERLTHLTHLALDQNQ 146
Query: 231 ISGFLPPTLGLLKRLQTIAIYT 252
+ L L ++
Sbjct: 147 LKSIPHGAFDRLSSLTHAYLFG 168
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 44/204 (21%), Positives = 65/204 (31%), Gaps = 78/204 (38%)
Query: 149 EQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGNKNL 207
+ L L+ NQ+ P +L +L +L+L NQL A+P + L L + G N+ L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQ-L 100
Query: 208 GGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCT 267
T LP + RL
Sbjct: 101 ---------------------TV----LPS--AVFDRL---------------------V 112
Query: 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327
L+ +++ N LT +P + L +L +L L QN L
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL------------------------ 147
Query: 328 TGSIPQ-TLGNLTSLQELQLSVNQ 350
SIP L+SL L N
Sbjct: 148 -KSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 18/159 (11%)
Query: 558 TKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASL-GKIPALAIALNLSWNQI 616
L L+ N+ P S + L+ L L SNQL +P + + L + L+L NQ+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTV-LDLGTNQL 100
Query: 617 CGELPA----ELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPF 672
LP+ L L L + N+L+ + L +L L + N +P F
Sbjct: 101 -TVLPSAVFDRLV---HLKELFMCCNKLTELPRGIERLTHLTHLAL-DQNQLKSIPHGAF 155
Query: 673 --FAKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAG 709
+ L + L GNP C +C D Y ++ + H
Sbjct: 156 DRLSSLTHAYLFGNPWDC----ECRDIMYLRNWVADHTS 190
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 31/117 (26%), Positives = 55/117 (47%), Gaps = 16/117 (13%)
Query: 887 GLSYLHHDCVPA-ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945
+ LH + ++HRD+K N+L+ + + DFGLAR++++ + + Q +G
Sbjct: 124 AVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 946 YGYI------APEY-ANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995
++ APE K S DV+S G +L E+ +P+ FP + Q
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI---FPGRDYRHQL 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 61/293 (20%), Positives = 95/293 (32%), Gaps = 65/293 (22%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSS---------EIATLSRIRHR 832
+IG G G V + VA+K KI F EIA L+R+ H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIK------KI-LRVFEDLIDCKRILREIAILNRLNHD 112
Query: 833 NIVRLL----GWGANRKTKL-LFYDYMPNGT-LGMLLHDGECAGLLEWDTRF---KIALG 883
++V++L + +L + + + L L E + + +G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPV--YLTELHIKTLLYNLLVG 168
Query: 884 VAEGLSYLH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
+ Y+H ILHRD+K N L+ + + DFGLAR V+ G+
Sbjct: 169 ----VKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 943 AGSYG-----------------------YIAPEYA-NMTKISEKSDVYSYGVVLLEIITG 978
Y APE +E DV+S G + E++
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 979 KKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDT-QIQEMLQALG 1030
K A D + D D K + Q+ + LG
Sbjct: 281 IKENVAYHADRGPLFPG-SSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG 332
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 38/139 (27%), Positives = 58/139 (41%), Gaps = 13/139 (9%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHR 902
+L F +Y G L L E RF A + L YLH D +++R
Sbjct: 77 HDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSALEYLHSRD----VVYR 129
Query: 903 DVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEK 962
D+K N++L + + DFGL + D + F G+ Y+APE
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT----FCGTPEYLAPEVLEDNDYGRA 185
Query: 963 SDVYSYGVVLLEIITGKKP 981
D + GVV+ E++ G+ P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 15/140 (10%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+++L F +Y+ G L + L E RF A ++ L+YLH I++RD
Sbjct: 82 ESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSA-EISLALNYLHER---GIIYRD 135
Query: 904 VKSHNILLGERYESCLADFGLAR--LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISE 961
+K N+LL L D+G+ + L D+ +F P YIAPE
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN------YIAPEILRGEDYGF 189
Query: 962 KSDVYSYGVVLLEIITGKKP 981
D ++ GV++ E++ G+ P
Sbjct: 190 SVDWWALGVLMFEMMAGRSP 209
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 38/139 (27%), Positives = 63/139 (45%), Gaps = 13/139 (9%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHR 902
KL +Y+ G L M L +E F +A ++ L +LH I++R
Sbjct: 93 GGKLYLILEYLSGGELFMQLE--REGIFMEDTACFYLA-EISMALGHLHQKG----IIYR 145
Query: 903 DVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEK 962
D+K NI+L + L DFGL + D + + F G+ Y+APE + +
Sbjct: 146 DLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT----FCGTIEYMAPEILMRSGHNRA 201
Query: 963 SDVYSYGVVLLEIITGKKP 981
D +S G ++ +++TG P
Sbjct: 202 VDWWSLGALMYDMLTGAPP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 40/138 (28%), Positives = 61/138 (44%), Gaps = 11/138 (7%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+L F +++ G L + + E RF A + L +LH I++RD
Sbjct: 96 PDRLFFVMEFVNGGDLMFHIQ--KSRRFDEARARFYAA-EIISALMFLHDK---GIIYRD 149
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKS 963
+K N+LL LADFG+ + E G +A F G+ YIAPE
Sbjct: 150 LKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTAT--FCGTPDYIAPEILQEMLYGPAV 205
Query: 964 DVYSYGVVLLEIITGKKP 981
D ++ GV+L E++ G P
Sbjct: 206 DWWAMGVLLYEMLCGHAP 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-09
Identities = 37/138 (26%), Positives = 63/138 (45%), Gaps = 11/138 (7%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+L F +Y+ G L + + E F A +A GL +L I++RD
Sbjct: 93 MDRLYFVMEYVNGGDLMYHIQ--QVGRFKEPHAVFYAA-EIAIGLFFLQSK---GIIYRD 146
Query: 904 VKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKS 963
+K N++L +ADFG+ + D + + F G+ YIAPE +
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT----FCGTPDYIAPEIIAYQPYGKSV 202
Query: 964 DVYSYGVVLLEIITGKKP 981
D +++GV+L E++ G+ P
Sbjct: 203 DWWAFGVLLYEMLAGQAP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 15/140 (10%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRD 903
+++L F +Y+ G L + H L E RF A ++ L+YLH I++RD
Sbjct: 125 ESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHER---GIIYRD 178
Query: 904 VKSHNILLGERYESCLADFGLAR--LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISE 961
+K N+LL L D+G+ + L D+ +F P YIAPE
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN------YIAPEILRGEDYGF 232
Query: 962 KSDVYSYGVVLLEIITGKKP 981
D ++ GV++ E++ G+ P
Sbjct: 233 SVDWWALGVLMFEMMAGRSP 252
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 32/147 (21%), Positives = 61/147 (41%), Gaps = 26/147 (17%)
Query: 557 LTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQI 616
+L + + L + + L LS+N + I +SL + L I L+L N I
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRI-LSLGRNLI 82
Query: 617 CGELPAELTGL----NKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPF 672
++ L + L L +S+N+++ L + +L NL VL +S+N ++ +
Sbjct: 83 -----KKIENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNN----KITNWG- 131
Query: 673 FAKLPLSVLSGNPSLC---FSGNQCAD 696
+ L+ L +GN +
Sbjct: 132 ----EIDKLAALDKLEDLLLAGNPLYN 154
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 29/120 (24%), Positives = 53/120 (44%), Gaps = 8/120 (6%)
Query: 259 IPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLS 318
+ L +++ L N + I S L ++NL L L +N + I + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIENLD-AVADTLE 96
Query: 319 IIDISMNSLTGSIPQTLGNLTSLQELQLSVNQIS--GEIPAQIGNCQRLAQIELDNNQIT 376
+ IS N + S+ + L +L+ L +S N+I+ GEI ++ +L + L N +
Sbjct: 97 ELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 32/118 (27%), Positives = 53/118 (44%), Gaps = 9/118 (7%)
Query: 331 IPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLT 390
+ TL L + + L LS N I +I + + + L + L N I I + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 391 LLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKL--LLLSNN 446
L++ +N++ + I NL + +S N +T I +L L+KL LLL+ N
Sbjct: 97 ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN--WGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 36/181 (19%), Positives = 59/181 (32%), Gaps = 39/181 (21%)
Query: 343 ELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGE 402
EL + I ++ A + + + L N I I S + NL +L + N ++ +
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-K 84
Query: 403 IPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLI 462
I + LE + +S N + GI +L L L + +N ++ G L
Sbjct: 85 IENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT-----NWGEIDKL- 136
Query: 463 RFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDE----------ITGCRNLTFL 512
L L L L N L + + NL L
Sbjct: 137 -----------------AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
Query: 513 D 513
D
Sbjct: 180 D 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 32/195 (16%), Positives = 68/195 (34%), Gaps = 37/195 (18%)
Query: 458 CSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSN 517
IR + + + L + + ++ + L + +N
Sbjct: 7 IKDAIRIFEERKSV------VATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTN 58
Query: 518 SIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGS 577
+I + + L + L+ L N + + +L +L ++ N+ A S+ S +
Sbjct: 59 NIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SL-SGIEK 113
Query: 578 CVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSH 637
V L++L +S+N+++ +W +I +L L+KL L L+
Sbjct: 114 LVNLRVLYMSNNKIT-------------------NWGEI-----DKLAALDKLEDLLLAG 149
Query: 638 NELSGDLHFLAELQN 652
N L D
Sbjct: 150 NPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 36/157 (22%), Positives = 60/157 (38%), Gaps = 33/157 (21%)
Query: 412 NLEAVDLSQ--NGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSN 469
E V+L + + + LK L L +NN+
Sbjct: 24 EAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE--------------------- 61
Query: 470 KLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQ 529
K++ + ++NL L LG N + I + L L + N IA +L +G+ +
Sbjct: 62 KISS-----LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEK 113
Query: 530 LVRLQFADLSDNSVGGMLSPD-LGSLSSLTKLVLNKN 565
LV L+ +S+N + D L +L L L+L N
Sbjct: 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 29/164 (17%), Positives = 60/164 (36%), Gaps = 11/164 (6%)
Query: 365 LAQIELDNNQITGAIPSEFGNLSNLTL--LFVWHNRLEGEIPPSISNCQNLEAVDLSQNG 422
+A+ + I + + L +E ++ ++S + + + LS N
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNN 59
Query: 423 LTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNL 482
+ I + ++ L L L N + I +L + N++ I L
Sbjct: 60 IE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL 114
Query: 483 KNLNFLDLGSNRLT--GSIPDEITGCRNLTFLDVHSNSIAGNLP 524
NL L + +N++T G I D++ L L + N + +
Sbjct: 115 VNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYK 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 20/93 (21%), Positives = 38/93 (40%), Gaps = 4/93 (4%)
Query: 93 NFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLR 152
+ + + +L L L + I A + L L +S N + + + L+ L L
Sbjct: 65 SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLY 121
Query: 153 LNSNQLEGAIPIQ-IGNLSSLTQLFLYDNQLTD 184
+++N++ I + L L L L N L +
Sbjct: 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 31/137 (22%), Positives = 54/137 (39%), Gaps = 13/137 (9%)
Query: 72 LNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSE 131
+ V L + + ++L + L LS N I ++ + L L L
Sbjct: 23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALST-NNIEKI-SSLSGMENLRILSLGR 79
Query: 132 NSLTGEIPRELCSLLRLEQLRLNSNQ---LEGAIPIQIGNLSSLTQLFLYDNQLTDAIP- 187
N + +I LE+L ++ NQ L G I L +L L++ +N++T+
Sbjct: 80 NLIK-KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEI 133
Query: 188 ATIGKLKNLEAIRAGGN 204
+ L LE + GN
Sbjct: 134 DKLAALDKLEDLLLAGN 150
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 45/241 (18%), Positives = 80/241 (33%), Gaps = 59/241 (24%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRN------IV 835
+G G GIV +V + SG A+K+ D + E+ + + H N
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYK---NRELDIMKVLDHVNIIKLVDYF 69
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRF-------------KIAL 882
G + + G + + + + ++ K+
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 883 GVAE-------------------GLSYLHHDCVPAILHRDVKSHNILLGERYESC---LA 920
+ ++H I HRD+K N+L+ + L
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNS--KDNTLKLC 184
Query: 921 DFGLAR-LVEDDSGGSFSANPQFAGSYGYIAPE-YANMTKISEKSDVYSYGVVLLEIITG 978
DFG A+ L+ + ++ S Y APE T+ + D++S G V E+I G
Sbjct: 185 DFGSAKKLIPSEPSVAYIC------SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
Query: 979 K 979
K
Sbjct: 239 K 239
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 56.5 bits (135), Expect = 2e-08
Identities = 23/166 (13%), Positives = 51/166 (30%), Gaps = 14/166 (8%)
Query: 492 SNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQL--VRLQFADLSDNSVGGMLSP 549
S + + L L + + L + + L D+ V +L
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGS 216
Query: 550 DLGSLSSLTKLVLNKNRFAGSIPSQL------GSCVKLQLLDLSSNQLSGNIPASLGKIP 603
DL +L L V ++ + L+ L + + + +
Sbjct: 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESD 276
Query: 604 ALA--IALNLSWNQICGE----LPAELTGLNKLGILDLSHNELSGD 643
L +++S + E L + + L +++ +N LS +
Sbjct: 277 ILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 7e-07
Identities = 26/168 (15%), Positives = 52/168 (30%), Gaps = 23/168 (13%)
Query: 516 SNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQL 575
S +L L + L + LS +L L + S+ +
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKG---TNNLSIGKKPRPNLKSLEIISGGLPDSVVEDI 213
Query: 576 GSCV--KLQLLDL---SSNQLSGNIPASL------GKIPALAIALNLSWNQICGELP--- 621
L+ L L + + P L L + + +
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKW-LGIVDAEEQNVVVEMF 272
Query: 622 AELTGLNKLGILDLSHNELSGD-----LHFLAELQNLVVLNVSHNNFS 664
E L +L +D+S L+ + L + ++++L +N+ +N S
Sbjct: 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.4 bits (114), Expect = 8e-06
Identities = 39/250 (15%), Positives = 82/250 (32%), Gaps = 30/250 (12%)
Query: 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS 444
L +L + + EGE I++ + +N G+F + +S
Sbjct: 105 KLPSLKQITIGXWGYEGEDCSDIAD-------GIVENKEKFAHFEGLFWGDIDFEEQEIS 157
Query: 445 NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEIT 504
+ P + L + NLK+L ++ S L S+ ++I
Sbjct: 158 WIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EIISGGLPDSVVEDIL 214
Query: 505 GCR--NLTFLDVH---SNSIAGNLPAGLHQLV------RLQFADLSDNSVGGMLSPDLGS 553
G NL L ++ + L L++ + D ++
Sbjct: 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLE 274
Query: 554 ---LSSLTKLVLNKNRF----AGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALA 606
L L + ++ A + + L+ +++ N LS + L K +L
Sbjct: 275 SDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK--SLP 332
Query: 607 IALNLSWNQI 616
+ +++S +Q
Sbjct: 333 MKIDVSDSQE 342
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 6e-05
Identities = 23/180 (12%), Positives = 56/180 (31%), Gaps = 16/180 (8%)
Query: 257 GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNN--LVGIIPPELGNC 314
+ P L L + + NLK+L + + + I+ +L N
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 315 SQLSIIDISMNSLTGSIPQTL------GNLTSLQELQLSVNQISGEIPAQIGNCQRLAQI 368
+L + + +L+ L + + + L Q+
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 369 E---LDNNQITG----AIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQN 421
E + +T + + +L + + +N L E+ + ++ +D+S +
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK-IDVSDS 340
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 6e-05
Identities = 25/178 (14%), Positives = 51/178 (28%), Gaps = 29/178 (16%)
Query: 209 GSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRL------QTIAIYTALLSGQIPPE 262
L + L + + T+ LK L ++ +L +P
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLP-- 219
Query: 263 LGDCTELQYIYLYENALTGSIPSKL------GNLKNLVNLFLWQNNLVGIIPPELGNC-- 314
+ +L E+ + NL L + ++
Sbjct: 220 --NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 315 -SQLSIIDISMNSLTGS----IPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQ 367
QL +DIS LT + + + L+ + + N +S E+ + L +
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM------KKELQK 329
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 2e-08
Identities = 32/194 (16%), Positives = 52/194 (26%), Gaps = 46/194 (23%)
Query: 784 IGQGRSGIVYKVTLPSGLTVAVK--RFRASDKISTGAFSSEIATLSRI------------ 829
IG+G G V++ VA+K D ++ + L I
Sbjct: 28 IGEGVFGEVFQTIADHT-PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 830 ---RHRNIVRLLGW----GANRKTKLLFYDYM--------------PNGTLGMLLHDGEC 868
R + L G+ L +D+ + L ++L
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 869 AGLLE--------WDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLA 920
LE T I + L+ HRD+ N+LL + L
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLH 204
Query: 921 DFGLARLVEDDSGG 934
+ S G
Sbjct: 205 YTLNGKSSTIPSCG 218
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 51/169 (30%), Positives = 78/169 (46%), Gaps = 29/169 (17%)
Query: 821 SEIATLSRIRHRNIVRLLGWGANRKTKLLFY--DYMPNGTLGMLLHDGECAGLLEWDTRF 878
E LS + H I+R+ WG + + +F DY+ G L LL + +F
Sbjct: 55 DERLMLSIVTHPFIIRM--WGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKF 110
Query: 879 KIALGVAEGLSYLH-HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFS 937
A V L YLH D I++RD+K NILL + + DFG A+ V D +++
Sbjct: 111 YAA-EVCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYT 162
Query: 938 ANPQFAGSYGYIAPEYANMTKISEKS-----DVYSYGVVLLEIITGKKP 981
G+ YIAPE +S K D +S+G+++ E++ G P
Sbjct: 163 ----LCGTPDYIAPEV-----VSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 56/368 (15%), Positives = 108/368 (29%), Gaps = 83/368 (22%)
Query: 98 LSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLR-----LEQLR 152
++ + G+N + + + LDLS N+L EL + L
Sbjct: 1 MNYKLTLHPGSNPVEEF---TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLN 57
Query: 153 LNSNQL--EGAIPIQ---IGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNL 207
L+ N L + + + +++T L L N L+ + L
Sbjct: 58 LSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYK-----------------SSDEL 100
Query: 208 GGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCT 267
+L + ++ L S + A +
Sbjct: 101 VKTLAA---IPFTITVLDLGWNDFSS-----------KSSSEFKQAFSNLP--------A 138
Query: 268 ELQYIYLYENALTG----SIPSKLGNL-KNLVNLFLWQNNL----VGIIPPEL-GNCSQL 317
+ + L N L + L + N+ +L L NNL + L + +
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV 198
Query: 318 SIIDISMNSLTGSIPQTLG-----NLTSLQELQLSVNQISGE----IPAQIGNCQRLAQI 368
+ +D+S N L L + L L +N + G + + + L +
Sbjct: 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTV 258
Query: 369 ELDNNQITG-------AIPSEFGNLSNLTLLFVWHNRLEGEIPPSISN-----CQNLEAV 416
LD + + A+ + F N+ + L+ + ISN +
Sbjct: 259 YLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVP 318
Query: 417 DLSQNGLT 424
L L
Sbjct: 319 SLLNQCLI 326
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 53/302 (17%), Positives = 93/302 (30%), Gaps = 66/302 (21%)
Query: 407 ISNCQNLEAVDLSQNGLTGPIPRGIFQL-----KKLNKLLLLSNNLSGVIPPEMGNCSSL 461
S + ++DLS N L + Q + L L N+L N L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK------NSDEL 71
Query: 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-----TGCRNLTFLDVHS 516
++ A N+ L+L N L+ DE+ +T LD+
Sbjct: 72 VQILAAIPA-------------NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118
Query: 517 NSI--------AGNLPAGLHQLVRLQFADLSDNSVGGM----LSPDLGSL-SSLTKLVLN 563
N + L +L N +G L L ++ +++ L L
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSL---NLRGNDLGIKSSDELIQILAAIPANVNSLNLR 175
Query: 564 KNRF----AGSIPSQLGSC-VKLQLLDLSSNQLSGN----IPASLGKIPALAIALNLSWN 614
N + L S + LDLS+N L + IP ++LNL N
Sbjct: 176 GNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLN 235
Query: 615 QI----CGELPAELTGLNKLGILDLSHNELSGD--------LHFLAELQNLVVLNVSHNN 662
+ L L L + L ++ + +Q +++++ +
Sbjct: 236 CLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKE 295
Query: 663 FS 664
Sbjct: 296 IH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 59/384 (15%), Positives = 115/384 (29%), Gaps = 90/384 (23%)
Query: 311 LGNCSQLSIIDISMNSLTGSIPQTLG-----NLTSLQELQLSVNQISGEIPAQIGNCQRL 365
++ +D+S+N+L L S+ L LS N + + N L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK------NSDEL 71
Query: 366 AQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-----SNCQNLEAVDLSQ 420
QI +N+T L + N L + + + + +DL
Sbjct: 72 VQILAAIP-------------ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118
Query: 421 NGLTGPIPRGIFQL--------KKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT 472
N + + + + L L N+L LI+ A
Sbjct: 119 NDFS---SKSSSEFKQAFSNLPASITSLNLRGNDLG-----IKS-SDELIQILAAIPA-- 167
Query: 473 GFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-----TGCRNLTFLDVHSNSI----AGNL 523
N+N L+L N L E+ + ++T LD+ +N + L
Sbjct: 168 -----------NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAEL 216
Query: 524 PAGL-HQLVRLQFADLSDNSVGG----MLSPDLGSLSSLTKLVLNKNRF-------AGSI 571
+ +L N + G L SL L + L+ + ++
Sbjct: 217 AYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKAL 276
Query: 572 PSQLGSCVKLQLLDLSSNQLSG----NIPASLGKIPALAIALNLSWNQI----CGELPAE 623
+ + K+ L+D + ++ I + ++ A +L + + E
Sbjct: 277 GAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIE 336
Query: 624 LTGLNK-LGILDLSHNELSGDLHF 646
+ L + L + H
Sbjct: 337 DLNIPDELRESIQTCKPL-LEHHH 359
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 53/356 (14%), Positives = 102/356 (28%), Gaps = 84/356 (23%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASL-----NQLNYLDLSENSLTGEIPRELCSLLR-----L 148
S+ L LSG +L E+ + + L+LS N L+ + EL L +
Sbjct: 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI 111
Query: 149 EQLRLNSNQL--EGAIPI---QIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGG 203
L L N + + +S+T L L N L
Sbjct: 112 TVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK-----------------S 154
Query: 204 NKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPEL 263
+ L L N+ + L +++ + L S
Sbjct: 155 SDELIQILAA---IPANVNSLNLRGNNLA-----------SKNCAELAKFLASI------ 194
Query: 264 GDCTELQYIYLYENALTGSIPSKLG-----NLKNLVNLFLWQNNL----VGIIPPELGNC 314
+ + L N L ++L ++V+L L N L + + +
Sbjct: 195 --PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252
Query: 315 SQLSIIDISMNSLTG-------SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQ 367
L + + + + ++ N+ + + + +I I N R
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELS 312
Query: 368 IELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGL 423
+ D +L N L+F ++ E ++ L + L
Sbjct: 313 GKADVP-----------SLLNQCLIFAQKHQTNIE---DLNIPDELRESIQTCKPL 354
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 34/116 (29%), Positives = 48/116 (41%), Gaps = 4/116 (3%)
Query: 90 VPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLE 149
VPT S S RL L L L QL L LS+N + L +L
Sbjct: 22 VPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79
Query: 150 QLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGN 204
L L+ N+L+ ++P + L+ L +L L NQL +L +L+ I N
Sbjct: 80 ILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 4/105 (3%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGE 137
L+L L F L L +L LS + S+P + L +L L L EN L
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 138 IPRELC-SLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQ 181
+P + L +L++L L++NQL+ L+SL +++L+ N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 355 IPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQN 412
+P I + RL EL++N++ F L+ LT L + N+++ +P +
Sbjct: 22 VPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 413 LEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSNNLSGV 450
L + L +N L +P G+F +L +L +L L +N L V
Sbjct: 78 LTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSV 115
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 6/95 (6%)
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSS 171
S+P I S L+L N L L +L +L L+ NQ++ ++P + L+
Sbjct: 21 SVPTGIPSSAT--RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 172 LTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGNK 205
LT L+L++N+L ++P + KL L+ + N+
Sbjct: 78 LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQ 111
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 10/104 (9%)
Query: 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIP----DEITGCRNLTFLDVHSNSIAGN 522
SNKL L L L L N++ S+P D++T LT L +H N + +
Sbjct: 36 ESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLT---KLTILYLHENKLQ-S 90
Query: 523 LPAGL-HQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKN 565
LP G+ +L +L+ L N + + L+SL K+ L+ N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 27/109 (24%), Positives = 40/109 (36%), Gaps = 2/109 (1%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
+ + L N L L L L L QN + + ++L+I+ + N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 327 LTGSIPQ-TLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQ 374
L S+P LT L+EL L NQ+ L +I L N
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 7/105 (6%)
Query: 489 DLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL-HQLVRLQFADLSDNSVGGML 547
S LT S+P I + T L++ SN + +LP G+ +L +L LS N + +
Sbjct: 13 RCNSKGLT-SVPTGIPS--SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLP 68
Query: 548 SPDLGSLSSLTKLVLNKNRFAGSIPSQL-GSCVKLQLLDLSSNQL 591
L+ LT L L++N+ S+P+ + +L+ L L +NQL
Sbjct: 69 DGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 54/287 (18%), Positives = 84/287 (29%), Gaps = 93/287 (32%)
Query: 784 IGQGRSGIVYKV-TLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR--------HRNI 834
+G G V+ + VA+K ++++ T EI L +R +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-YTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 835 VRLLGWGANRKTKLLFYDYMPNGT--------LGM----LLHDGECAGLLEWDTRFKIAL 882
V+LL F NGT LG + GL + KI
Sbjct: 104 VQLLDD---------FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK-KIIQ 153
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLG------------------------------ 912
V +GL YLH C I+H D+K NILL
Sbjct: 154 QVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 913 -------------------ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
E+ + +AD G A V Y + E
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-------YRSLEV 264
Query: 954 ANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000
+ + +D++S + E+ TG + + DH+
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR---DEDHI 308
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 9e-08
Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 16/152 (10%)
Query: 845 KTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHR 902
+TKL DY+ G L L + E + + + + L +LH I++R
Sbjct: 131 ETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVG-EIVLALEHLHKLG----IIYR 183
Query: 903 DVKSHNILLGERYESCLADFGLARL-VEDDSGGSFSANPQFAGSYGYIAPE-YANMTKIS 960
D+K NILL L DFGL++ V D++ ++ F G+ Y+AP+
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD----FCGTIEYMAPDIVRGGDSGH 239
Query: 961 EKS-DVYSYGVVLLEIITGKKPVDASFPDGQH 991
+K+ D +S GV++ E++TG P
Sbjct: 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 52/209 (24%), Positives = 77/209 (36%), Gaps = 22/209 (10%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH-RNIVRLLGWG 841
IG G G +Y T + +G VA+K K E ++ I + G
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWCG 74
Query: 842 ANRKTKLLFYDYMPNGTLGMLLHD--GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
A Y+ M LG L D C+ T +A + + Y+H
Sbjct: 75 AEGD-----YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 126
Query: 900 LHRDVKSHNILLGERYES---CLADFGLARLVEDDSGGS---FSANPQFAGSYGYIAPEY 953
+HRDVK N L+G + + DFGLA+ D + N G+ Y A
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASIN 185
Query: 954 ANMTK-ISEKSDVYSYGVVLLEIITGKKP 981
++ S + D+ S G VL+ G P
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 35/139 (25%), Positives = 57/139 (41%), Gaps = 8/139 (5%)
Query: 314 CSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNN 373
CS ++ + T S+P G L L N + L Q+ L N
Sbjct: 7 CSGTTV-ECYSQGRT-SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN 62
Query: 374 QITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIF 432
++ F L++LT L + N+L+ +P + L+ + L+ N L +P G+F
Sbjct: 63 KLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVF 120
Query: 433 -QLKKLNKLLLLSNNLSGV 450
+L +L L L N L V
Sbjct: 121 DKLTQLKDLRLYQNQLKSV 139
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 33/121 (27%), Positives = 49/121 (40%), Gaps = 6/121 (4%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL 146
VPT + L L +L L L L L N L L
Sbjct: 19 RTSVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLT 76
Query: 147 RLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGN 204
L L L++NQL+ ++P + L+ L +L L NQL ++P + KL L+ +R N
Sbjct: 77 SLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
Query: 205 K 205
+
Sbjct: 135 Q 135
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 10/109 (9%)
Query: 488 LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGL-HQLVRLQFADLSDNSVGGM 546
LDL +N L +LT L + N + +LP G+ ++L L + +LS N + +
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 547 LSPDLGSLSSLTKLVLNKNRFAGSIPS----QLGSCVKLQLLDLSSNQL 591
+ L+ L +L LN N+ S+P +L +L+ L L NQL
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKL---TQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 94 FTSLLSLNRLVLSGTNLTGSIPKEI-ASLNQLNYLDLSENSLTGEIPRELC-SLLRLEQL 151
F L SL L LS L S+P + L QL L L+ N L +P + L +L+ L
Sbjct: 72 FNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDL 129
Query: 152 RLNSNQL----EGAIPIQIGNLSSLTQLFLYDNQ 181
RL NQL +G L+SL ++L+DN
Sbjct: 130 RLYQNQLKSVPDGVF----DRLTSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 37/103 (35%), Positives = 51/103 (49%), Gaps = 8/103 (7%)
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGN-LSS 171
S+P I + YLDL NSL L L QL L N+L+ ++P + N L+S
Sbjct: 21 SVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 172 LTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGNKNLGGSLPH 213
LT L L NQL ++P + KL L+ + N+ L SLP
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQ-L-QSLPD 117
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 43/165 (26%), Positives = 62/165 (37%), Gaps = 23/165 (13%)
Query: 555 SSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWN 614
+ T L L N L L L N+L ++P + LNLS N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 615 QICGELPA----ELTGLNKLGILDLSHNEL----SGDLHFLAELQNLVVLNVSHNNFSGR 666
Q+ LP +LT +L L L+ N+L G L +L++L + + N
Sbjct: 87 QL-QSLPNGVFDKLT---QLKELALNTNQLQSLPDGVFDKLTQLKDLRL----YQNQLKS 138
Query: 667 VPDTPF--FAKLPLSVLSGNPSLCFSGNQCADSTYKKDGASRHAG 709
VPD F L L NP C C Y + ++H+G
Sbjct: 139 VPDGVFDRLTSLQYIWLHDNPWDC----TCPGIRYLSEWINKHSG 179
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 33/133 (24%), Positives = 59/133 (44%), Gaps = 4/133 (3%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
+ Y+ L N+L L +L L+L N L + + L+ +++S N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 327 LTGSIPQTL-GNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSEFG 384
L S+P + LT L+EL L+ NQ+ +P + +L + L NQ+ F
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD 145
Query: 385 NLSNLTLLFVWHN 397
L++L +++ N
Sbjct: 146 RLTSLQYIWLHDN 158
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 33/171 (19%), Positives = 57/171 (33%), Gaps = 41/171 (23%)
Query: 887 GLSYLHHDCVPA-ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGS 945
G +++H + I+HRD+K N LL + + DFGLAR + + + + +
Sbjct: 141 GENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 946 YG------------------YIAPEYA-NMTKISEKSDVYSYGVVLLEIITGKKPVDAS- 985
G Y APE ++ D++S G + E++ +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 986 ------FPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALG 1030
FP G D K D Q+ + +G
Sbjct: 257 TNRFPLFP-GSSCFPLSPDRNSKKVHEKSNRD---------QLNIIFNIIG 297
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-07
Identities = 54/220 (24%), Positives = 81/220 (36%), Gaps = 50/220 (22%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHR------NIV 835
+IG+G G V K VA+K R + A EI L +R + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNVI 162
Query: 836 RLLGWGANRK-----TKLL---FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEG 887
+L R +LL Y+ L+ + G R K A + +
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYE---------LIKKNKFQGFSLPLVR-KFAHSILQC 212
Query: 888 LSYLHHDCVPAILHRDVKSHNILLGERYES--CLADFGLARLVEDDSGGSFSANPQFAGS 945
L LH I+H D+K NILL ++ S + DFG +
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV------------- 256
Query: 946 YGYI------APEYANMTKISEKSDVYSYGVVLLEIITGK 979
Y YI APE + D++S G +L E++TG
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 5/106 (4%)
Query: 96 SLLSLNRLVLSGTNLT-GSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLN 154
+ ++ LVL G I A L +L L L + L L +L++L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 155 SNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIR 200
N++ G + + L +LT L L N+L D +T+ LK LE ++
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLK 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 33/135 (24%), Positives = 56/135 (41%), Gaps = 9/135 (6%)
Query: 385 NLSNLTLLFVWHNRL-EGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLL 443
+ + L + + + +G+I + NLE + L GL + + +L KL KL L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VS-NLPKLPKLKKLELS 79
Query: 444 SNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPE-IGNLKNLNFLDLGSNRLTGSIPD- 501
N + G + +L + NKL E + L+ L LDL + +T ++ D
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NLNDY 138
Query: 502 ---EITGCRNLTFLD 513
LT+LD
Sbjct: 139 RESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 24/97 (24%), Positives = 42/97 (43%), Gaps = 3/97 (3%)
Query: 257 GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ 316
G+I + L+++ L L S+ S L L L L L +N + G +
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 317 LSIIDISMNSLTG-SIPQTLGNLTSLQELQLSVNQIS 352
L+ +++S N L S + L L L+ L L +++
Sbjct: 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 25/137 (18%), Positives = 44/137 (32%), Gaps = 26/137 (18%)
Query: 289 NLKNLVNLFL-WQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347
+ L L + G I L + + L S+ L L L++L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI 407
N+I G + L + L N++ + L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPL------------------ 116
Query: 408 SNCQNLEAVDLSQNGLT 424
+ L+++DL +T
Sbjct: 117 KKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 25/113 (22%), Positives = 41/113 (36%), Gaps = 7/113 (6%)
Query: 433 QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGS 492
+++L L + G I +L + L + L L L+L
Sbjct: 25 AVRELV--LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELSE 80
Query: 493 NRLTGSIPDEITGCRNLTFLDVHSNSIA--GNLPAGLHQLVRLQFADLSDNSV 543
NR+ G + NLT L++ N + L L +L L+ DL + V
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 32/150 (21%), Positives = 52/150 (34%), Gaps = 31/150 (20%)
Query: 511 FLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGS 570
LD ++ G + + V L+F L + + + +L L L KL L++NR G
Sbjct: 30 VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG 86
Query: 571 IPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKL 630
+ L L+LS N+L + + L L L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLK-------------------DISTL-----EPLKKLECL 122
Query: 631 GILDLSHNELSGDLHF----LAELQNLVVL 656
LDL + E++ + L L L
Sbjct: 123 KSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 34/138 (24%), Positives = 48/138 (34%), Gaps = 33/138 (23%)
Query: 553 SLSSLTKLVLNKNRFA-GSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNL 611
+ +++ +LVL+ + G I V L+ L L + L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI------------------- 62
Query: 612 SWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAE-LQNLVVLNVSHNNFSGRVPDT 670
+ L L KL L+LS N + G L LAE L NL LN+S N +
Sbjct: 63 ---SVSN-----LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTL 113
Query: 671 PFFAKLP-LSVLS--GNP 685
KL L L
Sbjct: 114 EPLKKLECLKSLDLFNCE 131
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 9e-04
Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 4/90 (4%)
Query: 116 KEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQL 175
+ A++ +L LD +++ G+I + LE L L + L + L L +L
Sbjct: 21 RTPAAVRELV-LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKL 76
Query: 176 FLYDNQLTDAIPATIGKLKNLEAIRAGGNK 205
L +N++ + KL NL + GNK
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 37/94 (39%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 355 IPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQN 412
+PA I + QRL L+NNQIT P F +L NL L+ N+L IP +
Sbjct: 27 VPAGIPTDKQRL---WLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 413 LEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSN 445
L +DL+ N L IPRG F LK L + L +N
Sbjct: 83 LTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 36/94 (38%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSS 171
S+P I + Q L L+ N +T P L+ L+QL NSN+L AIP + L+
Sbjct: 26 SVPAGIPTDKQ--RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 172 LTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGN 204
LTQL L DN L +IP LK+L I N
Sbjct: 83 LTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 48/277 (17%), Positives = 95/277 (34%), Gaps = 42/277 (15%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRA--SDKISTGAFSSEIATLSRIRHRNIVRLL 838
G IGQG G +Y + S +V + G +E+ R ++
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ-- 97
Query: 839 GWGANRKTKLL----FYDYMPNGT------------LGMLLHD--GECAGLLEWDTRFKI 880
W RK K L ++ + G L A T ++
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQL 157
Query: 881 ALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESC--LADFGLARLVEDDSGG---S 935
+L + + L Y+H +H D+K+ N+LL + L D+GLA + +
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 936 FSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ 990
G+ E+ ++ S + D+ G +++ +TG P + + D +
Sbjct: 215 ADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269
Query: 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQ 1027
+V + + + + P +I + ++
Sbjct: 270 YV-RDSKIRYRENIASLMDKCFPAANAPG-EIAKYME 304
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 48/268 (17%), Positives = 87/268 (32%), Gaps = 49/268 (18%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH-RNIVRLL 838
G IG+G G++++ T L + VA+K E T + I +
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVY 72
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHD--GECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
+G ++ + LG L D C T A + + +H
Sbjct: 73 YFGQEGL-----HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 897 PAILHRDVKSHNILLGERYES-----CLADFGLARLVEDDSGGS---FSANPQFAGSYGY 948
+++RD+K N L+G + DFG+ + D + +G+ Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 949 IAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007
++ + S + D+ + G V + + G P W + K
Sbjct: 185 -MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-------------WQGLKAATNKQKY 230
Query: 1008 EVLDPKLQGHPDTQIQEMLQALGISLLC 1035
E +I E Q+ + LC
Sbjct: 231 E------------RIGEKKQSTPLRELC 246
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 8/94 (8%)
Query: 355 IPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQN 412
+P I Q L L +NQIT P F L+ LT L + +N+L +P +
Sbjct: 24 VPTGIPTTTQVL---YLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 413 LEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSN 445
L + L+ N L IPRG F LK L + LL+N
Sbjct: 80 LTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSS 171
S+P I + Q L L +N +T P L +L +L L++NQL +P + L+
Sbjct: 23 SVPTGIPTTTQ--VLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 172 LTQLFLYDNQLTDAIPATI-GKLKNLEAIRAGGN 204
LTQL L DNQL +IP LK+L I N
Sbjct: 80 LTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 51/212 (24%), Positives = 81/212 (38%), Gaps = 22/212 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLL 838
G IG G G +Y T + + VA+K K + E ++ I +
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVR 69
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHD--GECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
+G Y+ + LG L D C+ L T +A + + ++H
Sbjct: 70 WFGVEGD-----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123
Query: 897 PAILHRDVKSHNILLGERYES---CLADFGLARLVEDDSGGS---FSANPQFAGSYGYIA 950
LHRD+K N L+G + + DFGLA+ D S + N G+ Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180
Query: 951 PEYANMTK-ISEKSDVYSYGVVLLEIITGKKP 981
++ S + D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 51/222 (22%), Positives = 79/222 (35%), Gaps = 50/222 (22%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHR------NI 834
++IG+G G V K VA+K + A E+ L + I
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-EVRLLELMNKHDTEMKYYI 118
Query: 835 VRLLGWGANRK-----TKLL---FYDYM-PNGTLGMLLHDGECAGLLEWDTRFKIALGVA 885
V L R ++L YD + G+ L+ TR K A +
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNL----------TR-KFAQQMC 167
Query: 886 EGLSYLHHDCVPAILHRDVKSHNILLGERYESC--LADFGLARLVEDDSGGSFSANPQFA 943
L +L + +I+H D+K NILL S + DFG + +
Sbjct: 168 TALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI----------- 215
Query: 944 GSYGYI------APEYANMTKISEKSDVYSYGVVLLEIITGK 979
Y YI +PE D++S G +L+E+ TG+
Sbjct: 216 --YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 45/214 (21%), Positives = 76/214 (35%), Gaps = 24/214 (11%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH-RNIVRLL 838
G IG G G + L + VA+K + E ++ I ++
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ--LHLEYRFYKQLGSGDGIPQVY 71
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHD--GECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
+G K Y+ M LG L D C T IA+ + + Y+H
Sbjct: 72 YFGPCGK-----YNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125
Query: 897 PAILHRDVKSHNILLGERYES-----CLADFGLARLVEDDSGGS---FSANPQFAGSYGY 948
+++RDVK N L+G + DF LA+ D + + G+ Y
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 949 IAPEYANMTK-ISEKSDVYSYGVVLLEIITGKKP 981
++ K S + D+ + G + + + G P
Sbjct: 184 -MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 52/286 (18%), Positives = 97/286 (33%), Gaps = 67/286 (23%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVK--RFRASD------------KISTGAFSSEIAT 825
G IG G G++Y A + + +++ +
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 826 LSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRF------K 879
++ + I G G + K Y +M LG+ L + + F +
Sbjct: 102 RKQLDYLGIPLFYGSGLT-EFKGRSYRFMVMERLGIDLQK-----ISGQNGTFKKSTVLQ 155
Query: 880 IALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESC--LADFGLARLVEDDSGG--- 934
+ + + + L Y+H + +H D+K+ N+LLG + LAD+GL+ +
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 935 SFSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDG 989
+ G E+ ++ +S +SDV G +L + GK P
Sbjct: 213 QENPRKGHNG-----TIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP-------- 259
Query: 990 QHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLC 1035
W ++ KDPV V K + E+ Q++
Sbjct: 260 -----W----EQNLKDPVAVQTAKTN-----LLDELPQSVLKWAPS 291
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 49/263 (18%), Positives = 84/263 (31%), Gaps = 15/263 (5%)
Query: 234 FLPPTLGLLKRLQTIAIYTA-LLSGQIPPELGDCTELQYIYLYENALT-GSIPSKLGNLK 291
P G L IA Q E +Q++ L + + ++ L
Sbjct: 59 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 118
Query: 292 NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISM-NSLTGSIPQTLG-NLTSLQELQLS-V 348
L NL L L I L S L +++S + + QTL + + L EL LS
Sbjct: 119 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 178
Query: 349 NQISGEIPAQI--GNCQRLAQIELD--NNQIT-GAIPSEFGNLSNLTLL-FVWHNRLEGE 402
+ + + + Q+ L + + + NL L L+ +
Sbjct: 179 FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND 238
Query: 403 IPPSISNCQNLEAVDLSQ-NGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSL 461
L+ + LS+ + + ++ L L + G + L
Sbjct: 239 CFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL 298
Query: 462 IRFRANSNKLTGFIPPEIGNLKN 484
+ N + T P IGN KN
Sbjct: 299 ---QINCSHFTTIARPTIGNKKN 318
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 43/248 (17%), Positives = 78/248 (31%), Gaps = 38/248 (15%)
Query: 314 CSQLSIIDISMNSLT-GSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDN 372
++ +D+S + + ++ L + LQ L L ++S I + L ++ L
Sbjct: 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151
Query: 373 NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQ------NGLTGP 426
S L + +S+C L+ ++LS +
Sbjct: 152 CS----------GFSEFALQTL------------LSSCSRLDELNLSWCFDFTEKHVQVA 189
Query: 427 IPRGIFQLKKLNKLLLLSNNLSGVIPPEMG-NCSSLIRFR-ANSNKLTGFIPPEIGNLKN 484
+ + +LN L NL + C +L+ ++S L E L
Sbjct: 190 VAHVSETITQLN-LSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 248
Query: 485 LNFLDLGS-NRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQ-----FADL 538
L L L + E+ L L V G L L LQ F +
Sbjct: 249 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTI 308
Query: 539 SDNSVGGM 546
+ ++G
Sbjct: 309 ARPTIGNK 316
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 41/221 (18%), Positives = 72/221 (32%), Gaps = 24/221 (10%)
Query: 31 VNRQGEALLSWKRNWKGSDDGLSNWSPSDETP----------CKWFGVSCNLNNQVVGLD 80
V ++ L S + W+ D N P C + L
Sbjct: 35 VCKRWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR 94
Query: 81 LRYVDLLGHVPTN------FTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSE-NS 133
++++DL V + L L L G L+ I +A + L L+LS +
Sbjct: 95 VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 154
Query: 134 LTGEIPRELCSLL-RLEQLRLNSNQLEGAIPIQI---GNLSSLTQLFLYD--NQLTD-AI 186
+ + L S RL++L L+ +Q+ ++TQL L L +
Sbjct: 155 FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDL 214
Query: 187 PATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLA 227
+ + NL + + L E L + L+
Sbjct: 215 STLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 255
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 55/310 (17%), Positives = 85/310 (27%), Gaps = 78/310 (25%)
Query: 396 HNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEM 455
+ + ++ I N LE + L + + + L+ L E
Sbjct: 11 NRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHY---------EF 61
Query: 456 GNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCR-------- 507
N L +L L+L R+T C
Sbjct: 62 QNQRFSAE-----------------VLSSLRQLNLAGVRMTPV------KCTVVAAVLGS 98
Query: 508 ---NLTFLDVHSNSIAGNLPAGLHQLV----RLQFADLSDNSVG----GMLSPDLGS-LS 555
L +++ S + PAGL L+ R + L NS+G L L
Sbjct: 99 GRHALDEVNLASCQLD---PAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQC 155
Query: 556 SLTKLVLNKNRF----AGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAI---- 607
+T L L+ N + L + L L L L L
Sbjct: 156 QITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA--QLDRNRQL 213
Query: 608 -ALNLSWNQI----CGELPAELTGLNKLGILDLSHNELSGD-LHFLAE-------LQNLV 654
LN+++N L L +L L NELS + L + +V
Sbjct: 214 QELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVV 273
Query: 655 VLNVSHNNFS 664
V S
Sbjct: 274 VSLTEGTAVS 283
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 26/98 (26%), Positives = 42/98 (42%), Gaps = 11/98 (11%)
Query: 99 SLNRLVLSGTNLTGSIPKEIA-----SLNQLNYLDLSENSLTGEIPRELCS-LLRLEQLR 152
SL +L L+G +T +A + L+ ++L+ L R L LR +L
Sbjct: 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLG 132
Query: 153 LNSNQL--EGAIPIQ---IGNLSSLTQLFLYDNQLTDA 185
L N L E ++ + + +T L L +N LT A
Sbjct: 133 LQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAA 170
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 25/102 (24%), Positives = 35/102 (34%), Gaps = 13/102 (12%)
Query: 97 LLSLNRLVLSGTNLTGSIPKEIASL-----NQLNYLDLSENSLTGEIPRELCSLLR---- 147
L +L L +L K++ L Q+ L LS N LT L L
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 148 LEQLRLNSNQL--EGAIPI--QIGNLSSLTQLFLYDNQLTDA 185
+ L L L EG + Q+ L +L + N D
Sbjct: 185 VTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT 226
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 24/97 (24%), Positives = 41/97 (42%), Gaps = 10/97 (10%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQ-LNYLDLSENSLTGEIPRELCSLLR-----LEQLR 152
+L+ + L+ L + + + + L L NSL E ++L LL + LR
Sbjct: 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLR 161
Query: 153 LNSNQL--EGAIPI--QIGNLSSLTQLFLYDNQLTDA 185
L++N L G + + +S+T L L L D
Sbjct: 162 LSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDE 198
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 29/175 (16%), Positives = 59/175 (33%), Gaps = 41/175 (23%)
Query: 781 GNIIGQGRSGIVYKVT---------LPSGLTVAVK-------RFRASDKISTGAFSSEIA 824
+ + GI+Y+ P ++K F + A ++
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 825 ---TLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTR---- 877
L I +G+G ++ Y ++ +LG L L+ +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-----ALDVSPKHVLS 157
Query: 878 ----FKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESC--LADFGLAR 926
++A + + L +LH + +H +V + NI + +S LA +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1117 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.68 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.67 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.61 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.59 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.57 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.56 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.55 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.55 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.45 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.45 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.42 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.38 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.36 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.36 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.35 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.32 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.18 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.14 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.12 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.11 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.82 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.68 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.66 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.17 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.16 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.87 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.39 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.35 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.27 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.15 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.09 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.07 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.95 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.75 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.74 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.69 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.37 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.81 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.78 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.64 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.17 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.79 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.44 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 82.52 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.26 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.19 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-90 Score=876.22 Aligned_cols=658 Identities=33% Similarity=0.513 Sum_probs=556.3
Q ss_pred cccchhHHHHHHHHHhhccCCCCCCCCCCCCCCCCcceeeEEecCCCcEEEEecccccccCc---CCccccccccCCeEe
Q 001238 28 PYAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGH---VPTNFTSLLSLNRLV 104 (1117)
Q Consensus 28 ~~~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~~~C~W~gv~C~~~~~v~~l~l~~~~l~~~---~~~~~~~l~~L~~L~ 104 (1117)
..+.++|++|||+||+++.|+. .+++|.. +.+||.|+||+|+ +++|++++|++.++.|. +|+.|.++++|+.++
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~ 83 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLF 83 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEE
T ss_pred ccCCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccC
Confidence 3456889999999999999877 8999984 4579999999999 89999999999999998 888888888888888
Q ss_pred ccCCCCCCCchhhhcccccCcEeeccCCCcCCCCch--hhhhhhhhhhhhccCCCcCCCCchhc-cCCcCCcEEeccCCC
Q 001238 105 LSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPR--ELCSLLRLEQLRLNSNQLEGAIPIQI-GNLSSLTQLFLYDNQ 181 (1117)
Q Consensus 105 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~-~~L~~L~~L~L~~N~ 181 (1117)
++.|.+. .+|..|+++++|++|||++|.++|.+|. .++++++|++|+|++|.+.+.+|..+ +++++|++|+|++|+
T Consensus 84 ~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 84 LSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp CTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 8877765 3567788888888888888888888887 88888888888888888888877766 788888888888888
Q ss_pred CCCCCccc---ccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeeccccccccc
Q 001238 182 LTDAIPAT---IGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQ 258 (1117)
Q Consensus 182 l~~~~p~~---~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~ 258 (1117)
+++..|.. +.++++|++|++++|+. .+..| ++++++|++|++++|.+.+.+|. ++++++|++|++++|.+.+.
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l-~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~ 238 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKI-SGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEE-ESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcc-cccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence 88877776 78888888888888864 33333 37788888888888888877776 88888888888888888888
Q ss_pred CCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCC-CCCCEEEcCCCcCCCCCccccCC
Q 001238 259 IPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNC-SQLSIIDISMNSLTGSIPQTLGN 337 (1117)
Q Consensus 259 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~LdLs~N~l~~~~p~~l~~ 337 (1117)
+|..+..+++|++|+|++|.+++.+|.. .+++|++|++++|++++.+|..+..+ ++|++|+|++|.+++.+|..|++
T Consensus 239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~ 316 (768)
T 3rgz_A 239 FSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316 (768)
T ss_dssp HHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGG
T ss_pred ccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhc
Confidence 8888888888888888888888777764 77888888888888888888877664 88888888888888888888888
Q ss_pred CCCcceEecccccccCccccc-ccCCCCCcEEEecCccccCCCCccccccc-chHHHHhccccccccCCCCCCc--cccc
Q 001238 338 LTSLQELQLSVNQISGEIPAQ-IGNCQRLAQIELDNNQITGAIPSEFGNLS-NLTLLFVWHNRLEGEIPPSISN--CQNL 413 (1117)
Q Consensus 338 l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~--l~~L 413 (1117)
+++|++|+|++|.+++.+|.. +.++++|++|++++|++++.+|..+..++ +|+.|++++|++++.+|..+.. +++|
T Consensus 317 l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L 396 (768)
T 3rgz_A 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396 (768)
T ss_dssp CTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCC
T ss_pred CCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCc
Confidence 888888888888888777765 78888888888888888888888888776 7888888888888877777766 7788
Q ss_pred ceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCC
Q 001238 414 EAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493 (1117)
Q Consensus 414 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 493 (1117)
++|++++|++++.+|..+..+++|++|++++|++++.+|..|+++++|+.|++++|++++.+|..+..+++|++|+|++|
T Consensus 397 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 476 (768)
T 3rgz_A 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476 (768)
T ss_dssp CEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCC
Confidence 88888888888778888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCc
Q 001238 494 RLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPS 573 (1117)
Q Consensus 494 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 573 (1117)
++++.+|..+..+++|++|+|++|++.+.+|.++..+++|++|++++|++.+..+..+..+++|+.|++++|++.|.+|.
T Consensus 477 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~ 556 (768)
T 3rgz_A 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCG
T ss_pred cccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCCh
Confidence 88888888888888888888888888888888888888888888888888877777888888888888888887766554
Q ss_pred c----------------------------------------------------------------------cccccceeE
Q 001238 574 Q----------------------------------------------------------------------LGSCVKLQL 583 (1117)
Q Consensus 574 ~----------------------------------------------------------------------~~~l~~L~~ 583 (1117)
. |..+++|+.
T Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~ 636 (768)
T 3rgz_A 557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636 (768)
T ss_dssp GGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCE
T ss_pred HHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccE
Confidence 3 444678999
Q ss_pred EeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch-hhhcccceEEEeeccc
Q 001238 584 LDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF-LAELQNLVVLNVSHNN 662 (1117)
Q Consensus 584 L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~-l~~l~~L~~L~ls~N~ 662 (1117)
|||++|+++|.+|..++.++.+ +.|+|++|+++|.+|..|+++++|++||||+|+++|.+|. +..+++|++||||+|+
T Consensus 637 LdLs~N~l~g~ip~~l~~l~~L-~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~ 715 (768)
T 3rgz_A 637 LDMSYNMLSGYIPKEIGSMPYL-FILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715 (768)
T ss_dssp EECCSSCCBSCCCGGGGGCTTC-CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE
T ss_pred EECcCCcccccCCHHHhccccC-CEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc
Confidence 9999999999999999999999 7999999999999999999999999999999999998876 8999999999999999
Q ss_pred ccCCCCCCcccccCCcccccCCCCCCcCC-CCCCC
Q 001238 663 FSGRVPDTPFFAKLPLSVLSGNPSLCFSG-NQCAD 696 (1117)
Q Consensus 663 l~~~~p~~~~~~~~~~~~~~gN~~~c~~~-~~c~~ 696 (1117)
|+|.||+.++|.+++..+|.|||++||.+ .+|..
T Consensus 716 l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 716 LSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp EEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred ccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 99999999999999999999999999984 47864
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-72 Score=710.49 Aligned_cols=579 Identities=32% Similarity=0.508 Sum_probs=507.3
Q ss_pred ecccccccCc--CCccccccccCCeEeccCCCCCCCchh--hhcccccCcEeeccCCCcCCCCchhh-hhhhhhhhhhcc
Q 001238 80 DLRYVDLLGH--VPTNFTSLLSLNRLVLSGTNLTGSIPK--EIASLNQLNYLDLSENSLTGEIPREL-CSLLRLEQLRLN 154 (1117)
Q Consensus 80 ~l~~~~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~ 154 (1117)
++.+++..+. +|..|+.+++|++|+|++|+++|.+|. .++++++|++|||++|.+++.+|..+ ..+++|++|+|+
T Consensus 80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 3333444443 447899999999999999999998988 89999999999999999988888776 789999999999
Q ss_pred CCCcCCCCchh---ccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccc
Q 001238 155 SNQLEGAIPIQ---IGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSI 231 (1117)
Q Consensus 155 ~N~l~~~~p~~---~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~ 231 (1117)
+|++++..|.. ++++++|++|++++|++++.+|. +.+++|++|++++|+. .+.+|. ++++++|++|++++|.+
T Consensus 160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l-~~~~~~-l~~l~~L~~L~Ls~n~l 235 (768)
T 3rgz_A 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNF-STGIPF-LGDCSALQHLDISGNKL 235 (768)
T ss_dssp SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCC-CSCCCB-CTTCCSCCEEECCSSCC
T ss_pred CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcC-CCCCcc-cccCCCCCEEECcCCcC
Confidence 99999888877 78899999999999999876664 8889999999998874 456666 88999999999999999
Q ss_pred cccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCC-CCCcEEEccCCcCcccCCcC
Q 001238 232 SGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNL-KNLVNLFLWQNNLVGIIPPE 310 (1117)
Q Consensus 232 ~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p~~ 310 (1117)
.+.+|..+..+++|++|++++|.+.+.+|.. .+++|++|+|++|++++.+|..+.++ ++|++|+|++|++++.+|..
T Consensus 236 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~ 313 (768)
T 3rgz_A 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313 (768)
T ss_dssp CSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG
T ss_pred CCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchH
Confidence 9888889999999999999999988887775 88899999999999988888888775 89999999999999888888
Q ss_pred CCCCCCCCEEEcCCCcCCCCCccc-cCCCCCcceEecccccccCcccccccCCC-CCcEEEecCccccCCCCccccc--c
Q 001238 311 LGNCSQLSIIDISMNSLTGSIPQT-LGNLTSLQELQLSVNQISGEIPAQIGNCQ-RLAQIELDNNQITGAIPSEFGN--L 386 (1117)
Q Consensus 311 ~~~l~~L~~LdLs~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~--l 386 (1117)
|+++++|++|+|++|.+++.+|.. +.++++|++|+|++|.+++.+|..+.+++ +|++|++++|++++.+|..+.. +
T Consensus 314 ~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~ 393 (768)
T 3rgz_A 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393 (768)
T ss_dssp GGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTT
T ss_pred HhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhccc
Confidence 999999999999999998777765 88899999999999999888888888887 8999999999998888887776 7
Q ss_pred cchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceecc
Q 001238 387 SNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRA 466 (1117)
Q Consensus 387 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 466 (1117)
++|++|++++|++++.+|..+.++++|++|+|++|++++.+|..+..+++|++|++++|++++.+|..+..+++|++|++
T Consensus 394 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 473 (768)
T 3rgz_A 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473 (768)
T ss_dssp CCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred CCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEe
Confidence 88899999999998888888888889999999999988888888888889999999999998888888888899999999
Q ss_pred CCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCC
Q 001238 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGM 546 (1117)
Q Consensus 467 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 546 (1117)
++|++++.+|..+.++++|++|+|++|++++.+|.++..+++|++|+|++|++++.+|..+..+++|+.|++++|++.+.
T Consensus 474 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 553 (768)
T 3rgz_A 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT 553 (768)
T ss_dssp CSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESB
T ss_pred cCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCc
Confidence 99999888888888889999999999999888888888899999999999999888888888889999999988887643
Q ss_pred CC----------------------------------------------------------------------CCcCCCcc
Q 001238 547 LS----------------------------------------------------------------------PDLGSLSS 556 (1117)
Q Consensus 547 ~~----------------------------------------------------------------------~~~~~l~~ 556 (1117)
.+ ..|..+++
T Consensus 554 ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~ 633 (768)
T 3rgz_A 554 IPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633 (768)
T ss_dssp CCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBC
T ss_pred CChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccc
Confidence 22 23556788
Q ss_pred ccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEecc
Q 001238 557 LTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLS 636 (1117)
Q Consensus 557 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs 636 (1117)
|+.|+|++|+++|.+|..|+.++.|+.|+|++|+++|.+|..++.++.| +.||||+|+++|.+|..+..+++|++||||
T Consensus 634 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L-~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls 712 (768)
T 3rgz_A 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL-NILDLSSNKLDGRIPQAMSALTMLTEIDLS 712 (768)
T ss_dssp CCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC-CEEECCSSCCEECCCGGGGGCCCCSEEECC
T ss_pred ccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCC-CEEECCCCcccCcCChHHhCCCCCCEEECc
Confidence 9999999999999999999999999999999999999999999999999 899999999999999999999999999999
Q ss_pred CccccCCcchhhhcccceEEEeeccc-ccC
Q 001238 637 HNELSGDLHFLAELQNLVVLNVSHNN-FSG 665 (1117)
Q Consensus 637 ~N~l~~~~~~l~~l~~L~~L~ls~N~-l~~ 665 (1117)
+|+++|.+|....+..+....+.+|. |.|
T Consensus 713 ~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 713 NNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp SSEEEEECCSSSSGGGSCGGGGCSCTEEES
T ss_pred CCcccccCCCchhhccCCHHHhcCCchhcC
Confidence 99999999987777777777788885 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-63 Score=620.79 Aligned_cols=585 Identities=20% Similarity=0.193 Sum_probs=447.8
Q ss_pred EecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCc
Q 001238 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158 (1117)
Q Consensus 79 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 158 (1117)
+|++++++. .+|..+. +++++|+|++|++++..+..|+++++|++|||++|.+++..|..++++++|++|+|++|.+
T Consensus 9 ~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 85 (680)
T 1ziw_A 9 ADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85 (680)
T ss_dssp EECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCC
T ss_pred eECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCcc
Confidence 344444553 3777665 7899999999999988888899999999999999999988899999999999999999999
Q ss_pred CCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcc
Q 001238 159 EGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPT 238 (1117)
Q Consensus 159 ~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~ 238 (1117)
++..+..|+++++|++|+|++|++++..|..|+++++|++|++++|+ +.+..|..++++++|++|++++|.+++..+..
T Consensus 86 ~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 164 (680)
T 1ziw_A 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG-LSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164 (680)
T ss_dssp CCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSC-CSCCCCCSSSCCTTCCEEECCSSCCCCBCHHH
T ss_pred CccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCc-ccccCchhhcccccCCEEEccCCcccccCHHH
Confidence 95555579999999999999999998778899999999999999997 45677888999999999999999999887776
Q ss_pred cc--cccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCC---CCCCCcEEEccCCcCcccCCcCCCC
Q 001238 239 LG--LLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLG---NLKNLVNLFLWQNNLVGIIPPELGN 313 (1117)
Q Consensus 239 l~--~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~---~l~~L~~L~L~~n~l~~~~p~~~~~ 313 (1117)
+. .+++|+.|++++|.+.+..|..+..+++|+.|++.+|.+.+.....+. ..++|+.|++++|.+.+..|..|.+
T Consensus 165 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~ 244 (680)
T 1ziw_A 165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244 (680)
T ss_dssp HGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGG
T ss_pred hhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhc
Confidence 65 458999999999999998899999999999999999887643322221 3478999999999999988888888
Q ss_pred CCC--CCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCC-----CCc----c
Q 001238 314 CSQ--LSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGA-----IPS----E 382 (1117)
Q Consensus 314 l~~--L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----~p~----~ 382 (1117)
++. |++|+|++|++++..|..|+.+++|++|+|++|++++..|..|.++++|+.|++++|...+. +|. .
T Consensus 245 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~ 324 (680)
T 1ziw_A 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324 (680)
T ss_dssp GGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTT
T ss_pred cCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhh
Confidence 755 99999999999988888899999999999999999988888999999999999998765542 222 5
Q ss_pred cccccchHHHHhccccccccCCCCCCcccccceeecccccccCC-Cc-ccccC--CCCCCeeeccCccCCCCCCCCcccc
Q 001238 383 FGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP-IP-RGIFQ--LKKLNKLLLLSNNLSGVIPPEMGNC 458 (1117)
Q Consensus 383 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p-~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l 458 (1117)
|..+++|++|++++|++++..+..|..+++|++|++++|.+... ++ ..+.. .++|+.|++++|++++..|..|..+
T Consensus 325 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l 404 (680)
T 1ziw_A 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL 404 (680)
T ss_dssp TTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTC
T ss_pred cccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCC
Confidence 66777777777777777777777777777777777777765421 11 22222 2467777777777777777777777
Q ss_pred cccceeccCCCcccccCC-CCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccc--cccchhhhccccccc
Q 001238 459 SSLIRFRANSNKLTGFIP-PEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIA--GNLPAGLHQLVRLQF 535 (1117)
Q Consensus 459 ~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~ 535 (1117)
++|+.|++++|++++.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+. +..|..|..+++|+.
T Consensus 405 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~ 484 (680)
T 1ziw_A 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484 (680)
T ss_dssp TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCE
T ss_pred CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCE
Confidence 777777777777766544 56777777777777777777667777777777777777777765 456667777777777
Q ss_pred ccccCCcCCCCCCCCcCCCccccEEeccccccCCCCC--------cccccccceeEEeccccccccccccccCCchhHHH
Q 001238 536 ADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIP--------SQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAI 607 (1117)
Q Consensus 536 L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~ 607 (1117)
|++++|+|+++++..|.++++|+.|+|++|++++..+ ..|..+++|+.|+|++|+++...+..|..++++ +
T Consensus 485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L-~ 563 (680)
T 1ziw_A 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL-K 563 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-C
T ss_pred EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc-c
Confidence 7777777777777777777777777777777764321 235666777777777777763323345666666 5
Q ss_pred hhcCCCCcccCCccccccCCCCccEEeccCccccCCcch-hh-hcccceEEEeecccccCCCC
Q 001238 608 ALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF-LA-ELQNLVVLNVSHNNFSGRVP 668 (1117)
Q Consensus 608 ~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~-l~-~l~~L~~L~ls~N~l~~~~p 668 (1117)
.|+|++|+|++..+..|..+++|+.|||++|++++.++. +. .+++|+.|++++|++.|..+
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 666666666655555666666666666666666665544 33 46666666666666665544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-62 Score=613.21 Aligned_cols=582 Identities=21% Similarity=0.211 Sum_probs=516.3
Q ss_pred cceeeEEecC----------CCcEEEEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCC
Q 001238 63 CKWFGVSCNL----------NNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSEN 132 (1117)
Q Consensus 63 C~W~gv~C~~----------~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 132 (1117)
|.++-|.|.. ..++..|+++++.+.+..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 6666777742 246889999999999877778999999999999999999999999999999999999999
Q ss_pred CcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCC
Q 001238 133 SLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLP 212 (1117)
Q Consensus 133 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp 212 (1117)
.+++..+..|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|+. .+..|
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l-~~~~~ 162 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI-QALKS 162 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCC-CCBCH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcc-cccCH
Confidence 99954445799999999999999999977778999999999999999999999999999999999999999974 44445
Q ss_pred cccc--ccccccccccccccccccCCcccccccccceeecccccccccCCcCC---CCCCCCcEEecCCCccCCcCCccC
Q 001238 213 HEIG--NCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPEL---GDCTELQYIYLYENALTGSIPSKL 287 (1117)
Q Consensus 213 ~~l~--~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l---~~l~~L~~L~L~~n~l~~~~p~~l 287 (1117)
..++ .+++|+.|++++|.+.+..|..+..+.+|+.|++.++.+.+.....+ -..++|++|++++|.+++..|..|
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 5544 56899999999999999999999999999999999887654322211 134789999999999999999999
Q ss_pred CCCCC--CcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccC-----cccc---
Q 001238 288 GNLKN--LVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISG-----EIPA--- 357 (1117)
Q Consensus 288 ~~l~~--L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-----~~p~--- 357 (1117)
.+++. |++|+|++|++.+..|..|+.+++|++|+|++|.+++..|..|.++++|++|++++|...+ .+|.
T Consensus 243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~ 322 (680)
T 1ziw_A 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322 (680)
T ss_dssp GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence 98865 9999999999999989999999999999999999999999999999999999999886654 2333
Q ss_pred -cccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccc--cCCCCCCcc--cccceeecccccccCCCccccc
Q 001238 358 -QIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEG--EIPPSISNC--QNLEAVDLSQNGLTGPIPRGIF 432 (1117)
Q Consensus 358 -~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~ 432 (1117)
.|..+++|++|++++|++++..+..|.++++|++|++++|.++. .....|..+ ++|+.|++++|++++..|..+.
T Consensus 323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~ 402 (680)
T 1ziw_A 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred hhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence 78899999999999999999999999999999999999998543 233344443 5899999999999988899999
Q ss_pred CCCCCCeeeccCccCCCCCC-CCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCC--CCCCcccccCCCC
Q 001238 433 QLKKLNKLLLLSNNLSGVIP-PEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLT--GSIPDEITGCRNL 509 (1117)
Q Consensus 433 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L 509 (1117)
.+++|+.|++++|++.+.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..|..+++|
T Consensus 403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L 482 (680)
T 1ziw_A 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482 (680)
T ss_dssp TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence 99999999999999987665 68999999999999999999999999999999999999999997 5789999999999
Q ss_pred ceEEccCCccccccchhhhcccccccccccCCcCCCCCC--------CCcCCCccccEEeccccccCCCCCcccccccce
Q 001238 510 TFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS--------PDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKL 581 (1117)
Q Consensus 510 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~--------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 581 (1117)
++|+|++|+|++..+..|..+++|+.|++++|+++++.. ..|.++++|+.|+|++|+|+...+..|..+++|
T Consensus 483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 562 (680)
T 1ziw_A 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence 999999999999888899999999999999999998743 347889999999999999997777789999999
Q ss_pred eEEeccccccccccccccCCchhHHHhhcCCCCcccCCcccccc-CCCCccEEeccCccccCCcch
Q 001238 582 QLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELT-GLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 582 ~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~-~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
+.|||++|++++..+..|..++++ +.|+|++|+|++..|..+. .+++|+.|+|++|++.|+++.
T Consensus 563 ~~L~Ls~N~l~~l~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 563 KIIDLGLNNLNTLPASVFNNQVSL-KSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTC-CEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred ceeECCCCCCCcCCHhHhCCCCCC-CEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 999999999996666667888998 8999999999999988888 899999999999999998764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-58 Score=568.38 Aligned_cols=536 Identities=20% Similarity=0.235 Sum_probs=326.5
Q ss_pred EecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCc
Q 001238 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158 (1117)
Q Consensus 79 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 158 (1117)
+++++.++. .+|..+.. ++++|+|++|++++..|.+|+++++|++|||++|.+++..|..|.++++|++|+|++|++
T Consensus 17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 334444443 36666653 789999999999988889999999999999999999988899999999999999999999
Q ss_pred CCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcc
Q 001238 159 EGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPT 238 (1117)
Q Consensus 159 ~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~ 238 (1117)
++..|..|+++++|++|+|++|++++..|..++.+++|++|++++|+...-.+|..++ +++|+.|++++|.+.+..|..
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCC-CTTCCEEECCSSCCCEECHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccC-CcccCEEEcccCcccccChhh
Confidence 9888999999999999999999999877888999999999999988754333444444 778888888888777777777
Q ss_pred cccccccc--eeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCccc-----CCcCC
Q 001238 239 LGLLKRLQ--TIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGI-----IPPEL 311 (1117)
Q Consensus 239 l~~l~~L~--~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-----~p~~~ 311 (1117)
+..+++|+ .|++++|.+.+..|..+.. .+|++|++++|. .++..+..+.++....+.-+.+.+. .+..|
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~ 248 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHh
Confidence 77777777 6677777776655555443 567777777665 2333344444444333332222211 11112
Q ss_pred CCCC--CCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccch
Q 001238 312 GNCS--QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNL 389 (1117)
Q Consensus 312 ~~l~--~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 389 (1117)
..+. +|+.|++++|.+++..+..|..+++|++|++++|+++ .+|..+.++++|++|++++|++++..|..+..+++|
T Consensus 249 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 327 (606)
T 3t6q_A 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327 (606)
T ss_dssp GGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTC
T ss_pred chhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcC
Confidence 2221 4555555555555444444555555555555555555 444455555555555555555554444445555555
Q ss_pred HHHHhccccccccCCC-CCCcccccceeecccccccCCC--cccccCCCCCCeeeccCccCCCCCCCCcccccccceecc
Q 001238 390 TLLFVWHNRLEGEIPP-SISNCQNLEAVDLSQNGLTGPI--PRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRA 466 (1117)
Q Consensus 390 ~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 466 (1117)
+.|++++|.+.+.++. .+..+++|++|++++|.+++.. +..+..+++|++|++++|++.+..|..|..+++|++|++
T Consensus 328 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 407 (606)
T 3t6q_A 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407 (606)
T ss_dssp SEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred CEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence 5555555554433332 2444445555555555444322 333444444444444444444444444444444444444
Q ss_pred CCCcccccCCCC-cCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCC
Q 001238 467 NSNKLTGFIPPE-IGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGG 545 (1117)
Q Consensus 467 ~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~ 545 (1117)
++|++++..+.. |..+++|++|++++|++++..|..+..+++|++|++++|++.+...
T Consensus 408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--------------------- 466 (606)
T 3t6q_A 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI--------------------- 466 (606)
T ss_dssp TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEE---------------------
T ss_pred CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCcccc---------------------
Confidence 444444333222 4444444444444444444444444444444444444444432100
Q ss_pred CCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCcccccc
Q 001238 546 MLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELT 625 (1117)
Q Consensus 546 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~ 625 (1117)
.....+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++.+|..+..++.+ .|+|++|++++.+|..+.
T Consensus 467 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L--~L~L~~N~l~~~~~~~~~ 544 (606)
T 3t6q_A 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI--YLNLASNHISIILPSLLP 544 (606)
T ss_dssp CSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC--EEECCSSCCCCCCGGGHH
T ss_pred ccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc--EEECcCCcccccCHhhcc
Confidence 111334555566666666666665556666666666666666666666666666666665 566666666666666677
Q ss_pred CCCCccEEeccCccccCCcch
Q 001238 626 GLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 626 ~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
.+++|+.|||++|++.|+++.
T Consensus 545 ~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 545 ILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp HHHTSSEEECTTCCEECSGGG
T ss_pred cCCCCCEEeCCCCCccccCCc
Confidence 777777888888888777653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-58 Score=565.88 Aligned_cols=474 Identities=23% Similarity=0.286 Sum_probs=340.5
Q ss_pred chhHHHHHHHHHhhccCCCCC--------CCCCCCCCCCCcce---eeEEecCCCcEEEEecccccccCcCCcccccccc
Q 001238 31 VNRQGEALLSWKRNWKGSDDG--------LSNWSPSDETPCKW---FGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLS 99 (1117)
Q Consensus 31 ~~~~~~aLl~~k~~~~~~~~~--------l~sW~~~~~~~C~W---~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~ 99 (1117)
...|++||.+||+++.++.+. .++|..+ .+||.| +||+|+..+||++|+|+++++.|.+|+.|+.|++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCcc
Confidence 346999999999997666443 3479854 679999 9999998899999999999999999999999999
Q ss_pred CCeEeccCCCC------CC------CchhhhcccccCcEeeccCCCcCCCCchhhhh-hhhhhhhhcc------------
Q 001238 100 LNRLVLSGTNL------TG------SIPKEIASLNQLNYLDLSENSLTGEIPRELCS-LLRLEQLRLN------------ 154 (1117)
Q Consensus 100 L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~------------ 154 (1117)
|+.|+|++|++ .| .+|.+. +..|+ ++++.|.+.+.+|..+.. +..+..+++.
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l 183 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred ceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence 99999999976 34 677766 77888 999999999999988874 4566666666
Q ss_pred --------CCCcCCCCchhccCCcCCcEEeccCCCCCCC-----------------Cccccc--CcccchhhhccCCCCC
Q 001238 155 --------SNQLEGAIPIQIGNLSSLTQLFLYDNQLTDA-----------------IPATIG--KLKNLEAIRAGGNKNL 207 (1117)
Q Consensus 155 --------~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~n~~~ 207 (1117)
.|+++| +|..|+++++|++|+|++|++++. +|+.++ ++++|++|++++|+ +
T Consensus 184 ~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~-l 261 (636)
T 4eco_A 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP-N 261 (636)
T ss_dssp CTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCT-T
T ss_pred hhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCc-C
Confidence 678887 888888889999999999888875 777777 78888888887775 4
Q ss_pred CCCCCcccccccccccccccccc-ccc-cCCcccccc------cccceeecccccccccCCc--CCCCCCCCcEEecCCC
Q 001238 208 GGSLPHEIGNCTNLVMIGLAETS-ISG-FLPPTLGLL------KRLQTIAIYTALLSGQIPP--ELGDCTELQYIYLYEN 277 (1117)
Q Consensus 208 ~~~lp~~l~~l~~L~~L~l~~~~-~~~-~lp~~l~~l------~~L~~L~l~~~~l~~~~p~--~l~~l~~L~~L~L~~n 277 (1117)
.+.+|..++++++|++|++++|. +++ .+|..++.+ ++|++|++++|.+. .+|. .++.+++|++|+|++|
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence 46777777777777777777777 776 677777665 77777777777776 6666 6777777777777777
Q ss_pred ccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCC-CCEEEcCCCcCCCCCccccCCCC--CcceEecccccccCc
Q 001238 278 ALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ-LSIIDISMNSLTGSIPQTLGNLT--SLQELQLSVNQISGE 354 (1117)
Q Consensus 278 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~LdLs~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~~~ 354 (1117)
+++|.+| .|+++++|++|+|++|+++ .+|..+..+++ |++|++++|.++ .+|..+..++ +|++|++++|.+++.
T Consensus 341 ~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~ 417 (636)
T 4eco_A 341 QLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417 (636)
T ss_dssp CCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred cCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence 7777777 6777777777777777777 66666777777 777777777777 5666665544 677777777777777
Q ss_pred cccccc-------CCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCC-Ccc-------cccceeecc
Q 001238 355 IPAQIG-------NCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNC-------QNLEAVDLS 419 (1117)
Q Consensus 355 ~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l-------~~L~~L~Ls 419 (1117)
+|..|. .+.+|++|++++|+++...+..+..+++|+.|+|++|+++ .+|..+ ... ++|+.|+|+
T Consensus 418 ~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls 496 (636)
T 4eco_A 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLR 496 (636)
T ss_dssp TTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECC
T ss_pred chhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECc
Confidence 776666 6667777777777777433334455677777777777776 444332 222 266667777
Q ss_pred cccccCCCccccc--CCCCCCeeeccCccCCCCCCCCcccccccceeccC------CCcccccCCCCcCCCCCCCEEEcc
Q 001238 420 QNGLTGPIPRGIF--QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRAN------SNKLTGFIPPEIGNLKNLNFLDLG 491 (1117)
Q Consensus 420 ~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~------~N~l~~~~~~~~~~l~~L~~L~Ls 491 (1117)
+|+++ .+|..++ .+++|++|+|++|+|++ +|..+.++++|+.|+++ +|++.+.+|..|.++++|++|+|+
T Consensus 497 ~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls 574 (636)
T 4eco_A 497 FNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574 (636)
T ss_dssp SSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECC
T ss_pred CCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECC
Confidence 77666 4666665 66666666666666665 56666666666666663 344555555555555555555555
Q ss_pred CCcCCCCCCcccccCCCCceEEccCCccc
Q 001238 492 SNRLTGSIPDEITGCRNLTFLDVHSNSIA 520 (1117)
Q Consensus 492 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 520 (1117)
+|+++ .+|..+. ++|++|+|++|++.
T Consensus 575 ~N~l~-~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 575 SNDIR-KVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp SSCCC-BCCSCCC--TTCCEEECCSCTTC
T ss_pred CCcCC-ccCHhHh--CcCCEEECcCCCCc
Confidence 55552 4444433 45555555555544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=572.21 Aligned_cols=525 Identities=22% Similarity=0.234 Sum_probs=353.2
Q ss_pred EecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCC-chhhhhhhhhhhhhccCCC
Q 001238 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEI-PRELCSLLRLEQLRLNSNQ 157 (1117)
Q Consensus 79 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~ 157 (1117)
+|++++++.. +|. ..++|++|+|++|++++..|.+|.++++|++|||++|.+.+.+ |..|.++++|++|+|++|.
T Consensus 9 ~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~ 84 (844)
T 3j0a_A 9 AFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84 (844)
T ss_dssp EEESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred EEccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence 3455666654 665 3478999999999999888999999999999999999776666 7889999999999999999
Q ss_pred cCCCCchhccCCcCCcEEeccCCCCCCCCccc--ccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccC
Q 001238 158 LEGAIPIQIGNLSSLTQLFLYDNQLTDAIPAT--IGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFL 235 (1117)
Q Consensus 158 l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~l 235 (1117)
+++..|..|+++++|++|+|++|++++.+|.. |+++++|++|++++|+......+..++++++|++|++++|.+.+..
T Consensus 85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~ 164 (844)
T 3j0a_A 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC 164 (844)
T ss_dssp CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence 99888999999999999999999999877765 9999999999999998654445568899999999999999999988
Q ss_pred Ccccccc--cccceeecccccccccCCcCCCCCCC------CcEEecCCCccCCcCCccCCCC---CCCcEEEccCCc--
Q 001238 236 PPTLGLL--KRLQTIAIYTALLSGQIPPELGDCTE------LQYIYLYENALTGSIPSKLGNL---KNLVNLFLWQNN-- 302 (1117)
Q Consensus 236 p~~l~~l--~~L~~L~l~~~~l~~~~p~~l~~l~~------L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~L~~n~-- 302 (1117)
|..+..+ ++|+.|++++|.+.+..|..+..+++ |++|++++|.+++..|..+... .+++.|.+..+.
T Consensus 165 ~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~ 244 (844)
T 3j0a_A 165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG 244 (844)
T ss_dssp SGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCB
T ss_pred HHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccc
Confidence 8888888 88999999999998888888777766 8999999998888777766543 567777776333
Q ss_pred -------CcccCCcCCCCC--CCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCc
Q 001238 303 -------LVGIIPPELGNC--SQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNN 373 (1117)
Q Consensus 303 -------l~~~~p~~~~~l--~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 373 (1117)
+.+..+..|..+ ++|+.|+|++|.+.+..|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 245 ~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N 324 (844)
T 3j0a_A 245 AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324 (844)
T ss_dssp CSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESC
T ss_pred ccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCC
Confidence 222223334333 45666666666666555556666666666666666666555556666666666666666
Q ss_pred cccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCC
Q 001238 374 QITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPP 453 (1117)
Q Consensus 374 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 453 (1117)
++++..|..|..+++|+.|++++|++++..+..|..+++|++|+|++|.+++ ++ .+++|+.|++++|+++.. |.
T Consensus 325 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~~N~l~~l-~~ 398 (844)
T 3j0a_A 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLSGNKLVTL-PK 398 (844)
T ss_dssp CCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEESCCCCCC-CC
T ss_pred CCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccCCCCcccc-cc
Confidence 6665555556666666666666666655555555555566666666665552 21 144555555555555422 22
Q ss_pred CcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCC-cccccCCCCceEEccCCccccccch-hhhccc
Q 001238 454 EMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIP-DEITGCRNLTFLDVHSNSIAGNLPA-GLHQLV 531 (1117)
Q Consensus 454 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~ 531 (1117)
. .. +++.|++++|++++... ..+..+++|++|+|++|++++..+. .+..++
T Consensus 399 ~---~~------------------------~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 451 (844)
T 3j0a_A 399 I---NL------------------------TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451 (844)
T ss_dssp C---CT------------------------TCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCT
T ss_pred c---cc------------------------ccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCC
Confidence 1 23 44445555555543211 1223445555555555555433222 233344
Q ss_pred ccccccccCCcCCC-----CCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHH
Q 001238 532 RLQFADLSDNSVGG-----MLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALA 606 (1117)
Q Consensus 532 ~L~~L~Ls~N~i~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~ 606 (1117)
+|+.|++++|.++. ..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+. +++
T Consensus 452 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L- 528 (844)
T 3j0a_A 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANL- 528 (844)
T ss_dssp TCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCC-
T ss_pred ccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccc-
Confidence 55555555555542 2234556666666666666666666666666666777777777766654444332 333
Q ss_pred HhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch
Q 001238 607 IALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 607 ~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
+.|+|++|+|++.+|..| .+|+.|+|++|++.|+++.
T Consensus 529 ~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 529 EILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSC
T ss_pred cEEECCCCcCCCCChhHh---CCcCEEEecCCCccccccc
Confidence 455555555555555544 3567788888888876653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-57 Score=556.97 Aligned_cols=534 Identities=19% Similarity=0.181 Sum_probs=418.5
Q ss_pred CeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCC
Q 001238 101 NRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDN 180 (1117)
Q Consensus 101 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N 180 (1117)
+.++.++.+++ .+|..+.. .+++|||++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 15 ~~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 15 KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp TEEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 36788888888 78877764 7999999999999877889999999999999999999888999999999999999999
Q ss_pred CCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCC
Q 001238 181 QLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIP 260 (1117)
Q Consensus 181 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p 260 (1117)
++++..|..|+.+++|++|++++|+ +++..|..+.++++|++|++++|.+.+..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n~-------------------------i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~ 146 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQTG-------------------------ISSIDFIPLHNQKTLESLYLGSNHISSIKL 146 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTSC-------------------------CSCGGGSCCTTCTTCCEEECCSSCCCCCCC
T ss_pred cccccChhhhcccccccEeeccccC-------------------------cccCCcchhccCCcccEEECCCCcccccCc
Confidence 9988777777777777777766664 333334445556666666666666655443
Q ss_pred cCCCCCCCCcEEecCCCccCCcCCccCCCCCCCc--EEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCC
Q 001238 261 PELGDCTELQYIYLYENALTGSIPSKLGNLKNLV--NLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNL 338 (1117)
Q Consensus 261 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~--~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l 338 (1117)
+.+..+++|++|++++|.+++..|..|+.+++|+ +|++++|.+.+..|..|.. .+|+.|++++|. .++..+..+
T Consensus 147 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l 222 (606)
T 3t6q_A 147 PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGL 222 (606)
T ss_dssp CTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHT
T ss_pred ccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhc
Confidence 4444578888888888888877777788888888 7888888888766666544 578888888876 234444444
Q ss_pred CCcceEeccccccc-----CcccccccCCC--CCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCccc
Q 001238 339 TSLQELQLSVNQIS-----GEIPAQIGNCQ--RLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQ 411 (1117)
Q Consensus 339 ~~L~~L~Ls~N~l~-----~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 411 (1117)
.++....+..+.+. ...+..|..+. +|+.|++++|.+++..+..|+.+++|++|++++|+++ .+|..+..++
T Consensus 223 ~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~ 301 (606)
T 3t6q_A 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLS 301 (606)
T ss_dssp TTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCT
T ss_pred cccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccc
Confidence 44433333322221 12233333333 6888888888888877777888888888888888888 6777888888
Q ss_pred ccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCC-CcccccccceeccCCCcccccC--CCCcCCCCCCCEE
Q 001238 412 NLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPP-EMGNCSSLIRFRANSNKLTGFI--PPEIGNLKNLNFL 488 (1117)
Q Consensus 412 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L 488 (1117)
+|++|++++|++++..|..+..+++|++|++++|.+.+.+|. .+..+++|++|++++|++++.. +..+..+++|++|
T Consensus 302 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L 381 (606)
T 3t6q_A 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381 (606)
T ss_dssp TCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEE
T ss_pred cCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEE
Confidence 888888888888877777888888888888888888865554 4888888888888888888765 7778888889999
Q ss_pred EccCCcCCCCCCcccccCCCCceEEccCCccccccch-hhhcccccccccccCCcCCCCCCCCcCCCccccEEecccccc
Q 001238 489 DLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPA-GLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRF 567 (1117)
Q Consensus 489 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l 567 (1117)
++++|++++..|..|..+++|++|++++|.+.+..+. .+..+++|+.|++++|.+.+..+..|..+++|++|++++|++
T Consensus 382 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 461 (606)
T 3t6q_A 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461 (606)
T ss_dssp ECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBC
T ss_pred ECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCC
Confidence 9999888888888888888899999999888876554 488888888888888888888888888888899999999888
Q ss_pred CC---CCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCc
Q 001238 568 AG---SIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDL 644 (1117)
Q Consensus 568 ~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~ 644 (1117)
.+ ..+..+..+++|+.|++++|++++.+|..+..++.+ +.|+|++|++++..|..+..+++| .|||++|++++.+
T Consensus 462 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~ 539 (606)
T 3t6q_A 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM-NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539 (606)
T ss_dssp GGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTC-CEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCC
T ss_pred CccccccchhhccCCCccEEECCCCccCccChhhhccccCC-CEEECCCCccCcCChhHhCccccc-EEECcCCcccccC
Confidence 76 233568888889999999999888888888888888 788888888888888888888888 8888888888876
Q ss_pred ch-hhhcccceEEEeecccccCCCCC
Q 001238 645 HF-LAELQNLVVLNVSHNNFSGRVPD 669 (1117)
Q Consensus 645 ~~-l~~l~~L~~L~ls~N~l~~~~p~ 669 (1117)
+. +..+++|+.|++++|+++|..+.
T Consensus 540 ~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 540 PSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp GGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred HhhcccCCCCCEEeCCCCCccccCCc
Confidence 65 77888888888888888876654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-56 Score=568.75 Aligned_cols=526 Identities=22% Similarity=0.227 Sum_probs=406.5
Q ss_pred eEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCC-chhccCCcCCcEEeccCC
Q 001238 102 RLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAI-PIQIGNLSSLTQLFLYDN 180 (1117)
Q Consensus 102 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~L~~L~~L~L~~N 180 (1117)
..+.++++++ .+|. -.++|++|||++|.+++..|..|.++++|++|+|++|.+.+.+ |..|++|++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 5678889998 6776 5689999999999999888999999999999999999777677 788999999999999999
Q ss_pred CCCCCCcccccCcccchhhhccCCCCCCCCCCcc--ccccccccccccccccccccCC-cccccccccceeecccccccc
Q 001238 181 QLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHE--IGNCTNLVMIGLAETSISGFLP-PTLGLLKRLQTIAIYTALLSG 257 (1117)
Q Consensus 181 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~--l~~l~~L~~L~l~~~~~~~~lp-~~l~~l~~L~~L~l~~~~l~~ 257 (1117)
++++..|..|+++++|++|++++|.. .+.+|.. ++++++|++|++++|.+.+..+ ..++++++
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l-~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~------------- 149 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGL-SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNS------------- 149 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCC-SSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSS-------------
T ss_pred cCcccCHhHccCCcccCEeeCcCCCC-CcccccCccccccCCCCEEECCCCcccccccchhHhhCCC-------------
Confidence 99988888899888888888888863 3444443 6666666666666666655433 34444444
Q ss_pred cCCcCCCCCCCCcEEecCCCccCCcCCccCCCC--CCCcEEEccCCcCcccCCcCCCCCCC------CCEEEcCCCcCCC
Q 001238 258 QIPPELGDCTELQYIYLYENALTGSIPSKLGNL--KNLVNLFLWQNNLVGIIPPELGNCSQ------LSIIDISMNSLTG 329 (1117)
Q Consensus 258 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~------L~~LdLs~N~l~~ 329 (1117)
|++|+|++|.+++..|..+..+ ++|+.|++++|.+.+..|..++.+.+ |+.|++++|.+++
T Consensus 150 -----------L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~ 218 (844)
T 3j0a_A 150 -----------LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTV 218 (844)
T ss_dssp -----------CCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSST
T ss_pred -----------CCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCch
Confidence 4455555555444444444444 44555555555555444444444333 5555555555555
Q ss_pred CCccccCCC---CCcceEecc---------cccccCcccccccCC--CCCcEEEecCccccCCCCcccccccchHHHHhc
Q 001238 330 SIPQTLGNL---TSLQELQLS---------VNQISGEIPAQIGNC--QRLAQIELDNNQITGAIPSEFGNLSNLTLLFVW 395 (1117)
Q Consensus 330 ~~p~~l~~l---~~L~~L~Ls---------~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 395 (1117)
.++..+... ++++.|.++ .|.+.+.....|.++ ++|+.|++++|.+.+..|..|..+++|+.|+|+
T Consensus 219 ~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 298 (844)
T 3j0a_A 219 DITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298 (844)
T ss_dssp TTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEE
T ss_pred hHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECC
Confidence 544444322 345555544 334444444555554 678999999999988888888899999999999
Q ss_pred cccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccC
Q 001238 396 HNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFI 475 (1117)
Q Consensus 396 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 475 (1117)
+|++++..|..|..+++|++|+|++|++++..|..+..+++|++|++++|++.+..+..|.++++|++|++++|.+++.
T Consensus 299 ~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i- 377 (844)
T 3j0a_A 299 YNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI- 377 (844)
T ss_dssp SCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-
T ss_pred CCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-
Confidence 9999988888899999999999999999887788899999999999999999988888899999999999999999843
Q ss_pred CCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccc-hhhhcccccccccccCCcCCCCCCC-CcCC
Q 001238 476 PPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLP-AGLHQLVRLQFADLSDNSVGGMLSP-DLGS 553 (1117)
Q Consensus 476 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~-~~~~ 553 (1117)
..+++|+.|++++|+++ .+|.. ..+++.|++++|++++... ..+..+++|+.|++++|+++++... .+..
T Consensus 378 ----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 449 (844)
T 3j0a_A 378 ----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449 (844)
T ss_dssp ----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCS
T ss_pred ----cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccccccc
Confidence 33789999999999998 45543 4678999999999997533 3456889999999999999987654 5667
Q ss_pred CccccEEeccccccC-----CCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCC
Q 001238 554 LSSLTKLVLNKNRFA-----GSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLN 628 (1117)
Q Consensus 554 l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~ 628 (1117)
+++|+.|+|++|.++ +..+..|..+++|+.|+|++|+|++.+|..+..+++| +.|+|++|+|++..|..+. +
T Consensus 450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~l~~~~~~--~ 526 (844)
T 3j0a_A 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL-RGLSLNSNRLTVLSHNDLP--A 526 (844)
T ss_dssp CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC-SEEEEESCCCSSCCCCCCC--S
T ss_pred CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh-heeECCCCCCCccChhhhh--c
Confidence 899999999999997 4556778899999999999999998888888899998 7899999999987777776 8
Q ss_pred CccEEeccCccccCCcchhhhcccceEEEeecccccCCCCCC
Q 001238 629 KLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDT 670 (1117)
Q Consensus 629 ~L~~LdLs~N~l~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~ 670 (1117)
+|+.|||++|+|++.++.. +.+|+.|++++|++.|..+..
T Consensus 527 ~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 527 NLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECELS 566 (844)
T ss_dssp CCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSCC
T ss_pred cccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccccH
Confidence 8999999999999877652 457899999999998877643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=554.52 Aligned_cols=530 Identities=20% Similarity=0.197 Sum_probs=344.9
Q ss_pred EEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCC
Q 001238 78 GLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQ 157 (1117)
Q Consensus 78 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 157 (1117)
.+++++.++. .+|..+. +++++|+|++|++++..|..|+++++|++|||++|.+++..|..|.++++|++|+|++|.
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 3455555554 3677665 789999999999998888899999999999999999998788899999999999999999
Q ss_pred cCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCc
Q 001238 158 LEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPP 237 (1117)
Q Consensus 158 l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~ 237 (1117)
+++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|+.....+|..++++++|++|++++|.+.+..|.
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 99888999999999999999999999888789999999999999999876667899999999999999999999988888
Q ss_pred ccccccccc----eeecccccccccCCcCCCCCCCCcEEecCCCccC-CcCCccCCCCCCCcEEEccCCcCcccC-----
Q 001238 238 TLGLLKRLQ----TIAIYTALLSGQIPPELGDCTELQYIYLYENALT-GSIPSKLGNLKNLVNLFLWQNNLVGII----- 307 (1117)
Q Consensus 238 ~l~~l~~L~----~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~----- 307 (1117)
.+..+++|+ +|++++|.+.+..+..+... +|++|++++|.++ +.+|..+.++++|+.+++..+.+.+..
T Consensus 172 ~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~ 250 (606)
T 3vq2_A 172 DLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250 (606)
T ss_dssp TTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred hhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccccc
Confidence 888887766 68888887776555555444 7888888888776 356667777777877777655443210
Q ss_pred -CcCCCCCC--CCCEEEc-CCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCccc
Q 001238 308 -PPELGNCS--QLSIIDI-SMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEF 383 (1117)
Q Consensus 308 -p~~~~~l~--~L~~LdL-s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 383 (1117)
+..+..+. +++.+++ ..|.+.+.+|. +..+++|+.|++++|.+. .+| .+..+++|++|++++|.+ +.+| .+
T Consensus 251 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~ 325 (606)
T 3vq2_A 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL 325 (606)
T ss_dssp CGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC
T ss_pred ChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC
Confidence 01111111 2334444 44455544444 555555555555555554 233 455555555555555555 3444 22
Q ss_pred ccccchHHHHhccccccccCCCCCCcccccceeecccccccCC--CcccccCCCCCCeeeccCccCCCCCCCCccccccc
Q 001238 384 GNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP--IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSL 461 (1117)
Q Consensus 384 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 461 (1117)
.+++|+.|++++|+..+.+ .+..+++|++|++++|++++. +|..+..+++|++|++++|.+++ +|..
T Consensus 326 -~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~------- 394 (606)
T 3vq2_A 326 -DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSAN------- 394 (606)
T ss_dssp -CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCC-------
T ss_pred -CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhh-------
Confidence 4555555555555333222 334455555555555555432 24444444555555555555443 2344
Q ss_pred ceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCC-cccccCCCCceEEccCCccccccchhhhcccccccccccC
Q 001238 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIP-DEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSD 540 (1117)
Q Consensus 462 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 540 (1117)
|..+++|+.|++++|++.+..| ..+..+++|++|++++|.+.+..|..|..+++|+.|++++
T Consensus 395 -----------------~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 457 (606)
T 3vq2_A 395 -----------------FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457 (606)
T ss_dssp -----------------CTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTT
T ss_pred -----------------ccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCC
Confidence 4444455555555554444443 3444445555555555555444444444555555555555
Q ss_pred CcCCC-CCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCC
Q 001238 541 NSVGG-MLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGE 619 (1117)
Q Consensus 541 N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~ 619 (1117)
|++++ +.+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|..+..++++ +.|+|++|+|+ .
T Consensus 458 n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~-~ 535 (606)
T 3vq2_A 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL-STLDCSFNRIE-T 535 (606)
T ss_dssp CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTC-CEEECTTSCCC-C
T ss_pred CcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcC-CEEECCCCcCc-c
Confidence 55444 234455555666666666666665556666666666666666666665555555555555 45555555555 4
Q ss_pred ccccccCCC-CccEEeccCccccCCcch
Q 001238 620 LPAELTGLN-KLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 620 ~p~~l~~l~-~L~~LdLs~N~l~~~~~~ 646 (1117)
+|..+..++ +|+.|++++|++.|+++.
T Consensus 536 ~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 536 SKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp EESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred cCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 555566665 488888888888876654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=563.40 Aligned_cols=497 Identities=21% Similarity=0.255 Sum_probs=337.3
Q ss_pred ccchhHHHHHHHHHhhccCCCCCCCCCCCCC----CCC--cce------------eeEEecCCCcEEEEecccccccCcC
Q 001238 29 YAVNRQGEALLSWKRNWKGSDDGLSNWSPSD----ETP--CKW------------FGVSCNLNNQVVGLDLRYVDLLGHV 90 (1117)
Q Consensus 29 ~~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~----~~~--C~W------------~gv~C~~~~~v~~l~l~~~~l~~~~ 90 (1117)
++...|++||++||+++.++ +|+.++ .+| |.| .||+|+..+||++|+|+++++.|.+
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE
T ss_pred ccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcC
Confidence 34567999999999999765 786543 344 999 9999998899999999999999999
Q ss_pred CccccccccCCeEec-cCCCCCCCchhhhccc---------ccCcEee------c-cCCCcCCCC-----------chhh
Q 001238 91 PTNFTSLLSLNRLVL-SGTNLTGSIPKEIASL---------NQLNYLD------L-SENSLTGEI-----------PREL 142 (1117)
Q Consensus 91 ~~~~~~l~~L~~L~L-~~n~l~~~~p~~~~~l---------~~L~~L~------L-s~N~l~~~~-----------p~~~ 142 (1117)
|+.|++|++|+.|+| ++|.++|..|-..... ..++... . ....+++.+ +...
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 8898887744321111 0000000 0 000000000 0000
Q ss_pred hhhhhhhhhhccC--CCcCCCCchhccCCcCCcEEeccCCCCCC-----------------CCccccc--Ccccchhhhc
Q 001238 143 CSLLRLEQLRLNS--NQLEGAIPIQIGNLSSLTQLFLYDNQLTD-----------------AIPATIG--KLKNLEAIRA 201 (1117)
Q Consensus 143 ~~l~~L~~L~L~~--N~l~~~~p~~~~~L~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~l 201 (1117)
.....++.+.++. |.+++ +|..|++|++|++|+|++|++++ .+|+.++ ++++|++|++
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred ccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence 1112233333333 56665 66666666666666666666665 2666655 6666666666
Q ss_pred cCCCCCCCCCCcccccccccccccccccc-ccc-cCCccccccc-------ccceeecccccccccCCc--CCCCCCCCc
Q 001238 202 GGNKNLGGSLPHEIGNCTNLVMIGLAETS-ISG-FLPPTLGLLK-------RLQTIAIYTALLSGQIPP--ELGDCTELQ 270 (1117)
Q Consensus 202 ~~n~~~~~~lp~~l~~l~~L~~L~l~~~~-~~~-~lp~~l~~l~-------~L~~L~l~~~~l~~~~p~--~l~~l~~L~ 270 (1117)
++|+ +.+.+|..++++++|+.|++++|. +++ .+|..++.++ +|+.|++++|.+. .+|. .++.+++|+
T Consensus 499 s~N~-l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~ 576 (876)
T 4ecn_A 499 YNCP-NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLG 576 (876)
T ss_dssp ESCT-TCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCC
T ss_pred cCCC-CCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCC
Confidence 6664 345666666666666666666665 665 5666555555 7777777777776 6676 777777777
Q ss_pred EEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCC-CCEEEcCCCcCCCCCccccCCCCC--cceEecc
Q 001238 271 YIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ-LSIIDISMNSLTGSIPQTLGNLTS--LQELQLS 347 (1117)
Q Consensus 271 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~LdLs~N~l~~~~p~~l~~l~~--L~~L~Ls 347 (1117)
+|+|++|+++ .+| .|+++++|+.|+|++|++. .+|..+.++++ |+.|+|++|.++ .+|..+..++. |+.|+|+
T Consensus 577 ~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls 652 (876)
T 4ecn_A 577 LLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFS 652 (876)
T ss_dssp EEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECC
T ss_pred EEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECc
Confidence 7777777777 666 6777777777777777777 66777777777 777777777777 56666666543 7777777
Q ss_pred cccccCcccccc---c--CCCCCcEEEecCccccCCCCcc-cccccchHHHHhccccccccCCCCCC--------ccccc
Q 001238 348 VNQISGEIPAQI---G--NCQRLAQIELDNNQITGAIPSE-FGNLSNLTLLFVWHNRLEGEIPPSIS--------NCQNL 413 (1117)
Q Consensus 348 ~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~--------~l~~L 413 (1117)
+|++++.+|... . .+.+|+.|+|++|+++ .+|.. +..+++|+.|+|++|+++ .+|..+. ++++|
T Consensus 653 ~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L 730 (876)
T 4ecn_A 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLL 730 (876)
T ss_dssp SSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGC
T ss_pred CCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCc
Confidence 777776555322 2 2346777777777777 34443 346777777777777777 4444332 33489
Q ss_pred ceeecccccccCCCccccc--CCCCCCeeeccCccCCCCCCCCcccccccceeccCC------CcccccCCCCcCCCCCC
Q 001238 414 EAVDLSQNGLTGPIPRGIF--QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANS------NKLTGFIPPEIGNLKNL 485 (1117)
Q Consensus 414 ~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~------N~l~~~~~~~~~~l~~L 485 (1117)
+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|++++ |++.+.+|..|.++++|
T Consensus 731 ~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L 808 (876)
T 4ecn_A 731 TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSL 808 (876)
T ss_dssp CEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSC
T ss_pred cEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCC
Confidence 99999999998 6888887 88899999999999987 688888888888888876 66666777777777777
Q ss_pred CEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCC
Q 001238 486 NFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG 544 (1117)
Q Consensus 486 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 544 (1117)
+.|+|++|+| +.+|..+. ++|+.|+|++|++....+..+.....+..+.|.+|++.
T Consensus 809 ~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 809 IQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp CEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred CEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 7777777777 45666554 46777777777776666666665555555666665543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-56 Score=550.27 Aligned_cols=532 Identities=19% Similarity=0.211 Sum_probs=430.9
Q ss_pred CeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCC
Q 001238 101 NRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDN 180 (1117)
Q Consensus 101 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N 180 (1117)
+.++.++++++ .+|..+. ++|++|||++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 46888999998 7887665 78999999999999777778999999999999999999777888999999999999999
Q ss_pred CCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccc-cC
Q 001238 181 QLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSG-QI 259 (1117)
Q Consensus 181 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~-~~ 259 (1117)
++++..|..|+++++|++|++++|+ +.+..+..++++++|++|++++|.+.+ .+
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n~-------------------------l~~~~~~~~~~l~~L~~L~L~~n~l~~~~l 145 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVETK-------------------------LASLESFPIGQLITLKKLNVAHNFIHSCKL 145 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTSC-------------------------CCCSSSSCCTTCTTCCEEECCSSCCCCCCC
T ss_pred cccccChhhcCCcccCCEEEccCCc-------------------------cccccccccCCCCCCCEEeCCCCcccceec
Confidence 9988777777777777777776665 333333444555555555555555544 45
Q ss_pred CcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCc----EEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCC-CCCccc
Q 001238 260 PPELGDCTELQYIYLYENALTGSIPSKLGNLKNLV----NLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLT-GSIPQT 334 (1117)
Q Consensus 260 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~-~~~p~~ 334 (1117)
|..++++++|++|+|++|++++..|..|+.+++|+ +|++++|.+++..+..+... +|+.|++++|.++ +.+|..
T Consensus 146 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~ 224 (606)
T 3vq2_A 146 PAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTC 224 (606)
T ss_dssp CGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHH
T ss_pred hHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHH
Confidence 66777777777777777777776666666665544 67777777776555555444 7778888877776 345666
Q ss_pred cCCCCCcceEecccccccC------cccccccCCC--CCcEEEe-cCccccCCCCcccccccchHHHHhccccccccCCC
Q 001238 335 LGNLTSLQELQLSVNQISG------EIPAQIGNCQ--RLAQIEL-DNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPP 405 (1117)
Q Consensus 335 l~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~--~L~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 405 (1117)
+.++++|+.+++..+.+.+ ..+..+..+. +++.+++ ..|.+.+.+|. |..+++|+.|++++|.+. .+|
T Consensus 225 ~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~- 301 (606)
T 3vq2_A 225 LQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE- 301 (606)
T ss_dssp HHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-
T ss_pred hccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-
Confidence 7777777777776555432 1122222222 4566777 77788888777 888999999999999987 455
Q ss_pred CCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCccccc--CCCCcCCCC
Q 001238 406 SISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGF--IPPEIGNLK 483 (1117)
Q Consensus 406 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l~ 483 (1117)
.+..+++|++|++++|.+ +.+| .+ .+++|++|++++|+..+.. .+..+++|++|++++|++++. .|..+..++
T Consensus 302 ~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~ 376 (606)
T 3vq2_A 302 DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376 (606)
T ss_dssp CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCS
T ss_pred hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCC
Confidence 788899999999999999 4788 44 8999999999999665443 677899999999999999876 378889999
Q ss_pred CCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccc-hhhhcccccccccccCCcCCCCCCCCcCCCccccEEec
Q 001238 484 NLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLP-AGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVL 562 (1117)
Q Consensus 484 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 562 (1117)
+|++|++++|.+++ +|..+..+++|++|++++|++.+..| ..|..+++|+.|++++|.+.+..+..|..+++|+.|++
T Consensus 377 ~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 455 (606)
T 3vq2_A 377 SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455 (606)
T ss_dssp CCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred cccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEEC
Confidence 99999999999985 66889999999999999999998877 68999999999999999999999999999999999999
Q ss_pred cccccCC-CCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCcccc
Q 001238 563 NKNRFAG-SIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELS 641 (1117)
Q Consensus 563 ~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~ 641 (1117)
++|++.+ .+|..|..+++|+.|+|++|++++.+|..+..++++ +.|+|++|++++.+|..|..+++|+.|||++|+++
T Consensus 456 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL-QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC-CEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccC-CEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 9999997 478899999999999999999999889999999999 79999999999999999999999999999999999
Q ss_pred CCcchhhhcc-cceEEEeecccccCCCCCCc
Q 001238 642 GDLHFLAELQ-NLVVLNVSHNNFSGRVPDTP 671 (1117)
Q Consensus 642 ~~~~~l~~l~-~L~~L~ls~N~l~~~~p~~~ 671 (1117)
..++.+..++ +|+.|++++|++.|..+...
T Consensus 535 ~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~ 565 (606)
T 3vq2_A 535 TSKGILQHFPKSLAFFNLTNNSVACICEHQK 565 (606)
T ss_dssp CEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred ccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence 7666688887 59999999999998777543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=497.19 Aligned_cols=515 Identities=20% Similarity=0.227 Sum_probs=367.2
Q ss_pred EecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCc
Q 001238 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158 (1117)
Q Consensus 79 l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 158 (1117)
+++.+.++.. +|..+. .+++.|+|++|++++..+.+|+++++|++|||++|++++..|..|.++++|++|+|++|++
T Consensus 12 ~~c~~~~l~~-ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCSS-CCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCccc-cCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 3444444432 555544 4678888888888876677788888888888888888766667778888888888888888
Q ss_pred CCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcc
Q 001238 159 EGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPT 238 (1117)
Q Consensus 159 ~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~ 238 (1117)
++..|..|+++++|++|++++|++++..+..|+++++|++|++++|
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n---------------------------------- 134 (570)
T 2z63_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN---------------------------------- 134 (570)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSS----------------------------------
T ss_pred CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCC----------------------------------
Confidence 7666677888888888888888776533323333333333333333
Q ss_pred cccccccceeecccccccc-cCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCC----cEEEccCCcCcccCCcCCCC
Q 001238 239 LGLLKRLQTIAIYTALLSG-QIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNL----VNLFLWQNNLVGIIPPELGN 313 (1117)
Q Consensus 239 l~~l~~L~~L~l~~~~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L----~~L~L~~n~l~~~~p~~~~~ 313 (1117)
.+.+ .+|..|+++++|++|++++|++++..|..++.+++| +.|++++|.+.+..|..|..
T Consensus 135 ---------------~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~ 199 (570)
T 2z63_A 135 ---------------LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199 (570)
T ss_dssp ---------------CCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT
T ss_pred ---------------ccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhcc
Confidence 2222 245556666777777777777776666666666666 66777777777666666655
Q ss_pred CCCCCEEEcCCCcCCC-CCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCccccccc--chH
Q 001238 314 CSQLSIIDISMNSLTG-SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLS--NLT 390 (1117)
Q Consensus 314 l~~L~~LdLs~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~ 390 (1117)
+ +|+.|++++|.... .++..+..+++++.+.+..+.+.. ... +.......|..+. .++
T Consensus 200 ~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~--------~~~----------l~~~~~~~~~~l~~l~l~ 260 (570)
T 2z63_A 200 I-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN--------EGN----------LEKFDKSALEGLCNLTIE 260 (570)
T ss_dssp C-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC--------CSS----------CEECCTTTTGGGGGSEEE
T ss_pred C-cceeEecccccccccchhhhhcCccccceeeeccccccC--------chh----------hhhcchhhhccccccchh
Confidence 4 57777776664432 234445556666555554433221 001 1111112222222 245
Q ss_pred HHHhccc-cccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCC
Q 001238 391 LLFVWHN-RLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSN 469 (1117)
Q Consensus 391 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 469 (1117)
.+++.+| .+.+..+..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|. ..+++|++|++++|
T Consensus 261 ~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n 335 (570)
T 2z63_A 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSN 335 (570)
T ss_dssp EEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESC
T ss_pred hhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCC
Confidence 5556666 566667777777788888888888877 477777777 8888888888877 3343 46778888888888
Q ss_pred cccccCCCCcCCCCCCCEEEccCCcCCCCC--CcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCC
Q 001238 470 KLTGFIPPEIGNLKNLNFLDLGSNRLTGSI--PDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGML 547 (1117)
Q Consensus 470 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~ 547 (1117)
.+.+..+. ..+++|++|++++|++++.. |..+.++++|++|++++|.+.+..+. +..+++|+.|++++|.+.++.
T Consensus 336 ~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~ 412 (570)
T 2z63_A 336 KGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMS 412 (570)
T ss_dssp BSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCT
T ss_pred cccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCcccccc
Confidence 87766554 67888888888888887543 67788888888888888888866555 888888888888888888775
Q ss_pred C-CCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccc-cccccccCCchhHHHhhcCCCCcccCCcccccc
Q 001238 548 S-PDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS-GNIPASLGKIPALAIALNLSWNQICGELPAELT 625 (1117)
Q Consensus 548 ~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~ 625 (1117)
+ ..|..+++|+.|++++|.+.+..|..|..+++|+.|+|++|+++ +.+|..+..++++ +.|+|++|++++..|..|.
T Consensus 413 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L-~~L~l~~n~l~~~~~~~~~ 491 (570)
T 2z63_A 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL-TFLDLSQCQLEQLSPTAFN 491 (570)
T ss_dssp TSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC-CEEECTTSCCCEECTTTTT
T ss_pred chhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCC-CEEECCCCccccCChhhhh
Confidence 5 57888889999999999998888888888999999999999987 5788888888888 7899999999988888999
Q ss_pred CCCCccEEeccCccccCCcch-hhhcccceEEEeecccccCCCCCCccc
Q 001238 626 GLNKLGILDLSHNELSGDLHF-LAELQNLVVLNVSHNNFSGRVPDTPFF 673 (1117)
Q Consensus 626 ~l~~L~~LdLs~N~l~~~~~~-l~~l~~L~~L~ls~N~l~~~~p~~~~~ 673 (1117)
.+++|+.|+|++|++++.++. +..+++|+.|++++|+++|.+|...++
T Consensus 492 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 540 (570)
T 2z63_A 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 540 (570)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred cccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHH
Confidence 999999999999999987665 788899999999999999988875543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=498.11 Aligned_cols=490 Identities=21% Similarity=0.210 Sum_probs=363.6
Q ss_pred CcEEEEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhc
Q 001238 74 NQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRL 153 (1117)
Q Consensus 74 ~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (1117)
..+..++++++.+.+..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+.+++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46889999999998877888999999999999999999877888999999999999999999777789999999999999
Q ss_pred cCCCcCCCCchhccCCcCCcEEeccCCCCCC-CCcccccCcccchhhhccCCCCCCCCCCccccccccc----ccccccc
Q 001238 154 NSNQLEGAIPIQIGNLSSLTQLFLYDNQLTD-AIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNL----VMIGLAE 228 (1117)
Q Consensus 154 ~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L----~~L~l~~ 228 (1117)
++|++++..+..|+++++|++|++++|++++ .+|..|+++++|++|++++|+. .+..|..++.+++| +.+++++
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l-~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCC-CEECGGGGHHHHTCTTCCCEEECTT
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcc-ceecHHHccchhccchhhhhcccCC
Confidence 9999996666679999999999999999987 4688888888877777777753 33344455555555 4455555
Q ss_pred ccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccC-CcCCccCCCCCCCcEEEccCCcC----
Q 001238 229 TSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALT-GSIPSKLGNLKNLVNLFLWQNNL---- 303 (1117)
Q Consensus 229 ~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l---- 303 (1117)
|.+.+..|..+..+ +|++|++++|... ..++..+..+++++.+.+..+.+
T Consensus 187 n~l~~~~~~~~~~~-------------------------~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~ 241 (570)
T 2z63_A 187 NPMNFIQPGAFKEI-------------------------RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241 (570)
T ss_dssp CCCCEECTTTTTTC-------------------------EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCS
T ss_pred CCceecCHHHhccC-------------------------cceeEecccccccccchhhhhcCccccceeeeccccccCch
Confidence 55554444444333 4455555444222 12233344444444443322211
Q ss_pred --cccCCcCCCCCC--CCCEEEcCCC-cCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCC
Q 001238 304 --VGIIPPELGNCS--QLSIIDISMN-SLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGA 378 (1117)
Q Consensus 304 --~~~~p~~~~~l~--~L~~LdLs~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 378 (1117)
.......+..+. +++.+++++| .+.+.+|..+..+++|++|++++|.++ .+|..+..+ +|++|++++|.+. .
T Consensus 242 ~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~ 318 (570)
T 2z63_A 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-Q 318 (570)
T ss_dssp SCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-S
T ss_pred hhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-c
Confidence 111112222222 2455566665 556666666667777777777777776 466666666 7777777777776 4
Q ss_pred CCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCC--cccccCCCCCCeeeccCccCCCCCCCCcc
Q 001238 379 IPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPI--PRGIFQLKKLNKLLLLSNNLSGVIPPEMG 456 (1117)
Q Consensus 379 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 456 (1117)
+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. |..+..+++|++|++++|++.+..+. +.
T Consensus 319 l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~ 393 (570)
T 2z63_A 319 FPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FL 393 (570)
T ss_dssp CCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EE
T ss_pred cCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-cc
Confidence 443 3566777777777777655544 66778888888888887543 56677888888888888888865554 88
Q ss_pred cccccceeccCCCcccccCC-CCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccc-cccchhhhcccccc
Q 001238 457 NCSSLIRFRANSNKLTGFIP-PEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIA-GNLPAGLHQLVRLQ 534 (1117)
Q Consensus 457 ~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~ 534 (1117)
.+++|++|++++|++++..+ ..+.++++|++|++++|++++..|..|.++++|++|++++|.+. +.+|..|..+++|+
T Consensus 394 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~ 473 (570)
T 2z63_A 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473 (570)
T ss_dssp TCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred ccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCC
Confidence 88888888888888887665 46788888888999888888888888888888999999988887 56788888888888
Q ss_pred cccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecccccccccccc
Q 001238 535 FADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPA 597 (1117)
Q Consensus 535 ~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 597 (1117)
.|++++|+++++.+..|..+++|+.|++++|++++..+..|..+++|+.|++++|.+++..|.
T Consensus 474 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred EEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 888888888888888888888899999999998888888888889999999999998877663
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=452.40 Aligned_cols=263 Identities=25% Similarity=0.417 Sum_probs=208.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..|+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35677789999999999999853 478999999987766667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcc
Q 001238 850 FYDYMPNGTLGMLLHDGEC------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 917 (1117)
|||||++|+|.++++.... .+.++|.++++|+.|||+||+|||++ +||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999976431 24589999999999999999999999 99999999999999999999
Q ss_pred eeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHH
Q 001238 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 918 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~ 996 (1117)
||+|||+|+...... .........||++|||||++.+..|+.++|||||||++|||+| |+.||... ...+.+
T Consensus 198 Ki~DFGla~~~~~~~--~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-----~~~~~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTD--YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-----SNTEAI 270 (329)
T ss_dssp EECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS-----CHHHHH
T ss_pred EEcccccceeccCCC--cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC-----CHHHHH
Confidence 999999998765432 1223345689999999999999999999999999999999999 99999653 122222
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
....... . +..+...+..+.+++. .||+.||++|||++||++.|+.+.+.++
T Consensus 271 ~~i~~g~-~------~~~p~~~~~~~~~li~------~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 271 DCITQGR-E------LERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp HHHHHTC-C------CCCCTTCCHHHHHHHH------HHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred HHHHcCC-C------CCCcccccHHHHHHHH------HHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 2222221 1 1223334445555554 4999999999999999999999977543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=448.57 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=212.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46788899999999999999753 478899999987666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCccee
Q 001238 850 FYDYMPNGTLGMLLHDGE----------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
|||||++|+|.++++... ....++|.++.+++.|||+||+|||++ +||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 234599999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHH
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
+|||+|+...... .........||++|||||++.+..|+.++|||||||++|||+| |+.||.+. ...+.+..
T Consensus 170 ~DFGla~~~~~~~--~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-----~~~~~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTD--YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-----SNNEVIEC 242 (299)
T ss_dssp CCCSCHHHHTGGG--CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHH
T ss_pred CCcccceecCCCC--ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Confidence 9999998765422 1223345679999999999999999999999999999999998 99999753 12223333
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
...... +..+...+..+.+++. .||+.||++|||+++|.+.|+++.+.
T Consensus 243 i~~~~~-------~~~p~~~~~~~~~li~------~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQGRV-------LQRPRTCPQEVYELML------GCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHTCC-------CCCCTTCCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCC-------CCCCccchHHHHHHHH------HHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 222221 1123334445555554 49999999999999999999988653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=495.65 Aligned_cols=493 Identities=19% Similarity=0.217 Sum_probs=339.2
Q ss_pred CcceeeEEecCCCcEEEEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchh
Q 001238 62 PCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRE 141 (1117)
Q Consensus 62 ~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 141 (1117)
.|.|.|| |+.. ++++. .+|..+. ++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..
T Consensus 3 ~C~~~~~-c~~~---------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~ 69 (549)
T 2z81_A 3 SCDASGV-CDGR---------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69 (549)
T ss_dssp EECTTSE-EECT---------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTT
T ss_pred cCCCCce-EECC---------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhh
Confidence 4999998 9643 23333 4676654 68889999999998777888889999999999999988777788
Q ss_pred hhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCC-CCcccccCcccchhhhccCCCCCCCCCCcccccccc
Q 001238 142 LCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTD-AIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTN 220 (1117)
Q Consensus 142 ~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~ 220 (1117)
|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|++++|
T Consensus 70 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n---------------- 133 (549)
T 2z81_A 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV---------------- 133 (549)
T ss_dssp TTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEES----------------
T ss_pred ccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCC----------------
Confidence 8888888888888888887777778888888888888888875 23344444444443333333
Q ss_pred ccccccccccccccCCcccccccccceeecccccccccC-CcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEcc
Q 001238 221 LVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQI-PPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLW 299 (1117)
Q Consensus 221 L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 299 (1117)
...+.+ +..+..+++|++|++++|++++..|..++++++|++|+++
T Consensus 134 ---------------------------------~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 180 (549)
T 2z81_A 134 ---------------------------------ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180 (549)
T ss_dssp ---------------------------------SSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEE
T ss_pred ---------------------------------ccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecc
Confidence 211223 3467788888999999999988888888888899999998
Q ss_pred CCcCcccCCcCCCCCCCCCEEEcCCCcCCCCC--c-cccCCCCCcceEecccccccCccc----ccccCCCCCcEEEecC
Q 001238 300 QNNLVGIIPPELGNCSQLSIIDISMNSLTGSI--P-QTLGNLTSLQELQLSVNQISGEIP----AQIGNCQRLAQIELDN 372 (1117)
Q Consensus 300 ~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~--p-~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~ 372 (1117)
.|.+.......+..+++|++|++++|++++.. | .....+++|+.|++++|.+++..+ ..+..+++|+.|++++
T Consensus 181 ~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~ 260 (549)
T 2z81_A 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260 (549)
T ss_dssp CSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEES
T ss_pred cCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccc
Confidence 88876332223356888888999988888642 2 223456788888888888876443 3345677888888888
Q ss_pred ccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCC-----CcccccCCCCCCeeeccCccC
Q 001238 373 NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP-----IPRGIFQLKKLNKLLLLSNNL 447 (1117)
Q Consensus 373 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l 447 (1117)
|.+.+... +.. .....+..+.+|+.|++.++.+... ++..+....+|++|++++|++
T Consensus 261 ~~~~~~~~--~~~----------------~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l 322 (549)
T 2z81_A 261 CTLNGLGD--FNP----------------SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322 (549)
T ss_dssp CEEECCSC--CCC----------------CTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCC
T ss_pred cccccccc--ccc----------------cchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCcc
Confidence 88775321 000 0112234455666666666655421 111222345677777777777
Q ss_pred CCCCCCCc-ccccccceeccCCCcccccCC---CCcCCCCCCCEEEccCCcCCCCCC--cccccCCCCceEEccCCcccc
Q 001238 448 SGVIPPEM-GNCSSLIRFRANSNKLTGFIP---PEIGNLKNLNFLDLGSNRLTGSIP--DEITGCRNLTFLDVHSNSIAG 521 (1117)
Q Consensus 448 ~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~ 521 (1117)
. .+|..+ .++++|++|++++|++++.+| ..++.+++|++|+|++|++++..+ ..+..+++|++|++++|+|+
T Consensus 323 ~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~- 400 (549)
T 2z81_A 323 F-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH- 400 (549)
T ss_dssp C-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-
T ss_pred c-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-
Confidence 6 344443 467777777777777776543 346677777777777777775432 44677777777777777777
Q ss_pred ccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCC
Q 001238 522 NLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGK 601 (1117)
Q Consensus 522 ~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 601 (1117)
.+|..+..+++|++|++++|+|+.++...+ ++|+.|+|++|+|++.+ ..+++|+.|+|++|+|+ .+|. ...
T Consensus 401 ~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~---~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~ 471 (549)
T 2z81_A 401 PMPDSCQWPEKMRFLNLSSTGIRVVKTCIP---QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASL 471 (549)
T ss_dssp CCCSCCCCCTTCCEEECTTSCCSCCCTTSC---TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGG
T ss_pred cCChhhcccccccEEECCCCCcccccchhc---CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-ccc
Confidence 456666777777777777777776544322 46778888888877542 45777888888888887 6665 345
Q ss_pred chhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch
Q 001238 602 IPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 602 l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
++.+ +.|+|++|+|++.+|..|..+++|+.|||++|++.|+++.
T Consensus 472 l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 472 FPVL-LVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CTTC-CEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred CccC-CEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 5665 6677777777777777777777777777777777777664
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=501.89 Aligned_cols=510 Identities=19% Similarity=0.272 Sum_probs=327.0
Q ss_pred CcccchhHHHHHHHHHhhccCCCCCCCCCCCCCC---CCcceeeEE--ecCC--CcEEEEecccccccCcCCcccccccc
Q 001238 27 TPYAVNRQGEALLSWKRNWKGSDDGLSNWSPSDE---TPCKWFGVS--CNLN--NQVVGLDLRYVDLLGHVPTNFTSLLS 99 (1117)
Q Consensus 27 ~~~~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~---~~C~W~gv~--C~~~--~~v~~l~l~~~~l~~~~~~~~~~l~~ 99 (1117)
+......+...-.++++-+..-.+ .+|...++ ..|.|..-+ |... ..|++ ... .+
T Consensus 21 ~~~~~~~~~~d~~aL~~~~~~~~~--~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C---~~~-------------~~ 82 (636)
T 4eco_A 21 KLSRTAEYIKDYLALKEIWDALNG--KNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL---NSN-------------GR 82 (636)
T ss_dssp CCCCCCHHHHHHHHHHHHHHHTTG--GGCCCCC------CCCCCSSCGGGTTCCTTEEE---CTT-------------CC
T ss_pred echhhhhHHHHHHHHHHHHHHcCC--CCcccCCcCCccCCCCCCCCCcccccCCCCeEE---cCC-------------CC
Confidence 333445566677788877764333 47874332 125796322 3331 12332 110 35
Q ss_pred CCeEeccCCCCCCCchhhhcccccCcEeeccCCCc------CC------CCchhhhhhhhhhhhhccCCCcCCCCchhcc
Q 001238 100 LNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSL------TG------EIPRELCSLLRLEQLRLNSNQLEGAIPIQIG 167 (1117)
Q Consensus 100 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l------~~------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 167 (1117)
++.|+|++|+++|.+|++|++|++|++|||++|.+ .| .+|.+. +..|+ ++++.|.+.+.+|..++
T Consensus 83 V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~ 159 (636)
T 4eco_A 83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFS 159 (636)
T ss_dssp EEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSC
T ss_pred EEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHH
Confidence 78899999999999999999999999999999977 34 566655 77888 99999999998888776
Q ss_pred C-CcCCcEEeccCCCCCCCCcccccCcccchhhhccC-CCCCCCCCCcccccccccccccccccccccc-----------
Q 001238 168 N-LSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGG-NKNLGGSLPHEIGNCTNLVMIGLAETSISGF----------- 234 (1117)
Q Consensus 168 ~-L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~----------- 234 (1117)
. +..+..+++....+.. .....++.+.++. ++.+++ +|.+++++++|++|++++|.+++.
T Consensus 160 ~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~ 232 (636)
T 4eco_A 160 DLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS 232 (636)
T ss_dssp HHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTS
T ss_pred HHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccccc
Confidence 4 3344444444433321 2223344444443 223444 666677777777777777776664
Q ss_pred ------CCcccc--cccccceeecccccccccCCcCCCCCCCCcEEecCCCc-cCC-cCCccCCCC------CCCcEEEc
Q 001238 235 ------LPPTLG--LLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENA-LTG-SIPSKLGNL------KNLVNLFL 298 (1117)
Q Consensus 235 ------lp~~l~--~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~p~~l~~l------~~L~~L~L 298 (1117)
+|+.++ ++++|++|++++|.+.+.+|+.|+++++|++|+|++|+ ++| .+|..++++ ++|++|++
T Consensus 233 ~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L 312 (636)
T 4eco_A 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312 (636)
T ss_dssp HHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEEC
T ss_pred chhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEEC
Confidence 666666 67777777777777666777777777777777777776 666 666666655 67777777
Q ss_pred cCCcCcccCCc--CCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCC-CcEEEecCccc
Q 001238 299 WQNNLVGIIPP--ELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQR-LAQIELDNNQI 375 (1117)
Q Consensus 299 ~~n~l~~~~p~--~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l 375 (1117)
++|+++ .+|. .++++++|++|+|++|+++|.+| .++.+++|++|+|++|+++ .+|..+.++++ |++|++++|++
T Consensus 313 ~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l 389 (636)
T 4eco_A 313 GYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKL 389 (636)
T ss_dssp CSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCC
T ss_pred CCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcC
Confidence 777776 5666 66667777777777777766666 6666667777777777766 66666666666 77777777776
Q ss_pred cCCCCccccccc--chHHHHhccccccccCCCCCC-------cccccceeecccccccCCCccccc-CCCCCCeeeccCc
Q 001238 376 TGAIPSEFGNLS--NLTLLFVWHNRLEGEIPPSIS-------NCQNLEAVDLSQNGLTGPIPRGIF-QLKKLNKLLLLSN 445 (1117)
Q Consensus 376 ~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N 445 (1117)
+ .+|..+..++ +|+.|++++|++++.+|..+. .+++|++|+|++|+++ .+|..++ .+++|++|+|++|
T Consensus 390 ~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N 467 (636)
T 4eco_A 390 K-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGN 467 (636)
T ss_dssp S-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSS
T ss_pred c-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCC
Confidence 6 5566655543 666667777766666666666 5566667777777666 3444433 4666666677666
Q ss_pred cCCCCCCCCccccc-------ccceeccCCCcccccCCCCcC--CCCCCCEEEccCCcCCCCCCcccccCCCCceEEccC
Q 001238 446 NLSGVIPPEMGNCS-------SLIRFRANSNKLTGFIPPEIG--NLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHS 516 (1117)
Q Consensus 446 ~l~~~~~~~~~~l~-------~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 516 (1117)
+++.+.+..+.... +|++|++++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|++|+|++
T Consensus 468 ~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~ 545 (636)
T 4eco_A 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545 (636)
T ss_dssp CCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCS
T ss_pred CCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCC
Confidence 66633333333222 5666666666666 4455554 56666666666666664 555666666666666644
Q ss_pred CccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccc
Q 001238 517 NSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS 592 (1117)
Q Consensus 517 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 592 (1117)
|+ ++++|++.+..+..|..+++|+.|+|++|+| +.+|..+. ++|+.|||++|+++
T Consensus 546 N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 546 QR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp CB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred Cc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 33 2355666666666777777777777777777 45565554 67888888888776
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=442.33 Aligned_cols=257 Identities=24% Similarity=0.332 Sum_probs=207.4
Q ss_pred CCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++++.++||+|+||+||+|.+. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566789999999999999852 4688999999754 33345789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc
Q 001238 850 FYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE 916 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~ 916 (1117)
|||||++|+|.+++..... ...++|.++.+|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999965321 23589999999999999999999999 9999999999999999999
Q ss_pred ceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHH
Q 001238 917 SCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQW 995 (1117)
Q Consensus 917 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~ 995 (1117)
+||+|||+|+...... .........||++|||||++.++.|+.++|||||||++|||+| |+.||.+. . ..+.
T Consensus 184 ~Ki~DFGlar~~~~~~--~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--~---~~~~ 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAAD--YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--S---NQDV 256 (308)
T ss_dssp EEECCSCCBCGGGGGG--CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--C---HHHH
T ss_pred EEECCcccceeccCCC--ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--C---HHHH
Confidence 9999999998765422 1223445689999999999999999999999999999999998 89999753 1 2222
Q ss_pred HHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 996 VRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
+....... .+ ..+...+..+.+++. .||+.||++||+|+||++.|+.+
T Consensus 257 ~~~i~~~~-~~------~~p~~~~~~~~~li~------~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRNRQ-VL------PCPDDCPAWVYALMI------ECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTC-CC------CCCTTCCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCC-CC------CCcccchHHHHHHHH------HHcCCChhHCcCHHHHHHHHHhc
Confidence 22222221 11 122333444554444 49999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=438.06 Aligned_cols=260 Identities=30% Similarity=0.411 Sum_probs=201.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
+++++.++||+|+||+||+|++.+ .||||+++... ....++|.+|++++++++|||||++++++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 467888999999999999999743 69999987543 3345679999999999999999999998865 568999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
|++|+|.++++... +.+++.++.+|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999997643 3599999999999999999999999 999999999999999999999999999987654221
Q ss_pred CccccCCccccccccCChhhhcc---CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM---TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.......+||+.|||||++.. ..|+.++|||||||++|||+||+.||.+... ...+...+........
T Consensus 188 --~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----~~~~~~~~~~~~~~p~-- 258 (307)
T 3omv_A 188 --SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----RDQIIFMVGRGYASPD-- 258 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHTTCCCCC--
T ss_pred --ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhcCCCCCC--
Confidence 123345689999999999864 4589999999999999999999999964211 1122222222211111
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.+......+..+.+++. .||+.||++||||.||++.|+.++.
T Consensus 259 ~~~~~~~~~~~l~~li~------~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVA------DCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp STTSCTTSCHHHHHHHH------HHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred cccccccchHHHHHHHH------HHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11223333445555544 4999999999999999999998864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=444.33 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=203.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|++.+.||+|+||+||+|++ .+|+.||||++.... ....+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4799999999999999999985 569999999997543 2335679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
||+||+|.+++.... ...+++.+++.++.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 999999999997643 23478999999999999999999999 9999999999999999999999999999876431
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ...+.+..+......
T Consensus 179 ---~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i~~~~~~------- 243 (350)
T 4b9d_A 179 ---VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----SMKNLVLKIISGSFP------- 243 (350)
T ss_dssp ---HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHTCCC-------
T ss_pred ---cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHcCCCC-------
Confidence 12234568999999999999999999999999999999999999999642 333444444443321
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+.+++.. |++.||++|||+.|+++
T Consensus 244 ~~~~~~s~~~~~li~~------~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQ------LFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHH------HccCChhHCcCHHHHhc
Confidence 2233445566666665 99999999999999976
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=438.33 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=207.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
..|++.++||+|+||+||+|.+ .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4688889999999999999985 469999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
+||+|.+++... .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 999999999753 389999999999999999999999 99999999999999999999999999999875432
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ...+.+........... ..
T Consensus 225 --~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~~~~~~~~-----~~ 292 (346)
T 4fih_A 225 --PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAMKMIRDNLPPRL-----KN 292 (346)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSSCCCC-----SC
T ss_pred --CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHcCCCCCC-----Cc
Confidence 2345678999999999999999999999999999999999999999642 22223333222211110 01
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
....+....+++.. |++.||++|||+.|+++
T Consensus 293 ~~~~s~~~~dli~~------~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDR------LLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHH------HSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHH------HcCCChhHCcCHHHHhc
Confidence 11233455555555 99999999999999876
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=483.22 Aligned_cols=560 Identities=22% Similarity=0.218 Sum_probs=346.0
Q ss_pred cCCCCCCCCCCCCCCCCcceeeEEecCCCcEEEEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCc
Q 001238 46 KGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLN 125 (1117)
Q Consensus 46 ~~~~~~l~sW~~~~~~~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 125 (1117)
.|+.+.+++|..+ -|..|....|...+. .+++++.+|.. +|..+. +++++|+|++|+|++..|.+|.++++|+
T Consensus 7 ~~~~~~~~~~~~~--~p~~~~~c~~~~~~~--~~~c~~~~l~~-vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~ 79 (635)
T 4g8a_A 7 KDDDDKLAAANSS--IPESWEPCVEVVPNI--TYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQ 79 (635)
T ss_dssp --------------------CCSEEEETTT--EEECTTSCCSS-CCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCcchhhcccCC--CCCCCCCccccCCCC--EEECCCCCcCc-cCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCC
Confidence 4556668888743 345565544433332 34666667654 787765 5799999999999976678899999999
Q ss_pred EeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCC
Q 001238 126 YLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNK 205 (1117)
Q Consensus 126 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~ 205 (1117)
+|||++|+|++..|..|.+|++|++|+|++|++++..|..|++|++|++|+|++|++++..+..|+++++|++|++++|+
T Consensus 80 ~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~ 159 (635)
T 4g8a_A 80 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 159 (635)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCc
Confidence 99999999997677789999999999999999997667789999999999999999998777789999999999999998
Q ss_pred CCCCCCCccccccccccccccccccccccCCcccccccccc----eeecccccccccCCcCCCCCCCCcEEecCCCccCC
Q 001238 206 NLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQ----TIAIYTALLSGQIPPELGDCTELQYIYLYENALTG 281 (1117)
Q Consensus 206 ~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~----~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 281 (1117)
.....+|..++++++|++|++++|.+.+..|..+..+.+++ .++++.|.+....+..+ ....++.+++.+|....
T Consensus 160 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~ 238 (635)
T 4g8a_A 160 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSL 238 (635)
T ss_dssp CCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSH
T ss_pred cccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccc
Confidence 76667889999999999999999999988888888777665 45566666655443333 34456677777775543
Q ss_pred c-CCccCCCCCCCcEEEccCCcC------cccCCcCCCCCCCCCEEEcCCCcCCCC---CccccCCCCCcceEecccccc
Q 001238 282 S-IPSKLGNLKNLVNLFLWQNNL------VGIIPPELGNCSQLSIIDISMNSLTGS---IPQTLGNLTSLQELQLSVNQI 351 (1117)
Q Consensus 282 ~-~p~~l~~l~~L~~L~L~~n~l------~~~~p~~~~~l~~L~~LdLs~N~l~~~---~p~~l~~l~~L~~L~Ls~N~l 351 (1117)
. .+..+..+..++...+..+.. .......+..+..+..+++..+..... ++..+..+.+++.+++.+|.+
T Consensus 239 ~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~ 318 (635)
T 4g8a_A 239 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTI 318 (635)
T ss_dssp HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEE
T ss_pred cccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccc
Confidence 2 233456666666655543322 222233344455555555544433321 222344455666666666666
Q ss_pred cCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccC--CCcc
Q 001238 352 SGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTG--PIPR 429 (1117)
Q Consensus 352 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~ 429 (1117)
.... .+.....|+.|++.+|.+.+..+. .+..|+.+++..|.+... .....+++|+.|++++|.+.. ..+.
T Consensus 319 ~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~ 391 (635)
T 4g8a_A 319 ERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQ 391 (635)
T ss_dssp EECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCH
T ss_pred cccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhcccccccccccc
Confidence 5322 244455666666666666644332 234455555666655432 223355666666666666542 2344
Q ss_pred cccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCC-CCcCCCCCCCEEEccCCcCCCCCCcccccCCC
Q 001238 430 GIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIP-PEIGNLKNLNFLDLGSNRLTGSIPDEITGCRN 508 (1117)
Q Consensus 430 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 508 (1117)
.+..+.+|+.+++..|.+.. .+..+..+++|+.+++..|++....+ ..|.++++++.+++++|++.+..+..+..++.
T Consensus 392 ~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~ 470 (635)
T 4g8a_A 392 SDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 470 (635)
T ss_dssp HHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTT
T ss_pred chhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchh
Confidence 44455566666666665553 23445555556666655555443332 23555555555555555555555555555555
Q ss_pred CceEEccCCccc-cccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecc
Q 001238 509 LTFLDVHSNSIA-GNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLS 587 (1117)
Q Consensus 509 L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 587 (1117)
|+.|+|++|.+. +..|..|..+++|++ |+|++|+|++..|..|..+++|+.|+|+
T Consensus 471 L~~L~Ls~N~~~~~~~~~~~~~l~~L~~------------------------L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls 526 (635)
T 4g8a_A 471 LEVLKMAGNSFQENFLPDIFTELRNLTF------------------------LDLSQCQLEQLSPTAFNSLSSLQVLNMS 526 (635)
T ss_dssp CCEEECTTCEEGGGEECSCCTTCTTCCE------------------------EECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred hhhhhhhhcccccccCchhhhhccccCE------------------------EECCCCccCCcChHHHcCCCCCCEEECC
Confidence 555555555432 234444444444444 4444444444444445555555555555
Q ss_pred ccccccccccccCCchhHHHhhcCCCCcccCCccccccCC-CCccEEeccCccccCCcch
Q 001238 588 SNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGL-NKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 588 ~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l-~~L~~LdLs~N~l~~~~~~ 646 (1117)
+|+|++..|..|..+++| +.|+|++|+|++..|..|..+ ++|++|||++|+++|++..
T Consensus 527 ~N~l~~l~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 527 HNNFFSLDTFPYKCLNSL-QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp TSCCCBCCCGGGTTCTTC-CEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCcCCCCChhHHhCCCCC-CEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 555554444444444444 445555555555566666666 5799999999999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=434.44 Aligned_cols=260 Identities=23% Similarity=0.311 Sum_probs=208.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.+.|++.++||+|+||+||+|++ .+|+.||||+++.... ..+|++++++++|||||++++++.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35678888999999999999985 4699999999975432 34799999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC-cceeccccccccccCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-ESCLADFGLARLVEDDS 932 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~~~~~~ 932 (1117)
|+||+|.++++.. +.+++.++..++.||+.||+|||++ +||||||||+|||++.++ ++||+|||+|+......
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999764 3499999999999999999999999 999999999999999987 69999999999875432
Q ss_pred CCc-cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 933 GGS-FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 933 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
... .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+..... +.. ...... .+.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~---~i~~~~-~~~---- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCL---KIASEP-PPI---- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHH---HHHHSC-CGG----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHH---HHHcCC-CCc----
Confidence 211 122345689999999999999999999999999999999999999997643321 222 222221 111
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
+.++...+..+.+++.. |++.||++|||+.|+++.+....+...
T Consensus 276 ~~~~~~~s~~~~~li~~------~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQE------GLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp GGSCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hhcCccCCHHHHHHHHH------HccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 12334445566666665 999999999999999999887765543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=434.94 Aligned_cols=272 Identities=27% Similarity=0.354 Sum_probs=202.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCC----ceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRK----TKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~ 851 (1117)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+++|+..+.+++|||||++++++.+++ ..|+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 689999999975432 1223445666677899999999999998654 579999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC-----CCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC-----VPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
|||++|+|.++++.. .++|+.+.+++.|+++||+|||+++ .++||||||||+|||++.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999764 3899999999999999999999862 4589999999999999999999999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhccC------CCCcCCCeeehhhhHHHHHhCCCCCCCCC----------CCCh
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMT------KISEKSDVYSYGVVLLEIITGKKPVDASF----------PDGQ 990 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~vl~ell~g~~P~~~~~----------~~~~ 990 (1117)
................+||++|||||++.+. .|+.++|||||||++|||+||++||.... +...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 8765432222233456899999999998754 47789999999999999999988764321 1112
Q ss_pred hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
............. .+|.++..... ........+++..||+.||++||||.||++.|+++.++.
T Consensus 237 ~~~~~~~~~~~~~------~rp~~p~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 237 SVEEMRKVVCEQK------LRPNIPNRWQS-CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSC------CCCCCCGGGGS-SHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hHHHHHHHHhccc------CCCCCCccccc-hHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 2222222222221 22232222111 011112234677799999999999999999999987653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=490.58 Aligned_cols=463 Identities=19% Similarity=0.230 Sum_probs=357.8
Q ss_pred ccCCeEeccCCCCCCCchhhhcccccCcEeec-cCCCcCCCCchhhh---------hhhhhhhhhcc-------CCCcCC
Q 001238 98 LSLNRLVLSGTNLTGSIPKEIASLNQLNYLDL-SENSLTGEIPRELC---------SLLRLEQLRLN-------SNQLEG 160 (1117)
Q Consensus 98 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~~~---------~l~~L~~L~L~-------~N~l~~ 160 (1117)
.+++.|+|++|+++|.+|++|++|++|++||| ++|.++|..|-... .+..++...+. ...+.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46789999999999999999999999999999 99999877442211 11112111110 001111
Q ss_pred -----------CCchhccCCcCCcEEeccC--CCCCCCCcccccCcccchhhhccCCCCCCC-----------------C
Q 001238 161 -----------AIPIQIGNLSSLTQLFLYD--NQLTDAIPATIGKLKNLEAIRAGGNKNLGG-----------------S 210 (1117)
Q Consensus 161 -----------~~p~~~~~L~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~-----------------~ 210 (1117)
..+........++.+.+.. |++++ +|..|+++++|++|+|++|+ +.+ .
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~-Lsg~~i~~~~~~~s~n~~~g~ 480 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSP-FTYDNIAVDWEDANSDYAKQY 480 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCC-CCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCc-CCCCccccccccccccccccc
Confidence 1111223334455555654 89998 99999999999999999998 455 4
Q ss_pred CCcccc--ccccccccccccccccccCCcccccccccceeeccccc-ccc-cCCcCCCCC-------CCCcEEecCCCcc
Q 001238 211 LPHEIG--NCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTAL-LSG-QIPPELGDC-------TELQYIYLYENAL 279 (1117)
Q Consensus 211 lp~~l~--~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~-l~~-~~p~~l~~l-------~~L~~L~L~~n~l 279 (1117)
+|..++ ++++|++|++++|.+.+.+|..++++++|+.|++++|. +++ .+|..++.+ ++|++|+|++|++
T Consensus 481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L 560 (876)
T 4ecn_A 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560 (876)
T ss_dssp TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence 999988 99999999999999999999999999999999999998 888 888765554 5999999999999
Q ss_pred CCcCCc--cCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCC-cceEecccccccCccc
Q 001238 280 TGSIPS--KLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTS-LQELQLSVNQISGEIP 356 (1117)
Q Consensus 280 ~~~~p~--~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p 356 (1117)
+ .+|. .|+++++|++|+|++|+++ .+| .|+.+++|+.|+|++|+++ .+|..+..+++ |++|+|++|.++ .+|
T Consensus 561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp 635 (876)
T 4ecn_A 561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP 635 (876)
T ss_dssp C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCC
T ss_pred C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCc
Confidence 9 8998 9999999999999999999 788 9999999999999999999 88989999999 999999999999 788
Q ss_pred ccccCCCC--CcEEEecCccccCCCCccc---c--cccchHHHHhccccccccCCCCC-CcccccceeecccccccCCCc
Q 001238 357 AQIGNCQR--LAQIELDNNQITGAIPSEF---G--NLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPIP 428 (1117)
Q Consensus 357 ~~~~~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p 428 (1117)
..+..+.. |+.|++++|++++.+|... . .+++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+|+ .+|
T Consensus 636 ~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip 713 (876)
T 4ecn_A 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIP 713 (876)
T ss_dssp SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCC
T ss_pred hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccC
Confidence 88887764 9999999999998776432 2 3458999999999999 555544 58899999999999999 677
Q ss_pred ccccCCC--------CCCeeeccCccCCCCCCCCcc--cccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCC
Q 001238 429 RGIFQLK--------KLNKLLLLSNNLSGVIPPEMG--NCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGS 498 (1117)
Q Consensus 429 ~~~~~l~--------~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 498 (1117)
..++... +|+.|+|++|+|+ .+|..+. .+++|+.|++++|+|++ +|..+.++++|+.|+|++|+
T Consensus 714 ~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~---- 787 (876)
T 4ecn_A 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR---- 787 (876)
T ss_dssp TTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB----
T ss_pred hHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC----
Confidence 7766533 9999999999999 6788876 89999999999999997 68889999999999998744
Q ss_pred CCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccc
Q 001238 499 IPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSC 578 (1117)
Q Consensus 499 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 578 (1117)
++++|++.+.+|..|..+++|+.|+|++|+|+.++.. +. ++|+.|+|++|++....+..|...
T Consensus 788 --------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~Ip~~-l~--~~L~~LdLs~N~l~~i~~~~~~~~ 850 (876)
T 4ecn_A 788 --------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEK-LT--PQLYILDIADNPNISIDVTSVCPY 850 (876)
T ss_dssp --------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCCSC-CC--SSSCEEECCSCTTCEEECGGGHHH
T ss_pred --------------CcccccccccChHHHhcCCCCCEEECCCCCCCccCHh-hc--CCCCEEECCCCCCCccChHHcccc
Confidence 3334444444444444444444444444444333322 11 355555555555554444555555
Q ss_pred cceeEEeccccccc
Q 001238 579 VKLQLLDLSSNQLS 592 (1117)
Q Consensus 579 ~~L~~L~Ls~N~l~ 592 (1117)
..+..+.|++|++.
T Consensus 851 ~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 851 IEAGMYVLLYDKTQ 864 (876)
T ss_dssp HHTTCCEEECCTTS
T ss_pred ccchheeecCCCcc
Confidence 55555555555554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=429.07 Aligned_cols=249 Identities=20% Similarity=0.306 Sum_probs=208.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. +....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4689999999999999999975 57999999999753 2334567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|||+||+|.+++... +.+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999764 3499999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ...+.+........
T Consensus 186 ~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~~~~~------- 251 (311)
T 4aw0_A 186 SK--QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEGLIFAKIIKLEY------- 251 (311)
T ss_dssp TT--CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCC-------
T ss_pred CC--cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCC-------
Confidence 22 12345678999999999999999999999999999999999999999642 23334444444332
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++...+...+++++. |++.||++||+++|+..
T Consensus 252 -~~p~~~s~~~~dli~~------lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 252 -DFPEKFFPKARDLVEK------LLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -CCCTTCCHHHHHHHHH------HSCSSGGGSTTSGGGTC
T ss_pred -CCCcccCHHHHHHHHH------HccCCHhHCcChHHHcC
Confidence 2233444556666655 99999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=440.01 Aligned_cols=250 Identities=21% Similarity=0.328 Sum_probs=209.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.+.|++.++||+|+||+||+|++ .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 45799999999999999999985 46999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
|+||+|.++++.. .+++.++..++.||++||+|||++ +||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 9999999999753 389999999999999999999999 99999999999999999999999999999875432
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ...+.+........... .
T Consensus 302 ---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~i~~~~~~~~-----~ 368 (423)
T 4fie_A 302 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAMKMIRDNLPPRL-----K 368 (423)
T ss_dssp ---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSCCCCC-----S
T ss_pred ---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHcCCCCCC-----c
Confidence 2345678999999999999999999999999999999999999999642 22233333222211110 1
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.....+..+.++++. |+..||++|||+.|+++
T Consensus 369 ~~~~~s~~~~dli~~------~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 NLHKVSPSLKGFLDR------LLVRDPAQRATAAELLK 400 (423)
T ss_dssp CTTSSCHHHHHHHHH------HSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHH------HcCCChhHCcCHHHHhc
Confidence 122334556666665 99999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=414.97 Aligned_cols=246 Identities=21% Similarity=0.309 Sum_probs=191.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
-++|++.+.||+|+||+||+|.. .+|+.||||++... +....+++.+|++++++++|||||++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 35799999999999999999985 46999999999754 233456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+ +|+|.+++... +.+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 68999888764 3499999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
. ......+||+.|||||++.+..| +.++||||+||++|||++|+.||.+. ..............
T Consensus 165 ~-----~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~~i~~~~~----- 229 (275)
T 3hyh_A 165 G-----NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFKNISNGVY----- 229 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCC-----
T ss_pred C-----CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcCCC-----
Confidence 2 12345789999999999998776 57999999999999999999999642 23333333333321
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++...+...+++++. |++.||++|||++|+++
T Consensus 230 ---~~p~~~s~~~~~li~~------~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKR------MLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCCTTSCHHHHHHHHH------HSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHH------HccCChhHCcCHHHHHc
Confidence 2233345556666655 99999999999999987
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=471.89 Aligned_cols=455 Identities=19% Similarity=0.202 Sum_probs=305.0
Q ss_pred CeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCC
Q 001238 101 NRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDN 180 (1117)
Q Consensus 101 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N 180 (1117)
+.|++++|+++ .+|..+. ++|++|||++|.+++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46778888887 5776665 77888888888887666677777777777777777777666777777777777777777
Q ss_pred CCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccc-cC
Q 001238 181 QLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSG-QI 259 (1117)
Q Consensus 181 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~-~~ 259 (1117)
+++ .+|.. .+++|++ |++++|.+.+ .+
T Consensus 80 ~l~-~lp~~--~l~~L~~-------------------------------------------------L~L~~N~l~~~~~ 107 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKH-------------------------------------------------LDLSFNAFDALPI 107 (520)
T ss_dssp CCC-EEECC--CCCCCSE-------------------------------------------------EECCSSCCSSCCC
T ss_pred cee-ecCcc--ccCCccE-------------------------------------------------EeccCCccccccc
Confidence 776 34433 3333333 3333333333 35
Q ss_pred CcCCCCCCCCcEEecCCCccCCcCCccCCCCCCC--cEEEccCCcC--cccCCcCCCCCC-CCCEEEcCCCcCCCCCcc-
Q 001238 260 PPELGDCTELQYIYLYENALTGSIPSKLGNLKNL--VNLFLWQNNL--VGIIPPELGNCS-QLSIIDISMNSLTGSIPQ- 333 (1117)
Q Consensus 260 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~L~~n~l--~~~~p~~~~~l~-~L~~LdLs~N~l~~~~p~- 333 (1117)
|..|+.+++|++|++++|++++ ..+..+++| ++|++++|.+ .+..|..+..+. +...+++++|.+.+.++.
T Consensus 108 p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~ 184 (520)
T 2z7x_B 108 CKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDV 184 (520)
T ss_dssp CGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCC
T ss_pred hhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhh
Confidence 6777788889999999999886 456677777 9999999998 777888887766 344678888888876654
Q ss_pred ccCCCCCcceEeccccc-------ccCcccccccCCCCCcEEEecCccccCCCCcccc---cccchHHHHhccccccccC
Q 001238 334 TLGNLTSLQELQLSVNQ-------ISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG---NLSNLTLLFVWHNRLEGEI 403 (1117)
Q Consensus 334 ~l~~l~~L~~L~Ls~N~-------l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~ 403 (1117)
.+.++++|+.|++++|. +.+.+| .+..+++|+.|++++|.+++..+..+. ..++|++|++++|++++.+
T Consensus 185 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 263 (520)
T 2z7x_B 185 SVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263 (520)
T ss_dssp CCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCC
T ss_pred hhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCcc
Confidence 57788899999999987 666666 688888899999888887753322111 1235555666666665555
Q ss_pred CCCC-----CcccccceeecccccccCCCc-ccccCC---CCCCeeeccCccCCCCCCCCcccccccceeccCCCccccc
Q 001238 404 PPSI-----SNCQNLEAVDLSQNGLTGPIP-RGIFQL---KKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGF 474 (1117)
Q Consensus 404 ~~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 474 (1117)
|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+ .+.
T Consensus 264 p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l------------------------~~~ 317 (520)
T 2z7x_B 264 DFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRM------------------------VHM 317 (520)
T ss_dssp CCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCC------------------------CCC
T ss_pred ccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcc------------------------ccc
Confidence 5555 5555555555555555 233 233322 3445555555444 322
Q ss_pred CCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCcccc--ccchhhhcccccccccccCCcCCC-CCCCCc
Q 001238 475 IPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG--NLPAGLHQLVRLQFADLSDNSVGG-MLSPDL 551 (1117)
Q Consensus 475 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~i~~-~~~~~~ 551 (1117)
. .+..+++|++|++++|++++..|..+..+++|++|+|++|+|++ .+|..+..+++|+.|++++|++++ ++...|
T Consensus 318 ~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~ 395 (520)
T 2z7x_B 318 L--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395 (520)
T ss_dssp C--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSC
T ss_pred c--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchh
Confidence 1 12455666666666666666566666666666666666666665 344556666666666666666666 555556
Q ss_pred CCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCcc
Q 001238 552 GSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLG 631 (1117)
Q Consensus 552 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~ 631 (1117)
..+++|+.|++++|++++..|..+. ++|+.|||++|+++ .+|..++.++++ +.|+|++|+|++..+..|..+++|+
T Consensus 396 ~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L-~~L~L~~N~l~~l~~~~~~~l~~L~ 471 (520)
T 2z7x_B 396 SWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEAL-QELNVASNQLKSVPDGIFDRLTSLQ 471 (520)
T ss_dssp CCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTC-CEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred ccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCC-CEEECCCCcCCccCHHHhccCCccc
Confidence 6777777777777777766665543 57888888888887 677766677776 6777777777743333477788888
Q ss_pred EEeccCccccCCcch
Q 001238 632 ILDLSHNELSGDLHF 646 (1117)
Q Consensus 632 ~LdLs~N~l~~~~~~ 646 (1117)
.|||++|+++|+++.
T Consensus 472 ~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 472 KIWLHTNPWDCSCPR 486 (520)
T ss_dssp EEECCSSCBCCCHHH
T ss_pred EEECcCCCCcccCCc
Confidence 888888888887653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=419.46 Aligned_cols=247 Identities=27% Similarity=0.414 Sum_probs=194.9
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeec----CCceEEE
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN----RKTKLLF 850 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv 850 (1117)
|++.++||+|+||+||+|.+ .+++.||+|++... .....++|.+|++++++++|||||++++++.+ ++..|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35667899999999999975 46899999999753 23345679999999999999999999998865 3457999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-CCcceecccccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-RYESCLADFGLARLVE 929 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~ 929 (1117)
||||++|+|.+++++. +.+++..+..++.||++||+|||++. ++||||||||+|||++. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999764 34899999999999999999999981 13999999999999985 7999999999998643
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+. ........ .+.....+
T Consensus 184 ~------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~----~~~~~~~~-~i~~~~~~--- 248 (290)
T 3fpq_A 184 A------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIYR-RVTSGVKP--- 248 (290)
T ss_dssp T------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHHH-HHTTTCCC---
T ss_pred C------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC----CcHHHHHH-HHHcCCCC---
Confidence 2 12335689999999998874 6999999999999999999999999642 12222222 22222111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.++...+..+.+++.. ||+.||++|||++|+++
T Consensus 249 --~~~~~~~~~~~~~li~~------~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 --ASFDKVAIPEVKEIIEG------CIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGGGCCCHHHHHHHHH------HSCSSGGGSCCHHHHHT
T ss_pred --CCCCccCCHHHHHHHHH------HccCChhHCcCHHHHhc
Confidence 11222333445555554 99999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=433.19 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=210.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCC-CCcceEEeeeecC-C
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRH-RNIVRLLGWGANR-K 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~-~ 845 (1117)
.++|++.+.||+|+||+||+|.+. .++.||||+++.... ...++|.+|++++++++| ||||+++|+|.++ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 467999999999999999999743 246899999976433 335679999999999965 9999999998764 5
Q ss_pred ceEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 912 (1117)
..++|||||++|+|.++++.... ...+++.++..++.|||+||+|||++ +||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence 68999999999999999975321 24589999999999999999999999 999999999999999
Q ss_pred CCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChh
Q 001238 913 ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQH 991 (1117)
Q Consensus 913 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~ 991 (1117)
+++.+||+|||+|+...... .........||++|||||++.+..|+.++|||||||++|||+| |+.||.+... ...
T Consensus 220 ~~~~vKi~DFGlar~~~~~~--~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~-~~~ 296 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDP--DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEE 296 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHH
T ss_pred CCCCEEECcchhhhhcccCC--CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH-HHH
Confidence 99999999999999775432 2233456789999999999999999999999999999999998 9999975322 222
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
+.. .+..... +..+...+..+.+++. .||+.||++|||+.+|++.|+.+.+.
T Consensus 297 ~~~----~i~~g~~------~~~p~~~~~~~~~li~------~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 FCR----RLKEGTR------MRAPDYTTPEMYQTML------DCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHH----HHHHTCC------CCCCTTCCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH----HHHcCCC------CCCCccCCHHHHHHHH------HHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 222 2222211 1223334444555444 49999999999999999999988653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=464.83 Aligned_cols=456 Identities=18% Similarity=0.171 Sum_probs=301.6
Q ss_pred EEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCC
Q 001238 78 GLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQ 157 (1117)
Q Consensus 78 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 157 (1117)
.+|++++++. .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 5789999988 5888777 899999999999998888999999999999999999998889999999999999999999
Q ss_pred cCCCCchhccCCcCCcEEeccCCCCCC-CCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCC
Q 001238 158 LEGAIPIQIGNLSSLTQLFLYDNQLTD-AIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLP 236 (1117)
Q Consensus 158 l~~~~p~~~~~L~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp 236 (1117)
++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|+... ..+..+++|
T Consensus 81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L--------------- 138 (520)
T 2z7x_B 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHL--------------- 138 (520)
T ss_dssp CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTS---------------
T ss_pred ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch----hhccccccc---------------
Confidence 99 78877 89999999999999987 467777777777777777665211 122222222
Q ss_pred cccccccccceeecccccc--cccCCcCCCCCC-CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCC
Q 001238 237 PTLGLLKRLQTIAIYTALL--SGQIPPELGDCT-ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGN 313 (1117)
Q Consensus 237 ~~l~~l~~L~~L~l~~~~l--~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~ 313 (1117)
+|+.|++++|.+ .+..|..+..+. +...+++++|++.+.++. ..+.+
T Consensus 139 -------~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~-----------------------~~~~~ 188 (520)
T 2z7x_B 139 -------NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILD-----------------------VSVKT 188 (520)
T ss_dssp -------CEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCC-----------------------CCCTT
T ss_pred -------eeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhh-----------------------hhhhc
Confidence 003333333333 333333333332 122334444444333332 12334
Q ss_pred CCCCCEEEcCCCc-------CCCCCccccCCCCCcceEecccccccCccccccc---CCCCCcEEEecCccccCCCCccc
Q 001238 314 CSQLSIIDISMNS-------LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIG---NCQRLAQIELDNNQITGAIPSEF 383 (1117)
Q Consensus 314 l~~L~~LdLs~N~-------l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~ 383 (1117)
+++|+.|++++|. +.+.+| .++.+++|+.|++++|.+++..+..+. ..++|++|++++|+++|.+|..+
T Consensus 189 l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~ 267 (520)
T 2z7x_B 189 VANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD 267 (520)
T ss_dssp CSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCC
T ss_pred ccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccch
Confidence 4444444444443 333333 344455555555555544432211111 12355555555555555555554
Q ss_pred -----ccccchHHHHhccccccccCC-CCCCcc---cccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCC
Q 001238 384 -----GNLSNLTLLFVWHNRLEGEIP-PSISNC---QNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPE 454 (1117)
Q Consensus 384 -----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 454 (1117)
+.+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+... + .+..+++|++|++++|++++..|..
T Consensus 268 ~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~Ls~n~l~~~~~~~ 343 (520)
T 2z7x_B 268 FDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHM-L-CPSKISPFLHLDFSNNLLTDTVFEN 343 (520)
T ss_dssp CCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCC-C-CCSSCCCCCEEECCSSCCCTTTTTT
T ss_pred hhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccc-c-chhhCCcccEEEeECCccChhhhhh
Confidence 5555555555555555 233 222222 4567777777776532 1 1246677777777777777777777
Q ss_pred cccccccceeccCCCcccc--cCCCCcCCCCCCCEEEccCCcCCCCCCc-ccccCCCCceEEccCCccccccchhhhccc
Q 001238 455 MGNCSSLIRFRANSNKLTG--FIPPEIGNLKNLNFLDLGSNRLTGSIPD-EITGCRNLTFLDVHSNSIAGNLPAGLHQLV 531 (1117)
Q Consensus 455 ~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 531 (1117)
++++++|++|++++|++++ .+|..++.+++|++|+|++|++++.+|. .+..+++|++|++++|++++..|..+. +
T Consensus 344 ~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~ 421 (520)
T 2z7x_B 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P 421 (520)
T ss_dssp CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--T
T ss_pred hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--c
Confidence 7777777777777777775 4456677788888888888888764554 477778888888888888776666554 6
Q ss_pred ccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccc
Q 001238 532 RLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP 596 (1117)
Q Consensus 532 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 596 (1117)
+|+.|++++|+|+.++...+ .+++|+.|+|++|+|++..+..|..+++|+.|++++|++++..+
T Consensus 422 ~L~~L~Ls~N~l~~ip~~~~-~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 422 RIKVLDLHSNKIKSIPKQVV-KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp TCCEEECCSSCCCCCCGGGG-GCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCEEECCCCcccccchhhh-cCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 78888888888886655444 78888888888888885444458888899999999999886543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=462.73 Aligned_cols=477 Identities=18% Similarity=0.174 Sum_probs=297.5
Q ss_pred cEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeeccc
Q 001238 173 TQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYT 252 (1117)
Q Consensus 173 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~ 252 (1117)
.+.++++|.++ .+|..+. ++|++|++++| .+++..|..+.++++|++|++++
T Consensus 8 ~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n-------------------------~l~~~~~~~~~~l~~L~~L~Ls~ 59 (549)
T 2z81_A 8 GVCDGRSRSFT-SIPSGLT--AAMKSLDLSFN-------------------------KITYIGHGDLRACANLQVLILKS 59 (549)
T ss_dssp SEEECTTSCCS-SCCSCCC--TTCCEEECCSS-------------------------CCCEECSSTTSSCTTCCEEECTT
T ss_pred ceEECCCCccc-cccccCC--CCccEEECcCC-------------------------ccCccChhhhhcCCcccEEECCC
Confidence 34567777776 4555443 44555555554 44444455555555555555555
Q ss_pred ccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcc-cCCcCCCCCCCCCEEEcCCCcCCCCC
Q 001238 253 ALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVG-IIPPELGNCSQLSIIDISMNSLTGSI 331 (1117)
Q Consensus 253 ~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~LdLs~N~l~~~~ 331 (1117)
|.+.+..|..|..+++|++|+|++|++++..|..|+++++|++|++++|.+++ ..|..++++++|++|++++|.+.+.+
T Consensus 60 n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~ 139 (549)
T 2z81_A 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEI 139 (549)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEE
T ss_pred CCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCcccccc
Confidence 55555555556666666666666666665544456666666666666666654 23445666666666666666533333
Q ss_pred c-cccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcc-cccccchHHHHhccccccccC--C-CC
Q 001238 332 P-QTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE-FGNLSNLTLLFVWHNRLEGEI--P-PS 406 (1117)
Q Consensus 332 p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~--~-~~ 406 (1117)
| ..|.++++|++|++++|.+++..|..+..+++|++|++++|.+. .+|.. +..+++|++|++++|++++.. + ..
T Consensus 140 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 218 (549)
T 2z81_A 140 RRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218 (549)
T ss_dssp CTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSS
T ss_pred CHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccch
Confidence 3 45566666666666666666556666666666666666666654 22322 234556666666666665431 1 12
Q ss_pred CCcccccceeecccccccCCCcc----cccCCCCCCeeeccCccCCCCC------CCCcccccccceeccCCCcccccC-
Q 001238 407 ISNCQNLEAVDLSQNGLTGPIPR----GIFQLKKLNKLLLLSNNLSGVI------PPEMGNCSSLIRFRANSNKLTGFI- 475 (1117)
Q Consensus 407 ~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~l~~N~l~~~~- 475 (1117)
...+++|+.|++++|.+++..+. .+..+.+|+.+++++|.+.+.. ...+..+.+|+.|++.++.+....
T Consensus 219 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~ 298 (549)
T 2z81_A 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298 (549)
T ss_dssp CCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG
T ss_pred hhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhh
Confidence 23456666777777666543332 2344566777777777665431 123455666777777776655321
Q ss_pred ----CCCcCCCCCCCEEEccCCcCCCCCCccc-ccCCCCceEEccCCccccccch---hhhcccccccccccCCcCCCCC
Q 001238 476 ----PPEIGNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPA---GLHQLVRLQFADLSDNSVGGML 547 (1117)
Q Consensus 476 ----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~i~~~~ 547 (1117)
+..+..+.+|+.|++++|+++ .+|..+ ..+++|++|+|++|++.+..|. .+..+++|+.|++++|+++++.
T Consensus 299 ~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 377 (549)
T 2z81_A 299 FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377 (549)
T ss_dssp SCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHH
T ss_pred cccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccc
Confidence 111223457788888888877 555555 5678888888888888776543 3667778888888888887664
Q ss_pred C--CCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCcccccc
Q 001238 548 S--PDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELT 625 (1117)
Q Consensus 548 ~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~ 625 (1117)
. ..+..+++|+.|++++|+|+ .+|..+..+++|+.|++++|+++ .+|..+. +.+ +.|+|++|+|++.+ .
T Consensus 378 ~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L-~~L~Ls~N~l~~~~----~ 448 (549)
T 2z81_A 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTL-EVLDVSNNNLDSFS----L 448 (549)
T ss_dssp HHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTC-SEEECCSSCCSCCC----C
T ss_pred cchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCc-eEEECCCCChhhhc----c
Confidence 3 44777788888888888887 56677777788888888888877 4444332 334 67888888887643 4
Q ss_pred CCCCccEEeccCccccCCcchhhhcccceEEEeecccccCCCCC-CcccccCCcccccCCCCCCc
Q 001238 626 GLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPD-TPFFAKLPLSVLSGNPSLCF 689 (1117)
Q Consensus 626 ~l~~L~~LdLs~N~l~~~~~~l~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~gN~~~c~ 689 (1117)
.+++|+.|||++|+++ .+|....+++|++|+|++|++++.+|. ...+..+....+++|||.|.
T Consensus 449 ~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 449 FLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp CCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred cCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 6778888888888887 444456678888888888888877765 34567777778888888874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=422.45 Aligned_cols=242 Identities=24% Similarity=0.295 Sum_probs=194.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc----CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL----PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|++.+.||+|+||+||+|+. .+++.||||+++... .....++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4688999999999999999975 247899999997532 2233468899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
|||||+||+|.+++... +.+++.++..++.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999764 3499999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ...+.+........
T Consensus 178 ~~~----~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i~~~~~----- 243 (304)
T 3ubd_A 178 DHE----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-----DRKETMTMILKAKL----- 243 (304)
T ss_dssp -------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC-----
T ss_pred CCC----ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-----CHHHHHHHHHcCCC-----
Confidence 322 2334578999999999999999999999999999999999999999642 23334444443332
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~ 1046 (1117)
.++...+....++++. |++.||++||++
T Consensus 244 ---~~p~~~s~~~~~li~~------~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ---GMPQFLSPEAQSLLRM------LFKRNPANRLGA 271 (304)
T ss_dssp ---CCCTTSCHHHHHHHHH------HTCSSGGGSTTC
T ss_pred ---CCCCcCCHHHHHHHHH------HcccCHHHCCCC
Confidence 1233345556666665 999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=408.63 Aligned_cols=253 Identities=21% Similarity=0.329 Sum_probs=186.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCC--------
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK-------- 845 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-------- 845 (1117)
.+|++.+.||+|+||+||+|++ .+|+.||||+++... ....+++.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588899999999999999985 479999999997543 334467899999999999999999999886544
Q ss_pred ----ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecc
Q 001238 846 ----TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 846 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
..|+|||||++|+|.+++.........++..++.++.||++||+|||++ +||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 3689999999999999998765444467788899999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCc--------cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHH
Q 001238 922 FGLARLVEDDSGGS--------FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVI 993 (1117)
Q Consensus 922 fGla~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~ 993 (1117)
||+|+......... ....+..+||+.|||||++.+..|+.++||||+||++|||++ ||.. .....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~----~~~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST----QMERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS----HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC----ccHHH
Confidence 99998875432211 112345689999999999999999999999999999999996 7743 11222
Q ss_pred HHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 994 QWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+..... ...+ +..... .... ..++..|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~-~~~p-----~~~~~~-~~~~------~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLTDVRN-LKFP-----PLFTQK-YPCE------YVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHT-TCCC-----HHHHHH-CHHH------HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHhc-CCCC-----CCCccc-CHHH------HHHHHHHcCCChhHCcCHHHHhc
Confidence 22222211 1111 000000 1112 23455699999999999999876
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=450.76 Aligned_cols=526 Identities=22% Similarity=0.221 Sum_probs=341.9
Q ss_pred eEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCC
Q 001238 102 RLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQ 181 (1117)
Q Consensus 102 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~ 181 (1117)
..+=++.+++ .+|..+- ..+++|||++|+|++..|.+|.++++|++|||++|+|++..|..|++|++|++|+|++|+
T Consensus 35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 3455666777 6786553 478999999999996666789999999999999999997667789999999999999999
Q ss_pred CCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCc
Q 001238 182 LTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPP 261 (1117)
Q Consensus 182 l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~ 261 (1117)
|++..+..|.++++|++|++++|+ +++. .+.
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~-------------------------l~~l------------------------~~~ 142 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETN-------------------------LASL------------------------ENF 142 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSC-------------------------CCCS------------------------TTC
T ss_pred CCCCCHHHhcCCCCCCEEECCCCc-------------------------CCCC------------------------Chh
Confidence 987555666776666666666554 2222 222
Q ss_pred CCCCCCCCcEEecCCCccCC-cCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCC----CEEEcCCCcCCCCCccccC
Q 001238 262 ELGDCTELQYIYLYENALTG-SIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQL----SIIDISMNSLTGSIPQTLG 336 (1117)
Q Consensus 262 ~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L----~~LdLs~N~l~~~~p~~l~ 336 (1117)
.|+++++|++|+|++|.+++ .+|..++.+++|++|+|++|++++..+..|..+.++ ..++++.|.++...+..+
T Consensus 143 ~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~- 221 (635)
T 4g8a_A 143 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF- 221 (635)
T ss_dssp CCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-
T ss_pred hhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-
Confidence 33344444444444444432 233444444444444444444444444443332222 234455555543322222
Q ss_pred CCCCcceEecccccccC-cccccccCCCCCcEEEecCcc------ccCCCCcccccccchHHHHhcccccc---ccCCCC
Q 001238 337 NLTSLQELQLSVNQISG-EIPAQIGNCQRLAQIELDNNQ------ITGAIPSEFGNLSNLTLLFVWHNRLE---GEIPPS 406 (1117)
Q Consensus 337 ~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~------l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~~~~ 406 (1117)
....++.|++++|.... ..+..+..+..++...+..+. +.......+..+..+..+.+..+... ...+..
T Consensus 222 ~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~ 301 (635)
T 4g8a_A 222 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDL 301 (635)
T ss_dssp TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTT
T ss_pred cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhh
Confidence 22334445554443331 122233444444444332221 11222223333334443333333221 123344
Q ss_pred CCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCC
Q 001238 407 ISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLN 486 (1117)
Q Consensus 407 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 486 (1117)
+..+.+++.+++.+|.+... ..+.....|+.|++.+|.+.+..+. .+..|+.+++..|.+... .....+++|+
T Consensus 302 ~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~ 374 (635)
T 4g8a_A 302 FNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLE 374 (635)
T ss_dssp TGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCC
T ss_pred hhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccc
Confidence 55666777777777777632 2344556778888888877755443 345677777777776643 2345678888
Q ss_pred EEEccCCcCCC--CCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCC-CCCCcCCCccccEEecc
Q 001238 487 FLDLGSNRLTG--SIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGM-LSPDLGSLSSLTKLVLN 563 (1117)
Q Consensus 487 ~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~L~ 563 (1117)
.|++++|.+.. ..+..+..+.+|++|+++.|.+.. .+..+..+++|+.++++.|..... ....|..+.+++.++++
T Consensus 375 ~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls 453 (635)
T 4g8a_A 375 FLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 453 (635)
T ss_dssp EEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECT
T ss_pred cchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccccccccccccc
Confidence 88888888753 355666777888888888888774 445677788888888887775554 34567788888888888
Q ss_pred ccccCCCCCcccccccceeEEeccccccc-cccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccC
Q 001238 564 KNRFAGSIPSQLGSCVKLQLLDLSSNQLS-GNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSG 642 (1117)
Q Consensus 564 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~ 642 (1117)
.|.+.+..+..+..++.|+.|+|++|.+. +.+|..+..++++ +.|+|++|+|++.+|..|.++++|++|+|++|+|++
T Consensus 454 ~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L-~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~ 532 (635)
T 4g8a_A 454 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL-TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 532 (635)
T ss_dssp TSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCB
T ss_pred ccccccccccccccchhhhhhhhhhcccccccCchhhhhcccc-CEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCC
Confidence 88888888888888888888888888744 4567778888887 788888888888888888888888888998888888
Q ss_pred Ccch-hhhcccceEEEeecccccCCCCCCc-cc-ccCCcccccCCCCCCc
Q 001238 643 DLHF-LAELQNLVVLNVSHNNFSGRVPDTP-FF-AKLPLSVLSGNPSLCF 689 (1117)
Q Consensus 643 ~~~~-l~~l~~L~~L~ls~N~l~~~~p~~~-~~-~~~~~~~~~gN~~~c~ 689 (1117)
.++. +..+++|++|||++|+|++.+|+.- .+ ..+....+++|||.|.
T Consensus 533 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 533 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 6654 7788888899999998888877642 23 4677788899999985
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=446.20 Aligned_cols=353 Identities=17% Similarity=0.168 Sum_probs=223.7
Q ss_pred CcCCCCCCCCcEEecCCCccCCcCCccCCCCCCC--cEEEccCCcC--cccCCcCCCCCC--CCCEEEcCCCcCCCCCcc
Q 001238 260 PPELGDCTELQYIYLYENALTGSIPSKLGNLKNL--VNLFLWQNNL--VGIIPPELGNCS--QLSIIDISMNSLTGSIPQ 333 (1117)
Q Consensus 260 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~L~~n~l--~~~~p~~~~~l~--~L~~LdLs~N~l~~~~p~ 333 (1117)
|..|+++++|++|+|++|++++. .+..+++| ++|++++|.+ ++..|..+..+. .| .+++++|.+.+.++.
T Consensus 139 p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~ 214 (562)
T 3a79_B 139 CKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVN 214 (562)
T ss_dssp CGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCE
T ss_pred hHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEecCccchhhhhh
Confidence 44566677888888998888753 34555555 8888888888 777777776654 33 567788888776554
Q ss_pred -ccCCCCCcceEeccccc-----ccCcccccccCCCCCcEEEecCccccCCCCccc---ccccchHHHHhccccccccCC
Q 001238 334 -TLGNLTSLQELQLSVNQ-----ISGEIPAQIGNCQRLAQIELDNNQITGAIPSEF---GNLSNLTLLFVWHNRLEGEIP 404 (1117)
Q Consensus 334 -~l~~l~~L~~L~Ls~N~-----l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~~ 404 (1117)
.+..+++|+.|++++|. +.+ ....+..+++|+.|+++++.+.+.....+ ...++|++|++++|++++.+|
T Consensus 215 ~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip 293 (562)
T 3a79_B 215 MSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293 (562)
T ss_dssp EEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCC
T ss_pred hcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeecccc
Confidence 46677888888888874 222 22346677788888877776653211100 011245555555555554444
Q ss_pred CCC-----CcccccceeecccccccCCCc-ccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCC
Q 001238 405 PSI-----SNCQNLEAVDLSQNGLTGPIP-RGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPE 478 (1117)
Q Consensus 405 ~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 478 (1117)
..+ ..++.|+.++++.|.+ .+| ..+..+ ....+|++|++++|.+.... .
T Consensus 294 ~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~---------------------~~~~~L~~L~l~~n~~~~~~--~ 348 (562)
T 3a79_B 294 REEFTYSETALKSLMIEHVKNQVF--LFSKEALYSV---------------------FAEMNIKMLSISDTPFIHMV--C 348 (562)
T ss_dssp CCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHH---------------------HHTCCCSEEEEESSCCCCCC--C
T ss_pred chhhhcccccchheehhhccccee--ecChhhhhhh---------------------hccCcceEEEccCCCccccc--C
Confidence 444 3444444444444443 122 111111 00134555555555544221 1
Q ss_pred cCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccc--cchhhhcccccccccccCCcCCC-CCCCCcCCCc
Q 001238 479 IGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGN--LPAGLHQLVRLQFADLSDNSVGG-MLSPDLGSLS 555 (1117)
Q Consensus 479 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~i~~-~~~~~~~~l~ 555 (1117)
...+++|++|++++|++++..|..+.++++|++|+|++|++++. +|..|..+++|+.|++++|++++ ++...|..++
T Consensus 349 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~ 428 (562)
T 3a79_B 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428 (562)
T ss_dssp CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCT
T ss_pred ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcc
Confidence 24566677777777777666666677777777777777777653 24556667777777777777766 5556677777
Q ss_pred cccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEec
Q 001238 556 SLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDL 635 (1117)
Q Consensus 556 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdL 635 (1117)
+|+.|++++|++++..|..+. ++|+.|+|++|+++ .+|..++.++.+ +.|+|++|+|++..+..|..+++|+.|+|
T Consensus 429 ~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L-~~L~L~~N~l~~l~~~~~~~l~~L~~L~l 504 (562)
T 3a79_B 429 SILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQAL-QELNVASNQLKSVPDGVFDRLTSLQYIWL 504 (562)
T ss_dssp TCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCC-SEEECCSSCCCCCCTTSTTTCTTCCCEEC
T ss_pred cCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCC-CEEECCCCCCCCCCHHHHhcCCCCCEEEe
Confidence 888888888887766555443 57888888888887 677777777777 67888888887433333788888888888
Q ss_pred cCccccCCcch
Q 001238 636 SHNELSGDLHF 646 (1117)
Q Consensus 636 s~N~l~~~~~~ 646 (1117)
++|+++|+++.
T Consensus 505 ~~N~~~c~c~~ 515 (562)
T 3a79_B 505 HDNPWDCTCPG 515 (562)
T ss_dssp CSCCBCCCHHH
T ss_pred cCCCcCCCcch
Confidence 88888887765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=407.39 Aligned_cols=202 Identities=22% Similarity=0.335 Sum_probs=171.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeec------CCc
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGAN------RKT 846 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 846 (1117)
++|++.+.||+|+||+||+|.+ .+|+.||||+++... ....+++.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4789999999999999999975 579999999997543 2234568899999999999999999998653 367
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.|+|||||+ |+|.+++... +.+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 6799988764 3499999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.+..............+||+.|||||++.+. .|+.++||||+||++|||++|++||.+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 7754332233345567999999999998764 569999999999999999999999965
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=437.14 Aligned_cols=456 Identities=18% Similarity=0.165 Sum_probs=293.4
Q ss_pred EEEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCC
Q 001238 77 VGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSN 156 (1117)
Q Consensus 77 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 156 (1117)
..++++++++.+ +|..+. ++|++|+|++|++++..|.+|+++++|++|+|++|.+++..|+.|..+++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 467777777765 776655 67888888888888777778888888888888888888766777888888888888888
Q ss_pred CcCCCCchhccCCcCCcEEeccCCCCCC-CCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccC
Q 001238 157 QLEGAIPIQIGNLSSLTQLFLYDNQLTD-AIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFL 235 (1117)
Q Consensus 157 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~l 235 (1117)
+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|+... ..+..+++|
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L-------------- 169 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ----LDLLPVAHL-------------- 169 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT----TTTGGGTTS--------------
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc----Cchhhhhhc--------------
Confidence 887 66665 77888888888888775 234566666666666665554211 111111111
Q ss_pred Ccccccccccceeecccccc--cccCCcCCCCCC-CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCC
Q 001238 236 PPTLGLLKRLQTIAIYTALL--SGQIPPELGDCT-ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELG 312 (1117)
Q Consensus 236 p~~l~~l~~L~~L~l~~~~l--~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~ 312 (1117)
+|+.|++++|.+ .+..|..+..+. ..-.+++++|.+.+.++.. .+.
T Consensus 170 --------~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~-----------------------~~~ 218 (562)
T 3a79_B 170 --------HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNM-----------------------SVN 218 (562)
T ss_dssp --------CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEE-----------------------EES
T ss_pred --------eeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhh-----------------------ccc
Confidence 113333333333 333333333322 0113344455444433321 233
Q ss_pred CCCCCCEEEcCCCc-----CCCCCccccCCCCCcceEecccccccCcc----cccccCCCCCcEEEecCccccCCCCccc
Q 001238 313 NCSQLSIIDISMNS-----LTGSIPQTLGNLTSLQELQLSVNQISGEI----PAQIGNCQRLAQIELDNNQITGAIPSEF 383 (1117)
Q Consensus 313 ~l~~L~~LdLs~N~-----l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 383 (1117)
.+++|+.|++++|. +.+ ....+..+++|+.|+++++.+.+.. +..+ ...+|++|++++|.++|.+|..+
T Consensus 219 ~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~ 296 (562)
T 3a79_B 219 ALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREE 296 (562)
T ss_dssp SEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCC
T ss_pred ccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchh
Confidence 44445555555443 111 1123444555555555555443211 1111 12356666666666665555554
Q ss_pred -----ccccchHHHHhccccccccCC-CCCCc---ccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCC
Q 001238 384 -----GNLSNLTLLFVWHNRLEGEIP-PSISN---CQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPE 454 (1117)
Q Consensus 384 -----~~l~~L~~L~L~~N~l~~~~~-~~~~~---l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 454 (1117)
..++.|+.+++..|.+ .+| ..+.. ..+|+.|++++|.+... + ....+++|++|++++|++++..|..
T Consensus 297 ~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~-~-~~~~l~~L~~L~l~~n~l~~~~~~~ 372 (562)
T 3a79_B 297 FTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHM-V-CPPSPSSFTFLNFTQNVFTDSVFQG 372 (562)
T ss_dssp CCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCC-C-CCSSCCCCCEEECCSSCCCTTTTTT
T ss_pred hhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCcccc-c-CccCCCCceEEECCCCccccchhhh
Confidence 4555555555555554 222 11111 14688888888887632 1 1256788888888888888888888
Q ss_pred cccccccceeccCCCccccc--CCCCcCCCCCCCEEEccCCcCCCCCC-cccccCCCCceEEccCCccccccchhhhccc
Q 001238 455 MGNCSSLIRFRANSNKLTGF--IPPEIGNLKNLNFLDLGSNRLTGSIP-DEITGCRNLTFLDVHSNSIAGNLPAGLHQLV 531 (1117)
Q Consensus 455 ~~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 531 (1117)
++++++|++|++++|++++. +|..|.++++|++|+|++|++++.+| ..+..+++|++|++++|+|++..|..+. +
T Consensus 373 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~ 450 (562)
T 3a79_B 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--P 450 (562)
T ss_dssp CCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--T
T ss_pred hcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--C
Confidence 88888899999999988863 34678889999999999999987444 4578889999999999999876665543 6
Q ss_pred ccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccc
Q 001238 532 RLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP 596 (1117)
Q Consensus 532 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 596 (1117)
+|+.|++++|+|+.++...+ .+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++..|
T Consensus 451 ~L~~L~L~~N~l~~ip~~~~-~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 451 KVKVLDLHNNRIMSIPKDVT-HLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp TCSEEECCSSCCCCCCTTTT-SSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred cCCEEECCCCcCcccChhhc-CCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 88888888888887766655 88888888888888885444448888888888888888886554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=406.26 Aligned_cols=420 Identities=22% Similarity=0.252 Sum_probs=183.9
Q ss_pred ccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEE
Q 001238 96 SLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQL 175 (1117)
Q Consensus 96 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L 175 (1117)
+.++|++|++++|++ |.+|++|+++++|++|+|++|.++|.+|.+++.+++|++++++.|.. .+|++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 358899999999999 79999999999999999999999999999999999999998887753 568999
Q ss_pred eccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccc
Q 001238 176 FLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALL 255 (1117)
Q Consensus 176 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l 255 (1117)
++++|++++ +|.. .++|++|++++| .+++ +|.. +++|+.|++++|.+
T Consensus 77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n-------------------------~l~~-lp~~---~~~L~~L~l~~n~l 123 (454)
T 1jl5_A 77 ELNNLGLSS-LPEL---PPHLESLVASCN-------------------------SLTE-LPEL---PQSLKSLLVDNNNL 123 (454)
T ss_dssp ECTTSCCSC-CCSC---CTTCSEEECCSS-------------------------CCSS-CCCC---CTTCCEEECCSSCC
T ss_pred EecCCcccc-CCCC---cCCCCEEEccCC-------------------------cCCc-cccc---cCCCcEEECCCCcc
Confidence 999999885 4431 234444444444 3333 2221 13344444444433
Q ss_pred cccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCcccc
Q 001238 256 SGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTL 335 (1117)
Q Consensus 256 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l 335 (1117)
.+ +|.. .++|++|++++|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .+
T Consensus 124 ~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~ 191 (454)
T 1jl5_A 124 KA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-EL 191 (454)
T ss_dssp SC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CC
T ss_pred Cc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cc
Confidence 32 1110 1355555555555553 44 35555555555555555553 33322 355555555555553 33 35
Q ss_pred CCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccce
Q 001238 336 GNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEA 415 (1117)
Q Consensus 336 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 415 (1117)
+++++|++|++++|++++ +|... ++|++|++++|+++ .+| .|+.+++ |++
T Consensus 192 ~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~------------------------L~~ 241 (454)
T 1jl5_A 192 QNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPF------------------------LTT 241 (454)
T ss_dssp TTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTT------------------------CCE
T ss_pred cCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCC------------------------CCE
Confidence 555555555555555553 22211 34555555555554 333 2444444 444
Q ss_pred eecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcC
Q 001238 416 VDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRL 495 (1117)
Q Consensus 416 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 495 (1117)
|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++. |.. .++|+.|++++|++
T Consensus 242 L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l 309 (454)
T 1jl5_A 242 IYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEI 309 (454)
T ss_dssp EECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCC
T ss_pred EECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcC
Confidence 4444444442 3321 2344555555555443 2221 24455555555555432 110 13555566666655
Q ss_pred CCCCCcccccC-CCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCC--CCC
Q 001238 496 TGSIPDEITGC-RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAG--SIP 572 (1117)
Q Consensus 496 ~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~ 572 (1117)
++. + .+ ++|++|++++|++++ +|.. +++|+.|++++|+++.++. .+++|+.|++++|++++ .+|
T Consensus 310 ~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~lp~----~l~~L~~L~L~~N~l~~l~~ip 376 (454)
T 1jl5_A 310 RSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEVPE----LPQNLKQLHVEYNPLREFPDIP 376 (454)
T ss_dssp SEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSCCCCC
T ss_pred Ccc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccccccc----hhhhccEEECCCCCCCcCCCCh
Confidence 531 1 12 355666666666554 3322 3556666666666665444 24566666666666665 444
Q ss_pred cccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccC--CccccccCCCCccEEeccCccccCCcc
Q 001238 573 SQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICG--ELPAELTGLNKLGILDLSHNELSGDLH 645 (1117)
Q Consensus 573 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~--~~p~~l~~l~~L~~LdLs~N~l~~~~~ 645 (1117)
..+.. |+.|.+.|.+|..+ +++ +.|++++|++++ .+|. .|+.|++.+|.+.+.++
T Consensus 377 ~~l~~--------L~~n~~~~~i~~~~---~~L-~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~ 433 (454)
T 1jl5_A 377 ESVED--------LRMNSHLAEVPELP---QNL-KQLHVETNPLREFPDIPE------SVEDLRMNSERVVDPYE 433 (454)
T ss_dssp TTCCE--------EECCC---------------------------------------------------------
T ss_pred HHHHh--------hhhccccccccccc---CcC-CEEECCCCcCCccccchh------hHhheeCcCcccCCccc
Confidence 44432 23355555665532 334 566777777765 4553 34555667777766543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=395.17 Aligned_cols=201 Identities=23% Similarity=0.334 Sum_probs=171.5
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc----CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCce
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL----PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 847 (1117)
...++|++.++||+|+||+||+|+. .+++.||||++.... ...++.+|+++++.+ +|||||++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4567899999999999999999974 247899999987543 345788999999998 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-Ccceeccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGLAR 926 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla~ 926 (1117)
|+||||+++|+|.+++.. +++.++..++.|+++||+|||++ +||||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 999999999999999842 88999999999999999999999 99999999999999877 799999999998
Q ss_pred cccCCCCC------------------------ccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCC
Q 001238 927 LVEDDSGG------------------------SFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKP 981 (1117)
Q Consensus 927 ~~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P 981 (1117)
...+.... ........+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432110 00112345899999999998765 589999999999999999999999
Q ss_pred CCC
Q 001238 982 VDA 984 (1117)
Q Consensus 982 ~~~ 984 (1117)
|..
T Consensus 247 f~~ 249 (361)
T 4f9c_A 247 FYK 249 (361)
T ss_dssp SSC
T ss_pred CCC
Confidence 954
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=406.26 Aligned_cols=339 Identities=26% Similarity=0.337 Sum_probs=206.1
Q ss_pred CCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEec
Q 001238 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQL 346 (1117)
Q Consensus 267 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L 346 (1117)
++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .|+++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 456666676666665 5543 2566677777776664 2221 1567777777777774 55 4677777777777
Q ss_pred ccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCC
Q 001238 347 SVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP 426 (1117)
Q Consensus 347 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 426 (1117)
++|++++ +|..+ .+|++|++++|++++ +| .|+++++|+.|++++|++++ +|... ++|++|++++|.++ .
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~ 229 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-E 229 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-S
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-c
Confidence 7777764 44332 467777777777775 44 46777777777777777764 33322 48899999999998 5
Q ss_pred CcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccC
Q 001238 427 IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506 (1117)
Q Consensus 427 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 506 (1117)
+|. +..+++|++|++++|++++ +|.. +++|++|++++|++++ +|.. +++|++|++++|++++. |.. .
T Consensus 230 lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~ 296 (454)
T 1jl5_A 230 LPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---P 296 (454)
T ss_dssp CCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---C
T ss_pred ccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---C
Confidence 774 8889999999999999986 3433 3789999999999986 4443 37899999999998862 211 2
Q ss_pred CCCceEEccCCccccccchhhhcc-cccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEe
Q 001238 507 RNLTFLDVHSNSIAGNLPAGLHQL-VRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLD 585 (1117)
Q Consensus 507 ~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 585 (1117)
++|++|++++|++++. + .+ .+|+.|++++|++++++.. +++|+.|++++|++++ +|. .+++|+.|+
T Consensus 297 ~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~ 363 (454)
T 1jl5_A 297 PNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIELPAL----PPRLERLIASFNHLAE-VPE---LPQNLKQLH 363 (454)
T ss_dssp TTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSCCCCC----CTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred CcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccccccc----CCcCCEEECCCCcccc-ccc---hhhhccEEE
Confidence 6889999999998863 2 23 4788899999988876542 5788889999998884 454 467888999
Q ss_pred cccccccc--ccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccC--CcchhhhcccceEEEeecc
Q 001238 586 LSSNQLSG--NIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSG--DLHFLAELQNLVVLNVSHN 661 (1117)
Q Consensus 586 Ls~N~l~~--~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~--~~~~l~~l~~L~~L~ls~N 661 (1117)
+++|++++ .+|.+++ +|+.|++.+.+|.. +++|+.||+++|++++ .+| .+++.|.+.+|
T Consensus 364 L~~N~l~~l~~ip~~l~---------~L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP-----~sl~~L~~~~~ 426 (454)
T 1jl5_A 364 VEYNPLREFPDIPESVE---------DLRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP-----ESVEDLRMNSE 426 (454)
T ss_dssp CCSSCCSSCCCCCTTCC---------EEECCC------------------------------------------------
T ss_pred CCCCCCCcCCCChHHHH---------hhhhcccccccccc---cCcCCEEECCCCcCCccccch-----hhHhheeCcCc
Confidence 99999887 6676653 34557777777763 4678888888888886 343 24566777777
Q ss_pred cccCCCCC
Q 001238 662 NFSGRVPD 669 (1117)
Q Consensus 662 ~l~~~~p~ 669 (1117)
.+.+.+|.
T Consensus 427 ~~~~~~~~ 434 (454)
T 1jl5_A 427 RVVDPYEF 434 (454)
T ss_dssp --------
T ss_pred ccCCcccc
Confidence 77765553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=409.44 Aligned_cols=248 Identities=22% Similarity=0.263 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHH---HHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSS---EIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
++|++.++||+|+||+||+|+. .+|+.||||++.+.. ......+.+ ++++++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5789999999999999999985 469999999996431 112223333 466777889999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+|||||+||+|.+++... +.+++..++.++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+..
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999764 4599999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
... .....+||+.|||||++.. ..|+.++||||+||++|||++|++||.+.... ...+.........
T Consensus 343 ~~~------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~i~~~i~~~~---- 410 (689)
T 3v5w_A 343 SKK------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTMA---- 410 (689)
T ss_dssp SSC------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHHHHHHHHHCC----
T ss_pred CCC------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhhcCCC----
Confidence 542 2345689999999999964 57999999999999999999999999753222 2223333333322
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
..++...+...+.++.. |++.||.+|++ ++||.+
T Consensus 411 ----~~~p~~~S~~a~dLI~~------lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ----VELPDSFSPELRSLLEG------LLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CCCCTTSCHHHHHHHHH------HTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCCCccCCHHHHHHHHH------HccCCHhHCCCCCCCCHHHHhc
Confidence 12233445566666665 99999999997 677765
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=386.77 Aligned_cols=295 Identities=31% Similarity=0.508 Sum_probs=209.1
Q ss_pred ccchhHHHHHHHHHhhccCCCCCCCCCCCCCCCCcc--eeeEEecCC---CcEEEEecccccccC--cCCccccccccCC
Q 001238 29 YAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPCK--WFGVSCNLN---NQVVGLDLRYVDLLG--HVPTNFTSLLSLN 101 (1117)
Q Consensus 29 ~~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~~~C~--W~gv~C~~~---~~v~~l~l~~~~l~~--~~~~~~~~l~~L~ 101 (1117)
.|.+.|++||++||+++.++. .+++|..+ .+||. |.||+|+.. ++|+.++++++++.| .+|..|..+++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 488899999999999997665 79999764 56888 999999854 688888887777777 6777777777777
Q ss_pred eEeccC-CCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCC
Q 001238 102 RLVLSG-TNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDN 180 (1117)
Q Consensus 102 ~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N 180 (1117)
.|+|++ |++++.+|.+|+++++|++|+|++|.+++.+|..+..+++|++|+|++|++++.+|..|+++++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 777774 7777777777777777777777777776667766777777777777777776666666666666666666666
Q ss_pred CCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCC
Q 001238 181 QLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIP 260 (1117)
Q Consensus 181 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p 260 (1117)
++++.+|..++
T Consensus 160 ~l~~~~p~~l~--------------------------------------------------------------------- 170 (313)
T 1ogq_A 160 RISGAIPDSYG--------------------------------------------------------------------- 170 (313)
T ss_dssp CCEEECCGGGG---------------------------------------------------------------------
T ss_pred cccCcCCHHHh---------------------------------------------------------------------
Confidence 66554443333
Q ss_pred cCCCCCC-CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCC
Q 001238 261 PELGDCT-ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLT 339 (1117)
Q Consensus 261 ~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~ 339 (1117)
.++ +|++|+|++|++++.+|..|..++ |++|++++|++++..|..|..+++|++|+|++|.+++.+|. +..++
T Consensus 171 ----~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~ 244 (313)
T 1ogq_A 171 ----SFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSK 244 (313)
T ss_dssp ----CCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCT
T ss_pred ----hhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccC
Confidence 233 455666666666666666666665 66666666666666666666777777777777777655554 66667
Q ss_pred CcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcccc-ccc
Q 001238 340 SLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNR-LEG 401 (1117)
Q Consensus 340 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~ 401 (1117)
+|++|+|++|+|++.+|..|..+++|++|++++|++++.+|.. +.+++|+.|++++|. +.|
T Consensus 245 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp TCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred CCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 7777777777777777777777777777777777777766665 667777777777776 443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=411.76 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=208.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+++|+.++|||||++++++.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 35799999999999999999975 56999999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC--CcceeccccccccccCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER--YESCLADFGLARLVEDD 931 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl~DfGla~~~~~~ 931 (1117)
|+||+|.+++.... +.+++.++..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999986542 3489999999999999999999999 99999999999999854 89999999999987542
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ...+.+............
T Consensus 311 ~-----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~-----~~~~~~~~i~~~~~~~~~--- 377 (573)
T 3uto_A 311 Q-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRNVKSCDWNMDD--- 377 (573)
T ss_dssp S-----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHTTCCCCCS---
T ss_pred C-----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHHHHhCCCCCCc---
Confidence 1 233568999999999999999999999999999999999999999642 223333333333222211
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......+....++++ .|++.||++||++.|+++
T Consensus 378 -~~~~~~s~~~~dli~------~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 -SAFSGISEDGKDFIR------KLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -GGGTTSCHHHHHHHH------TTSCSSGGGSCCHHHHHH
T ss_pred -ccccCCCHHHHHHHH------HHccCChhHCcCHHHHhc
Confidence 122233444555554 499999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=381.08 Aligned_cols=283 Identities=34% Similarity=0.558 Sum_probs=227.8
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++...+++|++.+.||+|+||+||+|.+.+|+.||||++........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34456789999999999999999999988899999999887666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGEC-AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
||||+++|+|.+++..... ...+++.++.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999976532 23489999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCC-ChhHHHHHHHHHhcCCCCc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD-GQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~ 1007 (1117)
..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....+. ......|...... .....
T Consensus 190 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 266 (321)
T 2qkw_B 190 TELDQ--THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLE 266 (321)
T ss_dssp SSSSC--CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCCC
T ss_pred ccccc--cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccHH
Confidence 43221 12233457899999999999899999999999999999999999999764432 2234444433222 22333
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
..+++.+........ ......++..|++.||++||++.++++.|+.+.+..
T Consensus 267 ~~~~~~~~~~~~~~~--~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 267 QIVDPNLADKIRPES--LRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSSSCTTCSCHHH--HHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhcChhhccccCHHH--HHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 444554443332221 222334666799999999999999999999887643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=402.32 Aligned_cols=364 Identities=18% Similarity=0.196 Sum_probs=196.8
Q ss_pred CCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccC-CcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEe
Q 001238 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGII-PPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQ 345 (1117)
Q Consensus 267 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ 345 (1117)
++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 56777777777777666677777777777777777776443 44567777777777777777766667777777777777
Q ss_pred cccccccCccccc--ccCCCCCcEEEecCccccCCCCcc-cccccchHHHHhccccccccCCCCCCcc--cccceeeccc
Q 001238 346 LSVNQISGEIPAQ--IGNCQRLAQIELDNNQITGAIPSE-FGNLSNLTLLFVWHNRLEGEIPPSISNC--QNLEAVDLSQ 420 (1117)
Q Consensus 346 Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~ 420 (1117)
|++|.+++..+.. |.++++|++|++++|++++..|.. |.++++|++|++++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 7777776644443 667777777777777777665654 5666666666666666666666666554 4566666666
Q ss_pred ccccCCCccc--------ccCCCCCCeeeccCccCCCCCCCCcccc---cccceeccCCCcccccCCCCcCCCCCCCEEE
Q 001238 421 NGLTGPIPRG--------IFQLKKLNKLLLLSNNLSGVIPPEMGNC---SSLIRFRANSNKLTGFIPPEIGNLKNLNFLD 489 (1117)
Q Consensus 421 N~l~~~~p~~--------~~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 489 (1117)
|.+.+..+.. +..+++|++|++++|++.+..|..+... ++|+.|++++|.+.+..
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~-------------- 255 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS-------------- 255 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------
Confidence 6665432222 1223344444444444444333333222 33334444333332110
Q ss_pred ccCCcCCCCCCccccc--CCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEecccccc
Q 001238 490 LGSNRLTGSIPDEITG--CRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRF 567 (1117)
Q Consensus 490 Ls~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l 567 (1117)
+..+.+.+..+..+.+ .++|++|++++|.+.+..|..|..+++|+.|++++|+++++.+..|.++++|+.|+|++|.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 335 (455)
T 3v47_A 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335 (455)
T ss_dssp TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCcc
Confidence 0111111122222222 23455555555555555555555555555555555555555555555555555555555555
Q ss_pred CCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcc
Q 001238 568 AGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLH 645 (1117)
Q Consensus 568 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~ 645 (1117)
++..+..|..+++|+.|+|++|++++..|..+..++++ +.|+|++|+|++..+..|..+++|+.|+|++|+++|+++
T Consensus 336 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNL-KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCcChhHhcCcccCCEEECCCCcccccChhhccccccc-cEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 54445555555555555555555554444444444444 344444444443333334444444444444444444443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=393.49 Aligned_cols=354 Identities=19% Similarity=0.233 Sum_probs=255.0
Q ss_pred cccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcC-CccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEE
Q 001238 243 KRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSI-PSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIID 321 (1117)
Q Consensus 243 ~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~Ld 321 (1117)
++|++|++++|.+.+..|..|..+++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 55666666666666666666777777777777777665444 34566777777777777777766666777777777777
Q ss_pred cCCCcCCCCCccc--cCCCCCcceEecccccccCccccc-ccCCCCCcEEEecCccccCCCCcccccc--cchHHHHhcc
Q 001238 322 ISMNSLTGSIPQT--LGNLTSLQELQLSVNQISGEIPAQ-IGNCQRLAQIELDNNQITGAIPSEFGNL--SNLTLLFVWH 396 (1117)
Q Consensus 322 Ls~N~l~~~~p~~--l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L~~ 396 (1117)
|++|.+++.+|.. |..+++|++|+|++|.+++..|.. +.++++|++|++++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 7777776544443 666777777777777776665654 6667777777777777776666666655 5677777777
Q ss_pred ccccccCCCC--------CCcccccceeecccccccCCCcccccCC---CCCCeeeccCccCCCC----------CCCCc
Q 001238 397 NRLEGEIPPS--------ISNCQNLEAVDLSQNGLTGPIPRGIFQL---KKLNKLLLLSNNLSGV----------IPPEM 455 (1117)
Q Consensus 397 N~l~~~~~~~--------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~----------~~~~~ 455 (1117)
|.+.+..+.. +..+++|++|++++|++++..|..+... .+|+.|++++|.+.+. .+..+
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 7776544433 2355778888888888887777766554 7788888887755432 22233
Q ss_pred ccc--cccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhccccc
Q 001238 456 GNC--SSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRL 533 (1117)
Q Consensus 456 ~~l--~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 533 (1117)
..+ ++|++|++++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++|
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 332 578888888888888778888888888888888888887777788888888888888888887777788888888
Q ss_pred ccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccc
Q 001238 534 QFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP 596 (1117)
Q Consensus 534 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 596 (1117)
+.|++++|+++++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus 350 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 888888888888877788888888888888888887777777788888888888888886665
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=371.54 Aligned_cols=261 Identities=31% Similarity=0.458 Sum_probs=203.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
..+|++.+.||+|+||+||+|+. +|+.||||++..... ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45788999999999999999987 688999999875532 234578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA--ILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|+++|+|.+++........+++..++.++.|+++||+|||++ + |+||||||+||+++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999998754334489999999999999999999999 7 99999999999999999999999999986543
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+...........
T Consensus 192 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-----~~~~~~~~~~~~~~~----- 257 (309)
T 3p86_A 192 TF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-----NPAQVVAAVGFKCKR----- 257 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-----CHHHHHHHHHHSCCC-----
T ss_pred cc----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcCCC-----
Confidence 21 2234567999999999999999999999999999999999999999642 112222222111111
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
..++...+..+.++++. ||+.+|++||++.++++.|+.+.+..
T Consensus 258 -~~~~~~~~~~l~~li~~------~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 -LEIPRNLNPQVAAIIEG------CWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -CCCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -CCCCccCCHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHHhC
Confidence 12233444555665555 99999999999999999999987653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=373.77 Aligned_cols=281 Identities=39% Similarity=0.670 Sum_probs=225.1
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
++....++|++.+.||+|+||+||+|+..+|+.||||++..... .....+.+|++++++++||||+++++++.+.+..+
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 66778899999999999999999999988899999999875432 23347899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
+||||+++|+|.+++.... ....+++..+..++.|++.||+|||+++.++|+||||||+||+++.++.+||+|||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 9999999999999998753 233589999999999999999999998777999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCC---CCCChhHHHHHHHHHhcCC
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS---FPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~---~~~~~~~~~~~~~~~~~~~ 1004 (1117)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||+.. .........|+...... .
T Consensus 184 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~ 259 (326)
T 3uim_A 184 MDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE-K 259 (326)
T ss_dssp CCSSSS---CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS-C
T ss_pred cCcccc---cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc-h
Confidence 653321 2233456999999999999899999999999999999999999999631 12233444554433322 2
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
......+......... ........++..|++.||++||++.+|++.|+..
T Consensus 260 ~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 260 KLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CSTTSSCTTCTTSCCH--HHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhhhhcChhhccccCH--HHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 2333444444433322 2223344567779999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=366.64 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=208.3
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++..++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++|
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 34567899999999999999999984 57899999999876666677899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|+|.+++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999999764 389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||... .................
T Consensus 169 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~~~~~~~~~~--- 236 (297)
T 3fxz_A 169 EQ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-----NPLRALYLIATNGTPEL--- 236 (297)
T ss_dssp TT----CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHHCSCCC---
T ss_pred cc----cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCC---
Confidence 32 2234567999999999999999999999999999999999999999642 11122222222111110
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+.+++.. |++.||++||++.++++
T Consensus 237 --~~~~~~~~~~~~li~~------~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 --QNPEKLSAIFRDFLNR------CLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --SCGGGSCHHHHHHHHH------HSCSSTTTSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHH------HccCChhHCcCHHHHhh
Confidence 1112233445555554 99999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=370.69 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=211.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
++|.+.+.||+|+||+||+|.+ .+++.||+|++...+....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 4688899999999999999985 468999999987766666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++.... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999998643 3489999999999999999999999 9999999999999999999999999999876543221
Q ss_pred cc----------ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 935 SF----------SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 935 ~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
.. .......||+.|+|||++.+..++.++||||||+++|||++|..||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence 10 111256799999999999999999999999999999999999999865433221111111111111
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
..+...+..+.+++.. |++.||++||++.++++.|++++..
T Consensus 243 --------~~~~~~~~~l~~li~~------~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 --------YCPPNCPPSFFPITVR------CCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp --------TCCTTCCTTHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------cCCCCCCHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHHh
Confidence 1122333455555555 9999999999999999999988754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=361.86 Aligned_cols=278 Identities=35% Similarity=0.555 Sum_probs=218.3
Q ss_pred hHHHhccCCCCC------CeeeecCCeEEEEEEcCCCcEEEEEEeecCC----ccchHHHHHHHHHHhccCCCCcceEEe
Q 001238 770 SIGDATRSLTAG------NIIGQGRSGIVYKVTLPSGLTVAVKRFRASD----KISTGAFSSEIATLSRIRHRNIVRLLG 839 (1117)
Q Consensus 770 ~~~~~~~~~~~~------~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~ 839 (1117)
++..+++.|... +.||+|+||+||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++
T Consensus 19 ~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 97 (307)
T 2nru_A 19 ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97 (307)
T ss_dssp HHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence 566777777766 8999999999999987 68899999987532 223567899999999999999999999
Q ss_pred eeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCccee
Q 001238 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 840 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
++.+.+..++||||+++|+|.+++........+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl 174 (307)
T 2nru_A 98 FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKI 174 (307)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred EEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEE
Confidence 9999999999999999999999998654445689999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHH
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
+|||+++....... ........||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... .....+....
T Consensus 175 ~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~ 250 (307)
T 2nru_A 175 SDFGLARASEKFAQ--TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEI 250 (307)
T ss_dssp CCCTTCEECCSCSS--CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHH
T ss_pred eecccccccccccc--cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHHHHHh
Confidence 99999987654221 122345679999999998864 5899999999999999999999999753222 2222333333
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
........+.+++.+.......... ...++..|++.+|++||++.++++.|+++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~---l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 251 EDEEKTIEDYIDKKMNDADSTSVEA---MYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HTTSCCHHHHSCSSCSCCCHHHHHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhhhhhhccccccccchHHHHH---HHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222223334444443333222222 2245666999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=368.10 Aligned_cols=264 Identities=25% Similarity=0.410 Sum_probs=209.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|++.+.||+|+||+||+|.+. .+..||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357888999999999999999863 3556999999764 33345679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.++++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999997643 3489999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
..... ........+|+.|+|||++....++.++||||||+++|||++ |+.||... ............. .
T Consensus 203 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-----~~~~~~~~~~~~~-~--- 272 (325)
T 3kul_A 203 DDPDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-----TNRDVISSVEEGY-R--- 272 (325)
T ss_dssp ----C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS-----CHHHHHHHHHTTC-C---
T ss_pred cCccc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC-----CHHHHHHHHHcCC-C---
Confidence 43222 122334456889999999999999999999999999999999 99999642 1122222222211 1
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~~ 1062 (1117)
...+...+..+.+++.. ||+.||++||++.++++.|+.+.+.+.+
T Consensus 273 ---~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 273 ---LPAPMGCPHALHQLMLD------CWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ---CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ---CCCCCCcCHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 11222334455555554 9999999999999999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=367.73 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=204.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.++|++.+.||+|+||.||+|.+ .+|+.||||++... .....+++.+|+++++.++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45789999999999999999985 67999999999754 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999998764 3489999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCccccCCccccccccCChhhhccCCCC-cCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKIS-EKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
. .....+||+.|+|||++.+..++ .++||||+||++|||++|+.||.+. ..............
T Consensus 168 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~------ 231 (328)
T 3fe3_A 168 G-----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-----NLKELRERVLRGKY------ 231 (328)
T ss_dssp C-----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC------
T ss_pred C-----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCC------
Confidence 1 23456799999999999887775 7999999999999999999999642 22333333333321
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++...+....++++. |++.||++|||+.++++
T Consensus 232 --~~p~~~s~~~~~li~~------~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 --RIPFYMSTDCENLLKR------FLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CCCTTSCHHHHHHHHH------HCCSSTTTSCCHHHHTT
T ss_pred --CCCCCCCHHHHHHHHH------HCCCChhHCcCHHHHhc
Confidence 1222334455666655 99999999999999876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=373.62 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=210.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc--------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecC
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL--------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANR 844 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 844 (1117)
.++|++.+.||+|+||+||+|++ .++..||||+++... ....+++.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 35788899999999999999974 245689999997653 23346789999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL 911 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 911 (1117)
+..|+||||+++|+|.+++..... ...+++.+++.++.||++||+|||++ +|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999976432 13478999999999999999999999 99999999999999
Q ss_pred cCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCCh
Q 001238 912 GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ 990 (1117)
Q Consensus 912 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~ 990 (1117)
+.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~--~~ 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VE 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCT--TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GG
T ss_pred CCCCCEEEccccCCcccCcccc--eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC--HH
Confidence 9999999999999987654321 122334567889999999999999999999999999999999 999997532 22
Q ss_pred hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.....+ ..... +..+...+..+.+++.. ||+.+|++||++.++++.|+++..
T Consensus 313 ~~~~~~----~~~~~------~~~~~~~~~~l~~li~~------~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 ELFKLL----KEGHR------MDKPANCTNELYMMMRD------CWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GHHHHH----HTTCC------CCCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH----hcCCC------CCCCCCCCHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHH
Confidence 222222 11111 12233344455555555 999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=354.69 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=211.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.+.||+|+||+||+|.+.+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4688889999999999999998889999999998643 345689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.+++.... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 89 ~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 160 (269)
T 4hcu_A 89 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---Q 160 (269)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH---H
T ss_pred CCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc---c
Confidence 999999997643 3489999999999999999999999 9999999999999999999999999999866432 1
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
........+|+.|+|||++....++.++||||+|+++|||++ |+.||... .............. +..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-----~~~~~~~~~~~~~~-------~~~ 228 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTGFR-------LYK 228 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTCC-------CCC
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHhcCcc-------CCC
Confidence 223334567889999999999999999999999999999999 99999642 12222222222111 111
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
+...+..+.++++. |++.+|++||++.++++.|+++.+.
T Consensus 229 ~~~~~~~~~~li~~------~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PRLASTHVYQIMNH------CWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHH------HccCCcccCcCHHHHHHHHHHHHHc
Confidence 22334455555555 9999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=361.09 Aligned_cols=268 Identities=26% Similarity=0.409 Sum_probs=207.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-----CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeec--CCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN--RKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 847 (1117)
.++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788999999999999999973 3688999999987666666789999999999999999999998854 3568
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999997653 3489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCC----------CCChhHHHHHH
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASF----------PDGQHVIQWVR 997 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~----------~~~~~~~~~~~ 997 (1117)
...... .........+|..|+|||.+.+..++.++||||||+++|||++|..||.... .........+.
T Consensus 164 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 164 LPQDKE-FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccCCcc-eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 654321 1122334567888999999999999999999999999999999999986421 11111111222
Q ss_pred HHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 998 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
........ ...+...+..+.++++. ||+.||++||++.++++.|+++.+..
T Consensus 243 ~~~~~~~~------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 ELLKNNGR------LPRPDGCPDEIYMIMTE------CWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHTTCC------CCCCTTCCHHHHHHHHH------HSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhccCc------CCCCcCcCHHHHHHHHH------HcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 22222211 11223344455655555 99999999999999999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=364.16 Aligned_cols=264 Identities=26% Similarity=0.377 Sum_probs=201.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhc--cCCCCcceEEeeeec----CCceE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSR--IRHRNIVRLLGWGAN----RKTKL 848 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~----~~~~~ 848 (1117)
.++|++.+.||+|+||+||+|+. +|+.||||++... ....+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45799999999999999999988 7899999998653 33456667776666 799999999998654 34578
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------ccCCCceeeeccccCeEEEcCCCcceec
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH--------HDCVPAILHRDVKSHNILLGERYESCLA 920 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivHrDlkp~Nill~~~~~~kl~ 920 (1117)
+||||+++|+|.++++.. .+++..+.+++.|+++||+||| ++ +|+||||||+||+++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999653 3899999999999999999999 77 99999999999999999999999
Q ss_pred cccccccccCCCCCccccCCccccccccCChhhhccC------CCCcCCCeeehhhhHHHHHhC----------CCCCCC
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT------KISEKSDVYSYGVVLLEIITG----------KKPVDA 984 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~vl~ell~g----------~~P~~~ 984 (1117)
|||+++.................||+.|+|||++.+. .++.++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999987665433222233455899999999999876 556799999999999999999 888865
Q ss_pred CCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 985 SFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
............. .......................+. +++..||+.||++||++.+|++.|+++
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~------~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRK-VVCVDQQRPNIPNRWFSDPTLTSLA------KLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHH-HHTTSCCCCCCCGGGGGSHHHHHHH------HHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhH-HHhccCCCCCCChhhccCccHHHHH------HHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 4444333333222 2222111111100001111112233 355569999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=373.19 Aligned_cols=263 Identities=23% Similarity=0.417 Sum_probs=198.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
..+|++.+.||+|+||+||+|+.. ++..||||+++... ....++|.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999864 57789999997642 3345679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.++++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999998643 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
...... .......+|+.|+|||++....++.++||||||+++|||++ |+.||... .. .+......... .
T Consensus 199 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--~~---~~~~~~i~~~~-~--- 268 (373)
T 2qol_A 199 DDPEAA-YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--SN---QDVIKAVDEGY-R--- 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--CH---HHHHHHHHTTE-E---
T ss_pred cCCccc-eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--CH---HHHHHHHHcCC-C---
Confidence 432111 11222345788999999999999999999999999999998 99999642 11 12222221111 0
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
...+...+..+.+++. .||+.||++||++.+|++.|+++.+.+.
T Consensus 269 ---~~~~~~~~~~l~~li~------~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 269 ---LPPPMDCPAALYQLML------DCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp ---CCCCTTCBHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred ---CCCCccccHHHHHHHH------HHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 1112233344555544 4999999999999999999999876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=352.69 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=211.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.++|++.+.||+|+||+||+|+..++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 357889999999999999999988888999999976533 4567999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++.... ..+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 158 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-- 158 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC--
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh--
Confidence 9999999997642 3489999999999999999999999 99999999999999999999999999998765422
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
........+|+.|+|||.+....++.++||||+|+++|||++ |+.||... .............. ..
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~-------~~ 225 (268)
T 3sxs_A 159 -YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-----TNSEVVLKVSQGHR-------LY 225 (268)
T ss_dssp -EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHHTTCC-------CC
T ss_pred -hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc-----ChHHHHHHHHcCCC-------CC
Confidence 223334567788999999999999999999999999999999 99999642 11222222222211 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.+...+..+.+++.. |++.+|++||++.++++.|+.++++
T Consensus 226 ~~~~~~~~l~~li~~------~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 226 RPHLASDTIYQIMYS------CWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCTTSCHHHHHHHHH------TTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCcChHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHhhhc
Confidence 122233455555554 9999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=369.21 Aligned_cols=270 Identities=28% Similarity=0.397 Sum_probs=205.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCc----eEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT----KLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~lv 850 (1117)
.++|++.+.||+|+||+||+|++. ++.||||++..... ....+.+|+.++++++|||||++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357889999999999999999874 78999999975432 33456779999999999999999999887543 6999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC-------CCceeeeccccCeEEEcCCCcceecccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC-------VPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
|||+++|+|.++++.. .+++..+..++.|+++||+|||+.. .++|+||||||+||+++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999764 2899999999999999999999861 3489999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhcc-----CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCCh--------
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ-------- 990 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~-------- 990 (1117)
+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 177 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 177 LALKFEAGKS--AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp TCEEECTTSC--CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred cccccccccC--ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9987654322 122344679999999999876 3567789999999999999999999976432211
Q ss_pred ---hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 991 ---HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 991 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
....+......... .+.+....... ........++..||+.||++|||+.++++.|+++.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKK------RPVLRDYWQKH-AGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSCCHHHHHHHHTTSCC------CCCCCGGGGSS-HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccC------CCCcccccccc-chHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11222222211111 11111111100 1111223455569999999999999999999988753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=356.83 Aligned_cols=264 Identities=22% Similarity=0.381 Sum_probs=207.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.+.||+|+||+||+|.. .+++.||+|++..... ...+++.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35789999999999999999974 4689999999865432 2345788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999764 3489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. ........||+.|+|||++.+..++.++||||+|+++|||++|+.||... ............... ..
T Consensus 164 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~---~~ 232 (294)
T 4eqm_A 164 TS---LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE-----TAVSIAIKHIQDSVP---NV 232 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS-----CHHHHHHHHHSSCCC---CH
T ss_pred cc---ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhhccCC---Cc
Confidence 21 12233467999999999999999999999999999999999999999642 122222222222211 11
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-CHHHHHHHHHhhhcCCC
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-TMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-s~~~v~~~L~~~~~~~~ 1061 (1117)
.+......+..+.+++.. |++.||++|| +++++.+.|+.+..+..
T Consensus 233 ~~~~~~~~~~~l~~li~~------~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILR------ATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHSCTTSCHHHHHHHHH------HSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred chhcccCCCHHHHHHHHH------HhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 122233344455555554 9999999999 99999999998765544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=364.70 Aligned_cols=266 Identities=17% Similarity=0.245 Sum_probs=210.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788999999999999999984 5789999999875432 35689999999999 99999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc-----ceecccccccc
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE-----SCLADFGLARL 927 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~-----~kl~DfGla~~ 927 (1117)
|+ +++|.+++.... +.+++.+++.++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 999999998642 3499999999999999999999999 9999999999999998887 99999999987
Q ss_pred ccCCCCCc---cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC-
Q 001238 928 VEDDSGGS---FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK- 1003 (1117)
Q Consensus 928 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~- 1003 (1117)
........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA--DTLKERYQKIGDTKR 237 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--SSHHHHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc--ccHHHHHHHHHhhhc
Confidence 65433221 1123467899999999999999999999999999999999999999976422 22222222221111
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
..+.+. +....+ .+.++++ .|++.+|.+||++++|.+.|+++.....
T Consensus 238 ~~~~~~----~~~~~p-~~~~li~------~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 238 ATPIEV----LCENFP-EMATYLR------YVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HSCHHH----HTTTCH-HHHHHHH------HHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCHHH----HhccCh-HHHHHHH------HHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 011111 112222 4444444 4999999999999999999998865443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=364.69 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=200.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57899999999999999999754 789999999875432 2346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 159 (323)
T 3tki_A 87 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN- 159 (323)
T ss_dssp CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred CCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC-
Confidence 9999999999764 3489999999999999999999999 99999999999999999999999999998764322
Q ss_pred CccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+. ...... +
T Consensus 160 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~~-----~ 229 (323)
T 3tki_A 160 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKTYL-----N 229 (323)
T ss_dssp -EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH----TTCTTS-----T
T ss_pred -cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cccccC-----C
Confidence 1122345689999999999987775 7899999999999999999999976433322222221 111110 0
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
. ....+..+.++++. |++.||++||++.|+++.
T Consensus 230 ~-~~~~~~~~~~li~~------~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 P-WKKIDSAPLALLHK------ILVENPSARITIPDIKKD 262 (323)
T ss_dssp T-GGGSCHHHHHHHHH------HSCSSTTTSCCHHHHTTC
T ss_pred c-cccCCHHHHHHHHH------HccCChhhCcCHHHHhhC
Confidence 0 11223344454444 999999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=358.66 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=202.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.+.||+|+||+||+|++ .++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 4688889999999999999987 4789999998643 345679999999999999999999998874 5799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc-ceeccccccccccCCCCC
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE-SCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~-~kl~DfGla~~~~~~~~~ 934 (1117)
+|+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999987654445789999999999999999999932229999999999999998886 799999999765421
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ . +..
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~-~------~~~ 225 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---AFRIMWAVHNGT-R------PPL 225 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---HHHHHHHHHTTC-C------CCC
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---HHHHHHHHhcCC-C------CCc
Confidence 22346899999999999999999999999999999999999999753221 112222211111 1 122
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGS 1064 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~~~~ 1064 (1117)
....+..+.+++.. |++.||++||++.++++.|+.+.+......
T Consensus 226 ~~~~~~~l~~li~~------~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 226 IKNLPKPIESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp BTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred ccccCHHHHHHHHH------HhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 23334455555554 999999999999999999999876554433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=362.70 Aligned_cols=247 Identities=21% Similarity=0.276 Sum_probs=204.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|+.+ +|+.||+|+++.. .....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 46888999999999999999854 6899999999753 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999998754 3489999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||... ..............
T Consensus 159 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~------- 222 (337)
T 1o6l_A 159 G----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHERLFELILMEEI------- 222 (337)
T ss_dssp T----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC-------
T ss_pred C----CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-----CHHHHHHHHHcCCC-------
Confidence 1 1234568999999999999999999999999999999999999999642 22223333333221
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
.++...+..+.++++. |++.||++|| ++.++++
T Consensus 223 -~~p~~~s~~~~~li~~------lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 -RFPRTLSPEAKSLLAG------LLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCTTSCHHHHHHHHH------HTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCCCHHHHHHHHH------HhhcCHHHhcCCCCCCHHHHHc
Confidence 2233445566666665 9999999999 8999876
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=358.10 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=203.4
Q ss_pred CCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 778 LTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
|+..+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 666779999999999999865 7999999999877666677899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 127 ~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 195 (321)
T 2c30_A 127 GALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---- 195 (321)
T ss_dssp CBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----
T ss_pred CCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc----
Confidence 9999998753 389999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1016 (1117)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+......... .+.. ....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~-----~~~~~~~~~~~~~-~~~~----~~~~ 265 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD-----SPVQAMKRLRDSP-PPKL----KNSH 265 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSS-CCCC----TTGG
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCC-CCCc----Cccc
Confidence 1234567999999999999999999999999999999999999999642 1122222222221 1100 0011
Q ss_pred CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1017 ~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+..+.+++.. |++.||++||++.++++
T Consensus 266 ~~~~~l~~li~~------~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 266 KVSPVLRDFLER------MLVRDPQERATAQELLD 294 (321)
T ss_dssp GSCHHHHHHHHH------HSCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHH------HccCChhhCcCHHHHhc
Confidence 223345555554 99999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=363.24 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=206.1
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc------chHHHHHHHHHHhccCCCCcceEEeeeecCCc
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI------STGAFSSEIATLSRIRHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 846 (1117)
..+.|++.+.||+|+||+||+|... +|+.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467899999999999999999854 6899999999764321 34679999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC----cceeccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY----ESCLADF 922 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~Df 922 (1117)
.++||||+++|+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999764 3489999999999999999999999 999999999999998876 7999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
|+++...... ......||+.|+|||++....++.++||||+||++|||++|+.||.+. ...+........
T Consensus 164 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANITAV 233 (361)
T ss_dssp SSCEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHTT
T ss_pred CCceEcCCCC-----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhc
Confidence 9998765421 234567999999999999999999999999999999999999999642 222333333332
Q ss_pred CCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1003 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.... ++......+....++++. |+..||++||++.++++
T Consensus 234 ~~~~----~~~~~~~~s~~~~~li~~------~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SYDF----DEEFFSQTSELAKDFIRK------LLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCC----CHHHHTTSCHHHHHHHHH------HSCSSTTTSCCHHHHHT
T ss_pred CCCC----CchhccCCCHHHHHHHHH------HCCCChhHCcCHHHHhc
Confidence 2211 122223334455555555 99999999999999875
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=370.82 Aligned_cols=357 Identities=20% Similarity=0.231 Sum_probs=220.9
Q ss_pred CccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCc
Q 001238 91 PTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLS 170 (1117)
Q Consensus 91 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~ 170 (1117)
+..++.+++|++|++++|++++ +| .++.+++|++|+|++|++++ +| ++.+++|++|+|++|++++ +| +++++
T Consensus 35 ~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~ 106 (457)
T 3bz5_A 35 TISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLT 106 (457)
T ss_dssp EEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCT
T ss_pred ccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCC
Confidence 3445555666666666666654 34 45666666666666666653 33 5555666666666666554 23 55566
Q ss_pred CCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeec
Q 001238 171 SLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAI 250 (1117)
Q Consensus 171 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l 250 (1117)
+|++|++++|++++ +| ++.+ ++|++|++++|.+++. .++.+++|++|++
T Consensus 107 ~L~~L~L~~N~l~~-l~--~~~l-------------------------~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l 155 (457)
T 3bz5_A 107 KLTYLNCDTNKLTK-LD--VSQN-------------------------PLLTYLNCARNTLTEI---DVSHNTQLTELDC 155 (457)
T ss_dssp TCCEEECCSSCCSC-CC--CTTC-------------------------TTCCEEECTTSCCSCC---CCTTCTTCCEEEC
T ss_pred cCCEEECCCCcCCe-ec--CCCC-------------------------CcCCEEECCCCcccee---ccccCCcCCEEEC
Confidence 66666666665554 22 4444 4444444444444442 1555566666666
Q ss_pred ccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCC
Q 001238 251 YTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGS 330 (1117)
Q Consensus 251 ~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~ 330 (1117)
++|...+.+ .+..+++|++|++++|++++ +| ++.+++|+.|++++|++++. .++.+++|++|++++|++++
T Consensus 156 ~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~- 226 (457)
T 3bz5_A 156 HLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE- 226 (457)
T ss_dssp TTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-
T ss_pred CCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-
Confidence 666544444 36677777777777777775 44 67777777777777777754 37777777777777777775
Q ss_pred CccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcc
Q 001238 331 IPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNC 410 (1117)
Q Consensus 331 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 410 (1117)
+| ++.+++|++|++++|++++.. ++.+++|+.|++++|+ |+.|++++|.+.+.+| +..+
T Consensus 227 ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l 285 (457)
T 3bz5_A 227 ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGC 285 (457)
T ss_dssp CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTC
T ss_pred cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--cccc
Confidence 45 677777777777777777543 4456677777766653 4456667777666665 4566
Q ss_pred cccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEc
Q 001238 411 QNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDL 490 (1117)
Q Consensus 411 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 490 (1117)
++|+.|++++|.+.+.+|. ....|+.|++++| ++|++|++++|++++. .++++++|+.|++
T Consensus 286 ~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l 346 (457)
T 3bz5_A 286 RKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSC 346 (457)
T ss_dssp TTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEEC
T ss_pred ccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEEC
Confidence 7777777777776665553 2344444444443 5667777777777763 2667777777777
Q ss_pred cCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCC
Q 001238 491 GSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS 548 (1117)
Q Consensus 491 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~ 548 (1117)
++|+|++ ++.|..|++++|.+.|. ..+..|+.+++++|++++..|
T Consensus 347 ~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip 391 (457)
T 3bz5_A 347 VNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVS 391 (457)
T ss_dssp CSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECC
T ss_pred CCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcC
Confidence 7777764 24556666777776654 244556666666666664433
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=372.13 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=208.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||+||+|.+. +++.||||+++... ....++|.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356888999999999999999865 78999999987542 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++|+|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999997542 3489999999999999999999999 99999999999999999999999999998654311
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.........+++.|+|||++....++.++|||||||++|||++ |+.||... ..... ...+......
T Consensus 268 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~--~~~~~----~~~~~~~~~~----- 334 (377)
T 3cbl_A 268 --YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL--SNQQT----REFVEKGGRL----- 334 (377)
T ss_dssp --EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS--CHHHH----HHHHHTTCCC-----
T ss_pred --eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHH----HHHHHcCCCC-----
Confidence 1111123346788999999998999999999999999999998 99999642 11112 2222222111
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
..+...+..+.+++.. ||+.||++||++.++++.|+++.+.
T Consensus 335 -~~~~~~~~~l~~li~~------cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 -PCPELCPDAVFRLMEQ------CWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -CCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHH------HcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1122334455555554 9999999999999999999988653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=358.51 Aligned_cols=272 Identities=22% Similarity=0.275 Sum_probs=209.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCC--ceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK--TKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv 850 (1117)
.++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357899999999999999999864 58999999997543 334567889999999999999999999987665 77999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE----cCCCcceeccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL----GERYESCLADFGLAR 926 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfGla~ 926 (1117)
|||+++|+|.+++........+++.+++.++.|+++||+|||++ +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998765444589999999999999999999999 99999999999999 788889999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhc--------cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHH
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYAN--------MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .....+.+..
T Consensus 165 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~ 238 (319)
T 4euu_A 165 ELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG-PRRNKEVMYK 238 (319)
T ss_dssp ECCTTC-----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC-GGGCHHHHHH
T ss_pred ecCCCC-----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-cchhHHHHHH
Confidence 765432 223457999999999886 57889999999999999999999999964322 2223333444
Q ss_pred HHhcCCCCc-cc----------cCcccCC--CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 999 HLKSKKDPV-EV----------LDPKLQG--HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 999 ~~~~~~~~~-~~----------~~~~l~~--~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
.....+... .. ..+.++. .....+...+ ..++..|++.||++||+++|+++...+..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL--TPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHH--HHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHh--HHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 333322110 00 0001111 1112222222 23555699999999999999999887654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=368.34 Aligned_cols=264 Identities=26% Similarity=0.379 Sum_probs=209.1
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecC
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANR 844 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 844 (1117)
...++|++.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 3457899999999999999999962 356899999997643 23345789999999999 799999999998876
Q ss_pred Cc-eEEEEEecCCCChhhhhcCCCC-------------------------------------------------------
Q 001238 845 KT-KLLFYDYMPNGTLGMLLHDGEC------------------------------------------------------- 868 (1117)
Q Consensus 845 ~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 868 (1117)
+. .++||||+++|+|.++++....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 54 8999999999999999976532
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCC
Q 001238 869 --------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANP 940 (1117)
Q Consensus 869 --------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 940 (1117)
...+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~ 253 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKG 253 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT--CEEC-
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc--chhcc
Confidence 12288999999999999999999999 999999999999999999999999999987654322 23344
Q ss_pred ccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCc
Q 001238 941 QFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019 (1117)
Q Consensus 941 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1019 (1117)
...||+.|+|||++.+..++.++||||||+++|||++ |+.||...... ...... ...... ...+...+
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~----~~~~~~------~~~~~~~~ 322 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRR----LKEGTR------MRAPDYTT 322 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHH----HHHTCC------CCCCTTCC
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHH----HHcCCC------CCCCCCCC
Confidence 5678999999999999999999999999999999998 99999753222 222222 222111 11222334
Q ss_pred hhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1020 TQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1020 ~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
..+.+++. .|++.||++||++.++++.|+++.+
T Consensus 323 ~~l~~li~------~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 323 PEMYQTML------DCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHH------HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHH------HHccCChhhCCCHHHHHHHHHHHHH
Confidence 44555544 4999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=352.41 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=208.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.++|++.+.||+|+||+||+|++.+++.||+|+++... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45788899999999999999998888899999998643 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--- 173 (283)
T 3gen_A 102 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--- 173 (283)
T ss_dssp TTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH---
T ss_pred CCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc---
Confidence 9999999997642 3489999999999999999999999 9999999999999999999999999999876432
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.........+|+.|+|||++....++.++||||+|+++|||++ |+.||.... ............. ..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-----~~~~~~~~~~~~~-------~~ 241 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----NSETAEHIAQGLR-------LY 241 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHHHTTCC-------CC
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC-----hhHHHHHHhcccC-------CC
Confidence 1222334467889999999998999999999999999999998 999996421 1122222222111 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.+...+..+.+++.. |++.+|++||++.++++.|+++..+
T Consensus 242 ~~~~~~~~l~~li~~------~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 242 RPHLASEKVYTIMYS------CWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCTTCCHHHHHHHHH------TTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHH------HccCChhHCcCHHHHHHHHHHHhhc
Confidence 122334455555554 9999999999999999999988654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=363.18 Aligned_cols=264 Identities=27% Similarity=0.389 Sum_probs=210.5
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCc
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 846 (1117)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999863 35899999997643 2335678999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGEC---------------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVK 905 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 905 (1117)
.++||||+++|+|.+++..... ...+++.+++.++.||++||+|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 9999999999999999976421 14589999999999999999999999 99999999
Q ss_pred cCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCC
Q 001238 906 SHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDA 984 (1117)
Q Consensus 906 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~ 984 (1117)
|+||+++.++.+||+|||+++...... .........+|+.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSAD--YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGG--CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEEECCCCeEEEeecCCCcccccCc--cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999998764321 1122334568999999999999999999999999999999999 9999964
Q ss_pred CCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 985 SFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
. ...+......... . +..+...+..+.++++. ||+.||++||++.++++.|+++.+..
T Consensus 280 ~-----~~~~~~~~~~~~~-~------~~~~~~~~~~l~~li~~------~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 280 M-----AHEEVIYYVRDGN-I------LACPENCPLELYNLMRL------CWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp S-----CHHHHHHHHHTTC-C------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred C-----ChHHHHHHHhCCC-c------CCCCCCCCHHHHHHHHH------HcccCcccCCCHHHHHHHHHHHHhhh
Confidence 2 1122222222211 1 11223344455555555 99999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=366.49 Aligned_cols=264 Identities=26% Similarity=0.357 Sum_probs=212.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc--------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecC
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL--------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANR 844 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 844 (1117)
.++|.+.+.||+|+||+||+|+. ..+..||||+++... ....+++.+|+++++++ +|||||++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 35788999999999999999974 234689999997643 23346788999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL 911 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 911 (1117)
+..++||||+++|+|.+++..... ...+++.++++++.|+++||+|||++ +|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999976432 23489999999999999999999999 99999999999999
Q ss_pred cCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCCh
Q 001238 912 GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ 990 (1117)
Q Consensus 912 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~ 990 (1117)
++++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~----- 297 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----- 297 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCT--TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----
T ss_pred cCCCcEEEcccCcccccccccc--cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----
Confidence 9999999999999987654321 123344567899999999999999999999999999999999 99999642
Q ss_pred hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
...+.... +..... +..+...+..+.++++. ||+.||++||++.++++.|+++.....
T Consensus 298 ~~~~~~~~-~~~~~~------~~~~~~~~~~l~~li~~------~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 298 PVEELFKL-LKEGHR------MDKPSNCTNELYMMMRD------CWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp CHHHHHHH-HHTTCC------CCCCSSCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred CHHHHHHH-HHcCCC------CCCCccCCHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 12222222 222211 11223344455555555 999999999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=364.70 Aligned_cols=248 Identities=20% Similarity=0.272 Sum_probs=199.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 46799999999999999999985 46899999999753 223455678899999988 69999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++... +.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999764 3489999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+..........
T Consensus 176 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~~----- 241 (353)
T 3txo_A 176 CNG----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-----NEDDLFEAILNDEV----- 241 (353)
T ss_dssp C-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC-----
T ss_pred cCC----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCC-----
Confidence 221 2334568999999999999999999999999999999999999999642 22333333333321
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH------HHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM------KDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~------~~v~~ 1051 (1117)
.++...+.....+++. |++.||++||++ .++++
T Consensus 242 ---~~p~~~~~~~~~li~~------lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ---VYPTWLHEDATGILKS------FMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCTTSCHHHHHHHHH------HTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHH------HhhhCHHHccCCcccCCHHHHhh
Confidence 1223344455666655 999999999998 66655
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=360.90 Aligned_cols=269 Identities=23% Similarity=0.380 Sum_probs=194.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCC----cEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCce-
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSG----LTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK- 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~- 847 (1117)
.++|++.+.||+|+||+||+|..... ..||||+++.. .....+++.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 46799999999999999999986543 27999999754 333456799999999999999999999999877655
Q ss_pred -----EEEEEecCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCccee
Q 001238 848 -----LLFYDYMPNGTLGMLLHDGE---CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 848 -----~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
++||||+++|+|.+++.... ....+++.++..++.|+++||+|||++ +|+||||||+||++++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 99999999999999986532 112489999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHH
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
+|||+++....... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.... .......
T Consensus 179 ~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~--- 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDY--YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE--NAEIYNY--- 251 (323)
T ss_dssp CCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHH---
T ss_pred eecccccccccccc--ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC--hHHHHHH---
Confidence 99999987654321 122234457889999999999999999999999999999999 999997532 2222222
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCCCC
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEA 1066 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~ 1066 (1117)
..... . ...+...+..+.+++.. |++.||++||++.++++.++++...+......
T Consensus 252 ~~~~~-~------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 252 LIGGN-R------LKQPPECMEEVYDLMYQ------CWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp HHTTC-C------CCCCTTCCHHHHHHHHH------TTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred HhcCC-C------CCCCCccCHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 12111 1 11122333455555554 99999999999999999999998876544433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=353.74 Aligned_cols=259 Identities=23% Similarity=0.271 Sum_probs=198.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||+||+|+..+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 457899999999999999999988899999999975422 224678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++ +|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 7777776543 3489999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC-cccc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP-VEVL 1010 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1010 (1117)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+.......... ....
T Consensus 174 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 174 ----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--DQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ----C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--THHHHHHHHHCCCCTTTSGGG
T ss_pred ----ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHHCCCChHHhhhh
Confidence 22334578999999999875 56899999999999999999999999754322 2222222222111100 0000
Q ss_pred C------------------cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 D------------------PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~------------------~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. .......+....++ +..|++.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l------i~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDL------LSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHH------HHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHH------HHHHcCCChhHCCCHHHHhc
Confidence 0 00111122233444 44599999999999999986
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=371.18 Aligned_cols=367 Identities=19% Similarity=0.248 Sum_probs=177.0
Q ss_pred CCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCC
Q 001238 132 NSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSL 211 (1117)
Q Consensus 132 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~l 211 (1117)
....+..+..++++++|++|+|++|.+++ +| .++.+++|++|+|++|++++ +| ++.+++|++|++++|
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N------- 95 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSN------- 95 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSS-------
T ss_pred cCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCC-------
Confidence 33444444455666666666666666653 34 45666666666666666654 22 444444444444444
Q ss_pred CccccccccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCC
Q 001238 212 PHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLK 291 (1117)
Q Consensus 212 p~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 291 (1117)
.+++. | ++.+++|++|++++|.+.+ +| ++.+++|++|++++|++++ ++ +++++
T Consensus 96 ------------------~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~ 148 (457)
T 3bz5_A 96 ------------------KLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNT 148 (457)
T ss_dssp ------------------CCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCT
T ss_pred ------------------CCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCC
Confidence 33332 1 3344444444444444433 22 4445555555555555553 22 44555
Q ss_pred CCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEec
Q 001238 292 NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELD 371 (1117)
Q Consensus 292 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 371 (1117)
+|++|++++|+..+.+ .+..+++|++|++++|++++ +| ++.+++|+.|++++|++++. .++.+++|++|+++
T Consensus 149 ~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls 220 (457)
T 3bz5_A 149 QLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCS 220 (457)
T ss_dssp TCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECC
T ss_pred cCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECc
Confidence 5555555555333333 24455555555555555553 22 44455555555555555532 24445555555555
Q ss_pred CccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCC
Q 001238 372 NNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVI 451 (1117)
Q Consensus 372 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 451 (1117)
+|++++ +| ++.+++|+.|++++|++++.. +..+++|+.|++++|. |+.|++++|.+.+.+
T Consensus 221 ~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~ 280 (457)
T 3bz5_A 221 SNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYF 280 (457)
T ss_dssp SSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEE
T ss_pred CCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCcc
Confidence 555554 23 444445555555555554332 2233444444444432 233444444444433
Q ss_pred CCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhccc
Q 001238 452 PPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLV 531 (1117)
Q Consensus 452 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 531 (1117)
| ++.+++|+.|++++|.+.+.+|. ...+|+.|++++| ++|++|++++|+|++. + +..++
T Consensus 281 ~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~ 339 (457)
T 3bz5_A 281 Q--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNT 339 (457)
T ss_dssp E--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCT
T ss_pred c--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCC
Confidence 3 23445555555555544444332 1223333333332 3455555555555542 1 44455
Q ss_pred ccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecccccccccccccc
Q 001238 532 RLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASL 599 (1117)
Q Consensus 532 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 599 (1117)
+|+.|++++|+|+++ +.|..|.+++|.+.|. ..+..|..+++++|+++|.+|..+
T Consensus 340 ~L~~L~l~~N~l~~l--------~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 340 KLKSLSCVNAHIQDF--------SSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp TCSEEECCSSCCCBC--------TTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred cCcEEECCCCCCCCc--------cccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhH
Confidence 555555555555432 2344455555555543 234556666666666666666544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=361.75 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=210.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-----CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeee--cCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA--NRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~ 848 (1117)
++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999983 468899999998776666677999999999999999999999876 456688
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+++++|.+++.... +.+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999997642 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCC---------ChhHHHHHHHH
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD---------GQHVIQWVRDH 999 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~---------~~~~~~~~~~~ 999 (1117)
.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......+...
T Consensus 178 ~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDK-DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTC-SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred ccCC-ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5432 2222334557889999999999999999999999999999999999998542110 00011111122
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
...... ...+...+..+.++++. |++.||++||++.++++.|+.+.....
T Consensus 257 ~~~~~~------~~~~~~~~~~l~~li~~------~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LEEGQR------LPAPPACPAEVHELMKL------CWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHTTCC------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hhcccC------CCCCCcccHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 222111 11223344455665555 999999999999999999999866543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=369.40 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=208.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
++|++.+.||+|+||+||+|.+. +++.||||+++.. ......++.+|+.++++++|||||++++++...+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888999999999999999842 4678999999654 2334456889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC---cceecc
Q 001238 849 LFYDYMPNGTLGMLLHDGE----CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY---ESCLAD 921 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~D 921 (1117)
+||||+++|+|.+++.... ....+++.+++.++.||++||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997642 123489999999999999999999999 999999999999999555 599999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHH
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||... ...+......
T Consensus 228 FG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~-----~~~~~~~~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SNQEVLEFVT 300 (367)
T ss_dssp CHHHHHHHHHSS--CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHHHHH
T ss_pred Cccccccccccc--cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHH
Confidence 999986543211 122334568999999999999999999999999999999998 99999642 1122222222
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
... . ...+...+..+.++++. ||+.+|++||++.+|++.|+.+.+.+.
T Consensus 301 ~~~-~------~~~~~~~~~~l~~li~~------~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 301 SGG-R------MDPPKNCPGPVYRIMTQ------CWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp TTC-C------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred cCC-C------CCCCccCCHHHHHHHHH------HcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 221 1 11122333445555554 999999999999999999998876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=375.41 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=209.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.++|++.+.||+|+||+||+|.+.++..||||+++... ...++|.+|++++++++|||||++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45688889999999999999998888999999998643 45778999999999999999999999886 56789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.++++.... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 265 ~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~--- 337 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN--- 337 (454)
T ss_dssp TTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH---
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC---
Confidence 99999999986421 2378999999999999999999999 9999999999999999999999999999876431
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.........+|+.|+|||++....++.++|||||||++|||++ |+.||... ... +......... .. .
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--~~~---~~~~~i~~~~-~~------~ 405 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNP---EVIRALERGY-RM------P 405 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHH---HHHHHHHHTC-CC------C
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--CHH---HHHHHHHcCC-CC------C
Confidence 1222334457889999999999999999999999999999999 99999642 112 2222222211 11 1
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.+...+..+.+++.. ||+.||++||++.+|++.|+.+...
T Consensus 406 ~~~~~~~~l~~li~~------cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 406 RPENCPEELYNIMMR------CWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCHHHHHHHHH------HccCChhHCcCHHHHHHHHHHHHhc
Confidence 122333455555544 9999999999999999999988654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=364.06 Aligned_cols=248 Identities=19% Similarity=0.277 Sum_probs=198.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|++.++||+|+||+||+|+.+ +++.||||++++.. ....+.+.+|..+++++ +|||||++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357889999999999999999854 58899999997542 22345688999999887 89999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|..++... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999998764 3489999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCC---hhHHH-HHHHHHhcCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG---QHVIQ-WVRDHLKSKKD 1005 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~---~~~~~-~~~~~~~~~~~ 1005 (1117)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..... .........
T Consensus 205 ~~~----~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-- 278 (396)
T 4dc2_A 205 RPG----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-- 278 (396)
T ss_dssp CTT----CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--
T ss_pred cCC----CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--
Confidence 221 23445789999999999999999999999999999999999999996432111 11112 222222222
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~ 1046 (1117)
..++...+.....+++. |++.||++||++
T Consensus 279 ------~~~p~~~s~~~~~li~~------lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 ------IRIPRSLSVKAASVLKS------FLNKDPKERLGC 307 (396)
T ss_dssp ------CCCCTTSCHHHHHHHHH------HTCSCTTTSTTC
T ss_pred ------cCCCCcCCHHHHHHHHH------HhcCCHhHcCCC
Confidence 12233445556666665 999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=347.69 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=193.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCc----cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDK----ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||+|.+ .|+.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 4788899999999999999987 488999999875422 23467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC--------CCcceecccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE--------RYESCLADFG 923 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~--------~~~~kl~DfG 923 (1117)
||+++++|.+++... .+++..+..++.|+++||+|||+++..+|+||||||+||+++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999998643 3899999999999999999999992222999999999999986 6789999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ............
T Consensus 162 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~ 230 (271)
T 3dtc_A 162 LAREWHRT------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-----GLAVAYGVAMNK 230 (271)
T ss_dssp C-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-----HHHHHHHHHTSC
T ss_pred cccccccc------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHhhhcCC
Confidence 99866432 1224578999999999999999999999999999999999999996421 111122211111
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
. ....+...+..+.++++. |++.+|++||++.++++.|+++
T Consensus 231 ~------~~~~~~~~~~~~~~li~~------~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 L------ALPIPSTCPEPFAKLMED------CWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C------CCCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHC-
T ss_pred C------CCCCCcccCHHHHHHHHH------HhcCCcccCcCHHHHHHHHhcC
Confidence 1 112233344455655555 9999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=357.76 Aligned_cols=252 Identities=19% Similarity=0.228 Sum_probs=204.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.++|++.+.||+|+||+||+|... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 457899999999999999999754 68899999987543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC--CCcceeccccccccccCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE--RYESCLADFGLARLVEDD 931 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl~DfGla~~~~~~ 931 (1117)
+++|+|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999997642 3489999999999999999999999 9999999999999997 789999999999876542
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+.+............
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~--- 224 (321)
T 1tki_A 158 D-----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-----TNQQIIENIMNAEYTFDE--- 224 (321)
T ss_dssp C-----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCCCCCH---
T ss_pred C-----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC-----CHHHHHHHHHcCCCCCCh---
Confidence 1 223457999999999999888999999999999999999999999642 222333333333322211
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
......+..+.++++ .|++.||++|||+.|+++.
T Consensus 225 -~~~~~~s~~~~~li~------~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 -EAFKEISIEAMDFVD------RLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHHTTSCHHHHHHHH------TTSCSSGGGSCCHHHHHHS
T ss_pred -hhhccCCHHHHHHHH------HHcCCChhHCcCHHHHhcC
Confidence 111222334444444 5999999999999999883
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=356.26 Aligned_cols=251 Identities=21% Similarity=0.322 Sum_probs=203.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc------cchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK------ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346889999999999999999854 689999999975432 2356799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC----cceecccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY----ESCLADFG 923 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~DfG 923 (1117)
++||||+++|+|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999764 3489999999999999999999999 999999999999999887 89999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||... ...+.........
T Consensus 164 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~~~~~~ 233 (326)
T 2y0a_A 164 LAHKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANVSAVN 233 (326)
T ss_dssp TCEECCTTS-----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHHTC
T ss_pred CCeECCCCC-----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-----CHHHHHHHHHhcC
Confidence 998765322 223457999999999999899999999999999999999999999642 1222222222222
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.... +......+..+.++++. |++.||++||++.++++
T Consensus 234 ~~~~----~~~~~~~~~~~~~li~~------~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YEFE----DEYFSNTSALAKDFIRR------LLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCC----HHHHTTSCHHHHHHHHH------HSCSSGGGSCCHHHHHH
T ss_pred CCcC----ccccccCCHHHHHHHHH------HccCChhhCCCHHHHhc
Confidence 1111 11122333445555554 99999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=367.09 Aligned_cols=274 Identities=16% Similarity=0.260 Sum_probs=206.3
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcCC------CcEEEEEEeecCCccc-----------hHHHHHHHHHHhccCCCCcce
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLPS------GLTVAVKRFRASDKIS-----------TGAFSSEIATLSRIRHRNIVR 836 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~ 836 (1117)
..++|++.+.||+|+||+||+|.+.. ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998654 4789999987653211 112334556677788999999
Q ss_pred EEeeeecC----CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc
Q 001238 837 LLGWGANR----KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 837 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 912 (1117)
+++++... ...++||||+ +++|.+++.... +.+++.+++.++.||+.||+|||++ +|+||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99998764 4579999999 999999997642 4499999999999999999999999 999999999999999
Q ss_pred --CCCcceeccccccccccCCCCCc---cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCC
Q 001238 913 --ERYESCLADFGLARLVEDDSGGS---FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFP 987 (1117)
Q Consensus 913 --~~~~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~ 987 (1117)
.++.+||+|||+++......... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765432111 1122345699999999999999999999999999999999999999975332
Q ss_pred CChhHHHHHHHHHhcCCCCccccCcccC-CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 001238 988 DGQHVIQWVRDHLKSKKDPVEVLDPKLQ-GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062 (1117)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~~ 1062 (1117)
. ............. ...+.+++.+. ...+..+.++++. ||+.+|++||++.++++.|+++......
T Consensus 267 ~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~------cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 267 D-PKYVRDSKIRYRE--NIASLMDKCFPAANAPGEIAKYMET------VKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp C-HHHHHHHHHHHHH--CHHHHHHHHSCTTCCCHHHHHHHHH------HHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred C-HHHHHHHHHHhhh--hHHHHHHHhcccccCHHHHHHHHHH------HhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 2 2222222222211 11122222221 2233455555554 9999999999999999999988765443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=357.51 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=197.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc---chHHHHHHHHHHhccCCCCcceEEeeeecCCce---
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLLGWGANRKTK--- 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~--- 847 (1117)
.++|++.+.||+|+||+||+|.. .+++.||||+++..... ....+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45789999999999999999985 57899999999765322 235688999999999999999999998765543
Q ss_pred -EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 848 -LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 848 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
|+||||+++++|.++++.. +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999999754 3489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
....... .........||+.|+|||++.+..++.++||||||+++|||++|+.||... ...............+
T Consensus 165 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPVSVAYQHVREDPIP 238 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHCCCCC
T ss_pred ccccccc-ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhcCCCCC
Confidence 7654321 112334467999999999999999999999999999999999999999642 2222333333333222
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHH-HHHHHHHhhhc
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMK-DVAALLREIRQ 1058 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~-~v~~~L~~~~~ 1058 (1117)
.... ....+..+..++.. |++.||++||++. ++.+.+.+...
T Consensus 239 ~~~~----~~~~~~~l~~li~~------~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 239 PSAR----HEGLSADLDAVVLK------ALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHH----STTCCHHHHHHHHH------HTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cccc----cCCCCHHHHHHHHH------HHhcCHhhChhhHHHHHHHHHHHhc
Confidence 1111 22234455555554 9999999999655 45556665544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=354.03 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=203.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46888999999999999999854 69999999997532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 999999999999764 3489999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||... ..............
T Consensus 159 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~------- 220 (318)
T 1fot_A 159 ------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEKILNAEL------- 220 (318)
T ss_dssp ------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHCCC-------
T ss_pred ------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCC-------
Confidence 123457999999999999999999999999999999999999999642 22233333333321
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
.++...+..+.++++. |++.||++|| ++.++.+
T Consensus 221 -~~p~~~~~~~~~li~~------lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -RFPPFFNEDVKDLLSR------LITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCTTSCHHHHHHHHH------HTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHH------HhccCHHHcCCCcCCCHHHHhc
Confidence 2233444566666665 9999999999 8888875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=356.33 Aligned_cols=256 Identities=17% Similarity=0.318 Sum_probs=201.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC-C-------cEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS-G-------LTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
++|++.+.||+|+||+||+|.... + +.||+|++........+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 578889999999999999997532 3 57999999876666677899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc--------cee
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE--------SCL 919 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~--------~kl 919 (1117)
++||||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999998653 3389999999999999999999999 9999999999999998887 999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHH
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
+|||+++.... .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+.... . ..... .
T Consensus 163 ~Dfg~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~--~--~~~~~-~ 229 (289)
T 4fvq_A 163 SDPGISITVLP--------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--D--SQRKL-Q 229 (289)
T ss_dssp CCCCSCTTTSC--------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS--C--HHHHH-H
T ss_pred ccCcccccccC--------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc--c--hHHHH-H
Confidence 99999976532 123468899999999987 778999999999999999999655443211 1 11111 1
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASG 1063 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~~~ 1063 (1117)
...... .++...+..+.++++. |++.||++||++.++++.|+++.......
T Consensus 230 ~~~~~~--------~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 230 FYEDRH--------QLPAPKAAELANLINN------CMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp HHHTTC--------CCCCCSSCTTHHHHHH------HSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred HhhccC--------CCCCCCCHHHHHHHHH------HcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 111111 1112223345555555 99999999999999999999986544433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=360.74 Aligned_cols=265 Identities=25% Similarity=0.383 Sum_probs=209.6
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecC-CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRAS-DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRK 845 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 845 (1117)
..++|++.+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456899999999999999999984 24678999999754 233456799999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECA--------------------GLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVK 905 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 905 (1117)
..++||||+++|+|.+++...... ..+++..++.++.|+++||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999865321 2378999999999999999999999 99999999
Q ss_pred cCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCC
Q 001238 906 SHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDA 984 (1117)
Q Consensus 906 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~ 984 (1117)
|+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCcc--ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999987654322 223345568899999999999999999999999999999998 9999975
Q ss_pred CCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 985 SFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
... ....... ...... +..+...+..+..++.. ||+.||++||++.++++.|+.+....
T Consensus 278 ~~~-~~~~~~~----~~~~~~------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 278 IPV-DANFYKL----IQNGFK------MDQPFYATEEIYIIMQS------CWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCC-SHHHHHH----HHTTCC------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCc-HHHHHHH----HhcCCC------CCCCCCCCHHHHHHHHH------HcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 322 2222222 222111 11222334455555555 99999999999999999999886543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=345.67 Aligned_cols=252 Identities=19% Similarity=0.344 Sum_probs=204.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecC--CceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|++ +++.||||+++... ....+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 4688899999999999999998 48899999997653 23345789999999999999999999999887 7789999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eeeeccccCeEEEcCCCcceecccccccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA--ILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||+++|+|.+++..... ..+++.++..++.|+++||+|||++ + |+||||||+||+++.++.++++|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999987532 2489999999999999999999998 7 9999999999999999999999988876432
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCc---CCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISE---KSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
. ....||+.|+|||++.+..++. ++||||||+++|||++|+.||... ..............
T Consensus 165 ~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~~~-- 228 (271)
T 3kmu_A 165 S---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-----SNMEIGMKVALEGL-- 228 (271)
T ss_dssp C---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS-----CHHHHHHHHHHSCC--
T ss_pred c---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc-----ChHHHHHHHHhcCC--
Confidence 2 2346899999999998765554 799999999999999999999642 11222222222221
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.+..+...+..+.+++.. |++.||++||++.++++.|+++.+
T Consensus 229 ----~~~~~~~~~~~~~~li~~------~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 ----RPTIPPGISPHVSKLMKI------CMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----CCCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----CCCCCCCCCHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHhhc
Confidence 122334445566666665 999999999999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=350.10 Aligned_cols=266 Identities=17% Similarity=0.248 Sum_probs=212.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ..+.+.+|+++++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35789999999999999999984 579999999987543 345688999999999 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc-----ceecccccccc
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE-----SCLADFGLARL 927 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~-----~kl~DfGla~~ 927 (1117)
|+ +++|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999998642 3489999999999999999999999 9999999999999987776 99999999987
Q ss_pred ccCCCCCc---cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCCh-hHHHHHHHHHhcC
Q 001238 928 VEDDSGGS---FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ-HVIQWVRDHLKSK 1003 (1117)
Q Consensus 928 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~-~~~~~~~~~~~~~ 1003 (1117)
........ ........||+.|+|||++.+..++.++||||||+++|||++|+.||........ .....+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS- 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-
Confidence 76543221 1223456799999999999999999999999999999999999999976432221 111212111111
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
.+. +.+....+..+.+++.. |++.+|++||++++|++.|+++.+..
T Consensus 240 -~~~----~~~~~~~~~~l~~li~~------~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 240 -TPL----RELCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp -SCH----HHHTTTSCHHHHHHHHH------HHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -ccH----HHHHhhCcHHHHHHHHH------HhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 111 11222334455665555 99999999999999999999887643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=355.28 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=211.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... ....+++.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45788999999999999999974 345899999997543 33346788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeecccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGEC---------------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKS 906 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp 906 (1117)
++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999976432 12388999999999999999999999 999999999
Q ss_pred CeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCC
Q 001238 907 HNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDAS 985 (1117)
Q Consensus 907 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~ 985 (1117)
+||+++.++.+||+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEED--SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTS--CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred heEEEcCCCCEEEccccccccccccc--cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998765432 1223344567889999999999999999999999999999999 99999753
Q ss_pred CCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 986 FPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.. ......+ ..... +..+...+..+.+++.. |++.||++||++.++++.|+++..+
T Consensus 257 ~~--~~~~~~~----~~~~~------~~~~~~~~~~~~~li~~------~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PP--ERLFNLL----KTGHR------MERPDNCSEEMYRLMLQ------CWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CG--GGHHHHH----HTTCC------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CH--HHHHHHh----hcCCc------CCCCccCCHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHhh
Confidence 22 2222222 11111 11223344455555555 9999999999999999999988654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=349.41 Aligned_cols=258 Identities=26% Similarity=0.325 Sum_probs=196.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||+|+||+||+|+..+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999988899999999975432 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++ +|.+++.... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 975 8888887643 3489999999999999999999999 99999999999999999999999999998764321
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC--c---
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP--V--- 1007 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~--- 1007 (1117)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .......+.......... .
T Consensus 155 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 ---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ---cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHCCCChhhchhhh
Confidence 12234578999999999865 458999999999999999999999996521 111111121111110000 0
Q ss_pred --cccCcc-----------cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 --EVLDPK-----------LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 --~~~~~~-----------l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
...++. .....+....++++. |++.||++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~------~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK------MLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHH------HTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHH------HcCCCcccCCCHHHHhc
Confidence 001111 112233344455544 99999999999999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=344.69 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=211.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46888899999999999999988889999999986543 45689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+++|.+++.... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 87 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~---~ 158 (267)
T 3t9t_A 87 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---Q 158 (267)
T ss_dssp TCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH---H
T ss_pred CCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc---c
Confidence 999999997643 3489999999999999999999999 9999999999999999999999999999876421 1
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
........+|+.|+|||++....++.++||||+|+++|||++ |+.||... ...+.......... +..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~i~~~~~-------~~~ 226 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTGFR-------LYK 226 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTCC-------CCC
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC-----CHHHHHHHHhcCCc-------CCC
Confidence 122334567889999999998999999999999999999999 89999642 12222222222111 111
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
+...+..+.++++. |++.+|++||++.++++.|+++.+.
T Consensus 227 ~~~~~~~l~~li~~------~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 227 PRLASTHVYQIMNH------CWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CccCcHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHhc
Confidence 22334455555554 9999999999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=360.44 Aligned_cols=252 Identities=22% Similarity=0.320 Sum_probs=202.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45799999999999999999975 4689999999976432 23457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC---cceeccccccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY---ESCLADFGLARLV 928 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfGla~~~ 928 (1117)
||+++|+|.+++... +.+++.++..++.||++||+|||++ +|+||||||+||+++.++ .+||+|||+++..
T Consensus 108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999988764 3489999999999999999999999 999999999999998654 5999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ..................
T Consensus 182 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~ 251 (362)
T 2bdw_A 182 NDSE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYAQIKAGAYDYPS 251 (362)
T ss_dssp TTCC-----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCCCCT
T ss_pred cCCc-----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhCCCCCCc
Confidence 5321 233567999999999999989999999999999999999999999642 122222222222211111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
+. ....+..+.+++.. |++.||++||++.++++.
T Consensus 252 ---~~-~~~~~~~~~~li~~------~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 252 ---PE-WDTVTPEAKSLIDS------MLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---TG-GGGSCHHHHHHHHH------HSCSSGGGSCCHHHHTTS
T ss_pred ---cc-ccCCCHHHHHHHHH------HcCCChhhCcCHHHHhcC
Confidence 11 11223345555554 999999999999998763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=348.66 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=195.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688899999999999999985 4689999999975432 224678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++ ++.+.+.... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 4444444322 3489999999999999999999999 99999999999999999999999999998764321
Q ss_pred CCccccCCccccccccCChhhhccCC-CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTK-ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.......||+.|+|||++.+.. ++.++||||+||++|||++|..||... ......+.........+.....
T Consensus 156 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~----~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 156 ----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp ----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC----SSHHHHHHHHHHHHCCCCTTTC
T ss_pred ----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC----CCHHHHHHHHHHHhCCCChhhh
Confidence 2334557899999999987665 899999999999999999988886432 1122222222211111110000
Q ss_pred ---------------------cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 ---------------------PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ---------------------~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.......+....++++. |++.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~------~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN------LLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHH------HSCSSGGGSCCHHHHHT
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHH------HhccChhhCCCHHHHhc
Confidence 00111233444555554 99999999999999976
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=368.49 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=203.6
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
...++|++.+.||+|+||+||+|.. .+|+.||+|++..... ...+.+.+|++++++++|||||++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3456799999999999999999974 5789999999976532 234568999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc---CCCcceeccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG---ERYESCLADFGLAR 926 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~---~~~~~kl~DfGla~ 926 (1117)
||||+++|+|.+.+... +.+++..+..++.||++||+|||++ +|+||||||+||+++ +++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999988764 3489999999999999999999999 999999999999998 45789999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
...... .......||+.|+|||++....++.++||||+||++|+|++|+.||... ................
T Consensus 162 ~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~~~~ 232 (444)
T 3soa_A 162 EVEGEQ----QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-----DQHRLYQQIKAGAYDF 232 (444)
T ss_dssp CCCTTC----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHTCCCC
T ss_pred EecCCC----ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHhCCCCC
Confidence 765422 2234568999999999999999999999999999999999999999642 2222233332222221
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.. +. ....+..+.+++.. |++.||++||++.|+++
T Consensus 233 ~~---~~-~~~~s~~~~~li~~------~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 PS---PE-WDTVTPEAKDLINK------MLTINPSKRITAAEALK 267 (444)
T ss_dssp CT---TT-TTTSCHHHHHHHHH------HSCSSTTTSCCHHHHHH
T ss_pred Cc---cc-cccCCHHHHHHHHH------HcCCChhHCCCHHHHhc
Confidence 11 11 12233455555555 99999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=348.51 Aligned_cols=253 Identities=27% Similarity=0.476 Sum_probs=201.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccc-------hHHHHHHHHHHhccCCCCcceEEeeeecCCc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKIS-------TGAFSSEIATLSRIRHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 846 (1117)
.++|++.+.||+|+||+||+|.. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35788899999999999999985 578999999986543221 157899999999999999999999987654
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eeeeccccCeEEEcCCCc-----cee
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA--ILHRDVKSHNILLGERYE-----SCL 919 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~~~~~-----~kl 919 (1117)
++||||+++|+|.+.+.... ..+++..+..++.|+++||+|||++ + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999988887643 3489999999999999999999999 7 999999999999988776 999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhh--ccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHH
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA--NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~ 997 (1117)
+|||+++.... ......||+.|+|||++ ....++.++||||+|+++|||++|+.||........ ....
T Consensus 171 ~Dfg~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~ 240 (287)
T 4f0f_A 171 ADFGLSQQSVH-------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI---KFIN 240 (287)
T ss_dssp CCCTTCBCCSS-------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH---HHHH
T ss_pred CCCCccccccc-------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH---HHHH
Confidence 99999985432 12345799999999998 445678999999999999999999999975332221 1122
Q ss_pred HHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 998 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
...... ..+.++...+..+.++++. |++.||++||++.++++.|+++
T Consensus 241 ~~~~~~------~~~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 MIREEG------LRPTIPEDCPPRLRNVIEL------CWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHSC------CCCCCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHhccC------CCCCCCcccCHHHHHHHHH------HhcCChhhCcCHHHHHHHHHhC
Confidence 222211 1122333445566666665 9999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=361.39 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=202.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC-----CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS-----DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4688999999999999999975 46899999998642 12245779999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc---ceecccccc
Q 001238 850 FYDYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE---SCLADFGLA 925 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~DfGla 925 (1117)
||||+++|+|.+.+.... ....+++..+..++.||++||+|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988776432 223489999999999999999999999 9999999999999987654 999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
+...... .......||+.|+|||++....++.++||||+||++|||++|+.||... . .............
T Consensus 181 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~---~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 181 IQLGESG----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT---K---ERLFEGIIKGKYK 250 (351)
T ss_dssp EECCTTS----CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---H---HHHHHHHHHTCCC
T ss_pred eEecCCC----eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc---H---HHHHHHHHcCCCC
Confidence 8765422 1234567999999999999999999999999999999999999999652 1 1222222222211
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. .+......+..+.++++. |++.||++||++.++++
T Consensus 251 ~----~~~~~~~~s~~~~~li~~------~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 M----NPRQWSHISESAKDLVRR------MLMLDPAERITVYEALN 286 (351)
T ss_dssp C----CHHHHTTSCHHHHHHHHH------HTCSSTTTSCCHHHHHT
T ss_pred C----CccccccCCHHHHHHHHH------HCCCChhHCcCHHHHhc
Confidence 1 111112334455555554 99999999999999976
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=359.96 Aligned_cols=249 Identities=20% Similarity=0.306 Sum_probs=203.3
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCce
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 847 (1117)
...++|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34568999999999999999999864 68999999997532 23456688899999887 899999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
|+||||+++|+|.+++... +.+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999999764 3489999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+.........
T Consensus 168 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~---- 234 (345)
T 1xjd_A 168 NMLGD----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEELFHSIRMDN---- 234 (345)
T ss_dssp CCCTT----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCC----
T ss_pred cccCC----CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHHhCC----
Confidence 43221 1234568999999999999999999999999999999999999999642 2222333332222
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHH-HHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMK-DVA 1050 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~-~v~ 1050 (1117)
+.++...+..+.++++. |++.||++||++. ++.
T Consensus 235 ----~~~p~~~s~~~~~li~~------lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ----PFYPRWLEKEAKDLLVK------LFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CCCCTTSCHHHHHHHHH------HSCSSGGGSBTTBSCGG
T ss_pred ----CCCCcccCHHHHHHHHH------HhcCCHhHcCCChHHHH
Confidence 12233345556666655 9999999999987 654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=358.74 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=201.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCc----EEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGL----TVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|++.+.||+|+||+||+|.+. +++ +||+|++.... .....++.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46888899999999999999853 444 37888775432 333456889999999999999999999886 466899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++.... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999997642 3488999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
..... .......||+.|+|||++....++.++||||||+++|||++ |+.||..... ......+. .....
T Consensus 167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~----~~~~~-- 236 (325)
T 3kex_A 167 PDDKQ--LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLE----KGERL-- 236 (325)
T ss_dssp CCTTC--CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHH----TTCBC--
T ss_pred ccccc--ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHH----cCCCC--
Confidence 43221 22345578889999999999999999999999999999999 9999975322 22222222 11110
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
..+...+..+..++.. ||+.||++||++.++++.|+++...+
T Consensus 237 ----~~~~~~~~~~~~li~~------~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 237 ----AQPQICTIDVYMVMVK------CWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ----CCCTTBCTTTTHHHHH------HTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ----CCCCcCcHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111122234444444 99999999999999999999886543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=370.97 Aligned_cols=253 Identities=28% Similarity=0.414 Sum_probs=206.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCC-ceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRK-TKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~ 853 (1117)
.++|++.+.||+|+||+||+|.+. |+.||||+++... ..+.|.+|++++++++|||||++++++...+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 457888999999999999999884 7899999997643 4578999999999999999999999987665 78999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.+++..... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 999999999986432 3378999999999999999999999 9999999999999999999999999999854321
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.....+++.|+|||++....++.++|||||||++|||++ |+.||..... ..+...+. .... .
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~----~~~~------~ 405 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVE----KGYK------M 405 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--TTHHHHHH----TTCC------C
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----cCCC------C
Confidence 112357889999999999999999999999999999998 9999975422 22222222 1111 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
..+...+..+.++++. ||+.||++||++.++++.|+.+...
T Consensus 406 ~~p~~~~~~l~~li~~------cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKN------CWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHH------HcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1223344555665555 9999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=371.98 Aligned_cols=258 Identities=27% Similarity=0.427 Sum_probs=203.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.++|++.+.||+|+||+||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35688889999999999999998888889999998643 346789999999999999999999999876 6789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++.... ...+++.++..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 334 (452)
T 1fmk_A 261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 334 (452)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc--
Confidence 9999999997532 23489999999999999999999999 99999999999999999999999999998765321
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
........+|+.|+|||++....++.++||||||+++|||++ |+.||.+. ...+......... . ..
T Consensus 335 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-----~~~~~~~~i~~~~-~------~~ 401 (452)
T 1fmk_A 335 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERGY-R------MP 401 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTC-C------CC
T ss_pred -eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCC-C------CC
Confidence 122234457889999999999999999999999999999999 99999642 1122222222211 1 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.+...+..+.+++.. ||+.+|++||+++++++.|+.+...
T Consensus 402 ~~~~~~~~l~~li~~------cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 CPPECPESLHDLMCQ------CWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHhcc
Confidence 122334455555554 9999999999999999999988654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=350.64 Aligned_cols=264 Identities=23% Similarity=0.373 Sum_probs=207.2
Q ss_pred cCCCCCCeeeecCCeEEEEEE-----cCCCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecC--Cce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVT-----LPSGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 847 (1117)
+.|++.+.||+|+||.||+|+ ..+++.||||+++.. .....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 458888999999999999998 346899999999754 333457899999999999999999999999876 668
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++|+|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999996542 3489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCC---------CCChhHHHHHHH
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASF---------PDGQHVIQWVRD 998 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~---------~~~~~~~~~~~~ 998 (1117)
..... ..........||..|+|||++.+..++.++||||+|+++|||++|+.|+.... ..+......+..
T Consensus 176 ~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 176 IETDK-EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp CCTTC-CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred ccCCC-cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 75432 22233445678899999999999999999999999999999999999864310 011112222222
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
....... ...+...+..+.++++. |++.||++||++.++++.|+++.
T Consensus 255 ~~~~~~~------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGKR------LPCPPNCPDEVYQLMRK------CWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTCC------CCCCTTCCHHHHHHHHH------TTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCC------CCCCCCCCHHHHHHHHH------HcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222211 11223344455665555 99999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=349.98 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=194.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc--------------------------cchHHHHHHHHHHh
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK--------------------------ISTGAFSSEIATLS 827 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 827 (1117)
.++|++.+.||+|+||+||+|.. .+++.||||++..... ...+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35788999999999999999975 4689999999875421 12356889999999
Q ss_pred ccCCCCcceEEeeeec--CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccc
Q 001238 828 RIRHRNIVRLLGWGAN--RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVK 905 (1117)
Q Consensus 828 ~l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk 905 (1117)
+++||||+++++++.+ .+..++||||+++++|.+++.. +.+++.++..++.|+++||+|||++ +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999886 5678999999999999887643 3489999999999999999999999 99999999
Q ss_pred cCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCC---CCcCCCeeehhhhHHHHHhCCCCC
Q 001238 906 SHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK---ISEKSDVYSYGVVLLEIITGKKPV 982 (1117)
Q Consensus 906 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~vl~ell~g~~P~ 982 (1117)
|+||+++.++.+||+|||+++...... .......||+.|+|||++.... ++.++|||||||++|||++|+.||
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD----ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS----CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred HHHEEECCCCCEEEecCCCcccccccc----ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 999999999999999999998765322 1223457999999999987654 478899999999999999999999
Q ss_pred CCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 983 DASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
... ................ +. ....+..+.+++.. |++.||++||++.|+++
T Consensus 241 ~~~-----~~~~~~~~~~~~~~~~-----~~-~~~~~~~l~~li~~------~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDE-----RIMCLHSKIKSQALEF-----PD-QPDIAEDLKDLITR------MLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCS-----SHHHHHHHHHHCCCCC-----CS-SSCCCHHHHHHHHH------HTCSCTTTSCCHHHHTT
T ss_pred CCc-----cHHHHHHHHhcccCCC-----CC-ccccCHHHHHHHHH------HhhcChhhCCCHHHHhc
Confidence 642 1222222222221111 11 12234455555555 99999999999999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=352.52 Aligned_cols=263 Identities=27% Similarity=0.404 Sum_probs=212.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCCc-cchHHHHHHHHHHhcc-CCCCcceEEeeeecCCc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDK-ISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 846 (1117)
.++|++.+.||+|+||+||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45788999999999999999973 3578999999975533 3356789999999999 99999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE
Q 001238 847 KLLFYDYMPNGTLGMLLHDGEC---------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL 911 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 911 (1117)
.++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||++ +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999976432 12489999999999999999999999 99999999999999
Q ss_pred cCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCCh
Q 001238 912 GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ 990 (1117)
Q Consensus 912 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~ 990 (1117)
+.++.+||+|||+++....... ........+|+.|+|||++....++.++||||||+++|||++ |+.||..... ..
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~ 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-DS 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-SH
T ss_pred cCCCCEEEcccccccccccccc--ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc-hh
Confidence 9999999999999987754322 223344568889999999999999999999999999999999 9999975322 22
Q ss_pred hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.....+. .... +..+...+..+.++++. |++.||++||++.++++.|+++..+
T Consensus 256 ~~~~~~~----~~~~------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 256 KFYKMIK----EGFR------MLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HHHHHHH----HTCC------CCCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhc----cCCC------CCCcccCCHHHHHHHHH------HcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2222222 1111 11122334455555555 9999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=359.73 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=202.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+++++.++|||||++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4688999999999999999975 45889999998653 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999864 3489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccCCccccccccCChhhhcc---CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANM---TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
......+||+.|+|||++.. ..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 169 -----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~~~~----- 236 (384)
T 4fr4_A 169 -----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFETTV----- 236 (384)
T ss_dssp -----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHHHHHHCC-----
T ss_pred -----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhhcc-----
Confidence 23345689999999999864 45899999999999999999999999753222 2222233222221
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-HHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-MKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-~~~v~~ 1051 (1117)
..++...+..+..+++. |++.||++||+ +.++.+
T Consensus 237 ---~~~p~~~s~~~~~li~~------lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ---VTYPSAWSQEMVSLLKK------LLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCCTTSCHHHHHHHHH------HSCSSGGGSCCSHHHHHT
T ss_pred ---cCCCCcCCHHHHHHHHH------HhcCCHhHhcccHHHHHc
Confidence 12233344556666655 99999999998 676654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=354.91 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=193.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEc----CCCcEEEEEEeecCC----ccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL----PSGLTVAVKRFRASD----KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
++|++.+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5688999999999999999986 478999999997542 22345678899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
|+||||+++|+|.+++... +.+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999998754 3488999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
..... .......||+.|+|||++....++.++||||||+++|||++|+.||... .....+........
T Consensus 171 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~~~~--- 238 (327)
T 3a62_A 171 SIHDG----TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE-----NRKKTIDKILKCKL--- 238 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHTCC---
T ss_pred cccCC----ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhCCC---
Confidence 53321 1233567999999999999899999999999999999999999999642 22233333333221
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
.++...+..+.++++. |++.||++|| ++.++++
T Consensus 239 -----~~p~~~~~~~~~li~~------~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 -----NLPPYLTQEARDLLKK------LLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----CCCTTSCHHHHHHHHH------HSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHH------HHhcCHhhccCCCCCCHHHHHc
Confidence 1223344556666665 9999999999 6777766
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=358.20 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=199.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|.+.+.||+|+||+||+|.+ .+++.||||++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35789999999999999999985 57899999998743 122345789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+ +|+|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 78888887654 3489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.. .....+||+.|+|||++.+..+ ++++||||+||++|||++|+.||+....... ... ...
T Consensus 161 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------~~~----i~~ 222 (336)
T 3h4j_B 161 GN-----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------FKK----VNS 222 (336)
T ss_dssp SB-----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------BCC----CCS
T ss_pred Cc-----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------HHH----HHc
Confidence 21 2335579999999999988776 6899999999999999999999975322110 000 000
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.....+...+....++++. |++.||.+|||+.|+++.
T Consensus 223 ~~~~~p~~~s~~~~~li~~------~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRR------MIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHT------TSCSSGGGSCCHHHHTTC
T ss_pred CCCCCcccCCHHHHHHHHH------HcCCChhHCcCHHHHHhC
Confidence 1112233344455555554 999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=356.93 Aligned_cols=244 Identities=20% Similarity=0.246 Sum_probs=203.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46888899999999999999854 68999999997532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999764 3489999999999999999999999 9999999999999999999999999999876431
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+..........
T Consensus 195 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~------- 255 (350)
T 1rdq_E 195 -------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEKIVSGKV------- 255 (350)
T ss_dssp -------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC-------
T ss_pred -------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-----CHHHHHHHHHcCCC-------
Confidence 23468999999999999999999999999999999999999999642 22333333333321
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
.++...+..+.++++. |++.||++||+ ++++.+
T Consensus 256 -~~p~~~~~~~~~li~~------lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -RFPSHFSSDLKDLLRN------LLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCTTCCHHHHHHHHH------HSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHH------HhhcCHHhccCCccCCHHHHHh
Confidence 1233445566666665 99999999998 777765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=356.80 Aligned_cols=247 Identities=19% Similarity=0.268 Sum_probs=198.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|++.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|+++++++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999999999999864 68999999997642 22345678899999988 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|+|.+++... +.+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999998754 3489999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCC----hhHHHHHHHHHhcCCCC
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG----QHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~----~~~~~~~~~~~~~~~~~ 1006 (1117)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..............
T Consensus 163 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 235 (345)
T 3a8x_A 163 PG----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 235 (345)
T ss_dssp TT----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---
T ss_pred CC----CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---
Confidence 21 12345689999999999999999999999999999999999999996421111 11111222222221
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~ 1046 (1117)
..++...+....++++. |++.||++||++
T Consensus 236 -----~~~p~~~s~~~~~li~~------lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 -----IRIPRSLSVKAASVLKS------FLNKDPKERLGC 264 (345)
T ss_dssp -----CCCCTTSCHHHHHHHHH------HTCSSTTTSTTC
T ss_pred -----CCCCCCCCHHHHHHHHH------HhcCCHhHCCCC
Confidence 12233444556666655 999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=360.53 Aligned_cols=253 Identities=16% Similarity=0.262 Sum_probs=205.6
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
..++|++.+.||+|+||+||+|.. .+|+.||+|++..........+.+|++++++++||||+++++++.+.+..++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 456899999999999999999975 4689999999987655556678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC--CCcceeccccccccccC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE--RYESCLADFGLARLVED 930 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl~DfGla~~~~~ 930 (1117)
|+++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||+++....
T Consensus 129 ~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 129 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999987642 3489999999999999999999999 9999999999999974 47799999999987654
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. ......||+.|+|||++....++.++|||||||++|||++|+.||... .....+......... .
T Consensus 204 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~~~~i~~~~~~----~ 269 (387)
T 1kob_A 204 DE-----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLETLQNVKRCDWE----F 269 (387)
T ss_dssp TS-----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHHCCCC----C
T ss_pred Cc-----ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCC----C
Confidence 21 122347999999999999999999999999999999999999999642 122223322222211 1
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
++......+..+.++++ .|++.||++||++.++++
T Consensus 270 ~~~~~~~~s~~~~~li~------~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIK------NLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CSSTTTTSCHHHHHHHH------TTSCSSGGGSCCHHHHHT
T ss_pred CccccccCCHHHHHHHH------HHcCCChhHCcCHHHHhh
Confidence 11222233445555554 499999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=376.27 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=210.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCC-CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
..+|++.+.||+|+||.||+|.+.. ++.||||+++... ...++|.+|++++++++|||||++++++...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3468888999999999999998654 8899999997543 3567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.+++..... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 298 ~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 371 (495)
T 1opk_A 298 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-- 371 (495)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC--
T ss_pred cCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC--
Confidence 999999999976432 3489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.........+++.|+|||++....++.++|||||||++|||++ |+.||.... ...+.+.+. .... .
T Consensus 372 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~--~~~~~~~~~----~~~~------~ 438 (495)
T 1opk_A 372 -TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLE----KDYR------M 438 (495)
T ss_dssp -CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHH----TTCC------C
T ss_pred -ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH----cCCC------C
Confidence 1223334457789999999999999999999999999999999 999997532 222222222 1111 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
..+...+..+.+++.. ||+.||++||++.+|++.|+.+.+
T Consensus 439 ~~~~~~~~~l~~li~~------cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 ERPEGCPEKVYELMRA------CWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCHHHHHHHHH------HcCcChhHCcCHHHHHHHHHHHHh
Confidence 1223334455555554 999999999999999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=356.87 Aligned_cols=248 Identities=19% Similarity=0.261 Sum_probs=203.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|++.+.||+|+||+||+|+.+ +|+.||||+++.. .....+.+.+|.++++.+ +||+|+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 457899999999999999999865 4889999999753 223456788999999988 79999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++... +.+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999754 3489999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+..........
T Consensus 173 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~~----- 238 (353)
T 2i0e_A 173 WDG----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DEDELFQSIMEHNV----- 238 (353)
T ss_dssp CTT----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC-----
T ss_pred cCC----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhCCC-----
Confidence 221 1234568999999999999999999999999999999999999999642 22233333333221
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
.++...+..+.++++. |++.||++||+ +.++.+
T Consensus 239 ---~~p~~~s~~~~~li~~------lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ---AYPKSMSKEAVAICKG------LMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---CCCTTSCHHHHHHHHH------HTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---CCCCCCCHHHHHHHHH------HhhcCHHHcCCCCCCCHHHHhc
Confidence 1233444556666655 99999999995 466654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=357.05 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=209.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc--------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecC
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL--------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANR 844 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 844 (1117)
.++|++.+.||+|+||+||+|++ .+++.||||+++... ....+++.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 45789999999999999999975 356789999997543 23356788999999999 899999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL 911 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 911 (1117)
+..++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||++ +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999986532 12488999999999999999999999 99999999999999
Q ss_pred cCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCCh
Q 001238 912 GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ 990 (1117)
Q Consensus 912 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~ 990 (1117)
+.++.+||+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----- 263 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNID--YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----- 263 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTS--SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-----
T ss_pred cCCCCEEEccccccccccccc--cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-----
Confidence 999999999999998765422 1223334567889999999998899999999999999999999 99999642
Q ss_pred hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
...+......... . +..+...+..+.++++. |++.+|++||++.++++.|+++...
T Consensus 264 ~~~~~~~~~~~~~-~------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 264 PVEELFKLLKEGH-R------MDKPANCTNELYMMMRD------CWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp CHHHHHHHHHHTC-C------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHhcCC-C------CCCCccCCHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHhc
Confidence 1122222222211 1 11223334455555554 9999999999999999999988654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=356.65 Aligned_cols=258 Identities=21% Similarity=0.338 Sum_probs=198.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCc----EEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGL----TVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|++.+.||+|+||+||+|.+. +++ +||+|+++.. .....+++.+|++++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46888999999999999999853 444 4688887543 2345578999999999999999999999998754 789
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++.... +.+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999997643 3489999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+. .....
T Consensus 169 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~----~~~~~-- 238 (327)
T 3poz_A 169 AEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE----KGERL-- 238 (327)
T ss_dssp TTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHH----TTCCC--
T ss_pred CCcc--cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC--HHHHHHHHH----cCCCC--
Confidence 4322 122234467889999999999999999999999999999999 999997532 222222222 11111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
..+...+..+..++ ..||+.+|++||++.++++.|+.+...
T Consensus 239 ----~~~~~~~~~~~~li------~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 ----PQPPICTIDVYMIM------VKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----CCCTTBCHHHHHHH------HHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ----CCCccCCHHHHHHH------HHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11122233444444 459999999999999999999988754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.62 Aligned_cols=261 Identities=29% Similarity=0.459 Sum_probs=194.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.++||+|+||+||+|+.. ..||||+++... ....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 357999999999999999999864 369999987543 23346789999999999999999999965 4567899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999997543 3489999999999999999999999 99999999999999999999999999998654321
Q ss_pred CCccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
. ........||+.|+|||++. ...++.++||||||+++|||++|+.||..... ....... .........
T Consensus 175 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~----~~~~~~~~~- 246 (289)
T 3og7_A 175 G--SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIEM----VGRGSLSPD- 246 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-HHHHHHH----HHHTSCCCC-
T ss_pred c--cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-HHHHHHH----hcccccCcc-
Confidence 1 12234567999999999986 56788899999999999999999999965321 1122222 211111110
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.+.+....+..+.+++.. |++.+|++||++.++++.|+++.+
T Consensus 247 -~~~~~~~~~~~l~~li~~------~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 -LSKVRSNCPKRMKRLMAE------CLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -TTSSCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -hhhccccCCHHHHHHHHH------HccCChhhCCCHHHHHHHHHHHhh
Confidence 112223334455665555 999999999999999999998865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=355.04 Aligned_cols=272 Identities=26% Similarity=0.385 Sum_probs=201.6
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhcc--CCCCcceEEeeeecC----Cce
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI--RHRNIVRLLGWGANR----KTK 847 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~----~~~ 847 (1117)
..++|++.+.||+|+||.||+|+.. ++.||||++.... ...+.+|.+++... +||||+++++++... ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3468999999999999999999874 8999999986432 34455666666554 899999999998877 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC-----CCceeeeccccCeEEEcCCCcceeccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC-----VPAILHRDVKSHNILLGERYESCLADF 922 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~kl~Df 922 (1117)
++||||+++|+|.++++.. .+++..++.++.|++.||+|||+++ .++|+||||||+||+++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 9999999999999999754 3899999999999999999999762 348999999999999999999999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCCCcC------CCeeehhhhHHHHHhC----------CCCCCCCC
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEK------SDVYSYGVVLLEIITG----------KKPVDASF 986 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlG~vl~ell~g----------~~P~~~~~ 986 (1117)
|+++.................||+.|+|||++.+..++.+ +|||||||++|||++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9998765433322223345689999999999987766665 9999999999999999 67775543
Q ss_pred CCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 987 PDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
......... ........ ..+.++...... ........++..||+.||++||++.++++.|+++.+..
T Consensus 267 ~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 267 PSDPSYEDM-REIVCIKK-----LRPSFPNRWSSD-ECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CSSCCHHHH-HHHHTTSC-----CCCCCCGGGGGS-HHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCCchhhh-HHHHhhhc-----cCccccccchhh-HHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 333332222 22222111 111111111000 01111224555699999999999999999999987654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=344.96 Aligned_cols=258 Identities=27% Similarity=0.445 Sum_probs=208.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.++|++.+.||+|+||+||+|...+++.||||+++... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 35788899999999999999998888899999997543 346789999999999999999999998764 5689999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++++|.+++..... ..+++.++..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++......
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 163 (279)
T 1qpc_A 90 ENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-- 163 (279)
T ss_dssp TTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--
T ss_pred CCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc--
Confidence 99999999976421 2489999999999999999999999 99999999999999999999999999998765421
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
........+++.|+|||++....++.++||||||+++|||++ |+.||... ...+......... . +.
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~~~~~~-~------~~ 230 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLERGY-R------MV 230 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTC-C------CC
T ss_pred -cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc-----CHHHHHHHHhccc-C------CC
Confidence 222334567889999999998899999999999999999999 99999642 1122222222111 1 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.+...+..+.+++.. |++.+|++||++.++++.|+++...
T Consensus 231 ~~~~~~~~l~~li~~------~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 RPDNCPEELYQLMRL------CWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHH------HhccChhhCCCHHHHHHHHHHHHHh
Confidence 223334455555554 9999999999999999999988654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=358.39 Aligned_cols=264 Identities=22% Similarity=0.258 Sum_probs=203.1
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC-----CccchHHHHHHHHHHhccCCCCcceEEeeeec
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS-----DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN 843 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 843 (1117)
++....++|++.+.||+|+||+||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4556778899999999999999999975 56889999998643 23445679999999999999999999999999
Q ss_pred CCceEEEEEecCCCChhhhhcCCCC-------------------------------------CCCCCHHHHHHHHHHHHH
Q 001238 844 RKTKLLFYDYMPNGTLGMLLHDGEC-------------------------------------AGLLEWDTRFKIALGVAE 886 (1117)
Q Consensus 844 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~ 886 (1117)
.+..++||||+++|+|.+++..... ...+++..+..++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999852100 112457788899999999
Q ss_pred HHHHHhccCCCceeeeccccCeEEEcCCC--cceeccccccccccCCCCCccccCCccccccccCChhhhcc--CCCCcC
Q 001238 887 GLSYLHHDCVPAILHRDVKSHNILLGERY--ESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM--TKISEK 962 (1117)
Q Consensus 887 ~L~~LH~~~~~~ivHrDlkp~Nill~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 962 (1117)
||+|||++ +|+||||||+||+++.++ .+||+|||+++.................||+.|+|||++.. ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 89999999998765433333333456679999999999875 678999
Q ss_pred CCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCC
Q 001238 963 SDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAED 1042 (1117)
Q Consensus 963 ~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~ 1042 (1117)
+||||||+++|||++|+.||... ...+.............. +.. ...+..+.++++. |++.+|++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~li~~------~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGV-----NDADTISQVLNKKLCFEN---PNY-NVLSPLARDLLSN------LLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCTTS---GGG-GGSCHHHHHHHHH------HSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCC-----ChHHHHHHHHhcccccCC---ccc-ccCCHHHHHHHHH------HcCCChhH
Confidence 99999999999999999999642 222333333333221111 111 1223455555555 99999999
Q ss_pred CCCHHHHHH
Q 001238 1043 RPTMKDVAA 1051 (1117)
Q Consensus 1043 RPs~~~v~~ 1051 (1117)
||++.++++
T Consensus 322 Rps~~~~l~ 330 (345)
T 3hko_A 322 RFDAMRALQ 330 (345)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=367.01 Aligned_cols=255 Identities=21% Similarity=0.266 Sum_probs=204.2
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
...++|++.++||+|+||+||+|+.+ +++.||+|+++.. .....+.+.+|+++++.++|||||++++++.+.+..|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34578999999999999999999864 5899999999752 1223446889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+++|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 146 lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 999999999999999754 389999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCC----CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTK----ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
.... .......+||+.|+|||++.... ++.++|||||||++|||++|+.||... ..............
T Consensus 219 ~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 219 NKEG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----SLVGTYSKIMNHKN 290 (410)
T ss_dssp CTTS---EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTHHH
T ss_pred ccCC---cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC-----ChhhHHHHHHhccc
Confidence 5321 22344678999999999997655 889999999999999999999999642 22222333222110
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCC--CCCHHHHHHH
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAED--RPTMKDVAAL 1052 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~--RPs~~~v~~~ 1052 (1117)
... .|. ....+.....+++. |+..+|.+ ||++.||.+.
T Consensus 291 ~~~---~p~-~~~~s~~~~~li~~------lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 SLT---FPD-DNDISKEAKNLICA------FLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HCC---CCT-TCCCCHHHHHHHHH------HSSCGGGCTTSSCHHHHHTS
T ss_pred ccc---CCC-cccccHHHHHHHHH------HccChhhhCCCCCHHHHhcC
Confidence 000 011 12234456666655 99989988 9999999873
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=356.56 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=196.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCC-------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK------- 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------- 845 (1117)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999865 79999999997543 334567999999999999999999999886543
Q ss_pred --------------------------------------------------ceEEEEEecCCCChhhhhcCCCCCCCCCHH
Q 001238 846 --------------------------------------------------TKLLFYDYMPNGTLGMLLHDGECAGLLEWD 875 (1117)
Q Consensus 846 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~ 875 (1117)
..++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 278999999999999999887655567888
Q ss_pred HHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc--------cccCCccccccc
Q 001238 876 TRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS--------FSANPQFAGSYG 947 (1117)
Q Consensus 876 ~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~~~~gt~~ 947 (1117)
.++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......... ........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 99999999999999999999999999998776532111 122345679999
Q ss_pred cCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHH
Q 001238 948 YIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQ 1027 (1117)
Q Consensus 948 y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 1027 (1117)
|+|||++.+..++.++||||+|+++|||++|..|+. ........... ...+ ...........
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-------~~~~~~~~~~~-~~~~------~~~~~~~~~~~---- 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-------ERVRIITDVRN-LKFP------LLFTQKYPQEH---- 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-------HHHHHHHHHHT-TCCC------HHHHHHCHHHH----
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-------HHHHHHHHhhc-cCCC------cccccCChhHH----
Confidence 999999999999999999999999999999877652 11122222111 1100 00000111223
Q ss_pred HHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1028 ALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1028 ~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++..|++.||++||++.++++
T Consensus 304 --~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 --MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp --HHHHHHHCSSGGGSCCHHHHHH
T ss_pred --HHHHHHccCCCCcCCCHHHHhh
Confidence 3445599999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=349.42 Aligned_cols=202 Identities=27% Similarity=0.376 Sum_probs=161.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||+||+|... +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357999999999999999999854 68999999997543 2344678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 853 YMPNGTLGMLLHDGE---CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
|++ |+|.+++.... ....+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988876431 123489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 160 IPV----NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp SCC----CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCc----ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 321 12234578999999999876 4689999999999999999999999965
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=364.87 Aligned_cols=207 Identities=20% Similarity=0.213 Sum_probs=177.7
Q ss_pred ccCCCCCCeeeec--CCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQG--RSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|++.++||+| +||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578999999999 99999999864 69999999997543 2334568889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++..... +.+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999976532 3489999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCC---ccccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 930 DDSGG---SFSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 930 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
..... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 32111 1112233478999999999987 67999999999999999999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=346.89 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=195.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCC----CcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPS----GLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|++.+.||+|+||+||+|.... +..||+|+++... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3578889999999999999997532 5579999987542 333567899999999999999999999874 467899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999997643 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... .......+|+.|+|||++....++.++||||||+++|||++ |+.||.... .......+. ....
T Consensus 168 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~--~~~~~~~i~---~~~~---- 235 (281)
T 1mp8_A 168 DSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIE---NGER---- 235 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHH---TTCC----
T ss_pred cccc---cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC--HHHHHHHHH---cCCC----
Confidence 4221 12233457889999999999999999999999999999997 999997532 222222221 1111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
...+...+..+.+++.. |++.||++||++.++++.|+++.+
T Consensus 236 ---~~~~~~~~~~l~~li~~------~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 236 ---LPMPPNCPPTLYSLMTK------CWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ---CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHH
Confidence 11223344455555555 999999999999999999998754
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=374.84 Aligned_cols=348 Identities=21% Similarity=0.251 Sum_probs=246.0
Q ss_pred cEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCc
Q 001238 294 VNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNN 373 (1117)
Q Consensus 294 ~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 373 (1117)
+.++.++++++ .+|..+. ++|+.|||++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 46777777777 4565553 57888888888888777778888888888888888888777888888888888888888
Q ss_pred cccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCC
Q 001238 374 QITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPP 453 (1117)
Q Consensus 374 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 453 (1117)
++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|++++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 88866666677777888888888887777777777777777777777777766666777777777777777777766656
Q ss_pred CcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhccccc
Q 001238 454 EMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRL 533 (1117)
Q Consensus 454 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 533 (1117)
.|.++++|+.|++++|.+++..+..|..+++|+.|++++|.+.+.+|..+....+|++|+|++|+|++..+..|..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 67777777777777777776666667777777777777766665555555555567777777777665554556666666
Q ss_pred ccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCC
Q 001238 534 QFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSW 613 (1117)
Q Consensus 534 ~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~ 613 (1117)
+.|+|++|.|+++.+..|..+++|+.|+|++|++.+..|..|..+++|+.|+|++|+|+
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--------------------- 309 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT--------------------- 309 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCS---------------------
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCc---------------------
Confidence 66666666666665555555555555555555555555555555555555555555554
Q ss_pred CcccCCccccccCCCCccEEeccCccccCCcchhhhcccceEEEeecccccCCCCC
Q 001238 614 NQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPD 669 (1117)
Q Consensus 614 N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~l~~l~~L~~L~ls~N~l~~~~p~ 669 (1117)
+..+..|..+++|+.|+|++|++.|+++..+-+..+..+++.+|...+.-|.
T Consensus 310 ----~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 310 ----TLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp ----CCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred ----eeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 4455567778889999999999999887655444455566666666655554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.92 Aligned_cols=263 Identities=24% Similarity=0.382 Sum_probs=206.0
Q ss_pred CCCCCCeeeecCCeEEEEEEc-----CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecC--CceE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANR--KTKL 848 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 848 (1117)
.|++.+.||+|+||+||++.+ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 348899999999999998753 268899999998653 23356789999999999999999999999874 5678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+++|+|.+++.... +++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999997643 89999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCC---------CChhHHHHHHHH
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFP---------DGQHVIQWVRDH 999 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~---------~~~~~~~~~~~~ 999 (1117)
.... ..........+|+.|+|||++.+..++.++||||||+++|||++|+.||..... .+......+...
T Consensus 185 ~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGH-EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTC-SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccc-cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 5432 112233445688899999999999999999999999999999999999864210 001111112222
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
...... ...+...+..+.++++. |++.||++||++.++++.|+++.+.
T Consensus 264 ~~~~~~------~~~~~~~~~~l~~li~~------~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 264 LERGER------LPRPDKCPAEVYHLMKN------CWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHTTCC------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcccC------CCCCccccHHHHHHHHH------HcCCCcccCcCHHHHHHHHHHHHHh
Confidence 222211 11223344455555555 9999999999999999999988654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=352.72 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=201.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC-----CcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS-----GLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.+|++.+.||+|+||+||+|.... +..||||+++... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467778999999999999997532 3469999997543 2334568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++.... +.+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999997642 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
...... .......+|+.|+|||++....++.++||||||+++|||++ |+.||... . ..+......... ..
T Consensus 199 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~---~~~~~~~~~~~~-~~-- 269 (333)
T 1mqb_A 199 DDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--S---NHEVMKAINDGF-RL-- 269 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--C---HHHHHHHHHTTC-CC--
T ss_pred cccccc-cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC--C---HHHHHHHHHCCC-cC--
Confidence 432111 12223456789999999998999999999999999999999 99999642 1 122222222211 11
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
..+...+..+.+++.. ||+.+|++||++.++++.|+++.....
T Consensus 270 ----~~~~~~~~~l~~li~~------~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 270 ----PTPMDCPSAIYQLMMQ------CWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp ----CCCTTCBHHHHHHHHH------HTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ----CCcccCCHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 1122334455555554 999999999999999999998876543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=364.69 Aligned_cols=274 Identities=22% Similarity=0.275 Sum_probs=210.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCC--ceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK--TKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv 850 (1117)
.++|++.++||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357899999999999999999864 58999999997543 234567889999999999999999999988765 67999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE----cCCCcceeccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL----GERYESCLADFGLAR 926 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl~DfGla~ 926 (1117)
|||+++|+|.+++........+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998765444589999999999999999999999 99999999999999 778889999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhcc--------CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHH
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANM--------TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ...+.+..
T Consensus 165 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~-~~~~~~~~ 238 (396)
T 4eut_A 165 ELEDD-----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-RNKEVMYK 238 (396)
T ss_dssp ECCCG-----GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT-TCHHHHHH
T ss_pred EccCC-----CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc-chHHHHHH
Confidence 76432 23345679999999998865 567889999999999999999999996532222 22333333
Q ss_pred HHhcCCCCc-ccc----------CcccCC--CCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 999 HLKSKKDPV-EVL----------DPKLQG--HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 999 ~~~~~~~~~-~~~----------~~~l~~--~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.....+... ..+ ...++. .....+...+ ..++..|++.||++||+++++++.++++...
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l--~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL--TPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHH--HHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhc--hHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 333321110 000 001111 1112222222 2355569999999999999999999887654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=366.47 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=203.5
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
...++|++.++||+|+||+||+|+.+ +++.||||+++.. .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 44678999999999999999999865 5789999999752 1223345899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+++|+|.+++.... +.+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++..
T Consensus 151 lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999998632 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
.... .......+||+.|+|||++. ...++.++|||||||++|||++|+.||... ...+.........
T Consensus 226 ~~~~---~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 226 MEDG---TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETYGKIMNHK 297 (437)
T ss_dssp CTTS---CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTHH
T ss_pred ccCC---CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC-----ChhHHHHhhhhcc
Confidence 5322 12334568999999999987 567899999999999999999999999642 2222222222111
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCC--CCCHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAED--RPTMKDVAA 1051 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~--RPs~~~v~~ 1051 (1117)
.. ...|......+....++++. |+..+|++ ||+++|+++
T Consensus 298 ~~---~~~p~~~~~~s~~~~dLi~~------lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 ER---FQFPTQVTDVSENAKDLIRR------LICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HH---CCCCSSCCCSCHHHHHHHHT------TSSCGGGCTTTTTTHHHHT
T ss_pred cc---ccCCcccccCCHHHHHHHHH------HhcccccccCCCCHHHHhC
Confidence 00 00111112234455665554 77777877 999999977
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.19 Aligned_cols=266 Identities=26% Similarity=0.375 Sum_probs=205.1
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEcCC----CcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeee-ecCC
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTLPS----GLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWG-ANRK 845 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~ 845 (1117)
+....+|++.+.||+|+||+||+|...+ +..||+|++.... ....+++.+|++++++++||||+++++++ ..++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 3445678889999999999999997532 3368999987543 33456789999999999999999999985 4556
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..++||||+++|+|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred ceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence 7899999999999999997643 3488999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
+.................+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||..... ...... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~~~~~---~~~~~~ 250 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY---LLQGRR 250 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--TTHHHH---HHTTCC
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--HHHHHH---HhcCCC
Confidence 8765433222233445678899999999999999999999999999999999 5666654221 112111 111111
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
+..+...+..+.+++.. |++.+|++||++.++++.|+++....
T Consensus 251 -------~~~~~~~~~~l~~li~~------~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 251 -------LLQPEYCPDPLYEVMLK------CWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -------CCCCccCCHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11122233445555554 99999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=355.23 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=196.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCC--CCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRH--RNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|++++++++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45789999999999999999998889999999997543 2334678999999999986 9999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|| +.+++|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 5688999999864 3489999999999999999999999 999999999999997 57899999999987654
Q ss_pred CCCCccccCCccccccccCChhhhcc-----------CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHH
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANM-----------TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ....+...
T Consensus 160 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~ 233 (343)
T 3dbq_A 160 DTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISKLHAI 233 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHHHHH
T ss_pred ccc--cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----HHHHHHHH
Confidence 321 122335679999999999865 6788999999999999999999999964211 12222222
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
..... ....+...+..+.+++.. |++.||++||++.++++.-
T Consensus 234 ~~~~~------~~~~~~~~~~~l~~li~~------~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 234 IDPNH------EIEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HCTTS------CCCCCCCSCHHHHHHHHH------HTCSSTTTSCCHHHHHTSH
T ss_pred hcCCc------ccCCcccCCHHHHHHHHH------HcCCChhHCCCHHHHHhCc
Confidence 22111 112233334455555554 9999999999999998753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=355.17 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=186.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.++|++.+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 457889999999999999999865 58899999998543 345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceeccccccccccC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLADFGLARLVED 930 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGla~~~~~ 930 (1117)
+++|+|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999998764 3489999999999999999999999 9999999999999975 88999999999987643
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ................
T Consensus 204 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~i~~~~~~~~--- 271 (349)
T 2w4o_A 204 Q-----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG----DQFMFRRILNCEYYFI--- 271 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC----HHHHHHHHHTTCCCCC---
T ss_pred c-----cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc----cHHHHHHHHhCCCccC---
Confidence 2 122346799999999999998999999999999999999999999964221 1112222222221111
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+......+..+.++++ .|++.||++||++.++++
T Consensus 272 -~~~~~~~~~~~~~li~------~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 -SPWWDEVSLNAKDLVR------KLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TTTTTTSCHHHHHHHH------TTSCSSGGGSCCHHHHHH
T ss_pred -CchhhhCCHHHHHHHH------HHccCChhhCcCHHHHhc
Confidence 1112233344555554 499999999999999877
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=358.61 Aligned_cols=246 Identities=22% Similarity=0.288 Sum_probs=195.9
Q ss_pred CCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 781 GNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
.+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999975 56899999999876655667899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE--cCCCcceeccccccccccCCCCCccc
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL--GERYESCLADFGLARLVEDDSGGSFS 937 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill--~~~~~~kl~DfGla~~~~~~~~~~~~ 937 (1117)
.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||++ ++++.+||+|||+++......
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----- 243 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----- 243 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----
Confidence 98886542 3489999999999999999999999 99999999999999 567899999999998765422
Q ss_pred cCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCC
Q 001238 938 ANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017 (1117)
Q Consensus 938 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1017 (1117)
......||+.|+|||++....++.++|||||||++|||++|+.||... .....+........... +.....
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~~~----~~~~~~ 314 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-----NDAETLNNILACRWDLE----DEEFQD 314 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCCCSC----SGGGTT
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccCCCC----hhhhcc
Confidence 223457999999999999899999999999999999999999999642 22233333333222111 111123
Q ss_pred CchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1018 ~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+..+.+++. .|++.||++||++.++++
T Consensus 315 ~~~~~~~li~------~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFIS------KLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHH------TTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHH------HHcCCChhhCCCHHHHhc
Confidence 3444555554 499999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=355.87 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=209.2
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcCC------CcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLPS------GLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRK 845 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 845 (1117)
..++|++.+.||+|+||+||+|.... +..||+|++.... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35689999999999999999998532 3489999997653 23456789999999999 8999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGE-----------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER 914 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~ 914 (1117)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 9999999999999999987532 123478999999999999999999999 99999999999999999
Q ss_pred CcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHH
Q 001238 915 YESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVI 993 (1117)
Q Consensus 915 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~ 993 (1117)
+.+||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||..... .....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~ 277 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSN--YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV-NSKFY 277 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTT--SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-SHHHH
T ss_pred CeEEECccccccccccccc--eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch-hHHHH
Confidence 9999999999987654322 123344567889999999999999999999999999999998 9999975322 12222
Q ss_pred HHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 994 QWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
..+. .... ...+...+..+.+++.. |++.||++||++.++++.|+++..
T Consensus 278 ~~~~----~~~~------~~~~~~~~~~l~~li~~------~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 278 KLVK----DGYQ------MAQPAFAPKNIYSIMQA------CWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHH----HTCC------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh----cCCC------CCCCCCCCHHHHHHHHH------HhccChhhCcCHHHHHHHHHHHHH
Confidence 2222 1111 11122233455555554 999999999999999999988754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=359.03 Aligned_cols=268 Identities=18% Similarity=0.266 Sum_probs=208.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCC---------CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcce---------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPS---------GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR--------- 836 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 836 (1117)
.++|++.+.||+|+||+||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3679999999999999999998653 789999998754 46889999999999999987
Q ss_pred ------EEeeeec-CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeE
Q 001238 837 ------LLGWGAN-RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNI 909 (1117)
Q Consensus 837 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Ni 909 (1117)
+++++.. .+..++||||+ +++|.+++.... .+.+++.+++.++.|+++||+|||++ +|+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 5666665 67789999999 999999998652 23499999999999999999999999 999999999999
Q ss_pred EEcCCC--cceeccccccccccCCCCC---ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 910 LLGERY--ESCLADFGLARLVEDDSGG---SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 910 ll~~~~--~~kl~DfGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+++.++ .+||+|||+++........ .........||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876543211 11122345899999999999999999999999999999999999999976
Q ss_pred CCCCChhHHHHHHHHHhcCCCCccccCccc-CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 985 SFPDGQHVIQWVRDHLKSKKDPVEVLDPKL-QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
.................... ....+.. ....+..+.++++. |++.||++||++.++++.|+++.+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPG---PFVGPCGHWIRPSETLQKYLKV------VMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCC---CEECTTSCEECCCHHHHHHHHH------HHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcCHHHHHHHHHhccCChh---hhhhhccccCCCcHHHHHHHHH------HHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 43333333333332222211 1111110 11234455666555 999999999999999999999876544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=344.53 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=207.5
Q ss_pred cCCCCCC-eeeecCCeEEEEEEcC---CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGN-IIGQGRSGIVYKVTLP---SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|.+.+ .||+|+||.||+|... +++.||||+++... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999743 57889999997643 33456789999999999999999999998 45678999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999997542 3489999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... .........+|+.|+|||++....++.++||||||+++|||++ |+.||... ........+ .....
T Consensus 163 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~i----~~~~~---- 231 (287)
T 1u59_A 163 DDS-YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFI----EQGKR---- 231 (287)
T ss_dssp CSC-EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CTHHHHHHH----HTTCC----
T ss_pred Ccc-eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHH----hcCCc----
Confidence 321 1122334457899999999998899999999999999999998 99999653 222222222 11111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
+..+...+..+.+++.. |++.+|++||++.++++.|+.+.....
T Consensus 232 --~~~~~~~~~~l~~li~~------~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 232 --MECPPECPPELYALMSD------CWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp --CCCCTTCCHHHHHHHHH------TTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCcCHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 12233444556666555 999999999999999999998865443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=347.08 Aligned_cols=264 Identities=20% Similarity=0.285 Sum_probs=200.5
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
...++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34568999999999999999999854 689999999975432 22467889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+++++|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999999764 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||... .. ..+............
T Consensus 185 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~-~~~~~~~~~~~~~~~ 255 (309)
T 2h34_A 185 TDEK---LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-----QL-SVMGAHINQAIPRPS 255 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-----HH-HHHHHHHHSCCCCGG
T ss_pred cccc---cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-----hH-HHHHHHhccCCCCcc
Confidence 5321 12233457999999999999899999999999999999999999999642 11 123333333222211
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-CHHHHHHHHHhhhcCCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-TMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-s~~~v~~~L~~~~~~~~ 1061 (1117)
......+..+.+++.. |++.||++|| +++++++.|+++.....
T Consensus 256 ----~~~~~~~~~l~~li~~------~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 256 ----TVRPGIPVAFDAVIAR------GMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp ----GTSTTCCTHHHHHHHH------HTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ----ccCCCCCHHHHHHHHH------hccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 1223344456666665 9999999999 99999999998765443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=354.09 Aligned_cols=270 Identities=26% Similarity=0.362 Sum_probs=209.1
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhc--cCCCCcceEEeeeecCC----c
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSR--IRHRNIVRLLGWGANRK----T 846 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~ 846 (1117)
...++|++.+.||+|+||+||+|+. +|+.||||++... ..+.+.+|+++++. ++||||+++++++...+ .
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3456899999999999999999988 5899999998643 34567889998887 78999999999998776 7
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------ccCCCceeeeccccCeEEEcCCCcce
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH--------HDCVPAILHRDVKSHNILLGERYESC 918 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivHrDlkp~Nill~~~~~~k 918 (1117)
.++||||+++|+|.+++... .+++.+++.++.|++.||+||| +. +|+||||||+||+++.++.+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEE
T ss_pred eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEE
Confidence 89999999999999999764 3899999999999999999999 77 999999999999999999999
Q ss_pred eccccccccccCCCCCccccCCccccccccCChhhhccC------CCCcCCCeeehhhhHHHHHhC----------CCCC
Q 001238 919 LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT------KISEKSDVYSYGVVLLEIITG----------KKPV 982 (1117)
Q Consensus 919 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~vl~ell~g----------~~P~ 982 (1117)
|+|||+++.................||+.|+|||++... .++.++||||||+++|||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 999999987765332211233456799999999998765 344789999999999999999 7888
Q ss_pred CCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 983 DASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
............+......... .+.++.... ..........++..||+.||++||++.+|++.|+++.++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKL------RPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCC------CCCCCGGGG-TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccCcCcccHHHHHHHHHHHHh------CCCCccccc-chhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 6654443344444333322211 111111110 0011111223555699999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=355.86 Aligned_cols=253 Identities=22% Similarity=0.246 Sum_probs=194.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.++|++.+.||+|+||+||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457999999999999999999864 789999999976433 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc--ceeccccccccccCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE--SCLADFGLARLVEDD 931 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~DfGla~~~~~~ 931 (1117)
+++|+|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999998653 3489999999999999999999999 9999999999999987765 999999999754322
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcC-CCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEK-SDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.......||+.|+|||++.+..++.+ +||||+||++|||++|+.||...... ......+............
T Consensus 172 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~-- 243 (361)
T 3uc3_A 172 -----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRILSVKYSIPD-- 243 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-CCHHHHHHHHHTTCCCCCT--
T ss_pred -----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHhcCCCCCCC--
Confidence 12334579999999999988887655 89999999999999999999753222 2233333333332211111
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
....+..+.++++. |++.||++|||+.++++.
T Consensus 244 ----~~~~s~~~~~li~~------~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 ----DIRISPECCHLISR------IFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----TSCCCHHHHHHHHH------HSCSCTTTSCCHHHHHTS
T ss_pred ----cCCCCHHHHHHHHH------HccCChhHCcCHHHHHhC
Confidence 11233455555555 999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=365.45 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=206.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCC-CCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH-RNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.++||+|+||.||+|.+ .+++.||||++..... ..++.+|+++++.++| ++++.+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35799999999999999999985 5789999999875433 3468899999999986 666677777788888999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE---cCCCcceecccccccccc
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL---GERYESCLADFGLARLVE 929 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGla~~~~ 929 (1117)
|+ +++|.+++.... +.+++.+++.++.||+.||+|||++ +||||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999997532 3489999999999999999999999 99999999999999 688999999999998776
Q ss_pred CCCCCc---cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC-CC
Q 001238 930 DDSGGS---FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK-KD 1005 (1117)
Q Consensus 930 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~-~~ 1005 (1117)
...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KKQKYEKISEKKVAT 235 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--HHHHHHHHHHHHHHS
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh--HHHHHHHHhhccccc
Confidence 543221 223346789999999999999999999999999999999999999997643321 111111111110 00
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.. +.+....+..+.+++.. ||+.+|++||++.+|+++|+++..
T Consensus 236 ~~----~~l~~~~p~~l~~li~~------cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 236 SI----EALCRGYPTEFASYFHY------CRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp CH----HHHHTTSCHHHHHHHHH------HHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cH----HHHhcCCcHHHHHHHHH------HhcCChhhCcCHHHHHHHHHHHHH
Confidence 11 11122333455555554 999999999999999999988744
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=365.88 Aligned_cols=246 Identities=24% Similarity=0.367 Sum_probs=203.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999864 79999999997532 223467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999764 3489999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
. .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.. ..............
T Consensus 170 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~~~------ 233 (476)
T 2y94_A 170 E-----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD-----HVPTLFKKICDGIF------ 233 (476)
T ss_dssp C-----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS-----SSHHHHHHHHTTCC------
T ss_pred c-----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC-----CHHHHHHHHhcCCc------
Confidence 1 2234579999999999988765 68999999999999999999999742 12222333322221
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+.++++. |++.||++||++.++++
T Consensus 234 --~~p~~~s~~~~~Li~~------~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 --YTPQYLNPSVISLLKH------MLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CCCTTCCHHHHHHHHH------HTCSSTTTSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHH------HcCCCchhCcCHHHHHh
Confidence 1122334455565555 99999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=357.39 Aligned_cols=267 Identities=18% Similarity=0.263 Sum_probs=200.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCCcc-----------chHHHHHHHHHHhccCCCCcceEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASDKI-----------STGAFSSEIATLSRIRHRNIVRLLG 839 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~ 839 (1117)
.++|++.+.||+|+||+||+|... ++..||||++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999865 5788999998765321 1224667888999999999999999
Q ss_pred eeec----CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC
Q 001238 840 WGAN----RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY 915 (1117)
Q Consensus 840 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~ 915 (1117)
++.. ....++||||+ +++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9887 67889999999 999999998653 489999999999999999999999 999999999999999887
Q ss_pred --cceeccccccccccCCCCC---ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCCh
Q 001238 916 --ESCLADFGLARLVEDDSGG---SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ 990 (1117)
Q Consensus 916 --~~kl~DfGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~ 990 (1117)
.+||+|||+++........ .........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876533211 11122455799999999999999999999999999999999999999965332222
Q ss_pred hHHHHHHHHHhcCCCCccccCccc-CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 991 HVIQWVRDHLKSKKDPVEVLDPKL-QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
.... ........ ....+.... ....+..+.+++.. ||+.||++||++.+|++.|+...
T Consensus 269 ~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 269 AVQT-AKTNLLDE--LPQSVLKWAPSGSSCCEIAQFLVC------AHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHH-HHHHHHHT--TTHHHHHHSCTTSCCHHHHHHHHH------HHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHH-HHHhhccc--ccHHHHhhccccccHHHHHHHHHH------HhhcCcccCCCHHHHHHHHhccC
Confidence 2222 22222111 111111111 11334456666655 99999999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=359.76 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=195.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC--C--CcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeec-CCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP--S--GLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN-RKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~l 849 (1117)
..|++.+.||+|+||+||+|.+. + +..||||+++.. .....++|.+|++++++++||||+++++++.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35677889999999999999753 2 246899998653 33345679999999999999999999998654 567899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999997643 3478999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
..............+|+.|+|||++.+..++.++||||||+++|||++ |.+||..... ......+. ... ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--~~~~~~~~---~~~-~~-- 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLL---QGR-RL-- 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--SCHHHHHH---TTC-CC--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--HHHHHHHH---cCC-CC--
Confidence 432222223344567889999999999999999999999999999999 7778865322 22222221 111 11
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
..+...+..+.+++.. ||+.+|++||++.++++.|+++.....
T Consensus 316 ----~~p~~~~~~l~~li~~------cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 316 ----LQPEYCPDPLYEVMLK------CWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----CCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----CCCCCCCHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1122334455555554 999999999999999999999876544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=342.00 Aligned_cols=252 Identities=20% Similarity=0.220 Sum_probs=204.1
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
+..++|++.+.||+|+||+||+|... ++..||+|++........+++.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 44567999999999999999999754 57899999998765666788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE---cCCCcceeccccccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL---GERYESCLADFGLARLV 928 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGla~~~ 928 (1117)
||+++++|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++..
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 86 ELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999988764 3489999999999999999999999 99999999999999 78899999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... ......||+.|+|||++.+ .++.++||||+|+++|||++|+.||... ...+..............
T Consensus 160 ~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~ 228 (277)
T 3f3z_A 160 KPGK-----MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAP-----TDSEVMLKIREGTFTFPE 228 (277)
T ss_dssp CTTS-----CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCCCH
T ss_pred cCcc-----chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhCCCCCCc
Confidence 5322 2234579999999999875 4899999999999999999999999642 112222222222211111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. .....+..+.++++. |++.||++||++.++++
T Consensus 229 ~----~~~~~~~~~~~li~~------~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 K----DWLNVSPQAESLIRR------LLTKSPKQRITSLQALE 261 (277)
T ss_dssp H----HHTTSCHHHHHHHHH------HTCSSTTTSCCHHHHTT
T ss_pred h----hhhcCCHHHHHHHHH------HccCChhhCcCHHHHhc
Confidence 1 011223345555554 99999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=365.23 Aligned_cols=347 Identities=27% Similarity=0.399 Sum_probs=217.3
Q ss_pred CCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceE
Q 001238 265 DCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQEL 344 (1117)
Q Consensus 265 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L 344 (1117)
.+++|+.|++.+|.++ .+|. +..+++|++|+|++|.+++..+ +.++++|++|++++|.+++..+ +.++++|++|
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 3567888888888887 3553 7778888888888888875433 7788888888888888885544 7788888888
Q ss_pred ecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeeccccccc
Q 001238 345 QLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLT 424 (1117)
Q Consensus 345 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 424 (1117)
++++|.+++..+ +.++++|++|++++|.+++. + .+..+++|+.|+++ |.+.+..+ +.++++|+.|++++|.++
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS 190 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCC
Confidence 888888875433 77788888888888887743 2 36667777777764 44443322 666666667777666666
Q ss_pred CCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccc
Q 001238 425 GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEIT 504 (1117)
Q Consensus 425 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 504 (1117)
+ + ..+..+++|++|++++|++.+..| ++.+++|++|++++|++++. ..+..+++|+.|++++|++++..+ +.
T Consensus 191 ~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~ 262 (466)
T 1o6v_A 191 D-I-SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS 262 (466)
T ss_dssp C-C-GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred C-C-hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence 3 2 235556666666666666655433 45555555555555555533 235555555555555555554332 55
Q ss_pred cCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEE
Q 001238 505 GCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLL 584 (1117)
Q Consensus 505 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 584 (1117)
.+++|++|++++|.+++..+ +..+++|+.|++++|+++++.+ +..+++|+.|
T Consensus 263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--------------------------~~~l~~L~~L 314 (466)
T 1o6v_A 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--------------------------ISNLKNLTYL 314 (466)
T ss_dssp TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--------------------------GGGCTTCSEE
T ss_pred cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--------------------------hcCCCCCCEE
Confidence 55555555555555554332 4444444444444444444332 4445555555
Q ss_pred eccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcchhhhcccceEEEeeccccc
Q 001238 585 DLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFS 664 (1117)
Q Consensus 585 ~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~l~~l~~L~~L~ls~N~l~ 664 (1117)
+|++|++++..| +..++++ +.|++++|++++. ..+..+++|+.|++++|++++.+| +..+++|+.|++++|+++
T Consensus 315 ~L~~n~l~~~~~--~~~l~~L-~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 315 TLYFNNISDISP--VSSLTKL-QRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTC-CEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEE
T ss_pred ECcCCcCCCchh--hccCccC-CEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCccc
Confidence 555555554333 3444444 4555555555543 356677788888888888877666 777888888888888887
Q ss_pred CC
Q 001238 665 GR 666 (1117)
Q Consensus 665 ~~ 666 (1117)
+.
T Consensus 389 ~~ 390 (466)
T 1o6v_A 389 NA 390 (466)
T ss_dssp CC
T ss_pred CC
Confidence 63
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=349.74 Aligned_cols=269 Identities=21% Similarity=0.343 Sum_probs=200.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.+.||+|+||.||+|.. .+|+.||||+++... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35789999999999999999975 578999999997532 33345788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 851 YDYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
|||+++++|.+++.... ....+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986521 123489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... .......||+.|+|||++....++.++||||||+++|||++|+.||..... ............. .+
T Consensus 188 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~-~~--- 256 (310)
T 2wqm_A 188 SKT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEQCD-YP--- 256 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---CHHHHHHHHHTTC-SC---
T ss_pred CCC----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---hHHHHHHHhhccc-CC---
Confidence 321 122345789999999999999999999999999999999999999965322 2222222222211 11
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSE 1065 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~~~~~ 1065 (1117)
+......+..+.+++.. |++.||++||++.++++.++++....++..+
T Consensus 257 --~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 257 --PLPSDHYSEELRQLVNM------CINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp --CCCTTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred --CCcccccCHHHHHHHHH------HcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 11112334455665555 9999999999999999999999876554433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=345.41 Aligned_cols=260 Identities=25% Similarity=0.275 Sum_probs=196.6
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-----ccchHHHHHHHHHHhccC---CCCcceEEeeeecC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-----KISTGAFSSEIATLSRIR---HRNIVRLLGWGANR 844 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 844 (1117)
..++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356899999999999999999985 568999999987432 122346778888887775 99999999998776
Q ss_pred C-----ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCccee
Q 001238 845 K-----TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 845 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
. ..++||||++ |+|.+++..... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 599999887543 3389999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHH
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ........+...
T Consensus 162 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~i~~~ 234 (308)
T 3g33_A 162 ADFGLARIYSYQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN--SEADQLGKIFDL 234 (308)
T ss_dssp CSCSCTTTSTTCC-----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS--SHHHHHHHHHHH
T ss_pred eeCccccccCCCc-----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHH
Confidence 9999998764321 234567999999999999999999999999999999999999999652 111222222222
Q ss_pred HhcCCCCc--c-------ccCc-------ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1000 LKSKKDPV--E-------VLDP-------KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1000 ~~~~~~~~--~-------~~~~-------~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
........ . ...+ ......+..+.+++. .|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~------~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL------EMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHH------HHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHH------HHhcCCCccCCCHHHHhc
Confidence 11110000 0 0000 011122333444444 499999999999999876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=357.84 Aligned_cols=246 Identities=24% Similarity=0.292 Sum_probs=192.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHH-HhccCCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIAT-LSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|++.+.||+|+||+||+|+.+ +++.||||+++... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357889999999999999999864 58899999997543 2233456667776 577899999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++... +.+++..++.++.||+.||+|||++ +|+||||||+||+++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999998764 3488999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+..........
T Consensus 191 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~~~~~~~i~~~~~----- 256 (373)
T 2r5t_A 191 EHN----STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----NTAEMYDNILNKPL----- 256 (373)
T ss_dssp CCC----CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-----BHHHHHHHHHHSCC-----
T ss_pred cCC----CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhccc-----
Confidence 321 2334568999999999999999999999999999999999999999642 22333333333221
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v 1049 (1117)
.++...+..+.++++. |++.||++||++.+.
T Consensus 257 ---~~~~~~~~~~~~li~~------lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 257 ---QLKPNITNSARHLLEG------LLQKDRTKRLGAKDD 287 (373)
T ss_dssp ---CCCSSSCHHHHHHHHH------HTCSSGGGSTTTTTT
T ss_pred ---CCCCCCCHHHHHHHHH------HcccCHHhCCCCCCC
Confidence 1223344456666655 999999999997543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.16 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=211.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.++|++.+.||+|+||+||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 457888999999999999999865 48899999997543 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 91 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 165 (288)
T ss_dssp CTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred CCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence 999999999976432 3489999999999999999999999 99999999999999999999999999998765322
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
........+|+.|+|||++....++.++||||+|+++|||++ |+.||... ........+. .... .
T Consensus 166 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~--~~~~~~~~~~----~~~~------~ 231 (288)
T 3kfa_A 166 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLE----KDYR------M 231 (288)
T ss_dssp --SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHH----TTCC------C
T ss_pred --cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHh----ccCC------C
Confidence 223344567889999999999999999999999999999999 99999653 2222222222 1111 1
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
..+...+..+.++++. |++.||++||++.++++.|+.+..+
T Consensus 232 ~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 232 ERPEGCPEKVYELMRA------CWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHH------HhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1223334455565555 9999999999999999999887653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=349.59 Aligned_cols=266 Identities=26% Similarity=0.401 Sum_probs=209.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-----CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCC--ce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-----PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRK--TK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~ 847 (1117)
.++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688999999999999999973 468999999998766656678999999999999999999999886654 78
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++++|.+++.... ..+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999997653 3489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCC----------CCChhHHHHHH
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASF----------PDGQHVIQWVR 997 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~----------~~~~~~~~~~~ 997 (1117)
...... .........++..|+|||.+.+..++.++||||||+++|||++|+.||.... .........+.
T Consensus 195 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 195 LPQDKE-YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CCSSCS-EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccccc-ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 654321 1122334567888999999998899999999999999999999999985320 01111111222
Q ss_pred HHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 998 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
..+..... ...+...+..+.++++. ||+.||++||++.++++.|+++++
T Consensus 274 ~~~~~~~~------~~~~~~~~~~l~~li~~------cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 274 ELLKNNGR------LPRPDGCPDEIYMIMTE------CWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHTTCC------CCCCTTCCHHHHHHHHH------HSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhcCCC------CCCCCcccHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHH
Confidence 22222211 11123334455555555 999999999999999999998864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=368.85 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=194.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.. .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35789999999999999999974 56899999999753 333445678899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
|||+++|+|.+++... +.+++..+..++.|+++||+|||+ + +|+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999998764 348999999999999999999998 7 99999999999999999999999999998643
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ..............
T Consensus 301 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~----- 366 (446)
T 4ejn_A 301 KDG----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILMEEI----- 366 (446)
T ss_dssp C---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC-----
T ss_pred CCC----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC-----CHHHHHHHHHhCCC-----
Confidence 321 2334568999999999999999999999999999999999999999642 22222333332221
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
.++...+..+.+++.. |++.||++|| ++.++++
T Consensus 367 ---~~p~~~~~~~~~li~~------~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ---RFPRTLGPEAKSLLSG------LLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CCCTTSCHHHHHHHHH------HTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCccCCHHHHHHHHH------HcccCHHHhCCCCCCCHHHHHh
Confidence 1223344456666655 9999999999 9999976
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=363.55 Aligned_cols=348 Identities=26% Similarity=0.394 Sum_probs=291.9
Q ss_pred ccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCE
Q 001238 240 GLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSI 319 (1117)
Q Consensus 240 ~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 319 (1117)
..+++++.|++.++.+.. +| .+..+++|++|+|++|.+++.. . +.++++|++|++++|.+.+..+ +.++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~-~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDIT-P-LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCch-h-hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 457899999999998865 44 4889999999999999999654 4 9999999999999999996654 999999999
Q ss_pred EEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccc
Q 001238 320 IDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRL 399 (1117)
Q Consensus 320 LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 399 (1117)
|++++|.+++. +. +.++++|++|++++|.+++ ++ .+..+++|++|+++ |.+.+.. .+.++++|+.|++++|++
T Consensus 117 L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l 189 (466)
T 1o6v_A 117 LTLFNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKV 189 (466)
T ss_dssp EECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcC
Confidence 99999999965 43 8999999999999999985 34 48999999999997 5666443 389999999999999999
Q ss_pred cccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCc
Q 001238 400 EGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEI 479 (1117)
Q Consensus 400 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 479 (1117)
++. ..+..+++|++|++++|.+++..| +..+++|++|++++|++++. ..+..+++|+.|++++|++++..+ +
T Consensus 190 ~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~ 261 (466)
T 1o6v_A 190 SDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--L 261 (466)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred CCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--h
Confidence 854 348899999999999999997555 77899999999999999865 478899999999999999997755 8
Q ss_pred CCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccE
Q 001238 480 GNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTK 559 (1117)
Q Consensus 480 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~ 559 (1117)
..+++|++|++++|++++..+ +..+++|++|++++|++++..+ +..+++|+.|++++|+++++.+ +..+++|+.
T Consensus 262 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 335 (466)
T 1o6v_A 262 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 335 (466)
T ss_dssp TTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCE
T ss_pred hcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCE
Confidence 999999999999999997544 8899999999999999998655 7888999999999998887755 677778888
Q ss_pred EeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCcc
Q 001238 560 LVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNE 639 (1117)
Q Consensus 560 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~ 639 (1117)
|++++|++++. ..+..+++|+.|++++|++++.+| +..+++|+.|++++|+
T Consensus 336 L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~---------------------------~~~l~~L~~L~l~~n~ 386 (466)
T 1o6v_A 336 LFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP---------------------------LANLTRITQLGLNDQA 386 (466)
T ss_dssp EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG---------------------------GTTCTTCCEEECCCEE
T ss_pred eECCCCccCCc--hhhccCCCCCEEeCCCCccCccch---------------------------hhcCCCCCEEeccCCc
Confidence 88888877754 356677777777777777764443 4455666677777777
Q ss_pred ccCC
Q 001238 640 LSGD 643 (1117)
Q Consensus 640 l~~~ 643 (1117)
+++.
T Consensus 387 ~~~~ 390 (466)
T 1o6v_A 387 WTNA 390 (466)
T ss_dssp EECC
T ss_pred ccCC
Confidence 6653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=349.28 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=209.4
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCCc-cchHHHHHHHHHHhcc-CCCCcceEEeeeecCC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDK-ISTGAFSSEIATLSRI-RHRNIVRLLGWGANRK 845 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 845 (1117)
..++|++.+.||+|+||+||+|++ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 456899999999999999999973 3578999999976432 2345788999999999 7999999999987755
Q ss_pred -ceEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE
Q 001238 846 -TKLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL 911 (1117)
Q Consensus 846 -~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill 911 (1117)
..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||++ +|+||||||+||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEE
Confidence 48999999999999999987532 12378999999999999999999999 99999999999999
Q ss_pred cCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCCh
Q 001238 912 GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ 990 (1117)
Q Consensus 912 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~ 990 (1117)
+.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~ 258 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DE 258 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SH
T ss_pred CCCCCEEECCCccccccccCcc--ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch-hH
Confidence 9999999999999987654321 123345578899999999999999999999999999999998 9999975322 22
Q ss_pred hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.....+ ..... ...+...+..+.+++.. |++.||++||++.++++.|+.+.+.
T Consensus 259 ~~~~~~----~~~~~------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 259 EFCRRL----KEGTR------MRAPDYTTPEMYQTMLD------CWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHHHHH----HHTCC------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHh----ccCcc------CCCCCCCCHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHhh
Confidence 222222 11111 11222334445555544 9999999999999999999988653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=341.27 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=200.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 45788999999999999999975 457899999986532 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999998764 3389999999999999999999999 999999999999999999999999999865433
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
. ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||... .............
T Consensus 162 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~------- 223 (279)
T 3fdn_A 162 S------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVE------- 223 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTC-------
T ss_pred c------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-----cHHHHHHHHHhCC-------
Confidence 2 223457899999999999999999999999999999999999999642 2222222222221
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
...+...+..+.++++. |++.||++||++.++++.
T Consensus 224 -~~~~~~~~~~~~~li~~------~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -FTFPDFVTEGARDLISR------LLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCCTTSCHHHHHHHHH------HCCSSGGGSCCHHHHHHC
T ss_pred -CCCCCcCCHHHHHHHHH------HhccChhhCCCHHHHhhC
Confidence 12233344456666655 999999999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=351.55 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=190.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc-chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI-STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||+|+||+||+|... +++.||||+++..... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999864 7899999998754321 222456799999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
++ |+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 97 58888887643 3489999999999999999999999 99999999999999999999999999998654321
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||... ........+...... +.....+
T Consensus 155 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~---~~~~~~~ 226 (324)
T 3mtl_A 155 ---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS--TVEEQLHFIFRILGT---PTEETWP 226 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCC---CCTTTST
T ss_pred ---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHHHhCC---CChHhch
Confidence 22334578999999999876 67899999999999999999999999652 112222222222211 1111111
Q ss_pred cc----------------------CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KL----------------------QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l----------------------~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.. ....+....+++ ..|++.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li------~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLL------TKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHH------HHHSCSSGGGSCCHHHHTT
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHH------HHHcCcCcccCCCHHHHhc
Confidence 10 011223334444 4599999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=352.47 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=198.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCc----EEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGL----TVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|++.+.||+|+||+||+|.+. +++ +||+|.+... .....+++.+|++++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57889999999999999999853 444 3577777543 3345678999999999999999999999988754 789
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++.... +.+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999997643 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... .......+. ....
T Consensus 169 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~~~----~~~~--- 237 (327)
T 3lzb_A 169 AEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE----KGER--- 237 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHH----TTCC---
T ss_pred Cccc--cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHH----cCCC---
Confidence 4321 122234457889999999999999999999999999999999 999997532 222222222 1111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
...+...+..+.++++. ||+.||++||++.++++.|+++...+
T Consensus 238 ---~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 238 ---LPQPPICTIDVYMIMRK------CWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ---CCCCTTBCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ---CCCCccCCHHHHHHHHH------HcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11122233445555554 99999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=369.36 Aligned_cols=253 Identities=20% Similarity=0.261 Sum_probs=205.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|++++++++|||||++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 35688889999999999999985 46999999999653 223345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||++||+|.+++..... ..+++..++.++.||+.||+|||++ +||||||||+||+++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999876542 3489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............
T Consensus 339 ~~-----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~i~~~~------- 405 (576)
T 2acx_A 339 GQ-----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERLVKEVP------- 405 (576)
T ss_dssp TC-----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHHHHHCC-------
T ss_pred Cc-----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHHhhccc-------
Confidence 21 1234589999999999999899999999999999999999999997532211 1122222222111
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
..++...+..+..+++. |++.||++|| +++|+++
T Consensus 406 -~~~p~~~s~~~~dLI~~------lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 -EEYSERFSPQARSLCSQ------LLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -CCCCTTSCHHHHHHHHH------HTCSSGGGSTTCSSSHHHHHHT
T ss_pred -ccCCccCCHHHHHHHHH------hccCCHHHcCCCCCCCHHHHHh
Confidence 12233445566666665 9999999999 7788865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=351.40 Aligned_cols=262 Identities=22% Similarity=0.348 Sum_probs=209.0
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCc
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 846 (1117)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ....++.+|++++++++||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 3567899999999999999998753 367899999975432 234568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCccee
Q 001238 847 KLLFYDYMPNGTLGMLLHDGEC-------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
.++||||+++|+|.+++..... ...+++..+++++.|+++||+|||++ +|+||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEE
Confidence 9999999999999999875321 13478999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHH
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
+|||+++....... ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||... ...+....
T Consensus 180 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~~ 252 (322)
T 1p4o_A 180 GDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----SNEQVLRF 252 (322)
T ss_dssp CCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CHHHHHHH
T ss_pred CcCccccccccccc--cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC-----CHHHHHHH
Confidence 99999986643211 122234467899999999999999999999999999999999 89998642 11222222
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
..... . +..+...+..+.+++.. |++.+|++||++.++++.|++...
T Consensus 253 ~~~~~-~------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 VMEGG-L------LDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHTTC-C------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHcCC-c------CCCCCCCCHHHHHHHHH------HcCCCcccCcCHHHHHHHHHHhhc
Confidence 22211 1 11123334455555555 999999999999999999988754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=347.30 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=204.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc------chHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI------STGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ..+++.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456899999999999999999854 6899999999764321 356799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC----cceecccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY----ESCLADFG 923 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~DfG 923 (1117)
++||||+++++|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999764 3489999999999999999999999 999999999999999887 79999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+.........
T Consensus 165 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANITSVS 234 (321)
T ss_dssp TCEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHTTC
T ss_pred cceecCccc-----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhcc
Confidence 998765422 223457999999999999999999999999999999999999999642 2222333322222
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.. .++......+..+.++++ .|++.||++||++.++++
T Consensus 235 ~~----~~~~~~~~~~~~~~~li~------~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 YD----FDEEFFSHTSELAKDFIR------KLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC----CCHHHHTTCCHHHHHHHH------TTSCSSTTTSCCHHHHHH
T ss_pred cc----cChhhhcccCHHHHHHHH------HHcCCChhhCcCHHHHhc
Confidence 11 112222333444555544 499999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=354.12 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=201.5
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCc--------cchHHHHHHHHHHhccCCCCcceEEeeee
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDK--------ISTGAFSSEIATLSRIRHRNIVRLLGWGA 842 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 842 (1117)
+...++|++.+.||+|+||+||+|. ..+++.||||+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3456789999999999999999997 45789999999976532 13346788999999999999999999999
Q ss_pred cCCceEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecc
Q 001238 843 NRKTKLLFYDYMPNG-TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 843 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
+.+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence 999999999999777 9999997653 489999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHH
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
||+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ..
T Consensus 174 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~ 237 (335)
T 3dls_A 174 FGSAAYLERGK-----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------TV 237 (335)
T ss_dssp CTTCEECCTTC-----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------GT
T ss_pred cccceECCCCC-----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------HH
Confidence 99998765422 2234679999999999988776 7899999999999999999999964110 00
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
... ...+...+..+.++++. |++.||++||++.++++.
T Consensus 238 ~~~--------~~~~~~~~~~l~~li~~------~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 EAA--------IHPPYLVSKELMSLVSG------LLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTC--------CCCSSCCCHHHHHHHHH------HTCSSGGGSCCHHHHHHC
T ss_pred hhc--------cCCCcccCHHHHHHHHH------HccCChhhCcCHHHHhcC
Confidence 000 01122234455555555 999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=373.76 Aligned_cols=258 Identities=27% Similarity=0.427 Sum_probs=208.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.++|++.+.||+|+||+||+|.+.++..||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 35688889999999999999998888889999998644 346789999999999999999999999876 6789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++.... ...+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 344 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--- 416 (535)
T 2h8h_A 344 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN--- 416 (535)
T ss_dssp TTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH---
T ss_pred cCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC---
Confidence 9999999997532 23489999999999999999999999 9999999999999999999999999999876421
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.........++..|+|||++....++.++|||||||++|||++ |+.||... ...+.+....... . ..
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~-----~~~~~~~~i~~~~-~------~~ 484 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERGY-R------MP 484 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC-----CHHHHHHHHHTTC-C------CC
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCC-C------CC
Confidence 1122334457889999999999999999999999999999999 99999642 1122222222211 1 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.+...+..+.+++.. ||+.||++||++.+|++.|+.+...
T Consensus 485 ~~~~~~~~l~~li~~------cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 485 CPPECPESLHDLMCQ------CWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCHHHHHHHHH------HcCCChhHCcCHHHHHHHHHHHhhc
Confidence 122334455555554 9999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=352.05 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=201.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||+||+|..+ +|+.||||++..... ...+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457899999999999999999754 689999999976533 345788998888 79999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC----Ccceeccccccccc
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER----YESCLADFGLARLV 928 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~----~~~kl~DfGla~~~ 928 (1117)
|+++|+|.+++... +.+++.++..++.||+.||+|||++ +|+||||||+||++.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999998764 3489999999999999999999999 99999999999998543 35999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
..... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.............
T Consensus 171 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~i~~~~~~~~- 243 (342)
T 2qr7_A 171 RAENG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILARIGSGKFSLS- 243 (342)
T ss_dssp BCTTC----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--SCHHHHHHHHHHCCCCCC-
T ss_pred cCCCC----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--CCHHHHHHHHccCCcccC-
Confidence 54321 23345789999999999888899999999999999999999999975322 223333333333222111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.......+..+.++++. |++.||++||++.++++
T Consensus 244 ---~~~~~~~s~~~~~li~~------~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 244 ---GGYWNSVSDTAKDLVSK------MLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---STTTTTSCHHHHHHHHH------HTCSSTTTSCCHHHHTT
T ss_pred ---ccccccCCHHHHHHHHH------HCCCChhHCcCHHHHhc
Confidence 11223344555666655 99999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=361.28 Aligned_cols=255 Identities=21% Similarity=0.227 Sum_probs=201.3
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
..++|++.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|.+++..++||||+++++++.+.+..|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 457899999999999999999986 469999999997532 2234468899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 139 VmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 999999999999997532 2489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhc-------cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYAN-------MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
... .......+||+.|+|||++. ...++.++|||||||++|||++|+.||... ...+........
T Consensus 214 ~~~---~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~ 285 (412)
T 2vd5_A 214 ADG---TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD-----STAETYGKIVHY 285 (412)
T ss_dssp TTS---CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTH
T ss_pred CCC---ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhc
Confidence 422 12234568999999999987 357899999999999999999999999642 112222222211
Q ss_pred CCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCC---CCHHHHHH
Q 001238 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDR---PTMKDVAA 1051 (1117)
Q Consensus 1003 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~R---Ps~~~v~~ 1051 (1117)
... ...|......+....++++. |+. +|++| |+++|+.+
T Consensus 286 ~~~---~~~p~~~~~~s~~~~dli~~------lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 286 KEH---LSLPLVDEGVPEEARDFIQR------LLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHH---CCCC----CCCHHHHHHHHT------TSS-CGGGCTTTTTHHHHHT
T ss_pred ccC---cCCCccccCCCHHHHHHHHH------HcC-ChhhcCCCCCHHHHhc
Confidence 100 00122223344556666655 998 89988 58888866
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=341.49 Aligned_cols=252 Identities=22% Similarity=0.382 Sum_probs=183.6
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
+...++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|++++++++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 34456799999999999999999985 579999999996532 22346789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++++|.+++.... ..+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 99999999999999998642 3489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
..... .......||+.|+|||.+....++.++||||||+++|||++|+.||....... .......
T Consensus 162 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~------ 226 (278)
T 3cok_A 162 LKMPH----EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----TLNKVVL------ 226 (278)
T ss_dssp CC--------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCS------
T ss_pred ccCCC----CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----HHHHHhh------
Confidence 64321 12234578999999999998899999999999999999999999997532211 1111000
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+...+...+..+.+++.. |++.||++||++.++++
T Consensus 227 --~~~~~~~~~~~~~~~li~~------~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 --ADYEMPSFLSIEAKDLIHQ------LLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --SCCCCCTTSCHHHHHHHHH------HSCSSGGGSCCHHHHTT
T ss_pred --cccCCccccCHHHHHHHHH------HcccCHhhCCCHHHHhc
Confidence 0112233344455555554 99999999999999876
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=356.46 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=196.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccC--CCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIR--HRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv~ 851 (1117)
+.|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4699999999999999999998889999999997543 334567899999999996 599999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
| +.+++|.+++.... .+++.++..++.||++||+|||++ +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999998653 488999999999999999999999 999999999999996 589999999999876532
Q ss_pred CCCccccCCccccccccCChhhhcc-----------CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHH
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANM-----------TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
.. .......+||+.|+|||++.. ..++.++|||||||++|||++|+.||.... .....+....
T Consensus 208 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~~~~~~~~~ 281 (390)
T 2zmd_A 208 TT--SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----NQISKLHAII 281 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC----CHHHHHHHHH
T ss_pred Cc--cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh----HHHHHHHHHh
Confidence 21 112345679999999999865 468899999999999999999999996422 1122233322
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
..... ...+...+..+.+++.. |++.||++||++.++++.
T Consensus 282 ~~~~~------~~~~~~~~~~~~~li~~------~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNHE------IEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTSC------CCCCCCSCHHHHHHHHH------HTCSSTTTSCCHHHHHTS
T ss_pred Ccccc------CCCCccchHHHHHHHHH------HcccChhhCCCHHHHhhC
Confidence 22111 11223334455555554 999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=354.88 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=189.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeee--------cC
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGA--------NR 844 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~--------~~ 844 (1117)
..+|++.++||+|+||.||+|.+ .+++.||||++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35788999999999999999985 478999999997766666678899999999996 999999999883 33
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eeeeccccCeEEEcCCCcceeccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA--ILHRDVKSHNILLGERYESCLADF 922 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~~~~~~kl~Df 922 (1117)
...++||||+. |+|.+++......+.+++.+++.++.|++.||+|||++ + |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 45789999995 78988887543345599999999999999999999998 7 999999999999999999999999
Q ss_pred cccccccCCCCCcc--------ccCCccccccccCChhhh---ccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChh
Q 001238 923 GLARLVEDDSGGSF--------SANPQFAGSYGYIAPEYA---NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQH 991 (1117)
Q Consensus 923 Gla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~ 991 (1117)
|+++.......... .......||+.|+|||++ ....++.++||||||+++|||++|+.||.....
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---- 258 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK---- 258 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH----
Confidence 99987654322110 111245699999999998 567789999999999999999999999964211
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
...... ... ..........+.++++. |++.||++||++.++++.|+.+...
T Consensus 259 -~~~~~~----~~~------~~~~~~~~~~~~~li~~------~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 259 -LRIVNG----KYS------IPPHDTQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ------------CC------CCTTCCSSGGGHHHHHH------HSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHhhcC----ccc------CCcccccchHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111 100 01112223345555555 9999999999999999999988754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=345.59 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=197.1
Q ss_pred ccCCCCC-CeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAG-NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.+.|++. +.||+|+||+||+|.. .+++.||||++........+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3467774 7899999999999985 46899999999876666677899999999985 7999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc---ceeccccccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE---SCLADFGLARLV 928 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~DfGla~~~ 928 (1117)
||+++|+|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999764 3489999999999999999999999 9999999999999998776 899999999866
Q ss_pred cCCCCC---ccccCCccccccccCChhhhcc-----CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCCh---------h
Q 001238 929 EDDSGG---SFSANPQFAGSYGYIAPEYANM-----TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ---------H 991 (1117)
Q Consensus 929 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~---------~ 991 (1117)
...... .........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+. .
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 432111 1112234569999999999875 5688999999999999999999999976432210 0
Q ss_pred -HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 992 -VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 992 -~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
................. ......+..+.++++. |++.||++||++.|+++
T Consensus 245 ~~~~~~~~i~~~~~~~~~----~~~~~~~~~~~~li~~------~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPD----KDWAHISCAAKDLISK------LLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCCCCCH----HHHTTSCHHHHHHHHH------HSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCcccCc----hhcccCCHHHHHHHHH------HhhCChhhCCCHHHHhc
Confidence 11122222222211111 0111233445555554 99999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=345.67 Aligned_cols=264 Identities=23% Similarity=0.331 Sum_probs=205.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-C---CcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCce-EE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-S---GLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK-LL 849 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~l 849 (1117)
..|...++||+|+||+||+|.+. + +..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35667789999999999999742 2 33799999875432 3456789999999999999999999999876655 99
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+.+|+|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999998643 3489999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
..............+|+.|+|||.+.+..++.++||||||+++|||++|..|+.... ........+. ... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~---~~~-~---- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLA---QGR-R---- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHH---TTC-C----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhh---cCC-C----
Confidence 432212223345678999999999999999999999999999999999655543211 1222222221 111 1
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
...+...+..+.++++. |++.+|++||++.++++.|+++.....
T Consensus 247 --~~~~~~~~~~l~~li~~------~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 247 --LPQPEYCPDSLYQVMQQ------CWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp --CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred --CCCCccchHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11122334455555554 999999999999999999999876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=340.85 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=203.2
Q ss_pred cCCCCCC-eeeecCCeEEEEEEc---CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 776 RSLTAGN-IIGQGRSGIVYKVTL---PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 776 ~~~~~~~-~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
++|++.+ .||+|+||+||+|.+ .+++.||||+++... ....+++.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4677777 999999999999953 347899999997543 22356799999999999999999999998 5677899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++++|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999764 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... .........+|+.|+|||++....++.++||||||+++|||++ |+.||... ....... .+.....
T Consensus 169 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~----~~~~~~~--- 238 (291)
T 1xbb_A 169 ADEN-YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTA----MLEKGER--- 238 (291)
T ss_dssp TTCS-EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHH----HHHTTCC---
T ss_pred cCCC-cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHH----HHHcCCC---
Confidence 4321 1122233456789999999998899999999999999999999 99999652 1112222 2222111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
+..+...+..+.++++. ||+.||++||++.++++.|+++...
T Consensus 239 ---~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 239 ---MGCPAGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ---CCCCTTCCHHHHHHHHH------HTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHHH
Confidence 12233444556666655 9999999999999999999987543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=340.64 Aligned_cols=251 Identities=22% Similarity=0.400 Sum_probs=204.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeec----------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN---------- 843 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------- 843 (1117)
..+|++.+.||+|+||.||+|... +|+.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356889999999999999999865 79999999997643 467899999999999999999998754
Q ss_pred ------CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcc
Q 001238 844 ------RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917 (1117)
Q Consensus 844 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 917 (1117)
....++||||+++|+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 345789999999999999997543 23489999999999999999999999 99999999999999999999
Q ss_pred eeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHH
Q 001238 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997 (1117)
Q Consensus 918 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~ 997 (1117)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..|+.. ......
T Consensus 162 kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-------~~~~~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------TSKFFT 229 (284)
T ss_dssp EECCCTTCEESSCCS-----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-------HHHHHH
T ss_pred EECcchhheeccccc-----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-------HHHHHH
Confidence 999999998765432 22345699999999999999999999999999999999999988742 111111
Q ss_pred HHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 998 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
.. ... .++...+..+.++++. |++.||++||++.++++.++.+.+.+.
T Consensus 230 ~~-~~~---------~~~~~~~~~~~~li~~------~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 230 DL-RDG---------IISDIFDKKEKTLLQK------LLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HH-HTT---------CCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred Hh-hcc---------cccccCCHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11 111 1223334455555554 999999999999999999999876544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.60 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=208.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEee-eecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGW-GANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~-~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... .+++.+|+++++.++|++++..+.+ +...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46799999999999999999985 6799999999876433 3568999999999998876665554 466677899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE---cCCCcceecccccccccc
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL---GERYESCLADFGLARLVE 929 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGla~~~~ 929 (1117)
|+ +++|.+++.... +.+++.++..++.|+++||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 999999997432 3489999999999999999999999 99999999999999 488899999999998776
Q ss_pred CCCCCc---cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCC-ChhHHHHHHHHHhcCCC
Q 001238 930 DDSGGS---FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD-GQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 930 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~-~~~~~~~~~~~~~~~~~ 1005 (1117)
...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 237 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-- 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS--
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC--
Confidence 533211 11234568999999999999999999999999999999999999999764322 122222222211111
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
+.. .+....+..+.++++. |++.||++||++.++++.|+++.....
T Consensus 238 ~~~----~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 238 PIE----VLCKGYPSEFATYLNF------CRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp CHH----HHTTTSCHHHHHHHHH------HHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred chH----HHHhhCCHHHHHHHHH------HHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 111 1122334455555555 999999999999999999999876544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=341.65 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=204.9
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEee-eecCCceEEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGW-GANRKTKLLFY 851 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~-~~~~~~~~lv~ 851 (1117)
..++|++.+.||+|+||+||+|.. .+++.||||++..... .+++.+|+++++.++|++++..+.+ +...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346899999999999999999985 5789999998765432 3468899999999998877666654 46677889999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE---cCCCcceeccccccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL---GERYESCLADFGLARLV 928 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGla~~~ 928 (1117)
||+ +++|.+++.... +.+++.++..++.|+++||+|||++ +|+||||||+||++ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999987532 3489999999999999999999999 99999999999999 78899999999999877
Q ss_pred cCCCCCc---cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCC-hhH-HHHHHHHHhcC
Q 001238 929 EDDSGGS---FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG-QHV-IQWVRDHLKSK 1003 (1117)
Q Consensus 929 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~-~~~-~~~~~~~~~~~ 1003 (1117)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST- 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-
Confidence 6543211 123345689999999999999999999999999999999999999997643221 122 2222221111
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
+.. ......+..+.++++. |++.||++||++.++++.|+++.....
T Consensus 238 --~~~----~~~~~~~~~l~~li~~------~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 238 --PIE----VLCKGYPSEFATYLNF------CRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp --CHH----HHTTTSCHHHHHHHHH------HHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred --hhh----hhhccCCHHHHHHHHH------HHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 111 1122334455565555 999999999999999999998876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=353.14 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=204.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeee----cCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA----NRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~~~~~~l 849 (1117)
.++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999985 578999999997766666778999999999999999999999886 3346789
Q ss_pred EEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
||||+++|+|.+++... .....+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988752 1234589999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCc-----cccCCccccccccCChhhhccCC---CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHH
Q 001238 929 EDDSGGS-----FSANPQFAGSYGYIAPEYANMTK---ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 929 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
....... ........||+.|+|||++.... ++.++||||||+++|||++|+.||.............+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--- 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--- 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh---
Confidence 3211110 00112345799999999987543 689999999999999999999999532111222222111
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
..... ......+..+.+++.. |++.||++||++.++++.|+.+..
T Consensus 262 -~~~~~------~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 -NQLSI------PQSPRHSSALWQLLNS------MMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -CC--C------CCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -ccCCC------CccccCCHHHHHHHHH------HhhcChhhCCCHHHHHHHhhhcCC
Confidence 11000 1112233455555555 999999999999999999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=365.11 Aligned_cols=254 Identities=19% Similarity=0.255 Sum_probs=205.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|.+.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999864 69999999997532 233467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 852 DYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
||++||+|.+++.... ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987643 233589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...............
T Consensus 342 ~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~i~~~~~------ 410 (543)
T 3c4z_A 342 GQ----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAV------ 410 (543)
T ss_dssp TC----CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHHHHHCCC------
T ss_pred CC----cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHHHhhccc------
Confidence 32 1223458999999999999999999999999999999999999999753221 122333333333221
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH-----HHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM-----KDVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~-----~~v~~ 1051 (1117)
.++...+..+..+++. |++.||++||++ .++.+
T Consensus 411 --~~p~~~s~~~~~li~~------lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 --TYPDKFSPASKDFCEA------LLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCCTTSCHHHHHHHHH------HSCSSGGGSCCCBTTBSHHHHT
T ss_pred --CCCcccCHHHHHHHHH------hccCCHhHCCCCcccCHHHHHc
Confidence 2233445566666665 999999999975 55554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=341.05 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=195.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|.+.+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35788999999999999999975 468999999987643 3346789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE---cCCCcceeccccccccc
Q 001238 853 YMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL---GERYESCLADFGLARLV 928 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGla~~~ 928 (1117)
|+++|+|.+++.... ....+++..+..++.|+++||+|||++ +|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999886431 123489999999999999999999999 99999999999999 45678999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... ......||+.|+|||++. ..++.++||||+|+++|||++|+.||... ..................
T Consensus 178 ~~~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~-----~~~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 178 KSDE-----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT-----SLEEVQQKATYKEPNYAV 246 (285)
T ss_dssp --------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCCCC
T ss_pred CCcc-----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC-----CHHHHHhhhccCCccccc
Confidence 4321 233457999999999886 57899999999999999999999999642 122222222222111110
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.....+..+.++++. |++.||++||++.|+++
T Consensus 247 -----~~~~~~~~~~~li~~------~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 -----ECRPLTPQAVDLLKQ------MLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -------CCCCHHHHHHHHH------HTCSCTTTSCCHHHHHT
T ss_pred -----ccCcCCHHHHHHHHH------HccCChhhCcCHHHHhc
Confidence 011123345555554 99999999999999976
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.40 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=204.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc------cchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK------ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
++|++.+.||+|+||+||+|... +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999865 689999999875422 23567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC----cceeccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY----ESCLADFGL 924 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~DfGl 924 (1117)
+||||+++++|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999753 3489999999999999999999999 999999999999999877 899999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
++...... ......||+.|+|||++....++.++||||||+++|||++|+.||... ..............
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~ 228 (283)
T 3bhy_A 159 AHKIEAGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE-----TKQETLTNISAVNY 228 (283)
T ss_dssp CEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTCC
T ss_pred ceeccCCC-----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc-----chHHHHHHhHhccc
Confidence 98764321 223456899999999999899999999999999999999999999642 11222222222211
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH--HHHhhhcC
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA--LLREIRQE 1059 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~--~L~~~~~~ 1059 (1117)
.. .+......+..+.++++ .|++.||++||++.++++ .++.++..
T Consensus 229 ~~----~~~~~~~~~~~~~~li~------~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 229 DF----DEEYFSNTSELAKDFIR------RLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp CC----CHHHHTTCCHHHHHHHH------TTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred CC----cchhcccCCHHHHHHHH------HHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 11 11122233344455444 499999999999999988 55666544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=364.41 Aligned_cols=322 Identities=21% Similarity=0.184 Sum_probs=281.3
Q ss_pred cEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccc
Q 001238 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVN 349 (1117)
Q Consensus 270 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N 349 (1117)
+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 56777777777 5666554 57888888888888777778888888888888888888777888888888888888888
Q ss_pred cccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcc
Q 001238 350 QISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPR 429 (1117)
Q Consensus 350 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 429 (1117)
++++..+..|.++++|++|+|++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 88866666778888888888888888877788888888888888888888888888888999999999999999876666
Q ss_pred cccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCC
Q 001238 430 GIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNL 509 (1117)
Q Consensus 430 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 509 (1117)
.+..+++|+.|++++|++.+..+..|..+++|++|++++|.+.+.+|..+....+|+.|+|++|++++..+..|..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 78889999999999999998888899999999999999998888888777777899999999999996666789999999
Q ss_pred ceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecccc
Q 001238 510 TFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSN 589 (1117)
Q Consensus 510 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 589 (1117)
++|+|++|.|++..+..|..+++|+.|++++|+++++.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 99999999999988888999999999999999999999999999999999999999999888889999999999999999
Q ss_pred ccccc
Q 001238 590 QLSGN 594 (1117)
Q Consensus 590 ~l~~~ 594 (1117)
.++..
T Consensus 331 ~l~c~ 335 (477)
T 2id5_A 331 PLACD 335 (477)
T ss_dssp CEECS
T ss_pred CccCc
Confidence 99854
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.59 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=202.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46799999999999999999975 468999999997543 233467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc---ceeccccccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE---SCLADFGLARLV 928 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~DfGla~~~ 928 (1117)
||+++++|.+.+... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999998888754 3489999999999999999999999 9999999999999987655 999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||... ..................
T Consensus 159 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 159 NDSE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHRLYAQIKAGAYDYPS 228 (284)
T ss_dssp CSSC-----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCCCCT
T ss_pred ccCc-----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC-----chhHHHHHHHhccccCCc
Confidence 5322 233467999999999999999999999999999999999999999642 112222222222211111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
+. ....+..+.++++. |++.||++||++.++++.
T Consensus 229 ---~~-~~~~~~~~~~li~~------~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 ---PE-WDTVTPEAKSLIDS------MLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---TT-TTTSCHHHHHHHHH------HSCSSTTTSCCHHHHTTS
T ss_pred ---hh-hcccCHHHHHHHHH------HcccChhhCCCHHHHhcC
Confidence 11 12233455555555 999999999999999883
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=345.56 Aligned_cols=244 Identities=23% Similarity=0.264 Sum_probs=191.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.++||+|+||+||+|... +|+.||||++..... ....++..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999865 799999999865432 2233455566666555 8999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+ +++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 678888876543 3489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. ......||++|+|||++.+ .++.++|||||||++|||++|..|+.. ..... . +.... ..
T Consensus 211 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~-----~~~~~---~-~~~~~-----~~ 270 (311)
T 3p1a_A 211 G-----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG-----GEGWQ---Q-LRQGY-----LP 270 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS-----HHHHH---H-HTTTC-----CC
T ss_pred C-----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC-----ccHHH---H-HhccC-----CC
Confidence 1 2334569999999998875 799999999999999999999776642 11111 1 11111 11
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.+....+..+.+++.. |++.||++||++.++++
T Consensus 271 ~~~~~~~~~~l~~li~~------~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 PEFTAGLSSELRSVLVM------MLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHTTSCHHHHHHHHH------HSCSSTTTSCCHHHHHT
T ss_pred cccccCCCHHHHHHHHH------HcCCChhhCcCHHHHHh
Confidence 22233344555555555 99999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=351.23 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=198.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc---chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
+.|+..+.||+|+||+||+|.. .+|+.||||++...... ..+++.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999984 57899999999754322 2356889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||++ |++.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 67877775432 3489999999999999999999999 999999999999999999999999999986542
Q ss_pred CCCccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||... .....+..........
T Consensus 207 -------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~-----~~~~~~~~~~~~~~~~-- 272 (348)
T 1u5q_A 207 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNESPA-- 272 (348)
T ss_dssp -------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSCCCC--
T ss_pred -------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCC--
Confidence 22457999999999884 567899999999999999999999999642 1122222222222111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
......+..+.+++.. ||+.||++||++.++++..
T Consensus 273 ----~~~~~~~~~l~~li~~------~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 273 ----LQSGHWSEYFRNFVDS------CLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp ----CCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHTTCH
T ss_pred ----CCCCCCCHHHHHHHHH------HcccChhhCcCHHHHhhCh
Confidence 1122334455665555 9999999999999998743
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=339.21 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=202.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|++.+.||+|+||+||+|.+. ++..||+|++.... ....+++.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 457888999999999999999743 23469999987652 3345678999999999999999999998765 45689
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++++|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999997642 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.... .......+|+.|+|||++....++.++||||||+++|||++ |+.||... ........+.. .. .
T Consensus 165 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~--~~~~~~~~~~~---~~-~--- 232 (281)
T 3cc6_A 165 DEDY---YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIGVLEK---GD-R--- 232 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CGGGHHHHHHH---TC-C---
T ss_pred cccc---cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC--ChHHHHHHHhc---CC-C---
Confidence 4221 12234467889999999998999999999999999999998 99999642 22222222221 11 1
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
...+...+..+.+++.. |++.||++||++.++++.|+++.+
T Consensus 233 ---~~~~~~~~~~l~~li~~------~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 233 ---LPKPDLCPPVLYTLMTR------CWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHH------HccCCchhCcCHHHHHHHHHHHHH
Confidence 11122334455555555 999999999999999999988754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=347.31 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=204.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457889999999999999999864 58899999987542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988754 3489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...+..........
T Consensus 194 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~------ 258 (335)
T 2owb_A 194 DG----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----CLKETYLRIKKNEY------ 258 (335)
T ss_dssp TT----CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCC------
T ss_pred Cc----ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC-----CHHHHHHHHhcCCC------
Confidence 22 1233457999999999999999999999999999999999999999642 12222222222211
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.++...+..+.++++. |++.||++||++.++++.
T Consensus 259 --~~~~~~~~~~~~li~~------~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 --SIPKHINPVAASLIQK------MLQTDPTARPTINELLND 292 (335)
T ss_dssp --CCCTTSCHHHHHHHHH------HTCSSGGGSCCGGGGGGS
T ss_pred --CCCccCCHHHHHHHHH------HccCChhHCcCHHHHhcC
Confidence 1223344455555555 999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=339.35 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=199.3
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
.|.....||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455566899999999999985 5688999999987666666789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-CCcceeccccccccccCCCCC
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-RYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-~~~~kl~DfGla~~~~~~~~~ 934 (1117)
+++|.+++........+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999998754334477899999999999999999999 9999999999999987 8999999999998764321
Q ss_pred ccccCCccccccccCChhhhccCC--CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTK--ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.......||+.|+|||++.... ++.++||||||+++|||++|+.||..... .. .......... ..+
T Consensus 178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~-~~~~~~~~~~-------~~~ 245 (295)
T 2clq_A 178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE--PQ-AAMFKVGMFK-------VHP 245 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS--HH-HHHHHHHHHC-------CCC
T ss_pred --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc--hh-HHHHhhcccc-------ccc
Confidence 1233457899999999987643 88999999999999999999999964211 11 1111111111 112
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++...+..+.+++.. |++.||++||++.++++
T Consensus 246 ~~~~~~~~~~~~li~~------~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 EIPESMSAEAKAFILK------CFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCTTSCHHHHHHHHH------TTCSSTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHH------HccCChhhCCCHHHHhc
Confidence 3334445556665555 99999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=348.48 Aligned_cols=263 Identities=26% Similarity=0.413 Sum_probs=196.3
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCc-
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT- 846 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~- 846 (1117)
..++|.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3567899999999999999999743 35589999987542 2334678999999999999999999999877553
Q ss_pred ----eEEEEEecCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCccee
Q 001238 847 ----KLLFYDYMPNGTLGMLLHDG---ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCL 919 (1117)
Q Consensus 847 ----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl 919 (1117)
.++||||+++|+|.+++... .....+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 49999999999999998432 1234589999999999999999999999 9999999999999999999999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHH
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
+|||+++...... .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......
T Consensus 189 ~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~--- 261 (313)
T 3brb_A 189 ADFGLSKKIYSGD--YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ--NHEMYDY--- 261 (313)
T ss_dssp CSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHH---
T ss_pred eecCcceeccccc--ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC--HHHHHHH---
Confidence 9999998765422 1122334567889999999999999999999999999999999 899986532 1222222
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
...... +..+...+..+.+++.. |++.+|++||++.++++.|+++.+.
T Consensus 262 ~~~~~~-------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 262 LLHGHR-------LKQPEDCLDELYEIMYS------CWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHTTCC-------CCCBTTCCHHHHHHHHH------TTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCC-------CCCCccccHHHHHHHHH------HcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111111 11223334455555554 9999999999999999999988653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=373.73 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=197.8
Q ss_pred eeeecCCeEEEEEEcC---CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCCCC
Q 001238 783 IIGQGRSGIVYKVTLP---SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGT 858 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs 858 (1117)
.||+|+||+||+|.+. ++..||||+++... ....++|.+|++++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999753 46789999997643 3356789999999999999999999999876 56899999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcccc
Q 001238 859 LGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSA 938 (1117)
Q Consensus 859 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 938 (1117)
|.+++.... ..+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 422 L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTA 495 (613)
T ss_dssp HHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc-eeee
Confidence 999997542 4489999999999999999999999 999999999999999999999999999987653321 1122
Q ss_pred CCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCC
Q 001238 939 NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017 (1117)
Q Consensus 939 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1017 (1117)
.....+|+.|+|||++....++.++|||||||++|||++ |+.||... ....+...+. .... ...+..
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~~i~----~~~~------~~~p~~ 563 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIE----QGKR------MECPPE 563 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CSHHHHHHHH----TTCC------CCCCTT
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHH----cCCC------CCCCCc
Confidence 223346789999999999999999999999999999998 99999753 2222222222 1111 112233
Q ss_pred CchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1018 ~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.+..+.+++.. ||+.+|++||++.+|++.|+.+...
T Consensus 564 ~~~~l~~li~~------cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 564 CPPELYALMSD------CWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CCHHHHHHHHH------TTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHH------HcCCChhHCcCHHHHHHHHHHHHHH
Confidence 44455555554 9999999999999999999887543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=349.11 Aligned_cols=264 Identities=24% Similarity=0.348 Sum_probs=205.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
.++|++.+.||+|+||.||+|.+ .+++.||||++... ......++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45799999999999999999974 35779999999644 233455788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceec
Q 001238 848 LLFYDYMPNGTLGMLLHDGEC----AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLA 920 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~ 920 (1117)
++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||++ +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986432 13488999999999999999999999 9999999999999994 4469999
Q ss_pred cccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHH
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
|||+++....... ........||+.|+|||++....++.++||||||+++|||++ |+.||... . ........
T Consensus 186 Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~---~~~~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--S---NQEVLEFV 258 (327)
T ss_dssp CCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--C---HHHHHHHH
T ss_pred ccccccccccccc--cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--C---HHHHHHHH
Confidence 9999986543221 122334568999999999998999999999999999999998 99999642 1 12222222
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
.... . +..+...+..+.+++.. |++.||++||++.++++.++.+...+.
T Consensus 259 ~~~~-~------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 259 TSGG-R------MDPPKNCPGPVYRIMTQ------CWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HTTC-C------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred hcCC-C------CCCCCCCCHHHHHHHHH------HhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 2211 1 11223334455555555 999999999999999999998876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=365.51 Aligned_cols=196 Identities=23% Similarity=0.308 Sum_probs=164.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecC------C
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR------K 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 845 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||++... .....+++.+|+++++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999974 46899999999754 333456788999999999999999999998655 3
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..|+||||++++ +.+.+... +++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~~-----l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTSC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999765 55555432 88999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+..... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+
T Consensus 212 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 212 RTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp -----C-----CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecCCC-----cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 876432 123456899999999999999999999999999999999999999965
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=348.24 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=178.6
Q ss_pred CCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEEecCCCC
Q 001238 781 GNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYDYMPNGT 858 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs 858 (1117)
.+.||+|+||+||+|.. .+++.||||++... ....+.+|+++++.+. ||||+++++++.+.+..|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 57899999999999985 46899999999753 3467889999999997 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC---cceeccccccccccCCCCCc
Q 001238 859 LGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY---ESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 859 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~DfGla~~~~~~~~~~ 935 (1117)
|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|||+++......
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--- 163 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--- 163 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC---
Confidence 99999764 3489999999999999999999999 999999999999998765 89999999998654322
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCC--ChhHHHHHHHHHhcCCCCccccCcc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPD--GQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+............. ..
T Consensus 164 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~----~~ 238 (325)
T 3kn6_A 164 -QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE----GE 238 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC----SH
T ss_pred -CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC----cc
Confidence 2233457899999999999999999999999999999999999999753221 1222333333322221111 11
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.....+..+.++++. |++.||++||+++++++
T Consensus 239 ~~~~~s~~~~~li~~------~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQG------LLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHH------HHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHH------HCCCChhHCCCHHHHhc
Confidence 111223345555554 99999999999998865
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=353.04 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=201.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEc----CCCcEEEEEEeecCC----ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCc
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL----PSGLTVAVKRFRASD----KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKT 846 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 846 (1117)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788999999999999999986 478999999986432 23345678899999999 69999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.++||||+++|+|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999764 2489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 208 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~- 282 (355)
T 1vzo_A 208 EFVADE---TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE- 282 (355)
T ss_dssp ECCGGG---GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHCC-
T ss_pred ecccCC---CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHHHHHHHHhccC-
Confidence 664321 122345679999999999875 45789999999999999999999999753222 22333333333322
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHHH
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAAL 1052 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~~ 1052 (1117)
+.++...+..+.+++.. |++.||++|| ++.++++.
T Consensus 283 -------~~~~~~~~~~~~~li~~------~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 -------PPYPQEMSALAKDLIQR------LLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -------CCCCTTSCHHHHHHHHH------HTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------CCCCcccCHHHHHHHHH------HhhhCHHHhcCCCCCCHHHHHcC
Confidence 12233344455555555 9999999999 89998774
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.95 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=203.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457889999999999999999864 58899999987542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988754 3489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||... ...+.........
T Consensus 168 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~------- 231 (294)
T 2rku_A 168 DG----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-----CLKETYLRIKKNE------- 231 (294)
T ss_dssp TT----CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTC-------
T ss_pred Cc----cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhhcc-------
Confidence 22 1233457899999999999889999999999999999999999999642 1222222222221
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
..++...+..+.++++. |++.||++||++.++++.
T Consensus 232 -~~~~~~~~~~~~~li~~------~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 -YSIPKHINPVAASLIQK------MLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCCTTSCHHHHHHHHH------HTCSSGGGSCCGGGGGGS
T ss_pred -CCCccccCHHHHHHHHH------HcccChhhCcCHHHHhhC
Confidence 11223334455555555 999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=346.15 Aligned_cols=256 Identities=20% Similarity=0.294 Sum_probs=200.2
Q ss_pred HHhccCCCCC-CeeeecCCeEEEEEEcC-CCcEEEEEEeecC--CccchHHHHHHHHHHhccC-CCCcceEEeeeecCCc
Q 001238 772 GDATRSLTAG-NIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS--DKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKT 846 (1117)
Q Consensus 772 ~~~~~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 846 (1117)
....++|.+. +.||+|+||+||+|... +|+.||+|+++.. .......+.+|++++++++ ||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445567776 88999999999999754 6899999998753 2334567899999999994 6999999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceecccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLADFG 923 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfG 923 (1117)
.++||||+++|+|.+++.... .+.+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999986543 24589999999999999999999999 9999999999999998 7899999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
+++...... ......||+.|+|||++....++.++||||||+++|||++|+.||... .............
T Consensus 180 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~ 249 (327)
T 3lm5_A 180 MSRKIGHAC-----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-----DNQETYLNISQVN 249 (327)
T ss_dssp GCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTC
T ss_pred cccccCCcc-----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CchHHHHHHHhcc
Confidence 998765321 223457999999999999999999999999999999999999999642 1122222222222
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.... +......+..+.++++. |++.||++||+++++++
T Consensus 250 ~~~~----~~~~~~~~~~~~~li~~------~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 250 VDYS----EETFSSVSQLATDFIQS------LLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CCCC----TTTTTTSCHHHHHHHHH------HSCSSGGGSCCHHHHTT
T ss_pred cccC----chhhcccCHHHHHHHHH------HcCCChhhCcCHHHHhC
Confidence 1111 11122233445555554 99999999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=341.79 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=198.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecC-CceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANR-KTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e~ 853 (1117)
.++|++.+.||+|+||+||+|+. +|+.||||+++... ..+++.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 35788999999999999999987 58899999987543 456799999999999999999999986554 578999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++++|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999999997642 12378999999999999999999999 9999999999999999999999999999865432
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ...... . ..... .+
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~---~-~~~~~------~~ 233 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVP---R-VEKGY------KM 233 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHH---H-HTTTC------CC
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHH---H-HhcCC------CC
Confidence 123357889999999999999999999999999999998 999996532 122222 1 11111 12
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
..+...+..+.++++. |++.||++||++.++++.|+++...
T Consensus 234 ~~~~~~~~~l~~li~~------~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKN------CWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHH------HhcCChhhCCCHHHHHHHHHHHHhh
Confidence 2233444556666655 9999999999999999999988654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=336.80 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=197.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC----ccchHHHHHHHHHHhccCCCCcceEEeee--ecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD----KISTGAFSSEIATLSRIRHRNIVRLLGWG--ANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~--~~~~~~ 847 (1117)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36799999999999999999986 468999999997532 23356789999999999999999999988 445678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||++++ +.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 666665533 23489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCC--CCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTK--ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
....... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||... ..............
T Consensus 159 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAAD--DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-----NIYKLFENIGKGSY- 230 (305)
T ss_dssp CCTTCSS--CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHCCC-
T ss_pred cCccccc--cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHHHHHHhcCCC-
Confidence 6532211 1223456899999999987644 377999999999999999999999642 22233332222211
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.++...+..+.++++. |++.||++||++.++++.
T Consensus 231 -------~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -------AIPGDCGPPLSDLLKG------MLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -------CCCSSSCHHHHHHHHH------HTCSSTTTSCCHHHHHHS
T ss_pred -------CCCCccCHHHHHHHHH------HccCChhhCCCHHHHhcC
Confidence 1223344556666655 999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=354.47 Aligned_cols=254 Identities=13% Similarity=0.141 Sum_probs=202.5
Q ss_pred hccCCCCCCeeeecCCeEEEEEE------cCCCcEEEEEEeecCCccchHHHHHHHHHHhccC---CCCcceEEeeeecC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVT------LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR---HRNIVRLLGWGANR 844 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 844 (1117)
..++|.+.+.||+|+||+||+|. ..+++.||||+++.. ...++.+|++++++++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35679999999999999999993 456889999999754 3457888888888886 99999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---------
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGE--CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE--------- 913 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~--------- 913 (1117)
+..++||||+++|+|.+++.... ....+++.+++.++.||++||+|||++ +||||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 99999999999999999997421 224599999999999999999999999 9999999999999998
Q ss_pred --CCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChh
Q 001238 914 --RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQH 991 (1117)
Q Consensus 914 --~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~ 991 (1117)
++.+||+|||+|+........ ......+||++|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKG--TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTT--EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccCCEEEeeCchhhhhhccCCC--ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 899999999999865432211 23345679999999999999999999999999999999999999995421110
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCC-CchhHHHHHHHHhHhhhccCCCCCCC-CCHHHHHHHHHhhhcC
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGH-PDTQIQEMLQALGISLLCTSNRAEDR-PTMKDVAALLREIRQE 1059 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~~~i~~~C~~~~p~~R-Ps~~~v~~~L~~~~~~ 1059 (1117)
..+...+... ....+.+++.. |++.+|.+| |+++++.+.|+++...
T Consensus 293 ----------------~~~~~~~~~~~~~~~~~~~~~~------~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 ----------------CKPEGLFRRLPHLDMWNEFFHV------MLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ----------------EEECSCCTTCSSHHHHHHHHHH------HHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----------------eeechhccccCcHHHHHHHHHH------HcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0011111111 13344444444 999999998 6888998888877543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=347.56 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=194.0
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc-----chHHHHHHHHHHhccCCCCcceEEeeeec
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI-----STGAFSSEIATLSRIRHRNIVRLLGWGAN 843 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 843 (1117)
++....++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 34455678999999999999999999864 5899999998753221 13468899999999999999999999999
Q ss_pred CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 844 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
.+..++||||+++ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred CCceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecc
Confidence 9999999999986 8888887643 3488899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+. .....+......
T Consensus 158 ~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~-----~~~~~~~~i~~~ 228 (346)
T 1ua2_A 158 LAKSFGSPN----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-----SDLDQLTRIFET 228 (346)
T ss_dssp GGSTTTSCC----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHH
T ss_pred cceeccCCc----ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHHH
Confidence 998765322 22345678999999999865 45899999999999999999999998642 112222222221
Q ss_pred CCCCccccCccc--------------------CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1003 KKDPVEVLDPKL--------------------QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1003 ~~~~~~~~~~~l--------------------~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
...+.....+.. ....+..+.++++ .|++.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~------~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ------GLFLFNPCARITATQALKM 292 (346)
T ss_dssp HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHH------HHHCSSTTTSCCHHHHHTS
T ss_pred cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHH------HHhccChhhCCCHHHHhcC
Confidence 111111111110 0122234444444 4999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=355.69 Aligned_cols=203 Identities=30% Similarity=0.397 Sum_probs=162.9
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccC-CCCcceEEeeeecCC--ce
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRK--TK 847 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~ 847 (1117)
..++|++.+.||+|+||+||+|.. .+|+.||||++... ......++.+|+.+++++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 456899999999999999999974 57899999998643 2334556789999999997 999999999987544 68
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
|+||||++ |+|..++... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 6898888753 389999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCC-----------------ccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 928 VEDDSGG-----------------SFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 928 ~~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
....... .....+..+||+.|+|||++.+ ..++.++||||+||++|||++|++||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 6431110 1112345689999999999876 6789999999999999999999999965
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=337.59 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=202.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356889999999999999999864 68999999997543 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.++......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999998754 3489999999999999999999999 99999999999999999999999999998664321
Q ss_pred CCccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.........||+.|+|||++....+ +.++||||||+++|||++|+.||............+. ... ...
T Consensus 160 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~-~~~---- 228 (276)
T 2yex_A 160 --RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKK-TYL---- 228 (276)
T ss_dssp --EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH----TTC-TTS----
T ss_pred --chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh----hcc-ccc----
Confidence 1122345678999999999987665 7899999999999999999999976433322222221 111 110
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+. ....+..+.++++. |++.||++||++.++++
T Consensus 229 ~~-~~~~~~~~~~li~~------~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NP-WKKIDSAPLALLHK------ILVENPSARITIPDIKK 261 (276)
T ss_dssp TT-GGGSCHHHHHHHHH------HSCSSTTTSCCHHHHTT
T ss_pred Cc-hhhcCHHHHHHHHH------HCCCCchhCCCHHHHhc
Confidence 00 11223445555554 99999999999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=338.92 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=205.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.+.|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35688899999999999999974 568999999997553 3345789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999998753 389999999999999999999999 99999999999999999999999999998765422
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.......||+.|+|||++....++.++||||||+++|||++|+.||.... ............ .+
T Consensus 174 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~-------~~ 237 (303)
T 3a7i_A 174 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-----PMKVLFLIPKNN-------PP 237 (303)
T ss_dssp ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSC-------CC
T ss_pred ----cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC-----HHHHHHHhhcCC-------CC
Confidence 12334578999999999999999999999999999999999999996421 111121111111 12
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALL 1053 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L 1053 (1117)
.+....+..+.+++.. |++.+|++||++.++++..
T Consensus 238 ~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEA------CLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCSSCCHHHHHHHHH------HCCSSGGGSCCHHHHTTCH
T ss_pred CCccccCHHHHHHHHH------HcCCChhhCcCHHHHhhCh
Confidence 2333445556666655 9999999999999998743
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=341.67 Aligned_cols=199 Identities=26% Similarity=0.354 Sum_probs=169.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 47888999999999999999864 589999999865432 224568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999999988754 3389999999999999999999999 99999999999999999999999999998765322
Q ss_pred CCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||..
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 205 (311)
T 4agu_A 157 ----DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG 205 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ----cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 12234578999999999875 6789999999999999999999999965
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=347.89 Aligned_cols=201 Identities=23% Similarity=0.302 Sum_probs=164.6
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc--cchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK--ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
...++|++.+.||+|+||+||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3456899999999999999999974 5789999999975432 224567899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc-----CCCcceeccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG-----ERYESCLADFGL 924 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-----~~~~~kl~DfGl 924 (1117)
||||++ |+|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++ +++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 59999887653 389999999999999999999999 999999999999994 455699999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 184 a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 184 ARAFGIPI----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp HHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccCCcc----cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 98764321 223345789999999998764 589999999999999999999999964
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=335.85 Aligned_cols=245 Identities=24% Similarity=0.382 Sum_probs=202.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999854 68899999986431 223467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 999999999998764 2489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
......||+.|+|||++.+..++.++||||||+++|||++|+.||... .............
T Consensus 168 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~-------- 228 (284)
T 2vgo_A 168 ------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-----SHTETHRRIVNVD-------- 228 (284)
T ss_dssp ------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTC--------
T ss_pred ------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC-----CHhHHHHHHhccc--------
Confidence 123457899999999999999999999999999999999999999642 1122222222211
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..++...+..+.+++.. |++.||++||++.++++
T Consensus 229 ~~~~~~~~~~~~~li~~------~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 LKFPPFLSDGSKDLISK------LLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCCTTSCHHHHHHHHH------HSCSSGGGSCCHHHHHT
T ss_pred cCCCCcCCHHHHHHHHH------HhhcCHhhCCCHHHHhh
Confidence 12233344555666555 99999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=342.10 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=204.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcE--EEEEEeecC-CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLT--VAVKRFRAS-DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|++.+.||+|+||.||+|+.. +++. ||+|+++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46888999999999999999753 4654 499988753 233456789999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcc
Q 001238 851 YDYMPNGTLGMLLHDGE-------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 917 (1117)
|||+++|+|.+++.... ....+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997643 123589999999999999999999999 99999999999999999999
Q ss_pred eeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHH
Q 001238 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 918 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~ 996 (1117)
||+|||+++..... .......+++.|+|||++....++.++||||||+++|||++ |+.||... ...+..
T Consensus 182 kL~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-----~~~~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELY 251 (327)
T ss_dssp EECCTTCEESSCEE-----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHH
T ss_pred EEcccCcCcccccc-----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC-----cHHHHH
Confidence 99999999754321 12233467889999999998899999999999999999998 99999642 112222
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
.. +..... ...+...+..+.+++.. |++.+|++||++.++++.|+++..+..
T Consensus 252 ~~-~~~~~~------~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 252 EK-LPQGYR------LEKPLNCDDEVYDLMRQ------CWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HH-GGGTCC------CCCCTTBCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HH-hhcCCC------CCCCCCCCHHHHHHHHH------HccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 22 222111 11222334455555555 999999999999999999998876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=348.35 Aligned_cols=266 Identities=22% Similarity=0.257 Sum_probs=198.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeec--------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGAN-------- 843 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 843 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 45789999999999999999986 578999999986543 2234578899999999999999999999876
Q ss_pred CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 844 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
.+..++||||+++ ++.+.+.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999975 6766665542 3489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
+++.................||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........+......
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN--TEQHQLALISQLCGS 247 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCC
Confidence 998775433333334455688999999998875 56899999999999999999999999752 122222222222211
Q ss_pred CCCCccccCcccC------------CCCchhHHHH------HHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1003 KKDPVEVLDPKLQ------------GHPDTQIQEM------LQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1003 ~~~~~~~~~~~l~------------~~~~~~~~~~------l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. .....+... .........+ .....++..|++.||++||+++|+++
T Consensus 248 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 I---TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp C---CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C---ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1 111111110 0000000110 01234556699999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=353.61 Aligned_cols=251 Identities=20% Similarity=0.272 Sum_probs=189.0
Q ss_pred ccCCCCC-CeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhc-cCCCCcceEEeeeec----CCce
Q 001238 775 TRSLTAG-NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSR-IRHRNIVRLLGWGAN----RKTK 847 (1117)
Q Consensus 775 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~~ 847 (1117)
.++|.+. +.||+|+||+||+|.. .+|+.||||+++. ...+.+|++++.+ .+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456665 6899999999999975 4689999999863 2467889998754 489999999998765 5678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceeccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLADFGL 924 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGl 924 (1117)
|+||||+++|+|.+++..... ..+++.++..++.||++||+|||++ +|+||||||+||+++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999987532 3489999999999999999999999 9999999999999997 78999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCC--hhHHHHHHHHHhc
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDG--QHVIQWVRDHLKS 1002 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~--~~~~~~~~~~~~~ 1002 (1117)
++..... ......+||+.|+|||++....++.++|||||||++|||++|+.||....... ......+. ..
T Consensus 211 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~ 282 (400)
T 1nxk_A 211 AKETTSH-----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MG 282 (400)
T ss_dssp CEECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HT
T ss_pred ccccCCC-----CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cC
Confidence 9865432 12345678999999999999999999999999999999999999997543221 11222221 11
Q ss_pred CCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1003 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
...... +. ....+..+.++++ .|++.||++||++.++++.
T Consensus 283 ~~~~~~---~~-~~~~s~~~~~li~------~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYEFPN---PE-WSEVSEEVKMLIR------NLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCCCT---TT-TTTSCHHHHHHHH------TTSCSSGGGSCCHHHHHHS
T ss_pred cccCCC---cc-cccCCHHHHHHHH------HHCCCChhHCcCHHHHhcC
Confidence 111110 11 1223344555554 4999999999999999884
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=350.14 Aligned_cols=198 Identities=24% Similarity=0.279 Sum_probs=174.8
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccC-----CCCcceEEeeeecCCce
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-----HRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~~~~~~~~~~ 847 (1117)
..++|++.++||+|+||+||+|.. .+++.||||+++.. ......+..|++++++++ ||||+++++++...+..
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 356899999999999999999985 56899999999743 233456788999999996 99999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC--------------
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-------------- 913 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-------------- 913 (1117)
++||||+ +++|.+++..... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred EEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccc
Confidence 9999999 9999999987543 3489999999999999999999999 9999999999999975
Q ss_pred -----------CCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCC
Q 001238 914 -----------RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPV 982 (1117)
Q Consensus 914 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~ 982 (1117)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 789999999999865432 23457899999999999999999999999999999999999999
Q ss_pred CC
Q 001238 983 DA 984 (1117)
Q Consensus 983 ~~ 984 (1117)
..
T Consensus 260 ~~ 261 (360)
T 3llt_A 260 RT 261 (360)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=342.55 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=201.0
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
..++|.+.+.||+|+||+||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3457889999999999999999854 789999999987655455678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE---cCCCcceecccccccccc
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL---GERYESCLADFGLARLVE 929 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGla~~~~ 929 (1117)
|+++++|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||++ ++++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999988654 3489999999999999999999999 99999999999999 778999999999997643
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||... ................
T Consensus 161 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~~--- 226 (304)
T 2jam_A 161 NG------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE-----TESKLFEKIKEGYYEF--- 226 (304)
T ss_dssp CB------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHCCCCC---
T ss_pred CC------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcCCCCC---
Confidence 21 223456899999999999899999999999999999999999999642 1122222222222111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
........+..+.+++.. |++.||++||++.++++
T Consensus 227 -~~~~~~~~~~~~~~li~~------~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 -ESPFWDDISESAKDFICH------LLEKDPNERYTCEKALS 261 (304)
T ss_dssp -CTTTTTTSCHHHHHHHHH------HHCSSTTTSCCHHHHHT
T ss_pred -CccccccCCHHHHHHHHH------HcCCChhHCcCHHHHhc
Confidence 111222334455555555 99999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=348.31 Aligned_cols=272 Identities=26% Similarity=0.351 Sum_probs=194.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHH--HhccCCCCcceEEeeee-----cCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIAT--LSRIRHRNIVRLLGWGA-----NRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~-----~~~~~ 847 (1117)
.++|++.+.||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++. .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35788999999999999999987 68999999997542 3344445444 55589999999997543 23356
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC------CCceeeeccccCeEEEcCCCcceecc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC------VPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
++||||+++|+|.+++.... .++..+.+++.|+++||+|||+++ .++|+||||||+||+++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 89999999999999997643 588999999999999999999873 23899999999999999999999999
Q ss_pred ccccccccCCCCC----ccccCCccccccccCChhhhcc-------CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCCh
Q 001238 922 FGLARLVEDDSGG----SFSANPQFAGSYGYIAPEYANM-------TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ 990 (1117)
Q Consensus 922 fGla~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~ 990 (1117)
||+++........ .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 9999876543211 1122335579999999999876 4667899999999999999999777633211100
Q ss_pred ------------hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 991 ------------HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 991 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
.............. ..+.++...............++..||+.||++|||++|+++.|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 00111111111111 1112222111110011112234556999999999999999999999875
Q ss_pred C
Q 001238 1059 E 1059 (1117)
Q Consensus 1059 ~ 1059 (1117)
.
T Consensus 319 ~ 319 (336)
T 3g2f_A 319 I 319 (336)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=340.30 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=200.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeee--cCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGA--NRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~l 849 (1117)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999854 68999999997543 233567899999999999999999999874 4567899
Q ss_pred EEEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCc-----eeeeccccCeEEEcCCCcceecccc
Q 001238 850 FYDYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDCVPA-----ILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
||||+++++|.+++.... ....+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999987532 123489999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
+++...... .......||+.|+|||++....++.++||||||+++|||++|+.||... . ............
T Consensus 162 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~---~~~~~~~i~~~~ 232 (279)
T 2w5a_A 162 LARILNHDT----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--S---QKELAGKIREGK 232 (279)
T ss_dssp HHHHC---C----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS--S---HHHHHHHHHHTC
T ss_pred hheeecccc----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc--C---HHHHHHHHhhcc
Confidence 998764321 1122457899999999999889999999999999999999999999642 1 122222222221
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~ 1054 (1117)
. +.++...+..+.+++.. |++.||++||++.++++.+.
T Consensus 233 ~-------~~~~~~~~~~l~~li~~------~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 F-------RRIPYRYSDELNEIITR------MLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp C-------CCCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHTSTT
T ss_pred c-------ccCCcccCHHHHHHHHH------HcCCCcccCCCHHHHHhChh
Confidence 1 12233344556666655 99999999999999988553
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=358.45 Aligned_cols=253 Identities=19% Similarity=0.261 Sum_probs=190.1
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--------ccchHHHHHHHHHHhccCCCCcceEEeeeec
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--------KISTGAFSSEIATLSRIRHRNIVRLLGWGAN 843 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 843 (1117)
...++|.+.+.||+|+||+||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3456899999999999999999974 568999999987532 1122358899999999999999999998754
Q ss_pred CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC---cceec
Q 001238 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY---ESCLA 920 (1117)
Q Consensus 844 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~---~~kl~ 920 (1117)
+..++||||+++|+|.+++... +.+++.++..++.|+++||+|||++ +|+||||||+||+++.++ .+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 5579999999999999988764 3489999999999999999999999 999999999999997544 59999
Q ss_pred cccccccccCCCCCccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHH
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~ 997 (1117)
|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ......+.
T Consensus 285 DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i~ 358 (419)
T 3i6u_A 285 DFGHSKILGET-----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQIT 358 (419)
T ss_dssp CSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHHH
T ss_pred ecccceecCCC-----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHHh
Confidence 99999876432 1234567999999999875 367889999999999999999999999753222 22222221
Q ss_pred HHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 998 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
...... .+......+..+.++++. |++.||++||++.++++
T Consensus 359 ---~~~~~~----~~~~~~~~~~~~~~li~~------~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 ---SGKYNF----IPEVWAEVSEKALDLVKK------LLVVDPKARFTTEEALR 399 (419)
T ss_dssp ---TTCCCC----CHHHHTTSCHHHHHHHHH------HSCSSTTTSCCHHHHHH
T ss_pred ---cCCCCC----CchhhcccCHHHHHHHHH------HccCChhHCcCHHHHhC
Confidence 111111 111222333445555554 99999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=371.72 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=195.9
Q ss_pred CeeeecCCeEEEEEEc---CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTL---PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
+.||+|+||+||+|.+ ..++.||||+++... ....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999954 346889999997542 2335789999999999999999999999864 568899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.+++... +.+++.++..++.||++||+|||++ +||||||||+||+++.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YY 526 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc-cc
Confidence 9999999754 3489999999999999999999999 999999999999999999999999999987754321 12
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......+|+.|+|||++....++.++|||||||++|||++ |+.||... ....+.. . +..... ...+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~---~-i~~~~~------~~~p 594 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTA---M-LEKGER------MGCP 594 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHH---H-HHTTCC------CCCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHH---H-HHcCCC------CCCC
Confidence 22334467889999999999999999999999999999998 99999652 1112222 2 222211 1122
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
...+..+.+++.. ||+.||++||++.+|++.|+++.
T Consensus 595 ~~~~~~l~~li~~------cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 595 AGCPREMYDLMNL------CWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp TTCCHHHHHHHHH------HTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHH------HcCCCHhHCcCHHHHHHHHHHHH
Confidence 3344455555554 99999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=350.09 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=191.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCC------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK------ 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 845 (1117)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999975 569999999986532 223467889999999999999999999987653
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..|+||||+ +++|.+++... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 88999998763 389999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
+.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.. ....+........
T Consensus 176 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~l~~i~~~~g 243 (367)
T 1cm8_A 176 RQADS-------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-----HLDQLKEIMKVTG 243 (367)
T ss_dssp EECCS-------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHC
T ss_pred ccccc-------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhcC
Confidence 87543 2234578999999999876 789999999999999999999999996521 1122222211111
Q ss_pred CCccc-----------------------cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1005 DPVEV-----------------------LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1005 ~~~~~-----------------------~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+... -...+....+....++++. |++.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~------mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK------MLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHH------HSCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH------HccCChhHCCCHHHHhc
Confidence 11100 0011112233445555554 99999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=343.60 Aligned_cols=265 Identities=25% Similarity=0.375 Sum_probs=185.9
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34568999999999999999999854 68999999986542 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 851 YDYMPNGTLGMLLHDG-----ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
|||+++++|.+++... ...+.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988641 1234589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCC-ccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 926 RLVEDDSGG-SFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 926 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
+........ .........||+.|+|||++.. ..++.++||||||+++|||++|+.||...... . .........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~~~~~~~~~ 243 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--K---VLMLTLQND 243 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--G---HHHHHHTSS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--h---HHHHHhccC
Confidence 876532211 1112334579999999999875 56899999999999999999999999753221 1 111122221
Q ss_pred CCC--ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1004 KDP--VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1004 ~~~--~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
... ....++......+..+.+++.. |++.||++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~------~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHH------HCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHH------HccCChhhCcCHHHHhh
Confidence 111 1112223333444555555555 99999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.11 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=194.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57889999999999999999865 78999999987532 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++++|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999999764 2489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||... ..............
T Consensus 165 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~------ 228 (276)
T 2h6d_A 165 E-----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-----HVPTLFKKIRGGVF------ 228 (276)
T ss_dssp -----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC------
T ss_pred c-----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHhhcCcc------
Confidence 1 1234578999999999987665 68999999999999999999999642 12222222222211
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
.++...+..+.+++.. |++.||++||++.++++.
T Consensus 229 --~~~~~~~~~l~~li~~------~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 --YIPEYLNRSVATLLMH------MLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHS
T ss_pred --cCchhcCHHHHHHHHH------HccCChhhCCCHHHHHhC
Confidence 1222334455555555 999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.89 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=196.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC--CCc--EEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP--SGL--TVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
.++|++.+.||+|+||+||+|.+. +++ .||||+++.. .....+++.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357889999999999999999742 333 6899998754 2334567899999999999999999999988755 8
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||+++++|.+++.... +.+++.++.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999987642 3489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
...... .........+|+.|+|||++....++.++||||||+++|||++ |+.||... ...+.+..........
T Consensus 171 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDD-HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEGERL 244 (291)
T ss_dssp CCC-CC-EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTSCCCC
T ss_pred cccccc-chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC-----CHHHHHHHHHccCCCC
Confidence 654321 1222334567889999999998899999999999999999999 99999642 1222333322222111
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
......+..+.+++.. |++.||++||++.++++.|+++...
T Consensus 245 ------~~~~~~~~~l~~li~~------~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 245 ------PRPEDCPQDIYNVMVQ------CWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ------CCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ------CCCcCcCHHHHHHHHH------HccCCcccCcCHHHHHHHHHHhCcc
Confidence 1122334455555554 9999999999999999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=346.07 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=202.4
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc--------chHHHHHHHHHHhcc-CCCCcceEEeee
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI--------STGAFSSEIATLSRI-RHRNIVRLLGWG 841 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l~~~~ 841 (1117)
....++|++.+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 345567999999999999999999864 7999999999764321 134678899999999 799999999999
Q ss_pred ecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecc
Q 001238 842 ANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 842 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
...+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999999998754 3489999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhcc------CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHH
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM------TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~ 995 (1117)
||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... .....
T Consensus 244 fG~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~-----~~~~~ 313 (365)
T 2y7j_A 244 FGFSCHLEPGE-----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-----RQILM 313 (365)
T ss_dssp CTTCEECCTTC-----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHH
T ss_pred cCcccccCCCc-----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC-----CHHHH
Confidence 99998765422 2234679999999998863 35889999999999999999999999642 11222
Q ss_pred HHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 996 VRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
............. +. ....+..+.++++. |++.||++||++.++++
T Consensus 314 ~~~i~~~~~~~~~---~~-~~~~~~~~~~li~~------~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LRMIMEGQYQFSS---PE-WDDRSSTVKDLISR------LLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHTCCCCCH---HH-HSSSCHHHHHHHHH------HSCSSTTTSCCHHHHHH
T ss_pred HHHHHhCCCCCCC---cc-cccCCHHHHHHHHH------HcCCChhHCcCHHHHhc
Confidence 2222222211111 11 11223345555554 99999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=355.72 Aligned_cols=256 Identities=24% Similarity=0.297 Sum_probs=187.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecC----C--ceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANR----K--TKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~--~~~ 848 (1117)
.+|++.+.||+|+||+||+|++. +|+.||||++..... .+.+|++++++++|||||++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36888899999999999999864 689999999875432 345799999999999999999987432 2 357
Q ss_pred EEEEecCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-Ccceeccccccc
Q 001238 849 LFYDYMPNGTLGMLLHD-GECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGLAR 926 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGla~ 926 (1117)
+||||+++ ++.+.+.. ......+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 55555432 11224589999999999999999999999 99999999999999965 568999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHH------
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH------ 999 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~------ 999 (1117)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+.+.+...
T Consensus 206 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTC-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHH
T ss_pred hcccCC-----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHH
Confidence 764322 22345789999999998654 799999999999999999999999975211 11122222110
Q ss_pred -H-hcCCCCccccCccc---------CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1000 -L-KSKKDPVEVLDPKL---------QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1000 -~-~~~~~~~~~~~~~l---------~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+ .......+...+.+ ....+....++++ .|++.||++||++.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~------~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS------RLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHH------HHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHH------HhccCChhHCCCHHHHhC
Confidence 0 00001111111111 1122334444444 499999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=360.70 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=198.2
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
..++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.++|||||++++++.+.+..|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999854 68999999997542 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC---Ccceecccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER---YESCLADFGLARL 927 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfGla~~ 927 (1117)
|||+++|+|.+.+... ..+++..+..++.||++||+|||++ +|+||||||+||+++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999888654 3489999999999999999999999 99999999999999764 4599999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
.... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||... ...+.+...........
T Consensus 189 ~~~~-----~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~ 257 (494)
T 3lij_A 189 FENQ-----KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ-----TDQEILRKVEKGKYTFD 257 (494)
T ss_dssp CBTT-----BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCCCC
T ss_pred CCCC-----ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCC
Confidence 6532 1234567999999999986 57999999999999999999999999642 22233333333222211
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. +. ....+..+.++++. |++.||.+|||+.++++
T Consensus 258 ~---~~-~~~~s~~~~~li~~------~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 S---PE-WKNVSEGAKDLIKQ------MLQFDSQRRISAQQALE 291 (494)
T ss_dssp S---GG-GTTSCHHHHHHHHH------HTCSSTTTSCCHHHHHT
T ss_pred c---hh-cccCCHHHHHHHHH------HCCCChhhCccHHHHhc
Confidence 1 11 12233455555555 99999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=357.31 Aligned_cols=196 Identities=25% Similarity=0.333 Sum_probs=154.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeec-----CCc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN-----RKT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~ 846 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||++... .....+++.+|++++++++|||||++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 35799999999999999999975 46899999998653 23345678899999999999999999999843 356
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.|+||||+ +|+|.+++... ..+++..+..++.||++||+|||++ +||||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 57899988764 3489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCc-----------------------cccCCccccccccCChhhh-ccCCCCcCCCeeehhhhHHHHHh
Q 001238 927 LVEDDSGGS-----------------------FSANPQFAGSYGYIAPEYA-NMTKISEKSDVYSYGVVLLEIIT 977 (1117)
Q Consensus 927 ~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~vl~ell~ 977 (1117)
......... .......+||+.|+|||++ ....|+.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 765332110 0123456789999999976 56679999999999999999999
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=355.43 Aligned_cols=202 Identities=23% Similarity=0.320 Sum_probs=167.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecC-----Cc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR-----KT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 846 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||++... .....+++.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46799999999999999999975 46889999999753 233456789999999999999999999998766 56
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.|+||||++ |+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 6999998764 3489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCc------------------cccCCccccccccCChhhh-ccCCCCcCCCeeehhhhHHHHHhCCCCCC
Q 001238 927 LVEDDSGGS------------------FSANPQFAGSYGYIAPEYA-NMTKISEKSDVYSYGVVLLEIITGKKPVD 983 (1117)
Q Consensus 927 ~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~vl~ell~g~~P~~ 983 (1117)
......... ....+..+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 765432110 0123567899999999986 56679999999999999999998655553
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=348.35 Aligned_cols=199 Identities=29% Similarity=0.444 Sum_probs=174.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357899999999999999999864 68999999998652 3335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++... +.+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999999764 24899999999999999999999842 7999999999999999999999999999765432
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 186 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp -----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred -----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22345799999999999999999999999999999999999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=357.94 Aligned_cols=244 Identities=17% Similarity=0.203 Sum_probs=187.8
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHH---HHhccCCCCcceEE-------
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIA---TLSRIRHRNIVRLL------- 838 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~H~niv~l~------- 838 (1117)
...++|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|++ .+++++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3456789999999999999999985 56999999999743 3334567899994 55556899999998
Q ss_pred eeeecCC-----------------ceEEEEEecCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 001238 839 GWGANRK-----------------TKLLFYDYMPNGTLGMLLHDGEC----AGLLEWDTRFKIALGVAEGLSYLHHDCVP 897 (1117)
Q Consensus 839 ~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 897 (1117)
+++.+.+ ..|+||||+ +|+|.+++..... ...+++..++.++.||++||+|||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 225 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 225 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 5555443 278999999 6899999975321 11244688889999999999999999
Q ss_pred ceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccC-----------CCCcCCCee
Q 001238 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-----------KISEKSDVY 966 (1117)
Q Consensus 898 ~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~ 966 (1117)
+|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++|||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 999999999999999999999999999986432 2234467 999999999877 899999999
Q ss_pred ehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH
Q 001238 967 SYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM 1046 (1117)
Q Consensus 967 SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~ 1046 (1117)
||||++|||++|+.||....... ....+.+. ....+..+.+++.. |++.||++||++
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~----------------~~~~~~~~-~~~~~~~~~~li~~------~L~~dp~~Rpt~ 354 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALG----------------GSEWIFRS-CKNIPQPVRALLEG------FLRYPKEDRLLP 354 (377)
T ss_dssp HHHHHHHHHHHSSCCC------C----------------CSGGGGSS-CCCCCHHHHHHHHH------HTCSSGGGCCCH
T ss_pred HHHHHHHHHHHCCCCCccccccc----------------chhhhhhh-ccCCCHHHHHHHHH------HcCCCchhCCCH
Confidence 99999999999999996421110 01111111 12334455555554 999999999999
Q ss_pred HHHHH
Q 001238 1047 KDVAA 1051 (1117)
Q Consensus 1047 ~~v~~ 1051 (1117)
.++++
T Consensus 355 ~e~l~ 359 (377)
T 3byv_A 355 LQAME 359 (377)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=335.15 Aligned_cols=245 Identities=18% Similarity=0.283 Sum_probs=197.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.+.||+|+||+||+|... +++.||||+++... .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457899999999999999999864 79999999998642 33455788899999999 999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC---------------
Q 001238 851 YDYMPNGTLGMLLHDGEC-AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER--------------- 914 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~--------------- 914 (1117)
|||+++++|.+++..... .+.+++.++..++.|+++||+|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976421 13489999999999999999999999 99999999999999844
Q ss_pred ----CcceeccccccccccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCC
Q 001238 915 ----YESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDG 989 (1117)
Q Consensus 915 ----~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~ 989 (1117)
..+||+|||.++..... ....||+.|+|||++.+. .++.++||||||+++|||++|.+|+.. .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~----~ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP--------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----G 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS--------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS----S
T ss_pred cCCceEEEEcccccccccCCc--------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc----h
Confidence 47899999999876432 223589999999998765 667899999999999999999987642 1
Q ss_pred hhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 990 QHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. ... ...... .+.++...+..+.++++. |++.||++||++.++++
T Consensus 235 ~-~~~---~~~~~~-------~~~~~~~~~~~~~~li~~------~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 D-QWH---EIRQGR-------LPRIPQVLSQEFTELLKV------MIHPDPERRPSAMALVK 279 (289)
T ss_dssp H-HHH---HHHTTC-------CCCCSSCCCHHHHHHHHH------HTCSSGGGSCCHHHHHT
T ss_pred h-HHH---HHHcCC-------CCCCCcccCHHHHHHHHH------HhCCCcccCCCHHHHhh
Confidence 1 111 111111 123334445566666665 99999999999999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=334.50 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=196.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeec----CCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN----RKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 847 (1117)
.+.|++.+.||+|+||+||+|.. .++..||+|++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 34578888999999999999975 46889999998754 23345678999999999999999999998765 3557
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc--eeeeccccCeEEEc-CCCcceeccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA--ILHRDVKSHNILLG-ERYESCLADFGL 924 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~Nill~-~~~~~kl~DfGl 924 (1117)
++||||+++|+|.+++... +.+++..+..++.|+++||+|||++ + |+||||||+||+++ +++.+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999999764 3489999999999999999999998 7 99999999999998 789999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
++..... ......||+.|+|||++. ..++.++||||+|+++|||++|+.||... ............ ..
T Consensus 179 ~~~~~~~------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~~~~~-~~ 246 (290)
T 1t4h_A 179 ATLKRAS------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIYRRVTS-GV 246 (290)
T ss_dssp GGGCCTT------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHHHHHTT-TC
T ss_pred ccccccc------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc----CcHHHHHHHHhc-cC
Confidence 9754432 223457899999999887 56899999999999999999999999642 122222222221 11
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+ .......+..+.+++.. |++.||++||++.++++
T Consensus 247 ~~-----~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 KP-----ASFDKVAIPEVKEIIEG------CIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CC-----GGGGGCCCHHHHHHHHH------HSCSSGGGSCCHHHHHT
T ss_pred Cc-----cccCCCCCHHHHHHHHH------HccCChhhCCCHHHHhh
Confidence 11 11222333445555554 99999999999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=361.06 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=200.8
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
..++|++.++||+|+||+||+|... +++.||||++... .......+.+|++++++++|||||++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4467999999999999999999854 7899999998643 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc---CCCcceecccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG---ERYESCLADFGLARL 927 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~---~~~~~kl~DfGla~~ 927 (1117)
|||+++|+|.+.+... +.+++.++..++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999888654 3489999999999999999999999 999999999999995 456799999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||... ...+.+...........
T Consensus 174 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~ 242 (486)
T 3mwu_A 174 FQQNT-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-----NEYDILKRVETGKYAFD 242 (486)
T ss_dssp BCCC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCCSC
T ss_pred CCCCC-----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCC
Confidence 64321 2334579999999999875 5999999999999999999999999642 22233333332221111
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
. +. ....+..+.++++. |++.||++|||+.++++.
T Consensus 243 ~---~~-~~~~s~~~~~li~~------~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 L---PQ-WRTISDDAKDLIRK------MLTFHPSLRITATQCLEH 277 (486)
T ss_dssp S---GG-GGGSCHHHHHHHHH------HTCSSTTTSCCHHHHHHC
T ss_pred C---cc-cCCCCHHHHHHHHH------HcCCChhhCcCHHHHhcC
Confidence 1 11 11223345555555 999999999999999884
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=361.76 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=202.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC---ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD---KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357889999999999999999854 78999999997542 33467799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE---cCCCcceecccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL---GERYESCLADFGLARL 927 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill---~~~~~~kl~DfGla~~ 927 (1117)
|||+++|+|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999988764 3489999999999999999999999 99999999999999 5678999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||... ...+.+...........
T Consensus 179 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 179 FEASK-----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA-----NEYDILKKVEKGKYTFE 247 (484)
T ss_dssp BCCCC-----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCCC
T ss_pred ccccc-----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcCCCCCC
Confidence 65422 2234579999999999875 7999999999999999999999999642 22233333333221111
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. +.. ...+..+.++++. |++.+|++|||+.++++
T Consensus 248 ~---~~~-~~~s~~~~~li~~------~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 L---PQW-KKVSESAKDLIRK------MLTYVPSMRISARDALD 281 (484)
T ss_dssp S---GGG-GGSCHHHHHHHHH------HTCSSGGGSCCHHHHHT
T ss_pred C---ccc-ccCCHHHHHHHHH------HCCCChhHCcCHHHHhh
Confidence 1 111 1223445555555 99999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=341.13 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=194.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--------ccchHHHHHHHHHHhccCCCCcceEEeeeecCC
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--------KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 845 (1117)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 45799999999999999999975 468999999986432 122345889999999999999999999987654
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc---ceeccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE---SCLADF 922 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~Df 922 (1117)
.++||||+++++|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 89999999999999988754 3489999999999999999999999 9999999999999987664 999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHH
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
|+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ......+..
T Consensus 162 g~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~- 234 (322)
T 2ycf_A 162 GHSKILGET-----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITS- 234 (322)
T ss_dssp TTCEECCCC-----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHHH-
T ss_pred ccceecccc-----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHHh-
Confidence 999876432 1123457899999999874 467889999999999999999999999753222 122222221
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..... .+......+..+.++++. |++.||++||++.++++
T Consensus 235 --~~~~~----~~~~~~~~~~~~~~li~~------~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 --GKYNF----IPEVWAEVSEKALDLVKK------LLVVDPKARFTTEEALR 274 (322)
T ss_dssp --TCCCC----CHHHHTTSCHHHHHHHHH------HSCSSTTTSCCHHHHHT
T ss_pred --Ccccc----CchhhhhcCHHHHHHHHH------HcccCHhhCCCHHHHhh
Confidence 11111 112222334455555554 99999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=339.75 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=197.1
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467899999999999999999865 589999999987666667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999887532 3489999999999999999999999 9999999999999999999999999998643211
Q ss_pred CCccccCCccccccccCChhhh-----ccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYA-----NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
........||+.|+|||++ ....++.++||||||+++|||++|+.||... ............... .
T Consensus 171 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~-~ 241 (302)
T 2j7t_A 171 ---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSDPP-T 241 (302)
T ss_dssp ---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSCCC-C
T ss_pred ---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-----CHHHHHHHHhccCCc-c
Confidence 1122345789999999988 3567899999999999999999999999642 112222222222211 1
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. ..+...+..+.+++.. |++.||++||++.++++
T Consensus 242 -~---~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -L---LTPSKWSVEFRDFLKI------ALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -C---SSGGGSCHHHHHHHHH------HSCSCTTTSCCHHHHTT
T ss_pred -c---CCccccCHHHHHHHHH------HcccChhhCCCHHHHhc
Confidence 0 0112223345555554 99999999999999865
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=339.50 Aligned_cols=193 Identities=23% Similarity=0.298 Sum_probs=170.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeec--CCceEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGAN--RKTKLLF 850 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lv 850 (1117)
.++|++.+.||+|+||+||+|.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999974 57899999998743 3567999999999997 9999999999987 5678999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC-cceecccccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-ESCLADFGLARLVE 929 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~~~ 929 (1117)
|||+++++|.+++.. +++.++..++.|+++||+|||++ +|+||||||+||+++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999998853 78899999999999999999999 999999999999999776 89999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus 183 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 183 PGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp TTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCC-----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 432 2334578999999999876 6789999999999999999999999954
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=371.79 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=204.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecC---CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRAS---DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 849 (1117)
..+|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|.+++..+ +||+|+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 457899999999999999999854 6889999999753 223456688899999988 79999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.++++.. +.+++.+++.++.||+.||+|||++ +||||||||+|||++.++++||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999864 3489999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... ......+||+.|+|||++....|+.++|||||||++|||++|+.||.+. ...+..........
T Consensus 494 ~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~~~----- 559 (674)
T 3pfq_A 494 WDG----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DEDELFQSIMEHNV----- 559 (674)
T ss_dssp CTT----CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHSSCC-----
T ss_pred cCC----cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhCCC-----
Confidence 321 2344578999999999999999999999999999999999999999642 22333444433321
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCH-----HHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTM-----KDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~-----~~v~~ 1051 (1117)
.++...+..+.++++. |++.||++||++ ++|.+
T Consensus 560 ---~~p~~~s~~~~~li~~------lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ---AYPKSMSKEAVAICKG------LMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CCCTTSCHHHHHHHHH------HSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CCCccCCHHHHHHHHH------HccCCHHHCCCCCCCcHHHHhc
Confidence 2233445566666665 999999999987 66654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=346.86 Aligned_cols=196 Identities=23% Similarity=0.299 Sum_probs=161.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCC------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK------ 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 845 (1117)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999974 468999999997542 233456889999999999999999999987665
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999974 78777753 288999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+
T Consensus 175 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 175 RTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp --------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccc-----cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 865432 123346799999999999999999999999999999999999999965
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=358.84 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=200.8
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc-------------cchHHHHHHHHHHhccCCCCcceEE
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK-------------ISTGAFSSEIATLSRIRHRNIVRLL 838 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~ 838 (1117)
...++|++.++||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999854 688999999875421 2346789999999999999999999
Q ss_pred eeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC---
Q 001238 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY--- 915 (1117)
Q Consensus 839 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~--- 915 (1117)
+++.+.+..++||||+++|+|.+++... +.+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999988654 3489999999999999999999999 999999999999999776
Q ss_pred cceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHH
Q 001238 916 ESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995 (1117)
Q Consensus 916 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~ 995 (1117)
.+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||... ...+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~ 255 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY-----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ-----NDQDI 255 (504)
T ss_dssp SEEECCCTTCEECCTTS-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHH
T ss_pred cEEEEECCCCEEcCCCC-----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC-----CHHHH
Confidence 68999999998765421 233457999999999987 56999999999999999999999999642 22233
Q ss_pred HHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 996 VRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
+............ ......+..+.++++. |++.||.+|||+.++++.
T Consensus 256 ~~~i~~~~~~~~~----~~~~~~s~~~~~li~~------~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 256 IKKVEKGKYYFDF----NDWKNISDEAKELIKL------MLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHHCCCCCCH----HHHTTSCHHHHHHHHH------HTCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCCCCCc----cccCCCCHHHHHHHHH------HcCCChhHCCCHHHHhcC
Confidence 3333332211111 1112233455555555 999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=344.47 Aligned_cols=204 Identities=24% Similarity=0.309 Sum_probs=167.6
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCcc-----------chHHHHHHHHHHhccCCCCcceEE
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI-----------STGAFSSEIATLSRIRHRNIVRLL 838 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~ 838 (1117)
++....++|++.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++||||++++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 566778999999999999999999999888999999998643211 126789999999999999999999
Q ss_pred eeeec-----CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC
Q 001238 839 GWGAN-----RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE 913 (1117)
Q Consensus 839 ~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~ 913 (1117)
+++.. ....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD 169 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC
Confidence 98843 335799999997 68887777542 3589999999999999999999999 9999999999999999
Q ss_pred CCcceeccccccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 914 RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 914 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 170 ~~~~kl~Dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 170 NNDITICDFNLAREDTAD-----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp TCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCEEEEecCcccccccc-----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 999999999999854432 12334578999999998876 6789999999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.60 Aligned_cols=260 Identities=23% Similarity=0.285 Sum_probs=198.6
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc--CCCcEEEEEEeecCC--ccchHHHHHHHHHHhcc---CCCCcceEEeeee----
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL--PSGLTVAVKRFRASD--KISTGAFSSEIATLSRI---RHRNIVRLLGWGA---- 842 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~---- 842 (1117)
+.++|++.+.||+|+||+||+|.. .+|+.||+|+++... ......+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456899999999999999999986 468899999987432 22334677888888777 8999999999987
Q ss_pred -cCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecc
Q 001238 843 -NRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 843 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
.....++||||++ |+|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 699999876532 3489999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHh
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK 1001 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 1001 (1117)
||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.....
T Consensus 164 fg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGG-----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHC
T ss_pred CcccccccCC-----CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHHcC
Confidence 9999865421 23345678999999999998999999999999999999999999997521 1112222221111
Q ss_pred cCCCC--c-------ccc-------CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1002 SKKDP--V-------EVL-------DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1002 ~~~~~--~-------~~~-------~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..... . ... ...+....+..+.+++.. |++.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~------~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK------CLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHH------HSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHH------HcCCCcccCCCHHHHhc
Confidence 00000 0 000 011122334445555554 99999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=347.16 Aligned_cols=195 Identities=26% Similarity=0.384 Sum_probs=153.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecC------C
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANR------K 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 845 (1117)
.++|++.+.||+|+||.||+|. ..+|+.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4689999999999999999997 457899999998653 223456788999999999999999999988654 5
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
..++||||+ +++|.+++... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 78999888653 389999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+
T Consensus 180 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 180 RHTAD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccc-------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 87543 1234579999999999876 6889999999999999999999999965
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=346.56 Aligned_cols=256 Identities=19% Similarity=0.274 Sum_probs=201.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccc-----------------hHHHHHHHHHHhccCCCCcceE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKIS-----------------TGAFSSEIATLSRIRHRNIVRL 837 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 837 (1117)
.++|++.+.||+|+||.||+|.. +|+.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35799999999999999999998 89999999987532111 1789999999999999999999
Q ss_pred EeeeecCCceEEEEEecCCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEE
Q 001238 838 LGWGANRKTKLLFYDYMPNGTLGML------LHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNIL 910 (1117)
Q Consensus 838 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nil 910 (1117)
++++.+.+..++||||+++|+|.++ +.... ...+++..+..++.|++.||+|||+ + +|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 55422 3459999999999999999999999 8 9999999999999
Q ss_pred EcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccC-CCCc-CCCeeehhhhHHHHHhCCCCCCCCCCC
Q 001238 911 LGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISE-KSDVYSYGVVLLEIITGKKPVDASFPD 988 (1117)
Q Consensus 911 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlG~vl~ell~g~~P~~~~~~~ 988 (1117)
++.++.+||+|||.++..... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999999999999876432 23345799999999999876 6666 999999999999999999999753221
Q ss_pred ChhHHHHHHHHHhcCCCCccccC----c-------ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 989 GQHVIQWVRDHLKSKKDPVEVLD----P-------KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~~~----~-------~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
................... + ......+..+.++++. |++.||++||++.++++
T Consensus 259 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~------~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 ----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL------FLRKNPAERITSEDALK 322 (348)
T ss_dssp ----HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHH------HCCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHH------HccCChhhCCCHHHHhc
Confidence 2222222222111110000 0 0002334445555554 99999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=350.58 Aligned_cols=197 Identities=24% Similarity=0.264 Sum_probs=171.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc------CCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI------RHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~ 847 (1117)
..+|++.+.||+|+||+||+|.. .+++.||||+++.. ......+.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45789999999999999999975 46899999999754 23345678899988887 567999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc--ceecccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE--SCLADFGLA 925 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~--~kl~DfGla 925 (1117)
++||||+. ++|.+++..... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 689888876543 2389999999999999999999999 9999999999999999887 999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+.... ......||+.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 250 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 250 CYEHQ-------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp EETTC-------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecCC-------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 76542 22345789999999999999999999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=348.95 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=190.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCc------eE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT------KL 848 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~ 848 (1117)
..+|++.+.||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346899999999999999999987777799998875432 23479999999999999999999854432 78
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc-CCCcceecccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG-ERYESCLADFGLARL 927 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfGla~~ 927 (1117)
+||||++++.+............+++..+..++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999998765554433222234589999999999999999999999 999999999999999 799999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhc----
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS---- 1002 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~---- 1002 (1117)
..... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... ...+...+. ....
T Consensus 192 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~-~~g~p~~~ 264 (394)
T 4e7w_A 192 LIAGE-----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIK-VLGTPSRE 264 (394)
T ss_dssp CCTTC-----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH-HHCCCCHH
T ss_pred ccCCC-----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH-HhCCCCHH
Confidence 64332 2334578999999998865 4689999999999999999999999975311 111111111 1000
Q ss_pred -----CCCCccccCc---------ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1003 -----KKDPVEVLDP---------KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1003 -----~~~~~~~~~~---------~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.....+..-+ .+....+..+.+++. .|++.||++||++.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~------~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS------RLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHH------HHCCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHH------HHhCCChhhCCCHHHHhc
Confidence 0000000000 111223334445554 499999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=341.68 Aligned_cols=200 Identities=27% Similarity=0.392 Sum_probs=169.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc--chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI--STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999864 5899999998754322 2455789999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++++|.++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999998876542 389999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
. .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 178 ~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (331)
T 4aaa_A 178 G----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c----cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 122345789999999998765 789999999999999999999999965
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=342.90 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=197.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecC-----Cce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANR-----KTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 847 (1117)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 45789999999999999999975 468899999997543 22346788999999999999999999988654 367
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||++ |+|.+++... .+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 5899888753 389999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC---
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK--- 1003 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~--- 1003 (1117)
...... .........||+.|+|||++. ...++.++||||+||++|||++|+.||..... ......+.......
T Consensus 178 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGC-BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG--GGHHHHHHHHHCSCCHH
T ss_pred cCCCCC-ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh--HHHHHHHHHHhCCCCHH
Confidence 653211 111234568999999999865 45589999999999999999999999975321 22222222111100
Q ss_pred -----------------CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1004 -----------------KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1004 -----------------~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......-...+....+..+.++++ .|++.||++||++.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~------~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD------KMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHH------HHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHH------HHcCCChhhCCCHHHHhc
Confidence 000000001111222334444444 499999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=331.63 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=201.0
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc---------cchHHHHHHHHHHhccC-CCCcceEEeee
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK---------ISTGAFSSEIATLSRIR-HRNIVRLLGWG 841 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~ 841 (1117)
...++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34568999999999999999999864 689999999975431 12346788999999995 99999999999
Q ss_pred ecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecc
Q 001238 842 ANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 842 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
...+..++||||+++++|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999764 3489999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhc------cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHH
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN------MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQW 995 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~ 995 (1117)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||... .....
T Consensus 168 fg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~ 237 (298)
T 1phk_A 168 FGFSCQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-----KQMLM 237 (298)
T ss_dssp CTTCEECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHH
T ss_pred ccchhhcCCCc-----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc-----cHHHH
Confidence 99998765321 223457899999999885 456889999999999999999999999642 11222
Q ss_pred HHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 996 VRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
............. +. ....+..+.+++.. |++.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~---~~-~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGNYQFGS---PE-WDDYSDTVKDLVSR------FLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTCCCCCT---TT-GGGSCHHHHHHHHH------HCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCCcccCc---cc-ccccCHHHHHHHHH------HccCCcccCCCHHHHHh
Confidence 2222222211111 11 11223445555554 99999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=334.30 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=197.6
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
..++|++.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3567899999999999999999764 58999999997643 35678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999986422 3489999999999999999999999 99999999999999999999999999998765321
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
.......||+.|+|||++....++.++||||||+++|||++|+.||.... ............ .. ..
T Consensus 180 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~-~~-~~--- 245 (314)
T 3com_A 180 ----AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-----PMRAIFMIPTNP-PP-TF--- 245 (314)
T ss_dssp ----SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHSC-CC-CC---
T ss_pred ----cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhcCC-Cc-cc---
Confidence 12334578999999999999999999999999999999999999996421 111111111111 11 10
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+.+++.. |++.||++||++.++++
T Consensus 246 ~~~~~~~~~l~~li~~------~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 RKPELWSDNFTDFVKQ------CLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SSGGGSCHHHHHHHHH------HTCSCTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHH------HccCChhhCcCHHHHHh
Confidence 0112233455555555 99999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=335.80 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=195.5
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeec------C
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGAN------R 844 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------~ 844 (1117)
...++|++.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+++++++ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 4567899999999999999999985 578999999997543 3456889999999999 79999999999876 4
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 67899999999999999998653 23489999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHH
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH 999 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~ 999 (1117)
++...... .......||+.|+|||++. ...++.++||||||+++|||++|+.||.... ........
T Consensus 176 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~ 246 (326)
T 2x7f_A 176 SAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-----PMRALFLI 246 (326)
T ss_dssp TC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHH
T ss_pred ceecCcCc----cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHh
Confidence 98764321 1233457999999999986 5678999999999999999999999996421 11111111
Q ss_pred HhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1000 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.... .+ . ......+..+.++++. |++.||++||++.++++
T Consensus 247 ~~~~-~~-~----~~~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 247 PRNP-AP-R----LKSKKWSKKFQSFIES------CLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHSC-CC-C----CSCSCSCHHHHHHHHH------HCCSSGGGSCCHHHHHT
T ss_pred hcCc-cc-c----CCccccCHHHHHHHHH------HhccChhhCCCHHHHhh
Confidence 1111 11 1 1122334456666655 99999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=340.59 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=198.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||.||+|.... .||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678999999999999999998743 59999987542 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+++++|.+++.... ..+++.++..++.|+++||+|||++ +|+||||||+||+++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999997643 3488999999999999999999999 999999999999998 6799999999987653221
Q ss_pred CC-ccccCCccccccccCChhhhcc---------CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 933 GG-SFSANPQFAGSYGYIAPEYANM---------TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 933 ~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
.. .........||+.|+|||++.. ..++.++||||||+++|||++|+.||... ............
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~~~~~~~~~~ 258 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-----PAEAIIWQMGTG 258 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC-----CHHHHHHHHHTT
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHhccC
Confidence 11 1122234568999999999864 45788999999999999999999999642 111222222221
Q ss_pred CCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 001238 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPA 1061 (1117)
Q Consensus 1003 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~~ 1061 (1117)
. .+ .. .....+..+.+++.. |++.+|++||++.+++++|+++.+...
T Consensus 259 ~-~~-~~----~~~~~~~~l~~li~~------~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 259 M-KP-NL----SQIGMGKEISDILLF------CWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp C-CC-CC----CCSSCCTTHHHHHHH------HHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred C-CC-CC----CcCCCCHHHHHHHHH------HhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1 11 11 111233456666655 999999999999999999998876543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=346.19 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=193.3
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecC-------
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANR------- 844 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 844 (1117)
...++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+|+++++.++|||||++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 3456899999999999999999974 5799999999875432 234799999999999999999988443
Q ss_pred -------------------------------CceEEEEEecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 001238 845 -------------------------------KTKLLFYDYMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLH 892 (1117)
Q Consensus 845 -------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH 892 (1117)
...++||||++ |+|.+.+... ...+.+++..+..++.|+++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5777766531 12245899999999999999999999
Q ss_pred ccCCCceeeeccccCeEEEc-CCCcceeccccccccccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhh
Q 001238 893 HDCVPAILHRDVKSHNILLG-ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGV 970 (1117)
Q Consensus 893 ~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ 970 (1117)
++ +|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||
T Consensus 159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99 999999999999998 68899999999998764432 23345789999999988764 5899999999999
Q ss_pred hHHHHHhCCCCCCCCCCCChhHHHHHHHHHhc---------CCCCcccc---------CcccCCCCchhHHHHHHHHhHh
Q 001238 971 VLLEIITGKKPVDASFPDGQHVIQWVRDHLKS---------KKDPVEVL---------DPKLQGHPDTQIQEMLQALGIS 1032 (1117)
Q Consensus 971 vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~---------~~~l~~~~~~~~~~~l~~~~i~ 1032 (1117)
++|||++|+.||.+... .......+. .... .....+.. ...++...+..+.+++..
T Consensus 231 il~ell~g~~pf~~~~~-~~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~---- 304 (383)
T 3eb0_A 231 VFGELILGKPLFSGETS-IDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ---- 304 (383)
T ss_dssp HHHHHHHSSCSSCCSSH-HHHHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH----
T ss_pred HHHHHHhCCCCCCCCCh-HHHHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH----
Confidence 99999999999975211 111111111 1000 00000000 011222233344555554
Q ss_pred hhccCCCCCCCCCHHHHHH--HHHhhh
Q 001238 1033 LLCTSNRAEDRPTMKDVAA--LLREIR 1057 (1117)
Q Consensus 1033 ~~C~~~~p~~RPs~~~v~~--~L~~~~ 1057 (1117)
|++.||++|||+.|+++ .++.++
T Consensus 305 --~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 305 --ILRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp --HCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred --HccCChhhCCCHHHHhcCHHHHHHH
Confidence 99999999999999986 344444
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=337.19 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=190.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeee-----------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA----------- 842 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----------- 842 (1117)
.++|++.+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357899999999999999999865 58999999998776666678999999999999999999998873
Q ss_pred ---cCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc-CCCcce
Q 001238 843 ---NRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG-ERYESC 918 (1117)
Q Consensus 843 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~k 918 (1117)
+....++||||++ |+|.+++... .+++..+..++.|+++||+|||++ +|+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 3467799999997 6999998653 388999999999999999999999 999999999999997 567999
Q ss_pred eccccccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHH
Q 001238 919 LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997 (1117)
Q Consensus 919 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~ 997 (1117)
|+|||+++....... .........+|..|+|||.+.. ..++.++||||||+++|||++|+.||.... ......
T Consensus 162 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~ 235 (320)
T 2i6l_A 162 IGDFGLARIMDPHYS-HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-----ELEQMQ 235 (320)
T ss_dssp ECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred EccCccccccCCCcc-cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence 999999987643211 1122334567999999998765 678999999999999999999999997531 111222
Q ss_pred HHHhcCCCCccc----------------------cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 998 DHLKSKKDPVEV----------------------LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 998 ~~~~~~~~~~~~----------------------~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
............ -........+..+.+++ ..|++.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li------~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFL------EQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHH------HTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHH------HHHcCCCccccCCHHHHhC
Confidence 221111100000 00011122333444444 4599999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=353.32 Aligned_cols=254 Identities=11% Similarity=0.067 Sum_probs=178.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc---cchHHHHHHHHHHhcc--CCCCcceEE-------eee
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK---ISTGAFSSEIATLSRI--RHRNIVRLL-------GWG 841 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~ 841 (1117)
...|++.+.||+|+||+||+|.+ .+|+.||||++..... ...+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45688899999999999999985 4789999999987543 2345677886555555 699988755 333
Q ss_pred ecC-----------------CceEEEEEecCCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHhccCCCc
Q 001238 842 ANR-----------------KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTR------FKIALGVAEGLSYLHHDCVPA 898 (1117)
Q Consensus 842 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~ 898 (1117)
... ...|+||||++ |+|.+++.... ..+++..+ ..++.||++||+|||++ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 322 23799999998 89999998642 12455555 77889999999999999 9
Q ss_pred eeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHH
Q 001238 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEII 976 (1117)
Q Consensus 899 ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell 976 (1117)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 999999999999999999999999999866421 113467799999999987 78999999999999999999
Q ss_pred hCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 977 TGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 977 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+|+.||....+......... ............+. ....+..+.+++.. |++.||++||++.++++
T Consensus 288 tg~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~li~~------~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWKRP---SLRVPGTDSLAFGS-CTPLPDFVKTLIGR------FLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCTTCCCBC---CTTSCCCCSCCCTT-SSCCCHHHHHHHHH------HTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCcccccchhhh---hhhhccccccchhh-ccCCCHHHHHHHHH------HcCCChhhCCCHHHHhc
Confidence 99999976433211100000 00000000001111 12334455555555 99999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=349.42 Aligned_cols=203 Identities=24% Similarity=0.353 Sum_probs=154.8
Q ss_pred cCCCC-CCeeeecCCeEEEEEEcC---CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeee--cCCceEE
Q 001238 776 RSLTA-GNIIGQGRSGIVYKVTLP---SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGA--NRKTKLL 849 (1117)
Q Consensus 776 ~~~~~-~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~l 849 (1117)
+.|.+ +++||+|+||+||+|++. +++.||||++.... ....+.+|++++++++|||||++++++. .....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 568999999999999854 57899999997543 2457889999999999999999999984 4678899
Q ss_pred EEEecCCCChhhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE----cCCCccee
Q 001238 850 FYDYMPNGTLGMLLHDGE------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL----GERYESCL 919 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill----~~~~~~kl 919 (1117)
||||++ |+|.+++.... ....+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 57777665321 122489999999999999999999999 99999999999999 67789999
Q ss_pred ccccccccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 920 ADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 920 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
+|||+++...... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 174 ~Dfg~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 174 ADMGFARLFNSPL-KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EECCCceecCCCC-cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999998765321 11123345689999999999876 45899999999999999999999999653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=341.63 Aligned_cols=195 Identities=24% Similarity=0.369 Sum_probs=166.9
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCce---
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK--- 847 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~--- 847 (1117)
..++|.+.+.||+|+||+||+|.. .+|+.||||++.... ....+++.+|+++++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 346899999999999999999975 468999999997542 22346788999999999999999999999877655
Q ss_pred ---EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 848 ---LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 848 ---~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
++||||++ ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 688887743 289999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 191 a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 191 ARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp C---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 9865432 234578999999999877 7889999999999999999999999965
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=327.08 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=201.6
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
+...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345578999999999999999999864 68999999987542 334667999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC---Ccceecccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER---YESCLADFGLA 925 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~---~~~kl~DfGla 925 (1117)
+||||+++++|.+++... +.+++.++..++.|++.||+|||++ +|+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999998888654 2489999999999999999999999 99999999999999764 46999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
+...... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||... ...............
T Consensus 172 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNT-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-----NEYDILKRVETGKYA 240 (287)
T ss_dssp GTBCCCS-----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCC
T ss_pred eeecCCC-----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCC
Confidence 8764321 2234568999999998875 5899999999999999999999999642 122222222222211
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.. .+. ....+..+.++++. |++.||++||++.++++
T Consensus 241 ~~---~~~-~~~~~~~~~~li~~------~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FD---LPQ-WRTISDDAKDLIRK------MLTFHPSLRITATQCLE 276 (287)
T ss_dssp CC---SGG-GTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHH
T ss_pred CC---chh-hhhcCHHHHHHHHH------HcccChhhCcCHHHHhc
Confidence 11 011 12233455555555 99999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.35 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=183.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc--chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI--STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||+++..... ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 35788999999999999999985 57899999999754221 1223445555688889999999999999999999999
Q ss_pred EecCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 852 DYMPNGTLGMLLHDG-ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
||++ |+|.+++... .....+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 5887776542 12245899999999999999999999853 899999999999999999999999999987654
Q ss_pred CCCCccccCCccccccccCChhhh----ccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYA----NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
.. ......||+.|+|||++ ....++.++||||+|+++|||++|+.||.... .....+..........
T Consensus 163 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 163 DV-----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG----TPFQQLKQVVEEPSPQ 233 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS----CHHHHHHHHHHSCCCC
T ss_pred cc-----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC----chHHHHHHHhccCCCC
Confidence 22 22334799999999996 56678999999999999999999999996421 1222222222222111
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......+..+.+++.. |++.||++||++.++++
T Consensus 234 ------~~~~~~~~~~~~li~~------~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 ------LPADKFSAEFVDFTSQ------CLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------CCTTTSCHHHHHHHHH------HTCSSGGGSCCHHHHTT
T ss_pred ------cccccCCHHHHHHHHH------HhhcChhhCcCHHHHHh
Confidence 0112234445555554 99999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=339.79 Aligned_cols=202 Identities=24% Similarity=0.384 Sum_probs=169.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecC-----Cce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANR-----KTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 847 (1117)
.++|++.+.||+|+||+||+|... +|+.||||++.... .....++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467899999999999999999854 68999999997543 23345688999999999999999999987654 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
++||||++ |+|.+++... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 6899888753 389999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCc------cccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 928 VEDDSGGS------FSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 928 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
........ ........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 65332111 112234578999999998754 7789999999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=363.78 Aligned_cols=257 Identities=23% Similarity=0.373 Sum_probs=202.2
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC----CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 849 (1117)
.++|++.+.||+|+||+||+|.+. .+..||||+++... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 457889999999999999999753 25679999987543 233467899999999999999999999985 467899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||||+++|+|.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 468 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 999999999999997543 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
... ........+|+.|+|||++....++.++||||||+++|||++ |..||.+. . ..+.+........
T Consensus 543 ~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--~---~~~~~~~i~~~~~---- 610 (656)
T 2j0j_A 543 DST---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--K---NNDVIGRIENGER---- 610 (656)
T ss_dssp C-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--C---HHHHHHHHHHTCC----
T ss_pred CCc---ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--C---HHHHHHHHHcCCC----
Confidence 322 112234467889999999999999999999999999999997 99999642 1 1222222222211
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
+..+...+..+.+++.. ||+.||++||++.++++.|+++..
T Consensus 611 ---~~~~~~~~~~l~~li~~------~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 611 ---LPMPPNCPPTLYSLMTK------CWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCccccHHHHHHHHH------HcCCChhHCcCHHHHHHHHHHHHH
Confidence 11223344455555554 999999999999999999988754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=341.66 Aligned_cols=206 Identities=21% Similarity=0.246 Sum_probs=159.1
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCc--
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT-- 846 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-- 846 (1117)
......++|++.+.||+|+||+||+|.. .+|+.||||++..... ...++.+|++.++.++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 4456678999999999999999999986 4689999999875432 34467788889999999999999999865433
Q ss_pred -----eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--ccCCCceeeeccccCeEEEcC-CCcce
Q 001238 847 -----KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH--HDCVPAILHRDVKSHNILLGE-RYESC 918 (1117)
Q Consensus 847 -----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivHrDlkp~Nill~~-~~~~k 918 (1117)
.++||||++++.+..+.........+++..+..++.|++.||+||| ++ +|+||||||+||+++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEE
Confidence 7899999987533333221122345889999999999999999999 77 9999999999999997 89999
Q ss_pred eccccccccccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 919 LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 919 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
|+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 173 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE-----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp ECCCTTCBCCCTTS-----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EeeCCCceecCCCC-----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 99999998765432 22345789999999998654 489999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=332.19 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=195.4
Q ss_pred hccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccC--CCCcceEEeeeecCCceEE
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIR--HRNIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~l 849 (1117)
..++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++.+.+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 456799999999999999999998889999999997543 334567899999999997 5999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||| +.+++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||++++ +.+||+|||+++...
T Consensus 106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 56889999997643 489999999999999999999999 9999999999999965 899999999998765
Q ss_pred CCCCCccccCCccccccccCChhhhcc-----------CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHH
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANM-----------TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
.... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ....+..
T Consensus 178 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~~ 251 (313)
T 3cek_A 178 PDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISKLHA 251 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHHHH
T ss_pred Cccc--cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH----HHHHHHH
Confidence 4321 112234579999999999865 4688899999999999999999999964321 1222222
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
...... ...++...+..+.++++. |++.||++||++.++++.
T Consensus 252 ~~~~~~------~~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 IIDPNH------EIEFPDIPEKDLQDVLKC------CLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHCTTS------CCCCCCCSCHHHHHHHHH------HTCSSTTTSCCHHHHHTS
T ss_pred HHhccc------ccCCcccchHHHHHHHHH------HccCCcccCcCHHHHhcC
Confidence 222111 112223334455555555 999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=329.20 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=191.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeec----------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN---------- 843 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------- 843 (1117)
.++|++.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45788999999999999999985 47899999999653 2345678899999999999999999998754
Q ss_pred ---CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceec
Q 001238 844 ---RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLA 920 (1117)
Q Consensus 844 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 920 (1117)
.+..++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 346789999999999999997543 3478899999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCCC----------ccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCC
Q 001238 921 DFGLARLVEDDSGG----------SFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDG 989 (1117)
Q Consensus 921 DfGla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~ 989 (1117)
|||+++........ .........||+.|+|||++.+. .++.++||||||+++|||++ ||.. .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~----~ 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST----G 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS----H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC----c
Confidence 99999876432100 01123355799999999998754 78999999999999999998 5532 1
Q ss_pred hhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 990 QHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
............... ...+.+....+..+.++++. |++.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~------~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 MERVNILKKLRSVSI----EFPPDFDDNKMKVEKKIIRL------LIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHHHSTTC----CCCTTCCTTTSHHHHHHHHH------HTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHhcccccc----ccCccccccchHHHHHHHHH------HHhcCcccCcCHHHHhC
Confidence 222222322222111 11222333333445555555 99999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=345.65 Aligned_cols=199 Identities=23% Similarity=0.246 Sum_probs=168.4
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccC--------CCCcceEEeeee---
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIR--------HRNIVRLLGWGA--- 842 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~--- 842 (1117)
.++|++.++||+|+||+||+|.. .+++.||||+++.. ....+.+.+|++++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36799999999999999999974 56899999999754 334567889999999996 788999999887
Q ss_pred -cCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC------
Q 001238 843 -NRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY------ 915 (1117)
Q Consensus 843 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~------ 915 (1117)
.....++||||+ ++++.+.+.... .+.+++..++.++.||++||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 556789999999 455555554332 234899999999999999999999864 799999999999999775
Q ss_pred -------------------------------------------cceeccccccccccCCCCCccccCCccccccccCChh
Q 001238 916 -------------------------------------------ESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952 (1117)
Q Consensus 916 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE 952 (1117)
.+||+|||+++..... .....||+.|+|||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~aPE 263 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGCCHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCcccCCh
Confidence 7999999999876432 23457899999999
Q ss_pred hhccCCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 953 YANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 953 ~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
++.+..++.++|||||||++|||++|+.||...
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=334.78 Aligned_cols=251 Identities=19% Similarity=0.262 Sum_probs=169.6
Q ss_pred ccCCCCC-CeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHH-HHHhccCCCCcceEEeeeec----CCce
Q 001238 775 TRSLTAG-NIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEI-ATLSRIRHRNIVRLLGWGAN----RKTK 847 (1117)
Q Consensus 775 ~~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~----~~~~ 847 (1117)
.++|.+. +.||+|+||+||+|... +|+.||||++.... ...+|+ ..++.++||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4578885 46999999999999865 68999999987531 223333 34566799999999999876 4457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceeccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLADFGL 924 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGl 924 (1117)
++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||++ +|+||||||+||+++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999987532 3489999999999999999999999 9999999999999986 45599999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
++..... ......||+.|+|||++....++.++||||||+++|||++|+.||...... ..............
T Consensus 178 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 178 AKETTQN------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ--AISPGMKRRIRLGQ 249 (336)
T ss_dssp CEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ceecccc------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch--hhhhhHHHhhhccc
Confidence 9865432 223457899999999998889999999999999999999999999653221 11111111111100
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. ..........+..+.++++. |++.||++||++.++++
T Consensus 250 --~-~~~~~~~~~~~~~~~~li~~------~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 --Y-GFPNPEWSEVSEDAKQLIRL------LLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHH------HSCSSGGGSCCHHHHHH
T ss_pred --c-ccCchhhccCCHHHHHHHHH------HCCCChhHCcCHHHHhc
Confidence 0 00111112334455555555 99999999999999988
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=341.11 Aligned_cols=349 Identities=18% Similarity=0.204 Sum_probs=211.0
Q ss_pred CCCCCCCCCCCcceeeEEecCCCcEEEEecccccccCcCCccccccccCCeEeccCCCCCCCchhh-hcccccCcEeecc
Q 001238 52 LSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKE-IASLNQLNYLDLS 130 (1117)
Q Consensus 52 l~sW~~~~~~~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls 130 (1117)
+++|.....+||.|.++.|.... +.++....+. .....-..+.+++.|++++|.++ .+|.. +.++++|++|+|+
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~--~~i~~~~~~~--~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYD--VHIDMQTQDV--YFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ----CCEECBCC------EEEES--CEECSSCCCC--EESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECT
T ss_pred cCCCCCccceehhhhhhccceee--eeeecccccc--cccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECC
Confidence 67898765444455555553221 1111111111 11122235688999999999998 45544 7899999999999
Q ss_pred CCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCC
Q 001238 131 ENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGS 210 (1117)
Q Consensus 131 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~ 210 (1117)
+|.+++..|..|..+++|++|+|++|.+++..|..|+++++|++|+|++|+++...+..|+.+++|++|++++|+. .+.
T Consensus 78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l-~~~ 156 (390)
T 3o6n_A 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-ERI 156 (390)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC-CBC
T ss_pred CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCcc-Ccc
Confidence 9999876677899999999999999999988888899999999999999999864444568888888888888763 445
Q ss_pred CCccccccccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCC
Q 001238 211 LPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNL 290 (1117)
Q Consensus 211 lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 290 (1117)
.|..++++++|+.|++++|.+++. .+..+++|+.|++++|.+.+ +...++|++|++++|.++. +|.. ..
T Consensus 157 ~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~-~~~~--~~ 225 (390)
T 3o6n_A 157 EDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV-VRGP--VN 225 (390)
T ss_dssp CTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCE-EECC--CC
T ss_pred ChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeee-cccc--cc
Confidence 555677777777777777777654 24455566666666665543 1223455666666666553 2322 13
Q ss_pred CCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEe
Q 001238 291 KNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIEL 370 (1117)
Q Consensus 291 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 370 (1117)
++|++|++++|++++. +.+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|++|++
T Consensus 226 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L 302 (390)
T 3o6n_A 226 VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 302 (390)
T ss_dssp SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEEC
T ss_pred ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEEC
Confidence 4556666666665532 345555666666666666655555555555666666666665552 3444455555556666
Q ss_pred cCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeeccccccc
Q 001238 371 DNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLT 424 (1117)
Q Consensus 371 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 424 (1117)
++|+++ .+|..+..+++|+.|++++|+++.. + +..+++|+.|++++|++.
T Consensus 303 ~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEE
T ss_pred CCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCcc
Confidence 555555 3344444555555555555555432 1 334445555555555544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=338.10 Aligned_cols=200 Identities=25% Similarity=0.246 Sum_probs=170.5
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CC-----CcceEEeeeecCCc
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HR-----NIVRLLGWGANRKT 846 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~ 846 (1117)
..++|++.+.||+|+||+||+|.. .+++.||||+++.. .....++.+|+++++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 356899999999999999999975 46889999999753 233456788999998885 55 49999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc--CCCcceeccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG--ERYESCLADFGL 924 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~--~~~~~kl~DfGl 924 (1117)
.++||||++ |+|.+++..... +.+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 599998876542 3489999999999999999999952 12899999999999995 478899999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 208 a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 208 SCQLGQR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CEETTCC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecccc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9876432 2345789999999999999999999999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=335.51 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=191.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCc-----
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT----- 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 846 (1117)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35788999999999999999975 468999999997542 2234578899999999999999999999887654
Q ss_pred -eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 847 -KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 847 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
.++||||++ ++|.+++.. .+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 688877753 289999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHh---
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK--- 1001 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~--- 1001 (1117)
+..... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.+... ......+.....
T Consensus 174 ~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 174 RHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPG 244 (353)
T ss_dssp TC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHHHHHHHCBCC
T ss_pred cCCCCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCC
Confidence 865421 234578999999999876 6789999999999999999999999975311 111111111100
Q ss_pred -----------------cCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1002 -----------------SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1002 -----------------~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
........-........+..+.+++.. |++.||++||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~------~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK------MLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHH------HSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHH------HcCCCcccCCCHHHHhc
Confidence 000000000011112234455555555 99999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=334.07 Aligned_cols=197 Identities=23% Similarity=0.332 Sum_probs=171.8
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc--CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCC------CcceEEeeeecCCc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL--PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHR------NIVRLLGWGANRKT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~~~~~~ 846 (1117)
.++|++.+.||+|+||+||+|.. .+++.||||+++... ...+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35789999999999999999975 368899999997542 3456788999999998765 49999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-------------
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE------------- 913 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~------------- 913 (1117)
.++||||+ +++|.+++..... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 8899998876532 3488999999999999999999999 9999999999999987
Q ss_pred ------CCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 914 ------RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 914 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 668999999999865432 2345789999999999999999999999999999999999999964
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=329.61 Aligned_cols=243 Identities=22% Similarity=0.407 Sum_probs=189.7
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc------chHHHHHHHHHHhcc----CCCCcceEEee
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI------STGAFSSEIATLSRI----RHRNIVRLLGW 840 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~~~ 840 (1117)
....++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+++++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999975 46899999999754321 233466799999998 89999999999
Q ss_pred eecCCceEEEEEe-cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc-CCCcce
Q 001238 841 GANRKTKLLFYDY-MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG-ERYESC 918 (1117)
Q Consensus 841 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~k 918 (1117)
+...+..++|||| +++++|.+++... +.+++..++.++.|+++||+|||++ +|+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 7899999999764 3489999999999999999999999 999999999999999 889999
Q ss_pred eccccccccccCCCCCccccCCccccccccCChhhhccCCCC-cCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHH
Q 001238 919 LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKIS-EKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997 (1117)
Q Consensus 919 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~ 997 (1117)
|+|||+++..... ......||+.|+|||++....+. .++||||||+++|||++|+.||... ..
T Consensus 181 l~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~--- 244 (312)
T 2iwi_A 181 LIDFGSGALLHDE------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-------QE--- 244 (312)
T ss_dssp ECCCSSCEECCSS------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HH---
T ss_pred EEEcchhhhcccC------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-------HH---
Confidence 9999999876542 22345689999999998876664 5899999999999999999999631 11
Q ss_pred HHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 998 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..... ..++...+..+.+++.. |++.+|++||++.++++
T Consensus 245 -~~~~~--------~~~~~~~~~~~~~li~~------~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -ILEAE--------LHFPAHVSPDCCALIRR------CLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHHTC--------CCCCTTSCHHHHHHHHH------HTCSSTTTSCCHHHHHH
T ss_pred -Hhhhc--------cCCcccCCHHHHHHHHH------HccCChhhCcCHHHHhc
Confidence 11111 11223344455555554 99999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=332.20 Aligned_cols=241 Identities=24% Similarity=0.432 Sum_probs=196.7
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc------chHHHHHHHHHHhccC--CCCcceEEeeeecC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI------STGAFSSEIATLSRIR--HRNIVRLLGWGANR 844 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~ 844 (1117)
..++|++.+.||+|+||.||+|.. .+++.||||++...... ..+++.+|++++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 346799999999999999999974 57899999999754321 2346778999999996 59999999999999
Q ss_pred CceEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc-CCCcceeccc
Q 001238 845 KTKLLFYDYMPN-GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG-ERYESCLADF 922 (1117)
Q Consensus 845 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~Df 922 (1117)
+..++||||+.+ ++|.+++... +.+++..+..++.|+++||+|||++ +|+||||||+||+++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999976 8999998763 3489999999999999999999999 999999999999999 7899999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHh
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK 1001 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 1001 (1117)
|+++..... ......||+.|+|||++....+ +.++||||||+++|||++|+.||... . ....
T Consensus 195 g~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~-------~~~~ 257 (320)
T 3a99_A 195 GSGALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E-------EIIR 257 (320)
T ss_dssp TTCEECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H-------HHHH
T ss_pred ccccccccc------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----h-------hhhc
Confidence 999876532 2234579999999999887666 68899999999999999999999641 0 1111
Q ss_pred cCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1002 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
... ......+..+.++++. |++.||++||++.++++
T Consensus 258 ~~~--------~~~~~~~~~~~~li~~------~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 GQV--------FFRQRVSSECQHLIRW------CLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCC--------CCSSCCCHHHHHHHHH------HTCSSGGGSCCHHHHHT
T ss_pred ccc--------cccccCCHHHHHHHHH------HccCChhhCcCHHHHhc
Confidence 111 1122334455555555 99999999999999977
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=346.23 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=181.5
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEecC
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++.+.+..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 45556889999999998776668999999998753 245678999999987 89999999999999999999999995
Q ss_pred CCChhhhhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-------------Ccce
Q 001238 856 NGTLGMLLHDGECAG----LLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-------------YESC 918 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-------------~~~k 918 (1117)
|+|.+++....... ...+..++.++.||+.||+|||++ +|+||||||+||+++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999998653211 113334578999999999999999 99999999999999754 4899
Q ss_pred eccccccccccCCCCCccccCCccccccccCChhhhcc-------CCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCCh
Q 001238 919 LADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM-------TKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQ 990 (1117)
Q Consensus 919 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~ 990 (1117)
|+|||+++.................||++|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--- 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS--- 245 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT---
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh---
Confidence 99999998875432221122335679999999999865 678999999999999999999 9999964321
Q ss_pred hHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 991 HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.... .......... ........+. .....++..|++.||++||++.++++
T Consensus 246 ~~~~----i~~~~~~~~~-----~~~~~~~~~~--~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RESN----IIRGIFSLDE-----MKCLHDRSLI--AEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHH----HHHTCCCCCC-----CTTCCCHHHH--HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHH----HhcCCCCccc-----ccccccccch--HHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111 1111111111 1111111111 11223555699999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.24 Aligned_cols=256 Identities=24% Similarity=0.331 Sum_probs=175.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc-cchHHHHHHHH-HHhccCCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK-ISTGAFSSEIA-TLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.... ....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 35788999999999999999986 4689999999976532 23345556666 677789999999999999999999999
Q ss_pred EecCCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccccc
Q 001238 852 DYMPNGTLGMLLHDG--ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVE 929 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~ 929 (1117)
||+++ +|.+++... .....+++..+.+++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 777776531 11244899999999999999999999852 79999999999999999999999999998764
Q ss_pred CCCCCccccCCccccccccCChhhh----ccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYA----NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
... ......||+.|+|||++ ....++.++||||||+++|||++|+.||..... ....+......
T Consensus 178 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~--- 245 (327)
T 3aln_A 178 DSI-----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS----VFDQLTQVVKG--- 245 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCS---
T ss_pred ccc-----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch----HHHHHHHHhcC---
Confidence 321 22334799999999998 456789999999999999999999999964211 11111110110
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
....+........+..+.+++.. |++.||++||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~------~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNL------CLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHH------HTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcccccCCHHHHHHHHH------HhhCChhhCcCHHHHHh
Confidence 01111111122344455555555 99999999999999976
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=337.99 Aligned_cols=335 Identities=21% Similarity=0.223 Sum_probs=212.0
Q ss_pred CCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHH
Q 001238 313 NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLL 392 (1117)
Q Consensus 313 ~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 392 (1117)
.++++++|++++|.++...+..+..+++|++|+|++|.+++..+..|..+++|++|++++|.+++..|..|+++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 35788888888888885555556778888888888888887667778888888888888888887777777777777777
Q ss_pred HhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCccc
Q 001238 393 FVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT 472 (1117)
Q Consensus 393 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 472 (1117)
++++|+++...+..|..+++|++|++++|++++..|..+..+++|++|++++|++++. .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 7777777744444456777777777777777765556666667777777777766654 2444556666666666655
Q ss_pred ccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcC
Q 001238 473 GFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLG 552 (1117)
Q Consensus 473 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~ 552 (1117)
+. ...++|+.|++++|+++.. |.. ..++|+.|++++|.+++. ..+..
T Consensus 200 ~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~----------------------- 246 (390)
T 3o6n_A 200 TL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLN----------------------- 246 (390)
T ss_dssp EE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGG-----------------------
T ss_pred cc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcC-----------------------
Confidence 32 2234566666666665532 221 134555555555555532 23444
Q ss_pred CCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccE
Q 001238 553 SLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGI 632 (1117)
Q Consensus 553 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~ 632 (1117)
+++|+.|+|++|.+++..|..|..+++|+.|+|++|+++ .+|..+..++++ +.|+|++|+++ .+|..+..+++|+.
T Consensus 247 -l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L-~~L~L~~n~l~-~~~~~~~~l~~L~~ 322 (390)
T 3o6n_A 247 -YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL-KVLDLSHNHLL-HVERNQPQFDRLEN 322 (390)
T ss_dssp -CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTC-CEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred -CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCC-CEEECCCCcce-ecCccccccCcCCE
Confidence 445555555555555444555555555555555555555 234444445555 45555555555 34555666777777
Q ss_pred EeccCccccCCcchhhhcccceEEEeecccccCCCCCCcccccCCcccccCCCCCCcC
Q 001238 633 LDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFS 690 (1117)
Q Consensus 633 LdLs~N~l~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gN~~~c~~ 690 (1117)
|+|++|+++... +..+++|+.|++++|++++... ...+..+....+.+++..|..
T Consensus 323 L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 323 LYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp EECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCSCCCT
T ss_pred EECCCCccceeC--chhhccCCEEEcCCCCccchhH-HHHHHHHHhhcccccCceecc
Confidence 777777776542 5566777788888887776322 234556666677888888863
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=354.07 Aligned_cols=348 Identities=18% Similarity=0.186 Sum_probs=217.5
Q ss_pred CCCCCCCCCCCCcc----eeeEEecCCCcEEEEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcE
Q 001238 51 GLSNWSPSDETPCK----WFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNY 126 (1117)
Q Consensus 51 ~l~sW~~~~~~~C~----W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 126 (1117)
.+++|.++. .||. |.+|.|+. .++....+....+ .-..+.+++.|++++|.++...+..+.++++|++
T Consensus 8 ~l~~~~~~~-~C~~~~~~~~c~~~~~-----~i~~~~~~~~~~~--~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~ 79 (597)
T 3oja_B 8 NVKPRQPEY-KCIDSNLQYDCVFYDV-----HIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 79 (597)
T ss_dssp ---CCCSEE-CCCCC--CCSEEECSC-----EECSSCCCCEESC--SSGGGCCCSEEEESSCEESEECTHHHHHCCCCSE
T ss_pred cccCCCCCC-cCcccCcCceeEecCc-----eecccccccccCc--ccccCCCceEEEeeCCCCCCcCHHHHccCCCCcE
Confidence 478998654 3443 77766652 1222211111111 1224678899999999998544555788999999
Q ss_pred eeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCC
Q 001238 127 LDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKN 206 (1117)
Q Consensus 127 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~ 206 (1117)
|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+.+++|++|++++|.
T Consensus 80 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~- 158 (597)
T 3oja_B 80 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN- 158 (597)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC-
T ss_pred EECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCc-
Confidence 9999999997777889999999999999999998888888999999999999999986555556778877777777775
Q ss_pred CCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCcc
Q 001238 207 LGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSK 286 (1117)
Q Consensus 207 ~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 286 (1117)
+.+..|..++++++|+.|++++|.+++.. +.. +++|++|++++|.+++
T Consensus 159 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~------------------------l~~L~~L~l~~n~l~~----- 206 (597)
T 3oja_B 159 LERIEDDTFQATTSLQNLQLSSNRLTHVD---LSL------------------------IPSLFHANVSYNLLST----- 206 (597)
T ss_dssp CCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGG------------------------CTTCSEEECCSSCCSE-----
T ss_pred CCCCChhhhhcCCcCcEEECcCCCCCCcC---hhh------------------------hhhhhhhhcccCcccc-----
Confidence 34455555666666666666666655431 233 4455555555555543
Q ss_pred CCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCc
Q 001238 287 LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLA 366 (1117)
Q Consensus 287 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 366 (1117)
+...++|+.|++++|.+....+.. .++|+.|+|++|.+++ +..+..+++|++|+|++|.+++..|..|+++++|+
T Consensus 207 l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 281 (597)
T 3oja_B 207 LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281 (597)
T ss_dssp EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCC
T ss_pred ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCC
Confidence 122234555555555555332211 1455555566555553 23455555666666666666555555555566666
Q ss_pred EEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCcc
Q 001238 367 QIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNN 446 (1117)
Q Consensus 367 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 446 (1117)
.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++ +| +..+++|+.|++++|.
T Consensus 282 ~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~-~~--~~~~~~L~~L~l~~N~ 356 (597)
T 3oja_B 282 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHND 356 (597)
T ss_dssp EEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSC
T ss_pred EEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCC-cC--hhhcCCCCEEEeeCCC
Confidence 66666666553 3444455556666666666665 344555566666666666666664 22 4556677777777777
Q ss_pred CCC
Q 001238 447 LSG 449 (1117)
Q Consensus 447 l~~ 449 (1117)
+.+
T Consensus 357 ~~~ 359 (597)
T 3oja_B 357 WDC 359 (597)
T ss_dssp EEH
T ss_pred CCC
Confidence 653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=335.29 Aligned_cols=198 Identities=23% Similarity=0.316 Sum_probs=168.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccC-----------CCCcceEEeeeec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-----------HRNIVRLLGWGAN 843 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~ 843 (1117)
++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788999999999999999985 57899999999753 234567889999999886 8999999999876
Q ss_pred CC----ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc------C
Q 001238 844 RK----TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG------E 913 (1117)
Q Consensus 844 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~------~ 913 (1117)
.+ ..++||||+ +++|.+++..... +.+++..+..++.||+.||+|||+++ +|+||||||+||+++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 54 678999999 8999999876433 34899999999999999999999953 899999999999995 3
Q ss_pred CCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 914 RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 914 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 448999999999876432 23447899999999999999999999999999999999999999753
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=329.94 Aligned_cols=289 Identities=20% Similarity=0.272 Sum_probs=200.7
Q ss_pred cccchhHHHHHHHHHhhccCCC-CCCCCCC---CCCCCCcceeeEEecCCCcEEEEecccccccCcCCccccccccCCeE
Q 001238 28 PYAVNRQGEALLSWKRNWKGSD-DGLSNWS---PSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRL 103 (1117)
Q Consensus 28 ~~~~~~~~~aLl~~k~~~~~~~-~~l~sW~---~~~~~~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L 103 (1117)
..+..+|++||++||+++..++ +.+++|. ....++|.|.||+|+..... +. -.....++.|
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~----l~-----------~~~~~~l~~L 86 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADL----LE-----------DATQPGRVAL 86 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHH----HH-----------HHTSTTCCEE
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHH----Hh-----------cccccceeEE
Confidence 3456789999999999995444 4478994 44567899999999521100 00 0123567888
Q ss_pred eccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCC
Q 001238 104 VLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLT 183 (1117)
Q Consensus 104 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 183 (1117)
+|++|+++ .+|..++++++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..|+++++|++|+|++|++.
T Consensus 87 ~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~ 163 (328)
T 4fcg_A 87 ELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163 (328)
T ss_dssp EEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTC
T ss_pred EccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCc
Confidence 89999998 88888999999999999999998 89999999999999999999998 88999999999999999999888
Q ss_pred CCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCcCC
Q 001238 184 DAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPEL 263 (1117)
Q Consensus 184 ~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l 263 (1117)
+.+|..++.. .++..+.++++|++|++++|.++ .+|..+
T Consensus 164 ~~~p~~~~~~----------------~~~~~~~~l~~L~~L~L~~n~l~-------------------------~lp~~l 202 (328)
T 4fcg_A 164 TELPEPLAST----------------DASGEHQGLVNLQSLRLEWTGIR-------------------------SLPASI 202 (328)
T ss_dssp CCCCSCSEEE----------------C-CCCEEESTTCCEEEEEEECCC-------------------------CCCGGG
T ss_pred cccChhHhhc----------------cchhhhccCCCCCEEECcCCCcC-------------------------cchHhh
Confidence 8888766541 12223444444555554444444 344555
Q ss_pred CCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcce
Q 001238 264 GDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQE 343 (1117)
Q Consensus 264 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~ 343 (1117)
..+++|++|+|++|++++ +|..++++++|++|+|++|++.+.+|..|+.+++|++|+|++|.+.+.+|..+.++++|++
T Consensus 203 ~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~ 281 (328)
T 4fcg_A 203 ANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281 (328)
T ss_dssp GGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCE
T ss_pred cCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCE
Confidence 555566666666666663 4445666666666666666666666666666666666666666666666666666666666
Q ss_pred EecccccccCcccccccCCCCCcEEEecCcccc
Q 001238 344 LQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376 (1117)
Q Consensus 344 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 376 (1117)
|+|++|.+.+.+|..++++++|+.+++..|.+.
T Consensus 282 L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp EECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred EeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 666666666666666666666666666655544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=354.53 Aligned_cols=334 Identities=20% Similarity=0.221 Sum_probs=222.7
Q ss_pred CCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHH
Q 001238 314 CSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLF 393 (1117)
Q Consensus 314 l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 393 (1117)
+++++.|++++|.++...+..|..+++|++|+|++|.|++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 56788888888888866666677788888888888888877777888888888888888888877777777777777777
Q ss_pred hccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccc
Q 001238 394 VWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTG 473 (1117)
Q Consensus 394 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 473 (1117)
|++|.+++..+..|.++++|++|+|++|.+++..|..+..+++|++|++++|++++. .++.+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc
Confidence 777777755555567777777777777777766666666677777777777776654 24445556666666665553
Q ss_pred cCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCC
Q 001238 474 FIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGS 553 (1117)
Q Consensus 474 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~ 553 (1117)
. ...++|+.|++++|.++...+ .+ .++|+.|+|++|.+++ . ..+..
T Consensus 207 l-----~~~~~L~~L~ls~n~l~~~~~-~~--~~~L~~L~L~~n~l~~------------------------~--~~l~~ 252 (597)
T 3oja_B 207 L-----AIPIAVEELDASHNSINVVRG-PV--NVELTILKLQHNNLTD------------------------T--AWLLN 252 (597)
T ss_dssp E-----ECCTTCSEEECCSSCCCEEEC-SC--CSCCCEEECCSSCCCC------------------------C--GGGGG
T ss_pred c-----cCCchhheeeccCCccccccc-cc--CCCCCEEECCCCCCCC------------------------C--hhhcc
Confidence 2 223455666666665553221 11 1345555555555553 2 33444
Q ss_pred CccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEE
Q 001238 554 LSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGIL 633 (1117)
Q Consensus 554 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~L 633 (1117)
+++|+.|+|++|.|.+..|..|..+++|+.|+|++|++++ +|..+..+++| +.|+|++|.++ .+|..+..+++|+.|
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L-~~L~Ls~N~l~-~i~~~~~~l~~L~~L 329 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTL-KVLDLSHNHLL-HVERNQPQFDRLENL 329 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTC-CEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCC-cEEECCCCCCC-ccCcccccCCCCCEE
Confidence 5555555555555555555556666666666666666653 45555555555 56666666666 456666777888888
Q ss_pred eccCccccCCcchhhhcccceEEEeecccccCCCCCCcccccCCcccccCCCCCCcC
Q 001238 634 DLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFS 690 (1117)
Q Consensus 634 dLs~N~l~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gN~~~c~~ 690 (1117)
||++|++++.. +..+++|+.|+|++|+|+|... ...+..+....+.+++..|+.
T Consensus 330 ~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 330 YLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp ECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCCCCCT
T ss_pred ECCCCCCCCcC--hhhcCCCCEEEeeCCCCCChhH-HHHHHHHhhhccccccccCCc
Confidence 88888887653 5567788888888888876532 234666777778899999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=330.20 Aligned_cols=197 Identities=21% Similarity=0.293 Sum_probs=168.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CC-cEEEEEEeecCCccchHHHHHHHHHHhccCCCC------cceEEeeeecCCc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SG-LTVAVKRFRASDKISTGAFSSEIATLSRIRHRN------IVRLLGWGANRKT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~ 846 (1117)
.++|++.+.||+|+||+||+|... ++ +.||+|+++... ...+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 357999999999999999999753 44 789999997532 34567889999999997765 8999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEE---------------
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILL--------------- 911 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill--------------- 911 (1117)
.++||||+ ++++.+++..... ..+++.++..++.||++||+|||++ +|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 99999999 5566666654322 3489999999999999999999999 99999999999999
Q ss_pred ----cCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 912 ----GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 912 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 66789999999999865432 2345799999999999999999999999999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=324.10 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=178.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc-c-hHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI-S-TGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
.++|++.+.||+|+||.||+|... +|+.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356888899999999999999864 6899999999765322 1 233445556788889999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
||+ ++.+..+.... .+.+++..+..++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 55666555432 2348999999999999999999998 5 899999999999999999999999999976643
Q ss_pred CCCCccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
.. ......||+.|+|||++. ...++.++||||||+++|||++|+.||.... .....+.........
T Consensus 178 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~ 248 (318)
T 2dyl_A 178 DK-----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK----TDFEVLTKVLQEEPP 248 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC----SHHHHHHHHHHSCCC
T ss_pred Cc-----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC----ccHHHHHHHhccCCC
Confidence 21 223457999999999984 5678899999999999999999999996421 122233333332211
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.. +. ....+..+.+++.. |++.||.+||++.++++
T Consensus 249 ~~----~~-~~~~~~~l~~li~~------~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LL----PG-HMGFSGDFQSFVKD------CLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC----CS-SSCCCHHHHHHHHH------HTCSCTTTSCCHHHHTT
T ss_pred CC----Cc-cCCCCHHHHHHHHH------HccCChhHCcCHHHHhh
Confidence 10 11 11234455555555 99999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=340.46 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=181.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.+|.+.+.||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.+.+..|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 46888899999999997655555899999999975432 3467899999999 7999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-----CCcceecccccccccc
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-----RYESCLADFGLARLVE 929 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-----~~~~kl~DfGla~~~~ 929 (1117)
+ |+|.+++..... ...+.++..++.||++||+|||++ +|+||||||+||+++. ...+||+|||+++...
T Consensus 101 ~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 6 699999886542 244456678999999999999999 9999999999999953 3357799999998765
Q ss_pred CCCCCccccCCccccccccCChhhhc---cCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCC
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYAN---MTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKD 1005 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1117)
.... .........||++|+|||++. ...++.++||||+||++|||++ |+.||..... ........ . .
T Consensus 175 ~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------~~~~~~~~-~-~ 245 (432)
T 3p23_A 175 VGRH-SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------RQANILLG-A-C 245 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------HHHHHHTT-C-C
T ss_pred CCCc-ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------HHHHHHhc-c-C
Confidence 4321 112334567999999999987 4667889999999999999999 9999854211 11111111 1 1
Q ss_pred CccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1006 PVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1006 ~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......+ ....+.... .++..|++.||++||++.++++
T Consensus 246 ~~~~~~~--~~~~~~~~~------~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLDCLHP--EKHEDVIAR------ELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCTTSCT--TCHHHHHHH------HHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccCc--cccccHHHH------HHHHHHHhCCHhhCCCHHHHHh
Confidence 1111110 001111223 3455699999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=351.44 Aligned_cols=203 Identities=26% Similarity=0.393 Sum_probs=174.1
Q ss_pred hccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeec------CC
Q 001238 774 ATRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN------RK 845 (1117)
Q Consensus 774 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~ 845 (1117)
..++|++.+.||+|+||+||+|.. .+|+.||||+++.. .....+++.+|++++++++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 346899999999999999999975 46899999998754 33345678999999999999999999998765 66
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCc---ceeccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYE---SCLADF 922 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~---~kl~Df 922 (1117)
..++||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 7899999999999999998765444588999999999999999999999 9999999999999997765 899999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
|+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..
T Consensus 169 G~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 169 GYAKELDQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCCBTTSCC-----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccc-----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9998765432 22346799999999999999999999999999999999999999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=317.11 Aligned_cols=233 Identities=11% Similarity=0.064 Sum_probs=180.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCcc---chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999864 5899999999765332 2367899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++++|.++++.. ....++.+++.|+++||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999643 35567889999999999999999 99999999999999999999997443
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
|++ .++.++|||||||++|||++|+.||......... ..............
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~---- 225 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--APAERDTAGQPIEP---- 225 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--EECCBCTTSCBCCH----
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--HHHHHHhccCCCCh----
Confidence 333 3688999999999999999999999753221100 00000000000000
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
.......+..+.+++.. |++.||++| |+.++++.|+++....
T Consensus 226 ~~~~~~~~~~l~~li~~------~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAAR------SVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHCTTSCHHHHHHHHH------HHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hhcccCCCHHHHHHHHH------HcccCCccC-CHHHHHHHHHHHhccC
Confidence 01122334455555554 999999999 9999999999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=334.05 Aligned_cols=244 Identities=18% Similarity=0.227 Sum_probs=178.0
Q ss_pred HhccCCCCCCeeeecCCeEEEEEE-cCCCcEEEEEEeecCCc---cchHHHHHHHHHHhccCC-CCcce-----------
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRH-RNIVR----------- 836 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~----------- 836 (1117)
..++.|+..+.||+|+||+||+|. ..+|+.||||+++.... ...+.+.+|+.+++.++| +|...
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 445567888999999999999998 45799999999874322 235779999999999987 32211
Q ss_pred ----------EEeeeec-----CCceEEEEEecCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 001238 837 ----------LLGWGAN-----RKTKLLFYDYMPNGTLGMLLHD----GECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897 (1117)
Q Consensus 837 ----------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 897 (1117)
+..++.. ....+++|+++ +++|.+++.. ....+.+++..+..++.|+++||+|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 1111111 12346677765 7899988842 11223478899999999999999999999
Q ss_pred ceeeeccccCeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhh----------ccCCCCcCCCeee
Q 001238 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA----------NMTKISEKSDVYS 967 (1117)
Q Consensus 898 ~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~S 967 (1117)
+|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....++.++||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 9999999999999999999999999999865431 334567 999999998 5556889999999
Q ss_pred hhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHH
Q 001238 968 YGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMK 1047 (1117)
Q Consensus 968 lG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~ 1047 (1117)
|||++|||++|+.||....... ....+-+.. ...+..+.+++.. |++.||++||++.
T Consensus 303 lGvil~elltg~~Pf~~~~~~~----------------~~~~~~~~~-~~~~~~~~~li~~------~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALG----------------GSEWIFRSC-KNIPQPVRALLEG------FLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGS----------------CSGGGGSSC-CCCCHHHHHHHHH------HTCSSGGGSCCHH
T ss_pred HHHHHHHHHHCCCCCCCcchhh----------------hHHHHHhhc-ccCCHHHHHHHHH------HccCChhhCcCHH
Confidence 9999999999999996531110 000000111 1233455555554 9999999999977
Q ss_pred HHHH
Q 001238 1048 DVAA 1051 (1117)
Q Consensus 1048 ~v~~ 1051 (1117)
++++
T Consensus 360 ~~l~ 363 (413)
T 3dzo_A 360 QAME 363 (413)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 7643
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=317.14 Aligned_cols=307 Identities=24% Similarity=0.416 Sum_probs=151.0
Q ss_pred cccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCC
Q 001238 239 LGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLS 318 (1117)
Q Consensus 239 l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 318 (1117)
+..+++|+.|++.++.+.. ++ .+..+++|++|++++|++++ ++. +.++++|++|++++|.+++. +.+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence 3455556666665555543 22 25555555555555555553 222 55555555555555555532 2455555555
Q ss_pred EEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcccc
Q 001238 319 IIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNR 398 (1117)
Q Consensus 319 ~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 398 (1117)
+|++++|.+++. +. +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +.
T Consensus 114 ~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~-------------- 174 (347)
T 4fmz_A 114 ELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IA-------------- 174 (347)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GG--------------
T ss_pred EEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hc--------------
Confidence 555555555532 22 5555555555555554332222 25555555555555555543222 33
Q ss_pred ccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCC
Q 001238 399 LEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPE 478 (1117)
Q Consensus 399 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 478 (1117)
.+++|++|++++|.+++ ++. +..+++|+.|++++|.+.+..+ +..+++|++|++++|++++..+
T Consensus 175 ----------~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-- 238 (347)
T 4fmz_A 175 ----------NLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238 (347)
T ss_dssp ----------GCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred ----------cCCCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence 44444444444444442 222 4444445555555554443322 4444455555555555543322
Q ss_pred cCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCcccc
Q 001238 479 IGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLT 558 (1117)
Q Consensus 479 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 558 (1117)
+..+++|++|++++|++++. ..+..+++|++|++++|.+++. ..+..+++|+.|++++|++++..+..|..+++|+
T Consensus 239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence 44555555555555555432 2344555555555555555533 2344445555555555555444444445555555
Q ss_pred EEeccccccCCCCCcccccccceeEEeccccccc
Q 001238 559 KLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS 592 (1117)
Q Consensus 559 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 592 (1117)
.|++++|++++..| +..+++|+.||+++|.|+
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 55555555554443 555566666666666554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=313.73 Aligned_cols=309 Identities=22% Similarity=0.361 Sum_probs=217.3
Q ss_pred ccccccccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCC
Q 001238 213 HEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKN 292 (1117)
Q Consensus 213 ~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 292 (1117)
..+..+++|+.|+++++.+... | .+..+++|++|++++|.+.+..+ +..+++|++|++++|.+++ +| .+.++++
T Consensus 38 ~~~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~ 111 (347)
T 4fmz_A 38 VTQEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTN 111 (347)
T ss_dssp ECHHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTT
T ss_pred ccchhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCc
Confidence 3456889999999999999764 3 48999999999999999886444 9999999999999999995 44 6999999
Q ss_pred CcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecC
Q 001238 293 LVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDN 372 (1117)
Q Consensus 293 L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 372 (1117)
|++|++++|.+.+. +. +..+++|++|++++|.....++. +..+++|++|++++|.+.+..+ +..+++|++|++++
T Consensus 112 L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~ 186 (347)
T 4fmz_A 112 LRELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY 186 (347)
T ss_dssp CSEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTT
T ss_pred CCEEECcCCcccCc-hh-hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccC
Confidence 99999999999964 33 89999999999999977655554 8999999999999999986554 88999999999999
Q ss_pred ccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCC
Q 001238 373 NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIP 452 (1117)
Q Consensus 373 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 452 (1117)
|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|++++. +. +..+++|++|++++|++++.
T Consensus 187 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-- 258 (347)
T 4fmz_A 187 NQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISDI-- 258 (347)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--
T ss_pred Cccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCCC--
Confidence 99985433 6666666666666666664433 55556666666666666532 22 44555555555555555432
Q ss_pred CCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccc
Q 001238 453 PEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVR 532 (1117)
Q Consensus 453 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 532 (1117)
+ .+..+++|++|++++|++++. ..+..+++|++|++++|.+.+..+..|..+++
T Consensus 259 ~------------------------~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 312 (347)
T 4fmz_A 259 N------------------------AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312 (347)
T ss_dssp G------------------------GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTT
T ss_pred h------------------------hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhcccc
Confidence 2 344455555555555555532 23555555555555555555555555555555
Q ss_pred cccccccCCcCCCCCCCCcCCCccccEEeccccccC
Q 001238 533 LQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFA 568 (1117)
Q Consensus 533 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 568 (1117)
|+.|++++|+++++.+ +..+++|+.|++++|.|+
T Consensus 313 L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 313 LTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 5555555555555444 555556666666666553
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=355.27 Aligned_cols=238 Identities=21% Similarity=0.295 Sum_probs=187.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC--CCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCc-----e
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP--SGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT-----K 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~ 847 (1117)
++|++.+.||+|+||+||+|.+. +|+.||||++.... ......+.+|++++++++|||||++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57999999999999999999864 68999999986542 3344578899999999999999999999987665 6
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
|+||||+++++|.+++.. .+++.+++.++.||++||+|||++ +||||||||+||+++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999987754 389999999999999999999999 99999999999999986 899999999987
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
.... ....||++|+|||++.+. ++.++|||||||++|||++|..||........ +
T Consensus 231 ~~~~--------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------~- 285 (681)
T 2pzi_A 231 INSF--------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------P- 285 (681)
T ss_dssp TTCC--------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------C-
T ss_pred cccC--------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------------c-
Confidence 6432 345799999999998765 48899999999999999999998864211100 0
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-CHHHHHHHHHhh
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-TMKDVAALLREI 1056 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-s~~~v~~~L~~~ 1056 (1117)
. ..+.. .....+. .++..|++.||++|| +++++.+.+..+
T Consensus 286 ~-~~~~~--~~~~~l~------~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 E-DDPVL--KTYDSYG------RLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp T-TCHHH--HHCHHHH------HHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c-ccccc--ccCHHHH------HHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 00000 0011233 345559999999999 566677766654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-32 Score=308.60 Aligned_cols=294 Identities=20% Similarity=0.278 Sum_probs=189.5
Q ss_pred CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecc
Q 001238 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347 (1117)
Q Consensus 268 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls 347 (1117)
+++.++++++.++ .+|..+. ++|+.|++++|++.+..|..|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 5777777777777 5666553 577777887777777666777777778888887777777667777777777777777
Q ss_pred cccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcccccc--ccCCCCCCcccccceeecccccccC
Q 001238 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLE--GEIPPSISNCQNLEAVDLSQNGLTG 425 (1117)
Q Consensus 348 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~ 425 (1117)
+|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|.++ +..+..+..+ +|++|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 77777 4444443 67777777777777655556677777777777777764 2555566666 77777777777764
Q ss_pred CCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCccccc
Q 001238 426 PIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITG 505 (1117)
Q Consensus 426 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 505 (1117)
+|..+. ++|++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|+++ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 554443 46666666666666655556666666666666666666555555556666666666666665 45555555
Q ss_pred CCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccC--CCCCcccccccceeE
Q 001238 506 CRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFA--GSIPSQLGSCVKLQL 583 (1117)
Q Consensus 506 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~ 583 (1117)
+++|++|++++|+|++..+..|..... -....+|+.|++++|.+. +..|.+|..+++|+.
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~ 324 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTT
T ss_pred CccCCEEECCCCCCCccChhHcccccc------------------ccccccccceEeecCcccccccCcccccccchhhh
Confidence 555555555555555444433322100 001356777777777776 566777878888888
Q ss_pred Eeccccc
Q 001238 584 LDLSSNQ 590 (1117)
Q Consensus 584 L~Ls~N~ 590 (1117)
|++++|+
T Consensus 325 l~l~~n~ 331 (332)
T 2ft3_A 325 IQFGNYK 331 (332)
T ss_dssp EEC----
T ss_pred hhccccc
Confidence 8888775
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=314.96 Aligned_cols=258 Identities=30% Similarity=0.474 Sum_probs=179.1
Q ss_pred cccceeecccccccC--CCcccccCCCCCCeeeccC-ccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCE
Q 001238 411 QNLEAVDLSQNGLTG--PIPRGIFQLKKLNKLLLLS-NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNF 487 (1117)
Q Consensus 411 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 487 (1117)
.+++.|+|++|.+++ .+|..+.++++|++|++++ |++.+.+|..|+++++|++|++++|++++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 456677777777766 5666666666666666663 6666666666666666666666666666666666666666666
Q ss_pred EEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEecccccc
Q 001238 488 LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRF 567 (1117)
Q Consensus 488 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l 567 (1117)
|+|++|++++.+|..|..+++|++|+|++|+|++.+|..+..+. ++|+.|++++|++
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-----------------------~~L~~L~L~~N~l 186 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS-----------------------KLFTSMTISRNRL 186 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCC-----------------------TTCCEEECCSSEE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhh-----------------------hcCcEEECcCCee
Confidence 66666666666666666666666666666666655555555444 0455555555555
Q ss_pred CCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch-
Q 001238 568 AGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF- 646 (1117)
Q Consensus 568 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~- 646 (1117)
++.+|..|..+. |+.|+|++|++++.+|..+..++.+ +.|+|++|++++.+|. +..+++|+.|||++|++++.+|.
T Consensus 187 ~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~ 263 (313)
T 1ogq_A 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNT-QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCC-SEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGG
T ss_pred eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCC-CEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChH
Confidence 555555555554 6666666666666666666666666 5666666666655555 67788899999999999876654
Q ss_pred hhhcccceEEEeecccccCCCCCCcccccCCcccccCCCCCCcCC-CCC
Q 001238 647 LAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFSG-NQC 694 (1117)
Q Consensus 647 l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gN~~~c~~~-~~c 694 (1117)
+..+++|+.|+|++|+++|.+|....+.++....+.+||++||.+ ..|
T Consensus 264 l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred HhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCCCC
Confidence 888999999999999999999988888999999999999999853 345
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-32 Score=308.14 Aligned_cols=294 Identities=21% Similarity=0.271 Sum_probs=195.3
Q ss_pred CCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEec
Q 001238 292 NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELD 371 (1117)
Q Consensus 292 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 371 (1117)
+++.++++++.++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 6888888888887 5666553 688888888888887777788888888888888888887778888888888888888
Q ss_pred CccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccC--CCcccccCCCCCCeeeccCccCCC
Q 001238 372 NNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTG--PIPRGIFQLKKLNKLLLLSNNLSG 449 (1117)
Q Consensus 372 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~ 449 (1117)
+|+++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|.++. ..+..+..+ +|++|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 88888 4454433 567777777777765555556667777777777776642 445555555 66666666666664
Q ss_pred CCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhc
Q 001238 450 VIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQ 529 (1117)
Q Consensus 450 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 529 (1117)
+|..+. ++|++|++++|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+|+ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 333332 45666666666666555556666666666666666666555555666666666666666665 34444555
Q ss_pred ccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccc--cccccccCCchhHHH
Q 001238 530 LVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS--GNIPASLGKIPALAI 607 (1117)
Q Consensus 530 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~l~~ 607 (1117)
+++|+.|++++|+|++++...|.... + -.....|+.|++++|.++ +..|..+..++.+ +
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~----------------~--~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L-~ 323 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVG----------------F--GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR-L 323 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSS----------------C--CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCS-T
T ss_pred CccCCEEECCCCCCCccChhHccccc----------------c--ccccccccceEeecCcccccccCcccccccchh-h
Confidence 55555555555555544443333210 0 011467999999999998 6778888889988 7
Q ss_pred hhcCCCCc
Q 001238 608 ALNLSWNQ 615 (1117)
Q Consensus 608 ~L~Ls~N~ 615 (1117)
.+++++|+
T Consensus 324 ~l~l~~n~ 331 (332)
T 2ft3_A 324 AIQFGNYK 331 (332)
T ss_dssp TEEC----
T ss_pred hhhccccc
Confidence 89999885
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-33 Score=322.23 Aligned_cols=191 Identities=17% Similarity=0.136 Sum_probs=160.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC--------ccchHHHHHHHHHHhccC---------CCCcceE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--------KISTGAFSSEIATLSRIR---------HRNIVRL 837 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 837 (1117)
.++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35788999999999999999988 78999999997642 223367899999999886 6666665
Q ss_pred Eee-----------------eec-------------CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 001238 838 LGW-----------------GAN-------------RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEG 887 (1117)
Q Consensus 838 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 887 (1117)
.+. +.+ .+..|+||||+++|++.+.+.+ +.+++.+++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 554 333 6789999999999976666643 238999999999999999
Q ss_pred HHHHh-ccCCCceeeeccccCeEEEcCCC--------------------cceeccccccccccCCCCCccccCCcccccc
Q 001238 888 LSYLH-HDCVPAILHRDVKSHNILLGERY--------------------ESCLADFGLARLVEDDSGGSFSANPQFAGSY 946 (1117)
Q Consensus 888 L~~LH-~~~~~~ivHrDlkp~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~ 946 (1117)
|+||| ++ +|+||||||+|||++.++ .+||+|||+|+.... ...+||+
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---------~~~~gt~ 241 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---------GIVVFCD 241 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---------TEEECCC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---------CcEEEee
Confidence 99999 88 999999999999999887 899999999987653 1347999
Q ss_pred ccCChhhhccCCCCcCCCeeehhhh-HHHHHhCCCCCC
Q 001238 947 GYIAPEYANMTKISEKSDVYSYGVV-LLEIITGKKPVD 983 (1117)
Q Consensus 947 ~y~aPE~~~~~~~~~~~Dv~SlG~v-l~ell~g~~P~~ 983 (1117)
.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 999999998666 899999998777 778889999984
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=308.19 Aligned_cols=232 Identities=19% Similarity=0.237 Sum_probs=175.1
Q ss_pred ccCCCCC-CeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHH-hccCCCCcceEEeeeec----CCce
Q 001238 775 TRSLTAG-NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATL-SRIRHRNIVRLLGWGAN----RKTK 847 (1117)
Q Consensus 775 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~ 847 (1117)
.++|.+. +.||+|+||.||+|.. .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3456666 7899999999999975 5689999999864 24678899988 55589999999999876 6678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceeccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLADFGL 924 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGl 924 (1117)
++||||+++|+|.+++..... ..+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999987532 3489999999999999999999999 9999999999999998 78899999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
++... ...++.++||||+||++|||++|+.||....... ..........
T Consensus 167 a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----~~~~~~~~~~ 215 (299)
T 3m2w_A 167 AKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIR 215 (299)
T ss_dssp CEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSCCSSC
T ss_pred ccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-----hhHHHHHHHh
Confidence 97542 1346788999999999999999999996431110 0000000000
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
..............+..+.+++.. |++.||++||++.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~------~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRN------LLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHH------HTCSSTTTSCCHHHHHTS
T ss_pred hccccCCchhcccCCHHHHHHHHH------HcccChhhCCCHHHHhcC
Confidence 000000000012234445555554 999999999999999873
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.4e-32 Score=305.61 Aligned_cols=289 Identities=21% Similarity=0.305 Sum_probs=145.7
Q ss_pred CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecc
Q 001238 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347 (1117)
Q Consensus 268 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls 347 (1117)
+++.++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4555555555555 3444332 355555555555555444455555555555555555555445555555555555555
Q ss_pred cccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccc--cCCCCCCcccccceeecccccccC
Q 001238 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEG--EIPPSISNCQNLEAVDLSQNGLTG 425 (1117)
Q Consensus 348 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~ 425 (1117)
+|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|.+.. ..+..+..+++|++|++++|.++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 55555 3333332 455555555555554444444444444444444444432 334445555555555555555552
Q ss_pred CCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCccccc
Q 001238 426 PIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITG 505 (1117)
Q Consensus 426 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 505 (1117)
+|..+. ++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+++ .+|..+..
T Consensus 186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 333332 44445555555444444444444444444444444444444444444444444444444444 33444444
Q ss_pred CCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCC------CccccEEeccccccCC--CCCccccc
Q 001238 506 CRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGS------LSSLTKLVLNKNRFAG--SIPSQLGS 577 (1117)
Q Consensus 506 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~------l~~L~~L~L~~N~l~~--~~~~~~~~ 577 (1117)
+++|++|++++|+|+ +++...|.. ...++.|++++|.+.. ..|..|..
T Consensus 262 l~~L~~L~l~~N~i~------------------------~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 262 HKYIQVVYLHNNNIS------------------------AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp CSSCCEEECCSSCCC------------------------CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCcCEEECCCCcCC------------------------ccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 444444444444444 444333332 2566677777777652 55667777
Q ss_pred ccceeEEeccccc
Q 001238 578 CVKLQLLDLSSNQ 590 (1117)
Q Consensus 578 l~~L~~L~Ls~N~ 590 (1117)
+..++.++|++|+
T Consensus 318 ~~~l~~l~L~~N~ 330 (330)
T 1xku_A 318 VYVRAAVQLGNYK 330 (330)
T ss_dssp CCCGGGEEC----
T ss_pred ccceeEEEecccC
Confidence 7778888887774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=299.06 Aligned_cols=289 Identities=21% Similarity=0.294 Sum_probs=230.3
Q ss_pred ccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcC
Q 001238 244 RLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDIS 323 (1117)
Q Consensus 244 ~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs 323 (1117)
+++.++++++.+. .+|..+. +.|++|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4455555555544 3454443 578888888888887666678888888888888888887778888888888888888
Q ss_pred CCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccC--CCCcccccccchHHHHhccccccc
Q 001238 324 MNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITG--AIPSEFGNLSNLTLLFVWHNRLEG 401 (1117)
Q Consensus 324 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~ 401 (1117)
+|.++ .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|.++. ..+..|.++++|+.|++++|+++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 88888 4565554 688888888888887777778888888888888888853 667788888888999999888884
Q ss_pred cCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCC
Q 001238 402 EIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGN 481 (1117)
Q Consensus 402 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 481 (1117)
+|..+. ++|++|++++|++++..|..+..+++|++|++++|++++..+..|..+++|++|++++|+++ .+|..+..
T Consensus 186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 555443 78999999999999877888999999999999999999888889999999999999999999 67888999
Q ss_pred CCCCCEEEccCCcCCCCCCcccccC------CCCceEEccCCcccc--ccchhhhcccccccccccCCc
Q 001238 482 LKNLNFLDLGSNRLTGSIPDEITGC------RNLTFLDVHSNSIAG--NLPAGLHQLVRLQFADLSDNS 542 (1117)
Q Consensus 482 l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~ 542 (1117)
+++|++|+|++|+|++..+..|... +.|+.|++++|.+.. +.|..|..+..++.+++++|+
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 9999999999999998777777543 678888888888763 455666666677766666663
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-34 Score=344.37 Aligned_cols=266 Identities=20% Similarity=0.178 Sum_probs=132.7
Q ss_pred CcCCCCCCCCcEEecCCCccCCcCCccCC-----CCCCCcEEEccCCcCcccC----CcCCCCCCCCCEEEcCCCcCCCC
Q 001238 260 PPELGDCTELQYIYLYENALTGSIPSKLG-----NLKNLVNLFLWQNNLVGII----PPELGNCSQLSIIDISMNSLTGS 330 (1117)
Q Consensus 260 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-----~l~~L~~L~L~~n~l~~~~----p~~~~~l~~L~~LdLs~N~l~~~ 330 (1117)
+..+..+++|++|+|++|.+++..+..+. ..++|++|++++|++++.. +..+..+++|++|++++|.++..
T Consensus 106 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 185 (461)
T 1z7x_W 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA 185 (461)
T ss_dssp HHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchH
Confidence 44455566667777777766543333221 2445666666666665422 33344455666666666665533
Q ss_pred CccccC-----CCCCcceEecccccccCc----ccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccc
Q 001238 331 IPQTLG-----NLTSLQELQLSVNQISGE----IPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEG 401 (1117)
Q Consensus 331 ~p~~l~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 401 (1117)
.+..+. ..++|++|+|++|.+++. ++..+..+++|++|++++|.+++.....+
T Consensus 186 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l------------------ 247 (461)
T 1z7x_W 186 GVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAEL------------------ 247 (461)
T ss_dssp HHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHH------------------
T ss_pred HHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHH------------------
Confidence 332222 234556666666655542 34445555555555555555542110000
Q ss_pred cCCCCCCcccccceeecccccccCC----CcccccCCCCCCeeeccCccCCCCCCCCccc-----ccccceeccCCCccc
Q 001238 402 EIPPSISNCQNLEAVDLSQNGLTGP----IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGN-----CSSLIRFRANSNKLT 472 (1117)
Q Consensus 402 ~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~ 472 (1117)
.+..+..+++|++|++++|.++.. ++..+..+++|++|++++|.+....+..+.. .++|++|++++|.++
T Consensus 248 -~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~ 326 (461)
T 1z7x_W 248 -CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326 (461)
T ss_dssp -HHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCB
T ss_pred -HHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCc
Confidence 011122345666666666666532 3444455566666666666554332222221 135555555555555
Q ss_pred cc----CCCCcCCCCCCCEEEccCCcCCCCCCccccc-----CCCCceEEccCCcccc----ccchhhhccccccccccc
Q 001238 473 GF----IPPEIGNLKNLNFLDLGSNRLTGSIPDEITG-----CRNLTFLDVHSNSIAG----NLPAGLHQLVRLQFADLS 539 (1117)
Q Consensus 473 ~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls 539 (1117)
+. ++..+..+++|++|+|++|++++..+..+.. .++|++|+|++|.|++ .+|..+..+++|+.|+++
T Consensus 327 ~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~ 406 (461)
T 1z7x_W 327 AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 406 (461)
T ss_dssp GGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECC
T ss_pred hHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECC
Confidence 33 2334444555666666666555433333332 4456666666666554 445555555555555555
Q ss_pred CCcCC
Q 001238 540 DNSVG 544 (1117)
Q Consensus 540 ~N~i~ 544 (1117)
+|+|+
T Consensus 407 ~N~i~ 411 (461)
T 1z7x_W 407 NNCLG 411 (461)
T ss_dssp SSSCC
T ss_pred CCCCC
Confidence 55444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-35 Score=348.83 Aligned_cols=239 Identities=21% Similarity=0.125 Sum_probs=122.1
Q ss_pred CCcccccceeecccccccCCCccccc-----CCCCCCeeeccCccCCCC----CCCCcccccccceeccCCCcccccC--
Q 001238 407 ISNCQNLEAVDLSQNGLTGPIPRGIF-----QLKKLNKLLLLSNNLSGV----IPPEMGNCSSLIRFRANSNKLTGFI-- 475 (1117)
Q Consensus 407 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~-- 475 (1117)
+..+++|++|+|++|.++...+..+. ..++|++|++++|+++.. ++..+..+++|++|++++|++++..
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 33445555555555555432222222 133555555555555542 2334444555555555555554321
Q ss_pred ---CCCcCCCCCCCEEEccCCcCCCC----CCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCC
Q 001238 476 ---PPEIGNLKNLNFLDLGSNRLTGS----IPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS 548 (1117)
Q Consensus 476 ---~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~ 548 (1117)
+..+..+++|++|+|++|++++. ++..+..+++|++|++++|.+.+..+..+...
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~------------------ 307 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET------------------ 307 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH------------------
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH------------------
Confidence 12222455566666666665532 34445555566666666665554333333322
Q ss_pred CCcCCCccccEEeccccccCCC----CCcccccccceeEEeccccccccccccccCC-----chhHHHhhcCCCCcccC-
Q 001238 549 PDLGSLSSLTKLVLNKNRFAGS----IPSQLGSCVKLQLLDLSSNQLSGNIPASLGK-----IPALAIALNLSWNQICG- 618 (1117)
Q Consensus 549 ~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~~l~~~L~Ls~N~l~~- 618 (1117)
.....++|+.|++++|.+++. ++..+..+++|+.|||++|++++..+..+.. .+.+ +.|+|++|++++
T Consensus 308 -l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L-~~L~L~~n~i~~~ 385 (461)
T 1z7x_W 308 -LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL-RVLWLADCDVSDS 385 (461)
T ss_dssp -HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCC-CEEECTTSCCCHH
T ss_pred -hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCce-EEEECCCCCCChh
Confidence 001113455555555555433 2334445566666666666665443333321 2334 556666666664
Q ss_pred ---CccccccCCCCccEEeccCccccCCc-chhh-----hcccceEEEeecccccC
Q 001238 619 ---ELPAELTGLNKLGILDLSHNELSGDL-HFLA-----ELQNLVVLNVSHNNFSG 665 (1117)
Q Consensus 619 ---~~p~~l~~l~~L~~LdLs~N~l~~~~-~~l~-----~l~~L~~L~ls~N~l~~ 665 (1117)
.+|..+..+++|+.|||++|++++.. ..+. ....|+.|++.+|.+..
T Consensus 386 ~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 386 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp HHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred hHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 56677777788888888888877532 1111 12347777777766653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=282.86 Aligned_cols=283 Identities=22% Similarity=0.244 Sum_probs=188.9
Q ss_pred CCcceeeEEecCCCcEEEEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCC--CC
Q 001238 61 TPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTG--EI 138 (1117)
Q Consensus 61 ~~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~ 138 (1117)
+.|.|++|.|+..+ + ..+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++. .+
T Consensus 5 C~C~~~~l~c~~~~-----------l-~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 70 (306)
T 2z66_A 5 CSCSGTEIRCNSKG-----------L-TSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70 (306)
T ss_dssp CEEETTEEECCSSC-----------C-SSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEE
T ss_pred CeeCCCEEEcCCCC-----------c-ccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCc
Confidence 34899999997433 1 23555443 578899999999984333447899999999999999873 33
Q ss_pred chhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCc-ccccCcccchhhhccCCCCCCCCCCccccc
Q 001238 139 PRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIP-ATIGKLKNLEAIRAGGNKNLGGSLPHEIGN 217 (1117)
Q Consensus 139 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~ 217 (1117)
|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..++
T Consensus 71 ~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~----------------------- 126 (306)
T 2z66_A 71 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR----------------------- 126 (306)
T ss_dssp EHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCT-----------------------
T ss_pred ccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhcc-----------------------
Confidence 677777888888888888887 677778888888888888888775322 2233333
Q ss_pred cccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCC-cCCccCCCCCCCcEE
Q 001238 218 CTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTG-SIPSKLGNLKNLVNL 296 (1117)
Q Consensus 218 l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L 296 (1117)
+|++|++++|.+.+..+..+..+++|++|++++|.+++ .+|..+..+++|++|
T Consensus 127 --------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 180 (306)
T 2z66_A 127 --------------------------NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180 (306)
T ss_dssp --------------------------TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred --------------------------CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEE
Confidence 33333333333444455556666777777777777765 466677777777777
Q ss_pred EccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCC-CCcEEEecCccc
Q 001238 297 FLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQ-RLAQIELDNNQI 375 (1117)
Q Consensus 297 ~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l 375 (1117)
++++|++++..|..|..+++|++|+|++|.+++..+..+..+++|++|+|++|++++..|..+..++ +|++|++++|.+
T Consensus 181 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~ 260 (306)
T 2z66_A 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260 (306)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCE
T ss_pred ECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCe
Confidence 7777777766677777777777777777777766666677777777777777777777777777763 777777777777
Q ss_pred cCCCCc-c-cccccchHHHHhccccccccCCCCC
Q 001238 376 TGAIPS-E-FGNLSNLTLLFVWHNRLEGEIPPSI 407 (1117)
Q Consensus 376 ~~~~p~-~-~~~l~~L~~L~L~~N~l~~~~~~~~ 407 (1117)
++..+. + ...+...+.+.+..+.+....|..+
T Consensus 261 ~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~ 294 (306)
T 2z66_A 261 ACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 294 (306)
T ss_dssp ECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGG
T ss_pred ecccChHHHHHHHHhhhhhhccccccccCCchhh
Confidence 643211 1 1223333444444444444444443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-33 Score=341.47 Aligned_cols=450 Identities=13% Similarity=0.100 Sum_probs=269.1
Q ss_pred CcceeeEEecCCCcEEEEecccccccCcCCccccccccCCeEeccCCCC---CCCchhhh------------cccccCcE
Q 001238 62 PCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNL---TGSIPKEI------------ASLNQLNY 126 (1117)
Q Consensus 62 ~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l---~~~~p~~~------------~~l~~L~~ 126 (1117)
|++|++|.+....++ .+ .. ......+..+..+++|++|+|+++.. .+.+|..+ ..+++|++
T Consensus 41 ck~W~~~~~~~~~~l-~~--~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~ 116 (592)
T 3ogk_B 41 CRRWFKIDSETREHV-TM--AL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKS 116 (592)
T ss_dssp CHHHHHHHHHHCCEE-EE--SC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCE
T ss_pred hHHHHHhhhccccEE-EE--ee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCe
Confidence 447999865432222 22 11 12223344566788899999987432 12333322 27899999
Q ss_pred eeccCCCcCCCCchhhhhh--hhhhhhhccCCC-cCC-CCchhccCCcCCcEEeccCCCCCCC----CcccccCcccchh
Q 001238 127 LDLSENSLTGEIPRELCSL--LRLEQLRLNSNQ-LEG-AIPIQIGNLSSLTQLFLYDNQLTDA----IPATIGKLKNLEA 198 (1117)
Q Consensus 127 L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~N~-l~~-~~p~~~~~L~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~ 198 (1117)
|+|++|.+++..+..+..+ .+|++|+|++|. ++. .++..+.++++|++|+|++|.+++. ++..+..+++|++
T Consensus 117 L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~ 196 (592)
T 3ogk_B 117 VHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEV 196 (592)
T ss_dssp EEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCE
T ss_pred EEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccE
Confidence 9999999987777777774 459999999887 221 2344455789999999999998765 3334455666777
Q ss_pred hhccCCCCC---CCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecC
Q 001238 199 IRAGGNKNL---GGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLY 275 (1117)
Q Consensus 199 L~l~~n~~~---~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~ 275 (1117)
|++++|... .+.++..+.++++|+.| ++.+|.+.+ +|..+..+++|++|+++
T Consensus 197 L~L~~n~~~~~~~~~l~~~~~~~~~L~~L------------------------~L~~~~~~~-l~~~~~~~~~L~~L~l~ 251 (592)
T 3ogk_B 197 LNFYMTEFAKISPKDLETIARNCRSLVSV------------------------KVGDFEILE-LVGFFKAAANLEEFCGG 251 (592)
T ss_dssp EECTTCCCSSCCHHHHHHHHHHCTTCCEE------------------------ECSSCBGGG-GHHHHHHCTTCCEEEEC
T ss_pred EEeeccCCCccCHHHHHHHHhhCCCCcEE------------------------eccCccHHH-HHHHHhhhhHHHhhccc
Confidence 777666531 01222223344444444 444444433 33444555555555554
Q ss_pred CCccC---CcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCc-cccCCCCCcceEecccccc
Q 001238 276 ENALT---GSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIP-QTLGNLTSLQELQLSVNQI 351 (1117)
Q Consensus 276 ~n~l~---~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l 351 (1117)
.+... +..+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|++|+++++..
T Consensus 252 ~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~ 330 (592)
T 3ogk_B 252 SLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIG 330 (592)
T ss_dssp BCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGH
T ss_pred ccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccC
Confidence 32221 223344555666666666654322 445555566666666666666553322 2345666666666663322
Q ss_pred cCcccccccCCCCCcEEEec-----------CccccCCCC-cccccccchHHHHhccccccccCCCCCCc-ccccceeec
Q 001238 352 SGEIPAQIGNCQRLAQIELD-----------NNQITGAIP-SEFGNLSNLTLLFVWHNRLEGEIPPSISN-CQNLEAVDL 418 (1117)
Q Consensus 352 ~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L 418 (1117)
.+.++..+..+++|++|+++ .|.+++... ..+..+++|++|+++.|++++..+..+.. +++|+.|++
T Consensus 331 ~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l 410 (592)
T 3ogk_B 331 DRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRL 410 (592)
T ss_dssp HHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEE
T ss_pred HHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEE
Confidence 22333334456667777776 244443211 12334666777777667666655544543 677888888
Q ss_pred c----cccccCC-----CcccccCCCCCCeeeccCc--cCCCCCCCCcc-cccccceeccCCCcccc-cCCCCcCCCCCC
Q 001238 419 S----QNGLTGP-----IPRGIFQLKKLNKLLLLSN--NLSGVIPPEMG-NCSSLIRFRANSNKLTG-FIPPEIGNLKNL 485 (1117)
Q Consensus 419 s----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~~~~~~~~~-~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L 485 (1117)
+ .|.+++. ++..+..+++|++|++++| .+++..+..+. .+++|++|++++|++++ .++..+..+++|
T Consensus 411 ~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L 490 (592)
T 3ogk_B 411 VLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNL 490 (592)
T ss_dssp EECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTC
T ss_pred eecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCccc
Confidence 5 6667642 3333556788888888743 35544444443 37788888998888876 334456778999
Q ss_pred CEEEccCCcCCCC-CCcccccCCCCceEEccCCccccccchhhh-cccccccccccCC
Q 001238 486 NFLDLGSNRLTGS-IPDEITGCRNLTFLDVHSNSIAGNLPAGLH-QLVRLQFADLSDN 541 (1117)
Q Consensus 486 ~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N 541 (1117)
++|+|++|.+++. ++..+..+++|++|+|++|++++.....+. .++.+....+..+
T Consensus 491 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 491 QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp CEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred CeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 9999999998754 334456789999999999998865433333 4565555544443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=275.05 Aligned_cols=249 Identities=22% Similarity=0.257 Sum_probs=207.2
Q ss_pred cEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCC--CccccCCCCCcceEecc
Q 001238 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGS--IPQTLGNLTSLQELQLS 347 (1117)
Q Consensus 270 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~--~p~~l~~l~~L~~L~Ls 347 (1117)
+.++++++.++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++.. .|..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 46788888887 5676554 6888888888888855555678888899999998888733 25667778889999999
Q ss_pred cccccCcccccccCCCCCcEEEecCccccCCCC-cccccccchHHHHhccccccccCCCCCCcccccceeecccccccC-
Q 001238 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIP-SEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTG- 425 (1117)
Q Consensus 348 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~- 425 (1117)
+|.++ .+|..+..+++|++|++++|++++..+ ..|..+++|++|++++|++.+..+..+..+++|++|+|++|.+++
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 99888 567778888899999999998886655 578888888888888888888888888888999999999998876
Q ss_pred CCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCccccc
Q 001238 426 PIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITG 505 (1117)
Q Consensus 426 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 505 (1117)
.+|..+..+++|++|++++|++++..|..|..+++|++|++++|++++..+..+..+++|++|+|++|++++..|..+..
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 57888888889999999999998888888888999999999999998877778888999999999999999888888888
Q ss_pred CC-CCceEEccCCccccc
Q 001238 506 CR-NLTFLDVHSNSIAGN 522 (1117)
Q Consensus 506 l~-~L~~L~Ls~N~l~~~ 522 (1117)
++ +|++|+|++|.+.+.
T Consensus 246 ~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 246 FPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CCTTCCEEECTTCCEECS
T ss_pred hhccCCEEEccCCCeecc
Confidence 84 899999999998764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=290.06 Aligned_cols=284 Identities=19% Similarity=0.190 Sum_probs=195.6
Q ss_pred CCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCccccccee
Q 001238 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAV 416 (1117)
Q Consensus 337 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 416 (1117)
.++.....++++|.++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|++++..+..|.++++|++|
T Consensus 29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 3455566888888888 5666554 478899999999887766688888888888888888888777888888888888
Q ss_pred ecccccccCCCcccccCCCCCCeeeccCccCCCCCC-CCcccccccceeccCCC-cccccCCCCcCCCCCCCEEEccCCc
Q 001238 417 DLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIP-PEMGNCSSLIRFRANSN-KLTGFIPPEIGNLKNLNFLDLGSNR 494 (1117)
Q Consensus 417 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~ 494 (1117)
+|++|++++..+..+..+++|++|++++|++++..+ ..|.++++|++|++++| .+++..+..|.++++|++|++++|+
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 888888886444447788888888888888886555 47788888888888887 4666667778888888888888888
Q ss_pred CCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcc
Q 001238 495 LTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ 574 (1117)
Q Consensus 495 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 574 (1117)
+++..|..+..+++|++|++++|.+....+..+..+++|+.|++++|.++++....+..
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~--------------------- 244 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST--------------------- 244 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-------------------------
T ss_pred cCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc---------------------
Confidence 88777888888888888888888887544444555777777777777777654433221
Q ss_pred cccccceeEEecccccccc----ccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcc
Q 001238 575 LGSCVKLQLLDLSSNQLSG----NIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLH 645 (1117)
Q Consensus 575 ~~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~ 645 (1117)
......++.++|++|.+++ .+|..+..++++ +.|+|++|+|+...+..|..+++|+.|+|++|++.|+++
T Consensus 245 ~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L-~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGL-LELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp --CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccchhhccccccccccCcchhhhHHHHhcccCC-CEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 1112334444554444442 234444444444 444555555542222224556666666666666666554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=272.06 Aligned_cols=253 Identities=23% Similarity=0.277 Sum_probs=218.4
Q ss_pred ceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCC
Q 001238 414 EAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493 (1117)
Q Consensus 414 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 493 (1117)
+.++++++.++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 57888888887 466554 468888888888888887788888889999999999888888888888999999999999
Q ss_pred c-CCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCC
Q 001238 494 R-LTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIP 572 (1117)
Q Consensus 494 ~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 572 (1117)
+ ++...|..|..+++|++|++++|.+++..+..|..+++|++|++++|+++++.+..|..+++|+.|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 7 777778888889999999999999988888888889999999999999998888888899999999999999987777
Q ss_pred cccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcchhhhccc
Q 001238 573 SQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQN 652 (1117)
Q Consensus 573 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~l~~l~~ 652 (1117)
..|..+++|+.|+|++|++++..|..+..++++ +.|+|++|++++..+..+..+++|+.|+|++|++.++++..+-...
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~ 249 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL-MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW 249 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC-CEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccc-cEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHH
Confidence 778889999999999999998888899888888 7899999999988888899999999999999999998877555556
Q ss_pred ceEEEeecccccCCCCCC
Q 001238 653 LVVLNVSHNNFSGRVPDT 670 (1117)
Q Consensus 653 L~~L~ls~N~l~~~~p~~ 670 (1117)
++.++.+.|.+.+..|+.
T Consensus 250 l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 250 LQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp HHHCCSEECCCBEEESGG
T ss_pred HHhcccccCccccCCchH
Confidence 777888999999888864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-32 Score=333.39 Aligned_cols=442 Identities=16% Similarity=0.147 Sum_probs=294.9
Q ss_pred CCCCchhhhcccccCcEeeccCCCc---CCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCC
Q 001238 110 LTGSIPKEIASLNQLNYLDLSENSL---TGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAI 186 (1117)
Q Consensus 110 l~~~~p~~~~~l~~L~~L~Ls~N~l---~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~ 186 (1117)
+....+..+.++++|++|+|+++.. .+.+|..++... ...++.....+++|++|+|++|.+++..
T Consensus 61 ~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~------------~~~l~~l~~~~~~L~~L~L~~~~i~~~~ 128 (592)
T 3ogk_B 61 YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYV------------TPWVTEISNNLRQLKSVHFRRMIVSDLD 128 (592)
T ss_dssp GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBC------------HHHHHHHHHHCTTCCEEEEESCBCCHHH
T ss_pred cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccc------------hHHHHHHHhhCCCCCeEEeeccEecHHH
Confidence 3334555567888888888877532 133443322100 0001111224445555555555544444
Q ss_pred cccccCc--ccchhhhccCCCCCC-CCCCcccccccccccccccccccccc----CCcccccccccceeeccccccc---
Q 001238 187 PATIGKL--KNLEAIRAGGNKNLG-GSLPHEIGNCTNLVMIGLAETSISGF----LPPTLGLLKRLQTIAIYTALLS--- 256 (1117)
Q Consensus 187 p~~~~~l--~~L~~L~l~~n~~~~-~~lp~~l~~l~~L~~L~l~~~~~~~~----lp~~l~~l~~L~~L~l~~~~l~--- 256 (1117)
+..++.+ ++|++|++++|.... ..++..+.++++|++|++++|.+.+. ++..+..+++|+.|++++|.+.
T Consensus 129 ~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~ 208 (592)
T 3ogk_B 129 LDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKIS 208 (592)
T ss_dssp HHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCC
T ss_pred HHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccC
Confidence 4444432 225555555443111 01122223567777777777776655 3334567788888888888876
Q ss_pred -ccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCc---ccCCcCCCCCCCCCEEEcCCCcCCCCCc
Q 001238 257 -GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLV---GIIPPELGNCSQLSIIDISMNSLTGSIP 332 (1117)
Q Consensus 257 -~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~---~~~p~~~~~l~~L~~LdLs~N~l~~~~p 332 (1117)
+.++..+..+++|++|+|++|.+.+ +|..+.++++|++|+++.+... +..+..+..+++|+.|+++++... .+|
T Consensus 209 ~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~ 286 (592)
T 3ogk_B 209 PKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMP 286 (592)
T ss_dssp HHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGG
T ss_pred HHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHH
Confidence 3455556788999999999999985 7788999999999999864433 334457788999999999987544 678
Q ss_pred cccCCCCCcceEecccccccCccc-ccccCCCCCcEEEecCccccCCCCcccccccchHHHHhc-----------ccccc
Q 001238 333 QTLGNLTSLQELQLSVNQISGEIP-AQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVW-----------HNRLE 400 (1117)
Q Consensus 333 ~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~ 400 (1117)
..+..+++|++|+|++|.+++... ..+.++++|++|+++++...+.++..+..+++|++|+++ .|.++
T Consensus 287 ~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~ 366 (592)
T 3ogk_B 287 ILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVS 366 (592)
T ss_dssp GGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCC
T ss_pred HHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccC
Confidence 888889999999999999875443 446889999999999443333334444667889999999 36666
Q ss_pred ccCC-CCCCcccccceeecccccccCCCcccccC-CCCCCeeecc----CccCCCC-----CCCCcccccccceeccCCC
Q 001238 401 GEIP-PSISNCQNLEAVDLSQNGLTGPIPRGIFQ-LKKLNKLLLL----SNNLSGV-----IPPEMGNCSSLIRFRANSN 469 (1117)
Q Consensus 401 ~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L~~L~l~~N 469 (1117)
+... ..+..+++|++|+++.|.+++..+..+.. +++|+.|+++ .|++++. ++..+.++++|++|+++.|
T Consensus 367 ~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~ 446 (592)
T 3ogk_B 367 QRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR 446 (592)
T ss_dssp HHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECC
T ss_pred HHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecC
Confidence 4322 22345789999999999998766666665 8899999996 6777764 2223667889999999743
Q ss_pred --cccccCCCCcC-CCCCCCEEEccCCcCCC-CCCcccccCCCCceEEccCCccccc-cchhhhcccccccccccCCcCC
Q 001238 470 --KLTGFIPPEIG-NLKNLNFLDLGSNRLTG-SIPDEITGCRNLTFLDVHSNSIAGN-LPAGLHQLVRLQFADLSDNSVG 544 (1117)
Q Consensus 470 --~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~i~ 544 (1117)
.+++..+..+. .+++|++|+|++|++++ .++..+.++++|++|+|++|.|++. ++..+..+++|+.|++++|+++
T Consensus 447 ~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it 526 (592)
T 3ogk_B 447 QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526 (592)
T ss_dssp GGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred CCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence 36655444444 37889999999999875 3445567888999999999998754 3444567888999999999887
Q ss_pred CCCCCCcC-CCccccEEecccc
Q 001238 545 GMLSPDLG-SLSSLTKLVLNKN 565 (1117)
Q Consensus 545 ~~~~~~~~-~l~~L~~L~L~~N 565 (1117)
+.....+. .++.+....+..+
T Consensus 527 ~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 527 MTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp TTCTTGGGGCCTTEEEEEECCC
T ss_pred HHHHHHHHHhCCCcEEEEecCc
Confidence 76544443 4565655555543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-29 Score=284.30 Aligned_cols=277 Identities=19% Similarity=0.214 Sum_probs=144.1
Q ss_pred CCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEe
Q 001238 266 CTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQ 345 (1117)
Q Consensus 266 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ 345 (1117)
|+.....++++|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (353)
T 2z80_A 30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106 (353)
T ss_dssp ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence 334444556666665 4554443 3566666666666655444566666666666666666655555566666666666
Q ss_pred cccccccCcccccccCCCCCcEEEecCccccCCCC-cccccccchHHHHhccc-cccccCCCCCCcccccceeecccccc
Q 001238 346 LSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIP-SEFGNLSNLTLLFVWHN-RLEGEIPPSISNCQNLEAVDLSQNGL 423 (1117)
Q Consensus 346 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l 423 (1117)
|++|++++..+..|.++++|++|++++|++++..+ ..|.++++|++|++++| .+.+..+..|..+++|++|++++|++
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence 66666654444445556666666666665553222 24444444444444444 23333334444444444444444444
Q ss_pred cCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCccc
Q 001238 424 TGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI 503 (1117)
Q Consensus 424 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 503 (1117)
++..|..+..+++|++|++++|++.. ..+..+..+++|+.|++++|++++..+..+
T Consensus 187 ~~~~~~~l~~l~~L~~L~l~~n~l~~------------------------~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l 242 (353)
T 2z80_A 187 QSYEPKSLKSIQNVSHLILHMKQHIL------------------------LLEIFVDVTSSVECLELRDTDLDTFHFSEL 242 (353)
T ss_dssp CEECTTTTTTCSEEEEEEEECSCSTT------------------------HHHHHHHHTTTEEEEEEESCBCTTCCCC--
T ss_pred CccCHHHHhccccCCeecCCCCcccc------------------------chhhhhhhcccccEEECCCCcccccccccc
Confidence 43333333333333333333333322 111112223344444444444433322222
Q ss_pred c---cCCCCceEEccCCcccc----ccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCC
Q 001238 504 T---GCRNLTFLDVHSNSIAG----NLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAG 569 (1117)
Q Consensus 504 ~---~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 569 (1117)
. ....++.++|++|.+.+ .+|..+..+++|+.|++++|+|+.++...|..+++|+.|+|++|++.+
T Consensus 243 ~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 243 STGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp ----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence 1 23445555555555554 355566677777777777777777666667777777777887777764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=279.70 Aligned_cols=248 Identities=22% Similarity=0.236 Sum_probs=200.4
Q ss_pred CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecc
Q 001238 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347 (1117)
Q Consensus 268 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls 347 (1117)
....++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4567888888888 6777665 688899999999988888889999999999999999987777888889999999999
Q ss_pred cccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccc-cccccCCCCCCcccccceeecccccccCC
Q 001238 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHN-RLEGEIPPSISNCQNLEAVDLSQNGLTGP 426 (1117)
Q Consensus 348 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 426 (1117)
+|+|++..+..|..+++|++|+|++|+++...+..|.++++|+.|++++| .+....+..|.++++|++|+|++|+++ .
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~ 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence 99998777778888899999999999988777778888888888888884 455444456888888888888888887 3
Q ss_pred CcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccC
Q 001238 427 IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506 (1117)
Q Consensus 427 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 506 (1117)
+| .+..+++|++|+|++|+|++..|..|.++++|++|++++|++++..+..|.++++|++|+|++|+|++..+..|..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 55 36777788888888888887777778888888888888888877777777778888888888888877666777777
Q ss_pred CCCceEEccCCccc
Q 001238 507 RNLTFLDVHSNSIA 520 (1117)
Q Consensus 507 ~~L~~L~Ls~N~l~ 520 (1117)
++|+.|+|++|.+.
T Consensus 279 ~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 279 HHLERIHLHHNPWN 292 (440)
T ss_dssp TTCCEEECCSSCEE
T ss_pred cCCCEEEcCCCCcc
Confidence 77788888777765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=283.35 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=151.0
Q ss_pred CCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeecc
Q 001238 364 RLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLL 443 (1117)
Q Consensus 364 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 443 (1117)
....++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3456666666666 4454433 455556666666665555556666666666666666655444555555555555555
Q ss_pred CccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccC-CcCCCCCCcccccCCCCceEEccCCccccc
Q 001238 444 SNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGS-NRLTGSIPDEITGCRNLTFLDVHSNSIAGN 522 (1117)
Q Consensus 444 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 522 (1117)
+|+|+...+..|..+++|++|++++|++++..+..|.++++|++|+|++ |.+....+..|.++++|++|+|++|+|+
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-- 198 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-- 198 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS--
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc--
Confidence 5555554444555555555555555555544444555555555555555 2333233334444555555555555444
Q ss_pred cchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCc
Q 001238 523 LPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKI 602 (1117)
Q Consensus 523 ~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 602 (1117)
.++ .+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+
T Consensus 199 ----------------------~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 254 (440)
T 3zyj_A 199 ----------------------EIP--NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNL 254 (440)
T ss_dssp ----------------------SCC--CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTC
T ss_pred ----------------------ccc--ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCC
Confidence 332 24555566666666666665556666666666666666666666666666666
Q ss_pred hhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch
Q 001238 603 PALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 603 ~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
++| +.|+|++|+|++..+..|..+++|+.|+|++|++.|++..
T Consensus 255 ~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 255 QSL-VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TTC-CEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred CCC-CEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 666 5666666666666667788889999999999999997754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=283.50 Aligned_cols=232 Identities=21% Similarity=0.198 Sum_probs=145.9
Q ss_pred ccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEcc
Q 001238 412 NLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLG 491 (1117)
Q Consensus 412 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 491 (1117)
+++.|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 44445555555544444444455555555555555555445555555555555555555554444445555555555555
Q ss_pred CCcCCCCCCcccccCCCCceEEccC-CccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCC
Q 001238 492 SNRLTGSIPDEITGCRNLTFLDVHS-NSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGS 570 (1117)
Q Consensus 492 ~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 570 (1117)
+|+|+...+..|..+++|++|++++ |.+....+..|..+++|+.|++++|++++++ .+..+++|+.|+|++|+|++.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP--NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC--CCTTCTTCCEEECTTSCCSEE
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc--cccccccccEEECcCCcCccc
Confidence 5555544444555555555555555 3344333344555666666666666665552 356667777777777777777
Q ss_pred CCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch
Q 001238 571 IPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 571 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
.|..|..+++|+.|+|++|++++..|..|..+++| +.|+|++|+|++..+..|..+++|+.|+|++|++.|++..
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL-VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTC-CEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCC-CEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 77777777777777777777777777777777777 6777777777777777788888999999999999887754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-27 Score=279.79 Aligned_cols=248 Identities=21% Similarity=0.240 Sum_probs=180.3
Q ss_pred CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecc
Q 001238 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347 (1117)
Q Consensus 268 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls 347 (1117)
....++.+++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 3466777777777 5666554 577888888888887777778888888888888888887777778888888888888
Q ss_pred cccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcc-ccccccCCCCCCcccccceeecccccccCC
Q 001238 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWH-NRLEGEIPPSISNCQNLEAVDLSQNGLTGP 426 (1117)
Q Consensus 348 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 426 (1117)
+|+|++..+..|.++++|++|+|++|+++...+..|.++++|+.|++++ |.+....+..|..+++|++|+|++|++++
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~- 210 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD- 210 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-
Confidence 8888766666777788888888888887766666777777777777777 34444444467777778888888887774
Q ss_pred CcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccC
Q 001238 427 IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506 (1117)
Q Consensus 427 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 506 (1117)
+| .+..+++|++|+|++|+|++..|..|.++++|++|++++|++++..+..|.++++|+.|+|++|+|++..+..|..+
T Consensus 211 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 211 MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 34 35666777777777777777666777777777777777777776666677777777777777777776666666667
Q ss_pred CCCceEEccCCccc
Q 001238 507 RNLTFLDVHSNSIA 520 (1117)
Q Consensus 507 ~~L~~L~Ls~N~l~ 520 (1117)
++|+.|+|++|.+.
T Consensus 290 ~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 290 RYLVELHLHHNPWN 303 (452)
T ss_dssp TTCCEEECCSSCEE
T ss_pred cCCCEEEccCCCcC
Confidence 77777777777665
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=275.54 Aligned_cols=248 Identities=19% Similarity=0.234 Sum_probs=129.4
Q ss_pred hcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCc-CCCCchhcc-------CCcCCcEEeccCCCCCCCCccc
Q 001238 118 IASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL-EGAIPIQIG-------NLSSLTQLFLYDNQLTDAIPAT 189 (1117)
Q Consensus 118 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~-------~L~~L~~L~L~~N~l~~~~p~~ 189 (1117)
++..++|++|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 44555666666666666 455555544 66666666666 334555554 5666666666666666655555
Q ss_pred c--cCcccchhhhccCCCCCCCCCCcccccc-----ccccccccccccccccCCcccccccccceeeccccccccc--CC
Q 001238 190 I--GKLKNLEAIRAGGNKNLGGSLPHEIGNC-----TNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQ--IP 260 (1117)
Q Consensus 190 ~--~~l~~L~~L~l~~n~~~~~~lp~~l~~l-----~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~--~p 260 (1117)
+ +.+++|++|++++|+. .+. |..++.+ ++|++|++++|.+.+..|..+..+++|++|++++|.+.+. +|
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l-~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSW-ATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp SSSCCSCCCSEEEEESCBC-SSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHhcCCCccEEEccCCCC-cch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 4 5555555555555542 122 4444443 4555555555555555445555555555555555554432 12
Q ss_pred cCC--CCCCCCcEEecCCCccCC--cCC-ccCCCCCCCcEEEccCCcCcccCC-cCCCCCCCCCEEEcCCCcCCCCCccc
Q 001238 261 PEL--GDCTELQYIYLYENALTG--SIP-SKLGNLKNLVNLFLWQNNLVGIIP-PELGNCSQLSIIDISMNSLTGSIPQT 334 (1117)
Q Consensus 261 ~~l--~~l~~L~~L~L~~n~l~~--~~p-~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~LdLs~N~l~~~~p~~ 334 (1117)
..+ ..+++|++|+|++|++++ .++ ..+.++++|++|+|++|++++..| ..+..+++|++|+|++|+++ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 222 455555555555555552 111 222345555555555555555443 33444555555555555555 44444
Q ss_pred cCCCCCcceEecccccccCcccccccCCCCCcEEEecCcccc
Q 001238 335 LGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376 (1117)
Q Consensus 335 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 376 (1117)
+. ++|++|+|++|+|++. |. +..+++|++|++++|+++
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 43 4555555555555533 33 555555555555555554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-29 Score=278.69 Aligned_cols=250 Identities=21% Similarity=0.244 Sum_probs=163.2
Q ss_pred ccccccchHHHHhccccccccCCCCCCcccccceeeccccccc-CCCccccc-------CCCCCCeeeccCccCCCCCCC
Q 001238 382 EFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLT-GPIPRGIF-------QLKKLNKLLLLSNNLSGVIPP 453 (1117)
Q Consensus 382 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~ 453 (1117)
.++..++|+.|++++|.+ .+|..+... |+.|+|++|.++ ..+|..+. ++++|++|+|++|++++.+|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 356677788888888888 566555443 888888888883 34565554 678888888888888877777
Q ss_pred Cc--ccccccceeccCCCcccccCCCCcCCC-----CCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccc--cc
Q 001238 454 EM--GNCSSLIRFRANSNKLTGFIPPEIGNL-----KNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGN--LP 524 (1117)
Q Consensus 454 ~~--~~l~~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~ 524 (1117)
.+ ..+++|++|++++|++++. |..++.+ ++|++|+|++|++++..|..|..+++|++|+|++|++.+. .+
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 65 7788888888888888866 6777766 7888888888888877777888888888888888887654 22
Q ss_pred hhh--hcccccccccccCCcCCCCC---CCCcCCCccccEEeccccccCCCCC-cccccccceeEEeccccccccccccc
Q 001238 525 AGL--HQLVRLQFADLSDNSVGGML---SPDLGSLSSLTKLVLNKNRFAGSIP-SQLGSCVKLQLLDLSSNQLSGNIPAS 598 (1117)
Q Consensus 525 ~~~--~~l~~L~~L~Ls~N~i~~~~---~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~ 598 (1117)
..+ ..+++|+.|++++|+|+++. ...+..+++|+.|+|++|+|++..| ..+..+++|+.|+|++|+|+ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 333 55666666666666665321 2233345556666666666655443 33444556666666666655 44443
Q ss_pred cCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcchhhhcccceEEEeecccccC
Q 001238 599 LGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSG 665 (1117)
Q Consensus 599 l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~l~~l~~L~~L~ls~N~l~~ 665 (1117)
+. ++|+.|||++|++++. |.+..+++|++|+|++|++++
T Consensus 272 ~~---------------------------~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 272 LP---------------------------AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CC---------------------------SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTC
T ss_pred cc---------------------------CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCC
Confidence 33 4555555555555544 225555555566666665553
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=265.01 Aligned_cols=225 Identities=22% Similarity=0.277 Sum_probs=133.5
Q ss_pred cEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccc
Q 001238 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVN 349 (1117)
Q Consensus 270 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N 349 (1117)
+.++.+++.++ .+|..+ .++|++|++++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 46677777776 455433 356777777777777666666777777777777777777666666777777777777777
Q ss_pred c-ccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCc
Q 001238 350 Q-ISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIP 428 (1117)
Q Consensus 350 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 428 (1117)
. +....|..|..+++|++|++++|++++..|..|.++++|++|++++|++++..+..|..+++|++|+|++|+++
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---- 166 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS---- 166 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC----
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccc----
Confidence 5 66555666666667777777666666555555555555555555555554443444444555555555555554
Q ss_pred ccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCC
Q 001238 429 RGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRN 508 (1117)
Q Consensus 429 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 508 (1117)
+..+..|..+++|++|++++|++++..|..|..+++|+.|+|++|++++..+..+..+++
T Consensus 167 --------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 226 (285)
T 1ozn_A 167 --------------------SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (285)
T ss_dssp --------------------EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred --------------------ccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence 333334444455555555555555444555555555555555555555544444555555
Q ss_pred CceEEccCCcccc
Q 001238 509 LTFLDVHSNSIAG 521 (1117)
Q Consensus 509 L~~L~Ls~N~l~~ 521 (1117)
|++|++++|.+..
T Consensus 227 L~~L~l~~N~~~c 239 (285)
T 1ozn_A 227 LQYLRLNDNPWVC 239 (285)
T ss_dssp CCEEECCSSCEEC
T ss_pred cCEEeccCCCccC
Confidence 5555555555553
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=269.10 Aligned_cols=234 Identities=19% Similarity=0.257 Sum_probs=124.7
Q ss_pred CCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEec
Q 001238 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQL 346 (1117)
Q Consensus 267 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L 346 (1117)
+++++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 45666666666666 55555666666666666666665 55555556666666666666655 45555555555555555
Q ss_pred ccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCC
Q 001238 347 SVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP 426 (1117)
Q Consensus 347 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 426 (1117)
++|++.+.+|..+.. . ..+..|..+++|++|+|++|+++ .
T Consensus 158 ~~n~~~~~~p~~~~~------------------------~---------------~~~~~~~~l~~L~~L~L~~n~l~-~ 197 (328)
T 4fcg_A 158 RACPELTELPEPLAS------------------------T---------------DASGEHQGLVNLQSLRLEWTGIR-S 197 (328)
T ss_dssp EEETTCCCCCSCSEE------------------------E---------------C-CCCEEESTTCCEEEEEEECCC-C
T ss_pred CCCCCccccChhHhh------------------------c---------------cchhhhccCCCCCEEECcCCCcC-c
Confidence 555555555443322 0 11122334444444555555444 3
Q ss_pred CcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccC
Q 001238 427 IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506 (1117)
Q Consensus 427 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 506 (1117)
+|..+..+++|++|+|++|++++ +|..++.+++|++|++++|++.+.+|..|+.+++|++|+|++|++.+.+|..+..+
T Consensus 198 lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l 276 (328)
T 4fcg_A 198 LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276 (328)
T ss_dssp CCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGC
T ss_pred chHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcC
Confidence 44444445555555555555543 23344555555555555555555555555555555555555555555555555555
Q ss_pred CCCceEEccCCccccccchhhhcccccccccccCCcCC
Q 001238 507 RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG 544 (1117)
Q Consensus 507 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 544 (1117)
++|++|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 277 ~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 55555555555555555555555555555555555443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-29 Score=302.28 Aligned_cols=185 Identities=19% Similarity=0.149 Sum_probs=131.0
Q ss_pred eeeecCCeEEEEEE-cCCCcEEEEEEeecCC----------ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEE
Q 001238 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASD----------KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 783 ~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 850 (1117)
..+.|++|.+..++ ...|+.||+|++.... ....++|.+|+++|+++ .|+||+++++++.+++..|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666643 3358899999997542 12235699999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||++|++|.+++.+. ++++.. +|+.||++||+|+|++ |||||||||+|||++++|++||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999875 336654 5889999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCC
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKP 981 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P 981 (1117)
.. ......+||++|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 392 ~~----~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DC----SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CC----ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 23345689999999999874 567889999999998887666544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-28 Score=271.41 Aligned_cols=265 Identities=20% Similarity=0.210 Sum_probs=173.9
Q ss_pred EeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCC
Q 001238 103 LVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQL 182 (1117)
Q Consensus 103 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l 182 (1117)
++++++++...++..+..+++|++|||++|.+++..|..|..+++|++|+|++|++++..| ++.+++|++|+|++|++
T Consensus 15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l 92 (317)
T 3o53_A 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92 (317)
T ss_dssp ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEE
T ss_pred eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcc
Confidence 3444444432233333444455555555555554444555555555555555555553333 55555555555555555
Q ss_pred CCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCcC
Q 001238 183 TDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE 262 (1117)
Q Consensus 183 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~ 262 (1117)
++ +| ..++|++|+++ +|.+.+..+. .+++|++|++++|.+.+..+..
T Consensus 93 ~~-l~----~~~~L~~L~l~-------------------------~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~ 139 (317)
T 3o53_A 93 QE-LL----VGPSIETLHAA-------------------------NNNISRVSCS---RGQGKKNIYLANNKITMLRDLD 139 (317)
T ss_dssp EE-EE----ECTTCCEEECC-------------------------SSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBC
T ss_pred cc-cc----CCCCcCEEECC-------------------------CCccCCcCcc---ccCCCCEEECCCCCCCCccchh
Confidence 42 11 11333333333 3333322221 2345666666666666666667
Q ss_pred CCCCCCCcEEecCCCccCCcCCccCC-CCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCc
Q 001238 263 LGDCTELQYIYLYENALTGSIPSKLG-NLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSL 341 (1117)
Q Consensus 263 l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L 341 (1117)
+..+++|++|+|++|.+++..|..+. .+++|++|+|++|.+++. +....+++|++|+|++|++++ +|..+..+++|
T Consensus 140 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L 216 (317)
T 3o53_A 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGV 216 (317)
T ss_dssp TGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE--ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTC
T ss_pred hhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc--ccccccccCCEEECCCCcCCc-chhhhcccCcc
Confidence 77788888888888888877676664 788899999999998865 233458899999999999985 44558888999
Q ss_pred ceEecccccccCcccccccCCCCCcEEEecCcccc-CCCCcccccccchHHHHhcc-ccccccCCCC
Q 001238 342 QELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT-GAIPSEFGNLSNLTLLFVWH-NRLEGEIPPS 406 (1117)
Q Consensus 342 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~ 406 (1117)
++|+|++|+|+ .+|..+..+++|+.|++++|.+. +.+|..+..+++|+.|++.+ +.+++..+..
T Consensus 217 ~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp SEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred cEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 99999999998 57778888999999999999998 77788888999999999984 4566655543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-28 Score=273.67 Aligned_cols=261 Identities=20% Similarity=0.205 Sum_probs=160.9
Q ss_pred EecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccc
Q 001238 272 IYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQI 351 (1117)
Q Consensus 272 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 351 (1117)
++++.+.+...++..+..+++|++|+|++|++++..|..|.++++|++|+|++|.+++..+ +..+++|++|+|++|++
T Consensus 15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l 92 (317)
T 3o53_A 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92 (317)
T ss_dssp ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEE
T ss_pred eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcc
Confidence 3444444433233333334445555555555544444444555555555555555543322 44555555555555555
Q ss_pred cCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccc
Q 001238 352 SGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGI 431 (1117)
Q Consensus 352 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 431 (1117)
++.. ..++|++|++++|++++..+.. +++|+.|++++|++++..+..+..+++|++|+|++|.+++..+..+
T Consensus 93 ~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 164 (317)
T 3o53_A 93 QELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164 (317)
T ss_dssp EEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGG
T ss_pred cccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHH
Confidence 4221 1245555555555555433322 3445555555665555555566666777777777777766555555
Q ss_pred c-CCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCc
Q 001238 432 F-QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLT 510 (1117)
Q Consensus 432 ~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 510 (1117)
. .+++|++|+|++|+|++.. ....+++|++|++++|++++.. ..+..+++|++|+|++|+|+ .+|..+..+++|+
T Consensus 165 ~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~ 240 (317)
T 3o53_A 165 AASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240 (317)
T ss_dssp GGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCC
T ss_pred hhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcch-hhhcccCcccEEECcCCccc-chhhHhhcCCCCC
Confidence 3 5677777777777777552 2234778888888888888554 45888899999999999998 4677888889999
Q ss_pred eEEccCCccc-cccchhhhcccccccccccCC-cCCCC
Q 001238 511 FLDVHSNSIA-GNLPAGLHQLVRLQFADLSDN-SVGGM 546 (1117)
Q Consensus 511 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N-~i~~~ 546 (1117)
.|++++|.+. +.++..+..+++|+.+++++| .+.+.
T Consensus 241 ~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~ 278 (317)
T 3o53_A 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278 (317)
T ss_dssp EEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSS
T ss_pred EEEccCCCccCcCHHHHHhccccceEEECCCchhccCC
Confidence 9999999998 778888888888888888844 34443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-26 Score=275.53 Aligned_cols=266 Identities=27% Similarity=0.307 Sum_probs=164.7
Q ss_pred CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecc
Q 001238 268 ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347 (1117)
Q Consensus 268 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls 347 (1117)
+++.|++++|.++ .+|..+. ++|++|+|++|+++ .+|. .+++|++|+|++|++++ +|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence 5888999999998 6787665 78888999988888 4554 56888888888888884 554 56788888888
Q ss_pred cccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCC
Q 001238 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPI 427 (1117)
Q Consensus 348 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 427 (1117)
+|+|++ +|. .+++|+.|++++|++++ +|.. +++|++|++++| ++++ +
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N------------------------~l~~-l 156 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDN------------------------QLAS-L 156 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS------------------------CCSC-C
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCC------------------------cCCC-c
Confidence 888874 333 45677777777777774 3332 244444444444 4442 2
Q ss_pred cccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCC
Q 001238 428 PRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCR 507 (1117)
Q Consensus 428 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 507 (1117)
|. .+.+|+.|++++|+|+++ | ..+++|+.|++++|+|++ +|.. +++|+.|++++|.++. +|.. ++
T Consensus 157 ~~---~~~~L~~L~L~~N~l~~l-~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~ 221 (622)
T 3g06_A 157 PA---LPSELCKLWAYNNQLTSL-P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PS 221 (622)
T ss_dssp CC---CCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CT
T ss_pred CC---ccCCCCEEECCCCCCCCC-c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CC
Confidence 22 123444455555554432 2 223445555555555553 2221 2456666666666652 3322 35
Q ss_pred CCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecc
Q 001238 508 NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLS 587 (1117)
Q Consensus 508 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 587 (1117)
+|++|+|++|+|++ +| ..+++|+.|++++|+|+.++. .+++|+.|+|++|+|+ .+|..|..+++|+.|+|+
T Consensus 222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 56666666666664 33 233556666666666665544 3466777777777777 556667777777777777
Q ss_pred ccccccccccccCC
Q 001238 588 SNQLSGNIPASLGK 601 (1117)
Q Consensus 588 ~N~l~~~~p~~l~~ 601 (1117)
+|.+++.+|..+..
T Consensus 293 ~N~l~~~~~~~l~~ 306 (622)
T 3g06_A 293 GNPLSERTLQALRE 306 (622)
T ss_dssp SCCCCHHHHHHHHH
T ss_pred CCCCCCcCHHHHHh
Confidence 77777666655433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-25 Score=268.71 Aligned_cols=268 Identities=28% Similarity=0.341 Sum_probs=162.7
Q ss_pred cccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEcc
Q 001238 220 NLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLW 299 (1117)
Q Consensus 220 ~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 299 (1117)
+++.|++++|.++ .+|..+. ++|+.|++++|.+. .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 3555566666555 3444443 56666666666655 2443 4566777777777766 3554 55667777777
Q ss_pred CCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCC
Q 001238 300 QNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAI 379 (1117)
Q Consensus 300 ~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 379 (1117)
+|++++ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|++++ +|. .+.+|+.|++++|+|++ +
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-C
Confidence 777664 333 45667777777777663 4432 3667777777777663 332 23566667777777664 3
Q ss_pred CcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCccccc
Q 001238 380 PSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCS 459 (1117)
Q Consensus 380 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 459 (1117)
| ..+++|+.|++++|++++ +|.. +++|+.|++++|.++ .+|.. +++|++|+|++|+|++ +| ..++
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~ 241 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPS 241 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCT
T ss_pred c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCC
Confidence 3 334566666677776663 3332 356677777777776 34432 3567777777777765 33 3446
Q ss_pred ccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhccc
Q 001238 460 SLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLV 531 (1117)
Q Consensus 460 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 531 (1117)
+|+.|++++|+|+. +|. .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|.+++..|..+..++
T Consensus 242 ~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 242 ELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred cCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 67777777777763 333 4566777777777777 5566677777777777777777766666655544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=247.00 Aligned_cols=73 Identities=29% Similarity=0.407 Sum_probs=41.1
Q ss_pred CCCcceeeEEecCCCcEEEEecccccccCcCCccccccccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcC
Q 001238 60 ETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLT 135 (1117)
Q Consensus 60 ~~~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 135 (1117)
.++|.|.|+.|.+.+.+..++++++++.. +|..+. .++++|+|++|++++..+..|+++++|++|+|++|.++
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 74 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC
Confidence 36799999999876555566666655543 444333 34455555555554333334445555555555555444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-30 Score=316.56 Aligned_cols=459 Identities=15% Similarity=0.163 Sum_probs=252.1
Q ss_pred CcceeeEEecCCCcEEEEecccccccCcCC-ccccccccCCeEeccCCCCCC---Cc------------hhhhcccccCc
Q 001238 62 PCKWFGVSCNLNNQVVGLDLRYVDLLGHVP-TNFTSLLSLNRLVLSGTNLTG---SI------------PKEIASLNQLN 125 (1117)
Q Consensus 62 ~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~-~~~~~l~~L~~L~L~~n~l~~---~~------------p~~~~~l~~L~ 125 (1117)
|++|+++... ....+++..+. +..| ..+..+++|+.|+|+++.... .. +.-+..+++|+
T Consensus 34 ck~W~~~~~~---~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~ 108 (594)
T 2p1m_B 34 CKSWYEIERW---CRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108 (594)
T ss_dssp CHHHHHHHHH---HCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred HHHHHHhhhh---hceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence 4578887221 12234443321 2222 235677889999999875321 11 22235788999
Q ss_pred EeeccCCCcCCCCchhhh-hhhhhhhhhccCC-CcCCC-CchhccCCcCCcEEeccCCCCCCCCccccc----Ccccchh
Q 001238 126 YLDLSENSLTGEIPRELC-SLLRLEQLRLNSN-QLEGA-IPIQIGNLSSLTQLFLYDNQLTDAIPATIG----KLKNLEA 198 (1117)
Q Consensus 126 ~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~----~l~~L~~ 198 (1117)
+|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|+.
T Consensus 109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~ 188 (594)
T 2p1m_B 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188 (594)
T ss_dssp EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence 999999998877777776 6889999999998 55432 556666899999999999998775555444 3445666
Q ss_pred hhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCC--
Q 001238 199 IRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYE-- 276 (1117)
Q Consensus 199 L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~-- 276 (1117)
|++++|. +.+... .++..+..+++|+.|++.+|...+.+|..+..+++|++|+++.
T Consensus 189 L~l~~~~---~~~~~~-------------------~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~ 246 (594)
T 2p1m_B 189 LNISCLA---SEVSFS-------------------ALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYT 246 (594)
T ss_dssp EECTTCC---SCCCHH-------------------HHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCC
T ss_pred EEecccC---CcCCHH-------------------HHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEccccccc
Confidence 6665553 111100 0111122345555555555522222455555566666666433
Q ss_pred -----CccCCcCCccCCCCCCCcEE-EccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCC-ccccCCCCCcceEecccc
Q 001238 277 -----NALTGSIPSKLGNLKNLVNL-FLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSI-PQTLGNLTSLQELQLSVN 349 (1117)
Q Consensus 277 -----n~l~~~~p~~l~~l~~L~~L-~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~-p~~l~~l~~L~~L~Ls~N 349 (1117)
|.+.+ ++..+.++++|+.| .+.+... +.++..+..+++|++|+|++|.+++.. +..+..+++|++|++++|
T Consensus 247 ~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 324 (594)
T 2p1m_B 247 AEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324 (594)
T ss_dssp CCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred CccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc
Confidence 33443 34456777777777 3433322 234444446778888888888766432 223557788888888877
Q ss_pred cccCc-ccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCC-CcccccceeecccccccCCC
Q 001238 350 QISGE-IPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI-SNCQNLEAVDLSQNGLTGPI 427 (1117)
Q Consensus 350 ~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~ 427 (1117)
+... ++.....+++|++|++.++.-.| ....+.+++.....+ ..+++|+.|+++.|.+++..
T Consensus 325 -~~~~~l~~l~~~~~~L~~L~L~~~~~~g---------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~ 388 (594)
T 2p1m_B 325 -IEDAGLEVLASTCKDLRELRVFPSEPFV---------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAA 388 (594)
T ss_dssp -GHHHHHHHHHHHCTTCCEEEEECSCTTC---------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHH
T ss_pred -cCHHHHHHHHHhCCCCCEEEEecCcccc---------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHH
Confidence 4322 22223357778888774432100 000111111100001 12345555555555555433
Q ss_pred ccccc-CCCCCCeeecc--C----ccCCCCCC-----CCcccccccceeccCCCcccccCCCCcCC-CCCCCEEEccCCc
Q 001238 428 PRGIF-QLKKLNKLLLL--S----NNLSGVIP-----PEMGNCSSLIRFRANSNKLTGFIPPEIGN-LKNLNFLDLGSNR 494 (1117)
Q Consensus 428 p~~~~-~l~~L~~L~L~--~----N~l~~~~~-----~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~ 494 (1117)
+..+. .+++|+.|+++ + |+++.... ..+..+++|++|++++ .+++..+..+.. +++|+.|+|++|.
T Consensus 389 ~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~ 467 (594)
T 2p1m_B 389 LITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAG 467 (594)
T ss_dssp HHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCC
T ss_pred HHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCC
Confidence 33333 35556666665 2 33432111 1144556677777755 555444444444 6677777777777
Q ss_pred CCCCCCccc-ccCCCCceEEccCCccccccch-hhhcccccccccccCCcCCCCCCCCc-CCCccccEEeccccc
Q 001238 495 LTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPA-GLHQLVRLQFADLSDNSVGGMLSPDL-GSLSSLTKLVLNKNR 566 (1117)
Q Consensus 495 l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~i~~~~~~~~-~~l~~L~~L~L~~N~ 566 (1117)
+++..+..+ .++++|++|+|++|.+++.... ....+++|+.|++++|+++......+ ..+++|+...+..+.
T Consensus 468 i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 468 DSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp SSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred CcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 765444444 5577777777777777544333 33446777777777777643222222 344566555555553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-26 Score=274.73 Aligned_cols=237 Identities=22% Similarity=0.182 Sum_probs=150.7
Q ss_pred CCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceE
Q 001238 265 DCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQEL 344 (1117)
Q Consensus 265 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L 344 (1117)
.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..| |..+++|++|+|++|.+++..+ .++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 33456666666666665555556666666666666666654433 5556666666666665553221 1455555
Q ss_pred ecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeeccccccc
Q 001238 345 QLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLT 424 (1117)
Q Consensus 345 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 424 (1117)
++++|.|++..+. .+++|+.|++++|.++ +..|..+..+++|+.|+|++|.++
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~------------------------~~~~~~~~~l~~L~~L~Ls~N~l~ 157 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKIT------------------------MLRDLDEGCRSRVQYLDLKLNEID 157 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCC------------------------SGGGBCGGGGSSEEEEECTTSCCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCC------------------------CCCchhhcCCCCCCEEECCCCCCC
Confidence 5555555543332 2244455555555444 444445555566666666666666
Q ss_pred CCCccccc-CCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCccc
Q 001238 425 GPIPRGIF-QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI 503 (1117)
Q Consensus 425 ~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 503 (1117)
+..|..+. .+++|+.|+|++|.|++..+ +..+++|+.|++++|+|++..| .|..+++|+.|+|++|+|++ +|..+
T Consensus 158 ~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 158 TVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKAL 233 (487)
T ss_dssp EEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred CcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhh
Confidence 55555554 56666666666666665522 2347777888888888876544 48888889999999999885 67778
Q ss_pred ccCCCCceEEccCCccc-cccchhhhccccccccccc
Q 001238 504 TGCRNLTFLDVHSNSIA-GNLPAGLHQLVRLQFADLS 539 (1117)
Q Consensus 504 ~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls 539 (1117)
..+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus 234 ~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 88889999999999987 6677778888888877765
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=275.17 Aligned_cols=238 Identities=19% Similarity=0.193 Sum_probs=183.4
Q ss_pred ccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCE
Q 001238 240 GLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSI 319 (1117)
Q Consensus 240 ~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 319 (1117)
..+++|+.|++++|.+.+..|..|..+++|++|+|++|.+++..| |+.+++|++|+|++|.+++..+ .++|++
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~ 103 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET 103 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence 345599999999999999888999999999999999999997665 9999999999999999996543 389999
Q ss_pred EEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccc-cccchHHHHhcccc
Q 001238 320 IDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG-NLSNLTLLFVWHNR 398 (1117)
Q Consensus 320 LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~ 398 (1117)
|++++|.+++..+. .+++|+.|+|++|.+++..|..|+++++|+.|+|++|.+++.+|..|. .+++|+.|+|++|.
T Consensus 104 L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp EECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 99999999976554 458899999999999999899999999999999999999987777664 56666666666666
Q ss_pred ccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCC
Q 001238 399 LEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPE 478 (1117)
Q Consensus 399 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 478 (1117)
+++..+ +..+++|+.|+|++|.| ++.+| .|..+++|+.|++++|+|++ +|..
T Consensus 181 l~~~~~--~~~l~~L~~L~Ls~N~l------------------------~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~ 232 (487)
T 3oja_A 181 IYDVKG--QVVFAKLKTLDLSSNKL------------------------AFMGP-EFQSAAGVTWISLRNNKLVL-IEKA 232 (487)
T ss_dssp CCEEEC--CCCCTTCCEEECCSSCC------------------------CEECG-GGGGGTTCSEEECTTSCCCE-ECTT
T ss_pred cccccc--cccCCCCCEEECCCCCC------------------------CCCCH-hHcCCCCccEEEecCCcCcc-cchh
Confidence 654422 22344555555555544 43322 25555566666666666663 4556
Q ss_pred cCCCCCCCEEEccCCcCC-CCCCcccccCCCCceEEcc
Q 001238 479 IGNLKNLNFLDLGSNRLT-GSIPDEITGCRNLTFLDVH 515 (1117)
Q Consensus 479 ~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls 515 (1117)
+..+++|+.|++++|.+. +.+|..+..++.|+.|+++
T Consensus 233 l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred hccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 777788888888888887 5667777777777777775
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=244.14 Aligned_cols=207 Identities=19% Similarity=0.115 Sum_probs=82.2
Q ss_pred CCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccC
Q 001238 437 LNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHS 516 (1117)
Q Consensus 437 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 516 (1117)
|++|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|++++
T Consensus 30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 109 (276)
T 2z62_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (276)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence 44444444444433333344444444444444444433333344444444444444444433333344444444444444
Q ss_pred CccccccchhhhcccccccccccCCcCCCCC-CCCcCCCccccEEeccccccCCCCCccccccccee----EEecccccc
Q 001238 517 NSIAGNLPAGLHQLVRLQFADLSDNSVGGML-SPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQ----LLDLSSNQL 591 (1117)
Q Consensus 517 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~Ls~N~l 591 (1117)
|.+.+..+..+..+++|+.|++++|.++++. +..|..+++|+.|+|++|++++..+..|..+.+|+ .|++++|++
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l 189 (276)
T 2z62_A 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189 (276)
T ss_dssp SCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCC
T ss_pred CCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcc
Confidence 4443333323333333333333333333322 22333333333333333333333333333333333 444444444
Q ss_pred ccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcc
Q 001238 592 SGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLH 645 (1117)
Q Consensus 592 ~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~ 645 (1117)
++..+. .....++ +.|+|++|++++..+..|..+++|+.|+|++|+++|+++
T Consensus 190 ~~~~~~-~~~~~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 190 NFIQPG-AFKEIRL-KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CEECTT-SSCSCCE-EEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccCcc-ccCCCcc-cEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 422221 1122222 334444444443333344455555555555555555544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=236.11 Aligned_cols=208 Identities=23% Similarity=0.243 Sum_probs=153.5
Q ss_pred chHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccC
Q 001238 388 NLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRAN 467 (1117)
Q Consensus 388 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 467 (1117)
+|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|++++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555554444456666666666666666665445556666677777777777766666677777777777777
Q ss_pred CCcccccCCCCcCCCCCCCEEEccCCcCCCC-CCcccccCCCCceEEccCCccccccchhhhcccccc----cccccCCc
Q 001238 468 SNKLTGFIPPEIGNLKNLNFLDLGSNRLTGS-IPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQ----FADLSDNS 542 (1117)
Q Consensus 468 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~ 542 (1117)
+|++++..+..+..+++|++|++++|++++. +|..|..+++|++|+|++|++++..+..|..+.+|+ .|++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 7777766666788888888888888888764 578888888888888888888887777777777777 77888888
Q ss_pred CCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccc
Q 001238 543 VGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP 596 (1117)
Q Consensus 543 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 596 (1117)
++++.+..+... +|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus 189 l~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 189 MNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCEECTTSSCSC-CEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ccccCccccCCC-cccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 888777666554 78888888888887777778888888888888888885443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-25 Score=266.00 Aligned_cols=188 Identities=14% Similarity=0.202 Sum_probs=147.3
Q ss_pred CCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCcc--------chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 779 TAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI--------STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 779 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
...+.||+|+||+||+|.. .++.+|+|+....... ..+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999965 5788999987543211 134588999999999999999666666677788999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+||+++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999875 457999999999999999 9999999999999999 999999999998753
Q ss_pred CCCCc---cccCCccccccccCChhhhcc--CCCCcCCCeeehhhhHHHHHhCCCCCC
Q 001238 931 DSGGS---FSANPQFAGSYGYIAPEYANM--TKISEKSDVYSYGVVLLEIITGKKPVD 983 (1117)
Q Consensus 931 ~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~vl~ell~g~~P~~ 983 (1117)
..... ........||+.|||||++.. ..|+...|+|+..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 21100 001235689999999999986 678889999999999999988887773
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-28 Score=298.37 Aligned_cols=426 Identities=13% Similarity=0.131 Sum_probs=208.0
Q ss_pred ccccccccccccccccccc---cCCc------------ccccccccceeecccccccccCCcCCC-CCCCCcEEecCCC-
Q 001238 215 IGNCTNLVMIGLAETSISG---FLPP------------TLGLLKRLQTIAIYTALLSGQIPPELG-DCTELQYIYLYEN- 277 (1117)
Q Consensus 215 l~~l~~L~~L~l~~~~~~~---~lp~------------~l~~l~~L~~L~l~~~~l~~~~p~~l~-~l~~L~~L~L~~n- 277 (1117)
+..+++|+.|+++++.... ..|. ....+++|+.|++++|.+.+..+..+. .+++|++|+|++|
T Consensus 62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~ 141 (594)
T 2p1m_B 62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE 141 (594)
T ss_dssp HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE
T ss_pred HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC
Confidence 3456677777777654221 1111 112344555555555544443333332 3455555555554
Q ss_pred ccCCc-CCccCCCCCCCcEEEccCCcCcccCCcC----CCCCCCCCEEEcCCCc--CCC-CCccccCCCCCcceEecccc
Q 001238 278 ALTGS-IPSKLGNLKNLVNLFLWQNNLVGIIPPE----LGNCSQLSIIDISMNS--LTG-SIPQTLGNLTSLQELQLSVN 349 (1117)
Q Consensus 278 ~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~----~~~l~~L~~LdLs~N~--l~~-~~p~~l~~l~~L~~L~Ls~N 349 (1117)
.++.. ++..+.++++|++|+|++|.+++..+.. ...+++|+.|++++|. ++. .++..+.++++|++|+|++|
T Consensus 142 ~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 142 GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp EEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred CCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 33221 2222234455555555555544322221 1234455555555544 110 01111122345555555544
Q ss_pred -cccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCccccccee-ecccccccCCC
Q 001238 350 -QISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAV-DLSQNGLTGPI 427 (1117)
Q Consensus 350 -~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~ 427 (1117)
.+. .++..+..+++|++|+++.+... +..|.+.+ ++..+.++++|+.| .+.+.... .+
T Consensus 222 ~~~~-~l~~~~~~~~~L~~L~l~~~~~~-----------------~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l 281 (594)
T 2p1m_B 222 VPLE-KLATLLQRAPQLEELGTGGYTAE-----------------VRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YL 281 (594)
T ss_dssp SCHH-HHHHHHHHCTTCSEEECSBCCCC-----------------CCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GG
T ss_pred CcHH-HHHHHHhcCCcceEcccccccCc-----------------cchhhHHH-HHHHHhcCCCcccccCCcccchh-hH
Confidence 222 24444444455555543322210 22222332 22244556666666 33333222 34
Q ss_pred cccccCCCCCCeeeccCccCCCCCCC-CcccccccceeccCCCccccc-CCCCcCCCCCCCEEEcc---------CCcCC
Q 001238 428 PRGIFQLKKLNKLLLLSNNLSGVIPP-EMGNCSSLIRFRANSNKLTGF-IPPEIGNLKNLNFLDLG---------SNRLT 496 (1117)
Q Consensus 428 p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~Ls---------~N~l~ 496 (1117)
+..+..+++|++|++++|.+++.... .+..+++|++|++++| +++. ++.....+++|++|+|+ .|.++
T Consensus 282 ~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~ 360 (594)
T 2p1m_B 282 PAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALT 360 (594)
T ss_dssp GGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCC
T ss_pred HHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCC
Confidence 44444566777777777765532211 2345667777777766 3322 12222346777777773 34454
Q ss_pred CCCCcccc-cCCCCceEEccCCccccccchhhh-ccccccccccc--C----CcCCCCCCC-----CcCCCccccEEecc
Q 001238 497 GSIPDEIT-GCRNLTFLDVHSNSIAGNLPAGLH-QLVRLQFADLS--D----NSVGGMLSP-----DLGSLSSLTKLVLN 563 (1117)
Q Consensus 497 ~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~i~~~~~~-----~~~~l~~L~~L~L~ 563 (1117)
+.....+. ++++|++|+++.|.+++.....+. .+++|+.|+++ + |.+++.+.. .+..+++|+.|+|+
T Consensus 361 ~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~ 440 (594)
T 2p1m_B 361 EQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS 440 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECC
T ss_pred HHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeec
Confidence 33222332 467777777777777765555554 46777777777 3 444432211 14455677777776
Q ss_pred ccccCCCCCccccc-ccceeEEecccccccccccccc-CCchhHHHhhcCCCCcccCCccc-cccCCCCccEEeccCccc
Q 001238 564 KNRFAGSIPSQLGS-CVKLQLLDLSSNQLSGNIPASL-GKIPALAIALNLSWNQICGELPA-ELTGLNKLGILDLSHNEL 640 (1117)
Q Consensus 564 ~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~l-~~l~~l~~~L~Ls~N~l~~~~p~-~l~~l~~L~~LdLs~N~l 640 (1117)
+ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++| +.|+|++|.+++..+. .+..+++|+.|++++|++
T Consensus 441 ~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L-~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 441 G-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSL-RKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp S-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTC-CEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred C-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCc-CEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 6 455443444443 6677777777777765443333 334555 5666666666443333 233466777777777776
Q ss_pred cCCc-chh-hhcccceEEEeecccc
Q 001238 641 SGDL-HFL-AELQNLVVLNVSHNNF 663 (1117)
Q Consensus 641 ~~~~-~~l-~~l~~L~~L~ls~N~l 663 (1117)
+... ..+ ..++.|+...+..+..
T Consensus 519 ~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 519 SFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp BHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred CHHHHHHHHHhCCCCEEEEecCCCc
Confidence 4321 123 4456666555555543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-24 Score=233.41 Aligned_cols=231 Identities=18% Similarity=0.206 Sum_probs=185.9
Q ss_pred cccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCccccccccee
Q 001238 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464 (1117)
Q Consensus 385 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 464 (1117)
.+.++..+++..+.+.+.. .+..+++|+.|++++|.++. + ..+..+++|++|++++|++++. ..+..+++|++|
T Consensus 17 ~~~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 90 (272)
T 3rfs_A 17 AFAETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYL 90 (272)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEE
T ss_pred hHHHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEE
Confidence 3566777888888776543 35677888888888888873 3 3477788888888888888863 477888888888
Q ss_pred ccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCC
Q 001238 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG 544 (1117)
Q Consensus 465 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 544 (1117)
++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|+++
T Consensus 91 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 170 (272)
T 3rfs_A 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC
Confidence 88888888877777888888888888888888777777888888888888888888877777888888888888888888
Q ss_pred CCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccc
Q 001238 545 GMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAEL 624 (1117)
Q Consensus 545 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l 624 (1117)
++.+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|.+.+..| .+ ..|+++.|.++|.+|..+
T Consensus 171 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-------~l-~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 171 SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-------GI-RYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT-------TT-HHHHHHHHHTGGGBBCTT
T ss_pred ccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc-------HH-HHHHHHHHhCCCcccCcc
Confidence 8888888888888888888888888878778888888888888888876544 33 567777888888888777
Q ss_pred cCCCC
Q 001238 625 TGLNK 629 (1117)
Q Consensus 625 ~~l~~ 629 (1117)
+.+..
T Consensus 243 ~~~~~ 247 (272)
T 3rfs_A 243 GSVAP 247 (272)
T ss_dssp SCBCG
T ss_pred cccCC
Confidence 66654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-23 Score=227.71 Aligned_cols=232 Identities=22% Similarity=0.263 Sum_probs=170.1
Q ss_pred hhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccc
Q 001238 144 SLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVM 223 (1117)
Q Consensus 144 ~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~ 223 (1117)
.+.++..+++..+.+.... .+..+++|+.|++++|.++. + ..++.+++|++|++++|+
T Consensus 17 ~~~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~------------------ 74 (272)
T 3rfs_A 17 AFAETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNK------------------ 74 (272)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSC------------------
T ss_pred hHHHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCC------------------
Confidence 3456666777777665332 35567777777777777653 2 234444444444444443
Q ss_pred cccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcC
Q 001238 224 IGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNL 303 (1117)
Q Consensus 224 L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 303 (1117)
+.+ ++.+..+++|++|++++|.+.+..+..+..+++|++|+|++|++++..+..|+++++|++|++++|++
T Consensus 75 -------l~~--~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 145 (272)
T 3rfs_A 75 -------LHD--ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQL 145 (272)
T ss_dssp -------CCC--CGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred -------CCC--chhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCcc
Confidence 332 12445556666666666666666666778888888888888888877777788888888888888888
Q ss_pred cccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCccc
Q 001238 304 VGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEF 383 (1117)
Q Consensus 304 ~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 383 (1117)
++..+..|..+++|++|++++|++++..+..++.+++|++|+|++|++++..+..+..+++|++|++++|.+.+.
T Consensus 146 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~----- 220 (272)
T 3rfs_A 146 QSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT----- 220 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-----
T ss_pred CccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-----
Confidence 877777788888899999999888877777788888899999999988887777788888999999998887743
Q ss_pred ccccchHHHHhccccccccCCCCCCccccc
Q 001238 384 GNLSNLTLLFVWHNRLEGEIPPSISNCQNL 413 (1117)
Q Consensus 384 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 413 (1117)
+++|+.|+++.|+++|.+|..++.+...
T Consensus 221 --~~~l~~l~~~~n~~~g~ip~~~~~~~~~ 248 (272)
T 3rfs_A 221 --CPGIRYLSEWINKHSGVVRNSAGSVAPD 248 (272)
T ss_dssp --TTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred --CcHHHHHHHHHHhCCCcccCcccccCCC
Confidence 4568888899999988888888766543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=228.93 Aligned_cols=206 Identities=27% Similarity=0.287 Sum_probs=144.9
Q ss_pred ccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEcc
Q 001238 412 NLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLG 491 (1117)
Q Consensus 412 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 491 (1117)
+.+.+++++|.++ .+|..+. +++++|++++|++++..+..|.++++|++|++++|+++...+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4678888888888 4666554 567888888888877766677777777777777777776666666777777777777
Q ss_pred CCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCC
Q 001238 492 SNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSI 571 (1117)
Q Consensus 492 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 571 (1117)
+|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|++++|.|+++++..|..+++|+.|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 77777666666677777777777777777666666666666666666666666666666666666666666666666555
Q ss_pred CcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcc
Q 001238 572 PSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLH 645 (1117)
Q Consensus 572 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~ 645 (1117)
+..|..+++|+.|+|++|+++ +..+..|..+++|+.|+|++|++.+++.
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLK-------------------------RVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCS-------------------------CCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hhHhccCCCcCEEECCCCcCC-------------------------cCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 555656666666666665555 3334456677888999999999988765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-23 Score=229.57 Aligned_cols=207 Identities=25% Similarity=0.218 Sum_probs=138.9
Q ss_pred CCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCC
Q 001238 407 ISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLN 486 (1117)
Q Consensus 407 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 486 (1117)
+.++++++++++++|.++ .+|..+. +.++.|+|++|+|++..+..|.++++|++|++++|+|++..+ .+.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 345566677777777776 3555443 466677777777766666666666677777777776665433 25667777
Q ss_pred EEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccc
Q 001238 487 FLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNR 566 (1117)
Q Consensus 487 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~ 566 (1117)
+|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|+|+++++..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 7777777776 556666677777777777777776666666666666666666666666666666666666666666666
Q ss_pred cCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcc
Q 001238 567 FAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLH 645 (1117)
Q Consensus 567 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~ 645 (1117)
|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.|++.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~--------------------------~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY--------------------------TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC--------------------------CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC--------------------------ccChhhcccccCCeEEeCCCCccCcCc
Confidence 66555555666666666666666665 344445556688999999999998764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=225.64 Aligned_cols=204 Identities=25% Similarity=0.308 Sum_probs=117.2
Q ss_pred CCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCc
Q 001238 287 LGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLA 366 (1117)
Q Consensus 287 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 366 (1117)
+.++++++++++++|+++ .+|..+. ++++.|+|++|.+++..+..|..+++|++|+|++|.|++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 344555555555555555 2333332 3455555555555544444555555555555555555432211 3444444
Q ss_pred EEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCcc
Q 001238 367 QIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNN 446 (1117)
Q Consensus 367 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 446 (1117)
+|++++|++ + .+|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 81 ~L~Ls~N~l------------------------~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 135 (290)
T 1p9a_G 81 TLDLSHNQL------------------------Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (290)
T ss_dssp EEECCSSCC------------------------S-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcC------------------------C-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence 444444444 3 334445555666666666666665444556666666666666666
Q ss_pred CCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCcccc
Q 001238 447 LSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG 521 (1117)
Q Consensus 447 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 521 (1117)
|++..+..|..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|.+..
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 66666666666666677777777766555556666777777777777776 556666666677777777777653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=9.6e-25 Score=250.91 Aligned_cols=261 Identities=16% Similarity=0.170 Sum_probs=173.1
Q ss_pred EEEcCCCcCCCCCccccCCCCCcceEecccccccCccc----ccccCCC-CCcEEEecCccccCCCCcccccccchHHHH
Q 001238 319 IIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIP----AQIGNCQ-RLAQIELDNNQITGAIPSEFGNLSNLTLLF 393 (1117)
Q Consensus 319 ~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 393 (1117)
.+++++|.+++.+|..+...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|++++..+..|..+
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~------- 74 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI------- 74 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHH-------
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHH-------
Confidence 46788899998888877777779999999999887666 6777787 88889998888887666555543
Q ss_pred hccccccccCCCCCCc-ccccceeecccccccCCCcccccC----C-CCCCeeeccCccCCCCCCCCccc-----ccccc
Q 001238 394 VWHNRLEGEIPPSISN-CQNLEAVDLSQNGLTGPIPRGIFQ----L-KKLNKLLLLSNNLSGVIPPEMGN-----CSSLI 462 (1117)
Q Consensus 394 L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~ 462 (1117)
+.. .++|++|+|++|++++..+..+.. + ++|++|+|++|+|++..+..+.. .++|+
T Consensus 75 -------------l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 141 (362)
T 3goz_A 75 -------------LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141 (362)
T ss_dssp -------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCC
T ss_pred -------------HhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCcee
Confidence 001 145555555555555444443322 2 55666666666665544433322 24666
Q ss_pred eeccCCCcccccCC----CCcCCCC-CCCEEEccCCcCCCCCCcccc----cC-CCCceEEccCCccccc----cchhhh
Q 001238 463 RFRANSNKLTGFIP----PEIGNLK-NLNFLDLGSNRLTGSIPDEIT----GC-RNLTFLDVHSNSIAGN----LPAGLH 528 (1117)
Q Consensus 463 ~L~l~~N~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~~~~~~ 528 (1117)
+|++++|++++..+ ..+..++ +|++|+|++|++++..+..+. .+ ++|++|+|++|.|++. ++..+.
T Consensus 142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 66666666664332 2234444 788888888888766665444 33 5788888888888763 344555
Q ss_pred cc-cccccccccCCcCCCCCC----CCcCCCccccEEeccccccCCCC-------CcccccccceeEEeccccccccccc
Q 001238 529 QL-VRLQFADLSDNSVGGMLS----PDLGSLSSLTKLVLNKNRFAGSI-------PSQLGSCVKLQLLDLSSNQLSGNIP 596 (1117)
Q Consensus 529 ~l-~~L~~L~Ls~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~-------~~~~~~l~~L~~L~Ls~N~l~~~~p 596 (1117)
.+ ++|+.|+|++|.|++... ..+..+++|+.|+|++|.+.+.. +..+..+++|+.||+++|.+.+..+
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 53 478888888888877654 34566788888899888865443 3356778889999999999886644
Q ss_pred ccc
Q 001238 597 ASL 599 (1117)
Q Consensus 597 ~~l 599 (1117)
..+
T Consensus 302 ~~~ 304 (362)
T 3goz_A 302 IPI 304 (362)
T ss_dssp HHH
T ss_pred HHH
Confidence 433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-24 Score=248.35 Aligned_cols=259 Identities=16% Similarity=0.135 Sum_probs=166.6
Q ss_pred EEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCc----cccCCCC-CcceEecccccccCcccccccCC-----CC
Q 001238 295 NLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIP----QTLGNLT-SLQELQLSVNQISGEIPAQIGNC-----QR 364 (1117)
Q Consensus 295 ~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p----~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 364 (1117)
.+.++.|++++.+|..+...++|++|||++|.+++..+ ..+..++ +|++|+|++|.|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999988888888889999999999997776 7788888 99999999999998878777775 99
Q ss_pred CcEEEecCccccCCCCcccccc-----cchHHHHhccccccccCCCCCC----c-ccccceeecccccccCCCc----cc
Q 001238 365 LAQIELDNNQITGAIPSEFGNL-----SNLTLLFVWHNRLEGEIPPSIS----N-CQNLEAVDLSQNGLTGPIP----RG 430 (1117)
Q Consensus 365 L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~Ls~N~l~~~~p----~~ 430 (1117)
|++|+|++|++++..+..+... ++|++|++++|++++..+..+. . .++|++|+|++|.+++..+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999997776655443 6777777777777655443332 2 2567777777777764332 22
Q ss_pred ccCCC-CCCeeeccCccCCCCCCCCccc----c-cccceeccCCCccccc----CCCCcCC-CCCCCEEEccCCcCCCCC
Q 001238 431 IFQLK-KLNKLLLLSNNLSGVIPPEMGN----C-SSLIRFRANSNKLTGF----IPPEIGN-LKNLNFLDLGSNRLTGSI 499 (1117)
Q Consensus 431 ~~~l~-~L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~l~~N~l~~~----~~~~~~~-l~~L~~L~Ls~N~l~~~~ 499 (1117)
+..++ +|++|+|++|+|++..+..+.. + ++|++|++++|.|++. ++..+.. .++|++|+|++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 33343 6667777776666555443332 2 4566666666666542 2223333 235666666666655433
Q ss_pred Cc----ccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCC
Q 001238 500 PD----EITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGS 570 (1117)
Q Consensus 500 p~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 570 (1117)
+. .+..+++|++|+|++|.+.+..+..+..+ ...+..+++|+.|++++|.+.+.
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l-----------------~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKAL-----------------GAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHH-----------------HTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHH-----------------HHHhccCCceEEEecCCCcCCCc
Confidence 32 22344555555555555443322211110 12344555666666666666543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=228.57 Aligned_cols=228 Identities=19% Similarity=0.219 Sum_probs=156.2
Q ss_pred ccCCeEeccCCCCCCCc-hh--hhcccccCcEeeccCCCcCCCCchhh--hhhhhhhhhhccCCCcCCCCc----hhccC
Q 001238 98 LSLNRLVLSGTNLTGSI-PK--EIASLNQLNYLDLSENSLTGEIPREL--CSLLRLEQLRLNSNQLEGAIP----IQIGN 168 (1117)
Q Consensus 98 ~~L~~L~L~~n~l~~~~-p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~ 168 (1117)
..++.|.+.++.++... .. .+..+++|++|+|++|.+++.+|..+ ..+++|++|+|++|.+++..| ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 34677888877775321 11 12345679999999999988888887 888899999999999887655 45567
Q ss_pred CcCCcEEeccCCCCCCCCcccccCcccchhhhccCCCCCCC---CCCccccccccccccccccccccccCCccccccccc
Q 001238 169 LSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGG---SLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRL 245 (1117)
Q Consensus 169 L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~---~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L 245 (1117)
+++|++|+|++|++++..|..|+.+++|++|++++|+.... ..+..++++++|++|++++|+++.. +.
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~-------- 214 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP-TG-------- 214 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-HH--------
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-HH--------
Confidence 88899999999999887778888888888888888864210 1112234555555555555555321 10
Q ss_pred ceeecccccccccCCc-CCCCCCCCcEEecCCCccCCcCCccCCCC---CCCcEEEccCCcCcccCCcCCCCCCCCCEEE
Q 001238 246 QTIAIYTALLSGQIPP-ELGDCTELQYIYLYENALTGSIPSKLGNL---KNLVNLFLWQNNLVGIIPPELGNCSQLSIID 321 (1117)
Q Consensus 246 ~~L~l~~~~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~L~~n~l~~~~p~~~~~l~~L~~Ld 321 (1117)
.+. .+..+++|++|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..+. ++|++||
T Consensus 215 -------------~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~ 278 (310)
T 4glp_A 215 -------------VCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLD 278 (310)
T ss_dssp -------------HHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEE
T ss_pred -------------HHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEE
Confidence 111 13456677777777777776666666665 57777777777777 4566553 6788888
Q ss_pred cCCCcCCCCCccccCCCCCcceEeccccccc
Q 001238 322 ISMNSLTGSIPQTLGNLTSLQELQLSVNQIS 352 (1117)
Q Consensus 322 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 352 (1117)
|++|++++. |. +..+++|++|+|++|+|+
T Consensus 279 Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 279 LSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred CCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 888888753 33 567778888888888776
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5.4e-25 Score=250.57 Aligned_cols=267 Identities=16% Similarity=0.203 Sum_probs=175.3
Q ss_pred CcceeeEEecCCCcEEEEecccccccCcCCcccccc--ccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCC-C
Q 001238 62 PCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSL--LSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGE-I 138 (1117)
Q Consensus 62 ~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~ 138 (1117)
|+.|+++.|+ ...+..++++++.+. |..+..+ ..++.|++++|.+++..+. +.++++|++|+|++|.+++. +
T Consensus 36 c~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 36 CKRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp CHHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHH
Confidence 4579999886 334556666665543 3344555 6666777777776655444 45666777777777766544 6
Q ss_pred chhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCC-CCCCC-CcccccCcccchhhhccCCCCCCCCCCcccc
Q 001238 139 PRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDN-QLTDA-IPATIGKLKNLEAIRAGGNKNLGGSLPHEIG 216 (1117)
Q Consensus 139 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~ 216 (1117)
|..+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. +|..+..+++|++|++++|.
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~----------- 179 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF----------- 179 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCT-----------
T ss_pred HHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCC-----------
Confidence 666666666666666666666666666666666666666666 45431 34444445555555544441
Q ss_pred cccccccccccccccccc-CCccccccc-ccceeecccc--ccc-ccCCcCCCCCCCCcEEecCCCc-cCCcCCccCCCC
Q 001238 217 NCTNLVMIGLAETSISGF-LPPTLGLLK-RLQTIAIYTA--LLS-GQIPPELGDCTELQYIYLYENA-LTGSIPSKLGNL 290 (1117)
Q Consensus 217 ~l~~L~~L~l~~~~~~~~-lp~~l~~l~-~L~~L~l~~~--~l~-~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l 290 (1117)
.+++. ++..+..++ +|++|++++| .+. +.+|..+..+++|++|++++|. +++..+..+.++
T Consensus 180 -------------~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l 246 (336)
T 2ast_B 180 -------------DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 246 (336)
T ss_dssp -------------TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGC
T ss_pred -------------CcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCC
Confidence 44433 345556666 7777777776 333 4456667778889999999998 777777888889
Q ss_pred CCCcEEEccCCc-CcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCC-CCcceEecccccccCcccccccC
Q 001238 291 KNLVNLFLWQNN-LVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNL-TSLQELQLSVNQISGEIPAQIGN 361 (1117)
Q Consensus 291 ~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~ 361 (1117)
++|++|++++|. +.......+.++++|+.|++++| ++.. .+..+ .+|+.|++++|++++..|..+++
T Consensus 247 ~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 247 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp TTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCcccc
Confidence 999999999985 32222225778999999999998 4422 33333 34778889999999888887765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=218.01 Aligned_cols=203 Identities=20% Similarity=0.238 Sum_probs=116.6
Q ss_pred cCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCc-CCCCCccccCCCCCcceEeccc-ccccCcccccc
Q 001238 282 SIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS-LTGSIPQTLGNLTSLQELQLSV-NQISGEIPAQI 359 (1117)
Q Consensus 282 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~-l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~ 359 (1117)
.+|. +. ++|++|++++|++++..+..|.++++|++|++++|+ +++..+..|.++++|++|+|++ |++++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4555 33 267777777777776655567777777777777775 6655555666777777777776 67765555666
Q ss_pred cCCCCCcEEEecCccccCCCCcccccccchH---HHHhccc-cccccCCCCCCcccccc-eeecccccccCCCcccccCC
Q 001238 360 GNCQRLAQIELDNNQITGAIPSEFGNLSNLT---LLFVWHN-RLEGEIPPSISNCQNLE-AVDLSQNGLTGPIPRGIFQL 434 (1117)
Q Consensus 360 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l 434 (1117)
.++++|++|++++|++++ +|. |..+++|+ .|++++| ++++..+..|..+++|+ .|++++|+++ .+|..
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~---- 174 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY---- 174 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTT----
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHh----
Confidence 667777777777776664 443 54444444 5555555 44444444455555555 5555555554 23332
Q ss_pred CCCCeeeccCccCCCCCCCCcccccccceeccCCCc-ccccCCCCcCCC-CCCCEEEccCCcCCCCCCcccccCCCCceE
Q 001238 435 KKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNK-LTGFIPPEIGNL-KNLNFLDLGSNRLTGSIPDEITGCRNLTFL 512 (1117)
Q Consensus 435 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 512 (1117)
.|.. ++|++|++++|+ +++..+..|.++ ++|+.|+|++|++++. |.. .+++|+.|
T Consensus 175 -------------------~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L 231 (239)
T 2xwt_C 175 -------------------AFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKEL 231 (239)
T ss_dssp -------------------TTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEE
T ss_pred -------------------hcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCcee
Confidence 3333 455555555553 554444555555 6666666666666533 222 45566666
Q ss_pred EccCC
Q 001238 513 DVHSN 517 (1117)
Q Consensus 513 ~Ls~N 517 (1117)
+++++
T Consensus 232 ~l~~~ 236 (239)
T 2xwt_C 232 IARNT 236 (239)
T ss_dssp ECTTC
T ss_pred eccCc
Confidence 66554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=7e-22 Score=214.57 Aligned_cols=180 Identities=22% Similarity=0.262 Sum_probs=99.4
Q ss_pred CCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEcc
Q 001238 436 KLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVH 515 (1117)
Q Consensus 436 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 515 (1117)
..++++++++.++. +|..+. +.++.|++++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 34555666666553 333332 345555555555555444455555555555555555554444445555555555555
Q ss_pred CCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecccccccccc
Q 001238 516 SNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNI 595 (1117)
Q Consensus 516 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 595 (1117)
+|+|++ +++..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..
T Consensus 92 ~n~l~~------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 147 (251)
T 3m19_A 92 NNQLAS------------------------LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIP 147 (251)
T ss_dssp TSCCCC------------------------CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCcccc------------------------cChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccC
Confidence 555554 44444444555555555555555444444555555555555555555444
Q ss_pred ccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCC
Q 001238 596 PASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGD 643 (1117)
Q Consensus 596 p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~ 643 (1117)
+..+..++++ +.|+|++|+|++..+..|..+++|+.|+|++|+++++
T Consensus 148 ~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 148 AGAFDKLTNL-QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHcCcCcCC-CEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 4345455554 4555555555555566677888889999999999887
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-22 Score=216.62 Aligned_cols=197 Identities=18% Similarity=0.248 Sum_probs=98.6
Q ss_pred CCCeeeccCccCCCCCCCCcccccccceeccCCCc-ccccCCCCcCCCCCCCEEEccC-CcCCCCCCcccccCCCCceEE
Q 001238 436 KLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNK-LTGFIPPEIGNLKNLNFLDLGS-NRLTGSIPDEITGCRNLTFLD 513 (1117)
Q Consensus 436 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 513 (1117)
+|++|++++|+++++.+..|.++++|++|++++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 55555555555555544455555555555555554 5544444555555555555555 555544445555555555555
Q ss_pred ccCCccccccchhhhcccccc---cccccCC-cCCCCCCCCcCCCcccc-EEeccccccCCCCCcccccccceeEEeccc
Q 001238 514 VHSNSIAGNLPAGLHQLVRLQ---FADLSDN-SVGGMLSPDLGSLSSLT-KLVLNKNRFAGSIPSQLGSCVKLQLLDLSS 588 (1117)
Q Consensus 514 Ls~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 588 (1117)
+++|++++ +|. |..+++|+ .|++++| .++++++..|.++++|+ .|++++|+++...+..|.. .+|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 55555554 232 44444444 4444444 44444444444444444 4444444444222223332 4444444444
Q ss_pred cccccccccccCCchhHHHhhcCCCCcccCCccccccCC-CCccEEeccCccccCCcchhhhcccceEEEeecc
Q 001238 589 NQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGL-NKLGILDLSHNELSGDLHFLAELQNLVVLNVSHN 661 (1117)
Q Consensus 589 N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l-~~L~~LdLs~N~l~~~~~~l~~l~~L~~L~ls~N 661 (1117)
|+ .+++..+..|..+ ++|+.|||++|++++.++. .+++|+.|+++++
T Consensus 189 n~------------------------~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NK------------------------YLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CT------------------------TCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred CC------------------------CcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 42 1333333444555 5556666666666543332 4455556665554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=227.54 Aligned_cols=198 Identities=19% Similarity=0.192 Sum_probs=107.1
Q ss_pred CCEEEcCCCcCCCCCcccc--CCCCCcceEecccccccCccc----ccccCCCCCcEEEecCccccCCCCcccccccchH
Q 001238 317 LSIIDISMNSLTGSIPQTL--GNLTSLQELQLSVNQISGEIP----AQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLT 390 (1117)
Q Consensus 317 L~~LdLs~N~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 390 (1117)
|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|++++|++++..+..|+.+++|+
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 172 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT 172 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence 4444444444444444433 444444444444444443222 2223444445555555544444444444444444
Q ss_pred HHHhcccccccc---C-CCCCCcccccceeecccccccCCCcc----cccCCCCCCeeeccCccCCCCCCCCcccc---c
Q 001238 391 LLFVWHNRLEGE---I-PPSISNCQNLEAVDLSQNGLTGPIPR----GIFQLKKLNKLLLLSNNLSGVIPPEMGNC---S 459 (1117)
Q Consensus 391 ~L~L~~N~l~~~---~-~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l---~ 459 (1117)
+|+|++|++.+. . +..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|+|++..|..+..+ +
T Consensus 173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~ 251 (310)
T 4glp_A 173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSS 251 (310)
T ss_dssp EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCT
T ss_pred EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcC
Confidence 444444444321 1 1223566777777777777762 333 23456777777777777777666666555 4
Q ss_pred ccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccc
Q 001238 460 SLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIA 520 (1117)
Q Consensus 460 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 520 (1117)
+|++|++++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|+.|+|++|+|+
T Consensus 252 ~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 252 ALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp TCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred cCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 6666667666666 4454443 5677777777777643 32 455666666666666665
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-21 Score=212.14 Aligned_cols=182 Identities=21% Similarity=0.245 Sum_probs=159.6
Q ss_pred cccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEc
Q 001238 411 QNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDL 490 (1117)
Q Consensus 411 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 490 (1117)
.+.++++++++.++ .+|..+. +.++.|+|++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 45678888888888 5776655 57889999999998888888899999999999999999888888899999999999
Q ss_pred cCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCC
Q 001238 491 GSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGS 570 (1117)
Q Consensus 491 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 570 (1117)
++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+++++..|..+++|+.|+|++|+|++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999988888888999999999999999988777788899999999999999999888899999999999999999988
Q ss_pred CCcccccccceeEEecccccccccc
Q 001238 571 IPSQLGSCVKLQLLDLSSNQLSGNI 595 (1117)
Q Consensus 571 ~~~~~~~l~~L~~L~Ls~N~l~~~~ 595 (1117)
.+..|..+++|+.|+|++|++++..
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred CHHHHhCCCCCCEEEeeCCceeCCc
Confidence 8888999999999999999998653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-24 Score=252.32 Aligned_cols=254 Identities=17% Similarity=0.222 Sum_probs=140.9
Q ss_pred CCccCCCCCCCcEEEccCCcCccc----CCcCCCCCCCCCEEEcCCC---cCCCCCcccc-------CCCCCcceEeccc
Q 001238 283 IPSKLGNLKNLVNLFLWQNNLVGI----IPPELGNCSQLSIIDISMN---SLTGSIPQTL-------GNLTSLQELQLSV 348 (1117)
Q Consensus 283 ~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~LdLs~N---~l~~~~p~~l-------~~l~~L~~L~Ls~ 348 (1117)
++..+..+++|++|+|++|++.+. ++..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 444555555666666666665543 2233556666666666664 3333444433 5667777777777
Q ss_pred ccccC----cccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeeccccccc
Q 001238 349 NQISG----EIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLT 424 (1117)
Q Consensus 349 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 424 (1117)
|.+++ .+|..+..+++|++|+|++|.+++..+..+... |.. +..|++.+. .++|++|+|++|+++
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~~--l~~~~~~~~-------~~~L~~L~L~~n~l~ 172 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQE--LAVNKKAKN-------APPLRSIICGRNRLE 172 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHH--HHHHHHHHT-------CCCCCEEECCSSCCT
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--HHH--Hhhhhhccc-------CCCCcEEECCCCCCC
Confidence 77765 355566667777777777777654333333221 111 112222211 145666666666665
Q ss_pred -CCCc---ccccCCCCCCeeeccCccCCC-----CCCCCcccccccceeccCCCccc----ccCCCCcCCCCCCCEEEcc
Q 001238 425 -GPIP---RGIFQLKKLNKLLLLSNNLSG-----VIPPEMGNCSSLIRFRANSNKLT----GFIPPEIGNLKNLNFLDLG 491 (1117)
Q Consensus 425 -~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~l~~N~l~----~~~~~~~~~l~~L~~L~Ls 491 (1117)
+.++ ..+..+++|++|+|++|+|+. ..+..+..+++|+.|++++|.++ ..+|..+..+++|++|+|+
T Consensus 173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~ 252 (386)
T 2ca6_A 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252 (386)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence 2233 234455666666666666652 23335566666666666666664 3455556666666666666
Q ss_pred CCcCCCC----CCccccc--CCCCceEEccCCcccc----ccchhh-hcccccccccccCCcCCCCC
Q 001238 492 SNRLTGS----IPDEITG--CRNLTFLDVHSNSIAG----NLPAGL-HQLVRLQFADLSDNSVGGML 547 (1117)
Q Consensus 492 ~N~l~~~----~p~~~~~--l~~L~~L~Ls~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~i~~~~ 547 (1117)
+|++++. ++..+.. +++|++|+|++|.|++ .+|..+ ..+++|+.|++++|.+++..
T Consensus 253 ~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 253 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 6666543 3444422 6666666666666665 355554 44566666666666666544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=6.2e-24 Score=241.79 Aligned_cols=255 Identities=19% Similarity=0.223 Sum_probs=199.5
Q ss_pred cCCeEeccCCCCCCCchhhhccc--ccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCC-CchhccCCcCCcEE
Q 001238 99 SLNRLVLSGTNLTGSIPKEIASL--NQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGA-IPIQIGNLSSLTQL 175 (1117)
Q Consensus 99 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~L~~L~~L 175 (1117)
.++.+++++|++. |..+..+ +++++|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3678888888876 6667777 8888888888888865554 56788888888888888755 77788888888888
Q ss_pred eccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccc-cCCcccccccccceeecccc-
Q 001238 176 FLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISG-FLPPTLGLLKRLQTIAIYTA- 253 (1117)
Q Consensus 176 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~-~lp~~l~~l~~L~~L~l~~~- 253 (1117)
+|++|++++..|..++.+++|++|++++|. .+++ .++..+..+++|++|++++|
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~------------------------~l~~~~l~~~~~~~~~L~~L~l~~~~ 179 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCS------------------------GFSEFALQTLLSSCSRLDELNLSWCF 179 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCB------------------------SCCHHHHHHHHHHCTTCCEEECCCCT
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCC------------------------CCCHHHHHHHHhcCCCCCEEcCCCCC
Confidence 888888877677777666666666666653 2333 24555778899999999999
Q ss_pred ccccc-CCcCCCCCC-CCcEEecCCC--ccC-CcCCccCCCCCCCcEEEccCCc-CcccCCcCCCCCCCCCEEEcCCCc-
Q 001238 254 LLSGQ-IPPELGDCT-ELQYIYLYEN--ALT-GSIPSKLGNLKNLVNLFLWQNN-LVGIIPPELGNCSQLSIIDISMNS- 326 (1117)
Q Consensus 254 ~l~~~-~p~~l~~l~-~L~~L~L~~n--~l~-~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~LdLs~N~- 326 (1117)
.+.+. ++..+..++ +|++|+|++| .++ +.+|..+.++++|++|++++|. +++..+..+..+++|++|++++|.
T Consensus 180 ~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~ 259 (336)
T 2ast_B 180 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 259 (336)
T ss_dssp TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTT
T ss_pred CcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCC
Confidence 88764 677788999 9999999999 565 4677788899999999999999 777778889999999999999996
Q ss_pred CCCCCccccCCCCCcceEecccccccCcccccccCC-CCCcEEEecCccccCCCCccccc
Q 001238 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNC-QRLAQIELDNNQITGAIPSEFGN 385 (1117)
Q Consensus 327 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~ 385 (1117)
+.......+.++++|++|++++| ++.. .+..+ ..+..|++++|++++..|..++.
T Consensus 260 ~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 260 IIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp CCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCcccc
Confidence 33222235888999999999999 5432 33333 34777789999999999988765
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=8.4e-24 Score=245.54 Aligned_cols=239 Identities=18% Similarity=0.217 Sum_probs=155.9
Q ss_pred cccccCCCCCCeeeccCccCCCCCC----CCcccccccceeccCCC---cccccCCCCc-------CCCCCCCEEEccCC
Q 001238 428 PRGIFQLKKLNKLLLLSNNLSGVIP----PEMGNCSSLIRFRANSN---KLTGFIPPEI-------GNLKNLNFLDLGSN 493 (1117)
Q Consensus 428 p~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N---~l~~~~~~~~-------~~l~~L~~L~Ls~N 493 (1117)
+..+..+++|++|+|++|+|+...+ ..+..+++|++|++++| ++++.+|..+ ..+++|++|+|++|
T Consensus 25 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n 104 (386)
T 2ca6_A 25 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 104 (386)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCC
Confidence 3334444444444444444443311 22444555555555543 2333333333 56777777777777
Q ss_pred cCCC----CCCcccccCCCCceEEccCCccccccchhhh----cc---------cccccccccCCcCCCCCC----CCcC
Q 001238 494 RLTG----SIPDEITGCRNLTFLDVHSNSIAGNLPAGLH----QL---------VRLQFADLSDNSVGGMLS----PDLG 552 (1117)
Q Consensus 494 ~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l---------~~L~~L~Ls~N~i~~~~~----~~~~ 552 (1117)
++++ .+|..+..+++|++|+|++|.|++..+..+. .+ ++|+.|++++|+|+.... ..+.
T Consensus 105 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~ 184 (386)
T 2ca6_A 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184 (386)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHH
Confidence 7775 3566677777777777777777644433333 33 677777777777763222 2455
Q ss_pred CCccccEEeccccccCC-----CCCcccccccceeEEeccccccc----cccccccCCchhHHHhhcCCCCcccCC----
Q 001238 553 SLSSLTKLVLNKNRFAG-----SIPSQLGSCVKLQLLDLSSNQLS----GNIPASLGKIPALAIALNLSWNQICGE---- 619 (1117)
Q Consensus 553 ~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~~l~~l~~l~~~L~Ls~N~l~~~---- 619 (1117)
.+++|+.|+|++|+|+. ..+..+..+++|+.|+|++|.++ +.+|..+..+++| +.|+|++|+|++.
T Consensus 185 ~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L-~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL-RELGLNDCLLSARGAAA 263 (386)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC-CEEECTTCCCCHHHHHH
T ss_pred hCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCc-CEEECCCCCCchhhHHH
Confidence 66778888888887762 23446777888888888888885 5677777777777 6788888888765
Q ss_pred cccccc--CCCCccEEeccCccccC----Ccch-h-hhcccceEEEeecccccCCC
Q 001238 620 LPAELT--GLNKLGILDLSHNELSG----DLHF-L-AELQNLVVLNVSHNNFSGRV 667 (1117)
Q Consensus 620 ~p~~l~--~l~~L~~LdLs~N~l~~----~~~~-l-~~l~~L~~L~ls~N~l~~~~ 667 (1117)
+|..+. .+++|+.|+|++|+++. .++. + ..+++|+.|+|++|++++..
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 566663 48999999999999997 2443 4 56899999999999998543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-22 Score=221.57 Aligned_cols=148 Identities=14% Similarity=0.150 Sum_probs=119.2
Q ss_pred HhccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCc------------------cchHHHHHHHHHHhccCCCCc
Q 001238 773 DATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDK------------------ISTGAFSSEIATLSRIRHRNI 834 (1117)
Q Consensus 773 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~ni 834 (1117)
.....|.+++.||+|+||.||+|...+|+.||||+++.... ....++.+|++++++++|
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---
Confidence 34456777899999999999999887799999999964321 124568899999999994
Q ss_pred ceEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC
Q 001238 835 VRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER 914 (1117)
Q Consensus 835 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~ 914 (1117)
+++.+++.. +..++||||+++|+|.+ +.. .....++.|+++||+|||++ +|+||||||+||+++ +
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C
Confidence 555554433 55699999999999988 432 12346999999999999999 999999999999999 9
Q ss_pred CcceeccccccccccCCCCCccccCCccccccccCChhhhc
Q 001238 915 YESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955 (1117)
Q Consensus 915 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 955 (1117)
+.+||+|||+|+.. ..|+|||++.
T Consensus 229 ~~vkl~DFG~a~~~-----------------~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVEV-----------------GEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEET-----------------TSTTHHHHHH
T ss_pred CcEEEEECCCCeEC-----------------CCCCHHHHHH
Confidence 99999999999743 3478999875
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=223.57 Aligned_cols=240 Identities=20% Similarity=0.186 Sum_probs=171.0
Q ss_pred cEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCc-cccCCCCCcce-Eecc
Q 001238 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIP-QTLGNLTSLQE-LQLS 347 (1117)
Q Consensus 270 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p-~~l~~l~~L~~-L~Ls 347 (1117)
+.++.++++++ .+|..+. +++++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 56778888888 6777663 578888888888886666678888888888888888866554 45778887765 5666
Q ss_pred cccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcc-ccccccCCCCCCccc-ccceeecccccccC
Q 001238 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWH-NRLEGEIPPSISNCQ-NLEAVDLSQNGLTG 425 (1117)
Q Consensus 348 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~ 425 (1117)
+|+++...|..|.++++|++|++++|+++...+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~- 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-
Confidence 7888877788888888888888888888876666666667777777755 566655555666654 5778888888887
Q ss_pred CCcccccCCCCCCeeeccC-ccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCC-cCCCCCCccc
Q 001238 426 PIPRGIFQLKKLNKLLLLS-NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN-RLTGSIPDEI 503 (1117)
Q Consensus 426 ~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~ 503 (1117)
.+|...+...+|++|++++ |.++.+.+..|.++++|++|++++|+|+...+..|. +|+.|.+.++ .++ .+| .+
T Consensus 168 ~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~-~lP-~l 242 (350)
T 4ay9_X 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNLK-KLP-TL 242 (350)
T ss_dssp EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTCC-CCC-CT
T ss_pred CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCcC-cCC-Cc
Confidence 4666666667788888864 566655556777888888888888888755444444 4444444333 333 455 36
Q ss_pred ccCCCCceEEccCCc
Q 001238 504 TGCRNLTFLDVHSNS 518 (1117)
Q Consensus 504 ~~l~~L~~L~Ls~N~ 518 (1117)
..+++|+.++++++.
T Consensus 243 ~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 243 EKLVALMEASLTYPS 257 (350)
T ss_dssp TTCCSCCEEECSCHH
T ss_pred hhCcChhhCcCCCCc
Confidence 677777777776543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-21 Score=222.01 Aligned_cols=200 Identities=20% Similarity=0.192 Sum_probs=89.8
Q ss_pred CEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCC-cccccccchHH-HHhc
Q 001238 318 SIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIP-SEFGNLSNLTL-LFVW 395 (1117)
Q Consensus 318 ~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~ 395 (1117)
+.++.++++++ .+|..+. +++++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.+++++.+ +.+.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 34555555555 3444331 345555555555554333455555555555555555543333 24444444332 3334
Q ss_pred cccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccC-ccCCCCCCCCccccc-ccceeccCCCcccc
Q 001238 396 HNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS-NNLSGVIPPEMGNCS-SLIRFRANSNKLTG 473 (1117)
Q Consensus 396 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~ 473 (1117)
+|+++...|..|..+++|++|++++|++++..+..+....++..|++.+ |++..+.+..|..+. .++.|++++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 4555544455555555555555555555543333333444444444433 334433333333332 34444444444442
Q ss_pred cCCCCcCCCCCCCEEEccC-CcCCCCCCcccccCCCCceEEccCCcccc
Q 001238 474 FIPPEIGNLKNLNFLDLGS-NRLTGSIPDEITGCRNLTFLDVHSNSIAG 521 (1117)
Q Consensus 474 ~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 521 (1117)
+.+..| ...+|+.|++++ |.++.+.++.|.++++|++|+|++|+|+.
T Consensus 169 i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~ 216 (350)
T 4ay9_X 169 IHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216 (350)
T ss_dssp ECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC
T ss_pred CChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCc
Confidence 222222 223444444432 33332222334444444444444444443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=216.96 Aligned_cols=216 Identities=25% Similarity=0.384 Sum_probs=134.8
Q ss_pred ccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceec
Q 001238 386 LSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFR 465 (1117)
Q Consensus 386 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 465 (1117)
+.++..+.+..+.+++.+ .+..+++|++|++++|.++. +| .+..+++|++|++++|++++..+ +..+++|++|+
T Consensus 18 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~ 91 (308)
T 1h6u_A 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (308)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEE
Confidence 445566666666666432 24466777777777777763 44 46667777777777777775443 66677777777
Q ss_pred cCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCC
Q 001238 466 ANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGG 545 (1117)
Q Consensus 466 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~ 545 (1117)
+++|++++. ..+..+++|++|+|++|++++. + .+..+++|++|++++|.+++..+ +..+++|+.|++++|++++
T Consensus 92 L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred ccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 777777653 2566677777777777777643 2 26667777777777777665433 5566666666666666655
Q ss_pred CCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCcccccc
Q 001238 546 MLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELT 625 (1117)
Q Consensus 546 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~ 625 (1117)
+.+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|+++ +..| +.
T Consensus 166 ~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~-------------------------~~~~--l~ 214 (308)
T 1h6u_A 166 LTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQIS-------------------------DVSP--LA 214 (308)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCC-------------------------BCGG--GT
T ss_pred Chh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccC-------------------------cccc--cc
Confidence 443 5555555555555555554332 445555555555555554 3222 56
Q ss_pred CCCCccEEeccCccccCCc
Q 001238 626 GLNKLGILDLSHNELSGDL 644 (1117)
Q Consensus 626 ~l~~L~~LdLs~N~l~~~~ 644 (1117)
.+++|+.|+|++|++++.+
T Consensus 215 ~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 215 NTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp TCTTCCEEEEEEEEEECCC
T ss_pred CCCCCCEEEccCCeeecCC
Confidence 6777788888888887643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-21 Score=216.68 Aligned_cols=213 Identities=24% Similarity=0.369 Sum_probs=134.8
Q ss_pred cccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEc
Q 001238 411 QNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDL 490 (1117)
Q Consensus 411 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 490 (1117)
..+..+.+..+.+++.+ .+..+++|++|++++|.++.. + .+..+++|++|++++|++++..+ +..+++|++|+|
T Consensus 19 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L 92 (308)
T 1h6u_A 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL 92 (308)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred HHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEc
Confidence 34445556666665422 234567777777777777643 3 46667777777777777765443 666777777777
Q ss_pred cCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCC
Q 001238 491 GSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGS 570 (1117)
Q Consensus 491 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 570 (1117)
++|++++. ..+..+++|++|++++|++++..+ +..+++|+.|++++|.++++.+ +..++
T Consensus 93 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~--------------- 151 (308)
T 1h6u_A 93 SGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLT--------------- 151 (308)
T ss_dssp CSCCCSCC--GGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCT---------------
T ss_pred cCCcCCCc--hhhcCCCCCCEEECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCC---------------
Confidence 77776643 256666667777777666665321 5555555555555555554433 44444
Q ss_pred CCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcchhhhc
Q 001238 571 IPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAEL 650 (1117)
Q Consensus 571 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~l~~l 650 (1117)
+|+.|+|++|++++ ++. +..++++ +.|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+
T Consensus 152 ---------~L~~L~l~~n~l~~-~~~-l~~l~~L-~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-l~~l 216 (308)
T 1h6u_A 152 ---------NLQYLSIGNAQVSD-LTP-LANLSKL-TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LANT 216 (308)
T ss_dssp ---------TCCEEECCSSCCCC-CGG-GTTCTTC-CEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-GTTC
T ss_pred ---------CccEEEccCCcCCC-Chh-hcCCCCC-CEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc-ccCC
Confidence 44455555554442 222 4444444 445555555554333 6788999999999999997664 8899
Q ss_pred ccceEEEeecccccC
Q 001238 651 QNLVVLNVSHNNFSG 665 (1117)
Q Consensus 651 ~~L~~L~ls~N~l~~ 665 (1117)
++|+.|+|++|++++
T Consensus 217 ~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 217 SNLFIVTLTNQTITN 231 (308)
T ss_dssp TTCCEEEEEEEEEEC
T ss_pred CCCCEEEccCCeeec
Confidence 999999999999986
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.2e-21 Score=232.95 Aligned_cols=185 Identities=29% Similarity=0.395 Sum_probs=99.9
Q ss_pred CCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccC
Q 001238 100 LNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYD 179 (1117)
Q Consensus 100 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~ 179 (1117)
|+.|+|++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|++
T Consensus 61 L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 61 FSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDN 129 (571)
T ss_dssp CSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCS
T ss_pred ccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCC
Confidence 4455666666654 555442 56777777777776 566 335566666666666664 555 444 667777777
Q ss_pred CCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccC
Q 001238 180 NQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQI 259 (1117)
Q Consensus 180 N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~ 259 (1117)
|+|++ +|. .+
T Consensus 130 N~l~~-lp~---~l------------------------------------------------------------------ 139 (571)
T 3cvr_A 130 NQLTM-LPE---LP------------------------------------------------------------------ 139 (571)
T ss_dssp SCCSC-CCC---CC------------------------------------------------------------------
T ss_pred CcCCC-CCC---cC------------------------------------------------------------------
Confidence 66654 332 11
Q ss_pred CcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCC
Q 001238 260 PPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLT 339 (1117)
Q Consensus 260 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~ 339 (1117)
++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|. |..
T Consensus 140 -------~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~-- 200 (571)
T 3cvr_A 140 -------ALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV-- 200 (571)
T ss_dssp -------TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC---
T ss_pred -------ccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--
Confidence 233333444444432 232 23444444444444443 333 33 44555555555555 3333 332
Q ss_pred Cc-------ceEecccccccCcccccccCCCCCcEEEecCccccCCCCccccc
Q 001238 340 SL-------QELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGN 385 (1117)
Q Consensus 340 ~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 385 (1117)
+| +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|..|..
T Consensus 201 ~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 201 RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp -------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 44 67777777776 45666666777777777777777666655544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.9e-20 Score=194.58 Aligned_cols=181 Identities=22% Similarity=0.289 Sum_probs=127.4
Q ss_pred ceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCC
Q 001238 414 EAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493 (1117)
Q Consensus 414 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 493 (1117)
+.++++++.++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 46677777776 455544 347777888888777766666777777777777777777666666777777777777777
Q ss_pred cCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCc
Q 001238 494 RLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPS 573 (1117)
Q Consensus 494 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 573 (1117)
++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|++++|+++++.+..|..+++|+.|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 7776666667777777777777777776666666777777777777777777666666777777777777776553
Q ss_pred ccccccceeEEeccccccccccccccCCchh
Q 001238 574 QLGSCVKLQLLDLSSNQLSGNIPASLGKIPA 604 (1117)
Q Consensus 574 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 604 (1117)
.++.|+.|+++.|+++|.+|..++.++.
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 3446666777777777777766665543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.8e-20 Score=218.60 Aligned_cols=191 Identities=26% Similarity=0.374 Sum_probs=126.4
Q ss_pred CCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEec
Q 001238 292 NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELD 371 (1117)
Q Consensus 292 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 371 (1117)
+|+.|+|++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78888888888886 666553 67888888888888 566 446778888888888875 555 554 77777777
Q ss_pred CccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCC
Q 001238 372 NNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVI 451 (1117)
Q Consensus 372 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 451 (1117)
+|+|++ +|. .+++|+.|++++|+|++ +|. .+++|++|+|++|+|++ +
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-------------------------lp~---~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-------------------------LPE---LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-------------------------CCC---CCTTCCEEECCSSCCSC-C
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-------------------------CCC---cCCCcCEEECCCCCCCC-c
Confidence 777775 443 34455555555555543 332 23444444555554444 2
Q ss_pred CCCcccccccceeccCCCcccccCCCCcCC-----CCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchh
Q 001238 452 PPEMGNCSSLIRFRANSNKLTGFIPPEIGN-----LKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAG 526 (1117)
Q Consensus 452 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 526 (1117)
|. |. ++|+.|++++|+|+ .+|. |.. .+.|+.|+|++|+|+ .+|..+..+++|+.|+|++|.|++.+|..
T Consensus 176 p~-l~--~~L~~L~Ls~N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~ 249 (571)
T 3cvr_A 176 PE-LP--ESLEALDVSTNLLE-SLPA-VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES 249 (571)
T ss_dssp CC-CC--TTCCEEECCSSCCS-SCCC-CC--------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred ch-hh--CCCCEEECcCCCCC-chhh-HHHhhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence 33 33 45555555555555 3333 333 122399999999998 57888888999999999999999999988
Q ss_pred hhcccc
Q 001238 527 LHQLVR 532 (1117)
Q Consensus 527 ~~~l~~ 532 (1117)
|..+..
T Consensus 250 l~~l~~ 255 (571)
T 3cvr_A 250 LSQQTA 255 (571)
T ss_dssp HHHHHH
T ss_pred HHHhhc
Confidence 877654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=190.98 Aligned_cols=151 Identities=22% Similarity=0.244 Sum_probs=77.7
Q ss_pred EEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEeccccc
Q 001238 271 YIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQ 350 (1117)
Q Consensus 271 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 350 (1117)
.++++++.++ .+|..+ .++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus 11 ~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 4555555555 344333 2355556666665554444445555566666666665554444445555555555555555
Q ss_pred ccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeeccccccc
Q 001238 351 ISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLT 424 (1117)
Q Consensus 351 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 424 (1117)
+++..+..|.++++|++|++++|++++..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|.+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 55444444555555555555555555444444444444444444444444333333444445555555555443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-20 Score=234.66 Aligned_cols=269 Identities=18% Similarity=0.151 Sum_probs=135.1
Q ss_pred chhHHHHHHHHHhhccCCCCC-CCCCCCCCCCCcceeeEEecCCCcEEEEecccccccCcCCccccccccCCeE-----e
Q 001238 31 VNRQGEALLSWKRNWKGSDDG-LSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRL-----V 104 (1117)
Q Consensus 31 ~~~~~~aLl~~k~~~~~~~~~-l~sW~~~~~~~C~W~gv~C~~~~~v~~l~l~~~~l~~~~~~~~~~l~~L~~L-----~ 104 (1117)
...++++|+++......+... .++|.......+.|.+++++ ..+|+.++|.++++.. .+..+.....|..+ +
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVS-TPLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceec-CCccceEEeeCCCCCc-chhhHhhcCccCcccccCcc
Confidence 356889999999886544322 45786555556889999997 4778999998887765 34333333333332 2
Q ss_pred ccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCC
Q 001238 105 LSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTD 184 (1117)
Q Consensus 105 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~ 184 (1117)
++.|++. ..|..+..+..|++|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3334444 55788999999999999999998 89988999999999999999999 89999999999999999999999
Q ss_pred CCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCccccccccc-ceeecccccccccCCcCC
Q 001238 185 AIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRL-QTIAIYTALLSGQIPPEL 263 (1117)
Q Consensus 185 ~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L-~~L~l~~~~l~~~~p~~l 263 (1117)
.+|..|+.|++|++|+|++|.+ +.+|..|+++++|+.|+|++|.+++.+|..+..+... ..+++.+|.+.+.+|..
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l--~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~- 360 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMV--TTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE- 360 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCC--CCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred ccChhhcCCCCCCEEECCCCCC--CccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-
Confidence 7899999999999999999975 4789889999999999999999988888777655322 23566666666666543
Q ss_pred CCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCC
Q 001238 264 GDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTG 329 (1117)
Q Consensus 264 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~ 329 (1117)
|+.|+++.|... -..++ .+.+..+..+.++..+....+++|-+.+
T Consensus 361 -----l~~l~l~~n~~~---~~~~~-------------~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 361 -----RRFIEINTDGEP---QREYD-------------SLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp --------------------------------------------------------------CCCG
T ss_pred -----cceeEeeccccc---ccccC-------------Cccccccchhhcccccceeeeecccccc
Confidence 334445444110 01111 2333334445556666777778887753
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=9.3e-19 Score=212.62 Aligned_cols=198 Identities=21% Similarity=0.306 Sum_probs=146.9
Q ss_pred cccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCccccccccee
Q 001238 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464 (1117)
Q Consensus 385 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 464 (1117)
.+.++..+.+..+.+.+..+ +..+++|+.|++++|.+.. ++ .+..+++|+.|+|++|+|++..+ +..+++|+.|
T Consensus 19 ~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 92 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL 92 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred HHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence 35566777777777765433 4567778888888888774 44 46777888888888888876554 7778888888
Q ss_pred ccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCC
Q 001238 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG 544 (1117)
Q Consensus 465 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 544 (1117)
+|++|+|++. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.|.
T Consensus 93 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~ 166 (605)
T 1m9s_A 93 FLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166 (605)
T ss_dssp ECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred ECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence 8888888753 3677888888888888888753 4577888888888888888765 56777888888888888887
Q ss_pred CCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccc
Q 001238 545 GMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPAS 598 (1117)
Q Consensus 545 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 598 (1117)
++.+ +..+++|+.|+|++|+|.+. ..+..+++|+.|+|++|++++.....
T Consensus 167 ~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~ 216 (605)
T 1m9s_A 167 DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINH 216 (605)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCC
T ss_pred Cchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccc
Confidence 7765 77888888888888888754 35777888888888888887543333
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.1e-19 Score=195.56 Aligned_cols=193 Identities=21% Similarity=0.324 Sum_probs=155.4
Q ss_pred cccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCccccccccee
Q 001238 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464 (1117)
Q Consensus 385 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 464 (1117)
.+.++..+.+..+.+++.. .+..+++|+.|++++|.++. ++ .+..+++|++|++++|++++..+ +..+++|++|
T Consensus 22 ~l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L 95 (291)
T 1h6t_A 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWL 95 (291)
T ss_dssp HHHHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEE
Confidence 3556677777777776543 34577888999999998874 44 47778889999999999887654 8888899999
Q ss_pred ccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCC
Q 001238 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG 544 (1117)
Q Consensus 465 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 544 (1117)
++++|++++. ..+..+++|++|+|++|++++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|+|+
T Consensus 96 ~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~ 169 (291)
T 1h6t_A 96 FLDENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 169 (291)
T ss_dssp ECCSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc
Confidence 9999988863 3488889999999999998864 5688889999999999998865 57888889999999999988
Q ss_pred CCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecccccccc
Q 001238 545 GMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSG 593 (1117)
Q Consensus 545 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 593 (1117)
++.+ +..+++|+.|++++|.|++. + .+..+++|+.|++++|+++.
T Consensus 170 ~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 170 DIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred cchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 8765 88888999999999988854 3 47888899999999998874
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.6e-19 Score=187.80 Aligned_cols=157 Identities=22% Similarity=0.274 Sum_probs=110.1
Q ss_pred ceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCC
Q 001238 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDN 541 (1117)
Q Consensus 462 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 541 (1117)
+.+++++|.++. +|..+. ++|+.|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 567777777773 454443 56777777777777666667777777777777777777766777777777777777777
Q ss_pred cCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCcc
Q 001238 542 SVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELP 621 (1117)
Q Consensus 542 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p 621 (1117)
+|+.++...|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ +..+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~~~~ 145 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-------------------------TIAK 145 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-------------------------CCCT
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC-------------------------EECH
Confidence 777666666666666666666666666666666666666666666666655 3444
Q ss_pred ccccCCCCccEEeccCccccCCcch
Q 001238 622 AELTGLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 622 ~~l~~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
..|..+++|+.|+|++|++.|++..
T Consensus 146 ~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 146 GTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp TTTTTCTTCCEEECCSSCEECSGGG
T ss_pred HHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 5567788899999999999987654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.9e-19 Score=188.41 Aligned_cols=136 Identities=20% Similarity=0.218 Sum_probs=85.5
Q ss_pred ceEEccCCccccccc-hhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccc
Q 001238 510 TFLDVHSNSIAGNLP-AGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSS 588 (1117)
Q Consensus 510 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 588 (1117)
++|+|++|+|++..+ ..|..+++|+.|+|++|+|+++.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 114 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence 444444444444322 2344444455555555555555555555555666666666666655555566666666666666
Q ss_pred cccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch
Q 001238 589 NQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 589 N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
|+|++..|..|..+++| +.|+|++|+|++..|..|..+++|+.|+|++|+|+|+++.
T Consensus 115 N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 115 NRITCVGNDSFIGLSSV-RLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp SCCCCBCTTSSTTCTTC-SEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred CcCCeECHhHcCCCccC-CEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 66665556666666666 5666666666666677888889999999999999998764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-20 Score=228.54 Aligned_cols=216 Identities=23% Similarity=0.215 Sum_probs=140.4
Q ss_pred cccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCCcccccCcccchh
Q 001238 119 ASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEA 198 (1117)
Q Consensus 119 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 198 (1117)
+.+++|+.|+|++|+++ .+|.+++.|++|+.|++++|.....+|..+ ..+.+.+.+|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll-----------~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM-----------RALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHH-----------HHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHH-----------HhcccccCCHHHHHHHHhccc
Confidence 67889999999999997 899999999999999997765321222111 122344567777777777777
Q ss_pred hh-ccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCcCCCCCCCCcEEecCCC
Q 001238 199 IR-AGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYEN 277 (1117)
Q Consensus 199 L~-l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n 277 (1117)
|+ ++.|. +++|..+.+.+|.+....+ ..|+.|+|++|
T Consensus 414 L~~l~~n~------------~~~L~~l~l~~n~i~~l~~------------------------------~~L~~L~Ls~n 451 (567)
T 1dce_A 414 VDPMRAAY------------LDDLRSKFLLENSVLKMEY------------------------------ADVRVLHLAHK 451 (567)
T ss_dssp HCGGGHHH------------HHHHHHHHHHHHHHHHHHH------------------------------TTCSEEECTTS
T ss_pred Ccchhhcc------------cchhhhhhhhcccccccCc------------------------------cCceEEEecCC
Confidence 77 54442 3445555555555543211 13566777777
Q ss_pred ccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcc-c
Q 001238 278 ALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEI-P 356 (1117)
Q Consensus 278 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p 356 (1117)
+|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .++.+++|++|+|++|+|++.. |
T Consensus 452 ~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p 526 (567)
T 1dce_A 452 DLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAI 526 (567)
T ss_dssp CCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTT
T ss_pred CCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCc
Confidence 7664 554 666777777777777776 566667777777777777777774 55 5667777777777777777655 6
Q ss_pred ccccCCCCCcEEEecCccccCCCCcc---cccccchHHHH
Q 001238 357 AQIGNCQRLAQIELDNNQITGAIPSE---FGNLSNLTLLF 393 (1117)
Q Consensus 357 ~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~ 393 (1117)
..|+.+++|+.|+|++|++++.+|.. +..+++|+.|+
T Consensus 527 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp GGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred HHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 66777777777777777776554422 22355555553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.76 E-value=6.9e-19 Score=195.10 Aligned_cols=190 Identities=29% Similarity=0.354 Sum_probs=111.1
Q ss_pred CCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEcc
Q 001238 436 KLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVH 515 (1117)
Q Consensus 436 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 515 (1117)
++..+.+..+.+.+. ..+..+++|+.|++++|.+++. + .+..+++|++|+|++|++++..+ +..+++|++|+++
T Consensus 25 ~~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~ 98 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD 98 (291)
T ss_dssp HHHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhcCCCcccc--cchhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECC
Confidence 344445555555533 2234566677777777766644 2 36666677777777777765433 6666677777777
Q ss_pred CCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecccccccccc
Q 001238 516 SNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNI 595 (1117)
Q Consensus 516 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 595 (1117)
+|.+++. + .+..+++|+.|++++|+++++ ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|+++
T Consensus 99 ~n~l~~~-~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~--- 169 (291)
T 1h6t_A 99 ENKVKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS--- 169 (291)
T ss_dssp SSCCCCG-G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC---
T ss_pred CCcCCCC-h-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc---
Confidence 7766642 2 255566666666666666554 2355555555555555555543 34555555555555555554
Q ss_pred ccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcchhhhcccceEEEeecccccC
Q 001238 596 PASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSG 665 (1117)
Q Consensus 596 p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~l~~l~~L~~L~ls~N~l~~ 665 (1117)
+..| +..+++|+.|+|++|+++.. +.+..+++|+.|++++|+++.
T Consensus 170 ----------------------~~~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 170 ----------------------DIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp ----------------------CCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEEC
T ss_pred ----------------------cchh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccC
Confidence 3333 55666666677777766643 346666677777777776654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=5.1e-19 Score=202.84 Aligned_cols=181 Identities=25% Similarity=0.230 Sum_probs=111.7
Q ss_pred CeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcC-CCCCCCEEEccCCcCCCCCCcccccCCCCceEEccC
Q 001238 438 NKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIG-NLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHS 516 (1117)
Q Consensus 438 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 516 (1117)
+.+++++|+++. +|..+. ..++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 466777777764 344333 3466667777776666666665 666666666666666666666666666666666666
Q ss_pred CccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCccc---ccccceeEEecccccccc
Q 001238 517 NSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQL---GSCVKLQLLDLSSNQLSG 593 (1117)
Q Consensus 517 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~ 593 (1117)
|+|++..+..|..+++|+.|+|++|+|+.+.+..|.++++|+.|+|++|+|++..+..| ..+++|+.|||++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~- 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK- 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC-
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC-
Confidence 66666555556666666666666666666666666666666666666666654444444 34555555555555555
Q ss_pred ccccccCCchhHHHhhcCCCCcccCCccccccCCCC--ccEEeccCccccCCcch
Q 001238 594 NIPASLGKIPALAIALNLSWNQICGELPAELTGLNK--LGILDLSHNELSGDLHF 646 (1117)
Q Consensus 594 ~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~--L~~LdLs~N~l~~~~~~ 646 (1117)
+..+..|..++. |+.|+|++|+|.|++..
T Consensus 177 ------------------------~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 177 ------------------------KLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp ------------------------CCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred ------------------------ccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 333344455554 47889999999988753
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.8e-19 Score=200.49 Aligned_cols=177 Identities=22% Similarity=0.166 Sum_probs=147.4
Q ss_pred ceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcc-cccccceeccCCCcccccCCCCcCCCCCCCEEEccC
Q 001238 414 EAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMG-NCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGS 492 (1117)
Q Consensus 414 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 492 (1117)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57888888887 4776654 3578888888888888777787 888888888888888888778888888999999999
Q ss_pred CcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCc---CCCccccEEeccccccCC
Q 001238 493 NRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDL---GSLSSLTKLVLNKNRFAG 569 (1117)
Q Consensus 493 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~---~~l~~L~~L~L~~N~l~~ 569 (1117)
|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++++...| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99887777788888999999999999988888888889999999999999988887777 568999999999999997
Q ss_pred CCCcccccccc--eeEEecccccccc
Q 001238 570 SIPSQLGSCVK--LQLLDLSSNQLSG 593 (1117)
Q Consensus 570 ~~~~~~~~l~~--L~~L~Ls~N~l~~ 593 (1117)
..+..|..++. ++.|+|++|.+..
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred cCHHHhhhccHhhcceEEecCCCccC
Confidence 77777877776 4789999998873
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.1e-20 Score=225.90 Aligned_cols=216 Identities=18% Similarity=0.167 Sum_probs=100.4
Q ss_pred CCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHH
Q 001238 312 GNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTL 391 (1117)
Q Consensus 312 ~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 391 (1117)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|......|.. +..+.+.+.+|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhccc
Confidence 45566666777777666 56666666667777776655411011100 0011123344445555555555
Q ss_pred HH-hccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCc
Q 001238 392 LF-VWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNK 470 (1117)
Q Consensus 392 L~-L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 470 (1117)
|+ ++.|.+. .|..+.+++|.++. +|. ..|+.|+|++|+|++ +|. |+.+++|+.|++++|+
T Consensus 414 L~~l~~n~~~-----------~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYLD-----------DLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHHH-----------HHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhcccc-----------hhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 55 4444321 23334444444432 111 124444444444443 232 4444444444444444
Q ss_pred ccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCcccccc-chhhhcccccccccccCCcCCCCCCC
Q 001238 471 LTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNL-PAGLHQLVRLQFADLSDNSVGGMLSP 549 (1117)
Q Consensus 471 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~i~~~~~~ 549 (1117)
|+ .+|..|+++++|+.|+|++|+|++ +| .|..+++|++|+|++|+|++.. |..|..+++|+.|+|++|.++++++.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 44 334444445555555555555543 33 4444555555555555554443 44455555555555555554444332
Q ss_pred C---cCCCccccEEe
Q 001238 550 D---LGSLSSLTKLV 561 (1117)
Q Consensus 550 ~---~~~l~~L~~L~ 561 (1117)
. +..+++|+.|+
T Consensus 552 ~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 552 QERLAEMLPSVSSIL 566 (567)
T ss_dssp TTHHHHHCTTCSEEE
T ss_pred HHHHHHHCcccCccC
Confidence 1 12245555554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.8e-18 Score=207.22 Aligned_cols=109 Identities=28% Similarity=0.404 Sum_probs=66.3
Q ss_pred CCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCc
Q 001238 262 ELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSL 341 (1117)
Q Consensus 262 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L 341 (1117)
.+..+++|++|+|++|.+++ + ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++..| +..+++|
T Consensus 104 ~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L 177 (605)
T 1m9s_A 104 SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKL 177 (605)
T ss_dssp TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCC
Confidence 45566666666666666664 2 3466666666666666666643 456666666666666666665444 6666666
Q ss_pred ceEecccccccCcccccccCCCCCcEEEecCccccCC
Q 001238 342 QELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGA 378 (1117)
Q Consensus 342 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 378 (1117)
+.|+|++|+|++. + .+..+++|+.|+|++|.+.+.
T Consensus 178 ~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 178 QNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred CEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence 6666666666643 2 356666666666666666543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.1e-18 Score=180.50 Aligned_cols=152 Identities=22% Similarity=0.304 Sum_probs=85.7
Q ss_pred ceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCC
Q 001238 414 EAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493 (1117)
Q Consensus 414 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 493 (1117)
+.+++++|.++ .+|..+. ++|+.|++++|+|+++.+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45667777666 3555443 45666666666666555555555555555555555555555555555555555555555
Q ss_pred cCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCc
Q 001238 494 RLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPS 573 (1117)
Q Consensus 494 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 573 (1117)
+|+...+..|.++++|++|+|++|+|++. .+..|..+++|+.|+|++|+|++..+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~------------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCL------------------------RVDAFQDLHNLNLLSLYDNKLQTIAKG 146 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCC------------------------CTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEe------------------------CHHHcCCCCCCCEEECCCCcCCEECHH
Confidence 55544444445555555555555555544 444455555555555555555555555
Q ss_pred ccccccceeEEeccccccc
Q 001238 574 QLGSCVKLQLLDLSSNQLS 592 (1117)
Q Consensus 574 ~~~~l~~L~~L~Ls~N~l~ 592 (1117)
.|..+++|+.|+|++|.+.
T Consensus 147 ~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 147 TFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp TTTTCTTCCEEECCSSCEE
T ss_pred HHhCCCCCCEEEeCCCCcC
Confidence 5666666666666666665
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.8e-18 Score=182.07 Aligned_cols=156 Identities=23% Similarity=0.237 Sum_probs=90.4
Q ss_pred cceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccC
Q 001238 461 LIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSD 540 (1117)
Q Consensus 461 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 540 (1117)
.+.++.+++.++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|+
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-------------------- 77 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-------------------- 77 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC--------------------
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC--------------------
Confidence 344555555554 2333222 45555555555555555555555555555555555554
Q ss_pred CcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCc
Q 001238 541 NSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGEL 620 (1117)
Q Consensus 541 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~ 620 (1117)
.++...|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++| +.|+|++|+|++..
T Consensus 78 ----~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L-~~L~L~~N~l~~~~ 151 (229)
T 3e6j_A 78 ----ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHL-THLALDQNQLKSIP 151 (229)
T ss_dssp ----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTC-SEEECCSSCCCCCC
T ss_pred ----CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCC-CEEECCCCcCCccC
Confidence 444444455555555555555555444445555555555555555555 455555555555 45555666665555
Q ss_pred cccccCCCCccEEeccCccccCCcc
Q 001238 621 PAELTGLNKLGILDLSHNELSGDLH 645 (1117)
Q Consensus 621 p~~l~~l~~L~~LdLs~N~l~~~~~ 645 (1117)
+..|..+++|+.|+|++|++.|+++
T Consensus 152 ~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 152 HGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred HHHHhCCCCCCEEEeeCCCccCCcc
Confidence 5667888899999999999998876
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=189.37 Aligned_cols=136 Identities=21% Similarity=0.244 Sum_probs=107.1
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCCcE--EEEEEeecCCcc------------------------chHHHHHHHHHHhccC
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSGLT--VAVKRFRASDKI------------------------STGAFSSEIATLSRIR 830 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 830 (1117)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+++++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999987 68888 999997643111 0135789999999998
Q ss_pred CCCc--ceEEeeeecCCceEEEEEecCC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-ccCCCceeee
Q 001238 831 HRNI--VRLLGWGANRKTKLLFYDYMPN-G----TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH-HDCVPAILHR 902 (1117)
Q Consensus 831 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivHr 902 (1117)
|+++ +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.||+||| +. +|+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 8864 445543 356899999942 4 66665432 224466789999999999999 88 99999
Q ss_pred ccccCeEEEcCCCcceeccccccccc
Q 001238 903 DVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 903 Dlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
||||+|||+++ .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999765
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.8e-19 Score=193.17 Aligned_cols=171 Identities=20% Similarity=0.282 Sum_probs=127.0
Q ss_pred cccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCccccccccee
Q 001238 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464 (1117)
Q Consensus 385 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 464 (1117)
.+.++..+++++|.+++.. .+..+++|+.|++++|.++. ++ .+..+++|++|+|++|+|++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 5778899999999988543 57888899999999999884 55 67788888888888888886654 7888888888
Q ss_pred ccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCC
Q 001238 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG 544 (1117)
Q Consensus 465 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 544 (1117)
++++|++++. |. +.. ++|+.|+|++|++++. ..+..+++|++|+|++|+|++. + .+..+++|+.|++++|+|+
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 8888888764 32 222 7788888888888753 3577788888888888888764 2 5667777777777777776
Q ss_pred CCCCCCcCCCccccEEeccccccCCC
Q 001238 545 GMLSPDLGSLSSLTKLVLNKNRFAGS 570 (1117)
Q Consensus 545 ~~~~~~~~~l~~L~~L~L~~N~l~~~ 570 (1117)
++ ..+..+++|+.|++++|++.+.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 66 4556666666666666666544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=8e-18 Score=178.26 Aligned_cols=156 Identities=22% Similarity=0.233 Sum_probs=93.2
Q ss_pred ceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCC
Q 001238 414 EAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493 (1117)
Q Consensus 414 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 493 (1117)
+.+++++|.++ .+|..+.. .+++|+|++|+|++..+. ..|..+++|++|+|++|
T Consensus 14 ~~l~~s~n~l~-~iP~~~~~--~~~~L~L~~N~l~~~~~~-----------------------~~~~~l~~L~~L~L~~N 67 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIPQ--YTAELRLNNNEFTVLEAT-----------------------GIFKKLPQLRKINFSNN 67 (220)
T ss_dssp TEEECCSSCCS-SCCSCCCT--TCSEEECCSSCCCEECCC-----------------------CCGGGCTTCCEEECCSS
T ss_pred CEeEeCCCCcc-cCccCCCC--CCCEEEcCCCcCCccCch-----------------------hhhccCCCCCEEECCCC
Confidence 45666666666 34544322 334555555555544221 23455555555555555
Q ss_pred cCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCc
Q 001238 494 RLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPS 573 (1117)
Q Consensus 494 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 573 (1117)
+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..|.
T Consensus 68 ~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 68 KITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred cCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 55555455555555555555555555555555555555566666666666666666666677777777777777776677
Q ss_pred ccccccceeEEecccccccccc
Q 001238 574 QLGSCVKLQLLDLSSNQLSGNI 595 (1117)
Q Consensus 574 ~~~~l~~L~~L~Ls~N~l~~~~ 595 (1117)
.|..+++|+.|+|++|.+++..
T Consensus 148 ~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 148 AFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp TTTTCTTCCEEECCSCCEECSG
T ss_pred HhcCCCCCCEEEecCcCCcCCC
Confidence 7777777888888888777543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.1e-18 Score=215.00 Aligned_cols=189 Identities=22% Similarity=0.281 Sum_probs=108.1
Q ss_pred cCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCC
Q 001238 466 ANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGG 545 (1117)
Q Consensus 466 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~ 545 (1117)
+..|.+. ..+..|..++.|+.|+|++|++. .+|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+.
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~ 284 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTS 284 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSS
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCc
Confidence 3344444 45566777777777777777776 55666667777777777777777 566777777777777777777775
Q ss_pred CCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCcccccc
Q 001238 546 MLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELT 625 (1117)
Q Consensus 546 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~ 625 (1117)
+ +..|.++++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..++.+......|+|++|.+++.+|..
T Consensus 285 l-p~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~-- 360 (727)
T 4b8c_D 285 L-PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE-- 360 (727)
T ss_dssp C-CSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred c-ChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc--
Confidence 5 556777888888888888886 567778888888888898888888888887666555456888899988887754
Q ss_pred CCCCccEEeccCc--------cccCCcch-hhhcccceEEEeecccccC
Q 001238 626 GLNKLGILDLSHN--------ELSGDLHF-LAELQNLVVLNVSHNNFSG 665 (1117)
Q Consensus 626 ~l~~L~~LdLs~N--------~l~~~~~~-l~~l~~L~~L~ls~N~l~~ 665 (1117)
|+.|++++| .|.+..+. +..+..+....+++|-+.+
T Consensus 361 ----l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 361 ----RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ---------------------------------------------CCCG
T ss_pred ----cceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 456677777 22222221 3445555666677776653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.3e-17 Score=174.77 Aligned_cols=152 Identities=26% Similarity=0.309 Sum_probs=99.2
Q ss_pred cceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccC
Q 001238 413 LEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGS 492 (1117)
Q Consensus 413 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 492 (1117)
-+.++++++.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|++++|+|+...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 456777777776 4665543 6777777777777777777777777777777777777666556667777777777777
Q ss_pred CcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccC
Q 001238 493 NRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFA 568 (1117)
Q Consensus 493 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 568 (1117)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|.+.
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 7777666666677777777777777776 45555555555555555555555554444444444444444444443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-17 Score=181.36 Aligned_cols=171 Identities=20% Similarity=0.295 Sum_probs=135.5
Q ss_pred cccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEE
Q 001238 409 NCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFL 488 (1117)
Q Consensus 409 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 488 (1117)
.+.++..+++++|.+++ ++ .+..+++|+.|++++|+|+.. + .+..+++|++|++++|++++..+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 56677888888888874 44 567788888888888888854 3 67888888888888888886654 8888888888
Q ss_pred EccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccC
Q 001238 489 DLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFA 568 (1117)
Q Consensus 489 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 568 (1117)
+|++|++++. |. +.. ++|++|+|++|+|++. ..+..+++|+.|++++|+|+++. .+..+++|+.|+|++|+|+
T Consensus 91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcCc
Confidence 8888888853 33 222 7888888888888864 35888888888888888888874 6788888888888888888
Q ss_pred CCCCcccccccceeEEeccccccccc
Q 001238 569 GSIPSQLGSCVKLQLLDLSSNQLSGN 594 (1117)
Q Consensus 569 ~~~~~~~~~l~~L~~L~Ls~N~l~~~ 594 (1117)
+. ..+..+++|+.|++++|++++.
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 65 6678888888888888888855
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=171.99 Aligned_cols=175 Identities=21% Similarity=0.211 Sum_probs=106.2
Q ss_pred CEEEccCCcCCCCCCcccccCCCCceEEccCCccccccch-hhhcccccccccccCCcCCCCCCCCcCCCccccEEeccc
Q 001238 486 NFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPA-GLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNK 564 (1117)
Q Consensus 486 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~ 564 (1117)
+.+++++|.++ .+|..+.. +|++|++++|+|++..+. .|..+++|+.|+|++|+|+++.+..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67788888776 45554432 677777777777655543 255555555555555555555444455555555555555
Q ss_pred cccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCc
Q 001238 565 NRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDL 644 (1117)
Q Consensus 565 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~ 644 (1117)
|+|++..+.. |..+++| +.|+|++|+|++..|..|..+++|+.|+|++|+++|++
T Consensus 88 N~l~~~~~~~------------------------~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKM------------------------FLGLHQL-KTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSS------------------------STTCTTC-CEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHH------------------------hcCCCCC-CEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 5444444444 4444444 44555555555556667778889999999999999988
Q ss_pred chhhhcccceEEEeecccccCCCCCCcccccCCcccccCCCCCCcC
Q 001238 645 HFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFS 690 (1117)
Q Consensus 645 ~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gN~~~c~~ 690 (1117)
+..+-...++...+..+...+..|. .+.......+..+...|..
T Consensus 143 ~l~~~~~~l~~~~~~~~~~~C~~P~--~l~~~~l~~l~~~~~~C~~ 186 (192)
T 1w8a_A 143 HLAWFAEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp GGHHHHHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCC
T ss_pred cchHHHHHHHHcCCCCCCCCCCCCh--HHcCCChhhCcHhhcCcCC
Confidence 7533233344446667777766664 3445555566677777753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-18 Score=195.72 Aligned_cols=101 Identities=16% Similarity=0.081 Sum_probs=49.6
Q ss_pred CCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccc-cccccCCcCCCCCCCCcCCCccccEEe
Q 001238 483 KNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQ-FADLSDNSVGGMLSPDLGSLSSLTKLV 561 (1117)
Q Consensus 483 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 561 (1117)
++|+.|+|++|+++.+.+.+|.++++|+.|+|++| +..+.+.+|.++.+|+ .+++.+ .++.+...+|.++++|+.++
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 44444444444444444444444444444444444 4444444444444444 444444 44445555555555555555
Q ss_pred ccccccCCCCCcccccccceeEEe
Q 001238 562 LNKNRFAGSIPSQLGSCVKLQLLD 585 (1117)
Q Consensus 562 L~~N~l~~~~~~~~~~l~~L~~L~ 585 (1117)
+++|.++.+.+.+|.++++|+.++
T Consensus 304 l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 304 ATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp ECSSCCCEECTTTTCTTCCCCEEE
T ss_pred eCCCccCccchhhhcCCcchhhhc
Confidence 555555544455555555555554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.68 E-value=5.3e-17 Score=168.91 Aligned_cols=133 Identities=20% Similarity=0.259 Sum_probs=75.2
Q ss_pred CCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCC
Q 001238 407 ISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLN 486 (1117)
Q Consensus 407 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 486 (1117)
...+++|+.|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..|+.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356667777777777776 455 56666777777777775542 23455555556666655555555555555555555
Q ss_pred EEEccCCcCCCCCCcccccCCCCceEEccCCc-cccccchhhhcccccccccccCCcCCC
Q 001238 487 FLDLGSNRLTGSIPDEITGCRNLTFLDVHSNS-IAGNLPAGLHQLVRLQFADLSDNSVGG 545 (1117)
Q Consensus 487 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~i~~ 545 (1117)
+|+|++|++++..|..+..+++|++|++++|. ++. +| .+..+++|+.|++++|+|++
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcC
Confidence 55555555555455555555555555555555 332 22 34444444444444444443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=165.31 Aligned_cols=132 Identities=22% Similarity=0.250 Sum_probs=93.3
Q ss_pred ceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCc-ccccCCCCceEEccCCccccccchhhhcccccccccccC
Q 001238 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPD-EITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSD 540 (1117)
Q Consensus 462 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 540 (1117)
+.+++++|+++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 44555555554 33443332 666777777777655543 366677777777777777766667777777777777777
Q ss_pred CcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccc
Q 001238 541 NSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP 596 (1117)
Q Consensus 541 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 596 (1117)
|+|+++.+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 77777777777788888888888888888778888888888888888888886654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-17 Score=188.79 Aligned_cols=216 Identities=13% Similarity=0.061 Sum_probs=117.7
Q ss_pred ccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCc----cCCCCCCCCccccccc
Q 001238 386 LSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSN----NLSGVIPPEMGNCSSL 461 (1117)
Q Consensus 386 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N----~l~~~~~~~~~~l~~L 461 (1117)
+++|+.|+|.+ .++.+.+..|.+|++|+.|++++|.+....+..|..+.++..+.+..+ .........|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 44444444444 444333444444444444444444444333333444333333333331 1122223344444444
Q ss_pred c-eeccCCCc-ccccCCCCcCCCCCCCEEEccCCcCCCCCCccc-ccCCCCceEEccCCccccccchhhhcccccccccc
Q 001238 462 I-RFRANSNK-LTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADL 538 (1117)
Q Consensus 462 ~-~L~l~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 538 (1117)
+ .+.+.... +.......-....+++.+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+..|.++.+|+.+++
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 4 22222211 11110011112345556666554221 111112 23677888888888887777777888888888888
Q ss_pred cCCcCCCCCCCCcCCCcccc-EEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhH
Q 001238 539 SDNSVGGMLSPDLGSLSSLT-KLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPAL 605 (1117)
Q Consensus 539 s~N~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l 605 (1117)
.+| +..+...+|.++.+|+ .+.+.+ .++.+.+.+|..|.+|+.|++++|.++...+..|.++++|
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L 323 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPS 323 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCC
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcch
Confidence 777 7777888888888887 888877 6666667778888888888888888875555566666655
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=166.01 Aligned_cols=152 Identities=16% Similarity=0.274 Sum_probs=83.0
Q ss_pred cccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEE
Q 001238 241 LLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSII 320 (1117)
Q Consensus 241 ~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 320 (1117)
.+++|+.|++++|.+. .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..++.+++|++|
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 3344444444444443 233 3555555666666665444 22345556666666666666665555556666666666
Q ss_pred EcCCCcCCCCCccccCCCCCcceEeccccc-ccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccc
Q 001238 321 DISMNSLTGSIPQTLGNLTSLQELQLSVNQ-ISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRL 399 (1117)
Q Consensus 321 dLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 399 (1117)
+|++|.+++..|..++.+++|++|+|++|. ++ .+| .+..+++|++|++++|++++. + .+..+++|+.|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence 666666665555556666666666666665 43 333 455666666666666666542 2 455566666666666655
Q ss_pred c
Q 001238 400 E 400 (1117)
Q Consensus 400 ~ 400 (1117)
.
T Consensus 194 ~ 194 (197)
T 4ezg_A 194 G 194 (197)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.9e-16 Score=177.99 Aligned_cols=136 Identities=16% Similarity=0.172 Sum_probs=101.2
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCcc--------------chH--------HHHHHHHHHhccCCCCc
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI--------------STG--------AFSSEIATLSRIRHRNI 834 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------~~~--------~~~~E~~~l~~l~H~ni 834 (1117)
-|.+.+.||+|+||.||+|...+|+.||||+++..... ... ...+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38889999999999999999889999999987642100 000 12346666777655443
Q ss_pred c--eEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc
Q 001238 835 V--RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 835 v--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 912 (1117)
. +.+++ ...++||||++|++|..+... .....++.|++.+|.|||+. |||||||||.|||++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 2 22322 123799999999988765432 12356889999999999998 999999999999998
Q ss_pred CCC----------cceeccccccccc
Q 001238 913 ERY----------ESCLADFGLARLV 928 (1117)
Q Consensus 913 ~~~----------~~kl~DfGla~~~ 928 (1117)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 876 3789999987654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.61 E-value=6.1e-15 Score=170.22 Aligned_cols=114 Identities=9% Similarity=0.057 Sum_probs=67.6
Q ss_pred CCCcCCCCCCCEEEccCCcCC-----CCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCC
Q 001238 476 PPEIGNLKNLNFLDLGSNRLT-----GSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPD 550 (1117)
Q Consensus 476 ~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~ 550 (1117)
...|.++++|+.+++.+|.+. .+.+.+|.++++|+.++|. |.++.+...+|.++.+|+.+++..| ++.+...+
T Consensus 264 ~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~a 341 (401)
T 4fdw_A 264 SRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSA 341 (401)
T ss_dssp TTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTS
T ss_pred hhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHh
Confidence 334444444444444444332 2344555556666666665 3355555555666666666666433 56666677
Q ss_pred cCCCccccEEeccccccCCCCCccccccc-ceeEEeccccccc
Q 001238 551 LGSLSSLTKLVLNKNRFAGSIPSQLGSCV-KLQLLDLSSNQLS 592 (1117)
Q Consensus 551 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~ 592 (1117)
|.++ +|+.+.+.+|.+.......|..++ .++.|++..|.+.
T Consensus 342 F~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 342 FNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 7777 777777777777666666777663 6777777777654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.1e-15 Score=170.89 Aligned_cols=263 Identities=12% Similarity=0.152 Sum_probs=137.0
Q ss_pred CCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEe
Q 001238 291 KNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIEL 370 (1117)
Q Consensus 291 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 370 (1117)
..++.+.+.+ .++.+-...|.++ +|+.+++..| ++......|.+ .+|+.+.+.. .++.+.+..|.++.+|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4556666654 3444555566664 5777776655 55444445555 3566666654 444444556666666666666
Q ss_pred cCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCC
Q 001238 371 DNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGV 450 (1117)
Q Consensus 371 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 450 (1117)
.+|+++.+....|. ..+|+.+.+..+ ++.+....|.+|++|+.+++..| ++..-...|.+ .+|+.+.+ .|.++.+
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I 262 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNI 262 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEE
Confidence 66666644444444 355555555432 44444455555555555555543 33222222333 45555555 3344444
Q ss_pred CCCCcccccccceeccCCCccc-----ccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccch
Q 001238 451 IPPEMGNCSSLIRFRANSNKLT-----GFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPA 525 (1117)
Q Consensus 451 ~~~~~~~l~~L~~L~l~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 525 (1117)
...+|.+|++|+.+.+.+|.+. .+.+..|.++++|+.++|. |.++.+...+|.++++|+.++|..| ++.+...
T Consensus 263 ~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~ 340 (401)
T 4fdw_A 263 ASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFS 340 (401)
T ss_dssp CTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTT
T ss_pred ChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHH
Confidence 4555555555555555554443 2334455555555555555 3344444455555555555555333 4444445
Q ss_pred hhhcccccccccccCCcCCCCCCCCcCCCc-cccEEeccccc
Q 001238 526 GLHQLVRLQFADLSDNSVGGMLSPDLGSLS-SLTKLVLNKNR 566 (1117)
Q Consensus 526 ~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~-~L~~L~L~~N~ 566 (1117)
+|.++ +|+.+++++|.+..+....|.+++ +++.|++..+.
T Consensus 341 aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 341 AFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp SSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred hCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 55555 555555555555555555555552 45555555444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-15 Score=152.99 Aligned_cols=136 Identities=21% Similarity=0.200 Sum_probs=79.1
Q ss_pred CCCCeeeccCccCC-CCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEE
Q 001238 435 KKLNKLLLLSNNLS-GVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLD 513 (1117)
Q Consensus 435 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 513 (1117)
++|+.|++++|+++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 44555555566666666666665544 4555555555555555555544555555555555555
Q ss_pred ccCCccccccchhhhcccccccccccCCcCCCCCC-CCcCCCccccEEeccccccCCCCC---cccccccceeEEecccc
Q 001238 514 VHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS-PDLGSLSSLTKLVLNKNRFAGSIP---SQLGSCVKLQLLDLSSN 589 (1117)
Q Consensus 514 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N 589 (1117)
|++|.|+ +++. ..+..+++|+.|++++|.+++..+ ..|..+++|+.|++++|
T Consensus 102 Ls~N~l~------------------------~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n 157 (168)
T 2ell_A 102 LSGNKLK------------------------DISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157 (168)
T ss_dssp CBSSSCC------------------------SSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEET
T ss_pred ccCCccC------------------------cchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCC
Confidence 5555555 3322 345555666666666666665444 35666777777777777
Q ss_pred cccccccc
Q 001238 590 QLSGNIPA 597 (1117)
Q Consensus 590 ~l~~~~p~ 597 (1117)
.++ .+|.
T Consensus 158 ~~~-~~~~ 164 (168)
T 2ell_A 158 EDQ-EAPD 164 (168)
T ss_dssp TSC-BCCS
T ss_pred Chh-hccc
Confidence 766 4443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.5e-15 Score=153.37 Aligned_cols=132 Identities=22% Similarity=0.248 Sum_probs=100.1
Q ss_pred CCCcEEecCCCccC-CcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEe
Q 001238 267 TELQYIYLYENALT-GSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQ 345 (1117)
Q Consensus 267 ~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ 345 (1117)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 67788888888887 67777778888888888888888755 6778888888888888888876777777788888888
Q ss_pred cccccccCcc-cccccCCCCCcEEEecCccccCCCC---cccccccchHHHHhcccccc
Q 001238 346 LSVNQISGEI-PAQIGNCQRLAQIELDNNQITGAIP---SEFGNLSNLTLLFVWHNRLE 400 (1117)
Q Consensus 346 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~ 400 (1117)
|++|.|++.. +..+..+++|+.|++++|.+++..+ ..|..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 8888887542 2677788888888888888875544 35666666777777666665
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.6e-14 Score=165.79 Aligned_cols=312 Identities=13% Similarity=0.121 Sum_probs=212.4
Q ss_pred cCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCC
Q 001238 261 PELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTS 340 (1117)
Q Consensus 261 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~ 340 (1117)
.+|.+|++|+.+.|..+ ++..-...|.++++|+.+++.++ ++.+-...|.++++|+.+.+..+ +.......|.++..
T Consensus 65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence 45667777777777643 55334456777777777777654 55455566777777777666544 33244445655544
Q ss_pred cceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeeccc
Q 001238 341 LQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQ 420 (1117)
Q Consensus 341 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 420 (1117)
++......... .....|.++.+|+.+.+.++..+ +....|.++.+|+.+.+..| ++......|.++..|+.+.+..
T Consensus 142 ~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 142 KEITIPEGVTV--IGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp SEEECCTTCCE--ECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred cccccCccccc--cchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence 33333322222 33456777788888887665433 55567777778888877665 5545566778888888888776
Q ss_pred ccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCC
Q 001238 421 NGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIP 500 (1117)
Q Consensus 421 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 500 (1117)
+... +....+....|+.+.+..+ +..+....|.++..|+.+.+..+... .....|.++..++.+....+.+ ..
T Consensus 218 ~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~ 290 (394)
T 4fs7_A 218 SLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PE 290 (394)
T ss_dssp TCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CT
T ss_pred CceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---cc
Confidence 6543 3444555667787777543 44455667888888888888777554 6666788888888888876653 33
Q ss_pred cccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccc
Q 001238 501 DEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVK 580 (1117)
Q Consensus 501 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 580 (1117)
..|.++.+|+.+.+.++ +..+...+|.++.+|+.+++.++ ++.+...+|.++.+|+.+.+..| ++.+...+|.+|.+
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~ 367 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCIN 367 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTT
T ss_pred ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCC
Confidence 56778888888888765 66666777888888888888644 77888888888888888888776 66666778888888
Q ss_pred eeEEecccc
Q 001238 581 LQLLDLSSN 589 (1117)
Q Consensus 581 L~~L~Ls~N 589 (1117)
|+.+++..|
T Consensus 368 L~~i~lp~~ 376 (394)
T 4fs7_A 368 LKKVELPKR 376 (394)
T ss_dssp CCEEEEEGG
T ss_pred CCEEEECCC
Confidence 888888654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.2e-14 Score=164.03 Aligned_cols=330 Identities=12% Similarity=0.080 Sum_probs=228.9
Q ss_pred CcccccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCC
Q 001238 236 PPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCS 315 (1117)
Q Consensus 236 p~~l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 315 (1117)
..+|.++.+|+.+.+..+ +...-..+|.+|++|+.++|.++ ++..-...|.++.+|+.+.+..+ +.......|.++.
T Consensus 64 ~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 344555555666655432 33333456777777777777654 44334456777777777666544 4445555666665
Q ss_pred CCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhc
Q 001238 316 QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVW 395 (1117)
Q Consensus 316 ~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 395 (1117)
.+.......... .....|.++++|+.+.+..+... .....|.++.+|+.+.+..| ++.+....|.++..|+.+.+.
T Consensus 141 ~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~ 216 (394)
T 4fs7_A 141 FKEITIPEGVTV--IGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFP 216 (394)
T ss_dssp CSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCC
T ss_pred ccccccCccccc--cchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecC
Confidence 444433333222 23456777778888887655432 55567777788888877766 443555677777777777776
Q ss_pred cccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccC
Q 001238 396 HNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFI 475 (1117)
Q Consensus 396 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 475 (1117)
.+... +........+|+.+.+..+. +......+.....|+.+.+..+... +....|.++..++.+....+.+.
T Consensus 217 ~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~--- 289 (394)
T 4fs7_A 217 NSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP--- 289 (394)
T ss_dssp TTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---
T ss_pred CCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---
Confidence 65443 23344455678888876543 3244556777888999888877544 66778889999998888776543
Q ss_pred CCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCc
Q 001238 476 PPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLS 555 (1117)
Q Consensus 476 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~ 555 (1117)
...|..+.+|+.+.+..+ ++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+++..| ++.+...+|.++.
T Consensus 290 ~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 366 (394)
T 4fs7_A 290 EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI 366 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence 357888999999999765 66677788999999999999754 77777889999999999999877 8899999999999
Q ss_pred cccEEeccccccCCCCCcccccccceeEE
Q 001238 556 SLTKLVLNKNRFAGSIPSQLGSCVKLQLL 584 (1117)
Q Consensus 556 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 584 (1117)
+|+.+.+..+ +. .+..+|.++++|+.+
T Consensus 367 ~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 367 NLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 9999999866 43 345678899998875
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.6e-15 Score=148.36 Aligned_cols=127 Identities=20% Similarity=0.252 Sum_probs=97.3
Q ss_pred CCCcEEecCCCccC-CcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEe
Q 001238 267 TELQYIYLYENALT-GSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQ 345 (1117)
Q Consensus 267 ~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~ 345 (1117)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56788888888887 67777778888888888888888765 6778888888888888888876777777788888888
Q ss_pred cccccccCc-ccccccCCCCCcEEEecCccccCCCC---cccccccchHHHHhc
Q 001238 346 LSVNQISGE-IPAQIGNCQRLAQIELDNNQITGAIP---SEFGNLSNLTLLFVW 395 (1117)
Q Consensus 346 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~ 395 (1117)
+++|.+++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 888888753 34677888888888888888876554 356666666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=3.5e-15 Score=154.25 Aligned_cols=132 Identities=24% Similarity=0.371 Sum_probs=104.8
Q ss_pred CEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEecccc
Q 001238 486 NFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKN 565 (1117)
Q Consensus 486 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N 565 (1117)
+.+++++|.++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+++.+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 67899999998 5665543 58999999999998 56678888888888888888888888888888888888888888
Q ss_pred ccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcc
Q 001238 566 RFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLH 645 (1117)
Q Consensus 566 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~ 645 (1117)
+|++..+..|..+++|+.|+|++|+|++ ..+..|..+++|+.|+|++|++.|++.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~-------------------------~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISV-------------------------VPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCB-------------------------CCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCe-------------------------eChhhhhcCccccEEEeCCCCeecCCc
Confidence 8887777777777778777777777762 223346678889999999999998775
Q ss_pred h
Q 001238 646 F 646 (1117)
Q Consensus 646 ~ 646 (1117)
.
T Consensus 144 l 144 (193)
T 2wfh_A 144 M 144 (193)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.7e-14 Score=149.06 Aligned_cols=128 Identities=23% Similarity=0.307 Sum_probs=91.9
Q ss_pred ceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCC
Q 001238 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDN 541 (1117)
Q Consensus 462 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 541 (1117)
+.+++++|.++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|.|++..+..|..+++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 34555555555 3343332 46777777777776 55667777777777777777777766677777777777777777
Q ss_pred cCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecccccccc
Q 001238 542 SVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSG 593 (1117)
Q Consensus 542 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 593 (1117)
+|+++.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 7777777777778888888888888877666678888888888888888864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.55 E-value=6e-15 Score=145.74 Aligned_cols=127 Identities=16% Similarity=0.229 Sum_probs=74.9
Q ss_pred cccceeeccccccc-CCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEE
Q 001238 411 QNLEAVDLSQNGLT-GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLD 489 (1117)
Q Consensus 411 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 489 (1117)
++|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..++.+++|++|++++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 55666666666666 45565556666666666666666644 4555566666666666666655555555566666666
Q ss_pred ccCCcCCCC-CCcccccCCCCceEEccCCccccccc---hhhhccccccccccc
Q 001238 490 LGSNRLTGS-IPDEITGCRNLTFLDVHSNSIAGNLP---AGLHQLVRLQFADLS 539 (1117)
Q Consensus 490 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls 539 (1117)
+++|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666542 23555666666666666666665444 345555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.4e-14 Score=145.95 Aligned_cols=132 Identities=23% Similarity=0.286 Sum_probs=85.4
Q ss_pred ceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCC
Q 001238 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDN 541 (1117)
Q Consensus 462 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 541 (1117)
+.+++++|+++. +|..+ .++|++|++++|++++..+..|..+++|++|++++|+|++..+..|..+++|+.|++++|
T Consensus 10 ~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 444555555542 22222 245666666666666555555666666666666666666555555666666666666666
Q ss_pred cCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccc
Q 001238 542 SVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP 596 (1117)
Q Consensus 542 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 596 (1117)
+|+++++..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6666666667777777777777777776666667777888888888888775543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.52 E-value=5.6e-14 Score=143.16 Aligned_cols=111 Identities=24% Similarity=0.271 Sum_probs=63.9
Q ss_pred ccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhccccccccccc
Q 001238 460 SLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLS 539 (1117)
Q Consensus 460 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 539 (1117)
+|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 108 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence 44444444444444444444555555555555555554444445555555555555555555555555555666666666
Q ss_pred CCcCCCCCCCCcCCCccccEEeccccccCCC
Q 001238 540 DNSVGGMLSPDLGSLSSLTKLVLNKNRFAGS 570 (1117)
Q Consensus 540 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 570 (1117)
+|+|+++++..|..+++|+.|+|++|++.+.
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 6666666666666677777777777777654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-15 Score=157.84 Aligned_cols=152 Identities=25% Similarity=0.268 Sum_probs=87.5
Q ss_pred CCCCCCEEEccCCcCCCCCCc------ccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCC
Q 001238 481 NLKNLNFLDLGSNRLTGSIPD------EITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSL 554 (1117)
Q Consensus 481 ~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l 554 (1117)
....++.++++.|.+++..|. .+..+++|++|+|++|.|++ +| .+..++
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~----------------------- 70 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGME----------------------- 70 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHT-----------------------
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCC-----------------------
Confidence 344555566666666555544 55555555555555555554 33 444444
Q ss_pred ccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCcc-ccccCCCCccEE
Q 001238 555 SSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELP-AELTGLNKLGIL 633 (1117)
Q Consensus 555 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p-~~l~~l~~L~~L 633 (1117)
+|+.|++++|.|+ .+|..+..+++|+.|+|++|++++ +| .+..++++ +.|+|++|++++..+ ..+..+++|+.|
T Consensus 71 -~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L-~~L~l~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T 1ds9_A 71 -NLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL-RVLYMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp -TCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS-SEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred -CCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC-CEEECCCCcCCchhHHHHHhcCCCCCEE
Confidence 4444555555544 334444445555556666655553 33 34444444 455555555553222 467778888888
Q ss_pred eccCccccCCcch-----------hhhcccceEEEeeccccc
Q 001238 634 DLSHNELSGDLHF-----------LAELQNLVVLNVSHNNFS 664 (1117)
Q Consensus 634 dLs~N~l~~~~~~-----------l~~l~~L~~L~ls~N~l~ 664 (1117)
++++|++++.++. +..+++|+.|| +|.++
T Consensus 146 ~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred EecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 8888888776543 67788888876 66665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.45 E-value=8.4e-14 Score=141.70 Aligned_cols=132 Identities=15% Similarity=0.172 Sum_probs=76.3
Q ss_pred CCcccccceeecccccccCCCcccccCCC-CCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCC
Q 001238 407 ISNCQNLEAVDLSQNGLTGPIPRGIFQLK-KLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNL 485 (1117)
Q Consensus 407 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 485 (1117)
+.++.+|+.|++++|+++. +|. +..+. +|++|++++|+|++. ..|..+++|++|++++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4455666677777776663 343 33333 666666666666654 456666666666666666665444444666666
Q ss_pred CEEEccCCcCCCCCCc--ccccCCCCceEEccCCccccccch---hhhcccccccccccCCcC
Q 001238 486 NFLDLGSNRLTGSIPD--EITGCRNLTFLDVHSNSIAGNLPA---GLHQLVRLQFADLSDNSV 543 (1117)
Q Consensus 486 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~i 543 (1117)
++|+|++|+|+ .+|. .+..+++|+.|++++|.+....+. .+..+++|+.||+++|.+
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence 66666666665 3343 566666666666666666533221 255555555555555544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.45 E-value=6.1e-14 Score=142.75 Aligned_cols=133 Identities=14% Similarity=0.130 Sum_probs=93.5
Q ss_pred CCCCCCCCcEEecCCCccCCcCCccCCCCC-CCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCC
Q 001238 262 ELGDCTELQYIYLYENALTGSIPSKLGNLK-NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTS 340 (1117)
Q Consensus 262 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~ 340 (1117)
.+.++++|++|++++|+++ .+|. +..+. +|++|++++|++++. ..|..+++|++|+|++|.+++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 3456677888888888887 3454 44444 888888888888865 57788888888888888888654455577888
Q ss_pred cceEecccccccCcccc--cccCCCCCcEEEecCccccCCCCcc----cccccchHHHHhcccccc
Q 001238 341 LQELQLSVNQISGEIPA--QIGNCQRLAQIELDNNQITGAIPSE----FGNLSNLTLLFVWHNRLE 400 (1117)
Q Consensus 341 L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 400 (1117)
|++|+|++|.|+ .+|. .+..+++|+.|++++|.++. +|.. +..+++|+.|++++|.+.
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888888886 4554 67778888888888888773 3442 555555555555555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.4e-15 Score=158.28 Aligned_cols=150 Identities=23% Similarity=0.327 Sum_probs=83.1
Q ss_pred CCCeeeccCccCCCCCCC------CcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCC
Q 001238 436 KLNKLLLLSNNLSGVIPP------EMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNL 509 (1117)
Q Consensus 436 ~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 509 (1117)
.++.++++.|.+.+..|. .|..+++|++|++++|++++ +| .+..+++|++|++++|+++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 344444444444444333 45555555555555555554 33 5555566666666666665 445555555666
Q ss_pred ceEEccCCccccccchhhhcccccccccccCCcCCCCCC-CCcCCCccccEEeccccccCCCCCc----------ccccc
Q 001238 510 TFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS-PDLGSLSSLTKLVLNKNRFAGSIPS----------QLGSC 578 (1117)
Q Consensus 510 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----------~~~~l 578 (1117)
++|+|++|+|++ +| .+..+++|+.|++++|+|++++. ..+..+++|+.|++++|.+.+..|. .+..+
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l 173 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence 666666666664 23 45566666666666666655433 3455566666666666666544333 25566
Q ss_pred cceeEEeccccccc
Q 001238 579 VKLQLLDLSSNQLS 592 (1117)
Q Consensus 579 ~~L~~L~Ls~N~l~ 592 (1117)
++|+.|| +|.++
T Consensus 174 ~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 174 PNLKKLD--GMPVD 185 (198)
T ss_dssp SSCSEEC--CGGGT
T ss_pred CCcEEEC--CcccC
Confidence 6666665 55554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.1e-12 Score=146.40 Aligned_cols=313 Identities=14% Similarity=0.192 Sum_probs=135.7
Q ss_pred CCCCC-CCcEEecCCCccCCcCCccCCCCCCCcEEEccCCc---CcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCC
Q 001238 263 LGDCT-ELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNN---LVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNL 338 (1117)
Q Consensus 263 l~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l 338 (1117)
|.++. .|+.+.+.++ ++..-...|.++++|+.+.+..|. ++.+-..+|.++.+|+.+.+..+ ++......|..+
T Consensus 59 F~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c 136 (394)
T 4gt6_A 59 FCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHC 136 (394)
T ss_dssp TTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTC
T ss_pred ccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhh
Confidence 44442 3555555432 332333445555555555554442 33333344555555555544433 222333445555
Q ss_pred CCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeec
Q 001238 339 TSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDL 418 (1117)
Q Consensus 339 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 418 (1117)
.+|+.+.+..+. ..+....|..+.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-.. .....|..+..++....
T Consensus 137 ~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~ 212 (394)
T 4gt6_A 137 EELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITS 212 (394)
T ss_dssp TTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEE
T ss_pred ccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceecc
Confidence 555555554332 2233445555555555555443 22233333432 34444444333222 33445555556655555
Q ss_pred ccccccCCCcccccC--------------CCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCC
Q 001238 419 SQNGLTGPIPRGIFQ--------------LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKN 484 (1117)
Q Consensus 419 s~N~l~~~~p~~~~~--------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 484 (1117)
..+... .+...+.. ...+..+.+. +.+..+...+|.++..|+.+.+.++..+ +....|.++++
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~ 289 (394)
T 4gt6_A 213 DSESYP-AIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPA 289 (394)
T ss_dssp CCSSSC-BSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTT
T ss_pred cccccc-cccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccc
Confidence 444433 11111111 1122222221 2223333445555555555555443332 44445555555
Q ss_pred CCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccc
Q 001238 485 LNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNK 564 (1117)
Q Consensus 485 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~ 564 (1117)
|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+.+
T Consensus 290 L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~ 366 (394)
T 4gt6_A 290 LQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSG 366 (394)
T ss_dssp CCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESS
T ss_pred cccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECC
Confidence 5555554 3344344445555555555555433 44344445555555555555332 4455555555555555555555
Q ss_pred cccCCCCCcccccccceeEEeccccc
Q 001238 565 NRFAGSIPSQLGSCVKLQLLDLSSNQ 590 (1117)
Q Consensus 565 N~l~~~~~~~~~~l~~L~~L~Ls~N~ 590 (1117)
|... ..+|..+..|+.+.+..|.
T Consensus 367 ~~~~---~~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 367 SRSQ---WNAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp CHHH---HHTCBCCCCC---------
T ss_pred ceee---hhhhhccCCCCEEEeCCCC
Confidence 4332 1233344445555444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.36 E-value=2.5e-12 Score=129.77 Aligned_cols=109 Identities=23% Similarity=0.287 Sum_probs=93.0
Q ss_pred ccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEcc
Q 001238 412 NLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLG 491 (1117)
Q Consensus 412 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 491 (1117)
..+.+++++|.++ .+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578899999988 4776663 788899999999998888889999999999999999998877788899999999999
Q ss_pred CCcCCCCCCcccccCCCCceEEccCCcccccc
Q 001238 492 SNRLTGSIPDEITGCRNLTFLDVHSNSIAGNL 523 (1117)
Q Consensus 492 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 523 (1117)
+|+|++..+..|..+++|++|+|++|.+....
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 99999777778889999999999999887643
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.36 E-value=2.9e-12 Score=129.25 Aligned_cols=107 Identities=25% Similarity=0.298 Sum_probs=91.0
Q ss_pred CcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEeccc
Q 001238 269 LQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSV 348 (1117)
Q Consensus 269 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~ 348 (1117)
.+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 568889999888 5776664 7889999999999988888899999999999999999977777788899999999999
Q ss_pred ccccCcccccccCCCCCcEEEecCccccCC
Q 001238 349 NQISGEIPAQIGNCQRLAQIELDNNQITGA 378 (1117)
Q Consensus 349 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 378 (1117)
|+|++..+..|.++++|++|+|++|.+...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 999877777788899999999999988743
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.5e-12 Score=129.18 Aligned_cols=105 Identities=22% Similarity=0.268 Sum_probs=89.3
Q ss_pred cEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccc
Q 001238 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVN 349 (1117)
Q Consensus 270 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N 349 (1117)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 67888888887 6777665 78899999999999888888999999999999999999766666788999999999999
Q ss_pred cccCcccccccCCCCCcEEEecCccccC
Q 001238 350 QISGEIPAQIGNCQRLAQIELDNNQITG 377 (1117)
Q Consensus 350 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 377 (1117)
+|++..+..|..+++|++|+|++|.+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 9987666678889999999999998873
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.32 E-value=5e-12 Score=128.02 Aligned_cols=107 Identities=24% Similarity=0.292 Sum_probs=89.7
Q ss_pred cceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccC
Q 001238 413 LEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGS 492 (1117)
Q Consensus 413 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 492 (1117)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 367888888887 5777664 7888899999999888888888888999999999998877777788889999999999
Q ss_pred CcCCCCCCcccccCCCCceEEccCCccccc
Q 001238 493 NRLTGSIPDEITGCRNLTFLDVHSNSIAGN 522 (1117)
Q Consensus 493 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 522 (1117)
|+|++..+..|..+++|++|+|++|.+...
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 999876666788889999999999988854
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.9e-11 Score=138.95 Aligned_cols=303 Identities=11% Similarity=0.126 Sum_probs=219.6
Q ss_pred cCCcCCccCCCCC-CCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCc---CCCCCccccCCCCCcceEecccccccCc
Q 001238 279 LTGSIPSKLGNLK-NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS---LTGSIPQTLGNLTSLQELQLSVNQISGE 354 (1117)
Q Consensus 279 l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~---l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 354 (1117)
.+..-...|.+.+ .|+.+.+..+ ++.+-..+|.++++|+.+.++.|. ++..-...|.++.+|+.+.+..+ ++..
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 3333345677774 5999999765 776777899999999999998774 65445667888999999888765 4446
Q ss_pred ccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCC
Q 001238 355 IPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQL 434 (1117)
Q Consensus 355 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 434 (1117)
....|..+.+|+.+.+..+. ..+....|..+.+|+.+.+..+ ++......|.+ ..|+.+.+..+... .....|...
T Consensus 129 ~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c 204 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSEC 204 (394)
T ss_dssp CTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTC
T ss_pred hhhhhhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhc
Confidence 66788999999999997654 3355667888888888888665 44344555654 57888888766443 455667777
Q ss_pred CCCCeeeccCccCCCCCCCCcc-------------cccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCc
Q 001238 435 KKLNKLLLLSNNLSGVIPPEMG-------------NCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPD 501 (1117)
Q Consensus 435 ~~L~~L~L~~N~l~~~~~~~~~-------------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 501 (1117)
..++......+.........+. ....+..+.+. +.++......|.++..|+.+.+..+..+ +...
T Consensus 205 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~ 282 (394)
T 4gt6_A 205 FALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTG 282 (394)
T ss_dssp TTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTT
T ss_pred cccceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCc
Confidence 8888877766655422111111 11223333332 3344455667888999999999776554 6677
Q ss_pred ccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccce
Q 001238 502 EITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKL 581 (1117)
Q Consensus 502 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 581 (1117)
+|.++++|+.+.+. +.+..+....|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.+|.+|
T Consensus 283 aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L 359 (394)
T 4gt6_A 283 AFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTAL 359 (394)
T ss_dssp TTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTC
T ss_pred ccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCC
Confidence 88899999999996 5566677778999999999999765 88888899999999999999755 776778889999999
Q ss_pred eEEeccccccc
Q 001238 582 QLLDLSSNQLS 592 (1117)
Q Consensus 582 ~~L~Ls~N~l~ 592 (1117)
+.+++.+|...
T Consensus 360 ~~i~~~~~~~~ 370 (394)
T 4gt6_A 360 NNIEYSGSRSQ 370 (394)
T ss_dssp CEEEESSCHHH
T ss_pred CEEEECCceee
Confidence 99998887643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=134.66 Aligned_cols=147 Identities=15% Similarity=0.039 Sum_probs=115.8
Q ss_pred HHhccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEE
Q 001238 772 GDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 772 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv 850 (1117)
......|++...++.|+++.||++... ++.+++|+...........+.+|+++++.+. |..++++++++.+.+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344456888888898999999999864 6899999987532233457999999999994 67788999999988899999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcc------------------------------------
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD------------------------------------ 894 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------ 894 (1117)
|||++|.++.+.+.. ......++.+++++++.||+.
T Consensus 89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999876421 122346888999999999981
Q ss_pred --------------------CCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 895 --------------------CVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 895 --------------------~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
..+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 013699999999999998765667999988753
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=3.3e-13 Score=154.23 Aligned_cols=161 Identities=21% Similarity=0.200 Sum_probs=77.3
Q ss_pred CCCCEEEccCCcCCCCCCcccccC-----CCCceEEccCCccccccchhh-hcccccccccccCCcCCCCCCCCc-----
Q 001238 483 KNLNFLDLGSNRLTGSIPDEITGC-----RNLTFLDVHSNSIAGNLPAGL-HQLVRLQFADLSDNSVGGMLSPDL----- 551 (1117)
Q Consensus 483 ~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~i~~~~~~~~----- 551 (1117)
+.|+.|+|++|.|+......+... ++|++|+|++|.|+......+ ..+.+|+.|+|++|.|++.....+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 345555555555553322222221 456666666665543322222 223455555555555544332222
Q ss_pred CCCccccEEeccccccCCC----CCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCC
Q 001238 552 GSLSSLTKLVLNKNRFAGS----IPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGL 627 (1117)
Q Consensus 552 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l 627 (1117)
...++|++|+|++|.|+.. ++..+..+++|++|||++|.|++.-.. .++..+...
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~---------------------~L~~~L~~~ 210 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE---------------------LLAAQLDRN 210 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH---------------------HHHHHGGGC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH---------------------HHHHHHhcC
Confidence 1235566666666666532 223334566677777777766532100 122334444
Q ss_pred CCccEEeccCccccCCc-----chhhhcccceEEEeeccccc
Q 001238 628 NKLGILDLSHNELSGDL-----HFLAELQNLVVLNVSHNNFS 664 (1117)
Q Consensus 628 ~~L~~LdLs~N~l~~~~-----~~l~~l~~L~~L~ls~N~l~ 664 (1117)
++|+.|||++|.|+... ..+...++|++|||++|.++
T Consensus 211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence 55555666666554321 11334455666666666554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=1.7e-11 Score=139.54 Aligned_cols=131 Identities=21% Similarity=0.165 Sum_probs=75.0
Q ss_pred eEEccCC-ccccccchhhhcccccccccccC-CcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccc
Q 001238 511 FLDVHSN-SIAGNLPAGLHQLVRLQFADLSD-NSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSS 588 (1117)
Q Consensus 511 ~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 588 (1117)
.++++++ .|+. +|. +..+.+|+.|+|++ |+|+++.+..|.++++|+.|+|++|+|++..|..|..+++|+.|||++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3456665 5653 444 55555555555553 555555555555555555555555555555555555555555555555
Q ss_pred cccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch--hhhcccceEEEeecccccCC
Q 001238 589 NQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF--LAELQNLVVLNVSHNNFSGR 666 (1117)
Q Consensus 589 N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~--l~~l~~L~~L~ls~N~l~~~ 666 (1117)
|+|+ +..+..|..++ |+.|+|++|+|.+++.. +..+.......+..+++++.
T Consensus 90 N~l~-------------------------~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~ 143 (347)
T 2ifg_A 90 NALE-------------------------SLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCH 143 (347)
T ss_dssp SCCS-------------------------CCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCS
T ss_pred Cccc-------------------------eeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCC
Confidence 5554 33344444444 89999999999987653 44444344444556667666
Q ss_pred CCC
Q 001238 667 VPD 669 (1117)
Q Consensus 667 ~p~ 669 (1117)
-|.
T Consensus 144 ~~~ 146 (347)
T 2ifg_A 144 GQG 146 (347)
T ss_dssp SSS
T ss_pred CCh
Confidence 554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=3.1e-13 Score=154.39 Aligned_cols=159 Identities=18% Similarity=0.146 Sum_probs=88.5
Q ss_pred ccccceeecccccccCCCcccccCC-----CCCCeeeccCccCCCCCCCCc-ccccccceeccCCCcccccCCCCc----
Q 001238 410 CQNLEAVDLSQNGLTGPIPRGIFQL-----KKLNKLLLLSNNLSGVIPPEM-GNCSSLIRFRANSNKLTGFIPPEI---- 479 (1117)
Q Consensus 410 l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~---- 479 (1117)
++.|+.|+|++|.++......+... .+|++|+|++|.|+......+ ..+++|++|+|++|+|++.....+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3567888888888875333333322 577778888877764332222 234567777777777764433333
Q ss_pred -CCCCCCCEEEccCCcCCCC----CCcccccCCCCceEEccCCcccccc----chhhhcccccccccccCCcCCCCCCCC
Q 001238 480 -GNLKNLNFLDLGSNRLTGS----IPDEITGCRNLTFLDVHSNSIAGNL----PAGLHQLVRLQFADLSDNSVGGMLSPD 550 (1117)
Q Consensus 480 -~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~i~~~~~~~ 550 (1117)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++.. +..+...+.|+.|+|++|.|++.....
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 2346677777777776532 2333455667777777777766432 334444555555555555554432211
Q ss_pred ----cCCCccccEEeccccccC
Q 001238 551 ----LGSLSSLTKLVLNKNRFA 568 (1117)
Q Consensus 551 ----~~~l~~L~~L~L~~N~l~ 568 (1117)
+...++|+.|+|++|.|+
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCC
T ss_pred HHHHHHhCCCCCEEeccCCCCC
Confidence 112344555555555444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.3e-10 Score=132.05 Aligned_cols=106 Identities=15% Similarity=0.166 Sum_probs=86.8
Q ss_pred ceeecccc-cccCCCcccccCCCCCCeeeccC-ccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEcc
Q 001238 414 EAVDLSQN-GLTGPIPRGIFQLKKLNKLLLLS-NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLG 491 (1117)
Q Consensus 414 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 491 (1117)
..++++++ .|+ .+|. +..+.+|++|+|++ |+|+++.+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35678887 787 4777 88888888888885 88888877888888888888888888888888888888889999999
Q ss_pred CCcCCCCCCcccccCCCCceEEccCCccccc
Q 001238 492 SNRLTGSIPDEITGCRNLTFLDVHSNSIAGN 522 (1117)
Q Consensus 492 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 522 (1117)
+|+|++..+..|..++ |+.|+|++|.+...
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 9998876666676666 88999999888753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.5e-10 Score=125.65 Aligned_cols=137 Identities=16% Similarity=0.101 Sum_probs=102.5
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCC--cceEEeeeecCCceEEEEEec
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRN--IVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.+.+....+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ ++++++++...+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34433333355569999998777888999997643 2356889999999996544 567898888888889999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC---------------------------------------
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC--------------------------------------- 895 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------- 895 (1117)
+|.++. ... .+ ...++.++++.++.||+..
T Consensus 98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998884 221 11 2356778888888888742
Q ss_pred ----------------CCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 896 ----------------VPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 896 ----------------~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
.+.++|+|++|.||++++++.+.|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.11 E-value=3.3e-09 Score=122.09 Aligned_cols=314 Identities=12% Similarity=0.081 Sum_probs=157.2
Q ss_pred cccccccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCC
Q 001238 239 LGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLS 318 (1117)
Q Consensus 239 l~~l~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 318 (1117)
+....+|+.+.+... +...-..+|.+|++|+.+.|..+ ++..-...|.++ +|+.+.+..+ +..+-...|... +|+
T Consensus 42 ~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLD 116 (379)
T ss_dssp GGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCS
T ss_pred cccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Ccc
Confidence 333444555544322 22233456778888888888644 553444566665 5777776544 443444556554 688
Q ss_pred EEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcccc
Q 001238 319 IIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNR 398 (1117)
Q Consensus 319 ~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 398 (1117)
.+++..+-.. .....|.+ .+|+.+.+..+ ++......|..+..++.+.+..+.........+ . .+.
T Consensus 117 ~i~lp~~~~~-i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~-~----------~~~ 182 (379)
T 4h09_A 117 DFEFPGATTE-IGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYV-L----------YNK 182 (379)
T ss_dssp EEECCTTCCE-ECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTE-E----------EET
T ss_pred cccCCCcccc-cccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeecccce-e----------ccc
Confidence 8887654322 33334444 35666655543 333445567777777777766554331111000 0 000
Q ss_pred ccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCC
Q 001238 399 LEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPE 478 (1117)
Q Consensus 399 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 478 (1117)
.. .....+..+..+..+.+..+.-. .....+.....|+.+.+..+ +..+....|.++..|+.+.+..+ ++.+....
T Consensus 183 ~~-~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~a 258 (379)
T 4h09_A 183 NK-TILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFL 258 (379)
T ss_dssp TS-SEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTT
T ss_pred cc-ceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccc
Confidence 00 01111222333333333322211 22333444455555555433 33344445555555555555443 44344455
Q ss_pred cCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCcccc
Q 001238 479 IGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLT 558 (1117)
Q Consensus 479 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 558 (1117)
|.++.+|+.+.+..+ ++.+...+|.++++|+.+.+.++.++.+...+|.++.+|+.++|..+ ++.|...+|.++.+|+
T Consensus 259 F~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~ 336 (379)
T 4h09_A 259 LQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALS 336 (379)
T ss_dssp TTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred cceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCC
Confidence 555556666655433 43344445556666666666655555555555666666666665433 5555666666666666
Q ss_pred EEeccccccCCCCCcccccc
Q 001238 559 KLVLNKNRFAGSIPSQLGSC 578 (1117)
Q Consensus 559 ~L~L~~N~l~~~~~~~~~~l 578 (1117)
.+.+..+ ++.+...+|.++
T Consensus 337 ~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 337 TISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCCCCTT-CCEECTTTTTTS
T ss_pred EEEECCc-cCEEchhHhhCC
Confidence 6666443 443444555554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.2e-09 Score=125.78 Aligned_cols=293 Identities=12% Similarity=0.077 Sum_probs=190.4
Q ss_pred CCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCc
Q 001238 262 ELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSL 341 (1117)
Q Consensus 262 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L 341 (1117)
++....+|+.+.+.. .++..-...|.++.+|+.+.|..+ ++.+-..+|.++ +|+.+.+..+ ++......|.. .+|
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDL 115 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCc
Confidence 344556677776653 344333456777777777777543 554555566665 4666655433 33233333443 356
Q ss_pred ceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccc
Q 001238 342 QELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQN 421 (1117)
Q Consensus 342 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 421 (1117)
+.+.+..+-.. .....|.+. +|+.+.+..+ ++.+... .|..+.+++.+.+..+
T Consensus 116 ~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~------------------------~f~~~~~l~~~~~~~~ 168 (379)
T 4h09_A 116 DDFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDG------------------------IGYKAENLEKIEVSSN 168 (379)
T ss_dssp SEEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSC------------------------TTTTCTTCCEEEECTT
T ss_pred ccccCCCcccc-ccccccccc-eeeeeeccce-eeccccc------------------------hhcccccccccccccc
Confidence 66666544221 223333332 3444443322 2212223 3344444444443332
Q ss_pred ccc------------CCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEE
Q 001238 422 GLT------------GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLD 489 (1117)
Q Consensus 422 ~l~------------~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 489 (1117)
... ......+.....+..+.+..+. .......+..+..|+.+.+..+ ++......|.++..|+.+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~ 246 (379)
T 4h09_A 169 NKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIA 246 (379)
T ss_dssp CSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEE
T ss_pred cceeecccceecccccceeccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEE
Confidence 211 1122334445566666655433 3355667888899999998765 4546677899999999999
Q ss_pred ccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCC
Q 001238 490 LGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAG 569 (1117)
Q Consensus 490 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 569 (1117)
+..+ ++.+...+|.++.+|+.+.+..+ +..+....|..+.+|+.+++.++.++.+...+|.++.+|+.+.|..+ ++.
T Consensus 247 lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~ 323 (379)
T 4h09_A 247 IPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKT 323 (379)
T ss_dssp ECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCE
T ss_pred cCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccE
Confidence 9876 66677788999999999999755 66677778999999999999999999999999999999999999765 776
Q ss_pred CCCcccccccceeEEeccccccc
Q 001238 570 SIPSQLGSCVKLQLLDLSSNQLS 592 (1117)
Q Consensus 570 ~~~~~~~~l~~L~~L~Ls~N~l~ 592 (1117)
+...+|.+|.+|+.+.+..+ ++
T Consensus 324 I~~~aF~~C~~L~~i~ip~~-v~ 345 (379)
T 4h09_A 324 IQVYAFKNCKALSTISYPKS-IT 345 (379)
T ss_dssp ECTTTTTTCTTCCCCCCCTT-CC
T ss_pred EHHHHhhCCCCCCEEEECCc-cC
Confidence 77889999999999999765 55
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.3e-09 Score=124.49 Aligned_cols=141 Identities=14% Similarity=0.167 Sum_probs=106.8
Q ss_pred CCeeeecCCeEEEEEEcCCCcEEEEEEee--cCC-ccchHHHHHHHHHHhccC--CCCcceEEeeeecC---CceEEEEE
Q 001238 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFR--ASD-KISTGAFSSEIATLSRIR--HRNIVRLLGWGANR---KTKLLFYD 852 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~e 852 (1117)
.+.++.|.++.||++...+ ..+++|+.. ... ......+.+|+++++.+. +..+++++.++.+. +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999998754 578888775 322 123457889999999997 45678999988776 45899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC-------------------------------------
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC------------------------------------- 895 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------- 895 (1117)
|++|..+.+... ..++..++..++.+++++|+.||+..
T Consensus 122 ~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999988754221 12678888899999999999999731
Q ss_pred ------------------CCceeeeccccCeEEEcCCCc--ceecccccccc
Q 001238 896 ------------------VPAILHRDVKSHNILLGERYE--SCLADFGLARL 927 (1117)
Q Consensus 896 ------------------~~~ivHrDlkp~Nill~~~~~--~kl~DfGla~~ 927 (1117)
.+.++|||++|.||++++++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 58999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=9.4e-10 Score=122.37 Aligned_cols=189 Identities=21% Similarity=0.216 Sum_probs=125.2
Q ss_pred CCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCC--cceEEeeeecCC---ceEEEEEec
Q 001238 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRN--IVRLLGWGANRK---TKLLFYDYM 854 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e~~ 854 (1117)
.+.++.|.+..||++. ..+++|+.... .....+.+|+++++.+. +.. +++++..+...+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4569999999999864 46889986532 23567899999998883 333 456666554433 348899999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcc----------------------------------------
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD---------------------------------------- 894 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------- 894 (1117)
+|.++.+.... .++.+++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99888653322 267778888999999999999861
Q ss_pred ---------------CCCceeeeccccCeEEEcC--CCcceeccccccccccCCCCCccccC----------Cccccccc
Q 001238 895 ---------------CVPAILHRDVKSHNILLGE--RYESCLADFGLARLVEDDSGGSFSAN----------PQFAGSYG 947 (1117)
Q Consensus 895 ---------------~~~~ivHrDlkp~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~----------~~~~gt~~ 947 (1117)
..+.++|+|++|.||++++ ...+.++||+.+........-..... ..+....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1246899999999999998 45678999999875322100000000 00001111
Q ss_pred cCC-hhhhccCCCCcCCCeeehhhhHHHHHhCCCCC
Q 001238 948 YIA-PEYANMTKISEKSDVYSYGVVLLEIITGKKPV 982 (1117)
Q Consensus 948 y~a-PE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~ 982 (1117)
+.. |+.... .....+.|+++.++|++.+|+.+|
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222 332211 122358999999999999999876
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.82 E-value=1.9e-10 Score=123.18 Aligned_cols=67 Identities=25% Similarity=0.389 Sum_probs=37.1
Q ss_pred cccccCcEeeccCCCcCC--CCchhhhhhhhhhhhhccCCCcCCCCchhccCCc--CCcEEeccCCCCCCCCc
Q 001238 119 ASLNQLNYLDLSENSLTG--EIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLS--SLTQLFLYDNQLTDAIP 187 (1117)
Q Consensus 119 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~--~L~~L~L~~N~l~~~~p 187 (1117)
.++++|++|+||+|+|++ .+|..+..+++|++|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 345566666666666654 3445555666666666666666533 2233333 56666666666654443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.68 E-value=2e-09 Score=121.74 Aligned_cols=89 Identities=18% Similarity=0.175 Sum_probs=48.3
Q ss_pred ccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccC--CCCCcceEeccc--ccccCc-----c
Q 001238 285 SKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLG--NLTSLQELQLSV--NQISGE-----I 355 (1117)
Q Consensus 285 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~--~l~~L~~L~Ls~--N~l~~~-----~ 355 (1117)
..+..+++|+.|+|++|.-. .++. +. +++|++|+|..|.+.......++ .+++|+.|+|+. |...+. +
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 34456677777777766311 1222 33 67777777777776543333333 567777777753 221111 0
Q ss_pred cccc--cCCCCCcEEEecCcccc
Q 001238 356 PAQI--GNCQRLAQIELDNNQIT 376 (1117)
Q Consensus 356 p~~~--~~l~~L~~L~L~~N~l~ 376 (1117)
...+ ..+++|+.|+|.+|.+.
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~ 265 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQ 265 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTH
T ss_pred HHHHhcCCCCCcCEEeCCCCCCc
Confidence 1112 23567777777776665
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.66 E-value=2.3e-09 Score=121.19 Aligned_cols=187 Identities=17% Similarity=0.144 Sum_probs=97.0
Q ss_pred hhhcccccCcEeeccCCCcC---------CCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCCCCC
Q 001238 116 KEIASLNQLNYLDLSENSLT---------GEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAI 186 (1117)
Q Consensus 116 ~~~~~l~~L~~L~Ls~N~l~---------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~ 186 (1117)
.++.++++|+.|.+..+... +.++..+..+++|+.|+|++|.-. .+|. +. +++|++|+|..|.++...
T Consensus 133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHH
T ss_pred HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHH
Confidence 34455666666666544321 123344445556666666655211 2222 22 566666666666654332
Q ss_pred ccccc--CcccchhhhccCCCCC-CCCCCccccccccccccccccccccccCCccc--ccccccceeecccccccccCCc
Q 001238 187 PATIG--KLKNLEAIRAGGNKNL-GGSLPHEIGNCTNLVMIGLAETSISGFLPPTL--GLLKRLQTIAIYTALLSGQIPP 261 (1117)
Q Consensus 187 p~~~~--~l~~L~~L~l~~n~~~-~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l--~~l~~L~~L~l~~~~l~~~~p~ 261 (1117)
...++ .+++|+.|+|+.+.+. .+.. .+ ..+ .+.+ ..+++|+.|++.+|.+....+.
T Consensus 210 l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~~---~~l--------------~~~l~~~~~p~Lr~L~L~~~~i~~~~~~ 270 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLYVGVEDYGFDG--DM---NVF--------------RPLFSKDRFPNLKWLGIVDAEEQNVVVE 270 (362)
T ss_dssp HHHHHHSBCTTCCEEEEECBCGGGTCCS--CG---GGT--------------GGGSCTTTCTTCCEEEEESCTTHHHHHH
T ss_pred HHHHHHccCCCCcEEEEeccccccccch--hH---HHH--------------HHHHhcCCCCCcCEEeCCCCCCchHHHH
Confidence 22332 4556666655422110 0000 00 000 0011 2345666666666655432211
Q ss_pred CC---CCCCCCcEEecCCCccCCc----CCccCCCCCCCcEEEccCCcCcccCCcCCCC-CCCCCEEEcCCCc
Q 001238 262 EL---GDCTELQYIYLYENALTGS----IPSKLGNLKNLVNLFLWQNNLVGIIPPELGN-CSQLSIIDISMNS 326 (1117)
Q Consensus 262 ~l---~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~LdLs~N~ 326 (1117)
.+ ..+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.++...-..+.. + ...+|++.++
T Consensus 271 ~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 11 2467899999999988763 3444456789999999999887543333332 2 3668888887
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.2e-06 Score=96.95 Aligned_cols=136 Identities=20% Similarity=0.196 Sum_probs=97.3
Q ss_pred CCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCC---CcceEEeeee-cCCceEEEEEecCC
Q 001238 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHR---NIVRLLGWGA-NRKTKLLFYDYMPN 856 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~~ 856 (1117)
.+.++.|....||++ |..+++|+... ......+.+|+++++.+.+. .+++++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888999999998 56788888532 22346789999999999652 3667777764 45567899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcc------------------------------------------
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD------------------------------------------ 894 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------------ 894 (1117)
..+.+..... ++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~~-----l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMAV-----LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHTT-----SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhhh-----CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8887632211 34555556666666666666642
Q ss_pred ---------------CCCceeeeccccCeEEEcC---CCcc-eecccccccc
Q 001238 895 ---------------CVPAILHRDVKSHNILLGE---RYES-CLADFGLARL 927 (1117)
Q Consensus 895 ---------------~~~~ivHrDlkp~Nill~~---~~~~-kl~DfGla~~ 927 (1117)
..+.++|+|++|.||++++ ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2236799999999999997 4554 7999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.5e-06 Score=94.66 Aligned_cols=136 Identities=18% Similarity=0.156 Sum_probs=100.4
Q ss_pred CeeeecCCe-EEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEEecCCCC
Q 001238 782 NIIGQGRSG-IVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYDYMPNGT 858 (1117)
Q Consensus 782 ~~lg~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gs 858 (1117)
+.+..|..| .||+.... ++..+++|+-... ....+.+|++.++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345666666 69998754 4678899986532 3457889999998884 3347789999999999999999999988
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC-------------------------------------------
Q 001238 859 LGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC------------------------------------------- 895 (1117)
Q Consensus 859 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------- 895 (1117)
+.+..... ......++.++++.|+.||+..
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 87765432 1223456667777777777531
Q ss_pred ------------CCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 896 ------------VPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 896 ------------~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12489999999999999877777999998864
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.24 E-value=1.1e-07 Score=97.02 Aligned_cols=114 Identities=15% Similarity=0.128 Sum_probs=60.0
Q ss_pred cCCCCCCCEEEccCC-cCCCC----CCcccccCCCCceEEccCCccccc----cchhhhcccccccccccCCcCCCCC--
Q 001238 479 IGNLKNLNFLDLGSN-RLTGS----IPDEITGCRNLTFLDVHSNSIAGN----LPAGLHQLVRLQFADLSDNSVGGML-- 547 (1117)
Q Consensus 479 ~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~-- 547 (1117)
+...+.|++|+|++| .|... +...+...++|++|+|++|.|... +...+...+.|+.|+|++|.|++..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 334445555555555 44321 122233345555555555555432 2223333445555555555554422
Q ss_pred --CCCcCCCccccEEec--cccccCCC----CCcccccccceeEEeccccccc
Q 001238 548 --SPDLGSLSSLTKLVL--NKNRFAGS----IPSQLGSCVKLQLLDLSSNQLS 592 (1117)
Q Consensus 548 --~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 592 (1117)
...+...++|++|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 123344456777777 66777643 2334555678888888888875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=2.4e-06 Score=97.10 Aligned_cols=80 Identities=11% Similarity=0.066 Sum_probs=57.6
Q ss_pred Cee-eecCCeEEEEEEcC-------CCcEEEEEEeecCC---ccchHHHHHHHHHHhccC-C--CCcceEEeeeecC---
Q 001238 782 NII-GQGRSGIVYKVTLP-------SGLTVAVKRFRASD---KISTGAFSSEIATLSRIR-H--RNIVRLLGWGANR--- 844 (1117)
Q Consensus 782 ~~l-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~--- 844 (1117)
+.| +.|....+|++... +++.+++|+..... ......+.+|+++++.+. + -.+++++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 557 78888999998753 26788999865422 112356889999999884 3 3577888877655
Q ss_pred CceEEEEEecCCCChhh
Q 001238 845 KTKLLFYDYMPNGTLGM 861 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~ 861 (1117)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.17 E-value=7.5e-07 Score=95.29 Aligned_cols=80 Identities=29% Similarity=0.317 Sum_probs=67.7
Q ss_pred ccccCCeEeccCCCCCC--CchhhhcccccCcEeeccCCCcCCCCchhhhhhh--hhhhhhccCCCcCCCCc-------h
Q 001238 96 SLLSLNRLVLSGTNLTG--SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL--RLEQLRLNSNQLEGAIP-------I 164 (1117)
Q Consensus 96 ~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p-------~ 164 (1117)
++++|+.|+|++|+|++ .+|..+..+++|++|||++|+|++. .++..+. +|++|+|++|.+.+.+| .
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 47789999999999998 5678889999999999999999854 4566666 99999999999997666 3
Q ss_pred hccCCcCCcEEec
Q 001238 165 QIGNLSSLTQLFL 177 (1117)
Q Consensus 165 ~~~~L~~L~~L~L 177 (1117)
.+..+++|+.||=
T Consensus 246 il~~~P~L~~LDg 258 (267)
T 3rw6_A 246 IRERFPKLLRLDG 258 (267)
T ss_dssp HHHHCTTCCEESS
T ss_pred HHHHCcccCeECC
Confidence 4778899998863
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.16 E-value=1.4e-07 Score=96.11 Aligned_cols=91 Identities=14% Similarity=0.148 Sum_probs=40.5
Q ss_pred cccCCCCCCeeeccCc-cCCCC----CCCCcccccccceeccCCCcccccC----CCCcCCCCCCCEEEccCCcCCCC--
Q 001238 430 GIFQLKKLNKLLLLSN-NLSGV----IPPEMGNCSSLIRFRANSNKLTGFI----PPEIGNLKNLNFLDLGSNRLTGS-- 498 (1117)
Q Consensus 430 ~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~-- 498 (1117)
.+...+.|++|+|++| .|... +...+...++|++|+|++|+|.+.. ...+...++|++|+|++|.|.+.
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3445566777777776 66532 1122333444555555555544321 11222334445555555544421
Q ss_pred --CCcccccCCCCceEEc--cCCccc
Q 001238 499 --IPDEITGCRNLTFLDV--HSNSIA 520 (1117)
Q Consensus 499 --~p~~~~~l~~L~~L~L--s~N~l~ 520 (1117)
+...+...+.|++|+| ++|.|.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCC
Confidence 1223333444444444 444444
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=3e-05 Score=89.34 Aligned_cols=75 Identities=13% Similarity=0.136 Sum_probs=51.1
Q ss_pred CCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCc-------cchHHHHHHHHHHhccCC--C-CcceEEeeeecCCceEE
Q 001238 781 GNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDK-------ISTGAFSSEIATLSRIRH--R-NIVRLLGWGANRKTKLL 849 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~l~~~~~~~~~~~l 849 (1117)
.+.+|.|.++.||++... +++.|+||....... ...+++..|+++++.+.. | .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 468899998653211 234567889999988742 3 34566654 3455689
Q ss_pred EEEecCCC
Q 001238 850 FYDYMPNG 857 (1117)
Q Consensus 850 v~e~~~~g 857 (1117)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.91 E-value=4.8e-05 Score=83.79 Aligned_cols=138 Identities=18% Similarity=0.211 Sum_probs=93.5
Q ss_pred CCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccC---CCCcceEEeeeecCCceEEEEEecCCC
Q 001238 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR---HRNIVRLLGWGANRKTKLLFYDYMPNG 857 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~g 857 (1117)
.+.|+.|.+..+|++.. ++..+++|+.... ....+.+|++.++.+. ...++++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999986 4678889987643 3567899999999984 356889999888888899999999987
Q ss_pred Chhh-----------hhcCCCC---CC----------------CCCHHHHH---HHHH----------------HHHHH-
Q 001238 858 TLGM-----------LLHDGEC---AG----------------LLEWDTRF---KIAL----------------GVAEG- 887 (1117)
Q Consensus 858 sL~~-----------~l~~~~~---~~----------------~l~~~~~~---~i~~----------------~i~~~- 887 (1117)
.+.. .++.... .+ .-+|.... ++.. .++..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6421 1222111 00 01354321 1111 11111
Q ss_pred HHHHhc-cCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 888 LSYLHH-DCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 888 L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
.+.|.. ...|.+||+|+.+.|++++.++ +.|+||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223422 2357899999999999999887 8899973
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=3.7e-05 Score=86.59 Aligned_cols=140 Identities=19% Similarity=0.254 Sum_probs=82.0
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCC--CCcceEEe------eeecCCceEEEEEe
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH--RNIVRLLG------WGANRKTKLLFYDY 853 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~------~~~~~~~~~lv~e~ 853 (1117)
+.|+.|..+.||++...+| .+++|+.... .+++..|+++++.+.. -.+++++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999987555 5899988752 2445566676666631 13344443 12345667899999
Q ss_pred cCCCChh--------------hhhcCC---C--CC------CCCCHHHH-------------------------------
Q 001238 854 MPNGTLG--------------MLLHDG---E--CA------GLLEWDTR------------------------------- 877 (1117)
Q Consensus 854 ~~~gsL~--------------~~l~~~---~--~~------~~l~~~~~------------------------------- 877 (1117)
++|..+. ..+|.. . .. ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 011110 0 00 01123211
Q ss_pred HHHHHHHHHHHHHHhc----------cCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 878 FKIALGVAEGLSYLHH----------DCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 878 ~~i~~~i~~~L~~LH~----------~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
..+...+..++++|++ ...+.++|+|+++.||+++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111224446667763 123489999999999999888899999999775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.86 E-value=3.3e-05 Score=84.69 Aligned_cols=79 Identities=19% Similarity=0.331 Sum_probs=60.1
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCC---CCcceEEeeeecCCceEEEEEe
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH---RNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.+..++.+|.|..+.||+++..+|+.|++|+...........|.+|++.|+.+.- --+++++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3445678999999999999999999999998765544445678999999998842 2355666643 34899999
Q ss_pred cCCCCh
Q 001238 854 MPNGTL 859 (1117)
Q Consensus 854 ~~~gsL 859 (1117)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00024 Score=82.38 Aligned_cols=73 Identities=15% Similarity=0.254 Sum_probs=46.6
Q ss_pred CCeeeecCCeEEEEEEcCCCcEEEEEEeecC-----C--cc--chHHHHHHHHHHhc-cCCCCcceEEeeeecCCceEEE
Q 001238 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRAS-----D--KI--STGAFSSEIATLSR-IRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~-----~--~~--~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.+.+|.|..+.||++.. +++.++||..... . .. ....++.|+..+.. ..+..+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999975 5678999943221 1 11 22334444443322 2234667777765 5677999
Q ss_pred EEec-CC
Q 001238 851 YDYM-PN 856 (1117)
Q Consensus 851 ~e~~-~~ 856 (1117)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.39 E-value=4.3e-05 Score=75.62 Aligned_cols=39 Identities=10% Similarity=0.114 Sum_probs=24.4
Q ss_pred CCCCEEEccCCcCCCCCCcccccCCCCceEEccCCc-ccc
Q 001238 483 KNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNS-IAG 521 (1117)
Q Consensus 483 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~ 521 (1117)
..|+.|||+++.|+...-..+.++++|++|+|++|. |++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD 100 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIED 100 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCH
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCH
Confidence 356667777666665444555666777777777764 554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00065 Score=75.95 Aligned_cols=142 Identities=13% Similarity=0.162 Sum_probs=76.0
Q ss_pred CeeeecCCeE-EEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCC--CCcceEEeeeecCCceEEEEEecCCCC
Q 001238 782 NIIGQGRSGI-VYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH--RNIVRLLGWGANRKTKLLFYDYMPNGT 858 (1117)
Q Consensus 782 ~~lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~gs 858 (1117)
+.|+.|+... +|+....+|+.+++|...... ...+..|+++++.+.. -.+++++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3465565554 678776446778787654321 1345678888877742 23567777643333 78999997766
Q ss_pred hhhhhcCCC---------------------C--CCCCCHHHHH-------H-H------------HHHHHHHHHHHh---
Q 001238 859 LGMLLHDGE---------------------C--AGLLEWDTRF-------K-I------------ALGVAEGLSYLH--- 892 (1117)
Q Consensus 859 L~~~l~~~~---------------------~--~~~l~~~~~~-------~-i------------~~~i~~~L~~LH--- 892 (1117)
+.+++.... . .+.++..... . + ...+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654332110 0 0111111100 0 0 011112222221
Q ss_pred ccCCCceeeeccccCeEEEcCC----Ccceeccccccccc
Q 001238 893 HDCVPAILHRDVKSHNILLGER----YESCLADFGLARLV 928 (1117)
Q Consensus 893 ~~~~~~ivHrDlkp~Nill~~~----~~~kl~DfGla~~~ 928 (1117)
....+.++|||+.+.||+++.+ +.+.++||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123489999999999999874 67899999988753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.27 E-value=6.7e-05 Score=74.25 Aligned_cols=81 Identities=12% Similarity=0.184 Sum_probs=38.2
Q ss_pred ccceeccCCCcccccCCCCcCCCCCCCEEEccCCc-CCCCCCcccccC----CCCceEEccCCc-cccccchhhhccccc
Q 001238 460 SLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNR-LTGSIPDEITGC----RNLTFLDVHSNS-IAGNLPAGLHQLVRL 533 (1117)
Q Consensus 460 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~L 533 (1117)
.|+.|+++++.+++..-..+..+++|+.|+|++|. |++..-..+..+ ++|++|+|++|. |++..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555544433445556666666666653 443322333332 245666666553 543322333334444
Q ss_pred ccccccC
Q 001238 534 QFADLSD 540 (1117)
Q Consensus 534 ~~L~Ls~ 540 (1117)
+.|++++
T Consensus 142 ~~L~L~~ 148 (176)
T 3e4g_A 142 KYLFLSD 148 (176)
T ss_dssp CEEEEES
T ss_pred CEEECCC
Confidence 4444433
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00054 Score=76.16 Aligned_cols=143 Identities=13% Similarity=0.178 Sum_probs=81.6
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCC--cceEEee------eecCCceEEEEEe
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRN--IVRLLGW------GANRKTKLLFYDY 853 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lv~e~ 853 (1117)
+.|+.|....+|++...+| .+++|+.... ...+.+..|+++++.+...+ +++++.. ....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788899999987555 6889988652 12345777888888774222 3444422 1223567899999
Q ss_pred cCCCChhh--------------hhcCC----CCC-----CCCCHHHHHH------------HHHHHHHHHHHHhcc----
Q 001238 854 MPNGTLGM--------------LLHDG----ECA-----GLLEWDTRFK------------IALGVAEGLSYLHHD---- 894 (1117)
Q Consensus 854 ~~~gsL~~--------------~l~~~----~~~-----~~l~~~~~~~------------i~~~i~~~L~~LH~~---- 894 (1117)
++|..+.. .++.. ... +...|..... +...+.+.++++++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 01110 000 0011222110 011234455555432
Q ss_pred CCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 895 CVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 895 ~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
..++++|+|+.+.||++++++.+.++||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234799999999999999876668999987753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0024 Score=71.03 Aligned_cols=142 Identities=13% Similarity=0.124 Sum_probs=83.6
Q ss_pred CeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCC--cceEEee-----eecCCceEEEEEec
Q 001238 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRN--IVRLLGW-----GANRKTKLLFYDYM 854 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lv~e~~ 854 (1117)
+.++ |....||++...+|+.+++|+..... .....+..|+++++.+.... +++++.. ....+..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999987778789999986432 24567788999888884222 4445443 12244567899999
Q ss_pred CCCChhh-----------h---hcC----CC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHhc--
Q 001238 855 PNGTLGM-----------L---LHD----GE--CAGLLEWDTR----FKI---------------ALGVAEGLSYLHH-- 893 (1117)
Q Consensus 855 ~~gsL~~-----------~---l~~----~~--~~~~l~~~~~----~~i---------------~~~i~~~L~~LH~-- 893 (1117)
+|..+.. . ++. .. .....++... ..+ ...+...++.+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8864321 0 111 00 0011222111 000 1111122223221
Q ss_pred --cCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 894 --DCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 894 --~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
...+.++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234789999999999999 4 889999988764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0012 Score=72.67 Aligned_cols=71 Identities=10% Similarity=0.056 Sum_probs=47.0
Q ss_pred CCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCc-ceEEeeeecCCceEEEEEec-CCCC
Q 001238 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNI-VRLLGWGANRKTKLLFYDYM-PNGT 858 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 858 (1117)
.+.|+.|....+|++ +.+++|+....... .-...+|+++++.+...++ ++++++. .+..++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678999999999999 46888987653221 1234678888888743333 5666543 33457899999 6654
Q ss_pred h
Q 001238 859 L 859 (1117)
Q Consensus 859 L 859 (1117)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0013 Score=76.21 Aligned_cols=72 Identities=17% Similarity=0.245 Sum_probs=50.8
Q ss_pred CeeeecCCeEEEEEEcCC--------CcEEEEEEeecCCccchHHHHHHHHHHhccCCCC-cceEEeeeecCCceEEEEE
Q 001238 782 NIIGQGRSGIVYKVTLPS--------GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRN-IVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e 852 (1117)
+.|+.|....||++...+ ++.|++|+.... ...+.+.+|+.+++.+...+ .+++++.+.+ .+|||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 568888899999998653 578999988432 12245668999999885333 3677776542 38999
Q ss_pred ecCCCCh
Q 001238 853 YMPNGTL 859 (1117)
Q Consensus 853 ~~~~gsL 859 (1117)
|++|.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0016 Score=73.47 Aligned_cols=141 Identities=18% Similarity=0.207 Sum_probs=84.9
Q ss_pred CeeeecCCeEEEEEEcC--------CCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEE
Q 001238 782 NIIGQGRSGIVYKVTLP--------SGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+.+..|-...+|++... +++.|++|+.... ......+.+|.++++.+. +.-.+++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888899998864 2578999986432 223556779999998884 3334677776654 39999
Q ss_pred ecCCCChhhh-----------------hcCCCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHHh
Q 001238 853 YMPNGTLGML-----------------LHDGEC--AGLL--EWDTRFKIALGVAE-------------------GLSYLH 892 (1117)
Q Consensus 853 ~~~~gsL~~~-----------------l~~~~~--~~~l--~~~~~~~i~~~i~~-------------------~L~~LH 892 (1117)
|++|..+..- ++.... .... -+.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 111110 1112 24555555544322 223332
Q ss_pred ----cc-CCCceeeeccccCeEEEcCC----Ccceecccccccc
Q 001238 893 ----HD-CVPAILHRDVKSHNILLGER----YESCLADFGLARL 927 (1117)
Q Consensus 893 ----~~-~~~~ivHrDlkp~Nill~~~----~~~kl~DfGla~~ 927 (1117)
.. ....++|+|+.+.||+++++ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 11 22478999999999999876 6889999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0026 Score=73.92 Aligned_cols=73 Identities=16% Similarity=0.129 Sum_probs=48.7
Q ss_pred CeeeecCCeEEEEEEcCC-CcEEEEEEeecCCccchHHHHHHHHHHhccCCCCc-ceEEeeeecCCceEEEEEecCCCCh
Q 001238 782 NIIGQGRSGIVYKVTLPS-GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNI-VRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
+.|+.|-...+|++...+ +..|++|+....... .-...+|.++++.+...++ +++++++. + ..||||++|.++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 568888889999998755 578889987543221 1123689999999865444 57777663 2 359999987554
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00011 Score=74.08 Aligned_cols=110 Identities=10% Similarity=0.164 Sum_probs=56.6
Q ss_pred CCCCEEEccCC-cCCCC----CCcccccCCCCceEEccCCccccc----cchhhhcccccccccccCCcCCCCCCC----
Q 001238 483 KNLNFLDLGSN-RLTGS----IPDEITGCRNLTFLDVHSNSIAGN----LPAGLHQLVRLQFADLSDNSVGGMLSP---- 549 (1117)
Q Consensus 483 ~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~~~---- 549 (1117)
+.|++|+|++| +|... +-+.+...+.|+.|+|++|.|... +...+...+.|+.|+|++|.|++....
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 44555555553 44321 122333445555555555555432 223334445555555555555543221
Q ss_pred CcCCCccccEEeccccc---cCC----CCCcccccccceeEEeccccccc
Q 001238 550 DLGSLSSLTKLVLNKNR---FAG----SIPSQLGSCVKLQLLDLSSNQLS 592 (1117)
Q Consensus 550 ~~~~l~~L~~L~L~~N~---l~~----~~~~~~~~l~~L~~L~Ls~N~l~ 592 (1117)
++..-+.|++|+|++|. +.. .+..++...+.|+.|+++.|.+.
T Consensus 121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 22333557778887653 221 13345666778888888877654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0028 Score=71.90 Aligned_cols=73 Identities=14% Similarity=0.085 Sum_probs=45.7
Q ss_pred CeeeecCCeEEEEEEcCC---------CcEEEEEEeecCCccchHHHHHHHHHHhccCCCC-cceEEeeeecCCceEEEE
Q 001238 782 NIIGQGRSGIVYKVTLPS---------GLTVAVKRFRASDKISTGAFSSEIATLSRIRHRN-IVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~ 851 (1117)
+.++.|....+|++...+ ++.+++|+...... .......|.++++.+...+ ++++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888999987643 26888998764322 1123467888888885333 45677544 2 37899
Q ss_pred EecCCCCh
Q 001238 852 DYMPNGTL 859 (1117)
Q Consensus 852 e~~~~gsL 859 (1117)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987644
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.00021 Score=72.16 Aligned_cols=39 Identities=15% Similarity=0.261 Sum_probs=18.3
Q ss_pred ccccceeecccc-cccCC----CcccccCCCCCCeeeccCccCC
Q 001238 410 CQNLEAVDLSQN-GLTGP----IPRGIFQLKKLNKLLLLSNNLS 448 (1117)
Q Consensus 410 l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 448 (1117)
-+.|++|+|++| +|... +...+..-..|+.|+|++|+|.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 83 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence 345666666654 54321 2222333445555555555554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0046 Score=69.09 Aligned_cols=66 Identities=9% Similarity=0.130 Sum_probs=43.9
Q ss_pred cCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccC---CCCcceEEee------eecCCceEEEEEecCCC
Q 001238 787 GRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR---HRNIVRLLGW------GANRKTKLLFYDYMPNG 857 (1117)
Q Consensus 787 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~------~~~~~~~~lv~e~~~~g 857 (1117)
|....||++...+| .+++|+...... ..|+++++.+. -|.+++.+.. ....+..+++|+|++|.
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 33679999987777 899998765431 35666666663 1325555532 23346678999999987
Q ss_pred Ch
Q 001238 858 TL 859 (1117)
Q Consensus 858 sL 859 (1117)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 65
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0023 Score=60.27 Aligned_cols=61 Identities=25% Similarity=0.343 Sum_probs=43.0
Q ss_pred EEeccccccc-cccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch
Q 001238 583 LLDLSSNQLS-GNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 583 ~L~Ls~N~l~-~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
.+|.+++.|+ ..+|..+ +.-++.|+|++|+|+...+..|..+++|+.|+|++|+|.++...
T Consensus 12 ~v~Cs~~~L~~~~vP~~l---p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l 73 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF---PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL 73 (130)
T ss_dssp EEECCSSCCCTTTSCSCC---CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG
T ss_pred EEEeCCCCCccccCCCCC---CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc
Confidence 5666666665 2444432 22225677777777766677788899999999999999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.022 Score=65.12 Aligned_cols=73 Identities=7% Similarity=0.030 Sum_probs=49.6
Q ss_pred CeeeecCCeEEEEEEcCC--------CcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEE
Q 001238 782 NIIGQGRSGIVYKVTLPS--------GLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+.+..|-...+|++...+ ++.|++|+...... ..-...+|.++++.+. +.-.+++++.+. -+.|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 457778888999988653 57899998754322 1223468999998884 333456665432 378999
Q ss_pred ecCCCCh
Q 001238 853 YMPNGTL 859 (1117)
Q Consensus 853 ~~~~gsL 859 (1117)
|++|..+
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.78 E-value=0.012 Score=55.29 Aligned_cols=56 Identities=23% Similarity=0.335 Sum_probs=34.6
Q ss_pred EEEcCCCcCC-CCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCcccc
Q 001238 319 IIDISMNSLT-GSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376 (1117)
Q Consensus 319 ~LdLs~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 376 (1117)
.+|.+++.++ ..+|..+. ++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666665 23444332 35667777777776655566666777777777777654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.64 E-value=0.3 Score=49.43 Aligned_cols=104 Identities=13% Similarity=0.071 Sum_probs=65.9
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
-+|.++|+... .++++++++.++.|.+++|.-.-.+.. . ..+=+-|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 37888887653 459999999999999999877621100 1 1222346889999999987653 1110
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPV 982 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~ 982 (1117)
.....+.|||... ...+.+.=|||+|+++|..+--..|-
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0122456777653 34567788999999999998855543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.17 E-value=0.45 Score=54.15 Aligned_cols=30 Identities=33% Similarity=0.500 Sum_probs=24.8
Q ss_pred ceeeeccccCeEEE------cCCCcceecccccccc
Q 001238 898 AILHRDVKSHNILL------GERYESCLADFGLARL 927 (1117)
Q Consensus 898 ~ivHrDlkp~Nill------~~~~~~kl~DfGla~~ 927 (1117)
.++|+|+.+.||++ +++..++++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 3456789999988764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.79 E-value=0.43 Score=34.50 Aligned_cols=28 Identities=7% Similarity=-0.089 Sum_probs=14.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhheeccc
Q 001238 712 RVAMVVLLSAACALLLAALYIILGPRIR 739 (1117)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (1117)
+.++++.+++++++++++.++++++|++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 4445555555555555555555555444
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.44 E-value=0.53 Score=33.93 Aligned_cols=29 Identities=7% Similarity=-0.150 Sum_probs=14.4
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhhheeccc
Q 001238 711 ARVAMVVLLSAACALLLAALYIILGPRIR 739 (1117)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (1117)
++.++++.+++++++++++.++++++|++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 34444444455555555555555555443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=82.52 E-value=1.9 Score=31.02 Aligned_cols=26 Identities=15% Similarity=0.101 Sum_probs=11.3
Q ss_pred HHHHHHHHHHHHHHHHHHHhhheecc
Q 001238 713 VAMVVLLSAACALLLAALYIILGPRI 738 (1117)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (1117)
+++.+++.++++++++++++|++||+
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhh
Confidence 44444444433444444444444443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.26 E-value=3.4 Score=41.90 Aligned_cols=85 Identities=9% Similarity=0.025 Sum_probs=62.8
Q ss_pred CCCCcceEEeeeecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHhccCCCceeeeccccCe
Q 001238 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLS-YLHHDCVPAILHRDVKSHN 908 (1117)
Q Consensus 830 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivHrDlkp~N 908 (1117)
.||++ -..+-.+++...+.++.-+++.=...++. .+...+++++.+|+.... ++++. +|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCce
Confidence 68888 33344666777777776544322223322 678899999999999888 77765 888999999
Q ss_pred EEEcCCCcceecccccccc
Q 001238 909 ILLGERYESCLADFGLARL 927 (1117)
Q Consensus 909 ill~~~~~~kl~DfGla~~ 927 (1117)
+++|.++.+++.-.|+-..
T Consensus 115 L~f~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES 133 (219)
T ss_dssp EEECTTCCEEESCCEETTT
T ss_pred EEEeCCCcEEEEEcCCccc
Confidence 9999999999988887543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.19 E-value=2.2 Score=43.02 Aligned_cols=115 Identities=10% Similarity=0.088 Sum_probs=77.3
Q ss_pred CCCCcceEEeeeecCCceEEEEEecCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCe
Q 001238 830 RHRNIVRLLGWGANRKTKLLFYDYMPNG-TLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHN 908 (1117)
Q Consensus 830 ~H~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N 908 (1117)
.||+.+.. .+-.+++...+.|+.-+.+ +... ++ ..+...+++++.+|+...+++++. +|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 68888866 4555556555555543322 2222 22 267899999999999999777766 889999999
Q ss_pred EEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCC
Q 001238 909 ILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVD 983 (1117)
Q Consensus 909 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~ 983 (1117)
++++.++.+++.-.|+...+.+. =+.+|-+. -.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P~----------------~~~ee~fL----------~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDPL----------------PVSEAEFL----------TRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSCC----------------CCCHHHHH----------HHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCCCC----------------CCCHHHHH----------HHHHHHHHHHHcCCCCHH
Confidence 99999999999888775433211 01223211 124467888899988874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1117 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-31 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-30 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-08 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-08 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-27 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-23 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-22 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-15 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-14 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-10 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-07 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-07 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-62
Identities = 75/282 (26%), Positives = 116/282 (41%), Gaps = 24/282 (8%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGW 840
G IG G G VYK + V + A AF +E+ L + RH NI+ +G+
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 841 GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAIL 900
+ + +L LH E E IA A+G+ YLH I+
Sbjct: 73 S-TAPQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 901 HRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM---T 957
HRD+KS+NI L E + DFGLA + SG Q +GS ++APE M
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE--QLSGSILWMAPEVIRMQDKN 184
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017
S +SDVY++G+VL E++TG+ P + + + L P L
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIFMVGRGY-----LSPDLSKV 234
Query: 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
+ M + + C + ++RP + A + + +
Sbjct: 235 RSNCPKAMKR---LMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 9e-58
Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 26/276 (9%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGW 840
+G G+ G V+ VAVK + +S AF +E + +++H+ +VRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 841 GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAIL 900
+ +YM NG+L L L + +A +AEG++++ +
Sbjct: 77 VTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 901 HRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKIS 960
HRD+++ NIL+ + +ADFGLARL+ED+ + + APE N +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG---AKFPIKWTAPEAINYGTFT 188
Query: 961 EKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDT 1020
KSDV+S+G++L EI+T + P V +L+ V PD
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLERGYRMVR---------PDN 234
Query: 1021 QIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
+E+ Q + LC R EDRPT + ++L +
Sbjct: 235 CPEELYQ---LMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-56
Identities = 75/302 (24%), Positives = 121/302 (40%), Gaps = 24/302 (7%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
R++ IG+GR G V++ G VAVK F S + + +EI +RH NI+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENIL 60
Query: 836 RLLGW----GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
+ L DY +G+L L+ + + K+AL A GL++L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHL 116
Query: 892 HHDCV-----PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSY 946
H + V PAI HRD+KS NIL+ + C+AD GLA + + A G+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 947 GYIAPEY------ANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHL 1000
Y+APE + +++D+Y+ G+V EI V
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 1001 KSKKDPVEVLDPKLQGHPDTQIQ---EMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057
++ V + KL+ + + Q + I C R T + L ++
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 1058 QE 1059
Q+
Sbjct: 297 QQ 298
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-56
Identities = 72/281 (25%), Positives = 126/281 (44%), Gaps = 26/281 (9%)
Query: 778 LTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRL 837
LT IG G+ G+V+ + VA+K R +S F E + ++ H +V+L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
G + L +++M +G L L L +T + L V EG++YL C
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
++HRD+ + N L+GE ++DFG+ R V DD ++++ + +PE + +
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFS 177
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017
+ S KSDV+S+GV++ E+ + K + + + V D + P+L
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI----PYENRSNSEVVEDISTGFRLY----KPRL--- 226
Query: 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058
T + +++ C R EDRP + L EI +
Sbjct: 227 ASTHVYQIM------NHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-53
Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 26/284 (9%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR 836
SL +GQG G V+ T VA+K + +S AF E + ++RH +V+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L + + + +YM G+L + GE L +A +A G++Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
+HRD+++ NIL+GE +ADFGLARL+ED+ ++A + APE A
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALY 188
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016
+ + KSDV+S+G++L E+ T + + + V+ V + P
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRMPCPP---------- 237
Query: 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060
+ E L L C E+RPT + + A L +
Sbjct: 238 ----ECPESLHDLM--CQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-53
Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 38/295 (12%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFR-ASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+ +G G G+V+KV+ PSGL +A K E+ L IV G
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+ + ++M G+L +L G + K+++ V +GL+YL I
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KI 126
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
+HRDVK NIL+ R E L DFG++ + D SF G+ Y++PE T
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------VGTRSYMSPERLQGTHY 180
Query: 960 SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP------------- 1006
S +SD++S G+ L+E+ G+ P+ ++ + + + P
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 1007 ----------VEVLDPKLQGHPDTQIQEMLQALGISLL--CTSNRAEDRPTMKDV 1049
E+LD + P + + C +R +K +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 64/281 (22%), Positives = 115/281 (40%), Gaps = 26/281 (9%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIV 835
+ LT +G G+ G+V VA+K + +S F E + + H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
+L G ++ + +YM NG L L + E + ++ V E + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
LHRD+ + N L+ ++ ++DFGL+R V DD S + PE
Sbjct: 121 ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG---SKFPVRWSPPEVLM 174
Query: 956 MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
+K S KSD++++GV++ EI + K P + +H+
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLY-------- 221
Query: 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
P +++ I C +A++RPT K + + + ++
Sbjct: 222 -RPHLASEKVYT---IMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-52
Identities = 72/301 (23%), Positives = 118/301 (39%), Gaps = 44/301 (14%)
Query: 759 WELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGA 818
W L + + L IG+G G V G VAVK + A
Sbjct: 2 WALNM------------KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--A 46
Query: 819 FSSEIATLSRIRHRNIVRLLGWGANRKTKL-LFYDYMPNGTLGMLLHDGECAGLLEWDTR 877
F +E + ++++RH N+V+LLG K L + +YM G+L L +L D
Sbjct: 47 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCL 105
Query: 878 FKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFS 937
K +L V E + YL + +HRD+ + N+L+ E + ++DFGL +
Sbjct: 106 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---- 158
Query: 938 ANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR 997
+ APE K S KSDV+S+G++L EI + + P + ++ V
Sbjct: 159 ---TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVV 210
Query: 998 DHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057
++ PD + + + C A RP+ + L I+
Sbjct: 211 PRVEKGYKMDA---------PDGCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLEHIK 258
Query: 1058 Q 1058
Sbjct: 259 T 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-52
Identities = 69/292 (23%), Positives = 126/292 (43%), Gaps = 29/292 (9%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPSG-----LTVAVKRFRAS-DKISTGAFSSEIATLSRIR 830
+T +IG G G VYK L + + VA+K +A + F E + +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
H NI+RL G + K ++ +YM NG + E G + G+A G+ Y
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
L + +HRD+ + NIL+ ++DFGL+R++EDD +++ + + A
Sbjct: 126 LANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-GGKIPIRWTA 181
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010
PE + K + SDV+S+G+V+ E++T + + + V++ + D +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAINDGFR--------- 231
Query: 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
T + + + C RP D+ ++L ++ + P S
Sbjct: 232 -------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (465), Expect = 3e-52
Identities = 66/292 (22%), Positives = 119/292 (40%), Gaps = 28/292 (9%)
Query: 777 SLTAGNIIGQGRSGIVYKVTLPS----GLTVAVKRFRAS-DKISTGAFSSEIATLSRIRH 831
+ +IG G G V L + VA+K ++ + F SE + + + H
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
N++ L G ++ ++M NG+L L + G + G+A G+ YL
Sbjct: 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD-SGGSFSANPQFAGSYGYIA 950
+HRD+ + NIL+ ++DFGL+R +EDD S ++++ + A
Sbjct: 145 ADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010
PE K + SDV+SYG+V+ E+++ + + D + +D + +
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGER---PYWD------------MTNQDVINAI 246
Query: 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
+ + P L L L C RP + L ++ + P S
Sbjct: 247 EQDYRLPPPMDCPSALHQLM--LDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-52
Identities = 69/298 (23%), Positives = 117/298 (39%), Gaps = 28/298 (9%)
Query: 768 DLSIGDATRSLTAGNIIGQGRSGIVYKVTLP----SGLTVAVKRF-RASDKISTGAFSSE 822
+ IG ++ + +IG+G G VY TL + AVK R +D F +E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 823 IATLSRIRHRNIVRLLGWGANRKTKLLF-YDYMPNGTLGMLLHDGECAGLLEWDTRFKIA 881
+ H N++ LLG + L YM +G L + +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFG 136
Query: 882 LGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQ 941
L VA+G+ +HRD+ + N +L E++ +ADFGLAR + D S
Sbjct: 137 LQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 193
Query: 942 FAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK 1001
++A E K + KSDV+S+GV+L E++T P + L+
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQ 249
Query: 1002 SKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
++ P+ + + + L C +AE RP+ ++ + + I
Sbjct: 250 GRRLLQ----------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-52
Identities = 70/289 (24%), Positives = 117/289 (40%), Gaps = 30/289 (10%)
Query: 784 IGQGRSGIVYKVTL---PSGLTVAVKRFR-ASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G G G V + + VA+K + ++K T E + ++ + IVRL+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+L + G L L + ++ V+ G+ YL
Sbjct: 77 VCQAEA-LMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE---KNF 130
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
+HRD+ + N+LL R+ + ++DFGL++ + D ++A + APE N K
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKF 189
Query: 960 SEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018
S +SDV+SYGV + E ++ G+KP G V+ ++ + + P
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRMECPP------------ 235
Query: 1019 DTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPASGSEAH 1067
+ L AL C + EDRP V +R AS E H
Sbjct: 236 --ECPPELYALM--SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (462), Expect = 6e-52
Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 26/284 (9%)
Query: 778 LTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVR 836
+T + +G G+ G VY+ LTVAVK + D + F E A + I+H N+V+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
LLG + ++M G L L + + +A ++ + YL
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--- 133
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
+HRD+ + N L+GE + +ADFGL+RL+ D+ + + + APE
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK---FPIKWTAPESLAY 190
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016
K S KSDV+++GV+L EI T Q E+L+ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRM 235
Query: 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060
E + L C DRP+ ++ + QE
Sbjct: 236 ERPEGCPEKVYELM--RACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 32/281 (11%)
Query: 782 NIIGQGRSGIVYKVTLP---SGLTVAVKRFR--ASDKISTGAFSSEIATLSRIRHRNIVR 836
+G G G V K TVAVK + A+D +E + ++ + IVR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
++G ++ +L + G L L ++ ++ V+ G+ YL
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN- 127
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
+HRD+ + N+LL ++ + ++DFGL++ + D + A + APE N
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINY 184
Query: 957 TKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
K S KSDV+S+GV++ E + G+KP G V + +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGERMGC----------- 231
Query: 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
P +EM + LC + E+RP V LR
Sbjct: 232 --PAGCPREMYDLM---NLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-50
Identities = 73/306 (23%), Positives = 118/306 (38%), Gaps = 44/306 (14%)
Query: 778 LTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASDKIS-TGAFSSEIATLSRI- 829
L+ G +G G G V + T + +TVAVK + S ++ A SE+ LS +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 830 RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD---------------GECAGLLEW 874
H NIV LLG L+ +Y G L L + L+
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 875 DTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934
+ + VA+G+++L +HRD+ + NILL + + DFGLAR +++DS
Sbjct: 145 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQ 994
++APE + +SDV+SYG+ L E+ + P +
Sbjct: 202 VVKG--NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 995 WVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054
+++ + P+ EM I C RPT K + L+
Sbjct: 260 MIKEGFRMLS-------------PEHAPAEMYD---IMKTCWDADPLKRPTFKQIVQLIE 303
Query: 1055 EIRQEP 1060
+ E
Sbjct: 304 KQISES 309
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-50
Identities = 67/282 (23%), Positives = 113/282 (40%), Gaps = 35/282 (12%)
Query: 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTG--AFSSEIATLSRIRHR 832
R L IG+G VYK + + VA + + F E L ++H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 833 NIVRLLGWGA----NRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
NIVR +K +L + M +GTL L +++ + +GL
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGL 125
Query: 889 SYLHHDCVPAILHRDVKSHNILL-GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYG 947
+LH P I+HRD+K NI + G + D GLA L + G+
Sbjct: 126 QFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV------IGTPE 178
Query: 948 YIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007
++APE K E DVY++G+ +LE+ T + P + + Q+ Q R + S P
Sbjct: 179 FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYR-RVTSGVKP- 231
Query: 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
+++E+++ C ++R ++KD+
Sbjct: 232 ----ASFDKVAIPEVKEIIEG------CIRQNKDERYSIKDL 263
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-50
Identities = 59/277 (21%), Positives = 106/277 (38%), Gaps = 30/277 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTG--AFSSEIATLSRIRHRNIVRL 837
IG G G K+ G + K SE+ L ++H NIVR
Sbjct: 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68
Query: 838 LGWGANRKTKLLF--YDYMPNGTLGMLLHDGECA-GLLEWDTRFKIALGVAEGLSYLH-- 892
+R L+ +Y G L ++ G L+ + ++ + L H
Sbjct: 69 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
D +LHRD+K N+ L + L DFGLAR++ D+ + + F G+ Y++PE
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA----FVGTPYYMSPE 184
Query: 953 YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012
N +EKSD++S G +L E+ P + + K
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGKIREGK-------FR 232
Query: 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
++ ++ E++ + + RP+++++
Sbjct: 233 RIPYRYSDELNEIITR------MLNLKDYHRPSVEEI 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 9e-50
Identities = 77/306 (25%), Positives = 120/306 (39%), Gaps = 50/306 (16%)
Query: 781 GNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDKISTGA-FSSEIATLSRIRHRN 833
IG+G G V++ P VAVK + A F E A ++ + N
Sbjct: 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 77
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGL---------------------L 872
IV+LLG A K L ++YM G L L + L
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 873 EWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932
+ IA VA G++YL +HRD+ + N L+GE +ADFGL+R +
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHV 992
+ A+ A ++ PE + + +SDV++YGVVL EI + + V
Sbjct: 195 --YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-EEV 251
Query: 993 IQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052
I +VR D + P+ E+ + LC S DRP+ + +
Sbjct: 252 IYYVR-------------DGNILACPENCPLELYN---LMRLCWSKLPADRPSFCSIHRI 295
Query: 1053 LREIRQ 1058
L+ + +
Sbjct: 296 LQRMCE 301
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-49
Identities = 71/300 (23%), Positives = 116/300 (38%), Gaps = 43/300 (14%)
Query: 781 GNIIGQGRSGIVYKVTLPSG---LTVAVKRFR-ASDKISTGAFSSEIATLSRI-RHRNIV 835
++IG+G G V K + + A+KR + + K F+ E+ L ++ H NI+
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIAL 882
LLG +R L +Y P+G L L A L A
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 883 GVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQF 942
VA G+ YL +HRD+ + NIL+GE Y + +ADFGL+R E +
Sbjct: 135 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-----MG 186
Query: 943 AGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS 1002
++A E N + + SDV+SYGV+L EI++ G + +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYEKLPQG 242
Query: 1003 KKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEPAS 1062
+ P E+ + C + +RP+ + L + +E +
Sbjct: 243 YRLEK----------PLNCDDEVYD---LMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-48
Identities = 62/273 (22%), Positives = 102/273 (37%), Gaps = 35/273 (12%)
Query: 781 GNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGA---FSSEIATLSRIRHRNIVR 836
G +G+G+ G VY S +A+K + G E+ S +RH NI+R
Sbjct: 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L G+ + L +Y P GT+ L + +A LSY H
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS--- 124
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
++HRD+K N+LLG E +ADFG + G+ Y+ PE
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR------RTTLCGTLDYLPPEMIEG 178
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016
EK D++S GV+ E + GK P + + + + + + + +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRVEFTFPDFVTEGAR- 232
Query: 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
I +L+ RP +++V
Sbjct: 233 ---DLISRLLKH----------NPSQRPMLREV 252
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 3e-48
Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 49/301 (16%)
Query: 781 GNIIGQGRSGIVYKVTLPS------GLTVAVKRFR-ASDKISTGAFSSEIATLSRI-RHR 832
G ++G G G V T + VAVK + +D A SE+ ++++ H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 833 NIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHD--------------------GECAGLL 872
NIV LLG L ++Y G L L E +L
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 873 EWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932
++ A VA+G+ +L + +HRD+ + N+L+ + DFGLAR + DS
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218
Query: 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHV 992
++ ++APE + KSDV+SYG++L EI + P +
Sbjct: 219 --NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276
Query: 993 IQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052
+ +++ K + + +I ++Q+ C + + RP+ ++ +
Sbjct: 277 YKLIQNGFKMDQPF----------YATEEIYIIMQS------CWAFDSRKRPSFPNLTSF 320
Query: 1053 L 1053
L
Sbjct: 321 L 321
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 7e-48
Identities = 64/275 (23%), Positives = 105/275 (38%), Gaps = 38/275 (13%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA---FSSEIATLSRIRHRNIVRL 837
IG G G VY + + VA+K+ S K S E+ L ++RH N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 838 LGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVP 897
G T L +Y +L L+ + G +GL+YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---H 134
Query: 898 AILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA--- 954
++HRDVK+ NILL E L DFG A ++ + F G+ ++APE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--------SFVGTPYWMAPEVILAM 186
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
+ + K DV+S G+ +E+ K P + + + +++ +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNESPAL------- 234
Query: 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
E + S L +DRPT + +
Sbjct: 235 ---QSGHWSEYFRNFVDSCLQKI--PQDRPTSEVL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 64/272 (23%), Positives = 102/272 (37%), Gaps = 27/272 (9%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA-FSSEIATLSRIRHRNIVRLL 838
+G+G G V + VAVK + EI + H N+V+
Sbjct: 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
G + LF +Y G L + + + + G+ YLH
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG--- 123
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
I HRD+K N+LL ER ++DFGLA + ++ + G+ Y+APE +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--KMCGTLPYVAPELLKRRE 181
Query: 959 I-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017
+E DV+S G+VL ++ G+ P D Q W + K +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--------------EKKTYLN 227
Query: 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
P +I AL +L + R T+ D+
Sbjct: 228 PWKKIDSAPLALLHKILVEN--PSARITIPDI 257
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-47
Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 34/284 (11%)
Query: 770 SIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSR 828
S+GD + T IGQG SG VY + +G VA+++ + +EI +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 829 IRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGL 888
++ NIV L + +Y+ G+L ++ + + + + L
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQAL 129
Query: 889 SYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGY 948
+LH + ++HRD+KS NILLG L DFG + + + G+ +
Sbjct: 130 EFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST----MVGTPYW 182
Query: 949 IAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008
+APE K D++S G++ +E+I G+ P + + ++P+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLN---------------ENPLR 223
Query: 1009 VLDPKLQ-GHPDTQIQEMLQALGISLL--CTSNRAEDRPTMKDV 1049
L G P+ Q E L A+ L C E R + K++
Sbjct: 224 ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-47
Identities = 56/275 (20%), Positives = 100/275 (36%), Gaps = 31/275 (11%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G G G VYK + + A K + + EI L+ H NIV+LL
Sbjct: 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 76
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+ ++ G + ++ + E L + + L+YLH I
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA----- 954
+HRD+K+ NIL + LADFG++ F G+ ++APE
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----QRRDSFIGTPYWMAPEVVMCETS 187
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
K+DV+S G+ L+E+ + P + ++ + KS+ +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPH-----HELNPMRVLLKIAKSEPPTLAQPS--- 239
Query: 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
+ ++ L+ C + R T +
Sbjct: 240 --RWSSNFKDFLKK------CLEKNVDARWTTSQL 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 67/281 (23%), Positives = 114/281 (40%), Gaps = 30/281 (10%)
Query: 784 IGQGRSGIVYKVTLPS----GLTVAVKRFR---ASDKISTGAFSSEIATLSRIRHRNIVR 836
+G G G+V + + ++VAVK + S + F E+ + + HRN++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L G K++ + P G+L L + G T + A+ VAEG+ YL
Sbjct: 76 LYGVVLTPPMKMV-TELAPLGSL--LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR- 131
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
+HRD+ + N+LL R + DFGL R + + + + + APE
Sbjct: 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-HYVMQEHRKVPFAWCAPESLKT 188
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016
S SD + +GV L E+ T + G + Q + K + P+ +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE----PWIGLNGSQILHKIDKEGERL-----PRPED 239
Query: 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057
P + + C +++ EDRPT + L E +
Sbjct: 240 CPQ-------DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 1e-45
Identities = 56/272 (20%), Positives = 107/272 (39%), Gaps = 28/272 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G G G+V++VT +G A K + EI T+S +RH +V L
Sbjct: 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 90
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+ ++ Y++M G L + D + D + V +GL ++H +
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 900 LHRDVKSHNILLGERYES--CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
+H D+K NI+ + + L DFGL ++ + G+ + APE A
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-----QSVKVTTGTAEFAAPEVAEGK 200
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017
+ +D++S GV+ +++G P F G++ + +R+ + + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSP----FG-GENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
I+++L A R T+
Sbjct: 256 GKDFIRKLLLA----------DPNTRMTIHQA 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 61/284 (21%), Positives = 107/284 (37%), Gaps = 31/284 (10%)
Query: 781 GNIIGQGRSGIVYKVTLPS----GLTVAVKRFR-ASDKISTGAFSSEIATLSRIRHRNIV 835
G IG+G+ G V++ S L VA+K + + F E T+ + H +IV
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
+L+G + + G L L+ + A ++ L+YL
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 128
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
+HRD+ + N+L+ L DFGL+R +ED + S + ++APE N
Sbjct: 129 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS---KGKLPIKWMAPESIN 182
Query: 956 MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
+ + SDV+ +GV + EI+ G + ++ P+
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVK----PFQGVKNNDVIGRIENGERLPM-------- 230
Query: 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
P + + C + RP ++ A L I +E
Sbjct: 231 --PPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-44
Identities = 58/286 (20%), Positives = 112/286 (39%), Gaps = 31/286 (10%)
Query: 781 GNIIGQGRSGIVYKVTLPS-----GLTVAVKRFR-ASDKISTGAFSSEIATLSRIRHRNI 834
++G G G VYK + VA+K R A+ + E ++ + + ++
Sbjct: 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 73
Query: 835 VRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
RLLG T L MP G L L + E + + +A+G++YL
Sbjct: 74 CRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 129
Query: 895 CVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA 954
++HRD+ + N+L+ + DFGLA+L+ + + ++A E
Sbjct: 130 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--GKVPIKWMALESI 185
Query: 955 NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014
+ +SDV+SYGV + E++T P + + + + +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQ---------- 234
Query: 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060
P ++ I + C A+ RP +++ ++ ++P
Sbjct: 235 ---PPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-44
Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 32/284 (11%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA---FSSEIATLSRIRHRNIVR 836
G I+G+G V L + A+K I + E +SR+ H V+
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L + + Y NG L + + E TRF A E +S L +
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA----EIVSALEYLHG 126
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
I+HRD+K NILL E + DFG A+++ +S + + F G+ Y++PE
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN--SFVGTAQYVSPELLTE 184
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQG 1016
+ SD+++ G ++ +++ G P F G + + + +K + D E PK +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQK-IIKLEYDFPEKFFPKAR- 238
Query: 1017 HPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060
++++L A R +++ ++ P
Sbjct: 239 ---DLVEKLLVL----------DATKRLGCEEMEG-YGPLKAHP 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 158 bits (400), Expect = 6e-43
Identities = 47/272 (17%), Positives = 103/272 (37%), Gaps = 28/272 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G G G+V++ +G K + +EI+ ++++ H ++ L
Sbjct: 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 93
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
++ +L +++ G L + + + EGL ++H +I
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE---HSI 148
Query: 900 LHRDVKSHNILLGERYES--CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
+H D+K NI+ + S + DFGLA + D + + APE +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-----EIVKVTTATAEFAAPEIVDRE 203
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017
+ +D+++ GV+ +++G P F G+ ++ +++ + + E +
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSP----FA-GEDDLETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
I+ +LQ R T+ D
Sbjct: 259 AKDFIKNLLQK----------EPRKRLTVHDA 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 59/295 (20%), Positives = 121/295 (41%), Gaps = 36/295 (12%)
Query: 778 LTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFR-ASDKISTGAFSSEIATLSRIR 830
+T +GQG G+VY+ VA+K A+ F +E + +
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLH-------DGECAGLLEWDTRFKIALG 883
++VRLLG + + L+ + M G L L + ++A
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 884 VAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFA 943
+A+G++YL+ + +HRD+ + N ++ E + + DFG+ R + + + +
Sbjct: 142 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--YYRKGGKGL 196
Query: 944 GSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003
+++PE + SDV+S+GVVL EI T + + + V+++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRF-------- 247
Query: 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058
V++ L PD + + + +C + RP+ ++ + ++E +
Sbjct: 248 -----VMEGGLLDKPDNCPDMLFE---LMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (387), Expect = 4e-42
Identities = 67/286 (23%), Positives = 109/286 (38%), Gaps = 31/286 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFR---ASDKISTGAFSSEIATLSRIRHRNIVR 836
G I+G G V+ L VAVK R A D F E + + H IV
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 837 LLGWGANRKTKL----LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLH 892
+ G + +Y+ TL ++H G + ++ + L++ H
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH 128
Query: 893 HDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE 952
+ I+HRDVK NI++ + DFG+AR + D G+ Y++PE
Sbjct: 129 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-AVIGTAQYLSPE 184
Query: 953 YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012
A + +SDVYS G VL E++TG+ P F G + H++ P
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPP----FT-GDSPVSVAYQHVREDPIPPSARHE 239
Query: 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-TMKDVAALLREIR 1057
L + ++ + E+R T ++ A L +
Sbjct: 240 GL----SADLDAVVLK------ALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 6e-42
Identities = 70/302 (23%), Positives = 106/302 (35%), Gaps = 45/302 (14%)
Query: 778 LTAGNIIGQGRSGIVYKVTLPS--------GLTVAVKRFRA-SDKISTGAFSSEIATLSR 828
L G +G+G G V VAVK ++ + + SE+ +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 829 I-RHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGL-------------LEW 874
I +H+NI+ LLG + +Y G L L GL L
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 875 DTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934
A VA G+ YL +HRD+ + N+L+ E +ADFGLAR +
Sbjct: 135 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-- 189
Query: 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQ 994
+ ++APE + +SDV+S+GV+L EI T P ++
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-----PYPGVPVE 244
Query: 995 WVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLR 1054
+ LK + P E+ + C RPT K + L
Sbjct: 245 ELFKLLKEGHRMDK---------PSNCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLD 292
Query: 1055 EI 1056
I
Sbjct: 293 RI 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 9e-41
Identities = 52/271 (19%), Positives = 97/271 (35%), Gaps = 25/271 (9%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKIST-GAFSSEIATLSRIRHRNIVRLL 838
+++G G V + VA+K G+ +EIA L +I+H NIV L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ L + G L + + G ++ V + + YLH +
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
+ L E + ++DFGL+++ + S G+ GY+APE
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-----SVLSTACGTPGYVAPEVLAQKP 185
Query: 959 ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018
S+ D +S GV+ ++ G P F ++ + LK++ + +
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPP----FY-DENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 1019 DTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
I+ +++ E R T +
Sbjct: 241 KDFIRHLMEK----------DPEKRFTCEQA 261
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 3e-40
Identities = 59/297 (19%), Positives = 99/297 (33%), Gaps = 28/297 (9%)
Query: 767 LDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIAT 825
++L +G+ G IG G G +Y T + +G VA+K K E
Sbjct: 1 MELRVGN---RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKI 55
Query: 826 LSRIRHRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVA 885
++ + + W + + +L C+ T +A +
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMI 113
Query: 886 EGLSYLHHDCVPAILHRDVKSHNIL---LGERYESCLADFGLARLVEDDSGGSFSANPQ- 941
+ Y+H +HRDVK N L + + DFGLA+ D +
Sbjct: 114 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 942 --FAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDH 999
G+ Y + + S + D+ S G VL+ G P ++ R
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERIS 229
Query: 1000 LKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056
K P+EVL ++ L C S R +D+P + L R +
Sbjct: 230 EKKMSTPIEVLCKGY----PSEFATYLNF------CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 74/303 (24%), Positives = 111/303 (36%), Gaps = 43/303 (14%)
Query: 781 GNIIGQGRSGIVYKVT------LPSGLTVAVKRFRASDKISTG-AFSSEIATLSRIRHR- 832
G +G+G G V + + TVAVK + S A SE+ L I H
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77
Query: 833 NIVRLLGWGANRKTKLLF-YDYMPNGTLGMLLH-------------DGECAGLLEWDTRF 878
N+V LLG L+ ++ G L L + L +
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 879 KIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSA 938
+ VA+G+ +L +HRD+ + NILL E+ + DFGLAR + D
Sbjct: 138 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 939 NPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998
+ ++APE + +SDV+S+GV+L EI + G + +
Sbjct: 195 D--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----PYPGVKIDEEFCR 248
Query: 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058
LK PD EM Q + L C RPT ++ L + Q
Sbjct: 249 RLKEGTRMRA---------PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 296
Query: 1059 EPA 1061
A
Sbjct: 297 ANA 299
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 6e-40
Identities = 54/326 (16%), Positives = 112/326 (34%), Gaps = 43/326 (13%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G+G GIV++ S T K + EI+ L+ RHRNI+ L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHE 68
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+ + ++ ++++ + ++ A L V E L +LH I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 900 LHRDVKSHNILLGERYES--CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT 957
H D++ NI+ R S + +FG AR ++ + Y APE
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR-----LLFTAPEYYAPEVHQHD 178
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017
+S +D++S G ++ +++G P F + Q + + + ++ E ++
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP----FL-AETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 1018 PDTQIQEMLQALGISLLCTSNRAEDRPTMKDV--------------AALLREIRQEPASG 1063
+ +L + R T + ++R ++
Sbjct: 234 AMDFVDRLLVK----------ERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYH 283
Query: 1064 SEAHKPTAAKSTDTASYSSSSVTSAQ 1089
+ K + ++ S +
Sbjct: 284 TLIKKDLNMVVSAARISCGGAIRSQK 309
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (367), Expect = 3e-39
Identities = 44/289 (15%), Positives = 93/289 (32%), Gaps = 29/289 (10%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRN-IVRLL 838
G IG+G G++++ T L + VA+K E T + I +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVY 67
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+G +L D + +L G T A + + +H
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS--- 121
Query: 899 ILHRDVKSHNILLGERYES-----CLADFGLARLVEDDSGGSFSANPQ---FAGSYGYIA 950
+++RD+K N L+G + DFG+ + D + +G+ Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010
+ S + D+ + G V + + G P + + + KK +
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN---KQKYERIGEKKQSTPL- 237
Query: 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059
+L + + + + + P + L ++ +
Sbjct: 238 -RELCAGFPEEFYKYMH------YARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (363), Expect = 9e-39
Identities = 74/281 (26%), Positives = 108/281 (38%), Gaps = 23/281 (8%)
Query: 782 NIIGQGRSGIVYKVTLPSGLTVAVKRFR--ASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
IG+G G+VYK G T A+K+ R D+ EI+ L ++H NIV+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 840 WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+K +L ++++ +L C G LE T L + G++Y H +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---V 121
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANMTK 958
LHRD+K N+L+ E +ADFGLAR + Y AP+ K
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPV----RKYTHEIVTLWYRAPDVLMGSKK 177
Query: 959 ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ-HVIQWVRDHLKSKKDPVEVLDPKL--- 1014
S D++S G + E++ G Q I + SK P PK
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 1015 ----QGHPDTQIQEMLQALGISLL--CTSNRAEDRPTMKDV 1049
+ P + L GI LL R T K
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (361), Expect = 1e-38
Identities = 59/286 (20%), Positives = 100/286 (34%), Gaps = 43/286 (15%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA---------FSSEIATLSRIR 830
I+G+G S +V + P+ AVK + S A E+ L ++
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 831 -HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLS 889
H NI++L L +D M G L L + L KI + E +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVIC 124
Query: 890 YLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
LH I+HRD+K NILL + L DFG + ++ + G+ Y+
Sbjct: 125 ALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-----EVCGTPSYL 176
Query: 950 APEYA------NMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003
APE N ++ D++S GV++ ++ G P F + + +R +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FW-HRKQMLMLRMIMSGN 231
Query: 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
+ L + + R T ++
Sbjct: 232 YQFGSPEWDDYSDTVKDLVSRFLVV----------QPQKRYTAEEA 267
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-38
Identities = 74/332 (22%), Positives = 119/332 (35%), Gaps = 33/332 (9%)
Query: 781 GNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+IG G G+VY+ L SG VA+K+ + + E+ + ++ H NIVRL
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRY 80
Query: 840 WGANRKTK------LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
+ + K L DY+P + H L + L+Y+H
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 894 DCVPAILHRDVK-SHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP- 951
I HRD+K + +L + L DFG A+ + N + S Y AP
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-----EPNVSYICSRYYRAPE 192
Query: 952 EYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ-HVIQWV------RDHLKSKK 1004
T + DV+S G VL E++ G+ Q I V +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 1005 DPVEVLDPKLQGHPDTQI-QEMLQALGISLL--CTSNRAEDRPTMKDVAA--LLREIRQE 1059
+ E P+++ HP T++ + I+L R T + A E+R
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312
Query: 1060 PASGSEAHKPTAAKSTDTASYSSSSVTSAQLL 1091
A + T SS+ + L+
Sbjct: 313 NVKLPNGRDTPALFNFTTQELSSNPPLATILI 344
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 59/287 (20%), Positives = 99/287 (34%), Gaps = 44/287 (15%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFR---ASDKISTGAFSSEIATLSR-IRHRNIV 835
++G+G G V+ + A+K + E LS H +
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
+ ++ +Y+ G L + + A + GL +LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
I++RD+K NILL + +ADFG+ + + F G+ YIAPE
Sbjct: 124 ---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----AKTNTFCGTPDYIAPEILL 176
Query: 956 MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
K + D +S+GV+L E++ G+ P F +D E+
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP----FHG---------------QDEEELFHSIRM 217
Query: 1016 GHPDTQIQEMLQALGISLL--CTSNRAEDRPTMKDVAALLREIRQEP 1060
+P L+ LL E R ++ +IRQ P
Sbjct: 218 DNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRG------DIRQHP 256
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-38
Identities = 58/284 (20%), Positives = 106/284 (37%), Gaps = 19/284 (6%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFR-ASDKISTGAFSSEIATLSRIRHRNIVRLL 838
+ IG+G G+V + + VA+K+ + EI L R RH NI+ +
Sbjct: 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ + Y+ +G L+ L D + GL Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 129
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYA-NMT 957
+LHRD+K N+LL + + DFGLAR+ + D ++ + Y APE N
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD------ 1011
++ D++S G +L E+++ + Q S++D +++
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248
Query: 1012 ----PKLQGHPDTQIQEMLQALGISLL--CTSNRAEDRPTMKDV 1049
P P ++ + + LL + R ++
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 63/288 (21%), Positives = 98/288 (34%), Gaps = 34/288 (11%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTG-----AFSSEIATLSRIRHRNIV 835
+ +G+G+ VYK + VA+K+ + + EI L + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 836 RLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC 895
LL ++ L +D+M ++ + +L L +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 896 VPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYAN 955
ILHRD+K +N+LL E LADFGLA+ A + Y APE
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP----NRAYTHQVVTRWYRAPELLF 173
Query: 956 MTK-ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVR-----------DHLKSK 1003
+ D+++ G +L E++ P + Q R
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLL--CTSNRAEDRPTMKDV 1049
P V G P I + L+ R T
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 141 bits (357), Expect = 1e-37
Identities = 50/239 (20%), Positives = 92/239 (38%), Gaps = 22/239 (9%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA---FSSEIATLSRIRHRNIVR 836
+G G G V+ + +G A+K + + + E LS + H I+R
Sbjct: 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
+ G + + + DY+ G L LL + AE L +
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHS 122
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
I++RD+K NILL + + DFG A+ V D G+ YIAPE +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-------TYTLCGTPDYIAPEVVST 175
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
++ D +S+G+++ E++ G P + ++ L ++ + ++
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTP-----FYDSNTMKTYEKILNAELRFPPFFNEDVK 229
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (360), Expect = 2e-37
Identities = 62/288 (21%), Positives = 103/288 (35%), Gaps = 38/288 (13%)
Query: 781 GNIIGQGRSGIVYKVTLP-SGLTVAVKRF---RASDKISTGAFSSE---IATLSRIRHRN 833
IIG+G G VY +G A+K R K +E ++ +S
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
IV + D M G L L G+ A + GL ++H+
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN 125
Query: 894 DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEY 953
+++RD+K NILL E ++D GLA G++GY+APE
Sbjct: 126 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHASVGTHGYMAPEV 176
Query: 954 -ANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012
+D +S G +L +++ G P +H I R L + + P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTLTMAVELPDSFSP 234
Query: 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060
+L+ + ++ +LQ R A +E+++ P
Sbjct: 235 ELR----SLLEGLLQR----------DVNRRLGCLGRGA--QEVKESP 266
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-36
Identities = 66/298 (22%), Positives = 105/298 (35%), Gaps = 28/298 (9%)
Query: 781 GNIIGQGRSGIVYKVT--LPSGLTVAVKRFRASDKISTGAFS-----SEIATLSRIRHRN 833
IG+G G V+K G VA+KR R S + + L H N
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLG---MLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+VRL +T + + D + +T + + GL +
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
LH ++HRD+K NIL+ + LADFGLAR+ A + Y A
Sbjct: 132 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF-----QMALTSVVVTLWYRA 183
Query: 951 PEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ-HVIQWVRDHLKSKKDPVEV 1009
PE + + D++S G + E+ K S Q I V + P +V
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 1010 LDPKLQGH-----PDTQIQEMLQALGISLL--CTSNRAEDRPTMKDVAA--LLREIRQ 1058
P+ H P + + LG LL C + R + + +++ +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 54/280 (19%), Positives = 106/280 (37%), Gaps = 37/280 (13%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFR------ASDKISTGAFSSEIATLSRIRHRN 833
G +G G+ +V K +GL A K + + +S E++ L I+H N
Sbjct: 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 834 IVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH 893
++ L N+ +L + + G L L + E L + + + G+ ++
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV---YY 128
Query: 894 DCVPAILHRDVKSHNILLGERYES----CLADFGLARLVEDDSGGSFSANPQFAGSYGYI 949
I H D+K NI+L +R + DFGLA ++ + G+ ++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFV 183
Query: 950 APEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009
APE N + ++D++S GV+ +++G P G + + + + +
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGDTKQETLANVSAVNYEFEDE 238
Query: 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
I+ +L + R T++D
Sbjct: 239 YFSNTSALAKDFIRRLLVK----------DPKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-36
Identities = 54/278 (19%), Positives = 103/278 (37%), Gaps = 34/278 (12%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLL 838
++G G +G V ++ + A+K + K E+ R + +IVR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71
Query: 839 GWG----ANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD 894
A RK L+ + + G L + D E + I + E + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE-IMKSIGEAIQYLHS- 129
Query: 895 CVPAILHRDVKSHNILLGERYES---CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
I HRDVK N+L + + L DFG A+ + + + Y+AP
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-----SLTTPCYTPYYVAP 182
Query: 952 EYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011
E K + D++S GV++ ++ G P F + + + E +
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
P+ + +++ +++ R T+ +
Sbjct: 239 PEWSEVSE-EVKMLIRN------LLKTEPTQRMTITEF 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 68/287 (23%), Positives = 106/287 (36%), Gaps = 33/287 (11%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTG--AFSSEIATLSRIRHRNIVRLL 838
IG+G G+VYK +G VA+K+ R + EI+ L + H NIV+LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
L ++++ D + + +GL++ H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANMT 957
+LHRD+K N+L+ LADFGLAR + Y APE
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCK 178
Query: 958 KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGH 1017
S D++S G + E++T + FP G I + ++ P EV+ P +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRAL----FP-GDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 1018 PD-------------TQIQEMLQALGISLL--CTSNRAEDRPTMKDV 1049
PD +++ L G SLL R + K
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-35
Identities = 63/286 (22%), Positives = 104/286 (36%), Gaps = 31/286 (10%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLL 838
IG+G G V+K + VA+KR R D+ + EI L ++H+NIVRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ K L +++ + + C G L+ + + +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQD---LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
+LHRD+K N+L+ E LA+FGLAR + + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKL 178
Query: 959 ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018
S D++S G + E+ +P G V ++ + P E P + P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRP----LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 1019 D-------------TQIQEMLQALGISLL--CTSNRAEDRPTMKDV 1049
D + L A G LL R + ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-34
Identities = 59/280 (21%), Positives = 103/280 (36%), Gaps = 47/280 (16%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA------FSSEIATLSRIR--H 831
G ++G G G VY + L VA+K G E+ L ++
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 832 RNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
++RLL W + +L + G L+ + V E + +
Sbjct: 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHC 126
Query: 892 HHDCVPAILHRDVKSHNILL-GERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
H+ +LHRD+K NIL+ R E L DFG L++D F G+ Y
Sbjct: 127 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF------DGTRVYSP 177
Query: 951 PEY-ANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009
PE+ + V+S G++L +++ G P F + +I+
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRG-------------- 219
Query: 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDV 1049
+ ++ Q +++ C + R DRPT +++
Sbjct: 220 -QVFFRQRVSSECQHLIRW------CLALRPSDRPTFEEI 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-33
Identities = 56/293 (19%), Positives = 102/293 (34%), Gaps = 31/293 (10%)
Query: 782 NIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTG--AFSSEIATLSRIRHRNIVRLL 838
IGQG G V+K +G VA+K+ ++ EI L ++H N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 839 G--------WGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
+ + + L +D+ + G+L + ++ + GL Y
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYY 132
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
+H + ILHRD+K+ N+L+ LADFGLAR + + Y
Sbjct: 133 IHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 951 PE-YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVI-----------QWVRD 998
PE D++ G ++ E+ T + + Q + W
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLL--CTSNRAEDRPTMKDV 1049
+ +E++ + + D + + L+ R D
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-32
Identities = 53/239 (22%), Positives = 85/239 (35%), Gaps = 19/239 (7%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA---FSSEIATLSRIRHRNIVR 836
++G+G G V V +G A+K R I+ +E L RH +
Sbjct: 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 837 LLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCV 896
L +Y G L L E RF A E +S L +
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGA----EIVSALEYLHS 123
Query: 897 PAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANM 956
+++RD+K N++L + + DFGL + D + F G+ Y+APE
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----ATMKTFCGTPEYLAPEVLED 179
Query: 957 TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015
D + GVV+ E++ G+ P Q + L + L P+ +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQDHERLFELILMEEIRFPRTLSPEAK 233
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 5e-32
Identities = 69/287 (24%), Positives = 111/287 (38%), Gaps = 35/287 (12%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGW 840
+G G G V +G VA+K+ ++ E+ L +RH N++ LL
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 841 GANRKTKLLFYD-YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
+T F D Y+ +G L L D + + +GL Y+H +
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII-- 143
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPE-YANMTK 958
HRD+K N+ + E E + DFGLAR + + G + + Y APE N +
Sbjct: 144 -HRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-------YVVTRWYRAPEVILNWMR 195
Query: 959 ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD------- 1011
++ D++S G ++ E+ITGK F H+ Q + P E +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTL----FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 1012 -------PKLQGHPDTQIQEMLQALGISLL--CTSNRAEDRPTMKDV 1049
P+L+ I L ++LL AE R T +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (308), Expect = 7e-31
Identities = 48/249 (19%), Positives = 86/249 (34%), Gaps = 26/249 (10%)
Query: 783 IIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA---FSSEIATLSRIRHRNIVRLL 838
+G G G V V SG A+K + +E L + +V+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 839 GWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPA 898
+ + +Y+ G + L G A + YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD--- 161
Query: 899 ILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTK 958
+++RD+K N+L+ ++ + DFG A+ V+ G+ +APE
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-------TWTLCGTPEALAPEIILSKG 214
Query: 959 ISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHP 1018
++ D ++ GV++ E+ G P F IQ + K L+
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP----FF-ADQPIQIYEKIVSGKVRFPSHFSSDLKDL- 268
Query: 1019 DTQIQEMLQ 1027
++ +LQ
Sbjct: 269 ---LRNLLQ 274
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 122 bits (306), Expect = 2e-30
Identities = 87/402 (21%), Positives = 157/402 (39%), Gaps = 40/402 (9%)
Query: 119 ASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQ---LEGAIPIQIGNLSSLTQL 175
+L + L + ++T + + L ++ L+ + ++G + L++LTQ+
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDG-----VEYLNNLTQI 71
Query: 176 FLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFL 235
+NQLTD P + L L I N+ + + N T L + T I
Sbjct: 72 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129
Query: 236 PPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVN 295
T L + I + + L + + L NL L
Sbjct: 130 NLTNLNRLELSSNTISD----------ISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 296 LFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEI 355
L + N L + L + + N ++ P LT+L EL L+ NQ+
Sbjct: 180 LDISSNK--VSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD-- 233
Query: 356 PAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEA 415
+ + L ++L NNQI+ P L+ LT L + N++ P ++ L
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 289
Query: 416 VDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFI 475
++L++N I LK L L L NN+S + P + + + L R +NK++
Sbjct: 290 LELNEN--QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343
Query: 476 PPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSN 517
+ NL N+N+L G N+++ P + +T L ++
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 113 bits (282), Expect = 3e-27
Identities = 81/388 (20%), Positives = 152/388 (39%), Gaps = 62/388 (15%)
Query: 289 NLKNLVNLFLWQNNLVGIIPP-ELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347
L + L + N+ + +L + L + + S+ G + L +L ++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG----------------------- 384
NQ++ P + N +L I ++NNQI P
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 385 ----------NLSNLTLLFVWHNRLEGEIPPSISNCQNLE----AVDLSQNGLTGPIPRG 430
+S+++ L + + +++ + L L +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 431 IFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDL 490
+ +L L L+ +N +S + P +G ++L N N+L + +L NL LDL
Sbjct: 193 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 491 GSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPD 550
+N+++ P ++G LT L + +N I+ P L L L +L++N + +
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS 304
Query: 551 LGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALN 610
+L +LT L L N + P + S KLQ L ++N++S +SL + + L+
Sbjct: 305 --NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW-LS 357
Query: 611 LSWNQICGELPAELTGLNKLGILDLSHN 638
NQI P L L ++ L L+
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (266), Expect = 3e-25
Identities = 72/381 (18%), Positives = 140/381 (36%), Gaps = 52/381 (13%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
E L + +T ++ +L + L + + I + + L+ I+ S N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 77
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG-- 384
LT P L NLT L ++ ++ NQI+ P + + + +
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 385 -------NLSNLTLLFVWHNRLEGEIPPSISNCQNLE----AVDLSQNGLTGPIPRGIFQ 433
+S+++ L + + +++ + L L + + +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 434 LKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493
L L L+ +N +S + P +G ++L N N+L + +L NL LDL +N
Sbjct: 196 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 494 RLTGSIPDEITGCRNLTFLDVHSNSIAGNLP--------------------AGLHQLVRL 533
+++ P ++G LT L + +N I+ P + + L L
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 534 QFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSG 593
+ L N++ + SL+ L +L N+ S S L + + L NQ+S
Sbjct: 310 TYLTLYFNNISD--ISPVSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISD 365
Query: 594 NIPASLGKIPALAIALNLSWN 614
P L + + L L+
Sbjct: 366 LTP--LANLTRITQ-LGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (253), Expect = 1e-23
Identities = 79/361 (21%), Positives = 140/361 (38%), Gaps = 32/361 (8%)
Query: 97 LLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSN 156
L + L + SI + LN L ++ S N LT P L +L +L + +N+N
Sbjct: 43 LDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98
Query: 157 QLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPA------------TIGKLKNLEAIRAGGN 204
Q+ P+ + LF D + TI + L + +
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158
Query: 205 KNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELG 264
+ G + + L +S L L L+++ +S P +
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI- 217
Query: 265 DCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISM 324
T L + L N L L +L NL +L L N + + P L ++L+ + +
Sbjct: 218 -LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272
Query: 325 NSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG 384
N ++ P L LT+L L+L+ NQ+ E + I N + L + L N I+ P
Sbjct: 273 NQISNISP--LAGLTALTNLELNENQL--EDISPISNLKNLTYLTLYFNNISDISP--VS 326
Query: 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS 444
+L+ L LF +N++ S++N N+ + N ++ P + L ++ +L L
Sbjct: 327 SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382
Query: 445 N 445
Sbjct: 383 Q 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (253), Expect = 2e-23
Identities = 74/369 (20%), Positives = 129/369 (34%), Gaps = 33/369 (8%)
Query: 313 NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDN 372
++ + ++T ++ QT +L + LQ I I + L QI N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 373 NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLE---AVDLSQNGLTGPIPR 429
NQ+T P NL+ L + + +N++ P + ++ +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 430 GIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGN-------- 481
N + +S ++ + + + +N T N
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 482 --LKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLS 539
L NL L +N+++ P I NL L ++ N + L L L DL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 540 DNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASL 599
+N + + L L+ LT+L L N+ + P L L + S
Sbjct: 250 NNQISNL--APLSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISP 302
Query: 600 GKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVS 659
L L +N I P ++ L KL L ++N++S + LA L N+ L+
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAG 359
Query: 660 HNNFSGRVP 668
HN S P
Sbjct: 360 HNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.2 bits (238), Expect = 1e-21
Identities = 70/342 (20%), Positives = 124/342 (36%), Gaps = 30/342 (8%)
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
L +L ++ S LT P + +L +L + ++ N + P + L L
Sbjct: 60 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTL 117
Query: 152 RLNSNQLEGAIPI------------QIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAI 199
N + I ++S+L+ L + L NL +
Sbjct: 118 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177
Query: 200 RAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQI 259
+ S + TNL + IS P + L +++ L
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-- 233
Query: 260 PPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSI 319
L T L + L N ++ P L L L L L N + I P L + L+
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 289
Query: 320 IDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAI 379
++++ N L P + NL +L L L N IS P + + +L ++ NN+++
Sbjct: 290 LELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343
Query: 380 PSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQN 421
S NL+N+ L HN++ P ++N + + L+
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.9 bits (162), Expect = 4e-12
Identities = 51/216 (23%), Positives = 86/216 (39%), Gaps = 17/216 (7%)
Query: 63 CKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLN 122
+ L + P + +L+ L L+G L +ASL
Sbjct: 186 KVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLT 241
Query: 123 QLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQL 182
L LDL+ N ++ P L L +L +L+L +NQ+ P+ L++LT L L +NQ
Sbjct: 242 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQ- 296
Query: 183 TDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLL 242
+ I LKNL + N N+ P + + T L + A +S +L L
Sbjct: 297 -LEDISPISNLKNLTYLTLYFN-NISDISP--VSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 243 KRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENA 278
+ ++ +S P L + T + + L + A
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 1e-08
Identities = 21/104 (20%), Positives = 40/104 (38%), Gaps = 6/104 (5%)
Query: 53 SNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTG 112
+ + + + L L + ++ P +SL L RL + ++
Sbjct: 286 ALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSN 156
+A+L +N+L N ++ P L +L R+ QL LN
Sbjct: 344 --VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-29
Identities = 63/291 (21%), Positives = 103/291 (35%), Gaps = 37/291 (12%)
Query: 781 GNIIGQGRSGIVYKVTL----PSGLTVAVKRFR----ASDKISTGAFSSEIATLSRIRHR 832
++G G G V+ V +G A+K + +T +E L IR
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 833 -NIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYL 891
+V L L DY+ G L L + E + + + E + L
Sbjct: 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVG----EIVLAL 142
Query: 892 HHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAP 951
H I++RD+K NILL L DFGL++ D F G+ Y+AP
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET---ERAYDFCGTIEYMAP 199
Query: 952 E--YANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009
+ + + D +S GV++ E++TG P + + R LKS+ +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-GEKNSQAEISRRILKSEPPYPQE 258
Query: 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060
+ + IQ +L + R A EI++
Sbjct: 259 MSALAK----DLIQRLLMK----------DPKKRLGCGPRDA--DEIKEHL 293
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (291), Expect = 8e-29
Identities = 55/253 (21%), Positives = 93/253 (36%), Gaps = 27/253 (10%)
Query: 751 EDVEMGPPWELTLYNKLDLSIGDATRSLTAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFR 809
DV P E Y + G+ +G+G+ V++ + + V VK +
Sbjct: 11 TDVNTHRPREYWDYESHVVEWGNQDD-YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69
Query: 810 ASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLF--YDYMPNGTLGMLLHDG 866
+ EI L +R NI+ L + ++ ++++ N L
Sbjct: 70 ---PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-- 124
Query: 867 ECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES-CLADFGLA 925
L ++D RF + + L Y H I+HRDVK HN+++ + L D+GLA
Sbjct: 125 ---TLTDYDIRF-YMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
Query: 926 RLVEDDSGGSFSANPQFAGSYGYIAPE-YANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984
S + PE + D++S G +L +I K+P
Sbjct: 178 EFYHPGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-- 230
Query: 985 SFPDGQHVIQWVR 997
F + Q VR
Sbjct: 231 -FHGHDNYDQLVR 242
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 2e-28
Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 23/236 (9%)
Query: 781 GNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLG 839
+G G V+ + + VA+K R DK+ T A EI L R+ + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 840 WGANRKTKLL--FYDYMPNGTLGMLLHDGECAGLLEWDTRFK-----------IALGVAE 886
GAN KLL F PNG +++ + LL +++ I+ +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 887 GLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGLARLVEDDSGGSFSANPQFAGS 945
GL Y+H C I+H D+K N+L+ L +A L ++ +
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADL--GNACWYDEHYTNSIQT 192
Query: 946 YGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLK 1001
Y +PE +D++S ++ E+ITG + PD H DH+
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE---PDEGHSYTKDDDHIA 245
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 2e-27
Identities = 63/287 (21%), Positives = 104/287 (36%), Gaps = 35/287 (12%)
Query: 784 IGQGRSGIVYKVT-LPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGW 840
+G G G V +GL VAVK+ I E+ L ++H N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 841 GANRKTKLLFYD-YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAI 899
++ F D Y+ +G L++ L D + + GL Y+H +
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADII-- 143
Query: 900 LHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI 959
HRD+K N+ + E E + DFGLAR + A + N
Sbjct: 144 -HRDLKPSNLAVNEDCELKILDFGLARHTD------DEMTGYVATRWYRAPEIMLNWMHY 196
Query: 960 SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPD 1019
++ D++S G ++ E++TG+ FP G I ++ L+ P L K+
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTL----FP-GTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 1020 TQIQEMLQ---------------ALGISLL--CTSNRAEDRPTMKDV 1049
+ L L + LL ++ R T
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 111 bits (278), Expect = 2e-27
Identities = 83/307 (27%), Positives = 131/307 (42%), Gaps = 11/307 (3%)
Query: 33 RQGEALLSWKRNWKGSDDGLSNWSPS-DETPCKWFGVSCNLNNQ---VVGLDLRYVDLLG 88
+ +ALL K++ G+ LS+W P+ D W GV C+ + Q V LDL ++L
Sbjct: 6 QDKQALLQIKKDL-GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 89 --HVPTNFTSLLSLNRLVLSG-TNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSL 145
+P++ +L LN L + G NL G IP IA L QL+YL ++ +++G IP L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 146 LRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNK 205
L L + N L G +P I +L +L + N+++ AIP + G L
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 206 NLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGD 265
L G +P N ++ L + ++G
Sbjct: 185 RLTGKIPPTFANLNL--AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL 242
Query: 266 CTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMN 325
L + L N + G++P L LK L +L + NNL G I P+ GN + + + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANN 301
Query: 326 SLTGSIP 332
P
Sbjct: 302 KCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.4 bits (225), Expect = 2e-20
Identities = 72/253 (28%), Positives = 117/253 (46%), Gaps = 7/253 (2%)
Query: 269 LQYIYLYENALTG--SIPSKLGNLKNLVNLFLWQN-NLVGIIPPELGNCSQLSIIDISMN 325
+ + L L IPS L NL L L++ NLVG IPP + +QL + I+
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 326 SLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGN 385
+++G+IP L + +L L S N +SG +P I + L I D N+I+GAIP +G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 386 LSNLTL-LFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS 444
S L + + NRL G+IPP+ +N A + +F K + + L+
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 445 NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEIT 504
N ++G +L +N++ G +P + LK L+ L++ N L G IP +
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGG 288
Query: 505 GCRNLTFLDVHSN 517
+ +N
Sbjct: 289 NLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.4 bits (207), Expect = 4e-18
Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 10/269 (3%)
Query: 360 GNCQRLAQIELDNNQITGA--IPSEFGNLSNLTLLFVWHN-RLEGEIPPSISNCQNLEAV 416
R+ ++L + IPS NL L L++ L G IPP+I+ L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 417 DLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIP 476
++ ++G IP + Q+K L L N LSG +PP + + +L+ + N+++G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 477 PEIGNLKNLNF-LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQF 535
G+ L + + NRLTG IP S ++ + L +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD--LSRNMLEGDASVLFGSDKNTQ 224
Query: 536 ADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNI 595
+ +G +L L L NR G++P L L L++S N L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 596 PASLGKIPALAIALNLSWNQ-ICGE-LPA 622
P G + + + N+ +CG LPA
Sbjct: 285 P-QGGNLQRFDV-SAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 83.6 bits (205), Expect = 7e-18
Identities = 65/265 (24%), Positives = 101/265 (38%), Gaps = 7/265 (2%)
Query: 336 GNLTSLQELQLSVNQISG--EIPAQIGNCQRLAQIELDNN-QITGAIPSEFGNLSNLTLL 392
+ L LS + IP+ + N L + + + G IP L+ L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 393 FVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIP 452
++ H + G IP +S + L +D S N L+G +P I L L + N +SG IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 453 PEMGNCSSLIR-FRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTF 511
G+ S L + N+LTG IPP NL S + + G T
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDASVLFGSDKNTQ 224
Query: 512 LDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSI 571
+ + + L DL +N + G L L L L L ++ N G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 572 PSQLGSCVKLQLLDLSSNQLSGNIP 596
P G+ + + ++N+ P
Sbjct: 285 PQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.3 bits (191), Expect = 4e-16
Identities = 68/260 (26%), Positives = 101/260 (38%), Gaps = 6/260 (2%)
Query: 433 QLKKLNKLLLLSNNLSGV--IPPEMGNCSSLIRFR-ANSNKLTGFIPPEIGNLKNLNFLD 489
Q ++N L L NL IP + N L N L G IPP I L L++L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 490 LGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSP 549
+ ++G+IPD ++ + L LD N+++G LP + L L N + G +
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 550 DLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIAL 609
GS S L + + + L +DLS N L G+ G
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 610 NLSWNQICGELPAELTGLNKLGILDLSHNELSGDL-HFLAELQNLVVLNVSHNNFSGRVP 668
+ L+ DL +N + G L L +L+ L LNVS NN G +P
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 669 DTPFFAKLPLSVLSGNPSLC 688
+ +S + N LC
Sbjct: 286 QGGNLQRFDVSAYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.1 bits (188), Expect = 1e-15
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 5/261 (1%)
Query: 406 SISNCQNLEAVDLSQNGLTG--PIPRGIFQLKKLNKLLLLSN-NLSGVIPPEMGNCSSLI 462
+ + + +DLS L PIP + L LN L + NL G IPP + + L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 463 RFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGN 522
++G IP + +K L LD N L+G++P I+ NL + N I+G
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 523 LPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQ 582
+P +L + + + + ++L ++ +R + +
Sbjct: 165 IPDSYGSFSKLFTSMTISRN--RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 583 LLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSG 642
+ + S + L+L N+I G LP LT L L L++S N L G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 643 DLHFLAELQNLVVLNVSHNNF 663
++ LQ V ++N
Sbjct: 283 EIPQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 8e-10
Identities = 17/60 (28%), Positives = 32/60 (53%), Gaps = 1/60 (1%)
Query: 105 LSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPI 164
L + G++P+ + L L+ L++S N+L GEIP + +L R + +N+ P+
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.8 bits (125), Expect = 9e-08
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 1/82 (1%)
Query: 63 CKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLN 122
+ L+ + GLDLR + G +P T L L+ L +S NL G IP + +L
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQ 291
Query: 123 QLNYLDLSENSLTGEIPRELCS 144
+ + + N P C+
Sbjct: 292 RFDVSAYANNKCLCGSPLPACT 313
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-27
Identities = 61/318 (19%), Positives = 108/318 (33%), Gaps = 50/318 (15%)
Query: 768 DLSIGDATRSL----TAGNIIGQGRSGIVYKVT-LPSGLTVAVKRFRASDKISTGA--FS 820
+ +GD+T ++ IG G GIV VA+K+ + T A
Sbjct: 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY 64
Query: 821 SEIATLSRIRHRNIVRLLGWGANRKTK------LLFYDYMPNGTLGMLLHDGECAGLLEW 874
E+ + + H+NI+ LL +KT L + M ++ + +
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------H 118
Query: 875 DTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934
+ + + G+ +LH I+HRD+K NI++ + DFGLAR
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQ---- 990
+ + + Y APE E D++S G ++ E++ K Q
Sbjct: 176 TP-----YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
Query: 991 -----------------HVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISL 1033
V +V + K L P D++ ++ + L
Sbjct: 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290
Query: 1034 L--CTSNRAEDRPTMKDV 1049
L R ++ D
Sbjct: 291 LSKMLVIDPAKRISVDDA 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (265), Expect = 1e-25
Identities = 59/295 (20%), Positives = 112/295 (37%), Gaps = 19/295 (6%)
Query: 257 GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQ 316
G + P C L+ + + L +P L + L L N + I + N
Sbjct: 1 GPVCPFRCQC-HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKN 56
Query: 317 LSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376
L + + N ++ P L L+ L LS NQ+ Q L N+IT
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRV---HENEIT 113
Query: 377 GAIPSEFGNLSNLTLLFVWHNRLE--GEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQL 434
S F L+ + ++ + N L+ G + + L + ++ +T IP+G+
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP-- 170
Query: 435 KKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNR 494
L +L L N ++ V + ++L + + N ++ + N +L L L +N+
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 495 LTGSIPDEITGCRNLTFLDVHSNSIAG------NLPAGLHQLVRLQFADLSDNSV 543
L +P + + + + +H+N+I+ P + L N V
Sbjct: 231 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (248), Expect = 2e-23
Identities = 48/270 (17%), Positives = 98/270 (36%), Gaps = 15/270 (5%)
Query: 402 EIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSL 461
++P + + +DL N +T LK L+ L+L++N +S + P L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG 521
R + N+L L+ L + ++ S+ + + + L + +G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140
Query: 522 NLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKL 581
+ +L + ++D + + + G SLT+L L+ N+ + L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTN---ITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 582 QLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELS 641
L LS N +S SL P L + + P L + ++ L +N +S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV--PGGLADHKYIQVVYLHNNNIS 255
Query: 642 G-------DLHFLAELQNLVVLNVSHNNFS 664
+ + + +++ N
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.0 bits (240), Expect = 2e-22
Identities = 67/321 (20%), Positives = 123/321 (38%), Gaps = 41/321 (12%)
Query: 106 SGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQ 165
S L +PK++ LDL N +T + +L L L L +N++ P
Sbjct: 18 SDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 166 IGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIG 225
L L +L+L NQL + L+ L ++N + + N N ++
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEKMPKTLQELR-----VHENEITKVRKSVFNGLNQMI-- 127
Query: 226 LAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPS 285
+ + SG +L YI + + +T +IP
Sbjct: 128 -------------------VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 167
Query: 286 KLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQ 345
G +L L L N + + L + L+ + +S NS++ +L N L+EL
Sbjct: 168 --GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225
Query: 346 LSVNQISGEIPAQIGNCQRLAQIELDNNQITG------AIPSEFGNLSNLTLLFVWHNRL 399
L+ N++ ++P + + + + + L NN I+ P ++ + + ++ N +
Sbjct: 226 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
Query: 400 E-GEIPPSISNC-QNLEAVDL 418
+ EI PS C AV L
Sbjct: 285 QYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.7 bits (169), Expect = 3e-13
Identities = 50/266 (18%), Positives = 90/266 (33%), Gaps = 54/266 (20%)
Query: 475 IPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQ 534
+P ++ + LDL +N++T + +NL L + +N I+ P LV+L+
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 535 FADLSDNSVGG-----------------------MLSPDLGSLSSLTKLVLNKNRFAGSI 571
LS N + + + + +L N + +G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 572 PSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLG 631
KL + ++ ++ IP L P L+L N+I A L GLN L
Sbjct: 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 632 ILDLS------------------------HNELSGDLHFLAELQNLVVLNVSHNNFSGRV 667
L LS +N+L LA+ + + V+ + +NN S +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA-I 257
Query: 668 PDTPFFAKLPLSVLSGNPSLCFSGNQ 693
F + + + N
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.8 bits (94), Expect = 7e-04
Identities = 31/214 (14%), Positives = 73/214 (34%), Gaps = 25/214 (11%)
Query: 87 LGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLL 146
+ N + + + L + +G + +L+Y+ +++ ++T IP+ L
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP-- 171
Query: 147 RLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKN 206
L +L L+ N++ + L++L +L L N ++ ++ +L + NK
Sbjct: 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK- 230
Query: 207 LGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDC 266
+P + + + ++ L +IS P
Sbjct: 231 -LVKVPGGLADHKYIQVVYLHNNNISAIGSNDF------------------CPPGYNTKK 271
Query: 267 TELQYIYLYENALTGS--IPSKLGNLKNLVNLFL 298
+ L+ N + PS + + L
Sbjct: 272 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (242), Expect = 7e-23
Identities = 64/266 (24%), Positives = 101/266 (37%), Gaps = 8/266 (3%)
Query: 354 EIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNL 413
+P I +I L N+I+ + F NLT+L++ N L + + L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 414 EAVDLSQNGLTGPI-PRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT 472
E +DLS N + P L +L+ L L L + P ++L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 473 GFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVR 532
+L NL L L NR++ G +L L +H N +A P L R
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 533 LQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLS 592
L L N++ + + L L +L L LN N + + LQ SS+++
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261
Query: 593 GNIPASLGKIPALAIALNLSWNQICG 618
++P L L+ N + G
Sbjct: 262 CSLPQRLAGRD----LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (238), Expect = 2e-22
Identities = 54/283 (19%), Positives = 96/283 (33%), Gaps = 7/283 (2%)
Query: 143 CSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAG 202
C L+ A+P+ I ++ ++FL+ N+++ A+ +NL +
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 203 GNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE 262
N G + + P T L RL T+ + L P
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 263 LGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDI 322
LQY+YL +NAL +L NL +LFL N + + L + +
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 323 SMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE 382
N + P +L L L L N +S + + L + L++N +
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244
Query: 383 FGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTG 425
+ L + + +P + + L+ N L G
Sbjct: 245 -PLWAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (215), Expect = 2e-19
Identities = 59/261 (22%), Positives = 96/261 (36%), Gaps = 6/261 (2%)
Query: 282 SIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSL 341
++P + +FL N + + C L+I+ + N L L L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 342 QELQLSVNQISGEI-PAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLE 400
++L LS N + PA RL + LD + P F L+ L L++ N L+
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 401 GEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSS 460
+ + NL + L N ++ R L L++LLL N ++ V P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 461 LIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIA 520
L+ +N L+ + L+ L +L L N L S+ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVP 261
Query: 521 GNLPAGLH--QLVRLQFADLS 539
+LP L L RL DL
Sbjct: 262 CSLPQRLAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (208), Expect = 2e-18
Identities = 53/289 (18%), Positives = 97/289 (33%), Gaps = 31/289 (10%)
Query: 210 SLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTEL 269
++P I I L IS + + L + +++ +L+ L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 270 QYIYLYENALTGSI-PSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLT 328
+ + L +NA S+ P+ L L L L + L + P + L + + N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 329 GSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSN 388
T +L +L L L N+IS L ++ L N++ P F +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 389 LTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLS 448
L L+++ N L +++ + L+ + L+ N L K S+ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVP 261
Query: 449 GVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTG 497
+P L + L +N L G
Sbjct: 262 CSLPQ---------------------------RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (204), Expect = 5e-18
Identities = 55/296 (18%), Positives = 100/296 (33%), Gaps = 31/296 (10%)
Query: 106 SGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQ 165
L ++P I + +Q + L N ++
Sbjct: 19 PQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASF----------------------- 52
Query: 166 IGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIG 225
+LT L+L+ N L A L LE + N L P L +
Sbjct: 53 -RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111
Query: 226 LAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPS 285
L + P L LQ + + L D L +++L+ N ++
Sbjct: 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 286 KLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQ 345
L +L L L QN + + P + +L + + N+L+ + L L +LQ L+
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231
Query: 346 LSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEG 401
L+ N + A L + ++++ ++P L+ L + N L+G
Sbjct: 232 LNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (198), Expect = 4e-17
Identities = 65/283 (22%), Positives = 91/283 (32%), Gaps = 9/283 (3%)
Query: 405 PSISNCQNLEA--VDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLI 462
P C N Q GL +P GI ++ L N +S V C +L
Sbjct: 3 PGACVCYNEPKVTTSCPQQGLQA-VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLT 59
Query: 463 RFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSI-PDEITGCRNLTFLDVHSNSIAG 521
+SN L L L LDL N S+ P G L L + +
Sbjct: 60 ILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE 119
Query: 522 NLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKL 581
P L LQ+ L DN++ + L +LT L L+ NR + L
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179
Query: 582 QLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELS 641
L L N+++ P + + L L N + L L L L L+ N
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTL-YLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
Query: 642 GDLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGN 684
D L S + +P A L L+ N
Sbjct: 239 CDCRARPLWAWLQKFRGSSSEVPCSLP--QRLAGRDLKRLAAN 279
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (136), Expect = 3e-09
Identities = 47/231 (20%), Positives = 69/231 (29%), Gaps = 6/231 (2%)
Query: 52 LSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHV-PTNFTSLLSLNRLVLSGTNL 110
L+ + + + LDL L V P F L L+ L L L
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 111 TGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLS 170
P L L YL L +N+L L L L L+ N++ L
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 171 SLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETS 230
SL +L L+ N++ P L L + N + L + L +
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNP 236
Query: 231 ISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTG 281
L LQ ++ + +P L L N L G
Sbjct: 237 WVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.2 bits (228), Expect = 9e-22
Identities = 32/209 (15%), Positives = 69/209 (33%), Gaps = 37/209 (17%)
Query: 781 GNIIGQGRSGIVYKVTLPSGLTVAVKRFRAS----------DKISTGAFSSEIATLSRIR 830
G ++G+G+ V+ VK + FS +R
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 831 HRNIVRLLGWGANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSY 890
R + +L G + Y + N + M L D + + + ++ + E ++
Sbjct: 65 FRALQKLQGLAVPK-----VYAWEGNA-VLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 891 LHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIA 950
+H I+H D+ +N+L+ E + DF + V ++ +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEG------------WREILE 162
Query: 951 PEYANMT-----KISEKSDVYSYGVVLLE 974
+ N+ + D+ S +L+
Sbjct: 163 RDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (183), Expect = 3e-15
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 7/208 (3%)
Query: 310 ELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIE 369
E+ + ++ +LT ++P L L LS N + A + RL Q+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 370 LDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPR 429
LD ++T G L L L + HN+L+ + +D+S N LT
Sbjct: 62 LDRAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLG 118
Query: 430 GIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLD 489
+ L +L +L L N L + P + L + +N LT + L+NL+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 490 LGSNRLTGSIPDEITGCRNLTFLDVHSN 517
L N L +IP G L F +H N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 4e-10
Identities = 43/211 (20%), Positives = 73/211 (34%), Gaps = 8/211 (3%)
Query: 117 EIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLF 176
E++ + ++ + +LT +P +L + L L+ N L + + LTQL
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTI--LHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 177 LYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLP 236
L + G L L + N+ L + ++ + ++
Sbjct: 62 LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS--FNRLTSLPL 117
Query: 237 PTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNL 296
L L LQ + + L P L +L+ + L N LT L L+NL L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 297 FLWQNNLVGIIPPELGNCSQLSIIDISMNSL 327
L Q N + IP L + N
Sbjct: 178 LL-QENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 6e-10
Identities = 41/243 (16%), Positives = 73/243 (30%), Gaps = 32/243 (13%)
Query: 454 EMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLD 513
E+ +S + + LT +PP++ K+ L L N L + LT L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 514 VHSNSIAGNLPAGLHQLVRLQFADLSDN---------------------SVGGMLSPDLG 552
+ + G ++ + + + L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 553 SLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLS 612
L L +L L N P L KL+ L L++N L+ L + L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT-LLLQ 180
Query: 613 WNQICGELPAELTGLNKLGILDLSHNELSGD------LHFLAELQNLVVLNVSHNNFSGR 666
N + +P G + L L N + +L + V + +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAM 239
Query: 667 VPD 669
+
Sbjct: 240 TSN 242
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 43/213 (20%), Positives = 64/213 (30%), Gaps = 13/213 (6%)
Query: 92 TNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQL 151
+ S L +N NLT ++P ++ L LSEN L L RL QL
Sbjct: 7 SKVASHLEVN---CDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 152 RLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSL 211
L+ + ++ +L L D + + N SL
Sbjct: 61 NLDRAE-----LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 212 PHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPE-LGDCTELQ 270
P + + + LPP L ++P L L
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 271 YIYLYENALTGSIPSKLGNLKNLVNLFLWQNNL 303
+ L EN+L +IP L FL N
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 6e-08
Identities = 46/209 (22%), Positives = 61/209 (29%), Gaps = 8/209 (3%)
Query: 406 SISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFR 465
+S + V+ + LT +P + K L L N L + + L +
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 466 ANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPA 525
+ + G L L LDL N+L T DV N +
Sbjct: 62 LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 526 GLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLD 585
L L LQ L N + + L L KL L N L L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 586 LSSNQLSGNIPASLGKIPALAIALNLSWN 614
L N L IP L L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPF-AFLHGN 205
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.7 bits (174), Expect = 5e-14
Identities = 44/293 (15%), Positives = 90/293 (30%), Gaps = 25/293 (8%)
Query: 102 RLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEG- 160
L L+G NL + + S + + + + E S R++ + L+++ +E
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 161 AIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNL-GGSLPHEIGNCT 219
+ + S L L L +L+D I T+ K NL + G +L + +C+
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 220 NLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENAL 279
L + L+ + + +T L + +
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSET----------ITQLNLSGYRKNLQKSDLSTLV 171
Query: 280 TGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDIS-MNSLTGSIPQTLGNL 338
+ L E + L + +S + LG +
Sbjct: 172 RRCPNLVHLD-------LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224
Query: 339 TSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTL 391
+L+ LQ+ G + L +++ + T GN N +
Sbjct: 225 PTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 45/265 (16%), Positives = 77/265 (29%), Gaps = 15/265 (5%)
Query: 234 FLPPTLGLLKRLQTIAIYTA-LLSGQIPPELGDCTELQYIYLYENALTG-SIPSKLGNLK 291
P G L IA Q E +Q++ L + + ++ L
Sbjct: 12 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 71
Query: 292 NLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSL-----TGSIPQTLGNLTSLQELQL 346
L NL L L I L S L +++S S ++ + L L
Sbjct: 72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131
Query: 347 SVNQISGEIPAQIGNCQRLAQIELD----NNQITGAIPSEFGNLSNLTLLFVWHNRLEGE 402
A + + Q+ L N Q + + + L L+ +
Sbjct: 132 FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND 191
Query: 403 IPPSISNCQNLEAVDLSQ-NGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSL 461
L+ + LS+ + + ++ L L + G + L
Sbjct: 192 CFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL 251
Query: 462 IRFRANSNKLTGFIPPEIGNLKNLN 486
+ N + T P IGN KN
Sbjct: 252 ---QINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 3e-09
Identities = 43/298 (14%), Positives = 93/298 (31%), Gaps = 39/298 (13%)
Query: 127 LDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAI 186
LDL+ +L ++ L S + R + ++ + + + + + L ++ + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS- 61
Query: 187 PATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQ 246
+L + C+ L + L +S + TL L
Sbjct: 62 -----------------------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
Query: 247 TIAIYTALLSGQIPPE--------LGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFL 298
+ + + + L + E + ++ + L
Sbjct: 99 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158
Query: 299 WQNNLVGIIPPELGNCSQLSIIDISMNSL-TGSIPQTLGNLTSLQELQLS-VNQISGEIP 356
+N + + C L +D+S + + Q L LQ L LS I E
Sbjct: 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218
Query: 357 AQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLE 414
++G L +++ G + L +L + + P+I N +N E
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINC---SHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 1e-08
Identities = 37/275 (13%), Positives = 81/275 (29%), Gaps = 39/275 (14%)
Query: 79 LDLRYVDLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGE- 137
LDL +L V S + + + + + + ++ ++DLS + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62
Query: 138 IPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYD--NQLTDAIPATIGKLKN 195
+ L +L+ L L +L I + S+L +L L A+ +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 196 LEAIRAG------------------------------GNKNLGGSLPHEIGNCTNLVMIG 225
L+ + N + +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 226 LAETSISGFLPPTLGLLKRLQTIAI-YTALLSGQIPPELGDCTELQYIYLYENALTGSIP 284
+ L LQ +++ + + ELG+ L+ + ++ G++
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 285 SKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSI 319
L +L + ++ I P +GN I
Sbjct: 243 LLKEALPHLQ---INCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 6e-07
Identities = 38/277 (13%), Positives = 84/277 (30%), Gaps = 16/277 (5%)
Query: 342 QELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEG 401
Q L L+ + ++ ++ + +A + + + F + + + ++ +E
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60
Query: 402 EIPPSI-SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSS 460
I S C L+ + L L+ PI + + L +L L + + S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 461 LIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTG---------SIPDEITGCRNLTF 511
N + F + + L+G +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 512 LDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSP-DLGSLSSLTKLVLNKNRFAGS 570
S + + QL LQ LS + +LG + +L L + G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 571 IPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAI 607
+ + LQ ++ + + ++G I
Sbjct: 241 LQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 16/89 (17%), Positives = 34/89 (38%), Gaps = 5/89 (5%)
Query: 582 QLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELS 641
Q LDL+ L ++ L + IA + + L + ++ +DLS++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIE 59
Query: 642 GD--LHFLAELQNLVVLNVSHNNFSGRVP 668
L++ L L++ S +
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIV 88
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 60.4 bits (145), Expect = 1e-10
Identities = 38/230 (16%), Positives = 73/230 (31%), Gaps = 21/230 (9%)
Query: 289 NLKNLVNLFLWQNNLVGIIPP-ELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347
L N + + ++N+ + +L + LS + ++ G + L +L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELK 71
Query: 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI 407
NQI L + N+S + L +
Sbjct: 72 DNQI----------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
Query: 408 SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRAN 467
+ I N L N + N S L +A+
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 468 SNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSN 517
NK++ P + +L NL + L +N+++ P + NL + + +N
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 58.1 bits (139), Expect = 7e-10
Identities = 44/232 (18%), Positives = 77/232 (33%), Gaps = 20/232 (8%)
Query: 119 ASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLY 178
+L + ++++T + + L + L + +Q L++L L L
Sbjct: 16 PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELK 71
Query: 179 DNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPT 238
DNQ+TD P + KN+ + +L + + + L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 239 LGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFL 298
L L I + L YL S + L NL L L
Sbjct: 132 QVLYLDLNQITNISPL-----------AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180
Query: 299 WQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQ 350
N + I P L + L + + N ++ P L N ++L + L+ NQ
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 5e-08
Identities = 36/227 (15%), Positives = 72/227 (31%), Gaps = 19/227 (8%)
Query: 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNS 326
I ++ +T ++ +L + L + + I + + L +++ N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 327 LTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNL 386
+T P + EL + + I + A S L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 387 SNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNN 446
+ L G + N + DL+ + L KL L N
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP----------LANLSKLTTLKADDNK 184
Query: 447 LSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493
+S + P + + +LI +N+++ P + N NL + L +N
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 42/227 (18%), Positives = 79/227 (34%), Gaps = 23/227 (10%)
Query: 168 NLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGN--KNLGGSLPHEIGNCTNLVMIG 225
L++ ++ + +TD + T L + + A G + G + NL+ +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLE 69
Query: 226 LAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPS 285
L + I+ P ++ I T + + S
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 286 KLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQ 345
L L +N + L G+ + + + D++ L NL+ L L+
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP----------LANLSKLTTLK 179
Query: 346 LSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLL 392
N+IS P + + L ++ L NNQI+ P N SNL ++
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 37/221 (16%), Positives = 69/221 (31%), Gaps = 24/221 (10%)
Query: 409 NCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANS 468
N + ++ +T + + L + L ++ + + ++LI
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 469 NKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLH 528
N++T P + L + +I + ++ + L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 529 QL--------------VRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ 574
L LS + L +LS LT L + N+ + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 575 LGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQ 615
L S L + L +NQ+S P L L I + L+ NQ
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFI-VTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 8e-06
Identities = 31/215 (14%), Positives = 69/215 (32%), Gaps = 16/215 (7%)
Query: 457 NCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHS 516
++ I+ A + +T + +L + L +T +I + NL L++
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 517 NSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLS--------SLTKLVLNKNRFA 568
N I P + + ++ + + + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 569 GSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICG---ELPAELT 625
L L++ Q A + + LA L+ + + L
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192
Query: 626 GLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSH 660
L L + L +N++S D+ LA NL ++ +++
Sbjct: 193 SLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 34/218 (15%), Positives = 67/218 (30%), Gaps = 23/218 (10%)
Query: 242 LKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQN 301
L IA + ++ + D + + + +T +I + L NL+ L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 302 NLVGIIPPELGNCSQLSIIDISMNSLTGSIPQ--------------TLGNLTSLQELQLS 347
+ + P + + + +I T +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI 407
+ +I L + + NLS LT L N++ P +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 408 SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSN 445
++ NL V L N ++ P + L ++ L+N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNL-FIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 33/220 (15%), Positives = 68/220 (30%), Gaps = 23/220 (10%)
Query: 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS 444
L+N + + + + + ++ + + G+T I G+ L L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKD 72
Query: 445 NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGS------------ 492
N ++ + P + + + N K I +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 493 --NRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPD 550
I + + + + L L +L DN + +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI--SP 190
Query: 551 LGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQ 590
L SL +L ++ L N+ + P L + L ++ L +NQ
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 21/69 (30%), Positives = 35/69 (50%), Gaps = 5/69 (7%)
Query: 113 SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSL 172
S +A+L++L L +N ++ P L SL L ++ L +NQ+ P + N S+L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 173 TQLFLYDNQ 181
+ L NQ
Sbjct: 220 FIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 5/65 (7%)
Query: 93 NFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLR 152
+L L L ++ P +ASL L + L N ++ P L + L +
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 153 LNSNQ 157
L +NQ
Sbjct: 224 L-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 9/58 (15%), Positives = 21/58 (36%), Gaps = 3/58 (5%)
Query: 606 AIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNF 663
AI + + + + L+ + L ++ + + L NL+ L + N
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQI 75
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 58.5 bits (140), Expect = 5e-10
Identities = 37/204 (18%), Positives = 73/204 (35%), Gaps = 16/204 (7%)
Query: 313 NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDN 372
++ ++ S+T ++ Q L S+ ++ + + I I + ++ L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 373 NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIF 432
N++T P NL NL LF+ N+++ LS G+
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLK----SLSLEHNGISDINGLV 131
Query: 433 QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGS 492
L +L L L +N ++ + + N + L L L L
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQI----SDIVPLAGLTKLQNLYLSK 187
Query: 493 NRLTGSIPDEITGCRNLTFLDVHS 516
N ++ + G +NL L++ S
Sbjct: 188 NHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 2e-08
Identities = 48/221 (21%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 109 NLTGSIPKEI------ASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAI 162
+ T ++P I + + +L + S+T + + L ++Q+ N++ ++
Sbjct: 5 SETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQ 62
Query: 163 PIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLV 222
IQ L ++T+LFL N+LTD P + LKNL + NK S ++ +L
Sbjct: 63 GIQ--YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLS 118
Query: 223 MIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGS 282
+ + I+G + Q ++Y L T+L + L +N ++
Sbjct: 119 LEHNGISDINGLVHLP-------QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI 171
Query: 283 IPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDIS 323
+P L L L NL+L +N++ + L L ++++
Sbjct: 172 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 36/203 (17%), Positives = 62/203 (30%), Gaps = 16/203 (7%)
Query: 457 NCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHS 516
+ I+ +T + L +++ + ++ + I N+T L ++
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 517 NSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLG 576
N + L L+ + K + ++ I +
Sbjct: 78 NKLTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 577 SCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLS 636
L N + + L LS L GL KL L LS
Sbjct: 133 LPQLES------LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLS 186
Query: 637 HNELSGDLHFLAELQNLVVLNVS 659
N +S DL LA L+NL VL +
Sbjct: 187 KNHIS-DLRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 26/204 (12%), Positives = 63/204 (30%), Gaps = 16/204 (7%)
Query: 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLS 444
+ + + + + + +++ + + + + +GI L + KL L
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77
Query: 445 NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEIT 504
N L+ + ++L + I +
Sbjct: 78 NKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 505 GCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNK 564
+ + ++ + + L +L L D + + L L+ L L L+K
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTKLQNLYLSK 187
Query: 565 NRFAGSIPSQLGSCVKLQLLDLSS 588
N + + + L L +L+L S
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 41/218 (18%), Positives = 74/218 (33%), Gaps = 28/218 (12%)
Query: 417 DLSQNGLTGPIPRG-IF---QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLT 472
L +T P P IF + K L +++ + +S+ + AN++ +
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59
Query: 473 GFIPPEIGNLKNLNFLDLGSNRLTG---------------SIPDEITGCRNLTFLDVHSN 517
I L N+ L L N+LT + S
Sbjct: 60 SVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117
Query: 518 SIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGS 577
S+ N + ++ LV L + + + S + + ++ I L
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAG 176
Query: 578 CVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQ 615
KLQ L LS N +S ++ +L + L + L L +Q
Sbjct: 177 LTKLQNLYLSKNHIS-DLR-ALAGLKNLDV-LELF-SQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 35/205 (17%), Positives = 66/205 (32%), Gaps = 17/205 (8%)
Query: 168 NLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLA 227
+ + L +TDA+ T +L +++ I A + I N+ + L
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDI---KSVQGIQYLPNVTKLFLN 76
Query: 228 ETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKL 287
++ P L L+ + + + E+ I +
Sbjct: 77 GNKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 288 GNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347
+ + L LS+ D ++ + L LT LQ L LS
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTKLQNLYLS 186
Query: 348 VNQISGEIPAQIGNCQRLAQIELDN 372
N IS ++ A + + L +EL +
Sbjct: 187 KNHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 26/177 (14%), Positives = 53/177 (29%), Gaps = 24/177 (13%)
Query: 260 PPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSI 319
+ + I + + + L N+ LFL N L I P L N L
Sbjct: 39 AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGW 94
Query: 320 IDIS-----------------MNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNC 362
+ + SL + + L L +L+ + + +
Sbjct: 95 LFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSR 154
Query: 363 QRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLS 419
+ I L+ L L++ N + +++ +NL+ ++L
Sbjct: 155 LTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 39/203 (19%), Positives = 68/203 (33%), Gaps = 16/203 (7%)
Query: 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWH 396
+ L ++ + + QI +N+ I L N+T LF+
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 397 NRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMG 456
N+L P + NL+ + + K K L L +N I +
Sbjct: 78 NKLTDIKPLA-----NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 457 NCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHS 516
+ N+ + L L+ L L N+++ +P + G L L +
Sbjct: 133 LPQLESLYLGNNKITDITVLS---RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 517 NSIAGNLPAGLHQLVRLQFADLS 539
N I+ +L A L L L +L
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 12/76 (15%), Positives = 30/76 (39%), Gaps = 8/76 (10%)
Query: 595 IPASLGKI-----PALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAE 649
+P + +I A I NL + + LN + + +++++ + +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQY 66
Query: 650 LQNLVVLNVSHNNFSG 665
L N+ L ++ N +
Sbjct: 67 LPNVTKLFLNGNKLTD 82
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 1e-08
Identities = 27/127 (21%), Positives = 48/127 (37%), Gaps = 9/127 (7%)
Query: 319 IIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGA 378
++ ++ LT + L L + L LS N++ PA + + L L +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCL--EVLQASDNALE 56
Query: 379 IPSEFGNLSNLTLLFVWHNRLEG-EIPPSISNCQNLEAVDLSQNGLTGP---IPRGIFQL 434
NL L L + +NRL+ + +C L ++L N L R L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 435 KKLNKLL 441
++ +L
Sbjct: 117 PSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 4e-07
Identities = 29/130 (22%), Positives = 46/130 (35%), Gaps = 15/130 (11%)
Query: 560 LVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGE 619
L L ++ L + + LDLS N+L PA + AL L + E
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALE 56
Query: 620 LPAELTGLNKLGILDLSHNELSG--DLHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLP 677
+ L +L L L +N L + L LV+LN+ N+ +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE-------EGIQ 109
Query: 678 LSVLSGNPSL 687
+ PS+
Sbjct: 110 ERLAEMLPSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 6e-07
Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 259 IPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLS 318
+ L + ++ L N L P+ L L+ L L N L + + N +L
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV--DGVANLPRLQ 68
Query: 319 IIDISMNSLTG-SIPQTLGNLTSLQELQLSVNQISGE 354
+ + N L + Q L + L L L N + E
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 30/128 (23%), Positives = 50/128 (39%), Gaps = 9/128 (7%)
Query: 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTG 329
+ ++L LT + L L + +L L N L +PP L L ++ S N+L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN 57
Query: 330 SIPQTLGNLTSLQELQLSVNQI-SGEIPAQIGNCQRLAQIELDNNQITGA---IPSEFGN 385
NL LQEL L N++ + +C RL + L N +
Sbjct: 58 VDGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 386 LSNLTLLF 393
L +++ +
Sbjct: 116 LPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 9e-07
Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 6/107 (5%)
Query: 488 LDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGML 547
L L LT + + +T LD+ N + P L L L+ SDN++ +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV- 58
Query: 548 SPDLGSLSSLTKLVLNKNRFAG-SIPSQLGSCVKLQLLDLSSNQLSG 593
+ +L L +L+L NR + L SC +L LL+L N L
Sbjct: 59 -DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 1e-06
Identities = 20/110 (18%), Positives = 42/110 (38%), Gaps = 6/110 (5%)
Query: 342 QELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEG 401
+ L L+ ++ + + + ++L +N++ P+ L L +L N
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--L 55
Query: 402 EIPPSISNCQNLEAVDLSQNGLTG-PIPRGIFQLKKLNKLLLLSNNLSGV 450
E ++N L+ + L N L + + +L L L N+L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 2e-06
Identities = 20/103 (19%), Positives = 38/103 (36%), Gaps = 6/103 (5%)
Query: 396 HNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEM 455
H L + + + +DLS N L P + L+ L +L +++ + +
Sbjct: 7 HKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALENVDGV 61
Query: 456 GNCSSLIRFRANSNKLTGFIPPE-IGNLKNLNFLDLGSNRLTG 497
N L +N+L + + + L L+L N L
Sbjct: 62 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 6e-06
Identities = 25/119 (21%), Positives = 43/119 (36%), Gaps = 7/119 (5%)
Query: 537 DLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIP 596
L+ + + L L +T L L+ NR P+ L + L++L S N L
Sbjct: 4 HLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG 60
Query: 597 ASLGKIPALAIALNLSWNQI-CGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLV 654
+ L L N++ L +L +L+L N L + L ++
Sbjct: 61 VANLPRL---QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 4e-05
Identities = 27/117 (23%), Positives = 44/117 (37%), Gaps = 27/117 (23%)
Query: 103 LVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRL-------------- 148
L L+ +LT + + L + +LDLS N L P L +L L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 149 --------EQLRLNSNQLEGAIPIQ-IGNLSSLTQLFLYDNQLTDAIPATIGKLKNL 196
++L L +N+L+ + IQ + + L L L N L +L +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 8e-05
Identities = 25/127 (19%), Positives = 45/127 (35%), Gaps = 10/127 (7%)
Query: 126 YLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDA 185
L L+ LT + L LL + L L+ N+L P L++L L +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55
Query: 186 -IPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAE---TSISGFLPPTLGL 241
+ L L+ + N+ + + +C LV++ L G +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 242 LKRLQTI 248
L + +I
Sbjct: 116 LPSVSSI 122
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (124), Expect = 3e-08
Identities = 30/154 (19%), Positives = 59/154 (38%), Gaps = 6/154 (3%)
Query: 258 QIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQL 317
Q+ + + L L L V L ++++ + N +L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67
Query: 318 SIIDISMNSLTG--SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQI 375
+++S N L + + +L+ L LS N++ E +L ++ LD N +
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 376 TGAIPSEFGNLSNLTLLFVWHNRLEG-EIPPSIS 408
+ + +S + F RL+G E+PP I+
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (105), Expect = 9e-06
Identities = 21/136 (15%), Positives = 46/136 (33%), Gaps = 5/136 (3%)
Query: 330 SIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNL 389
+ + + L + + + + ++ + N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 390 TLLFVWHNRLEG--EIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNL 447
L + +NRL ++ + NL+ ++LS N L + KL +L L N+L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 448 SGVIPPEMGNCSSLIR 463
S + S++
Sbjct: 128 SDTFRDQSTYISAIRE 143
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 0.001
Identities = 32/146 (21%), Positives = 54/146 (36%), Gaps = 14/146 (9%)
Query: 522 NLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKL 581
L + + L + PDL + + L + A ++ + +L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 582 QLLDLSSNQLSG--NIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNE 639
L+LS+N+L ++ + + K P L I LNLS N++ E + KL L L N
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKI-LNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 640 LSGD--------LHFLAELQNLVVLN 657
LS L+ L+
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.001
Identities = 24/155 (15%), Positives = 47/155 (30%), Gaps = 15/155 (9%)
Query: 369 ELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIP 428
EL Q+ + + + + L P + ++ +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA--TL 57
Query: 429 RGIFQ-LKKLNKLLLLSNNLSGV--IPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNL 485
R I + + +L L L +N L + + + +L + N+L + L
Sbjct: 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117
Query: 486 NFLDLGSNRLTGSIPDE-------ITGCRNLTFLD 513
L L N L+ + D+ L LD
Sbjct: 118 EELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 4e-08
Identities = 23/91 (25%), Positives = 39/91 (42%), Gaps = 9/91 (9%)
Query: 323 SMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSE 382
+N+ + I SL+EL +S N++ E+PA +RL N + +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPEL 322
Query: 383 FGNLSNLTLLFVWHNRLEGEIPPSISNCQNL 413
NL L + +N L E P + ++L
Sbjct: 323 PQNLKQLHV---EYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 395 WHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPE 454
+ N EI +LE +++S N L +P +L++L S N +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI----ASFNHLAEVPEL 322
Query: 455 MGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNF 487
N L N L P ++++L
Sbjct: 323 PQNLKQL---HVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 56/329 (17%), Positives = 93/329 (28%), Gaps = 24/329 (7%)
Query: 143 CSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLK--NLEAIR 200
C + +L LN+ L ++P +L L N LT+ +P LK ++
Sbjct: 35 CLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLTE-LPELPQSLKSLLVDNNN 89
Query: 201 AGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIP 260
+L L + + L + + S + + +
Sbjct: 90 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGN 149
Query: 261 PELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSII 320
+L + ELQ + + K L + N + PEL N L+ I
Sbjct: 150 NQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209
Query: 321 DISMNSLTGSIPQTLGNLTSLQELQLSVNQISG--------EIPAQIGNCQRLAQIELDN 372
N L + L
Sbjct: 210 YADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL 269
Query: 373 NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIF 432
N + I S +L L V +N+L E+P + L S N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAE-VPELPQ 324
Query: 433 QLKKLNKLLLLSNNLSGVIPPEMGNCSSL 461
LK+L+ + N L P + L
Sbjct: 325 NLKQLH---VEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 6e-07
Identities = 20/92 (21%), Positives = 38/92 (41%), Gaps = 9/92 (9%)
Query: 562 LNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELP 621
N + I S L+ L++S+N+L +PA ++ L S+N + E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL----ERLIASFNHL-AEVP 320
Query: 622 AELTGLNKLGILDLSHNELSGDLHFLAELQNL 653
L +L + +N L +++L
Sbjct: 321 ELPQNLKQL---HVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 1e-06
Identities = 24/132 (18%), Positives = 41/132 (31%), Gaps = 9/132 (6%)
Query: 41 WKRNWKGSDDGLSNWSPSDETPCKWFGVSCNLNNQVVGLDLRYVDLLGHVPTNFTSLLSL 100
N + + P T + +++ + + SL
Sbjct: 227 EALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSL 286
Query: 101 NRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEG 160
L +S L +P A +L L S N L E+P + L+QL + N L
Sbjct: 287 EELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE 338
Query: 161 AIPIQIGNLSSL 172
P ++ L
Sbjct: 339 -FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 9/94 (9%)
Query: 345 QLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIP 404
+N S EI + L ++ + NN++ +P+ L L N L E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIAS---FNHLA-EVP 320
Query: 405 PSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLN 438
N + L + N L P ++ L
Sbjct: 321 ELPQNLKQL---HVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 4e-06
Identities = 19/95 (20%), Positives = 34/95 (35%), Gaps = 12/95 (12%)
Query: 469 NKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLH 528
N + I +L L++ +N+L +P L L N + +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELPQ 324
Query: 529 QLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLN 563
L +L + N + PD+ S+ L +N
Sbjct: 325 NLKQL---HVEYNPLREF--PDI--PESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 22/63 (34%), Positives = 29/63 (46%), Gaps = 8/63 (12%)
Query: 609 LNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHNNFSGRVP 668
LN+S N++ ELPA L +L S N L+ QNL L+V +N P
Sbjct: 289 LNVSNNKLI-ELPALPPRLERL---IASFNHLA---EVPELPQNLKQLHVEYNPLRE-FP 340
Query: 669 DTP 671
D P
Sbjct: 341 DIP 343
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 3e-05
Identities = 16/90 (17%), Positives = 35/90 (38%), Gaps = 10/90 (11%)
Query: 515 HSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQ 574
+ N+ + + + L+ ++S+N L L +L+ + N +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNK----LIELPALPPRLERLIASFNHL-AEVPEL 322
Query: 575 LGSCVKLQLLDLSSNQLSG--NIPASLGKI 602
+ L+ L + N L +IP S+ +
Sbjct: 323 PQN---LKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 0.001
Identities = 18/94 (19%), Positives = 33/94 (35%), Gaps = 10/94 (10%)
Query: 153 LNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLP 212
N I SL +L + +N+L + +PA +L+ L A + N +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLIA-----SFNHLAEVP 320
Query: 213 HEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQ 246
N L + + P ++ L+
Sbjct: 321 ELPQNLKQL---HVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 0.001
Identities = 20/65 (30%), Positives = 26/65 (40%), Gaps = 5/65 (7%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158
+ L L+ L+ S+P+ L L S NSLT E+P SL L N L
Sbjct: 39 QAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 159 EGAIP 163
P
Sbjct: 94 SDLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.004
Identities = 17/66 (25%), Positives = 26/66 (39%), Gaps = 5/66 (7%)
Query: 122 NQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQ 181
Q + L+L+ L+ +P LE L + N L +P +L SL
Sbjct: 38 RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 182 LTDAIP 187
L+D P
Sbjct: 93 LSDLPP 98
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 51.7 bits (122), Expect = 6e-08
Identities = 43/188 (22%), Positives = 72/188 (38%), Gaps = 9/188 (4%)
Query: 405 PSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEM-GNCSSLIR 463
P++ +C+ VD + GL IPR I +LLL N L + + G L++
Sbjct: 3 PAMCHCEGTT-VDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVK 58
Query: 464 FRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNL 523
N+LTG P ++ L LG N++ G L L+++ N I+ +
Sbjct: 59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118
Query: 524 PAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQL 583
P L L + ++ L K LN PS++ +Q+
Sbjct: 119 PGSFEHLNSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRD---VQI 174
Query: 584 LDLSSNQL 591
DL ++
Sbjct: 175 KDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.9 bits (112), Expect = 1e-06
Identities = 41/189 (21%), Positives = 67/189 (35%), Gaps = 10/189 (5%)
Query: 453 PEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITG-CRNLTF 511
P M +C L IP +I + L L N L D + G +L
Sbjct: 3 PAMCHCEGT-TVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVK 58
Query: 512 LDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSI 571
L++ N + G P +Q L +N + + + L L L L N+ + +
Sbjct: 59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118
Query: 572 PSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLG 631
P L L+L+SN + N L +L+ P+++ +
Sbjct: 119 PGSFEHLNSLTSLNLASNPFNCNCH--LAWFAEWLRKKSLNGGAARCGAPSKVRDVQ--- 173
Query: 632 ILDLSHNEL 640
I DL H+E
Sbjct: 174 IKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 28/176 (15%), Positives = 66/176 (37%), Gaps = 7/176 (3%)
Query: 210 SLPHEIGNCTNLVMIGLAETSISGFLPPTL-GLLKRLQTIAIYTALLSGQIPPELGDCTE 268
+P +I + + L + + L G L L + + L+G P +
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 269 LQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLT 328
+Q + L EN + L L L L+ N + ++P + + L+ ++++ N
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 329 GSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFG 384
+ L++ L+ P+++ + Q +L +++ + + G
Sbjct: 140 CNCHLA-WFAEWLRKKSLNGGAARCGAPSKVRDVQIK---DLPHSEFKCSSENSEG 191
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 53.3 bits (126), Expect = 8e-08
Identities = 58/349 (16%), Positives = 108/349 (30%), Gaps = 45/349 (12%)
Query: 317 LSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376
L + I+ S+ L S++E+ LS N I E + + + +
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN-------IASKK-- 59
Query: 377 GAIPSEFGNLSNLTLLFVWHNRLEGEIPP-------SISNCQNLEAVDLSQNGLTGPIPR 429
+L ++ R++ EIP ++ C L V LS N
Sbjct: 60 --------DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111
Query: 430 GIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLD 489
+ + L + + P+ G + NK PP + N L+
Sbjct: 112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 171
Query: 490 LGSNRLTGSIP------DEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSV 543
GS + + +N + + + L V + +
Sbjct: 172 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG 231
Query: 544 GGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCV------KLQLLDLSSNQLSGNIPA 597
L+ L S +L +L LN + + + LQ L L N++ +
Sbjct: 232 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 291
Query: 598 SL-----GKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELS 641
+L K+P L L L+ N+ E + + ++ EL
Sbjct: 292 TLKTVIDEKMPDLLF-LELNGNRF-SEEDDVVDEIREV-FSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 41/327 (12%), Positives = 85/327 (25%), Gaps = 19/327 (5%)
Query: 291 KNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTG----SIPQTLGNLTSLQELQL 346
K+L L + L + I +S N++ + + + + L+ +
Sbjct: 8 KSL-KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 347 SVNQISGEIPAQIGNCQRLAQIELDNNQIT---GAIPSEFGNLSNLTLLFVWHNRLEGEI 403
S + L Q L ++ + + + F+ + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 404 PPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIR 463
+ +++ + + L ++ N L E R
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 464 FRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNL 523
+ I PE L L + D + L + S
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 524 PAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCV---- 579
GL+ + +V S L L L N L + +
Sbjct: 247 ELGLND---CLLSARGAAAVVDAFS--KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 580 -KLQLLDLSSNQLSGNIPASLGKIPAL 605
L L+L+ N+ S + +I +
Sbjct: 302 PDLLFLELNGNRFSE-EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 37/332 (11%), Positives = 101/332 (30%), Gaps = 33/332 (9%)
Query: 146 LRLEQLRLNSNQLEG--AIPIQIGNLSSLTQLFLYDNQLTD----AIPATIGKLKNLEAI 199
+ + L+L++ E ++ + S+ ++ L N + + I K+LE
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 200 RAGGNKNLGGS---------LPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAI 250
L + C L + L++ + L T
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 251 YTALLSGQIPPELGDCTELQYIYLYENALTGSIPS--KLGNLKNLVNLFLWQNNLVGIIP 308
+ L + + P+ G L N + P + +N + +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 309 PELGNCSQLSIIDISMNSLTGSIPQTLGNLTSL----QELQLSVNQISGEIPAQIGNCQR 364
L + ++ I + + + L L + + S + + +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 365 LAQIELDNNQITGAIPSEFGN------LSNLTLLFVWHNRLEGEIPPSI-----SNCQNL 413
L ++ L++ ++ + + L L + +N +E + ++ +L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 414 EAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSN 445
++L+ N + + +++++
Sbjct: 305 LFLELNGNRFSE-EDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 4e-05
Identities = 41/313 (13%), Positives = 87/313 (27%), Gaps = 9/313 (2%)
Query: 282 SIPSKLGNLKNLVNLFLWQNNL----VGIIPPELGNCSQLSIIDISMNS---LTGSIPQT 334
S+ + L ++ + L N + + + + L I + S + IP+
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 335 LGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFV 394
L L ++ + A Q L + + L +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 395 WHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPE 454
E + N L ++ +N L + + + ++LL + I PE
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 455 MGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDV 514
L + + L + + C
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 515 HSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFA--GSIP 572
L Q +RLQ+ ++ ++V + + + L L LN NRF+ +
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVV 321
Query: 573 SQLGSCVKLQLLD 585
++ +
Sbjct: 322 DEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 5e-04
Identities = 14/106 (13%), Positives = 32/106 (30%), Gaps = 26/106 (24%)
Query: 105 LSGTNLTGSIPKEIA------SLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158
L+ L+ + L L L N + + R L +++
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID----------- 298
Query: 159 EGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGN 204
+ L L L N+ ++ + +++ + + R G
Sbjct: 299 --------EKMPDLLFLELNGNRFSE-EDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 8/66 (12%), Positives = 23/66 (34%), Gaps = 7/66 (10%)
Query: 93 NFTSLLSLNRLVLSGTNLTGSIPKEIAS-----LNQLNYLDLSENSLT--GEIPRELCSL 145
+ + L L L + + + + + L +L+L+ N + ++ E+ +
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
Query: 146 LRLEQL 151
Sbjct: 328 FSTRGR 333
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 1e-07
Identities = 19/79 (24%), Positives = 33/79 (41%), Gaps = 6/79 (7%)
Query: 120 SLNQLNYLDLSENSLTGEIPRELCSLLR-LEQLRLNSNQLEG----AIPIQIGNLSSLTQ 174
SL+ + LD+ L+ EL LL+ + +RL+ L I + +L +
Sbjct: 1 SLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 175 LFLYDNQLTDAIPATIGKL 193
L L N+L D + +
Sbjct: 60 LNLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 2e-07
Identities = 16/117 (13%), Positives = 35/117 (29%), Gaps = 21/117 (17%)
Query: 340 SLQELQLSVNQISGEIPAQI-GNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNR 398
+Q L + ++S A++ Q+ + LD+ +T A +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD---------------- 46
Query: 399 LEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEM 455
I ++ L ++L N L + Q + + +L
Sbjct: 47 ----ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 4e-07
Identities = 19/80 (23%), Positives = 32/80 (40%), Gaps = 9/80 (11%)
Query: 99 SLNRLVLSGTNLTG----SIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLR-----LE 149
L L L+ +++ S+ + + + L LDLS N L +L +R LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 150 QLRLNSNQLEGAIPIQIGNL 169
QL L + ++ L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 5e-07
Identities = 17/83 (20%), Positives = 31/83 (37%), Gaps = 9/83 (10%)
Query: 313 NCSQLSIIDISMNSLTG----SIPQTLGNLTSLQELQLSVNQISGEIPAQIG-----NCQ 363
S L ++ ++ ++ S+ TL SL+EL LS N + Q+
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 364 RLAQIELDNNQITGAIPSEFGNL 386
L Q+ L + + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 6e-07
Identities = 19/97 (19%), Positives = 31/97 (31%), Gaps = 15/97 (15%)
Query: 289 NLKNLVNLFLWQNNL----VGIIPPELGNCSQLSIIDISMNSLTGSIPQTLG-----NLT 339
L L+L ++ + L L +D+S N L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 340 SLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT 376
L++L L S E+ RL +E D +
Sbjct: 427 LLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 10/94 (10%)
Query: 98 LSLNRLVLSGTNLTGSIPKEIAS-LNQLNYLDLSENSLTGEIPRELCSLLR----LEQLR 152
L + L + L+ + E+ L Q + L + LT +++ S LR L +L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 153 LNSNQLEGAIPIQIG-----NLSSLTQLFLYDNQ 181
L SN+L + + +L L +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 2e-06
Identities = 12/95 (12%), Positives = 28/95 (29%), Gaps = 9/95 (9%)
Query: 356 PAQIGNCQRLAQIELDNNQITG----AIPSEFGNLSNLTLLFVWHNRLEGEIPPSIS--- 408
L + L + ++ ++ + +L L + +N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 409 --NCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLL 441
LE + L + + + L+K L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 4e-06
Identities = 18/95 (18%), Positives = 36/95 (37%), Gaps = 10/95 (10%)
Query: 579 VKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQI----CGELPAELTGLNKLGILD 634
+ +Q LD+ +LS A L + + L + C ++ + L L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 635 LSHNELSGD-LHFLAEL-----QNLVVLNVSHNNF 663
L NEL +H + + + L++ +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 18/97 (18%), Positives = 34/97 (35%), Gaps = 9/97 (9%)
Query: 69 SCNLNNQVVGLDLRYVDLL-GHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIAS----LNQ 123
S ++ + LD++ +L L + L LT + K+I+S
Sbjct: 1 SLDIQS----LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPA 56
Query: 124 LNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEG 160
L L+L N L + L+ ++ L+
Sbjct: 57 LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 7e-06
Identities = 17/93 (18%), Positives = 30/93 (32%), Gaps = 10/93 (10%)
Query: 508 NLTFLDVHSNSIAGN-LPAGLHQLVRLQFADLSDNSVGGM----LSPDLGSLSSLTKLVL 562
++ LD+ ++ L L + Q L D + +S L +L +L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 563 NKNRFAGSIPSQLGS-----CVKLQLLDLSSNQ 590
N + K+Q L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 14/76 (18%), Positives = 25/76 (32%), Gaps = 5/76 (6%)
Query: 531 VRLQFADLSDNSVG-GMLSPDLGSLSSLTKLVLNKNRF----AGSIPSQLGSCVKLQLLD 585
+ +Q D+ + + L L + L+ I S L L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 586 LSSNQLSGNIPASLGK 601
L SN+L + +
Sbjct: 62 LRSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 10/93 (10%)
Query: 292 NLVNLFLWQNNLVGIIPPEL-GNCSQLSIIDISMNSLTG----SIPQTLGNLTSLQELQL 346
++ +L + L EL Q ++ + LT I L +L EL L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 347 SVNQISGEIPAQIG-----NCQRLAQIELDNNQ 374
N++ + ++ ++ L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 21/83 (25%), Positives = 28/83 (33%), Gaps = 8/83 (9%)
Query: 555 SSLTKLVLNKNRF----AGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKI----PALA 606
S L L L S+ + L + L+ LDLS+N L L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 607 IALNLSWNQICGELPAELTGLNK 629
L L E+ L L K
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 19/88 (21%), Positives = 30/88 (34%), Gaps = 9/88 (10%)
Query: 524 PAGLHQLVRLQFADLSDNSVGGM----LSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCV 579
L+ L+D V L+ L + SL +L L+ N + QL V
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 580 K-----LQLLDLSSNQLSGNIPASLGKI 602
+ L+ L L S + L +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 12/63 (19%), Positives = 21/63 (33%), Gaps = 6/63 (9%)
Query: 609 LNLSWNQICGELPAEL-TGLNKLGILDLSHNELSGD-----LHFLAELQNLVVLNVSHNN 662
L++ ++ AEL L + ++ L L+ L L LN+ N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 663 FSG 665
Sbjct: 67 LGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 13/85 (15%), Positives = 28/85 (32%), Gaps = 9/85 (10%)
Query: 380 PSEFGNLSNLTLLFVWHNRLEGE----IPPSISNCQNLEAVDLSQNGLTGPIPRGIFQ-- 433
S L +L++ + + ++ +L +DLS N L + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 434 ---LKKLNKLLLLSNNLSGVIPPEM 455
L +L+L S + +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 0.001
Identities = 13/112 (11%), Positives = 34/112 (30%), Gaps = 26/112 (23%)
Query: 412 NLEAVDLSQNGLT-GPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNK 470
+++++D+ L+ + L++ + L L+ ++ +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------ 50
Query: 471 LTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-----TGCRNLTFLDVHSN 517
+ L L+L SN L + T + L + +
Sbjct: 51 --------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 15/84 (17%), Positives = 28/84 (33%), Gaps = 10/84 (11%)
Query: 468 SNKLTGFIPPEI-GNLKNLNFLDLGSNRLTG----SIPDEITGCRNLTFLDVHSNSI--- 519
+L+ E+ L+ + L LT I + L L++ SN +
Sbjct: 11 CEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV 70
Query: 520 -AGNLPAGL-HQLVRLQFADLSDN 541
+ GL ++Q L +
Sbjct: 71 GVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 40/200 (20%), Positives = 67/200 (33%), Gaps = 16/200 (8%)
Query: 313 NCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDN 372
++ + ++T ++ QT +L + LQ I I + L QI N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71
Query: 373 NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIF 432
NQ+T L NLT L + N I
Sbjct: 72 NQLTD-----ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN---QITDIDP 123
Query: 433 QLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGS 492
N L ++ + + +SL + +SN++T P + NL L LD+ S
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 493 NRLTGSIPDEITGCRNLTFL 512
N+++ + NL L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.7 bits (117), Expect = 4e-07
Identities = 32/201 (15%), Positives = 64/201 (31%), Gaps = 18/201 (8%)
Query: 289 NLKNLVNLFLWQNNLVGIIPP-ELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347
L + L + N+ + +L + L + + S+ G + L +L ++ S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70
Query: 348 VNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSI 407
NQ++ L + + + +I
Sbjct: 71 NNQLTD--------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122
Query: 408 SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRAN 467
L + T + L L +L SN ++ + P + N ++L R +
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 468 SNKLTGFIPPEIGNLKNLNFL 488
SNK++ + L NL L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 30/189 (15%), Positives = 60/189 (31%), Gaps = 18/189 (9%)
Query: 481 NLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSD 540
L LG +T ++ T +T L I ++ G+ L L + S+
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 541 NSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLG 600
N + + + + N+ + + + ++ +L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 601 KIPALAIALNLSWNQICGEL-------------PAELTGLNKLGILDLSHNELSGDLHFL 647
++ + ++ L L L LD+S N++S D+ L
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVS-DISVL 190
Query: 648 AELQNLVVL 656
A+L NL L
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 35/198 (17%), Positives = 65/198 (32%), Gaps = 16/198 (8%)
Query: 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWH 396
L + L ++ + + ++ ++ D I L+NLT + +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 397 NRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMG 456
N+L P I N L N +
Sbjct: 72 NQLTDITPLKNLTKLV------DILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125
Query: 457 NCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHS 516
N ++L R +SN + + L +L L+ SN++T P + L LD+ S
Sbjct: 126 NLTNLNRLELSSNTI--SDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 517 NSIAGNLPAGLHQLVRLQ 534
N ++ + L +L L+
Sbjct: 182 NKVSD--ISVLAKLTNLE 197
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 36/199 (18%), Positives = 65/199 (32%), Gaps = 17/199 (8%)
Query: 119 ASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLY 178
+L + L + ++T + + L ++ L+ + ++ ++ L++LTQ+
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFS 70
Query: 179 DNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPT 238
+NQLTD P + ++ L + + L
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 239 LGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFL 298
L TI L T LQ + N +T P L NL L L +
Sbjct: 131 NRLELSSNTI---------SDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDI 179
Query: 299 WQNNLVGIIPPELGNCSQL 317
N + I L + L
Sbjct: 180 SSNKVSDI--SVLAKLTNL 196
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.1 bits (115), Expect = 9e-07
Identities = 34/239 (14%), Positives = 68/239 (28%), Gaps = 32/239 (13%)
Query: 308 PPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQ 367
+ +CS + + +T IP L + EL+ + ++ L +
Sbjct: 2 HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 368 IELDNNQITGAIPSEFGNLSNLTL--LFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTG 425
IE+ N + I ++ + N L P + N NL+ + +S G+
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 426 PIPRGIFQLKKLNKL-------------------------LLLSNNLSGVIPPEMGNCSS 460
+ L L L+ N I N +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 461 LIRFRANSNKLTGFIPPEI-GNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNS 518
L + N +P ++ LD+ R+ + + L ++
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.1 bits (115), Expect = 9e-07
Identities = 35/224 (15%), Positives = 63/224 (28%), Gaps = 6/224 (2%)
Query: 127 LDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAI 186
E+ +T EIP +L +LR +L L ++ + N + + I
Sbjct: 13 FLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 187 PATIGKLKNLEAIRAG---GNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLK 243
A + N + ++I + L K
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 244 RLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNL 303
L I + + + +G E ++L +N + + NNL
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 304 VGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLS 347
+ S I+DIS + L NL L+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 3e-05
Identities = 39/242 (16%), Positives = 77/242 (31%), Gaps = 17/242 (7%)
Query: 368 IELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPI 427
+++T IPS+ N L +L + S +LE +++SQN + I
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 428 PRGIFQLKKLNKLLLLS--NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNL 485
+F + + NNL + P N +L ++ + +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 486 NFLDLGS--NRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSV 543
LD+ N T + L ++ N I + + +N++
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 544 GGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIP 603
+ + S L +++ R L + KL+ +L K+P
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY----------NLKKLP 239
Query: 604 AL 605
L
Sbjct: 240 TL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 27/246 (10%), Positives = 66/246 (26%), Gaps = 10/246 (4%)
Query: 139 PRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEA 198
+C +++ IP + + +L +L +LE
Sbjct: 2 HHRICHC-SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 199 IRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQ 258
I N L N L I + + + ++ P + +
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 259 IPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVN---LFLWQNNLVGIIPPELGNCS 315
+P + + + ++ + + + L+L +N + I
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 316 QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQI 375
+ N+L + L +S +I + N ++L +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL--RARSTYNL 235
Query: 376 TGAIPS 381
+P+
Sbjct: 236 K-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 27/250 (10%), Positives = 54/250 (21%), Gaps = 19/250 (7%)
Query: 99 SLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQL 158
S + + +T IP ++ L L LE++ ++ N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 159 EGAIPIQIGNLSSLTQLFLYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHE---I 215
I + + + + LP
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 216 GNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPELGDCTELQYIYLY 275
L+ I + +GL + + + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 276 ENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTL 335
N L V L + + + + L N +L
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY------------ 233
Query: 336 GNLTSLQELQ 345
NL L L+
Sbjct: 234 -NLKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 31/224 (13%), Positives = 53/224 (23%), Gaps = 33/224 (14%)
Query: 258 QIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQN---------------- 301
+IP +L + L +L + + QN
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 302 ----------NLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQI 351
NL+ I P N L + IS + + L + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 352 SGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVW-HNRLEGEIPPSI-SN 409
I + L N+ N E+P +
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 410 CQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPP 453
+D+S+ + +P + L KL S +P
Sbjct: 200 ASGPVILDISRTRIHS-LPSYGLE--NLKKLRARSTYNLKKLPT 240
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (111), Expect = 1e-06
Identities = 19/154 (12%), Positives = 38/154 (24%), Gaps = 2/154 (1%)
Query: 261 PELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPEL-GNCSQLSI 319
P+ + + L +NL L++ + + +L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 320 IDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAI 379
+ I + L P L L LS N + + + N
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 380 PSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNL 413
L V +L+ +++ N
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 25/153 (16%), Positives = 45/153 (29%), Gaps = 11/153 (7%)
Query: 309 PELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQI-GNCQRLAQ 367
P+ S + + + L +L EL + Q + + L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 368 IELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPI 427
+ + + + P F L+ L + N LE + +L+ + LS N L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 428 PRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSS 460
L L G +P + C
Sbjct: 120 --------ALRWLQRWEEEGLGGVPEQKLQCHG 144
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 29/153 (18%), Positives = 51/153 (33%), Gaps = 4/153 (2%)
Query: 453 PEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI-TGCRNLTF 511
P+ R + + +NL L + + + + G L
Sbjct: 2 PDACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 512 LDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSI 571
L + + + P H RL +LS N++ LS SL +LVL+ N S
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 572 PSQ-LGSCVKLQLLDLSSNQLSGNIPASLGKIP 603
+ L + L + +L + L +P
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMP 152
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 3e-04
Identities = 24/134 (17%), Positives = 47/134 (35%), Gaps = 3/134 (2%)
Query: 258 QIPPELGDCTELQYIYLYENALTGSIPSKL-GNLKNLVNLFLWQNNLVGIIPPELGNCSQ 316
L L +Y+ + + L L NL + ++ L + P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 317 LSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQ-IGNCQRLAQIELDNNQI 375
LS +++S N+L S+ SLQEL LS N + + + + + ++
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKL 140
Query: 376 TGAIPSEFGNLSNL 389
++ N
Sbjct: 141 QCHGQGPLAHMPNA 154
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 25/100 (25%), Positives = 45/100 (45%), Gaps = 4/100 (4%)
Query: 85 DLLGHVPTNFTSLLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCS 144
+L+ +T+ + L L G + I A+L+Q + +D S+N +
Sbjct: 6 ELIEQAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--L 61
Query: 145 LLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLTD 184
L RL+ L +N+N++ L LT+L L +N L +
Sbjct: 62 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 101
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 22/136 (16%), Positives = 46/136 (33%), Gaps = 7/136 (5%)
Query: 309 PELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQI 368
+ N + +D+ + I L + S N+I +RL +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 369 ELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEG----EIPPSISNCQNLEAVDLSQNGLT 424
++NN+I L +LT L + +N L + S+ + L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 425 GPIPRGIFQLKKLNKL 440
I+++ ++ L
Sbjct: 129 HYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 4e-04
Identities = 23/136 (16%), Positives = 41/136 (30%), Gaps = 7/136 (5%)
Query: 289 NLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSV 348
N L L + +I Q ID S N + L L+ L ++
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKTLLVNN 72
Query: 349 NQISGEIPAQIGNCQRLAQIELDNNQITG----AIPSEFGNLSNLTLLFVWHNRLEGEIP 404
N+I L ++ L NN + + +L+ L +L +
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 405 PSISNCQNLEAVDLSQ 420
I + +D +
Sbjct: 133 YVIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 5e-04
Identities = 14/136 (10%), Positives = 38/136 (27%), Gaps = 7/136 (5%)
Query: 261 PELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSII 320
+ + + + L + I + L + N + + +L +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 68
Query: 321 DISMNSLTGSIPQTLGNLTSLQELQLSVNQISG-EIPAQIGNCQRLAQIELDN---NQIT 376
++ N + L L EL L+ N + + + + L + +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 377 GAIPSEFGNLSNLTLL 392
+ + +L
Sbjct: 129 HYRLYVIYKVPQVRVL 144
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 30/205 (14%), Positives = 60/205 (29%), Gaps = 26/205 (12%)
Query: 285 SKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQEL 344
+K +K+ + +F + ++V ++ + I+ + TL L + + L
Sbjct: 2 AKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIE--------KMDATLSTLKACKHL 53
Query: 345 QLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIP 404
LS N I +I + + + L L + +++ +
Sbjct: 54 ALSTNNIE-KISS-LSGMENL--RILSLGRNLIKKIENLDAVADTLEELWISYNQIASLS 109
Query: 405 PSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464
+ + L KL LLL N L
Sbjct: 110 GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK------------ 157
Query: 465 RANSNKLTGFIPPEIGNLKNLNFLD 489
+N + + + L NL LD
Sbjct: 158 --ENNATSEYRIEVVKRLPNLKKLD 180
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1117 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.81 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.72 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.42 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.42 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.42 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.38 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.23 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.22 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.19 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.38 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.47 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.35 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.08 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.47 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.44 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.99 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.79 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=418.62 Aligned_cols=261 Identities=29% Similarity=0.423 Sum_probs=203.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||+|+||+||+|+++ ..||||+++.. .....++|.+|++++++++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 57899999999999999999874 36999998754 33445789999999999999999999998754 568999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.+++.... +.+++.++..++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999997643 3489999999999999999999999 999999999999999999999999999987654221
Q ss_pred CccccCCccccccccCChhhhcc---CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM---TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
........||+.|||||++.. ..|+.++|||||||++|||+||+.||.+... ...+............
T Consensus 160 --~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~~~p~-- 230 (276)
T d1uwha_ 160 --SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----RDQIIFMVGRGYLSPD-- 230 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHHTSCCCC--
T ss_pred --cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhcCCCCCc--
Confidence 123345689999999999864 3588999999999999999999999975321 1112222222211111
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.+......+..+.+++.. ||+.||++|||+++|++.|+.+++.
T Consensus 231 ~~~~~~~~~~~l~~li~~------cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAE------CLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp GGGSCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred chhccccchHHHHHHHHH------HcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 112233344455555554 9999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=414.18 Aligned_cols=256 Identities=28% Similarity=0.446 Sum_probs=199.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467888999999999999999988999999999754 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|.+++.... ..+++.++..++.|||+||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-- 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-- 156 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc--
Confidence 999999987653 3489999999999999999999999 999999999999999999999999999987654321
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhC-CCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITG-KKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......||+.|+|||++.+..|+.++|||||||++|||+|+ ++||.. ....+.+........ +..
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-----~~~~~~~~~i~~~~~-------~~~ 223 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-----RSNSEVVEDISTGFR-------LYK 223 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-----CCHHHHHHHHHHTCC-------CCC
T ss_pred -eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-----CCHHHHHHHHHhcCC-------CCC
Confidence 223345789999999999999999999999999999999995 555532 122222332222211 111
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
+...+..+.+++. .||+.||++||++++|++.|+++.+
T Consensus 224 p~~~~~~l~~li~------~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 224 PRLASTHVYQIMN------HCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CTTSCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHH------HHccCCHhHCcCHHHHHHHHHHHHh
Confidence 2233344454444 4999999999999999999998864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=416.06 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=208.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 45799999999999999999985 56999999999876655677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.+++... .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 99 ~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred cCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 9999999988653 389999999999999999999999 99999999999999999999999999999775432
Q ss_pred CccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+. .....+........... .
T Consensus 171 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~~~~~~~~~~-----~ 237 (293)
T d1yhwa1 171 ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-----NPLRALYLIATNGTPEL-----Q 237 (293)
T ss_dssp ---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHHCSCCC-----S
T ss_pred ---ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC-----CHHHHHHHHHhCCCCCC-----C
Confidence 2334568999999999999999999999999999999999999999642 12222333332221111 1
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.+...+...+++++. |++.||++|||+.|+++
T Consensus 238 ~~~~~s~~~~~li~~------~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNR------CLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHH------HTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHH------HccCChhHCcCHHHHhc
Confidence 122334456666655 99999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=409.87 Aligned_cols=245 Identities=24% Similarity=0.396 Sum_probs=205.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|+. .+|+.||+|++... +....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 3688899999999999999986 46899999998643 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..+..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999764 3489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
......||+.|||||++.+..|+.++|||||||++|||++|+.||.+. ...+......+..
T Consensus 160 ------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~-------- 220 (263)
T d2j4za1 160 ------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVE-------- 220 (263)
T ss_dssp ------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHTTC--------
T ss_pred ------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-----CHHHHHHHHHcCC--------
Confidence 223467999999999999999999999999999999999999999642 2233333333322
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..++...+....+++.. |++.||++|||++|+++
T Consensus 221 ~~~p~~~s~~~~~li~~------~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 FTFPDFVTEGARDLISR------LLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHH------HccCCHhHCcCHHHHHc
Confidence 12233344556666555 99999999999999976
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=412.47 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=200.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||+|+||+||+|.+ .+|+.||||++.... ....+++.+|++++++++|||||++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4688999999999999999985 469999999997543 23346799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+++|+|.+++... +.+++.++..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~- 157 (271)
T d1nvra_ 85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN- 157 (271)
T ss_dssp CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT-
T ss_pred cCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC-
Confidence 9999999999754 3499999999999999999999999 99999999999999999999999999998775432
Q ss_pred CccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 934 GSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
........+||+.|||||++.+..+ +.++||||+||++|||++|+.||............ ..... ....
T Consensus 158 -~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~----~~~~~-~~~~---- 227 (271)
T d1nvra_ 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKK-TYLN---- 227 (271)
T ss_dssp -EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH----HHTTC-TTST----
T ss_pred -ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCC-CCCC----
Confidence 1223446789999999999988776 57899999999999999999999754322221111 11111 1100
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.....+....++++. |++.||++|||++|+++
T Consensus 228 -~~~~~s~~~~~li~~------~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 -PWKKIDSAPLALLHK------ILVENPSARITIPDIKK 259 (271)
T ss_dssp -TGGGSCHHHHHHHHH------HSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHH------HcCCChhHCcCHHHHhc
Confidence 011223344455544 99999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=411.93 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=206.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.+.||+|+||+||+|.+++++.||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4688889999999999999999888999999997543 456789999999999999999999998755 56799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|.+++..... ..+++.++.+++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+..... .
T Consensus 91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~---~ 163 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---E 163 (272)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS---C
T ss_pred CCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC---c
Confidence 9999998766432 2489999999999999999999999 9999999999999999999999999999987542 2
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
........||+.|||||++....++.++|||||||++|||+||..|+... ....+.+....... . +..+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~----~~~~~~~~~i~~~~-~------~~~p 232 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----MTNPEVIQNLERGY-R------MVRP 232 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT----CCHHHHHHHHHTTC-C------CCCC
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC----CCHHHHHHHHHhcC-C------CCCc
Confidence 23344567999999999999999999999999999999999966554321 11222222222211 1 1222
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
...+..+.++++ .||+.||++||||++|++.|+.+.
T Consensus 233 ~~~~~~l~~li~------~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 233 DNCPEELYQLMR------LCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp TTCCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccChHHHHHHHH------HHcCCCHhHCcCHHHHHHHhhhhh
Confidence 334445555554 499999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-46 Score=416.85 Aligned_cols=262 Identities=23% Similarity=0.419 Sum_probs=198.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CC---cEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SG---LTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.+|++.++||+|+||+||+|+++ ++ ..||||++... .....++|.+|++++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45777899999999999999864 23 36899988654 333456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
||||++|+|.+++.... +.+++.++.+++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999887643 3589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCCc-cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 931 DSGGS-FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 931 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
..... ........||+.|||||++....++.++|||||||++|||+| |+.||... ...+.+....... .
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~-----~~~~~~~~i~~~~-~--- 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----TNQDVINAIEQDY-R--- 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTC-C---
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC-----CHHHHHHHHHcCC-C---
Confidence 32221 122233568999999999999999999999999999999998 89999642 1122222222221 1
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
+..+...+..+.+++. .||+.||++||++++|++.|+++.+.+
T Consensus 252 ---~~~~~~~~~~l~~li~------~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 252 ---LPPPMDCPSALHQLML------DCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp ---CCCCTTCCHHHHHHHH------HHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---CCCCccchHHHHHHHH------HHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 1112233445555554 499999999999999999999987654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-47 Score=414.56 Aligned_cols=259 Identities=27% Similarity=0.405 Sum_probs=211.3
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
++|++.+.||+|+||+||+|.+. +|+.||||+++.. ....++|.+|++++++++|||||++++++.+++..++||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 46888899999999999999864 5889999998754 345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++..... ..+++..+..++.|||+||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 96 ~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-- 169 (287)
T d1opja_ 96 TYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-- 169 (287)
T ss_dssp TTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS--
T ss_pred cCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC--
Confidence 99999999876432 4589999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
........||+.|+|||++.+..|+.++|||||||++|||++|..||... ..... +...+..... +..
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~----~~~~~-~~~~i~~~~~------~~~ 237 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQ-VYELLEKDYR------MER 237 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHH-HHHHHHTTCC------CCC
T ss_pred -ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc----chHHH-HHHHHhcCCC------CCC
Confidence 22334456899999999999999999999999999999999977776431 11122 2222222211 222
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
+...+..+.+++.. ||+.||++|||+++|++.|+.+.++
T Consensus 238 ~~~~~~~l~~li~~------cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 238 PEGCPEKVYELMRA------CWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CccchHHHHHHHHH------HcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 33444455555554 9999999999999999999887654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=400.77 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=210.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999999889999999998653 356789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|++..++.... ..+++..+++++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-- 155 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-- 155 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--
T ss_pred CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc--
Confidence 999999877653 3488999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.......||+.|+|||.+....++.++|||||||++|||+| |+.||... ...+......... . +..
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-----~~~~~~~~i~~~~-~------~~~ 222 (258)
T d1k2pa_ 156 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-----TNSETAEHIAQGL-R------LYR 222 (258)
T ss_dssp -CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CHHHHHHHHHTTC-C------CCC
T ss_pred -eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-----CHHHHHHHHHhCC-C------CCC
Confidence 23344679999999999999999999999999999999998 89999653 1222222222211 1 112
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
+...+..+.++++. ||+.||++|||++++++.|.+
T Consensus 223 p~~~~~~l~~li~~------cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYS------CWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHH------TTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHHHHHHHHH------HccCCHhHCcCHHHHHHHhhC
Confidence 23334456666655 999999999999999998865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=411.74 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=205.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
+.|++.+.||+|+||+||+|++ .+|+.||||+++.......+++.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688899999999999999985 568999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++.+.. +.+++.++..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--- 163 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--- 163 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH---
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC---
Confidence 9999999876532 3489999999999999999999999 9999999999999999999999999999765421
Q ss_pred ccccCCccccccccCChhhhc-----cCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYAN-----MTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
........||+.|+|||++. ...|+.++||||+||++|||++|+.||.+... .+.+...........
T Consensus 164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-----~~~~~~i~~~~~~~~-- 235 (288)
T d2jfla1 164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-----MRVLLKIAKSEPPTL-- 235 (288)
T ss_dssp -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGHHHHHHHSCCCCC--
T ss_pred -cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCCCC--
Confidence 12334568999999999984 45689999999999999999999999975321 122223333221111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..+...+..+.++++. ||+.||++|||++|+++
T Consensus 236 ---~~~~~~s~~~~~li~~------~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 ---AQPSRWSSNFKDFLKK------CLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---SSGGGSCHHHHHHHHH------HSCSSTTTSCCHHHHTT
T ss_pred ---CccccCCHHHHHHHHH------HccCChhHCcCHHHHhc
Confidence 1112234455565555 99999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=408.76 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=192.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeec--CCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGAN--RKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv 850 (1117)
++|++.+.||+|+||+||+|+. .+|+.||||++.... +...+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 4688899999999999999975 568999999997543 2334568999999999999999999998865 4567999
Q ss_pred EEecCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhccC--CCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 851 YDYMPNGTLGMLLHDGE-CAGLLEWDTRFKIALGVAEGLSYLHHDC--VPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
|||+++|+|.+++.... ..+.+++..++.++.|+++||+|||+++ ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986531 2345999999999999999999999872 11499999999999999999999999999998
Q ss_pred ccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 928 VEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
..... .......||+.|||||++.+..|+.++|||||||++|||++|+.||.+. ...+..........
T Consensus 164 ~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-----~~~~~~~~i~~~~~--- 231 (269)
T d2java1 164 LNHDT----SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQKELAGKIREGKF--- 231 (269)
T ss_dssp C---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHTCC---
T ss_pred cccCC----CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-----CHHHHHHHHHcCCC---
Confidence 75422 1234568999999999999999999999999999999999999999642 22222232222221
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.++...+..+.++++. |++.||++|||++|+++
T Consensus 232 ----~~~~~~~s~~l~~li~~------~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 ----RRIPYRYSDELNEIITR------MLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHT
T ss_pred ----CCCCcccCHHHHHHHHH------HcCCChhHCcCHHHHHh
Confidence 12233445566666655 99999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=407.38 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=205.7
Q ss_pred cCCCCCC-eeeecCCeEEEEEEcC---CCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGN-IIGQGRSGIVYKVTLP---SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|.+.+ +||+|+||+||+|.++ ++..||||+++.. .....++|.+|++++++++|||||++++++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455666 4999999999999753 4568999999754 33345779999999999999999999999865 568999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|+|.+++.... +.+++.++.+++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999886543 3489999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.. ..........||+.|+|||++....++.++|||||||++|||+| |+.||.+.. ...+...+ .....
T Consensus 162 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i----~~~~~---- 230 (285)
T d1u59a_ 162 DD-SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFI----EQGKR---- 230 (285)
T ss_dssp CS-CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHH----HTTCC----
T ss_pred cc-cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHH----HcCCC----
Confidence 32 22233345678999999999999999999999999999999998 999997532 22222222 22211
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
+..+...+..+.+++. .||+.+|++||++.+|.+.|+....
T Consensus 231 --~~~p~~~~~~l~~li~------~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 --MECPPECPPELYALMS------DCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp --CCCCTTCCHHHHHHHH------HTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCcCCHHHHHHHH------HHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1223334445555555 4999999999999999999986643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=408.02 Aligned_cols=249 Identities=20% Similarity=0.314 Sum_probs=203.1
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++++.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688999999999999999985 57999999998743 2334567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..++.++.|++.||+|||++ +||||||||+||++++++.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988754 3499999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ..............
T Consensus 162 ~~--~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~~~~~------- 227 (288)
T d1uu3a_ 162 SK--QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEYLIFQKIIKLEY------- 227 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHTTCC-------
T ss_pred Cc--ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-----CHHHHHHHHHcCCC-------
Confidence 21 12334568999999999999999999999999999999999999999742 22233333333221
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.++...+....++++. |++.||++|||++|+.+
T Consensus 228 -~~p~~~s~~~~~li~~------~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -DFPEKFFPKARDLVEK------LLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CCCTTCCHHHHHHHHT------TSCSSGGGSTTSGGGTC
T ss_pred -CCCccCCHHHHHHHHH------HccCCHhHCcCHHHHcC
Confidence 2233344555555554 99999999999998755
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=404.44 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=199.4
Q ss_pred CCCCCCeeeecCCeEEEEEEcCCC-----cEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLPSG-----LTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
.|++.++||+|+||+||+|.++.. ..||||+++... .....+|.+|++++++++|||||+++|++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 577789999999999999975432 479999997543 23345789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+.+|++.+++.... +.+++.++.+++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 88 TEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999998877543 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
... .........||+.|||||++....++.++|||||||++|||++|..|+.... ...+.+.. +.....
T Consensus 163 ~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~~~~~~~~-i~~~~~----- 231 (283)
T d1mqba_ 163 DPE-ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKA-INDGFR----- 231 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHH-HHTTCC-----
T ss_pred CCc-cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----CHHHHHHH-HhccCC-----
Confidence 322 1122334578999999999999999999999999999999999766654321 11222222 222211
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
+..+...+..+.+++. .||+.+|++||+|.+|++.|+++.+.+
T Consensus 232 -~~~~~~~~~~l~~li~------~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 232 -LPTPMDCPSAIYQLMM------QCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp -CCCCTTCBHHHHHHHH------HHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -CCCchhhHHHHHHHHH------HHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 1222334444555444 499999999999999999999887653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=400.96 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=196.7
Q ss_pred CeeeecCCeEEEEEEcC---CCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecCC
Q 001238 782 NIIGQGRSGIVYKVTLP---SGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMPN 856 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~ 856 (1117)
++||+|+||+||+|.++ .++.||||+++.. +....++|.+|++++++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999753 3578999999653 23335679999999999999999999999865 567899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCcc
Q 001238 857 GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGSF 936 (1117)
Q Consensus 857 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 936 (1117)
|+|.++++... .+++.++.+++.||++||+|||++ +||||||||+|||++.++.+|++|||+++...... ...
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~-~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYY 164 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC-SEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccc-ccc
Confidence 99999987643 489999999999999999999999 99999999999999999999999999998765432 222
Q ss_pred ccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 937 SANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
.......||++|||||++....++.++|||||||++|||++ |+.||.+. .. .+.... +..... +..+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--~~---~~~~~~-i~~~~~------~~~p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KG---SEVTAM-LEKGER------MGCP 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CH---HHHHHH-HHTTCC------CCCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--CH---HHHHHH-HHcCCC------CCCC
Confidence 33345679999999999999999999999999999999998 89999752 11 222222 222211 1223
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
...+..+.+++. .||+.||++||++++|.+.|+..
T Consensus 233 ~~~~~~~~~li~------~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 233 AGCPREMYDLMN------LCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TTCCHHHHHHHH------HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cccCHHHHHHHH------HHcCCCHhHCcCHHHHHHHhhCH
Confidence 334445555554 49999999999999999988765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=411.62 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=205.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC------CcEEEEEEeecC-CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS------GLTVAVKRFRAS-DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 847 (1117)
++|+++++||+|+||+||+|++.. ...||+|++... .......+.+|+++++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578899999999999999997532 236999998653 333456789999999998 899999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccC
Q 001238 848 LLFYDYMPNGTLGMLLHDGEC--------------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSH 907 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~ 907 (1117)
++||||+++|+|.++++.... .+.+++..++.++.||++||+|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999976431 23489999999999999999999999 9999999999
Q ss_pred eEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCC
Q 001238 908 NILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASF 986 (1117)
Q Consensus 908 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~ 986 (1117)
||+++.++.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||++ |+.||.+..
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccccccCCeEEEeeccccccccCCCc--eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999987654322 223345678999999999999999999999999999999998 899997532
Q ss_pred CCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHh
Q 001238 987 PDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLRE 1055 (1117)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~ 1055 (1117)
. ...+... +..... +..+...+..+.+++.. ||+.||++|||++||++.|..
T Consensus 272 ~-~~~~~~~----~~~~~~------~~~p~~~~~~l~~li~~------cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 V-DANFYKL----IQNGFK------MDQPFYATEEIYIIMQS------CWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp C-SHHHHHH----HHTTCC------CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHH
T ss_pred H-HHHHHHH----HhcCCC------CCCCCcCCHHHHHHHHH------HcCCChhHCcCHHHHHHHHhC
Confidence 2 2222222 222211 12233444555655555 999999999999999999853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=416.44 Aligned_cols=198 Identities=30% Similarity=0.462 Sum_probs=176.5
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||+|+++... ....+++.+|++++++++|||||++++++.++++.|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45789999999999999999985 578999999997643 3335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|+++|+|.+++.+. +.+++.++..++.|+++||+|||+ + +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999764 348999999999999999999997 5 8999999999999999999999999999876532
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||..
T Consensus 159 ------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 159 ------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp ------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 23456899999999999999999999999999999999999999965
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=399.04 Aligned_cols=247 Identities=27% Similarity=0.410 Sum_probs=194.3
Q ss_pred CCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeec----CCceEEE
Q 001238 778 LTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN----RKTKLLF 850 (1117)
Q Consensus 778 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv 850 (1117)
|++.++||+|+||+||+|.+ .+++.||+|++... .....+.|.+|++++++++|||||++++++.+ ....|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 35667899999999999985 46889999998754 23345678999999999999999999998864 3457899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc-CCCcceecccccccccc
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG-ERYESCLADFGLARLVE 929 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~-~~~~~kl~DfGla~~~~ 929 (1117)
|||+++|+|.+++... +.+++.++..++.||++||+|||++. ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999999764 34899999999999999999999981 1399999999999996 57899999999998643
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.. .....+||+.|||||++.+ .|+.++||||+||++|||++|+.||... .......+. +.....+
T Consensus 167 ~~------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~----~~~~~~~~~-i~~~~~~--- 231 (270)
T d1t4ha_ 167 AS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIYRR-VTSGVKP--- 231 (270)
T ss_dssp TT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHHHH-HTTTCCC---
T ss_pred CC------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc----ccHHHHHHH-HHcCCCC---
Confidence 21 2235689999999999875 6999999999999999999999999642 122222222 2222111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+.+.......+.++++. |++.||++|||++|+++
T Consensus 232 --~~~~~~~~~~~~~li~~------~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 --ASFDKVAIPEVKEIIEG------CIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGGGCCCHHHHHHHHH------HSCSSGGGSCCHHHHHT
T ss_pred --cccCccCCHHHHHHHHH------HccCCHhHCcCHHHHhC
Confidence 12222333445555554 99999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=401.51 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=202.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYMP 855 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~ 855 (1117)
++|++.+.||+|+||+||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 468899999999999999999888889999999754 3456789999999999999999999999855 56799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCCc
Q 001238 856 NGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGGS 935 (1117)
Q Consensus 856 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 935 (1117)
+|+|..++..... +.++|.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 95 ~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~--- 167 (285)
T d1fmka3 95 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--- 167 (285)
T ss_dssp TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC---
Confidence 9999988876432 3489999999999999999999999 99999999999999999999999999998765322
Q ss_pred cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcccC
Q 001238 936 FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKLQ 1015 (1117)
Q Consensus 936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1015 (1117)
........||+.|+|||++....++.++|||||||++|||++|..|+... ....+.+....... . +..+
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~----~~~~~~~~~i~~~~-~------~~~~ 236 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG----MVNREVLDQVERGY-R------MPCP 236 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT----CCHHHHHHHHHTTC-C------CCCC
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC----CCHHHHHHHHHhcC-C------CCCC
Confidence 22334567999999999999999999999999999999999976665432 12222222222221 1 1123
Q ss_pred CCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1016 GHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1016 ~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
...+..+.+++. .||+.||++||++++|+++|+.....
T Consensus 237 ~~~~~~l~~li~------~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 237 PECPESLHDLMC------QCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTSCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cccCHHHHHHHH------HHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 333445555544 59999999999999999999887643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-45 Score=406.98 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=190.3
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
.+.|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45689999999999999999985 468999999997543 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc---CCCcceecccccccccc
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG---ERYESCLADFGLARLVE 929 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~---~~~~~kl~DfGla~~~~ 929 (1117)
|++||+|.+++... +.+++.++..++.||+.||+|||++ +||||||||+||++. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999764 3499999999999999999999999 999999999999995 57899999999998764
Q ss_pred CCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 930 DDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ...+.............
T Consensus 162 ~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~~~~~~~~-- 229 (307)
T d1a06a_ 162 PGS-----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE-----NDAKLFEQILKAEYEFD-- 229 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHTTCCCCC--
T ss_pred CCC-----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHhccCCCCC--
Confidence 321 233568999999999999999999999999999999999999999642 22233333333332211
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.......+..+.+++.. |++.||++|||++|+++
T Consensus 230 --~~~~~~~s~~~~~li~~------~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 --SPYWDDISDSAKDFIRH------LMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --TTTTTTSCHHHHHHHHH------HSCSSGGGSCCHHHHHH
T ss_pred --CccccCCCHHHHHHHHH------HccCCHhHCcCHHHHhc
Confidence 11222334456666655 99999999999999876
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6e-45 Score=410.54 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=207.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4799999999999999999985 579999999998766666678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC--CCcceeccccccccccCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE--RYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~--~~~~kl~DfGla~~~~~~~ 932 (1117)
++|+|.+++.... +.+++.++..++.||+.||+|||++ +||||||||+|||++. ++.+||+|||+|+......
T Consensus 106 ~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999986542 4599999999999999999999999 9999999999999964 6789999999998775432
Q ss_pred CCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCc
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDP 1012 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1117)
......||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ...+.+............
T Consensus 181 -----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~~~~~~~~~---- 246 (350)
T d1koaa2 181 -----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRNVKSCDWNMDD---- 246 (350)
T ss_dssp -----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHTCCCSCC----
T ss_pred -----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCCc----
Confidence 233568999999999999999999999999999999999999999642 223333443333322211
Q ss_pred ccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1013 KLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1013 ~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
......+....++++. |++.||++|||++|+++
T Consensus 247 ~~~~~~s~~~~~li~~------~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 247 SAFSGISEDGKDFIRK------LLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGGGCCHHHHHHHHH------HCCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHH------HccCChhHCcCHHHHhc
Confidence 1112233455555555 99999999999999977
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-45 Score=404.28 Aligned_cols=245 Identities=26% Similarity=0.367 Sum_probs=200.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc---chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI---STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
+.|+..+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588889999999999999974 57899999999765332 2356889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
|||++|++..++... +.+++.+++.++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999998776543 3489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCccccCCccccccccCChhhhcc---CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcc
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANM---TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVE 1008 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1117)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+. ...+.+..........
T Consensus 168 -------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-----~~~~~~~~i~~~~~~~-- 233 (309)
T d1u5ra_ 168 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAMSALYHIAQNESPA-- 233 (309)
T ss_dssp -------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHHHHHHSCCCC--
T ss_pred -------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHhCCCCC--
Confidence 234579999999999853 46899999999999999999999999642 2223333333332111
Q ss_pred ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1009 VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1009 ~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. .....+..+.++++. |++.||++|||++|+++
T Consensus 234 ~----~~~~~s~~~~~li~~------~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 L----QSGHWSEYFRNFVDS------CLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C----SCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHTT
T ss_pred C----CCCCCCHHHHHHHHH------HCcCChhHCcCHHHHHh
Confidence 1 122344556666655 99999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-44 Score=408.37 Aligned_cols=252 Identities=16% Similarity=0.247 Sum_probs=207.9
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999985 57999999999876655667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc--CCCcceeccccccccccCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG--ERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~--~~~~~kl~DfGla~~~~~~ 931 (1117)
|++|+|.+++.... ..+++.+++.++.||+.||+|||++ +||||||||+|||++ .++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988776542 3489999999999999999999999 999999999999998 5789999999999887543
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+. ...+.+...........
T Consensus 183 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~~~~~~~~---- 248 (352)
T d1koba_ 183 E-----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLETLQNVKRCDWEFD---- 248 (352)
T ss_dssp S-----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHHHCCCCCC----
T ss_pred C-----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCC----
Confidence 2 233467999999999999999999999999999999999999999642 22333333333332221
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
+......+....+++. .|++.||++|||+.|+++
T Consensus 249 ~~~~~~~s~~~~~li~------~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIK------NLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp SSTTTTSCHHHHHHHH------TTSCSSGGGSCCHHHHHT
T ss_pred cccccCCCHHHHHHHH------HHccCChhHCcCHHHHhc
Confidence 1222233445555554 499999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=397.35 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=205.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC------ccchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD------KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
.++|++++.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999985 579999999997532 22356799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC----cceecccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY----ESCLADFG 923 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~----~~kl~DfG 923 (1117)
|+|||||++|+|.+++... +.+++..++.++.|++.||+|||++ +||||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999764 3499999999999999999999999 999999999999998776 48999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+. ...+.+.......
T Consensus 163 ~a~~~~~~~-----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQETLANVSAVN 232 (293)
T ss_dssp TCEECTTSC-----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHTTC
T ss_pred hhhhcCCCc-----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcC
Confidence 998765422 234567999999999999999999999999999999999999999642 2223333333332
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
..... ......+....++++ .|++.||++|||++|+++
T Consensus 233 ~~~~~----~~~~~~s~~~~~li~------~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YEFED----EYFSNTSALAKDFIR------RLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCH----HHHTTSCHHHHHHHH------TTSCSSGGGSCCHHHHHH
T ss_pred CCCCc----hhcCCCCHHHHHHHH------HHccCChhHCcCHHHHhc
Confidence 22111 112233344555555 499999999999999876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=392.51 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=198.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeec-CCceEEEEEec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGAN-RKTKLLFYDYM 854 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 854 (1117)
++|++.+.||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++|||||+++|++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 3577889999999999999998 5789999999754 345789999999999999999999998865 46689999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++..... ..+++..+++++.||++||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 99999999975421 2389999999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCcc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPK 1013 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1117)
.....+|+.|+|||++.+..+++++|||||||++|||+| |++||... ....+...+. .. ..+.
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~----~~------~~~~ 220 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVE----KG------YKMD 220 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHT----TT------CCCC
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHH----cC------CCCC
Confidence 223468899999999999999999999999999999998 78887643 2223333332 11 1123
Q ss_pred cCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1014 LQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1014 l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.+...+..+.++++. ||+.||++|||+.+++++|++++..
T Consensus 221 ~~~~~~~~~~~li~~------cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 221 APDGCPPAVYEVMKN------CWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHH------HcccCHhHCcCHHHHHHHHHHHHhC
Confidence 334444566666555 9999999999999999999988653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-44 Score=399.28 Aligned_cols=260 Identities=27% Similarity=0.379 Sum_probs=206.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCCc-cchHHHHHHHHHHhccCCCCcceEEeeeecCCce
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASDK-ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 847 (1117)
.++|++.+.||+|+||+||+|+++ +++.||||+++.... ...++|.+|++++++++||||+++++++...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 467999999999999999999753 467899999975432 2356799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeecccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGEC---------------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKS 906 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp 906 (1117)
++||||+++|+|.++++.... ...+++..+..++.|++.||+|||++ +||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcc
Confidence 999999999999999864321 12388999999999999999999999 999999999
Q ss_pred CeEEEcCCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCC-CCCCCC
Q 001238 907 HNILLGERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGK-KPVDAS 985 (1117)
Q Consensus 907 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~-~P~~~~ 985 (1117)
+|||++.++.+||+|||+|+...... .........||+.|+|||.+....|+.++|||||||++|||++|. +||...
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSAD--YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGG--CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cceEECCCCcEEEccchhheeccCCc--cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 99999999999999999998664322 122334567899999999999999999999999999999999985 566532
Q ss_pred CCCChhHHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhh
Q 001238 986 FPDGQHVIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIR 1057 (1117)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~ 1057 (1117)
...+.+..... ... +..+...+..+.+++ ..||+.+|++||||.||+++|+++.
T Consensus 247 -----~~~e~~~~v~~-~~~------~~~p~~~~~~~~~li------~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 -----AHEEVIYYVRD-GNI------LACPENCPLELYNLM------RLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -----CHHHHHHHHHT-TCC------CCCCTTCCHHHHHHH------HHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----CHHHHHHHHHc-CCC------CCCCccchHHHHHHH------HHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22222333222 211 122333334444444 4599999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.8e-44 Score=394.33 Aligned_cols=261 Identities=24% Similarity=0.374 Sum_probs=204.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc---cchHHHHHHHHHHhccCCCCcceEEeeeecCCc----
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK---ISTGAFSSEIATLSRIRHRNIVRLLGWGANRKT---- 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 846 (1117)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.... ...++|.+|+++++.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35789999999999999999975 5799999999975432 234578999999999999999999998876543
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.|+||||++||+|.+++... +.+++.+++.++.||++||+|||++ +||||||||+||+++.++..+++|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988764 3489999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDP 1006 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1117)
....... ........+||+.|+|||++.+..+++++||||+||++|||++|+.||.+. ...+...........+
T Consensus 160 ~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPVSVAYQHVREDPIP 233 (277)
T ss_dssp ECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHCCCCC
T ss_pred hhccccc-cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc-----CHHHHHHHHHhcCCCC
Confidence 6644322 223344568999999999999999999999999999999999999999642 2334444555544333
Q ss_pred ccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-CHHHHHHHHHhhh
Q 001238 1007 VEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-TMKDVAALLREIR 1057 (1117)
Q Consensus 1007 ~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-s~~~v~~~L~~~~ 1057 (1117)
..... ...+..+.++++. |++.||++|| +++++.+.|.+++
T Consensus 234 ~~~~~----~~~s~~l~~li~~------~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARH----EGLSADLDAVVLK------ALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTS----SSCCHHHHHHHHH------HTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred Cchhc----cCCCHHHHHHHHH------HccCCHhHCHhHHHHHHHHHHHHh
Confidence 32222 2334455666655 9999999999 8999999998875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=399.49 Aligned_cols=247 Identities=21% Similarity=0.275 Sum_probs=206.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++++.||+|+||+||+|+. .+|+.||||++++. .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4688999999999999999985 57999999999753 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+++|+|.+++... +.+++..++.++.|++.||+|||++ +||||||||+|||++++|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998764 3489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. ......+||+.|+|||++.+..|+.++||||+||++|||++|++||.+. ...+..........
T Consensus 159 ~----~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~-----~~~~~~~~i~~~~~------- 222 (337)
T d1o6la_ 159 G----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHERLFELILMEEI------- 222 (337)
T ss_dssp T----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC-------
T ss_pred C----cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc-----CHHHHHHHHhcCCC-------
Confidence 2 2334578999999999999999999999999999999999999999652 22333333333321
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
.++...+.....+++. |++.||++||+ +.++++
T Consensus 223 -~~p~~~s~~~~dli~~------~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -RFPRTLSPEAKSLLAG------LLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCTTSCHHHHHHHHH------HTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCccCCHHHHHHHHh------hccCCchhhcccccccHHHHHc
Confidence 2233444555666655 99999999995 777765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-44 Score=397.34 Aligned_cols=244 Identities=24% Similarity=0.351 Sum_probs=204.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688999999999999999985 56999999999743 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||++||++..++.... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999887653 378899999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ...+..........
T Consensus 158 -------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i~~~~~------- 218 (316)
T d1fota_ 158 -------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEKILNAEL------- 218 (316)
T ss_dssp -------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHCCC-------
T ss_pred -------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-----CHHHHHHHHHcCCC-------
Confidence 23568999999999999999999999999999999999999999642 23333444443322
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
.++...+..+.++++. |+..||.+|| +++++++
T Consensus 219 -~~p~~~s~~~~~li~~------~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -RFPPFFNEDVKDLLSR------LITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCTTSCHHHHHHHHH------HTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHH------HhhhCHHhccccchhhHHHHHc
Confidence 1223344456666665 9999999996 8888876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=391.38 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=196.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC--CC--cEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP--SG--LTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
++|++.+.||+|+||+||+|++. ++ ..||||+++.. .....++|.+|++++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 46888999999999999999742 23 47899998653 23335679999999999999999999999976 4678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+++|++.+++.... +.+++..+.+++.|+|+||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999998877542 3499999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
..... .........||..|+|||++.+..++.++|||||||++|||++ |+.||.+. ...+.+....+....+
T Consensus 162 ~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~~~~~i~~~~~~~- 234 (273)
T d1u46a_ 162 PQNDD-HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKIDKEGERL- 234 (273)
T ss_dssp CC-CC-EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTSCCCC-
T ss_pred ccCCC-cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-----CHHHHHHHHHhCCCCC-
Confidence 54322 2233345578899999999999999999999999999999998 89999642 2223333333332211
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhh
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREI 1056 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~ 1056 (1117)
..+...+..+.+++.. ||+.||++|||+.+|.+.|++.
T Consensus 235 -----~~~~~~~~~l~~li~~------cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 -----PRPEDCPQDIYNVMVQ------CWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCcccccHHHHHHHHH------HcCCChhHCcCHHHHHHHHHhc
Confidence 1223334455555555 9999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=390.84 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=195.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCC----CcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPS----GLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|++.+.||+|+||+||+|.+.. +..||||+++.. .....+.|.+|++++++++|||||++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 468889999999999999997532 457899988654 3333567999999999999999999999986 4678999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|++.+++.... +.+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 86 ~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999999876543 3489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
.. ........||+.|+|||++....++.++|||||||++|||++ |++||.... ...+...+. ... .
T Consensus 161 ~~---~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~--~~~~~~~i~---~~~-~---- 227 (273)
T d1mp8a_ 161 ST---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIE---NGE-R---- 227 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHH---TTC-C----
T ss_pred Cc---ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC--HHHHHHHHH---cCC-C----
Confidence 22 123345578999999999999999999999999999999998 899997532 222322222 211 1
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
+..+...+..+.+++.. ||+.||++|||+.+|++.|+.+.+
T Consensus 228 --~~~~~~~~~~~~~li~~------cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 228 --LPMPPNCPPTLYSLMTK------CWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp --CCCCTTCCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHH------HcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11233344555665555 999999999999999999988754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=397.20 Aligned_cols=272 Identities=26% Similarity=0.349 Sum_probs=201.4
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCC----ceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRK----TKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~ 851 (1117)
++|.+.+.||+|+||+||+|++ +|+.||||+++.... ....++.|+..+++++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5677889999999999999987 689999999865422 1222344555667789999999999987654 578999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC-----CCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC-----VPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
||+++|+|.+++++. .++|.++.+++.|+|.||+|+|+.. .++||||||||+|||+++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999864 2899999999999999999999731 2499999999999999999999999999999
Q ss_pred cccCCCCCccccCCccccccccCChhhhccC------CCCcCCCeeehhhhHHHHHhCCCCCCCCCCC---------Chh
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMT------KISEKSDVYSYGVVLLEIITGKKPVDASFPD---------GQH 991 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~---------~~~ 991 (1117)
.................||++|+|||++... .++.++|||||||++|||+||..||...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 8765443333344567899999999998754 3678999999999999999999887432111 011
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
............. .+|.++.... ..........++..||+.||++|||+.||++.|+++.++
T Consensus 237 ~~~~~~~~~~~~~-----~~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 237 SVEEMRKVVCEQK-----LRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSC-----CCCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc-----cCCCCCcccC-ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1222222222211 1222222111 111222233567789999999999999999999988754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=392.66 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=196.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecC-Cc
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANR-KT 846 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 846 (1117)
++|++.++||+|+||+||+|.+. +++.||||+++... ....+.+.+|.+.+.++ +|+|||++++++... +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 57899999999999999999742 35789999987543 33345678888888887 689999999987654 46
Q ss_pred eEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC
Q 001238 847 KLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE 913 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~ 913 (1117)
.++|||||++|+|.++++.... ...+++.++..++.||++||+|||++ +||||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 8999999999999999975321 23489999999999999999999999 9999999999999999
Q ss_pred CCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhC-CCCCCCCCCCChhH
Q 001238 914 RYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITG-KKPVDASFPDGQHV 992 (1117)
Q Consensus 914 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g-~~P~~~~~~~~~~~ 992 (1117)
++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++| .+||... .....+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~-~~~~~~ 246 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEF 246 (299)
T ss_dssp GGCEEECC------CCSCTT--SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CCSHHH
T ss_pred CCcEEEccCcchhhcccccc--ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC-CHHHHH
Confidence 99999999999987654322 2234456899999999999999999999999999999999996 5577542 222222
Q ss_pred HHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 993 IQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
... +..... +..+...+..+.+++. .||+.||++|||++|+++.|+++.+
T Consensus 247 ~~~----~~~~~~------~~~~~~~~~~l~~li~------~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 CRR----LKEGTR------MRAPDYTTPEMYQTML------DCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHH----HHHTCC------CCCCTTCCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----HhcCCC------CCCCccCCHHHHHHHH------HHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222 222211 1223333444555444 4999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=395.82 Aligned_cols=257 Identities=22% Similarity=0.339 Sum_probs=200.2
Q ss_pred CCCCCCeeeecCCeEEEEEEcC-CCc----EEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTLP-SGL----TVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
+|++.++||+|+||+||+|.+. +|+ +||+|+++.. .....++|.+|++++++++|||||+++++|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 5888999999999999999753 444 6899988643 334567899999999999999999999999864 56788
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+.+|+|.+++.... ..+++..+++++.|||+||+|||++ +||||||||+||+++.++.+||+|||+|+....
T Consensus 89 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 99999999998887643 3489999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChhHHHHHHHHHhcCCCCccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQHVIQWVRDHLKSKKDPVEV 1009 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1117)
... ........||+.|+|||++.++.|+.++|||||||++|||+| |++||++.. ...+...+.. ...+
T Consensus 164 ~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~--~~~~~~~i~~----~~~~--- 232 (317)
T d1xkka_ 164 EEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEK----GERL--- 232 (317)
T ss_dssp TCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--GGGHHHHHHH----TCCC---
T ss_pred ccc--cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHc----CCCC---
Confidence 322 122334568999999999999999999999999999999998 899986532 2233333322 2111
Q ss_pred cCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1010 LDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1010 ~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
..+...+..+..++. .||+.||++|||+.+|++.++.+.+.
T Consensus 233 ---~~p~~~~~~~~~li~------~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 233 ---PQPPICTIDVYMIMV------KCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ---CCCTTBCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CCCcccCHHHHHHHH------HhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 112233344455444 49999999999999999999887654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=390.38 Aligned_cols=257 Identities=26% Similarity=0.368 Sum_probs=204.3
Q ss_pred CCeeeecCCeEEEEEEcCC----CcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeec-CCceEEEEEec
Q 001238 781 GNIIGQGRSGIVYKVTLPS----GLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN-RKTKLLFYDYM 854 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~ 854 (1117)
.++||+|+||+||+|.+.+ ...||||+++.. +....++|.+|++++++++|||||+++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999998643 236899999743 44455789999999999999999999999765 46789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
++|+|.+++.... ...++..+++++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999988653 3478899999999999999999999 9999999999999999999999999999987654443
Q ss_pred ccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccCccc
Q 001238 935 SFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLDPKL 1014 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1014 (1117)
.........||+.|+|||.+....++.++||||||+++|||++|+.||..... ..+. ........ .+ ..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~---~~~i~~g~-~~------~~ 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDI---TVYLLQGR-RL------LQ 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------C---HHHHHTTC-CC------CC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHH---HHHHHcCC-CC------CC
Confidence 33444556799999999999999999999999999999999998888754221 1122 22222221 11 11
Q ss_pred CCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1015 QGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1015 ~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
+...+..+.+++. .||+.||++||++.||++.|+++...
T Consensus 256 p~~~~~~l~~li~------~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 256 PEYCPDPLYEVML------KCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CTTCCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCcHHHHHHHH------HHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 2233444555444 59999999999999999999999764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=392.48 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=210.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc------CCCcEEEEEEeecCC-ccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCce
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL------PSGLTVAVKRFRASD-KISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTK 847 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 847 (1117)
++|+++++||+|+||.||+|++ .+++.||||+++... .....+|.+|+.+++++ +|||||++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788899999999999999974 346789999997643 33445789999999999 699999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc
Q 001238 848 LLFYDYMPNGTLGMLLHDGE---------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 912 (1117)
++||||+++|+|.++++... ....+++..+.+++.||++||+|||++ +||||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999987542 123488999999999999999999999 999999999999999
Q ss_pred CCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhC-CCCCCCCCCCChh
Q 001238 913 ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITG-KKPVDASFPDGQH 991 (1117)
Q Consensus 913 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g-~~P~~~~~~~~~~ 991 (1117)
.++.+|++|||+++....... ........||+.|+|||++....++.++|||||||++|||+|+ ++||.. ......
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~-~~~~~~ 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-MPVDSK 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCSSHH
T ss_pred ccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC-CCHHHH
Confidence 999999999999997764322 2344567899999999999999999999999999999999995 555543 233333
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
+...+.. ... +..+...+..+.+++.. ||+.||++||++.+|+++|+++..+
T Consensus 257 ~~~~i~~----~~~------~~~~~~~~~~l~~Li~~------cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 FYKMIKE----GFR------MLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHH----TCC------CCCCTTSCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhc----CCC------CCCcccccHHHHHHHHH------HcCCChhHCcCHHHHHHHHHHhhcc
Confidence 3333332 211 12223334455555554 9999999999999999999876543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=390.81 Aligned_cols=259 Identities=28% Similarity=0.446 Sum_probs=204.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC-CCc--EEEEEEeecC-CccchHHHHHHHHHHhcc-CCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP-SGL--TVAVKRFRAS-DKISTGAFSSEIATLSRI-RHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|++.++||+|+||+||+|.++ +|. .||||+++.. .....++|.+|+++++++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 47888899999999999999864 344 5788887643 333556799999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcc
Q 001238 851 YDYMPNGTLGMLLHDGE-------------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYES 917 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~ 917 (1117)
|||+++|+|.++++... ....+++.++.+++.|||+||.|+|++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997642 234599999999999999999999999 99999999999999999999
Q ss_pred eeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCC-CCCCCCCCCChhHHHHH
Q 001238 918 CLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGK-KPVDASFPDGQHVIQWV 996 (1117)
Q Consensus 918 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~-~P~~~~~~~~~~~~~~~ 996 (1117)
||+|||+++..... .......||..|+|||.+....++.++|||||||++|||++|. +||... ...+..
T Consensus 167 kl~DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELY 236 (309)
T ss_dssp EECCTTCEESSCEE-----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHH
T ss_pred EEcccccccccccc-----ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----CHHHHH
Confidence 99999999865432 1223456899999999999999999999999999999999975 466432 222222
Q ss_pred HHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 001238 997 RDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQEP 1060 (1117)
Q Consensus 997 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~~ 1060 (1117)
.. +..... +..+...+..+..++.. ||+.||++||+|++|++.|+++.+..
T Consensus 237 ~~-i~~~~~------~~~~~~~~~~~~~li~~------cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 237 EK-LPQGYR------LEKPLNCDDEVYDLMRQ------CWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HH-GGGTCC------CCCCTTBCHHHHHHHHH------HTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HH-HHhcCC------CCCCccCCHHHHHHHHH------HcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 22 222211 22233344455665555 99999999999999999999987643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=395.14 Aligned_cols=251 Identities=19% Similarity=0.237 Sum_probs=205.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
.++|++.+.||+|+||+||+|.+ .+|+.||||+++.... ....+.+|++++++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 35789999999999999999985 4689999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC--CcceeccccccccccCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER--YESCLADFGLARLVEDD 931 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~--~~~kl~DfGla~~~~~~ 931 (1117)
|+||+|.+++.... ..+++.+++.++.||++||+|||++ +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999997642 3489999999999999999999999 99999999999999854 47899999999876432
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
. ......+|+.|+|||...+..|+.++||||+||++|||++|+.||... ...+.+..............
T Consensus 158 ~-----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~- 226 (321)
T d1tkia_ 158 D-----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-----TNQQIIENIMNAEYTFDEEA- 226 (321)
T ss_dssp C-----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHHHTCCCCCHHH-
T ss_pred C-----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCCCCCChhh-
Confidence 1 233467899999999999999999999999999999999999999642 22333344433332222211
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
....+....++++. |+..||++|||+.|+++
T Consensus 227 ---~~~~s~~~~~li~~------~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 ---FKEISIEAMDFVDR------LLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---HTTSCHHHHHHHHT------TSCSSGGGSCCHHHHHH
T ss_pred ---ccCCCHHHHHHHHH------HccCChhHCcCHHHHhc
Confidence 12233345555554 99999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.8e-43 Score=382.15 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=201.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc---------chHHHHHHHHHHhccC-CCCcceEEeeeecC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI---------STGAFSSEIATLSRIR-HRNIVRLLGWGANR 844 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 844 (1117)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+++.+|++++++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999985 57999999999764321 1235788999999997 99999999999999
Q ss_pred CceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccc
Q 001238 845 KTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGL 924 (1117)
Q Consensus 845 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGl 924 (1117)
+..|+||||+++|+|.++++.. +.+++.+++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 9999999999999999999754 3499999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhcc------CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHH
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANM------TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRD 998 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~ 998 (1117)
++...... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||.+. ........
T Consensus 157 a~~~~~~~-----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~-----~~~~~~~~ 226 (277)
T d1phka_ 157 SCQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-----KQMLMLRM 226 (277)
T ss_dssp CEECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred eeEccCCC-----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC-----CHHHHHHH
Confidence 99875422 2345689999999998863 35688999999999999999999999753 12222233
Q ss_pred HHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 999 HLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 999 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.......... +. ....+..+.+++.. |++.||++||+++|+++
T Consensus 227 i~~~~~~~~~---~~-~~~~s~~~~~li~~------~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMSGNYQFGS---PE-WDDYSDTVKDLVSR------FLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHTCCCCCT---TT-GGGSCHHHHHHHHH------HCCSSGGGSCCHHHHTT
T ss_pred HHhCCCCCCC---cc-cccCCHHHHHHHHH------HccCChhHCcCHHHHHc
Confidence 3333221111 11 11233455555555 99999999999999865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-43 Score=395.60 Aligned_cols=244 Identities=20% Similarity=0.246 Sum_probs=204.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~ 851 (1117)
++|++.+.||+|+||+||+|++ .+|+.||||++... +....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4688899999999999999975 57999999998643 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDD 931 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~ 931 (1117)
||+.+|+|..++... +.+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998764 3489999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCccccC
Q 001238 932 SGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVLD 1011 (1117)
Q Consensus 932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1117)
.....||+.|||||++.+..|+.++||||+||++|||++|+.||.+. ..............
T Consensus 195 -------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i~~~~~------- 255 (350)
T d1rdqe_ 195 -------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEKIVSGKV------- 255 (350)
T ss_dssp -------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCC-------
T ss_pred -------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-----CHHHHHHHHhcCCC-------
Confidence 23568999999999999999999999999999999999999999642 23333444433322
Q ss_pred cccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1012 PKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1012 ~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
..+...+..+.++++. |++.||.+|+ +++++++
T Consensus 256 -~~p~~~s~~~~~li~~------~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -RFPSHFSSDLKDLLRN------LLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCTTCCHHHHHHHHH------HSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCccCCHHHHHHHHH------HhhhCHHhccccccccHHHHHc
Confidence 1223344556666665 9999999994 8899876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-43 Score=387.81 Aligned_cols=260 Identities=27% Similarity=0.351 Sum_probs=204.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC--------CCcEEEEEEeecCCc-cchHHHHHHHHHHhcc-CCCCcceEEeeeecCC
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP--------SGLTVAVKRFRASDK-ISTGAFSSEIATLSRI-RHRNIVRLLGWGANRK 845 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 845 (1117)
++|.+++.||+|+||.||+|+.. ++..||||+++.... ....++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 46888899999999999999742 235799999976533 3346788899999888 8999999999999999
Q ss_pred ceEEEEEecCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGEC-------------AGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLG 912 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~ 912 (1117)
..++||||+++|+|.+++..... ...+++.++++++.|++.||+|||++ +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 99999999999999999976532 23489999999999999999999999 999999999999999
Q ss_pred CCCcceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHh-CCCCCCCCCCCChh
Q 001238 913 ERYESCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIIT-GKKPVDASFPDGQH 991 (1117)
Q Consensus 913 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~-g~~P~~~~~~~~~~ 991 (1117)
.++.+||+|||+++....... ........||+.|+|||.+.++.|+.++|||||||++|||++ |++||....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~----- 242 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 242 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCT--TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred CCCCeEeccchhhcccccccc--ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-----
Confidence 999999999999998765332 223445679999999999999999999999999999999998 788886421
Q ss_pred HHHHHHHHHhcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 992 VIQWVRDHLKSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
..+ +...+..... +..+...+..+.+++. +||+.||++|||+.||++.|+++..
T Consensus 243 ~~~-~~~~i~~~~~------~~~p~~~~~~l~~li~------~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 243 VEE-LFKLLKEGHR------MDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHH-HHHHHHTTCC------CCCCSSCCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH-HHHHHHcCCC------CCCCccchHHHHHHHH------HHccCCHhHCcCHHHHHHHHHHHhh
Confidence 112 2222222221 1223334445555554 4999999999999999999998754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.9e-43 Score=395.76 Aligned_cols=248 Identities=22% Similarity=0.263 Sum_probs=197.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC---ccchHHHHH---HHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD---KISTGAFSS---EIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ......+.+ |+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 4688999999999999999985 469999999986431 112233444 466777788999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
+||||+++|+|.+++... +.+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999764 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
... ......||+.|+|||++.. ..|+.++||||+||++|||++|+.||...... ......+.....
T Consensus 158 ~~~------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~----- 224 (364)
T d1omwa3 158 SKK------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTM----- 224 (364)
T ss_dssp SSS------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHHHSSSC-----
T ss_pred CCC------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccC-----
Confidence 542 2334579999999999864 56899999999999999999999999764322 222222211111
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCC-----HHHHHH
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPT-----MKDVAA 1051 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs-----~~~v~~ 1051 (1117)
.+.++...+..+.+++.. |++.||++||+ ++|+++
T Consensus 225 ---~~~~~~~~s~~~~~li~~------~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ---AVELPDSFSPELRSLLEG------LLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---CCCCCSSSCHHHHHHHHH------HTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---CCCCCCCCCHHHHHHHHH------HcccCHHHhCCCcccCHHHHHc
Confidence 112233445566666665 99999999999 677765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=390.11 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=201.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC---CccchHHHHHHHHHHh-ccCCCCcceEEeeeecCCceEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS---DKISTGAFSSEIATLS-RIRHRNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv 850 (1117)
++|.+.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4688899999999999999975 46999999999743 2233456677777765 68999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccC
Q 001238 851 YDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVED 930 (1117)
Q Consensus 851 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 930 (1117)
|||+++|+|.+++... +.+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999764 3489999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCcccc
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPVEVL 1010 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1117)
.. .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+. ...+.........
T Consensus 156 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i~~~~------- 219 (320)
T d1xjda_ 156 GD----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEELFHSIRMDN------- 219 (320)
T ss_dssp TT----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCC-------
T ss_pred cc----ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCC-------
Confidence 22 2334568999999999999999999999999999999999999999642 2223333333222
Q ss_pred CcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHH-HHHH
Q 001238 1011 DPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMK-DVAA 1051 (1117)
Q Consensus 1011 ~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~-~v~~ 1051 (1117)
+.++...+....++++. |++.||++||++. ++.+
T Consensus 220 -~~~p~~~s~~~~dli~~------~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -PFYPRWLEKEAKDLLVK------LFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCCTTSCHHHHHHHHH------HSCSSGGGSBTTBSCGGG
T ss_pred -CCCCccCCHHHHHHHHH------hcccCCCCCcCHHHHHHh
Confidence 22233344556666665 9999999999985 6754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=384.98 Aligned_cols=260 Identities=22% Similarity=0.348 Sum_probs=207.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEcC------CCcEEEEEEeecC-CccchHHHHHHHHHHhccCCCCcceEEeeeecCCceE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLP------SGLTVAVKRFRAS-DKISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 848 (1117)
++|++.++||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++|||||++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 46788899999999999999753 3578999999754 2333456899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecc
Q 001238 849 LFYDYMPNGTLGMLLHDGE-------CAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLAD 921 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~D 921 (1117)
+||||+++|+|.+++.... ....+++..+.+++.|+|+||+|||++ +|+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 9999999999999886421 122478999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCC-CCCCCCCCCChhHHHHHHHHH
Q 001238 922 FGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGK-KPVDASFPDGQHVIQWVRDHL 1000 (1117)
Q Consensus 922 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~-~P~~~~~~~~~~~~~~~~~~~ 1000 (1117)
||+|+....... ........||+.|+|||.+.+..++.++||||||+++|||++|. +||.. ....+......
T Consensus 177 FGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-----~~~~~~~~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-----LSNEQVLRFVM 249 (308)
T ss_dssp TTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----SCHHHHHHHHH
T ss_pred cccceeccCCcc--eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHH
Confidence 999987654321 22234457899999999999999999999999999999999985 66643 22333333333
Q ss_pred hcCCCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1001 KSKKDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1001 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
... . +..+...+..+.+++. .||+.+|++|||+.+|++.|++..+
T Consensus 250 ~~~-~------~~~p~~~~~~l~~li~------~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGG-L------LDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTC-C------CCCCTTCCHHHHHHHH------HHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCC-C------CCCcccchHHHHHHHH------HHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222 1 1122333444555544 4999999999999999999987643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-43 Score=391.19 Aligned_cols=253 Identities=20% Similarity=0.263 Sum_probs=193.3
Q ss_pred ccCCCCC-CeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhcc-CCCCcceEEeeeec----CCce
Q 001238 775 TRSLTAG-NIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRI-RHRNIVRLLGWGAN----RKTK 847 (1117)
Q Consensus 775 ~~~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~ 847 (1117)
.++|.+. +.||+|+||+||+|++ .+|+.||||+++. .+.+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3468776 4699999999999975 5799999999864 34678899987665 89999999998865 4568
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceeccccc
Q 001238 848 LLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLADFGL 924 (1117)
Q Consensus 848 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGl 924 (1117)
|+|||||+||+|.+++..... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 999999999999999986432 3489999999999999999999999 9999999999999985 46799999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
|+...... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .....+.......
T Consensus 161 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~--~~~~~~~~~i~~~- 232 (335)
T d2ozaa1 161 AKETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKTRIRMG- 232 (335)
T ss_dssp CEECCCCC-----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC-
T ss_pred eeeccCCC-----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH--HHHHHHHHHHhcC-
Confidence 98765432 234568999999999999999999999999999999999999999653221 1111111111100
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHH
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAAL 1052 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~ 1052 (1117)
... .........+....++++ .|++.||++||++.|+++.
T Consensus 233 -~~~-~~~~~~~~~s~~~~~li~------~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 -QYE-FPNPEWSEVSEEVKMLIR------NLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -SSS-CCTTHHHHSCHHHHHHHH------HHSCSSTTTSCCHHHHHHS
T ss_pred -CCC-CCCcccccCCHHHHHHHH------HHccCChhHCcCHHHHHcC
Confidence 000 000001112334444444 4999999999999999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=381.75 Aligned_cols=194 Identities=27% Similarity=0.338 Sum_probs=165.8
Q ss_pred CCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCcc-----chHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEec
Q 001238 781 GNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKI-----STGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDYM 854 (1117)
Q Consensus 781 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~ 854 (1117)
.++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999999986 46999999998654221 1346889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCCC
Q 001238 855 PNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSGG 934 (1117)
Q Consensus 855 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 934 (1117)
+++++..+.... ..+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-- 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-- 154 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc--
Confidence 998887776543 3488899999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 935 SFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 935 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
......+||+.|+|||++.. ..|+.++||||+||++|||++|++||.+
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 155 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 22335679999999998864 5689999999999999999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=379.53 Aligned_cols=200 Identities=26% Similarity=0.355 Sum_probs=170.0
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+++.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788999999999999999985 579999999996542 2335679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
|+.++.+....... ...+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765554443332 23499999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCccccCCccccccccCChhhhccCC-CCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTK-ISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||.+
T Consensus 157 ----~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 157 ----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp ----BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ----ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 2344568999999999877655 57899999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=376.66 Aligned_cols=239 Identities=23% Similarity=0.425 Sum_probs=194.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCc------cchHHHHHHHHHHhccC--CCCcceEEeeeecCCc
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDK------ISTGAFSSEIATLSRIR--HRNIVRLLGWGANRKT 846 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 846 (1117)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... ....++.+|++++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4789999999999999999985 5799999999875321 12234778999999996 8999999999999999
Q ss_pred eEEEEEecCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCC-Ccceeccccc
Q 001238 847 KLLFYDYMPN-GTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGER-YESCLADFGL 924 (1117)
Q Consensus 847 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~-~~~kl~DfGl 924 (1117)
.++||||+.+ +++.+++... +.+++.+++.++.|+++||+|||++ +|+||||||+||+++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5777777653 3489999999999999999999999 99999999999999854 7999999999
Q ss_pred cccccCCCCCccccCCccccccccCChhhhccCCC-CcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcC
Q 001238 925 ARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKI-SEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSK 1003 (1117)
Q Consensus 925 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 1003 (1117)
|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||... . ...+..
T Consensus 158 a~~~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~-------~i~~~~ 220 (273)
T d1xwsa_ 158 GALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E-------EIIRGQ 220 (273)
T ss_dssp CEECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H-------HHHHCC
T ss_pred ceecccc------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----h-------HHhhcc
Confidence 9865432 2345689999999999987665 57799999999999999999999641 1 111211
Q ss_pred CCCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1004 KDPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1004 ~~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
. .++...+....++++. |++.||++|||++|+++
T Consensus 221 ~--------~~~~~~s~~~~~li~~------~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 V--------FFRQRVSSECQHLIRW------CLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C--------CCSSCCCHHHHHHHHH------HTCSSGGGSCCHHHHHT
T ss_pred c--------CCCCCCCHHHHHHHHH------HccCCHhHCcCHHHHhc
Confidence 1 1223345566666655 99999999999999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-41 Score=372.57 Aligned_cols=199 Identities=28% Similarity=0.373 Sum_probs=171.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.++||+|+||+||+|++++|+.||||+++... ....+++.+|+.++++++|||||++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 4788999999999999999998899999999997542 23356899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCCC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDSG 933 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 933 (1117)
+.++.+..+.... +.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 9888777776544 3499999999999999999999999 99999999999999999999999999998765422
Q ss_pred CccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 934 GSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.......|++.|+|||.+.. ..++.++||||+||++|||++|+.||.+
T Consensus 155 ---~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 155 ---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ---cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 22334578999999998865 4568999999999999999999999965
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.5e-41 Score=377.62 Aligned_cols=293 Identities=30% Similarity=0.496 Sum_probs=199.7
Q ss_pred ccchhHHHHHHHHHhhccCCCCCCCCCCCCCCCCc--ceeeEEecCC---CcEEEEecccccccC--cCCccccccccCC
Q 001238 29 YAVNRQGEALLSWKRNWKGSDDGLSNWSPSDETPC--KWFGVSCNLN---NQVVGLDLRYVDLLG--HVPTNFTSLLSLN 101 (1117)
Q Consensus 29 ~~~~~~~~aLl~~k~~~~~~~~~l~sW~~~~~~~C--~W~gv~C~~~---~~v~~l~l~~~~l~~--~~~~~~~~l~~L~ 101 (1117)
-|.++|++||++||+++.++ ..+++|..+ .+|| .|+||+|+.. +||++|+|+++++.| .+|+.|++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~-~~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCC-GGGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCC-CcCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 48899999999999999876 469999854 4788 4999999854 379999998888877 4677777777777
Q ss_pred eEeccC-CCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCC
Q 001238 102 RLVLSG-TNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDN 180 (1117)
Q Consensus 102 ~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N 180 (1117)
+|+|++ |+++|.+|++|++|++|++|||++|++.+..|..+..+.+|+++++++|.+.+.+|..++++++|+++++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 777775 6777777777777777777777777777767777777777777777777777777777777777777777777
Q ss_pred CCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCC
Q 001238 181 QLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIP 260 (1117)
Q Consensus 181 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p 260 (1117)
++++.+|+.++.+.++
T Consensus 160 ~l~~~ip~~~~~l~~l---------------------------------------------------------------- 175 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKL---------------------------------------------------------------- 175 (313)
T ss_dssp CCEEECCGGGGCCCTT----------------------------------------------------------------
T ss_pred cccccccccccccccc----------------------------------------------------------------
Confidence 7766555544433221
Q ss_pred cCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCC
Q 001238 261 PELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTS 340 (1117)
Q Consensus 261 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~ 340 (1117)
++.+++++|++++..|..+.++..+ .+++.++...+.+|..+..+++|+.+++++|.+.+.+| .++.+++
T Consensus 176 --------~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~ 245 (313)
T d1ogqa_ 176 --------FTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKN 245 (313)
T ss_dssp --------CCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTT
T ss_pred --------ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 2344555555555555555554332 45555555555555555566666666666666654433 3555566
Q ss_pred cceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcccc
Q 001238 341 LQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNR 398 (1117)
Q Consensus 341 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 398 (1117)
|++|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 246 L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred cccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 66666666666666666666666666666666666665553 4556666666666665
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-41 Score=372.94 Aligned_cols=259 Identities=23% Similarity=0.271 Sum_probs=194.6
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CC-CcEEEEEEeecC--CccchHHHHHHHHHHhcc---CCCCcceEEeeeec----
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PS-GLTVAVKRFRAS--DKISTGAFSSEIATLSRI---RHRNIVRLLGWGAN---- 843 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~---- 843 (1117)
.++|++.++||+|+||+||+|++ ++ ++.||||+++.. .......+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999985 34 678999998653 222344677888887776 79999999998853
Q ss_pred -CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccc
Q 001238 844 -RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADF 922 (1117)
Q Consensus 844 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~Df 922 (1117)
....+++|||++++.+........ ..+++..++.++.|+++||+|||++ +||||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 346789999999887765554432 3489999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 923 GLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 923 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
|+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.. .......+......
T Consensus 161 g~~~~~~~~-----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCGG-----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCC
T ss_pred hhhhhhccc-----ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCC
Confidence 999865432 23456789999999999999999999999999999999999999997531 11111222111110
Q ss_pred CCC--------Cc-c-------ccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1003 KKD--------PV-E-------VLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1003 ~~~--------~~-~-------~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
... .. . ...+.+....+....++++. |++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~------mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK------CLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHH------HSCSSTTTSCCHHHHHT
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHH------HCcCChhHCcCHHHHhc
Confidence 000 00 0 00011122233344455544 99999999999999876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-40 Score=364.82 Aligned_cols=264 Identities=16% Similarity=0.251 Sum_probs=207.8
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCC-CCcceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH-RNIVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++++.||+|+||+||+|++ .+|+.||||++.... ..+.+.+|++.++.++| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 5799999999999999999985 468999999986543 23468899999999975 8999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC-----CCcceeccccccccc
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE-----RYESCLADFGLARLV 928 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~-----~~~~kl~DfGla~~~ 928 (1117)
+ +++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+|+..
T Consensus 83 ~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9 789998887643 3489999999999999999999999 9999999999999974 578999999999987
Q ss_pred cCCCCCc---cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChh-HHHHHHHHHhcCC
Q 001238 929 EDDSGGS---FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQH-VIQWVRDHLKSKK 1004 (1117)
Q Consensus 929 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~-~~~~~~~~~~~~~ 1004 (1117)
....... .......+||+.|||||++.+..++.++|||||||++|||++|+.||.+....... ....+..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~--~ 234 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ--S 234 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH--H
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC--C
Confidence 6443221 12344578999999999999999999999999999999999999999754332221 1111111111 1
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQE 1059 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~~ 1059 (1117)
.+.. .+....+..+.++++. |++.+|++||+++.+.+.++++.+.
T Consensus 235 ~~~~----~l~~~~p~~l~~ii~~------~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 235 TPLR----ELCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp SCHH----HHTTTSCHHHHHHHHH------HHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CChH----HhcCCCCHHHHHHHHH------HhcCCcccCcCHHHHHHHHHHHHHH
Confidence 1111 1222233455555554 9999999999999999999887543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-40 Score=365.38 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=198.7
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCC-cceEEeeeecCCceEEEEEe
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRN-IVRLLGWGANRKTKLLFYDY 853 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~e~ 853 (1117)
++|++.+.||+|+||+||+|.+ .+|+.||||++..... .+++..|++++++++|++ |+.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4699999999999999999975 5689999999876432 346889999999998766 55556667788888999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcC---CCcceeccccccccccC
Q 001238 854 MPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGE---RYESCLADFGLARLVED 930 (1117)
Q Consensus 854 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~---~~~~kl~DfGla~~~~~ 930 (1117)
+. +++.+.+.... +.+++..+..++.|++.||+|||++ +||||||||+||+++. +..+|++|||+|+....
T Consensus 85 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 94 56655554432 3489999999999999999999999 9999999999999864 45799999999998765
Q ss_pred CCCCc---cccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCCCCc
Q 001238 931 DSGGS---FSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKKDPV 1007 (1117)
Q Consensus 931 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1117)
..... ........||+.|||||++.+..++.++|||||||++|||++|+.||......... .............+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHSCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-HHHHHhhcccCCCCh
Confidence 43221 22345668999999999999999999999999999999999999999754322111 111111111111111
Q ss_pred cccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001238 1008 EVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRPTMKDVAALLREIRQ 1058 (1117)
Q Consensus 1008 ~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RPs~~~v~~~L~~~~~ 1058 (1117)
+.+....+..+.++++. ||+.+|++||+++++.+.|+.+..
T Consensus 238 ----~~~~~~~p~~~~~li~~------cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 ----EVLCKGYPSEFATYLNF------CRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----HHHTTTSCHHHHHHHHH------HHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----hHhccCCCHHHHHHHHH------HccCChhHCcCHHHHHHHHHHHHH
Confidence 11222334455555555 999999999999999999987644
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-40 Score=366.43 Aligned_cols=268 Identities=22% Similarity=0.253 Sum_probs=195.0
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecC--CccchHHHHHHHHHHhccCCCCcceEEeeeec--------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRAS--DKISTGAFSSEIATLSRIRHRNIVRLLGWGAN-------- 843 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 843 (1117)
.++|++.++||+|+||+||+|++ .+|+.||||++... .....+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 35789999999999999999985 57999999998644 33345678999999999999999999998755
Q ss_pred CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccc
Q 001238 844 RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFG 923 (1117)
Q Consensus 844 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfG 923 (1117)
.+..++||||++++.+....... ..+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+|++|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 34679999999888776655443 3488999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhc
Q 001238 924 LARLVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKS 1002 (1117)
Q Consensus 924 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 1002 (1117)
+++................+||+.|+|||++... .+++++||||+||++|||++|+.||.+. ........+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~--~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN--TEQHQLALISQLCGS 240 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHHHCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC--CHHHHHHHHHHhcCC
Confidence 9987765433333344456899999999998654 6899999999999999999999999642 122222222222211
Q ss_pred CCCC-ccccC--------cccCCCCchhHHHH-------HHHHhHhhhccCCCCCCCCCHHHHHH
Q 001238 1003 KKDP-VEVLD--------PKLQGHPDTQIQEM-------LQALGISLLCTSNRAEDRPTMKDVAA 1051 (1117)
Q Consensus 1003 ~~~~-~~~~~--------~~l~~~~~~~~~~~-------l~~~~i~~~C~~~~p~~RPs~~~v~~ 1051 (1117)
.... ....+ ....... ...... ....+++..|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQK-RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCC-BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhccccccc-ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1000 00000 0000000 011111 11234566799999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-40 Score=370.93 Aligned_cols=196 Identities=30% Similarity=0.373 Sum_probs=164.0
Q ss_pred CCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCcceEEeeeecC------CceEE
Q 001238 777 SLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNIVRLLGWGANR------KTKLL 849 (1117)
Q Consensus 777 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 849 (1117)
+|+..++||+|+||+||+|++ .+|+.||||+++.... .+.+|++++++++|||||++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 477789999999999999986 4699999999976532 335799999999999999999988543 34689
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC-cceeccccccccc
Q 001238 850 FYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-ESCLADFGLARLV 928 (1117)
Q Consensus 850 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~~ 928 (1117)
||||++++.+..+.........+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998775555443322334599999999999999999999999 999999999999999775 8999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.... ......||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||..
T Consensus 174 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 174 VRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CTTS-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cCCc-----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 5432 2334679999999998764 5789999999999999999999999964
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-40 Score=369.51 Aligned_cols=202 Identities=25% Similarity=0.352 Sum_probs=168.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC-ccchHHHHHHHHHHhccCCCCcceEEeeeecCC----ceE
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD-KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK----TKL 848 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~ 848 (1117)
+.+|+++++||+|+||+||+|.. .+|+.||||+++... ....+++.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45689999999999999999974 679999999997543 333567889999999999999999999986643 235
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccc
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLV 928 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~ 928 (1117)
++++|+.+|+|.+++... .+++..++.++.|+++||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666777899999999754 389999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccCCccccccccCChhhhc-cCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 929 EDDSGGSFSANPQFAGSYGYIAPEYAN-MTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
..... ........+||+.|+|||++. ...++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 160 DPDHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CGGGC-BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCc-cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 54321 112234567999999999874 45678999999999999999999999965
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=366.96 Aligned_cols=195 Identities=27% Similarity=0.388 Sum_probs=164.1
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCC------
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRK------ 845 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 845 (1117)
.++|+++++||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999985 569999999997542 233457889999999999999999999987654
Q ss_pred ceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceecccccc
Q 001238 846 TKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLA 925 (1117)
Q Consensus 846 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla 925 (1117)
+.|+||||+ +++|..+.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 469999999 67788777643 399999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccCCccccccccCChhhhcc-CCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 926 RLVEDDSGGSFSANPQFAGSYGYIAPEYANM-TKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
+.... ..+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 169 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 169 RQADS-------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp EECCS-------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccCC-------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 87643 2345679999999998875 4578999999999999999999999965
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=363.86 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=201.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEc----CCCcEEEEEEeecC----CccchHHHHHHHHHHhccCC-CCcceEEeeeecCCc
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL----PSGLTVAVKRFRAS----DKISTGAFSSEIATLSRIRH-RNIVRLLGWGANRKT 846 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 846 (1117)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4688999999999999999974 25889999998643 22345678899999999977 899999999999999
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.++||||+.+|+|.+++.... .+.+..+..++.|++.||+|+|++ +||||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999987653 377899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCccccCCccccccccCChhhhccC--CCCcCCCeeehhhhHHHHHhCCCCCCCCCCCChhHHHHHHHHHhcCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMT--KISEKSDVYSYGVVLLEIITGKKPVDASFPDGQHVIQWVRDHLKSKK 1004 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~vl~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1117)
...... ........|++.|+|||.+... .++.++||||+||++|||++|+.||...... ..............
T Consensus 178 ~~~~~~---~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~-~~~~~i~~~~~~~~- 252 (322)
T d1vzoa_ 178 EFVADE---TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE- 252 (322)
T ss_dssp ECCGGG---GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHCC-
T ss_pred hhcccc---cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcccCC-
Confidence 764322 2234456899999999998654 4678999999999999999999999764332 22223333322222
Q ss_pred CCccccCcccCCCCchhHHHHHHHHhHhhhccCCCCCCCC-----CHHHHHH
Q 001238 1005 DPVEVLDPKLQGHPDTQIQEMLQALGISLLCTSNRAEDRP-----TMKDVAA 1051 (1117)
Q Consensus 1005 ~~~~~~~~~l~~~~~~~~~~~l~~~~i~~~C~~~~p~~RP-----s~~~v~~ 1051 (1117)
+.++...+..+.++++. |++.||++|| +++|+++
T Consensus 253 -------~~~~~~~s~~~~~li~~------~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -------PPYPQEMSALAKDLIQR------LLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCTTSCHHHHHHHHH------HTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCcccCCHHHHHHHHH------HcccCHHHcCCCCcccHHHHHc
Confidence 12233455567777766 9999999999 4788765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-39 Score=354.51 Aligned_cols=198 Identities=26% Similarity=0.347 Sum_probs=173.6
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecCCceEEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e 852 (1117)
++|++.++||+|+||+||+|++ .+|+.||||+++... .....++.+|+.+++.++|||||++++++.+.+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4788999999999999999985 578999999997543 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccccccCCC
Q 001238 853 YMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLARLVEDDS 932 (1117)
Q Consensus 853 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~~~~~~ 932 (1117)
++.++++..++... +.+++..++.++.|+++||+|||++ +||||||||+|||++.++.+|++|||.++......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999998887754 3488999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCccccCCccccccccCChhhhccCC-CCcCCCeeehhhhHHHHHhCCCCCC
Q 001238 933 GGSFSANPQFAGSYGYIAPEYANMTK-ISEKSDVYSYGVVLLEIITGKKPVD 983 (1117)
Q Consensus 933 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~vl~ell~g~~P~~ 983 (1117)
.......+++.|+|||.+.... ++.++||||+||++|||++|+.||.
T Consensus 156 ----~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 156 ----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp ----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ----ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 1233446788999999887654 6899999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-39 Score=360.52 Aligned_cols=192 Identities=23% Similarity=0.294 Sum_probs=167.2
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeec--CCceEEEE
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGAN--RKTKLLFY 851 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lv~ 851 (1117)
++|+++++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|++++++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999985 57999999998753 3567899999999995 9999999999874 45689999
Q ss_pred EecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCC-cceeccccccccccC
Q 001238 852 DYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERY-ESCLADFGLARLVED 930 (1117)
Q Consensus 852 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~-~~kl~DfGla~~~~~ 930 (1117)
||+++++|..+.+ .+++.+++.++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999977642 389999999999999999999999 999999999999998655 689999999987654
Q ss_pred CCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 931 DSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 183 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 183 GQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp TC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CC-----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 32 23456789999999987764 579999999999999999999999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-38 Score=356.62 Aligned_cols=195 Identities=23% Similarity=0.281 Sum_probs=158.9
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeec------CCc
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGAN------RKT 846 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 846 (1117)
++|++.++||+|+||+||+|.+ .+|+.||||+++... ....+++.+|+.++++++|||||++++++.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999985 469999999997543 3334568899999999999999999999864 367
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.|+||||+.++.+.. +.. .+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~-~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHH-HTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHh-hhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 899999997665544 332 288999999999999999999999 99999999999999999999999999988
Q ss_pred cccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
..... .......+|+.|+|||++.+..+++++||||+||++|||++|+.||.+
T Consensus 168 ~~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 168 TAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccc-----cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 66542 233456799999999999999999999999999999999999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-38 Score=358.53 Aligned_cols=196 Identities=25% Similarity=0.356 Sum_probs=165.7
Q ss_pred ccCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCC--ccchHHHHHHHHHHhccCCCCcceEEeeeecC-----Cc
Q 001238 775 TRSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASD--KISTGAFSSEIATLSRIRHRNIVRLLGWGANR-----KT 846 (1117)
Q Consensus 775 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 846 (1117)
.++|++.++||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999984 579999999997543 23345788999999999999999999988643 34
Q ss_pred eEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceeccccccc
Q 001238 847 KLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLADFGLAR 926 (1117)
Q Consensus 847 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~ 926 (1117)
.+++|+|+.+|+|.+++... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 46777888899999999653 399999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCCCccccCCccccccccCChhhhccC-CCCcCCCeeehhhhHHHHHhCCCCCCC
Q 001238 927 LVEDDSGGSFSANPQFAGSYGYIAPEYANMT-KISEKSDVYSYGVVLLEIITGKKPVDA 984 (1117)
Q Consensus 927 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~vl~ell~g~~P~~~ 984 (1117)
.... ......||+.|+|||..... .++.++||||+||++|||++|+.||.+
T Consensus 170 ~~~~-------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 170 HTDD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp CCTG-------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCc-------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 6532 33456799999999987654 568999999999999999999999964
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-33 Score=322.14 Aligned_cols=199 Identities=21% Similarity=0.220 Sum_probs=160.5
Q ss_pred cCCCCCCeeeecCCeEEEEEEc-CCCcEEEEEEeecCCccchHHHHHHHHHHhccC-----------CCCcceEEeeeec
Q 001238 776 RSLTAGNIIGQGRSGIVYKVTL-PSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-----------HRNIVRLLGWGAN 843 (1117)
Q Consensus 776 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~ 843 (1117)
.+|+++++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++++. |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999985 579999999997543 23467888999988875 5789999988754
Q ss_pred --CCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEcCCCc----
Q 001238 844 --RKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLGERYE---- 916 (1117)
Q Consensus 844 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~~---- 916 (1117)
....+++|+++..+..............+++..+..++.||++|++|||+ . +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 34566777776655443333322333458899999999999999999998 6 8999999999999987653
Q ss_pred --ceeccccccccccCCCCCccccCCccccccccCChhhhccCCCCcCCCeeehhhhHHHHHhCCCCCCCC
Q 001238 917 --SCLADFGLARLVEDDSGGSFSANPQFAGSYGYIAPEYANMTKISEKSDVYSYGVVLLEIITGKKPVDAS 985 (1117)
Q Consensus 917 --~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~vl~ell~g~~P~~~~ 985 (1117)
++++|||.++.... .....+||+.|+|||++....++.++||||+||+++||++|+.||...
T Consensus 169 ~~~kl~dfg~s~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEECCCTTCEETTB-------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ceeeEeeccccccccc-------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 89999999986543 223467999999999999999999999999999999999999999653
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=7.2e-30 Score=285.00 Aligned_cols=258 Identities=30% Similarity=0.477 Sum_probs=181.9
Q ss_pred ccceeecccccccC--CCcccccCCCCCCeeeccC-ccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEE
Q 001238 412 NLEAVDLSQNGLTG--PIPRGIFQLKKLNKLLLLS-NNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFL 488 (1117)
Q Consensus 412 ~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 488 (1117)
.++.|+|++|.+++ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|++++|++.+..+..+..+..|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 56777777777766 3566677777777777765 66666666666666666666666666666666666666666666
Q ss_pred EccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccC
Q 001238 489 DLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFA 568 (1117)
Q Consensus 489 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 568 (1117)
++++|++.+.+|..+..++.|+.+++++|.+.+.+|..+..+..+ ++.+++++|+++
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l-----------------------~~~l~~~~n~l~ 187 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL-----------------------FTSMTISRNRLT 187 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT-----------------------CCEEECCSSEEE
T ss_pred ccccccccccCchhhccCcccceeecccccccccccccccccccc-----------------------cccccccccccc
Confidence 666666666666666666666666666666666666655544433 244555566666
Q ss_pred CCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch-h
Q 001238 569 GSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF-L 647 (1117)
Q Consensus 569 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~-l 647 (1117)
+..|..+..+..+ .+++++|.+.+.+|..++.++.+ ..+++++|.+++.+| .+..+++|+.|||++|+++|.+|. +
T Consensus 188 ~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l-~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l 264 (313)
T d1ogqa_ 188 GKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNT-QKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCC-SEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred ccccccccccccc-ccccccccccccccccccccccc-ccccccccccccccc-ccccccccccccCccCeecccCChHH
Confidence 5556555555433 57777777777777777666666 567777777766554 577788888888888888876654 8
Q ss_pred hhcccceEEEeecccccCCCCCCcccccCCcccccCCCCCCcC-CCCCC
Q 001238 648 AELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFS-GNQCA 695 (1117)
Q Consensus 648 ~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gN~~~c~~-~~~c~ 695 (1117)
..+++|++|||++|+|+|.+|+...+.+++..++.||+.+||. .++|.
T Consensus 265 ~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 265 TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred hCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence 8888899999999999998998777888988999999999987 46773
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=4e-28 Score=279.13 Aligned_cols=356 Identities=27% Similarity=0.366 Sum_probs=175.2
Q ss_pred eccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCCCCC
Q 001238 104 VLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDNQLT 183 (1117)
Q Consensus 104 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 183 (1117)
.+..+++++.++. ..+.+|++|++++|+++ .+ +.+..|++|++|+|++|++++ +|. |++|++|++|++++|++.
T Consensus 28 ~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEECH--HHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccCH--HHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCC-Ccc-ccCCcccccccccccccc
Confidence 3444445444332 34455555555555554 23 235555555555555555553 222 555555555555555555
Q ss_pred CCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeecccccccccCCcCC
Q 001238 184 DAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLSGQIPPEL 263 (1117)
Q Consensus 184 ~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~~~~p~~l 263 (1117)
+. + .++++++|+.|++++|.... .........+.......+.+....+............... ......+
T Consensus 102 ~i-~-~l~~l~~L~~L~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 171 (384)
T d2omza2 102 DI-T-PLANLTNLTGLTLFNNQITD---IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQ-----VTDLKPL 171 (384)
T ss_dssp CC-G-GGTTCTTCCEEECCSSCCCC---CGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEES-----CCCCGGG
T ss_pred cc-c-cccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc-----cchhhhh
Confidence 32 2 24555555555554443211 0111122223333333333322111111111111111100 0111223
Q ss_pred CCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcce
Q 001238 264 GDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQE 343 (1117)
Q Consensus 264 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~ 343 (1117)
...+.........|... ....+..+++++.+++++|.+++..| +..+++|+.|++++|.++. ++ .+..+++|+.
T Consensus 172 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 245 (384)
T d2omza2 172 ANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTD 245 (384)
T ss_dssp TTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred ccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-cc-hhhcccccch
Confidence 33333444444444333 23334445555555555555554322 2334455555555555552 22 3444555555
Q ss_pred EecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccc
Q 001238 344 LQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGL 423 (1117)
Q Consensus 344 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 423 (1117)
|++++|.+++..+ +..+++|++|++++|++++ .. .+..++.++.++++.|.+
T Consensus 246 L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~------------------------~~--~~~~~~~l~~l~~~~n~l 297 (384)
T d2omza2 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISN------------------------IS--PLAGLTALTNLELNENQL 297 (384)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC------------------------CG--GGTTCTTCSEEECCSSCC
T ss_pred hccccCccCCCCc--ccccccCCEeeccCcccCC------------------------CC--cccccccccccccccccc
Confidence 5555555543222 4444555555555554442 21 134455566666666666
Q ss_pred cCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCccc
Q 001238 424 TGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEI 503 (1117)
Q Consensus 424 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 503 (1117)
++ ...+..+..++.|++++|++++.. .+..+++|++|++++|+|++. + .|+++++|++|+|++|+|++..| +
T Consensus 298 ~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l 369 (384)
T d2omza2 298 ED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--L 369 (384)
T ss_dssp SC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--G
T ss_pred cc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--h
Confidence 53 223555666677777777776543 266677777777777777643 2 57777888888888888876544 7
Q ss_pred ccCCCCceEEccCC
Q 001238 504 TGCRNLTFLDVHSN 517 (1117)
Q Consensus 504 ~~l~~L~~L~Ls~N 517 (1117)
.++++|+.|+|++|
T Consensus 370 ~~l~~L~~L~L~~N 383 (384)
T d2omza2 370 ANLTRITQLGLNDQ 383 (384)
T ss_dssp TTCTTCSEEECCCE
T ss_pred ccCCCCCEeeCCCC
Confidence 77888888888776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=7.5e-28 Score=276.79 Aligned_cols=340 Identities=26% Similarity=0.320 Sum_probs=160.9
Q ss_pred CCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEec
Q 001238 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQL 346 (1117)
Q Consensus 267 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L 346 (1117)
.+|++|++++|.|+. + ..+..+++|++|+|++|+|++. + .++++++|++|++++|++.+. + .++++++|+.|++
T Consensus 44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccc-c-ccccccccccccc
Confidence 345555555555542 2 2344555555555555555532 1 255555555555555555532 2 1455555555555
Q ss_pred ccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCC
Q 001238 347 SVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP 426 (1117)
Q Consensus 347 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 426 (1117)
++|.+++..+ ......+..+....|.+....+................ .....+...+.........|...
T Consensus 118 ~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-- 188 (384)
T d2omza2 118 FNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV-----TDLKPLANLTTLERLDISSNKVS-- 188 (384)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESC-----CCCGGGTTCTTCCEEECCSSCCC--
T ss_pred cccccccccc--cccccccccccccccccccccccccccccccccccccc-----chhhhhccccccccccccccccc--
Confidence 5555543222 22233444444444444422221111111111000000 11111222333333444444332
Q ss_pred CcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccC
Q 001238 427 IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506 (1117)
Q Consensus 427 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 506 (1117)
....+..+++++.+++++|.+++..| +..+++|++|++++|++++. +.+..+++|+.|++++|++++.. .+..+
T Consensus 189 ~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~ 262 (384)
T d2omza2 189 DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGL 262 (384)
T ss_dssp CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTC
T ss_pred cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--ccccc
Confidence 23344555566666666666654432 34445555566666655532 24555566666666666665432 25555
Q ss_pred CCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEec
Q 001238 507 RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDL 586 (1117)
Q Consensus 507 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 586 (1117)
++|++|++++|++.+..+ +..+..++.++++.|.+.++. .+..+++++.|++++|++++.. .+..+++|+.|++
T Consensus 263 ~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~~--~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS--PISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCG--GGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEEC
T ss_pred ccCCEeeccCcccCCCCc--ccccccccccccccccccccc--ccchhcccCeEECCCCCCCCCc--ccccCCCCCEEEC
Confidence 566666666665554322 444444444455544444321 2344444444444444444332 1444444444444
Q ss_pred cccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcchhhhcccceEEEeecc
Q 001238 587 SSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSHN 661 (1117)
Q Consensus 587 s~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~l~~l~~L~~L~ls~N 661 (1117)
++|+|+ + ++ .|.++++|++|||++|++++.++ +..+++|+.|+|++|
T Consensus 337 ~~n~l~-------------------------~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 337 ANNKVS-------------------------D-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCC-------------------------C-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCCCC-------------------------C-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 444444 2 22 35566777777777777765443 666777777777776
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=2.5e-25 Score=246.93 Aligned_cols=280 Identities=22% Similarity=0.315 Sum_probs=141.2
Q ss_pred CcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEeccc
Q 001238 269 LQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSV 348 (1117)
Q Consensus 269 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~ 348 (1117)
++.++-++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|++++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 455666666666 4555543 4566666666666654445566666666666666666655566666666666666666
Q ss_pred ccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcccccc--ccCCCCCCcccccceeecccccccCC
Q 001238 349 NQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLE--GEIPPSISNCQNLEAVDLSQNGLTGP 426 (1117)
Q Consensus 349 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~ 426 (1117)
|+|+ .+|..+ ...++.|++.+|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.++ .
T Consensus 89 n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~ 164 (305)
T d1xkua_ 89 NQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 164 (305)
T ss_dssp SCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-S
T ss_pred CccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-c
Confidence 6666 333322 235566666666665443333333333333333333221 122233344444555555555444 2
Q ss_pred CcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccC
Q 001238 427 IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGC 506 (1117)
Q Consensus 427 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 506 (1117)
+|..+ +++|++|++++|.+. +..+..|..++.+++|++++|.+++..+..+.++
T Consensus 165 l~~~~--~~~L~~L~l~~n~~~------------------------~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l 218 (305)
T d1xkua_ 165 IPQGL--PPSLTELHLDGNKIT------------------------KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218 (305)
T ss_dssp CCSSC--CTTCSEEECTTSCCC------------------------EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred cCccc--CCccCEEECCCCcCC------------------------CCChhHhhcccccccccccccccccccccccccc
Confidence 33222 234444444444444 4444444444444444444444444444444444
Q ss_pred CCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCc------CCCccccEEeccccccC--CCCCcccccc
Q 001238 507 RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDL------GSLSSLTKLVLNKNRFA--GSIPSQLGSC 578 (1117)
Q Consensus 507 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~------~~l~~L~~L~L~~N~l~--~~~~~~~~~l 578 (1117)
++|++|+|++|+|+. +|.+|..+++|+.|+|++|+|+.++...| ..+.+|+.|+|++|++. ...|.+|.-+
T Consensus 219 ~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~ 297 (305)
T d1xkua_ 219 PHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297 (305)
T ss_dssp TTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred ccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhccc
Confidence 444444444444442 23344444444444444444444443333 34566777777777765 3455555544
Q ss_pred ccee
Q 001238 579 VKLQ 582 (1117)
Q Consensus 579 ~~L~ 582 (1117)
....
T Consensus 298 ~~~~ 301 (305)
T d1xkua_ 298 YVRA 301 (305)
T ss_dssp CCGG
T ss_pred ccCc
Confidence 4333
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.3e-24 Score=240.97 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=208.2
Q ss_pred cCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCC
Q 001238 258 QIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGN 337 (1117)
Q Consensus 258 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~ 337 (1117)
.+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++|+++ .+|..+
T Consensus 24 ~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~-- 98 (305)
T d1xkua_ 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM-- 98 (305)
T ss_dssp SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--
T ss_pred ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch--
Confidence 3455443 57888888888888544457888888888888888888777788888888888888888888 455433
Q ss_pred CCCcceEecccccccCcccccccCCCCCcEEEecCcccc--CCCCcccccccchHHHHhccccccccCCCCCCcccccce
Q 001238 338 LTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQIT--GAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEA 415 (1117)
Q Consensus 338 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 415 (1117)
...++.|++++|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|+++ .+|..+ +++|+.
T Consensus 99 ~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~ 175 (305)
T d1xkua_ 99 PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTE 175 (305)
T ss_dssp CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSE
T ss_pred hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCE
Confidence 357888888888888777777777788888888877543 344567788888889999999887 344443 578999
Q ss_pred eecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcC
Q 001238 416 VDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRL 495 (1117)
Q Consensus 416 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 495 (1117)
|++++|.+++..+..+..++.++.|++++|++.+..+..|.++++|++|+|++|+|+ .+|..|.++++|++|+|++|+|
T Consensus 176 L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i 254 (305)
T d1xkua_ 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254 (305)
T ss_dssp EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred EECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCcc
Confidence 999999999888888999999999999999999988889999999999999999998 4577899999999999999999
Q ss_pred CCCCCccc------ccCCCCceEEccCCccc--cccchhhhcccc
Q 001238 496 TGSIPDEI------TGCRNLTFLDVHSNSIA--GNLPAGLHQLVR 532 (1117)
Q Consensus 496 ~~~~p~~~------~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~ 532 (1117)
+.+....| ..+.+|+.|+|++|.++ ...|..|.-+..
T Consensus 255 ~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~ 299 (305)
T d1xkua_ 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299 (305)
T ss_dssp CCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCC
T ss_pred CccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhccccc
Confidence 86544443 35677888888888775 344555554433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.1e-25 Score=244.65 Aligned_cols=251 Identities=23% Similarity=0.277 Sum_probs=199.9
Q ss_pred eeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEcc-CC
Q 001238 415 AVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLG-SN 493 (1117)
Q Consensus 415 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls-~N 493 (1117)
.++.++++++ .+|..+. +.+++|+|++|+|+.+.+..|.++++|++|++++|++....+..+.++..++.++.+ .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 4556666666 4665543 456778888888877766777888888888888888877777777777777777654 56
Q ss_pred cCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCc
Q 001238 494 RLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPS 573 (1117)
Q Consensus 494 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 573 (1117)
.++...+..|.++++|++|++++|.+....+..+....+|+.+++++|+|+++++..|..+++|+.|++++|+|++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 66666677788888888888888888777777777778888888888888888888888888888888888888877788
Q ss_pred ccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcchhhhcccc
Q 001238 574 QLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNL 653 (1117)
Q Consensus 574 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~l~~l~~L 653 (1117)
+|..+++|+.+++++|++++..|..|..++++ ++|++++|++++..|..|..+++|+.|+|++|++.|+++..+-...+
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L-~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l 250 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL-MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL 250 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTC-CEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHH
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhc-ccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHH
Confidence 88888888888888888888788888888887 78888888888888889999999999999999999998765445567
Q ss_pred eEEEeecccccCCCCC
Q 001238 654 VVLNVSHNNFSGRVPD 669 (1117)
Q Consensus 654 ~~L~ls~N~l~~~~p~ 669 (1117)
+.+....+++.+..|.
T Consensus 251 ~~~~~~~~~~~C~~p~ 266 (284)
T d1ozna_ 251 QKFRGSSSEVPCSLPQ 266 (284)
T ss_dssp HHCCSEECCCBEEESG
T ss_pred HhCcCCCCceEeCCch
Confidence 7888888888887665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1e-24 Score=239.14 Aligned_cols=236 Identities=23% Similarity=0.217 Sum_probs=155.6
Q ss_pred chHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeecc-CccCCCCCCCCcccccccceecc
Q 001238 388 NLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLL-SNNLSGVIPPEMGNCSSLIRFRA 466 (1117)
Q Consensus 388 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~l 466 (1117)
++++|+|++|+|++..+..|.++++|++|++++|++....+..+..+..++.+... .|.++...+..|.++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 34455555555554444455566666666666666665555555555666665543 45555555666777777777777
Q ss_pred CCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCC
Q 001238 467 NSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGM 546 (1117)
Q Consensus 467 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 546 (1117)
++|.+....+..+...++|+.+++++|+|+++.+..|..+++|+.|++++|+|++..+..|..+++|+.+++++|+++++
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 77777666666677777777777777777766666677777777777777777776677777777777777777777777
Q ss_pred CCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCcccccc
Q 001238 547 LSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELT 625 (1117)
Q Consensus 547 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~ 625 (1117)
.+..|..+++|+.|++++|++.+..+..|..+.+|+.|+|++|.+...-+ +..+....+.+....++++...|..+.
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~--~~~l~~~l~~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG--GHHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc--chHHHHHHHhCcCCCCceEeCCchHHc
Confidence 77777777788888888888887777778888888888888888875432 111222224555555666655555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=8.9e-23 Score=220.91 Aligned_cols=205 Identities=25% Similarity=0.215 Sum_probs=133.1
Q ss_pred ccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEE
Q 001238 410 CQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLD 489 (1117)
Q Consensus 410 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 489 (1117)
...+.+++.+++.|+ .+|..+. +.+++|+|++|+|+++.+..|.++++|++|+|++|+|+.. + .++.+++|++|+
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~ 83 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLD 83 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEE
T ss_pred cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccc
Confidence 344555677777777 4665543 3566777777777666556666666777777777766633 2 345666777777
Q ss_pred ccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCC
Q 001238 490 LGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAG 569 (1117)
Q Consensus 490 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 569 (1117)
|++|+++ ..+..+.++++|++|++++|.+.+..+..+..+.+++.|++++|.++.+++..+..+++|+.|++++|+|++
T Consensus 84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~ 162 (266)
T d1p9ag_ 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (266)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred ccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence 7777776 345566666677777777766666555556666666666666666666666556666666666666666665
Q ss_pred CCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcch
Q 001238 570 SIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHF 646 (1117)
Q Consensus 570 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~ 646 (1117)
..+..|..+++|++|||++|+|+ .+|..+..+++|+.|+|++|+|.|++..
T Consensus 163 ~~~~~~~~l~~L~~L~Ls~N~L~--------------------------~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 163 LPAGLLNGLENLDTLLLQENSLY--------------------------TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCC--------------------------CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cCccccccccccceeecccCCCc--------------------------ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 55555555666666666666555 4455556678899999999999997653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.1e-22 Score=208.29 Aligned_cols=163 Identities=15% Similarity=0.233 Sum_probs=121.4
Q ss_pred CCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCcc------------------chHHHHHHHHHHhccCCCCcceEEee
Q 001238 779 TAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKI------------------STGAFSSEIATLSRIRHRNIVRLLGW 840 (1117)
Q Consensus 779 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~niv~l~~~ 840 (1117)
.++++||+|+||+||+|...+|+.||||+++..... ......+|++.+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999888999999987532110 01234568889999999999998875
Q ss_pred eecCCceEEEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceeeeccccCeEEEcCCCcceec
Q 001238 841 GANRKTKLLFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDCVPAILHRDVKSHNILLGERYESCLA 920 (1117)
Q Consensus 841 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~Nill~~~~~~kl~ 920 (1117)
.. .+++|||++++.+.. ++...+.+++.|+++|++|||++ +|+||||||+|||++++ .++++
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 32 379999998865533 33344567999999999999999 99999999999999965 48899
Q ss_pred cccccccccCCCCCccccCCccccccccCCh------hhhccCCCCcCCCeeehhhhH
Q 001238 921 DFGLARLVEDDSGGSFSANPQFAGSYGYIAP------EYANMTKISEKSDVYSYGVVL 972 (1117)
Q Consensus 921 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dv~SlG~vl 972 (1117)
|||+|+....... ..|... |.+ .+.|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW------------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999986543211 111111 121 36788999999986443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=8.8e-22 Score=212.98 Aligned_cols=199 Identities=27% Similarity=0.290 Sum_probs=125.2
Q ss_pred CCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhc
Q 001238 316 QLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVW 395 (1117)
Q Consensus 316 ~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 395 (1117)
.+...|.+++.|+ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+.. + .++.+++|+.|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccc
Confidence 3334444444444 2343332 3445555555555443344445555555555555555422 1 23344455555555
Q ss_pred cccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccC
Q 001238 396 HNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFI 475 (1117)
Q Consensus 396 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 475 (1117)
+|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++...+..+..++.++.+++++|+|++..
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence 55554 23445666677777777777777655566666777777777777777777777777778888888888887777
Q ss_pred CCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCcccc
Q 001238 476 PPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG 521 (1117)
Q Consensus 476 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 521 (1117)
+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 777888888888888888887 677777778888888888887763
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.81 E-value=1.2e-18 Score=196.24 Aligned_cols=200 Identities=26% Similarity=0.321 Sum_probs=120.5
Q ss_pred CCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEec
Q 001238 267 TELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQL 346 (1117)
Q Consensus 267 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~L 346 (1117)
.++++|+|++|.++ .+|+. .++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 36889999999998 57864 468899999999998 567654 57889999999988 34432 146899999
Q ss_pred ccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCC
Q 001238 347 SVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP 426 (1117)
Q Consensus 347 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 426 (1117)
++|.+. .+|. ++.+++|+.|++++|.+... +..+ ..+..+.+..+... ....+..++.++.+++++|.+..
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~- 176 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK- 176 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS-
T ss_pred cccccc-cccc-hhhhccceeecccccccccc-cccc---ccccchhhcccccc--ccccccccccceecccccccccc-
Confidence 999988 4554 57788999999988888743 3332 23334444444332 23445566667777777766652
Q ss_pred CcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCC
Q 001238 427 IPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLT 496 (1117)
Q Consensus 427 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 496 (1117)
.+.. ....+.+...++.+.. + ..+..++.|+.+++++|.... .+. ...++..+++.+|.+.
T Consensus 177 ~~~~---~~~~~~l~~~~~~~~~-~-~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~ 237 (353)
T d1jl5a_ 177 LPDL---PLSLESIVAGNNILEE-L-PELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLT 237 (353)
T ss_dssp CCCC---CTTCCEEECCSSCCSS-C-CCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCS
T ss_pred cccc---cccccccccccccccc-c-ccccccccccccccccccccc-ccc---cccccccccccccccc
Confidence 2221 1223344444444331 1 123444555555555554432 111 1233444455554443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=4.4e-18 Score=191.64 Aligned_cols=261 Identities=26% Similarity=0.317 Sum_probs=157.0
Q ss_pred cccceeecccccccccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEc
Q 001238 243 KRLQTIAIYTALLSGQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDI 322 (1117)
Q Consensus 243 ~~L~~L~l~~~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdL 322 (1117)
.++++|+++++.++ .+|+. .++|++|+|++|+|+ .+|..+ .+|++|++++|+++. ++.. .+.|++||+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---ccccccccc
Confidence 35778888888775 46653 457888888888888 667654 467888888888773 3321 135888888
Q ss_pred CCCcCCCCCccccCCCCCcceEecccccccCcccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhcccccccc
Q 001238 323 SMNSLTGSIPQTLGNLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGE 402 (1117)
Q Consensus 323 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 402 (1117)
++|.++ .+|. ++.+++|+.|++++|.+... +.. ...+..+.+.++... ....+..++.++.+++.+|.+..
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~- 176 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK- 176 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS-
T ss_pred cccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc--ccccccccccceecccccccccc-
Confidence 888887 4553 56788888888888877633 322 345666777666554 23456677777888888887763
Q ss_pred CCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCC
Q 001238 403 IPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNL 482 (1117)
Q Consensus 403 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 482 (1117)
.+... ...+.+..+++.+. .++ .+..++.|+.+++++|.... .+. ...++..+.+..|.+... + ...
T Consensus 177 ~~~~~---~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~-~---~~~ 243 (353)
T d1jl5a_ 177 LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDL-P---ELP 243 (353)
T ss_dssp CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCC-C---CCC
T ss_pred ccccc---cccccccccccccc-ccc-cccccccccccccccccccc-ccc---cccccccccccccccccc-c---ccc
Confidence 22221 23455666666555 333 34567788888888887663 232 234566677777776632 2 223
Q ss_pred CCCCEEEccCCcCCCCCCcccccC-CCCceEEccCCccccccchhhhcccccccccccCCcCCCC
Q 001238 483 KNLNFLDLGSNRLTGSIPDEITGC-RNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGM 546 (1117)
Q Consensus 483 ~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~ 546 (1117)
..+...++..|.+.+. ..+ ......++..|.+.+.. ..+++|++|++++|+|+.+
T Consensus 244 ~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~~----~~~~~L~~L~Ls~N~l~~l 299 (353)
T d1jl5a_ 244 QSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRSLC----DLPPSLEELNVSNNKLIEL 299 (353)
T ss_dssp TTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEEC----CCCTTCCEEECCSSCCSCC
T ss_pred cccccccccccccccc-----ccccchhcccccccCcccccc----ccCCCCCEEECCCCccCcc
Confidence 4566677766665432 111 23445555555555321 1233444555555544443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=3.1e-18 Score=174.78 Aligned_cols=175 Identities=21% Similarity=0.224 Sum_probs=122.5
Q ss_pred ceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCC-CCCcccccCCCCceEEccCCccccccchhhhcccccccccccC
Q 001238 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTG-SIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSD 540 (1117)
Q Consensus 462 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 540 (1117)
+.++.++|+++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|+|++|.+....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 34556666666 3444432 467777777777765 3455667777788888877777777777777777888888888
Q ss_pred CcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCc
Q 001238 541 NSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGEL 620 (1117)
Q Consensus 541 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~ 620 (1117)
|+|+.+++.+|.++++|++|+|++|+|++..+++|..+++|++|+|++|.+....+.. .+......+.+..|.++...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~--~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA--WFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH--HHHHHHHHHCCSGGGCBBCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH--HHhhhhhhhcccCCCeEeCC
Confidence 8888888888888888888888888888777888888888888888888887443211 12222356677777777666
Q ss_pred cccccCCCCccEEeccCccccCCc
Q 001238 621 PAELTGLNKLGILDLSHNELSGDL 644 (1117)
Q Consensus 621 p~~l~~l~~L~~LdLs~N~l~~~~ 644 (1117)
|..+ ..++.+||+.|.+.|..
T Consensus 166 p~~l---~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 166 PSKV---RDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp STTT---TTSBGGGSCTTTCCCCC
T ss_pred Chhh---cCCEeeecCHhhCcCCC
Confidence 6543 44556677777776644
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=5.9e-18 Score=179.92 Aligned_cols=217 Identities=18% Similarity=0.193 Sum_probs=98.7
Q ss_pred cEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccCCCCCcceEecccccccCcc-cccccCCCCCcEEEecC
Q 001238 294 VNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLGNLTSLQELQLSVNQISGEI-PAQIGNCQRLAQIELDN 372 (1117)
Q Consensus 294 ~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~ 372 (1117)
+.++.++++++ .+|+.+. +++++|||++|+|+...+..|.++++|++|+|++|.+...+ +..|.++++++++.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 34555555555 3443331 34555555555555433334555555555555555554322 23444555555554432
Q ss_pred -ccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcc-cccCCCCCCeeeccCccCCCC
Q 001238 373 -NQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPR-GIFQLKKLNKLLLLSNNLSGV 450 (1117)
Q Consensus 373 -N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~ 450 (1117)
|.+....+..|. ++++|++|++++|.+....+. .+..+..+..+...++++..+
T Consensus 88 ~n~l~~~~~~~~~------------------------~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i 143 (242)
T d1xwdc1 88 ANNLLYINPEAFQ------------------------NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 143 (242)
T ss_dssp CTTCCEECTTSEE------------------------CCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEE
T ss_pred ccccccccccccc------------------------ccccccccccchhhhcccccccccccccccccccccccccccc
Confidence 344433444444 444444444444444321111 111233333333344444444
Q ss_pred CCCCccccc-ccceeccCCCcccccCCCCcCCCCCCC-EEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhh
Q 001238 451 IPPEMGNCS-SLIRFRANSNKLTGFIPPEIGNLKNLN-FLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLH 528 (1117)
Q Consensus 451 ~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 528 (1117)
.+..|.+++ .++.|++++|+++...+..|. ..+++ .+++++|+|+.+.+..|.++++|++|+|++|+|+...+..|.
T Consensus 144 ~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~ 222 (242)
T d1xwdc1 144 ERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 222 (242)
T ss_dssp CTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred cccccccccccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence 344444332 445555555555533333332 22322 233455555544344455555555555555555544444455
Q ss_pred cccccccccc
Q 001238 529 QLVRLQFADL 538 (1117)
Q Consensus 529 ~l~~L~~L~L 538 (1117)
++++|+.+++
T Consensus 223 ~l~~L~~l~~ 232 (242)
T d1xwdc1 223 NLKKLRARST 232 (242)
T ss_dssp TCCEEESSSE
T ss_pred CCcccccCcC
Confidence 5555555444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1.8e-17 Score=174.14 Aligned_cols=210 Identities=25% Similarity=0.362 Sum_probs=124.1
Q ss_pred cccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCccccccccee
Q 001238 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464 (1117)
Q Consensus 385 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 464 (1117)
.+.++..++++.+++++.. .+..+.+|++|++.+|.|+. + ..+..+++|++|++++|++++..| +..+++|+++
T Consensus 17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence 4555666777777777543 45667778888888887774 4 346777777777777777765432 6666777777
Q ss_pred ccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCC
Q 001238 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG 544 (1117)
Q Consensus 465 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 544 (1117)
++++|.++.. ..+..+++|+.+++++|...+. ..+...+.+..+.++++.+.... .+...++|+.|++++|.+.
T Consensus 91 ~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 91 ELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp ECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCC
T ss_pred cccccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccc
Confidence 7777766633 2466667777777777766533 23555566666666666665332 2444555555555555554
Q ss_pred CCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccc
Q 001238 545 GMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAEL 624 (1117)
Q Consensus 545 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l 624 (1117)
+.. .|.++++|+.|+|++|++++. + .|..+++|+ +|+|++|+|++..| +
T Consensus 165 ~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~-------------------------~L~Ls~N~lt~i~~--l 213 (227)
T d1h6ua2 165 DLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLI-------------------------EVHLKNNQISDVSP--L 213 (227)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCC-------------------------EEECTTSCCCBCGG--G
T ss_pred cch--hhcccccceecccCCCccCCC-h-hhcCCCCCC-------------------------EEECcCCcCCCCcc--c
Confidence 332 244444444444444444432 1 134444444 45555555543322 6
Q ss_pred cCCCCccEEeccC
Q 001238 625 TGLNKLGILDLSH 637 (1117)
Q Consensus 625 ~~l~~L~~LdLs~ 637 (1117)
.++++|+.||+++
T Consensus 214 ~~l~~L~~L~lsn 226 (227)
T d1h6ua2 214 ANTSNLFIVTLTN 226 (227)
T ss_dssp TTCTTCCEEEEEE
T ss_pred ccCCCCCEEEeeC
Confidence 6777888888863
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=3.7e-21 Score=225.64 Aligned_cols=210 Identities=22% Similarity=0.143 Sum_probs=100.7
Q ss_pred CCCeeeccCccCCCCCC----CCcccccccceeccCCCcccc-----cCCCCcCCCCCCCEEEccCCcCCCC----CCcc
Q 001238 436 KLNKLLLLSNNLSGVIP----PEMGNCSSLIRFRANSNKLTG-----FIPPEIGNLKNLNFLDLGSNRLTGS----IPDE 502 (1117)
Q Consensus 436 ~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 502 (1117)
....+++..+.+..... ..+...+.++.+++.+|++.. ..+..+.....++.|++++|.+... ....
T Consensus 199 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~ 278 (460)
T d1z7xw1 199 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 278 (460)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred cccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccc
Confidence 44455555554432110 112234555566666655432 1122233345566666666665422 1122
Q ss_pred cccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCc----ccccc
Q 001238 503 ITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPS----QLGSC 578 (1117)
Q Consensus 503 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l 578 (1117)
+...+.++.+++++|.+.......+... .......|+.+++++|.++..... .+..+
T Consensus 279 l~~~~~l~~l~l~~n~i~~~~~~~l~~~-------------------l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~ 339 (460)
T d1z7xw1 279 LRAKESLKELSLAGNELGDEGARLLCET-------------------LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 339 (460)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHH-------------------HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHC
T ss_pred ccccccccccccccccccccccchhhcc-------------------ccccccccccccccccchhhhhhhhcccccccc
Confidence 3345566666666666543222221110 001123445555555554432211 22233
Q ss_pred cceeEEeccccccccc----cccccCC-chhHHHhhcCCCCcccC----CccccccCCCCccEEeccCccccCCcch---
Q 001238 579 VKLQLLDLSSNQLSGN----IPASLGK-IPALAIALNLSWNQICG----ELPAELTGLNKLGILDLSHNELSGDLHF--- 646 (1117)
Q Consensus 579 ~~L~~L~Ls~N~l~~~----~p~~l~~-l~~l~~~L~Ls~N~l~~----~~p~~l~~l~~L~~LdLs~N~l~~~~~~--- 646 (1117)
.+|++|||++|++++. ++..+.. .+.| +.|+|++|+|+. .+++.+..+++|+.|||++|+++.....
T Consensus 340 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L-~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~ 418 (460)
T d1z7xw1 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVL-RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418 (460)
T ss_dssp SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCC-CEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHH
T ss_pred cchhhhheeeecccCcccchhhhhhhcccCCC-CEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHH
Confidence 4566666666665432 2222322 2223 456666666653 2444566677888888888887643211
Q ss_pred --hh-hcccceEEEeecccccC
Q 001238 647 --LA-ELQNLVVLNVSHNNFSG 665 (1117)
Q Consensus 647 --l~-~l~~L~~L~ls~N~l~~ 665 (1117)
+. ....|+.|++++|.+..
T Consensus 419 ~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 419 ESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHTSTTCCCCEEECTTCCCCH
T ss_pred HHHHhCCCccCEEECCCCCCCH
Confidence 11 22357888888887764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=6.2e-18 Score=177.72 Aligned_cols=208 Identities=27% Similarity=0.383 Sum_probs=122.0
Q ss_pred cccCCeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEe
Q 001238 97 LLSLNRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLF 176 (1117)
Q Consensus 97 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~ 176 (1117)
+.++..++++.+++++.+ .+..|.+|++|++++|+++ .++ .+..+++|++|+|++|++++..| +.++++|++|+
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 344444556666666433 3456666677777777666 343 46666666666666666664333 66666666666
Q ss_pred ccCCCCCCCCcccccCcccchhhhccCCCCCCCCCCccccccccccccccccccccccCCcccccccccceeeccccccc
Q 001238 177 LYDNQLTDAIPATIGKLKNLEAIRAGGNKNLGGSLPHEIGNCTNLVMIGLAETSISGFLPPTLGLLKRLQTIAIYTALLS 256 (1117)
Q Consensus 177 L~~N~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~lp~~l~~l~~L~~L~l~~~~~~~~lp~~l~~l~~L~~L~l~~~~l~ 256 (1117)
+++|.++. ++ .+..+++|+.+.++++. ..
T Consensus 92 ~~~n~~~~-i~-~l~~l~~L~~l~l~~~~-------------------------~~------------------------ 120 (227)
T d1h6ua2 92 LSGNPLKN-VS-AIAGLQSIKTLDLTSTQ-------------------------IT------------------------ 120 (227)
T ss_dssp CCSCCCSC-CG-GGTTCTTCCEEECTTSC-------------------------CC------------------------
T ss_pred cccccccc-cc-ccccccccccccccccc-------------------------cc------------------------
Confidence 66666652 22 24444444444443332 21
Q ss_pred ccCCcCCCCCCCCcEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCCCccccC
Q 001238 257 GQIPPELGDCTELQYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGSIPQTLG 336 (1117)
Q Consensus 257 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~l~ 336 (1117)
+ ...+...+.++.+.++.+.+... ..+.+.++|++|++++|.+.+. ..++++++|+.|||++|++++ ++ .++
T Consensus 121 ~--~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~ 192 (227)
T d1h6ua2 121 D--VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-IS-PLA 192 (227)
T ss_dssp C--CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGG
T ss_pred c--cchhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCccCC-Ch-hhc
Confidence 1 11234445666666666666532 2355666777777777766533 236677777777777777764 33 266
Q ss_pred CCCCcceEecccccccCcccccccCCCCCcEEEec
Q 001238 337 NLTSLQELQLSVNQISGEIPAQIGNCQRLAQIELD 371 (1117)
Q Consensus 337 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 371 (1117)
++++|++|+|++|++++..| +.++++|+.|+++
T Consensus 193 ~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp GCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred CCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 77777777777777774332 6677777777775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.2e-17 Score=177.54 Aligned_cols=201 Identities=16% Similarity=0.110 Sum_probs=119.4
Q ss_pred chHHHHhccccccccCCCCCCcccccceeecccccccCCC-cccccCCCCCCeeecc-CccCCCCCCCCcccccccceec
Q 001238 388 NLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPI-PRGIFQLKKLNKLLLL-SNNLSGVIPPEMGNCSSLIRFR 465 (1117)
Q Consensus 388 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~ 465 (1117)
++++|++++|+++...+..|.++++|++|++++|.+...+ +..|..++.++++.+. .|++....+..|.++++|+.++
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 3445555555554333344555555555555555554332 2234455555555544 2455555555566666666666
Q ss_pred cCCCcccccCCC-CcCCCCCCCEEEccCCcCCCCCCcccccCC-CCceEEccCCccccccchhhhcccccccccccCCcC
Q 001238 466 ANSNKLTGFIPP-EIGNLKNLNFLDLGSNRLTGSIPDEITGCR-NLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSV 543 (1117)
Q Consensus 466 l~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i 543 (1117)
+++|+++...+. .+..++.+..+..+++++....+..|.+++ .++.|++++|+++...+..|.....++.+++++|+|
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l 189 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTC
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhcccccccccc
Confidence 666666533221 233455555666666666655556666554 577777777777755554444433344445677777
Q ss_pred CCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccc
Q 001238 544 GGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSS 588 (1117)
Q Consensus 544 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 588 (1117)
+.++...|.++++|+.|+|++|+|+...+..|..+.+|+.|++.+
T Consensus 190 ~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 777777777778888888888888766666677777777776643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=6e-18 Score=172.61 Aligned_cols=176 Identities=20% Similarity=0.227 Sum_probs=122.4
Q ss_pred CCEEEccCCcCCCCCCcccccCCCCceEEccCCcccc-ccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEecc
Q 001238 485 LNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG-NLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLN 563 (1117)
Q Consensus 485 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~ 563 (1117)
.+.+++++|+++ .+|..+. +++++|+|++|+|++ ..+..|..+++|+.|++++|.+..+.+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 457888888888 5665543 577888888888865 334456666666666666666666666666666666666666
Q ss_pred ccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCC
Q 001238 564 KNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGD 643 (1117)
Q Consensus 564 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~ 643 (1117)
+|+|+...+.+|.++++|++|+|++|+|+ +..|..|..+++|++|+|++|++.++
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~-------------------------~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQIS-------------------------CVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCC-------------------------EECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccCHHHHhCCCcccccccCCcccc-------------------------ccCHHHhcCCcccccccccccccccc
Confidence 66666555556666666666666666555 44455677888999999999999988
Q ss_pred cchhhhcccceEEEeecccccCCCCCCcccccCCcccccCCCCCCcC
Q 001238 644 LHFLAELQNLVVLNVSHNNFSGRVPDTPFFAKLPLSVLSGNPSLCFS 690 (1117)
Q Consensus 644 ~~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gN~~~c~~ 690 (1117)
++..+-...++.+++..|.+++..|.. +.......+..|...|..
T Consensus 142 ~~~~~~~~~l~~~~l~~~~~~c~~p~~--l~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 142 CHLAWFAEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp GGGHHHHHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCCC
T ss_pred cchHHHhhhhhhhcccCCCeEeCCChh--hcCCEeeecCHhhCcCCC
Confidence 765443445777888899998877753 556666778888888854
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=1.7e-17 Score=170.24 Aligned_cols=179 Identities=28% Similarity=0.377 Sum_probs=101.8
Q ss_pred ceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCC
Q 001238 462 IRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDN 541 (1117)
Q Consensus 462 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 541 (1117)
..+.++.+.+++.++ ...+.++++|++++|.++.. ..+..+++|++|++++|+|++..+ +.++++|+.|++++|
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence 334444444443321 23345555555555555532 234555555555555555554322 555555555555555
Q ss_pred cCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCcc
Q 001238 542 SVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELP 621 (1117)
Q Consensus 542 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p 621 (1117)
.+..+. .+.++++|+.|++++|.+... ..+..+++|+.|++++|+++ .+| .+..++.+ +.|++++|++++..
T Consensus 95 ~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L-~~L~l~~n~l~~l~- 166 (199)
T d2omxa2 95 QIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSL-QQLNFSSNQVTDLK- 166 (199)
T ss_dssp CCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTC-SEEECCSSCCCCCG-
T ss_pred cccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccc-cccccccccccCCc-
Confidence 555443 255566666666666665532 23556666666666666665 233 35555555 56666666665432
Q ss_pred ccccCCCCccEEeccCccccCCcchhhhcccceEE
Q 001238 622 AELTGLNKLGILDLSHNELSGDLHFLAELQNLVVL 656 (1117)
Q Consensus 622 ~~l~~l~~L~~LdLs~N~l~~~~~~l~~l~~L~~L 656 (1117)
.+.++++|+.||+++|+++. ++.+..+++|++|
T Consensus 167 -~l~~l~~L~~L~ls~N~i~~-i~~l~~L~~L~~L 199 (199)
T d2omxa2 167 -PLANLTTLERLDISSNKVSD-ISVLAKLTNLESL 199 (199)
T ss_dssp -GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCSEE
T ss_pred -cccCCCCCCEEECCCCCCCC-CccccCCCCCCcC
Confidence 36778888888888888774 4567777777765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=2.8e-17 Score=170.13 Aligned_cols=181 Identities=28% Similarity=0.342 Sum_probs=95.5
Q ss_pred eeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCcc
Q 001238 440 LLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSI 519 (1117)
Q Consensus 440 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 519 (1117)
..+..+.+.+.++. ..+.+|++|++++|.+++.. .+..+++|++|+|++|+|++.. .+..+++|++|++++|+|
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 34455555443321 23455555556555555332 2455555555555555555322 244555555555555555
Q ss_pred ccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCCCCcccccccceeEEecccccccccccccc
Q 001238 520 AGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASL 599 (1117)
Q Consensus 520 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l 599 (1117)
++. + .+..+++|+.|++++|.+..+ ..+..++.++.+++++|.+++. ..+
T Consensus 103 ~~l-~-~l~~l~~L~~L~l~~~~~~~~--------------------------~~l~~l~~l~~l~~~~n~l~~~--~~~ 152 (210)
T d1h6ta2 103 KDL-S-SLKDLKKLKSLSLEHNGISDI--------------------------NGLVHLPQLESLYLGNNKITDI--TVL 152 (210)
T ss_dssp CCG-G-GGTTCTTCCEEECTTSCCCCC--------------------------GGGGGCTTCCEEECCSSCCCCC--GGG
T ss_pred ccc-c-ccccccccccccccccccccc--------------------------cccccccccccccccccccccc--ccc
Confidence 532 2 244455555555555544432 2344444555555555554421 123
Q ss_pred CCchhHHHhhcCCCCcccCCccccccCCCCccEEeccCccccCCcchhhhcccceEEEeec
Q 001238 600 GKIPALAIALNLSWNQICGELPAELTGLNKLGILDLSHNELSGDLHFLAELQNLVVLNVSH 660 (1117)
Q Consensus 600 ~~l~~l~~~L~Ls~N~l~~~~p~~l~~l~~L~~LdLs~N~l~~~~~~l~~l~~L~~L~ls~ 660 (1117)
..++++ +.+++++|++++.. .+.++++|+.|||++|+++. ++.+..+++|++|+|++
T Consensus 153 ~~l~~L-~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 153 SRLTKL-DTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209 (210)
T ss_dssp GGCTTC-SEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEE
T ss_pred cccccc-cccccccccccccc--cccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEccC
Confidence 334444 44555555555322 26677788888888888763 55677788888888764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=9.1e-21 Score=222.22 Aligned_cols=196 Identities=15% Similarity=0.093 Sum_probs=102.0
Q ss_pred CCCCCCEEEcCCCcCCC-----CCccccCCCCCcceEecccccccCc----ccccccCCCCCcEEEecCccccCCCCccc
Q 001238 313 NCSQLSIIDISMNSLTG-----SIPQTLGNLTSLQELQLSVNQISGE----IPAQIGNCQRLAQIELDNNQITGAIPSEF 383 (1117)
Q Consensus 313 ~l~~L~~LdLs~N~l~~-----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 383 (1117)
..+.++.+++++|.+.. ..+........|+.|++++|.+... ....+...+.++.+++++|.++......+
T Consensus 224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l 303 (460)
T d1z7xw1 224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 303 (460)
T ss_dssp HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred ccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 34555666666655431 1122233345566666666655422 12223345556666666665542111000
Q ss_pred ccccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcc----cccCCCCCCeeeccCccCCCC----CCCCc
Q 001238 384 GNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPR----GIFQLKKLNKLLLLSNNLSGV----IPPEM 455 (1117)
Q Consensus 384 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~----~~~~~ 455 (1117)
. . .. ......|+.+++++|.++..... .+....+|++|+|++|+|+.. +++.+
T Consensus 304 ~------~----------~l---~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l 364 (460)
T d1z7xw1 304 C------E----------TL---LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGL 364 (460)
T ss_dssp H------H----------HH---TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHH
T ss_pred h------c----------cc---cccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhh
Confidence 0 0 00 01123456666666665532222 222344666666666666432 11222
Q ss_pred -ccccccceeccCCCccccc----CCCCcCCCCCCCEEEccCCcCCCCCCccc----c-cCCCCceEEccCCccccccch
Q 001238 456 -GNCSSLIRFRANSNKLTGF----IPPEIGNLKNLNFLDLGSNRLTGSIPDEI----T-GCRNLTFLDVHSNSIAGNLPA 525 (1117)
Q Consensus 456 -~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~~~~~~ 525 (1117)
...+.|++|+|++|.|++. ++..+..+++|++|+|++|+|+......| . ..+.|+.|++++|.+......
T Consensus 365 ~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~ 444 (460)
T d1z7xw1 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444 (460)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred hcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHH
Confidence 2345677777777777642 33445567888889999888875333332 2 234689999999988765544
Q ss_pred hh
Q 001238 526 GL 527 (1117)
Q Consensus 526 ~~ 527 (1117)
.+
T Consensus 445 ~l 446 (460)
T d1z7xw1 445 RL 446 (460)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=9.5e-17 Score=164.59 Aligned_cols=184 Identities=23% Similarity=0.370 Sum_probs=123.4
Q ss_pred cccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCccccccccee
Q 001238 385 NLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRF 464 (1117)
Q Consensus 385 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 464 (1117)
++.+...+.++.+.+++.+. ...+.++++|++++|.++. + .++..+++|++|++++|+|++..+ ++++++|++|
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L 89 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 89 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence 45566677788887775542 3456788888888888874 3 346677888888888888876433 7777777777
Q ss_pred ccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCC
Q 001238 465 RANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVG 544 (1117)
Q Consensus 465 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~ 544 (1117)
++++|.+.... .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++... ..+..+++|+.|++++|+++
T Consensus 90 ~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 90 LMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp ECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC
T ss_pred ccccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--cccccccccccccccccccc
Confidence 77777776432 367777777777777777643 3466777777777777777642 24666677777777777766
Q ss_pred CCCCCCcCCCccccEEeccccccCCCCCcccccccceeEE
Q 001238 545 GMLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLL 584 (1117)
Q Consensus 545 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 584 (1117)
++. .|+++++|+.|++++|+|++. + .+..+++|+.|
T Consensus 164 ~l~--~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 164 DLK--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred CCc--cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 653 356666666666666666542 2 35555655554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.5e-16 Score=164.59 Aligned_cols=187 Identities=21% Similarity=0.328 Sum_probs=145.2
Q ss_pred ccchHHHHhccccccccCCCCCCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceec
Q 001238 386 LSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFR 465 (1117)
Q Consensus 386 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 465 (1117)
+.+.....+..+.+++.++. ..+.+|++|++++|.++. ++ .+..+++|++|++++|+|++.. .++.+++|++|+
T Consensus 23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~ 96 (210)
T d1h6ta2 23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLF 96 (210)
T ss_dssp HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCccccccc
Confidence 45566667777777765542 356788899999998884 33 4777889999999999988653 367888899999
Q ss_pred cCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCC
Q 001238 466 ANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGG 545 (1117)
Q Consensus 466 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~ 545 (1117)
+++|++++. + .+.++++|+.|++++|.+.. ...+..+++++.+++++|.+++. ..+..+++|+.+++++|++++
T Consensus 97 l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 97 LDENKVKDL-S-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp CCSSCCCCG-G-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred ccccccccc-c-cccccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccc
Confidence 999988854 3 58888899999999998863 34688888999999999988753 356778888888888888887
Q ss_pred CCCCCcCCCccccEEeccccccCCCCCcccccccceeEEeccc
Q 001238 546 MLSPDLGSLSSLTKLVLNKNRFAGSIPSQLGSCVKLQLLDLSS 588 (1117)
Q Consensus 546 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 588 (1117)
+. .+.++++|++|+|++|+|++ ++ .+..+++|+.|+|++
T Consensus 171 i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 171 IV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 64 37788888888888888874 33 578888888888864
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=4.5e-16 Score=168.98 Aligned_cols=93 Identities=18% Similarity=0.160 Sum_probs=49.2
Q ss_pred CCCCCCcEEEccCC-cCcccCCcCCCCCCCCCEEEcCCC-cCCCCCccccCCCCCcceEecccccccC-cccccccCCCC
Q 001238 288 GNLKNLVNLFLWQN-NLVGIIPPELGNCSQLSIIDISMN-SLTGSIPQTLGNLTSLQELQLSVNQISG-EIPAQIGNCQR 364 (1117)
Q Consensus 288 ~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~LdLs~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~ 364 (1117)
.++++|++|++++| .+++.....+.++++|++|+|++| .++......++++++|+.|+++++ ++. .+......+++
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~ 250 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPH 250 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTT
T ss_pred cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcc
Confidence 34556666666654 344444455566666666666663 455444445666666777777665 221 22222223444
Q ss_pred CcEEEecCccccCCCCcccc
Q 001238 365 LAQIELDNNQITGAIPSEFG 384 (1117)
Q Consensus 365 L~~L~L~~N~l~~~~p~~~~ 384 (1117)
| .+..++++...+..++
T Consensus 251 L---~i~~~~ls~~~~~~~~ 267 (284)
T d2astb2 251 L---QINCSHFTTIARPTIG 267 (284)
T ss_dssp S---EESCCCSCCTTCSSCS
T ss_pred c---cccCccCCCCCCCccC
Confidence 3 3455666655555444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=8.9e-14 Score=136.31 Aligned_cols=128 Identities=16% Similarity=0.141 Sum_probs=82.0
Q ss_pred CCcccccceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCC
Q 001238 407 ISNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLN 486 (1117)
Q Consensus 407 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 486 (1117)
+.++.++++|+|++|+|+. ++..+..+++|+.|+|++|+|+.. +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 4455667777777777773 555556677777777777777644 3466677777777777777755555556677777
Q ss_pred EEEccCCcCCCCCC-cccccCCCCceEEccCCcccccc---chhhhccccccccc
Q 001238 487 FLDLGSNRLTGSIP-DEITGCRNLTFLDVHSNSIAGNL---PAGLHQLVRLQFAD 537 (1117)
Q Consensus 487 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~ 537 (1117)
.|++++|+|+.... ..+..+++|++|++++|.++... +..+..+++|++||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 77777777764321 35666777777777777776432 12355566666655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.42 E-value=1.1e-13 Score=128.84 Aligned_cols=100 Identities=30% Similarity=0.420 Sum_probs=74.4
Q ss_pred CeEeccCCCCCCCchhhhcccccCcEeeccCCCcCCCCchhhhhhhhhhhhhccCCCcCCCCchhccCCcCCcEEeccCC
Q 001238 101 NRLVLSGTNLTGSIPKEIASLNQLNYLDLSENSLTGEIPRELCSLLRLEQLRLNSNQLEGAIPIQIGNLSSLTQLFLYDN 180 (1117)
Q Consensus 101 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N 180 (1117)
|.|+|++|+++ .++ .++++++|++|||++|+|+ .+|+.++.+++|++|++++|+++ .+| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 46788888887 555 4788888888888888887 67777888888888888888888 455 4788888888888888
Q ss_pred CCCCCCc-ccccCcccchhhhccCCC
Q 001238 181 QLTDAIP-ATIGKLKNLEAIRAGGNK 205 (1117)
Q Consensus 181 ~l~~~~p-~~~~~l~~L~~L~l~~n~ 205 (1117)
+++.... ..++.+++|++|++++|+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCc
Confidence 8875321 345666666666666664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=5.4e-14 Score=137.90 Aligned_cols=128 Identities=18% Similarity=0.122 Sum_probs=62.5
Q ss_pred ccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCc
Q 001238 431 IFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLT 510 (1117)
Q Consensus 431 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 510 (1117)
+.+..++++|+|++|+|+.+ +..+..+++|+.|++++|+|+.. +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 33444555556665555533 33344455555555555555432 2244455555555555555433333344444555
Q ss_pred eEEccCCccccccchhhhcccccccccccCCcCCCCCC-CCcCCCccccEEeccccccCCCC---CcccccccceeEEe
Q 001238 511 FLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS-PDLGSLSSLTKLVLNKNRFAGSI---PSQLGSCVKLQLLD 585 (1117)
Q Consensus 511 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~ 585 (1117)
.|++++|+|+ ++.. ..+..+++|+.|++++|.++... +..+..+++|+.||
T Consensus 91 ~L~L~~N~i~------------------------~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLV------------------------ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCC------------------------CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceecccccc------------------------ccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 5555555444 3321 23445555555666666554321 12355566676666
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=8.1e-15 Score=158.87 Aligned_cols=254 Identities=18% Similarity=0.215 Sum_probs=145.5
Q ss_pred cEEecCCCccCCcCCccCCCCCCCcEEEccCCcCcccCCcCCCCCCCCCEEEcCCCcCCCC-CccccCCCCCcceEeccc
Q 001238 270 QYIYLYENALTGSIPSKLGNLKNLVNLFLWQNNLVGIIPPELGNCSQLSIIDISMNSLTGS-IPQTLGNLTSLQELQLSV 348 (1117)
Q Consensus 270 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~LdLs~N~l~~~-~p~~l~~l~~L~~L~Ls~ 348 (1117)
+.|||+++.+.+.....+.. ..+..+.++...+.... .......+|++||+++|.++.. ++..+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 46888888775332222211 23456666666655332 2334556888888888887643 344567788888888888
Q ss_pred ccccCcccccccCCCCCcEEEecCc-cccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccc-cccCC
Q 001238 349 NQISGEIPAQIGNCQRLAQIELDNN-QITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQN-GLTGP 426 (1117)
Q Consensus 349 N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~ 426 (1117)
|.+++..+..+..+++|++|+++++ .++... ++.+ +..+++|++|+++++ .++..
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~---------l~~l--------------~~~~~~L~~L~ls~c~~~~~~ 137 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA---------LQTL--------------LSSCSRLDELNLSWCFDFTEK 137 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH---------HHHH--------------HHHCTTCCEEECCCCTTCCHH
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccc---------cchh--------------hHHHHhccccccccccccccc
Confidence 8887777777888888888888874 343110 1110 123456666666664 23311
Q ss_pred -CcccccC-CCCCCeeeccCc--cCCCC-CCCCcccccccceeccCCC-cccccCCCCcCCCCCCCEEEccCC-cCCCCC
Q 001238 427 -IPRGIFQ-LKKLNKLLLLSN--NLSGV-IPPEMGNCSSLIRFRANSN-KLTGFIPPEIGNLKNLNFLDLGSN-RLTGSI 499 (1117)
Q Consensus 427 -~p~~~~~-l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~ 499 (1117)
+...+.. .+.|+.|+++++ .++.. +...+.++++|++|++++| .+++.....+..+++|++|+|++| .+++..
T Consensus 138 ~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~ 217 (284)
T d2astb2 138 HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET 217 (284)
T ss_dssp HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGG
T ss_pred cchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHH
Confidence 1122222 356777777653 23221 1112245667777777664 466566666777777888888773 566555
Q ss_pred CcccccCCCCceEEccCCcccc-ccchhhhcccccccccccCCcCCCCCCCCcC
Q 001238 500 PDEITGCRNLTFLDVHSNSIAG-NLPAGLHQLVRLQFADLSDNSVGGMLSPDLG 552 (1117)
Q Consensus 500 p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~ 552 (1117)
...+..+++|+.|+++++ +.. .+......+++ |++..+.++.+..+.++
T Consensus 218 l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~---L~i~~~~ls~~~~~~~~ 267 (284)
T d2astb2 218 LLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPH---LQINCSHFTTIARPTIG 267 (284)
T ss_dssp GGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTT---SEESCCCSCCTTCSSCS
T ss_pred HHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcc---ccccCccCCCCCCCccC
Confidence 566777777888887776 332 12222223333 33455555555444443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.40 E-value=9.1e-15 Score=163.68 Aligned_cols=224 Identities=17% Similarity=0.174 Sum_probs=116.0
Q ss_pred CCCCCCCcEEEccCCcCccc----CCcCCCCCCCCCEEEcCCCcCCCC----------CccccCCCCCcceEeccccccc
Q 001238 287 LGNLKNLVNLFLWQNNLVGI----IPPELGNCSQLSIIDISMNSLTGS----------IPQTLGNLTSLQELQLSVNQIS 352 (1117)
Q Consensus 287 l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~LdLs~N~l~~~----------~p~~l~~l~~L~~L~Ls~N~l~ 352 (1117)
+.+...|++|+|++|.+... +...+...++|+.|+++++..... +...+...++|++|+|++|.+.
T Consensus 27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 106 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 106 (344)
T ss_dssp HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred HhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccc
Confidence 33344455555555544321 222344555556666555443311 1123455677777777777776
Q ss_pred Cc----ccccccCCCCCcEEEecCccccCCCCcccccccchHHHHhccccccccCCCCCCcccccceeecccccccCC--
Q 001238 353 GE----IPAQIGNCQRLAQIELDNNQITGAIPSEFGNLSNLTLLFVWHNRLEGEIPPSISNCQNLEAVDLSQNGLTGP-- 426 (1117)
Q Consensus 353 ~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-- 426 (1117)
.. +...+..+++|++|++++|.+.......++ ..+..+...... ...+.|+.+++++|.++..
T Consensus 107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~~~~~~~---------~~~~~L~~l~l~~n~i~~~~~ 175 (344)
T d2ca6a1 107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVNKKA---------KNAPPLRSIICGRNRLENGSM 175 (344)
T ss_dssp TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHHHHHHHH---------HTCCCCCEEECCSSCCTGGGH
T ss_pred cccccchhhhhcccccchheeccccccccccccccc--cccccccccccc---------ccCcccceeeccccccccccc
Confidence 53 233445667788888888876522111111 123333222211 1235677888888877632
Q ss_pred --CcccccCCCCCCeeeccCccCCCC-----CCCCcccccccceeccCCCccccc----CCCCcCCCCCCCEEEccCCcC
Q 001238 427 --IPRGIFQLKKLNKLLLLSNNLSGV-----IPPEMGNCSSLIRFRANSNKLTGF----IPPEIGNLKNLNFLDLGSNRL 495 (1117)
Q Consensus 427 --~p~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l 495 (1117)
+...+...+.|++|+|++|+|... +...+..++.|+.|++++|.++.. +...+..+++|++|+|++|.|
T Consensus 176 ~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i 255 (344)
T d2ca6a1 176 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 255 (344)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred ccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCcc
Confidence 222334566777777777776532 223445556666666666665432 223345556666666666666
Q ss_pred CCCCCccc----cc--CCCCceEEccCCcccc
Q 001238 496 TGSIPDEI----TG--CRNLTFLDVHSNSIAG 521 (1117)
Q Consensus 496 ~~~~p~~~----~~--l~~L~~L~Ls~N~l~~ 521 (1117)
++.....+ .. ...|++|++++|+|+.
T Consensus 256 ~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~ 287 (344)
T d2ca6a1 256 SARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 287 (344)
T ss_dssp CHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred CchhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence 53222222 11 2446666666666553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.38 E-value=4.5e-15 Score=166.23 Aligned_cols=139 Identities=22% Similarity=0.226 Sum_probs=68.3
Q ss_pred CCCCceEEccCCccccc----cchhhhcccccccccccCCcCCCC-----CCCCcCCCccccEEeccccccCCC----CC
Q 001238 506 CRNLTFLDVHSNSIAGN----LPAGLHQLVRLQFADLSDNSVGGM-----LSPDLGSLSSLTKLVLNKNRFAGS----IP 572 (1117)
Q Consensus 506 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~~ 572 (1117)
.+.|+.|++++|.+... +...+.....|+.|++++|.|+.. ....+..+++|+.|+|++|.++.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 34455555555554422 122233444555555555554321 112344445555555555555421 22
Q ss_pred cccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCcccccc--CCCCccEEeccCccccCCc-----c
Q 001238 573 SQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELPAELT--GLNKLGILDLSHNELSGDL-----H 645 (1117)
Q Consensus 573 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p~~l~--~l~~L~~LdLs~N~l~~~~-----~ 645 (1117)
..+..+++|++|+|++|.|++.-... +-..+. ....|+.||+++|+++.+. .
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~---------------------l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~ 295 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSARGAAA---------------------VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 295 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHH---------------------HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHH
T ss_pred ccccccccchhhhhhcCccCchhhHH---------------------HHHHhhhccCCCCCEEECCCCcCChHHHHHHHH
Confidence 33445555666666666554321111 111122 2345778888888776421 1
Q ss_pred hhh-hcccceEEEeecccccC
Q 001238 646 FLA-ELQNLVVLNVSHNNFSG 665 (1117)
Q Consensus 646 ~l~-~l~~L~~L~ls~N~l~~ 665 (1117)
.+. .+++|+.|+|++|++..
T Consensus 296 ~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 296 VIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHCTTCCEEECTTSBSCT
T ss_pred HHHccCCCCCEEECCCCcCCC
Confidence 132 45678888888888764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.37 E-value=1e-12 Score=122.16 Aligned_cols=103 Identities=28% Similarity=0.400 Sum_probs=67.7
Q ss_pred ceeecccccccCCCcccccCCCCCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCC
Q 001238 414 EAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN 493 (1117)
Q Consensus 414 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 493 (1117)
+.|+|++|+++ .++ .+..+++|++|++++|+|+. +|+.|+.+++|+.|++++|+|++. | .++.+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 35677777776 343 36666777777777777763 455666677777777777777643 2 4677777777777777
Q ss_pred cCCCCC-CcccccCCCCceEEccCCcccc
Q 001238 494 RLTGSI-PDEITGCRNLTFLDVHSNSIAG 521 (1117)
Q Consensus 494 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~ 521 (1117)
+|+... ...+..+++|+.|++++|.++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 776432 2456677777777777777753
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=1.9e-11 Score=118.49 Aligned_cols=111 Identities=14% Similarity=0.123 Sum_probs=92.4
Q ss_pred CcccccceeecccccccCCCcccccCCCCCCeeeccCc-cCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCC
Q 001238 408 SNCQNLEAVDLSQNGLTGPIPRGIFQLKKLNKLLLLSN-NLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLN 486 (1117)
Q Consensus 408 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 486 (1117)
+.+...+.++++++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|++++|+|+.+.+..|..+++|+
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 34556677888888888 57888888899999999766 48887788899999999999999999988888899999999
Q ss_pred EEEccCCcCCCCCCcccccCCCCceEEccCCccc
Q 001238 487 FLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIA 520 (1117)
Q Consensus 487 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 520 (1117)
+|+|++|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 84 ~L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 84 RLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp EEECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ceeccCCCCcccChhhhccc-cccccccCCCccc
Confidence 99999999996555555544 6999999999886
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=8.6e-12 Score=121.02 Aligned_cols=107 Identities=21% Similarity=0.187 Sum_probs=65.3
Q ss_pred ccceeccCCCcccccCCCCcCCCCCCCEEEccCC-cCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccc
Q 001238 460 SLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSN-RLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADL 538 (1117)
Q Consensus 460 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 538 (1117)
....++.+++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|+.|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3444555555555 33455666666667776544 366555566666666777777777666666666666666666666
Q ss_pred cCCcCCCCCCCCcCCCccccEEeccccccC
Q 001238 539 SDNSVGGMLSPDLGSLSSLTKLVLNKNRFA 568 (1117)
Q Consensus 539 s~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 568 (1117)
++|+|+.++...|..+ +|+.|+|++|.+.
T Consensus 88 s~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 88 SFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred cCCCCcccChhhhccc-cccccccCCCccc
Confidence 6666666665555443 4666666666553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.22 E-value=2.9e-13 Score=137.50 Aligned_cols=143 Identities=22% Similarity=0.250 Sum_probs=79.0
Q ss_pred CCCEEEccCC--cCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCCCCcCCCccccEEe
Q 001238 484 NLNFLDLGSN--RLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLV 561 (1117)
Q Consensus 484 ~L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 561 (1117)
.++.++++++ .+. .++..+..+++|++|+|++|+|+.+ + .|..+++|+.|++++|.|+.++ ..+..+++|+.|+
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i~-~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKIE-NLDAVADTLEELW 99 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSCS-SHHHHHHHCCEEE
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccccc-ccccccccccccc
Confidence 3455555543 233 3445666666777777777766643 2 3566666666666666665442 1222234455555
Q ss_pred ccccccCCCCCcccccccceeEEeccccccccccccccCCchhHHHhhcCCCCcccCCcc-ccccCCCCccEEeccCccc
Q 001238 562 LNKNRFAGSIPSQLGSCVKLQLLDLSSNQLSGNIPASLGKIPALAIALNLSWNQICGELP-AELTGLNKLGILDLSHNEL 640 (1117)
Q Consensus 562 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~l~~~L~Ls~N~l~~~~p-~~l~~l~~L~~LdLs~N~l 640 (1117)
+++|+|+.. ..+..+++|+.|++++|+++ .... ..+..+++|+.|+|++|++
T Consensus 100 l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~-------------------------~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 100 ISYNQIASL--SGIEKLVNLRVLYMSNNKIT-------------------------NWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp CSEEECCCH--HHHHHHHHSSEEEESEEECC-------------------------CHHHHHHHTTTTTCSEEEECSSHH
T ss_pred ccccccccc--ccccccccccccccccchhc-------------------------cccccccccCCCccceeecCCCcc
Confidence 555555421 22444455555555555544 2111 3467778888888888887
Q ss_pred cCCcch-----------hhhcccceEEE
Q 001238 641 SGDLHF-----------LAELQNLVVLN 657 (1117)
Q Consensus 641 ~~~~~~-----------l~~l~~L~~L~ 657 (1117)
....+. +..+++|+.||
T Consensus 153 ~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 153 YNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 653221 45677777776
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.19 E-value=1.4e-13 Score=139.96 Aligned_cols=87 Identities=28% Similarity=0.371 Sum_probs=38.9
Q ss_pred cCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCccccccchhhhcccccccccccCCcCCCCCC-CCcCCCccc
Q 001238 479 IGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAGNLPAGLHQLVRLQFADLSDNSVGGMLS-PDLGSLSSL 557 (1117)
Q Consensus 479 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~~-~~~~~l~~L 557 (1117)
+..+++|+.|+|++|+|+ .+|..+..+++|++|++++|+|+.. ..+..+++|+.|++++|+|+++.. ..|..+++|
T Consensus 66 l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L 142 (198)
T d1m9la_ 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142 (198)
T ss_dssp HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTC
T ss_pred ccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccccccccccccchhccccccccccCCCcc
Confidence 334444444444444444 2233333333444444444444432 224444445555555554444322 234455555
Q ss_pred cEEeccccccC
Q 001238 558 TKLVLNKNRFA 568 (1117)
Q Consensus 558 ~~L~L~~N~l~ 568 (1117)
+.|+|++|++.
T Consensus 143 ~~L~L~~N~l~ 153 (198)
T d1m9la_ 143 EDLLLAGNPLY 153 (198)
T ss_dssp SEEEECSSHHH
T ss_pred ceeecCCCccc
Confidence 55555555554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=2.7e-07 Score=97.36 Aligned_cols=149 Identities=15% Similarity=0.054 Sum_probs=105.3
Q ss_pred hHHHhccCCCCCCeeeecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceE
Q 001238 770 SIGDATRSLTAGNIIGQGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKL 848 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 848 (1117)
++...-..|++.+..+-++.+.||++.. +++.+++|+...........+.+|++.+..+. +--+++++.++.+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444445666655544445578999875 55677888887655445557889999988774 444678888888888899
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhccC---------------------------------
Q 001238 849 LFYDYMPNGTLGMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHDC--------------------------------- 895 (1117)
Q Consensus 849 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------- 895 (1117)
+||++++|.++.+..... .....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998886654321 112335566677777777531
Q ss_pred -----------------------CCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 896 -----------------------VPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 896 -----------------------~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
.+.++|+|+.|.||++++++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12489999999999999876677999998763
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=1.2e-08 Score=99.18 Aligned_cols=103 Identities=18% Similarity=0.133 Sum_probs=44.4
Q ss_pred CCCeeeccCccCCCCCCCCcccccccceeccCCCcccccCCCCcCCCCCCCEEEccCCcCCCCC--CcccccCCCCceEE
Q 001238 436 KLNKLLLLSNNLSGVIPPEMGNCSSLIRFRANSNKLTGFIPPEIGNLKNLNFLDLGSNRLTGSI--PDEITGCRNLTFLD 513 (1117)
Q Consensus 436 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~ 513 (1117)
..+.|++++++.. ..+..+..+..+...+|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3445565554422 12333333333443333322 22223344555666666666665332 22344455555555
Q ss_pred ccCCccccccchhhhcccccccccccCCcC
Q 001238 514 VHSNSIAGNLPAGLHQLVRLQFADLSDNSV 543 (1117)
Q Consensus 514 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i 543 (1117)
|++|.|+...+-.+....+|+.+++++|.+
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl 127 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSL 127 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTT
T ss_pred cccCccccchhhhhhhccccceeecCCCCc
Confidence 555555543332222233344444444443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=5.7e-08 Score=94.16 Aligned_cols=66 Identities=21% Similarity=0.237 Sum_probs=29.3
Q ss_pred ccccccceeccCCCcccccC--CCCcCCCCCCCEEEccCCcCCCCCCcccccCCCCceEEccCCcccc
Q 001238 456 GNCSSLIRFRANSNKLTGFI--PPEIGNLKNLNFLDLGSNRLTGSIPDEITGCRNLTFLDVHSNSIAG 521 (1117)
Q Consensus 456 ~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 521 (1117)
..++.|++|++++|+|+... +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|.+..
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 34445555555555554321 1223344555555555555543322222233345555555555443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.07 E-value=5.6e-06 Score=86.39 Aligned_cols=131 Identities=18% Similarity=0.104 Sum_probs=90.7
Q ss_pred eeeecCC-eEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCC--CCcceEEeeeecCCceEEEEEecCCCCh
Q 001238 783 IIGQGRS-GIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRH--RNIVRLLGWGANRKTKLLFYDYMPNGTL 859 (1117)
Q Consensus 783 ~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL 859 (1117)
.+..|.. +.||+....++..+++|...... ...+.+|++.++.+.. -.+++++.++.+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455554 68999998788889999865443 3457889998888743 3467788888888889999999998765
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhcc---------------------------------------------
Q 001238 860 GMLLHDGECAGLLEWDTRFKIALGVAEGLSYLHHD--------------------------------------------- 894 (1117)
Q Consensus 860 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------- 894 (1117)
.... ... ...+.++++.++.||+.
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4311 111 11223444444444431
Q ss_pred ----------CCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 895 ----------CVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 895 ----------~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
..+.++|+|+.|.||+++++..+.|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 113589999999999999876677999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.47 E-value=0.00018 Score=79.66 Aligned_cols=75 Identities=13% Similarity=0.140 Sum_probs=50.6
Q ss_pred CeeeecCCeEEEEEEcCC-CcEEEEEEeecC-------CccchHHHHHHHHHHhccC-C--CCcceEEeeeecCCceEEE
Q 001238 782 NIIGQGRSGIVYKVTLPS-GLTVAVKRFRAS-------DKISTGAFSSEIATLSRIR-H--RNIVRLLGWGANRKTKLLF 850 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lv 850 (1117)
+.||.|....||++...+ ++.|+||.-... -....++...|++.++.+. + ..+++++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 678999965321 1223456677998888773 3 346666654 44566899
Q ss_pred EEecCCCC
Q 001238 851 YDYMPNGT 858 (1117)
Q Consensus 851 ~e~~~~gs 858 (1117)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.35 E-value=2.4e-05 Score=75.51 Aligned_cols=114 Identities=17% Similarity=0.156 Sum_probs=55.4
Q ss_pred ccccceeccCCC-ccccc----CCCCcCCCCCCCEEEccCCcCCCC----CCcccccCCCCceEEccCCccccccchhhh
Q 001238 458 CSSLIRFRANSN-KLTGF----IPPEIGNLKNLNFLDLGSNRLTGS----IPDEITGCRNLTFLDVHSNSIAGNLPAGLH 528 (1117)
Q Consensus 458 l~~L~~L~l~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 528 (1117)
.+.|++|+|+++ .++.. +...+...+.|++|+|++|.+... +...+...+.|++|+|++|.|+......+.
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 355566666542 34321 112334445555555555555421 112233445555555555555432111111
Q ss_pred cccccccccccCCcCCCCCCCCcCCCccccEEeccccccCCC-------CCcccccccceeEEecccccc
Q 001238 529 QLVRLQFADLSDNSVGGMLSPDLGSLSSLTKLVLNKNRFAGS-------IPSQLGSCVKLQLLDLSSNQL 591 (1117)
Q Consensus 529 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~Ls~N~l 591 (1117)
.++...++|++|++++|++... +...+...+.|+.|+++.+..
T Consensus 94 --------------------~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 94 --------------------RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp --------------------HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred --------------------HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 1233345566667766655432 234455667888888877654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.21 E-value=4.1e-05 Score=73.75 Aligned_cols=109 Identities=12% Similarity=0.069 Sum_probs=74.7
Q ss_pred CCCCCCeeeccCc-cCCCC----CCCCcccccccceeccCCCcccccCCC----CcCCCCCCCEEEccCCcCCCCC----
Q 001238 433 QLKKLNKLLLLSN-NLSGV----IPPEMGNCSSLIRFRANSNKLTGFIPP----EIGNLKNLNFLDLGSNRLTGSI---- 499 (1117)
Q Consensus 433 ~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~---- 499 (1117)
+.++|++|+|+++ .++.. +...+...+.|++|++++|.+...... .+...+.|++|+|++|.|+...
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4578999999974 46532 223466778999999999999754333 3445689999999999997532
Q ss_pred CcccccCCCCceEEccCCccccc-------cchhhhcccccccccccCC
Q 001238 500 PDEITGCRNLTFLDVHSNSIAGN-------LPAGLHQLVRLQFADLSDN 541 (1117)
Q Consensus 500 p~~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~Ls~N 541 (1117)
-..+...+.|++|+|++|.+... +...+...+.|+.|+++.+
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 23456678899999999876643 2233344455555554443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.08 E-value=0.0011 Score=71.02 Aligned_cols=136 Identities=13% Similarity=0.118 Sum_probs=80.0
Q ss_pred CeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCc--ceEEe-----eeecCCceEEEEEecCCCChhh
Q 001238 789 SGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNI--VRLLG-----WGANRKTKLLFYDYMPNGTLGM 861 (1117)
Q Consensus 789 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~~ 861 (1117)
--.||++..++|+.|++|+.+.. ..+.+++..|.+.+..+....+ +..+. .....+..+.+++|++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35899999989999999998754 3356778899999888853332 11111 2234566788999998754321
Q ss_pred -----------hh-------cCCC--CCCCCCH-------------------HHHHHHHHHHHHHHHHHh----ccCCCc
Q 001238 862 -----------LL-------HDGE--CAGLLEW-------------------DTRFKIALGVAEGLSYLH----HDCVPA 898 (1117)
Q Consensus 862 -----------~l-------~~~~--~~~~l~~-------------------~~~~~i~~~i~~~L~~LH----~~~~~~ 898 (1117)
.+ .... .....++ ..+..+...+.+.++.+. +....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 0000 0011111 111112222222333332 223457
Q ss_pred eeeeccccCeEEEcCCCcceecccccccc
Q 001238 899 ILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 899 ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
+||+|+.+.||+++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 35789998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.47 E-value=0.0059 Score=67.09 Aligned_cols=72 Identities=15% Similarity=0.203 Sum_probs=50.3
Q ss_pred CeeeecCCeEEEEEEcCC--------CcEEEEEEeecCCccchHHHHHHHHHHhccC-CCCcceEEeeeecCCceEEEEE
Q 001238 782 NIIGQGRSGIVYKVTLPS--------GLTVAVKRFRASDKISTGAFSSEIATLSRIR-HRNIVRLLGWGANRKTKLLFYD 852 (1117)
Q Consensus 782 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e 852 (1117)
+.|+.|-.-.+|++..++ .+.|.+++.-. ....-...+|.++++.+. +.-.+++++++.+ +.|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 568888889999998543 35677777652 223345678999999884 4445678887653 68999
Q ss_pred ecCCCCh
Q 001238 853 YMPNGTL 859 (1117)
Q Consensus 853 ~~~~gsL 859 (1117)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.44 E-value=0.00018 Score=69.05 Aligned_cols=41 Identities=20% Similarity=0.182 Sum_probs=23.2
Q ss_pred CCCccccEEec--cccccCC----CCCcccccccceeEEeccccccc
Q 001238 552 GSLSSLTKLVL--NKNRFAG----SIPSQLGSCVKLQLLDLSSNQLS 592 (1117)
Q Consensus 552 ~~l~~L~~L~L--~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~ 592 (1117)
...++|+.++| ++|.+.. .+...+...++|+.|+++.|...
T Consensus 99 ~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 99 QSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp GGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 33455554333 4555543 23344556788888888776543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.99 E-value=0.00042 Score=66.30 Aligned_cols=86 Identities=19% Similarity=0.196 Sum_probs=38.8
Q ss_pred CCCCCCEEEccCCcCCCCC----CcccccCCCCceEEccCCccccc----cchhhhccccccc--ccccCCcCCCCCC--
Q 001238 481 NLKNLNFLDLGSNRLTGSI----PDEITGCRNLTFLDVHSNSIAGN----LPAGLHQLVRLQF--ADLSDNSVGGMLS-- 548 (1117)
Q Consensus 481 ~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~--L~Ls~N~i~~~~~-- 548 (1117)
..+.|++|+|++|.++... -..+...+.++.|++++|.+... +...+...+.|+. |++++|.+++...
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 4445555555555554221 11233445555555555555432 1223344445543 3334444443211
Q ss_pred --CCcCCCccccEEeccccc
Q 001238 549 --PDLGSLSSLTKLVLNKNR 566 (1117)
Q Consensus 549 --~~~~~l~~L~~L~L~~N~ 566 (1117)
..+...++|++|+++.+.
T Consensus 124 La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCCCcCEEeCcCCC
Confidence 122344566677666554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.79 E-value=0.014 Score=61.66 Aligned_cols=155 Identities=12% Similarity=0.072 Sum_probs=83.3
Q ss_pred hHHHhccCCCCCCeee-----ecCCeEEEEEEcCCCcEEEEEEeecCCccchHHHHHHHHHHhccCCCCc--ceEEe---
Q 001238 770 SIGDATRSLTAGNIIG-----QGRSGIVYKVTLPSGLTVAVKRFRASDKISTGAFSSEIATLSRIRHRNI--VRLLG--- 839 (1117)
Q Consensus 770 ~~~~~~~~~~~~~~lg-----~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~--- 839 (1117)
++.....+|.+++... .|---+.|+++..+|+ +++|++.... ..+++..|++++..+...++ +..+.
T Consensus 7 el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 7 ELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp HHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred HHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecC
Confidence 4555566777765543 4555788999876664 8899886432 33466778888877743322 22111
Q ss_pred ---eeecCCceEEEEEecCCCChhhhh--------------c----CCC--CCCCCC------------------HHHHH
Q 001238 840 ---WGANRKTKLLFYDYMPNGTLGMLL--------------H----DGE--CAGLLE------------------WDTRF 878 (1117)
Q Consensus 840 ---~~~~~~~~~lv~e~~~~gsL~~~l--------------~----~~~--~~~~l~------------------~~~~~ 878 (1117)
+....+....++.+..+......- + ... ...... .....
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence 122234556777777665332100 0 000 000000 00111
Q ss_pred HHHHHHHHHHHHHhc-cCCCceeeeccccCeEEEcCCCcceecccccccc
Q 001238 879 KIALGVAEGLSYLHH-DCVPAILHRDVKSHNILLGERYESCLADFGLARL 927 (1117)
Q Consensus 879 ~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~Nill~~~~~~kl~DfGla~~ 927 (1117)
..+......+...+. ....++||+|+.+.||+++++...-++||+.+..
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 222222233333322 1234899999999999999887778999998853
|